PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nookala, AR; Li, JH; Ande, A; Wang, L; Vaidya, NK; Li, WH; Kumar, S; Kumar, A				Nookala, Anantha R.; Li, Junhao; Ande, Anusha; Wang, Lei; Vaidya, Naveen K.; Li, Weihua; Kumar, Santosh; Kumar, Anil			Effect of Methamphetamine on Spectral Binding, Ligand Docking and Metabolism of Anti-HIV Drugs with CYP3A4	PLOS ONE			English	Article							PROTEASE INHIBITORS; CYTOCHROMES P450; ANTIRETROVIRAL DRUGS; FLEXIBILITY; INFECTION; ENZYMES; SITE	Cytochrome P450 3A4 (CYP3A4) is the major drug metabolic enzyme, and is involved in the metabolism of antiretroviral drugs, especially protease inhibitors (PIs). This study was undertaken to examine the effect of methamphetamine on the binding and metabolism of PIs with CYP3A4. We showed that methamphetamine exhibits a type I spectral change upon binding to CYP3A4 with delta A(max) and K-D of 0.016 +/- 0.001 and 204 +/- 18 mu M, respectively. Methamphetamine-CYP3A4 docking showed that methamphetamine binds to the heme of CYP3A4 in two modes, both leading to N-demethylation. We then studied the effect of methamphetamine binding on PIs with CYP3A4. Our results showed that methamphetamine alters spectral binding of nelfinavir but not the other type I PIs (lopinavir, atazanavir, tipranavir). The change in spectral binding for nelfinavir was observed at both delta A(max) (0.004 +/- 0.0003 vs. 0.0068 +/- 0.0001) and K-D (1.42 +/- 0.36 vs. 2.93 +/- 0.08 mu M) levels. We further tested effect of methamphetamine on binding of 2 type II PIs; ritonavir and indinavir. Our results showed that methamphetamine alters the ritonavir binding to CYP3A4 by decreasing both the delta A(max) (0.0038 +/- 0.0003 vs. 0.0055 +/- 0.0003) and K-D (0.043 +/- 0.0001 vs. 0.065 +/- 0.001 nM), while indinavir showed only reduced K-D in presence of methamphetamine (0.086 +/- 0.01 vs. 0.174 +/- 0.03 nM). Furthermore, LC-MS/MS studies in high CYP3A4 human liver microsomes showed a decrease in the formation of hydroxy ritonavir in the presence of methamphetamine. Finally, CYP3A4 docking with lopinavir and ritonavir in the absence and presence of methamphetamine showed that methamphetamine alters the docking of ritonavir, which is consistent with the results obtained from spectral binding and metabolism studies. Overall, our results demonstrated differential effects of methamphetamine on the binding and metabolism of PIs with CYP3A4. These findings have clinical implication in terms of drug dose adjustment of antiretroviral medication, especially with ritonavir-boosted antiretroviral therapy, in HIV-1-infected individuals who abuse methamphetamine.	[Nookala, Anantha R.; Ande, Anusha; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA; [Li, Junhao; Wang, Lei; Li, Weihua] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China; [Vaidya, Naveen K.] Univ Missouri, Dept Math & Stat, Kansas City, MO 64110 USA; [Kumar, Santosh] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA	University of Missouri System; University of Missouri Kansas City; East China University of Science & Technology; University of Missouri System; University of Missouri Kansas City; University of Tennessee System; University of Tennessee Health Science Center	Kumar, A (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA.	kumaran@umkc.edu	LI, Weihua/G-7190-2011; Nookala, Anantha Ram/ABV-0636-2022; Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022; Nookala, Anantha Ram/ABT-0475-2022		NIDA/NIH [DA025011, DA 025528]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025011, R01DA025528] Funding Source: NIH RePORTER	NIDA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by grants (DA025011 and DA 025528) from NIDA/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Buchacz K, 2005, AIDS, V19, P1423, DOI 10.1097/01.aids.0000180794.27896.fb; Chiba M, 2001, DRUG METAB DISPOS, V29, P1; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Earla R, 2014, DRUG METAB DISPOS, V42, P2097, DOI 10.1124/dmd.114.059378; Fichtenbaum CJ, 2002, CLIN PHARMACOKINET, V41, P1195, DOI 10.2165/00003088-200241140-00004; Hales G, 2000, ANTIVIR THER, V5, P19; Hirani VN, 2004, DRUG METAB DISPOS, V32, P1462, DOI 10.1124/dmd.104.001743; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kreth KP, 2000, BIOCHEM PHARMACOL, V59, P1563, DOI 10.1016/S0006-2952(00)00284-7; Kumar GN, 1996, J PHARMACOL EXP THER, V277, P423; Kumar S, 2011, ALCOHOL CLIN EXP RES, V35, P2121, DOI 10.1111/j.1530-0277.2011.01575.x; Kumar S, 2010, BIOCHEM BIOPH RES CO, V402, P163, DOI 10.1016/j.bbrc.2010.10.014; Kuwayama K, 2012, J FORENSIC SCI, V57, P1008, DOI 10.1111/j.1556-4029.2011.02039.x; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Meyer MR, 2009, DRUG METAB DISPOS, V37, P1152, DOI 10.1124/dmd.108.026203; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; Negishi M, 1996, FASEB J, V10, P683, DOI 10.1096/fasebj.10.7.8635685; Pal D, 2006, J NEUROIMMUNE PHARM, V1, P323, DOI 10.1007/s11481-006-9034-2; Pal D, 2011, LIFE SCI, V88, P959, DOI 10.1016/j.lfs.2010.09.012; Park M, 2013, J BIOL CHEM, V288, P33324, DOI 10.1074/jbc.M113.483487; Plankey MW, 2007, JAIDS-J ACQ IMM DEF, V45, P85, DOI 10.1097/QAI.0b013e3180417c99; Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109; Sheng YY, 2014, J MOL GRAPH MODEL, V54, P90, DOI 10.1016/j.jmgm.2014.09.005; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Walsky RL, 2004, DRUG METAB DISPOS, V32, P647, DOI 10.1124/dmd.32.6.647; Walubo A, 2007, EXPERT OPIN DRUG MET, V3, P583, DOI 10.1517/17425225.3.4.583; Wang X, 2012, CURR HIV RES, V10, P407, DOI 10.2174/157016212802138797; Welter J, 2013, ANAL BIOANAL CHEM, V405, P3125, DOI 10.1007/s00216-013-6741-4	30	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146529	10.1371/journal.pone.0146529	http://dx.doi.org/10.1371/journal.pone.0146529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741368	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600054
J	Pascual, J; Blanco, S; Garcia-Lopez, M; Garcia-Salamanca, A; Bursakov, SA; Genilloud, O; Bills, GF; Ramos, JL; van Dillewijn, P				Pascual, Javier; Blanco, Silvia; Garcia-Lopez, Marina; Garcia-Salamanca, Adela; Bursakov, Sergey A.; Genilloud, Olga; Bills, Gerald F.; Ramos, Juan L.; van Dillewijn, Pieter			Assessing Bacterial Diversity in the Rhizosphere of Thymus zygis Growing in the Sierra Nevada National Park (Spain) through Culture-Dependent and Independent Approaches	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ELEVATED ATMOSPHERIC CO2; MICROBIAL DIVERSITY; PYROSEQUENCING REVEALS; SEQUENCE-ANALYSIS; DEEP-SEA; SOIL; GENE; ROOTS; RARE	Little is known of the bacterial communities associated with the rhizosphere of wild plant species found in natural settings. The rhizosphere bacterial community associated with wild thyme, Thymus zygis L., plants was analyzed using cultivation, the creation of a near-full length 16S rRNA gene clone library and 454 amplicon pyrosequencing. The bacterial community was dominated by Proteobacteria (mostly Alphaproteobacteria and Betaproteobacteria), Actinobacteria, Acidobacteria, and Gemmatimonadetes. Although each approach gave a different perspective of the bacterial community, all classes/subclasses detected in the clone library and the cultured bacteria could be found in the pyrosequencing datasets. However, an exception caused by inconclusive taxonomic identification as a consequence of the short read length of pyrotags together with the detection of singleton sequences which corresponded to bacterial strains cultivated from the same sample highlight limitations and considerations which should be taken into account when analysing and interpreting amplicon datasets. Amplicon pyrosequencing of replicate rhizosphere soil samples taken a year later permit the definition of the core microbiome associated with Thymus zygis plants. Abundant bacterial families and predicted functional profiles of the core microbiome suggest that themain drivers of the bacterial community in the Thymus zygis rhizosphere are related to the nutrients originating from the plant root and to their participation in biogeochemical cycles thereby creating an intricate relationship with this aromatic plant to allow for a feedback ecological benefit.	[Pascual, Javier; Blanco, Silvia; Garcia-Salamanca, Adela; Bursakov, Sergey A.; Ramos, Juan L.; van Dillewijn, Pieter] CSIC, Estn Expt Zaidin, Granada, Spain; [Pascual, Javier; Garcia-Lopez, Marina; Genilloud, Olga; Bills, Gerald F.] MEDINA Fdn, Ctr Excellence Innovat Med Res, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	van Dillewijn, P (corresponding author), CSIC, Estn Expt Zaidin, Granada, Spain.	pieter.vandillewijn@eez.csic.es	pascual, javier/M-5964-2019; van Dillewijn, Pieter/O-3728-2014; Genilloud, Olga/I-2779-2015; Bursakov, Sergey/AAX-3201-2020	pascual, javier/0000-0002-1900-7099; van Dillewijn, Pieter/0000-0001-7626-0958; Genilloud, Olga/0000-0002-4202-1219; Ramos, Juan L./0000-0002-8731-7435; Bills, Gerald/0000-0003-2352-8417	Spanish Ministry of Economy and Competitiveness [CSD2007-00005, SAF2010-15010, BIO2010-17227]; FEDER funds; Network of National Parks (OAPN) within the Spanish Ministry of Agriculture, Food and the Environment (MAAMA) [590/2012]; Junta de Andalucia [P12-BIO-772]	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds(European Commission); Network of National Parks (OAPN) within the Spanish Ministry of Agriculture, Food and the Environment (MAAMA); Junta de Andalucia(Junta de Andalucia)	This research was supported by the CSD2007-00005, SAF2010-15010 and BIO2010-17227 projects of the Spanish Ministry of Economy and Competitiveness and co-financed with FEDER funds. Additional financial support was obtained from the Network of National Parks (OAPN) within the Spanish Ministry of Agriculture, Food and the Environment (MAAMA) (project 590/2012) and the Junta de Andalucia (project P12-BIO-772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2015, SOIL BIOL BIOCHEM, V80, P70, DOI 10.1016/j.soilbio.2014.09.028; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Basilio A, 2003, J APPL MICROBIOL, V95, P814, DOI 10.1046/j.1365-2672.2003.02049.x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chamorro D, 2013, PLANT ECOL, V214, P1431, DOI 10.1007/s11258-013-0264-0; Cheng M, 2015, CATENA, V124, P77, DOI 10.1016/j.catena.2014.09.006; Coats VC, 2014, MOL ECOL, V23, P1318, DOI 10.1111/mec.12544; Cobo-Diaz JF, 2015, MICROB ECOL, V69, P895, DOI 10.1007/s00248-015-0586-7; Cobo-Diaz JF, 2014, SYST APPL MICROBIOL, V37, P177, DOI 10.1016/j.syapm.2013.09.008; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Davis KER, 2011, ENVIRON MICROBIOL, V13, P798, DOI 10.1111/j.1462-2920.2010.02384.x; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Donn S, 2015, ENVIRON MICROBIOL, V17, P610, DOI 10.1111/1462-2920.12452; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Garcia-Salamanca A, 2013, MICROB BIOTECHNOL, V6, P36, DOI 10.1111/j.1751-7915.2012.00358.x; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jin H, 2014, SYST APPL MICROBIOL, V37, P376, DOI 10.1016/j.syapm.2014.05.001; Jordan MJ, 2009, IND CROP PROD, V29, P145, DOI 10.1016/j.indcrop.2008.04.021; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Koeberl M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00400; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lesaulnier C, 2008, ENVIRON MICROBIOL, V10, P926, DOI 10.1111/j.1462-2920.2007.01512.x; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McGuinness M, 2009, INT J ENV RES PUB HE, V6, P2226, DOI 10.3390/ijerph6082226; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nguyen LM, 2011, J ARID ENVIRON, V75, P917, DOI 10.1016/j.jaridenv.2011.04.028; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramos JL, 2005, CURR OPIN BIOTECH, V16, P275, DOI 10.1016/j.copbio.2005.03.010; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sanchez-Castro I, 2012, MYCORRHIZA, V22, P449, DOI 10.1007/s00572-011-0421-z; Sanchez-Hidalgo M, 2012, ANTON LEEUW INT J G, V102, P361, DOI 10.1007/s10482-012-9746-7; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sotomayor JA, 2004, J AGR FOOD CHEM, V52, P5418, DOI 10.1021/jf0496245; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Tian YQ, 2014, MICROB ECOL, V68, P794, DOI 10.1007/s00248-014-0461-y; Torres-Cortes G, 2012, PLANT SOIL, V357, P275, DOI 10.1007/s11104-012-1152-4; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watt M, 2006, ENVIRON MICROBIOL, V8, P871, DOI 10.1111/j.1462-2920.2005.00973.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Winston ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099641; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	68	33	33	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146558	10.1371/journal.pone.0146558	http://dx.doi.org/10.1371/journal.pone.0146558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741495	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600055
J	Puchner, R; Edlinger, M; Mur, E; Eberl, G; Herold, M; Kufner, P; Puchner, A; Puchner, SE; Redlich, K; Alkin, A; Machold, K				Puchner, Rudolf; Edlinger, Michael; Mur, Erich; Eberl, Gabriele; Herold, Manfred; Kufner, Peter; Puchner, Antonia; Puchner, Stephan E.; Redlich, Kurt; Alkin, Alois; Machold, Klaus			Interface Management between General Practitioners and Rheumatologists-Results of a Survey Defining a Concept for Future Joint Recommendations	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; RHEUMATOID-ARTHRITIS; JOB-SATISFACTION; STRATEGIES; REFERRALS; QUALITY; ACCESS; COHORT; IMPACT; DELAYS	Objective To measure the views of general practitioners (GPs) and rheumatologists in a nationwide evaluation, so as to optimise their cooperation in managing patients with inflammatory rheumatic diseases. Methods A questionnaire covering aspects of collaboration was sent, both by mail and/or by email, to all GPs and rheumatologists in Austria. Topics covered were (i) examinations and interventions to be performed before referral, (ii) the spectrum of diseases to be referred, and (iii) the role of GPs in follow-up and continuous management of patients. Results 1,229 GPs of the 4,016 GPs (31%) and 110 of the 180 rheumatologists (61%) responded to the questionnaire. In cases of suspected arthritis, 99% of the GPs and 92% of the rheumatologists recommended specific laboratory tests, and 92% and 70%, respectively, recommended X-rays of affected joints before referral. Rheumatoid arthritis and spondyloarthritis, psoriatic arthritis and connective tissue disease were unanimously seen as indications for referral to a rheumatologist. Only 12% of rheumatologists felt responsible for the treatment of hand osteoarthritis and fibromyalgia. 80% of GPs and 85% of rheumatologists were of the opinion that treatment with disease-modifying drugs should be initiated by a specialist. Subsequent drug prescription and administration by GPs was supported by a majority of GPs and rheumatologists, with a concomitant rheumatologist follow-up every three to six months. Conclusion The considerable consensus between the two professional groups constitutes a solid base for future joint recommendations, with the aim to accelerate the diagnostic process and the initiation of adequate therapy.	[Puchner, Rudolf] Rheumatol Practise Dr Puchner, Wels, Austria; [Edlinger, Michael] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Mur, Erich; Herold, Manfred] Med Univ Innsbruck, Dept Internal Med 1, A-6020 Innsbruck, Austria; [Eberl, Gabriele] Klinikum Malcherhof Baden, Baden Bei Wien, Switzerland; [Kufner, Peter] Private Practise Dr Kufner, Innsbruck, Austria; [Puchner, Antonia; Redlich, Kurt; Machold, Klaus] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria; [Puchner, Stephan E.] Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria; [Alkin, Alois] Ctr Excellence Med, Linz, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Vienna; Medical University of Vienna	Puchner, R (corresponding author), Rheumatol Practise Dr Puchner, Wels, Austria.	rudolf.puchner@cc-net.at		Machold, Klaus/0000-0002-9551-1975; Edlinger, Michael/0000-0001-8801-3268	Pfizer Austria [WP387446]; Austrian Medical Association; Austrian Society for General Practice and Family Medicine	Pfizer Austria(Pfizer); Austrian Medical Association; Austrian Society for General Practice and Family Medicine	This project was supported by an unrestricted educational grant (to the Austrian Society of Rheumatology and Rehabilitation) from Pfizer Austria Grand number: WP387446, www.pfizermed.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank the Austrian Medical Association and the Austrian Society for General Practice and Family Medicine for their promotion and support.	Behmann M, 2012, DTSCH ARZTEBL INT, V109, P193, DOI 10.3238/arztebl.2012.0193; Bernatsky S, 2010, CLIN RHEUMATOL, V29, P645, DOI 10.1007/s10067-010-1383-9; Bykerk V, 2010, ARTHRITIS RHEUM-US, V62, P3519, DOI 10.1002/art.27691; Emery P, 2002, ANN RHEUM DIS, V61, P290, DOI 10.1136/ard.61.4.290; Fautrel B, 2010, RHEUMATOLOGY, V49, P147, DOI 10.1093/rheumatology/kep340; Gartner M, 2012, ANN RHEUM DIS, V71, P363, DOI 10.1136/annrheumdis-2011-200315; Goetz K, 2013, FAM MED, V45, P95; Grimshaw JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471; Harrington T, 2008, J RHEUMATOL, V35, P1233; Pham T, 2011, JOINT BONE SPINE, V78, P15, DOI 10.1016/S1297-319X(11)70001-X; Puchner R, 2014, WIEN KLIN WOCHENSCHR, V126, pS227, DOI [10.1007/s00508-014-0671-9, DOI 10.1007/S00508-014-0671-9]; Qian JY, 2010, RHEUMATOL INT, V30, P705, DOI 10.1007/s00296-009-1297-5; Rat AC, 2004, JOINT BONE SPINE, V71, P190, DOI 10.1016/j.jbspin.2003.09.003; Raza K, 2011, ANN RHEUM DIS, V70, P1822, DOI 10.1136/ard.2011.151902; Roberts C, 2002, RHEUMATOLOGY, V41, P503, DOI 10.1093/rheumatology/41.5.503; Robinson PC, 2010, JCR-J CLIN RHEUMATOL, V16, P267, DOI 10.1097/RHU.0b013e3181eeb499; Roux CH, 2005, ANN RHEUM DIS, V64, P606, DOI 10.1136/ard.2004.020784; Schulpen GJC, 2003, ANN RHEUM DIS, V62, P159, DOI 10.1136/ard.62.2.159; Sieper J, 2005, ANN RHEUM DIS, V64, P659, DOI 10.1136/ard.2004.028753; Smolen JS, 2012, CLIN EXP RHEUMATOL, V30, pS2; Stuby U, 2007, CLIN RHEUMATOL, V26, P1863, DOI 10.1007/s10067-007-0590-5; van der Linden MPM, 2010, ARTHRITIS RHEUM-US, V62, P3537, DOI 10.1002/art.27692; Villeneuve E, 2013, ANN RHEUM DIS, V72, P13, DOI 10.1136/annrheumdis-2011-201063; Westhoff G, 2010, Z RHEUMATOL, V69, P910, DOI 10.1007/s00393-010-0715-0	24	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146149	10.1371/journal.pone.0146149	http://dx.doi.org/10.1371/journal.pone.0146149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741702	gold, Green Published, Green Submitted			2022-12-27	WOS:000367810600021
J	Zhang, YL; Thai, K; Kepecs, DM; Gilbert, RE				Zhang, Yanling; Thai, Kerri; Kepecs, David M.; Gilbert, Richard E.			Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CONVERTING-ENZYME-INHIBITION; MEDIATED GLOMERULAR INJURY; SELECTIVE SGLT2 INHIBITOR; INDUCED DIABETIC-RATS; KINASE-C-BETA; ANGIOTENSIN-II; SUBTOTAL NEPHRECTOMY; GLYCEMIC CONTROL; HEALTHY-SUBJECTS	Pharmacological inhibition of the proximal tubular sodium-glucose linked cotransporter-2 (SGLT2) leads to glycosuria in both diabetic and non-diabetic settings. As a consequence of their ability to modulate tubuloglomerular feedback, SGLT2 inhibitors, like agents that block the renin-angiotensin system, reduce intraglomerular pressure and single nephron GFR, potentially affording renoprotection. To examine this further we administered the SGLT2 inhibitor, dapagliflozin, to 5/6 (subtotally) nephrectomised rats, a model of progressive chronic kidney disease (CKD) that like CKD in humans is characterised by single nephron hyperfiltration and intraglomerular hypertension and where angiotensin converting enzyme inhibitors and angiotensin receptor blockers are demonstrably beneficial. When compared with untreated rats, both sham surgery and 5/6 nephrectomised rats that had received dapagliflozin experienced substantial glycosuria. Nephrectomised rats developed hypertension, heavy proteinuria and declining GFR that was unaffected by the administration of dapagliflozin. Similarly, SGLT2 inhibition did not attenuate the extent of glomerulosclerosis, tubulointerstitial fibrosis or overexpression of the profibrotic cytokine, transforming growth factor-beta 1 mRNA in the kidneys of 5/6 nephrectomised rats. While not precluding beneficial effects in the diabetic setting, these findings indicate that SGLT2 inhibition does not have renoprotective effects in this classical model of progressive non-diabetic CKD.	[Gilbert, Richard E.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Gilbert, RE (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.	richard.gilbert@utoronto.ca			TD Bank; Canadian Institutes of Health Research; Canada Research Chairs Program	TD Bank; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by research grants from TD Bank, Canadian Institutes of Health Research and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Allen Terri J, 2004, Curr Diab Rep, V4, P435, DOI 10.1007/s11892-004-0053-1; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; Benigni A, 1999, AM J KIDNEY DIS, V33, P746, DOI 10.1016/S0272-6386(99)70229-5; BRENNER BM, 1983, KIDNEY INT, V23, P647, DOI 10.1038/ki.1983.72; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; Cherney DZI, 2014, CAN J DIABETES, V38, P356, DOI 10.1016/j.jcjd.2014.05.006; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Connelly KA, 2009, CIRC-HEART FAIL, V2, P129, DOI 10.1161/CIRCHEARTFAILURE.108.765750; Cordonnier DJ, 1999, J AM SOC NEPHROL, V10, P1253; DAVALOS M, 1978, AM J PHYSIOL, V235, pF605, DOI 10.1152/ajprenal.1978.235.6.F605; De Nicola L, 2014, AM J KIDNEY DIS, V64, P16, DOI 10.1053/j.ajkd.2014.02.010; DeFronzo RA, 2013, DIABETES CARE, V36, P3169, DOI 10.2337/dc13-0387; Fujimori Y, 2009, EUR J PHARMACOL, V609, P148, DOI 10.1016/j.ejphar.2009.03.007; Gembardt F, 2014, AM J PHYSIOL-RENAL, V307, pF317, DOI 10.1152/ajprenal.00145.2014; Gilbert RE, 2014, DIABETES METAB, V40, pS23, DOI 10.1016/S1262-3636(14)72692-8; Gilbert RE, 1998, DIABETES, V47, P414, DOI 10.2337/diabetes.47.3.414; Gilbert RE, 1999, AM J PATHOL, V155, P429, DOI 10.1016/S0002-9440(10)65139-5; Gilbert RE, 2014, KIDNEY INT, V86, P693, DOI 10.1038/ki.2013.451; Gilbert RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047160; HAYASHI K, 1992, J AM SOC NEPHROL, V2, P1578; Heerspink HJL, 2013, DIABETES OBES METAB, V15, P853, DOI 10.1111/dom.12127; Houlihan CA, 2002, DIABETES CARE, V25, P1072, DOI 10.2337/diacare.25.6.1072; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kasichayanula S, 2014, CLIN PHARMACOKINET, V53, P17, DOI 10.1007/s40262-013-0104-3; Kelly D J, 2006, Kidney Int, V69, P1954, DOI 10.1038/sj.ki.5000376; Kelly DJ, 2005, J AM SOC NEPHROL, V16, P1654, DOI 10.1681/ASN.2004070578; Kelly DJ, 2004, J AM SOC NEPHROL, V15, P2619, DOI 10.1097/01.ASN.0000139066.77892.04; Komala MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108994; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P520, DOI 10.1038/clpt.2008.251; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P513, DOI 10.1038/clpt.2008.250; Langham RG, 2006, DIABETES CARE, V29, P2670, DOI 10.2337/dc06-0911; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; List JF, 2011, KIDNEY INT, V79, pS20, DOI 10.1038/ki.2010.512; Munger KA, 2012, BRENNER RECTORS KIDN, DOI DOI 10.1016/B978-1-4160-6193-9.10003-X; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Ruggenenti P, 1997, LANCET, V349, P1857; SEYERHANSEN K, 1983, KIDNEY INT, V23, P643, DOI 10.1038/ki.1983.71; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Shannon JA, 1935, J CLIN INVEST, V14, P393, DOI 10.1172/JCI100690; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Thomson SC, 2012, AM J PHYSIOL-REG I, V302, pR75, DOI 10.1152/ajpregu.00357.2011; Toke A, 2001, CONTRIB NEPHROL, V135, P34; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; WISEMAN MJ, 1985, NEW ENGL J MED, V312, P617, DOI 10.1056/NEJM198503073121004; WOLF G, 1993, J CLIN INVEST, V92, P1366, DOI 10.1172/JCI116710; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Yuen DA, 2013, STEM CELLS, V31, P2408, DOI 10.1002/stem.1502; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521	53	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0144640	10.1371/journal.pone.0144640	http://dx.doi.org/10.1371/journal.pone.0144640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741142	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600004
J	Ford, MJ; Hempelmann, J; Hanson, MB; Ayres, KL; Baird, RW; Emmons, CK; Lundin, JI; Schorr, GS; Wasser, SK; Park, LK				Ford, Michael J.; Hempelmann, Jennifer; Hanson, M. Bradley; Ayres, Katherine L.; Baird, Robin W.; Emmons, Candice K.; Lundin, Jessica I.; Schorr, Gregory S.; Wasser, Samuel K.; Park, Linda K.			Estimation of a Killer Whale (Orcinus orca) Population's Diet Using Sequencing Analysis of DNA from Feces	PLOS ONE			English	Article							MOLECULAR ANALYSIS; PREY ABUNDANCE; DIVERSITY; DECLINE	Estimating diet composition is important for understanding interactions between predators and prey and thus illuminating ecosystem function. The diet of many species, however, is difficult to observe directly. Genetic analysis of fecal material collected in the field is therefore a useful tool for gaining insight into wild animal diets. In this study, we used high-throughput DNA sequencing to quantitatively estimate the diet composition of an endangered population of wild killer whales (Orcinus orca) in their summer range in the Salish Sea. We combined 175 fecal samples collected between May and September from five years between 2006 and 2011 into 13 sample groups. Two known DNA composition control groups were also created. Each group was sequenced at a similar to 330bp segment of the 16s gene in the mitochondrial genome using an Illumina MiSeq sequencing system. After several quality controls steps, 4,987,107 individual sequences were aligned to a custom sequence database containing 19 potential fish prey species and the most likely species of each fecal-derived sequence was determined. Based on these alignments, salmonids made up >98.6% of the total sequences and thus of the inferred diet. Of the six salmonid species, Chinook salmon made up 79.5% of the sequences, followed by coho salmon (15%). Over all years, a clear pattern emerged with Chinook salmon dominating the estimated diet early in the summer, and coho salmon contributing an average of >40% of the diet in late summer. Sockeye salmon appeared to be occasionally important, at >18% in some sample groups. Non-salmonids were rarely observed. Our results are consistent with earlier results based on surface prey remains, and confirm the importance of Chinook salmon in this population's summer diet.	[Ford, Michael J.; Hempelmann, Jennifer; Hanson, M. Bradley; Emmons, Candice K.; Park, Linda K.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Ayres, Katherine L.; Lundin, Jessica I.; Wasser, Samuel K.] Univ Washington, Dept Biol, Ctr Conservat Biol, Seattle, WA 98195 USA; [Baird, Robin W.; Schorr, Gregory S.] Cascadia Res Collect, Olympia, WA 98501 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Ford, MJ (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, 2725 Montlake Blvd E, Seattle, WA 98112 USA.	mike.ford@noaa.gov	Wasser, Samuel K/I-5542-2015; Baird, Robin/Y-8230-2019	Baird, Robin/0000-0002-9419-6336	Northwest Fisheries Science Center, National Marine Fisheries Service, National Oceanic and Atmospheric Administration; Washington Sea Grant [NA10OAR417005]; Canadian Consulate General; Center for Conservation Biology; Northwest Science Association; U.S. Environmental Protection Agency STAR Fellowship Assistance Agreement [91735201]	Northwest Fisheries Science Center, National Marine Fisheries Service, National Oceanic and Atmospheric Administration; Washington Sea Grant; Canadian Consulate General; Center for Conservation Biology; Northwest Science Association; U.S. Environmental Protection Agency STAR Fellowship Assistance Agreement	Funding was provided by the Northwest Fisheries Science Center, National Marine Fisheries Service, National Oceanic and Atmospheric Administration; Washington Sea Grant award no. NA10OAR417005; Canadian Consulate General; Center for Conservation Biology; Northwest Science Association; and the U.S. Environmental Protection Agency STAR Fellowship Assistance Agreement no. 91735201.	Allen BM, 2014, NOAA TECHICAL MEMORA, P277; Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; Baird RW, 2000, CETACEAN SOCIETIES, P127; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Ford J. K. B., 2000, KILLER WHALES NATURA; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Ford M, 2011, NOAA TECHNICAL MEMOR, V113, P1; Ford MJ, 2011, J HERED, V102, P537, DOI 10.1093/jhered/esr067; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; Hauser DDW, 2007, MAR ECOL PROG SER, V351, P301, DOI 10.3354/meps07117; Hilborn R., 2012, EFFECTS SALMON FISHE; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Krahn MM., 2004, NOAA TECHNICAL MEMOR, V62, P1; Ling KH, 2008, FOOD CHEM, V110, P538, DOI 10.1016/j.foodchem.2008.02.066; Marshall KN, 2016, CONSERV LETT, V9, P70, DOI 10.1111/conl.12186; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Matejusova I, 2008, J APPL ECOL, V45, P632, DOI 10.1111/j.1365-2664.2007.01429.x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Musiani M, 2004, BIOSCIENCE, V54, P50, DOI 10.1641/0006-3568(2004)054[0050:TPOWPP]2.0.CO;2; NMFS, 2008, REC PLAN END SO RES; Parker A, 1996, GENOME, V39, P793, DOI 10.1139/g96-099; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Reeves R, 2004, WORKSH SHORTC CET TA, P363; Riesch R, 2012, BIOL J LINN SOC, V106, P1, DOI 10.1111/j.1095-8312.2012.01872.x; Rigg R, 2011, ORYX, V45, P272, DOI 10.1017/S0030605310000074; Saulitis E, 2000, MAR MAMMAL SCI, V16, P94, DOI 10.1111/j.1748-7692.2000.tb00906.x; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Swain DP, 2015, MAR ECOL PROG SER, V519, P165, DOI 10.3354/meps11012; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Trzcinski MK, 2006, ECOL APPL, V16, P2276, DOI 10.1890/1051-0761(2006)016[2276:CDOAAC]2.0.CO;2; U.S. Army Corp of Engineers, DOUBL CREST CORM MAN; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x	40	43	46	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144956	10.1371/journal.pone.0144956	http://dx.doi.org/10.1371/journal.pone.0144956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735849	Green Published, gold			2022-12-27	WOS:000367805100016
J	Buscot, MJ; Magnussen, CG; Juonala, M; Pitkanen, N; Lehtimaki, T; Viikari, JSA; Kahonen, M; Hutri-Kahonen, N; Schork, NJ; Raitakari, OT; Thomson, RJ				Buscot, Marie-jeanne; Magnussen, Costan G.; Juonala, Markus; Pitkanen, Niina; Lehtimaki, Terho; Viikari, Jorma S. A.; Kahonen, Mika; Hutri-Kahonen, Nina; Schork, Nicholas J.; Raitakari, Olli T.; Thomson, Russell J.			The Combined Effect of Common Genetic Risk Variants on Circulating Lipoproteins Is Evident in Childhood: A Longitudinal Analysis of the Cardiovascular Risk in Young Finns Study	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; GENOME-WIDE ASSOCIATION; HEART-DISEASE RISK; LIPID-LEVELS; HDL-CHOLESTEROL; LOCI; TRIGLYCERIDES; CHILDREN; ATHEROSCLEROSIS; PREVENTION	Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) are modifiable risk factors for cardiovascular disease. Several genetic loci for predisposition to abnormal LDL-C, HDL-C and TG have been identified. However, it remains unclear whether these loci are consistently associated with serum lipid levels at each age or with unique developmental trajectories. Therefore, we assessed the association between genome wide association studies (GWAS) derived polygenic genetic risk scores and LDL-C, HDL-C, and triglyceride trajectories from childhood to adulthood using data available from the 27-year European 'Cardiovascular Risk in Young Finns' Study. For 2,442 participants, three weighted genetic risk scores (wGRSs) for HDL-C (38 SNPs), LDLC (14 SNPs) and triglycerides (24 SNPs) were computed and tested for association with serum lipoprotein levels measured up to 8 times between 1980 and 2011. The categorical analyses revealed no clear divergence of blood lipid trajectories over time between wGRSs categories, with participants in the lower wGRS quartiles tending to have average lipoprotein concentrations 30 to 45% lower than those in the upper-quartile wGRS beginning at age 3 years and continuing through to age 49 years (where the upper-quartile wGRS have 4-7 more risk alleles than the lower wGRS group). Continuous analyses, however, revealed a significant but moderate time-dependent genetic interaction for HDL-Cand triglycerides levels tended to be lower in childhood and become more pronounced after the age of 25 years. Although the influence of genetic factors on age-specific lipoprotein values and developmental trajectories is complex, our data show that wGRSs are highly predictive of HDL-C, LDL-C, and triglyceride levels at all ages. levels, with the association between HDL-C and the continuous HDL-C risk score weakening slightly with age. Conversely, in males, the association between the continuous TG genetic risk score	[Buscot, Marie-jeanne; Magnussen, Costan G.; Thomson, Russell J.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Magnussen, Costan G.; Juonala, Markus; Pitkanen, Niina; Viikari, Jorma S. A.; Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Juonala, Markus; Viikari, Jorma S. A.; Raitakari, Olli T.] Univ Turku, Dept Med, Turku, Finland; [Juonala, Markus; Viikari, Jorma S. A.; Raitakari, Olli T.] Turku Univ Hosp, Div Med, FIN-20520 Turku, Finland; [Juonala, Markus] Murdoch Children Res Inst, Parkville, Vic, Australia; [Lehtimaki, Terho] Univ Tampere, Fimlab Ltd, FIN-33101 Tampere, Finland; [Lehtimaki, Terho; Hutri-Kahonen, Nina] Tampere Univ Hosp, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Hutri-Kahonen, Nina] Univ Tampere, Sch Med, Dept Pediat, FIN-33101 Tampere, Finland; [Schork, Nicholas J.] J Craig Venter Inst, Human Biol, La Jolla, CA USA	University of Tasmania; Menzies Institute for Medical Research; University of Turku; University of Turku; University of Turku; Murdoch Children's Research Institute; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University; J. Craig Venter Institute	Buscot, MJ (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	m.buscot@utas.edu.au	Lehtimäki, Terho/AAD-1094-2022; Magnussen, Costan/AAA-8260-2020; Thomson, Russell J/H-5653-2012; Raitakari, Olli/AAQ-7389-2021; Magnussen, Costan/J-7177-2014	Lehtimäki, Terho/0000-0002-2555-4427; Thomson, Russell J/0000-0003-4949-4120; Schork, Nicholas/0000-0003-0920-5013; Kahonen, Mika/0000-0002-4510-7341; Juonala, Markus/0000-0001-9498-364X; BUSCOT, Marie-jeanne/0000-0002-9055-5928; Magnussen, Costan/0000-0002-6238-5730	Academy of Finland [126925, 121584, 124282, 129378, 117797, 265877, 41071]; Social Insurance Institution of Finland; Turku University Foundation, Paavo Nurmi Foundation; Juho Vainio Foundation; Sigrid Juselius Foundation; Maud Kuistila Foundation; Research funds from the Kuopio; Turku and Tampere University Hospitals; Finnish Foundation of Cardiovascular Research; Finnish Medical Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation; Public Health Fellowship [APP1037559]; Fimlab Ltd	Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Turku University Foundation, Paavo Nurmi Foundation; Juho Vainio Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Maud Kuistila Foundation; Research funds from the Kuopio; Turku and Tampere University Hospitals; Finnish Foundation of Cardiovascular Research; Finnish Medical Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Public Health Fellowship; Fimlab Ltd	The Young Finn study was financially supported by the Academy of Finland (grants 126925, 121584, 124282, 129378, 117797, 265877, and 41071), the Social Insurance Institution of Finland, the Turku University Foundation, Paavo Nurmi Foundation, Juho Vainio Foundation, Sigrid Juselius Foundation, Maud Kuistila Foundation, Research funds from the Kuopio, Turku and Tampere University Hospitals, the Finnish Foundation of Cardiovascular Research, the Finnish Medical Foundation, the Orion-Farmos Research Foundation, and the Finnish Cultural Foundation. CGM holds a National Health and Medical Research Council Early Career Fellowship (Public Health Fellowship, APP1037559). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the present manuscript. Fimlab Ltd provided support in the form of salaries for author TL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Badimon L, 2012, ANN NY ACAD SCI, V1254, P18, DOI 10.1111/j.1749-6632.2012.06480.x; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bouillon K, 2011, HEART, V97, P923, DOI 10.1136/hrt.2010.216309; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; Choy PC, 2004, BIOCHEM CELL BIOL, V82, P212, DOI 10.1139/o03-085; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; De Groot LJ, 2010, GENETIC BASIS LIPID; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Graham I, 2012, CURR CARDIOL REP, V14, P709, DOI 10.1007/s11886-012-0313-7; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Isaacs A, 2013, ARTERIOSCL THROM VAS, V33, P2233, DOI 10.1161/ATVBAHA.113.301236; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kavey REW, 2003, CIRCULATION, V107, P1562, DOI 10.1161/01.CIR.0000061521.15730.6E; KOSTNER GM, 1976, CLIN CHEM, V22, P695; Lardizabal JA, 2010, VASC HEALTH RISK MAN, V6, P843, DOI 10.2147/VHRM.S9474; LAUER RM, 1992, PEDIATRICS, V89, P495; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mirman D., 2014, GROWTH CURVE ANAL VI; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Piccolo Stephen R, 2009, BMC Proc, V3 Suppl 7, pS46; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinto Pereira SM, 2013, LIFE COURSE BODY MAS, P1215; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Porkka KVK, 1997, AM J EPIDEMIOL, V146, P64, DOI 10.1093/oxfordjournals.aje.a009192; R Core Team, 2021, R LANGUAGE ENV STAT; Raiko JRH, 2010, J INTERN MED, V267, P370, DOI 10.1111/j.1365-2796.2009.02148.x; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tikkanen E, 2011, CIRC-CARDIOVASC GENE, V4, P673, DOI 10.1161/CIRCGENETICS.111.960369; Toth PP, 2004, CIRCULATION, V109, P1809, DOI 10.1161/01.CIR.0000126889.97626.B8; van Capelleveen JC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0326-8; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wineinger Nathan E., 2013, Frontiers in Genetics, V4, P86, DOI 10.3389/fgene.2013.00086; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	56	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146081	10.1371/journal.pone.0146081	http://dx.doi.org/10.1371/journal.pone.0146081			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731281	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400090
J	Faraj, SF; Bezerra, SM; Yousefi, K; Fedor, H; Glavaris, S; Han, M; Partin, AW; Humphreys, E; Tosoian, J; Johnson, MH; Davicioni, E; Trock, BJ; Schaeffer, EM; Ross, AE; Netto, GJ				Faraj, Sheila F.; Bezerra, Stephania M.; Yousefi, Kasra; Fedor, Helen; Glavaris, Stephanie; Han, Misop; Partin, Alan W.; Humphreys, Elizabeth; Tosoian, Jeffrey; Johnson, Michael H.; Davicioni, Elai; Trock, Bruce J.; Schaeffer, Edward M.; Ross, Ashley E.; Netto, George J.			Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy	PLOS ONE			English	Article							PATHOLOGY-CONSENSUS-CONFERENCE; INTERNATIONAL-SOCIETY; PROSTATIC-CARCINOMA; INTEROBSERVER REPRODUCIBILITY; CANCER; ADENOCARCINOMA; PREDICTION; SPECIMENS; PROGNOSIS; BIOPSY	In 2005, the International Society of Urological Pathology (ISUP) introduced several modifications to the original Gleason system that were intended to enhance the prognostic power of Gleason score (GS). The objective of this study was to clinically validate the 2005 ISUP Gleason grading system for its ability to detect metastasis. We queried our institutional RP database for men with NCCN clinically localized intermediate to high-risk disease undergoing radical prostatectomy (RP) between 1992 and 2010 with no additional treatment until the time of metastatic progression. A case-cohort design was utilized. A total of 333 available RP samples were re-reviewed and GS was reassigned per the 2005 ISUP Gleason system. Cumulative incidence of metastasis was 0%, 8.4%, 24.5% and 44.4% among specimens that were downgraded, unchanged, had one point GS increase and two point GS increase, respectively. The hazard ratio for metastasis raised in GS 8 and 9 compared to GS 7 from 2.77 and 5.91 to 3.49 and 9.31, respectively. The survival c-index of GS increased from 0.70 to 0.80 when samples were re-graded at 5 years post RP. The c-index of the reassigned GS was higher than the original GS (0.77 vs 0.64) for predicting PCSM at 10 years post RP. The regraded GS improved the prediction of metastasis and PCSM. This validates the updated Gleason grading system using an unambiguous clinical endpoint and highlights the need for reassignment of Gleason grading according to 2005 ISUP system when considering comparisons of novel biomarkers to clinicopathological variables in archival cohorts.	[Faraj, Sheila F.; Bezerra, Stephania M.; Ross, Ashley E.; Netto, George J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Fedor, Helen; Glavaris, Stephanie; Han, Misop; Partin, Alan W.; Humphreys, Elizabeth; Tosoian, Jeffrey; Johnson, Michael H.; Trock, Bruce J.; Schaeffer, Edward M.; Ross, Ashley E.; Netto, George J.] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA; [Ross, Ashley E.; Netto, George J.] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Yousefi, Kasra; Davicioni, Elai] GenomeDx Biosci, Vancouver, BC, Canada	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; GenomeDx Biosciences	Netto, GJ (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	gnetto1@jhmi.edu		Netto, George/0000-0003-3915-9134; Glavaris, Stephanie/0000-0002-8695-052X				Allsbrook WC, 2001, HUM PATHOL, V32, P74, DOI 10.1053/hupa.2001.21134; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Berney DM, 2007, BJU INT, V100, P1240, DOI 10.1111/j.1464-410X.2007.07199.x; Billis A, 2008, J UROLOGY, V180, P548, DOI 10.1016/j.juro.2008.04.018; Bostrom PJ, 2015, EUR UROL, V68, P1033, DOI 10.1016/j.eururo.2015.04.008; Carter HB, 2012, J CLIN ONCOL, V30, P4294, DOI 10.1200/JCO.2012.44.0586; Egevad L, 2012, ARCH PATHOL LAB MED, V136, P426, DOI 10.5858/arpa.2011-0495-RA; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Epstein JI, 2014, AM J SURG PATHOL, V38, pE6, DOI 10.1097/PAS.0000000000000238; Faisal FA, 2014, BJU INT, V114, pE120, DOI 10.1111/bju.12771; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Helpap B, 2006, VIRCHOWS ARCH, V449, P622, DOI 10.1007/s00428-006-0310-6; LIN DY, 1993, J AM STAT ASSOC, V88, P1341, DOI 10.2307/2291275; Mohler JL, 2013, J NATL COMPR CANC NE, V11, P1471, DOI 10.6004/jnccn.2013.0174; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Ross AE, 2016, PROSTATE CANCER P D, V19, P1, DOI 10.1038/pcan.2015.31; Ross AE, 2016, EUR UROL, V69, P157, DOI 10.1016/j.eururo.2015.05.042; Tsivian M, 2009, UROLOGY, V74, P1090, DOI 10.1016/j.urology.2009.03.043; Uemura H, 2009, BJU INT, V103, P1190, DOI 10.1111/j.1464-410X.2008.08197.x; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Zareba P, 2009, HISTOPATHOLOGY, V55, P384, DOI 10.1111/j.1365-2559.2009.03405.x	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146189	10.1371/journal.pone.0146189	http://dx.doi.org/10.1371/journal.pone.0146189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731672	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400111
J	Feczko, EJ; Bliss-Moreau, E; Walum, H; Pruett, JR; Parr, LA				Feczko, Eric J.; Bliss-Moreau, Eliza; Walum, Hasse; Pruett, John R., Jr.; Parr, Lisa A.			The Macaque Social Responsiveness Scale (mSRS): A Rapid Screening Tool for Assessing Variability in the Social Responsiveness of Rhesus Monkeys (Macaca mulatta)	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; MATERNAL IMMUNE ACTIVATION; AUTISTIC TRAITS; DIAGNOSTIC INTERVIEW; NEONATAL AMYGDALA; PRIMATES; BEHAVIOR; VALIDATION; CHILDREN; LESIONS	Understanding the biological mechanisms underlying human neuropsychiatric disorders, such as autism spectrum disorder (ASD), has been hindered by the lack of a robust, translational animal model. Rhesus monkeys (Macaca mulatta) display many of the same social behaviors that are affected in ASD, making them an excellent animal species in which to model social impairments. However, the social impairments associated with ASD may reflect extreme ends of a continuous distribution of traits. Thus, to validate the rhesus monkey as an animal model for studying social impairments that has strong translational relevance for ASD, researchers need an easily-implemented measurement tool that can quantify variation in social behavior dimensionally. The Social Responsiveness Scale (SRS) is a 65-item survey that identifies both typical and atypical social behaviors in humans that covary with ASD symptom severity. A chimpanzee SRS has already been validated and the current study adapted this tool for use in the rhesus monkey (mSRS). Fifteen raters completed the mSRS for 105 rhesus monkeys living at the Yerkes National Primate Research Center. The mSRS scores showed a unimodal distribution with a positive skew that identified 6 statistical outliers. Inter-rater reliability was very strong, but only 17 of the 36 questions showed positive intra-item reliability. The results of an exploratory factor analysis identified 3 factors that explained over 60% of the variance, with 12 items significantly loading onto the primary factor. These items reflected behaviors associated with social avoidance, social anxiety or inflexibility and social confidence. These initial findings are encouraging and suggest that variability in the social responsiveness of rhesus monkeys can be quantified using the mSRS: a tool that has strong translational relevance for human disorders. With further modification, the mSRS may provide an promising new direction for research on the biological mechanisms underlying social impairments.	[Feczko, Eric J.; Walum, Hasse; Parr, Lisa A.] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Feczko, Eric J.; Walum, Hasse; Parr, Lisa A.] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30329 USA; [Bliss-Moreau, Eliza] Univ Calif Davis, Calif Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Pruett, John R., Jr.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Parr, Lisa A.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University; University of California System; University of California Davis; Washington University (WUSTL); Emory University	Parr, LA (corresponding author), Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.	lparr@emory.edu			National Institutes of Mental Health [P50MH073921, P50MH100023, R01MH104534, K9910138]; National Institutes for Health and Human Development [R01MH093510, R01HD055741]; Swedish Brain Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011, R01HD055741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104534, R01MH093510, P50MH100023] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes for Health and Human Development; Swedish Brain Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Mental Health (P50MH073921, P50MH100023, R01MH104534, www.nih.gov) to LAP, National Institutes of Mental Health (K9910138) to EBM, National Institutes of Mental Health and National Institutes for Health and Human Development (R01MH093510, R01HD055741) to JRP, Swedish Brain Foundation to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHEVALIER J, 1994, NEUROPSYCHOLOGIA, V32, P627, DOI 10.1016/0028-3932(94)90025-6; Bachevalier J, 2001, BEHAV NEUROSCI, V115, P545, DOI 10.1037//0735-7044.115.3.545; Bauman MD, 2004, J NEUROSCI, V24, P711, DOI 10.1523/JNEUROSCI.3263-03.2004; Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025; Beisner BA, 2014, AM J PRIMATOL, V76, P111, DOI 10.1002/ajp.22214; Bliss-Moreau E, 2013, J COGNITIVE NEUROSCI, V25, P2124, DOI 10.1162/jocn_a_00483; Bliss-Moreau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071170; Bolte S, 2008, AUTISM RES, V1, P354, DOI 10.1002/aur.49; Bowers K, 2015, PEDIATR DRUGS, V17, P115, DOI 10.1007/s40272-014-0106-0; Brown GR, 2000, PRIMATES, V41, P63, DOI 10.1007/BF02557462; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Constantino JN, 2006, AM J PSYCHIAT, V163, P294, DOI 10.1176/appi.ajp.163.2.294; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Duvekot J, 2014, J AUTISM DEV DISORDE; Faughn C, 2015, J AUTISM DEV DISORD, V45, P1483, DOI 10.1007/s10803-014-2273-9; Frazier TW, 2014, AUTISM, V18, P31, DOI 10.1177/1362361313500382; Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817; HINDE R. A., 1962, PROC ZOOL SOC LONDON, V138, P1; Hus V, 2013, J CHILD PSYCHOL PSYC, V54, P216, DOI 10.1111/j.1469-7610.2012.02589.x; Kamio Y, 2013, ACTA PSYCHIAT SCAND, V128, P45, DOI 10.1111/acps.12034; Kamphuis S, 2009, EUR J NEUROSCI, V29, P1732, DOI 10.1111/j.1460-9568.2009.06730.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Machado CJ, 2015, BIOL PSYCHIAT, V77, P823, DOI 10.1016/j.biopsych.2014.07.035; Marrus N, 2011, J AM ACAD CHILD PSY, V50, P508, DOI 10.1016/j.jaac.2011.01.009; Michopoulos V, 2012, HORM BEHAV, V62, P389, DOI 10.1016/j.yhbeh.2012.07.014; Miranda-Dominguez O, 2014, J NEUROSCI, V34, P5552, DOI 10.1523/JNEUROSCI.4229-13.2014; Moadab G, 2015, BEHAV NEUROSCI, V129, P339, DOI 10.1037/bne0000062; Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150; Parr LA, 2002, BEHAV NEUROSCI, V116, P378, DOI 10.1037//0735-7044.116.3.378; Parr LA, 2011, PHILOS T R SOC B, V366, P1764, DOI 10.1098/rstb.2010.0358; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Piven J, 1997, AM J PSYCHIAT, V154, P185; Ruhela RK, 2015, ANN NEUROSCI, V22, P44, DOI 10.5214/ans.0972.7531.220210; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Takei R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0302-z; THIERRY B, 1985, BEHAV PROCESS, V11, P89, DOI 10.1016/0376-6357(85)90105-6; VESSEY SH, 1984, POLITICAL PSYCHOL, V5, P623; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Weir RK, 2015, BRAIN BEHAV IMMUN, V48, P139, DOI 10.1016/j.bbi.2015.03.009; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792	47	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145956	10.1371/journal.pone.0145956	http://dx.doi.org/10.1371/journal.pone.0145956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731103	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400071
J	Hodkinson, P; Argent, A; Wallis, L; Reid, S; Perera, R; Harrison, S; Thompson, M; English, M; Maconochie, I; Ward, A				Hodkinson, Peter; Argent, Andrew; Wallis, Lee; Reid, Steve; Perera, Rafael; Harrison, Sian; Thompson, Matthew; English, Mike; Maconochie, Ian; Ward, Alison			Pathways to Care for Critically Ill or Injured Children: A Cohort Study from First Presentation to Healthcare Services through to Admission to Intensive Care or Death	PLOS ONE			English	Article							CONFIDENTIAL INQUIRY; DISTRICT HOSPITALS; MORTALITY; DELIVERY	Purpose Critically ill or injured children require prompt identification, rapid referral and quality emergency management. We undertook a study to evaluate the care pathway of critically ill or injured children to identify preventable failures in the care provided. Methods A year-long cohort study of critically ill and injured children was performed in Cape Town, South Africa, from first presentation to healthcare services until paediatric intensive care unit (PICU) admission or emergency department death, using expert panel review of medical records and caregiver interview. Main outcomes were expert assessment of overall quality of care; avoidability of severity of illness and PICU admission or death and the identification of modifiable factors. Results The study enrolled 282 children, 252 emergency PICU admissions, and 30 deaths. Global quality of care was graded good in 10% of cases, with half having at least one major impact modifiable factor. Key modifiable factors related to access to care and identification of the critically ill, assessment of severity, inadequate resuscitation, and delays in decision making and referral. Children were transferred with median time from first presentation to PICU admission of 12.3 hours. There was potentially avoidable severity of illness in 185 (74%) of children, and death prior to PICU admission was avoidable in 17/30 (56.7%) of children. Conclusions The study presents a novel methodology, examining quality of care across an entire system, and highlighting the complexity of the pathway and the modifiable events amenable to interventions, that could reduce mortality and morbidity, and optimize utilization of scarce critical care resources; as well as demonstrating the importance of continuity and quality of care.	[Hodkinson, Peter; Wallis, Lee] Univ Cape Town, Div Emergency Med, ZA-7925 Cape Town, South Africa; [Argent, Andrew] Univ Cape Town, Dept Paediat, ZA-7925 Cape Town, South Africa; [Reid, Steve] Univ Cape Town, Directorate Primary Hlth Care, ZA-7925 Cape Town, South Africa; [Perera, Rafael; Harrison, Sian; Ward, Alison] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Thompson, Matthew] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [English, Mike] Univ Oxford, Nuffield Dept Med, Oxford, England; [English, Mike] KEMRI Wellcome Trust Res Programme, Nairobi, Kenya; [Maconochie, Ian] Univ London Imperial Coll Sci Technol & Med, Paediat Emergency Med, London, England; [Maconochie, Ian] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	University of Cape Town; University of Cape Town; University of Cape Town; University of Oxford; University of Washington; University of Washington Seattle; University of Oxford; Imperial College London; Imperial College London	Hodkinson, P (corresponding author), Univ Cape Town, Div Emergency Med, ZA-7925 Cape Town, South Africa.	pwhodkinson@gmail.com	Reid, Stephen/AAY-6101-2020; Hodkinson, PW W/N-3122-2018; Argent, Andrew/J-1605-2019	Hodkinson, PW W/0000-0002-0376-7982; Argent, Andrew/0000-0001-9333-2036; Reid, Steve/0000-0003-2826-2304; Perera, Rafael/0000-0003-2418-2091; Wallis, Lee/0000-0003-2711-3139; Maconochie, Ian/0000-0001-6319-8550	Wellcome Trust [WT091107MA]; Nuffield Department of Primary Care Health Sciences, Oxford University	Wellcome Trust(Wellcome TrustEuropean Commission); Nuffield Department of Primary Care Health Sciences, Oxford University	The study was funded by the Wellcome Trust (WT091107MA) and the Nuffield Department of Primary Care Health Sciences, Oxford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barasa EW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001238; Berry L., 2013, SOUTH AFRICAN CHILD; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Brent AJ, 2011, ARCH DIS CHILD, V96, P361, DOI 10.1136/adc.2010.183111; Campbell H, 2008, PEDIATRICS, V121, pE984, DOI 10.1542/peds.2007-1395; Christian CW, 2010, PEDIATRICS, V126, P592, DOI 10.1542/peds.2010-2006; DEVLIN HB, 1985, J ROY SOC MED, V78, P698; Drife J, 2008, BEST PRACT RES CL OB, V22, P501, DOI 10.1016/j.bpobgyn.2007.10.005; Drife J, 2012, SAJOG-S AFR J OBSTET, V18, P32; Egdell P, 2008, EMERG MED J, V25, P745, DOI 10.1136/emj.2007.054965; English M, 2005, ARCH DIS CHILD, V90, P974, DOI 10.1136/adc.2005.074468; English M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-42; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; Harnden A, 2009, BRIT J GEN PRACT, V59, P819, DOI 10.3399/bjgp09X472520; ?hlstr?m P., 2012, THIS IS LEAN RESOLVI; IBM, 2012, SPSS STAT WIND VERS; Institute of Medicine Committee on Data Standards for Patient Safety, 2004, ACH NEW STAND CAR; Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P494, DOI 10.1097/PCC.0b013e318207096c; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Launay E, 2010, PEDIATR CRIT CARE ME, V11, P469, DOI 10.1097/PCC.0b013e3181ce752e; Lewis G., 2007, THE SEVENTH REPORT O; Mathews B, 2008, CHILD MALTREATMENT, V13, P50, DOI 10.1177/1077559507310613; Mohan G, 1996, BRIT J GEN PRACT, V46, P529; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Mooney H, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5138; Nadel S, 1998, J ACCID EMERG MED, V15, P298; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Papworth S, 2005, SEMIN FETAL NEONAT M, V10, P39, DOI 10.1016/j.siny.2004.09.013; Paul R, 2012, PEDIATRICS, V130, pE273, DOI 10.1542/peds.2012-0094; Pearson GA, 2011, ARCH DIS CHILD, V96, P927, DOI 10.1136/adc.2009.177071; Rimsza ME, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e11; Seiger N, 2013, PEDIATRICS, V132, pE841, DOI 10.1542/peds.2012-3594; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Statistics South Africa, 2012, CENS 2011 MUN REP W; Tucker KM, 2009, J SPEC PEDIATR NURS, V14, P79, DOI 10.1111/j.1744-6155.2008.00178.x; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Weindling AM, 2003, ARCH DIS CHILD, V88, P1034, DOI 10.1136/adc.88.12.1034	37	33	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145473	10.1371/journal.pone.0145473	http://dx.doi.org/10.1371/journal.pone.0145473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731245	Green Published, gold			2022-12-27	WOS:000367801400036
J	Kim, D; Kim, HE; Kim, CH				Kim, Doory; Kim, Han-Eol; Kim, Chang-Hong			Effect of Composition and Impurities on the Phosphorescence of Green-Emitting Alkaline Earth Aluminate Phosphor	PLOS ONE			English	Article							PERSISTENT LUMINESCENCE; EU2+; SRAL2O4-EU2+; MECHANISM; DY3+	Recent improvements to SrAl2O4:Eu2+, Dy3+ phosphors have enabled the use of luminescent hosts with a stable crystal structure and high physical and chemical stability, thus overcoming the bottleneck in the applicability of ZnS:Cu phosphors. However, enhancement of afterglow lifetime and brightness in SrAl2O4:Eu2+, Dy3+ phosphors remains a challenging task. Here, we have improved the afterglow characteristics in terms of persistence time and brightness by a systematic investigation of the composition of Eu-doped alkaline earth aluminate SrAl2O4:Eu2+, Dy3+ crystals. We found that a Dy3+/Eu2+ ratio of similar to 2.4 and similar to 0.935 mol Eu2+ (per mol of SrAl2O4) gave the brightest and longest emissions (11% and 9% increase for each). Doping with Si4+ also resulted in a slight increase in brightness up to similar to 15%. Doping with alkali metal or alkaline earth metal significantly enhanced the phosphorescence intensity. In particular, doping with 0.005 mol Li+ (per mol of SrAl2O4) alone boosted the phosphorescence intensity to 239% of the initial value, as compared to that observed for the non-doped crystal, while doping with 0.01 mol Mg2+ and 0.005 mol Li+ (per 1 mol SrAl2O4) boosted the phosphorescence intensity up to 313% of the initial value. The results of this investigation are expected to act as a guideline for the synthesis of bright and long persistent phosphors, and facilitate the development of persistent phosphors with afterglow characteristics superior to those of conventional phosphors.	[Kim, Doory] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kim, Han-Eol] Gwangju Inst Sci & Technol, Gwangju, South Korea; [Kim, Chang-Hong] Korea Inst Sci & Technol, Seoul, South Korea	Harvard University; Gwangju Institute of Science & Technology (GIST); Korea Institute of Science & Technology (KIST)	Kim, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kim33@fas.harvard.edu		Kim, Doory/0000-0002-2675-106X				ABBRUSCATO V, 1971, J ELECTROCHEM SOC, V118, P930, DOI 10.1149/1.2408226; Aitasalo T, 2003, J SOLID STATE CHEM, V171, P114, DOI 10.1016/S0022-4596(02)00194-9; Aitasalo T, 2002, J ALLOY COMPD, V341, P76, DOI 10.1016/S0925-8388(02)00068-3; Clabau F, 2005, CHEM MATER, V17, P3904, DOI 10.1021/cm050763r; Clabau F, 2007, SOLID STATE SCI, V9, P608, DOI 10.1016/j.solidstatesciences.2007.03.020; Holsa J, 2001, J ALLOY COMPD, V323, P326, DOI 10.1016/S0925-8388(01)01084-2; Katsumata T, 1997, J ELECTROCHEM SOC, V144, pL243, DOI 10.1149/1.1837931; Kinoshita T, 1999, J APPL PHYS, V86, P3729, DOI 10.1063/1.371243; Lima NBD, 2013, SCI REPORTS, P3; Lin YH, 2003, J ALLOY COMPD, V348, P76, DOI 10.1016/S0925-8388(02)00796-X; Liu ZF, 2004, MICROELECTRON J, V35, P375, DOI 10.1016/s0026-2692(03)00249-0; Matsuzawa T, 1996, J ELECTROCHEM SOC, V143, P2670, DOI 10.1149/1.1837067; Palilla FC, 1968, J ELECTROCHEMICAL SO, V115; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Wang D, 2002, J LUMIN, V97, P1, DOI 10.1016/S0022-2313(01)00413-6	15	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145434	10.1371/journal.pone.0145434	http://dx.doi.org/10.1371/journal.pone.0145434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731086	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400035
J	Kim, Y; Koo, YS; Lee, HY; Lee, SY				Kim, Yeshin; Koo, Yong Seo; Lee, Hee Young; Lee, Seo-Young			Can Continuous Positive Airway Pressure Reduce the Risk of Stroke in Obstructive Sleep Apnea Patients? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TRANSIENT ISCHEMIC ATTACK; CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; MORTALITY; THERAPY; ASSOCIATION	Background and Purpose Obstructive sleep apnea (OSA) has been shown to increase the risk of stroke. Although continuous positive airway pressure (CPAP) is considered the treatment of choice for OSA, whether treating OSA with CPAP reduces the risk of stroke remains unclear. We aimed to evaluate the effects of CPAP on incidence of stroke in patients with OSA. Materials and Methods We conducted a systematic review and meta-analysis of all published studies that provided the number of incident strokes in OSA patients in light of their treatment status with CPAP. Results We identified 8 relevant studies: one randomized controlled study (RCT), 5 cohort studies, and 2 studies using administrative health data. The two overlapping cohort studies in women and the elderly and the 2 studies using administrative health data had analyzed the impact of CPAP on stroke apart from cardiac events, whereas the others had focused on the overall cardiovascular events. Based on a meta-analysis of the cohort studies, treatment with CPAP was associated with a lower incidence of stroke and cardiac events with relative risks of 0.27 [0.14-0.53], and 0.54 [0.38-0.75], respectively, although this could not be reproduced in the RCT and the studies using administrative data. Conclusions Treating with CPAP in patients with OSA might decrease the risk of stroke, although there is some conflicting evidence. Such effect was more pronounced in stroke than in cardiac events. Future studies analyzing stroke apart from cardiac disease would be of interest.	[Kim, Yeshin; Lee, Seo-Young] Kangwon Natl Univ, Coll Med, Dept Neurol, Chuncheon Si, Gangwon Do, South Korea; [Koo, Yong Seo] Korea Univ, Coll Med, Dept Neurol, Seoul 136705, South Korea; [Lee, Hee Young] Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Songnam, Gyeonggi Do, South Korea	Kangwon National University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Lee, HY (corresponding author), Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Songnam, Gyeonggi Do, South Korea.	lhy0313@gmail.com; leeseoyoung@kangwon.ac.kr	lee, hy/GRS-0797-2022		Kangwon National University (KR)	Kangwon National University (KR)	This work was funded by Kangwon National University (KR) (www.kangwon.ac.kr) and the grant recipient was SYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Kangwon National University.	Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Bassetti CL, 2006, STROKE, V37, P967, DOI 10.1161/01.STR.0000208215.49243.c3; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Benjamin JA, 2008, POSTGRAD MED J, V84, P15, DOI 10.1136/pgmj.2007.062836; Birkbak J, 2014, J CLIN SLEEP MED, V10, P103, DOI 10.5664/jcsm.3376; Buchner NJ, 2007, AM J RESP CRIT CARE, V176, P1274, DOI 10.1164/rccm.200611-1588OC; Campos-Rodriguez F, 2014, AM J RESP CRIT CARE, V189, P1544, DOI 10.1164/rccm.201311-2012OC; Campos-Rodriguez F, 2012, ANN INTERN MED, V156, P115, DOI 10.7326/0003-4819-156-2-201201170-00006; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Elwood P, 2006, J EPIDEMIOL COMMUN H, V60, P69, DOI 10.1136/jech.2005.039057; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kasai T, 2012, CIRCULATION, V126, P1495, DOI 10.1161/CIRCULATIONAHA.111.070813; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim SY, 2013, J CLIN EPIDEMIOL, V66, P408, DOI 10.1016/j.jclinepi.2012.09.016; Lamberts M, 2014, J INTERN MED, V276, P659, DOI 10.1111/joim.12302; Lavie P, 2007, EUR RESPIR REV, V16, P203, DOI 10.1183/09059180.00010610; Lee SA, 2008, SLEEP, V31, P1207; Loke YK, 2012, CIRC-CARDIOVASC QUAL, V5, P720, DOI 10.1161/CIRCOUTCOMES.111.964783; Martinez-Garcia MA, 2012, EUR RESPIR J, V39, P906, DOI 10.1183/09031936.00011311; Martinez-Garcia MA, 2012, AM J RESP CRIT CARE, V186, P909, DOI 10.1164/rccm.201203-0448OC; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Molnar MZ, 2015, THORAX; Montserrat JM, 2001, AM J RESP CRIT CARE, V164, P608, DOI 10.1164/ajrccm.164.4.2006034; Mooe T, 2001, AM J RESP CRIT CARE, V164, P1910, DOI 10.1164/ajrccm.164.10.2101072; Parra O, 2011, EUR RESPIR J, V37, P1128, DOI 10.1183/09031936.00034410; Peter B, 2011, PRINCIPLES PRACTICE, P1233; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Yaggi H, 2003, CLIN CHEST MED, V24, P223, DOI 10.1016/S0272-5231(03)00027-3; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104	34	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146317	10.1371/journal.pone.0146317	http://dx.doi.org/10.1371/journal.pone.0146317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731604	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400147
J	Real, E; Jover, L; Verdaguer, R; Griera, A; Segalas, C; Alonso, P; Contreras, F; Arteman, A; Menchon, JM				Real, Eva; Jover, Lluis; Verdaguer, Ricard; Griera, Antoni; Segalas, Cinto; Alonso, Pino; Contreras, Fernando; Arteman, Antoni; Menchon, Jose M.			Factors Associated with Long-Term Sickness Absence Due to Mental Disorders: A Cohort Study of 7.112 Patients during the Spanish Economic Crisis	PLOS ONE			English	Article							TO-WORK INTERVENTION; DISABILITY PENSION; PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; HEALTH-PROBLEMS; LEAVE; DURATION; SPAIN; EMPLOYEES; DIAGNOSIS	Background Mental health problems are very common and often lead to prolonged sickness absence, having serious economic repercussions for most European countries. Periods of economic crisis are important social phenomena that are assumed to increase sickness absence due to mental disorders, although research on this topic remains scarce. The aim of this study was to gather data on long-term sickness absence (and relapse) due to mental disorders in Spain during a period of considerable socio-economic crisis. Methods Relationships were analyzed (using chi-squared tests and multivariate modelling via binary logistic regression) between clinical, social/employment-related and demographic factors associated and long-term sickness absence (>60 consecutive days) due to mental disorders in a cohort of 7112 Spanish patients during the period 2008-2012. Results Older age, severe mental disorders, being self-employed, having a non-permanent contract, and working in the real estate and construction sector were associated with an increased probability of long-term sickness absence (gender had a mediating role with respect to some of these variables). Relapses were associated with short-term sick leave (return to work due to 'improvement') and with working in the transport sector and public administration. Conclusions Aside from medical factors, other social/employment-related and demographic factors have a significant influence on the duration of sickness absence due to mental disorders.	[Real, Eva; Segalas, Cinto; Alonso, Pino; Contreras, Fernando; Menchon, Jose M.] Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Dept Psychiat, Barcelona, Spain; [Real, Eva; Segalas, Cinto; Alonso, Pino; Contreras, Fernando; Menchon, Jose M.] Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos III Hlth Inst, Barcelona, Spain; [Jover, Lluis] Univ Barcelona, Fac Med, Dept Publ Hlth, Biostat Unit, Barcelona 7, Spain; [Verdaguer, Ricard; Griera, Antoni] Egarsat, Mutual Soc Work Accidents & Work Related Illnesse, Egarsat, Spain; [Arteman, Antoni] SSM Serveis Salut Mental SL, Comprehens Hlth Serv Sick Doctors, Galatea Fdn, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona	Real, E (corresponding author), Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Dept Psychiat, Barcelona, Spain.	ereal@bellvitgehospital.cat	Alonso, Pino/AAI-3439-2020; Jover, Lluís/D-2192-2011; Contreras, Fernando/S-5217-2017; Menchon, Jose/A-5242-2009	Jover, Lluís/0000-0003-0631-1398; Segalas, Cinto/0000-0002-0959-0356; Contreras, Fernando/0000-0003-2929-2804; Menchon, Jose/0000-0002-6231-6524; Alonso, Pino/0000-0002-5779-9111	the Instituto de Salud Carlos III (ISCIII) [JR14/00038]	the Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III)	ER was supported by a Juan Rodes contract (JR14/00038) from the Instituto de Salud Carlos III (ISCIII). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAT, 2011, AF CONT COM; Andersen MF, 2014, J OCCUP REHABIL, V24, P709, DOI 10.1007/s10926-014-9498-5; Arends I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071937; Bartoll X, 2014, EUR J PUBLIC HEALTH, V24, P415, DOI 10.1093/eurpub/ckt208; Benavides FG, 2010, GAC SANIT, V24, P215, DOI 10.1016/j.gaceta.2009.12.002; Bernal JAL, 2013, EUR J PUBLIC HEALTH, V23, P732, DOI 10.1093/eurpub/ckt083; BRENNER MH, 1983, SOC SCI MED, V17, P1125, DOI 10.1016/0277-9536(83)90005-9; Catalina-Romero C, 2013, GAC SANIT, V27, P40, DOI 10.1016/j.gaceta.2011.12.008; Delclos J, 2013, GAC SANIT, V27, P81, DOI 10.1016/j.gaceta.2012.04.005; Ejeby K, 2014, SCAND J PRIM HEALTH, V32, P67, DOI 10.3109/02813432.2014.909163; FEDEA, 2014, PRIM INF OBS SAN FED; Foss L, 2010, J OCCUP ENVIRON MED, V52, P698, DOI 10.1097/JOM.0b013e3181e98731; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Gjesdal S, 2003, SCAND J PUBLIC HEALT, V31, P246, DOI 10.1080/14034940210165154; González Beatriz, 2004, Gac Sanit, V18, P82, DOI 10.1157/13062255; Haro JM, 2006, MED CLIN-BARCELONA, V126, P445, DOI 10.1157/13086324; Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469; Hensing G, 1996, BRIT J PSYCHIAT, V169, P740, DOI 10.1192/bjp.169.6.740; Hosmer D. W., 2013, APPL LOGISTIC REGRES; INE, 2008, ENC POBL ACT EPA PRI; INE, 2013, ENC POBL ACT EPA PRI; INSS, 2014, MAN TIEMP OPT INC TE; Kessler RC, 2007, J CLIN PSYCHIAT, V68, P10; Lund T, 2008, OCCUP ENVIRON MED, V65, P28, DOI 10.1136/oem.2006.031393; Lytsy P, 2014, INT J REHABIL RES; Martin MHT, 2013, J OCCUP REHABIL, V23, P621, DOI 10.1007/s10926-013-9421-5; Mittendorfer-Rutz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099869; Navarro-Mateu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137293; OECD The OECD Mental Health and Work Project, 2011, OECD MENT HLTH WORK; Organisation for Economic Co-operation and Development (OECD), 2011, SOC GLANC 2011 OECD, DOI [10.1787/soc_glance-2011-en, DOI 10.1787/SOC_GLANCE-2011-EN]; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Rice DP, 1998, BRIT J PSYCHIAT, V173, P4, DOI 10.1192/S0007125000293458; Roelen CAM, 2012, OCCUP MED-OXFORD, V62, P379, DOI 10.1093/occmed/kqs065; Roelen CA, 2014, J OCCUP REHABIL; Roelen CA, 2013, EUR J PUBLIC HEALTH, V23, P128, DOI 10.1093/eurpub/cks036; Romera I, 2010, EUR PSYCHIAT, V25, P58, DOI 10.1016/j.eurpsy.2009.02.007; Royo-Bordonada M, 1999, Gac Sanit, V13, P177; Sandanger I, 2000, SCAND J PUBLIC HEALT, V28, P244, DOI 10.1080/14034940050500474; Shiels C, 2004, BRIT J GEN PRACT, V54, P86; Slany C, 2014, INT J OCCUP ENV HEAL, V20, P16, DOI 10.1179/2049396713Y.0000000048; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Vaez M, 2007, SOC PSYCH PSYCH EPID, V42, P381, DOI 10.1007/s00127-007-0189-9; Vlasveld MC, 2013, J OCCUP REHABIL, V23, P309, DOI 10.1007/s10926-012-9406-9; Wang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096025	44	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146382	10.1371/journal.pone.0146382	http://dx.doi.org/10.1371/journal.pone.0146382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26730603	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400166
J	Zhang, JF; Wu, M; Yu, JW; Li, XL; Pei, WF				Zhang, Jinfa; Wu, Man; Yu, Jiwen; Li, Xingli; Pei, Wenfeng			Breeding Potential of Introgression Lines Developed from Interspecific Crossing between Upland Cotton (Gossypium hirsutum) and Gossypium barbadense: Heterosis, Combining Ability and Genetic Effects	PLOS ONE			English	Article							HOST-PLANT GERMPLASM; FIBER-QUALITY; YIELD COMPONENTS; F2 HYBRIDS; INHERITANCE; IMPROVEMENT; CULTIVARS; RESTORATION; LENGTH	Upland cotton (Gossypium hirstum L.), which produces more than 95% of the world natural cotton fibers, has a narrow genetic base which hinders progress in cotton breeding. Introducing germplasm from exotic sources especially from another cultivated tetraploid G. barbadense L. can broaden the genetic base of Upland cotton. However, the breeding potential of introgression lines (ILs) in Upland cotton with G. barbadense germplasm integration has not been well addressed. This study involved six ILs developed from an interspecific crossing and back-crossing between Upland cotton and G. barbadense and represented one of the first studies to investigate breeding potentials of a set of ILs using a full diallel analysis. Highmid-parent heterosis was detected in several hybrids between ILs and a commercial cultivar, which also out-yielded the high-yielding cultivar parent in F-1, F-2 and F-3 generations. A further analysis indicated that general ability (GCA) variance was predominant for all the traits, while specific combining ability (SCA) variance was either non-existent or much lower than GCA. The estimated GCA effects and predicted additive effects for parents in each trait were positively correlated (at P<0.01). Furthermore, GCA and additive effects for each trait were also positively correlated among generations (at P<0.05), suggesting that F-2 and F-3 generations can be used as a proxy to F-1 in analyzing combining abilities and estimating genetic parameters. In addition, differences between reciprocal crosses in F-1 and F-2 were not significant for yield, yield components and fiber quality traits. But maternal effects appeared to be present for seed oil and protein contents in F-3. This study identified introgression lines as good general combiners for yield and fiber quality improvement and hybrids with high heterotic vigor in yield, and therefore provided useful information for further utilization of introgression lines in cotton breeding.	[Zhang, Jinfa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Wu, Man; Yu, Jiwen; Li, Xingli; Pei, Wenfeng] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Peoples R China	New Mexico State University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhang, JF (corresponding author), New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.	jinzhang@nmsu.edu; yujw666@hotmail.com			National Natural Science Foundation of China [31301367, 31301368]; 863 National High-Tech Research Development Program in China [2012AA101108]; New Mexico Agricultural Experiment Station	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 National High-Tech Research Development Program in China(National High Technology Research and Development Program of China); New Mexico Agricultural Experiment Station	This work was supported by the National Natural Science Foundation of China (grant 31301367 and grant 31301368), 863 National High-Tech Research Development Program in China (grant 2012AA101108) and New Mexico Agricultural Experiment Station.	Baker J. L., 1975, Cotton Growing Review, V52, P209; BHARDWAJ HL, 1984, J AGR SCI, V103, P511, DOI 10.1017/S0021859600043604; Braden CA, 2009, CROP SCI, V49, P756, DOI 10.2135/cropsci2008.07.0418; Campbell BT, 2008, CROP SCI, V48, P593, DOI 10.2135/cropsci2007.06.0362; Cheatham C. L., 2003, Journal of Cotton Science, V7, P16; Coyle GG, 1997, CROP SCI, V37, P1118, DOI 10.2135/cropsci1997.0011183X003700040014x; Davis D. D., 1978, Advances in Agronomy, V30, P129; Dong HZ, 2004, CURR SCI INDIA, V86, P778; FURBECK SM, 1993, EUPHYTICA, V69, P203, DOI 10.1007/BF00022366; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Gutierrez OA, 2002, CROP SCI, V42, P1841, DOI 10.2135/cropsci2002.1841; Hinze LL, 2011, EUPHYTICA, V181, P115, DOI 10.1007/s10681-011-0442-x; Li XL, 2000, SCI AGR SINICA, V33, P111; Li XL, 2001, HENAN AGR SCI, P13; Lu HJ, 2011, AUST J CROP SCI, V5, P384; Lukonge EP, 2008, EUPHYTICA, V161, P383, DOI 10.1007/s10681-007-9587-z; Meredith Jr WR, 1984, QUANTITATIVE GENETIC, P131; Meredith W. R. Jr., 1998, Journal of Cotton Science, V2, P77; MEREDITH WR, 1990, CROP SCI, V30, P1045, DOI 10.2135/cropsci1990.0011183X003000050018x; MEYER VG, 1975, J HERED, V66, P23, DOI 10.1093/oxfordjournals.jhered.a108566; Ragsdale PI, 2007, CROP SCI, V47, P1013, DOI 10.2135/cropsci2006.09.0627; Smith CW, 2010, CROP SCI, V50, P567, DOI 10.2135/cropsci2009.04.0202; Sun J., 1994, ACTA GOSSYPII SIN, V3, P135; TANG B, 1993, CROP SCI, V33, P700, DOI 10.2135/cropsci1993.0011183X003300040012x; TANG B, 1993, CROP SCI, V33, P706, DOI 10.2135/cropsci1993.0011183X003300040013x; THOMSON NJ, 1989, AUST J AGR RES, V39, P973; THOMSON NJ, 1989, AUST J AGR RES, V39, P991; THOMSON NJ, 1971, AUST J AGR RES, V22, P759, DOI 10.1071/AR9710759; Tyagi P, 2014, EUPHYTICA, V195, P117, DOI 10.1007/s10681-013-0987-y; WEAVER DB, 1977, CROP SCI, V17, P497, DOI 10.2135/cropsci1977.0011183X001700040003x; [邢朝柱 XING Chaozhu], 2007, [棉花学报, Cotton Science], V19, P337; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JW, 2012, EUPHYTICA, V187, P191, DOI 10.1007/s10681-012-0630-3; Zeng LH, 2011, CROP SCI, V51, P2362, DOI 10.2135/cropsci2010.09.0536; Zeng LH, 2011, CROP SCI, V51, P60, DOI 10.2135/cropsci2010.07.0413; Zhang JF, 2007, PLANT BREEDING, V126, P164, DOI 10.1111/j.1439-0523.2007.01303.x; Zhang JF, 2005, CROP SCI, V45, P2363, DOI 10.2135/cropsci2005.0140; Zhang JF, 2001, CROP SCI, V41, P289, DOI 10.2135/cropsci2001.412289x; Zhang JF, 2001, CROP SCI, V41, P283, DOI 10.2135/cropsci2001.412283x; Zhang JF, 2014, EUPHYTICA, V198, P1, DOI 10.1007/s10681-014-1094-4; Zhang YD, 2005, AGRON J, V97, P1097, DOI 10.2134/agronj2004.0260; Zhu J, 1989, THESIS; Zhu J., 1993, J BIOMATH, V8, P32	43	16	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0143646	10.1371/journal.pone.0143646	http://dx.doi.org/10.1371/journal.pone.0143646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730964	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400007
J	Hoffer, ME; Szczupak, M; Kiderman, A; Crawford, J; Murphy, S; Marshall, K; Pelusso, C; Balaban, C				Hoffer, Michael E.; Szczupak, Mikhaylo; Kiderman, Alexander; Crawford, James; Murphy, Sara; Marshall, Kathryn; Pelusso, Constanza; Balaban, Carey			Neurosensory Symptom Complexes after Acute Mild Traumatic Brain Injury	PLOS ONE			English	Article							SEX-DIFFERENCES; CONCUSSION; MANAGEMENT	Mild Traumatic Brain Injury (mTBI) is a prominent public health issue. To date, subjective symptom complaints primarily dictate diagnostic and treatment approaches. As such, the description and qualification of these symptoms in the mTBI patient population is of great value. This manuscript describes the symptoms of mTBI patients as compared to controls in a larger study designed to examine the use of vestibular testing to diagnose mTBI. Five symptom clusters were identified: Post-Traumatic Headache/Migraine, Nausea, Emotional/Affective, Fatigue/Malaise, and Dizziness/Mild Cognitive Impairment. Our analysis indicates that individuals with mTBI have headache, dizziness, and cognitive dysfunction far out of proportion to those without mTBI. In addition, sleep disorders and emotional issues were significantly more common amongst mTBI patients than non-injured individuals. A simple set of questions inquiring about dizziness, headache, and cognitive issues may provide diagnostic accuracy. The consideration of other symptoms may be critical for providing prognostic value and treatment for best short-term outcomes or prevention of long-term complications.	[Hoffer, Michael E.; Szczupak, Mikhaylo; Murphy, Sara; Pelusso, Constanza] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Hoffer, Michael E.; Szczupak, Mikhaylo; Pelusso, Constanza] Univ Miami, Sports Performance & Wellness Inst, Miami, FL USA; [Hoffer, Michael E.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Kiderman, Alexander] Neurokinetics Inc, Pittsburgh, PA USA; [Crawford, James; Marshall, Kathryn] Madigan Army Med Ctr, Dept Otolaryngol, Tacoma, WA 98431 USA; [Balaban, Carey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA	University of Miami; University of Miami; University of Miami; Madigan Army Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoffer, ME (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.	Michael.hoffer@miami.edu	Murphy, Sara/GRJ-1785-2022; Balaban, Carey/O-6586-2019; Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Szczupak, Mikhaylo/0000-0002-2569-2184; Murphy, Sara/0000-0003-3197-2649	Head Health Challenge II grant (National Football League, Underarmor, General Electric); Department of Defense [W81XWH-12-C-0205]	Head Health Challenge II grant (National Football League, Underarmor, General Electric); Department of Defense(United States Department of Defense)	This work was supported by Head Health Challenge II grant (National Football League, Underarmor, General Electric) and Department of Defense grant W81XWH-12-C-0205. The authors received no specific funding for this work.	Balaban CD, 2015, 2015 MIDW M ASS RES; Cantu R., 2009, J ATHL TRAINING, V44, P434, DOI [DOI 10.4085/1062-6050-44.4.434, 10.4085/1062-6050-44.4.434]; CELENTANO DD, 1990, SOC SCI MED, V30, P1289, DOI 10.1016/0277-9536(90)90309-G; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Hoffer ME, 2015, 2015 MIDW M ASS RES; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kiderman A, 2015, 2015 MIDW M ASS RES; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; MacGregor EA, 2011, HEADACHE, V51, P843, DOI 10.1111/j.1526-4610.2011.01904.x; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Suarez H, 2011, ACTA OTO-LARYNGOL, V131, P377, DOI 10.3109/00016489.2010.534113; Talkowski ME, 2005, J COGNITIVE NEUROSCI, V17, P1432, DOI 10.1162/0898929054985419; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Yardley L, 2001, J NEUROL NEUROSUR PS, V71, P48, DOI 10.1136/jnnp.71.1.48	17	10	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146039	10.1371/journal.pone.0146039	http://dx.doi.org/10.1371/journal.pone.0146039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727256	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000367681500047
J	Perdices, A; Bohlen, J; Slechtova, V; Doadrio, I				Perdices, Anabel; Bohlen, Joerg; Slechtova, Vendula; Doadrio, Ignacio			Molecular Evidence for Multiple Origins of the European Spined Loaches (Teleostei, Cobitidae)	PLOS ONE			English	Article							CYTOCHROME-B GENE; PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; COBITOIDEA TELEOSTEI; MITOCHONDRIAL; PHYLOGEOGRAPHY; CYPRINIFORMES; EVOLUTIONARY; CYPRINIDAE; NUCLEAR	We present a phylogenetic investigation of the Northern Clade, the major monophyletic clade within the freshwater fish family Cobitidae, one of the most prominent families of freshwater fishes found in Asian and European waters. Phylogenetic reconstructions based on the cytochrome b and RAG-1 genes show the genera Microcobitis, Sabanejewia, Koreocobitis and Kichulchoia as monophyletic groups. These reconstructions also show a Cobitis sensu lato and a Misgurnus sensu lato group. The Cobitis sensu lato group includes all species of Cobitis, Iksookimia, Niwaella and Kichulchoia, while the Misgurnus sensu lato group includes Misgurnus, Paramisgurnus and Koreocobitis. Although the monophyly of both the Cobitis sensu lato and Misgurnus sensu lato groups is supported, relationships within the groups are incongruent with current generic definitions. The absence of monophyly of most genera included in the Cobitis sensu lato group (Cobitis, Iksookimia and Niwaella) or their low genetic differentiation (Kichuchoia) supports their consideration as synonyms of Cobitis. Molecular phylogenies indicate that the Asian species of Misgurnus experienced a mitochondrial introgression from a lineage of Cobitis. We also find two nuclear haplotypes in the same Cobitis species from the Adriatic area that, in the absence of morphological differentiation, may indicate molecular introgression. Most lineages within the Northern Clade consist of species found in East Asia. However, some lineages also contain species from Europe and Asia Minor. The phylogenetic relationships presented here are consistent with previous studies suggesting an East Asian origin of the Northern Clade. According to the current distributions and phylogenetic relationships of the Misgurnus sensu lato and Cobitis clade lineages, particularly of M. fossilis and C. melanoleuca, the range expansion of East Asian species into Europe was most likely via Siberia into Northern and Central Europe. Phylogenetic analyses also show that the Cobitis sensu lato group consists of two clear subgroups (I and II), each presenting geographical differences. Subgroup I is distributed exclusively in East Asian drainages with an Eastern European offshoot (C. melanoleuca), whereas Subgroup II includes species widespread throughout Europe (including the Mediterranean), Asia Minor, the Black Sea and the Caucasus, with some lineages related to species restricted to East Asia.	[Perdices, Anabel; Doadrio, Ignacio] CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain; [Bohlen, Joerg; Slechtova, Vendula] Inst Anim Physiol & Genet, Lab Fish Genet, Libechov, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences	Perdices, A (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain.	aperdices@mncn.csic.es	Doadrio, Ignacio/F-8448-2016	Doadrio, Ignacio/0000-0003-4863-9711	Ministerio de Ciencia e Innovacion (Spain) [CGL2007-61010]; Ministerio de Economia y Competitividad (Spain) [CTM2014-57949-R]; Grant Agency of the Czech Republic [206/08/0637]; Academy of Sciences of the Czech Republic [RVO 67985904]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad (Spain)(Spanish Government); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This project was partially supported by Projects Ref. CGL2007-61010 Ministerio de Ciencia e Innovacion (Spain) and CTM2014-57949-R Ministerio de Economia y Competitividad (Spain) to A. Perdices, by grant 206/08/0637 of the Grant Agency of the Czech Republic, and RVO 67985904 of the Academy of Sciences of the Czech Republic to J. Bohlen and V. Slechtova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2008, HYDROBIOLOGIA, V615, P103, DOI 10.1007/s10750-008-9558-y; Banarescu P., 1990, ZOOGEOGRAPHY FRESH W, V1; Banarescu P., 1991, ZOOGEOGRAPHY FRESH W, V2; BANARESCU P, 1991, CYPRINID FISHES SYST, P127; Bianco P.G., 1990, Ichthyological Exploration of Freshwaters, V1, P167; Bohlen J, 2007, J FISH BIOL, V71, P186, DOI 10.1111/j.1095-8649.2007.01547.x; Bohlen J, 2006, MOL PHYLOGENET EVOL, V39, P552, DOI 10.1016/j.ympev.2005.12.007; Bohlen J, 2010, ICHTHYOL EXPLOR FRES, V21, P295; Chen Jingxing, 1981, Transactions of the Chinese Ichthyological Society, P21; Chiang TY, 2010, J FISH BIOL, V76, P1173, DOI 10.1111/j.1095-8649.2010.02589.x; Doadrio I, 2004, MOL PHYLOGENET EVOL, V33, P802, DOI 10.1016/j.ympev.2004.07.008; Doadrio I., 2003, Graellsia, V59, P457; Durand JD, 2003, J HERED, V94, P315, DOI 10.1093/jhered/esg074; Durand JD, 2000, P ROY SOC B-BIOL SCI, V267, P1687; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gambetta L., 1934, Bollettino dei Musei di Zoologia e di Anatomia Comparata Torino, V44, P297; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kitagawa T, 2011, FOLIA ZOOL, V60, P343; Kotlik P, 2004, MOL ECOL, V13, P87, DOI 10.1046/j.1365-294X.2003.02021.x; Kottelat M, 2012, RAFFLES B ZOOL, P1; Levy A, 2009, J BIOGEOGR, V36, P55, DOI 10.1111/j.1365-2699.2008.01969.x; Ludwig A, 2001, ZOOL J LINN SOC-LOND, V131, P381, DOI 10.1111/j.1096-3642.2001.tb02242.x; Machordom A, 2001, MOL PHYLOGENET EVOL, V18, P252, DOI 10.1006/mpev.2000.0876; Markova S, 2010, MOL PHYLOGENET EVOL, V55, P488, DOI 10.1016/j.ympev.2010.01.030; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Perdices A, 2003, MOL PHYLOGENET EVOL, V26, P289, DOI 10.1016/S1055-7903(02)00334-2; Perdices A, 2001, MOL PHYLOGENET EVOL, V19, P468, DOI 10.1006/mpev.2000.0900; Perdices A, 2008, MOL PHYLOGENET EVOL, V46, P382, DOI 10.1016/j.ympev.2007.05.007; Perdices A, 2015, ZOOL SCR, V44, P29, DOI 10.1111/zsc.12085; Perdices A, 2012, ICHTHYOL RES, V59, P113, DOI 10.1007/s10228-011-0259-6; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Pesic V, 2013, ZOOKEYS, P69, DOI 10.3897/zookeys.281.4409; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rylkova K, 2013, AQUACULTURE, V380, P13, DOI 10.1016/j.aquaculture.2012.11.027; Saitoh K, 2004, ZOOL SCI, V21, P795, DOI 10.2108/zsj.21.795; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanda R, 2008, FOLIA ZOOL, V57, P42; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Slechtova V, 2006, MOL PHYLOGENET EVOL, V39, P529, DOI 10.1016/j.ympev.2005.09.018; Slechtova V, 2008, MOL PHYLOGENET EVOL, V47, P812, DOI 10.1016/j.ympev.2007.12.018; Slechtova V, 2007, MOL PHYLOGENET EVOL, V44, P1358, DOI 10.1016/j.ympev.2007.02.019; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2012, PAUP PHYLOGENETIC AN; Sytchevskaya EK., 1989, T JOINT SOVIET MONGO, V39, P83; Tang QY, 2008, HYDROBIOLOGIA, V605, P17, DOI 10.1007/s10750-008-9296-1; Tang QY, 2006, MOL PHYLOGENET EVOL, V39, P347, DOI 10.1016/j.ympev.2005.08.007; Tang QY, 2005, HYDROBIOLOGIA, V544, P249, DOI 10.1007/s10750-005-0863-4; VASILEVA ED, 2001, J ICHTHYOL, V41, P553; Vladykov VD, 1935, J MORPHOL, V57, P275, DOI 10.1002/jmor.1050570114; Yang L, 2015, MOL PHYLOGENET EVOL, V85, P97, DOI 10.1016/j.ympev.2015.01.014; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545	53	27	32	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0144628	10.1371/journal.pone.0144628	http://dx.doi.org/10.1371/journal.pone.0144628			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727121	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500005
J	Sakamoto, T; Kobayashi, S; Yamada, D; Nagano, H; Tomokuni, A; Tomimaru, Y; Noda, T; Gotoh, K; Asaoka, T; Wada, H; Kawamoto, K; Marubashi, S; Eguchi, H; Doki, Y; Mori, M				Sakamoto, Takuya; Kobayashi, Shogo; Yamada, Daisaku; Nagano, Hiroaki; Tomokuni, Akira; Tomimaru, Yoshito; Noda, Takehiro; Gotoh, Kunihito; Asaoka, Tadafumi; Wada, Hiroshi; Kawamoto, Koichi; Marubashi, Shigeru; Eguchi, Hidetoshi; Doki, Yuichiro; Mori, Masaki			A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; PANCREATIC-CANCER; BREAST-CANCER; TGF-BETA; MOLECULAR-MECHANISMS; CURATIVE RESECTION; FEEDBACK LOOP; CELL-LINES; PHASE-II; CHOLANGIOCARCINOMA	Epithelial-mesenchymal transition (EMT) is involved in the characteristics of malignancy, such as invasion, metastasis, and chemoresistance. In biliary tract cancer (BTC), EMT is induced by transforming growth factor-beta 1 (TGF-beta 1). The EMT is reversible; therefore, it is conceivable that it could be related to some epigenetic changes. We focused on histone deacetylase (HDAC) inhibitors as regulators of TGF-beta 1 signaling, and investigated their effect on EMT and chemoresistance. We employed four BTC cell lines (MzChA-1, gemcitabine-resistant MzChA-1, TFK-1, and gemcitabine-resistant TFK-1) and used vorinostat as the HDAC inhibitor. The relative mRNA expression of an epithelial marker (CDH1) and mesenchymal markers (CDH2, vimentin, SNAI1) were measured by qRT-PCR to evaluate factors associated with EMT. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was performed to evaluate the chemoresistance of each cell line. In addition, NOD/SCID mice were used to evaluate the effect of vorinostat in vivo. In the parent MzChA-1 and TFK-1 cell lines, TGF-beta 1 induced EMT and chemoresistance; while vorinostat inhibited the EMT and chemoresistance induced by TGF-beta 1. In gemcitabine-resistant cell lines that highly expressed TGF-beta 1, vorinostat inhibited EMT and attenuated chemoresistance. We showed that vorinostat inhibits nuclear translocation of SMAD4 which is a signaling factor of TGF-beta 1, and this is one of the mechanisms by which vorinostat regulates EMT. We also showed that vorinostat attenuates the binding affinity of SMAD4 to the CDH1-related transcription factors SNAI1, SNAI2, ZEB1, ZEB2, and TWIST. Furthermore, combination therapy with vorinostat and gemcitabine improved survival time in the mice xenografted with gemcitabine resistant MzChA-1 cells. In conclusion, vorinostat regulated TGF-beta 1-induced EMT and chemoresistance through inhibition of SMAD4 nuclear translocation.	[Sakamoto, Takuya; Kobayashi, Shogo; Yamada, Daisaku; Nagano, Hiroaki; Tomokuni, Akira; Tomimaru, Yoshito; Noda, Takehiro; Gotoh, Kunihito; Asaoka, Tadafumi; Wada, Hiroshi; Kawamoto, Koichi; Marubashi, Shigeru; Eguchi, Hidetoshi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Kobayashi, Shogo] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, Osaka, Osaka 5378511, Japan	Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Eguchi, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg, Yamadaoka 2-2 E2, Suita, Osaka 5650871, Japan.	heguchi@gesurg.med.osaka-u.ac.jp			JSPS [24592024, 26861069]; Grants-in-Aid for Scientific Research [26861069] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research of JSPS ((C) 24592024), and Grand-in-Aid for Young Scientists of JSPS ((B) 26861069).	Abaza MSI, 2014, INT J MOL MED, V34, P513, DOI 10.3892/ijmm.2014.1795; Bellucci L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054102; Cassier PA, 2014, ANN ONCOL, V25, P1074, DOI 10.1093/annonc/mdu045; Chanmee T, 2014, J BIOL CHEM, V289, P26038, DOI 10.1074/jbc.M114.564120; Chung CL, 2012, AM J RESP CELL MOL, V46, P437, DOI 10.1165/rcmb.2011-0118OC; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Fakih MG, 2012, CANCER CHEMOTH PHARM, V69, P743, DOI 10.1007/s00280-011-1762-1; Farrell J, 2014, J PROTEOME RES, V13, P2874, DOI 10.1021/pr5000285; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Irvine RA, 2002, MOL CELL BIOL, V22, P6689, DOI 10.1128/MCB.22.19.6689-6696.2002; Jang JY, 2005, ANN SURG, V241, P77, DOI 10.1097/01.sla.0000150166.94732.88; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaimori A, 2010, HEPATOLOGY, V52, P1033, DOI 10.1002/hep.23765; Kawabata M, 1999, J BIOCHEM, V125, P9, DOI 10.1093/oxfordjournals.jbchem.a022273; Kim HJ, 2014, SURG TODAY, V44, P1879, DOI 10.1007/s00595-014-0846-z; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Kobayashi S, 2011, J SURG ONCOL, V104, P499, DOI 10.1002/jso.21971; Krug LM, 2015, LANCET ONCOL, V16, P447, DOI 10.1016/S1470-2045(15)70056-2; Kurahara H, 2012, J SURG ONCOL, V105, P655, DOI 10.1002/jso.23020; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li XL, 2014, MOL CELL BIOL, V34, P533, DOI 10.1128/MCB.01043-13; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Murakami S, 2014, SURG TODAY, V44, P1847, DOI 10.1007/s00595-013-0825-9; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Nakashima S, 2015, CANCER SCI, V106, P584, DOI 10.1111/cas.12652; Ngamphaiboon N, 2015, INVEST NEW DRUG, V33, P225, DOI 10.1007/s10637-014-0174-6; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nitta T, 2014, BRIT J CANCER, V111, P1363, DOI 10.1038/bjc.2014.415; Ogunwobi OO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063765; Ramaswamy B, 2012, BREAST CANCER RES TR, V132, P1063, DOI 10.1007/s10549-011-1928-x; Reguart N, 2014, LUNG CANCER, V84, P161, DOI 10.1016/j.lungcan.2014.02.011; Rodrigues MF, 2015, J CELL BIOCHEM, V116, P797, DOI 10.1002/jcb.25036; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIMIZU Y, 1992, INT J CANCER, V52, P252, DOI 10.1002/ijc.2910520217; Sui XB, 2015, CANCER LETT, V360, P106, DOI 10.1016/j.canlet.2015.02.009; Sun SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091610; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Tu YF, 2014, BREAST CANCER RES TR, V146, P145, DOI 10.1007/s10549-014-3008-5; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Yamada D, 2013, EUR J CANCER, V49, P1725, DOI 10.1016/j.ejca.2012.12.002; Yamada D, 2012, ANN SURG ONCOL, V19, pS355, DOI 10.1245/s10434-011-1797-x; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	50	47	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145985	10.1371/journal.pone.0145985	http://dx.doi.org/10.1371/journal.pone.0145985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726879	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500043
J	Tamada, H; Naito, H; Kitamori, K; Hayashi, Y; Yamagishi, N; Kato, M; Nakajima, T				Tamada, Hazuki; Naito, Hisao; Kitamori, Kazuya; Hayashi, Yumi; Yamagishi, Nozomi; Kato, Masashi; Nakajima, Tamie			Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats	PLOS ONE			English	Article							LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC-FIBROSIS; INSULIN-RESISTANCE; HEPATOCELLULAR-CARCINOMA; PATHOLOGICAL SEVERITY; NATURAL-HISTORY; WEIGHT-LOSS; MICE; MODEL	Nonalcoholic steatohepatitis is related to lifestyle, particularly to dietary habits. We developed diet-induced fibrotic steatohepatitis model stroke-prone spontaneously hypertensive 5/Dmcr (SHRSP5/Dmcr) rats showing steatosis, hepatic inflammation, and severe fibrosis induced by high-fat and -cholesterol (HFC) diet feeding. We aimed to clarify the efficacy of dietary intervention on the disease before and after the appearance of fibrosis. Male SHRSP5/Dmcr rats were divided into 9 groups; of these, 6 groups were fed control or HFC diet for several weeks and the remaining 3 groups represented the dietary intervention groups, which were fed the control diet after HFC diet feeding for 2 (before the appearance of fibrosis) or 8 (after the appearance of fibrosis) weeks. Dietary intervention before the appearance of fibrosis significantly improved the steatosis and reset the increased serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and serum total cholesterol (TC) levels. However, dietary intervention after the appearance of fibrosis was unable to reset the levels of hepatic TC, serum ALT, and fibrogenesis-related markers and had only a minor influence on hepatic fibrosis, although it reset the increased expression of transforming growth factor (TGF)-beta 1 and alpha-smooth muscle actin (SMA). It was noted that dietary intervention improved the increased AST levels; however, aggregated CD68-positive cells were still observed around the fibrosis area, which may be related to the findings of inflammatory cytokine mRNAs. Taken together, dietary intervention for fibrotic steatohepatitis improved steatosis, although it could not completely improve fibrosis.	[Tamada, Hazuki; Kitamori, Kazuya] Kinjo Gakuin Univ, Dept Human Life & Environm, Nagoya, Aichi, Japan; [Naito, Hisao] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Nagoya, Aichi, Japan; [Hayashi, Yumi] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi, Japan; [Yamagishi, Nozomi; Kato, Masashi] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Nagoya, Aichi, Japan; [Nakajima, Tamie] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan	Fujita Health University; Nagoya University; Nagoya University; Chubu University	Nakajima, T (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan.	tnasu23@med.nagoya-u.ac.jp		Nakajima, Tamie/0000-0002-0474-7019; Naito, Hisao/0000-0003-4228-637X	Japan Society for the Promotion of Science [15H04788, 25870865]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (B. 15H04788) and a Grant-in-Aid for Young Scientists (B. 25870865) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/).	Alba LM, 2003, ALIMENT PHARM THER, V17, P977, DOI 10.1046/j.1365-2036.2003.01493.x; ANDERSEN T, 1991, J HEPATOL, V12, P224, DOI 10.1016/0168-8278(91)90942-5; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Beraza N, 2008, GUT, V57, P655, DOI 10.1136/gut.2007.134288; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Chen SM, 2008, J CHIN MED ASSOC, V71, P551, DOI 10.1016/S1726-4901(08)70168-0; Cong WN, 2008, LIFE SCI, V82, P983, DOI 10.1016/j.lfs.2008.01.022; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Huang MA, 2005, AM J GASTROENTEROL, V100, P1072, DOI 10.1111/j.1572-0241.2005.41334.x; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Ioannou GN, 2009, HEPATOLOGY, V50, P175, DOI 10.1002/hep.22941; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Jeong W, 2005, J VET MED SCI, V67, P235, DOI 10.1292/jvms.67.235; Kargulewicz A, 2014, PRZ GASTROENTEROL, V9, P18, DOI 10.5114/pg.2014.40845; Khosravi S, 2011, HEPAT MON, V11, P452; Kitamori Kazuya, 2012, Environmental Health and Preventive Medicine, V17, P173, DOI 10.1007/s12199-011-0235-9; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Lefkowitch JH, 2002, MODERN PATHOL, V15, P699, DOI 10.1097/01.MP.0000019579.30842.96; Li CH, 2005, WORLD J GASTROENTERO, V11, P7620, DOI 10.3748/wjg.v11.i48.7620; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Okada H, 2012, CANCER RES, V72, P4459, DOI 10.1158/0008-5472.CAN-12-0028; Park JW, 2007, J GASTROEN HEPATOL, V22, P491, DOI 10.1111/j.1440-1746.2006.04758.x; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Ramdhan DH, 2010, ENVIRON HEALTH PERSP, V118, P1557, DOI 10.1289/ehp.1001928; ROZENTAL P, 1967, AM J DIG DIS, V12, P198, DOI 10.1007/BF02233443; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Ueno T, 1997, J HEPATOL, V27, P103, DOI 10.1016/S0168-8278(97)80287-5; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; YAMORI Y, 1981, JPN CIRC J, V45, P1068, DOI 10.1253/jcj.45.1068; Yasutake K, 2009, SCAND J GASTROENTERO, V44, P471, DOI 10.1080/00365520802588133; Yetti H, 2013, LIFE SCI, V93, P673, DOI 10.1016/j.lfs.2013.09.013	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145939	10.1371/journal.pone.0145939	http://dx.doi.org/10.1371/journal.pone.0145939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727365	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500038
J	Heffron, R; Cohen, CR; Ngure, K; Bukusi, E; Were, E; Kiarie, J; Mugo, N; Celum, C; Baeten, JM				Heffron, Renee; Cohen, Craig R.; Ngure, Kenneth; Bukusi, Elizabeth; Were, Edwin; Kiarie, James; Mugo, Nelly; Celum, Connie; Baeten, Jared M.		Partners PrEP Study; Partners Prevention HSV HIV Transm; Partners Demonstration Project Tea	A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy	PLOS ONE			English	Article							AFFECTED COUPLES; RISK; PROPHYLAXIS; PREVENTION	Introduction HIV-1 prevention programs targeting HIV-1 serodiscordant couples need to identify couples that are likely to become pregnant to facilitate discussions about methods to minimize HIV-1 risk during pregnancy attempts (i.e. safer conception) or effective contraception when pregnancy is unintended. A clinical prediction tool could be used to identify HIV-1 serodiscordant couples with a high likelihood of pregnancy within one year. Methods Using standardized clinical prediction methods, we developed and validated a tool to identify heterosexual East African HIV-1 serodiscordant couples with an increased likelihood of becoming pregnant in the next year. Datasets were from three prospectively followed cohorts, including nearly 7,000 couples from Kenya and Uganda participating in HIV-1 prevention trials and delivery projects. Results The final score encompassed the age of the woman, woman's number of children living, partnership duration, having had condomless sex in the past month, and non-use of an effective contraceptive. The area under the curve (AUC) for the probability of the score to correctly predict pregnancy was 0.74 (95% CI 0.72-0.76). Scores >= 7 predicted a pregnancy incidence of >17% per year and captured 78% of the pregnancies. Internal and external validation confirmed the predictive ability of the score. Discussion A pregnancy likelihood score encompassing basic demographic, clinical and behavioral factors defined African HIV-1 serodiscordant couples with high one-year pregnancy incidence rates. This tool could be used to engage African HIV-1 serodiscordant couples in counseling discussions about fertility intentions in order to offer services for safer conception or contraception that align with their reproductive goals.	[Heffron, Renee; Ngure, Kenneth; Bukusi, Elizabeth; Mugo, Nelly; Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Heffron, Renee; Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA USA; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Ngure, Kenneth] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Bukusi, Elizabeth] Kenya Govt Med Res Ctr, Microbiol Res, Nairobi, Kenya; [Mugo, Nelly] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya; [Mugo, Nelly] Kenya Govt Med Res Ctr, Dept Obstet & Gynecol, Nairobi, Kenya; [Were, Edwin] Moi Univ, Dept Reprod Hlth, Eldoret, Kenya; [Kiarie, James] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Jomo Kenyatta University of Agriculture & Technology; Kenya Medical Research Institute; Kenya Medical Research Institute; Kenya Medical Research Institute; Moi University; University of Nairobi	Heffron, R (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	rheffron@uw.edu	Heffron, Renee/AAG-5002-2020; Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; John-Stewart, Grace/0000-0002-4301-1573; Donnell, Deborah/0000-0002-0587-7480; Rees, Helen/0000-0003-1442-6734; Were, Edwin/0000-0002-4783-0795; kiarie, james/0000-0003-4180-7858	Eunice Kennedy Shriver National Institute of Child Health and Human Development [K99HD076679, R00HD076679]; Bill and Melinda Gates Foundation [OPP26469, OPP47674, OPP1056051]; National Institute of Mental Health of the US National Institutes of Health [R01 MH095507]; United States Agency for International Development [AID-OAA-A-12-00023]; American people through USAID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD076679, R00HD076679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095507] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States Agency for International Development(United States Agency for International Development (USAID)); American people through USAID(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	RH was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K99HD076679 and R00HD076679). Funding for the Partners HSV/HIV Transmission Study and the Partners PrEP Study was provided by the Bill and Melinda Gates Foundation (OPP26469 & OPP47674). The Partners Demonstration Project is funded by the Bill & Melinda Gates Foundation (OPP1056051), the National Institute of Mental Health of the US National Institutes of Health (R01 MH095507), and the United States Agency for International Development (AID-OAA-A-12-00023). This work is made possible by the generous support of the American people through USAID; the contents are the responsibility of the authors and do not necessarily reflect the views of USAID, NIH, or the United States Government.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Baeten J HRea, 2015, C RETR OPP INF SEATT; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Centers for Disease Control (CDC), 1985, MMWR Morb Mortal Wkly Rep, V34, P721; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Guthrie BL, 2010, AIDS BEHAV, V14, P1066, DOI 10.1007/s10461-010-9716-x; Irungu E, 2014, HIV RES PREVENTION R; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; Kiernan M, 2001, PSYCHOL METHODS, V6, P35, DOI 10.1037//1082-989X.6.1.35; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Matthews LT, 2009, AIDS BEHAV, V13, pS5, DOI 10.1007/s10461-009-9551-0; McDonald S, 2012, PAEDIATR PERINAT EP, V26, P316, DOI 10.1111/j.1365-3016.2012.01286.x; Mmeje Okeoma, 2012, Infect Dis Obstet Gynecol, V2012, P587651, DOI 10.1155/2012/587651; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Mujugira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025828; Ngure K, 2012, AIDS, V26, P513, DOI 10.1097/QAD.0b013e32834f981c; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Schuit E, 2012, BJOG-INT J OBSTET GY, V119, P915, DOI 10.1111/j.1471-0528.2012.03334.x; Schwartz SR, 2014, AIDS, V28, pS277, DOI 10.1097/QAD.0000000000000330; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306	26	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145515	10.1371/journal.pone.0145515	http://dx.doi.org/10.1371/journal.pone.0145515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720412	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900013
J	Kerr, J; Takemoto, M; Bolling, K; Atkin, A; Carlson, J; Rosenberg, D; Crist, K; Godbole, S; Lewars, B; Pena, C; Merchant, G				Kerr, Jacqueline; Takemoto, Michelle; Bolling, Khalisa; Atkin, Andrew; Carlson, Jordan; Rosenberg, Dori; Crist, Katie; Godbole, Suneeta; Lewars, Brittany; Pena, Claudia; Merchant, Gina			Two-Arm Randomized Pilot Intervention Trial to Decrease Sitting Time and Increase Sit-To-Stand Transitions in Working and Non-Working Older Adults	PLOS ONE			English	Article							TELEVISION VIEWING TIME; SEDENTARY TIME; HEALTH OUTCOMES; US ADULTS; ALL-CAUSE; MORTALITY; FEASIBILITY; RISK; WORKSTATIONS; ASSOCIATION	Background Excessive sitting has been linked to poor health. It is unknown whether reducing total sitting time or increasing brief sit-to-stand transitions is more beneficial. We conducted a randomized pilot study to assess whether it is feasible for working and non-working older adults to reduce these two different behavioral targets. Methods Thirty adults (15 workers and 15 non-workers) age 50-70 years were randomized to one of two conditions (a 2-hour reduction in daily sitting or accumulating 30 additional brief sit-to-stand transitions per day). Sitting time, standing time, sit-to-stand transitions and stepping were assessed by a thigh worn inclinometer (activPAL). Participants were assessed for 7 days at baseline and followed while the intervention was delivered (2 weeks). Mixed effects regression analyses adjusted for days within participants, device wear time, and employment status. Time by condition interactions were investigated. Results Recruitment, assessments, and intervention delivery were feasible. The 'reduce sitting' group reduced their sitting by two hours, the 'increase sit-to-stand' group had no change in sitting time (p <.001). The sit-to-stand transition group increased their sit-to-stand transitions, the sitting group did not (p <.001). Conclusions This study was the first to demonstrate the feasibility and preliminary efficacy of specific sedentary behavioral goals.	[Kerr, Jacqueline; Takemoto, Michelle; Bolling, Khalisa; Crist, Katie; Godbole, Suneeta; Lewars, Brittany; Pena, Claudia; Merchant, Gina] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Atkin, Andrew] Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Act Res CEDAR, Cambridge CB2 0QQ, England; [Carlson, Jordan] Childrens Mercy Hosp, Kansas City, MO USA; [Rosenberg, Dori] Grp Hlth Res Inst, Seattle, WA USA	University of California System; University of California San Diego; University of Cambridge; Children's Mercy Hospital	Kerr, J (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA.	jkerr@ucsd.edu			Department of Family Medicine & Public Health, UCSD; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence [RES-590-28-0002]; British Heart Foundation; Department of Health, Economic and Social Research Council; Wellcome Trust under UK Clinical Research Collaboration; Medical Research Council; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12015/7, MC_UP_1001/2, MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UP_1001/2, MR/K023187/1, MC_UU_12015/7] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL119352] Funding Source: NIH RePORTER	Department of Family Medicine & Public Health, UCSD; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Department of Health, Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The pilot study was supported by funds provided by the Department of Family Medicine & Public Health, UCSD. The work of Andrew J Atkin was supported by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence (RES-590-28-0002). Funding from the British Heart Foundation, Department of Health, Economic and Social Research Council, Medical Research Council, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhajah TA, 2012, AM J PREV MED, V43, P298, DOI 10.1016/j.amepre.2012.05.027; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Evans RE, 2012, AM J PREV MED, V43, P293, DOI 10.1016/j.amepre.2012.05.010; Fitzsimons CF, 2013, PREV MED, V57, P718, DOI 10.1016/j.ypmed.2013.07.017; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Gilson ND, 2012, PREV MED, V54, P65, DOI 10.1016/j.ypmed.2011.10.012; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Harrington DM, 2014, J SCI MED SPORT, V17, P371, DOI 10.1016/j.jsams.2013.07.017; Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421; Healy GN, 2013, PREV MED, V57, P43, DOI 10.1016/j.ypmed.2013.04.004; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Kozey-Keadle S, 2012, J OBES, V2012, DOI 10.1155/2012/282303; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Neuhaus M, 2014, AM J PREV MED, V46, P30, DOI 10.1016/j.amepre.2013.09.009; Owen N, 2000, Exerc Sport Sci Rev, V28, P153; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Rosenberg DE, 2015, HEALTH EDUC BEHAV, V42, P669, DOI 10.1177/1090198115577378; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 1998, AM J PREV MED, V15, P379, DOI 10.1016/S0749-3797(98)00076-2; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wijndaele K, 2009, CANCER CAUSE CONTROL, V20, P1355, DOI 10.1007/s10552-009-9356-5	32	31	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145427	10.1371/journal.pone.0145427	http://dx.doi.org/10.1371/journal.pone.0145427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735919	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000367805100026
J	Rajakulendran, S; Pitceathly, RDS; Taanman, JW; Costello, H; Sweeney, MG; Woodward, CE; Jaunmuktane, Z; Holton, JL; Jacques, TS; Harding, BN; Fratter, C; Hanna, MG; Rahman, S				Rajakulendran, Sanjeev; Pitceathly, Robert D. S.; Taanman, Jan-Willem; Costello, Harry; Sweeney, Mary G.; Woodward, Cathy E.; Jaunmuktane, Zane; Holton, Janice L.; Jacques, Thomas S.; Harding, Brian N.; Fratter, Carl; Hanna, Michael G.; Rahman, Shamima			A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease	PLOS ONE			English	Article							DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MUTATIONS; PHENOTYPE; SPECTRUM; FEATURES; ENCEPHALOMYOPATHY; DOMINANT; EPILEPSY; MYOPATHY	Mutations in the nuclear gene POLG (encoding the catalytic subunit of DNA polymerase gamma) are an important cause of mitochondrial disease. The most common POLG mutation, A467T, appears to exhibit considerable phenotypic heterogeneity. The mechanism by which this single genetic defect results in such clinical diversity remains unclear. In this study we evaluate the clinical, neuropathological and mitochondrial genetic features of four unrelated patients with homozygous A467T mutations. One patient presented with the severe and lethal Alpers-Huttenlocher syndrome, which was confirmed on neuropathology, and was found to have a depletion of mitochondrial DNA (mtDNA). Of the remaining three patients, one presented with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), one with a phenotype in the Myoclonic Epilepsy, Myopathy and Sensory Ataxia (MEMSA) spectrum and one with Sensory Ataxic Neuropathy, Dysarthria and Ophthalmoplegia (SANDO). All three had secondary accumulation of multiple mtDNA deletions. Complete sequence analysis of muscle mtDNA using the MitoChip resequencing chip in all four cases demonstrated significant variation in mtDNA, including a pathogenic MT-ND5 mutation in one patient. These data highlight the variable and overlapping clinical and neuropathological phenotypes and downstream molecular defects caused by the A467T mutation, which may result from factors such as the mtDNA genetic background, nuclear genetic modifiers and environmental stressors.	[Rajakulendran, Sanjeev; Pitceathly, Robert D. S.; Hanna, Michael G.] UCL Inst Neurol, London WC1N 3BG, England; [Rajakulendran, Sanjeev; Pitceathly, Robert D. S.; Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Rajakulendran, Sanjeev; Hanna, Michael G.] MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Pitceathly, Robert D. S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neuroscince, London SE5 8AF, England; [Taanman, Jan-Willem] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England; [Costello, Harry; Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, London WC1N 1EH, England; [Sweeney, Mary G.; Woodward, Cathy E.] UCL Inst Neurol, Dept Neurogenet, London WC1N 3BG, England; [Sweeney, Mary G.; Woodward, Cathy E.; Jaunmuktane, Zane; Holton, Janice L.] Natl Hosp Neurol, London WC1N 3BG, England; [Jaunmuktane, Zane; Holton, Janice L.] UCL Inst Neurol, Div Neuropathol, London WC1N 3BG, England; [Jacques, Thomas S.] UCL Inst Child Hlth, Dev Biol & Canc Programme, London WC1N 1EH, England; [Jacques, Thomas S.] Great Ormond St Hosp Children Fdn Trust, Dept Histopathol, London WC1N 1EH, England; [Harding, Brian N.] Childrens Hosp Philadelphia, Div Neuropathol, Philadelphia, PA 19104 USA; [Fratter, Carl] Churchill Hosp, Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Oxford OX3 7LE, England; [Rahman, Shamima] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; King's College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Rahman, S (corresponding author), UCL Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, London WC1N 1EH, England.	shamima.rahman@ucl.ac.uk	Taanman, Jan W/A-5379-2011; Jacques, Thomas/C-2209-2008; Holton, Janice L/F-6831-2011; Rahman, Shamima/M-7904-2019; Rahman, Shamima/C-5232-2008; Jaunmuktane, Zane/ABC-9039-2020	Taanman, Jan W/0000-0002-5476-9785; Jacques, Thomas/0000-0002-7833-2158; Holton, Janice L/0000-0002-3882-5249; Rahman, Shamima/0000-0003-2088-730X; Jaunmuktane, Zane/0000-0001-7738-8881; Pitceathly, Robert/0000-0002-6123-4551; Hanna, Michael/0000-0003-0825-4075	Wellcome Trust Clinical Research Training Fellowship; Myositis UK; National Institute for Health Research Biomedical Research Centres at Great Ormond Street Hospital; University College London Hospitals, an MRC Centre for Neuromuscular Diseases grant [G0601943]; UK NHS Specialised Service for Rare Mitochondrial Diseases of Adults and Children; Medical Research Council [MR/K000608/1, G0601943, G0200335] Funding Source: researchfish; National Institute for Health Research [CL-2013-17-005] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1260] Funding Source: researchfish; MRC [G0200335, G0601943, MR/K000608/1] Funding Source: UKRI	Wellcome Trust Clinical Research Training Fellowship(Wellcome Trust); Myositis UK; National Institute for Health Research Biomedical Research Centres at Great Ormond Street Hospital; University College London Hospitals, an MRC Centre for Neuromuscular Diseases grant; UK NHS Specialised Service for Rare Mitochondrial Diseases of Adults and Children; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	S. Rajakulendran was supported by a Wellcome Trust Clinical Research Training Fellowship. JLH is supported by Myositis UK. S. Rahman is the Great Ormond Street Children's Charity Professor of Paediatric Metabolic Medicine. This research was supported in part by the National Institute for Health Research Biomedical Research Centres at Great Ormond Street Hospital and University College London Hospitals, an MRC Centre for Neuromuscular Diseases grant (G0601943) and the UK NHS Specialised Service for Rare Mitochondrial Diseases of Adults and Children.	Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007; Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P673, DOI 10.1023/A:1022881231253; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; McHugh JC, 2010, MUSCLE NERVE, V41, P265, DOI 10.1002/mus.21494; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076; Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232; Rahman S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000411; Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759; Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488; Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z; Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395; Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A; Xie HBM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-402; Zhadanov SI, 2005, BIOCHEM BIOPH RES CO, V332, P1115, DOI 10.1016/j.bbrc.2005.05.059	32	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145500	10.1371/journal.pone.0145500	http://dx.doi.org/10.1371/journal.pone.0145500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735972	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100027
J	Wang, L; Zhang, S; Luo, JY; Wang, CY; Lv, LM; Zhu, XZ; Li, CH; Cui, JJ				Wang, Li; Zhang, Shuai; Luo, Jun-Yu; Wang, Chun-Yi; Lv, Li-Min; Zhu, Xiang-Zhen; Li, Chun-Hua; Cui, Jin-Jie			Identification of Aphis gossypii Glover (Hemiptera: Aphididae) Biotypes from Different Host Plants in North China	PLOS ONE			English	Article							DNA SEQUENCE DIVERGENCE; ECOLOGICAL SPECIALIZATION; COTTON APHID; PEA APHID; GREENBUG HOMOPTERA; POPULATIONS; DIVERSITY; RACES	Background The cotton-melon aphid, Aphis gossypii Glover (Hemiptera: Aphididae), is a polyphagous species with a worldwide distribution and a variety of biotypes. North China is a traditional agricultural area with abundant winter and summer hosts of A. gossypii. While the life cycles of A. gossypii on different plants have been well studied, those of the biotypes of North China are still unclear. Results Host transfer experiments showed that A. gossypii from North China has two host-specialized biotypes: cotton and cucumber. Based on complete mitochondrial sequences, we identified a molecular marker with five single-nucleotide polymorphisms to distinguish the biotypes. Using this marker, a large-scale study of biotypes on primary winter and summer hosts was conducted. All A. gossypii collected from three primary hosts-hibiscus, pomegranate, and Chinese prickly ash-were cotton biotypes, with more cotton-melon aphids found on hibiscus than the other two species. In May, alate cotton and cucumber biotypes coexisted on cotton and cucumber seedlings, but each preferred its natal host. Both biotypes existed on zucchini, although the cucumber biotype was more numerous. Aphids on muskmelon were all cucumber biotypes, whereas most aphids on kidney bean were cotton biotypes. Aphids on seedlings of potato and cowpea belong to other species. In August, aphids on cotton and cucumber were the respective biotypes, with zucchini still hosting both biotypes as before. Thus, the biotypes had different fitnesses on different host plants. Conclusions Two host-specialized biotypes (cotton and cucumber) are present in North China. Hibiscus, pomegranate, and Chinese prickly ash can serve as winter hosts for the cotton biotype but not the cucumber biotype in North China. The fitnesses of the two host-specialized biotypes differ on various summer hosts. When alate aphids migrate to summer hosts, they cannot accurately land on the corresponding plant.	[Wang, Li; Zhang, Shuai; Luo, Jun-Yu; Wang, Chun-Yi; Lv, Li-Min; Zhu, Xiang-Zhen; Li, Chun-Hua; Cui, Jin-Jie] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Cui, JJ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	cuijinjie@126.com		Zhang, Shuai/0000-0003-3646-1522	Transgenic Major Projects Program of the Ministry of Science and Technology, China [2014ZX08011-002]; National Natural Science Foundation of China [31201518]	Transgenic Major Projects Program of the Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Transgenic Major Projects Program of the Ministry of Science and Technology, China (2014ZX08011-002) and the National Natural Science Foundation of China (31201518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bo Chu (CRI, CAAS) for help with sample collection. This work was funded by the Transgenic Major Projects Program of the Ministry of Science and Technology, China (2014ZX08011-002) and the National Natural Science Foundation of China (31201518).	Agarwala BK, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.3401; ANDO Y, 1992, JPN J APPL ENTOMOL Z, V36, P61, DOI 10.1303/jjaez.36.61; Anstead JA, 2002, B ENTOMOL RES, V92, P17, DOI 10.1079/BER2001141; Birkle LM, 1999, HEREDITY, V82, P605, DOI 10.1046/j.1365-2540.1999.00509.x; BLACKMAN R.L., 1984, ORIENT INSECTS; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; Brevault T, 2008, AGR FOREST ENTOMOL, V10, P215, DOI 10.1111/j.1461-9563.2008.00377.x; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Chan C. K., 1991, APHID TRANSMITTED VI; Charaabi K, 2008, B ENTOMOL RES, V98, P333, DOI 10.1017/S0007485307005585; CLARIDGE MF, 1980, ENTOMOL EXP APPL, V27, P23, DOI 10.1007/BF00377236; Ebert TA, 1997, SOUTHWEST ENTOMOL, V22, P116; Frantz A, 2006, J EVOLUTION BIOL, V19, P392, DOI 10.1111/j.1420-9101.2005.01025.x; GULDEMOND JA, 1994, ENVIRON ENTOMOL, V23, P1235, DOI 10.1093/ee/23.5.1235; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Inaizumi M, 1980, SPECIAL B COLL AGR U; Kocourek F, 1994, EFFECT TEMPERATURE D; KRING JAMES B., 1959, ANN ENT SOC AMER, V52, P284, DOI 10.1093/aesa/52.3.284; Liu XD, 2008, ECOL RES, V23, P919, DOI 10.1007/s11284-007-0458-9; Liu XiangDong, 2002, Agricultural Sciences in China, V1, P1211; Margaritopoulos JT, 2006, B ENTOMOL RES, V96, P153, DOI 10.1079/BER2005410; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Porter DR, 1997, J ECON ENTOMOL, V90, P1055, DOI 10.1093/jee/90.5.1055; Satar S, 2013, ANN APPL BIOL, V162, P41, DOI 10.1111/j.1744-7348.2012.00578.x; SAXENA RC, 1987, INSECT SCI APPL, V8, P453, DOI 10.1017/S1742758400022475; Shufran KA, 2000, INSECT MOL BIOL, V9, P179, DOI 10.1046/j.1365-2583.2000.00177.x; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Sunnucks P, 1997, B ENTOMOL RES, V87, P425, DOI 10.1017/S0007485300037433; Thomas S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-47; Vanlerberghe-Masutti F, 1998, MOL ECOL, V7, P905, DOI 10.1046/j.1365-294x.1998.00421.x; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Wu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060832; Wu ZS, 2004, ANN ENTOMOL SOC AM, V97, P209, DOI 10.1603/0013-8746(2004)097[0209:TSAICA]2.0.CO;2; Xia J., 1997, BIOL CONTROL COTTON; Zhang S, 2016, MITOCHONDRIAL DNA A, V27, P854, DOI 10.3109/19401736.2014.919474	36	26	33	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146345	10.1371/journal.pone.0146345	http://dx.doi.org/10.1371/journal.pone.0146345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735973	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100045
J	Anuracpreeda, P; Chawengkirttikul, R; Sobhon, P				Anuracpreeda, Panat; Chawengkirttikul, Runglawan; Sobhon, Prasert			Immunodiagnosis of Fasciola gigantica Infection Using Monoclonal Antibody-Based Sandwich ELISA and Immunochromatographic Assay for Detection of Circulating Cathepsin L1 Protease	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CYSTEINE PROTEINASE; KDA ANTIGEN; DIAGNOSIS; CATTLE; EXPRESSION; CLEAVAGE; TEGUMENT; CLONING; SERA	Background Tropical fasciolosis caused by Fasciola gigantica infection is one of the major diseases infecting ruminants in the tropical regions of Africa and Asia including Thailand. Parasitological diagnosis of fasciolosis is often unreliable and possesses low sensitivity. Therefore, the detection of circulating parasite antigens is thought to be a better alternative for diagnosis of fasciolosis, as it reflects the real parasite burden. Methods In this study, we have produced a monoclonal antibody (MoAb) against recombinant F. gigantica cathepsin L1 (rFgCatL1), and developed both sandwich enzyme-linked immunosorbent assay (sandwich ELISA) and immunochromatographic (IC) test for rapid detection of circulating cathepsin L1 protease (CatL1) in the sera from mice experimentally and cattle naturally infected with Fasciola gigantica. MoAb 4E3 and biotinylated rabbit anti-recombinant CatL1 antibody were selected due to their high reactivities and specificities. Results The lower detection limits of sandwich ELISA and IC test were 3 pg/ml and 0.256 ng/ml, respectively. Sandwich ELISA and IC test could detect F. gigantica infection from day 1 to 35 post infection. In experimental mice, the sensitivity, specificity and accuracy were 95%, 100% and 98.6% (for sandwich ELISA), and 93%, 100% and 98.2% (for IC test), while in natural cattle they were 98.3%, 100% and 99.5%(for sandwich ELISA), and 96.7%, 100% and 99.1% (for IC test). Conclusions These two assay methods showed high efficiencies and precisions for diagnosis of fasciolosis by F. gigantica.	[Anuracpreeda, Panat] Mahidol Univ, Div Agr Sci, Saiyok, Kanchanaburi, Thailand; [Anuracpreeda, Panat; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Chawengkirttikul, Runglawan] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand	Mahidol University; Mahidol University; Mahidol University	Anuracpreeda, P (corresponding author), Mahidol Univ, Div Agr Sci, Kanchanaburi Campus, Saiyok, Kanchanaburi, Thailand.	panat.anu@mahidol.ac.th	Anuracpreeda, Panat/GLR-2244-2022		Thailand Research Fund (Senior Research Scholar Fellowship); Faculty of Science, Mahidol University; Thailand Research Fund; Mahidol University	Thailand Research Fund (Senior Research Scholar Fellowship)(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University	This research was financially supported by research grants from The Thailand Research Fund (Senior Research Scholar Fellowship) and Faculty of Science, Mahidol University, to Prasert Sobhon, and research grants from The Thailand Research Fund and Mahidol University to Panat Anuracpreeda.	Al-Yousif Y, 2002, CLIN DIAGN LAB IMMUN, V9, P723, DOI 10.1128/CDLI.9.3.723-724.2002; Anuracpreeda P, 2006, ACTA TROP, V100, P31, DOI 10.1016/j.actatropica.2006.09.006; Anuracpreeda P, 2015, ACTA TROP, V143, P18, DOI 10.1016/j.actatropica.2014.12.003; Anuracpreeda P, 2014, ACTA TROP, V136, P1, DOI 10.1016/j.actatropica.2014.04.012; Anuracpreeda P, 2013, ACTA TROP, V127, P38, DOI 10.1016/j.actatropica.2013.03.020; Anuracpreeda P, 2009, EXP PARASITOL, V123, P334, DOI 10.1016/j.exppara.2009.08.014; Arafa M. S., 1999, Journal of the Egyptian Society of Parasitology, V29, P911; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Demerdash ZA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-176; Dixit AK, 2002, VET PARASITOL, V109, P233, DOI 10.1016/S0304-4017(02)00202-9; ESPINO AM, 1994, J CLIN MICROBIOL, V32, P190, DOI 10.1128/JCM.32.1.190-193.1994; Estuningsih SE, 1997, INT J PARASITOL, V27, P1419, DOI 10.1016/S0020-7519(97)00096-9; FAGBEMI BO, 1995, VET PARASITOL, V58, P235, DOI 10.1016/0304-4017(94)00718-R; Fagbemi BO, 1997, VET PARASITOL, V69, P231, DOI 10.1016/S0304-4017(96)01056-4; FAGBEMI BO, 1995, VET PARASITOL, V57, P309, DOI 10.1016/0304-4017(94)00684-5; GALEN RS, 1980, PEDIATR CLIN N AM, V27, P861; Grams R, 2001, PARASITOL INT, V50, P105, DOI 10.1016/S1383-5769(01)00068-X; HAMMOND JA, 1972, T ROY SOC TROP MED H, V66, P547; Hillyer GV, 1999, FASCIOLOSIS, P435; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGLEY RJ, 1989, AM J TROP MED HYG, V41, P472, DOI 10.4269/ajtmh.1989.41.472; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maleewong W, 1999, AM J TROP MED HYG, V61, P648, DOI 10.4269/ajtmh.1999.61.648; Mas-Coma S, 2014, HELMINTH INFECT THEI, P93; Meemon K, 2010, EXP PARASITOL, V125, P371, DOI 10.1016/j.exppara.2010.03.003; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Ngom B, 2010, ANAL BIOANAL CHEM, V397, P1113, DOI 10.1007/s00216-010-3661-4; Raina OK, 2006, ACTA TROP, V98, P145, DOI 10.1016/j.actatropica.2006.03.004; Smits HL, 2001, CLIN DIAGN LAB IMMUN, V8, P166, DOI 10.1128/CDLI.8.1.166-169.2001; Soulsby E, 1965, TXB VET CLIN PARASIT, VI; Spithill TW, 1999, FASCIOLOSIS, P465; Srihakim S, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P352; Sriveny D, 2006, VET PARASITOL, V135, P25, DOI 10.1016/j.vetpar.2005.10.016; Sukhapesna V., 1994, J THAI VET MED, V45, P45; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Velusamy R, 2004, VET PARASITOL, V119, P187, DOI 10.1016/j.vetpar.2003.09.023; Viyanant V, 1997, ASIAN PAC J ALLERGY, V15, P153; Wongwairot S, 2015, PARASITOL RES, V114, P133, DOI 10.1007/s00436-014-4170-8; YAMASAKI H, 1993, BIOCHEM MOL BIOL INT, V31, P537; Yamasaki H, 2002, INT J PARASITOL, V32, P1031, DOI 10.1016/S0020-7519(02)00057-7	40	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145650	10.1371/journal.pone.0145650	http://dx.doi.org/10.1371/journal.pone.0145650			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731402	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400046
J	Cooper, DA; Cordery, DV; Zajdenverg, R; Ruxrungtham, K; Arasteh, K; Bergmann, F; Neto, JLD; Scherer, J; Chaves, RL; Robinson, P				Cooper, David A.; Cordery, Damien V.; Zajdenverg, Roberto; Ruxrungtham, Kiat; Arasteh, Keikawus; Bergmann, Frank; de Andrade Neto, Jose L.; Scherer, Joseph; Chaves, Ricardo L.; Robinson, Patrick		Study Team	Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naive HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; TREATMENT-EXPERIENCED PATIENTS; PROTEASE INHIBITOR TIPRANAVIR; ACTIVE ANTIRETROVIRAL THERAPY; ONCE-DAILY DOLUTEGRAVIR; DOUBLE-BLIND; DRUG-RESISTANCE; PHENOTYPIC CHARACTERIZATION; DISOPROXIL FUMARATE; PLUS RITONAVIR	Ritonavir-boosted tipranavir (TPV/r) was evaluated as initial therapy in treatment-naive HIV-1-infected patients because of its potency, unique resistance profile, and high genetic barrier. Trial 1182.33, an open-label, randomized trial, compared two TPV/r dose combinations versus ritonavir-boosted lopinavir (LPV/r). Eligible adults, who had no prior antiretroviral therapy were randomized to twice daily (BID) 500/100 mg TPV/r, 500/200 mg TPV/r, or 400/100 mg LPV/r. Each treatment group also received Tenofovir 300 mg + Lamivudine 300 mg QD. The primary endpoint was a confirmed viral load (VL) <50 copies/mL at week 48 without prior antiretroviral regimen changes. Primary analyses examined CD4-adjusted response rates for non-inferiority, using a 15% non-inferiority margin. At week 48, VL<50 copies/mL was 68.4%, 69.9%, and 72.4% in TPV/r100, TPV/r200, and LPV/r groups, respectively, and TPV/r groups showed non-inferiority to LPV/r. Discontinuation due to adverse events was higher in TPV/r100 (10.3%) and TPV/r200 (15.3%) recipients versus LPV/r (3.2%) recipients. The frequency of grade >= 3 transaminase elevations was higher in the TPV/r200 group than the other groups, leading to closure of this group. However, upon continued treatment or following re-introduction after treatment interruption, transaminase elevations returned to grade <= 2 in > 65% of patients receiving either TPV/r200 or TPV/r100. The trial was subsequently discontinued; primary objectives were achieved and continuing TPV/r100 was less tolerable than standard of care for initial highly active antiretroviral therapy. All treatment groups had similar 48-week treatment responses. TPV/r100 and TPV/r200 regimens resulted in sustained treatment responses, which were non-inferior to LPV/r at 48 weeks. When compared with the LPV/r regimen and examined in the light of more current regimens, these TPV/r regimens do not appear to be the best options for treatmentnaive patients based on their safety profiles.	[Cooper, David A.; Cordery, Damien V.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Zajdenverg, Roberto] GlaxoSmithKline, Med Affairs HIV Infect Dis & Immuneinflammatory D, Rio De Janeiro, Brazil; [Ruxrungtham, Kiat] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; [Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Arasteh, Keikawus] Epimed GmbH, Vivantes Auguste Viktoria Hosp, Berlin, Germany; [Bergmann, Frank] Humboldt Univ, Dept Internal Med Infectiol & Pulmonol, D-10099 Berlin, Germany; [de Andrade Neto, Jose L.] Inst AZ Pesquisa E Ensino, Pesquisa E Ensino, Brazil; [Scherer, Joseph; Robinson, Patrick] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Chaves, Ricardo L.] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany	University of New South Wales Sydney; Kirby Institute; GlaxoSmithKline; Thai Red Cross Society; Chulalongkorn University; Humboldt University of Berlin; Boehringer Ingelheim; Boehringer Ingelheim	Cooper, DA (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	dcooper@kirby.unsw.edu.au		Alvarez-Moreno, Carlos Arturo/0000-0001-5419-4494; Ruxrungtham, Kiat/0000-0001-7348-2352; Leen, Clifford/0000-0001-8439-7719	Boehringer-Ingelheim; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476] Funding Source: NIH RePORTER	Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by Boehringer-Ingelheim. Author Joseph Scherer is employed by Boehringer-Ingelheim. Patrick Robinson was formerly employed by Boehringer-Ingelheim during the planning, conduct analysis, and manuscript preparation. Ricardo L. Chaves was employed by Boehringer-Ingelheim during the course of the study. Boehringer-Ingelheim played a role in study design, data collection, analysis, preparation of the manuscript, and decision to publish. Roberto Zajdenverg is employed by GlaxoSmithKline. GlaxoSmithKline provided support in the form of salary for author RZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. GlaxoSmithKline was the source of the background ARV medication, but played no additional role in the study.	Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Cahn P, 2006, CLIN INFECT DIS, V43, P1347, DOI 10.1086/508352; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; Cingolani A, 2002, AIDS, V16, P369, DOI 10.1097/00002030-200202150-00008; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Cohen C, 2014, AIDS, V28, P989, DOI 10.1097/QAD.0000000000000169; Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996; Condra JH, 2000, J INFECT DIS, V182, P758, DOI 10.1086/315782; Cooper D, 2006, 8 INT C DRUG THER HI; de Mendoza C, 2007, EXPERT OPIN PHARMACO, V8, P839, DOI 10.1517/14656566.8.6.839; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Doyon L, 2005, ANTIVIR RES, V68, P27, DOI 10.1016/j.antiviral.2005.07.003; Fatkenheuer G, 1997, AIDS, V11, pF113, DOI 10.1097/00002030-199714000-00001; Gathe J, 2006, CLIN INFECT DIS, V43, P1337, DOI 10.1086/508353; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Johnson Victoria A, 2008, Top HIV Med, V16, P62; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; King MS, 2004, J INFECT DIS, V190, P280, DOI 10.1086/422037; Larder BA, 2000, AIDS, V14, P1943, DOI 10.1097/00002030-200009080-00009; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Li JZ, 2012, ANTIMICROB AGENTS CH, V56, P5998, DOI 10.1128/AAC.01217-12; MacGregor TR, 2004, HIV CLIN TRIALS, V5, P371, DOI 10.1310/RRX7-49ME-27V7-MWWV; McCallister S, 2004, JAIDS-J ACQ IMM DEF, V35, P376, DOI 10.1097/00126334-200404010-00007; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Patick AK, 1998, ANTIMICROB AGENTS CH, V42, P2637, DOI 10.1128/AAC.42.10.2637; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Stanford HIVDB Team, 2012, STANF U HIV RES DAT; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Swenson LC, 2014, AIDS, V28, P1125, DOI 10.1097/QAD.0000000000000203; Vingerhoets J, 2010, AIDS, V24, P503, DOI 10.1097/QAD.0b013e32833677ac; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9	38	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144917	10.1371/journal.pone.0144917	http://dx.doi.org/10.1371/journal.pone.0144917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730818	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400016
J	de Brito, DM; Maracaja-Coutinho, V; de Farias, ST; Batista, LV; do Rego, TG				de Brito, Daniel M.; Maracaja-Coutinho, Vinicius; de Farias, Savio T.; Batista, Leonardo V.; do Rego, Thais G.			A Novel Method to Predict Genomic Islands Based on Mean Shift Clustering Algorithm	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; VIBRIO-VULNIFICUS; CORYNEBACTERIUM-GLUTAMICUM; PATHOGENICITY ISLANDS; SEQUENCE; DNA; IDENTIFICATION; TOOLS; BIOSYNTHESIS; CHROMOSOME	Genomic Islands (GIs) are regions of bacterial genomes that are acquired from other organisms by the phenomenon of horizontal transfer. These regions are often responsible for many important acquired adaptations of the bacteria, with great impact on their evolution and behavior. Nevertheless, these adaptations are usually associated with pathogenicity, antibiotic resistance, degradation and metabolism. Identification of such regions is of medical and industrial interest. For this reason, different approaches for genomic islands prediction have been proposed. However, none of them are capable of predicting precisely the complete repertory of GIs in a genome. The difficulties arise due to the changes in performance of different algorithms in the face of the variety of nucleotide distribution in different species. In this paper, we present a novel method to predict GIs that is built upon mean shift clustering algorithm. It does not require any information regarding the number of clusters, and the bandwidth parameter is automatically calculated based on a heuristic approach. The method was implemented in a new user-friendly tool named MSGIP-Mean Shift Genomic Island Predictor. Genomes of bacteria with GIs discussed in other papers were used to evaluate the proposed method. The application of this tool revealed the same GIs predicted by other methods and also different novel unpredicted islands. A detailed investigation of the different features related to typical GI elements inserted in these new regions confirmed its effectiveness. Stand-alone and user-friendly versions for this new methodology are available at http://msgip.integrativebioinformatics.me.	[de Brito, Daniel M.; Batista, Leonardo V.; do Rego, Thais G.] Univ Fed Paraiba, Ctr Informat, Dept Informat, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Maracaja-Coutinho, Vinicius] Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile; [Maracaja-Coutinho, Vinicius; de Farias, Savio T.] Univ Fed Paraiba, Ctr Ciencias Exatas & Nat, Dept Biol Mol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Maracaja-Coutinho, Vinicius] Inst Vand, Joao Pessoa, Paraiba, Brazil; [Maracaja-Coutinho, Vinicius] Beagle Bioinformat, Santiago, Chile	Universidade Federal da Paraiba; Universidad Mayor; Universidade Federal da Paraiba	do Rego, TG (corresponding author), Univ Fed Paraiba, Ctr Informat, Dept Informat, BR-58059900 Joao Pessoa, Paraiba, Brazil.	gaudenciothais@gmail.com	Maracaja-Coutinho, Vinicius/R-5256-2019; Batista, Leonardo/GLS-3624-2022	Maracaja-Coutinho, Vinicius/0000-0002-8873-9381; Gaudencio do Rego, Thais/0000-0002-6608-4900	Santander Universidades; Beagle Bioinformatics	Santander Universidades; Beagle Bioinformatics	VMC developed part of this research as a visiting researcher at Departamento de Biologia Molecular, Centro de Ciencias Exatas e da Natureza, Universidade Federal da Paraiba, through the program "Becas Iberoamerica - Jovenes Profesores e Investigadores", funded by Santander Universidades. The author VMC receives partial salaries from Beagle Bioinformatics. This funder provided support in the form of salaries for author VMC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.; VMC developed a part of this research as a visiting researcher at the Departamento de Biologia Molecular, Centro de Ciencias Exatas e da Natureza, Universidade Federal da Paraiba, through the program "Becas Iberoamerica-Jovenes Profesores e Investigadores", funded by Santander Universidades.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bishop-Lilly KA, 2013, GENOME ANNOUNCEMENTS, V1, DOI [10.1128/genomeA.00399-13, DOI 10.1128/GEN0MEA.00399-13]; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; Che DS, 2014, PATHOGENS, V3, P36, DOI 10.3390/pathogens3010036; Che DS, 2011, BIOINFORMATION, V7, P311; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Derpanis K.G., 2005, LECT NOTES, V32, P1; Dhillon BK, 2015, NUCLEIC ACIDS RES; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Georgescu B, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P456; Gladieux P, 2014, MOL ECOL, V23, P753, DOI 10.1111/mec.12631; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hasan MS, 2012, BIOINFORMATION, V8, P203, DOI 10.6026/97320630008203; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim EJ, 2015, TRENDS IN MICROBIOLO; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Mormann S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-205; Nag S, 2006, SADHANA-ACAD P ENG S, V31, P105, DOI 10.1007/BF02719776; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Osborn AM, 2002, PLASMID, V48, P202; Ou HY, 2007, NUCLEIC ACIDS RES, V35, pW97, DOI 10.1093/nar/gkm380; Rajan I, 2007, BIOINFORMATICS, V23, P2672, DOI 10.1093/bioinformatics/btm405; Roos TE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-427; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Waterhouse JC, 2006, MICROBIOL-SGM, V152, P1777, DOI 10.1099/mic.0.28647-0; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Wu CG, 2010, APPL ENVIRON MICROB, V76, P5815, DOI 10.1128/AEM.03079-09; Zhang CT, 2004, NAT BIOTECHNOL, V22, P1078, DOI 10.1038/nbt0904-1078b; Zhang R, 2004, BIOINFORMATICS, V20, P612, DOI 10.1093/bioinformatics/btg453	44	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146352	10.1371/journal.pone.0146352	http://dx.doi.org/10.1371/journal.pone.0146352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731657	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400156
J	Liu, L; Ecker, TM; Schumann, S; Siebenrock, KA; Zheng, GY				Liu, Li; Ecker, Timo Michael; Schumann, Steffen; Siebenrock, Klaus-Arno; Zheng, Guoyan			Evaluation of Constant Thickness Cartilage Models vs. Patient Specific Cartilage Models for an Optimized Computer-Assisted Planning of Periacetabular Osteotomy	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; JOINT CONTACT PRESSURE; ACETABULAR DYSPLASIA; FEMOROACETABULAR IMPINGEMENT; HUMAN HIPS; FOLLOW-UP; LABRUM; MECHANICS	Modern computerized planning tools for periacetabular osteotomy (PAO) use either morphology-based or biomechanics-based methods. The latter relies on estimation of peak contact pressures and contact areas using either patient specific or constant thickness cartilage models. We performed a finite element analysis investigating the optimal reorientation of the acetabulum in PAO surgery based on simulated joint contact pressures and contact areas using patient specific cartilage model. Furthermore we investigated the influences of using patient specific cartilage model or constant thickness cartilage model on the biomechanical simulation results. Ten specimens with hip dysplasia were used in this study. Image data were available from CT arthrography studies. Bone models were reconstructed. Mesh models for the patient specific cartilage were defined and subsequently loaded under previously reported boundary and loading conditions. Peak contact pressures and contact areas were estimated in the original position. Afterwards we used a validated preoperative planning software to change the acetabular inclination by an increment of 5 degrees and measured the lateral center edge angle (LCE) at each reorientation position. The position with the largest contact area and the lowest peak contact pressure was defined as the optimal position. In order to investigate the influence of using patient specific cartilage model or constant thickness cartilage model on the biomechanical simulation results, the same procedure was repeated with the same bone models but with a cartilage mesh of constant thickness. Comparison of the peak contact pressures and the contact areas between these two different cartilage models showed that good correlation between these two cartilage models for peak contact pressures (r = 0.634 is an element of [0.6, 0.8], p < 0.001) and contact areas (r = 0.872 > 0.8, p < 0.001). For both cartilage models, the largest contact areas and the lowest peak pressures were found at the same position. Our study is the first study comparing peak contact pressures and contact areas between patient specific and constant thickness cartilage models during PAO planning. Good correlation for these two models was detected. Computer assisted planning with FE modeling using constant thickness cartilage models might be a promising PAO planning tool when a conventional CT is available.	[Liu, Li; Schumann, Steffen; Zheng, Guoyan] Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland; [Ecker, Timo Michael; Siebenrock, Klaus-Arno] Univ Bern, Inselspital, Dept Orthopaed Surg, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Liu, L (corresponding author), Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland.	li.liu@istb.unibe.ch	, Guoyan/M-3617-2018; Zheng, Guoyan/C-8079-2014	, Guoyan/0000-0003-4173-0379; Siebenrock, Klaus Arno/0000-0003-3627-4313; Ecker, Timo Michael/0000-0002-5909-2101	University of Utah; Japanese-Swiss Science and Technology Cooperation Program	University of Utah; Japanese-Swiss Science and Technology Cooperation Program	This work was supported the open source dysplastic hips image data from the University of Utah [17] and partially supported by the Japanese-Swiss Science and Technology Cooperation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; First and second author contributed equally during conduction of this study, analysis of the data and assembly of the manuscript. This work was supported the open source dysplastic hips image data from the University of Utah [17] and partially supported by the Japanese-Swiss Science and Technology Cooperation Program.	Anderson AE, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2953472; Armand M, 2005, ACTA ORTHOP, V76, P303, DOI 10.1080/00016470510030742; Armiger RS, 2009, ACTA ORTHOP, V80, P155, DOI 10.3109/17453670902947390; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Caligaris M, 2008, OSTEOARTHR CARTILAGE, V16, P1220, DOI 10.1016/j.joca.2008.02.020; Clohisy JC, 2009, CLIN ORTHOP RELAT R, V467, P666, DOI 10.1007/s11999-008-0626-4; Dandachli W, 2008, J BONE JOINT SURG BR, V90B, P1428, DOI 10.1302/0301-620X.90B11.20073; Dutoit M, 1999, Acta Orthop Belg, V65, P288; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; GANZ R, 1988, CLIN ORTHOP RELAT R, P26; Haefeli PC, 2015, CLIN ORTHOP RELAT R, V473, P3725, DOI 10.1007/s11999-015-4382-y; Harris MD, 2012, J ORTHOP RES, V30, P1133, DOI 10.1002/jor.22040; Henak CR, 2014, OSTEOARTHR CARTILAGE, V22, P210, DOI 10.1016/j.joca.2013.11.003; Henak CR, 2011, J BIOMECH, V44, P2201, DOI 10.1016/j.jbiomech.2011.06.011; Janzen DL, 1998, SKELETAL RADIOL, V27, P352, DOI 10.1007/s002560050397; KLAUE K, 1988, CLIN ORTHOP RELAT R, P15; Konrath GA, 1998, J BONE JOINT SURG AM, V80A, P1781, DOI 10.2106/00004623-199812000-00008; Lepisto Jyri, 2008, Suom Ortoped Traumatol, V31, P186; Liu L, 2015, MED ENG PHYS, V37, P1169, DOI 10.1016/j.medengphy.2015.09.002; Liu L., 2014, COMPUTER ASSISTED PL, P643; MILLIS MB, 1992, CLIN ORTHOP RELAT R, P154; Niknafs N., 2013, FRONTIERS BIOENGINEE, V1, P1, DOI DOI 10.3389/FBI0E.2013.00020; Phillips ATM, 2007, MED ENG PHYS, V29, P739, DOI 10.1016/j.medengphy.2006.08.010; Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3; Tannast M, 2008, J ORTHOP RES, V26, P1199, DOI 10.1002/jor.20653; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Tannast M, 2015, CLIN ORTHOP RELAT R, V473, P1234, DOI 10.1007/s11999-014-4038-3; Zhao X, 2010, J ORTHOP SCI, V15, P632, DOI 10.1007/s00776-010-1511-z; Zou ZM, 2013, J ORTHOP RES, V31, P472, DOI 10.1002/jor.22245	29	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146452	10.1371/journal.pone.0146452	http://dx.doi.org/10.1371/journal.pone.0146452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731107	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400178
J	Naicker, N; de Jager, P; Naidoo, S; Mathee, A				Naicker, Nisha; de Jager, Pieter; Naidoo, Shan; Mathee, Angela			Household Factors Associated with Self-Harm in Johannesburg, South African Urban-Poor Households	PLOS ONE			English	Article							SUICIDE ATTEMPTS; MENTAL-HEALTH; DOMESTIC VIOLENCE; WOMENS HEALTH; RISK-FACTORS; MULTICOUNTRY; COUNTRIES; INJURIES; ILLNESS; PEOPLE	Introduction Low and middle income countries bear the majority burden of self-harm, yet there is a paucity of evidence detailing risk-factors for self-harm in these populations. This study aims to identify environmental, socio-economic and demographic household-level risk factors for self-harm in five impoverished urban communities in Johannesburg, South Africa. Methods Annual serial cross-sectional surveys were undertaken in five impoverished urban communities in Johannesburg for the Health, Environment and Development (HEAD) study. Logistic regression analysis using the HEAD study data (2006-2011) was conducted to identify household-level risk factors associated with self-harm (defined as a self-reported case of a fatal or non-fatal suicide attempt) within the household during the preceding year. Stepwise multivariate logistic regression analysis was employed to identify factors associated with self-harm. Results A total of 2 795 household interviews were conducted from 2006 to 2011. There was no significant trend in self-harm over time. Results from the final model showed that self-harm was significantly associated with households exposed to a violent crime during the past year (Adjusted Odds Ratio (AOR) 5.72; 95% CI 1.64-19.97); that have a member suffering from a chronic medical condition (AOR 8.95; 95% 2.39-33.56) and households exposed to indoor smoking (AOR 4.39; CI 95% 1.14-16.47). Conclusion This study provides evidence on household risk factors of self-harm in settings of urban poverty and has highlighted the potential for a more cost-effective approach to identifying those at risk of self-harm based on household level factors.	[Naicker, Nisha; Mathee, Angela] South African Med Res Council, Environm & Hlth Res Unit, Johannesburg, South Africa; [Naicker, Nisha; de Jager, Pieter; Naidoo, Shan; Mathee, Angela] Univ Witwatersrand, Sch Publ Hlth, Dept Community Med, Johannesburg, South Africa; [de Jager, Pieter] Natl Inst Occupat Hlth, Epidemiol & Surveillance Unit, Natl Hlth Lab Serv, Johannesburg, South Africa; [Mathee, Angela] Univ Johannesburg, Fac Hlth Sci, Johannesburg, South Africa	South African Medical Research Council; University of Witwatersrand; National Health Laboratory Service; University of Johannesburg	Naicker, N (corresponding author), South African Med Res Council, Environm & Hlth Res Unit, Johannesburg, South Africa.	nisha.naicker@mrc.ac.za						Aaron R, 2004, LANCET, V363, P1117, DOI 10.1016/S0140-6736(04)15896-0; Bertolote Jose Manoel, 2004, Crisis, V25, P147, DOI 10.1027/0227-5910.25.4.147; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Chen VCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130044; Devries K, 2011, SOC SCI MED, V73, P79, DOI 10.1016/j.socscimed.2011.05.006; Dome P, 2011, J PSYCHIATR RES, V45, P488, DOI 10.1016/j.jpsychires.2010.08.011; Donald M, 2006, AUST NZ J PSYCHIAT, V40, P87, DOI 10.1111/j.1440-1614.2006.01747.x; Dooley D, 1996, ANNU REV PUBL HEALTH, V17, P449, DOI 10.1146/annurev.pu.17.050196.002313; Dorpat TL, 1968, SUICIDAL BEHAVIORS, P209; Dzator J, 2013, J BEHAV HEALTH SER R, V40, P71, DOI 10.1007/s11414-012-9305-z; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Gisle L, 2013, SOC PSYCH PSYCH EPID, V48, P1115, DOI 10.1007/s00127-012-0621-7; GLASSMAN AH, 1993, AM J PSYCHIAT, V150, P546; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Juurlink DN, 2004, ARCH INTERN MED, V164, P1179, DOI 10.1001/archinte.164.11.1179; Kapp C, 2008, LANCET, V371, P1986, DOI 10.1016/S0140-6736(08)60852-1; Kapusta ND, 2008, SOC PSYCH PSYCH EPID, V43, P311, DOI 10.1007/s00127-008-0317-1; Li Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-524; Masango SM, 2008, S AFR FAM PRACT, V50, P25, DOI 10.1080/20786204.2008.10873774; Maselko J, 2008, J EPIDEMIOL COMMUN H, V62, P817, DOI 10.1136/jech.2007.069351; Mathews S, 2008, B WORLD HEALTH ORGAN, V86, P552, DOI 10.2471/BLT.07.043786; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McLaughlin J, 2012, CLIN PSYCHOL REV, V32, P677, DOI 10.1016/j.cpr.2012.08.002; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184; Phillips MR, 2012, LANCET, V379, P2318, DOI 10.1016/S0140-6736(12)60913-1; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Pitman A, 2012, LANCET, V379, P2383, DOI 10.1016/S0140-6736(12)60731-4; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Schlebusch L, 2012, AFR J PSYCHIATRY, V15, P436, DOI [10.4314/ajpsy.v15i6.56, http://dx.doi.org/10.4314/ajpsy.v15i6.56]; Schlebusch L, 2010, AFR J PSYCHIATRY, V13, P280; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Shah A, 2009, INT J PSYCHIAT CLIN, V13, P259, DOI 10.3109/13651500902887656; Shahid M, 2008, INT J INJ CONTROL SA, V15, P233, DOI 10.1080/17457300802149811; Sharan P, 2009, BRIT J PSYCHIAT, V195, P354, DOI 10.1192/bjp.bp.108.050187; Shaw M, 2004, ANNU REV PUBL HEALTH, V25, P397, DOI 10.1146/annurev.publhealth.25.101802.123036; Sisask M, 2010, ARCH SUICIDE RES, V14, P44, DOI 10.1080/13811110903479052; Stein DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010574; Toprak S, 2011, PSYCHIAT RES, V187, P140, DOI 10.1016/j.psychres.2010.09.009; Vijayakumar Lakshmi, 2004, World Psychiatry, V3, P158; Vijayakumar L, 2005, CRISIS, V26, P112, DOI 10.1027/0227-5910.26.3.112; World Health Organization, 2014, PREV SUIC PREV SUIC; Wu CY, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-101	47	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146239	10.1371/journal.pone.0146239	http://dx.doi.org/10.1371/journal.pone.0146239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731114	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400125
J	Tognon, M; Corallini, A; Manfrini, M; Taronna, A; Butel, JS; Pietrobon, S; Trevisiol, L; Bononi, I; Vaccher, E; Barbanti-Brodano, G; Martini, F; Mazzoni, E				Tognon, Mauro; Corallini, Alfredo; Manfrini, Marco; Taronna, Angelo; Butel, Janet S.; Pietrobon, Silvia; Trevisiol, Lorenzo; Bononi, Ilaria; Vaccher, Emanuela; Barbanti-Brodano, Giuseppe; Martini, Fernanda; Mazzoni, Elisa			Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects	PLOS ONE			English	Article							PREVALENT SIMIAN-VIRUS-40 INFECTION; PROTEIN-STRUCTURE PREDICTION; SEROLOGIC EVIDENCE; I-TASSER; ASSOCIATION; VIRUS; POLYOMAVIRUSES; OSTEOSARCOMA; EXPRESSION; HUMANS	Simian Virus 40, experimentally assayed in vitro in different animal and human cells and in vivo in rodents, was classified as a small DNA tumor virus. In previous studies, many groups identified Simian Virus 40 sequences in healthy individuals and cancer patients using PCR techniques, whereas others failed to detect the viral sequences in human specimens. These conflicting results prompted us to develop a novel indirect ELISA with synthetic peptides, mimicking Simian Virus 40 capsid viral protein antigens, named mimotopes. This immunologic assay allowed us to investigate the presence of serum antibodies against Simian Virus 40 and to verify whether Simian Virus 40 is circulating in humans. In this investigation two mimotopes from Simian Virus 40 large T antigen, the viral replication protein and oncoprotein, were employed to analyze for specific reactions to human sera antibodies. This indirect ELISA with synthetic peptides from Simian Virus 40 large T antigen was used to assay a new collection of serum samples from healthy subjects. This novel assay revealed that serum antibodies against Simian Virus 40 large T antigen mimotopes are detectable, at low titer, in healthy subjects aged from 18-65 years old. The overall prevalence of reactivity with the two Simian Virus 40 large T antigen peptides was 20%. This new ELISA with two mimotopes of the early viral regions is able to detect in a specific manner Simian Virus 40 large T antigen-antibody responses.	[Tognon, Mauro; Manfrini, Marco; Pietrobon, Silvia; Bononi, Ilaria; Martini, Fernanda; Mazzoni, Elisa] Univ Ferrara, Sect Pathol, I-44100 Ferrara, Italy; [Tognon, Mauro; Manfrini, Marco; Pietrobon, Silvia; Bononi, Ilaria; Martini, Fernanda; Mazzoni, Elisa] Univ Ferrara, Sect Oncol, I-44100 Ferrara, Italy; [Tognon, Mauro; Manfrini, Marco; Pietrobon, Silvia; Bononi, Ilaria; Martini, Fernanda; Mazzoni, Elisa] Univ Ferrara, Sect Expt Biol, I-44100 Ferrara, Italy; [Corallini, Alfredo; Taronna, Angelo; Barbanti-Brodano, Giuseppe] Univ Ferrara, Microbiol Sect, I-44100 Ferrara, Italy; [Butel, Janet S.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Trevisiol, Lorenzo] Univ Verona, Dept Surg, I-37100 Verona, Italy; [Vaccher, Emanuela] Natl Canc Inst, IRCCS, Ctr Riferimento Oncol, Dept Med Oncol, Aviano, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara; Baylor College of Medicine; University of Verona; IRCCS Aviano (CRO)	Martini, F (corresponding author), Univ Ferrara, Sect Pathol, I-44100 Ferrara, Italy.	mrf@unife.it; elisa.mazzoni@unife.it	Trevisiol, Lorenzo/ABD-6737-2020; Vaccher, Emanuela/AAC-9372-2020; Mazzoni, Elisa/K-6313-2016	Trevisiol, Lorenzo/0000-0002-2732-238X; Butel, Janet/0000-0002-6876-3245; Vaccher, Emanuela/0000-0003-3386-5142; Manfrini, Marco/0000-0003-3154-9269; Bononi, Ilaria/0000-0002-5286-5845; Mazzoni, Elisa/0000-0001-6829-8569	Fondazione Veronesi, Milan; Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan; Fondazione Buzzi UNICEM, Casale Monferrato; Associazione Sammarinese per la lotta contro le Leucemie e le Emopatie Maligne, San Marino; Istituto Superiore di Sanita, Roma; Regione Emilia Romagna, Bologna; Fondazione Cassa di Risparmio di Cento, Cento; University Hospital of Ferrara; University of Ferrara, Ferrara, Italy	Fondazione Veronesi, Milan(Fondazione Umberto Veronesi); Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan(Fondazione AIRC per la ricerca sul cancro); Fondazione Buzzi UNICEM, Casale Monferrato; Associazione Sammarinese per la lotta contro le Leucemie e le Emopatie Maligne, San Marino; Istituto Superiore di Sanita, Roma; Regione Emilia Romagna, Bologna(Regione Emilia Romagna); Fondazione Cassa di Risparmio di Cento, Cento; University Hospital of Ferrara; University of Ferrara, Ferrara, Italy	Dr. Elisa Mazzoni is a fellowship recipient of the Fondazione Veronesi, Milan. This work was supported, in part, by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Fondazione Buzzi UNICEM, Casale Monferrato; Associazione Sammarinese per la lotta contro le Leucemie e le Emopatie Maligne (A.S. L.E.M.), San Marino; Istituto Superiore di Sanita (I.S.S), Roma; Regione Emilia Romagna, Bologna; Fondazione Cassa di Risparmio di Cento, Cento; University Hospital of Ferrara; and University of Ferrara, Ferrara, Italy.	Amara K, 2007, INT J CANCER, V121, P2693, DOI 10.1002/ijc.23038; An P, 2012, ANNU REV MICROBIOL, V66, P213, DOI 10.1146/annurev-micro-092611-150154; Barbanti-Brodano G, 2004, JNCI-J NATL CANCER I, V96, P803, DOI 10.1093/jnci/djh151; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; Bononi I, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-38; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Butel J. S., 2010, Viral oncology: basic science and clinical applications, P165; Butel JS, 2012, CURR OPIN VIROL, V2, P508, DOI 10.1016/j.coviro.2012.06.004; Butel JS, 2012, CURR CANCER RES, P377, DOI 10.1007/978-1-4614-0016-5_15; Butel JS, 1999, JNCI-J NATL CANCER I, V91, P119, DOI 10.1093/jnci/91.2.119; Carbone M, 2005, CANCER RES, V65, P10120, DOI 10.1158/0008-5472.CAN-05-1911; Carter JJ, 2003, JNCI-J NATL CANCER I, V95, P1522, DOI 10.1093/jnci/djg074; Comar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110700; Corallini A, 2012, HUM IMMUNOL, V73, P502, DOI 10.1016/j.humimm.2012.02.009; Cutrone R, 2005, CANCER RES, V65, P10273, DOI 10.1158/0008-5472.CAN-05-2028; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gjoerup O, 2010, ADV CANCER RES, V106, P1, DOI 10.1016/S0065-230X(10)06001-X; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Heinsohn S, 2009, ONCOL REP, V21, P289, DOI 10.3892/or_00000220; Jafar S, 1998, J MED VIROL, V54, P276, DOI 10.1002/(SICI)1096-9071(199804)54:4<276::AID-JMV7>3.0.CO;2-1; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; KIT S, 1969, INT J CANCER, V4, P384, DOI 10.1002/ijc.2910040403; Li GW, 2010, INFECT IMMUN, V78, P898, DOI 10.1128/IAI.00513-09; Lundstig A, 2005, J GEN VIROL, V86, P1703, DOI 10.1099/vir.0.80783-0; Martini Fernanda, 2007, Infect Agent Cancer, V2, P13, DOI 10.1186/1750-9378-2-13; Martini F, 2013, EPIDEMIOLOGY, V24, P464, DOI 10.1097/EDE.0b013e31828d3ae6; Mazzoni E, 2013, J INFECTION, V67, P356, DOI 10.1016/j.jinf.2013.06.002; Mazzoni E, 2016, HEAD NECK-J SCI SPEC, V38, P232, DOI 10.1002/hed.23879; Mazzoni E, 2015, CANCER-AM CANCER SOC, V121, P708, DOI 10.1002/cncr.29137; Mazzoni E, 2014, NEURO-ONCOLOGY, V16, P513, DOI 10.1093/neuonc/not217; Mazzoni E, 2012, P NATL ACAD SCI USA, V109, P18066, DOI 10.1073/pnas.1213238109; Mazzoni E, 2012, EXP HEMATOL, V40, P466, DOI 10.1016/j.exphem.2012.02.008; Meneses A, 2005, HAEMATOLOGICA, V90, P1635; Pancaldi C, 2009, J INFECTION, V58, P53, DOI 10.1016/j.jinf.2008.10.014; Paracchin V, 2005, MOL MED, V11, P48, DOI 10.2119/2005-00007.Taioli; Pipas JM, 2009, VIROLOGY, V384, P294, DOI 10.1016/j.virol.2008.11.024; Ribeiro T, 2010, NEUROL SCI, V31, P517, DOI 10.1007/s10072-010-0353-y; Rivera Z, 2008, CURR OPIN PULM MED, V14, P316, DOI 10.1097/MCP.0b013e3283018220; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SAWAI ET, 1989, J VIROL, V63, P3961, DOI 10.1128/JVI.63.9.3961-3973.1989; SHAH K, 1976, AM J EPIDEMIOL, V103, P1; Stratton K, 2003, IMMUNIZATION SAFETY; SWEET BH, 1960, P SOC EXP BIOL MED, V105, P420, DOI 10.3181/00379727-105-26128; Taronna A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061182; Tognon M, 2015, CANCER-AM CANCER SOC, V121, P2618, DOI 10.1002/cncr.29404; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; Vanchiere JA, 2016, J PEDIAT INF DIS SOC, V5, P210, DOI 10.1093/jpids/piu101; Vanchiere JA, 2009, J CLIN MICROBIOL, V47, P2388, DOI 10.1128/JCM.02472-08; Vilchez RA, 2005, VIROLOGY, V342, P38, DOI 10.1016/j.virol.2005.06.053; Viscidi RP, 2003, CLIN DIAGN LAB IMMUN, V10, P278, DOI 10.1128/CDLI.10.2.278-285.2003; Wang HT, 2007, INT J MOL MED, V20, P501; Wong C, 2013, J INFECTION, V66, P67, DOI 10.1016/j.jinf.2012.08.014; WRIGHT PW, 1971, P NATL ACAD SCI USA, V68, P973, DOI 10.1073/pnas.68.5.973; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhen HN, 1999, CANCER, V86, P2124, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2124::AID-CNCR34>3.0.CO;2-D; Ziadi S, 2012, PATHOL ONCOL RES, V18, P691, DOI 10.1007/s12253-012-9496-x	57	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145720	10.1371/journal.pone.0145720	http://dx.doi.org/10.1371/journal.pone.0145720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731525	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400047
J	Won, D; Chelladurai, P				Won, Doyeon; Chelladurai, Packianathan			Competitive Advantage in Intercollegiate Athletics: Role of Intangible Resources	PLOS ONE			English	Article							STRATEGIC MANAGEMENT; CAPABILITIES; SUCCESS; ALUMNI; VIEW	The present research explored the dynamics of competitive advantages in intercollegiate athletics by investigating the contribution of intangible resources (i.e., athletic and academic reputations) on the generation of more tangible resources (i.e., human and financial resources), which in turn influence the athletic performance (i.e., winning record) and academic performance (i.e., graduation rates), and gender equity. The research was based entirely on archival data of 324 NCAA Division I member institutions. The results of the SEM supported the study's basic arguments that tangible resources are the sources of competitive advantages in Division I intercollegiate athletics, and that intangible resources contribute to the generation of tangible resources.	[Won, Doyeon] Yonsei Univ, Seoul 120749, South Korea; [Chelladurai, Packianathan] Troy Univ, Troy, AL USA	Yonsei University; Troy University System; Troy University	Won, D (corresponding author), Yonsei Univ, Seoul 120749, South Korea.	dwon@yonsei.ac.kr	Won, Doyeon/M-8245-2016	Won, Doyeon/0000-0003-4336-9767				Anderson KS, 2011, J APPL SPORT MANAG, V3, P10; Ary D., 2019, INTRO RES ED, V10th; Associated Press, 2015, 2015 16 APR PEN NCAA; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Barney J.B, 1995, ACAD MANAGE EXEC, V9, P49, DOI [10.5465/ame.1995.9512032192, DOI 10.5465/AME.1995.9512032192, DOI 10.5465/ame.1995.9512032192]; BARNEY JB, 1986, ACAD MANAGE REV, V11, P656, DOI 10.2307/258317; Berman SL, 2002, ACAD MANAGE J, V45, P13, DOI 10.2307/3069282; BOWMAN EH, 1974, SLOAN MANAGE REV, V15, P35; Carmeli A, 2004, STRATEGIC MANAGE J, V25, P1257, DOI 10.1002/smj.428; Carmeli A., 2004, EUR MANAG J, V22, P110, DOI DOI 10.1016/J.EMJ.2003.11.010; Chelladurai P, 1984, Can J Appl Sport Sci, V9, P33; CHELLADURAI P, 1984, RES Q EXERCISE SPORT, V55, P74, DOI 10.1080/02701367.1984.10605358; Chressanthis GA, 2003, SOCIOL SPORT J, V10, P286; COLLIS DJ, 1991, STRATEGIC MANAGE J, V12, P49, DOI 10.1002/smj.4250120906; Cunningham BM, 2002, J HUM RESOUR, V37, P540, DOI 10.2307/3069681; Cunningham G. B., 2004, European Sport Management Quarterly, V4, P3, DOI 10.1080/16184740408737464; Cunningham GB, 2003, APPL RES COACHING AT, V18, P37; Deephouse DL, 2000, J MANAGE, V26, P1091, DOI 10.1177/014920630002600602; DIERICKX I, 1989, MANAGE SCI, V35, P1504, DOI 10.1287/mnsc.35.12.1504; Duderstadt JJ, 2000, INTERCOLLEGIATE ATHL; GODFREY PC, 1995, STRATEGIC MANAGE J, V16, P519, DOI 10.1002/smj.4250160703; Goff B, 2000, J SPORT MANAGE, V14, P85, DOI 10.1123/jsm.14.2.85; GRANT RM, 1991, CALIF MANAGE REV, V33, P114, DOI 10.2307/41166664; Gregersen HB, 1999, J HIGH TECH MANAGE R, V10, P37; HALL R, 1993, STRATEGIC MANAGE J, V14, P607, DOI 10.1002/smj.4250140804; HALL R, 1992, STRATEGIC MANAGE J, V13, P135, DOI 10.1002/smj.4250130205; Hoskisson RE, 1999, J MANAGE, V25, P417, DOI 10.1177/014920639902500307; Humphreys BR, 2007, J SPORT MANAGE, V21, P265, DOI 10.1123/jsm.21.2.265; Klien RB, 1998, PRINCIPALS PRACTICE; MAHONEY JT, 1992, STRATEGIC MANAGE J, V13, P363, DOI 10.1002/smj.4250130505; National Association of Collegiate Directors of Athletics, 2015, SEARS DIR CUP; National Collegiate Athletics Association, 2014, MENS BASK STAT; National Collegiate Athletics Association, 2013, 2004 2012 REV EXP NC; National Collegiate Athletics Association, 2003, PART SPORTS SPONS PA; Nelson R., 1982, EVOL THEOR; Office of Postsecondary Education, 2014, EQ ATHL; Penrose E., 2009, THEORY GROWTH FIRM; Petersons College Database, 2004, PET COLL GUID; Raitz KB, 1995, THEATER OF SPORT; Schumacker R.E., 2010, BEGINNERS GUIDE STRU, V3rd ed.; Smart D. L., 2003, European Sport Management Quarterly, V3, P165, DOI 10.1080/16184740308721949; Smart DL, 2000, J SPORT MANAGE, V14, P133, DOI 10.1123/jsm.14.2.133; Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z; Toma JD, 1998, RES HIGH EDUC, V39, P633, DOI 10.1023/A:1018757807834; Trail G, 2000, J SPORT MANAGE, V14, P154, DOI 10.1123/jsm.14.2.154; Tucker IB, 2004, ECON EDUC REV, V23, P655, DOI 10.1016/j.econedurev.2004.03.001; Underwood J, 1980, SPORTS ILLUSTRA 0519, P36; WERNERFELT B, 1987, STRATEGIC MANAGE J, V8, P187, DOI 10.1002/smj.4250080209; Williamson O.E., 1975, MARKETS HIERARCHIES; Wolfe R, 2006, HUM RESOUR MANAGE-US, V45, P111, DOI 10.1002/hrm.20100; Wolfe RA, 2002, ORGAN SCI, V13, P64, DOI 10.1287/orsc.13.1.64.544	51	17	17	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145782	10.1371/journal.pone.0145782	http://dx.doi.org/10.1371/journal.pone.0145782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731118	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400053
J	De Rose, F; Marotta, R; Poddighe, S; Talani, G; Catelani, T; Setzu, MD; Solla, P; Marrosu, F; Sanna, E; Kasture, S; Acquas, E; Liscia, A				De Rose, Francescaelena; Marotta, Roberto; Poddighe, Simone; Talani, Giuseppe; Catelani, Tiziano; Setzu, Maria Dolores; Solla, Paolo; Marrosu, Francesco; Sanna, Enrico; Kasture, Sanjay; Acquas, Elio; Liscia, Anna			Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration	PLOS ONE			English	Article							EARLY-ONSET PARKINSONISM; MUTATIONS; GENE; NEURONS; PINK1; BRAIN; LOCALIZATION; DEGENERATION; MITOCHONDRIA; DYSFUNCTION	The common fruit fly Drosophila melanogaster (Dm) is a simple animal species that contributed significantly to the development of neurobiology whose leucine-rich repeat kinase 2 mutants (LRRK2) loss-of-function in the WD40 domain represent a very interesting tool to look into physiopathology of Parkinson's disease (PD). Accordingly, LRRK2 Dm have also the potential to contribute to reveal innovative therapeutic approaches to its treatment. Withania somnifera Dunal, a plant that grows spontaneously also in Mediterranean regions, is known in folk medicine for its anti-inflammatory and protective properties against neurodegeneration. The aim of this study was to evaluate the neuroprotective effects of its standardized root methanolic extract (Wse) on the LRRK2 loss-of-function Dm model of PD. To this end mutant and wild type (WT) flies were administered Wse, through diet, at different concentrations as larvae and adults (L+/A(+)) or as adults (L-/A(+)) only. LRRK2 mutants have a significantly reduced lifespan and compromised motor function and mitochondrial morphology compared to WT flies 1% Wse-enriched diet, administered to Dm LRRK2 as L-/A(+) and improved a) locomotor activity b) muscle electrophysiological response to stimuli and also c) protected against mitochondria degeneration. In contrast, the administration of Wse to Dm LRRK2 as L+/A(+), no matter at which concentration, worsened lifespan and determined the appearance of increased endosomal activity in the thoracic ganglia. These results, while confirming that the LRRK2 loss-of-function in the WD40 domain represents a valid model of PD, reveal that under appropriate concentrations Wse can be usefully employed to counteract some deficits associated with the disease. However, a careful assessment of the risks, likely related to the impaired endosomal activity, is required.	[De Rose, Francescaelena; Sanna, Enrico; Acquas, Elio; Liscia, Anna] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Marotta, Roberto; Catelani, Tiziano] Fdn Ist Italiano Tecnol, Nanochem Dept, Genoa, Italy; [Poddighe, Simone; Setzu, Maria Dolores] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Talani, Giuseppe] CNR, Inst Neurosci, Cagliari, Italy; [Solla, Paolo; Marrosu, Francesco] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Kasture, Sanjay] Pinnacle Biomed Res Inst, Bhopal, India	University of Cagliari; Istituto Italiano di Tecnologia - IIT; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari	Liscia, A (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	liscia@unica.it	Marotta, Roberto/HGV-1599-2022; Solla, Paolo/GQZ-7556-2022; Acquas, Elio/G-1705-2010; sanna, enrico/HHY-8509-2022; Solla, Paolo/R-5366-2016; Solla, Paolo/AAL-9671-2020; Marotta, Roberto/B-5382-2014	Solla, Paolo/0000-0002-2982-0665; Acquas, Elio/0000-0002-4783-9319; Marotta, Roberto/0000-0003-0634-5483; Liscia, Anna/0000-0002-1629-2090; Poddighe, Simone/0000-0002-7244-9240	Fondazione Banco di Sardegna (ITA) [0172/2014]	Fondazione Banco di Sardegna (ITA)	This work was supported by Fondazione Banco di Sardegna (ITA) no. 0172/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Allen Marcus J, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5453; Alviano DS, 2009, CURR PHARM BIOTECHNO, V10, P106, DOI 10.2174/138920109787048607; Augustin H, 2011, JOVE-J VIS EXP, DOI 10.3791/2412; Berg D, 2005, BRAIN, V128, P3000, DOI 10.1093/brain/awh666; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bonifati V, 2006, EUR J HUM GENET, V14, P1061, DOI 10.1038/sj.ejhg.5201695; Celotto AM, 2005, MOL INTERV, V5, P292, DOI 10.1124/mi.5.5.9; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Dagenais M L-CSS BB, 2000, SCI BASIS THERAPEUTI, V5, P334; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Higashi S, 2007, BRAIN RES, V1155, P208, DOI 10.1016/j.brainres.2007.04.034; Humphrey DM, 2012, HUM MOL GENET, V21, P2698, DOI 10.1093/hmg/dds096; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jansen RLM, 2014, EFFECTS 5 AYURVEDIC; Jay Prakash, 2013, Advances in Bioscience and Biotechnology, V4, P1; Kasture S, 2013, ORIENTAL PHARM EXP M, V13, P165, DOI 10.1007/s13596-013-0126-2; Kawasaki F, 1999, J NEUROPHYSIOL, V82, P123, DOI 10.1152/jn.1999.82.1.123; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuboyama T, 2014, BIOL PHARM BULL, V37, P892, DOI 10.1248/bpb.b14-00022; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lautier C, 2008, AM J HUM GENET, V82, P822, DOI 10.1016/j.ajhg.2008.01.015; Lee S, 2012, BIOCHEM SOC T, V40, P1047, DOI 10.1042/BST20120113; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Li TX, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/942412; Lieu CA, 2010, PARKINSONISM RELAT D, V16, P458, DOI 10.1016/j.parkreldis.2010.04.015; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388; Mata IF, 2005, NEUROGENETICS, V6, P171, DOI 10.1007/s10048-005-0005-1; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Ng CH, 2012, J NEUROSCI, V32, P14311, DOI 10.1523/JNEUROSCI.0499-12.2012; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Poddighe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110802; Poddighe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073156; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Taymans JM, 2006, J NEUROCHEM, V98, P951, DOI 10.1111/j.1471-4159.2006.03919.x; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350; Xiao L, 2012, GLIA, V60, P1037, DOI 10.1002/glia.22333; Xie CL, 2014, NEUROL SCI, V35, P1495, DOI 10.1007/s10072-014-1878-2; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	61	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146140	10.1371/journal.pone.0146140	http://dx.doi.org/10.1371/journal.pone.0146140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727265	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500057
J	Kim, BJ; Linton, K; Cho, S; Ha, JH				Kim, Bum Jung; Linton, Kristen; Cho, Sean; Ha, Jung-Hwa			The Relationship between Neuroticism, Hopelessness, and Depression in Older Korean Immigrants	PLOS ONE			English	Article							PERSONALITY-TRAITS; LIVING ARRANGEMENTS; SUICIDE IDEATION; ADULTS; AMERICANS; SYMPTOMS; PEOPLE; ELDERS; RISK	Purpose This study aimed to investigate the relationship between neuroticism, hopelessness, and depression among older Korean immigrants. To extend this line of research, this study aimed to examine the effects of neuroticism and hopelessness in predicting depression among older Korean immigrants. Methods Data for this study came from a survey of 220 first generation Korean immigrants aged 65 years or older in Los Angeles County in 2012. Data were collected by face-to-face interviews with trained social workers using a structured questionnaire translated into Korean. All interviews were conducted in Korean. The neuroticism sub-scale of the Eysenck Personality Questionnaire was used to assess neuroticism (EPQN). Hopelessness was measured by the Beck Hopelessness Scale (BHS). Depression was measured by the 20-item Center of Epidemiological Studies Depression (CES-D) scale. Results The study found that age (beta =.26, p<.01), gender (beta = -.13, p<.01), income (beta = -.13, p<.01), neuroticism (beta =.51, p<.01), and hopelessness (beta =.15, p<.01) were significant predictors of depression. Conclusion The study provides preventive strategies that would help in the development of depressionreduction services or programs for the population, especially for those living with neuroticism and hopelessness.	[Kim, Bum Jung; Cho, Sean] Univ Hawaii Manoa, Myron B Thompson Sch Social Work, Honolulu, HI 96822 USA; [Linton, Kristen] Calif State Univ Channel Isl, Hlth Sci Program, Camarillo, CA USA; [Ha, Jung-Hwa] Seoul Natl Univ, Dept Social Welf, Seoul, South Korea	University of Hawaii System; University of Hawaii Manoa; California State University System; California State University Channel Islands; Seoul National University (SNU)	Kim, BJ (corresponding author), Univ Hawaii Manoa, Myron B Thompson Sch Social Work, Honolulu, HI 96822 USA.	bjk2001@hawaii.edu						Abelmann Nancy., 2009, BLUE DREAMS KOREAN A; Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Barnhofer T, 2010, BEHAV RES THER, V48, P275, DOI 10.1016/j.brat.2009.12.005; Beautrais AL, 1999, SUICIDE LIFE-THREAT, V29, P37; Beck A.T., 1988, BECK HOPELESSNESS SC; Chi SE, 2005, PERS INDIV DIFFER, V39, P669, DOI 10.1016/j.paid.2005.02.017; Chioqueta AP, 2005, PERS INDIV DIFFER, V38, P1283, DOI 10.1016/j.paid.2004.08.010; Choi SE, 2013, RES GERONTOLOGICAL N, V6; Choi Y.H., 2008, J KOREAN GERONTOLOGI, V28, P345; Eysenck H.J., 1975, EYSENCK PERSONALITY; Eysenck S.B., 1985, KOREAN J PSYCHOL, V5, P51; Hayward RD, 2013, AM J GERIAT PSYCHIAT, V21, P88, DOI 10.1016/j.jagp.2012.11.012; Heisel MJ, 2006, J AFFECT DISORDERS, V90, P175, DOI 10.1016/j.jad.2005.11.005; Iliceto P, 2013, SOC PSYCH PSYCH EPID, V48, P1105, DOI 10.1007/s00127-012-0608-4; Jang YR, 2014, ASIAN AM J PSYCHOL, V5, P200, DOI 10.1037/a0032591; Jeon GS, 2013, J GERONTOL B-PSYCHOL, V68, P963, DOI 10.1093/geronb/gbt084; Ka Y, 2010, PASTOR PSYCHOL, V59, P221, DOI 10.1007/s11089-010-0274-y; Kim BJ, 2014, AGING MENT HEALTH, V18, P619, DOI 10.1080/13607863.2013.866631; Kim Illsoo, 2014, NEW URBAN IMMIGRANTS; Kim W, 2015, J GERONTOL SOC WORK, V58, P86, DOI 10.1080/01634372.2014.919977; Klem L., 1995, READING UNDERSTANDIN; KOH JY, 1987, GERONTOLOGIST, V27, P66, DOI 10.1093/geront/27.1.66; Lam D, 2003, PSYCHOL MED, V33, P469, DOI 10.1017/S0033291702007304; Leong F T, 2001, Ment Health Serv Res, V3, P201, DOI 10.1023/A:1013177014788; McCrae RR, 2001, J PERS, V69, P819, DOI 10.1111/1467-6494.696166; Mui AC, 2006, SOC WORK, V51, P243, DOI 10.1093/sw/51.3.243; Mui AC, 2014, AGEING INT, V39, P274, DOI 10.1007/s12126-013-9183-6; Park K., 1997, KOREAN AM DREAM IMMI, DOI [10.7591/9781501724558, DOI 10.7591/9781501724558]; Phua VC, 2001, J COMP FAM STUD, V32, P263; Pompili M, 2007, PSYCHOL REP, V100, P375, DOI 10.2466/PR0.100.2.375-378; PUSHKAR D, 1995, PSYCHOL AGING, V10, P294, DOI 10.1037/0882-7974.10.2.294; Radloff L, 1986, COMMUNITY SURVEYS PS, P177; Scommegna P., 2013, TODAYS RES AGING OCT; Sharma D K, 1985, Indian J Psychiatry, V27, P83; Sharpe DL, 2008, J FAM ECON ISS, V29, P570, DOI 10.1007/s10834-008-9122-y; Shin Jinah K, 2002, Issues Ment Health Nurs, V23, P461, DOI 10.1080/01612840290052640; Shin SH, 2012, INT NURS REV, V59, P252, DOI 10.1111/j.1466-7657.2011.00946.x; Sohn L, 2004, J AM GERIATR SOC, V52, P1946, DOI 10.1111/j.1532-5415.2004.52524.x; Sohn Linda, 2004, J Cross Cult Gerontol, V19, P203, DOI 10.1023/B:JCCG.0000034219.97686.69; Song H, 2012, SOC BEHAV PERSONAL, V40, P1153, DOI 10.2224/sbp.2012.40.7.1153; StataCorp L. P., 2013, STAT 13	41	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145520	10.1371/journal.pone.0145520	http://dx.doi.org/10.1371/journal.pone.0145520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727476	Green Submitted, gold, Green Published			2022-12-27	WOS:000367681500019
J	Lu, JC; Jing, J; Yao, Q; Fan, K; Wang, GH; Feng, RX; Liang, YJ; Chen, L; Ge, YF; Yao, B				Lu, Jin-Chun; Jing, Jun; Yao, Qi; Fan, Kai; Wang, Guo-Hong; Feng, Rui-Xiang; Liang, Yuan-Jiao; Chen, Li; Ge, Yi-Feng; Yao, Bing			Relationship between Lipids Levels of Serum and Seminal Plasma and Semen Parameters in 631 Chinese Subfertile Men	PLOS ONE			English	Article							BODY-MASS INDEX; FATTY-ACID-COMPOSITION; QUALITY-CONTROL; ASTHENOZOOSPERMIC MALES; REPRODUCTIVE HORMONES; WAIST CIRCUMFERENCE; MOUSE TESTIS; SPERM; SPERMATOZOA; STANDARDIZATION	Objective This prospective study was designed to investigate the relationship between lipids levels in both serum and seminal plasma and semen parameters. Methods 631 subfertile men were enrolled. Their obesity-associated markers were measured, and semen parameters were analyzed. Also, seminal plasma and serum TC, TG, HDL and LDL and serum FFA, FSH, LH, total testosterone (TT), estradiol (E2) and SHBG levels were detected. Results Seminal plasma and serum TG, TC and LDL levels were positively related to age. Serum TC, TG and LDL were positively related to obesity-associated markers (P < 0.001), while only seminal plasma TG was positively related to them (P < 0.05). For lipids levels in serum and seminal plasma, only TG level had slightly positive correlation between them (r = 0.081, P = 0.042). There was no significant correlation between serum lipids levels and semen parameters. However, seminal plasma TG, TC, LDL and HDL levels were negatively related to one or several semen parameters, including semen volume (SV), sperm concentration (SC), total sperm count (TSC), sperm motility, progressive motility (PR) and total normal-progressively motile sperm counts (TNPMS). Moreover, seminal plasma TG, TC, LDL and HDL levels in patients with oligospermatism, asthenospermia and teratozoospermia were higher than those with normal sperm concentration, motility or morphology. After adjusting age and serum LH, FSH, TT, E2 and SHBG levels, linear regression analysis showed that SV was still significantly correlated with seminal plasma LDL (P = 0.012), both of SC and TSC with seminal plasma HDL (P = 0.028 and 0.002), and both of PR and sperm motility with seminal plasma TC (P = 0.012 and 0.051). Conclusion The abnormal metabolism of lipids in male reproductive system may contribute to male factor infertility.	[Lu, Jin-Chun; Jing, Jun; Yao, Qi; Fan, Kai; Wang, Guo-Hong; Feng, Rui-Xiang; Liang, Yuan-Jiao; Chen, Li; Ge, Yi-Feng; Yao, Bing] Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Reprod Med Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Lu, Jin-Chun] PLA, Jiangsu Corps, Dept Lab Sci, Nanjing Hosp,Armed Police Force, Nanjing, Jiangsu, Peoples R China	Nanjing University	Liang, YJ (corresponding author), Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Reprod Med Ctr, Nanjing 210008, Jiangsu, Peoples R China.	yuanjiao1965@126.com; 2424572228@qq.com			State Key Development Program for Basic Research of China [2013CB945200]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was funded by State Key Development Program for Basic Research of China (http://www.most.gov.cn) (2013CB945200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy Y, 2006, PROSTAG LEUKOTR ESS, V75, P75, DOI 10.1016/j.plefa.2006.06.002; Argov-Argaman N, 2013, THERIOGENOLOGY, V80, P712, DOI 10.1016/j.theriogenology.2013.05.024; Cabler S, 2010, ASIAN J ANDROL, V12, P480, DOI 10.1038/aja.2010.38; Casado ME, 2013, PROSTAG LEUKOTR ESS, V88, P227, DOI 10.1016/j.plefa.2012.12.005; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Ebesunun M O, 2004, West Afr J Med, V23, P290; Casado ME, 2012, J LIPID RES, V53, P2586, DOI 10.1194/jlr.M028076; Erdemir F, 2012, ACTAS UROL ESP, V36, P153, DOI [10.1016/j.acuroe.2012.05.003, 10.1016/j.acuro.2011.06.019]; Ergun A, 2007, ARCH ANDROLOGY, V53, P21, DOI 10.1080/01485010600888961; Furland NE, 2011, LIPIDS, V46, P443, DOI 10.1007/s11745-011-3527-3; Hagiuda J, 2014, ANDROLOGIA, V46, P131, DOI 10.1111/and.12057; HUACUJA L, 1981, ARCH ANDROLOGY, V7, P343, DOI 10.3109/01485018108999329; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Keber R, 2013, J LIPID RES, V54, P20, DOI 10.1194/jlr.R032326; Lenzi A, 2002, CONTRACEPTION, V65, P301, DOI 10.1016/S0010-7824(02)00276-7; Lu JC, 2006, ARCH ANDROLOGY, V52, P447, DOI 10.1080/01485010600822705; Lu JC, 2015, ANDROLOGIA, V47, P1047, DOI 10.1111/and.12376; Lu JC, 2014, ANDROLOGIA, V46, P329, DOI 10.1111/and.12093; Lu JC, 2007, J ANDROL, V28, P207, DOI 10.2164/jandrol.106.001552; Lu JC, 2007, CLIN CHIM ACTA, V375, P76, DOI 10.1016/j.cca.2006.06.005; MacDonald AA, 2013, HUM REPROD, V28, P3178, DOI 10.1093/humrep/det379; MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047; Maqdasy S, 2013, MOL CELL ENDOCRINOL, V368, P30, DOI 10.1016/j.mce.2012.06.011; Martini AC, 2010, FERTIL STERIL, V94, P1739, DOI 10.1016/j.fertnstert.2009.11.017; Masson D, 2003, MOL HUM REPROD, V9, P457, DOI 10.1093/molehr/gag062; Meseguer M, 2004, J ASSIST REPROD GEN, V21, P445, DOI 10.1007/s10815-004-8761-7; Nolan JP, 1997, FASEB J, V11, P670, DOI 10.1096/fasebj.11.8.9240968; Petersson H, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-10; RANA APS, 1993, BIOCHIM BIOPHYS ACTA, V1210, P1, DOI 10.1016/0005-2760(93)90041-7; Reverchon M, 2013, M S-MED SCI, V29, P417, DOI 10.1051/medsci/2013294016; Scolari S, 2010, BIOCHEMISTRY-US, V49, P9027, DOI 10.1021/bi101257c; SEBASTIAN SM, 1987, J REPROD FERTIL, V79, P373; Sermondade N, 2013, HUM REPROD UPDATE, V19, P221, DOI 10.1093/humupd/dms050; Shayeb AG, 2011, REPROD BIOMED ONLINE, V23, P717, DOI 10.1016/j.rbmo.2011.07.018; SHERIFF DS, 1982, ANDROLOGIA, V14, P150; Tavilani H, 2006, ANDROLOGIA, V38, P173, DOI 10.1111/j.1439-0272.2006.00735.x; Tavilani H, 2007, PROSTAG LEUKOTR ESS, V77, P45, DOI 10.1016/j.plefa.2007.07.001; World Health Organization, 2010, LAB MAN EX PROC HUM	38	24	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146304	10.1371/journal.pone.0146304	http://dx.doi.org/10.1371/journal.pone.0146304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726884	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500073
J	Arciero, E; Biagini, SA; Chen, Y; Xue, YL; Luiselli, D; Tyler-Smith, C; Pagani, L; Ayub, Q				Arciero, Elena; Biagini, Simone Andrea; Chen, Yuan; Xue, Yali; Luiselli, Donata; Tyler-Smith, Chris; Pagani, Luca; Ayub, Qasim			Genes Regulated by Vitamin D in Bone Cells Are Positively Selected in East Asians	PLOS ONE			English	Article							GENOME-WIDE; POPULATION DIFFERENTIATION; NATURAL-SELECTION; MINERAL DENSITY; SIGNATURES; SEQUENCE; HEALTH; LRP5; INTROGRESSION; PIGMENTATION	Vitamin D and folate are activated and degraded by sunlight, respectively, and the physiological processes they control are likely to have been targets of selection as humans expanded from Africa into Eurasia. We investigated signals of positive selection in gene sets involved in the metabolism, regulation and action of these two vitamins in worldwide populations sequenced by Phase I of the 1000 Genomes Project. Comparing allele frequency-spectrum-based summary statistics between these gene sets and matched control genes, we observed a selection signal specific to East Asians for a gene set associated with vitamin D action in bones. The selection signal was mainly driven by three genes CXXC finger protein 1 (CXXC1), low density lipoprotein receptor-related protein 5 (LRP5) and runt-related transcription factor 2 (RUNX2). Examination of population differentiation and haplotypes allowed us to identify several candidate causal regulatory variants in each gene. Four of these candidate variants (one each in CXXC1 and RUNX2 and two in LRP5) had a >70% derived allele frequency in East Asians, but were present at lower (20-60%) frequency in Europeans as well, suggesting that the adaptation might have been part of a common response to climatic and dietary changes as humans expanded out of Africa, with implications for their role in vitamin D-dependent bone mineralization and osteoporosis insurgence. We also observed haplotype sharing between East Asians, Finns and an extinct archaic human (Denisovan) sample at the CXXC1 locus, which is best explained by incomplete lineage sorting.	[Arciero, Elena; Chen, Yuan; Xue, Yali; Tyler-Smith, Chris; Ayub, Qasim] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Arciero, Elena; Biagini, Simone Andrea; Luiselli, Donata; Pagani, Luca] Univ Bologna, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy; [Pagani, Luca] Univ Cambridge, Div Biol Anthropol, Cambridge CB2 1QH, England	Wellcome Trust Sanger Institute; University of Bologna; University of Cambridge	Ayub, Q (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England.	qa1@sanger.ac.uk	Biagini, Simone Andrea/I-3807-2019; Pagani, Luca/G-8511-2017	Biagini, Simone Andrea/0000-0002-4488-3162; Pagani, Luca/0000-0002-6639-524X; Ayub, Qasim/0000-0003-3291-0917	Wellcome Trust [098051]; Erasmus Lifelong Learning Programme (LLP); ERC [FP7 - 261213]	Wellcome Trust(Wellcome TrustEuropean Commission); Erasmus Lifelong Learning Programme (LLP); ERC(European Research Council (ERC)European Commission)	This work was supported by The Wellcome Trust (098051). EA was supported by the Erasmus Lifelong Learning Programme (LLP). LP was supported by the ERC Starting Investigator grant FP7 - 261213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ayub Q, 2013, AM J HUM GENET, V92, P696, DOI 10.1016/j.ajhg.2013.03.019; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Borradale DC, 2012, NUTR REV, V70, P414, DOI 10.1111/j.1753-4887.2012.00485.x; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carlone DL, 2001, MOL CELL BIOL, V21, P7601, DOI 10.1128/MCB.21.22.7601-7606.2001; Colonna V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r88; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fagny M, 2014, MOL BIOL EVOL, V31, P1850, DOI 10.1093/molbev/msu118; Fay JC, 2000, GENETICS, V155, P1405; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Hider JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-150; Hoffbrand AV, 2001, BRIT J HAEMATOL, V113, P579, DOI 10.1046/j.1365-2141.2001.02822.x; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Hu M, 2012, HUM GENET, V131, P665, DOI 10.1007/s00439-011-1111-9; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Lim U, 2007, BLOOD, V109, P3050, DOI 10.1182/blood-2006-07-034330; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pybus M, 2014, NUCLEIC ACIDS RES, V42, pD903, DOI 10.1093/nar/gkt1188; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Salbaum JM, 2012, PROG MOL BIOL TRANSL, V108, P129, DOI 10.1016/B978-0-12-398397-8.00006-X; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; TAJIMA F, 1989, GENETICS, V123, P585; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Xuan DY, 2008, ANN CLIN LAB SCI, V38, P15; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yuen AWC, 2010, MED HYPOTHESES, V74, P39, DOI 10.1016/j.mehy.2009.08.007	55	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146072	10.1371/journal.pone.0146072	http://dx.doi.org/10.1371/journal.pone.0146072			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719974	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900041
J	Xu, PP; Ren, L; Zhu, DX; Lin, Q; Zhong, YS; Tang, WT; Feng, QY; Zheng, P; Ji, ML; Wei, Y; Xu, JM				Xu, Pingping; Ren, Li; Zhu, Dexiang; Lin, Qi; Zhong, Yunshi; Tang, Wentao; Feng, Qingyang; Zheng, Peng; Ji, Meiling; Wei, Ye; Xu, Jianmin			Open Right Hemicolectomy: Lateral to Medial or Medial to Lateral Approach?	PLOS ONE			English	Article							COLORECTAL-CANCER; COLON-CANCER; LAPAROSCOPIC SURGERY; OPEN RESECTION; TRIAL; COLECTOMY; STATISTICS; SURVIVAL	Objective Currently, no published studies have compared the clinical outcomes of the medial-to-lateral approach (MA) and lateral-to-medial approach (LA) for open right hemicolectomy. Thus, the present study aimed to assess whether one of these approaches has any potential benefits over the other. Methods A retrospective study was performed of all patients who underwent open right hemicolectomy with pathologically confirmed disease who met the eligibility criteria between June 2008 and June 2012. The population was divided into an MA group and an LA group by propensity scoring. We compared patient demographic and clinical characteristic variables between the two groups and assessed short-term and long-term outcomes. Results A total of 450 patients (MA, n = 150; LA, n = 300) were evaluated. The operation time (MA, 138.4 minutesvs. LA, 166.2 minutes; P <.05) and blood loss (MA, 52.0mL vs. LA, 62.6mL; P <.05) were significantly lower in the MA group. No differences in the number of harvested lymph nodes and oncologic outcomes were observed between the two groups. Further subgroup analysis for stage III colon cancer revealed that the MA group had significantly more retrieved lymph nodes (MA, 18.8vs. LA, 16.0; P =.028). There were no differences in other variables between the two groups. Conclusions The MA reduced operative time and blood loss compared with the LA. We thus concluded that the MA provided short-term benefits compared with the LA in open right hemicolectomy for right-sided colon cancer.	[Xu, Pingping; Ren, Li; Zhu, Dexiang; Lin, Qi; Tang, Wentao; Feng, Qingyang; Zheng, Peng; Ji, Meiling; Wei, Ye; Xu, Jianmin] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China; [Zhong, Yunshi] Fudan Univ, Zhongshan Hosp, Dept Endoscopy Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wei, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China.	13818661815@126.com; xujmin@aliyun.com	Zhong, Yun/HCH-6868-2022		National Natural Science Foundation of China [81272390, 81372315, 81472228]; Advanced Suitably Technique Project of Health System in Shanghai [2013SY013]; Joint Research Program on the Critical Illness of Health System in Shanghai [2013ZYJB0011]; Shanghai Science and Technology Committee Project [13JC1401601, 134119a4800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advanced Suitably Technique Project of Health System in Shanghai; Joint Research Program on the Critical Illness of Health System in Shanghai; Shanghai Science and Technology Committee Project(Shanghai Science & Technology Committee)	This study was supported by the National Natural Science Foundation of China (81272390, 81372315, 81472228), the Advanced Suitably Technique Project of Health System in Shanghai (2013SY013), the Joint Research Program on the Critical Illness of Health System in Shanghai (2013ZYJB0011), and the Shanghai Science and Technology Committee Project (13JC1401601, 134119a4800).	Ballantyne GH, 2006, SURG LAPARO ENDO PER, V16, P406, DOI 10.1097/01.sle.0000213732.03204.50; Bonjer HJ, 2009, LANCET ONCOL, V10, P44, DOI 10.1016/S1470-2045(08)70310-3; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Ding J, 2013, WORLD J SURG, V37, P863, DOI 10.1007/s00268-012-1888-2; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; Gu J, 2013, COLORECTAL DIS, V15, P1345, DOI 10.1111/codi.12269; Han DP, 2014, SURG TODAY, V44, P868, DOI 10.1007/s00595-013-0697-z; Kennedy RH, 2014, J CLIN ONCOL, V32, P1804, DOI 10.1200/JCO.2013.54.3694; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Lee GH, 2015, EJSO-EUR J SURG ONC, V41, P300, DOI 10.1016/j.ejso.2014.11.001; Li JCM, 2012, INT J COLORECTAL DIS, V27, P95, DOI 10.1007/s00384-011-1294-5; Liang Jin-Tung, 2007, Ann Surg Oncol, V14, P1878, DOI 10.1245/s10434-006-9153-2; Liang JT, 2003, WORLD J SURG, V27, P190, DOI 10.1007/s00268-002-6437-y; Milsom JW, 1998, J AM COLL SURGEONS, V187, P46, DOI 10.1016/S1072-7515(98)00132-X; Nakamura T, 2009, SURG TODAY, V39, P1040, DOI 10.1007/s00595-009-4011-z; Pigazzi A, 2007, J GASTROINTEST SURG, V11, P778, DOI 10.1007/s11605-007-0120-4; Poon JTC, 2009, WORLD J SURG, V33, P2177, DOI 10.1007/s00268-009-0173-5; Rondelli F, 2012, COLORECTAL DIS, V14, pE447, DOI 10.1111/j.1463-1318.2012.03054.x; Rotholtz NA, 2009, SURG LAPARO ENDO PER, V19, P43, DOI 10.1097/SLE.0b013e31818e91f3; Senagore AJ, 2003, DIS COLON RECTUM, V46, P503, DOI 10.1007/s10350-004-6590-5; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Veldkamp R, 2004, SURG ENDOSC, V18, P1163, DOI 10.1007/s00464-003-8253-3; Yan Jun, 2010, Zhonghua Wei Chang Wai Ke Za Zhi, V13, P403; Zhu DX, 2012, ANN SURG ONCOL, V19, P2860, DOI 10.1245/s10434-012-2356-9	25	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145175	10.1371/journal.pone.0145175	http://dx.doi.org/10.1371/journal.pone.0145175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720634	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900006
J	Guerin, GR; Biffin, E; Baruch, Z; Lowe, AJ				Guerin, Greg R.; Biffin, Ed; Baruch, Zdravko; Lowe, Andrew J.			Identifying Centres of Plant Biodiversity in South Australia	PLOS ONE			English	Article							GRASS CENCHRUS-CILIARIS; SPECIES RICHNESS; ENDEMISM; ESTIMATORS; VEGETATION; DIVERSITY; PATTERNS; INVASION; RAINFALL; EXAMPLE	We aimed to identify regional centres of plant biodiversity in South Australia, a sub-continental land area of 983,482 km(2), by mapping a suite of metrics. Broad-brush conservation issues associated with the centres were mapped, specifically climate sensitivity, exposure to habitat fragmentation, introduced species and altered fire regimes. We compiled 727,417 plant species records from plot-based field surveys and herbarium records and mapped the following: species richness (all species; South Australian endemics; conservation-dependent species; introduced species); georeferenced weighted endemism, phylogenetic diversity, georeferenced phylogenetic endemism; and measures of beta diversity at local and state-wide scales. Associated conservation issues mapped were: climate sensitivity measured via ordination and non-linear modelling; habitat fragmentation represented by the proportion of remnant vegetation within a moving window; fire prone landscapes assessed using fire history records; invasive species assessed through diversity metrics, species distribution and literature. Compared to plots, herbarium data had higher spatial and taxonomic coverage but records were more biased towards major transport corridors. Beta diversity was influenced by sampling intensity and scale of comparison. We identified six centres of high plant biodiversity for South Australia: Western Kangaroo Island; Southern Mount Lofty Ranges; Anangu Pitjantjatjara Yankunytjatjara lands; Southern Flinders Ranges; Southern Eyre Peninsula; Lower South East. Species composition in the arid-mediterranean ecotone was the most climate sensitive. Fragmentation mapping highlighted the dichotomy between extensive land-use and high remnancy in the north and intensive land-use and low remnancy in the south. Invasive species were most species rich in agricultural areas close to population centres. Fire mapping revealed large variation in frequency across the state. Biodiversity scores were not always congruent between metrics or datasets, notably for categorical endemism to South Australia versus georeferenced weighted endemism, justifying diverse approaches and cautious interpretation. The study could be extended to high resolution assessments of biodiversity centres and cost: benefit analysis for interventions.	[Guerin, Greg R.; Biffin, Ed; Baruch, Zdravko; Lowe, Andrew J.] Univ Adelaide, Sch Biol Sci, Terr Ecosyst Res Network, Adelaide Node, Adelaide, SA 5005, Australia; [Biffin, Ed; Lowe, Andrew J.] Dept Environm Water & Nat Resources, Sci Monitoring & Knowledge, Adelaide, SA, Australia	University of Adelaide	Guerin, GR (corresponding author), Univ Adelaide, Sch Biol Sci, Terr Ecosyst Res Network, Adelaide Node, North Terrace, Adelaide, SA 5005, Australia.	greg.guerin@adelaide.edu.au	Guerin, Greg R./R-8955-2019	Lowe, Andrew/0000-0003-1139-2516; Guerin, Greg/0000-0002-2104-6695	Terrestrial Ecosystem Research Network; South Australian Department of Environment, Water and Natural Resources	Terrestrial Ecosystem Research Network; South Australian Department of Environment, Water and Natural Resources	This research was supported by the Terrestrial Ecosystem Research Network and the South Australian Department of Environment, Water and Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AN, 2015, J BIOGEOGR, V42, P2313, DOI 10.1111/jbi.12599; [Anonymous], 2014, R LANG ENV STAT COMP; AW NRM Board (Alinytjara Wilurara Natural Resources Management Board), 2010, AL WIL REG NRM PLAN; Barker W, 2005, CENSUS S AUSTR VASCU; Butler Don W., 2003, Ecological Management & Restoration, V4, P120, DOI 10.1046/j.1442-8903.2003.00146.x; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Cardoso P, 2014, METHODS ECOL EVOL, V5, P452, DOI 10.1111/2041-210X.12173; Charles SP, 2015, STAT DOWNSCALED CLIM; Clarke K, 2011, ECOL INDIC, V11, P132, DOI 10.1016/j.ecolind.2010.07.002; Clarke PJ, 2005, J VEG SCI, V16, P237, DOI 10.1111/j.1654-1103.2005.tb02361.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Droissart V, 2012, BIOTROPICA, V44, P44, DOI 10.1111/j.1744-7429.2011.00777.x; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; EPA, 2013, STAT ENV S AUSTR; EPA, 2008, STAT OUR ENV STAT EN; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Geri F, 2013, BIODIVERS CONSERV, V22, P1679, DOI 10.1007/s10531-013-0503-7; Gill AM, 2014, LAND, V3, P1091, DOI 10.3390/land3031091; Gonzalez-Orozco CE, 2014, DIVERS DISTRIB, V20, P46, DOI 10.1111/ddi.12129; Gonzalez-Orozco CE, 2012, CONSERV GENET, V13, P1269, DOI 10.1007/s10592-012-0370-x; Gonzalez-Orozco CE, 2011, AUST J BOT, V59, P600, DOI 10.1071/BT11112; Guerin Greg R., 2015, SoftwareX, V3-4, P22, DOI 10.1016/j.softx.2015.10.002; Guerin GR, 2015, BIODIVERS CONSERV, V24, P2877, DOI 10.1007/s10531-015-0977-6; Guerin GR, 2015, METHODS ECOL EVOL, V6, P845, DOI 10.1111/2041-210X.12361; Guerin GR, 2014, GLOBAL ECOL BIOGEOGR, V23, P1062, DOI 10.1111/geb.12184; Guerin GR, 2013, ECOGRAPHY, V36, P1086, DOI 10.1111/j.1600-0587.2013.00215.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Laffan SW, 2003, J BIOGEOGR, V30, P511, DOI 10.1046/j.1365-2699.2003.00875.x; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; McCallum KP, 2014, AUSTRAL ECOL, V39, P17, DOI 10.1111/aec.12041; Miller G, 2010, RANGELAND J, V32, P353, DOI 10.1071/RJ09076; Mishler BD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5473; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Paltridge R, 2011, AUSTRALASIAN PLANT C, V19, P10; Read John L., 2011, Australian Mammalogy, V33, P214, DOI 10.1071/AM10040; Reese GC, 2014, GLOBAL ECOL BIOGEOGR, V23, P585, DOI 10.1111/geb.12144; Robinson A. C., 1988, BIOL SURVEY GAWLER R; Rosauer D, 2009, MOL ECOL, V18, P4061, DOI 10.1111/j.1365-294X.2009.04311.x; Schmidt-Lebuhn AN, 2013, BIODIVERS CONSERV, V22, P905, DOI 10.1007/s10531-013-0457-9; Slatyer C, 2007, J BIOGEOGR, V34, P583, DOI 10.1111/j.1365-2699.2006.01647.x; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Smyth A, 2009, RANGELAND J, V31, P307, DOI 10.1071/RJ08026; Stevenson LA, 2012, J BRYOL, V34, P101, DOI 10.1179/1743282012Y.0000000004; Thackway R., 1995, INTERIM BIOGEOGRAPHI; Tokmakoff A, 2014, P IEEE INT C E-SCI, P249, DOI 10.1109/eScience.2014.55; Traill LW, 2013, RES REP BIODIVERS ST, V3, P1, DOI DOI 10.2147/RRBS.S40301; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Yang WJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P1284, DOI 10.1111/geb.12225	53	26	28	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144779	10.1371/journal.pone.0144779	http://dx.doi.org/10.1371/journal.pone.0144779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735131	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100012
J	Lampert, A; Hoffmann, GF; Ries, M				Lampert, Anette; Hoffmann, Georg F.; Ries, Markus			Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; REPORTING BIAS; PUBLICATION; MORTALITY; EFFICACY	Introduction Although selective reporting of clinical trial results introduces bias into evidence based clinical decision making, publication bias in pediatric epilepsy is unknown today. Since there is a considerable ambiguity in the treatment of an important and common clinical problem, pediatric seizures, we assessed the public availability of results of phase 3 clinical trials that evaluated treatments of seizures in children and adolescents as a surrogate for the extent of publication bias in pediatric epilepsy. Methods We determined the proportion of published and unpublished study results of phase 3 clinical trials that were registered as completed on ClinicalTrials.gov. We searched ClinicalTrials. gov, PubMed, and Google Scholar for publications and contacted principal investigators or sponsors. The analysis was performed according to STROBE criteria. Results Considering studies that were completed before 2014 (N = 99), 75 (76%) pediatric phase 3 clinical trials were published but 24 (24%) remained unpublished. The unpublished studies concealed evidence from 4,437 patients. Mean time-to-publication was 25 SD +/- 15.6 months, more than twice as long as mandated. Conclusion Ten years after the ICMJE's clinical trials registration initiative there is still a considerable amount of selective reporting and delay of publication that potentially distorts the body of evidence in the treatment of pediatric seizures.	[Lampert, Anette] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany; [Lampert, Anette] Heidelberg Univ, Cooperat Unit Clin Pharm, Heidelberg, Germany; [Hoffmann, Georg F.; Ries, Markus] Univ Heidelberg Hosp, Ctr Pediat & Adolescent Med, Ctr Rare Disorders, Pediat Neurol & Metab Med, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Ries, M (corresponding author), Univ Heidelberg Hosp, Ctr Pediat & Adolescent Med, Ctr Rare Disorders, Pediat Neurol & Metab Med, Heidelberg, Germany.	markus.ries@med.uni-heidelberg.de	Ries, Markus/AAE-4934-2020	Ries, Markus/0000-0002-5054-5741	Dr. August and Dr. Anni Lesmuller foundation	Dr. August and Dr. Anni Lesmuller foundation	AL received a personal scholarship from "Dr. August and Dr. Anni Lesmuller foundation." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; Berg AT, 2013, NEUROLOGY, V81, P1166, DOI 10.1212/WNL.0b013e3182a55fb9; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; COWLEY AJ, 1993, INT J CARDIOL, V40, P161, DOI 10.1016/0167-5273(93)90279-P; CRAMER J, 1995, EPILEPSIA, V36, P1111, DOI 10.1111/j.1528-1157.1995.tb00469.x; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; EMA, ASSESSMENT OF THE PA; FDAAA, EXPANDED CLINICAL TR; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Greenwood RS, 2000, EPILEPSIA, V41, pS42, DOI 10.1111/j.1528-1157.2000.tb01523.x; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; ICMJE, RECOMMENDATIONS FOR; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Marson AG, 1997, EPILEPSIA, V38, P859, DOI 10.1111/j.1528-1157.1997.tb01251.x; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; MUNRO AJ, 1993, BRIT MED J, V307, P1340, DOI 10.1136/bmj.307.6915.1340; Nevalainen O, 2014, NEUROLOGY, V83, P1968, DOI 10.1212/WNL.0000000000001005; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; PEARN J, 1995, BRIT MED J, V310, P1313, DOI 10.1136/bmj.310.6990.1313; Potschka Heidrun, 2012, Handb Clin Neurol, V108, P741, DOI 10.1016/B978-0-444-52899-5.00025-3; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Tishler CL, 2011, PEDIATRICS, V127, P949, DOI 10.1542/peds.2010-2585; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	33	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144973	10.1371/journal.pone.0144973	http://dx.doi.org/10.1371/journal.pone.0144973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735955	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100018
J	Yin, QY; Zhu, L; Liu, D; Irwin, DM; Zhang, SY; Pan, YH				Yin, Qiuyuan; Zhu, Lei; Liu, Di; Irwin, David M.; Zhang, Shuyi; Pan, Yi-Hsuan			Molecular Evolution of the Nuclear Factor (Erythroid-Derived 2)-Like 2 Gene Nrf2 in Old World Fruit Bats (Chiroptera: Pteropodidae)	PLOS ONE			English	Article							OXIDATIVE STRESS; RECOMBINATION; PHYLOGENY; LONGEVITY; INFERENCE; SELECTION; MICE	Mammals developed antioxidant systems to defend against oxidative damage in their daily life. Enzymatic antioxidants and low molecular weight antioxidants (LMWAs) constitute major parts of the antioxidant systems. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2, encoded by the Nrf2 gene) is a central transcriptional regulator, regulating transcription, of many antioxidant enzymes. Frugivorous bats eat large amounts of fruits that contain high levels of LMWAs such as vitamin C, thus, a reliance on LMWAs might greatly reduce the need for antioxidant enzymes in comparison to insectivorous bats. Therefore, it is possible that frugivorous bats have a reduced need for Nrf2 function due to their substantial intake of diet-antioxidants. To test whether the Nrf2 gene has undergone relaxed evolution in fruit-eating bats, we obtained Nrf2 sequences from 16 species of bats, including four Old World fruit bats (Pteropodidae) and one New World fruit bat (Phyllostomidae). Our molecular evolutionary analyses revealed changes in the selection pressure acting on Nrf2 gene and identified seven specific amino acid substitutions that occurred on the ancestral lineage leading to Old World fruit bats. Biochemical experiments were conducted to examine Nrf2 in Old World fruit bats and showed that the amount of catalase, which is regulated by Nrf2, was significantly lower in the brain, heart and liver of Old World fruit bats despite higher levels of Nrf2 protein in Old World fruit bats. Computational predictions suggest that three of these seven amino acid replacements might be deleterious to Nrf2 function. Therefore, the results suggest that Nrf2 gene might have experienced relaxed constraint in Old World fruit bats, however, we cannot rule out the possibility of positive selection. Our study provides the first data on the molecular adaptation of Nrf2 gene in frugivorous bats in compensation to the increased levels of LWMAs from their fruit-diet.	[Yin, Qiuyuan; Zhu, Lei] E China Normal Univ, Engn Res Ctr Mol Therapeut & New Drug Dev, Lab Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Zhu, Lei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhu, Lei] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China; [Liu, Di] E China Normal Univ, Inst Estuarine & Coastal Res, Lab Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhang, Shuyi] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110161, Peoples R China; [Pan, Yi-Hsuan] E China Normal Univ, Sch Life Sci, Lab Mol Ecol & Evolut, Shanghai 200062, Peoples R China	East China Normal University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; East China Normal University; University of Toronto; Shenyang Agricultural University; East China Normal University	Zhang, SY (corresponding author), Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110161, Peoples R China.	szhang_sau@126.com; yihsuanp@gmail.com	Pan, Yi-Hsuan/ABG-6271-2020	Pan, Yi-Hsuan/0000-0001-5156-9887; Irwin, David/0000-0001-6131-4933	National Science Foundation of China [31100273/C030101, 31172077, 31570382]; Key Construction Program of the National '985 Project'; 211 Project; Shanghai Excellent Academic Leaders Project [11XD1402000]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Construction Program of the National '985 Project'; 211 Project(Anhui UniversityMinistry of Education, China); Shanghai Excellent Academic Leaders Project	This work was supported by grants from the National Science Foundation of China ( No. 31100273/C030101) to YP, and the Key Construction Program of the National '985 Project' and '211 Project' and Shanghai Excellent Academic Leaders Project (No. 11XD1402000) and the National Science Foundation of China (Grant No. 31172077, 31570382) to SZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Barnes MR, 2003, BIOINFORMATICS FOR G; Birdsey GM, 2005, P ROY SOC B-BIOL SCI, V272, P833, DOI 10.1098/rspb.2004.3011; Boutten A, 2011, TRENDS MOL MED, V17, P363, DOI 10.1016/j.molmed.2011.02.006; Brunet-Rossinni AK, 2004, MECH AGEING DEV, V125, P11, DOI 10.1016/j.mad.2003.09.003; Brunet-Rossinni AK, 2004, BIOGERONTOLOGY, V5, P211, DOI 10.1023/B:BGEN.0000038022.65024.d8; Brunet-Rossinni Anja K., 2009, P315; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Choi Y, 2012, PREDICTING THE FUNCT; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Dreger H, 2009, CARDIOVASC RES; Ferrari R, 1998, EUR HEART J, V19, pB2; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garbarino VR, 2015, ARCH BIOCH BIOPHYS; Grune T, 2005, LOW MOLECULAR WEIGHT, P77; Harasym J, 2014, NUTRITION, V30, P511, DOI 10.1016/j.nut.2013.08.019; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; Hill JE, 1984, BATS A NATURAL HISTO; Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kunz TH, 2006, BAT ECOLOGY; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Liu Y, 2012, MOL BIOL EVOL, V29, P1507, DOI 10.1093/molbev/mss013; Maddison WP, 2011, MESQUITE A MODULAR S; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; MARSHALL AG, 1985, ZOOL J LINN SOC-LOND, V83, P351, DOI 10.1111/j.1096-3642.1985.tb01181.x; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; MILTON K, 1987, EXPERIENTIA, V43, P339, DOI 10.1007/BF01945577; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Neuweiler G., 2000, THE BIOLOGY OF BATS; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, STAT BIOL HEALTH, P125, DOI 10.1007/0-387-27733-1_6; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reisman S.A., 2009, TOXICOL SCI; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneeberger K, 2014, NATURWISSENSCHAFTEN, V101, P285, DOI 10.1007/s00114-014-1155-5; Sharp PM, 1997, NATURE, V385, P111, DOI 10.1038/385111a0; Shen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097483; Shen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033197; Shen B, 2011, J MOL EVOL, V73, P109, DOI 10.1007/s00239-011-9460-5; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; THOMAS DW, 1984, PHYSIOL ZOOL, V57, P457, DOI 10.1086/physzool.57.4.30163347; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsagkogeorga G, 2013, CURR BIOL, V23, P2262, DOI 10.1016/j.cub.2013.09.014; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Wilhelm D, 2007, COMP BIOCHEM PHYS C, V146, P214, DOI 10.1016/j.cbpc.2006.11.015; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Wilson DE, 2005, MAMMAL SPECIES OF TH; Wu D, 2009, OXIDATIVE STRESS AND; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2005, P NATL ACAD SCI USA, V102, P3179, DOI 10.1073/pnas.0500371102; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou XM, 2012, SYST BIOL, V61, P150, DOI 10.1093/sysbio/syr089; Zhu L, 2015, PLOS ONE, V10	67	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146274	10.1371/journal.pone.0146274	http://dx.doi.org/10.1371/journal.pone.0146274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735303	Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100040
J	Bazar, G; Kovacs, Z; Tsenkova, R				Bazar, George; Kovacs, Zoltan; Tsenkova, Roumiana			Evaluating Spectral Signals to Identify Spectral Error	PLOS ONE			English	Article							MULTIVARIATE CURVE RESOLUTION; CORRELATION SPECTROSCOPY; LEAST-SQUARES	Since the precision and accuracy level of a chemometric model is highly influenced by the quality of the raw spectral data, it is very important to evaluate the recorded spectra and describe the erroneous regions before qualitative and quantitative analyses or detailed band assignment. This paper provides a collection of basic spectral analytical procedures and demonstrates their applicability in detecting errors of near infrared data. Evaluation methods based on standard deviation, coefficient of variation, mean centering and smoothing techniques are presented. Applications of derivatives with various gap sizes, even below the bandpass of the spectrometer, are shown to evaluate the level of spectral errors and find their origin. The possibility for prudent measurement of the third overtone region of water is also highlighted by evaluation of a complex data recorded with various spectrometers.	[Bazar, George; Kovacs, Zoltan; Tsenkova, Roumiana] Kobe Univ, Grad Sch Agr Sci, Biomeasurement Technol Lab, Kobe, Hyogo 657, Japan; [Bazar, George] Kaposvar Univ, Fac Agr & Environm Sci, Inst Food & Agr Prod Qualificat, Kaposvar, Hungary; [Kovacs, Zoltan] Corvinus Univ Budapest, Fac Food Sci, Dept Phys & Control, Budapest, Hungary	Kobe University; Hungarian University of Agriculture & Life Sciences; Kaposvar University; Corvinus University Budapest	Bazar, G (corresponding author), Kobe Univ, Grad Sch Agr Sci, Biomeasurement Technol Lab, Kobe, Hyogo 657, Japan.	bazar@agrilab.hu	Kovacs, Zoltan/Q-6939-2019; Tsenkova, Roumiana/ABB-7980-2021; Bazar, George/A-2986-2013; Kovacs, Zoltan/A-9721-2012	Kovacs, Zoltan/0000-0003-0641-8830; Tsenkova, Roumiana/0000-0002-9733-7587; Bazar, George/0000-0001-9829-4366; Kovacs, Zoltan/0000-0003-0641-8830	Japan Society for the Promotion of Science [P12409]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/), grant number P12409 (GB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, NEAR INFRARED TECHNO; Chaplin M, WATER ABSORPTION SPE; Collins JR, 1925, PHYS REV, P771; Czarnik-Matusewicz B, 2005, ANAL CHIM ACTA, V544, P15, DOI 10.1016/j.aca.2005.04.040; Davies AMC, 2011, SPECTROSC EUR, V23, P24; Davies AMC, 2011, SPECTROSC EUR, V23, P24; Fearn T, 2003, NIR NEWS, V14, P12; Gowen AA, 2013, ANAL CHIM ACTA, V759, P8, DOI 10.1016/j.aca.2012.10.007; Hopkins D., 2001, NIR NEWS, V12, P3; Nas T., 2002, MULTIVARIATE CALIBRA, V2nd ed.; Norris K., 2001, NIR NEWS, V12, P6, DOI [10.1255/nirn.613, DOI 10.1255/NIRN.613]; Norris KH, 1992, NIR NEWS, V3, P4; Norris KH, 2009, NIR NEWS, V20, P11; Norris KH, 1998, NIR NEWS, V9, P3; Norris KH, 2013, COMMUNICATION; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Segtnan VH, 2001, ANAL CHEM, V73, P3153, DOI 10.1021/ac010102n; Willimas P., 2013, NIR NEWS, V24, P24	18	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146249	10.1371/journal.pone.0146249	http://dx.doi.org/10.1371/journal.pone.0146249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731541	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400128
J	Costabile, A; Deaville, ER; Morales, AM; Gibson, GR				Costabile, Adele; Deaville, Eddie R.; Morales, Agustin Martin; Gibson, Glenn R.			Prebiotic Potential of a Maize-Based Soluble Fibre and Impact of Dose on the Human Gut Microbiota	PLOS ONE			English	Article							DOUBLE-BLIND; HEALTH; PROBIOTICS; POLYDEXTROSE; MODULATION; INULIN; FERMENTATION; TOLERANCE; DIVERSITY; ESTABLISH	Dietary management of the human gut microbiota towards a more beneficial composition is one approach that may improve host health. To date, a large number of human intervention studies have demonstrated that dietary consumption of certain food products can result in significant changes in the composition of the gut microbiota i.e. the prebiotic concept. Thus the prebiotic effect is now established as a dietary approach to increase beneficial gut bacteria and it has been associated with modulation of health biomarkers and modulation of the immune system. Promitor (TM) Soluble Corn Fibre (SCF) is a well-known maize-derived source of dietary fibre with potential selective fermentation properties. Our aim was to determine the optimum prebiotic dose of tolerance, desired changes to microbiota and fermentation of SCF in healthy adult subjects. A double-blind, randomised, parallel study was completed where volunteers (n = 8/treatment group) consumed 8, 14 or 21 g from SCF (6, 12 and 18 g/fibre delivered respectively) over 14-d. Over the range of doses studied, SCF was well tolerated Numbers of bifidobacteria were significantly higher for the 6 g/fibre/day compared to 12g and 18g/fibre delivered/day (mean 9.25 and 9.73 Log10 cells/g fresh faeces in the pre-treatment and treatment periods respectively). Such a numerical change of 0.5 Log10 bifidobacteria/g fresh faeces is consistent with those changes observed for inulin- type fructans, which are recognised prebiotics. A possible prebiotic effect of SCF was therefore demonstrated by its stimulation of bifidobacteria numbers in the overall gut microbiota during a short-term intervention.	[Costabile, Adele; Deaville, Eddie R.; Morales, Agustin Martin; Gibson, Glenn R.] Univ Reading, Dept Food & Nutr Sci, Reading RG6 6AP, Berks, England; [Costabile, Adele] Univ Roehampton, Whitelands Coll, Dept Life Sci, Hlth Sci Res Ctr, London SW15 4JD, England	University of Reading; Roehampton University	Costabile, A (corresponding author), Univ Reading, Dept Food & Nutr Sci, POB 226, Reading RG6 6AP, Berks, England.	a.costabile@reading.ac.uk		Costabile, Adele/0000-0003-3185-030X	Tate & Lyle Ingredients Americas LLC	Tate & Lyle Ingredients Americas LLC	The present study was funded by Tate & Lyle Ingredients Americas LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Perrot A., 2009, PREBIOTICS PROBIOTIC, P259; Bassaganya-Riera J, 2011, J NUTR, V141, P1318, DOI 10.3945/jn.111.139022; Boge T, 2009, VACCINE, V27, P5677, DOI 10.1016/j.vaccine.2009.06.094; Boler BMV, 2011, BRIT J NUTR, V106, P1864, DOI 10.1017/S0007114511002388; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Calame W, 2008, BRIT J NUTR, V100, P1269, DOI 10.1017/S0007114508981447; Candela M, 2015, CRIT REV MICROBIOL, V41, P165, DOI 10.3109/1040841X.2013.813900; Costabile A, 2010, BRIT J NUTR, V104, P1007, DOI 10.1017/S0007114510001571; Cummings JH, 2004, EUR J NUTR, V43, P118, DOI 10.1007/s00394-004-1205-4; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Druart C, 2014, ADV NUTR, V5, p624S, DOI 10.3945/an.114.005835; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Goel AK, 2006, DEFENCE SCI J, V56, P513, DOI 10.14429/dsj.56.1917; Golowczyc MA, 2007, INT J FOOD MICROBIOL, V118, P264, DOI 10.1016/j.ijfoodmicro.2007.07.042; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Housez B, 2012, J HUM NUTR DIET, V25, P488, DOI 10.1111/j.1365-277X.2012.01252.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kolida S, 2007, EUR J CLIN NUTR, V61, P1189, DOI 10.1038/sj.ejcn.1602636; Kolida S, 2007, J NUTR, V137, p2503S, DOI 10.1093/jn/137.11.2503S; Konings E, 2014, BRIT J NUTR, V111, P111, DOI 10.1017/S0007114513002183; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lin Chuan-Sheng, 2014, Biomed J, V37, P259, DOI 10.4103/2319-4170.138314; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; MANN GV, 1974, AM J CLIN NUTR, V27, P464, DOI 10.1093/ajcn/27.5.464; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Maukonen J, 2014, P NUTR SOC, P1; Roberfroid Marcel B., 2008, P39, DOI 10.1201/9780849381829.ch3; Sanders ME, 2014, ANN NY ACAD SCI, V1309, P19, DOI 10.1111/nyas.12377; Sangwan V, 2011, J FOOD SCI, V76, pR103, DOI 10.1111/j.1750-3841.2011.02131.x; SLAVIN JL, 1987, J AM DIET ASSOC, V87, P1164; Stewart ML, 2010, ANN NUTR METAB, V56, P91, DOI 10.1159/000275962; Strozzi GP, 2008, J CLIN GASTROENTEROL, V42, pS179, DOI 10.1097/MCG.0b013e31818087d8; Timm DA, 2013, J NUTR, V143, P473, DOI 10.3945/jn.112.170118; Torres DPM, 2010, COMPR REV FOOD SCI F, V9, P438, DOI 10.1111/j.1541-4337.2010.00119.x; Tuohy KM, 2005, CURR PHARM DESIGN, V11, P75, DOI 10.2174/1381612053382331; Turroni F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00437; van Loveren H, 2012, ANNU REV FOOD SCI T, V3, P247, DOI 10.1146/annurev-food-022811-101206; Vester Boler BM, 2011, BR J NUTR, P1; Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035; Whisner CM, 2014, BRIT J NUTR, V112, P446, DOI 10.1017/S0007114514000981	48	24	27	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144457	10.1371/journal.pone.0144457	http://dx.doi.org/10.1371/journal.pone.0144457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731113	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000367801400008
J	Diaz, F; Gamon, M; Hofman, JM; Kiciman, E; Rothschild, D				Diaz, Fernando; Gamon, Michael; Hofman, Jake M.; Kiciman, Emre; Rothschild, David			Online and Social Media Data As an Imperfect Continuous Panel Survey	PLOS ONE			English	Article								There is a large body of research on utilizing online activity as a survey of political opinion to predict real world election outcomes. There is considerably less work, however, on using this data to understand topic-specific interest and opinion amongst the general population and specific demographic subgroups, as currently measured by relatively expensive surveys. Here we investigate this possibility by studying a full census of all Twitter activity during the 2012 election cycle along with the comprehensive search history of a large panel of Internet users during the same period, highlighting the challenges in interpreting online and social media activity as the results of a survey. As noted in existing work, the online population is a non-representative sample of the offline world (e.g., the U.S. voting population). We extend this work to show how demographic skew and user participation is non-stationary and difficult to predict over time. In addition, the nature of user contributions varies substantially around important events. Furthermore, we note subtle problems in mapping what people are sharing or consuming online to specific sentiment or opinion measures around a particular topic. We provide a framework, built around considering this data as an imperfect continuous panel survey, for addressing these issues so that meaningful insight about public interest and opinion can be reliably extracted from online and social media data.	[Diaz, Fernando; Hofman, Jake M.; Rothschild, David] Microsoft Res, New York, NY USA; [Gamon, Michael; Kiciman, Emre] Microsoft Res, Redmond, WA USA	Microsoft; Microsoft	Rothschild, D (corresponding author), Microsoft Res, New York, NY USA.	DavidMR@Microsoft.com		Kiciman, Emre/0000-0001-5429-468X	Microsoft	Microsoft(Microsoft)	The authors' work is funded 100% through the authors' employment at Microsoft. There is no additional funding of the authors' work. No one other than the authors had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfonso O, 2013, P 6 INT WORKSH EXPL, P9; [Anonymous], 2012, ARXIV12046441; [Anonymous], 2014, PEW RES POL POL AM P; [Anonymous], 2012, PEN RES ASS REPR PUB; Beam C, 2009, LIES DAMN LIES VOTES; Beauchamp N, 2013, M AUT TEXT AN LOND S; Bermingham A, 2011, SENT ANAL AI MEETS P; Biemer PP, 2010, PUBLIC OPIN QUART, V74, P817, DOI 10.1093/poq/nfq058; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Borondo J, 2012, CHAOS, V22, DOI 10.1063/1.4729139; Boutet A, 2012, ICWSM; Broder A., 2002, SIGIR Forum, V36, P3, DOI 10.1145/792550.792552; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Budak C, 2015, SOCIOL SCI, V2, P370, DOI 10.15195/v2.a18; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Ceron A, 2013, NEW MEDIA SOC; Chang J, 2010, P 4 INT AAAI C WEBL; Chen L, 2012, LECT NOTES COMPUT SC, V7710, P379, DOI 10.1007/978-3-642-35386-4_28; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Choy Murphy, 2012, ARXIV12110938; Conover MD, 2013, PLOS ONE, V85; Diaz F, P 2 ACM INT C WEB SE, P182; DiGrazia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079449; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Gayo-Avello D, 2011, COMMUN ACM, V54, P121, DOI 10.1145/2001269.2001297; Gayo-Avello Daniel, 2011, ICWSM; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S., 2012, ICWSM; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Golder SA, 2012, SOCIAL SCI SOCIAL ME; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Groves RM, 2010, PUBLIC OPIN QUART, V74, P849, DOI 10.1093/poq/nfq065; Hampton K., 2011, SOCIAL NETWORKING SI; Hanna A, 2011, ICWSM; He YL, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P3901; Hecht B, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P237; Huberman BA, 2008, P INT C COMP SUPP CO; Huberty Mark Edward, 2013, P 2 WORKSH POL EL DA, P23, DOI [DOI 10.1145/2508436.2508439, 10.1145/2508436.2508439]; Imran M, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2771588; Java A., P 9 WEBKDD 1 SNA KDD; Jiang J, 2011, TECHNICAL PAPER SERI; Johnson C, 2012, CLASSIFYING POLITICA; Jungherr A, 2012, SOCIAAL SCI COMPUTER; Kairam SR, 2013, P ICWSM 2013 7 INT A; Kiciman E, 2012, 6 INT AAAI C WEBL SO; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; Lampos V., P 51 ANN M ASS COMP, P993; Larsson A, 2012, NORDICOM REV; Lee J, 2013, ICONFERENCE, P351, DOI DOI 10.9776/13210; Lui C., 2011, IADIS INT C, V1; Metaxas PT, 2012, SCIENCE, V338, P472, DOI 10.1126/science.1230456; Metaxas PT, 2011, WHAT EDITED RETWEETS; Mitchell Amy, 2013, TWITTER REACTION EVE; Monti C., 2013, P 2 INT WORKSH ISS S; Morstatter F, 2013, P ICWSM; Mustafaraj E, 2011, PRIVACY SECURITY RIS; OConnor B., 2010, ICWSM, P122; Pennacchiotti M., 2011, P INT AAAI C WEB SOC, VVolume 5; Ratkiewicz J, P 20 INT C COMP WORL; Rosenquist J., 2021, P INT AAAI C WEB SOC, V5, P554; Schober MF, 2015, PUBLIC OPINION Q; Sebastiani F, 2008, P 31 ANN INT ACM SIG, P339, DOI DOI 10.1145/1390334.1390393; Shi L, 2012, P SOC NETW SOC MED A, V7; Skoric M, SYST SCI HICSS 2012; Soler JM, 2012, P 2012 INT C ADV SOC; Tang C, 2011, LECT NOTES COMPUT SC, V6637, P344; Tumasjan A, 2010, PREDICTING ELECT TWI; Vallina-Rodriguez N, 2012 INT C 2012 INT; Wang W, 2015, INT J FORECASTING; Wu S, P 20 INT C WORLD WID; Yeager D. S., 2011, PUBLIC OPINION Q; Yom-Tov E, 2013, ACM T INFORM SYST, V31, DOI 10.1145/2414782.2414786; Zamal FA, 2012, P 6 INT AAAI C WEBL	73	49	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145406	10.1371/journal.pone.0145406	http://dx.doi.org/10.1371/journal.pone.0145406			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26730933	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400034
J	Esmaeili, S; Naddaf, SR; Pourhossein, B; Shahraki, AH; Amiri, FB; Gouya, MM; Mostafavi, E				Esmaeili, Saber; Naddaf, Saied Reza; Pourhossein, Behzad; Shahraki, Abdolrazagh Hashemi; Amiri, Fahimeh Bagheri; Gouya, Mohammad Mehdi; Mostafavi, Ehsan			Seroprevalence of Brucellosis, Leptospirosis, and Q Fever among Butchers and Slaughterhouse Workers in South-Eastern Iran	PLOS ONE			English	Article							RISK OCCUPATIONAL GROUPS; SEROEPIDEMIOLOGICAL SURVEY; COXIELLA-BURNETII; INFECTIOUS-DISEASES; SEROLOGIC SURVEY; ANTIBODIES; PROVINCE; EPIDEMIOLOGY; POPULATION; LIVESTOCK	Zoonotic diseases can be occupational hazards to people who work in close contact with animals or their carcasses. In this cross-sectional study, 190 sera were collected from butchers and slaughterhouse workers in different regions of the Sistan va Baluchestan province, in Iran in 2011. A questionnaire was filled for each participant to document personal and behavioural information. The sera were tested for detection of specific IgG antibodies against brucellosis, leptospirosis, and Q fever (phase I and II) using commercial enzyme-linked immunosorbent assays (ELISA). The seroprevalence of brucellosis was 7.9%, leptospirosis 23.4%, and phase I and II of Q fever were 18.1% and 14.4%, respectively. The seroprevalence of Q fever and leptospirosis, but not brucellosis, varied among regions within the province (p = 0.01). Additionally, a significant relationship was found between seropositivity of Q fever and camel slaughtering (p = 0.04). Reduced seropositivity rate of brucellosis was associated with use of personal protective equipment (PPE) (p = 0.004). This study shows that brucellosis, leptospirosis and Q fever occur among butchers and slaughterhouse workers in this area.	[Esmaeili, Saber; Pourhossein, Behzad; Shahraki, Abdolrazagh Hashemi; Amiri, Fahimeh Bagheri; Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran; [Esmaeili, Saber; Shahraki, Abdolrazagh Hashemi; Mostafavi, Ehsan] Pasteur Inst Iran, Natl Reference Lab Plague Tularemia & Q Fever, Res Ctr Emerging & Reemerging Infect Dis, Kabudar Ahang, Hamadan, Iran; [Esmaeili, Saber] Tarbiat Modares Univ, Fac Med Sci, Dept Bacteriol, Tehran, Iran; [Naddaf, Saied Reza] Pasteur Inst Iran, Dept Parasitol, Tehran, Iran; [Pourhossein, Behzad] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran; [Amiri, Fahimeh Bagheri] Univ Tehran, Dept Epidemiol, Fac Vet Med, Tehran, Iran; [Gouya, Mohammad Mehdi] Minist Hlth, Ctr Dis Control, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tarbiat Modares University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; University of Tehran	Mostafavi, E (corresponding author), Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran.	mostafavi@pasteur.ac.ir	Pourhossein, Behzad/ABG-4336-2020; Mostafavi, Ehsan/A-7627-2011; Hashemi Shahraki, Abdolrazagh/AAG-2663-2021; Amiri, Fahimeh Bagheri/M-7724-2019; Esmaeili, Saber/F-2620-2017; Gouya, Mohammad Mehdi/ABI-4325-2020; Naddaf, Saied Reza/W-2757-2017	Pourhossein, Behzad/0000-0002-4263-0612; Mostafavi, Ehsan/0000-0002-1997-517X; Hashemi Shahraki, Abdolrazagh/0000-0003-1852-194X; Amiri, Fahimeh Bagheri/0000-0003-2943-2846; Esmaeili, Saber/0000-0003-1920-1737; Naddaf, Saied Reza/0000-0002-0751-8692	Centre for Disease Control and Prevention of the Iranian Ministry of Health	Centre for Disease Control and Prevention of the Iranian Ministry of Health	The authors appreciate the financial support of the Centre for Disease Control and Prevention of the Iranian Ministry of Health; this work was approved by the Pasteur Institute of Iran (Session No. 508). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Al Sekait MA, 1999, ANN SAUDI MED, V19, P219, DOI 10.5144/0256-4947.1999.219; Alavi SM, 2012, JUNDISHAPUR J MICROB, V5, P384, DOI 10.5812/jjm.3248; Alavi-Naini R, 2006, J INFECTION, V52, P378, DOI 10.1016/j.jinf.2005.07.015; Amini B., 2010, Iranian Journal of Clinical Infectious Diseases, V5, P152; Angelakis E, 2011, IRAN J PUBLIC HEALTH, V40, P1; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Aygen B, 2002, MED MALADIES INFECT, V32, P485, DOI 10.1016/S0399-077X(02)00403-1; Barbuddhe S. B., 2000, Journal of Communicable Diseases, V32, P295; Battelli Giorgio, 2008, Vet Ital, V44, P601; Berktas M, 2011, TURK KLIN TIP BILIM, V31, P45, DOI 10.5336/medsci.2009-15348; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Doosti A., 2014, Comparative Clinical Pathology, V23, P43, DOI 10.1007/s00580-012-1567-6; Dreyfus A, 2014, INT J ENV RES PUB HE, V11, P1756, DOI 10.3390/ijerph110201756; Esmaeili S, 2014, VECTOR-BORNE ZOONOT, V14, P189, DOI 10.1089/vbz.2013.1382; Esmaeili S, 2014, VECTOR-BORNE ZOONOT, V14, P41, DOI 10.1089/vbz.2013.1379; Esmaeili S, 2013, ANN AGR ENV MED, V20, P708; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Gonçalves Daniela Dib, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P135, DOI 10.1590/S0036-46652006000300004; Honarmand H, 2007, IRAN J PUBLIC HEALTH, V36, P68; Imandar M., 2011, SCI J KURDISTAN U ME, V16, P77; Karimi A, 2003, East Mediterr Health J, V9, P178; Khalili M., 2012, Asian Pacific Journal of Tropical Disease, V2, P448, DOI 10.1016/S2222-1808(12)60098-X; Khalili Mohammad, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS209, DOI 10.12980/APJTB.4.2014C1268; Khalili M, 2010, T ROY SOC TROP MED H, V104, P623, DOI 10.1016/j.trstmh.2010.04.002; Khalili M, 2009, AM J TROP MED HYG, V80, P1031, DOI 10.4269/ajtmh.2009.80.1031; Majd N, 2012, ASIAN PACIFIC J TROP, V2, P550; Missailidis S, 2014, INT J TROPICAL DIS H, V4, P147; Mostafavi E., 2012, Asian Journal of Epidemiology, V5, P66, DOI 10.3923/aje.2012.66.74; Mostafavi E, 2011, J EPIDEMIOL COMMUN H, V65, pA136, DOI 10.1136/jech.2011.142976e.47; Mukhtar F, 2010, J PAK MED ASSOC, V60, P1031; Mukhtar Fatima, 2008, J Ayub Med Coll Abbottabad, V20, P57; Nikokar I, 2011, J RES MED SCI, V16, P1366; Omokhodion FO, 2013, J PUBLIC HEALTH-HEID, V21, P131, DOI 10.1007/s10389-012-0528-5; Parizadeh SMJ, 2009, PAKISTAN J NUTR, V8, P139, DOI DOI 10.3923/pjn.2009.139.144; Rabbani khourasgani M., 2008, COMP CLIN PATHOL, V17, P267, DOI DOI 10.1007/s00580-007-0685-z; Rahimi E, 2011, FOODBORNE PATHOG DIS, V8, P307, DOI 10.1089/fpd.2010.0684; Ramos TRR, 2008, BRAZ J INFECT DIS, V12, P133, DOI 10.1590/S1413-86702008000200007; RIEMANN HP, 1975, AM J EPIDEMIOL, V102, P386, DOI 10.1093/oxfordjournals.aje.a112177; Rodriguez-Parra ME, 2012, AFR J MICROBIOL RES, V6, P1584, DOI 10.5897/AJMR11.1539; Roushan MRH, 2010, INT J INFECT DIS, V14, pE250, DOI 10.1016/j.ijid.2009.05.008; Saeed KMI, 2012, INT J INFECT DIS, V16, pE37, DOI 10.1016/j.ijid.2012.05.094; Sakhaee Ehsanollah, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P227, DOI 10.1016/S2221-1691(11)60032-4; Saleem MH, 2013, PAK J ZOOL, V45, P909; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Sharma S, 2006, AM J TROP MED HYG, V74, P278, DOI 10.4269/ajtmh.2006.74.278; Swai ES, 2009, ZOONOSES PUBLIC HLTH, V56, P183, DOI 10.1111/j.1863-2378.2008.01175.x; Taravati M, 2007, URMIA MED J, V18, P459; Van den Brom R, 2009, SMALL RUMINANT RES, V86, P74, DOI 10.1016/j.smallrumres.2009.09.022; Vande-Yousefi J, 1997, 3 NAT C DIS TRANSM H, P59; Wallace MR, 2002, CLIN INFECT DIS, V34, pS171, DOI 10.1086/340704; Wiethoelter AK, 2015, P NATL ACAD SCI USA, V112, P9662, DOI 10.1073/pnas.1422741112; Yoo Seok-Ju, 2009, J Prev Med Public Health, V42, P237, DOI 10.3961/jpmph.2009.42.4.237; Zakeri S, 2010, AM J TROP MED HYG, V82, P899, DOI 10.4269/ajtmh.2010.09-0721	54	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144953	10.1371/journal.pone.0144953	http://dx.doi.org/10.1371/journal.pone.0144953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731333	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400019
J	Gompper, ME; Lesmeister, DB; Ray, JC; Malcolm, JR; Kays, R				Gompper, Matthew E.; Lesmeister, Damon B.; Ray, Justina C.; Malcolm, Jay R.; Kays, Roland			Differential Habitat Use or Intraguild Interactions: What Structures a Carnivore Community?	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; ESTIMATING SITE OCCUPANCY; TOP PREDATORS; INTERFERENCE COMPETITION; CLIMATE-CHANGE; LANDSCAPE; FOXES; ABUNDANCE; SURVIVAL; COYOTES	Differential habitat use and intraguild competition are both thought to be important drivers of animal population sizes and distributions. Habitat associations for individual species are well-established, and interactions between particular pairs of species have been highlighted in many focal studies. However, community-wide assessments of the relative strengths of these two factors have not been conducted. We built multi-scale habitat occupancy models for five carnivore taxa of New York's Adirondack landscape and assessed the relative performance of these models against ones in which co-occurrences of potentially competing carnivore species were also incorporated. Distribution models based on habitat performed well for all species. Black bear (Ursus americanus) and fisher (Martes pennanti) distribution was similar in that occupancy of both species was negatively associated with paved roads. However, black bears were also associated with larger forest fragments and fishers with smaller forest fragments. No models with habitat features were more supported than the null habitat model for raccoons (Procyon lotor). Martens (Martes americana) were most associated with increased terrain ruggedness and elevation. Weasel (Mustela spp.) occupancy increased with the cover of deciduous forest. For most species dyads habitat-only models were more supported than those models with potential competitors incorporated. The exception to this finding was for the smallest carnivore taxa (marten and weasel) where habitat plus coyote abundance models typically performed better than habitat-only models. Assessing this carnivore community as whole, we conclude that differential habitat use is more important than species interactions in maintaining the distribution and structure of this carnivore guild.	[Gompper, Matthew E.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO USA; [Lesmeister, Damon B.] US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Corvallis, OR USA; [Ray, Justina C.] Wildlife Conservat Soc Canada, Toronto, ON, Canada; [Malcolm, Jay R.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Kays, Roland] North Carolina Museum Nat Sci, Raleigh, NC USA; [Kays, Roland] N Carolina State Univ, Raleigh, NC 27695 USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; University of Toronto; University of North Carolina; North Carolina State University	Lesmeister, DB (corresponding author), US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Corvallis, OR USA.	dlesmeister@fs.fed.us		Kays, Roland/0000-0002-2947-6665	Wildlife Conservation Society; Geraldine R. Dodge Foundation; National Geographic Society; New York State Museum; New York Biodiversity Research Institute; New York Department of Environmental Conservation; National Science Foundation [DEB 0347609]	Wildlife Conservation Society; Geraldine R. Dodge Foundation; National Geographic Society(National Geographic Society); New York State Museum; New York Biodiversity Research Institute; New York Department of Environmental Conservation; National Science Foundation(National Science Foundation (NSF))	Financial support for this work came from the Wildlife Conservation Society, the Geraldine R. Dodge Foundation, the National Geographic Society, the New York State Museum, the New York Biodiversity Research Institute, the New York Department of Environmental Conservation, and the National Science Foundation (DEB 0347609).	Apps CD, 2006, ECOGRAPHY, V29, P561, DOI 10.1111/j.0906-7590.2006.04564.x; Arjo WM, 2002, J MAMMAL, V83, P754, DOI 10.1644/1545-1542(2002)083<0754:DOBWAC>2.0.CO;2; Atwood TC, 2010, J MAMMAL, V91, P490, DOI 10.1644/09-MAMM-A-078.1; Aubry K.B., 2006, ECOLOGICAL CHARACTER; Aubry KB, 2003, BIOL CONSERV, V114, P79, DOI 10.1016/S0006-3207(03)00003-X; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Bowman J, 2010, CAN J ZOOL, V88, P454, DOI 10.1139/Z10-019; Brundige GC, 1993, THESIS; Bull Evelyn L., 2001, Northwestern Naturalist, V82, P1, DOI 10.2307/3536640; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carroll C, 2007, CONSERV BIOL, V21, P1092, DOI 10.1111/j.1523-1739.2007.00719.x; Choate JR, 1998, J MAMMAL, V79, P1416; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Cooch E., 2009, PROGRAM MARK GENTLE; de Oliveira TG, 2014, J MAMM EVOL, V21, P427, DOI 10.1007/s10914-013-9251-4; Donadio E, 2006, AM NAT, V167, P524, DOI 10.1086/501033; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; Farias V, 2005, J ZOOL, V266, P249, DOI 10.1017/S0952836905006850; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Fener HM, 2005, CAN FIELD NAT, V119, P1; Fox LB, 1990, THESIS; Garvey PM, 2014, BIOL INVASIONS, P1; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Gosselink TE, 2007, J WILDLIFE MANAGE, V71, P1862, DOI 10.2193/2006-020; Henke SE, 1999, J WILDLIFE MANAGE, V63, P1066, DOI 10.2307/3802826; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines JE, 2006, PRESENCE 3 0 SOFTWAR; Johnson CJ, 2001, OECOLOGIA, V127, P590, DOI 10.1007/s004420000573; Kamler JF, 2004, AM MIDL NAT, V151, P27, DOI 10.1674/0003-0031(2004)151[0027:SACMAF]2.0.CO;2; Kamler JF, 2003, J WILDLIFE MANAGE, V67, P317, DOI 10.2307/3802773; Kays RW, 2008, ECOL APPL, V18, P1014, DOI 10.1890/07-0298.1; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Lesmeister DB, 2009, J WILDLIFE MANAGE, V73, P18, DOI 10.2193/2007-447; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; LITVAITIS JA, 1989, CAN J ZOOL, V67, P1180, DOI 10.1139/z89-170; Lourenco R, 2014, BIOL REV, V89, P270, DOI 10.1111/brv.12054; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mattisson J, 2011, CAN J ZOOL, V89, P79, DOI 10.1139/Z10-097; MCCARTHY BC, 1994, CAN J FOREST RES, V24, P1317, DOI 10.1139/x94-172; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; Mutshinda CM, 2009, P ROY SOC B-BIOL SCI, V276, P2923, DOI 10.1098/rspb.2009.0523; Neale JCC, 2001, OIKOS, V94, P236, DOI 10.1034/j.1600-0706.2001.940204.x; Nelson JL, 2007, J WILDLIFE MANAGE, V71, P1467, DOI 10.2193/2006-234; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; O'Connell Allan F. Jr, 1992, Northeast Wildlife, V49, P36; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; PALOMARES F, 1995, CONSERV BIOL, V9, P295, DOI 10.1046/j.1523-1739.1995.9020295.x; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; St-Pierre C, 2006, ECOGRAPHY, V29, P487, DOI 10.1111/j.0906-7590.2006.04395.x; Steinmetz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014509; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak AT, 2009, BEHAV ECOL SOCIOBIOL, V64, P279, DOI 10.1007/s00265-009-0845-z; Wengert GM, 2014, J WILDLIFE MANAGE, V78, P603, DOI 10.1002/jwmg.698; Wilson RR, 2010, OECOLOGIA, V164, P921, DOI 10.1007/s00442-010-1797-8; [No title captured]	60	45	46	1	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146055	10.1371/journal.pone.0146055	http://dx.doi.org/10.1371/journal.pone.0146055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731404	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400082
J	Harada, KH; Tanaka, K; Sakamoto, H; Imanaka, M; Niisoe, T; Hitomi, T; Kobayashi, H; Okuda, H; Inoue, S; Kusakawa, K; Oshima, M; Watanabe, K; Yasojima, M; Takasuga, T; Koizumi, A				Harada, Kouji H.; Tanaka, Keiko; Sakamoto, Hiroko; Imanaka, Mie; Niisoe, Tamon; Hitomi, Toshiaki; Kobayashi, Hatasu; Okuda, Hiroko; Inoue, Sumiko; Kusakawa, Koichi; Oshima, Masayo; Watanabe, Kiyohiko; Yasojima, Makoto; Takasuga, Takumi; Koizumi, Akio			Biological Monitoring of Human Exposure to Neonicotinoids Using Urine Samples, and Neonicotinoid Excretion Kinetics	PLOS ONE			English	Article							INSECTICIDES; METABOLITES; TOXICITY; TIME; MICE	Background Neonicotinoids, which are novel pesticides, have entered into usage around the world because they are selectively toxic to arthropods and relatively non-toxic to vertebrates. It has been suggested that several neonicotinoids cause neurodevelopmental toxicity in mammals. The aim was to establish the relationship between oral intake and urinary excretion of neonicotinoids by humans to facilitate biological monitoring, and to estimate dietary neonicotinoid intakes by Japanese adults. Methodology/Principal Findings Deuterium-labeled neonicotinoid (acetamiprid, clothianidin, dinotefuran, and imidacloprid) microdoses were orally ingested by nine healthy adults, and 24 h pooled urine samples were collected for 4 consecutive days after dosing. The excretion kinetics were modeled using one-and two-compartment models, then validated in a non-deuterium-labeled neonicotinoid microdose study involving 12 healthy adults. Increased urinary concentrations of labeled neonicotinoids were observed after dosing. Clothianidin was recovered unchanged within 3 days, and most dinotefuran was recovered unchanged within 1 day. Around 10% of the imidacloprid dose was excreted unchanged. Most of the acetamiprid was metabolized to desmethyl-acetamiprid. Spot urine samples from 373 Japanese adults were analyzed for neonicotinoids, and daily intakes were estimated. The estimated average daily intake of these neonicotinoids was 0.53-3.66 mu g/day. The highest intake of any of the neonicotinoids in the study population was 64.5 mu g/day for dinotefuran, and this was <1% of the acceptable daily intake.	[Harada, Kouji H.; Niisoe, Tamon; Hitomi, Toshiaki; Kobayashi, Hatasu; Okuda, Hiroko; Inoue, Sumiko; Kusakawa, Koichi; Oshima, Masayo; Koizumi, Akio] Kyoto Univ, Dept Hlth & Environm Sci, Grad Sch Med, Kyoto 6068501, Japan; [Tanaka, Keiko; Sakamoto, Hiroko] Kyoto Bunkyo Jr Coll, Dept Food Nutr, Uji 6110041, Japan; [Imanaka, Mie] Kyoto Koka Womens Univ, Dept Hlth & Nutr, Kyoto 6150882, Japan; [Watanabe, Kiyohiko; Yasojima, Makoto; Takasuga, Takumi] Shimadzu Techno Res Inc, Nishikyo Ku, Kyoto 6048435, Japan	Kyoto University	Koizumi, A (corresponding author), Kyoto Univ, Dept Hlth & Environm Sci, Grad Sch Med, Kyoto 6068501, Japan.	koizumi.akio.5v@kyoto-u.ac.jp	Kobayashi, Hatasu/R-8012-2019	Kobayashi, Hatasu/0000-0002-5664-6869; Harada, Kouji/0000-0001-7319-123X	Japanese Ministry of Health, Labour and Welfare [H24-Food-002]; Shimadzu Techno-Research Incorporated	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Shimadzu Techno-Research Incorporated	This study was supported by a Grant-in-Aid for Health Sciences Research to AK from the Japanese Ministry of Health, Labour and Welfare (H24-Food-002) (http://www.mhlw.go.jp/english). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shimadzu Techno-Research Incorporated provided support in the form of salaries and research materials for authors TT, MY, KW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	EFSA Panel on Plant Protection Products and their Residues, 2013, EFSA J, V11, P3471; European Commission, 2013, OFFICIAL J EUROPEAN; Food Safety Commission of Japan, RISK ASS REP LMID; Food Safety Commission of Japan, RISK ASS REP THIAM; Food Safety Commission of Japan, RISK ASS REP AC; Food Safety Commission of Japan, RISK ASS REP CLOTH; Food Safety Commission of Japan, RISK ASS REP DIN; Ford KA, 2006, CHEM RES TOXICOL, V19, P1549, DOI 10.1021/tx0601859; Ford KA, 2006, CHEM RES TOXICOL, V19, P944, DOI 10.1021/tx0600696; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; KOIZUMI A, 1980, AM IND HYG ASSOC J, V41, P693, DOI 10.1080/15298668091425527; Koizumi Akio, 2009, Environmental Health and Preventive Medicine, V14, P307, DOI 10.1007/s12199-009-0101-1; Liu ZH, 2011, PEST MANAG SCI, V67, P1245, DOI 10.1002/ps.2174; National Institute for Environmental Studies of Japan, CHEM DAT; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Shi XY, 2009, J AGR FOOD CHEM, V57, P4861, DOI 10.1021/jf900250f; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Taira K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080332; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Ueyama J, 2014, J OCCUP HEALTH, V56, P461, DOI 10.1539/joh.14-0077-OA; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	22	75	78	7	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146335	10.1371/journal.pone.0146335	http://dx.doi.org/10.1371/journal.pone.0146335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731104	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400152
J	Jehle, J; Hoyer, FF; Schone, B; Pfeifer, P; Schild, K; Jenniches, I; Bindila, L; Lutz, B; Lutjohann, D; Zimmer, A; Nickenig, G				Jehle, Julian; Hoyer, Friedrich Felix; Schoene, Benedikt; Pfeifer, Philipp; Schild, Katharina; Jenniches, Imke; Bindila, Laura; Lutz, Beat; Luetjohann, Dieter; Zimmer, Andreas; Nickenig, Georg			Myeloid-Specific Deletion of Diacylglycerol Lipase a Inhibits Atherogenesis in ApoE-Deficient Mice	PLOS ONE			English	Article							ACTIVATED ENDOCANNABINOID SYSTEM; CANNABINOID CB2 RECEPTOR; DISEASE; CELLS; 2-ARACHIDONOYLGLYCEROL; ATHEROSCLEROSIS; INVOLVEMENT; BINDS	Background The endocannabinoid 2-arachidonoylglycerol (2-AG) is a known modulator of inflammation. Despite its high concentration in vascular tissue, the role of 2-AG in atherogenesis has not yet been examined. Methods ApoE-deficient mice were sublethally irradiated and reconstituted with bone marrow from mice with a myeloid-specific knockout of the 2-AG synthesising enzyme diacylglycerol lipase alpha (Dagla) or control bone marrow with an intact 2-AG biosynthesis. After a cholesterol- rich diet for 8 weeks, plaque size and plaque morphology were examined in chimeric mice. Circulating inflammatory cells were assessed by flow cytometry. Aortic tissue and plasma levels of endocannabinoids were measured using liquid chromatography-multiple reaction monitoring. Results Mice with Dagla-deficient bone marrow and circulating myeloid cells showed a significantly reduced plaque burden compared to controls. The reduction in plaque size was accompanied by a significantly diminished accumulation of both neutrophil granulocytes and macrophages in atherosclerotic lesions of Dagla-deficient mice. Moreover, CB2 expression and the amount of oxidised LDL within atherosclerotic lesions was significantly reduced. FACS analyses revealed that levels of circulating inflammatory cells were unaltered in Dagla-deficient mice. Conclusions Myeloid synthesis of the endocannabinoid 2-AG appears to promote vascular inflammation and atherogenesis. Thus, myeloid-specific disruption of 2-AG synthesis may represent a potential novel therapeutic strategy against atherosclerosis.	[Jehle, Julian; Schoene, Benedikt; Pfeifer, Philipp; Schild, Katharina; Nickenig, Georg] Univ Bonn, Klin Innere Med 2, Bonn, Germany; [Hoyer, Friedrich Felix] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Jenniches, Imke; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Bindila, Laura; Lutz, Beat] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, D-55122 Mainz, Germany; [Luetjohann, Dieter] Univ Bonn, Inst Klin Chem & Klin Pharmakol, Bonn, Germany	University of Bonn; Harvard University; Massachusetts General Hospital; University of Bonn; Johannes Gutenberg University of Mainz; University of Bonn	Jehle, J (corresponding author), Univ Bonn, Klin Innere Med 2, Bonn, Germany.	julian.jehle@ukb.uni-bonn.de	Hoyer, Friedrich/AAC-8097-2022; Zimmer, Andreas/B-8357-2009; Lutz, Beat/AAG-4538-2022; Lutz, Beat/AFK-6229-2022		Deutsche Forschungsgemeinschaft [FOR926 SP6]; Bonfor programm (Gerok scholarship)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bonfor programm (Gerok scholarship)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to AZ (FOR926 SP6) and by the Bonfor programm (Gerok scholarship to JJ). GN and AZ are members of the Excellence Cluster Immunosensation.; We thank Theresa Schmitz, Anna Flender, Kathrin Paul-Krahe Heike Slomka and Anja Kerksiek for excellent technical assistance. We are grateful to Dr. rer. nat. Garbe for the irradiation of the mice. This work was supported by a grant from the Deutsche Forschungsgemeinschaft to AZ (FOR926 SP6) and by the Bonfor programm (Gerok scholarship to JJ). GN and AZ are members of the Excellence Cluster Immunosensation.	ALLEN AC, 1992, J NEUROCHEM, V58, P1130, DOI 10.1111/j.1471-4159.1992.tb09372.x; Chavez-Sanchez L, 2014, ARCH MED RES, V45, P1, DOI 10.1016/j.arcmed.2013.11.007; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dol-Gleizes F, 2009, ARTERIOSCL THROM VAS, V29, P12, DOI 10.1161/ATVBAHA.108.168757; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Hoyer FF, 2014, J MOL CELL CARDIOL, V66, P126, DOI 10.1016/j.yjmcc.2013.11.013; Hoyer FF, 2011, J MOL CELL CARDIOL, V51, P1007, DOI 10.1016/j.yjmcc.2011.08.008; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Jiang LS, 2009, CARDIOVASC RES, V81, P805, DOI 10.1093/cvr/cvn344; Kishimoto S, 2003, J BIOL CHEM, V278, P24469, DOI 10.1074/jbc.M301359200; Lenglet S, 2013, ARTERIOSCL THROM VAS, V33, P215, DOI 10.1161/ATVBAHA.112.300275; Lomazzo E, 2015, NEUROPSYCHOPHARMACOL, V40, P488, DOI 10.1038/npp.2014.198; Mach F, 2008, J NEUROENDOCRINOL, V20, P53, DOI 10.1111/j.1365-2826.2008.01685.x; Marazzi J, 2011, J IMMUNOL METHODS, V373, P219, DOI 10.1016/j.jim.2011.08.021; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mimura T, 2012, INT ARCH ALLERGY IMM, V159, P149, DOI 10.1159/000336167; Montecucco F, 2009, ATHEROSCLEROSIS, V205, P433, DOI 10.1016/j.atherosclerosis.2008.12.040; Nowbar AN, 2014, INT J CARDIOL, V174, P293, DOI 10.1016/j.ijcard.2014.04.096; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7	25	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146267	10.1371/journal.pone.0146267	http://dx.doi.org/10.1371/journal.pone.0146267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731274	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400135
J	Joos, O; Silva, R; Amouzou, A; Moulton, LH; Perin, J; Bryce, J; Mullany, LC				Joos, Olga; Silva, Romesh; Amouzou, Agbessi; Moulton, Lawrence H.; Perin, Jamie; Bryce, Jennifer; Mullany, Luke C.			Evaluation of a mHealth Data Quality Intervention to Improve Documentation of Pregnancy Outcomes by Health Surveillance Assistants in Malawi: A Cluster Randomized Trial	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; JOB-SATISFACTION; CASE-MANAGEMENT; CHILD SURVIVAL; WORKERS; REGISTRATION; PERFORMANCE; EXPERIENCES; SYSTEM; IMPACT	Background While community health workers are being recognized as an integral work force with growing responsibilities, increased demands can potentially affect motivation and performance. The ubiquity of mobile phones, even in hard-to-reach communities, has facilitated the pursuit of novel approaches to support community health workers beyond traditional modes of supervision, job aids, in-service training, and material compensation. We tested whether supportive short message services (SMS) could improve reporting of pregnancies and pregnancy outcomes among community health workers (Health Surveillance Assistants, or HSAs) in Malawi. Methods and Findings We designed a set of one-way SMS that were sent to HSAs on a regular basis during a 12-month period. We tested the effectiveness of the cluster-randomized intervention in improving the complete documentation of a pregnancy. We defined complete documentation as a pregnancy for which a specific outcome was recorded. HSAs in the treatment group received motivational and data quality SMS. HSAs in the control group received only motivational SMS. During baseline and intervention periods, we matched reported pregnancies to reported outcomes to determine if reporting of matched pregnancies differed between groups and by period. The trial is registered as ISCTRN24785657. Conclusions Study results show that the mHealth intervention improved the documentation of matched pregnancies in both the treatment (OR 1.31, 95% CI: 1.10-1.55, p<0.01) and control (OR 1.46, 95% CI: 1.11-1.91, p = 0.01) groups relative to the baseline period, despite differences in SMS content between groups. The results should be interpreted with caution given that the study was underpowered. We did not find a statistically significant difference in matched pregnancy documentation between groups during the intervention period (OR 0.94, 95% CI: 0.63-1.38, p = 0.74). mHealth applications have the potential to improve the tracking and data quality of pregnancies and pregnancy outcomes, particularly in low-resource settings.	[Joos, Olga; Silva, Romesh; Amouzou, Agbessi; Moulton, Lawrence H.; Perin, Jamie; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Silva, Romesh] UN, Div Stat, Econ & Social Commiss Western Asia, Beirut, Lebanon; [Amouzou, Agbessi] UNICEF, New York, NY USA; [Mullany, Luke C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Ctr Maternal & Neonatal Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; UNICEF; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Joos, O (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	ojoos1@jhu.edu		Joos, Olga/0000-0003-0335-4982; Amouzou, Agbessi/0000-0002-6262-3866	Foreign Affairs, Trade, and Development Canada [7056791]	Foreign Affairs, Trade, and Development Canada	Jennifer Bryce, the PI, received grant 7056791 from Foreign Affairs, Trade, and Development Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Health Surveillance Assistants for participating in the study and the HSA supervisors, RMM district coordinators, district health officers, and environmental health officers in Balaka and Salima for supporting HSAs and for their role in RMM. We are grateful for the leadership and staff of the Malawi National Statistics Office, namely Kingsley Laija, and IIP colleagues who assisted with data management and costing, namely Elizabeth Hazel, Lois Park, and Andrew Marsh. We also thank Sara Laufer for her assistance in cleaning and preparing the study data for analysis. We are extremely appreciative of Frontline SMS for making the messaging platform open source and providing timely and helpful technological support. We are also grateful to Foreign Affairs, Trade and Development Canada for their generous financial support of the Real-Time Monitoring of Under-Five Mortality project.	Agarwal S, 2015, TROP MED INT HEALTH, V20, P1003, DOI 10.1111/tmi.12525; Allotey P, 2001, SOC SCI MED, V52, P1007, DOI 10.1016/S0277-9536(00)00207-0; Amouzou A, 2013, PLOS ONE, V9, DOI [10.1371/journal.pone.0088939, DOI 10.1371/J0URNAL.P0NE.0088939]; Amouzou A, 2013, TROP MED INT HEALTH, V18, P1231, DOI 10.1111/tmi.12167; Aranda-Jan CB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-188; Baseman JG, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-295; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Bryce J, UNDER REVIEW AS PART; Callaghan-Koru JA, 2012, AM J TROP MED HYG, V87, P61, DOI 10.4269/ajtmh.2012.11-0665; Census and Survey Processing System, 2012, CSPRO SOFTW VERS 5 0; Chang LW, 2011, AIDS BEHAV, V15, P1776, DOI 10.1007/s10461-011-9995-x; de Tolly K, 2012, TELEMED E-HEALTH, V18, P18, DOI 10.1089/tmj.2011.0058; Department of Economic and Social Affairs, 2012, UN DEV STRAT 2015; DeRenzi Brian, 2012, IMPROVING COMMUNITY, P25, DOI [10.1145/2160673.2160677, DOI 10.1145/2160673.2160677]; Diallo DA, 1996, T ROY SOC TROP MED H, V90, P610, DOI 10.1016/S0035-9203(96)90405-8; Eldridge S, 2012, PRACTICAL GUIDE CLUS; Fogarty L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-11; Frontline SMS, 2012, FRONTL SMS SOFTW VER; Guenther T, 2012, AM J TROP MED HYG, V87, P77, DOI 10.4269/ajtmh.2012.11-0747; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hall CS, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25606; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Head KJ, 2013, SOC SCI MED, V97, P41, DOI 10.1016/j.socscimed.2013.08.003; Hill K, COLLECTION IN PRESS; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Huaman MA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-16; Independent Expert Review Group, 2014, EV WOM EV CHILD STRE; Jewkes R, 1998, SOC SCI MED, V46, P1043, DOI 10.1016/S0277-9536(97)10036-3; Jones COH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038636; Joos O, COLLECTION IN PRESS; Kallander K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2130; Kok MC, 2013, MALAWI MED J, V25, P5; Kok MC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0001-3; Kok MC, 2014, HLTH POLICY PLAN, V2014, P1, DOI DOI 10.1093/HEAP0L/CZU126; Kuipers Pim, 2008, Aust New Zealand Health Policy, V5, P17, DOI 10.1186/1743-8462-5-17; Kurumop SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076578; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Labrique AB, 2012, REPROD HEALTH MATTER, V20, P113, DOI 10.1016/S0968-8080(12)39631-6; Leon N, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-123; Lubiganon P, 1990, INT J EPIDEMIOL, V19, P997; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; McCawBinns AM, 1996, INT J EPIDEMIOL, V25, P807, DOI 10.1093/ije/25.4.807; Ministry of Health, 2011, HLTH SECT STRAT PLAN; Ministry of Health, 2009, HLTH SERV ASS TRAIN; Moulton Lawrence H, 2004, Clin Trials, V1, P297, DOI 10.1191/1740774504cn024oa; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Park LG, 2014, J ADV NURS, V70, P1932, DOI 10.1111/jan.12400; Roberton T, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0010-x; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Singh P, 2013, ONE MILLION COMMUNIT; Singh P, 2013, LANCET, V382, P363, DOI 10.1016/S0140-6736(12)62002-9; Smith S, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-24; StataCorp, 2011, STAT STAT SOFTW REL, P173; UN, 2015, MILLENNIUM DEV GOALS; World Health Organization & Global Health Workforce Alliance, 2008, COUNTR CAS STUD ETH; Zimba E, 2012, HEALTH POLICY PLANN, V27, P88, DOI 10.1093/heapol/czs043; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	57	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145238	10.1371/journal.pone.0145238	http://dx.doi.org/10.1371/journal.pone.0145238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731401	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400028
J	Kim, H; Myoung, S; Koom, WS; Kim, NK; Kim, MJ; Ahn, JB; Hur, H; Lim, JS				Kim, Honsoul; Myoung, Sungmin; Koom, Woong Sub; Kim, Nam Kyu; Kim, Myeong-Jin; Ahn, Joong Bae; Hur, Hyuk; Lim, Joon Seok			MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection	PLOS ONE			English	Article							MESORECTAL FASCIA INVASION; PREOPERATIVE CHEMORADIOTHERAPY; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; MARGIN; ACCURACY; CHEMOTHERAPY; RECURRENCE; SURVIVAL; MERCURY	Purpose Rectal cancer patients achieving pCR are known to have an excellent prognosis, yet no widely accepted consensus on risk stratification and post-operative management (e.g., adjuvant therapy) has been established. This study aimed to identify magnetic resonance imaging (MRI) high-risk factors for tumor relapse in pathological complete remission (pCR) achieved by rectal cancer patients who have undergone neoadjuvant concurrent chemoradiation therapy (CRT) and curative resection. Materials and Methods We analyzed 88 (male/female = 55/33, median age, 59.5 years [range 34-78]) pCR-proven rectal cancer patients who had undergone pre-CRT MRI, CRT, post-CRT MRI and curative surgery between July 2005 and December 2012. Patients were observed for post-operative tumor relapse. We analyzed the pre/post-CRT MRIs for parameters including mrT stage, mesorectal fascia (mrMRF) status, tumor volume, tumor regression grade (mrTRG), nodal status (mrN), and extramural vessel invasion (mrEMVI). We performed univariate analysis and Kaplan-Meier survival analysis. Results Post-operative tumor relapse occurred in seven patients (8.0%, n = 7/88) between 5.7 and 50.7 (median 16.8) months. No significant relevance was observed between tumor volume, volume reduction rate, mrTRG, mrT, or mrN status. Meanwhile, positive mrMRF (Ppre-CRT = 0.018, Ppre/post-CRT = 0.006) and mrEMVI (Ppre-CRT = 0.026, Ppre-/post-CRT = 0.008) were associated with higher incidence of post-operative tumor relapse. Kaplan-Meier survival analysis revealed a higher risk of tumor relapse in patients with positive mrMRF (Ppre-CRT = 0.029, Ppre-/post-CRT = 0.009) or mrEMVI (Ppre-CRT = 0.024, Ppre-/post-CRT = 0.003). Conclusion Positive mrMRF and mrEMVI status was associated with a higher risk of post-operative tumor relapse of pCR achieved by rectal cancer patients, and therefore, can be applied for risk stratification and to individualize treatment plans.	[Kim, Honsoul; Kim, Myeong-Jin; Lim, Joon Seok] Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul 120752, South Korea; [Myoung, Sungmin] Jungwon Univ, Dept Med Informat, Goesan 367805, South Korea; [Koom, Woong Sub] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul 120752, South Korea; [Kim, Nam Kyu; Hur, Hyuk] Yonsei Univ, Coll Med, Dept Surg, Div Colon & Rectal Surg, Seoul 120752, South Korea; [Ahn, Joong Bae] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; Jungwon University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Hur, H (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Div Colon & Rectal Surg, Seoul 120752, South Korea.	hhyuk@yuhs.ac; jslim1@yuhs.ac	Lim, Joon Seok/R-7753-2019; Kim, Myeong-Jin/E-1623-2011	Lim, Joon seok/0000-0002-0334-5042; Kim, Nam-Kyu/0000-0003-0639-5632; Koom, Woong Sub/0000-0002-9435-7750; Hur, Hyuk/0000-0002-9864-7229; Kim, Myeong-Jin/0000-0001-7949-5402; Ahn, Joong Bae/0000-0001-6787-1503	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [2014-31-0115]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study (2014-31-0115) was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea. URL: http://www.mw.go.kr/.	Bernstein TE, 2009, BRIT J SURG, V96, P1348, DOI 10.1002/bjs.6739; Chan AKP, 2005, INT J RADIAT ONCOL, V61, P665, DOI 10.1016/j.ijrobp.2004.06.206; Chand M, 2015, ANN SURG, V261, P473, DOI 10.1097/SLA.0000000000000848; Chiang JM, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-197; Glynne-Jones R, 2008, DIS COLON RECTUM, V51, P10, DOI 10.1007/s10350-007-9080-8; Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32; Hunter CJ, 2012, ANN SURG ONCOL, V19, P1199, DOI 10.1245/s10434-011-2036-1; Hur H, 2014, DIS COLON RECTUM, V57, P592, DOI 10.1097/DCR.0000000000000109; Kim H, 2010, RADIOLOGY, V254, P485, DOI 10.1148/radiol.09090587; Kim JH, 2004, EUR J RADIOL, V52, P78, DOI 10.1016/j.ejrad.2003.12.005; Kim SH, 2009, J MAGN RESON IMAGING, V29, P1093, DOI 10.1002/jmri.21742; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; Madbouly KM, 2014, AM J SURG, V208, P332, DOI 10.1016/j.amjsurg.2013.10.023; Mantke R, 2012, EJSO-EUR J SURG ONC, V38, P259, DOI 10.1016/j.ejso.2011.12.013; Mignanelli ED, 2010, DIS COLON RECTUM, V53, P251, DOI 10.1007/DCR.0b013e3181bcd3cc; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Oberholzer K, 2012, J MAGN RESON IMAGING, V36, P658, DOI 10.1002/jmri.23687; Park IJ, 2014, WORLD J GASTROENTERO, V20, P2023, DOI 10.3748/wjg.v20.i8.2023; Patel UB, 2012, AM J ROENTGENOL, V199, pW486, DOI 10.2214/AJR.11.8210; Santos MD, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/572149; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Smith NJ, 2008, BRIT J SURG, V95, P229, DOI 10.1002/bjs.5917; Taylor FGM, 2014, J CLIN ONCOL, V32, P34, DOI 10.1200/JCO.2012.45.3258; Vliegen RFA, 2008, RADIOLOGY, V246, P454, DOI 10.1148/radiol.2462070042; Williamson JS, 2014, BRIT J SURG, V101, P1290, DOI 10.1002/bjs.9570	25	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146235	10.1371/journal.pone.0146235	http://dx.doi.org/10.1371/journal.pone.0146235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730717	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400123
J	King, RB; Stanford, KM; Jones, PC; Bekker, K				King, Richard B.; Stanford, Kristin M.; Jones, Peter C.; Bekker, Kent			Size Matters: Individual Variation in Ectotherm Growth and Asymptotic Size	PLOS ONE			English	Article							COLOR-PATTERN VARIATION; LAKE-ERIE WATERSNAKE; GARTER SNAKES; LIFE-HISTORY; THAMNOPHIS ELEGANS; BODY-SIZE; POPULATION; PREY; EVOLUTION; SURVIVAL	Body size, and, by extension, growth has impacts on physiology, survival, attainment of sexual maturity, fecundity, generation time, and population dynamics, especially in ectotherm animals that often exhibit extensive growth following attainment of sexual maturity. Frequently, growth is analyzed at the population level, providing useful population mean growth parameters but ignoring individual variation that is also of ecological and evolutionary significance. Our long-term study of Lake Erie Watersnakes, Nerodia sipedon insularum, provides data sufficient for a detailed analysis of population and individual growth. We describe population mean growth separately for males and females based on size of known age individuals (847 captures of 769 males, 748 captures of 684 females) and annual growth increments of individuals of unknown age (1,152 males, 730 females). We characterize individual variation in asymptotic size based on repeated measurements of 69 males and 71 females that were each captured in five to nine different years. The most striking result of our analyses is that asymptotic size varies dramatically among individuals, ranging from 631-820 mm snout-vent length in males and from 835-1125 mm in females. Because female fecundity increases with increasing body size, we explore the impact of individual variation in asymptotic size on lifetime reproductive success using a range of realistic estimates of annual survival. When all females commence reproduction at the same age, lifetime reproductive success is greatest for females with greater asymptotic size regardless of annual survival. But when reproduction is delayed in females with greater asymptotic size, lifetime reproductive success is greatest for females with lower asymptotic size when annual survival is low. Possible causes of individual variation in asymptotic size, including individual-and cohort-specific variation in size at birth and early growth, warrant further investigation.	[King, Richard B.; Stanford, Kristin M.; Jones, Peter C.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Stanford, Kristin M.] Ohio State Univ, FT Stone Lab, Put In Bay, OH USA; [Bekker, Kent] Toledo Zoo, Dept Herpetol, Toledo, OH USA	Northern Illinois University; University System of Ohio; Ohio State University	King, RB (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	rbking@niu.edu						Andrews R.M., 1982, Biology of Reptilia, V13, P273; Armstrong DP, 2013, ECOL MODEL, V250, P119, DOI 10.1016/j.ecolmodel.2012.10.022; Baron JP, 2010, J ANIM ECOL, V79, P640, DOI 10.1111/j.1365-2656.2010.01661.x; Bekker KA, 2007, THESIS; Blouin-Demers G, 2002, J ZOOL, V256, P1, DOI 10.1017/S0952836902000018; Brodie Edmund D. III, 1993, P315; Bronikowski AM, 1999, ECOLOGY, V80, P2314, DOI 10.1890/0012-9658(1999)080[2314:TEEOLH]2.0.CO;2; Bronikowski AM, 2000, EVOLUTION, V54, P1760; Brown GP, 2007, J EVOLUTION BIOL, V20, P588, DOI 10.1111/j.1420-9101.2006.01256.x; Brown GP, 1999, COPEIA, P723, DOI 10.2307/1447605; Brown RP, 1999, ECOGRAPHY, V22, P277, DOI 10.1111/j.1600-0587.1999.tb00503.x; Calder WA., 1984, SIZE FUNCTION LIFE H; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Eguchi T, 2012, HERPETOLOGICA, V68, P76, DOI 10.1655/HERPETOLOGICA-D-11-00050.1; FABENS AJ, 1965, GROWTH, V29, P265; FAZIO BB, 1999, FED REGISTER, V64, P47126; FRAZER NB, 1990, COPEIA, P112; Gibbons J.W., 2004, N AM WATERSNAKES NAT; Gregory P.T., 1982, Biology of Reptilia, V13, P53; GREGORY PT, 1994, J ZOOL, V232, P313, DOI 10.1111/j.1469-7998.1994.tb01575.x; HALLIDAY TR, 1988, J HERPETOL, V22, P253, DOI 10.2307/1564148; HOUSTON D, 1994, COPEIA, P726; Jones PC, 2009, COPEIA, P437, DOI 10.1643/CH-08-119; King RB, 2006, CAN J ZOOL, V84, P108, DOI 10.1139/Z05-182; King RB, 1997, BIOSCIENCE, V47, P279, DOI 10.2307/1313189; KING RB, 1995, EVOLUTION, V49, P885, DOI 10.1111/j.1558-5646.1995.tb02324.x; KING RB, 1993, J HERPETOL, V27, P175, DOI 10.2307/1564934; King RB, 2002, FUNCT ECOL, V16, P766, DOI 10.1046/j.1365-2435.2002.00678.x; KING RB, 1986, COPEIA, P757; KING RB, 1993, EVOLUTION, V47, P1819, DOI 10.1111/j.1558-5646.1993.tb01272.x; King RB, 2014, LAKE ERIE WATERSNAKE; King RB, 2006, HERPETOL MONOGR, V20, P83, DOI 10.1655/0733-1347(2007)20[83:PSARCO]2.0.CO;2; King Richard B., 2008, South American Journal of Herpetology, V3, P155, DOI 10.2994/1808-9798(2008)3[155:RCOACP]2.0.CO;2; Lindeman PV, 1997, HERPETOLOGICA, V53, P179; Mack EW, 2015, THESIS; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; Manier MK, 2007, J EVOLUTION BIOL, V20, P1705, DOI 10.1111/j.1420-9101.2007.01401.x; MICHOD RE, 1979, AM NAT, V113, P531, DOI 10.1086/283411; Nelson KJ, 2000, J HERPETOL, V34, P32, DOI 10.2307/1565235; OBrien TK, 2014, THESIS; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Roff Derek A., 1992; Sasaki K, 2009, CONSERV BIOL, V23, P93, DOI 10.1111/j.1523-1739.2008.01067.x; Shine R., 2000, Animal Behaviour Forum, V59, pF4, DOI 10.1006/anbe.1999.1338; Shine R, 2001, ANIM BEHAV, V61, P1133, DOI 10.1006/anbe.2001.1712; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Stafford CP, 2014, CAN J FISH AQUAT SCI, V71, P10, DOI 10.1139/cjfas-2013-0115; STAMPS JA, 1992, OECOLOGIA, V92, P503, DOI 10.1007/BF00317842; STAMPS JA, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P75, DOI 10.2307/1466997; Stanford KM, 2004, COPEIA, P465; Stanford KM, 2012, THESIS; Stanford KM, 2010, J FISH WILDL MANAG, V1, P122, DOI 10.3996/052010-JFWM-013; Tucker AD, 2006, AUST J ZOOL, V54, P409, DOI 10.1071/ZO06099; US Fish and Wildlife Service, 2011, FED REGISTER, V76, P50680; *US FISH WILDL SER, 2003, LAK ER WAT NER SIP I	57	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146299	10.1371/journal.pone.0146299	http://dx.doi.org/10.1371/journal.pone.0146299			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730712	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400141
J	Musundire, R; Osuga, IM; Cheseto, X; Irungu, J; Torto, B				Musundire, Robert; Osuga, Isaac M.; Cheseto, Xavier; Irungu, Janet; Torto, Baldwyn			Aflatoxin Contamination Detected in Nutrient and Anti-Oxidant Rich Edible Stink Bug Stored in Recycled Grain Containers	PLOS ONE			English	Article							MONOUNSATURATED FATTY-ACIDS; FLAVONOIDS; MANAGEMENT; FOOD	Recently, there has been multi-agency promotion of entomophagy as an environmentally-friendly source of food for the ever increasing human population especially in the developing countries. However, food quality and safety concerns must first be addressed in this context. We addressed these concerns in the present study using the edible stink bug Encosternum delegorguei, which is widely consumed in southern Africa. We analysed for mycotoxins, and health beneficials including antioxidants, amino acids and essential fatty acids using liquid chromatography coupled to quadrupole time of flight mass spectrometry (LC-Qtof-MS) and coupled gas chromatography (GC)-MS. We also performed proximate analysis to determine nutritional components. We identified the human carcinogen mycotoxin (aflatoxin B-1) at low levels in edible stink bugs that were stored in traditonally woven wooden dung smeared baskets and gunny bags previously used to store cereals. However, it was absent in insects stored in clean zip lock bags. On the other hand, we identified 10 fatty acids, of which 7 are considered essential fatty acids for human nutrition and health; 4 flavonoids and 12 amino acids of which two are considered the most limiting amino acids in cereal based diets. The edible stink bug also contained high crude protein and fats but was a poor source of minerals, except for phosphorus which was found in relatively high levels. Our results show that the edible stink bug is a nutrient-and antioxidant-rich source of food and health benefits for human consumption. As such, use of better handling and storage methods can help eliminate contamination of the edible stink bug with the carcinogen aflatoxin and ensure its safety as human food.	[Musundire, Robert; Osuga, Isaac M.; Cheseto, Xavier; Irungu, Janet; Torto, Baldwyn] Icipe, Behav & Chem Ecol Dept, Nairobi, Kenya; [Musundire, Robert] Chinhoyi Univ Technol, Dept Crop Sci & Postharvest Technol, Chinhoyi, Zimbabwe; [Osuga, Isaac M.] Kenyatta Univ, Dept Agr Resources Management, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); Kenyatta University	Torto, B (corresponding author), Icipe, Behav & Chem Ecol Dept, POB 30772-00100, Nairobi, Kenya.	btorto@icipe.org		Cheseto, Xavier/0000-0002-9779-0357	German Academic Exchange Service (DAAD) under Postdoctoral Fellowships in SUbSaharan Africa at DAAD [A/1394098]	German Academic Exchange Service (DAAD) under Postdoctoral Fellowships in SUbSaharan Africa at DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	German Academic Exchange Service (DAAD) under Postdoctoral Fellowships in SUbSaharan Africa at DAAD supported Centres of Excellence Grant A/1394098.	Abdel-Moein NM, 2011, GRASAS ACEITES, V62, P365, DOI 10.3989/gya.125010; Alberice JV, 2013, J CHROMATOGR A, V1318, P163, DOI 10.1016/j.chroma.2013.10.002; Asfaw N., 1994, ECON BOT, V48, P258, DOI [10.1007/BF02862326,258, DOI 10.1007/BF02862326,258]; Azziz-Baumgartner E, 2005, ENVIRON HEALTH PERSP, V113, P1779, DOI 10.1289/ehp.8384; Bengal W, 2013, IJMPS, V3, P31; Cappozzo J, 2008, CHROMATOGR TODAY, P3; Chavunduka D.M., 1975, RHODESIA SCI NEWS, V9, P217; Cheseto X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127171; Christie W.W., 1993, ADV LIPID METHODOLOG, P69, DOI DOI 10.1016/0009-3084(94)02308-5; Cotty PJ, 2007, INT J FOOD MICROBIOL, V119, P109, DOI 10.1016/j.ijfoodmicro.2007.07.060; Dhanasekaran D, 2011, AFLATOXINS - BIOCHEMISTRY AND MOLECULAR BIOLOGY, P221; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Dzerefos CM, 2009, J APPL ENTOMOL, V133, P749, DOI 10.1111/j.1439-0418.2009.01425.x; Dzerefos CM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-20; Dzerefos CM, 2014, THESIS; GRUNDY SM, 1989, J NUTR, V119, P529, DOI 10.1093/jn/119.4.529; Hamilton ML, 2012, PHYTOCHEMISTRY, V84, P169, DOI 10.1016/j.phytochem.2012.08.005; Helrich KC, 1990, OFF METH AN AOAC, P750; Jared JJ, 2016, PEST MANAG SCI, V72, P828, DOI 10.1002/ps.4100; Kumar N.R., 2012, INT J PHARM BIO SCI, V3, P344; Kwashirai VC, 2007, J HIST GEOGR, V33, P816, DOI 10.1016/j.jhg.2006.10.023; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Mawere M, 2014, THESIS; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; Oberdorster E, 2001, J STEROID BIOCHEM, V77, P229, DOI 10.1016/S0960-0760(01)00067-X; Oguntokun MO, 2015, ARTI GRAFICHE STEPHA, V73, P521; Omotoso O.T., 2006, Journal of Zhejiang University Science B, V7, P51, DOI 10.1631/jzus.2006.B0051; Picker M, 2002, AFRICAN ZOOLOGY, P440; RamosElorduy J, 1997, ECOL FOOD NUTR, V36, P247, DOI 10.1080/03670244.1997.9991519; Reddy SV WF, 2015, PROPERTIES AFLATOXIN; Simmonds MSJ, 2001, PHYTOCHEMISTRY, V56, P245, DOI 10.1016/S0031-9422(00)00453-2; Spiller GA, 1995, HDB LIPIDS HUMAN NUT, P22; Teffo LS, 2007, S AFR J SCI, V103, P434; Teffo LS, 2010, S AFR J BOT, V76, P25, DOI 10.1016/j.sajb.2009.06.010; United Nations, 2013, ESAJPWP228 UN; Van Huis A., 2013, FUTURE PROSPECTS FOO, V171; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Xiaoming C, 2010, FOREST INSECTS FOOD, P85; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Zand RSR, 2002, J CHROMATOGR B, V777, P219, DOI 10.1016/S1570-0232(02)00213-1	40	30	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145914	10.1371/journal.pone.0145914	http://dx.doi.org/10.1371/journal.pone.0145914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731419	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400064
J	Portugal, LCL; Rosa, MJ; Rao, A; Bebko, G; Bertocci, MA; Hinze, AK; Bonar, L; Almeida, JRC; Perlman, SB; Versace, A; Schirda, C; Travis, M; Gill, MK; Demeter, C; Diwadkar, VA; Ciuffetelli, G; Rodriguez, E; Forbes, EE; Sunshine, JL; Holland, SK; Kowatch, RA; Birmaher, B; Axelson, D; Horwitz, SM; Arnold, EL; Fristad, MA; Youngstrom, EA; Findling, RL; Pereira, M; Oliveira, L; Phillips, ML; Mourao-Miranda, J				Portugal, Liana C. L.; Rosa, Maria Joao; Rao, Anil; Bebko, Genna; Bertocci, Michele A.; Hinze, Amanda K.; Bonar, Lisa; Almeida, Jorge R. C.; Perlman, Susan B.; Versace, Amelia; Schirda, Claudiu; Travis, Michael; Gill, Mary Kay; Demeter, Christine; Diwadkar, Vaibhav A.; Ciuffetelli, Gary; Rodriguez, Eric; Forbes, Erika E.; Sunshine, Jeffrey L.; Holland, Scott K.; Kowatch, Robert A.; Birmaher, Boris; Axelson, David; Horwitz, Sarah M.; Arnold, Eugene L.; Fristad, Mary A.; Youngstrom, Eric A.; Findling, Robert L.; Pereira, Mirtes; Oliveira, Leticia; Phillips, Mary L.; Mourao-Miranda, Janaina			Can Emotional and Behavioral Dysregulation in Youth Be Decoded from Functional Neuroimaging?	PLOS ONE			English	Article							BIPOLAR DISORDER; LONGITUDINAL ASSESSMENT; CHILDREN; FMRI; ADOLESCENTS; CIRCUITRY; SYMPTOMS; VALIDITY; ANXIETY; MANIA	Introduction High comorbidity among pediatric disorders characterized by behavioral and emotional dysregulation poses problems for diagnosis and treatment, and suggests that these disorders may be better conceptualized as dimensions of abnormal behaviors. Furthermore, identifying neuroimaging biomarkers related to dimensional measures of behavior may provide targets to guide individualized treatment. We aimed to use functional neuroimaging and pattern regression techniques to determine whether patterns of brain activity could accurately decode individual-level severity on a dimensional scale measuring behavioural and emotional dysregulation at two different time points. Methods A sample of fifty-seven youth (mean age: 14.5 years; 32 males) was selected from a multisite study of youth with parent-reported behavioral and emotional dysregulation. Participants performed a block-design reward paradigm during functional Magnetic Resonance Imaging (fMRI). Pattern regression analyses consisted of Relevance Vector Regression (RVR) and two cross-validation strategies implemented in the Pattern Recognition for Neuroimaging toolbox (PRoNTo). Medication was treated as a binary confounding variable. Decoded and actual clinical scores were compared using Pearson's correlation coefficient (r) and mean squared error (MSE) to evaluate the models. Permutation test was applied to estimate significance levels. Results Relevance Vector Regression identified patterns of neural activity associated with symptoms of behavioral and emotional dysregulation at the initial study screen and close to the fMRI scanning session. The correlation and the mean squared error between actual and decoded symptoms were significant at the initial study screen and close to the fMRI scanning session. However, after controlling for potential medication effects, results remained significant only for decoding symptoms at the initial study screen. Neural regions with the highest contribution to the pattern regression model included cerebellum, sensory-motor and fronto-limbic areas. Conclusions The combination of pattern regression models and neuroimaging can help to determine the severity of behavioral and emotional dysregulation in youth at different time points.	[Portugal, Liana C. L.; Rosa, Maria Joao; Rao, Anil; Mourao-Miranda, Janaina] UCL, Dept Comp Sci, Ctr Computat Stat & Machine Learning, London, England; [Portugal, Liana C. L.; Pereira, Mirtes; Oliveira, Leticia] Univ Fed Fluminense, Dept Physiol & Pharmacol, Niteroi, RJ, Brazil; [Bebko, Genna; Bertocci, Michele A.; Hinze, Amanda K.; Bonar, Lisa; Almeida, Jorge R. C.; Perlman, Susan B.; Versace, Amelia; Schirda, Claudiu; Travis, Michael; Gill, Mary Kay; Ciuffetelli, Gary; Rodriguez, Eric; Forbes, Erika E.; Birmaher, Boris; Axelson, David; Phillips, Mary L.] Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA; [Demeter, Christine; Sunshine, Jeffrey L.; Findling, Robert L.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Diwadkar, Vaibhav A.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI USA; [Holland, Scott K.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Kowatch, Robert A.] Nationwide Childrens Hosp, Res Inst, Columbus, MS USA; [Horwitz, Sarah M.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Arnold, Eugene L.; Fristad, Mary A.] Ohio State Univ, Dept Psychiat, Columbus, OH 43210 USA; [Youngstrom, Eric A.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Findling, Robert L.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA; [Phillips, Mary L.] Cardiff Univ, Dept Psychol Med, Cardiff CF10 3AX, S Glam, Wales	University of London; University College London; Universidade Federal Fluminense; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Case Western Reserve University; Case Western Reserve University Hospital; Wayne State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; New York University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Cardiff University	Mourao-Miranda, J (corresponding author), UCL, Dept Comp Sci, Ctr Computat Stat & Machine Learning, London, England.	j.mourao-miranda@ucl.ac.uk	Versace, Amelia/G-1772-2018; Pereira, Mirtes Garcia/J-6222-2016; Mourao-Miranda, Janaina/AAT-2985-2021; Fristad, Mary A/AAW-6472-2021; Mourao-Miranda, Janaina/AAS-2072-2021; Youngstrom, Eric A./ABE-3258-2020; bertocci, michele/AAQ-2875-2021; Oliveira, Leticia/P-1159-2019; Portugal, Liana Catarina/AAR-1905-2021; Duarte Rosa, Maria Joao/K-3185-2015	Versace, Amelia/0000-0001-9925-5203; Pereira, Mirtes Garcia/0000-0003-4682-223X; Mourao-Miranda, Janaina/0000-0002-3309-8441; Youngstrom, Eric A./0000-0003-2251-6860; Oliveira, Leticia/0000-0002-8450-2264; Portugal, Liana/0000-0001-5086-5721; Schirda, Claudiu/0000-0002-5036-0640; Duarte Rosa, Maria Joao/0000-0001-9822-3752; Horwitz, Sarah/0000-0002-5262-1170	Wellcome Trust [WT086565/Z/08/Z, WT102845/Z/13/Z]; National Institute of Mental Health [2R01 MH73953-06A1, 2R01 MH73816-06A1, 2R01 MH73967-06A1, 2R01 MH73801-06A1]; CNPq/Brazil; CAPES/Brazil; FAPERJ/Brazil; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH101076, R01MH073967, R01MH073816, R01MH073801, T32MH018951, P30MH090322, R01MH073953] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ/Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the Wellcome Trust under grants no. WT086565/Z/08/Z and WT102845/Z/13/Z (Dr Janaina Mourao-Miranda, University College London); and by the National Institute of Mental Health grants 2R01 MH73953-06A1 (Dr. Boris Birmaher and Dr. Mary L. Phillips, University of Pittsburgh), 2R01 MH73816-06A1 (Dr. Scott Holland, Children's Hospital Medical Center), 2R01 MH73967-06A1 (Dr. Robert Findling, Case Western Reserve University), and 2R01 MH73801-06A1 (Dr. Mary Fristad, Ohio State University). LCLP was funded by CNPq/Brazil and CAPES/Brazil, LO and MP were funded by FAPERJ/Brazil and CNPq/Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnold LE, 2011, BIPOLAR DISORD, V13, P509, DOI 10.1111/j.1399-5618.2011.00948.x; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Barkley R. A., 2010, J ADHD RELAT DISORD, V1, P1; Bebko G, 2014, JAMA PSYCHIAT, V71, P71, DOI 10.1001/jamapsychiatry.2013.2870; Chu C, 2011, NEUROIMAGE, V56, P662, DOI 10.1016/j.neuroimage.2010.03.058; Cohen JR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00075; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Findling RL, 2010, J CLIN PSYCHIAT, V71, P1664, DOI 10.4088/JCP.09m05859yel; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Forbes EE, 2006, J CHILD PSYCHOL PSYC, V47, P1031, DOI 10.1111/j.1469-7610.2006.01673.x; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Friston KJ, 2008, NEUROIMAGE, V39, P181, DOI 10.1016/j.neuroimage.2007.08.013; Gong QY, 2014, NEUROPSYCHOPHARMACOL, V39, P681, DOI 10.1038/npp.2013.251; Hasler G, 2006, BIOL PSYCHIAT, V60, P93, DOI 10.1016/j.biopsych.2005.11.006; Hoerl AE, 2000, TECHNOMETRICS, V42, P80, DOI 10.2307/1271436; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Leibenluft E, 2003, BIOL PSYCHIAT, V53, P1009, DOI 10.1016/S0006-3223(03)00069-6; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mochcoyitch MD, 2014, J AFFECT DISORDERS, V167, P336, DOI 10.1016/j.jad.2014.06.041; Mourao-Miranda J, 2012, BIPOLAR DISORD, V14, P451, DOI 10.1111/j.1399-5618.2012.01019.x; Musser ED, 2011, J ABNORM CHILD PSYCH, V39, P841, DOI 10.1007/s10802-011-9499-1; OBrien BS, 1996, J ABNORM CHILD PSYCH, V24, P223, DOI 10.1007/BF01441486; Paparrigopoulos T, 2008, EPILEPSY RES, V81, P30, DOI 10.1016/j.eplepsyres.2008.04.011; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2014, AM J PSYCHIAT, V171, P829, DOI 10.1176/appi.ajp.2014.13081008; Phillips ML, 2006, AM J PSYCHIAT, V163, P1135, DOI 10.1176/appi.ajp.163.7.1135; Rao A, 2015, 2015 INT WORKSH IEEE; Schrouff J, 2013, P IEEE INT WORKSH PA; Schrouff J, 2013, NEUROINFORMATICS, P1; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Singh MK, 2013, J AM ACAD CHILD PSY, V52, P68, DOI 10.1016/j.jaac.2012.10.004; Singh MK, 2012, BIPOLAR DISORD, V14, P585, DOI 10.1111/j.1399-5618.2012.01043.x; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Townsend J, 2012, BIPOLAR DISORD, V14, P326, DOI 10.1111/j.1399-5618.2012.01021.x; Weschler D, WESCHLER ABBREVATED; Youngstrom E, 2005, BIPOLAR DISORD, V7, P507, DOI 10.1111/j.1399-5618.2005.00269.x; Youngstrom EA, 2004, J AM ACAD CHILD PSY, V43, P847, DOI 10.1097/01.chi.0000125091.35109.1e; Youngstrom EA, 2001, PSYCHOL ASSESSMENT, V13, P267, DOI 10.1037/1040-3590.13.2.267; Youngstrom EA, 2008, J CLIN PSYCHIAT, V69, P831, DOI 10.4088/JCP.v69n0517; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046833	49	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0117603	10.1371/journal.pone.0117603	http://dx.doi.org/10.1371/journal.pone.0117603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731403	gold, Green Published, Green Accepted			2022-12-27	WOS:000367801400001
J	Zhao, A; Xue, Y; Zhang, YM; Li, WJ; Yu, K; Wang, PY				Zhao, Ai; Xue, Yong; Zhang, Yumei; Li, Wenjun; Yu, Kai; Wang, Peiyu			Nutrition Concerns of Insufficient and Excessive Intake of Dietary Minerals in Lactating Women: A Cross-Sectional Survey in Three Cities of China	PLOS ONE			English	Article							BREAST-FEEDING WOMEN; NORTH CHINA; CALCIUM; MILK; PHOSPHORUS; PATTERNS; SODIUM; IRON	Objective Objectives of this study were 1) to investigate the mineral intake by Chinese lactating women, 2) to explore the dietary source of minerals, and 3) the ratios between different dietary minerals. Methods A total of 468 lactating women in 5-240 days post-partum participated in this study. Food intakes by participants were measured using one time of 24-hour dietary recall, and minerals from food were calculated based on the Chinese Food Composition Table, second edition. Results In post-partum, women had inadequate food intake. 81.0% of women's daily intake of dairy products was lower than 300g, and 97.1% of women's daily intake of salt over 6g. For mineral intake, there were 81.8%, 59.0%, 47.6%, 45.7% and 66.8% of women's calcium, magnesium, iron, zinc and selenium intake lower than the estimated average requirement, respectively, and 91.7% of women's excessive intake of sodium. The calcium/phosphorus and sodium/potassium ratios were 0.41 +/- 0.26/1 and 3.13 +/- 2.89/1, respectively. Considering the dietary sources of minerals, 27.3%, 25.3% and 30.1% of iron, zinc and calcium were from animal-based food, respectively, and 60.3%, 66.1% and 58.0% of iron, zinc and calcium were from plant-based food, respectively. The phosphorus-protein ratio was 0.014 +/- 0.003/1. Lactation stage was associated with nutrient intake. Women within 30 days postpartum and the ones who live in Guangzhou had a significantly lower intake of certain minerals, while women with a high education experience had a high intake of calcium, potassium, iron and zinc. Productive age, whether obese or not, and delivery ways were not associated with mineral intakes (P all > 0.05). Conclusion Chinese women in three studied cities had an inappropriate food intake and resulted in both insufficient and excessive intakes of certain minerals.	[Zhao, Ai; Xue, Yong; Wang, Peiyu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China; [Zhang, Yumei] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China; [Li, Wenjun] Nestle Nutr Inst, Beijing, Peoples R China; [Yu, Kai] Nestle Res Ctr Beijing, Beijing, Peoples R China	Peking University; Peking University	Zhang, YM (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China.	zhangyumei111@gmail.com	Yu, Kai/GNW-6026-2022	Yu, Kai/0000-0002-5013-7289	Nestle China Limited; Nestle Research Center, Maternal Infant Nutrition and Growth Study (MING Study) [DNUT-101546]	Nestle China Limited(Nestle SA); Nestle Research Center, Maternal Infant Nutrition and Growth Study (MING Study)(Nestle SA)	This study is funded by Nestle China Limited and Nestle Research Center, and is part of the Maternal Infant Nutrition and Growth Study (MING Study, DNUT-101546). The funder contributed to the study design. Co-author Wenjun Li is employed by Nestle Nutrition Institute and co-author Kai Yu is employed by Nestle Research Center. Nestle provided support in the form of salaries for authors WL and KY, and contributed to the study design, but did not have any additional role in data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, CLIN NUTR, V20, P411; Aubuchon-Endsley NL, 2015, J ACAD NUTR DIET, V115, P939, DOI 10.1016/j.jand.2014.12.017; Buehlmeier J, 2012, J CLIN ENDOCR METAB, V97, P4789, DOI 10.1210/jc.2012-2857; Caire-Juvera G, 2007, J AM COLL NUTR, V26, P156, DOI 10.1080/07315724.2007.10719597; Chao JCJ, 2004, J NUTR BIOCHEM, V15, P37, DOI 10.1016/j.jnutbio.2003.09.009; Chien YC, 2009, PUBLIC HEALTH NUTR, V12, P382, DOI 10.1017/S1368980008002152; Chinese Society of Nutrition, 2010, CHIN BAL DIET PAG; Chinese Society Of Nutrition, 2014, CHIN DIET REF INT 20; da Costa THM, 2010, J NUTR, V140, P2227, DOI 10.3945/jn.110.123489; Ding M, 2010, ASIA PAC J CLIN NUTR, V19, P344; Emmett PM, 1997, EARLY HUM DEV, V49, pS7, DOI 10.1016/S0378-3782(97)00051-0; Garcia-Ortiz L, 2012, ATHEROSCLEROSIS, V225, P497, DOI 10.1016/j.atherosclerosis.2012.09.038; Huang LiChun, 2011, Chinese Preventive Medicine, V12, P1034; Ito S, ASIA PAC J; Kartchner Robin, 2003, J Holist Nurs, V21, P100, DOI 10.1177/0898010103021002002; Lee HS, 2013, J HUM HYPERTENS, V27, P298, DOI 10.1038/jhh.2012.43; Lee KJ, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-114; Luan DC, 2008, DIABETES CARE, V31, P285, DOI 10.2337/dc07-0921; Ma GS, 2005, J AGR FOOD CHEM, V53, P10285, DOI 10.1021/jf052051r; Malek L, 2015, WORLD REV NUTR DIET, V113, P127, DOI 10.1159/000367872; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Picciano MF, 2003, J NUTR, V133, p1997S, DOI 10.1093/jn/133.6.1997S; Sanchez CL, 2008, ARCH LATINOAM NUTR, V58, P371; Takeda E, 2012, NUTR REV, V70, P311, DOI 10.1111/j.1753-4887.2012.00473.x; Thomas M, 2006, AM J OBSTET GYNECOL, V194, P937, DOI 10.1016/j.ajog.2005.05.032; Yang YX., 2009, CHINA FOOD COMPOSITI; Zhao A, 2014, CHINESE MED J-PEKING, V127, P2643, DOI 10.3760/cma.j.issn.0366-6999.20133258	27	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146483	10.1371/journal.pone.0146483	http://dx.doi.org/10.1371/journal.pone.0146483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730592	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400184
J	Mishima, Y; Ishihara, S; Oka, A; Fukuba, N; Oshima, N; Sonoyama, H; Yamashita, N; Tada, Y; Kusunoki, R; Moriyama, I; Yuki, T; Kawashima, K; Kinoshita, Y				Mishima, Yoshiyuki; Ishihara, Shunji; Oka, Akihiko; Fukuba, Nobuhiko; Oshima, Naoki; Sonoyama, Hiroki; Yamashita, Noritsugu; Tada, Yasumasa; Kusunoki, Ryusaku; Moriyama, Ichiro; Yuki, Takafumi; Kawashima, Kousaku; Kinoshita, Yoshikazu			Decreased Frequency of Intestinal Regulatory CD5(+) B Cells in Colonic Inflammation	PLOS ONE			English	Article							B10 CELLS; T-CELLS; EXPRESSION; DISEASE; LYMPHOCYTES; INITIATION; INDUCTION; NUMBERS; MICE	Background CD5(+) B cells are a type of regulatory immune cells, though the involvement of this B cell subset in intestinal inflammation and immune regulation is not fully understood. Methods We examined the distribution of CD5(+) B cells in various mouse organs. Expression levels of CD11b, IgM, and toll-like receptor (TLR)-4 and -9 in B cells were evaluated. In vitro, TLR-stimulated IL-10 production by colonic lamina propria (LP) CD5(+) and CD5(-) B cells was measured. In vivo, mice with acute or chronic dextran sulfate sodium (DSS)-induced colonic injury were examined, and the frequency of colonic LP CD5(+) B cells in those was assessed by flow cytometry. Results The expression level of TLR9 was higher in colonic LP CD5(+) B cells as compared to CD5(-) B cells. Colonic LP CD5(+) B cells produced greater amounts of IL-10 following stimulation with TLR ligands, especially TLR9, as compared with the LP CD5(-) B cells. Acute intestinal inflammation transiently decreased the frequency of colonic LP CD5(+) B cells, while chronic inflammation induced a persistent decrease in colonic LP CD5(+) B cells and led to a CD5(-) B cell-dominant condition. Conclusion A persistent altered mucosal B cell population caused by chronic gut inflammation may be involved in the pathogenesis of inflammatory bowel diseases.	[Mishima, Yoshiyuki; Ishihara, Shunji; Oka, Akihiko; Fukuba, Nobuhiko; Oshima, Naoki; Sonoyama, Hiroki; Yamashita, Noritsugu; Tada, Yasumasa; Kusunoki, Ryusaku; Moriyama, Ichiro; Yuki, Takafumi; Kawashima, Kousaku; Kinoshita, Yoshikazu] Shimane Univ, Fac Med, Dept Internal Med 2, Izumo, Shimane, Japan; [Moriyama, Ichiro] Shimane Univ Hosp, Ctr Canc, Izumo, Shimane, Japan	Shimane University; Shimane University	Ishihara, S (corresponding author), Shimane Univ, Fac Med, Dept Internal Med 2, Izumo, Shimane, Japan.	si360405@med.shimane-u.ac.jp	Mishima, Yoshiyuki/K-2029-2019; Oka, Akihiko/AAF-3908-2020; fukuba, nobuhiko/ABG-6658-2021	Oka, Akihiko/0000-0001-6451-8413; Mishima, Yoshiyuki/0000-0001-5261-6411				Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Aybar LT, 2015, CLIN EXP IMMUNOL, V180, P178, DOI 10.1111/cei.12483; Begum-Haque S, 2011, J NEUROIMMUNOL, V232, P136, DOI 10.1016/j.jneuroim.2010.10.031; Berkowitz D, 2013, HUM IMMUNOL, V74, P1519, DOI 10.1016/j.humimm.2013.08.285; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Hassan J, 1996, CLIN EXP IMMUNOL, V103, P353; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; KROESE FGM, 1993, INT IMMUNOL, V5, P1317, DOI 10.1093/intimm/5.10.1317; Le Pottier L, 2007, AUTOIMMUN REV, V6, P149, DOI 10.1016/j.autrev.2006.09.011; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Lundy SK, 2002, INFECT IMMUN, V70, P812, DOI 10.1128/IAI.70.2.812-819.2002; Mageed RA, 2012, AUTOIMMUN REV, V11, P795, DOI 10.1016/j.autrev.2012.02.007; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; Maseda D, 2013, J IMMUNOL, V191, P2780, DOI 10.4049/jimmunol.1300649; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mease PJ, 2008, J RHEUMATOL, V35, P1245; Meyer-Bahlburg A, 2015, ANN NY ACAD SCI, V1362, P122, DOI 10.1111/nyas.12801; Mishima Y, 2015, CELL MOL GASTROENTER, V1, P295, DOI 10.1016/j.jcmgh.2015.01.002; Mishima Y, 2010, IMMUNOLOGY, V131, P473, DOI 10.1111/j.1365-2567.2010.03318.x; Mishima Y, 2009, SCAND J GASTROENTERO, V44, P172, DOI 10.1080/00365520802433223; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Oka A, 2014, INFLAMM BOWEL DIS, V20, P315, DOI 10.1097/01.MIB.0000437983.14544.d5; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Polese L, 2007, INT J COLORECTAL DIS, V22, P1005, DOI 10.1007/s00384-007-0298-7; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Renaudineau Y, 2004, AUTOIMMUN REV, V3, P516, DOI 10.1016/j.autrev.2004.07.035; Shimomura Y, 2008, INT IMMUNOL, V20, P729, DOI 10.1093/intimm/dxn031; Tan Y, 2014, J HUAZHONG U SCI-MED, V34, P785, DOI 10.1007/s11596-014-1353-6; Yanaba K, 2011, AM J PATHOL, V178, P735, DOI 10.1016/j.ajpath.2010.10.022; Youinou P, 2011, CRIT REV IMMUNOL, V31, P31, DOI 10.1615/CritRevImmunol.v31.i1.30	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146191	10.1371/journal.pone.0146191	http://dx.doi.org/10.1371/journal.pone.0146191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727001	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500064
J	Szollosi, D; Erdei, A; Gyimesi, G; Magyar, C; Hegedus, T				Szoellosi, Daniel; Erdei, Aron; Gyimesi, Gergely; Magyar, Csaba; Hegedus, Tamas			Access Path to the Ligand Binding Pocket May Play a Role in Xenobiotics Selection by AhR	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DISCRETE MOLECULAR-DYNAMICS; PAS-B DOMAIN; MULTIDRUG-RESISTANCE; STRUCTURAL BASIS; FUNCTIONAL DOMAINS; DOCKING; IDENTIFICATION; EFFICIENT; PROTEINS	Understanding of multidrug binding at the atomic level would facilitate drug design and strategies to modulate drug metabolism, including drug transport, oxidation, and conjugation. Therefore we explored the mechanism of promiscuous binding of small molecules by studying the ligand binding domain, the PAS-B domain of the aryl hydrocarbon receptor (AhR). Because of the low sequence identities of PAS domains to be used for homology modeling, structural features of the widely employed HIF-2 alpha and a more recent suitable template, CLOCK were compared. These structures were used to build AhR PAS-B homology models. We performed molecular dynamics simulations to characterize dynamic properties of the PAS-B domain and the generated conformational ensembles were employed in in silico docking. In order to understand structural and ligand binding features we compared the stability and dynamics of the promiscuous AhR PAS-B to other PAS domains exhibiting specific interactions or no ligand binding function. Our exhaustive in silico binding studies, in which we dock a wide spectrum of ligand molecules to the conformational ensembles, suggest that ligand specificity and selection may be determined not only by the PAS-B domain itself, but also by other parts of AhR and its protein interacting partners. We propose that ligand binding pocket and access channels leading to the pocket play equally important roles in discrimination of endogenous molecules and xenobiotics.	[Szoellosi, Daniel; Erdei, Aron; Hegedus, Tamas] Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, H-1094 Budapest, Hungary; [Szoellosi, Daniel; Hegedus, Tamas] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1094 Budapest, Hungary; [Erdei, Aron] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, H-1083 Budapest, Hungary; [Gyimesi, Gergely] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Magyar, Csaba] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; University of Bern; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Hegedus, T (corresponding author), Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, H-1094 Budapest, Hungary.	hegedus@hegelab.org	Szöllösi, Dániel/ABH-9228-2020; Gyimesi, Gergely/AAL-7340-2021; Magyar, Csaba/P-8288-2019	Szöllösi, Dániel/0000-0003-4641-3065; Gyimesi, Gergely/0000-0002-2054-4633; Magyar, Csaba/0000-0002-5023-6180	Bolyai Fellowship of the Hungarian Academy of Sciences; NKFIH [K 111678]; OTKA [NK 100482]; Marie Curie Actions International Fellowship Program (IFP) TransCure	Bolyai Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Marie Curie Actions International Fellowship Program (IFP) TransCure	This work was supported by a Bolyai Fellowship of the Hungarian Academy of Sciences (TH), NKFIH K 111678 (TH), and OTKA NK 100482 (CM). Gergely Gyimesi was funded by the Marie Curie Actions International Fellowship Program (IFP) TransCure (www.nccr-transcure.ch).	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Blacklock K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003679; Cao F, 2013, ENVIRON TOXICOL PHAR, V36, P626, DOI 10.1016/j.etap.2013.06.004; Carlson DB, 2002, J BIOCHEM MOL TOXIC, V16, P317, DOI 10.1002/jbt.10051; Chen YK, 2012, BIOCHEM PHARMACOL, V83, P1112, DOI 10.1016/j.bcp.2012.01.030; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dagliyan O, 2013, P NATL ACAD SCI USA, V110, P6800, DOI 10.1073/pnas.1218319110; Dagliyan O, 2011, STRUCTURE, V19, P1837, DOI 10.1016/j.str.2011.09.014; de Waal PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108607; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Ding F, 2013, J CHEM INF MODEL, V53, P1871, DOI 10.1021/ci300478y; Ding F, 2010, J CHEM INF MODEL, V50, P1623, DOI 10.1021/ci100218t; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Ekins S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000594; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Fraccalvieri D, 2013, BIOCHEMISTRY-US, V52, P714, DOI 10.1021/bi301457f; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Getzoff ED, 2003, NAT STRUCT BIOL, V10, P663, DOI 10.1038/nsb958; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Key J, 2009, J AM CHEM SOC, V131, P17647, DOI 10.1021/ja9073062; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Masetti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094986; Melo F, 2007, PROTEIN SCI, V16, P2412, DOI 10.1110/ps.072895107; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Motto I, 2011, J CHEM INF MODEL, V51, P2868, DOI 10.1021/ci2001617; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Nuti R, 2014, J CHEM INF MODEL, V54, P3373, DOI 10.1021/ci5005459; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; Odio C, 2013, BIOCHEMISTRY-US, V52, P1746, DOI 10.1021/bi301722k; Ohkura K, 2009, ANTICANCER RES, V29, P935; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Proctor EA, 2012, BIOPHYS J, V102, P144, DOI 10.1016/j.bpj.2011.11.4008; Proctor EA, 2011, WIRES COMPUT MOL SCI, V1, P80, DOI 10.1002/wcms.4; Punj S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088726; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Schmidtke P, 2011, BIOINFORMATICS; Schrodinger L.L.C., 2015, SMALL MOL DRUG DISCO; Seifert C, 2012, BIOPHYS J, V103, P2195, DOI 10.1016/j.bpj.2012.09.008; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Soshilov AA, 2014, MOL CELL BIOL, V34, P1707, DOI 10.1128/MCB.01183-13; Straub FB., 1964, MOL BIOL PROBLEMS PE, P182; Szollosi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095795; Team RC, 2014, R LANG ENV STAT COMP; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Turk D, 2009, IDRUGS, V12, P246; Vohra S, 2013, PROTEIN SCI, V22, P1218, DOI 10.1002/pro.2309; Vreede J, 2003, J BIOL CHEM, V278, P18434, DOI 10.1074/jbc.M301701200; Watkins RE, 2003, J MOL BIOL, V331, P815, DOI 10.1016/S0022-2836(03)00795-2; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wong CF, 2015, EXPERT OPIN DRUG DIS, V10, P1189, DOI 10.1517/17460441.2015.1078308; Xie W, 2004, DRUG DISCOV TODAY, V9, P442, DOI 10.1016/S1359-6446(04)03061-2; Xing YN, 2012, TOXICOL SCI, V129, P86, DOI 10.1093/toxsci/kfs194; Yuan JT, 2013, ENVIRON TOXICOL CHEM, V32, P1453, DOI 10.1002/etc.2191; ZAVODSZKY P., 1966, ACTA BIOCHIM BIOPHYS ACAD SCI HUNG, V1, P389	79	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146066	10.1371/journal.pone.0146066	http://dx.doi.org/10.1371/journal.pone.0146066			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727491	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000367681500050
J	Xue, X; Chen, Q; Zhao, G; Zhao, JY; Duan, Z; Zheng, PS				Xue, Xiang; Chen, Qing; Zhao, Gang; Zhao, Jin-Yan; Duan, Zhao; Zheng, Peng-Sheng			The Overexpression of TGF-beta and CCN2 in Intrauterine Adhesions Involves the NF-kappa B Signaling Pathway	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; PULMONARY-FIBROSIS; LIVER FIBROSIS; FIBROGENESIS; FIBROBLASTS; TGF-BETA-1; INDUCTION; CELLS	Intrauterine adhesions (IUA) are a significant cause of menstrual disturbance and infertility, but their pathogenesis still remains unclear. Here, we investigated the expression of TGF-beta and CCN2 in IUA endometrial tissue by immunohistochemistry, western blotting and qRT-PCR assays, and found the expression of TGF-beta and CCN2 in the endometrial tissue of IUA was significantly increased compared to normal endometrium and uterine septum (P<0.01), suggesting that TGF-beta and CCN2 may play an important role in the formation of IUA. Moreover, the activity of the NF-kappa B signaling pathway in endometrial tissue of IUA was also significantly enhanced compared to normal endometrial and uterine septum (P<0.01) and positively correlated with the expression of TGF-beta and CCN2, which suggested that TGF-beta and CCN2 expression may be involved in the NF-kappa B signaling pathway. Blocking the NF-kappa B signaling pathway using SN50 resulted in the reduced expression of TGF-beta in RL95-2 cells, which confirmed the association of the NF-kappa B signaling pathway and TGF-beta in endometrial cells. Additionally, the expression of TGF-beta and CCN2 was associated with IUA recurrence, which provides a potential prognostic indictor for IUA. Together, these results demonstrated that TGF-beta and CCN2 play an important role in IUA formation, whose mechanism was associated with the activation of the NF-kappa B signaling pathway.	[Xue, Xiang; Chen, Qing; Zhao, Gang; Zhao, Jin-Yan; Duan, Zhao] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Obstet & Gynaecol, Xian 710049, Peoples R China; [Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Reprod Med, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Reprod Med, Xian 710049, Peoples R China.	zpsheng@mail.xjtu.edu.cn			Department of Science & Technology of Shaanxi Province [2012K17-02-02]	Department of Science & Technology of Shaanxi Province	This study was supported by Department of Science & Technology of Shaanxi Province (2012K17-02-02) http://ywgl.snstd.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman JM, 2008, SEMIN REPROD MED, V26, P349, DOI 10.1055/s-0028-1082393; Blanc B., 1997, GYNAECOL ENDOSC, V6, P225, DOI [10.1046/j.1365-2508.1997.1050522.x, DOI 10.1046/J.1365-2508.1997.1050522.X]; Capella-Allouc S, 1999, HUM REPROD, V14, P1230, DOI 10.1093/humrep/14.5.1230; Chen SR, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0036-y; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; di Mola FF, 1999, ANN SURG, V230, P63, DOI 10.1097/00000658-199907000-00010; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Evans-Hoeker EA, 2014, SEMIN REPROD MED, V32, P392, DOI 10.1055/s-0034-1376358; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He TY, 2014, AGE, V36, P1079, DOI 10.1007/s11357-014-9623-6; Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013; Huang LS, 2013, FASEB J, V27, P1749, DOI 10.1096/fj.12-219634; Jiang JS, 2014, PEDIAT NEONATOLOGY, DOI [10.1016/j.pedneo.2014.11.003, DOI 10.1016/J.PEDNE0.2014.11.003]; Kobayashi S, 2012, STEM CELLS, V30, P2631, DOI 10.1002/stem.1257; Kong DS, 2013, J GASTROEN HEPATOL, V28, P1223, DOI 10.1111/jgh.12147; Leask A, 2004, J INVEST DERMATOL, V122, P1, DOI 10.1046/j.0022-202X.2003.22133.x; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; Li J, 2014, MICRO NANO LETT, V9, P34, DOI 10.1049/mnl.2013.0579; Paradis V, 1999, HEPATOLOGY, V30, P968, DOI 10.1002/hep.510300425; Park JO, 2013, J SPINAL DISORD TECH, V26, pE6, DOI 10.1097/BSD.0b013e3182698501; Preutthipan Sangchai, 2000, Journal of the Medical Association of Thailand, V83, P42; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Rancoule C, 2011, EXPERT OPIN INV DRUG, V20, P657, DOI 10.1517/13543784.2011.566864; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412; Sun X, 2015, LIFE SCI, V122, P8, DOI 10.1016/j.lfs.2014.11.033; Tache D, 2011, ROM J MORPHOL EMBRYO, V52, P409; Tao Zhi, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P734; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Yu D, 2008, FERTIL STERIL, V89, P759, DOI 10.1016/j.fertnstert.2008.02.096	32	31	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146159	10.1371/journal.pone.0146159	http://dx.doi.org/10.1371/journal.pone.0146159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719893	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900048
J	Hart, PJ; O'Shaughnessy, CM; Siggins, MK; Bobat, S; Kingsley, RA; Goulding, DA; Crump, JA; Reyburn, H; Micoli, F; Dougan, G; Cunningham, AF; MacLennan, CA				Hart, Peter J.; O'Shaughnessy, Colette M.; Siggins, Matthew K.; Bobat, Saeeda; Kingsley, Robert A.; Goulding, David A.; Crump, John A.; Reyburn, Hugh; Micoli, Francesca; Dougan, Gordon; Cunningham, Adam F.; MacLennan, Calman A.			Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen	PLOS ONE			English	Article							INVASIVE NONTYPHOIDAL SALMONELLA; SERUM RESISTANCE; POLYSACCHARIDE; COMPLEMENT; MUTANTS; CELLS; PROTECTION	Salmonella enterica serovar Typhi expresses a capsule of Vi polysaccharide, while most Salmonella serovars, including S. Enteritidis and S. Typhimurium, do not. Both S. Typhi and S. Enteritidis express the lipopolysaccharide O:9 antigen, yet there is little evidence of cross-protection from anti-O:9 antibodies. Vaccines based on Vi polysaccharide have efficacy against typhoid fever, indicating that antibodies against Vi confer protection. Here we investigate the role of Vi capsule and antibodies against Vi and O:9 in antibody-dependent complement-and phagocyte-mediated killing of Salmonella. Using isogenic Vi-expressing and non-Vi-expressing derivatives of S. Typhi and S. Typhimurium, we show that S. Typhi is inherently more sensitive to serum and blood than S. Typhimurium. Vi expression confers increased resistance to both complement-and phagocyte-mediated modalities of antibodydependent killing in human blood. The Vi capsule is associated with reduced C3 and C5b-9 deposition, and decreased overall antibody binding to S. Typhi. However, purified human anti-Vi antibodies in the presence of complement are able to kill Vi-expressing Salmonella, while killing by anti-O:9 antibodies is inversely related to Vi expression. Human serum depleted of antibodies to antigens other than Vi retains the ability to kill Vi-expressing bacteria. Our findings support a protective role for Vi capsule in preventing complement and phagocyte killing of Salmonella that can be overcome by specific anti-Vi antibodies, but only to a limited extent by anti-O:9 antibodies.	[Hart, Peter J.; O'Shaughnessy, Colette M.; Siggins, Matthew K.; Bobat, Saeeda; Cunningham, Adam F.; MacLennan, Calman A.] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Kingsley, Robert A.; Goulding, David A.; MacLennan, Calman A.] Wellcome Trust Sanger Inst, Cambridge, England; [Crump, John A.; Dougan, Gordon] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand; [Crump, John A.] Tumaini Univ, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Crump, John A.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC 27706 USA; [Crump, John A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA; [Reyburn, Hugh] London Sch Hyg & Trop Med, London WC1, England; [Micoli, Francesca] GlaxoSmithKline Co, Sclavo Behring Vaccines Inst Global Hlth, Siena, Italy; [MacLennan, Calman A.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England	University of Birmingham; Wellcome Trust Sanger Institute; University of Otago; Kilimanjaro Christian Medical Centre; Duke University; Duke University; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of Oxford; Jenner Institute	MacLennan, CA (corresponding author), Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England.	calman.maclennan@ndm.ox.ac.uk	Crump, John A./AAZ-6289-2020; Siggins, Matthew/AAE-7211-2021; Crump, John A./AAZ-6412-2020; MacLennan, Calman A/L-9343-2014	Crump, John A./0000-0002-4529-102X; Siggins, Matthew/0000-0003-2504-6518; Crump, John A./0000-0002-4529-102X; MacLennan, Calman A/0000-0001-9694-0846; Kingsley, Robert/0000-0002-0194-6485; Cunningham, Adam/0000-0003-0248-964X	MRC; GlaxoSmithKline; Sclavo Behring Vaccines Institute for Global Health, a GlaxoSmithKline Company; BBSRC [BB/L009986/1, BB/F022778/1] Funding Source: UKRI; MRC [G9818340, G0701275] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F022778/1, BB/L009986/1] Funding Source: researchfish; Medical Research Council [G0701275, G9818340] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); Sclavo Behring Vaccines Institute for Global Health, a GlaxoSmithKline Company; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PJH was supported by an MRC PhD studentship. CAM received a clinical research fellowship from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sclavo Behring Vaccines Institute for Global Health, a GlaxoSmithKline Company, provided support in the form of salary for author FM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Boyd MA, 2014, CLIN VACCINE IMMUNOL, V21, P712, DOI 10.1128/CVI.00115-14; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Crawford RW, 2013, MBIO, V4, DOI 10.1128/mBio.00232-13; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; DOUGAN G, 1987, MOL GEN GENET, V207, P402, DOI 10.1007/BF00331607; Felix A, 1934, LANCET, V2, P186; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; GEMSKI P, 1980, FEMS MICROBIOL LETT, V9, P193, DOI 10.1016/0378-1097(80)90123-8; Goh YS, 2013, J IMMUNOL METHODS, V387, P121, DOI 10.1016/j.jim.2012.10.005; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Janis C, 2011, INFECT IMMUN, V79, P2481, DOI 10.1128/IAI.01265-10; Jansen AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002131; LOONEY RJ, 1986, J LAB CLIN MED, V108, P506; Maclennan CA, 2014, HUM VACCIN IMMUNOTHE, V10; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2013, EXPERT REV ANTI-INFE, V11, P443, DOI [10.1586/ERI.13.27, 10.1586/eri.13.27]; Marshall JL, 2012, J IMMUNOL, V189, P5527, DOI 10.4049/jimmunol.1103166; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE696, DOI 10.1016/S2214-109X(14)70286-4; Nyirenda TS, 2014, J INFECT DIS, V210, P56, DOI 10.1093/infdis/jiu045; O'Shaughnessy CM, 2013, J IMMUNOL METHODS, V387, P199, DOI 10.1016/j.jim.2012.10.015; PICKARD D, 1994, INFECT IMMUN, V62, P3984, DOI 10.1128/IAI.62.9.3984-3993.1994; Raffatellu M, 2007, INFECT IMMUN, V75, P4342, DOI 10.1128/IAI.01571-06; Rondini S, 2011, CLIN VACCINE IMMUNOL, V18, P460, DOI 10.1128/CVI.00387-10; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Siggins MK, 2014, EUR J IMMUNOL, V44, P1093, DOI 10.1002/eji.201343529; Simon R, 2011, INFECT IMMUN, V79, P4240, DOI 10.1128/IAI.05484-11; Szu SC, 2013, EXPERT REV VACCINES, V12, P1273, DOI 10.1586/14760584.2013.845529; Vogel U, 1997, INFECT IMMUN, V65, P4022, DOI 10.1128/IAI.65.10.4022-4029.1997; Wain J, 2005, J CLIN MICROBIOL, V43, P1158, DOI 10.1128/JCM.43.3.1158-1165.2005; Wain J, 2015, LANCET, V385, P1136, DOI 10.1016/S0140-6736(13)62708-7; Wangdi T, 2012, GUT MICROBES, V3, P88, DOI 10.4161/gmic.18602; Wilson RP, 2011, INFECT IMMUN, V79, P830, DOI 10.1128/IAI.00961-10	32	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145945	10.1371/journal.pone.0145945	http://dx.doi.org/10.1371/journal.pone.0145945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741681	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000367810600014
J	Liu, JZ; Li, HY; Liu, ZB; Wu, QY; Xu, YF				Liu, Jingzhe; Li, Hongyin; Liu, Zhibo; Wu, Qingyu; Xu, Yufeng			Complete Preoperative Evaluation of Pulmonary Atresia with Ventricular Septal Defect with Multi-Detector Computed Tomography	PLOS ONE			English	Article							CARDIAC-CATHETERIZATION; ANGIOGRAPHY; CT; ARTERIES; CHILDREN; INFANTS; REPAIR; TETRALOGY; STENOSIS; FALLOT	Objective To compare multi-detector computed tomography (MDCT) with cardiac catheterization and transthoracic echocardiography (TTE) in comprehensive evaluation of the global cardiovascular anatomy in patients with pulmonary atresia with ventricular septal defect (PA-VSD). Methods The clinical and imaging data of 116 patients with PA-VSD confirmed by surgery were reviewed. Using findings at surgery as the reference standard, data from MDCT, TTE and catheterization were reviewed for assessment of native pulmonary vasculature and intracardiac defects. Results MDCT was more accurate than catheterization and TTE in identification of native pulmonary arteries. MDCT is also the most accurate test for delineation of the major aortopulmonary collateral arteries. The inter-modality agreement for evaluation of overriding aorta and VSD were both excellent. In the subgroup with surgical correlation, excellent agreement was found between TTE and surgery, and substantial agreement was also found at MDCT. Conclusion MDCT can correctly delineate the native pulmonary vasculatures and intracardiac defects and may be a reliable method for noninvasive assessment of global cardiovascular abnormalities in patients with PA-VSD.	[Liu, Jingzhe; Liu, Zhibo] Tsinghua Univ, Hosp 1, Dept Radiol, Beijing 100084, Peoples R China; [Li, Hongyin; Wu, Qingyu] Tsinghua Univ, Hosp 1, Ctr Heart, Beijing 100084, Peoples R China; [Xu, Yufeng] Peking Univ, Hosp 1, Dept Radiol, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University	Xu, YF (corresponding author), Peking Univ, Hosp 1, Dept Radiol, Beijing 100871, Peoples R China.	dr_xuyf@163.com			Chow Tai Fook Medical Research Special Fund [202836019-02]	Chow Tai Fook Medical Research Special Fund	This work was funded by Chow Tai Fook Medical Research Special Fund (202836019-02) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acherman RJ, 1996, J AM COLL CARDIOL, V28, P1308, DOI 10.1016/S0735-1097(96)00302-6; Amark KM, 2006, J AM COLL CARDIOL, V47, P1448, DOI 10.1016/j.jacc.2005.10.068; BLUEMKE DA, 1995, RADIOLOGY, V195, P317, DOI 10.1148/radiology.195.2.7724744; DEBONO D, 1993, BRIT HEART J, V70, P297; Einstein AJ, 2012, EUR HEART J, V33, P573, DOI 10.1093/eurheartj/ehr281; Faletra F, 2007, ECHOCARDIOGR-J CARD, V24, P998, DOI 10.1111/j.1540-8175.2007.00534.x; Geva T, 2002, CIRCULATION, V106, P473, DOI 10.1161/01.CIR.0000023624.33478.18; Geva T, 2001, CARDIOLOGY, P1; Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001; Hofbeck M, 1998, PROG PEDIATR CARDIOL, V9, P113, DOI 10.1016/S1058-9813(98)00052-6; Holmqvist C, 2001, ACTA RADIOL, V42, P63, DOI 10.1034/j.1600-0455.2001.042001063.x; Justino H, 2006, PEDIATR RADIOL, V36, P146, DOI 10.1007/s00247-006-0194-2; Kawano T, 2000, AM HEART J, V139, P654; LIAO PK, 1985, J AM COLL CARDIOL, V6, P1343, DOI 10.1016/S0735-1097(85)80223-0; Lin MT, 2012, EUR J PEDIATR, V171, P579, DOI 10.1007/s00431-011-1621-4; Mackie AS, 2003, J AM COLL CARDIOL, V41, P852, DOI 10.1016/S0735-1097(02)02960-1; Powell AJ, 2000, INT J CARDIAC IMAG, V16, P169, DOI 10.1023/A:1006486225047; Reddy VM, 2000, CIRCULATION, V101, P1826, DOI 10.1161/01.CIR.101.15.1826; Schlosser T, 2007, ACTA RADIOL, V48, P30, DOI 10.1080/02841850601067611; Schlosser T, 2005, AM J ROENTGENOL, V184, P765, DOI 10.2214/ajr.184.3.01840765; SONDHEIMER HM, 1982, CIRCULATION, V65, P1020, DOI 10.1161/01.CIR.65.5.1020; Strouse PJ, 1996, AM J ROENTGENOL, V167, P1175, DOI 10.2214/ajr.167.5.8911176; Tchervenkov C I, 2000, Ann Thorac Surg, V69, pS97; VICK GW, 1994, AM HEART J, V127, P1341, DOI 10.1016/0002-8703(94)90054-X; Westra SJ, 1999, AM J ROENTGENOL, V173, P109, DOI 10.2214/ajr.173.1.10397109; Westra SJ, 1999, RADIOLOGY, V213, P502, DOI 10.1148/radiology.213.2.r99nv16502	26	7	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146380	10.1371/journal.pone.0146380	http://dx.doi.org/10.1371/journal.pone.0146380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741649	Green Submitted, gold, Green Published			2022-12-27	WOS:000367810600035
J	Shiga, T; Nakamura, TJ; Komine, C; Goto, Y; Mizoguchi, Y; Yoshida, M; Kondo, Y; Kawaguchi, M				Shiga, Tatsuomi; Nakamura, Takahiro J.; Komine, Chiaki; Goto, Yoshikuni; Mizoguchi, Yasushi; Yoshida, Midori; Kondo, Yasuhiko; Kawaguchi, Maiko			A Single Neonatal Injection of Ethinyl Estradiol Impairs Passive Avoidance Learning and Reduces Expression of Estrogen Receptor a in the Hippocampus and Cortex of Adult Female Rats	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BISPHENOL-A; BEHAVIORAL ALTERATIONS; DORSAL HIPPOCAMPUS; EXPOSURE; ACTIVATION; MECHANISMS; RETRIEVAL; CADMIUM; ALPHA	Although perinatal exposure of female rats to estrogenic compounds produces irreversible changes in brain function, it is still unclear how the amount and timing of exposure to those substances affect learning function, or if exposure alters estrogen receptor a (ER alpha) expression in the hippocampus and cortex. In adult female rats, we investigated the effects of neonatal exposure to a model estrogenic compound, ethinyl estradiol (EE), on passive avoidance learning and ER alpha expression. Female Wistar-Imamichi rats were subcutaneously injected with oil, 0.02 mg/kg EE, 2 mg/kg EE, or 20 mg/kg 17 beta-estradiol within 24 h after birth. All females were tested for passive avoidance learning at the age of 6 weeks. Neonatal 0.02 mg/kg EE administration significantly disrupted passive avoidance compared with oil treatment in gonadally intact females. In a second experiment, another set of experimental females, treated as described above, was ovariectomized under pentobarbital anesthesia at 10 weeks of age. At 15-17 weeks of age, half of each group received a subcutaneous injection of 5 mu g estradiol benzoate a day before the passive avoidance learning test. Passive avoidance learning behavior was impaired by the 0.02 mg/kg EE dose, but notably only in the estradiol benzoate-injected group. At 17-19 weeks of age, hippocampal and cortical samples were collected from rats with or without the 5 mu g estradiol benzoate injection, and western blots used to determine ER alpha expression. A significant decrease in ER alpha expression was observed in the hippocampus of the estradiol-injected, neonatal EE-treated females. The results demonstrated that exposure to EE immediately after birth decreased learning ability in adult female rats, and that this may be at least partly mediated by the decreased expression of ER alpha in the hippocampus.	[Shiga, Tatsuomi; Nakamura, Takahiro J.; Komine, Chiaki; Mizoguchi, Yasushi; Kawaguchi, Maiko] Meiji Univ, Sch Agr, Kanagawa, Japan; [Nakamura, Takahiro J.; Goto, Yoshikuni] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo, Japan; [Yoshida, Midori] Natl Inst Hlth Sci, Div Pathol, Tokyo, Japan; [Kondo, Yasuhiko] Teikyo Univ Sci, Sch Life & Environm Sci, Tokyo, Japan	Meiji University; National Institute of Health Sciences - Japan	Kawaguchi, M (corresponding author), Meiji Univ, Sch Agr, Kanagawa, Japan.	maiko@meiji.ac.jp	Nakamura, Takahiro J./W-5316-2019	Kondo, Yasuhiko/0000-0003-1062-1524	Research on Risk of Chemical Substances, Health and Laboratory Sciences Research Grants, Ministry of Health, Labour and Welfare, Japan [H25-KAGAKU-IPPANN-003]	Research on Risk of Chemical Substances, Health and Laboratory Sciences Research Grants, Ministry of Health, Labour and Welfare, Japan	This work was supported by Research on Risk of Chemical Substances, Health and Laboratory Sciences Research Grants, Ministry of Health, Labour and Welfare, Japan (H25-KAGAKU-IPPANN-003) to MK (http://www.mhlw.go.jp/english/index.html).	Baarendse PJJ, 2008, HIPPOCAMPUS, V18, P11, DOI 10.1002/hipo.20356; BARANSKI B, 1984, TOXICOL LETT, V22, P53, DOI 10.1016/0378-4274(84)90045-6; Burwell RD, 2004, J NEUROSCI, V24, P3826, DOI 10.1523/JNEUROSCI.0410-04.2004; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DUSTERBERG B, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1187; GONALVES CR, 2010, ENVIRON TOXICOL PHAR, V30, P195, DOI DOI 10.1016/J.ETAP.2010.06.003; Gore AC, 2011, MOL ENDOCRINOL, V25, P2157, DOI 10.1210/me.2011-1210; Hamada T, 2010, ENDOCRINOLOGY, V151, P1923, DOI 10.1210/en.2009-1022; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Kawaguchi M, 2010, EXP ANIM TOKYO, V59, P631, DOI 10.1538/expanim.59.631; Khurana S, 2000, ENDOCRINOLOGY, V141, P4512, DOI 10.1210/en.141.12.4512; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Kundakovic M, 2011, BRAIN BEHAV IMMUN, V25, P1084, DOI 10.1016/j.bbi.2011.02.005; Leon-Olea M, 2014, GEN COMP ENDOCR, V203, P158, DOI 10.1016/j.ygcen.2014.02.005; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Lynch JF, 2014, HORM BEHAV, V66, P421, DOI 10.1016/j.yhbeh.2014.06.017; Monje L, 2007, J ENDOCRINOL, V194, P201, DOI 10.1677/JOE-07-0014; Negishi T, 2004, ENVIRON HEALTH PERSP, V112, P1159, DOI 10.1289/ehp.6961; Nozawa K, 2014, REPROD TOXICOL, V46, P77, DOI 10.1016/j.reprotox.2014.03.001; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Peluso MEM, 2014, TOXICOLOGY, V325, P200, DOI 10.1016/j.tox.2014.09.008; SMITH CC, 2009, PSYCHONEUROENDOCRINO, V34, P130, DOI DOI 10.1016/j.psyneuen.2009.06.003; Spencer JL, 2008, FRONT NEUROENDOCRIN, V29, P219, DOI 10.1016/j.yfrne.2007.08.006; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Takahashi M, 2013, REPROD TOXICOL, V40, P16, DOI 10.1016/j.reprotox.2013.05.005; Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102; Waters EM, 2009, BRAIN RES, V1290, P1, DOI 10.1016/j.brainres.2009.06.090; Xu XH, 2015, J NEUROCHEM, V132, P572, DOI 10.1111/jnc.12998; Yoon K, 2014, J TOXICOL ENV HEAL B, V17, P127, DOI 10.1080/10937404.2014.882194	29	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146136	10.1371/journal.pone.0146136	http://dx.doi.org/10.1371/journal.pone.0146136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741502	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600020
J	Petit, M; Guihot, AL; Grimaud, L; Vessieres, E; Toutain, B; Menet, MC; Nivet-Antoine, V; Arnal, JF; Loufrani, L; Procaccio, V; Henrion, D				Petit, Marie; Guihot, Anne-Laure; Grimaud, Linda; Vessieres, Emilie; Toutain, Bertrand; Menet, Marie-Claude; Nivet-Antoine, Valerie; Arnal, Jean-Francois; Loufrani, Laurent; Procaccio, Vincent; Henrion, Daniel			Resveratrol Improved Flow-Mediated Outward Arterial Remodeling in Ovariectomized Rats with Hypertrophic Effect at High Dose	PLOS ONE			English	Article							MESENTERIC RESISTANCE ARTERIES; BLOOD-FLOW; POSTISCHEMIC NEOVASCULARIZATION; ENDOTHELIAL DYSFUNCTION; MITOCHONDRIAL-FUNCTION; DEPENDENT DILATION; HYPERTENSIVE-RATS; OXIDATIVE STRESS; KEY ROLE; AGE	Objectives Chronic increases in blood flow in resistance arteries induce outward remodeling associated with increased wall thickness and endothelium-mediated dilatation. This remodeling is essential for collateral arteries growth following occlusion of a large artery. As estrogens have a major role in this remodeling, we hypothesized that resveratrol, described as possessing phytoestrogen properties, could improve remodeling in ovariectomized rats. Methods Blood flow was increased in vivo in mesenteric arteries after ligation of adjacent arteries in 3-month old ovariectomized rats treated with resveratrol (5 or 37.5 mg/kg per day: RESV5 or RESV37.5) or vehicle. After 2 weeks arterial structure and function were measured in vitro in high flow (HF) and normal flow (NF) arteries isolated from each rat. Results Arterial diameter was greater in HF than in NF arteries in ovariectomized rats treated with RESV5 or RESV37.5, not in vehicle-treated rats. In mice lacking estrogen receptor alpha diameter was equivalent in HF and NF arteries whereas in mice treated with RESV5 diameter was greater in HF than in NF vessels. A compensatory increase in wall thickness and a greater phenylephrine-mediated contraction were observed in HF arteries. This was more pronounced in HF arteries from RESV37.5-treated rats. ERK1/2 phosphorylation, involved in hypertrophy and contraction, were higher in RESV37.5-treated rats than in RESV5- and vehicle-treated rats. Endothelium-dependent relaxation was greater in HF than in NF arteries in RESV5- treated rats only. In HF arteries from RESV37.5-treated rats relaxation was increased by superoxide reduction and markers of oxidative stress (p67phox, GP91phox) were higher than in the 2 other groups. Conclusion Resveratrol improved flow-mediated outward remodeling in ovariectomized rats thus providing a potential therapeutic tool in menopause-associated ischemic disorders. This effect seems independent of the estrogen receptor alpha. Nevertheless, caution should be taken with high doses inducing excessive contractility and hypertrophy in association with oxidative stress in HF arteries.	[Petit, Marie; Grimaud, Linda; Vessieres, Emilie; Toutain, Bertrand; Loufrani, Laurent; Procaccio, Vincent; Henrion, Daniel] Univ Angers, Angers, France; [Guihot, Anne-Laure; Loufrani, Laurent; Procaccio, Vincent; Henrion, Daniel] CNRS UMR 6214, Angers, France; [Loufrani, Laurent; Procaccio, Vincent; Henrion, Daniel] INSERM UMRS 1083, Angers, France; [Vessieres, Emilie; Henrion, Daniel] CARFI Cardiovasc Funct In Vitro Facil, Angers, France; [Nivet-Antoine, Valerie] Paris Descartes Univ, Fac Pharm, UMR S1140, Paris, France; [Nivet-Antoine, Valerie] Georges Pompidou European Hosp, AP HP, Dept Biochem, Paris, France; [Menet, Marie-Claude; Loufrani, Laurent] Paris Descartes Univ, Fac Pharm, UMR S1144, Paris, France; [Menet, Marie-Claude; Loufrani, Laurent] Cochin Hosp, AP HP, Dept Biochem, Paris, France; [Loufrani, Laurent; Procaccio, Vincent; Henrion, Daniel] Univ Hosp CHU Angers, Angers, France; [Arnal, Jean-Francois] Univ Toulouse 3, Univ Hosp Toulouse, INSERM U1048, F-31062 Toulouse, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Henrion, D (corresponding author), Univ Angers, Angers, France.	daniel.henrion@inserm.fr	Menet, Marie-Claude/ABB-3019-2020; Toutain, Bertrand/M-1982-2015; Henrion, Daniel/N-7023-2015; Nivet-Antoine, Valerie/R-1981-2017; Menet, Marie Claude/N-4723-2017; Henrion, Daniel/AAK-1995-2021; Henrion, Daniel/J-8141-2015	Henrion, Daniel/0000-0003-1094-0285; Nivet-Antoine, Valerie/0000-0003-2490-0428; Menet, Marie Claude/0000-0002-3180-9588; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Toutain, Bertrand/0000-0002-7571-4062; procaccio, Vincent/0000-0002-1537-4684; ARNAL, Jean Francois/0000-0003-2229-6300	Region Pays de la Loire (MITOVASC project); French Foundation for Medical Research (FRM) [DPM20121125554]	Region Pays de la Loire (MITOVASC project)(Region Pays de la Loire); French Foundation for Medical Research (FRM)(Fondation pour la Recherche Medicale)	This work was supported in part by the Region Pays de la Loire (MITOVASC project) and by the French Foundation for Medical Research (FRM, Vincent PROCACCIO and Daniel HENRION, DPM20121125554).	Baron S, 2014, J GERONTOL A-BIOL, V69, P260, DOI 10.1093/gerona/glt081; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bedarida T, 2014, AM J PHYSIOL-HEART C, V307, pH649, DOI 10.1152/ajpheart.00291.2014; Belin de Chantemele EJ, 2009, CARDIOVASC RES; Ben Driss A, 2000, CIRCULATION, V101, P2764, DOI 10.1161/01.CIR.101.23.2764; Borrelli F, 2010, MATURITAS, V66, P333, DOI 10.1016/j.maturitas.2010.05.010; Bouvet C, 2007, HYPERTENSION, V50, P248, DOI 10.1161/HYPERTENSIONAHA.107.088716; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Cousin M, 2010, HYPERTENSION, V55, P109, DOI 10.1161/HYPERTENSIONAHA.108.127456; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; de Chantemele EJB, 2009, CARDIOVASC RES, V81, P788, DOI 10.1093/cvr/cvn334; de Cremoux P, 2010, MATURITAS, V65, P334, DOI 10.1016/j.maturitas.2009.12.019; Desquiret-Dumas V, 2013, J BIOL CHEM, V288, P36662, DOI 10.1074/jbc.M113.466490; Dumont O, 2008, CARDIOVASC RES, V77, P600, DOI 10.1093/cvr/cvm055; Dumont O, 2007, ARTERIOSCL THROM VAS, V27, P317, DOI 10.1161/01.ATV.0000254684.80662.44; Dumont O, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/859793; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Freidja ML, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-55; Freidja ML, 2012, DIABETES, V61, P1562, DOI 10.2337/db11-0750; Freidja ML, 2011, J HYPERTENS, V29, P102, DOI 10.1097/HJH.0b013e32833db36e; HENRION D, 1992, CIRC RES, V71, P339, DOI 10.1161/01.RES.71.2.339; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Iglarz M, 1998, CARDIOVASC RES, V39, P657, DOI 10.1016/S0008-6363(98)00151-5; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Krebs EE, 2004, OBSTET GYNECOL, V104, P824, DOI 10.1097/01.AOG.0000140688.71638.d3; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lenfant F, 2011, MATURITAS, V68, P165, DOI 10.1016/j.maturitas.2010.11.016; Lethaby AE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001395.pub3; Levy BI, 2008, CIRCULATION, V118, P968, DOI 10.1161/CIRCULATIONAHA.107.763730; Li H, 2010, NITRIC OXIDE, V26, P102; Loufrani L, 2002, ARTERIOSCL THROM VAS, V22, P1579, DOI 10.1161/01.ATV.0000032652.24932.1A; Mandala M, 2012, BASIC CLIN PHARMACOL, V110, P12, DOI 10.1111/j.1742-7843.2011.00793.x; Menet MC, 2013, ANAL CHIM ACTA, V761, P128, DOI 10.1016/j.aca.2012.11.048; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Miller SJ, 2007, AM J PHYSIOL-HEART C, V292, pH2523, DOI 10.1152/ajpheart.01296.2006; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mulvany MJ, 2002, NEWS PHYSIOL SCI, V17, P105, DOI 10.1152/nips.01366.2001; Mulvany MJ, 2002, CURR HYPERTENS REP, V4, P49, DOI 10.1007/s11906-002-0053-y; Pourageaud F, 1997, AM J PHYSIOL-HEART C, V273, pH1699, DOI 10.1152/ajpheart.1997.273.4.H1699; Pourageaud F, 1998, AM J PHYSIOL-HEART C, V274, pH1301, DOI 10.1152/ajpheart.1998.274.4.H1301; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rizzoni D, 2006, CURR HYPERTENS REP, V8, P90, DOI 10.1007/s11906-006-0046-3; Rosenfeld ME, 2002, ATHEROSCLEROSIS, V164, P251, DOI 10.1016/S0021-9150(02)00178-8; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Tang YH, 2012, J NUTR BIOCHEM, V23, P1410, DOI 10.1016/j.jnutbio.2011.08.008; Tarhouni K, 2014, AM J PHYSIOL-HEART C, V307, pH504, DOI 10.1152/ajpheart.00986.2013; Tarhouni K, 2013, ARTERIOSCL THROM VAS, V33, P605, DOI 10.1161/ATVBAHA.112.300334; Tarhouni K, 2014, ARTERIOSCL THROM VAS, V34, P1281, DOI 10.1161/ATVBAHA.114.303404; Tuttle JL, 2002, AM J PHYSIOL-HEART C, V283, pH146, DOI 10.1152/ajpheart.00766.2001; Tuttle JL, 2002, MICROCIRCULATION, V9, P343, DOI 10.1038/sj.mn.7800151; Unthank JL, 1996, CIRC RES, V79, P1015, DOI 10.1161/01.RES.79.5.1015; van den Akker J, 2010, J VASC RES, V47, P183, DOI 10.1159/000255962; Vessieres E, 2013, VASC PHARMACOL, V58, P356, DOI 10.1016/j.vph.2013.03.001; Vessieres E, 2012, VASC PHARMACOL, V57, P173, DOI 10.1016/j.vph.2012.03.006; Vessieres E, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00145; Wang X, 2002, AM J PHYSIOL-HEART C, V282, pH2309, DOI 10.1152/ajpheart.00772.2001; Zhou XS, 2008, AM J PHYSIOL-HEART C, V295, pH1008, DOI 10.1152/ajpheart.00114.2008	63	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146148	10.1371/journal.pone.0146148	http://dx.doi.org/10.1371/journal.pone.0146148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734763	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100037
J	Ford, MM; Highfield, LD				Ford, Mary Margaret; Highfield, Linda D.			Exploring the Spatial Association between Social Deprivation and Cardiovascular Disease Mortality at the Neighborhood Level	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GEOGRAPHICALLY-WEIGHTED REGRESSION; MAJOR RISK-FACTORS; UNITED-STATES; SOCIOECONOMIC-STATUS; HEALTH DISPARITIES; RACIAL DISPARITIES; CANCER INCIDENCE; AIR-POLLUTION; PREVENTION	Cardiovascular disease (CVD), the leading cause of death in the United States, is impacted by neighborhood-level factors including social deprivation. To measure the association between social deprivation and CVD mortality in Harris County, Texas, global (Ordinary Least Squares (OLS) and local (Geographically Weighted Regression (GWR)) models were built. The models explored the spatial variation in the relationship at a census-tract level while controlling for age, income by race, and education. A significant and spatially varying association (p < .01) was found between social deprivation and CVD mortality, when controlling for all other factors in the model. The GWR model provided a better model fit over the analogous OLS model (R-2 = .65 vs. .57), reinforcing the importance of geography and neighborhood of residence in the relationship between social deprivation and CVD mortality. Findings from the GWR model can be used to identify neighborhoods at greatest risk for poor health outcomes and to inform the placement of community-based interventions.	[Ford, Mary Margaret] St Lukes Episcopal Hlth Char, Houston, TX USA; [Highfield, Linda D.] Univ Texas Sch Publ Hlth, Dept Management Policy & Community Hlth, Houston, TX USA	Saint Lukes Episcopal Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Ford, MM (corresponding author), New York City Dept Hlth & Mental Hyg, Div Dis Control, New York, NY 10013 USA.	ford.mary.m@gmail.com		Ford, Mary/0000-0003-3256-4276				Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Aylin P, 2001, INT J EPIDEMIOL, V30, P1100, DOI 10.1093/ije/30.5.1100; Becares L, 2013, HEALTH PLACE, V22, P48, DOI 10.1016/j.healthplace.2013.03.005; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Bunker SJ, 2003, MED J AUSTRALIA, V178, P272, DOI 10.5694/j.1326-5377.2003.tb05193.x; Charlton M., 2009, GEOGRAPHICALLY WEIGH; Comber AJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-44; Cooper R, 2000, CIRCULATION, V102, P3137; Cubbin C, 2006, SCAND J PUBLIC HEALT, V34, P228, DOI 10.1080/14034940500327935; Cummins SCJ, 2005, AM J PREV MED, V29, P308, DOI 10.1016/j.amepre.2005.06.011; Evans GW, 2002, CHILD DEV, V73, P1238, DOI 10.1111/1467-8624.00469; Ewart CK, 2002, HEALTH PSYCHOL, V21, P254, DOI 10.1037//0278-6133.21.3.254; Farber S, 2007, J GEOGR SYST, V9, P371, DOI 10.1007/s10109-007-0051-3; Ford MH, 2014, TEXAS PUBLIC HLTH J, V66, P20; Fotheringham A, 2009, GWR 4 0 70; Fotheringham A. S., 2003, GEOGRAPHICALLY WEIGH; Fotheringham AS, 1999, GEOGR ANAL, V31, P340; Gebreab SY, 2012, HEALTH PLACE, V18, P1006, DOI 10.1016/j.healthplace.2012.06.006; GeoLytics, 2010, ANN EST 2001 2010; Gilthorpe MS, 1995, J EPIDEMIOL COMMUN H, V49, pS45, DOI 10.1136/jech.49.Suppl_2.S45; Griffith D.A., 1999, CASEBOOK SPATIAL STA; Haggard LM, 1998, UTAHS HLTH ANN REV, P18; Janghorbani M, 2006, J MATERN-FETAL NEO M, V19, P85, DOI 10.1080/14767050500363428; Jones DW, 2000, AM J MED SCI, V319, P131, DOI 10.1097/00000441-200003000-00001; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Kurian AK, 2007, ETHNIC DIS, V17, P143; Litman T, 2006, J TRANSP ENG, V132, P11, DOI 10.1061/(ASCE)0733-947X(2006)132:1(11); Macintyre S, 1998, J EPIDEMIOL COMMUN H, V52, P657, DOI 10.1136/jech.52.10.657; Maheswaran R, 2005, EUR HEART J, V26, P2543, DOI 10.1093/eurheartj/ehi457; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mitchell A., 2005, ESRI GUIDE GIS ANAL, V2; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Nakaya T, 2009, SEMIPARAMETRIC GEOGR; Odoi A, 2014, SPAT SPATIO-TEMPORAL, V11, P109, DOI 10.1016/j.sste.2014.10.001; Qian Z, 2010, CITIES, V27, P31, DOI 10.1016/j.cities.2009.11.006; Quillian L, 2003, POPUL RES POLICY REV, V22, P221, DOI 10.1023/A:1026077008571; Renart G, 2013, REV PANAM SALUD PUBL, V34, P83; Rezaeian M, 2007, J EPIDEMIOL COMMUN H, V61, P98, DOI 10.1136/jech.2005.043117; ROSENBAUM PR, 1984, BIOMETRICS, V40, P437, DOI 10.2307/2531396; Rothman K, 1986, MODERN EPIDEMIOLOGY; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Schuurman N, 2007, J URBAN HEALTH, V84, P591, DOI 10.1007/s11524-007-9193-3; SPENCE DPS, 1993, BRIT MED J, V307, P759, DOI 10.1136/bmj.307.6907.759; Stafford M, 2003, INT J EPIDEMIOL, V32, P357, DOI 10.1093/ije/dyg084; StataCorp, 2021, STATA STAT SOFTWARE; Thomas AJ, 2005, AM J PUBLIC HEALTH, V95, P1417, DOI 10.2105/AJPH.2004.048165; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Townsend PP., 1988, HLTH DEPRIVATION INE; U.S. Census Bureau PD, 2013, ANN EST RES POP SEX; *US CENS BUR, 2012, 2010 GEOGR TERMS CON; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248; Wang Q, 2005, GLOBAL ECOL BIOGEOGR, V14, P379, DOI 10.1111/j.1466-822x.2005.00153.x; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	58	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146085	10.1371/journal.pone.0146085	http://dx.doi.org/10.1371/journal.pone.0146085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731424	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400091
J	Xia, JB; Zhao, XM; Chen, YP; Fang, Y; Zhao, ZG				Xia, Jiangbao; Zhao, Ximei; Chen, Yinping; Fang, Ying; Zhao, Ziguo			Responses of Water and Salt Parameters to Groundwater Levels for Soil Columns Planted with Tamarix chinensis	PLOS ONE			English	Article							SALINIZATION; FLUCTUATION; IRRIGATION; SALINITY; CLIMATE; FLOW	Groundwater is the main water resource for plant growth and development in the saline soil of the Yellow River Delta in China. To investigate the variabilities and distributions of soil water and salt contents at various groundwater level (G(L)), soil columns with planting Tamarix chinensis Lour were established at six different G(L). The results demonstrated the following: With increasing G(L), the relative soil water content (RWC) declined significantly, whereas the salt content (S-C) and absolute soil solution concentration (C-S) decreased after the initial increase in the different soil profiles. A G(L) of 1.2 m was the turning point for variations in the soil water and salt contents, and it represented the highest G(L) that could maintain the soil surface moist within the soil columns. Both the S-C and C-S reached the maximum levels in these different soil profiles at a G(L) of 1.2 m. With the raise of soil depth, the RWC increased significantly, whereas the S-C increased after an initial decrease. The mean S-C values reached 0.96% in the top soil layer; however, the rates at which the C-S and RWC decreased with the G(L) were significantly reduced. The RWC and S-C presented the greatest variations at the medium (0.9-1.2 m) and shallow water levels (0.6 m) respectively, whereas the C-S presented the greatest variation at the deep water level (1.5-1.8 m). The RWC, S-C and C-S in the soil columns were all closely related to the G(L). However, the correlations among the parameters varied greatly within different soil profiles, and the most accurate predictions of the G(L) were derived from the RWC in the shallow soil layer or the S-C in the top soil layer. A G(L) at 1.5-1.8 m was moderate for planting T. chinensis seedlings under saline groundwater conditions.	[Xia, Jiangbao; Zhao, Ximei; Chen, Yinping; Fang, Ying; Zhao, Ziguo] Binzhou Univ, Shandong Prov Key Lab Ecoenvironm Sci Yellow Rive, Binzhou 256603, Peoples R China	Binzhou University	Xia, JB (corresponding author), Binzhou Univ, Shandong Prov Key Lab Ecoenvironm Sci Yellow Rive, Binzhou 256603, Peoples R China.	xiajb@163.com			National Natural Science Foundation of China [31370702]; Key Project of Shandong Province Natural Science Foundation, China [ZR2015JL014]; Key Research and Development Project of Shandong Province [2015GNC111022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Shandong Province Natural Science Foundation, China; Key Research and Development Project of Shandong Province	The study was financially supported by National Natural Science Foundation of China (No. 31370702), the Key Project of Shandong Province Natural Science Foundation, China (No. ZR2015JL014), and the Key Research and Development Project of Shandong Province (No. 2015GNC111022).	[安乐生 An Lesheng], 2015, [地理科学, Scientia Geographica Sinica], V35, P358; [安乐生 An Lesheng], 2011, [水科学进展, Advances in Water Science], V22, P689; [常春龙 Chang Chunlong], 2014, [灌溉排水学报, Journal of Irrigation and Drainage], V33, P315; Chaudhuri S, 2014, J HYDROL, V513, P376, DOI 10.1016/j.jhydrol.2014.03.033; Chaudhuri S, 2014, SCI TOTAL ENVIRON, V472, P370, DOI [10.1016/j.scitotenv.2014.05.013, 10.1016/j.scitotenv.2013.10.120]; Chen YongBao, 2014, Acta Pedologica Sinica, V51, P75; [邓宝山 Deng Baoshan], 2015, [干旱区地理, Arid Land Geography], V38, P599; Duan YH, 2015, J GEOCHEM EXPLOR, V149, P106, DOI 10.1016/j.gexplo.2014.12.001; Gao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073570; Ibrahimi MK, 2014, ARAB J GEOSCI, V7, P3901, DOI 10.1007/s12517-013-1084-1; Ibrakhimov M., 2007, Irrigation and Drainage Systems, V21, P219, DOI 10.1007/s10795-007-9033-3; Jie Z, 2011, HYDROGEOL J, V19, P1487, DOI 10.1007/s10040-011-0772-8; Jordan MM, 2004, ENVIRON GEOL, V45, P448, DOI 10.1007/s00254-003-0894-y; Lavers DA, 2015, J HYDROL, V523, P179, DOI 10.1016/j.jhydrol.2015.01.060; [李彬 Li Bin], 2014, [水土保持学报, Journal of Soil and Water Conservation], V28, P117; [刘虎俊 Liu Hujun], 2012, [干旱区研究, Arid Zone Research], V29, P335; Mohamed M, 2015, GEOTHERMICS, V53, P171, DOI 10.1016/j.geothermics.2014.05.013; Nippert JB, 2010, OECOLOGIA, V162, P283, DOI 10.1007/s00442-009-1455-1; [阮本清 RUAN Benqing], 2008, [水利学报, Journal of Hydraulic Engineering], V39, P573; Rudzianskaite A, 2008, ENVIRON GEOL, V56, P289, DOI 10.1007/s00254-007-1164-1; Seeboonruang U, 2013, ENVIRON EARTH SCI, V69, P1803, DOI 10.1007/s12665-012-2012-5; Sun JiuSheng, 2012, Xinjiang Agricultural Sciences, V49, P1471; Talebnejad R, 2015, AGR WATER MANAGE, V148, P177, DOI 10.1016/j.agwat.2014.10.005; Wang ShuiXian, 2004, Journal of Xinjiang Agricultural University, V27, P52; [王卫星 Wang Weixing], 2015, [物探与化探, Geophysical and Geochemical Exploration], V39, P172; [魏彬 Wei Bin], 2013, [中国沙漠, Journal of Desert Research], V33, P1110; Wichelns D, 2015, AGR WATER MANAGE, V157, P31, DOI 10.1016/j.agwat.2014.08.016; [吴启侠 WU Qi-xia], 2009, [湖北农业科学, Hubei Agricultural Sciences], V48, P604; Xie WP, 2013, J INTEGR AGR, V12, P711, DOI 10.1016/S2095-3119(13)60289-0; [姚荣江 YAO Rongjiang], 2007, [农业环境科学学报, Journal of Agro-Environment Science], V26, P2118; Yao RongJiang, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P45; Yin LH, 2015, J HYDROL, V528, P435, DOI 10.1016/j.jhydrol.2015.06.063; Zhang CX, 2013, CHEMOSPHERE, V92, P337, DOI 10.1016/j.chemosphere.2013.01.020; [赵新风 Zhao Xinfeng], 2010, [水土保持学报, Journal of Soil and Water Conservation], V24, P75; [赵欣胜 ZHAO Xinsheng], 2011, [生态科学, Ecologic Science], V30, P142	35	10	14	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145828	10.1371/journal.pone.0145828	http://dx.doi.org/10.1371/journal.pone.0145828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730602	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400059
J	Zhao, MD; Huang, JS; Zhang, XC; Gui, KK; Xiong, M; Yin, WP; Yuan, FL; Cai, GP				Zhao, Ming-Dong; Huang, Jian-Shu; Zhang, Xin-Chao; Gui, Ke-Ke; Xiong, Min; Yin, Wang-Ping; Yuan, Feng-Lai; Cai, Guo-Ping			Construction of Radial Defect Models in Rabbits to Determine the Critical Size Defects	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; ZEALAND WHITE-RABBIT; RESORBABLE POLYMERIC MEMBRANES; SEGMENTAL DIAPHYSEAL DEFECTS; MATRIX PROTEINS; LONG-BONE; REGENERATION; MARROW; REPAIR; BMP-2	Many studies aimed at investigating bone repair have been conducted through animal models in recent years. However, limitations do exist in these models due to varying regeneration potential among different animal species. Even using the same animal, big differences exist in the size of critical size defects (CSD) involving the same region. This study aimed to investigate the standardization of radial bone defect models in rabbits and further establish more reliable CSD data. A total of 40 6-month-old New Zealand white rabbits of clean grade totaling 80 radial bones were prepared for bone defect models, according to the principle of randomization. Five different sizes (1.0, 1.2, 1.4, 1.7 and 2.0 cm) of complete periosteal defects were introduced under anesthesia. At 12 weeks postoperatively, with the gradual increase in defect size, the grades of bone growth were significantly decreased in all 5 groups. X-ray, CT scans and H&E staining of the 1.4, 1.7, and 2.0-cm groups showed lower grades of bone growth than that of the 1.0 and 1.2-cm groups respectively (P < 0.05). Using rabbit radial defect model involving 6-month-old healthy New Zealand white rabbits, this study indicates that in order to be critical sized, defects must be greater than 1.4 cm.	[Zhao, Ming-Dong; Zhang, Xin-Chao; Gui, Ke-Ke; Xiong, Min; Yin, Wang-Ping; Cai, Guo-Ping] Fudan Univ, Jinshan Hosp, Dept Orthopaed, Shanghai 201508, Peoples R China; [Huang, Jian-Shu] Fudan Univ, Jinshan Hosp, Dept Occupat Med, Shanghai 201508, Peoples R China; [Yuan, Feng-Lai] Nantong Univ, Hosp Affiliated 3, Dept Orthopaed & Cent Lab, Wuxi 214041, Jiangsu, Peoples R China	Fudan University; Fudan University; Nantong University	Yuan, FL (corresponding author), Nantong Univ, Hosp Affiliated 3, Dept Orthopaed & Cent Lab, Wuxi 214041, Jiangsu, Peoples R China.	bjjq88@163.com; jinshancgp@sina.com			Shanghai Municipal Health Bureau youth Foundation [2012-138, 2012-167]; Nature Science Foundation [81202160]; Shanghai Health and Family Planning Commission Project [2014-403]; Shanghai Young Physician Training Program [2012-30, 2012-31]	Shanghai Municipal Health Bureau youth Foundation; Nature Science Foundation; Shanghai Health and Family Planning Commission Project; Shanghai Young Physician Training Program	This study was in part supported by Shanghai Municipal Health Bureau youth Foundation (2012-138, Zhao MD and 2012-167, Huang JS), Nature Science Foundation (81202160, Huang JS), Shanghai Health and Family Planning Commission Project (2014-403, Zhang XC) and Shanghai Young Physician Training Program (2012-30, 2012-31, Zhao MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Jian Dong (Department of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai, 200032, China) for his technical supports. We also thank Professor Xuan-Guang Ye (Department of Pathology, Jinshan Hospital, Fudan University, Shanghai, 201508, China) for his help of histological analysis. This study was in part supported by Shanghai Municipal Health Bureau youth Foundation (2012-138, Zhao MD and 2012-167, Huang JS), Nature Science Foundation (81202160, Huang JS), Shanghai Health and Family Planning Commission Project (2014-403, Zhang XC) and Shanghai Young Physician Training Program (2012-30, 2012-31, Zhao MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalami OO, 2004, PLAST RECONSTR SURG, V114, P713, DOI 10.1097/01.PRS.0000131016.12754.30; Amorosa LF, 2013, INT J NANOMED, V8, P1637, DOI 10.2147/IJN.S42855; Batista JD, 2015, LASERS MED SCI; Beck A, 2013, BONE, V56, P312, DOI 10.1016/j.bone.2013.06.025; Beck LS, 1998, J PHARM SCI-US, V87, P1379, DOI 10.1021/js9800883; Bodde EWH, 2008, J BIOMED MATER RES A, V85A, P206, DOI 10.1002/jbm.a.31549; BOLANDER ME, 1986, J BONE JOINT SURG AM, V68A, P1264, DOI 10.2106/00004623-198668080-00018; Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004; Bostrom M, 1996, CLIN ORTHOP RELAT R, P272, DOI 10.1097/00003086-199606000-00034; Bronoosh P, 2015, INT J ORAL MAX SURG, V44, P277, DOI 10.1016/j.ijom.2014.09.020; Cacchioli A., 2006, Annali della Facolta di Medicina Veterinaria, Universita di Parma, V26, P97; Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005; Caporali Evelyn Hasegawa Gonçalves, 2006, Acta Cir. Bras., V21, P366, DOI 10.1590/S0102-86502006000600003; Cheng BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070234; Cheng LJ, 2012, APPL SURF SCI, V262, P188, DOI 10.1016/j.apsusc.2012.04.122; Chow SC, 2001, J PHARMACOKINET PHAR, V28, P155, DOI 10.1023/A:1011503032353; El-Ghannam A, 2007, J ORAL MAXIL SURG, V65, P1495, DOI 10.1016/j.joms.2006.10.031; Fernandez-Tresguerres-Hernandez-Gil Isabel, 2006, Med Oral Patol Oral Cir Bucal, V11, pE151; Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018; Gogolewski S, 2000, BIOMATERIALS, V21, P2513, DOI 10.1016/S0142-9612(00)00119-8; Gosain AK, 2000, PLAST RECONSTR SURG, V106, P360, DOI 10.1097/00006534-200008000-00018; Gugala Z, 1999, J ORTHOP TRAUMA, V13, P187, DOI 10.1097/00005131-199903000-00006; Hedberg EL, 2005, TISSUE ENG, V11, P1356, DOI 10.1089/ten.2005.11.1356; Iwaniec UT, 2007, J BONE MINER RES, V22, P394, DOI 10.1359/JBMR.061118; JOHNSON EE, 1989, CLIN ORTHOP RELAT R, P254; Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010; Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014; KAWEBLUM M, 1994, J ORTHOPAED RES, V12, P747, DOI 10.1002/jor.1100120519; Kieser M, 1999, J Biopharm Stat, V9, P641, DOI 10.1081/BIP-100101200; Kim Ho-Chul, 2015, Maxillofac Plast Reconstr Surg, V37, P16, DOI 10.1186/s40902-015-0015-3; Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3; Kokubu T, 2003, JOURNAL OF ORTHOPAED, V21, P510; MASOUD I, 1986, J ORTHOP RES, V4, P221, DOI 10.1002/jor.1100040211; Meinig RP, 2002, INJURY, V33, P58, DOI 10.1016/S0020-1383(02)00133-X; Minier K, 2014, VET COMP ORTHOPAED, V27, P411, DOI 10.3415/VCOT-14-03-0036; Niemeyer P, 2010, TRANSPLANTATION HUMA, P900; Novotny SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104339; Pekkarinen T, 2006, ACTA ORTHOP, V77, P952, DOI 10.1080/17453670610013286; Poser L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/348635; Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050; Rivas R, 2002, J BONE JOINT SURG AM, V84A, P85, DOI 10.2106/00004623-200201000-00013; Schmidmaier G, 2009, INJURY, V40, P39; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Sculean A, 2001, J PERIODONTOL, V72, P190, DOI 10.1902/jop.2001.72.2.190; Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006; Shimizu T, 2015, INJURY; Sohn Joo-Yeon, 2010, J Periodontal Implant Sci, V40, P180, DOI 10.5051/jpis.2010.40.4.180; Thor ALI, 2013, CLIN IMPLANT DENT R, V15, P759, DOI 10.1111/j.1708-8208.2011.00405.x; Xu F, 2014, J BIOMAT SCI-POLYM E, V25, P2080, DOI 10.1080/09205063.2014.970604; Xu Y T, 2001, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V15, P183; Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003; Zhang Y, 1999, Zhonghua Wai Ke Za Zhi, V37, P399; Zhao MD, 2011, MICROSURG, V31, P130, DOI 10.1002/micr.20854; Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043	54	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146301	10.1371/journal.pone.0146301	http://dx.doi.org/10.1371/journal.pone.0146301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731011	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400143
J	Choi, Y; Oh, DY; Park, H; Kim, TY; Lee, KH; Han, SW; Im, SA; Kim, TY; Bang, YJ				Choi, Younak; Oh, Do-Youn; Park, Hyunkyung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue			More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; PRETREATMENT NEUTROPHIL; MICROENVIRONMENT; OUTCOMES; PET	Introduction Neutrophil to lymphocyte ratio (NLR) and standard uptake value (SUV) by F-18-FDG PET represent host immunity and tumor metabolic activity, respectively. We investigated NLR and maximum SUV (SUVmax) as prognostic markers in metastatic pancreatic cancer (MPC) patients who receive palliative chemotherapy. Methods We reviewed 396 MPC patients receiving palliative chemotherapy. NLR was obtained before and after the first cycle of chemotherapy. In 118 patients with PET prior to chemotherapy, SUVmax was collected. Cut-off values were determined by ROC curve. Results In multivariate analysis of all patients, NLR and change in NLR after the first cycle of chemotherapy (Delta NLR) were independent prognostic factors for overall survival (OS). We scored the risk considering NLR and Delta NLR and identified 4 risk groups with different prognosis (risk score 0 vs 1 vs 2 vs 3: OS 9.7 vs 7.9 vs 5.7 vs 2.6 months, HR 1 vs 1.329 vs 2.137 vs 7.915, respectively; P<0.001). In PET cohort, NLR and SUVmax were independently prognostic for OS. Prognostication model using both NLR and SUVmax could define 4 risk groups with different OS (risk score 0 vs 1 vs 2 vs 3: OS 11.8 vs 9.8 vs 7.2 vs 4.6 months, HR 1 vs 1.536 vs 2.958 vs 5.336, respectively; P<0.001). Conclusions NLR and SUVmax as simple parameters of host immunity and metabolic activity of tumor cell, respectively, are independent prognostic factors for OS in MPC patients undergoing palliative chemotherapy.	[Choi, Younak; Oh, Do-Youn; Park, Hyunkyung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Oh, DY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	ohdoyoun@snu.ac.kr	Bang, Yung Jue/J-2759-2012	Bang, Yung Jue/0000-0001-6000-4597				Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Cho IR, 2014, GASTRIC CANCER, V17, P703, DOI 10.1007/s10120-013-0330-2; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; HAWKINS RA, 1992, J NUCL MED, V33, P339; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Luo GP, 2015, ANN SURG ONCOL, V22, P670, DOI 10.1245/s10434-014-4021-y; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MCCOLL SR, 1992, J EXP MED, V176, P593, DOI 10.1084/jem.176.2.593; MINN H, 1988, J NUCL MED, V29, P1521; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Ryu IS, 2013, J NUCL MED, V54, P1032, DOI 10.2967/jnumed.112.116053; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Spicer JD, 2012, CANCER RES, V72, P3919, DOI 10.1158/0008-5472.CAN-11-2393; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Yao YW, 2013, CANCER IMMUNOL IMMUN, V62, P471, DOI 10.1007/s00262-012-1347-9; ZASADNY KR, 1993, RADIOLOGY, V189, P847, DOI 10.1148/radiology.189.3.8234714	27	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145692	10.1371/journal.pone.0145692	http://dx.doi.org/10.1371/journal.pone.0145692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727470	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500029
J	Domazet, SL; Tarp, J; Huang, T; Gejl, AK; Andersen, LB; Froberg, K; Bugge, A				Domazet, Sidsel L.; Tarp, Jakob; Huang, Tao; Gejl, Anne Kaer; Andersen, Lars Bo; Froberg, Karsten; Bugge, Anna			Associations of Physical Activity, Sports Participation and Active Commuting on Mathematic Performance and Inhibitory Control in Adolescents	PLOS ONE			English	Article							EXECUTIVE FUNCTION; AEROBIC FITNESS; COGNITIVE PERFORMANCE; CHILDREN; EXERCISE; SCHOOL; BENEFITS; HEALTH; MATH	Objectives To examine objectively measured physical activity level, organized sports participation and active commuting to school in relation to mathematic performance and inhibitory control in adolescents. Methods The design was cross-sectional. A convenient sample of 869 sixth and seventh grade students (12-14 years) was invited to participate in the study. A total of 568 students fulfilled the inclusion criteria and comprised the final sample for this study. Mathematic performance was assessed by a customized test and inhibitory control was assessed by a modified Eriksen flanker task. Physical activity was assessed with GT3X and GT3X+ accelerometers presented in sex-specific quartiles of mean counts per minute and mean minutes per day in moderate-to-vigorous physical activity. Active commuting and sports participation was self-reported. Mixed model regression was applied. Total physical activity level was stratified by bicycling status in order to bypass measurement error subject to the accelerometer. Results Non-cyclists in the 2nd quartile of counts per minute displayed a higher mathematic score, so did cyclists in the 2nd and 3rd quartile of moderate-to-vigorous physical activity relative to the least active quartile. Non-cyclists in the 3rd quartile of counts per minute had an improved reaction time and cyclists in the 2nd quartile of counts per minute and moderate-to-vigorous physical activity displayed an improved accuracy, whereas non-cyclists in the 2nd quartile of counts per minute showed an inferior accuracy relative to the least active quartile. Bicycling to school and organized sports participation were positively associated with mathematic performance. Conclusions Sports participation and bicycling were positively associated with mathematic performance. Results regarding objectively measured physical activity were mixed. Although, no linear nor dose-response relationship was observed there was no indication of a higher activity level impairing the scholastic or cognitive performance.	[Domazet, Sidsel L.; Tarp, Jakob; Huang, Tao; Gejl, Anne Kaer; Andersen, Lars Bo; Froberg, Karsten; Bugge, Anna] Univ Southern Denmark, Div Exercise Epidemiol, Dept Sports Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark; [Huang, Tao] Shanghai Jiao Tong Univ, Dept Phys Educ, Shanghai 200030, Peoples R China; [Andersen, Lars Bo] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway	University of Southern Denmark; Shanghai Jiao Tong University; Norwegian School of Sport Sciences	Domazet, SL (corresponding author), Univ Southern Denmark, Div Exercise Epidemiol, Dept Sports Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark.	sdomazet@health.sdu.dk	Bugge, Anna/P-5100-2016	Bugge, Anna/0000-0002-8345-1434; Kaer Gejl, Anne/0000-0001-6781-2263; Domazet, Sidsel Louise/0000-0002-3128-1875; Tarp, Jakob/0000-0002-9186-7077	Danish Ministry of Education [51401]	Danish Ministry of Education	This work was supported by Grant no. 51401, Danish Ministry of Education (http://eng.uvm.dk/). KF received the funding.	Berchicci M, 2015, NEUROSCIENCE, V298, P211, DOI 10.1016/j.neuroscience.2015.04.028; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Booth JN, 2013, MENT HEALTH PHYS ACT, V6, P212, DOI 10.1016/j.mhpa.2013.09.002; Bugge A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-967; Burkhalter TM, 2011, ADV NUTR, V2, p201S, DOI 10.3945/an.111.000331; Chaddock L, 2011, J INT NEUROPSYCH SOC, V17, P975, DOI 10.1017/S1355617711000567; Chaddock-Heyman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134115; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cragg L, 2014, TRENDS NEUROSCI EDUC, V3, P63, DOI 10.1016/j.tine.2013.12.001; Das JP, 1994, WECHSLER INDIVIDUAL; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Esteban-Cornejo I, 2014, ACTA PAEDIATR, V103, pE501, DOI 10.1111/apa.12757; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175; Huang T, 2015, J PEDIATR-US, V167, P810, DOI 10.1016/j.jpeds.2015.07.009; Iughetti L, 2011, NEUROPEPTIDES, V45, P205, DOI 10.1016/j.npep.2011.02.002; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kristensen PL, 2010, EUR J APPL PHYSIOL, V110, P267, DOI 10.1007/s00421-010-1491-x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Pindus D, 2014, PSYCHOL RES, P1; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Syvaoja HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103559; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tarp J, 2014, J PHYS ACT HLTH; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Tomporowski PD, 2011, PREV MED, V52, pS3, DOI 10.1016/j.ypmed.2011.01.028; Trost S, 2000, MED SCI SPORTS EXERC, V32; Van Dijk ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-799; Van Dijk ML, 2014, J SPORT EXERC PSYCHO; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875	33	24	24	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146319	10.1371/journal.pone.0146319	http://dx.doi.org/10.1371/journal.pone.0146319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727211	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500076
J	Leiwe, MN; Hendry, AC; Bard, AD; Eglen, SJ; Lowe, AS; Thompson, ID				Leiwe, Marcus N.; Hendry, Aenea C.; Bard, Andrew D.; Eglen, Stephen J.; Lowe, Andrew S.; Thompson, Ian D.			Geniculo-Cortical Projection Diversity Revealed within the Mouse Visual Thalamus	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; NICOTINIC ACETYLCHOLINE-RECEPTOR; RETINAL GANGLION-CELLS; MICE LACKING; DIRECTION; MAPS; RECONSTRUCTION; PATTERNS; LAMINA; BRAIN	The mouse dorsal lateral geniculate nucleus (dLGN) is an intermediary between retina and primary visual cortex (V1). Recent investigations are beginning to reveal regional complexity in mouse dLGN. Using local injections of retrograde tracers into V1 of adult and neonatal mice, we examined the developing organisation of geniculate projection columns: the population of dLGN-V1 projection neurons that converge in cortex. Serial sectioning of the dLGN enabled the distribution of labelled projection neurons to be reconstructed and collated within a common standardised space. This enabled us to determine: the organisation of cells within the dLGN-V1 projection columns; their internal organisation (topology); and their order relative to V1 (topography). Here, we report parameters of projection columns that are highly variable in young animals and refined in the adult, exhibiting profiles consistent with shell and core zones of the dLGN. Additionally, such profiles are disrupted in adult animals with reduced correlated spontaneous activity during development. Assessing the variability between groups with partial least squares regression suggests that 4-6 cryptic lamina may exist along the length of the projection column. Our findings further spotlight the diversity of the mouse dLGN-an increasingly important model system for understanding the pre-cortical organisation and processing of visual information. Furthermore, our approach of using standardised spaces and pooling information across many animals will enhance future functional studies of the dLGN.	[Leiwe, Marcus N.; Hendry, Aenea C.; Bard, Andrew D.; Lowe, Andrew S.; Thompson, Ian D.] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Eglen, Stephen J.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge Computat Biol Inst, Cambridge CB3 9EW, England	University of London; King's College London; University of Cambridge	Lowe, AS (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Guys Campus, London WC2R 2LS, England.	andrew.lowe@kcl.ac.uk; ian.thompson@kcl.ac.uk	Lowe, Andrew S/J-4801-2013; Eglen, Stephen/AAF-9008-2020	Lowe, Andrew S/0000-0001-6650-7486; Eglen, Stephen/0000-0001-8607-8025; Leiwe, Marcus/0000-0002-3493-7091	Wellcome Trust [083205]; MRC; Medical Research Council [1523313] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by a Wellcome Trust grant jointly awarded to IDT and SJE (083205, www.wellcome.ac.uk), and by MRC PhD Studentships awarded to MNL and ACH (http://www.mrc.ac.uk/).	Bansal A, 2000, J NEUROSCI, V20, P7672; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Cheng TW, 2010, J NEUROSCI, V30, P16376, DOI 10.1523/JNEUROSCI.3455-10.2010; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Dhande OS, 2014, CURR OPIN NEUROBIOL, V24, P133, DOI 10.1016/j.conb.2013.08.006; Grubb MS, 2004, VISION RES, V44, P3365, DOI 10.1016/j.visres.2004.09.003; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Inayat S, 2015, J NEUROSCI, V35, P7992, DOI 10.1523/JNEUROSCI.0173-15.2015; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; Marshel J, 2012, ANTERIOR POSTERIOR D, V76, P13; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Nikolaou N, 2012, NEURON, V76, P317, DOI 10.1016/j.neuron.2012.08.040; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Yarrow S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087178; Zhao XY, 2013, J NEUROSCI, V33, P12751, DOI 10.1523/JNEUROSCI.0095-13.2013	23	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0144846	10.1371/journal.pone.0144846	http://dx.doi.org/10.1371/journal.pone.0144846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727264	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500007
J	Weissova, K; Bartos, A; Sladek, M; Novakova, M; Sumova, A				Weissova, Kamila; Bartos, Ales; Sladek, Martin; Novakova, Marta; Sumova, Alena			Moderate Changes in the Circadian System of Alzheimer's Disease Patients Detected in Their Home Environment	PLOS ONE			English	Article							HUMAN SUPRACHIASMATIC NUCLEUS; CEREBROSPINAL-FLUID; DAYTIME SLEEPINESS; MELATONIN RHYTHM; GENE-EXPRESSION; CLOCK; AGE; DEMENTIA; SCN; DISTURBANCES	Alzheimer's disease (AD) is a neurodegenerative disease often accompanied with disruption of sleep-wake cycle. The sleep-wake cycle is controlled by mechanisms involving internal timekeeping (circadian) regulation. The aim of our present pilot study was to assess the circadian system in patients with mild form of AD in their home environment. In the study, 13 elderly AD patients and 13 age-matched healthy control subjects (the patient's spouses) were enrolled. Sleep was recorded for 21 days by sleep diaries in all participants and checked by actigraphy in 4 of the AD patient/control couples. The samples of saliva and buccal mucosa were collected every 4 hours during the same 24 h-interval to detect melatonin and clock gene (PER1 and BMAL1) mRNA levels, respectively. The AD patients exhibited significantly longer inactivity interval during the 24 h and significantly higher number of daytime naps than controls. Daily profiles of melatonin levels exhibited circadian rhythms in both groups. Compared with controls, decline in amplitude of the melatonin rhythm in AD patients was not significant, however, in AD patients more melatonin profiles were dampened or had atypical waveforms. The clock genes PER1 and BMAL1 were expressed rhythmically with high amplitudes in both groups and no significant differences in phases between both groups were detected. Our results suggest moderate differences in functional state of the circadian system in patients with mild form of AD compared with healthy controls which are present in conditions of their home dwelling.	[Weissova, Kamila; Sladek, Martin; Novakova, Marta; Sumova, Alena] Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Prague, Czech Republic; [Bartos, Ales] Charles Univ Prague, Dept Neurol, Fac Med 3, Prague, Czech Republic; [Bartos, Ales] Natl Inst Mental Hlth, Klecany, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; National Institute of Mental Health - Czech Republic	Sumova, A (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Prague, Czech Republic.	sumova@biomed.cas.cz	Bartos, Ales/C-4353-2019; Sládek, Martin/C-3383-2012; Sumova, Alena/C-3390-2012; Weissova, Kamila/X-1856-2018	Bartos, Ales/0000-0002-8020-8252; Sládek, Martin/0000-0002-9744-9386; Sumova, Alena/0000-0003-4126-5470; Weissova, Kamila/0000-0002-3023-4751	Czech Science Foundation [P304/12/G069]; Internal Grant Agency, Ministry of Health of the Czech Republic [NT 13183]; National Institute of Mental Health (NIMH-CZ) [ED2.1.00/03.0078]; European Regional Development Fund	Czech Science Foundation(Grant Agency of the Czech Republic); Internal Grant Agency, Ministry of Health of the Czech Republic; National Institute of Mental Health (NIMH-CZ); European Regional Development Fund(European Commission)	The study was supported by the Czech Science Foundation grant No. P304/12/G069 (AS), the Internal Grant Agency, Ministry of Health of the Czech Republic NT 13183 (AB), the National Institute of Mental Health (NIMH-CZ) grant No. ED2.1.00/03.0078 and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Baloyannis SJ, 2014, AM J ALZHEIMERS DIS; Bedrosian TA, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt128; BLAZER DG, 1995, J GERONTOL A-BIOL, V50, pM280, DOI 10.1093/gerona/50A.5.M280; Bonanni E, 2005, J SLEEP RES, V14, P311, DOI 10.1111/j.1365-2869.2005.00462.x; Cermakian N, 2011, J BIOL RHYTHM, V26, P160, DOI 10.1177/0748730410395732; Coogan AN, 2013, BIOL PSYCHIAT, V74, P333, DOI 10.1016/j.biopsych.2012.11.021; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Duffy JF, 2002, AM J PHYSIOL-ENDOC M, V282, pE297, DOI 10.1152/ajpendo.00268.2001; Duffy JF, 2002, NEUROSCI LETT, V318, P117, DOI 10.1016/S0304-3940(01)02427-2; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harper DG, 2008, BRAIN, V131, P1609, DOI 10.1093/brain/awn049; Harper DG, 2005, AM J GERIAT PSYCHIAT, V13, P359, DOI 10.1176/appi.ajgp.13.5.359; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hatfield CF, 2004, BRAIN, V127, P1061, DOI 10.1093/brain/awh129; HOFMAN MA, 1995, NEUROBIOL AGING, V16, P965, DOI 10.1016/0197-4580(95)02016-0; Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001; HOFMAN MA, 1994, BRAIN RES, V651, P134, DOI 10.1016/0006-8993(94)90689-0; Kalsbeek A, 2011, ESSAYS BIOCHEM, V49, P137, DOI [10.1042/bse0490137, 10.1042/BSE0480137]; Lee JH, 2007, AM J GERIAT PSYCHIAT, V15, P620, DOI 10.1097/JGP.0b013e3180381521; Liu RY, 2000, J NEUROPATH EXP NEUR, V59, P314, DOI 10.1093/jnen/59.4.314; Liu RY, 1999, J CLIN ENDOCR METAB, V84, P323, DOI 10.1210/jc.84.1.323; McCurry SM, 1999, J GERIATR PSYCH NEUR, V12, P53, DOI 10.1177/089198879901200203; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; MYERS BL, 1995, NEUROSCI BIOBEHAV R, V19, P553, DOI 10.1016/0149-7634(95)00018-6; Novakova M, 2014, INDIAN J EXP BIOL, V52, P404; Novakova M, 2013, CHRONOBIOL INT, V30, P607, DOI 10.3109/07420528.2012.754455; Novakova M, 2012, J CLIN ENDOCR METAB, V97, pE312, DOI 10.1210/jc.2011-2750; Novakova M, 2011, CHRONOBIOL INT, V28, P630, DOI 10.3109/07420528.2011.596983; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; SATLIN A, 1991, NEUROPSYCHOPHARMACOL, V5, P115; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Skene DJ, 2003, EXP GERONTOL, V38, P199, DOI 10.1016/S0531-5565(02)00198-5; Stopa EG, 1999, J NEUROPATH EXP NEUR, V58, P29, DOI 10.1097/00005072-199901000-00004; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; Van Someren EJW, 2000, CHRONOBIOL INT, V17, P233, DOI 10.1081/CBI-100101046; Vandenberghe R, 2005, POSTGRAD MED J, V81, P343, DOI 10.1136/pgmj.2004.028290; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; VITIELLO MV, 1990, J GERONTOL, V45, pM131, DOI 10.1093/geronj/45.4.M131; Wu YH, 2007, SLEEP MED, V8, P623, DOI 10.1016/j.sleep.2006.11.010; Wu YH, 2006, FASEB J, V20, P1874, DOI 10.1096/fj.05-4446fje; Zeitzer JM, 2007, SLEEP, V30, P1437, DOI 10.1093/sleep/30.11.1437; Zeitzer JM, 1999, AM J MED, V107, P432, DOI 10.1016/S0002-9343(99)00266-1; ZHOU JN, 1995, NEUROBIOL AGING, V16, P571, DOI 10.1016/0197-4580(95)00043-E; Zhou JN, 2003, J PINEAL RES, V35, P125, DOI 10.1034/j.1600-079X.2003.00065.x; Zhou JN, 2003, J PINEAL RES, V34, P11, DOI 10.1034/j.1600-079X.2003.01897.x	52	39	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146200	10.1371/journal.pone.0146200	http://dx.doi.org/10.1371/journal.pone.0146200			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727258	gold, Green Submitted, Green Published			2022-12-27	WOS:000367681500067
J	Yan, XQ; Li, M; Chen, ZQ; Zhu, Y; Song, YW; Zhang, H				Yan, Xiaoqin; Li, Mu; Chen, Zhiqi; Zhu, Ying; Song, Yinwei; Zhang, Hong			Schlemm's Canal and Trabecular Meshwork in Eyes with Primary Open Angle Glaucoma: A Comparative Study Using High-Frequency Ultrasound Biomicroscopy	PLOS ONE			English	Article							AQUEOUS OUTFLOW SYSTEM; INTRAOCULAR-PRESSURES; COLLECTOR CHANNELS; HUMOR OUTFLOW; IOP ELEVATION; PERFUSION; HISTOPATHOLOGY; VARIABILITY; TRABECTOME; TISSUE	We investigated in vivo changes in Schlemm's canal and the trabecular meshwork in eyes with primary open angle glaucoma (POAG). Relationships between Schlemm's canal diameter, trabecular meshwork thickness, and intraocular pressure (IOP) were examined. Forty POAG patients and 40 normal individuals underwent 80-MHz Ultrasound Biomicroscopy examinations. The Schlemm's canal and trabecular meshwork were imaged in superior, inferior, nasal and temporal regions. Normal individuals had an observable Schlemm's canal in 80.3% of sections, a meridional canal diameter of 233.0 +/- 34.5 mu m, a coronal diameter of 44.5 +/- 12.6 mu m and a trabecular meshwork thickness of 103.9 +/- 11.1 mu m, in POAG patients, Schlemm's canal was observable in 53.1% of sections, a meridional canal diameter of 195.6 +/- 31.3 mu m, a coronal diameter of 35.7 +/- 8.0 mu m, and a trabecular meshwork thickness of 88.3 +/- 13.2 mu m, which significantly differed from normal (both p < 0.001). Coronal canal diameter (r = -0.623, p < 0.001) and trabecular meshwork thickness (r = -0.663, p < 0.001) were negatively correlated with IOP, but meridional canal diameter was not (r = -0.160, p = 0.156). Schlemm's canal was observable in 50.5% and 56.6% of POAG patients with normal (< 21 mmHg) and elevated (> 21 mmHg) IOP, respectively (chi = 1.159, p = 0.282). Coronal canal diameter was significantly lower in the elevated IOP group (32.6 +/- 4.9 mu m) than in the normal IOP group (35.7 +/- 8.0 mu m, p < 0.001). This was also true of trabecular meshwork thickness (81.9 +/- 10.0 mu m vs. 97.1 +/- 12.0 mu m, p < 0.001). In conclusion, eyes with POAG had fewer sections with an observable Schlemm's canal. Canal diameter and trabecular meshwork thickness were also lower than normal in POAG patients. Schlemm's canal coronal diameter and trabecular meshwork thickness were negatively correlated with IOP.	[Yan, Xiaoqin; Li, Mu; Chen, Zhiqi; Zhu, Ying; Song, Yinwei; Zhang, Hong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Ophthalmol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Song, YW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Ophthalmol, Wuhan 430074, Peoples R China.	huqiu55616173@163.com; dr_zhanghong@vip.163.com			Natural Science Foundation of China [81170842, 81300760]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by grants No 81170842 from the Natural Science Foundation of China [http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list] to HZ, and by grants No 81300760 from the Natural Science Foundation of China [http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list] to ZC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; AKAGI Y, 1976, CELL TISSUE RES, V173, P261; Allingham RR, 1996, EXP EYE RES, V62, P101, DOI 10.1006/exer.1996.0012; Asrani S, 2008, ARCH OPHTHALMOL-CHIC, V126, P765, DOI 10.1001/archopht.126.6.765; Battista SA, 2008, INVEST OPHTH VIS SCI, V49, P5346, DOI 10.1167/iovs.08-1707; Bull H, 2011, GRAEF ARCH CLIN EXP, V249, P1537, DOI 10.1007/s00417-011-1728-3; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Dietlein TS, 2000, BRIT J OPHTHALMOL, V84, P1354, DOI 10.1136/bjo.84.12.1354; Filla MS, 2009, INVEST OPHTH VIS SCI, V50, P5723, DOI 10.1167/iovs.08-3215; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Gong H, 2014, SURG INNOVATIONS GLA, V1, P3; Gong H, 2009, AM GLAUC SOC 19 ANN; GRANT W M, 1951, Am J Ophthalmol, V34, P1603; GRANT WM, 1963, ARCH OPHTHALMOL-CHIC, V69, P783; Grieshaber MC, 2010, INVEST OPHTH VIS SCI, V51, P1498, DOI 10.1167/iovs.09-4327; Hamanaka T, 2011, INVEST OPHTH VIS SCI, V52, P8849, DOI 10.1167/iovs.11-7591; Hann CR, 2014, INVEST OPHTH VIS SCI, V55, P5834, DOI 10.1167/iovs.14-14128; Hann CR, 2009, INVEST OPHTH VIS SCI, V50, P1692, DOI 10.1167/iovs.08-2375; HOFFMANN F, 1971, Ophthalmic Research, V2, P37; Hong JX, 2013, OPHTHALMOLOGY, V120, P709, DOI 10.1016/j.ophtha.2012.10.008; Huang JY, 2015, SOFT MATTER, V11, P2857, DOI 10.1039/c4sm01949k; Irshad FA, 2010, OPHTHALMOLOGY, V117, P916, DOI 10.1016/j.ophtha.2009.09.041; JOHNSTONE MA, 1973, AM J OPHTHALMOL, V75, P365, DOI 10.1016/0002-9394(73)91145-8; Kagemann L, 2015, JOVE-J VIS EXP, DOI 10.3791/52611; Kagemann L, 2014, INVEST OPHTH VIS SCI, V55, P1805, DOI 10.1167/iovs.13-13264; Last JA, 2011, INVEST OPHTH VIS SCI, V52, P2147, DOI 10.1167/iovs.10-6342; Li GR, 2014, INVEST OPHTH VIS SCI, V55, P3737, DOI 10.1167/iovs.13-13700; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; Maeda M, 2013, J GLAUCOMA, V22, P205, DOI 10.1097/IJG.0b013e3182311b92; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; MILLARD CB, 1987, EXP EYE RES, V45, P623, DOI 10.1016/S0014-4835(87)80071-4; Minckler DS, 2005, OPHTHALMOLOGY, V112, P1540; Minckler DS, 2005, OPHTHALMOLOGY, V112, P962, DOI 10.1016/j.ophtha.2004.12.043; Orsida BE, 1996, AUST NZ J OPHTHALMOL, V24, P21, DOI 10.1111/j.1442-9071.1996.tb00985.x; Pescosolido N, 2012, ULTRASTRUCT PATHOL, V36, P102, DOI 10.3109/01913123.2011.634090; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; RODRIGUES MM, 1976, T OPHTHAL SOC UK, V96, P245; ROHEN JW, 1972, A GRAEF ARCH KLIN EX, V183, P251, DOI 10.1007/BF00496153; ROSENQUIST R, 1989, CURR EYE RES, V8, P1233, DOI 10.3109/02713688909013902; SEGAWA K, 1979, ANN OPHTHALMOL, V11, P49; Shi GH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016016; Stamer WD, 2015, PROG RETIN EYE RES, V44, P86, DOI 10.1016/j.preteyeres.2014.08.002; Swain DL, 2015, INVEST OPHTH VIS SCI, V56, P1638, DOI 10.1167/iovs.14-15593; TENGROTH B, 1984, ACTA OPHTHALMOL, V62, P999; Tun TA, 2013, GRAEF ARCH CLIN EXP, V251, P1587, DOI 10.1007/s00417-013-2285-8; Usui T, 2011, INVEST OPHTH VIS SCI, V52, P6934, DOI 10.1167/iovs.10-7009; Wang F, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116008; Winkelmann A, 2008, ANN ANAT, V190, P223, DOI 10.1016/j.aanat.2007.12.002; Yang CYC, 2013, INVEST OPHTH VIS SCI, V54, P5859, DOI 10.1167/iovs.12-10930; Zhou EH, 2012, J R SOC INTERFACE, V9, P1144, DOI 10.1098/rsif.2011.0733	50	45	49	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145824	10.1371/journal.pone.0145824	http://dx.doi.org/10.1371/journal.pone.0145824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726880	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500033
J	Waheed, Z; van Mil, HGJ; Hussein, MAS; Jumin, R; Ahad, BG; Hoeksema, BW				Waheed, Zarinah; van Mil, Harald G. J.; Hussein, Muhammad Ali Syed; Jumin, Robecca; Ahad, Bobita Golam; Hoeksema, Bert W.			Coral Reefs at the Northernmost Tip of Borneo: An Assessment of Scleractinian Species Richness Patterns and Benthic Reef Assemblages	PLOS ONE			English	Article							MARINE PROTECTED AREAS; SPERMONDE ARCHIPELAGO; PULAU-BANGGI; FUNGIIDAE; DIVERSITY; RECOVERY; RESERVES; MANAGEMENT; FISHERIES; FISH	The coral reefs at the northernmost tip of Sabah, Borneo will be established under a marine protected area: the Tun Mustapha Park (TMP) by the end of 2015. This area is a passage where the Sulu Sea meets the South China Sea and it is situated at the border of the area of maximum marine biodiversity, the Coral Triangle. The TMP includes fringing and patch reefs established on a relatively shallow sea floor. Surveys were carried out to examine features of the coral reefs in terms of scleractinian species richness, and benthic reef assemblages following the Reef Check substrate categories, with emphasis on hard coral cover. Variation in scleractinian diversity was based on the species composition of coral families Fungiidae (n = 39), Agariciidae (n = 30) and Euphylliidae (n = 15). The number of coral species was highest at reefs with a larger depth gradient i.e. at the periphery of the study area and in the deep South Banggi Channel. Average live hard coral cover across the sites was 49%. Only 7% of the examined reefs had > 75% hard coral cover, while the majority of the reef sites were rated fair (51%) and good (38%). Sites with low coral cover and high rubble fragments are evidence of blast fishing, although the observed damage appeared old. Depth was a dominant factor in influencing the coral species composition and benthic reef communities in the TMP. Besides filling in the information gaps regarding species richness and benthic cover for reef areas that were previously without any data, the results of this study together with information that is already available on the coral reefs of TMP will be used to make informed decisions on zoning plans for conservation priorities in the proposed park.	[Waheed, Zarinah; Hoeksema, Bert W.] Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands; [Waheed, Zarinah; Hussein, Muhammad Ali Syed] Univ Malaysia Sabah, Borneo Marine Res Inst, Kota Kinabalu, Sabah, Malaysia; [Waheed, Zarinah; van Mil, Harald G. J.] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Jumin, Robecca; Ahad, Bobita Golam] WWF Malaysia, Kota Kinabalu, Sabah, Malaysia	Naturalis Biodiversity Center; Universiti Malaysia Sabah; Leiden University; Leiden University - Excl LUMC; World Wildlife Fund	Waheed, Z (corresponding author), Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands.	zarinah.waheed@naturalis.nl	Hoeksema, Bert W/B-2973-2010; Waheed, Zarinah/AAL-6325-2020; Hoeksema, Bert W./U-8530-2019; Hussein, Muhammad Ali Syed/I-7636-2016	Hoeksema, Bert W/0000-0001-8259-3783; Waheed, Zarinah/0000-0002-0061-0090; Hoeksema, Bert W./0000-0001-8259-3783; Hussein, Muhammad Ali Syed/0000-0002-0554-5590	Ministry of Science, Technology and Innovation (MOSTI), Malaysia; USAID Coral Triangle Support Partnership (CTSP)	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); USAID Coral Triangle Support Partnership (CTSP)(United States Agency for International Development (USAID))	This research was carried out during the Tun Mustapha Park Expedition (TMPE) 2012 that was funded by the Ministry of Science, Technology and Innovation (MOSTI), Malaysia and USAID Coral Triangle Support Partnership (CTSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affendi Y, 2012, SEMPORNA MARINE ECOL, P118; [Anonymous], 2013, WWF FACTHSEET ESTABL; [Anonymous], 2013, WWF FACTSHEET DEV ZO; Becking LE, 2006, MAR ECOL-EVOL PERSP, V27, P76, DOI 10.1111/j.1439-0485.2005.00051.x; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Benzoni F, 2012, CONTRIB ZOOL, V81, P125, DOI 10.1163/18759866-08103001; BEST MB, 1989, NETH J SEA RES, V23, P107, DOI 10.1016/0077-7579(89)90005-7; Bongaerts P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-205; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2002, REEFS RISK SE ASIA; Burke L, 2012, REEFS RISK REVISITED; Burns T., 2004, 4 ANN REPORT GREENFO; Burns T, 2005, SUMMARY ALL REPORTS; Chou L., 2003, STATUS CORAL REEFS P; Chou LM, 1994, P 3 ASEAN AUSTR S LI, V1, P1; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Cleary DFR, 2006, BIODIVERS CONSERV, V15, P3653, DOI 10.1007/s10531-004-4692-y; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; Coelho VR, 2007, AQUAT CONSERV, V17, P666, DOI 10.1002/aqc.822; Colwell R, 2009, STAT ESTIMATION SPEC; Daw T, 2003, 3 ANN REPORT GREENFO; Daw T, 2002, 2 ANN REPORT GREENFO; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; DINESEN Z D, 1980, Memoirs of the Queensland Museum, V20, P181; Ditlev H., 2003, Zoologische Mededelingen (Leiden), V77, P193; Done T.J., 1983, Australian Institute of Marine Science Contribution, P107; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Dumaup JNB, 2003, CONSERVATION PLAN SU; Fenner D., 2001, PULAU BANGGI PROJECT; Fisher H., 2000, THESIS; Fox HE, 2003, MAR POLLUT BULL, V46, P1024, DOI 10.1016/S0025-326X(03)00246-7; Fox HE, 2006, ECOL APPL, V16, P1631, DOI 10.1890/1051-0761(2006)016[1631:RFBFOC]2.0.CO;2; Fox J., 2019, R COMPANION APPL REG, V.; Gittenberger A, 2011, CONTRIB ZOOL, V80, P107, DOI 10.1163/18759866-08002002; Green A, 2004, EXP WORKSH HELD SE A; Green AL, 2008, 108 TNC COR TRIANGL; Green AL, 2014, COAST MANAGE, V42, P143, DOI 10.1080/08920753.2014.877763; Halpern BS, 2003, ECOL APPL, V13, pS117; Harding S, 2001, 1 ANN REPORT GREENFO; Hill JJ, 2004, METHODS ECOLOGICAL M; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; Hodgson G., 2006, REEF CHECK INSTRUCTI; Hoeksema BW, 2011, CORAL REEFS, V30, P975, DOI 10.1007/s00338-011-0784-9; Hoeksema B. W., 1993, Zoologische Mededelingen (Leiden), V67, P1; Hoeksema BW, 2014, RAFFLES B ZOOL, V62, P566; Hoeksema BW, 2014, ZOOKEYS, P57, DOI 10.3897/zookeys.371.6677; Hoeksema BW, 2012, CONTRIB ZOOL, V81, P199, DOI 10.1163/18759866-08104002; Hoeksema BW, 2012, ZOOSYSTEMA, V34, P429, DOI 10.5252/z2012n2a14; Hoeksema BW, 2012, RAFFLES B ZOOL, V60, P183; Hoeksema BW, 2009, RAFFLES B ZOOL, P91; Hoeksema Bert W., 2007, V29, P117; Hoeksema BW, 2004, CORAL REEFS, V23, P492, DOI 10.1007/s00338-004-0402-1; HOEKSEMA BW, 1991, MAR ECOL PROG SER, V74, P225, DOI 10.3354/meps074225; Hoeksema BW, 1989, ZOOLOGISCHE VERHANDE, V254, P1; Hoeksema BW, 2003, MARINE BIODIVERSITY, P7; Huang DW, 2015, MAR BIODIVERS, V45, P157, DOI 10.1007/s12526-014-0236-1; Huntington BE, 2011, CORAL REEFS, V30, P1077, DOI 10.1007/s00338-011-0809-4; International Hydrographic Organization, 1953, SPECIAL PUBLICATION, V28; Jontila JBS, 2010, BENTHIC COMMUNITIES; Jumin R, 2009, ECOSYSTEM BASED MANA; Jumin R, 2011, DECISION POINT, V49, P4; Jumin R., 2009, OCCURRENCE THREATS S; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Koh L, 2002, 202 REST NAT U SING; Lee YL, 2007, ESTABLISHING SOCIOLO; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Malaysian Meteorological Department, 2013, MONS CHANG WINDS; Mathias JA, 1978, COASTAL RESOURCES W, P117; McClanahan TR, 2003, MAR ECOL PROG SER, V261, P135, DOI 10.3354/meps261135; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Mohd Firdaus AN., 2013, THESIS; Moll H., 1986, UNESCO Reports in Marine Science, V40, P112; Moll H, 1983, THESIS; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Munro C., 2005, METHODS STUDY MARINE, V3, P112, DOI [10.1002/9780470995129.ch4, DOI 10.1002/9780470995129.CH4]; Murphy G, 2005, 5 ANN REPORT GREENFO; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Pilcher N, 2001, STATUS CORAL REEFS E; R Core Team, 2013, LANG ENV STAT COMP; Raymundo LJ, 2007, MAR POLLUT BULL, V54, P1009, DOI 10.1016/j.marpolbul.2007.02.006; Reef Check Malaysia, 2010, REEF CHECK MAL ANN S; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Sabah Warta Kerajaan Negeri, 2014, WARTA KERAJAAN  0828, VLXIX, P1671; Schmitt EF, 2002, CORAL REEFS, V21, P216, DOI 10.1007/s00338-002-0216-y; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Tanzil JTI, 2004, 62004 REST NAT U SIN; Teh L, 2005, FISH RES, V76, P359, DOI 10.1016/j.fishres.2005.07.009; Teh LSL, 2007, CORAL REEFS, V26, P251, DOI 10.1007/s00338-006-0182-x; Teh L, 2007, MAR POLICY, V31, P451, DOI 10.1016/j.marpol.2007.01.001; Turak E, 2011, FIELD GUIE REEF BUIL; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; VERON J.E.N., 2000, CORALS WORLD, V2; Veron J.E.N, 1980, AUST I MAR SCI MONOG, P1, DOI DOI 10.5962/BHL.TITLE.60646; Waheed Z, 2013, MAR BIODIVERS, V43, P37, DOI 10.1007/s12526-012-0130-7; Waheed Z, 2009, STATUS CORAL REEFS S; Waheed Z, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.517.9308; Waheed Z, 2014, RAFFLES B ZOOL, V62, P66; Watts ME, 2014, ENVIRON MODELL SOFTW, V24, P1513; Weeks R, 2014, COAST MANAGE, V42, P183, DOI 10.1080/08920753.2014.877768; Wells DR, 1977, BALAMBANGAN REPORT 1; Wells JW, 1954, PROF PAP US GEOL SUR, V260, p[385, 94]; Whitaker D, 2014, CLUSTSIG SIMILARITY; White AT, 2014, COAST MANAGE, V42, P87, DOI 10.1080/08920753.2014.878177; Wood EM, 1979, TECHNICAL REPORT; Wooldridge SA, 2014, BIOESSAYS, V36, P1041, DOI 10.1002/bies.201400074; Wyrtki K., 1961, PHYS OCEANOGRAPHY SE, V1st Ed, P195	112	28	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146006	10.1371/journal.pone.0146006	http://dx.doi.org/10.1371/journal.pone.0146006			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719987	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510900033
J	den Reijer, PM; Haisma, EM; Lemmens-den Toom, NA; Willemse, J; Koning, RA; Demmers, JAA; Dekkers, DHW; Rijkers, E; El Ghalbzouri, A; Nibbering, PH; van Wamel, W				den Reijer, P. M.; Haisma, E. M.; Lemmens-den Toom, N. A.; Willemse, J.; Koning, R. A.; Demmers, J. A. A.; Dekkers, D. H. W.; Rijkers, E.; El Ghalbzouri, A.; Nibbering, P. H.; van Wamel, W.			Detection of Alpha-Toxin and Other Virulence Factors in Biofilms of Staphylococcus aureus on Polystyrene and a Human Epidermal Model	PLOS ONE			English	Article							PANTON-VALENTINE LEUCOCIDIN; GAMMA-HEMOLYSIN; IMMUNE-RESPONSE; IN-VITRO; METHICILLIN-RESISTANT; ANTIBODY-RESPONSES; INFECTION; SKIN; EXPRESSION; SARA	Background & Aim The ability of Staphylococcus aureus to successfully colonize (a) biotic surfaces may be explained by biofilm formation and the actions of virulence factors. The aim of the present study was to establish the presence of 52 proteins, including virulence factors such as alpha-toxin, during biofilm formation of five different (methicillin resistant) S. aureus strains on Leiden human epidermal models (LEMs) and polystyrene surfaces (PS) using a competitive Luminex-based assay. Results All five S. aureus strains formed biofilms on PS, whereas only three out of five strains formed biofilms on LEMs. Out of the 52 tested proteins, six functionally diverse proteins (ClfB, glucosaminidase, IsdA, IsaA, SACOL0688 and nuclease) were detected in biofilms of all strains on both PS and LEMs. At the same time, four toxins (alpha-toxin, gamma-hemolysin B and leukocidins D and E), two immune modulators (formyl peptide receptor-like inhibitory protein and Staphylococcal superantigen-like protein 1), and two other proteins (lipase and LytM) were detectable in biofilms by all five S. aureus strains on LEMs, but not on PS. In contrast, fibronectin- binding protein B (FnbpB) was detectable in biofilms by all S. aureus biofilms on PS, but not on LEMs. These data were largely confirmed by the results from proteomic and transcriptomic analyses and in case of alpha-toxin additionally by GFP-reporter technology. Conclusion Functionally diverse virulence factors of (methicillin-resistant) S. aureus are present during biofilm formation on LEMs and PS. These results could aid in identifying novel targets for future treatment strategies against biofilm-associated infections.	[den Reijer, P. M.; Lemmens-den Toom, N. A.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Haisma, E. M.; Nibbering, P. H.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [Haisma, E. M.; El Ghalbzouri, A.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Willemse, J.; Koning, R. A.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Demmers, J. A. A.; Dekkers, D. H. W.; Rijkers, E.] Erasmus Univ, Med Ctr, Prote Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	den Reijer, PM (corresponding author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	p.denreijer@erasmusmc.nl	Demmers, Jeroen AA/F-4046-2016	Demmers, Jeroen AA/0000-0002-8757-9611; van Wamel, Willem/0000-0001-9145-9121; Koning, Roman/0000-0001-6736-7147	Dutch Burns Foundation [10.106]	Dutch Burns Foundation	This work was supported by the Dutch Burns Foundation (project number 10.106; https://brandwondenstichting.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2012, MICROBIOL-SGM, V158, P1504, DOI 10.1099/mic.0.057018-0; Anderson MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00064; Babra C, 2014, J BASIC MICROB, V54, P721, DOI 10.1002/jobm.201200557; Benson MA, 2011, MOL MICROBIOL, V81, P659, DOI 10.1111/j.1365-2958.2011.07720.x; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Brady RA, 2011, INFECT IMMUN, V79, P1797, DOI 10.1128/IAI.00451-10; Brauweiler AM, 2013, J ALLERGY CLIN IMMUN, V131, P421, DOI 10.1016/j.jaci.2012.10.030; Chu XM, 2013, RES MICROBIOL, V164, P695, DOI 10.1016/j.resmic.2013.06.001; Croes S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-229; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; El Ghalbzouri A, 2008, TOXICOL IN VITRO, V22, P1311, DOI 10.1016/j.tiv.2008.03.012; Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Ezepchuk YV, 1996, J INVEST DERMATOL, V107, P603, DOI 10.1111/1523-1747.ep12583377; Fechter P, 2014, FEBS LETT, V588, P2523, DOI 10.1016/j.febslet.2014.05.037; Fritz SA, 2013, CLIN INFECT DIS, V56, P1554, DOI 10.1093/cid/cit123; Gil C, 2014, INFECT IMMUN, V82, P1017, DOI 10.1128/IAI.01419-13; Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x; Gouaux E, 1997, PROTEIN SCI, V6, P2631; Guillet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003767; Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14; Haisma EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082800; Holland DB, 2009, FEMS MICROBIOL LETT, V290, P149, DOI 10.1111/j.1574-6968.2008.01402.x; Hong SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100499; Hu CY, 2012, BIOCHEM BIOPH RES CO, V419, P617, DOI 10.1016/j.bbrc.2012.02.057; Itoh S, 2013, BIOCHEM BIOPH RES CO, V433, P127, DOI 10.1016/j.bbrc.2013.02.050; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; KAMIO Y, 1993, FEBS LETT, V321, P15, DOI 10.1016/0014-5793(93)80611-W; Katayama Y, 2013, J BACTERIOL, V195, P1194, DOI 10.1128/JB.01786-12; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kolar SL, 2013, MICROBIOLOGYOPEN, V2, P18, DOI 10.1002/mbo3.55; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lemmens N, 2011, MICROB PATHOGENESIS, V50, P192, DOI 10.1016/j.micpath.2010.12.006; Li DM, 2008, INFECT IMMUN, V76, P1068, DOI 10.1128/IAI.01069-07; Luong TT, 2009, INFECT IMMUN, V77, P335, DOI 10.1128/IAI.00872-08; Manaskova SH, 2013, J IMMUNOL METHODS, V397, P18, DOI 10.1016/j.jim.2013.07.016; Martins TB, 2006, J IMMUNOL METHODS, V316, P97, DOI 10.1016/j.jim.2006.08.007; Mesrati I, 2010, J HOSP INFECT, V75, P265, DOI 10.1016/j.jhin.2010.03.015; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Morrison JM, 2011, FUTURE MICROBIOL, V6, P1141, DOI [10.2217/FMB.11.102, 10.2217/fmb.11.102]; Mu CH, 2012, J BASIC MICROB, V52, P636, DOI 10.1002/jobm.201100426; Muthukrishnan G, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-221; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Olson PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001287; Otto M, 2010, VIRULENCE, V1, P49, DOI 10.4161/viru.1.1.10453; Percival SL, 2012, WOUND REPAIR REGEN, V20, P647, DOI 10.1111/j.1524-475X.2012.00836.x; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Pier GB, 2013, HUM VACC IMMUNOTHER, V9, P1865, DOI 10.4161/hv.25182; Ponec M, 1997, J INVEST DERMATOL, V109, P348, DOI 10.1111/1523-1747.ep12336024; Porcelijn L, 2014, TRANSFUSION, V54, P1486, DOI 10.1111/trf.12509; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Roll A, 2004, CURR OPIN ALLERGY CL, V4, P373, DOI 10.1097/00130832-200410000-00008; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Rosenstein R, 2000, BIOCHIMIE, V82, P1005, DOI 10.1016/S0300-9084(00)01180-9; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Speziale P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00171; Tavares A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098634; Thakoersing VS, 2012, EXP DERMATOL, V21, P865, DOI 10.1111/exd.12031; Tkaczyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075103; Van Wamel WJB, 2007, INFECT IMMUN, V75, P924, DOI 10.1128/IAI.00941-06; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Verkaik N, 2008, J IMMUNOL METHODS, V335, P121, DOI 10.1016/j.jim.2008.02.022; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; Wu W, 2014, VIRUS RES, V187, P84, DOI 10.1016/j.virusres.2013.12.037; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Zielinska AK, 2012, MOL MICROBIOL, V86, P1183, DOI 10.1111/mmi.12048; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	75	40	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145722	10.1371/journal.pone.0145722	http://dx.doi.org/10.1371/journal.pone.0145722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741798	Green Published, gold			2022-12-27	WOS:000367810600008
J	Lohinai, Z; Dome, P; Szilagyi, Z; Ostoros, G; Moldvay, J; Hegedus, B; Dome, B; Weiss, GJ				Lohinai, Zoltan; Dome, Peter; Szilagyi, Zsuzsa; Ostoros, Gyula; Moldvay, Judit; Hegedus, Balazs; Dome, Balazs; Weiss, Glen J.			From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)	PLOS ONE			English	Article							SURVIVAL; CHEMOTHERAPY; INHIBITION; TARGETS; STATINS; TRIAL	Backgrounds Based on in vitro data and results of a recent drug repositioning study, some medications approved by the FDA for the treatment of various non-malignant disorders were demonstrated to have anti-SCLC activity in preclinical models. The aim of our study is to confirm whether use of these medications is associated with survival benefit. Methods Consecutive patients with pathologically confirmed, stage 4 SCLC were analyzed in this retrospective study. Patients that were prescribed statins, aspirin, clomipramine (tricyclic antidepressant; TCA), selective serotonin reuptake inhibitors (SSRIs), doxazosin or prazosin (alpha 1-adrenergic receptor antagonists; ADRA1) were identified. Results There were a total of 876 patients. Aspirin, statins, SSRIs, ADRA1, and TCA were administered in 138, 72, 20, 28, and 5 cases, respectively. A statistically significant increase in median OS was observed only in statin-treated patients when compared to those not receiving any of the aforementioned medications (OS, 8.4 vs. 6.1 months, respectively; p = 0.002). The administration of SSRIs, aspirin, and ADRA1 did not result in a statistically significant OS benefit (median OS, 8.5, 6.8, and 6.0 months, respectively). The multivariate Cox model showed that, besides age and ECOG PS, radiotherapy was an independent survival predictor (Hazard Ratio, 2.151; 95% confidence interval, 1.828-2.525; p < 0.001). Conclusions Results of drug repositioning studies using only preclinical data or small numbers of patients should be treated with caution before application in the clinic. Our data demonstrated that radiotherapy appears to be an independent survival predictor in stage 4 SCLC, therefore confirming the results of other prospective and retrospective studies.	[Lohinai, Zoltan; Szilagyi, Zsuzsa; Ostoros, Gyula; Moldvay, Judit; Dome, Balazs] Natl Koranyi Inst Pulmonol, Budapest, Hungary; [Dome, Peter] Semmelweis Univ, Kutvolgyi Clin Ctr, Dept Clin & Theoret Mental Hlth, H-1085 Budapest, Hungary; [Dome, Peter] Natl Inst Psychiat & Addict, Budapest, Hungary; [Hegedus, Balazs; Dome, Balazs] Med Univ Vienna, Ctr Comprehens Canc, Div Thorac Surg, Translat Thorac Oncol Lab, Vienna, Austria; [Hegedus, Balazs] Semmelweis Univ, Hungarian Acad Sci, Mol Oncol Res Grp, H-1085 Budapest, Hungary; [Dome, Balazs] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Lohinai, Zoltan; Weiss, Glen J.] Canc Treatment Ctr Amer, Western Reg Med Ctr, Goodyear, AZ USA	Semmelweis University; Medical University of Vienna; Hungarian Academy of Sciences; Semmelweis University; Medical University of Vienna	Lohinai, Z (corresponding author), Natl Koranyi Inst Pulmonol, Budapest, Hungary.	zoltan.lohinai@koranyi.hu	Hegedus, Balazs/B-6076-2008; Moldvay, Judit/U-6959-2019; Conde, Rosa/B-1495-2012; CASTRO ALIJA, MARIA JOSE/ABD-7316-2020	Hegedus, Balazs/0000-0002-4341-4153; Conde, Rosa/0000-0002-6636-5729; CASTRO ALIJA, MARIA JOSE/0000-0002-1852-4318; Ostoros, Gyula/0000-0001-5339-7257; Dome, Balazs/0000-0001-8799-8624	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Lung Cancer Research Scholarship of the Hungarian Society of Pulmonology; ESMO Translational Research Fellowship	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Lung Cancer Research Scholarship of the Hungarian Society of Pulmonology; ESMO Translational Research Fellowship	Peter Dome is a recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. Zoltan Lohinai was supported by the Lung Cancer Research Scholarship of the Hungarian Society of Pulmonology 2015 and the ESMO Translational Research Fellowship 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors were supported by Lung Cancer Research Scholarship of the Hungarian Society of Pulmonology 2015 (ZL); ESMO Translational Research Fellowship 2015 (ZL); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (PD).	Barrera I, 2014, INT REV PSYCHIATR, V26, P31, DOI 10.3109/09540261.2013.864259; Caprario LC, 2013, J THORAC ONCOL, V8, P1272, DOI 10.1097/JTO.0b013e3182a007ba; Cardwell CR, 2015, CANCER EPIDEM BIOMAR, V24, P833, DOI 10.1158/1055-9965.EPI-15-0052; Ferlay J, CANC INCIDENCE MORTA; Gillman PK, 2007, BRIT J PHARMACOL, V151, P737, DOI 10.1038/sj.bjp.0707253; Han JY, 2011, CANCER-AM CANCER SOC, V117, P2178, DOI 10.1002/cncr.25790; Hanbali EUD A. S., 2006, J CLIN ONCOLOTY S, V24; Hindler K, 2006, ONCOLOGIST, V11, P306, DOI 10.1634/theoncologist.11-3-306; Ishii H, 2015, J THORAC ONCOL, V10, P426, DOI 10.1097/JTO.0000000000000414; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Jiao MK, 2015, CURR TOP MED CHEM, V15, P767, DOI 10.2174/1568026615666150302105831; Jonathan W., 2015, 15 ANN TARG THER TRE; Kalemkerian GP, 2014, EXPERT OPIN PHARMACO, V15, P2385, DOI 10.1517/14656566.2014.957180; Khanzada UK, 2006, ONCOGENE, V25, P877, DOI 10.1038/sj.onc.1209117; LAD T, 1994, CHEST, V106, pS320, DOI 10.1378/chest.106.6.320S; LEBEAU B, 1993, CANCER, V71, P1741, DOI 10.1002/1097-0142(19930301)71:5<1741::AID-CNCR2820710507>3.0.CO;2-Q; Lee JM, 2008, CRIT REV ONCOL HEMAT, V66, P208, DOI 10.1016/j.critrevonc.2008.01.004; Lin KL, 2014, CHINESE J PHYSIOL, V57, P256, DOI 10.4077/CJP.2014.BAC208; Mirsadraee S, 2012, WORLD J RADIOL, V4, P128, DOI 10.4329/wjr.v4.i4.128; Neal J, 2015, PHASE 2A DESIPRAMINE; Ochmanski Wladyslaw, 2008, Przegl Lek, V65, P321; Roudier E, 2006, MOL CANCER THER, V5, P2706, DOI 10.1158/1535-7163.MCT-06-0352; Seckl Michael, 2013, J CLIN ONCOL, V31, P7595; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slotman BJ, 2015, LANCET, V385, P36, DOI 10.1016/S0140-6736(14)61085-0; Teicher BA, 2014, BIOCHEM PHARMACOL, V87, P211, DOI 10.1016/j.bcp.2013.09.014; Zhang WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-793	27	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144797	10.1371/journal.pone.0144797	http://dx.doi.org/10.1371/journal.pone.0144797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735301	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100013
J	Blacklock, C; Bradley, DCG; Mickan, S; Willcox, M; Roberts, N; Bergstrom, A; Mant, D				Blacklock, Claire; Bradley, Daniela C. Goncalves; Mickan, Sharon; Willcox, Merlin; Roberts, Nia; Bergstroem, Anna; Mant, David			Impact of Contextual Factors on the Effect of Interventions to Improve Health Worker Performance in Sub-Saharan Africa: Review of Randomised Clinical Trials	PLOS ONE			English	Article							MALARIA TREATMENT GUIDELINES; QUALITY-OF-CARE; SOUTH-AFRICA; EDUCATIONAL OUTREACH; TUBERCULOSIS TREATMENT; COMPLEX INTERVENTIONS; ENHANCED SUPERVISION; RURAL MWANZA; MANAGEMENT; ADHERENCE	Background Africa bears 24% of the global burden of disease but has only 3% of the world's health workers. Substantial variation in health worker performance adds to the negative impact of this significant shortfall. We therefore sought to identify interventions implemented in sub-Saharan African aiming to improve health worker performance and the contextual factors likely to influence local effectiveness. Methods and Findings A systematic search for randomised controlled trials of interventions to improve health worker performance undertaken in sub-Saharan Africa identified 41 eligible trials. Data were extracted to define the interventions' components, calculate the absolute improvement in performance achieved, and document the likelihood of bias. Within-study variability in effect was extracted where reported. Statements about contextual factors likely to have modified effect were subjected to thematic analysis. Interventions to improve health worker performance can be very effective. Two of the three trials assessing mortality impact showed significant reductions in death rates (age<5 case fatality 5% versus 10%, p<0.01; maternal in-hospital mortality 6.8/1000 versus 10.3/1000; p<0.05). Eight of twelve trials focusing on prescribing had a statistically significant positive effect, achieving an absolute improvement varying from 9% to 48%. However, reported range of improvement between centres within trials varied substantially, in many cases exceeding the mean effect. Nine contextual themes were identified as modifiers of intervention effect across studies; most frequently cited were supply-line failures, inadequate supervision or management, and failure to follow-up training interventions with ongoing support, in addition to staff turnover. Conclusions Interventions to improve performance of existing staff and service quality have the potential to improve patient care in underserved settings. But in order to implement interventions effectively, policy makers need to understand and address the contextual factors which can contribute to differences in local effect. Researchers therefore must recognise the importance of reporting how context may modify effect size.	[Blacklock, Claire; Mickan, Sharon; Willcox, Merlin; Mant, David] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Blacklock, Claire] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Bradley, Daniela C. Goncalves] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Mickan, Sharon] Gold Coast Hlth, Brisbane, Qld, Australia; [Mickan, Sharon] Griffith Univ, Nathan, Qld 4111, Australia; [Roberts, Nia] Univ Oxford, Knowledge Ctr, Nuffield Dept Populat Hlth, Oxford, England; [Roberts, Nia] Univ Oxford, Knowledge Ctr, Bodleian Healthcare Lib, Oxford, England; [Bergstroem, Anna] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden; [Bergstroem, Anna] UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London, England	University of Oxford; University of Leeds; University of Oxford; Griffith University; University of Oxford; University of Oxford; Uppsala University; University of London; University College London	Blacklock, C (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	claire.blacklock@phc.ox.ac.uk	Willcox, Merlin/I-6255-2019; Mickan, Sharon/AAZ-6262-2021; Roberts, Nia W/F-9842-2010	Willcox, Merlin/0000-0002-5227-3444; Mickan, Sharon/0000-0002-5690-1997; Roberts, Nia W/0000-0002-1142-6440; Goncalves Bradley, Daniela/0000-0002-5186-3792				Alexander CL, 2013, INT PERSPECT PSYCHOL, V2, P14; Autry AM, 2013, OBSTET GYNECOL, V122, P127, DOI 10.1097/AOG.0b013e3182964b8c; Awad AI, 2006, EUR J CLIN PHARMACOL, V62, P135, DOI 10.1007/s00228-005-0089-4; Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Bachmann MO, 2010, INT J TUBERC LUNG D, V14, P311; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Baumgartner JN, 2012, STUD FAMILY PLANN, V43, P305, DOI 10.1111/j.1728-4465.2012.00328.x; Bergstrom A, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0305-2; Bergstrom A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-117; Bexell A, 1996, J CLIN EPIDEMIOL, V49, P355, DOI 10.1016/0895-4356(95)00059-3; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Bonell C, 2012, SOC SCI MED, V75, P2299, DOI 10.1016/j.socscimed.2012.08.032; Brown H, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-7; Buchanan H, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-216; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Dieleman Marjolein, 2009, Health Res Policy Syst, V7, P7, DOI 10.1186/1478-4505-7-7; Dumont A, 2013, LANCET, V382, P146, DOI 10.1016/S0140-6736(13)60593-0; Effective Practice and Organisation of Care (EPOC), 2014, DAT COLL CHECKL; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Estabrooks CA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-234; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Gilroy K, 2004, PATIENT EDUC COUNS, V54, P35, DOI 10.1016/s0738-3991(03)00189-7; Grant A, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-15; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Harrison A, 2000, AIDS, V14, P2769, DOI 10.1097/00002030-200012010-00017; Harrison MB, 2010, CAN MED ASSOC J, V182, pE78, DOI 10.1503/cmaj.081232; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Jennings L, 2015, MATERN CHILD HLTH J, V19, P557, DOI 10.1007/s10995-014-1537-5; Jennings L, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-75; Kalua K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-S1-S6; Kauye F, 2014, PSYCHOL MED, V44, P657, DOI 10.1017/S0033291713001141; Larke N, 2010, J ADOLESCENT HEALTH, V47, P512, DOI 10.1016/j.jadohealth.2010.03.020; Lewin Simon, 2009, BMJ, V339, pb3496, DOI 10.1136/bmj.b3496; Liambila W, 2010, PATIENT EDUC COUNS, V81, P368, DOI 10.1016/j.pec.2010.09.001; LOEVINSOHN BP, 1992, B WORLD HEALTH ORGAN, V70, P335; Mbacham WF, 2014, LANCET GLOB HEALTH, V2, pE346, DOI 10.1016/S2214-109X(14)70201-3; Mbonye MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084945; Meyer JC, 2001, MED EDUC, V35, P833, DOI 10.1046/j.1365-2923.2001.01000.x; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore G., PROCESS EVALUATION C; Moosa S, 2013, LANCET GLOB HEALTH, V1, pE332, DOI 10.1016/S2214-109X(13)70119-0; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Nzinga J, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-45; Nzinga J, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-44; Oakley A, BMJ, V332, P413; Okwen M, 2014, PUBLIC HEALTH, V128, P96, DOI 10.1016/j.puhe.2013.10.007; Opiyo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055067; Opondo C, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-109; Pattinson RC, 2005, ACTA PAEDIATR, V94, P924, DOI 10.1080/08035250510028399; Pirkle CM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-24; Plummer ML, 2006, AIDS CARE, V18, P460, DOI 10.1080/09540120500220367; Rawson RA, 2013, SUBST ABUS, V34, P108, DOI 10.1080/08897077.2012.691445; Reynolds HW, 2008, HEALTH POLICY PLANN, V23, P56, DOI 10.1093/heapol/czm037; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2015, DAT COLL CHECKL; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Stanback J, 2007, INT J QUAL HEALTH C, V19, P68, DOI 10.1093/intqhc/mzl072; Stein J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-240; Steyn K, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20796; Straus Sharon E, 2009, CMAJ, V181, P165, DOI 10.1503/cmaj.081229; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; Trap B, 2001, HEALTH POLICY PLANN, V16, P273, DOI 10.1093/heapol/16.3.273; Weaver MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051319; Were MC, 2013, PEDIATRICS, V131, pE789, DOI 10.1542/peds.2012-2072; World Health Report, 2006, WORK TOG HLTH; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6; Zwarenstein M, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-30; Zwarenstein M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2022	73	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145206	10.1371/journal.pone.0145206	http://dx.doi.org/10.1371/journal.pone.0145206			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731097	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400026
J	Cecchini, MP; Viviani, D; Sandri, M; Hahner, A; Hummel, T; Zancanaro, C				Cecchini, Maria Paola; Viviani, Dario; Sandri, Marco; Haehner, Antje; Hummel, Thomas; Zancanaro, Carlo			Olfaction in People with Down Syndrome: A Comprehensive Assessment across Four Decades of Age	PLOS ONE			English	Article							ODOR IDENTIFICATION; ALZHEIMERS-DISEASE; DYSFUNCTION; DISCRIMINATION; DEMENTIA; DEFICITS; TESTS; THRESHOLDS; PLAQUES; TANGLES	Background Down syndrome (DS) shows neuropathology similar to Alzheimer disease, which presents olfactory impairment. Previous work showed olfactory impairment in DS, but a comprehensive evaluation of olfactory function in DS is lacking. Methods We investigated a large number (n = 56; M = 31, F = 25) DS participants (age range18-57y) using the "Sniffin' Sticks" Extended test. This comprises three subtests (threshold, discrimination, and identification) yielding a global score (TDI) defining normosmia, hyposmia, and functional anosmia. To the best of our knowledge, this is the second largest group of DS people investigated for olfactory function ever. Age-and sex matched euploid individuals (n = 53) were the control. Results In DS, TDI was lower (16.7 +/- 5.13 vs. 35.4 +/- 3.74; P<0.001), with DS people performing worse in any subtests (P<0.001 for all); 27 DS participants showed functional anosmia (i.e., TDI<16). In DS, age was weakly and negatively correlated with TDI (r = -0.28, P = 0.036) and identification (r = -0.34, P = 0.012). When participants were stratified in young adults (18-29y) and older adults (30-61y), a significant effect of age was found for identification in both DS (young adults, 8.3 +/- 2.58; older adults, 6.9 +/- 2.99; P = 0.031) and control (youngadult, 14.3 +/- 1.18, older adult, 13.0 +/- 1.54; P = 0.016). Conclusion Olfactory function is overall severely impaired in DS people and may be globally impaired at relatively young age, despite of reportedly normal smell. However, specificity of this olfactory profile to DS should be considered with some caution because cognition was not evaluated in all DS participants and comparison with a control group of non-DS individuals having cognitive disabilities was lacking. Further study is required to longitudinally assess olfactory dysfunction in DS and to correlate it with brain pathology.	[Cecchini, Maria Paola; Sandri, Marco; Zancanaro, Carlo] Univ Verona, Anat & Histol Sect, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Viviani, Dario] Osped Sacro Cuore Don Calabria, UO Pediat, Negrar, Italy; [Haehner, Antje; Hummel, Thomas] Univ Dresden, Sch Med, Smell & Taste Clin, Dept Otorhinolaryngol, Dresden, Germany	University of Verona; IRCCS Sacro Cuore Don Calabria; Technische Universitat Dresden	Cecchini, MP (corresponding author), Univ Verona, Anat & Histol Sect, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	mariapaola.cecchini@univr.it	Sandri, Marco/L-2875-2013	Sandri, Marco/0000-0002-1422-5695	Fondation Jerome Lejeune; Ministry of University and Research of Italy (Prin)	Fondation Jerome Lejeune; Ministry of University and Research of Italy (Prin)	This work was supported by grants from the Fondation Jerome Lejeune (Paris, http://www.fondationlejeune.org/en/) and the Ministry of University and Research of Italy (Prin 2010-2011 https://www.researchitaly.it/en/researching/funding/programmes/research-projects-of-national-interest/) to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants from the Italian Ministry of University and Research (PRIN 2010-2011) and the Fondation Jerome Lejeune, Paris. The authors warmly thank the "AGBD: Associazione Genitori Bambini Down", Marzana (VR), "Centro Polifunzionale Don Calabria", Verona, Societa Cooperativa Sociale "I Piosi", Sommacampagna (VR), Associazione Casa del Sole Onlus-CEOD "Villa Dora", Garda (VR) for help with recruiting Down participants. We gratefully acknowledge the assistance of: Dr. Roberta Pizzolo, Dr. Lucia Baldassa, Mrs Tiziana Bonaconsa, Dr. Barbara Montagnana, Dr. Flora Panico, Mr Luigi Martari, Dr. Nadia Cottini and we thank all the families who contributed to this research.	Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; Brainerd MG, 1928, STUDY PHYS MENTAL CH; BURGER PC, 1973, AM J PATHOL, V73, P457; CAIN WS, 1991, J EXP PSYCHOL HUMAN, V17, P382, DOI 10.1037/0096-1523.17.2.382; Chen MA, 2006, OTOLARYNG HEAD NECK, V134, P741, DOI 10.1016/j.otohns.2005.12.035; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 2014, FRONT PSYCHOL, V5, P20, DOI [DOI 10.3389/FPSYG.2014.00020, DOI 10.3389/fpsyg.2014.00020]; Dulay MF, 2008, J CLIN EXP NEUROPSYC, V30, P327, DOI 10.1080/13803390701415892; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; HEMDAL P, 1993, NEUROPSYCHOLOGIA, V31, P977, DOI 10.1016/0028-3932(93)90152-P; HOF PR, 1995, ARCH NEUROL-CHICAGO, V52, P379, DOI 10.1001/archneur.1995.00540280065020; Horvath S, 2015, AGING CELL, V14, P491, DOI 10.1111/acel.12325; Huttenbrink KB, 2013, DTSCH ARZTEBL INT, V110, P1, DOI 10.3238/arztebl.2013.0001; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Johns A, 2012, RES DEV DISABIL, V33, P583, DOI 10.1016/j.ridd.2011.11.001; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Larsson M, 1997, CHEM SENSES, V22, P623, DOI 10.1093/chemse/22.6.623; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; Larsson M, 1999, NEUROPSYCHOLOGY, V13, P47, DOI 10.1037/0894-4105.13.1.47; Lotsch J, 2008, CHEM SENSES, V33, P17, DOI 10.1093/chemse/bjm058; Lotsch J, 2006, BEHAV BRAIN RES, V170, P78, DOI 10.1016/j.bbr.2006.02.013; Mann D M, 1989, Prog Clin Biol Res, V317, P849; MANN DMA, 1986, NEUROPATH APPL NEURO, V12, P447, DOI 10.1111/j.1365-2990.1986.tb00053.x; MANN DMA, 1988, HISTOPATHOLOGY, V13, P125, DOI 10.1111/j.1365-2559.1988.tb02018.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McKeown DA, 1996, J NEUROL NEUROSUR PS, V61, P412, DOI 10.1136/jnnp.61.4.412; MORGAN CD, 1995, J CLIN EXP NEUROPSYC, V17, P793, DOI 10.1080/01688639508405168; MOTTE J, 1989, ACTA NEUROPATHOL, V77, P535, DOI 10.1007/BF00687256; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Murphy C, 1996, NEUROBIOL AGING, V17, P631; MURPHY C, 1990, NEUROBIOL AGING, V11, P465, DOI 10.1016/0197-4580(90)90014-Q; MURPHY C, 1986, PHYSIOL BEHAV, V37, P177, DOI 10.1016/0031-9384(86)90402-6; Nijjar RK, 2002, NEUROBIOL AGING, V23, P65, DOI 10.1016/S0197-4580(01)00263-9; OLIVER C, 1986, PSYCHOL MED, V16, P307, DOI 10.1017/S0033291700009120; Penrose L. S., 1933, MENTAL DEFECT; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Rohn Troy T, 2014, J Parkinsons Dis Alzheimers Dis, V1; Shu CH, 2009, AMJ RHINOL ALLERGY, V23, P413, DOI 10.2500/ajra.2009.23.3343; Sliger M, 2004, J ALZHEIMERS DIS, V6, P397; Sorokowska A, 2015, EUR ARCH OTO-RHINO-L, V272, P1937, DOI 10.1007/s00405-014-3263-4; Sorokowska A, 2015, ATTEN PERCEPT PSYCHO, V77, P731, DOI 10.3758/s13414-014-0811-3; WARNER MD, 1988, BIOL PSYCHIAT, V23, P836, DOI 10.1016/0006-3223(88)90073-X; Wehling E, 2015, RHINOLOGY, V53, P89, DOI [10.4193/Rhin14.081, 10.4193/Rhino14.081]; Wetter S, 1999, CLIN NEUROPHYSIOL, V110, P1563, DOI 10.1016/S1388-2457(99)00086-3; Zigman WB, 2013, DEV DISABIL RES REV, V18, P51, DOI 10.1002/ddrr.1128; ZUCCO GM, 1994, PERCEPT MOTOR SKILL, V78, P627, DOI 10.2466/pms.1994.78.2.627	49	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146486	10.1371/journal.pone.0146486	http://dx.doi.org/10.1371/journal.pone.0146486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26730728	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400185
J	Gela, A; Bhongir, RKV; Mori, M; Keenan, P; Morgelin, M; Erjefalt, JS; Herwald, H; Egesten, A; Kasetty, G				Gela, Anele; Bhongir, Ravi K. V.; Mori, Michiko; Keenan, Paul; Morgelin, Matthias; Erjefalt, Jonas S.; Herwald, Heiko; Egesten, Arne; Kasetty, Gopinath			Osteopontin That Is Elevated in the Airways during COPD Impairs the Antibacterial Activity of Common Innate Antibiotics	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; THYMIC STROMAL LYMPHOPOIETIN; PSEUDOMONAS-AERUGINOSA; EXACERBATIONS; EXPRESSION; PROTECTS; MIDKINE; SURFACE; ASTHMA	Bacterial infections of the respiratory tract contribute to exacerbations and disease progression in chronic obstructive pulmonary disease (COPD). There is also an increased risk of invasive pneumococcal disease in COPD. The underlying mechanisms are not fully understood but include impaired mucociliary clearance and structural remodeling of the airways. In addition, antimicrobial proteins that are constitutively expressed or induced during inflammatory conditions are an important part of the airway innate host defense. In the present study, we show that osteopontin (OPN), a multifunctional glycoprotein that is highly upregulated in the airways of COPD patients co-localizes with several antimicrobial proteins expressed in the airways. In vitro, OPN bound lactoferrin, secretory leukocyte peptidase inhibitor (SLPI), midkine, human beta defensin-3 (hBD-3), and thymic stromal lymphopoietin (TSLP) but showed low or no affinity for lysozyme and LL-37. Binding of OPN impaired the antibacterial activity against the important bacterial pathogens Streptococcus pneumoniae and Pseudomonas aeruginosa. Interestingly, OPN reduced lysozyme-induced killing of S. pneumoniae, a finding that could be explained by binding of OPN to the bacterial surface, thereby shielding the bacteria. A fragment of OPN generated by elastase of P. aeruginosa retained some inhibitory effect. Some antimicrobial proteins have additional functions. However, the muramidase-activity of lysozyme and the protease inhibitory function of SLPI were not affected by OPN. Taken together, OPN can contribute to the impairment of innate host defense by interfering with the function of antimicrobial proteins, thus increasing the vulnerability to acquire infections during COPD.	[Gela, Anele; Bhongir, Ravi K. V.; Keenan, Paul; Egesten, Arne; Kasetty, Gopinath] Lund Univ, Dept Clin Sci Lund, Resp Med & Allergol, SE-22184 Lund, Sweden; [Morgelin, Matthias; Herwald, Heiko] Lund Univ, Dept Clin Sci Lund, Infect Med, SE-22184 Lund, Sweden; [Mori, Michiko; Erjefalt, Jonas S.] Lund Univ, Airway Inflammat Unit, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University; Lund University; Lund University	Kasetty, G (corresponding author), Lund Univ, Dept Clin Sci Lund, Resp Med & Allergol, SE-22184 Lund, Sweden.	gopinath.kasetty@med.lu.se	Herwald, Heiko/AAN-3708-2021; Bhongir, Ravi Kiran Varma/E-4514-2015	Herwald, Heiko/0000-0002-8111-2842; Bhongir, Ravi Kiran Varma/0000-0001-6648-1781; Erjefalt, Jonas/0000-0002-6716-3010	Swedish Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; Swedish Government Funds for Clinical Research; Swedish Foundation for Strategic Research; foundation of Th. C. Bergh; foundation of Alfred Osterlund; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; Swedish Government Funds for Clinical Research; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); foundation of Th. C. Bergh; foundation of Alfred Osterlund; Royal Physiographic Society in Lund	This work was supported by the Swedish Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, Swedish Government Funds for Clinical Research (ALF), the Swedish Foundation for Strategic Research, the foundations of Th. C. Bergh, and Alfred Osterlund and the Royal Physiographic Society in Lund (KFS).	Bals R, 2006, CURR DRUG TARGETS, V7, P743, DOI 10.2174/138945006777435227; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Cole AM, 2005, J LEUKOCYTE BIOL, V78, P1081, DOI 10.1189/jlb.0205073; Dajani R, 2005, AM J RESP CELL MOL, V32, P548, DOI 10.1165/rcmb.2005-0059OC; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Inghammar M, 2013, CLIN MICROBIOL INFEC, V19, P1148, DOI 10.1111/1469-0691.12182; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jovic S, 2015, J CYST FIBROS, V14, P453, DOI 10.1016/j.jcf.2014.11.010; Konno S, 2006, J INTERF CYTOK RES, V26, P562, DOI 10.1089/jir.2006.26.562; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Lee SJ, 2014, CLIN RESPIR J, V8, P305, DOI 10.1111/crj.12072; Linge HM, 2013, MOL MED, V19, P314, DOI 10.2119/molmed.2013.00045; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nordin SL, 2013, J INNATE IMMUN, V5, P519, DOI 10.1159/000346709; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; Papaporfyriou A, 2014, CHEST, V146, P951, DOI 10.1378/chest.13-2440; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Singh PK, 2000, AM J PHYSIOL-LUNG C, V279, pL799, DOI 10.1152/ajplung.2000.279.5.L799; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Sonesson A, 2011, EXP DERMATOL, V20, P1004, DOI 10.1111/j.1600-0625.2011.01391.x; THOMPSON AB, 1990, J LAB CLIN MED, V115, P148; Tomee JFC, 1998, THORAX, V53, P114, DOI 10.1136/thx.53.2.114; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; van der Windt GJW, 2011, J INFECT DIS, V203, P1850, DOI 10.1093/infdis/jir185; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Xu GW, 2005, J CLIN INVEST, V115, P1060; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790	32	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146192	10.1371/journal.pone.0146192	http://dx.doi.org/10.1371/journal.pone.0146192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731746	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400112
J	Johnston, HB; Ganatra, B; Nguyen, MH; Habib, N; Afework, MF; Harries, J; Iyengar, K; Moodley, J; Lema, HY; Constant, D; Sen, S				Johnston, Heidi Bart; Ganatra, Bela; Nguyen, My Huong; Habib, Ndema; Afework, Mesganaw Fantahun; Harries, Jane; Iyengar, Kirti; Moodley, Jennifer; Lema, Hailu Yeneneh; Constant, Deborah; Sen, Swapnaleen			Accuracy of Assessment of Eligibility for Early Medical Abortion by Community Health Workers in Ethiopia, India and South Africa	PLOS ONE			English	Article							PHYSICIAN ASSISTANTS; MENSTRUAL REGULATION; RURAL BANGLADESH; SERVICES; CARE; TERMINATION; VALIDATION; PROVIDERS; PREGNANCY; MIDWIVES	Objective To assess the accuracy of assessment of eligibility for early medical abortion by community health workers using a simple checklist toolkit. Design Diagnostic accuracy study. Setting Ethiopia, India and South Africa. Methods Two hundred seventeen women in Ethiopia, 258 in India and 236 in South Africa were enrolled into the study. A checklist toolkit to determine eligibility for early medical abortion was validated by comparing results of clinician and community health worker assessment of eligibility using the checklist toolkit with the reference standard exam. Results Accuracy was over 90% and the negative likelihood ratio <0.1 at all three sites when used by clinician assessors. Positive likelihood ratios were 4.3 in Ethiopia, 5.8 in India and 6.3 in South Africa. When used by community health workers the overall accuracy of the toolkit was 92% in Ethiopia, 80% in India and 77% in South Africa negative likelihood ratios were 0.08 in Ethiopia, 0.25 in India and 0.22 in South Africa and positive likelihood ratios were 5.9 in Ethiopia and 2.0 in India and South Africa. Conclusion The checklist toolkit, as used by clinicians, was excellent at ruling out participants who were not eligible, and moderately effective at ruling in participants who were eligible for medical abortion. Results were promising when used by community health workers particularly in Ethiopia where they had more prior experience with use of diagnostic aids and longer professional training. The checklist toolkit assessments resulted in some participants being wrongly assessed as eligible for medical abortion which is an area of concern. Further research is needed to streamline the components of the tool, explore optimal duration and content of training for community health workers, and test feasibility and acceptability.	[Johnston, Heidi Bart; Ganatra, Bela; Nguyen, My Huong; Habib, Ndema] WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, CH-1211 Geneva, Switzerland; [Johnston, Heidi Bart] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Afework, Mesganaw Fantahun] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Harries, Jane; Moodley, Jennifer; Constant, Deborah] Univ Cape Town, Womens Hlth Res Unit, Sch Publ Hlth & Family Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Iyengar, Kirti; Sen, Swapnaleen] Act Res & Training Hlth, Udaipur, Rajasthan, India	The World Bank; United Nations Population Fund; World Health Organization; University of Basel; Swiss Tropical & Public Health Institute; Addis Ababa University; University of Cape Town	Ganatra, B (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, CH-1211 Geneva, Switzerland.	ganatrab@who.int	Harries, Jane/R-6504-2019	Harries, Jane/0000-0001-7359-8419; Ganatra, Bela/0000-0002-4812-4577	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization	The UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization (BG). The Department coordinated technical review of study protocols by an external peer group and provided support for the publication of study results.	Abbas D, 2015, CONTRACEPTION, V92, P197, DOI 10.1016/j.contraception.2015.06.018; Abdella A, 2013, GLOB PUBLIC HEALTH, V8, P417, DOI 10.1080/17441692.2013.778310; Baqui AH, 2009, TROP MED INT HEALTH, V14, P1448, DOI 10.1111/j.1365-3156.2009.02397.x; Basu JK, 2013, J OBSTET GYNAECOL, V33, P605, DOI 10.3109/01443615.2013.783002; BHATIA S, 1980, STUD FAMILY PLANN, V11, P213, DOI 10.2307/1966378; Celletti F, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000366082.68321.d6; Constant D, 2014, SAMJ S AFR MED J, V104, P302, DOI 10.7196/SAMJ.7408; Darmstadt GL, 2009, B WORLD HEALTH ORGAN, V87, P12, DOI 10.2471/BLT.07.050666; Dickson-Tetteh K, 2002, INT FAM PLAN PERSPEC, V28, P144, DOI 10.2307/3088257; FREEDMAN MA, 1986, AM J PUBLIC HEALTH, V76, P550, DOI 10.2105/AJPH.76.5.550; Goldman MB, 2004, AM J PUBLIC HEALTH, V94, P1352, DOI 10.2105/AJPH.94.8.1352; Heunis JC, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-27; Jejeebhoy SJ, 2012, INT PERSPECT SEX R H, V38, P133, DOI 10.1363/3813312; Jejeebhoy SJ, 2011, CONTRACEPTION, V84, P615, DOI 10.1016/j.contraception.2011.08.010; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Malarcher S, 2011, CONTRACEPTION, V83, P495, DOI 10.1016/j.contraception.2010.08.013; National Department of Health (South Africa), 2012, SAV MOTH 2008 2010 5; National Department of Health (South Africa), 2010, REENG PRIM HLTH CAR; Raymond EG, 2015, CONTRACEPTION, V92, P212, DOI 10.1016/j.contraception.2015.04.008; Sample Registration System, 2006, MAT MORT IND TRENDS; Sanhueza SP, 2015, REPROD HLTH MATTE S1, V22, P75, DOI DOI 10.1016/S0968-8080(15)43825-X; Schonberg D, 2014, CONTRACEPTION, V90, P480, DOI 10.1016/j.contraception.2014.07.004; SCOTTI RJ, 1976, CONTRACEPTION, V14, P367, DOI 10.1016/S0010-7824(76)80051-0; Warriner IK, 2006, LANCET, V368, P1965, DOI 10.1016/S0140-6736(06)69742-0; Warriner IK, 2011, LANCET, V377, P1155, DOI 10.1016/S0140-6736(10)62229-5; Weitz TA, 2013, AM J PUBLIC HEALTH, V103, P454, DOI 10.2105/AJPH.2012.301159; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2013, UNS AB GLOB REG EST; World Health Organization, 2012, WHO REC OPT HLTH WOR	29	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146305	10.1371/journal.pone.0146305	http://dx.doi.org/10.1371/journal.pone.0146305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731176	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400144
J	Silva, R; Amouzou, A; Munos, M; Marsh, A; Hazel, E; Victora, C; Black, R; Bryce, J				Silva, Romesh; Amouzou, Agbessi; Munos, Melinda; Marsh, Andrew; Hazel, Elizabeth; Victora, Cesar; Black, Robert; Bryce, Jennifer		RMM Working Grp	Can Community Health Workers Report Accurately on Births and Deaths? Results of Field Assessments in Ethiopia, Malawi and Mali	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CIVIL REGISTRATION; MORTALITY	Introduction Most low-income countries lack complete and accurate vital registration systems. As a result, measures of under-five mortality rates rely mostly on household surveys. In collaboration with partners in Ethiopia, Ghana, Malawi, and Mali, we assessed the completeness and accuracy of reporting of births and deaths by community-based health workers, and the accuracy of annualized under-five mortality rate estimates derived from these data. Here we report on results from Ethiopia, Malawi and Mali. Method In all three countries, community health workers (CHWs) were trained, equipped and supported to report pregnancies, births and deaths within defined geographic areas over a period of at least fifteen months. In-country institutions collected these data every month. At each study site, we administered a full birth history (FBH) or full pregnancy history (FPH), to women of reproductive age via a census of households in Mali and via household surveys in Ethiopia and Malawi. Using these FBHs/FPHs as a validation data source, we assessed the completeness of the counts of births and deaths and the accuracy of under-five, infant, and neonatal mortality rates from the community-based method against the retrospective FBH/FPH for rolling twelve-month periods. For each method we calculated total cost, average annual cost per 1,000 population, and average cost per vital event reported. Results On average, CHWs submitted monthly vital event reports for over 95 percent of catchment areas in Ethiopia and Malawi, and for 100 percent of catchment areas in Mali. The completeness of vital events reporting by CHWs varied: we estimated that 30%-90% of annualized expected births (i.e. the number of births estimated using a FPH) were documented by CHWs and 22%-91% of annualized expected under-five deaths were documented by CHWs. Resulting annualized under-five mortality rates based on the CHW vital events reporting were, on average, under-estimated by 28% in Ethiopia, 32% in Malawi, and 9% in Mali relative to comparable FPHs. Costs per vital event reported ranged from $21 in Malawi to $149 in Mali. Discussion Our findings in Mali suggest that CHWs can collect complete and high-quality vital events data useful for monitoring annual changes in under-five mortality rates. Both the supervision of CHWs in Mali and the rigor of the associated field-based data quality checks were of a high standard, and the size of the pilot area in Mali was small (comprising of approximately 53,205 residents in 4,200 households). Hence, there are remaining questions about whether this level of vital events reporting completeness and data quality could be maintained if the approach was implemented at scale. Our experience in Malawi and Ethiopia suggests that, in some settings, establishing and maintaining the completeness and quality of vital events reporting by CHWs over time is challenging. In this sense, our evaluation in Mali falls closer to that of an efficacy study, whereas our evaluations in Ethiopia and Malawi are more akin to an effectiveness study. Our overall findings suggest that no one-size-fitsall approach will be successful in guaranteeing complete and accurate reporting of vital events by CHWs.	[Silva, Romesh; Amouzou, Agbessi; Munos, Melinda; Marsh, Andrew; Hazel, Elizabeth; Black, Robert; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA; [Silva, Romesh] UN, Econ & Social Commiss Western Asia, Beirut, Lebanon; [Amouzou, Agbessi] UNICEF, Div Data Res & Policy, New York, NY USA; [Victora, Cesar] Univ Fed Pelotas, Pelotas, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; UNICEF; Universidade Federal de Pelotas	Silva, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA.	rsilva@jhu.edu	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Marsh, Andrew/GVU-6571-2022	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Hazel, Elizabeth A./0000-0002-9176-3278; Amouzou, Agbessi/0000-0002-6262-3866; Munos, Melinda/0000-0002-1349-8026	Canadian Department of Foreign Affairs, Trade and Development under the Catalytic Initiative; Bill & Melinda Gates Foundation (BMGF); UNICEF Ethiopia	Canadian Department of Foreign Affairs, Trade and Development under the Catalytic Initiative; Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UNICEF Ethiopia	This study was funded by a grant from the Canadian Department of Foreign Affairs, Trade and Development under the Catalytic Initiative to Save a Million Lives to the Institute of International Programs, Johns Hopkins Bloomberg School of Public Health. In Malawi and Ethiopia, the RMM work benefitted from the joint presence of broader evaluations supported by the Bill & Melinda Gates Foundation (BMGF). UNICEF Ethiopia also funded evaluation activities that were complementary to the RMM project in that country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8; Amouzou A, 2015, PLOS ONE; Amouzou A, 2013, TROP MED INT HEALTH, V18, P1231, DOI 10.1111/tmi.12167; Becker S, 2014, DHS METHODOLOGICAL R; Bhutta ZA, GLOBAL EXPERIENCE CO; Bryce J, 2015, PLOS MED; Clark S, 2012, 118 U WASH CTR STAT; [Commission on Information and Accountability for Womens and Childrens Health Independent Expert Review Group], 2015, FIN REP EV WOM EV CH; Dwi Kosen, LANCET, V381, pS118; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; International Labour Organization, 2008, INT STAND CLASS OCC; Joos O, 2015, PLOS ONE; Kok MC, 2013, MALAWI MED J, V25, P5; Lewis T, 2012, B WORLD HEALTH ORGAN, V90, P332, DOI 10.2471/BLT.11.099820; Malqvist Mats, 2008, BMC Int Health Hum Rights, V8, P4, DOI 10.1186/1472-698X-8-4; Mathers C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000265; Miller NP, 2014, AM J TROP MED HYG, V91, P424, DOI 10.4269/ajtmh.13-0751; Munos MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132164; Hoa NP, 2012, B WORLD HEALTH ORGAN, V90, P764, DOI 10.2471/BLT.11.100750; Office of the Registrar General & Census Commissioner India, 2012, IND SAMPL REG SYST; Pedersen J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001289; Piette JD, 2012, B WORLD HEALTH ORGAN, V90, P365, DOI 10.2471/BLT.11.099069; R Core Team, 2021, R LANGUAGE ENV STAT; Setel PW, 2005, B WORLD HEALTH ORGAN, V83, P611; Siegel, 2004, METHODS MAT DEMOGRAP; Singh P, 2013, LANCET, V382, P363, DOI 10.1016/S0140-6736(12)62002-9; Slauter W, 2011, MEDIA HIST, V17, P1, DOI 10.1080/13688804.2011.532371; UNICEF WHO World Bank UN-DESA Population Division, 2014, PLOS MED; United Nations, SUST DEV GOALS KNOWL; United Nations, 2013, DEM YB 2013; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD MORT REP 2011; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Ye Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-741	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144662	10.1371/journal.pone.0144662	http://dx.doi.org/10.1371/journal.pone.0144662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731544	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400011
J	De Grove, KC; Provoost, S; Verhamme, FM; Bracke, KR; Joos, GF; Maes, T; Brusselle, GG				De Grove, Katrien C.; Provoost, Sharen; Verhamme, Fien M.; Bracke, Ken R.; Joos, Guy F.; Maes, Tania; Brusselle, Guy G.			Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NATURAL HELPER-CELLS; AIRWAY INFLAMMATION; ADAPTIVE IMMUNITY; TYPE-2 IMMUNITY; HYPERREACTIVITY; ASTHMA; FOLLICLES; IL-13; COPD	Background Innate lymphoid cells (ILC) are a new family of innate immune cells that have emerged as important regulators of tissue homeostasis and inflammation. However, limited data are available concerning the relative abundance and characteristics of ILC in the human lung. Methods The aim of this study was to characterize and enumerate the different ILC subsets in human lung by multi-color flow cytometry. Results Within the CD45(+) Lin(-) CD127(+) pulmonary ILC population, we identified group 1 (ILC1), group 2 (ILC2) and group 3 (ILC3) innate lymphoid cells using specific surface markers (i.e. IL12R beta 2, CRTH2 and CD117 respectively) and key transcription factors (i.e. T-bet, GATA-3 and ROR gamma T respectively). Based on the presence of NKp44, ILC3 were further subdivided in natural cytotoxicity receptor (NCR)(+) and NCR- ILC3. In addition, we demonstrated the production of signature cytokines IFN-gamma, IL-5, IL-17A, IL-22 and GM-CSF in the pulmonary ILC population. Interestingly, we observed a tendency to a higher frequency of NCR- ILC3 in lungs of patients with chronic obstructive pulmonary disease (COPD) compared with controls. Conclusions We show that the three main ILC subsets are present in human lung. Importantly, the relative abundance of ILC subsets tended to change in COPD patients in comparison to control individuals.	[De Grove, Katrien C.; Provoost, Sharen; Verhamme, Fien M.; Bracke, Ken R.; Joos, Guy F.; Maes, Tania; Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium	Ghent University; Ghent University Hospital	Provoost, S (corresponding author), Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium.	sharen.provoost@UGent.be	Maes, Tania/M-8675-2016; Bracke, Ken R/GSN-7630-2022	Maes, Tania/0000-0002-3037-6928; Bracke, Ken R/0000-0001-5906-4605; Brusselle, Guy/0000-0001-7021-8505; Verhamme, Anne/0000-0002-2201-1865	Interuniversity Attraction Poles Programme (IUAP) - Belgian State - Belgian Science Policy [P7/30]; Concerted Research Action of the Ghent University (BOF/GOA) [01G02714]; Fund for Scientific Research - Flanders (FWO-Vlaanderen) [G.0897.12]	Interuniversity Attraction Poles Programme (IUAP) - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Concerted Research Action of the Ghent University (BOF/GOA); Fund for Scientific Research - Flanders (FWO-Vlaanderen)(FWO)	This project is supported by the Interuniversity Attraction Poles Programme (IUAP) - Belgian State - Belgian Science Policy (P7/30), Concerted Research Action of the Ghent University (BOF/GOA, 01G02714) and by the Fund for Scientific Research - Flanders (FWO-Vlaanderen, G.0897.12). SP is a postdoctoral researcher of the Fund for Scientific Research - Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Brusselle GG, 2009, EUR RESPIR J, V34, P219, DOI 10.1183/09031936.00150208; Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Carrega P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9280; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Dyring-Andersen B, 2014, BRIT J DERMATOL, V170, P609, DOI 10.1111/bjd.12658; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Katchar K, 2005, EUR RESPIR J, V26, P77, DOI 10.1183/09031936.05.00030805; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kwon BI, 2013, AM J RESP CRIT CARE, V188, P577, DOI 10.1164/rccm.201302-0295OC; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Montaldo E, 2015, EUR J IMMUNOL, V45, P2171, DOI 10.1002/eji.201545598; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Pauwels R A, 2001, Respir Care, V46, P798; Roos AB, 2015, AM J RESP CRIT CARE, V191, P1232, DOI 10.1164/rccm.201410-1861OC; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Van Pottelberge GR, 2010, EUR RESPIR J, V36, P781, DOI 10.1183/09031936.00140409; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018	36	99	100	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145961	10.1371/journal.pone.0145961	http://dx.doi.org/10.1371/journal.pone.0145961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727464	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500039
J	Hauber, DJ; Grogan, DW; DeBry, RW				Hauber, David J.; Grogan, Dennis W.; DeBry, Ronald W.			Mutations to Less-Preferred Synonymous Codons in a Highly Expressed Gene of Escherichia coli: Fitness and Epistatic Interactions	PLOS ONE			English	Article							CHOICE PATTERNS; BINDING-SITE; USAGE; SELECTION; BIAS; POPULATION; EVOLUTION; VARIABILITY; ADAPTATION; DROSOPHILA	Codon-tRNA coevolution to maximize protein production has been, until recently, the dominant hypothesis to explain codon-usage bias in highly expressed bacterial genes. Two predictions of this hypothesis are 1) selection is weak; and 2) similar silent replacements at different codons should have similar fitness consequence. We used an allele-replacement strategy to change five specific 3rd-codon-position (silent) sites in the highly expressed Escherichia coli ribosomal protein gene rplQ from the wild type to a less-preferred alternative. We introduced the five mutations within a 10-codon region. Four of the silent sites were chosen to test the second prediction, with a CTG to CTA mutation being introduced at two closely linked leucine codons and an AAA to AAG mutation being introduced at two closely linked lysine codons. We also introduced a fifth silent mutation, a GTG to GTA mutation at a valine codon in the same genic region. We measured the fitness effect of the individual mutations by competing each single-mutant strain against the parental wild-type strain, using a disrupted form of the araA gene as a selectively neutral phenotypic marker to distinguish between strains in direct competition experiments. Three of the silent mutations had a fitness effect of vertical bar s vertical bar > 0.02, which is contradictory to the prediction that selection will be weak. The two leucine mutations had significantly different fitness effects, as did the two lysine mutations, contradictory to the prediction that similar mutations at different codons should have similar fitness effects. We also constructed a strain carrying all five silent mutations in combination. Its fitness effect was greater than that predicted from the individual fitness values, suggesting that negative synergistic epistasis acts on the combination allele.	[Hauber, David J.; Grogan, Dennis W.; DeBry, Ronald W.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University of Cincinnati	DeBry, RW (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	ron.debry@uc.edu			Sigma Xi	Sigma Xi	The work was supported by Sigma Xi Graduate Student Grant-in-Aid-of-Research, https://www.sigmaxi.org/programs/grants-in-aid. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 1997, GENETICS, V146, P295; Akashi H, 1997, GENE, V205, P269, DOI 10.1016/S0378-1119(97)00400-9; Berg OG, 1997, NUCLEIC ACIDS RES, V25, P1397, DOI 10.1093/nar/25.7.1397; Berg OG, 1996, GENETICS, V142, P1379; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BULMER M, 1991, GENETICS, V129, P897; DAVIS BD, 1948, J AM CHEM SOC, V70, P4267, DOI 10.1021/ja01192a520; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; DGJMHaGH Peters, 1974, CHEM SEPARATIONS MEA; Firnberg E, 2014, MOL BIOL EVOL, V31, P1581, DOI 10.1093/molbev/msu081; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1981, NUCLEIC ACIDS RES, V9, pR43; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HERENDEEN SL, 1979, J BACTERIOL, V139, P185, DOI 10.1128/JB.139.1.185-194.1979; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1982, JPN J GENET, V57, P671; IKEMURA T, 1981, JPN J GENET, V56, P603; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; JASKUNAS SR, 1975, P NATL ACAD SCI USA, V72, P5036, DOI 10.1073/pnas.72.12.5036; Jones T, 2002, FOOD MICROBIOL, V19, P83, DOI 10.1006/fmic.2001.0465; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; LEDERBERG J, 1948, J AM CHEM SOC, V70, P4267, DOI 10.1021/ja01192a521; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1988, EVOLUTION, V42, P425, DOI 10.1111/j.1558-5646.1988.tb04149.x; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; LI WH, 1978, GENETICS, V90, P349; Lind PA, 2013, PLOS ONE, P8; Lind PA, 2010, SCIENCE, V330, P825, DOI 10.1126/science.1194617; MEEK DW, 1984, NUCLEIC ACIDS RES, V12, P5813, DOI 10.1093/nar/12.14.5813; Piganeau G, 2001, GENET RES, V78, P171, DOI 10.1017/S0016672301005249; PRaDKR Bevington, 2003, DATA REDUCTION ERROR; RENDI R, 1962, J BIOL CHEM, V237, P3711; ROLINSON GN, 1977, J ANTIMICROB CHEMOTH, V3, P541, DOI 10.1093/jac/3.6.541; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1989, NUCLEIC ACIDS RES, V17, P5029, DOI 10.1093/nar/17.13.5029; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Xia XH, 2015, GENETICS, V199, P573, DOI 10.1534/genetics.114.172106; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146375	10.1371/journal.pone.0146375	http://dx.doi.org/10.1371/journal.pone.0146375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727272	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500077
J	Krieber, M; Bartl-Pokorny, KD; Pokorny, FB; Einspieler, C; Langmann, A; Korner, C; Falck-Ytter, T; Marschik, PB				Krieber, Magdalena; Bartl-Pokorny, Katrin D.; Pokorny, Florian B.; Einspieler, Christa; Langmann, Andrea; Koerner, Christof; Falck-Ytter, Terje; Marschik, Peter B.			The Relation between Reading Skills and Eye Movement Patterns in Adolescent Readers: Evidence from a Regular Orthography	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; PERCEPTUAL SPAN; CHILDREN; GERMAN; ACQUISITION; FREQUENCY; WORDS; TASKS; AGE	Over the past decades, the relation between reading skills and eye movement behavior has been well documented in English-speaking cohorts. As English and German differ substantially with regard to orthographic complexity (i.e. grapheme-phoneme correspondence), we aimed to delineate specific characteristics of how reading speed and reading comprehension interact with eye movements in typically developing German-speaking (Austrian) adolescents. Eye movements of 22 participants (14 females; mean age = 13; 6 years; months) were tracked while they were performing three tasks, namely silently reading words, texts, and pseudowords. Their reading skills were determined by means of a standardized German reading speed and reading comprehension assessment (Lesegeschwindigkeits- und -verstandnistest fur Klassen 6-12). We found that (a) reading skills were associated with various eye movement parameters in each of the three reading tasks; (b) better reading skills were associated with an increased efficiency of eye movements, but were primarily linked to spatial reading parameters, such as the number of fixations per word, the total number of saccades and saccadic amplitudes; (c) reading speed was a more reliable predictor for eye movement parameters than reading comprehension; (d) eye movements were highly correlated across reading tasks, which indicates consistent reading performances. Contrary to findings in English-speaking cohorts, the reading skills neither consistently correlated with temporal eye movement parameters nor with the number or percentage of regressions made while performing any of the three reading tasks. These results indicate that, although reading skills are associated with eye movement patterns irrespective of language, the temporal and spatial characteristics of this association may vary with orthographic consistency.	[Krieber, Magdalena; Bartl-Pokorny, Katrin D.; Pokorny, Florian B.; Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Ctr Physiol Med, Inst Physiol, Res Unit IDN Interdisciplinary Dev Neurosci, Graz, Austria; [Pokorny, Florian B.] Tech Univ Munich, Machine Intelligence & Signal Proc Grp, D-80290 Munich, Germany; [Pokorny, Florian B.; Marschik, Peter B.] BioTechMed Graz, BEE PRI, Graz, Austria; [Langmann, Andrea] Med Univ Graz, Dept Strabism Pediat Ophthalmol & Rehabil Visuall, Graz, Austria; [Koerner, Christof] Graz Univ, Dept Psychol, Cognit Psychol & Neurosci, Graz, Austria; [Falck-Ytter, Terje; Marschik, Peter B.] Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders KIND, Stockholm, Sweden; [Falck-Ytter, Terje] Uppsala Univ, Dept Psychol, Uppsala, Sweden	Medical University of Graz; Technical University of Munich; Medical University of Graz; University of Graz; Karolinska Institutet; Uppsala University	Marschik, PB (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Physiol, Res Unit IDN Interdisciplinary Dev Neurosci, Graz, Austria.	peter.marschik@medunigraz.at	Einspieler, Christa/HHS-6481-2022; Bartl-Pokorny, Katrin/C-5396-2014; Marschik, Peter/F-8195-2011	Marschik, Peter/0000-0001-8932-0980; Pokorny, Florian/0000-0001-9203-2904; Bartl-Pokorny, Katrin D./0000-0002-2658-1056; Korner, Christof/0000-0002-3846-2337	Austrian Science Fund FWF [P16984, P25241]; Country of Styria; City of Graz; Lanyar Foundation [P337]; COST Action [BM1004]; Austrian Science Fund (FWF) [P 25241] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Country of Styria; City of Graz; Lanyar Foundation; COST Action(European Cooperation in Science and Technology (COST)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Fund FWF (P16984, P25241), the Country of Styria, COST Action BM1004, the City of Graz and the Lanyar Foundation (P337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby J, 2005, Q J EXP PSYCHOL-A, V58, P1065, DOI 10.1080/02724980443000476; Bartl-Pokorny KD, 2013, DEV NEUROREHABIL, V16, P188, DOI 10.3109/17518423.2013.773101; Blythe H. I., 2011, OXFORD HDB EYE MOVEM, P643, DOI [10.1093/oxfordhb/9780199539789.013.0036, DOI 10.1093/OXFORDHB/9780199539789.013.0036]; Chace KH, 2005, CAN J EXP PSYCHOL, V59, P209, DOI 10.1037/h0087476; De Luca M, 2002, BRAIN LANG, V80, P617, DOI 10.1006/brln.2001.2637; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; Durrwachter U, 2010, ANN DYSLEXIA, V60, P86, DOI 10.1007/s11881-010-0034-9; EVERATT J, 1994, LANG SPEECH, V37, P283, DOI 10.1177/002383099403700305; Findlay J. M., 2003, ACTIVE VISION PSYCHO; George D, 2003, SPSS WINDOWS STEP ST; Haikio T, 2009, J EXP CHILD PSYCHOL, V102, P167, DOI 10.1016/j.jecp.2008.04.002; Hawelka S, 2005, VISION RES, V45, P855, DOI 10.1016/j.visres.2004.10.007; Hawelka S, 2013, LANG COGNITIVE PROC, V28, P1134, DOI 10.1080/01690965.2012.696665; Hawelka S, 2010, COGNITION, V115, P367, DOI 10.1016/j.cognition.2009.11.004; Huestegge L, 2009, VISION RES, V49, P2948, DOI 10.1016/j.visres.2009.09.012; Hutzler F, 2006, NEUROPSYCHOLOGIA, V44, P637, DOI 10.1016/j.neuropsychologia.2005.06.006; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; Jared D, 1999, J EXP PSYCHOL GEN, V128, P219, DOI 10.1037/0096-3445.128.3.219; Joseph HSSL, 2009, VISION RES, V49, P2078, DOI 10.1016/j.visres.2009.05.015; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kwon M, 2007, VISION RES, V47, P2889, DOI 10.1016/j.visres.2007.08.002; Libertus ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098573; MacKeben M, 2004, J VISION, V4, P388, DOI 10.1167/4.5.4; Marschik PB, 2007, EARLY HUM DEV, V83, P107, DOI 10.1016/j.earlhumdev.2006.05.009; McConkie G.W., 1991, VISION VISUAL DYSLEX; Moll K, 2010, LESE RECHTSCHREIBTES; Rau AK, 2015, J EXP CHILD PSYCHOL, V130, P92, DOI 10.1016/j.jecp.2014.09.012; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; Rayner K, 2010, PSYCHON B REV, V17, P834, DOI 10.3758/PBR.17.6.834; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Schneider W, 2007, LGVT LESEGESCHWINDIG; Schullerer P, 1999, B U BIOL UMWELTKUNDE, V8, P7; Seassau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070261; Trauzettel-Klosinski S, 2010, ACTA OPHTHALMOL, V88, P681, DOI 10.1111/j.1755-3768.2009.01523.x; Vitu F, 2001, VISION RES, V41, P3513, DOI 10.1016/S0042-6989(01)00166-3; Vorstius C, 2014, VIS COGN, V22, P458, DOI 10.1080/13506285.2014.881445; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	38	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145934	10.1371/journal.pone.0145934	http://dx.doi.org/10.1371/journal.pone.0145934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727255	gold, Green Submitted, Green Published			2022-12-27	WOS:000367681500037
J	Li, YX; Zhang, LL; Qu, T; Li, L; Zhang, GF				Li, Yingxiang; Zhang, Linlin; Qu, Tao; Li, Li; Zhang, Guofan			Characterization of Oyster Voltage-Dependent Anion Channel 2 (VDAC2) Suggests Its Involvement in Apoptosis and Host Defense	PLOS ONE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; CELL-DEATH; CRASSOSTREA-GIGAS; TISSUE DISTRIBUTION; EXPRESSION ANALYSIS; GENE-EXPRESSION; BAK ACTIVATION; IMMUNE DEFENSE	Genomic and transcriptomic studies have revealed a sophisticated and powerful apoptosis regulation network in oyster, highlighting its adaptation to sessile life in a highly stressful intertidal environment. However, the functional molecular basis of apoptosis remains largely unexplored in oysters. In this study, we focused on a representative apoptotic gene encoding voltage-dependent anion channel 2 (VDAC2), a porin that abounds at the mitochondrial outer membrane. This is the first report on the identification and characterization of a VDAC gene in the Pacific oyster, Crassostrea gigas (CgVDAC2). The full length of CgVDAC2 was 1,738 bp with an open reading frame of 843 bp that encoded a protein of 281 amino acids. A four-element eukaryotic porin signature motif, a conserved ATP binding motif, and a VKAKV-like sequence were identified in the predicted CgVDAC2. Expression pattern analysis in different tissues and developmental stages as well as upon infection by ostreid herpesvirus 1 revealed the energy supply-related and immunity-related expression of CgVDAC2. CgVDAC2 was co-localized with mitochondria when it was transiently transfected into HeLa cells. Overexpression of CgVDAC2 in HEK293T cells suppressed the UV irradiation-induced apoptosis by inhibiting the pro-apoptotic function of CgBak. RNA interference induced reduction in CgVDAC2 expression showed a promoted apoptosis level upon UV light irradiation in hemocytes. The yeast two-hybrid system and co-immunoprecipitation assay indicated a direct interaction between CgVDAC2 and the pro-apoptotic protein CgBak. This study revealed the function of VDAC2 in oyster and provided new insights into its involvement in apoptosis modulation and host defense in mollusks.	[Li, Yingxiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Yingxiang; Zhang, Linlin; Qu, Tao; Li, Li; Zhang, Guofan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Li, Yingxiang; Zhang, Linlin; Qu, Tao; Li, Li; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Li, Yingxiang; Zhang, Linlin; Qu, Tao; Li, Li; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Zhang, Linlin/I-4970-2014; li, li/GPX-3938-2022; Li, Li/AEM-3636-2022	Zhang, Linlin/0000-0003-0247-7710; Li, Yingxiang/0000-0001-6671-2965	National Basic Research Program of China (973 Program) [2010CB126402]; National Natural Science Foundation of China [31302219]; National High Technology Research and Development Program (863 program) [2012AA10A405]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; Taishan Scholars Climbing Program of Shandong	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Earmarked Fund for Modern Agro-industry Technology Research System; Taishan Scholars Climbing Program of Shandong	This research was supported by National Basic Research Program of China (973 Program, No. 2010CB126402), the National Natural Science Foundation of China (31302219), the National High Technology Research and Development Program (863 program, 2012AA10A405), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48) and Taishan Scholars Climbing Program of Shandong. All the funders had important roles in study design, data collection and analysis.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Arnoult D, 2009, SEMIN IMMUNOL, V21, P223, DOI 10.1016/j.smim.2009.05.009; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; BATHORI G, 1993, BIOCHIM BIOPHYS ACTA, V1145, P168, DOI 10.1016/0005-2736(93)90394-F; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Bender CE, 2012, P NATL ACAD SCI USA, V109, P4904, DOI 10.1073/pnas.1120680109; Bolter B, 2001, EMBO J, V20, P935, DOI 10.1093/emboj/20.5.935; Buettner R, 2000, P NATL ACAD SCI USA, V97, P3201, DOI 10.1073/pnas.060242297; Cesar MD, 2004, ARCH BIOCHEM BIOPHYS, V422, P191, DOI 10.1016/j.abb.2003.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Clybouw C, 2005, J IMMUNOL, V175, P2968, DOI 10.4049/jimmunol.175.5.2968; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; Estevez-Calvar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061502; Galluzzi L, 2007, NAT CELL BIOL, V9, P487, DOI 10.1038/ncb0507-487; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Graham BH, 2005, MOL GENET METAB, V85, P308, DOI 10.1016/j.ymgme.2005.03.009; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hughes FM, 2010, FISH SHELLFISH IMMUN, V29, P247, DOI 10.1016/j.fsi.2010.03.003; Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222; Lasi M, 2010, CELL RES, V20, P812, DOI 10.1038/cr.2010.66; Lazarou M, 2010, J BIOL CHEM, V285, P36876, DOI 10.1074/jbc.M110.159301; Lee AC, 1996, J BIOL CHEM, V271, P26724, DOI 10.1074/jbc.271.43.26724; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liu BJ, 2010, BIOCHEM BIOPH RES CO, V397, P633, DOI 10.1016/j.bbrc.2010.06.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu AJ, 2007, FISH SHELLFISH IMMUN, V23, P601, DOI 10.1016/j.fsi.2007.01.007; Lu AJ, 2015, FISH PHYSIOL BIOCHEM, V41, P899, DOI 10.1007/s10695-015-0056-7; McDowell IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105097; MILEIKOVSKY SA, 1973, MAR BIOL, V23, P11, DOI 10.1007/BF00394107; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Premkumar A, 2002, J NEUROCHEM, V82, P345, DOI 10.1046/j.1471-4159.2002.00966.x; Qu T, 2015, DEV COMP IMMUNOL, V51, P74, DOI 10.1016/j.dci.2015.02.011; Raghavan A, 2012, BBA-BIOMEMBRANES, V1818, P1477, DOI 10.1016/j.bbamem.2011.10.019; Ren DC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000274; Renault T, 2011, DEV COMP IMMUNOL, V35, P725, DOI 10.1016/j.dci.2011.02.004; Romero A, 2015, FISH SHELLFISH IMMUN; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Rostovtseva TK, 2002, BIOPHYS J, V82, P193, DOI 10.1016/S0006-3495(02)75386-1; Saccone C, 2003, J MOL EVOL, V57, pS277, DOI 10.1007/s00239-003-0037-9; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sampson MJ, 1996, GENOMICS, V36, P192, DOI 10.1006/geno.1996.0445; Sampson MJ, 1996, GENOMICS, V33, P283, DOI 10.1006/geno.1996.0193; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Segarra A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-580; Shen XB, 2014, FISH SHELLFISH IMMUN, V37, P96, DOI 10.1016/j.fsi.2014.01.009; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SMITH MD, 1995, J BIOL CHEM, V270, P28331; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Villinger S, 2014, J BIOL CHEM, V289, P13397, DOI 10.1074/jbc.M113.524173; Wang KCHC, 2010, FISH SHELLFISH IMMUN, V29, P94, DOI 10.1016/j.fsi.2010.02.020; WIDDOWS J, 1991, AQUACULTURE, V94, P147, DOI 10.1016/0044-8486(91)90115-N; Xiang ZM, 2015, FISH SHELLFISH IMMUN, V42, P225, DOI 10.1016/j.fsi.2014.11.013; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Yehezkel G, 2007, J CELL PHYSIOL, V212, P551, DOI 10.1002/jcp.21048; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31; Yu F, 2012, FISH SHELLFISH IMMUN, V33, P899, DOI 10.1016/j.fsi.2012.07.021; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08693; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	71	8	10	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146049	10.1371/journal.pone.0146049	http://dx.doi.org/10.1371/journal.pone.0146049			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727366	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500048
J	Prinja, S; Bahuguna, P; Mohan, P; Mazumder, S; Taneja, S; Bhandari, N; van den Hombergh, H; Kumar, R				Prinja, Shankar; Bahuguna, Pankaj; Mohan, Pavitra; Mazumder, Sarmila; Taneja, Sunita; Bhandari, Nita; van den Hombergh, Henri; Kumar, Rajesh			Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India	PLOS ONE			English	Article							CARE; HEALTH; MORTALITY; LEVEL; IMCI	Introduction Despite the evidence for preventing childhood morbidity and mortality, financial resources are cited as a constraint for Governments to scale up the key health interventions in some countries. We evaluate the cost effectiveness of implementing IMNCI program in India from a health system and societal perspective. Methods We parameterized a decision analytic model to assess incremental cost effectiveness of IMNCI program as against routine child health services for infant population at district level in India. Using a 15-years time horizon from 2007 to 2022, we populated the model using data on costs and effects as found from a cluster-randomized trial to assess effectiveness of IMNCI program in Haryana state. Effectiveness was estimated as reduction in infant illness episodes, deaths and disability adjusted life years (DALY). Incremental cost per DALY averted was used to estimate cost effectiveness of IMNCI. Future costs and effects were discounted at a rate of 3%. Probabilistic sensitivity analysis was undertaken to estimate the probability of IMNCI to be cost effective at varying willingness to pay thresholds. Results Implementation of IMNCI results in a cumulative reduction of 57384 illness episodes, 2369 deaths and 76158 DALYs among infants at district level from 2007 to 2022. Overall, from a health system perspective, IMNCI program incurs an incremental cost of USD 34.5 (INR 1554) per DALY averted, USD 34.5 (INR 1554) per life year gained, USD 1110 (INR 49963) per infant death averted. There is 90% probability for ICER to be cost effective at INR IMNCI program incurs an additional cost of USD 24.1 (INR 1082) per DALY averted, USD 773 (INR 34799) per infant death averted and USD 26.3 (INR 1183) per illness averted in during infancy. Conclusion IMNCI program in Indian context is very cost effective and should be scaled-up as a major child survival strategy.	[Prinja, Shankar; Bahuguna, Pankaj; Kumar, Rajesh] PGIMER, Sch Publ Hlth, Chandigarh, India; [Mohan, Pavitra; van den Hombergh, Henri] UNICEF India Country Off, New Delhi, India; [Mazumder, Sarmila; Taneja, Sunita; Bhandari, Nita] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Prinja, S (corresponding author), PGIMER, Sch Publ Hlth, Chandigarh, India.	shankarprinja@gmail.com	Mazumder, Sarmila/AAD-8952-2020	Mazumder, Sarmila/0000-0003-4200-6112; Bahuguna, Pankaj/0000-0001-9952-6077	World Health Organization, Geneva (through an umbrella grant from USAID); United Nations Children's Fund, New Delhi; GLOBVAC Program of the Research Council of Norway [183722]; Centre for Intervention Science in Maternal and Child Health (RCN Project), Centre for International Health, University of Bergen (Norway) [223269]	World Health Organization, Geneva (through an umbrella grant from USAID)(United States Agency for International Development (USAID)World Health Organization); United Nations Children's Fund, New Delhi; GLOBVAC Program of the Research Council of Norway; Centre for Intervention Science in Maternal and Child Health (RCN Project), Centre for International Health, University of Bergen (Norway)	The study was funded by the World Health Organization, Geneva (through an umbrella grant from USAID); the United Nations Children's Fund, New Delhi; and the GLOBVAC Program of the Research Council of Norway through grant No 183722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Centre for Health Research and Development, Society for Applied Studies is grateful for the core support provided by the Department of Child and Adolescent Health and Development, World Health Organization (Geneva) and the Centre for Intervention Science in Maternal and Child Health (RCN Project No. 223269), Centre for International Health, University of Bergen (Norway).	Adam T, 2005, B WORLD HEALTH ORGAN, V83, P369; Adam T, 2009, HEALTH POLICY, V89, P97, DOI 10.1016/j.healthpol.2008.04.014; Ahmed HM, 2010, HEALTH POLICY, V96, P128, DOI 10.1016/j.healthpol.2010.01.013; Amaral João, 2004, Cad. Saúde Pública, V20, pS209, DOI 10.1590/S0102-311X2004000800016; [Anonymous], 2007, NAT FAM HLTH SURV 3; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhandari N, 2011, SAS IMNCI RCT STUDY; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Butraporn P, 1999, SE ASIAN J TROP MED, V30; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Drummond MF, 2015, METHODS EC EVALUATIO; Edejer T, 2003, MAKING CHOIES HLTH W; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Fox-Rushby J, 2006, EC EVALUATION; Gouws E, 2004, B WORLD HEALTH ORGAN, V82, P509; Gupta M, 2012, HLTH POLICY PLAN; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Kamolratanakul P, 2001, AM J TROP MED HYG, V65, P279, DOI 10.4269/ajtmh.2001.65.279; Khan MM, 2002, J HEALTH POPUL NUTR, V20, P42; KHAN MM, 2000, HUMAN RESOURCES HLTH, V4, P73; Kolstad PR, 1998, TROP MED INT HEALTH, V3, P691, DOI 10.1046/j.1365-3156.1998.00290.x; Kumar D, 2009, HEALTH POLICY PLANN, V24, P94, DOI 10.1093/heapol/czn051; LeFevre AE, 2013, B WORLD HEALTH ORGAN, V91, P736, DOI 10.2471/BLT.12.117127; Mangham-Jefferies L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-243; Mazumder S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4988; MoHFW, 2011, OP STT SPEC NEWB CAR; MoHFW, 1997, RCH PROGR SCHEM IMPL; National Sample Survey Organisation (NSSO), 2006, MORB HLTH CAR COND A; Prinja S, 2013, J TROPICAL PEDIAT, P1, DOI DOI 10.1093/TROPEJ/FMT007; Prinja S, 2015, COST DELIVERIN UNPUB; Prinja S, 2015, APPL HEALTH ECON HEA, P1; Prinja S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091781; Prinja S, 2013, INDIAN PEDIATR, V50, P839, DOI 10.1007/s13312-013-0234-6; Prinja S, 2012, INDIAN J MED RES, V136, P421; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Sharma A K, 1999, Indian J Public Health, V43, P156; Suryanarayana M.H., 2011, INEQUALITY ADJUSTED, P31; UNICEF, 2010, INT MAN NEON CHILDL; UNICEF/ WHO/ The World Bank/ UN Pop Div, 2013, LEV TRENDS CHILD MOR; WHO, 2005, CHOOSING INT AR COST; World Bank, DAT WORLD DEV IND; World Health Organization, 2013, COUNTR PROF NEON CHI; World Health Organization, 2005, GLOB BURD DIS 2004 U; World Health Organization, 2003, INT MAN NEON CHILDH; World Health Organization, 2010, UN ACC SCAL PRIOR HI	46	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145043	10.1371/journal.pone.0145043	http://dx.doi.org/10.1371/journal.pone.0145043			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727369	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500008
J	Richter, N; Tiddeman, B; Haun, DBM				Richter, Nadja; Tiddeman, Bernard; Haun, Daniel B. M.			Social Preference in Preschoolers: Effects of Morphological Self-Similarity and Familiarity	PLOS ONE			English	Article							INFANTS PREFER; COOPERATION; TESTS; ME	Adults prefer to interact with others that are similar to themselves. Even slight facial self-resemblance can elicit trust towards strangers. Here we investigate if preschoolers at the age of 5 years already use facial self-resemblance when they make social judgments about others. We found that, in the absence of any additional knowledge about prospective peers, children preferred those who look subtly like themselves over complete strangers. Thus, subtle morphological similarities trigger social preferences well before adulthood.	[Richter, Nadja; Haun, Daniel B. M.] Max Planck Inst Evolutionary Anthropol, Res Grp Comparat Cognit Anthropol, Leipzig, Germany; [Richter, Nadja] Univ Jena, Dept Dev Psychol, Jena, Germany; [Tiddeman, Bernard] Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3FG, Dyfed, Wales; [Tiddeman, Bernard] Aberystwyth Univ, Res Inst Visual Comp, Aberystwyth SY23 3FG, Dyfed, Wales; [Haun, Daniel B. M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Haun, Daniel B. M.] Univ Leipzig, Dept Early Child Dev & Culture, D-04109 Leipzig, Germany	Max Planck Society; Friedrich Schiller University of Jena; Aberystwyth University; Aberystwyth University; Max Planck Society; Leipzig University	Richter, N (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	nrichter@umn.edu		Tiddeman, Bernard/0000-0001-7570-1192	Max Planck Society for the Advancement of Science	Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission)	This research was funded by the Max Planck Society for the Advancement of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailenson JN, 2008, PUBLIC OPIN QUART, V72, P935, DOI 10.1093/poq/nfn064; BERSCHEID E, 1971, J EXP SOC PSYCHOL, V7, P173, DOI 10.1016/0022-1031(71)90065-5; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Bressan P, 2009, BIOL LETTERS, V5, P336, DOI 10.1098/rsbl.2008.0789; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; Cohen E, 2013, EVOL HUM BEHAV, V34, P230, DOI 10.1016/j.evolhumbehav.2013.02.001; DeBruine LM, 2008, ARCH SEX BEHAV, V37, P64, DOI 10.1007/s10508-007-9266-0; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; Dunham Y, 2011, CHILD DEV, V82, P793, DOI 10.1111/j.1467-8624.2011.01577.x; Fawcett CA, 2010, J EXP CHILD PSYCHOL, V105, P345, DOI 10.1016/j.jecp.2009.12.002; Giang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047809; Gruenfeld DH, 2010, HDB SOC PSYCHOL, V3, P33; Hamlin JK, 2013, PSYCHOL SCI, V24, P589, DOI 10.1177/0956797612457785; Haun DB, 2013, ME HOMOPHILY BASED A; Heyes C, 2013, LIFE MIND-PHILOS ISS, P313; Hothorn T., 2015, EXACTRANKTESTS EXACT; JACKLIN CN, 1978, CHILD DEV, V49, P557, DOI 10.1111/j.1467-8624.1978.tb02355.x; Jones JT, 2004, J PERS SOC PSYCHOL, V87, P665, DOI 10.1037/0022-3514.87.5.665; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kinzler KD, 2010, EUR J SOC PSYCHOL, V40, P581, DOI 10.1002/ejsp.739; Krupp DB, 2008, EVOL HUM BEHAV, V29, P49, DOI 10.1016/j.evolhumbehav.2007.08.002; Mahajan N, 2012, COGNITION, V124, P227, DOI 10.1016/j.cognition.2012.05.003; Maloney LT, 2006, J VIS, P6; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; R Core Team, 2013, R LANG ENV STAT COMP; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Verosky SC, 2013, J EXP SOC PSYCHOL, V49, P661, DOI 10.1016/j.jesp.2013.02.004; Warnes G. R., 2015, GTOOLS VARIOUS R PRO; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zajonc RB, 2001, CURR DIR PSYCHOL SCI, V10, P224, DOI 10.1111/1467-8721.00154; Zimmerman DW, 2012, BRIT J MATH STAT PSY, V65, P122, DOI 10.1111/j.2044-8317.2011.02017.x	34	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145443	10.1371/journal.pone.0145443	http://dx.doi.org/10.1371/journal.pone.0145443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727132	Green Published, gold			2022-12-27	WOS:000367681500015
J	de Kroon, LMG; Narcisi, R; Davidson, ENB; Cleary, MA; van Beuningen, HM; Koevoet, WJLM; van Osch, GJVM; van der Kraan, PM				de Kroon, Laurie M. G.; Narcisi, Roberto; Davidson, Esmeralda N. Blaney; Cleary, Mairead A.; van Beuningen, Henk M.; Koevoet, Wendy J. L. M.; van Osch, Gerjo J. V. M.; van der Kraan, Peter M.			Activin Receptor-Like Kinase Receptors ALK5 and ALK1 Are Both Required for TGF beta-Induced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-VITRO CHONDROGENESIS; CARTILAGE REPAIR; EXPRESSION; TRANSPLANTATION; DEFECTS; CHONDROCYTE; ACTIVATION; OSTEOBLAST; TGF-BETA-1	Introduction Bone marrow-derived mesenchymal stem cells (BMSCs) are promising for cartilage regeneration because BMSCs can differentiate into cartilage tissue-producing chondrocytes. Transforming Growth Factor beta (TGF beta) is crucial for inducing chondrogenic differentiation of BMSCs and is known to signal via Activin receptor-Like Kinase (ALK) receptors ALK5 and ALK1. Since the specific role of these two TGF beta receptors in chondrogenesis is unknown, we investigated whether ALK5 and ALK1 are expressed in BMSCs and whether both receptors are required for chondrogenic differentiation of BMSCs. Materials & Methods ALK5 and ALK1 gene expression in human BMSCs was determined with RT-qPCR. To induce chondrogenesis, human BMSCs were pellet-cultured in serum-free chondrogenic medium containing TGF beta 1. Chondrogenesis was evaluated by aggrecan and collagen type IIa1 RT-qPCR analysis, and histological stainings of proteoglycans and collagen type II. To overexpress constitutively active (ca) receptors, BMSCs were transduced either with caALK5 or caALK1. Expression of ALK5 and ALK1 was downregulated by transducing BMSCs with shRNA against ALK5 or ALK1. Results ALK5 and ALK1 were expressed in in vitro-expanded as well as in pellet-cultured BMSCs from five donors, but mRNA levels of both TGF beta receptors did not clearly associate with chondrogenic induction. TGF beta increased ALK5 and decreased ALK1 gene expression in chondrogenically differentiating BMSC pellets. Neither caALK5 nor caALK1 overexpression induced cartilage matrix formation as efficient as that induced by TGF beta. Moreover, short hairpin-mediated downregulation of either ALK5 or ALK1 resulted in a strong inhibition of TGF beta-induced chondrogenesis. Conclusion ALK5 as well as ALK1 are required for TGF beta-induced chondrogenic differentiation of BMSCs, and TGF beta not only directly induces chondrogenesis, but also modulates ALK5 and ALK1 receptor signaling in BMSCs. These results imply that optimizing cartilage formation by mesenchymal stem cells will depend on activation of both receptors.	[de Kroon, Laurie M. G.; Davidson, Esmeralda N. Blaney; van Beuningen, Henk M.; van der Kraan, Peter M.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Expt Rheumatol, NL-6525 ED Nijmegen, Netherlands; [de Kroon, Laurie M. G.; Narcisi, Roberto; Cleary, Mairead A.; van Osch, Gerjo J. V. M.] Erasmus MC Univ Med Ctr, Dept Orthoped, Rotterdam, Netherlands; [Cleary, Mairead A.] Univ Coll Dublin, Sch Vet Med, Sect Vet Clin Sci, Dublin 2, Ireland; [Koevoet, Wendy J. L. M.; van Osch, Gerjo J. V. M.] Erasmus MC Univ Med Ctr, Dept Otorhinolaryngol, Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; University College Dublin; Erasmus University Rotterdam; Erasmus MC	van der Kraan, PM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Expt Rheumatol, NL-6525 ED Nijmegen, Netherlands.	Peter.vanderKraan@radboudumc.nl	Cleary, Mairead/AAP-2737-2021; Davidson, E.N. Blaney/L-4204-2015; van der Kraan, Peter M/D-9115-2011; de Kroon, Laurie MG/P-9068-2015	Davidson, E.N. Blaney/0000-0003-3514-0313; de Kroon, Laurie MG/0000-0003-2306-2290	Dutch Arthritis Foundation [11-1-404]; Netherlands Institute for Regenerative Medicine [FES0908]; National Institute of Child Health and Human Development; ReumaFonds [11-1-404] Funding Source: researchfish	Dutch Arthritis Foundation; Netherlands Institute for Regenerative Medicine; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ReumaFonds	PMvdK received funding from the Dutch Arthritis Foundation (grant number 11-1-404; http://www.reumafonds.nl/), and this work was funded by the Netherlands Institute for Regenerative Medicine (grant number FES0908; www.nirm.nl). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Prof. Dr. P. ten Dijke (Leiden University Medical Center, the Netherlands) for providing adenoviruses overexpressing constitutively active ALK5 or constitutively active ALK1 or LacZ, and plasmid DNA of MISSION (R) (Sigma-Aldrich) TRC-Hs1.5 shRNA clones targeting ALK5 (TRCN0000039773) or ALK1 (TRCN0000000355) and Empty Vector Control (SHC001). The II-II6B3 monoclonal antibody against collagen type II developed by T.F. Linsenmayer was obtained from the Developmental Studies Hybridoma Bank, originally developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biology (Iowa City, IA).	ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Bauge C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3247; Bloom BB, 1996, BBA-MOL CELL RES, V1312, P243, DOI 10.1016/0167-4889(96)00043-2; Brady K, 2014, STEM CELLS DEV, V23, P541, DOI 10.1089/scd.2013.0301; Cassiede P, 1996, J BONE MINER RES, V11, P1264; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Davidson ENB, 2009, J IMMUNOL, V182, P7937, DOI 10.4049/jimmunol.0803991; De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; Elkasrawy M, 2011, GROWTH FACTORS, V29, P253, DOI 10.3109/08977194.2011.599324; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hellingman CA, 2011, TISSUE ENG PT A, V17, P1157, DOI [10.1089/ten.TEA.2010.0043, 10.1089/ten.tea.2010.0043]; Hunziker EB, 2015, OSTEOARTHR CARTILAGE, V23, P334, DOI 10.1016/j.joca.2014.12.011; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kaul G, 2012, KNEE SURG SPORT TR A, V20, P2315, DOI 10.1007/s00167-011-1853-x; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; Lux Andreas, 2006, BMC Cardiovasc Disord, V6, P13, DOI 10.1186/1471-2261-6-13; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Matsunobu T, 2009, DEV BIOL, V332, P325, DOI 10.1016/j.ydbio.2009.06.002; Melke P, 2006, BIOPHYS J, V91, P4368, DOI [10.1529/biophysj.105.080408, 10.1529/biophysj.106.080408]; Menke A, 1999, BBA-MOL CELL RES, V1449, P178, DOI 10.1016/S0167-4889(99)00011-7; MORELAND RB, 1995, J UROLOGY, V153, P826, DOI 10.1016/S0022-5347(01)67730-9; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Muraglia A, 2000, J CELL SCI, V113, P1161; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; Shelbourne KD, 2003, J BONE JOINT SURG AM, V85A, P8, DOI 10.2106/00004623-200300002-00002; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Wakitani S, 2002, MICROSC RES TECHNIQ, V58, P14, DOI 10.1002/jemt.10111; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Yamasaki S, 2014, CARTILAGE, V5, P196, DOI 10.1177/1947603514534681; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063	47	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146124	10.1371/journal.pone.0146124	http://dx.doi.org/10.1371/journal.pone.0146124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720610	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900046
J	Kampf, M; Tessenow, E; Kenett, DY; Kantelhardt, JW				Kaempf, Mirko; Tessenow, Eric; Kenett, Dror Y.; Kantelhardt, Jan W.			The Detection of Emerging Trends Using Wikipedia Traffic Data and Context Networks	PLOS ONE			English	Article							SEARCH BEHAVIOR; GOOGLE; SCIENCE; NEWS	Can online media predict new and emerging trends, since there is a relationship between trends in society and their representation in online systems? While several recent studies have used Google Trends as the leading online information source to answer corresponding research questions, we focus on the online encyclopedia Wikipedia often used for deeper topical reading. Wikipedia grants open access to all traffic data and provides lots of additional (semantic) information in a context network besides single keywords. Specifically, we suggest and study context-normalized and time-dependent measures for a topic's importance based on page-view time series of Wikipedia articles in different languages and articles related to them by internal links. As an example, we present a study of the recently emerging Big Data market with a focus on the Hadoop ecosystem, and compare the capabilities of Wikipedia versus Google in predicting its popularity and life cycles. To support further applications, we have developed an open web platform to share results of Wikipedia analytics, providing context-rich and language-independent relevance measures for emerging trends.	[Kaempf, Mirko; Kantelhardt, Jan W.] Univ Halle Wittenberg, Inst Phys, Sachsen Anhalt, Germany; [Tessenow, Eric] Univ Leeds, Sch Media & Commun, Leeds, W Yorkshire, England; [Kenett, Dror Y.] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Kenett, Dror Y.] Boston Univ, Dept Phys, Boston, MA 02215 USA	Martin Luther University Halle Wittenberg; University of Leeds; Boston University; Boston University	Kampf, M (corresponding author), Univ Halle Wittenberg, Inst Phys, Sachsen Anhalt, Germany.	mirko.kaempf@googlemail.com	Kantelhardt, Jan/AAF-7955-2019	Kantelhardt, Jan/0000-0002-9293-0293	European Union (FP7 ICT project SOCIONICAL) [231288]; German Research Society (DFG) [KA 1676/4]; Office of Naval Research (ONR) [N000141410738]	European Union (FP7 ICT project SOCIONICAL); German Research Society (DFG)(German Research Foundation (DFG)); Office of Naval Research (ONR)(Office of Naval Research)	The authors would like to thank Tobias Preis for valuable comments and discussions regarding the combination of time series analysis and network analysis techniques. The Wikipedia click count data set was created and provided by the Wikimedia Foundation. MK and JK are thankful to the European Union (FP7 ICT project SOCIONICAL, grant 231288) and the German Research Society (DFG, grant KA 1676/4) for financial support. DYK is thankful to the Office of Naval Research (ONR Grant N000141410738) for financial support.	Alanyali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03578; Baram-Tsabari A, 2015, PUBLIC UNDERST SCI, V24, P326, DOI 10.1177/0963662513491369; Barchiesi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128470; Brigo F, 2015, EPILEPSY BEHAV, V49, P146, DOI 10.1016/j.yebeh.2015.02.029; Brin S., 1998, 7 INT WORLD WID WEB; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Cha Y, 2015, ENVIRON POLLUT, V198, P97, DOI 10.1016/j.envpol.2014.12.027; Chebolu P, 2008, PROCEEDINGS OF THE NINETEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1010; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; Domnich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127754; Dong XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120039; Hanke M, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.3; Havlin S, 2012, EUR PHYS J-SPEC TOP, V214, P273, DOI 10.1140/epjst/e2012-01695-x; Heiberger RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135311; Hickmann KS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004239; Hjorland B, 2002, J AM SOC INF SCI TEC, V53, P960, DOI 10.1002/asi.10132; Kampf M, 2012, PHYSICA A, V391, P6101, DOI 10.1016/j.physa.2012.07.004; Kampf M., 2013, INT J COMPUT APPL, V74, P1, DOI DOI 10.5120/12974-0233; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kristoufek L, 2015, PHYSICA A, V428, P194, DOI 10.1016/j.physa.2015.02.057; Krotzsch M, 2006, LECT NOTES COMPUT SC, V4273, P935; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liu R., 2014, 8 SNA KDD WORKSH SNA; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Page Lawrence, 1999, TECHNICAL REPORT; Pavlicek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127084; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Schreck B., 2013, PREPRINT; Schroeder R, 2015, INFORM COMMUN SOC, V18, P1039, DOI 10.1080/1369118X.2015.1008538; Segev E, 2010, INT J INTERNET SCI, V5, P48; T. H. Group, 1997, HIERARCHICAL DATA FO; Telfer S, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0074-9; Nguyen T, 2015, J EPIDEMIOL COMMUN H, V69, P693, DOI 10.1136/jech-2014-204523; Wang Z., 2006, LEARNING DIFFUSION I; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048386; Yasseri T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030091, 10.1371/journal.pone.0038869]	41	13	13	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0141892	10.1371/journal.pone.0141892	http://dx.doi.org/10.1371/journal.pone.0141892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720074	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510900002
J	Shandilya, S; Kurz, MC; Ward, KR; Najarian, K				Shandilya, Sharad; Kurz, Michael C.; Ward, Kevin R.; Najarian, Kayvan			Integration of Attributes from Non-Linear Characterization of Cardiovascular Time-Series for Prediction of Defibrillation Outcomes	PLOS ONE			English	Article							TIDAL CARBON-DIOXIDE; CORONARY PERFUSION-PRESSURE; HOSPITAL CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; PRECORDIAL COMPRESSION; LOGISTIC-REGRESSION; SUCCESS	Objective The timing of defibrillation is mostly at arbitrary intervals during cardio-pulmonary resuscitation (CPR), rather than during intervals when the out-of-hospital cardiac arrest (OOH-CA) patient is physiologically primed for successful countershock. Interruptions to CPR may negatively impact defibrillation success. Multiple defibrillations can be associated with decreased post-resuscitation myocardial function. We hypothesize that a more complete picture of the cardiovascular system can be gained through non-linear dynamics and integration of multiple physiologic measures from biomedical signals. Materials and Methods Retrospective analysis of 153 anonymized OOH-CA patients who received at least one defibrillation for ventricular fibrillation (VF) was undertaken. A machine learning model, termed Multiple Domain Integrative (MDI) model, was developed to predict defibrillation success. We explore the rationale for non-linear dynamics and statistically validate heuristics involved in feature extraction for model development. Performance of MDI is then compared to the amplitude spectrum area (AMSA) technique. Results 358 defibrillations were evaluated (218 unsuccessful and 140 successful). Non-linear properties (Lyapunov exponent > 0) of the ECG signals indicate a chaotic nature and validate the use of novel non-linear dynamic methods for feature extraction. Classification using MDI yielded ROC-AUC of 83.2% and accuracy of 78.8%, for the model built with ECG data only. Utilizing 10-fold cross-validation, at 80% specificity level, MDI (74% sensitivity) outperformed AMSA (53.6% sensitivity). At 90% specificity level, MDI had 68.4% sensitivity while AMSA had 43.3% sensitivity. Integrating available end-tidal carbon dioxide features into MDI, for the available 48 defibrillations, boosted ROC-AUC to 93.8% and accuracy to 83.3% at 80% sensitivity. Conclusion At clinically relevant sensitivity thresholds, the MDI provides improved performance as compared to AMSA, yielding fewer unsuccessful defibrillations. Addition of partial end-tidal carbon dioxide (PetCO2) signal improves accuracy and sensitivity of the MDI prediction model.	[Shandilya, Sharad] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurz, Michael C.] Univ Alabama Birmingham, Sch Med, Dept Emergency Med, Birmingham, AL USA; [Najarian, Kayvan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Ward, Kevin R.; Najarian, Kayvan] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Ward, Kevin R.; Najarian, Kayvan] Univ Michigan, Dept Emergency Med, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA	Virginia Commonwealth University; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shandilya, S (corresponding author), Virginia Commonwealth Univ, Richmond, VA 23284 USA.	shandilya.sharad@gmail.com						Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; BECK CS, 1947, JAMA-J AM MED ASSOC, V135, P985, DOI 10.1001/jama.1947.62890150005007a; Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BROWN R, 1991, PHYS REV A, V43, P2787, DOI 10.1103/PhysRevA.43.2787; CALLAHAM M, 1990, CRIT CARE MED, V18, P358, DOI 10.1097/00003246-199004000-00002; Cheskes S, 2011, CIRCULATION, V124, P58, DOI 10.1161/CIRCULATIONAHA.110.010736; DUDA RO, 2001, PATTERN CLASSIFICATI; Firoozabadi R, 2013, J ELECTROCARDIOL, V46, P473, DOI 10.1016/j.jelectrocard.2013.06.007; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Genkin A, 2007, TECHNOMETRICS, V49, P291, DOI 10.1198/004017007000000245; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gundersen K, 2008, RESUSCITATION, V76, P279, DOI 10.1016/j.resuscitation.2007.07.019; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; He M, 2013, CLIN EXPT CARDIOLOGY, P1; Kantz H., 1997, NONLINEAR TIME SERIE; Kingsbury, 2015, 9 EUR SIGN PROC C EU, DOI DOI 10.5281/ZENODO.36900; Koster RW, 2010, RESUSCITATION, V81, pE48, DOI 10.1016/j.resuscitation.2010.08.005; Levine RL, 1997, NEW ENGL J MED, V337, P301, DOI 10.1056/NEJM199707313370503; LEWIS LM, 1992, ANN EMERG MED, V21, P1131, DOI 10.1016/S0196-0644(05)80658-4; Marn-Pernat A, 2001, CRIT CARE MED, V29, P2360, DOI 10.1097/00003246-200112000-00019; Nakagawa Yoshihide, 2013, Tokai J Exp Clin Med, V38, P71; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; Povoas HP, 2002, RESUSCITATION, V53, P77, DOI 10.1016/S0300-9572(01)00488-9; Quinlan R., 1993, PROGRAMS MACHINE LEA; Reynolds JC, 2012, RESUSCITATION, V83, P1497, DOI 10.1016/j.resuscitation.2012.04.013; Ristagno G, 2008, ANAESTH INTENS CARE, V36, P46, DOI 10.1177/0310057X0803600108; RIVERS EP, 1992, ANN EMERG MED, V21, P1094, DOI 10.1016/S0196-0644(05)80650-X; SANDERS AB, 1989, JAMA-J AM MED ASSOC, V262, P1347, DOI 10.1001/jama.262.10.1347; SANDERS AB, 1985, AM J EMERG MED, V3, P147, DOI 10.1016/0735-6757(85)90039-7; Sato Y, 1997, CRIT CARE MED, V25, P733, DOI 10.1097/00003246-199705000-00005; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Shandilya S., 2011, 2011 IEEE/ICME International Conference on Complex Medical Engineering - CME 2011, P9, DOI 10.1109/ICCME.2011.5876696; Shandilya S, 2013, 8 INT MULT COMP GLOB, P214; Shandilya S, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-116; Steen S, 2003, RESUSCITATION, V58, P249, DOI 10.1016/S0300-9572(03)00265-X; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tang WC, 2004, J AM COLL CARDIOL, V43, P1228, DOI 10.1016/j.jacc.2003.10.055; VELLEKOOP M, 1994, AM MATH MON, V101, P353, DOI 10.2307/2975629; Wang H, 2010, RESUSCITATION, V81, P617, DOI 10.1016/j.resuscitation.2010.01.027; Watson JN, 2004, RESUSCITATION, V63, P269, DOI 10.1016/j.resuscitation.2004.06.012; WAYNE MA, 1995, ANN EMERG MED, V25, P762, DOI 10.1016/S0196-0644(95)70204-0; Werndl C, 2009, BRIT J PHILOS SCI, V60, P195, DOI 10.1093/bjps/axn053; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Xie JL, 1997, CIRCULATION, V96, P683; Young Clayton, 2004, Crit Care Med, V32, pS356, DOI 10.1097/01.CCM.0000134353.55378.88; Yu T, 2002, CIRCULATION, V106, P368, DOI 10.1161/01.CIR.0000021429.22005.2E	49	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0141313	10.1371/journal.pone.0141313	http://dx.doi.org/10.1371/journal.pone.0141313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741805	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600001
J	Chang, BJ; Samal, AB; Vlach, J; Fernandez, TF; Brooke, D; Prevelige, PE; Saad, JS				Chang, Bliss J.; Samal, Alexandra B.; Vlach, Jiri; Fernandez, Timothy F.; Brooke, Dewey; Prevelige, Peter E., Jr.; Saad, Jamil S.			Identification of the Calmodulin-Binding Domains of Fas Death Receptor	PLOS ONE			English	Article							TARGET RECOGNITION; CHOLANGIOCARCINOMA CELLS; COMPLEX STRUCTURE; STRUCTURAL BASIS; EF-HANDS; NMR; PROTEIN; APOPTOSIS; ACTIVATION; DIVERSITY	The extrinsic apoptotic pathway is initiated by binding of a Fas ligand to the ectodomain of the surface death receptor Fas protein. Subsequently, the intracellular death domain of Fas (FasDD) and that of the Fas-associated protein (FADD) interact to form the core of the death-inducing signaling complex (DISC), a crucial step for activation of caspases that induce cell death. Previous studies have shown that calmodulin (CaM) is recruited into the DISC in cholangiocarcinoma cells and specifically interacts with FasDD to regulate the apoptotic/survival signaling pathway. Inhibition of CaM activity in DISC stimulates apoptosis significantly. We have recently shown that CaM forms a ternary complex with FasDD (2: 1 CaM: FasDD). However, the molecular mechanism by which CaM binds to two distinct FasDD motifs is not fully understood. Here, we employed mass spectrometry, nuclear magnetic resonance (NMR), biophysical, and biochemical methods to identify the binding regions of FasDD and provide a molecular basis for the role of CaM in Fas-mediated apoptosis. Proteolytic digestion and mass spectrometry data revealed that peptides spanning residues 209-239 (Fas-Pep1) and 251-288 (Fas-Pep2) constitute the two CaM-binding regions of FasDD. To determine the molecular mechanism of interaction, we have characterized the binding of recombinant/synthetic Fas-Pep1 and Fas-Pep2 peptides with CaM. Our data show that both peptides engage the N- and C-terminal lobes of CaM simultaneously. Binding of Fas-Pep1 to CaM is entropically driven while that of Fas-Pep2 to CaM is enthalpically driven, indicating that a combination of electrostatic and hydrophobic forces contribute to the stabilization of the FasDD-CaM complex. Our data suggest that because Fas-Pep1 and Fas-Pep2 are involved in extensive intermolecular contacts with the death domain of FADD, binding of CaM to these regions may hinder its ability to bind to FADD, thus greatly inhibiting the initiation of apoptotic signaling pathway.	[Chang, Bliss J.; Samal, Alexandra B.; Vlach, Jiri; Fernandez, Timothy F.; Brooke, Dewey; Prevelige, Peter E., Jr.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	saad@uab.edu	Brooke, Dewey/AAZ-8307-2021	Brooke, Dewey/0000-0003-4290-3809; Chang, Bliss/0000-0002-4551-0499; Vlach, Jiri/0000-0002-0874-2055; Saad, Jamil/0000-0001-9503-6484	Comprehensive Cancer Center at the University of Alabama at Birmingham (NCI) [P30 CA013148]; NIH [1S10RR026478]; Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER	Comprehensive Cancer Center at the University of Alabama at Birmingham (NCI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the Comprehensive Cancer Center at the University of Alabama at Birmingham (funded by the NCI grant P30 CA013148) through a pilot grant to JSS, and the High-Field NMR facility and the x-ray core facility that houses the Auto-ITC200 (acquired through NIH grant 1S10RR026478).; We thank Jay McDonald and Yabing Chen at the University of Alabama at Birmingham for providing the Fas molecular clone and for helpful discussion. We also thank David King (Howard Hughes Medical Institute, University of California Berkeley) for helping with mass spectrometry. BJC thanks the Arnold and Mabel Beckman Foundation for the undergraduate fellowship.	Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Ahn EY, 2003, AM J PATHOL, V163, P2053, DOI 10.1016/S0002-9440(10)63563-8; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Cao P, 2014, ACTA CRYSTALLOGR D, V70, P1604, DOI 10.1107/S1399004714006919; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Chen YB, 2006, AM J PATHOL, V169, P1833, DOI 10.2353/ajpath.2006.060234; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dewhurst LO, 1997, BRIT J CANCER, V75, P860, DOI 10.1038/bjc.1997.153; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fernandez TF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.471821; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GIETZEN K, 1982, BIOCHEM J, V207, P541, DOI 10.1042/bj2070541; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Ishida H, 2010, J BIOL CHEM, V285, P38502, DOI 10.1074/jbc.M110.131201; ITO H, 1991, ANTICANCER RES, V11, P249; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Moorthy AK, 2001, J BIOMOL STRUCT DYN, V19, P47, DOI 10.1080/07391102.2001.10506719; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Pan G, 1999, AM J PATHOL, V155, P193, DOI 10.1016/S0002-9440(10)65113-9; Pawar P, 2009, CLIN CANCER RES, V15, P1288, DOI 10.1158/1078-0432.CCR-08-1150; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Peter ME, 2015, CELL DEATH DIFFER, V22, P549, DOI 10.1038/cdd.2015.3; Peter M E, 1999, Results Probl Cell Differ, V23, P25; Pignochino Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-631; Que FG, 1999, HEPATOLOGY, V30, P1398, DOI 10.1002/hep.510300618; RASMUSSEN CD, 1992, J PHYSIOL-PARIS, V86, P83, DOI 10.1016/S0928-4257(05)80011-7; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIIVARI K, 1995, FEBS LETT, V366, P104, DOI 10.1016/0014-5793(95)00504-3; Stec B, 2012, FEBS LETT, V586, P1675, DOI 10.1016/j.febslet.2012.04.026; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vickers SM, 2002, ANN SURG, V235, P872, DOI 10.1097/00000658-200206000-00016; Villarroel A, 2014, J MOL BIOL, V426, P2717, DOI 10.1016/j.jmb.2014.05.016; Vlach J, 2014, J BIOL CHEM, V289, P8697, DOI 10.1074/jbc.M113.543694; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Yuan KY, 2011, J BIOL CHEM, V286, P24776, DOI 10.1074/jbc.M110.202804; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411	64	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146493	10.1371/journal.pone.0146493	http://dx.doi.org/10.1371/journal.pone.0146493			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735300	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100049
J	Groves, MD; Crouch, B; Coombs, GW; Jordan, D; Pang, S; Barton, MD; Giffard, P; Abraham, S; Trott, DJ				Groves, Mitchell D.; Crouch, Bethany; Coombs, Geoffrey W.; Jordan, David; Pang, Stanley; Barton, Mary D.; Giffard, Phil; Abraham, Sam; Trott, Darren J.			Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolated from Australian Veterinarians	PLOS ONE			English	Article							HEALTH-CARE WORKERS; COLONIZATION; PREVALENCE; CARRIAGE; HORSES; OUTBREAK; ANIMALS; HUMANS; STAFF	This work investigated the molecular epidemiology and antimicrobial resistance of methicillin- resistant Staphylococcus aureus (MRSA) isolated from veterinarians in Australia in 2009. The collection (n = 44) was subjected to extensive molecular typing (MLST, spa, SCCmec, dru, PFGE, virulence and antimicrobial resistance genotyping) and antimicrobial resistance phenotyping by disk diffusion. MRSA was isolated from Australian veterinarians representing various occupational emphases. The isolate collection was dominated by MRSA strains belonging to clonal complex (CC) 8 and multilocus sequence type (ST) 22. CC8 MRSA (ST8-IV [2B], spa t064; and ST612-IV [2B], spa variable,) were strongly associated with equine practice veterinarians (OR = 17.5, 95% CI = 3.3-92.5, P < 0.001) and were often resistant to gentamicin and rifampicin. ST22-IV [2B], spa variable, were strongly associated with companion animal practice veterinarians (OR = 52.5, 95% CI = 5.2-532.7, P < 0.001) and were resistant to ciprofloxacin. A single pig practice veterinarian carried ST398V [5C2], spa t1451. Equine practice and companion animal practice veterinarians frequently carried multiresistant-CC8 and ST22 MRSA, respectively, whereas only a single swine specialist carried MRSA ST398. The presence of these strains in veterinarians may be associated with specific antimicrobial administration practices in each animal species.	[Groves, Mitchell D.; Coombs, Geoffrey W.; Jordan, David; Pang, Stanley; Abraham, Sam] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Crouch, Bethany; Barton, Mary D.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Coombs, Geoffrey W.; Pang, Stanley] Fiona Stanley Hosp, Path West Lab Med, Dept Microbiol, Murdoch, WA, Australia; [Jordan, David] New South Wales Dept Primary Ind, Wollongbar, NSW, Australia; [Giffard, Phil] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Trott, Darren J.] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia	Murdoch University; University of South Australia; NSW Department of Primary Industries; Charles Darwin University; Menzies School of Health Research; University of Adelaide	Abraham, S (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	s.abraham@murdoch.edu.au; darren.trott@adelaide.edu.au	Jordan, David/P-7281-2019	Abraham, Sam/0000-0003-0950-2317; Pang, Stanley/0000-0001-9165-5704; Giffard, Phil/0000-0002-3030-9127; Coombs, Geoffrey/0000-0003-1635-6506	Australian Research Council [LP130100736]; Australian Veterinary Association	Australian Research Council(Australian Research Council); Australian Veterinary Association	This study was funded in part by Australian Research Council grant LP130100736. The authors would like to acknowledge the Australian Veterinary Association for partially funding the MRSA screening study under the 'One World One Health' conference theme for the 2009 AVA Conference. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Australian Veterinary Association for partially funding the MRSA screening study under the 'One World One Health' conference theme for the 2009 AVA Conference. We also gratefully acknowledge the veterinary conference convenors and organisers for allowing collection of swabs and data during their conferences, and Julie Pearson from the Department of Microbiology, Fiona Stanley Hospital, PathWest Laboratory Medicine-WA for her expertise in PFGE.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Allen JL, 2013, AUST VET J, V91, P215, DOI 10.1111/avj.12060; Axon JE, 2011, AUST VET J, V89, P221, DOI 10.1111/j.1751-0813.2011.00711.x; Cheng AC, 2012, EMERG INFECT DIS, V18, P1453, DOI 10.3201/eid1809.111515; Clinical and Laboratory Standards Institute, 2012, CLSI DOCUMENT M100 S; Coombs GW, 2007, INFECT CONT HOSP EP, V28, P845, DOI 10.1086/518726; Coombs GW, 2014, COMMUN DIS INTELL, V38, pE59; Coombs GW, 2013, J GLOB ANTIMICROB RE, V1, P149, DOI 10.1016/j.jgar.2013.04.005; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs Geoffrey W N GR, 2013, COMMUN DIS INTELL, V38, pE309; Costa AM, 2005, DIAGN MICR INFEC DIS, V51, P13, DOI 10.1016/j.diagmicrobio.2004.08.014; Crowley J, 2013, EQUINE VET J, V45, P20, DOI 10.1111/evj.12166; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Garcia-Alvarez L, 2012, J ANTIMICROB CHEMOTH, V67, pI37, DOI 10.1093/jac/dks206; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Groves MD, 2014, J ANTIMICROB CHEMOTH, V69, P1426, DOI 10.1093/jac/dkt526; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13; Hart J, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-7; Holder J, 2010, AUST VET HIST RECORD, P7; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jordan D, 2011, AUST VET J, V89, P152, DOI 10.1111/j.1751-0813.2011.00710.x; Loeffler A, 2005, J ANTIMICROB CHEMOTH, V56, P692, DOI 10.1093/jac/dki312; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394; O'Brien FG, 2006, NAT PROTOC, V1, P3028, DOI 10.1038/nprot.2006.382; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; The European Committee on Antimicrobial Susceptibility Testing, 2013, BREAK POINT TABL INT; Trott D D J, 2013, AUST MICROBIOLOGIST, V34, P28; Verkade E, 2013, CLIN INFECT DIS, V57, pE11, DOI 10.1093/cid/cit228; Verwer PEB, 2012, EUR J CLIN MICROBIOL, V31, P1067, DOI 10.1007/s10096-011-1408-6; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; Weese JS, 2005, JAVMA-J AM VET MED A, V226, P580, DOI 10.2460/javma.2005.226.580; Weese JS, 2006, VET MICROBIOL, V114, P160, DOI 10.1016/j.vetmic.2005.11.054; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	40	26	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146034	10.1371/journal.pone.0146034	http://dx.doi.org/10.1371/journal.pone.0146034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735694	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000367805100033
J	Hui, LL; Leung, GM; Schooling, CM				Hui, L. L.; Leung, Gabriel M.; Schooling, C. Mary			Social Patterning in Adiposity in Adolescence: Prospective Observations from the Chinese Birth Cohort "Children of 1997''	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CARDIOVASCULAR RISK; YOUNG FINNS; LIFE-COURSE; DEVELOPING-COUNTRIES; ABDOMINAL OBESITY; SEXUAL-MATURATION; EARLY ADULTHOOD; SECULAR TREND; CHILDHOOD	Introduction Low early life socio-economic position is more strongly associated with adiposity among women than men. We examined whether the sex difference of social patterning in general and central adiposity exists before adulthood. Methods In Hong Kong's "Children of 1997" birth cohort, we used multivariable regression to examine the association of parental education, a marker of early life socio-economic position, with body mass index (BMI) (n = 7252, 88% follow-up) and waist-height ratio (n = 5636, 68% follow-up), at 14 years. Results Parental education of Grade 9 or below, compared to Grade 12 or above, was associated with higher waist-height ratio z-score particularly in girls (0.30, 95% confidence interval (CI) 0.19, 0.41) compared to boys (0.12, 95% CI 0.02, 0.22) (p for sex interaction = 0.02). Lower parental education was associated with greater BMI z-score in adolescents of locally born mothers, but not adolescents of migrant mothers, with no difference by sex. Conclusions Different social patterning in different markers of adiposity may imply different sociological and biological mediating pathways. A stronger association between low early life socio-economic position and waist-height ratio in adolescent girls may indicate sex-specific influences of SEP related early life exposures on central adiposity.	[Hui, L. L.; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Schooling, C. Mary] CUNY Hunter Coll, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Schooling, CM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	cms1@hku.hk		Leung, Gabriel/0000-0002-2503-6283; HUI, Lai Ling/0000-0003-0688-3329; Schooling, Mary/0000-0001-9933-5887	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF Grant] [216106]; Health and Health Services Research Fund [HHSRF Grant] [03040771]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong; RFCID grant [04050172]; HHSRF grant [08090761]; Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR [09101061]	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF Grant]; Health and Health Services Research Fund [HHSRF Grant]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong(University of Hong Kong); RFCID grant; HHSRF grant; Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR	This work is a sub-study of the "Children of 1997" birth cohort which was initially supported by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF Grant # 216106] and re-established in 2005 with support from the Health and Health Services Research Fund [HHSRF Grant # 03040771], and the University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong. This sub-study builds on information added to the birth cohort by RFCID grant # 04050172 and HHSRF grant # 08090761, and was funded by the Health and Health Services Research Fund [HHSRF Grant # 09101061], Government of the Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton AA, 2013, CIRCULATION, V127, P905, DOI 10.1161/CIRCULATIONAHA.112.115782; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Barros AJD, 2006, INT J EPIDEMIOL, V35, P1233, DOI 10.1093/ije/dyl160; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Bourdieu P., 1984, DISTINCTION SOCIAL C; Brunner E, 1999, J EPIDEMIOL COMMUN H, V53, P757, DOI 10.1136/jech.53.12.757; Census and Statistics Department, 2017, THEM REP HOUS INC DI; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Due P, 2009, INT J OBESITY, V33, P1084, DOI 10.1038/ijo.2009.128; Fernandez-Alvira JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-80; Gonzalez DA, 2009, PUBLIC HEALTH NUTR, V12, P2225, DOI 10.1017/S1368980009990607; Gordon-Larsen P, 2003, OBES RES, V11, P121, DOI 10.1038/oby.2003.20; Huen KF, 1997, ACTA PAEDIATR, V86, P1121, DOI 10.1111/j.1651-2227.1997.tb14820.x; Jansen PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069676; Juonala M, 2012, ARTERIOSCL THROM VAS, V32, P1024, DOI 10.1161/ATVBAHA.111.243261; Kavikondala S, 2010, SOC SCI MED, V70, P834, DOI 10.1016/j.socscimed.2009.11.009; Kivimaki M, 2006, HEART, V92, P474, DOI 10.1136/hrt.2005.067108; Kivimaki M, 2006, ANN EPIDEMIOL, V16, P737, DOI 10.1016/j.annepidem.2006.01.004; Laitinen J, 2001, AM J CLIN NUTR, V74, P287; Langenberg C, 2003, J EPIDEMIOL COMMUN H, V57, P816, DOI 10.1136/jech.57.10.816; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Morgen CS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-520; Murray ET, 2011, ANN EPIDEMIOL, V21, P589, DOI 10.1016/j.annepidem.2011.04.005; Ness AR, 2006, INT J PEDIATR OBES, V1, P59, DOI 10.1080/17477160600569339; POWER C, 1988, INT J OBESITY, V12, P445; Regidor E, 2004, EUR J CLIN NUTR, V58, P488, DOI 10.1038/sj.ejcn.1601835; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2008, AM J EPIDEMIOL, V167, P419, DOI 10.1093/aje/kwm329; Schooling CM, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.086553; Schooling CM, 2010, DIABETOLOGIA, V53, P393, DOI 10.1007/s00125-009-1613-3; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Schooling CM, 2011, INT J EPIDEMIOL, V40, P1556, DOI 10.1093/ije/dyr128; Schooling CM, 2010, ARCH DIS CHILD, V95, P437, DOI 10.1136/adc.2009.168542; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wardle J, 2006, BRIT MED J, V332, P1130, DOI 10.1136/bmj.38807.594792.AE; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Wong GWK, 1996, ACTA PAEDIATR, V85, P620, DOI 10.1111/j.1651-2227.1996.tb14101.x; Yoon YS, 2006, OBESITY, V14, P909, DOI 10.1038/oby.2006.105	41	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146198	10.1371/journal.pone.0146198	http://dx.doi.org/10.1371/journal.pone.0146198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26735134	Green Published, gold			2022-12-27	WOS:000367805100039
J	Liu, XX; Yang, JZ; Chen, XJ; Li, LP				Liu, Xiangxiang; Yang, Jingzhen; Chen, Xiaojun; Li, Liping			Knowledge, Attitudes and Behaviors on Child Passenger Safety among Expectant Mothers and Parents of Newborns: A Qualitative and Quantitative Approach	PLOS ONE			English	Article							RESTRAINT USE; INJURY; CHINA; LAWS	Objective To investigate the knowledge, attitudes, and intended behaviors about use of child safety seats among parents of newborns and explore expectant mothers' views and decisions regarding child safety seats use. Methods A cross-sectional survey and semi-structured interview were conducted in the maternity departments of two hospitals in China. Parents of newborns were recruited after delivery and surveyed on their knowledge, attitudes and behaviors regarding child safety seats use. Pregnant women were also interviewed to learn about their views and decisions regarding child safety seats use. Both quantitative and qualitative methods were used to analyze the data collected. Results Of a total of 242 parents of newborns recruited in the quantitative survey, 202 (83.5%) parents had heard of child safety seats and 149 (61.6%) parents reported they would use child safety seats for their babies. Parents' knowledge, car ownership, occupation, and income were significantly associated with their decision regarding use of child safety seats. Three themes were identified from the qualitative interview of 30 pregnant women: (1) the pregnant women perceived child passenger safety as important; (2) the car ownership and price and quality of child safety seats were major influencing factors of their decisions on use of child safety seats; and (3) lack of awareness and lack of laws requiring use were perceived to contribute to low use of child safety seats in China. Conclusion Lack of knowledge and awareness on child passenger safety were found to be two most important factors associated with low use of child safety seats. Effective interventions are urgently needed to improve parents' knowledge before laws are enacted and implemented.	[Liu, Xiangxiang; Li, Liping] Shantou Univ, Injury Prevent Res Ctr, Coll Med, Shantou 515041, Peoples R China; [Yang, Jingzhen] Univ Iowa, Injury Prevent Res & Police Ctr, Iowa City, IA USA; [Chen, Xiaojun] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou 515041, Peoples R China	Shantou University; University of Iowa; Shantou University	Li, LP (corresponding author), Shantou Univ, Injury Prevent Res Ctr, Coll Med, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	lpli@stu.edu.cn		Liu, Xiangxiang/0000-0003-2319-0604				Bae JY, 2014, SOC SCI MED, V100, P30, DOI 10.1016/j.socscimed.2013.10.035; Brown J, 2006, J PAEDIATR CHILD H, V42, P345, DOI 10.1111/j.1440-1754.2006.00870.x; Chen X, 2014, BMC PUBLIC HEALTH, V14, P8; Chen XJ, 2014, AM J PREV MED, V46, P85, DOI 10.1016/j.amepre.2013.08.017; Child Safety Seat Auditorium, 2014, CHILDR YOUNG 4 YEARS; Eichelberger AH, 2012, TRAFFIC INJ PREV, V13, P631, DOI 10.1080/15389588.2012.660663; Erkoboni D, 2010, INJURY PREV, V16, P296, DOI 10.1136/ip.2009.023341; Eventov-Friedman S, 2014, ACTA PAEDIATR, V103, P57, DOI 10.1111/apa.12431; Grivna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068636; Hunter K, 2015, AM J PUBLIC HEALTH, V105, P584, DOI 10.2105/AJPH.2014.302308; Koppel S, 2013, ACCIDENT ANAL PREV, V51, P18, DOI 10.1016/j.aap.2012.10.009; Nelson A, 2015, TRAFFIC INJ PREV, V16, P240, DOI 10.1080/15389588.2014.931578; Nugmanova Z, 2014, INJURY PREV, P4; Observatory ERS, 2010, TRAFF SAF BAS FACTS, P13; Olufunlayo TF, 2012, INJURY PREV, V18, P216, DOI 10.1136/injuryprev-2011-040047; Pan SM, 2012, INJURY PREV, V18, P133, DOI 10.1136/injuryprev-2011-040049; Pan SM, 2011, ACCIDENT ANAL PREV, V43, P2195, DOI 10.1016/j.aap.2011.06.014; Peden M, 2008, WORD REPORT CHILD IN; Purc-Stephenson RJ, 2010, INT J INJ CONTROL SA, V17, P231, DOI 10.1080/17457300.2010.487155; Shenzhen News, SHENZHEN NEWS; Simniceanu A, 2014, TRAFFIC INJ PREV, V15, P734, DOI 10.1080/15389588.2013.867483; Skjerven-Martinsen, 2013, ACCIDENT ANAL PREV, V59, P479, DOI 10.1016/j.aap.2013.07.023; Tessier K, 2010, ACCIDENT ANAL PREV, V42, P1041, DOI 10.1016/j.aap.2009.12.011; Yu G, 2014, FORUM, V2, P2, DOI DOI 10.1371/J0URNAL.P0NE.0109399; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105986; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925; Zonfrillo MR, 2014, J PEDIAT	27	10	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146121	10.1371/journal.pone.0146121	http://dx.doi.org/10.1371/journal.pone.0146121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26735974	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100036
J	Seth, A; Matias, R; Veloso, AP; Delp, SL				Seth, Ajay; Matias, Ricardo; Veloso, Antonio P.; Delp, Scott L.			A Biomechanical Model of the Scapulothoracic Joint to Accurately Capture Scapular Kinematics during Shoulder Movements	PLOS ONE			English	Article							MUSCULOSKELETAL MODEL; UPPER EXTREMITY; SKIN MARKER; SIMULATION; MOTION; DEVIATION; SOFTWARE; DYNAMICS; OPENSIM; COMPLEX	The complexity of shoulder mechanics combined with the movement of skin relative to the scapula makes it difficult to measure shoulder kinematics with sufficient accuracy to distinguish between symptomatic and asymptomatic individuals. Multibody skeletal models can improvemotion capture accuracy by reducing the space of possible joint movements, and models are used widely to improve measurement of lower limb kinematics. In this study, we developed a rigid-body model of a scapulothoracic joint to describe the kinematics of the scapula relative to the thorax. This model describes scapular kinematics with four degrees of freedom: 1) elevation and 2) abduction of the scapula on an ellipsoidal thoracic surface, 3) upward rotation of the scapula normal to the thoracic surface, and 4) internal rotation of the scapula to lift the medial border of the scapula off the surface of the thorax. The surface dimensions and joint axes can be customized to match an individual's anthropometry. We compared the model to "gold standard" bone-pin kinematics collected during three shoulder tasks and found modeled scapular kinematics to be accurate to within 2mm root-mean-squared error for individual bone-pin markers across all markers and movement tasks. As an additional test, we added random and systematic noise to the bone-pin marker data and found that the model reduced kinematic variability due to noise by 65% compared to Euler angles computed without the model. Our scapulothoracic joint model can be used for inverse and forward dynamics analyses and to compute joint reaction loads. The computational performance of the scapulothoracic joint model is well suited for real-time applications; it is freely available for use with OpenSim 3.2, and is customizable and usable with other OpenSim models.	[Seth, Ajay; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Matias, Ricardo; Veloso, Antonio P.] Univ Lisbon, LBMF, Fac Motricidade Humana, P-1699 Lisbon, Portugal; [Matias, Ricardo] Setubal Polytech Inst, Sch Healthcare, Setubal, Portugal; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Universidade de Lisboa; Stanford University	Seth, A (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	aseth@stanford.edu	Matias, Ricardo/AAG-7178-2019; Veloso, António P/F-5064-2013; Matias, Ricardo/L-5043-2014	Veloso, António P/0000-0003-1068-1113; Matias, Ricardo/0000-0003-1785-2640; Seth, Ajay/0000-0003-4217-1580; Delp, Scott/0000-0002-9643-7551	National Institutes of Health [U54 GM072970, R24 HD065690]; DARPA Warrior Web project; Portuguese Science and Technology Foundation [FCT-PTDC/DES/ 103178/2008, SFRH/BD/41846/2007]; National Institute of Child Health and Human Development/National Institutes of Health grant [K01HD042491]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065690, P2CHD065690] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD042491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA Warrior Web project; Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); National Institute of Child Health and Human Development/National Institutes of Health grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AS, SD supported by National Institutes of Health grants U54 GM072970, R24 HD065690 and the DARPA Warrior Web project; RM, AV supported by the Portuguese Science and Technology Foundation, project grant FCT-PTDC/DES/ 103178/2008 and PhD grant SFRH/BD/41846/2007 to RM. Experimental data was collected by Paula Ludewig supported by the National Institute of Child Health and Human Development/National Institutes of Health grant K01HD042491 to the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Kibler W, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2013-092425; Blana D, 2008, J BIOMECH, V41, P1714, DOI 10.1016/j.jbiomech.2008.03.001; Bolsterlee B, 2013, MED BIOL ENG COMPUT, V51, P953, DOI 10.1007/s11517-013-1099-5; Bourne DA, 2011, ANN BIOMED ENG, V39, P777, DOI 10.1007/s10439-010-0185-1; Breteler MDK, 1999, J BIOMECH, V32, P1191, DOI 10.1016/S0021-9290(99)00122-0; Chadwick EK, 2014, IEEE T BIO-MED ENG, V61, P1947, DOI 10.1109/TBME.2014.2309727; Chadwick EK, 2009, IEEE T BIO-MED ENG, V56, P941, DOI 10.1109/TBME.2008.2005946; Charlton IW, 2006, P I MECH ENG H, V220, P801, DOI 10.1243/09544119JEIM147; De Baets L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079046; de Groot JH, 2001, CLIN BIOMECH, V16, P735, DOI 10.1016/S0268-0033(01)00065-1; De Groote F, 2008, J BIOMECH, V41, P3390, DOI 10.1016/j.jbiomech.2008.09.035; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dickerson Clark R., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P389, DOI 10.1080/10255840701592727; Dvir Z, 1978, J BIOMECH; FEATHERSTONE R, 1983, INT J ROBOT RES, V2, P13, DOI 10.1177/027836498300200102; Garner BRIAN A., 1999, Comput Methods Biomech Biomed Engin, V2, P107, DOI 10.1080/10255849908907981; Golub G.H, 1996, J HOPKINS STUDIES MA; Hicks JL, 2014, J BIOMECH ENG, DOI [10.1115/1.4029304, DOI 10.1115/1.4029304]; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Jain A, 2010, ROBOT MULTIBODY DYNA, P128; Karlsson D, 1992, J BIOMECH; Kibler W, 1998, AM J SPORTS MED, V26; Lawrence RL, 2014, J ORTHOP SPORT PHYS, V44, P636, DOI 10.2519/jospt.2014.5339; Lebel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079945; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Ludewig PM, 2009, J BONE JOINT SURG AM, V91A, P378, DOI 10.2106/JBJS.G.01483; Matsui K, 2006, J ORTHOP SCI, V11, P180, DOI 10.1007/s00776-005-1000-y; Maurel W, 2000, COMPUT GRAPH-UK, V24, P203, DOI 10.1016/S0097-8493(99)00155-7; McClure PW, 2001, J SHOULDER ELB SURG, V10, P269, DOI 10.1067/mse.2001.112954; PETZOLD L, 1982, SIAM J SCI STAT COMP, V3, P367, DOI 10.1137/0903023; Roren A, 2015, MANUAL THER, V20, P46, DOI 10.1016/j.math.2014.06.006; Saul KR, 2015, COMPUT METHOD BIOMEC, V18, P1445, DOI 10.1080/10255842.2014.916698; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Seth A, 2010, NONLINEAR DYNAM, V62, P291, DOI 10.1007/s11071-010-9717-3; Sherman MA, 2011, PROC IUTAM, V2, P241, DOI 10.1016/j.piutam.2011.04.023; Srikumaran U, 2014, J BONE JT SURG, V122, P1; Struyf F, 2011, SCAND J MED SCI SPOR, V21, P352, DOI 10.1111/j.1600-0838.2010.01274.x; Valente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112625; van Andel C, 2009, GAIT POSTURE, V29, P123, DOI 10.1016/j.gaitpost.2008.07.012; VANDERHELM FCT, 1994, J BIOMECH, V27, P551, DOI 10.1016/0021-9290(94)90065-5; Veeger HEJ, 2007, J BIOMECH, V40, P2119, DOI 10.1016/j.jbiomech.2006.10.016; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	46	60	60	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0141028	10.1371/journal.pone.0141028	http://dx.doi.org/10.1371/journal.pone.0141028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734761	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100001
J	Staton, C; Vissoci, J; Gong, EY; Toomey, N; Wafula, R; Abdelgadir, J; Zhou, Y; Liu, C; Pei, FD; Zick, B; Ratliff, CD; Rotich, C; Jadue, N; de Andrade, L; von Isenburg, M; Hocker, M				Staton, Catherine; Vissoci, Joao; Gong, Enying; Toomey, Nicole; Wafula, Rebeccah; Abdelgadir, Jihad; Zhou, Yi; Liu, Chen; Pei, Fengdi; Zick, Brittany; Ratliff, Camille D.; Rotich, Claire; Jadue, Nicole; de Andrade, Luciano; von Isenburg, Megan; Hocker, Michael			Road Traffic Injury Prevention Initiatives: A Systematic Review and Metasummary of Effectiveness in Low and Middle Income Countries	PLOS ONE			English	Review							BRAZILIAN CITY; IMPACT; SAFETY; LEGISLATION; ACCIDENTS; PROGRAM	Background Road traffic injuries (RTIs) are a growing but neglected global health crisis, requiring effective prevention to promote sustainable safety. Low- and middle-income countries (LMICs) share a disproportionately high burden with 90% of the world's road traffic deaths, and where RTIs are escalating due to rapid urbanization and motorization. Although several studies have assessed the effectiveness of a specific intervention, no systematic reviews have been conducted summarizing the effectiveness of RTI prevention initiatives specifically performed in LMIC settings; this study will help fill this gap. Methods In accordance with PRISMA guidelines we searched the electronic databases MEDLINE, EMBASE, Scopus, Web of Science, TRID, Lilacs, Scielo and Global Health. Articles were eligible if they considered RTI prevention in LMICs by evaluating a prevention-related intervention with outcome measures of crash, RTI, or death. In addition, a reference and citation analysis was conducted as well as a data quality assessment. A qualitative metasummary approach was used for data analysis and effect sizes were calculated to quantify the magnitude of emerging themes. Results Of the 8560 articles from the literature search, 18 articles from 11 LMICs fit the eligibility and inclusion criteria. Of these studies, four were from Sub-Saharan Africa, ten from Latin America and the Caribbean, one from the Middle East, and three from Asia. Half of the studies focused specifically on legislation, while the others focused on speed control measures, educational interventions, enforcement, road improvement, community programs, or a multifaceted intervention. Conclusion Legislation was the most common intervention evaluated with the best outcomes when combined with strong enforcement initiatives or as part of a multifaceted approach. Because speed control is crucial to crash and injury prevention, road improvement interventions in LMIC settings should carefully consider how the impact of improvements will affect speed and traffic flow. Further road traffic injury prevention interventions should be performed in LMICs with patient-centered outcomes in order to guide injury prevention in these complex settings.	[Staton, Catherine; Hocker, Michael] Duke Univ, Med Ctr, Emergency Med, Durham, NC USA; [Staton, Catherine; Vissoci, Joao; Gong, Enying; Toomey, Nicole; Wafula, Rebeccah; Abdelgadir, Jihad; Zhou, Yi; Liu, Chen; Pei, Fengdi; Zick, Brittany; Ratliff, Camille D.; Rotich, Claire; Jadue, Nicole; von Isenburg, Megan] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [de Andrade, Luciano] State Univ West Parana, Dept Nursing, Foz Do Iguacu, Parana, Brazil	Duke University; Duke University; Universidade Estadual do Oeste do Parana	Staton, C (corresponding author), Duke Univ, Med Ctr, Emergency Med, Durham, NC USA.	catherine.lynch@duke.edu	von Isenburg, Megan/R-8105-2016	Gong, Enying/0000-0003-2203-0369; Staton, Catherine/0000-0002-6468-2894; von Isenburg, Megan/0000-0001-6084-5775	FOGARTY INTERNATIONAL CENTER [K01TW010000] Funding Source: NIH RePORTER	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Abegaz T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-539; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P77, DOI 10.1076/icsp.10.1.77.14113; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Andreuccetti G, 2011, ADDICTION, V106, P2124, DOI 10.1111/j.1360-0443.2011.03521.x; Bacchieri Giancarlo, 2010, Rev. Saúde Pública, V44, P867, DOI 10.1590/S0034-89102010000500012; Bank T.W., 2015, COUNTR LEND GROUPS; Bishai D, 2008, INJURY PREV, V14, P223, DOI 10.1136/ip.2008.018341; Blantari Jones, 2005, Int J Inj Contr Saf Promot, V12, P23, DOI 10.1080/17457300512331342199; Chandran A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087482; Davies GR, 2014, INT J EPIDEMIOL, V43, P1615, DOI 10.1093/ije/dyu103; De Andrade SM, 2008, TRAFFIC INJ PREV, V9, P450, DOI 10.1080/15389580802272831; de Figueiredo LFP, 2001, INJURY, V32, P91, DOI 10.1016/S0020-1383(00)00172-8; Duperrex O., 2002, COCHRANE DATABASE SY, DOI [10.1002/14651858.CD001531, DOI 10.1002/14651858.CD001531]; Espitia-Hardeman V, 2008, SALUD PUBLICA MEXICO, V50, pS69, DOI 10.1590/S0036-36342008000700011; FARAGE LUCIANO, 2002, Rev. Assoc. Med. Bras., V48, P163, DOI 10.1590/S0104-42302002000200037; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; Gomez-Garcia L, 2014, CAD SAUDE PUBLICA, V30, P1281, DOI 10.1590/0102-311X00121813; Garcell HG, 2008, GAC SANIT, V22, P344, DOI 10.1157/13125356; Harris M., 2009, CALL FOR A DECADE OF; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hijar Martha, 2003, Inj Control Saf Promot, V10, P37, DOI 10.1076/icsp.10.1.37.14108; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJ, 1996, GLOBAL BURDEN DIS; Mutto Milton, 2002, Afr Health Sci, V2, P89; Nadesan-Reddy N, 2013, SAMJ, S. Afr. med. j., V103, P621, DOI 10.7196/samj.7024; Organization WH, 2011, SAVING MILLIONS OF L; Organization WH, 2008, WORLD REPORT ON ROAD; Organization WH, 2013, WHO GLOBAL STATUS RE; Passmore J, 2010, TRAFFIC INJ PREV, V11, P202, DOI 10.1080/15389580903497121; Peden M., 2004, WORLD REPORT ROAD TR; Porchia B R, 2014, Ann Ig, V26, P63, DOI 10.7416/ai.2014.1959; Rahimi-Movaghar V, 2010, PUBLIC HEALTH, V124, P190, DOI 10.1016/j.puhe.2010.02.014; Salvarani CP, 2009, SURG NEUROL, V72, P6, DOI 10.1016/j.surneu.2007.10.008; Sandelowski M, 2003, NURS RES, V52, P226, DOI 10.1097/00006199-200307000-00004; Sandelowski M, 2007, RES NURS HEALTH, V30, P99, DOI 10.1002/nur.20176; Services N.K.C.f.t.H., 2015, EFFECTIVE PRACTICE A; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Spinks A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004445.pub2; Sterne J., 2014, ON BEHALF OF THE DEV; Sumner SA, 2014, INJURY, V45, P1681, DOI 10.1016/j.injury.2014.04.034; Swaddiwudhipong W, 1998, TROP MED INT HEALTH, V3, P767, DOI 10.1046/j.1365-3156.1998.00301.x; Vissoci J. R. N., 2013, ARXIV PREPRINT ARXIV; Wells GA, 2014, NEWCASTLEOTTAWA SCAL; World Health Organization, 2009, GLOB STAT REP ROAD S; WPoTRE E.T.S.C, 1999, POLICE ENFORCEMENT S; Zimmerman K, 2015, TRAFFIC INJ PREV, V16, P456, DOI 10.1080/15389588.2014.973491	50	93	93	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144971	10.1371/journal.pone.0144971	http://dx.doi.org/10.1371/journal.pone.0144971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26735918	Green Published, gold			2022-12-27	WOS:000367805100017
J	Chen, ML; Wang, CY; Wang, W; Ji, GB; Hu, B; Du, M; Liu, GS; Li, ZP; Wang, WY; Lin, XZ; Zheng, WB; Chen, JM				Chen, Mingliang; Wang, Chenying; Wang, Wei; Ji, Gubiao; Hu, Bin; Du, Mi; Liu, Guosheng; Li, Zengpeng; Wang, Weiyi; Lin, Xiangzhi; Zheng, Weibing; Chen, Jianming			De Novo Assembly and Characterization of Early Embryonic Transcriptome of the Horseshoe Crab Tachypleus tridentatus	PLOS ONE			English	Article							LIMULUS-POLYPHEMUS; PAX GENES; EVOLUTION; CHELICERATA; PATHWAYS	The horseshoe crab Tachypleus tridentatus is a unique marine species and a potential model for marine invertebrate. Limited genomic and transcriptional data are currently available to understand the molecular mechanisms underlying the embryonic development of T. tridentatus. Here, we reported for the first time the de novo transcriptome assembly for T. tridentatus at embryonic developmental stage using Illumina RNA-seq platform. Approximate 38 million reads were obtained and further assembled into 133,212 unigenes. Sequence homology analysis against public databases revealed that 33,796 unigenes could be annotated with gene descriptions. Of the annotated unigenes, we identified a number of key components of several conserved metazoan signaling pathways (Hedgehog, Wnt, TGF-beta and Notch pathways) and other important regulatory genes involved in embryonic development. Targeted searching of Pax family genes which play critical roles in the formation of tissue and organ during embryonic development identified a complete set of Pax family genes. Moreover, the full length T. tridentatus Pax1/9a (TtPax1/9a) and Pax1/9b (TtPax1/9b) cDNA sequences were determined based on the transcriptome, demonstrating the immediate application of our database. Using quantitative real time PCR, we analyzed the expression patterns of TtPax1/9a and TtPax1/9b in different tissues of horseshoe crab. Taking advantage of Drosophila model, we further found that TtPax1/9b, but not TtPax1/9a, can partly rescue the Drosophila homolog Poxm dysfunction-caused lethality at the larval stage. Our study provides the embryonic transcriptome of T. tridentatus which could be immediately used for gene discovery and characterization, functional genomics studies in T. tridentatus. This transcriptome database will also facilitate the investigations of molecular mechanisms underlying embryonic development of T. tridentatus and other marine arthropods as well.	[Chen, Mingliang; Wang, Chenying; Wang, Wei; Ji, Gubiao; Hu, Bin; Du, Mi; Liu, Guosheng; Li, Zengpeng; Wang, Weiyi; Chen, Jianming] State Ocean Adm, State Key Lab Breeding Base Marine Genet Resource, South China Sea Bioresource Exploitat & Utilizat, Inst Oceanog 3, Xiamen, Fujian Province, Peoples R China; [Lin, Xiangzhi; Zheng, Weibing] State Ocean Adm, Ctr Marine Biotechnol, Inst Oceanog 3, Xiamen, Fujian Province, Peoples R China	State Oceanic Administration; State Oceanic Administration	Chen, JM (corresponding author), State Ocean Adm, State Key Lab Breeding Base Marine Genet Resource, South China Sea Bioresource Exploitat & Utilizat, Inst Oceanog 3, Xiamen, Fujian Province, Peoples R China.	chenjm@xmu.edu.cn	Wang, Weiyi/GZN-0408-2022	Liu, Guosheng/0000-0002-8069-6268; Wang, Weiyi/0000-0003-3163-9491; wang, chenying/0000-0001-8400-8576	marine public welfare grant [201005022]; OMRA research grant [DY125-15-T-03]; National Natural Science Foundation of China [31171366, 31271567]	marine public welfare grant; OMRA research grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by marine public welfare grant 201005022 (http://www.soa.gov.cn/) to JC, COMRA research grant DY125-15-T-03 (http://www.comra.org/) to JC and grants from the National Natural Science Foundation of China 31171366 and 31271567 (http://www.nsfc.gov.cn/) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias Alfonso Martinez, 2008, V420, P1, DOI 10.1007/978-1-59745-583-1_1; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Botton ML, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P45, DOI 10.1007/978-0-387-89959-6_3; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Duan H, 2007, DEVELOPMENT, V134, P3985, DOI 10.1242/dev.008821; Fisher D.C., 1984, P196; Gilbert SF, 2006, DEV BIOL; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harzsch S, 2006, DEV DYNAM, V235, P2641, DOI 10.1002/dvdy.20866; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2011, CELL MOL LIFE SCI, V68, P243, DOI 10.1007/s00018-010-0536-y; Kamaruzzaman BY, 2011, ASIAN J BIOTECHNOL, V3, P302, DOI DOI 10.3923/AJBKR.2011.302.309; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Mittmann B, 2003, DEV GENES EVOL, V213, P9, DOI 10.1007/s00427-002-0285-5; Mittmann B, 2002, BIOL BULL-US, V203, P221, DOI 10.2307/1543407; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; Pearson SM, 1997, DEV BIOL STAND, V34, P7; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI [10.1038/NMETH.1800, 10.1038/nmeth.1800]; Rudkin DM, 2008, PALAEONTOLOGY, V51, P1, DOI 10.1111/j.1475-4983.2007.00746.x; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Sekiguchi K., 1982, Progress in Clinical and Biological Research, V81, P53; SEKIGUCHI K, 1988, BIOL BULL, V174, P337, DOI 10.2307/1541959; Sekiguchi K., 1988, BIOL HORSESHOE CRABS; Smith SA, 2005, LAB ANIMAL, V34, P27, DOI 10.1038/laban0705-27; Sugita H., 1982, Progress in Clinical and Biological Research, V81, P75; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Twyman R, 2001, BIOS INSTANT NOTES D; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Walls EA, 2002, REV FISH SCI, V10, P39, DOI 10.1080/20026491051677; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wunderlich Z, 2011, CURR OPIN GENET DEV, V21, P711, DOI 10.1016/j.gde.2011.07.005; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3	40	5	5	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145825	10.1371/journal.pone.0145825	http://dx.doi.org/10.1371/journal.pone.0145825			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731763	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400058
J	Harmon, TM; Fisher, KA; McGlynn, MG; Stover, J; Warren, MJ; Teng, Y; Naveke, A				Harmon, Thomas M.; Fisher, Kevin A.; McGlynn, Margaret G.; Stover, John; Warren, Mitchell J.; Teng, Yu; Naeveke, Arne			Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low-and Middle-Income Countries	PLOS ONE			English	Article							HIV VACCINES; TRANSMISSION; INFECTION; MODEL	Background The Investment Framework Enhanced (IFE) proposed in 2013 by the Joint United Nations Programme on HIV/AIDS (UNAIDS) explored how maximizing existing interventions and adding emerging prevention options, including a vaccine, could further reduce new HIV infections and AIDS-related deaths in low-and middle-income countries (LMICs). This article describes additional modeling which looks more closely at the potential health impact and cost-effectiveness of AIDS vaccination in LMICs as part of UNAIDS IFE. Methods An epidemiological model was used to explore the potential impact of AIDS vaccination in LMICs in combination with other interventions through 2070. Assumptions were based on perspectives from research, vaccination and public health experts, as well as observations from other HIV/AIDS interventions and vaccination programs. Sensitivity analyses varied vaccine efficacy, duration of protection, coverage, and cost. Results If UNAIDS IFE goals were fully achieved, new annual HIV infections in LMICs would decline from 2.0 million in 2014 to 550,000 in 2070. A 70% efficacious vaccine introduced in 2027 with three doses, strong uptake and five years of protection would reduce annual new infections by 44% over the first decade, by 65% the first 25 years and by 78% to 122,000 in 2070. Vaccine impact would be much greater if the assumptions in UNAIDS IFE were not fully achieved. An AIDS vaccine would be cost-effective within a wide range of scenarios. Interpretation Even a modestly effective vaccine could contribute strongly to a sustainable response to HIV/AIDS and be cost-effective, even with optimistic assumptions about other interventions. Higher efficacy would provide even greater impact and cost-effectiveness, and would support broader access. Vaccine efficacy and cost per regimen are critical in achieving cost-effectiveness, with cost per regimen being particularly critical in low-income countries and at lower efficacy levels.	[Harmon, Thomas M.] Int AIDS Vaccine Initiat, New York, NY 10038 USA; [Fisher, Kevin A.; Warren, Mitchell J.] AVAC, New York, NY USA; [Stover, John; Teng, Yu] Avenir Hlth, Glastonbury, CT USA	International AIDS Vaccine Initiative	Harmon, TM (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10038 USA.	tharmon@iavi.org; anaeveke@iavi.org			United States Agency for International Development (USAID) [AID-OAA- A-11-00020]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The study was funded through the generous support of the American people by the United States Agency for International Development (USAID) under Cooperative Agreement No. AID-OAA- A-11-00020. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	AVAC, 2015, AIDS VACC RES OV; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Esparza J, 2013, VACCINE, V31, P3502, DOI 10.1016/j.vaccine.2013.05.018; GAVI, 2015, VACC ALL COUNTR EL S; Hankins CA, 2011, VACCINE, V29, P6069, DOI 10.1016/j.vaccine.2011.07.001; Harmon T, 2015, VACCINES-BASEL, V3, P1, DOI 10.3390/vaccines3010001; Henry J., 2015, 734711 UNAIDS HENRY; IAVIReport, 2015, CLIN TRIALS DAT DAT; International Association of Providers of AIDS Care, GLOB HIV POL WATCH A; Jit M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7584; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Lema D, 2014, SCAND J IMMUNOL, V80, P1, DOI 10.1111/sji.12184; Levin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101114; Levine OS, 2010, CURR OPIN INFECT DIS, V23, P236, DOI 10.1097/QCO.0b013e328338c135; National Institute of Allergy and Infectious Diseases, 2015, NIH SPONS HIV VACC T; Newall AT, 2014, PHARMACOECONOMICS, V32, P525, DOI 10.1007/s40273-014-0162-x; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Raymond A, 2014, J INT AIDS SOC, V17, P13, DOI 10.7448/IAS.17.4.19507; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2007, HEALTH AFFAIR, V26, P1147, DOI 10.1377/hlthaff.26.4.1147; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; UNAIDS, FAST TRACK END AIDS; UNAIDS, 2015, AIDS CHANG EV MDG 6; UNAIDS, 2015, AIDSINFO EP STAT UNA; World Health Organization, 2001, 200113984 WHO COMM M; World Health Organization, 2015, GUID START ANT THER	28	26	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146387	10.1371/journal.pone.0146387	http://dx.doi.org/10.1371/journal.pone.0146387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731116	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400169
J	Hu, SL; Xiong, W; Dai, ZQ; Zhao, HL; Feng, H				Hu, Sheng Li; Xiong, Wei; Dai, Zhi Qiang; Zhao, Heng Li; Feng, Hua			Cognitive Changes during Prolonged Stay at High Altitude and Its Correlation with C-Reactive Protein	PLOS ONE			English	Article							INFLAMMATORY BIOMARKERS; CEREBRAL OXYGENATION; TOTAL HOMOCYSTEINE; VASCULAR DEMENTIA; HYPOBARIC HYPOXIA; BRAIN VOLUME; IMPAIRMENT; PERFORMANCE; EXPOSURE; DECLINE	Hypersensitive C-reaction protein (hsCRP) may be a risk factor for cognitive impairment resulting from Alzheimer's disease (AD), stroke, and vascular dementia. This study explored the correlation of peripheral blood hsCRP level with cognitive decline due to high altitude exposure. The study was conducted on 100 male military participants who had never been to high altitude. Cerebral oxygen saturation monitoring, event related potentials (P300, N200) detection, and neurocognitive assessment was performed and total hsCRP, interleukin-6 (IL-6), and homocysteine was estimated at 500m altitude, 3650m altitude, 3day, 1, and 3 month post arriving at the base camp (4400m), and 1 month after coming back to the 500m altitude. High altitude increased brain oxygen saturation, prolonged P300 and N200 latencies, injured cognitive functions, and raised plasma hsCRP levels. But they all recovered in varying degrees at 1 and 3 month post arriving at the base camp (4400m). P300 latencies and hsCRP levels were strongly correlated to cognitive performances. These results suggested that cognitive deterioration occurred during the acute period of exposure to high altitude and may recover probably owning to acclimatization after extended stay at high altitude. Plasma hsCRP is inversely correlated to neurological cognition and it may be a potential biomarker for the prediction of high altitude induced cognitive dysfunction.	[Hu, Sheng Li; Dai, Zhi Qiang; Zhao, Heng Li; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Collaborat Innovat Ctr Brain Sci, Chongqing 400038, Peoples R China; [Xiong, Wei] Third Mil Med Univ, Southwest Hosp, Dept Respirat, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Collaborat Innovat Ctr Brain Sci, Chongqing 400038, Peoples R China.	fenghua8888@vip.163.com	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217	National Natural Science Foundation of China [81471261]; major special program of PLA in China [AWS12J004]; Southwest Hospital Science Program [SWH2014JS01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); major special program of PLA in China; Southwest Hospital Science Program	This work was supported by grants from the National Natural Science Foundation of China (No. 81471261), the major special program of PLA in China (No. AWS12J004), and Southwest Hospital Science Program (No. SWH2014JS01).	Bettcher BM, 2012, BRAIN BEHAV IMMUN, V26, P103, DOI 10.1016/j.bbi.2011.07.240; Bonnon M, 2000, AVIAT SPACE ENVIR MD, V71, P678; Davis JE, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-014-0039-x; Gao YX, 2015, EUR J NEUROL, V22, P1363, DOI 10.1111/ene.12507; Goldstein FC, 2015, INT J GERIATR PSYCH, V30, P934, DOI 10.1002/gps.4238; Gorelick PB, 2010, ANN NY ACAD SCI, V1207, P155, DOI 10.1111/j.1749-6632.2010.05726.x; Hadolt I, 2003, NEUROL RES, V25, P183, DOI 10.1179/016164103101201175; Hayashi R, 2000, J NEUROL SCI, V178, P52, DOI 10.1016/S0022-510X(00)00362-2; Hayashi R, 2005, CLIN NEUROPHYSIOL, V116, P1471, DOI 10.1016/j.clinph.2005.02.020; Imray CHE, 1998, WILD ENVIRON MED, V9, P198, DOI 10.1580/1080-6032(1998)009[0198:NISITA]2.3.CO;2; Jefferson AL, 2007, NEUROLOGY, V68, P1032, DOI 10.1212/01.wnl.0000257815.20548.df; Jordanova V, 2007, INT J GERIATR PSYCH, V22, P966, DOI 10.1002/gps.1772; Kinoshita M, 2013, EPIGENETICS-US, V8, P584, DOI 10.4161/epi.24621; Kliper E, 2013, STROKE, V44, P1433, DOI 10.1161/STROKEAHA.111.000536; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; Miralbell J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.020; Mooijaart SP, 2013, J INTERN MED, V274, P77, DOI 10.1111/joim.12052; Noble JM, 2010, ARCH NEUROL-CHICAGO, V67, P87, DOI 10.1001/archneurol.2009.308; Pratico D, 2000, NEUROBIOL AGING, V21, P441, DOI 10.1016/S0197-4580(00)00141-X; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Richardson C, 2011, CLIN NEUROPHYSIOL, V122, P1726, DOI 10.1016/j.clinph.2011.02.001; Rostrup M, 1998, ACTA PHYSIOL SCAND, V162, P389, DOI 10.1046/j.1365-201X.1998.00335.x; Satizabal CL, 2012, NEUROLOGY, V78, P720, DOI 10.1212/WNL.0b013e318248e50f; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Sharma VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101448; SHUKITTHALE B, 1994, BEHAV NEURAL BIOL, V62, P244, DOI 10.1016/S0163-1047(05)80023-8; Singh S B, 2003, Indian J Physiol Pharmacol, V47, P52; Sudduth TL, 2013, J CEREBR BLOOD F MET, V33, P708, DOI 10.1038/jcbfm.2013.1; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Vidal JS, 2008, NEUROEPIDEMIOLOGY, V30, P207, DOI 10.1159/000126914; Wang JY, 2013, NEUROTOXICOL TERATOL, V35, P28, DOI 10.1016/j.ntt.2012.12.003; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Wright CB, 2004, NEUROLOGY, V63, P254, DOI 10.1212/01.WNL.0000129986.19019.5D; Zuliani G, 2007, J PSYCHIATR RES, V41, P686, DOI 10.1016/j.jpsychires.2006.02.008	36	47	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146290	10.1371/journal.pone.0146290	http://dx.doi.org/10.1371/journal.pone.0146290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731740	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400139
J	Li, HH; Lv, MJ; Song, LQ; Zhang, JP; Gao, AN; Li, LH; Liu, WH				Li, Huanhuan; Lv, Mingjie; Song, Liqiang; Zhang, Jinpeng; Gao, Ainong; Li, Lihui; Liu, Weihua			Production and Identification of Wheat-Agropyron cristatum 2P Translocation Lines	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CYTOGENETIC CHARACTERIZATION; CONFERRING RESISTANCE; DURUM-WHEAT; CRESTED WHEATGRASS; TRITICUM-TAUSCHII; POWDERY MILDEW; CHROMOSOME 6P; LEAF RUST; INTROGRESSION	Agropyron cristatum (L.) Gaertn. (2n = 28, PPPP), a wild relative of common wheat, possesses many potentially valuable traits that can be transferred to common wheat through breeding programs. The wheat-A. cristatum disomic addition and translocation lines can be used as bridge materials to introduce alien chromosomal segments to wheat. Wheat-A. cristatum 2P disomic addition line II-9-3 was highly resistant to powdery mildew and leaf rust, which was reported in our previous study. However, some translocation lines induced from II-9-3 have not been reported. In this study, some translocation lines were induced from II-9-3 by(60)Co-Upsilon irradiation and gametocidal chromosome 2C and then identified by cytological methods. Forty-nine wheat-A. cristatum translocation lines were obtained and various translcoation types were identified by GISH (genomic in situ hybridization), such as whole-arm, segmental and intercalary translocations. Dual-color FISH (fluorescent in situ hybridization) was applied to identify the wheat chromosomes involved in the translocations, and the results showed that A. cristatum 2P chromosome segments were translocated to the different wheat chromosomes, including 1A, 2A, 3A, 4A, 5A, 6A, 7A, 3B, 5B, 7B, 1D, 4D and 6D. Many different types of wheat-A. cristatum alien translocation lines would be valuable for not only identifying and cloning A. cristatum 2P-related genes and understanding the genetics and breeding effects of the translocation between A. cristatum chromosome 2P and wheat chromosomes, but also providing new germplasm resources for the wheat genetic improvement.	[Li, Huanhuan; Lv, Mingjie; Song, Liqiang; Zhang, Jinpeng; Gao, Ainong; Li, Lihui; Liu, Weihua] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, LH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	lilihui@caas.cn; liuweihua@caas.cn		Lyu, Mingjie/0000-0001-5325-4010	National High Technology Research and Development Program ("863" Program) of China [2011AA100102]; National Scientific and Technological Supporting Program of China [2013BAD01B02]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); National Scientific and Technological Supporting Program of China	This work was supported by the grant of the National High Technology Research and Development Program ("863" Program) of China (No. 2011AA100102) and the National Scientific and Technological Supporting Program of China (No. 2013BAD01B02). WHL received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAY KH, 1990, CROP SCI, V30, P79, DOI 10.2135/cropsci1990.0011183X003000010018x; Badaeva ED, 2007, GENOME, V50, P907, DOI 10.1139/G07-072; Bie TD, 2007, J INTEGR PLANT BIOL, V49, P1619, DOI 10.1111/j.1774-7909.2007.00578.x; Cao YP, 2009, J GENET GENOMICS, V36, P313, DOI 10.1016/S1673-8527(08)60120-4; Ceoloni C, 2006, GEN RESOUR CHROM ENG, V2, P27; CHEN Q, 1989, CR ACAD SCI III-VIE, V309, P519; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Danilova TV, 2014, THEOR APPL GENET, V127, P715, DOI 10.1007/s00122-013-2253-z; Calderon MD, 2012, PLANT BREEDING, V131, P733, DOI 10.1111/j.1439-0523.2012.02010.x; Dewey DR, 1984, GENOMIC SYSTEM CLASS; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; DUBIN HJ, 1981, ANNU REV PHYTOPATHOL, V19, P41, DOI 10.1146/annurev.py.19.090181.000353; Endo TR, 2007, CHROMOSOME RES, V15, P67, DOI 10.1007/s10577-006-1100-3; Faris JD, 2008, CHROMOSOME RES, V16, P1097, DOI 10.1007/s10577-008-1261-3; FRIEBE B, 1991, THEOR APPL GENET, V81, P381, DOI 10.1007/BF00228680; FRIEBE B, 1992, THEOR APPL GENET, V83, P775, DOI 10.1007/BF00226697; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Fu BS, 2013, THEOR APPL GENET, V126, P913, DOI 10.1007/s00122-012-2025-1; Fu SL, 2014, J PLANT RES, V127, P743, DOI 10.1007/s10265-014-0659-6; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054057; Gill BS, 2006, ADV AGRON, V89, P73, DOI 10.1016/S0065-2113(05)89002-9; GRIFFEY CA, 1993, PLANT DIS, V77, P618, DOI 10.1094/PD-77-0618; Han HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091066; Hao YF, 2015, THEOR APPL GENET, V128, P465, DOI 10.1007/s00122-014-2445-1; HSIAO C, 1989, GENOME, V32, P1079, DOI 10.1139/g89-557; Huang C, 2013, J PLANT GENET RESOUR, V4, P004; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Jubault M, 2006, GENOME, V49, P190, DOI 10.1139/G05-074; Khan M. H., 2013, Agricultural Sciences, V4, P292; Kidwell Kimberlee K., 1992, P1; LI L, 1991, Scientia Agricultura Sinica, V24, P1; Li L, 1995, CHINESE SCI ABSTRA B; Li L.H., 1993, ACTA GENET SIN, V15, P45; Li L.H., 1997, ACTA GENET SIN, V24, P154; Li Li-hui, 1998, Acta Genetica Sinica, V25, P538; Li RD, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0331-4; LIMIN AE, 1990, GENOME, V33, P581, DOI 10.1139/g90-085; Liu WH, 2010, GENOME, V53, P472, DOI [10.1139/G10-023, 10.1139/g10-023]; Liu WX, 2013, THEOR APPL GENET, V126, P1167, DOI 10.1007/s00122-013-2044-6; Luan Y, 2010, PLANTA, V232, P501, DOI 10.1007/s00425-010-1187-9; Martin A, 1999, GENOME, V42, P519, DOI 10.1139/gen-42-3-519; Martin A, 1998, HEREDITAS, V129, P113, DOI 10.1111/j.1601-5223.1998.00113.x; McIntosh R, 2013, MACGENE 2012 CATALOG; MUKAI Y, 1993, GENOME, V36, P489, DOI 10.1139/g93-067; Niu Z, 2014, THEOR APPL GENET, V127, P969, DOI 10.1007/s00122-014-2272-4; Ochoa V, 2015, EUPHYTICA, V201, P89, DOI 10.1007/s10681-014-1190-5; Pang YH, 2014, J GENET GENOMICS, V41, P205, DOI 10.1016/j.jgg.2013.11.008; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Placido DF, 2013, PLANT PHYSIOL, V161, P1806, DOI 10.1104/pp.113.214262; Qi ZJ, 2010, THEOR APPL GENET, V121, P589, DOI 10.1007/s00122-010-1332-7; Ren Y, 2012, THEOR APPL GENET, V125, P1253, DOI 10.1007/s00122-012-1910-y; Sears E., 1956, GENETICS PLANT BREED; SEARS ER, 1993, CROP SCI, V33, P897, DOI 10.2135/cropsci1993.0011183X003300050004x; SHARMA D, 1966, CAN J GENET CYTOL, V8, P137, DOI 10.1139/g66-018; Smith DC, 1942, J AGRIC RES, V64, P0033; Soliman MH, 2001, HEREDITAS, V135, P183, DOI 10.1111/j.1601-5223.2001.00183.x; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069501; Su WY, 2013, GENET MOL RES, V12, P2227, DOI 10.4238/2013.July.8.4; Tiwari VK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-273; Wang DW, 2009, J GENET GENOMICS, V36, P509, DOI 10.1016/S1673-8527(08)60141-1; WHITE W. J., 1940, SCI AGRIC [OTTAWA], V21, P198; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Ye XL, 2015, THEOR APPL GENET, V128, P797, DOI 10.1007/s00122-015-2466-4; Zhang QP, 2005, EUPHYTICA, V145, P317, DOI 10.1007/s10681-005-1743-8; Zhang RQ, 2014, THEOR APPL GENET, V127, P523, DOI 10.1007/s00122-013-2244-0; Zhang RQ, 2012, GENOME, V55, P639, DOI [10.1139/G2012-051, 10.1139/g2012-051]; Zhao RH, 2013, THEOR APPL GENET, V126, P2921, DOI 10.1007/s00122-013-2181-y	68	25	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145928	10.1371/journal.pone.0145928	http://dx.doi.org/10.1371/journal.pone.0145928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731742	Green Published, gold			2022-12-27	WOS:000367801400067
J	Markianos, K; Bischoff, E; Mitri, C; Guelbeogo, WM; Gneme, A; Eiglmeier, K; Holm, I; Sagnon, N; Vernick, KD; Riehle, MM				Markianos, Kyriacos; Bischoff, Emmanuel; Mitri, Christian; Guelbeogo, Wamdaogo M.; Gneme, Awa; Eiglmeier, Karin; Holm, Inge; Sagnon, N'Fale; Vernick, Kenneth D.; Riehle, Michelle M.			Genetic Structure of a Local Population of the Anopheles gambiae Complex in Burkina Faso	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; HUMAN MALARIA PARASITES; MOLECULAR-FORMS; GENOMIC ISLANDS; S FORMS; INCIPIENT SPECIATION; SPECIAL EMPHASIS; SPECIES COMPLEX; VECTOR; RESISTANCE	Members of the Anopheles gambiae species complex are primary vectors of human malaria in Africa. Population heterogeneities for ecological and behavioral attributes expand and stabilize malaria transmission over space and time, and populations may change in response to vector control, urbanization and other factors. There is a need for approaches to comprehensively describe the structure and characteristics of a sympatric local mosquito population, because incomplete knowledge of vector population composition may hinder control efforts. To this end, we used a genome-wide custom SNP typing array to analyze a population collection from a single geographic region in West Africa. The combination of sample depth (n = 456) and marker density (n = 1536) unambiguously resolved population subgroups, which were also compared for their relative susceptibility to natural genotypes of Plasmodium falciparum malaria. The population subgroups display fluctuating patterns of differentiation or sharing across the genome. Analysis of linkage disequilibrium identified 19 new candidate genes for association with underlying population divergence between sister taxa, A. coluzzii (M-form) and A. gambiae (S-form).	[Markianos, Kyriacos] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Bischoff, Emmanuel; Mitri, Christian; Eiglmeier, Karin; Holm, Inge; Vernick, Kenneth D.] Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasites & Insect Vectors, CNRS,Unit Hosts Vectors & Pathogens,URA3012, F-75015 Paris, France; [Bischoff, Emmanuel; Mitri, Christian; Eiglmeier, Karin; Holm, Inge; Vernick, Kenneth D.] CNRS, Unit Hosts Vectors & Pathogens, URA3012, F-75015 Paris, France; [Guelbeogo, Wamdaogo M.; Gneme, Awa; Sagnon, N'Fale] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Vernick, Kenneth D.; Riehle, Michelle M.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Minnesota System; University of Minnesota Twin Cities	Vernick, KD (corresponding author), Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasites & Insect Vectors, CNRS,Unit Hosts Vectors & Pathogens,URA3012, F-75015 Paris, France.	kvernick@pasteur.fr	Bischoff, Emmanuel/F-1197-2011	Bischoff, Emmanuel/0000-0003-4655-4247; Markianos, Kyriacos/0000-0003-0214-6014; Mitri, Christian/0000-0003-3882-2029	European Commission, FP7 Infrastructures [228421 Infravec]; European Research Council [323173]; National Institutes of Health, NIAID R01 [AI073685]; French Laboratoire d'Excellence, "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	European Commission, FP7 Infrastructures(European Commission); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health, NIAID R01; French Laboratoire d'Excellence, "Integrative Biology of Emerging Infectious Diseases"	This work received financial support to KDV from the European Commission (http://ec.europa.eu/research/fp7/index_en.cfm), FP7 Infrastructures #228421 Infravec; European Research Council (http://erc.europa.eu/funding-and-grants), Support for frontier research, Advanced Grant #323173; National Institutes of Health (http://grants.nih.gov/grants/guide/index.html?CFID=49130899&CFTOKEN=42657567&jsessionid= f630163215e4bea230912b25e13534c77157), NIAID R01 #AI073685; and French Laboratoire d'Excellence (http://www.enseignementsup-recherche.gouv.fr/cid55551/investissements-avenir-projets-labex-par-region-domaine.html), "Integrative Biology of Emerging Infectious Diseases" #ANR-10-LABX-62-IBEID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Cohuet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-227; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1977, NATURE, V266, P832, DOI 10.1038/266832a0; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Crawford JE, 2012, G3-GENES GENOM GENET, V2, P1505, DOI 10.1534/g3.112.004473; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Fryxell RTT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-133; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Githeko A. K., 1996, Parassitologia (Rome), V38, P481; Gneme A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-204; Gneme A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-67; Illumina, 2014, GEN GEN MOD US GUID; Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110; Lee Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-75; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Ndiath MO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-340; Ndiath MO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-136; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Pinto J, 2013, EVOL APPL, V6, P910, DOI 10.1111/eva.12075; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Riehle MM, 2011, SCIENCE, V331, P596, DOI 10.1126/science.1196759; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027920; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Stathopoulos S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003897; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618; Tripet F, 2003, AM J TROP MED HYG, V68, P1; Turner TL, 2010, MOL ECOL, V19, P848, DOI 10.1111/j.1365-294X.2010.04532.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Wang-Sattler R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001249; Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; White BJ, 2007, AM J TROP MED HYG, V76, P334; White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2	62	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145308	10.1371/journal.pone.0145308	http://dx.doi.org/10.1371/journal.pone.0145308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731649	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400030
J	Peng, ZC; Andersson, K; Lindholm, J; Dethlefsen, O; Pramana, S; Pawitan, Y; Nister, M; Nilsson, S; Li, CD				Peng, Zhuochun; Andersson, Karl; Lindholm, Johan; Dethlefsen, Olga; Pramana, Setia; Pawitan, Yudi; Nister, Monica; Nilsson, Sten; Li, Chunde			Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; MANAGEMENT	Background A previously reported expression signature of three genes (IGFBP3, F3 and VGLL3) was shown to have potential prognostic value in estimating overall and cancer-specific survivals at diagnosis of prostate cancer in a pilot cohort study using freshly frozen Fine Needle Aspiration (FNA) samples. Methods We carried out a new cohort study with 241 prostate cancer patients diagnosed from 20042007 with a follow-up exceeding 6 years in order to verify the prognostic value of gene expression signature in formalin fixed paraffin embedded (FFPE) prostate core needle biopsy tissue samples. The cohort consisted of four patient groups with different survival times and death causes. A four multiplex one-step RT-qPCR test kit, designed and optimized for measuring the expression signature in FFPE core needle biopsy samples, was used. In archive FFPE biopsy samples the expression differences of two genes (IGFBP3 and F3) were measured. The survival time predictions using the current clinical parameters only, such as age at diagnosis, Gleason score, PSA value and tumor stage, and clinical parameters supplemented with the expression levels of IGFBP3 and F3, were compared. Results When combined with currently used clinical parameters, the gene expression levels of IGFBP3 and F3 are improving the prediction of survival time as compared to using clinical parameters alone. Conclusion The assessment of IGFBP3 and F3 gene expression levels in FFPE prostate cancer tissue would provide an improved survival prediction for prostate cancer patients at the time of diagnosis.	[Peng, Zhuochun; Nister, Monica; Nilsson, Sten; Li, Chunde] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Andersson, Karl] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Lindholm, Johan; Nister, Monica] Karolinska Univ Hosp, Clin Pathol Cytol, Stockholm, Sweden; [Dethlefsen, Olga; Pramana, Setia; Pawitan, Yudi] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Nilsson, Sten; Li, Chunde] Karolinska Univ Hosp, Clin Oncol, Stockholm, Sweden; [Peng, Zhuochun; Li, Chunde] Chundsell Med AB, Stockholm, Sweden; [Andersson, Karl] Ridgeview Instruments AB, Uppsala, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Li, CD (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Chunde.li@ki.se	Dethlefsen, Olga/AAE-1395-2022; Dethlefsen, Olga/I-5163-2012	Dethlefsen, Olga/0000-0003-0502-1401; Dethlefsen, Olga/0000-0003-0502-1401; Pramana, Setia/0000-0002-8590-1451; Li, Chunde/0000-0003-4331-079X	Uppsala Bio; Swedish Cancer Society; King Gustaf V Jubilee Foundation; Stockholm county council; Chundsell Medicals AB; Ridgeview Instruments AB	Uppsala Bio; Swedish Cancer Society(Swedish Cancer Society); King Gustaf V Jubilee Foundation; Stockholm county council(Stockholm County Council); Chundsell Medicals AB(HOGANAS ABStatisticon AB); Ridgeview Instruments AB	This work was financed by Uppsala Bio (http://www.uppsalabio.com/), the Swedish Cancer Society (http://www.cancerfonden.se/sv/Informationin-English/), the King Gustaf V Jubilee Foundation (http://www.rahfo.se/Metamenyn/In-English/) and the Stockholm county council (http://www.sll.se/omlandstinget/Information-in-%20English1/). Chundsell Medicals AB and Ridgeview Instruments AB provided support in the form of salaries for authors ZP and KA, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amin MB, 2014, ARCH PATHOL LAB MED, V138, P1387, DOI 10.5858/arpa.2014-0219-SA; Bratt O, 2015, EUROPEAN UROLOGY, DOI [10.1016/eururo.2014.12.026, DOI 10.1016/EURUR0.2014.12.026]; Choudhury AD, 2012, EUR UROL, V62, P577, DOI 10.1016/j.eururo.2012.05.054; Crook J, 2013, SEMIN RADIAT ONCOL, V23, P165, DOI 10.1016/j.semradonc.2013.01.002; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; Das J, 2014, CANCER INFORM, V13, P85, DOI 10.4137/CIN.S14064; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Maksem JA, 2007, DIAGN CYTOPATHOL, V35, P778, DOI 10.1002/dc.20764; Overholser S, 2015, J UROLOGY, DOI [10.1016/j.juro.2015.01.089, DOI 10.1016/J.JUR0.2015.01.089]; Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56; Peng Z, 2014, PROSTATE CANCER P D, V17, P81, DOI 10.1038/pcan.2013.57; Peng ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109610; Yeo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089395	15	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145545	10.1371/journal.pone.0145545	http://dx.doi.org/10.1371/journal.pone.0145545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731648	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400039
J	Spengler, N; Hofflin, J; Moazenzadeh, A; Mager, D; MacKinnon, N; Badilita, V; Wallrabe, U; Korvink, JG				Spengler, Nils; Hoefflin, Jens; Moazenzadeh, Ali; Mager, Dario; MacKinnon, Neil; Badilita, Vlad; Wallrabe, Ulrike; Korvink, Jan G.			Heteronuclear Micro-Helmholtz Coil Facilitates mu m-Range Spatial and Sub-Hz Spectral Resolution NMR of nL-Volume Samples on Customisable Microfluidic Chips	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; DESIGN; PROBE	We present a completely revised generation of a modular micro-NMR detector, featuring an active sample volume of similar to 100 nL, and an improvement of 87% in probe efficiency. The detector is capable of rapidly screening different samples using exchangeable, application-specific, MEMS-fabricated, microfluidic sample containers. In contrast to our previous design, the sample holder chips can be simply sealed with adhesive tape, with excellent adhesion due to the smooth surfaces surrounding the fluidic ports, and so withstand pressures of similar to 2.5 bar, while simultaneously enabling high spectral resolution up to 0.62 Hz for H2O, due to its optimised geometry. We have additionally reworked the coil design and fabrication processes, replacing liquid photoresists by dry film stock, whose final thickness does not depend on accurate volume dispensing or precise levelling during curing. We further introduced mechanical alignment structures to avoid time-intensive optical alignment of the chip stacks during assembly, while we exchanged the laser-cut, PMMA spacers by diced glass spacers, which are not susceptible to melting during cutting. Doing so led to an overall simplification of the entire fabrication chain, while simultaneously increasing the yield, due to an improved uniformity of thickness of the individual layers, and in addition, due to more accurate vertical positioning of the wirebonded coils, now delimited by a post base plateau. We demonstrate the capability of the design by acquiring a H-1 spectrum of similar to 11 nmol sucrose dissolved in D2O, where we achieved a linewidth of 1.25 Hz for the TSP reference peak. Chemical shift imaging experiments were further recorded from voxel volumes of only similar to 1.5nL, which corresponded to amounts of just 1.5 nmol per voxel for a 1 M concentration. To extend the micro-detector to other nuclei of interest, we have implemented a trap circuit, enabling heteronuclear spectroscopy, demonstrated by two H-1/C-13 2D HSQC experiments.	[Spengler, Nils; Mager, Dario; MacKinnon, Neil; Badilita, Vlad; Korvink, Jan G.] Karlsruhe Inst Technol, Inst Microstruct Technol, Eggenstein Leopoldshafen, Germany; [Spengler, Nils; Korvink, Jan G.] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Hoefflin, Jens] Univ Freiburg, IMTEK Dept Microsyst Engn, Lab Simulat, D-79106 Freiburg, Germany; [Moazenzadeh, Ali; Wallrabe, Ulrike] Univ Freiburg, IMTEK Dept Microsyst Engn, Lab Microactuators, D-79106 Freiburg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Freiburg; University of Freiburg; University of Freiburg	Spengler, N (corresponding author), Karlsruhe Inst Technol, Inst Microstruct Technol, Eggenstein Leopoldshafen, Germany.	nils.spengler@kit.edu	Korvink, Jan G./C-6136-2009; Badilita, Vlad/G-2862-2012; MacKinnon, Neil/I-2398-2015; Badilita, Vlad/W-5407-2019; Wallrabe, Ulrike/F-5217-2013	Korvink, Jan G./0000-0003-4354-7295; MacKinnon, Neil/0000-0002-9362-4845; Badilita, Vlad/0000-0002-7956-345X; Wallrabe, Ulrike/0000-0003-0532-1519	European Research Council (ERC) [290586]; Karlsruhe Institute of Technology; Freiburg Institute for Advanced Studies (FRIAS); University of Freiburg; Heinrich Heine University Dusseldorf	European Research Council (ERC)(European Research Council (ERC)European Commission); Karlsruhe Institute of Technology(Helmholtz Association); Freiburg Institute for Advanced Studies (FRIAS)(Fonds de la Recherche Scientifique - FNRS); University of Freiburg; Heinrich Heine University Dusseldorf	NS, DM, NM, VB, and JGK received funding from the European Research Council (ERC, http://erc.europa.eu) grant no. 290586 NMCEL and from the Karlsruhe Institute of Technology (KIT, http://www.kit.edu). NS and JGK further received funding from the Freiburg Institute for Advanced Studies (FRIAS, http://www.frias.uni-freiburg.de). JH, AM, and UW received funding from the University of Freiburg (www.uni-freiburg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Michael Pauls for recording the SEM images, Lorenz Litzenberger for making the polished cuts, and Kay Steffen for electroplating. We thank Volker Lehmann from Bruker BioSpin and Prof. Dr. Ulrich Flogel from Heinrich Heine University Dusseldorf for support with CSI data processing.	Chandrashekar S, 2012, NAT MATER, V11, P311, DOI [10.1038/nmat3246, 10.1038/NMAT3246]; Ehrmann K, 2007, LAB CHIP, V7, P373, DOI 10.1039/b614044k; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Huesgen T, 2010, SENSOR ACTUAT A-PHYS, V162, P137, DOI 10.1016/j.sna.2010.06.008; KAN S, 1980, REV SCI INSTRUM, V51, P887, DOI 10.1063/1.1136352; Kc R, 2009, J MAGN RESON, V197, P186, DOI 10.1016/j.jmr.2008.12.020; Kratt K, 2009, SENSOR ACTUAT A-PHYS, V156, P328, DOI 10.1016/j.sna.2009.10.010; Leidich S, 2009, CONCEPT MAGN RESON B, V35B, P11, DOI 10.1002/cmr.b.20131; Levitt MH, 2008, SPIN DYNAMICS BASICS, VSecond; Meier RC, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/4/045021; Mohmmadzadeh M, 2011, J MAGN RESON, V208, P20, DOI 10.1016/j.jmr.2010.09.021; Muller P, 2010, J MICROELECTROMECH S, V19, P1477, DOI 10.1109/JMEMS.2010.2079917; Olson DL, 2004, ANAL CHEM, V76, P2966, DOI 10.1021/ac035426l; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; PECK TL, 1995, J MAGN RESON SER B, V108, P114, DOI 10.1006/jmrb.1995.1112; Ryan H, 2014, LAB CHIP, V14, P1678, DOI 10.1039/c3lc51431e; Satyanarayana S, 2005, J MICROELECTROMECH S, V14, P392, DOI 10.1109/JMEMS.2004.839334; Simoes RV, 2010, NMR BIOMED, V23, P23, DOI 10.1002/nbm.1421; Spengler N, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/034004; Subramanian R, 1998, ANAL CHEM, V70, P2454, DOI 10.1021/ac980299s; Sutton BP, 2005, MAGN RESON MED, V54, P9, DOI 10.1002/mrm.20531; Uchiyama S, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/11/114009; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vulto P, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/7/077001; Walton JH, 2003, ANAL CHEM, V75, P5030, DOI 10.1021/ac034073n; Wapler MC, 2014, J MAGN RESON, V242, P233, DOI 10.1016/j.jmr.2014.02.005; Webb AG, 1997, PROG NUCL MAG RES SP, V31, P1, DOI 10.1016/S0079-6565(97)00004-6; Zhang X, 2001, J MAGN RESON, V153, P254, DOI 10.1006/jmre.2001.2441	29	38	39	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146384	10.1371/journal.pone.0146384	http://dx.doi.org/10.1371/journal.pone.0146384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730968	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400168
J	Kogovsek, P; Pompe-Novak, M; Petek, M; Fragner, L; Weckwerth, W; Gruden, K				Kogovsek, Polona; Pompe-Novak, Marusa; Petek, Marko; Fragner, Lena; Weckwerth, Wolfram; Gruden, Kristina			Primary Metabolism, Phenylpropanoids and Antioxidant Pathways Are Regulated in Potato as a Response to Potato virus Y Infection	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; CHLOROTIC-MOTTLE VIRUS; GENE-EXPRESSION; REAL-TIME; GABA ACCUMULATION; PLANTS; TOBACCO; TRANSAMINASE; RESISTANCE; DECARBOXYLASE	Potato production is one of the most important agricultural sectors, and it is challenged by various detrimental factors, including virus infections. To control losses in potato production, knowledge about the virus-plant interactions is crucial. Here, we investigated the molecular processes in potato plants as a result of Potato virus Y (PVY) infection, the most economically important potato viral pathogen. We performed an integrative study that links changes in the metabolome and gene expression in potato leaves inoculated with the mild PVYN and aggressive PVYNTN isolates, for different times through disease development. At the beginning of infection (1 day post-inoculation), virus-infected plants showed an initial decrease in the concentrations of metabolites connected to sugar and amino-acid metabolism, the TCA cycle, the GABA shunt, ROS scavangers, and phenylpropanoids, relative to the control plants. A pronounced increase in those metabolites was detected at the start of the strong viral multiplication in infected leaves. The alterations in these metabolic pathways were also seen at the gene expression level, as analysed by quantitative PCR. In addition, the systemic response in the metabolome to PVY infection was analysed. Systemic leaves showed a less-pronounced response with fewer metabolites altered, while phenylpropanoid-associated metabolites were strongly accumulated. There was a more rapid onset of accumulation of ROS scavengers in leaves inoculated with PVYN than those inoculated with PVYNTN. This appears to be related to the lower damage observed for leaves of potato infected with the milder PVYN strain, and at least partially explains the differences between the phenotypes observed.	[Kogovsek, Polona; Pompe-Novak, Marusa; Petek, Marko; Gruden, Kristina] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Kogovsek, Polona] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Fragner, Lena; Weckwerth, Wolfram] Univ Vienna, Dept Ecogen & Syst Biol, Fac Life Sci, Vienna, Austria; [Weckwerth, Wolfram] Univ Vienna, Vienna Metab Ctr VIME, A-1090 Vienna, Austria	National Institute of Biology - Slovenia; University of Ljubljana; University of Vienna; University of Vienna	Kogovsek, P (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Vecna Pot 111, Ljubljana, Slovenia.	polona.kogovsek@nib.si	Petek, Marko/L-6692-2019; Gruden, kristina/AAI-6439-2020; Weckwerth, Wolfram/G-5811-2010	Petek, Marko/0000-0003-3644-7827; Kogovsek, Polona/0000-0002-4035-0115; Pompe Novak, Marusa/0000-0003-4176-849X; Weckwerth, Wolfram/0000-0002-9719-6358; gruden, kristina/0000-0001-5906-8569	Slovenian Research Agency [Z1-4133, N4-0026, P4-0165]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported financially by the Slovenian Research Agency (https://www.arrs.gov.si/en/novo.asp): grant numbers Z1-4133 (PK), N4-0026 (KG) and P4-0165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay N, 2012, J PLANT PHYSIOL, V169, P452, DOI 10.1016/j.jplph.2011.11.006; [Anonymous], [No title captured]; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Baebler S, 2014, J EXP BOT, V65, P1095, DOI 10.1093/jxb/ert447; Baebler S, 2009, MOL PLANT PATHOL, V10, P263, DOI 10.1111/j.1364-3703.2008.00530.x; Baebler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029009; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bazzini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028466; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Choi YH, 2006, J NAT PROD, V69, P742, DOI 10.1021/np050535b; Clark SM, 2009, J EXP BOT, V60, P1743, DOI 10.1093/jxb/erp044; Crosslin JM, 2013, AM J POTATO RES, V90, P2, DOI 10.1007/s12230-012-9286-8; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fernandez-Calvino L, 2014, PLANT PHYSIOL, V166, P1821, DOI 10.1104/pp.114.250340; Forlani G, 2014, PLANT BIOLOGY, V16, P1127, DOI 10.1111/plb.12165; Fouad WM, 2006, PLANT MOL BIOL, V60, P495, DOI 10.1007/s11103-005-4844-9; Goyer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1666-2; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Kandan A, 2002, FOLIA MICROBIOL, V47, P121, DOI 10.1007/BF02817669; Kogovsek P, 2008, J VIROL METHODS, V149, P1, DOI 10.1016/j.jviromet.2008.01.025; Kogovsek P, 2010, PLANT PATHOL, V59, P1121, DOI 10.1111/j.1365-3059.2010.02340.x; Kogovsek P, 2013, PROG BOT, V74, P101, DOI 10.1007/978-3-642-30967-0_3; Koike S, 2013, PLANT CELL PHYSIOL, V54, P793, DOI 10.1093/pcp/pct035; Komatsu K, 2010, MOL PLANT MICROBE IN, V23, P283, DOI 10.1094/MPMI-23-3-0283; Kostyn K, 2012, PLANT SCI, V190, P103, DOI 10.1016/j.plantsci.2012.03.011; Lehrer AT, 2007, PHYSIOL MOL PLANT P, V70, P180, DOI 10.1016/j.pmpp.2007.09.005; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Mari A, 2013, METABOLOMICS, V9, P599, DOI 10.1007/s11306-012-0473-x; Belles JM, 2008, PLANT SCI, V174, P524, DOI 10.1016/j.plantsci.2008.02.008; Park DH, 2010, PLANT J, V64, P318, DOI 10.1111/j.1365-313X.2010.04327.x; Petek M, 2014, MOL ECOL, V23, P5378, DOI 10.1111/mec.12932; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Lopez-Gresa MP, 2012, J PLANT PHYSIOL, V169, P1586, DOI 10.1016/j.jplph.2012.05.021; Pompe-Novak M, 2005, PHYSIOL MOL PLANT P, V67, P237, DOI 10.1016/j.pmpp.2006.02.005; Postnikova OA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-101; Quenouille J, 2013, MOL PLANT PATHOL, V14, P439, DOI 10.1111/mpp.12024; Rodrigo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040526; Rodriguez M, 2012, PLANT SCI, V196, P107, DOI 10.1016/j.plantsci.2012.08.008; Rodriguez M, 2010, J PLANT PHYSIOL, V167, P1137, DOI 10.1016/j.jplph.2010.03.004; Sade D, 2015, METABOLOMICS, V11, P81, DOI 10.1007/s11306-014-0670-x; Seifi HS, 2013, MOL PLANT MICROBE IN, V26, P475, DOI 10.1094/MPMI-07-12-0176-CR; Shabala S, 2011, PLANT CELL ENVIRON, V34, P406, DOI 10.1111/j.1365-3040.2010.02251.x; Shadle GL, 2003, PHYTOCHEMISTRY, V64, P153, DOI 10.1016/S0031-9422(03)00151-1; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Shimajiri Y, 2013, PLANT BIOTECHNOL J, V11, P594, DOI 10.1111/pbi.12050; Solomon PS, 2003, MOL PLANT PATHOL, V4, P203, DOI 10.1046/j.1364-3703.2003.00161.x; Srivastava S, 2012, PHYTOCHEMISTRY, V80, P8, DOI 10.1016/j.phytochem.2012.05.007; Stare T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1925-2; Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Zeier J, 2013, PLANT CELL ENVIRON, V36, P2085, DOI 10.1111/pce.12122; Zurbriggen MD, 2010, PLANT SIGNAL BEHAV, V5, P393, DOI 10.4161/psb.5.4.10793	55	35	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146135	10.1371/journal.pone.0146135	http://dx.doi.org/10.1371/journal.pone.0146135			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727123	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500055
J	Fjellstrom, O; Larsson, N; Yasuda, S; Tsuchida, T; Oguma, T; Marley, A; Wennberg-Huldt, C; Hovdal, D; Fukuda, H; Yoneyama, Y; Sasaki, K; Johansson, A; Lundqvist, S; Brengdahl, J; Isaacs, RJ; Brown, D; Geschwindner, S; Benthem, L; Priest, C; Turnbull, A				Fjellstrom, Ola; Larsson, Niklas; Yasuda, Shin-ichiro; Tsuchida, Takuma; Oguma, Takahiro; Marley, Anna; Wennberg-Huldt, Charlotte; Hovdal, Daniel; Fukuda, Hajime; Yoneyama, Yukimi; Sasaki, Kazuyo; Johansson, Anders; Lundqvist, Sara; Brengdahl, Johan; Isaacs, Richard J.; Brown, Daniel; Geschwindner, Stefan; Benthem, Lambertus; Priest, Claire; Turnbull, Andrew			Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents	PLOS ONE			English	Article							MOLECULAR-MECHANISM; IDENTIFICATION; DEFICIENCY; DISCOVERY	Type 2 diabetes (T2D) occurs when there is insufficient insulin release to control blood glucose, due to insulin resistance and impaired beta-cell function. The GPR39 receptor is expressed in metabolic tissues including pancreatic beta-cells and has been proposed as a T2D target. Specifically, GPR39 agonists might improve beta-cell function leading to more adequate and sustained insulin release and glucose control. The present study aimed to test the hypothesis that GPR39 agonism would improve glucose stimulated insulin secretion in vivo. A high throughput screen, followed by a medicinal chemistry program, identified three novel potent Zn2+ modulated GPR39 agonists. These agonists were evaluated in acute rodent glucose tolerance tests. The results showed a lack of glucose lowering and insulinotropic effects not only in lean mice, but also in diet-induced obese (DIO) mice and Zucker fatty rats. It is concluded that Zn2+ modulated GPR39 agonists do not acutely stimulate insulin release in rodents.	[Fjellstrom, Ola; Johansson, Anders] AstraZeneca R&D Gothenburg, Med Chem CVMD iMed, Molndal, Sweden; [Larsson, Niklas; Lundqvist, Sara; Brengdahl, Johan; Geschwindner, Stefan] AstraZeneca R&D Gothenburg, Discovery Sci, Molndal, Sweden; [Yasuda, Shin-ichiro; Tsuchida, Takuma; Oguma, Takahiro; Sasaki, Kazuyo] Mitsubishi Tanabe Pharma Corp, Pharmacol Res Labs 2, Toda, Saitama, Japan; [Marley, Anna; Priest, Claire] AstraZeneca R&D, Discovery Sci, Mereside, England; [Wennberg-Huldt, Charlotte; Benthem, Lambertus] AstraZeneca R&D Gothenburg, Biosci CVMD iMed, Molndal, Sweden; [Hovdal, Daniel] AstraZeneca R&D Gothenburg, DMPK CVMD iMed, Molndal, Sweden; [Fukuda, Hajime; Yoneyama, Yukimi] Mitsubishi Tanabe Pharma Corp, DMPK Res Labs, Toda, Saitama, Japan; [Isaacs, Richard J.; Brown, Daniel] Mol Sensing Inc, Nashville, TN USA; [Turnbull, Andrew] AstraZeneca R&D Gothenburg, CVMD iMed, Molndal, Sweden	AstraZeneca; AstraZeneca; Mitsubishi Tanabe Pharma Corporation; AstraZeneca; AstraZeneca; AstraZeneca; Mitsubishi Tanabe Pharma Corporation; AstraZeneca	Fjellstrom, O (corresponding author), AstraZeneca R&D Gothenburg, Med Chem CVMD iMed, Molndal, Sweden.	ola.fjellstrom@astrazeneca.com	Johansson, Anders/L-4628-2019	Johansson, Anders/0000-0002-1467-6795	AstraZeneca; Mitsubishi Tanabe Pharma Corporation; Molecular Sensing Inc.	AstraZeneca(AstraZeneca); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Molecular Sensing Inc.	AstraZeneca, Mitsubishi Tanabe Pharma Corporation and Molecular Sensing Inc. provided the funding for this research. All authors are or were employees of either AstraZeneca, Mitsubishi Tanabe Pharma Corporation and Molecular Sensing, Inc. AstraZeneca and Mitsubishi Tanabe Pharma Corporation provided the funding for this research. AstraZeneca, Mitsubishi Tanabe Pharma Corporation and Molecular Sensing, Inc. provided support in the form of salaries for authors OF, NL, AM, CWH, DH, AJ, SL, JB, SG, LB, CP, AT, SY, TT, TO, HF, YY, RJI, and DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Bassilana F, 2014, NAT CHEM BIOL, V10, P343, DOI 10.1038/nchembio.1481; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Boehm M, 2013, ACS MED CHEM LETT, V4, P1079, DOI 10.1021/ml400275z; Bornhop DJ, 2007, SCIENCE, V317, P1732, DOI 10.1126/science.1146559; CAROLI S, 1994, CRIT REV ANAL CHEM, V24, P363, DOI 10.1080/10408349408048824; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; Depoortere I, 2012, CURR OPIN PHARMACOL, V12, P647, DOI 10.1016/j.coph.2012.07.019; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Egerod KL, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/401258; Fang Y, 2011, INT J ELECTROCHEM, V2011, DOI 10.4061/2011/460850; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Holst B, 2009, ENDOCRINOLOGY, V150, P2577, DOI 10.1210/en.2008-1250; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lu J, 2012, J AM CHEM SOC, V134, P1454, DOI 10.1021/ja210496n; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Ohishi T, 2012, EXPERT OPIN INV DRUG, V21, P321, DOI 10.1517/13543784.2012.657797; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Petersen PS, 2011, FASEB J, V25, P3803, DOI 10.1096/fj.11-184531; Peukert S, 2014, ACS MED CHEM LETT, V5, P1114, DOI 10.1021/ml500240d; Popovics P, 2011, CELL MOL LIFE SCI, V68, P85, DOI 10.1007/s00018-010-0517-1; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Storjohann L, 2008, FEBS LETT, V582, P2583, DOI 10.1016/j.febslet.2008.06.030; Tremblay F, 2009, ENDOCRINOLOGY, V150, P2586, DOI 10.1210/en.2008-1251; Verhulst PJ, 2011, J NEUROENDOCRINOL, V23, P490, DOI 10.1111/j.1365-2826.2011.02132.x; Yasuda SI, 2007, J RECEPT SIG TRANSD, V27, P235, DOI 10.1080/10799890701506147	30	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145849	10.1371/journal.pone.0145849	http://dx.doi.org/10.1371/journal.pone.0145849			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720709	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900022
J	Tai, CL; Tsai, TT; Lai, PL; Chen, YL; Liu, MY; Chen, LH				Tai, Ching-Lung; Tsai, Tsung-Ting; Lai, Po-Liang; Chen, Yi-Lu; Liu, Mu-Yi; Chen, Lih-Huei			A Biomechanical Comparison of Expansive Pedicle Screws for Severe Osteoporosis: The Effects of Screw Design and Cement Augmentation	PLOS ONE			English	Article							FIXATION STRENGTH; CALCIUM-PHOSPHATE; PULLOUT STRENGTH; MINERAL DENSITY; SPINE; STABILIZATION; INSTRUMENTATION; INJECTION	Expansive pedicle screws significantly improve fixation strength in osteoporotic spines. However, the previous literature does not adequately address the effects of the number of lengthwise slits and the extent of screw expansion on the strength of the bone/screw interface when expansive screws are used with or without cement augmentation. Herein, four designs for expansive pedicle screws with different numbers of lengthwise slits and different screw expansion levels were evaluated. Synthetic bones simulating severe osteoporosis were used to provide a comparative platform for each screw design. The prepared specimens were then tested for axial pullout failure. Regardless of screw design, screws with cement augmentation demonstrated significantly higher pullout strength than pedicle screws without cement augmentation (p < 0.001). For screws without cement augmentation, solid screws exhibited the lowest pullout strength compared to the four expansive groups (p < 0.01). No significant differences in pullout strength were observed between the expansive screws with different designs (p > 0.05). Taken together, our results show that pedicle screws combined with cement augmentation may greatly increase screw fixation regardless of screws with or without expansion. An increase in both the number of slits and the extent of screw expansion had little impact on the screw-anchoring strength. Cement augmentation is the most influential factor for improving screw pullout strength.	[Tai, Ching-Lung; Chen, Yi-Lu; Liu, Mu-Yi] Chang Gung Univ, Dept Mech Engn, Grad Inst Med Mechatron, Taoyuan, Taiwan; [Tsai, Tsung-Ting; Lai, Po-Liang; Chen, Lih-Huei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Bone & Joint Res Ctr,Dept Orthoped Surg, Taoyuan 33332, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, LH (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Bone & Joint Res Ctr,Dept Orthoped Surg, Taoyuan 33332, Taiwan.	lhchen2132@cgmh.org.tw		Tsai, Tsung-Ting/0000-0002-7776-7627	Chang Gung Memorial Hospital [CMRPG3C0091, CMRPG3C0092]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This research was supported by a research grant (CMRPG3C0091, CMRPG3C0092) from Chang Gung Memorial Hospital (https://www.cgmh.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, F543 ASTM; Bianco RJ, 2014, J SPINAL DISORD TECH, V19, P3415; Bullmann V, 2010, ORTHOPADE, V39, P673, DOI 10.1007/s00132-010-1602-8; Burval DJ, 2007, SPINE, V32, P1077, DOI 10.1097/01.brs.0000261566.38422.40; Chang MC, 2008, SPINE, V33, pE317, DOI 10.1097/BRS.0b013e31816f6c73; Charles YP, 2015, ORTHOP TRAUMATOL-SUR, V101, P369, DOI 10.1016/j.otsr.2015.01.005; Chen LH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-33; Chen LH, 2009, CLIN BIOMECH, V24, P613, DOI 10.1016/j.clinbiomech.2009.05.002; Choma TJ, 2011, SPINE, V36, P454, DOI 10.1097/BRS.0b013e3181d449ec; Cincu Rafael, 2015, Asian J Neurosurg, V10, P75, DOI 10.4103/1793-5482.145120; Cook SD, 2000, J SPINAL DISORD, V13, P230, DOI 10.1097/00002517-200006000-00006; Cook Stephen D, 2004, Spine J, V4, P402, DOI 10.1016/j.spinee.2003.11.010; Fisher C, 2009, J NEUROSURG-SPINE, V10, P207, DOI 10.3171/2008.12.SPINE0844; Galbusera F, 2015, EUR SPINE J, V24, P1005, DOI 10.1007/s00586-015-3768-6; Gao MX, 2011, CLIN BIOMECH, V26, P238, DOI 10.1016/j.clinbiomech.2010.10.008; Gibson L, 1988, CELLULAR SOLIDS, P316; Hadjipavlou AG, 1997, J SPINAL DISORD, V10, P12; HALVORSON TL, 1994, SPINE, V19, P2415, DOI 10.1097/00007632-199411000-00008; Haq Mian Iftikhar Ul, 2015, J Ayub Med Coll Abbottabad, V27, P171; Hashemi A, 2009, SPINE J, V9, P404, DOI 10.1016/j.spinee.2008.07.001; Kiner DW, 2008, SPINE, V33, P2618, DOI 10.1097/BRS.0b013e3181882cac; Ko CC, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1052; Koktekir E, 2015, J NEUROSURG-SPINE, V22, P596, DOI 10.3171/2014.10.SPINE14669; Krenn MH, 2008, J NEUROSURG-SPINE, V9, P90, DOI 10.3171/SPI/2008/9/7/090; Liu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074827; Masaki T, 2009, SPINE, V34, pE724, DOI 10.1097/BRS.0b013e3181adc0e9; McKoy BE, 2000, J BIOMED MATER RES, V53, P216, DOI 10.1002/(SICI)1097-4636(2000)53:3<216::AID-JBM5>3.0.CO;2-O; Moon BJ, 2009, J KOREAN NEUROSURG S, V46, P305, DOI 10.3340/jkns.2009.46.4.305; Ponnusamy KE, 2011, SPINE J, V11, P54, DOI 10.1016/j.spinee.2010.09.024; Renner SM, 2004, SPINE, V29, pE212, DOI 10.1097/00007632-200406010-00020; Riaz-ur-Rehman, 2011, J PAK MED ASSOC, V61, P1005; Shea TM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/748393; Wu JC, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11125; Wu Xiao-tao, 2007, Chin J Traumatol, V10, P327; Yi XD, 2008, SPINE, V33, P2503, DOI 10.1097/BRS.0b013e318184e750; Zhuang XM, 2010, SPINE, V35, pE925, DOI 10.1097/BRS.0b013e3181c5fb21	36	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146294	10.1371/journal.pone.0146294	http://dx.doi.org/10.1371/journal.pone.0146294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720724	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900055
J	Wang, YN				Wang, Yi Nan			Authenticity and Relationship Satisfaction: Two Distinct Ways of Directing Power to Self-Esteem	PLOS ONE			English	Article							PERSONALITY; CONCEPTUALIZATION	Possessing power contributes to high self-esteem, but how power enhances self-esteem is still unknown. As power is associated with both self-oriented goals and social-responsibility goals, we proposed that power predicts self-esteem through two positive personal and interpersonal results: authenticity and relationship satisfaction. Three studies were carried out with a total of 505 Chinese participants, including college students and adults, who completed surveys that assessed personal power, self-esteem, authenticity, relationship satisfaction, communal orientation, and social desirability. Hierarchical multiple regression analyses demonstrated that power, authenticity, and relationship satisfaction each uniquely contributed to self-esteem. More importantly, multiple mediation analysis showed that authenticity and relationship satisfaction both mediated the effects of power on self-esteem, even when controlling for participants' communal orientation and social desirability. Our findings demonstrate that authenticity and relationship satisfaction represent two key mechanisms by which power is associated with self-esteem.	[Wang, Yi Nan] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China	Beijing Normal University	Wang, YN (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	yynnwang@gmail.com						Anderson C, 2012, J PERS, V80, P313, DOI 10.1111/j.1467-6494.2011.00734.x; [Anonymous], 1961, BECOMING PERSON THER; [Anonymous], 1965, ACCEPTANCE COMMITMEN; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bentley CG, 2007, SEX ROLES, V57, P483, DOI 10.1007/s11199-007-9280-7; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Chen S, 2001, J PERS SOC PSYCHOL, V80, P173, DOI 10.1037//0022-3514.80.2.173; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037/0022-3514.37.1.12; CLARK MS, 1987, J PERS SOC PSYCHOL, V53, P94, DOI 10.1037/0022-3514.53.1.94; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Galinsky AD, 2008, J PERS SOC PSYCHOL, V95, P1450, DOI 10.1037/a0012633; Goldman BM., 2002, ANN AM PSYCHOTHER AS, V5, P18; HAYS RD, 1989, EDUC PSYCHOL MEAS, V49, P629, DOI 10.1177/001316448904900315; Judge TA, 2002, J APPL PSYCHOL, V87, P765, DOI 10.1037/0021-9010.87.4.765; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; Kernis MH, 2003, PSYCHOL INQ, V14, P1, DOI 10.1207/S15327965PLI1401_01; Kifer Y, 2013, PSYCHOL SCI, V24, P280, DOI 10.1177/0956797612450891; Kitayama S, 1997, J PERS SOC PSYCHOL, V72, P1245, DOI 10.1037/0022-3514.72.6.1245; Kitayama S., 2000, CULTURE SUBJECTIVE W, P113, DOI [10.1007/978-90-481-2352-0_2, DOI 10.1007/978-90-481-2352-0_2]; Koole SL, 2003, PSYCHOL INQ, V14, P43; Leary M.R., 1995, EFFICACY AGENCY SELF, P123, DOI DOI 10.1007/978-1-4899-1280-0_7; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leary MR, 2003, PSYCHOL INQ, V14, P52; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mast MS, 2009, J PERS SOC PSYCHOL, V97, P835, DOI 10.1037/a0016234; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sheldon KM, 1997, J PERS SOC PSYCHOL, V73, P1380, DOI 10.1037/0022-3514.73.6.1380; TESSER A, 2001, BLACKWELL HDB SOCIAL, P479, DOI DOI 10.1002/9780470998519; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Uchida Y, 2001, INTERPERSONAL SOURCE; Uchida Y., 2004, J HAPPINESS STUD, V5, P223, DOI DOI 10.1007/S10902-004-8785-9; Wang YN, 2014, ASIAN J SOCIAL PSYCH; Wojciszke B, 2007, SOC COGNITION, V25, P472, DOI 10.1521/soco.2007.25.4.472; Wood AM, 2008, J COUNS PSYCHOL, V55, P385, DOI 10.1037/0022-0167.55.3.385	35	14	14	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146050	10.1371/journal.pone.0146050	http://dx.doi.org/10.1371/journal.pone.0146050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TR	26720814	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510900039
J	Choi, CK; Ho, DN; Hui, KF; Kao, RY; Chiang, AKS				Choi, Chung King; Ho, Dona N.; Hui, Kwai Fung; Kao, Richard Y.; Chiang, Alan K. S.			Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROTEIN-KINASE; NASOPHARYNGEAL CARCINOMA; SIGNAL-TRANSDUCTION; PHORBOL ESTERS; BZLF1 GENE; B-CELLS; ACTIVATION; THERAPY; INFECTION	Phorbol esters, which are protein kinase C (PKC) activators, and histone deacetylase (HDAC) inhibitors, which cause enhanced acetylation of cellular proteins, are the main classes of chemical inducers of Epstein-Barr virus (EBV) lytic cycle in latently EBV-infected cells acting through the PKC pathway. Chemical inducers which induce EBV lytic cycle through alternative cellular pathways may aid in defining the mechanisms leading to lytic cycle reactivation and improve cells' responsiveness towards lytic induction. We performed a phenotypic screening on a chemical library of 50,240 novel small organic compounds to identify novel class(es) of strong inducer(s) of EBV lytic cycle in gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC) cells. Five hit compounds were selected after three successive rounds of increasingly stringent screening. All five compounds are structurally diverse from each other and distinct from phorbol esters or HDAC inhibitors. They neither cause hyperacetylation of histone proteins nor significant PKC activation at their working concentrations, suggesting that their biological mode of action are distinct from that of the known chemical inducers. Two of the five compounds with rapid lytic-inducing action were further studied for their mechanisms of induction of EBV lytic cycle. Unlike HDAC inhibitors, lytic induction by both compounds was not inhibited by rottlerin, a specific inhibitor of PKC delta. Interestingly, both compounds could cooperate with HDAC inhibitors to enhance EBV lytic cycle induction in EBV-positive epithelial cancer cells, paving way for the development of strategies to increase cells' responsiveness towards lytic reactivation. One of the two compounds bears structural resemblance to iron chelators and the other strongly activates the MAPK pathways. These structurally diverse novel organic compounds may represent potential new classes of chemicals that can be used to investigate any alternative mechanism(s) leading to EBV lytic cycle reactivation from latency.	[Choi, Chung King; Ho, Dona N.; Hui, Kwai Fung; Chiang, Alan K. S.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Kao, Richard Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chiang, Alan K. S.] Univ Hong Kong, Ctr Nasopharyngeal Carcinoma Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chiang, AKS (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	chiangak@hkucc.hku.hk	Chiang, Alan/L-8849-2018; HUI, Kwai Fung/H-5248-2019	Chiang, Alan/0000-0002-1089-5325; HUI, Kwai Fung/0000-0002-5572-8395	EBV research grant [200004525]; NPC Area of Excellence (AoE/M Center for Nasopharyngeal Carcinoma Research) grant [06/08]	EBV research grant; NPC Area of Excellence (AoE/M Center for Nasopharyngeal Carcinoma Research) grant	This project is funded by EBV research (#200004525) and NPC Area of Excellence (AoE/M 06/08 Center for Nasopharyngeal Carcinoma Research) grants of A.K.S.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; BARRANCO SC, 1983, CANCER RES, V43, P1703; Becker E, 1999, J LAB CLIN MED, V134, P510, DOI 10.1016/S0022-2143(99)90173-7; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chiang AKS, 2015, CANC CELL MICROENVIR; COUNTRYMAN J, 1987, J VIROL, V61, P3672, DOI 10.1128/JVI.61.12.3672-3679.1987; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Daigle D, 2010, J VIROL, V84, P993, DOI 10.1128/JVI.01745-09; DAVIES AH, 1991, J VIROL, V65, P6838, DOI 10.1128/JVI.65.12.6838-6844.1991; Fahmi H, 2000, J VIROL, V74, P5810, DOI 10.1128/JVI.74.13.5810-5818.2000; Fang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044810; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; Fenton M, 1999, J VIROL, V73, P8913, DOI 10.1128/JVI.73.10.8913-8916.1999; FLEMINGTON E, 1990, J VIROL, V64, P4549, DOI 10.1128/JVI.64.9.4549-4552.1990; FLEMINGTON E, 1990, J VIROL, V64, P1217, DOI 10.1128/JVI.64.3.1217-1226.1990; Fu DX, 2008, NAT MED, V14, P1118, DOI 10.1038/nm.1864; Fu DX, 2007, CLIN CANCER RES, V13, P1453, DOI 10.1158/1078-0432.CCR-06-2295; Gao X, 2001, VIROLOGY, V286, P91, DOI 10.1006/viro.2001.0965; Gao XR, 2004, J VIROL, V78, P11798, DOI 10.1128/JVI.78.21.11798-11806.2004; Ghosh SK, 2012, BLOOD, V119, P1008, DOI 10.1182/blood-2011-06-362434; Gradoville L, 2002, J VIROL, V76, P5612, DOI 10.1128/JVI.76.11.5612-5626.2002; Hagemeier SR, 2012, J VIROL, V86, P13360, DOI 10.1128/JVI.01850-12; Hong GK, 2005, J VIROL, V79, P13984, DOI 10.1128/JVI.79.22.13984-13992.2005; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Huang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084919; Hui KF, 2012, INT J CANCER, V131, P1930, DOI 10.1002/ijc.27439; Hui KF, 2010, INT J CANCER, V126, P2479, DOI 10.1002/ijc.24945; Hui KF, 2016, INT J CANCER, V138, P125, DOI 10.1002/ijc.29698; Hui KF, 2014, BRIT J HAEMATOL, V167, P639, DOI 10.1111/bjh.13089; Hui KF, 2013, MOL CANCER THER, V12, P747, DOI 10.1158/1535-7163.MCT-12-0811; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Kieff E, 2007, FIELDS VIROLOGY; Kim DN, 2013, J GEN VIROL, V94, P497, DOI 10.1099/vir.0.045237-0; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Lee HH, 2008, J GEN VIROL, V89, P878, DOI 10.1099/vir.0.83533-0; Liang CL, 2002, J BIOL CHEM, V277, P23345, DOI 10.1074/jbc.M107420200; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; Meng Q, 2010, J VIROL, V84, P4534, DOI 10.1128/JVI.02487-09; Molesworth SJ, 2000, J VIROL, V74, P6324, DOI 10.1128/JVI.74.14.6324-6332.2000; Nawandar DM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005195; NUTTER LM, 1987, CANCER RES, V47, P4407; Oh ST, 2004, VIROLOGY, V320, P330, DOI 10.1016/j.virol.2003.12.005; Oussaief L, 2009, J BIOL CHEM, V284, P23912, DOI 10.1074/jbc.M109.036483; Park JG, 1997, INT J CANCER, V70, P443, DOI 10.1002/(SICI)1097-0215(19970207)70:4<443::AID-IJC12>3.0.CO;2-G; Perrine SR, 2007, BLOOD, V109, P2571, DOI 10.1182/blood-2006-01-024703; Rickinson A, 2007, FIELDS VIROLOGY; ROONEY CM, 1989, J VIROL, V63, P3109, DOI 10.1128/JVI.63.7.3109-3116.1989; SHIMIZU N, 1993, J VIROL, V67, P3240, DOI 10.1128/JVI.67.6.3240-3245.1993; Shirley CM, 2011, BLOOD, V117, P6297, DOI 10.1182/blood-2011-01-332379; SINCLAIR AJ, 1991, J VIROL, V65, P2237, DOI 10.1128/JVI.65.5.2237-2244.1991; Stoker SD, 2015, J CANCER RES CLIN, V141, P1845, DOI 10.1007/s00432-015-1969-3; Tikhmyanova N, 2014, ACS CHEM BIOL, V9, P785, DOI 10.1021/cb4006326; Tsai PF, 2011, J VIROL, V85, P2373, DOI 10.1128/JVI.01602-10; Wildeman MA, 2012, CLIN CANCER RES, V18, P5061, DOI 10.1158/1078-0432.CCR-12-0574; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991	58	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145994	10.1371/journal.pone.0145994	http://dx.doi.org/10.1371/journal.pone.0145994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717578	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500110
J	Fontijn, RD; Volger, OL; van der Pouw-Kraan, TC; Doddaballapur, A; Leyen, T; Baggen, JM; Boon, RA; Horrevoets, AJG				Fontijn, Ruud D.; Volger, Oscar L.; van der Pouw-Kraan, Tineke C.; Doddaballapur, Anuradha; Leyen, Thomas; Baggen, Josefien M.; Boon, Reinier A.; Horrevoets, Anton J. G.			Expression of Nitric Oxide-Transporting Aquaporin-1 Is Controlled by KLF2 and Marks Non-Activated Endothelium In Vivo	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-2; GENE-EXPRESSION; CELL-MIGRATION; ATHEROSCLEROSIS; ANGIOGENESIS; ICAM-1; NO	The flow-responsive transcription factor Kruppel-like factor 2 (KLF2) maintains an anticoagulant, anti-inflammatory endothelium with sufficient nitric oxide (NO)-bioavailability. In this study, we aimed to explore, both in vitro and in human vascular tissue, expression of the NO-transporting transmembrane pore aquaporin-1 (AQP1) and its regulation by atheroprotective KLF2 and atherogenic inflammatory stimuli. In silico analysis of gene expression profiles from studies that assessed the effects of KLF2 overexpression in vitro and atherosclerosis in vivo on endothelial cells, identifies AQP1 as KLF2 downstream gene with elevated expression in the plaque-free vessel wall. Biomechanical and pharmaceutical induction of KLF2 in vitro is accompanied by induction of AQP1. Chromosome immunoprecipitation (CHIP) confirms binding of KLF2 to the AQP1 promoter. Inflammatory stimulation of endothelial cells leads to repression of AQP1 transcription, which is restrained by KLF2 overexpression. Immunohistochemistry reveals expression of aquaporin-1 in non-activated endothelium overlying macrophage-poor intimae, irrespective whether these intimae are characterized as being plaque-free or as containing advanced plaque. We conclude that AQP1 expression is subject to KLF2-mediated positive regulation by atheroprotective shear stress and is downregulated under inflammatory conditions both in vitro and in vivo. Thus, endothelial expression of AQP1 characterizes the atheroprotected, non-inflamed vessel wall. Our data provide support for a continuous role of KLF2 in stabilizing the vessel wall via co-temporal expression of eNOS and AQP1 both preceding and during the pathogenesis of atherosclerosis.	[Fontijn, Ruud D.; Volger, Oscar L.; van der Pouw-Kraan, Tineke C.; Leyen, Thomas; Baggen, Josefien M.; Horrevoets, Anton J. G.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Doddaballapur, Anuradha; Boon, Reinier A.] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60054 Frankfurt, Germany	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Goethe University Frankfurt	Fontijn, RD (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	r.fontijn@vumc.nl	Boon, Reinier A/E-8423-2011	Boon, Reinier A/0000-0001-7944-9748	Netherlands Organization for Scientific Research (NWO-Genomics grant) [050-10-014]; Deutsche Forschungsgemeinschaft [SFB834/B9]; Dutch Heart Foundation [2008B105]; European Vascular Genomics Network [LSHM-CT-2003-503254]	Netherlands Organization for Scientific Research (NWO-Genomics grant); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dutch Heart Foundation(Netherlands Heart Foundation); European Vascular Genomics Network	Funding came from Netherlands Organization for Scientific Research (NWO-Genomics grant 050-10-014 to AJGH), the Deutsche Forschungsgemeinschaft (SFB834/B9 to RAB), Dutch Heart Foundation (grant 2008B105 to AJGH), and European Vascular Genomics Network (LSHM-CT-2003-503254; Brussels, B to AJGH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Boon RA, 2010, BLOOD, V115, P2533, DOI 10.1182/blood-2009-06-228726; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Fontijn RD, 2014, STEM CELL RES, V13, P367, DOI 10.1016/j.scr.2014.09.004; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Herrera M, 2007, AM J PHYSIOL-RENAL, V292, pF1443, DOI 10.1152/ajprenal.00353.2006; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Kaneko K, 2008, MICROVASC RES, V75, P297, DOI 10.1016/j.mvr.2007.12.003; Kitagawa K, 2002, ATHEROSCLEROSIS, V160, P305, DOI 10.1016/S0021-9150(01)00587-1; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Montiel V, 2014, PFLUG ARCH EUR J PHY, V466, P237, DOI 10.1007/s00424-013-1325-x; Mun GI, 2013, BIOCHEM BIOPH RES CO, V430, P554, DOI 10.1016/j.bbrc.2012.11.114; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Rutkovskiy A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0393-6; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; VANDERWAL AC, 1992, AM J PATHOL, V141, P1427; Verkman AS, 2006, KIDNEY INT, V69, P1120, DOI 10.1038/sj.ki.5000226; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Volger OL, 2007, AM J PATHOL, V171, P326, DOI 10.2353/ajpath.2007.061196; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502	31	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145777	10.1371/journal.pone.0145777	http://dx.doi.org/10.1371/journal.pone.0145777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717516	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500069
J	Reis, T				Reis, Tania			Effects of Synthetic Diets Enriched in Specific Nutrients on Drosophila Development, Body Fat, and Lifespan	PLOS ONE			English	Article							MELANOGASTER; OBESITY; RESTRICTION; CONSUMPTION; METABOLISM; MORTALITY; WEIGHT; HEALTH; ENERGY	Gene-diet interactions play a crucial but poorly understood role in susceptibility to obesity. Accordingly, the development of genetically tractable model systems to study the influence of diets in obesity-prone genetic backgrounds is a focus of current research. Here I present a modified synthetic Drosophila diet optimized for timely larval development, a stage dedicated to energy storage. Specifically increasing the levels of individual macronutrients-carbohydrate, lipid, or protein-resulted in markedly different organismal effects. A high-carbohydrate diet adversely affected the timing of development, size, early lifespan and body fat. Strikingly, quadrupling the amount of dietary lipids had none of these effects. Diets rich in protein appeared to be the most beneficial, as larvae developed faster, with no change in size, into long-lived adults. I believe this synthetic diet will significantly facilitate the study of gene-diet interactions in organismal energy balance.	[Reis, Tania] Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Reis, T (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Anschutz Med Campus, Aurora, CO 80045 USA.	tania.reis@ucdenver.edu		Reis, Tania/0000-0001-6879-1265	National Institutes of Health [1F32DK077401, NIDDK K01DK095932]; American Heart Association [12BGIA11930014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095932, P30DK048520, F32DK077401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (1F32DK077401 and NIDDK K01DK095932) and the American Heart Association (12BGIA11930014).	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Baumbach J, 2014, CELL METAB, V19, P331, DOI 10.1016/j.cmet.2013.12.004; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Bruce KD, 2013, EXP GERONTOL, V48, P1129, DOI [10.1016/j.exger.2013.02.003, 10.1016/j.exge]; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Itskov PM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00012; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jumbo-Lucioni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-297; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lee WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067308; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Piper MDW, 2014, NAT METHODS, V11, P100, DOI [10.1038/NMETH.2731, 10.1038/nmeth.2731]; Piper MDW, 2005, J GERONTOL A-BIOL, V60, P549, DOI 10.1093/gerona/60.5.549; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Qi L, 2014, CURR OPIN LIPIDOL, V25, P27, DOI 10.1097/MOL.0000000000000037; Reis T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001206; SANG JH, 1956, J EXP BIOL, V33, P45; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2	30	44	44	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146758	10.1371/journal.pone.0146758	http://dx.doi.org/10.1371/journal.pone.0146758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741692	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600063
J	Muroski, ME; Morshed, RA; Cheng, Y; Vemulkar, T; Mansell, R; Han, Y; Zhang, LJ; Aboody, KS; Cowburn, RP; Lesniak, MS				Muroski, Megan E.; Morshed, Ramin A.; Cheng, Yu; Vemulkar, Tarun; Mansell, Rhodri; Han, Yu; Zhang, Lingjiao; Aboody, Karen S.; Cowburn, Russell P.; Lesniak, Maciej S.			Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment	PLOS ONE			English	Article							CLINICAL-USE; DELIVERY; NANOPARTICLES; TRACKING; THERAPY; GLIOBLASTOMA; CARRIERS	Stem cells have recently garnered attention as drug and particle carriers to sites of tumors, due to their natural ability to track to the site of interest. Specifically, neural stem cells (NSCs) have demonstrated to be a promising candidate for delivering therapeutics to malignant glioma, a primary brain tumor that is not curable by current treatments, and inevitably fatal. In this article, we demonstrate that NSCs are able to internalize 2 mu m magnetic discs (SD), without affecting the health of the cells. The SD can then be remotely triggered in an applied 1 T rotating magnetic field to deliver a payload. Furthermore, we use this NSC-SD delivery system to deliver the SD themselves as a therapeutic agent to mechanically destroy glioma cells. NSCs were incubated with the SD overnight before treatment with a 1T rotating magnetic field to trigger the SD release. The potential timed release effects of the magnetic particles were tested with migration assays, confocal microscopy and immunohistochemistry for apoptosis. After the magnetic field triggered SD release, glioma cells were added and allowed to internalize the particles. Once internalized, another dose of the magnetic field treatment was administered to trigger mechanically induced apoptotic cell death of the glioma cells by the rotating SD. We are able to determine that NSC-SD and magnetic field treatment can achieve over 50% glioma cell death when loaded at 50 SD/cell, making this a promising therapeutic for the treatment of glioma.	[Muroski, Megan E.; Han, Yu; Lesniak, Maciej S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Morshed, Ramin A.; Zhang, Lingjiao] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA; [Cheng, Yu] Tongji Univ, Sch Med, Inst Biomed Engn & Nano Sci, Shanghai East Hosp, Shanghai 200029, Peoples R China; [Vemulkar, Tarun; Mansell, Rhodri; Cowburn, Russell P.] Univ Cambridge, Cavendish Lab, Thin Film Magnetism Grp, Cambridge CB3 0HE, England; [Aboody, Karen S.] Beckman Res Inst City Hope, Dept Neurosci, Duarte, CA USA; [Aboody, Karen S.] Beckman Res Inst City Hope, Div Neurosurg, Duarte, CA USA	Northwestern University; Feinberg School of Medicine; University of Chicago; Tongji University; University of Cambridge; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Cheng, Y (corresponding author), Tongji Univ, Sch Med, Inst Biomed Engn & Nano Sci, Shanghai East Hosp, Shanghai 200029, Peoples R China.	yucheng@tongji.edu.cn; maciej.lesniak@northwestern.edu	Han, Yu/GZA-9220-2022; zhang, lingjiao/AAC-9015-2019; Mansell, Rhodri/A-1450-2013; Zixuan, Huang/ABI-3557-2020	Mansell, Rhodri/0000-0002-6026-0731; Zhang, Lingjiao/0000-0003-0700-4584; /0000-0002-6491-1589; Morshed, Ramin/0000-0001-8464-6041	National Institute of Health [R01NS077388, U01NS069997]; Engineering and Physical Sciences Research Council [1232881] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069997, R01NS077388] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health R01NS077388, U01NS069997, http://www.nih.gov/.	Aboody KS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005365; Ahmed AU, 2013, JNCI-J NATL CANCER I, V105, P968, DOI 10.1093/jnci/djt141; Ahmed AU, 2011, MOL THER, V19, P1714, DOI 10.1038/mt.2011.100; Balyasnikova IV, 2011, CANCER LETT, V310, P148, DOI 10.1016/j.canlet.2011.06.029; Balyasnikova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009750; Cheng DF, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-195; Cheng Y, 2013, SMALL, V9, P4123, DOI 10.1002/smll.201301111; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Domenech M, 2013, ACS NANO, V7, P5091, DOI 10.1021/nn4007048; Gutova M, 2013, STEM CELL TRANSL MED, V2, P766, DOI 10.5966/sctm.2013-0049; Huang XL, 2013, BIOMATERIALS, V34, P1772, DOI 10.1016/j.biomaterials.2012.11.032; Kim DH, 2010, NAT MATER, V9, P165, DOI [10.1038/NMAT2591, 10.1038/nmat2591]; Metz MZ, 2013, STEM CELL TRANSL MED, V2, P983, DOI 10.5966/sctm.2012-0177; Mooney R, 2014, ACS NANO, V8, P12450, DOI 10.1021/nn505147w; Mooney R, 2014, FUTURE ONCOL, V10, P401, DOI [10.2217/FON.13.217, 10.2217/fon.13.217]; Rachakatla RS, 2010, ACS NANO, V4, P7093, DOI 10.1021/nn100870z; Roger M, 2010, BIOMATERIALS, V31, P8393, DOI 10.1016/j.biomaterials.2010.07.048; Sadhukha T, 2014, J CONTROL RELEASE, V196, P243, DOI 10.1016/j.jconrel.2014.10.015; Stuckey DW, 2014, NAT REV CANCER, V14, P683, DOI 10.1038/nrc3798; van de Water JAJM, 2012, P NATL ACAD SCI USA, V109, P16642, DOI 10.1073/pnas.1202832109; Vemulkar T, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4926336; Wu X, 2008, J NEUROSURG, V108, P320, DOI 10.3171/JNS/2008/108/2/0320; Xu CJ, 2012, NANO LETT, V12, P4131, DOI 10.1021/nl301658q; Zhang XF, 2015, BIOMATERIALS, V39, P269, DOI 10.1016/j.biomaterials.2014.11.003; Zhao J, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/40/405101	25	23	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145129	10.1371/journal.pone.0145129	http://dx.doi.org/10.1371/journal.pone.0145129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734932	Green Submitted, gold, Green Published			2022-12-27	WOS:000367805100020
J	Fortin, JK; Rode, KD; Hilderbrand, GV; Wilder, J; Farley, S; Jorgensen, C; Marcot, BG				Fortin, Jennifer K.; Rode, Karyn D.; Hilderbrand, Grant V.; Wilder, James; Farley, Sean; Jorgensen, Carole; Marcot, Bruce G.			Impacts of Human Recreation on Brown Bears (Ursus arctos): A Review and New Management Tool	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; BAYESIAN BELIEF NETWORKS; GRIZZLY BEAR; REPRODUCTIVE STRATEGY; BEHAVIORAL-RESPONSES; HUMAN DISTURBANCE; POSITIVE IMPACTS; WILDLIFE; SALMON; CONSERVATION	Increased popularity of recreational activities in natural areas has led to the need to better understand their impacts on wildlife. The majority of research conducted to date has focused on behavioral effects from individual recreations, thus there is a limited understanding of the potential for population-level or cumulative effects. Brown bears (Ursus arctos) are the focus of a growing wildlife viewing industry and are found in habitats frequented by recreationists. Managers face difficult decisions in balancing recreational opportunities with habitat protection for wildlife. Here, we integrate results from empirical studies with expert knowledge to better understand the potential population-level effects of recreational activities on brown bears. We conducted a literature review and Delphi survey of brown bear experts to better understand the frequencies and types of recreations occurring in bear habitats and their potential effects, and to identify management solutions and research needs. We then developed a Bayesian network model that allows managers to estimate the potential effects of recreational management decisions in bear habitats. A higher proportion of individual brown bears in coastal habitats were exposed to recreation, including photography and bear-viewing than bears in interior habitats where camping and hiking were more common. Our results suggest that the primary mechanism by which recreation may impact brown bears is through temporal and spatial displacement with associated increases in energetic costs and declines in nutritional intake. Killings in defense of life and property were found to be minimally associated with recreation in Alaska, but are important considerations in population management. Regulating recreation to occur predictably in space and time and limiting recreation in habitats with concentrated food resources reduces impacts on food intake and may thereby, reduce impacts on reproduction and survival. Our results suggest that decisions managers make about regulating recreational activities in time and space have important consequences for bear populations. The Bayesian network model developed here provides a new tool for managers to balance demands of multiple recreational activities while supporting healthy bear populations.	[Fortin, Jennifer K.; Rode, Karyn D.] US Geol Survey, Alaska Sci Ctr Anchorage, Anchorage, AK USA; [Hilderbrand, Grant V.] Natl Pk Serv Alaska Reg, Anchorage, AK USA; [Wilder, James] US Fish & Wildlife Serv, Anchorage, AK USA; [Farley, Sean] Alaska Dept Fish & Game, Anchorage, AK 99518 USA; [Jorgensen, Carole] US Forest Serv, Chugach Natl Forest, USDA, Anchorage, AK USA; [Marcot, Bruce G.] US Forest Serv, Pacific NW Res Stn, USDA, Portland, OR 97208 USA; [Fortin, Jennifer K.] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Alaska Department of Fish & Game; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Fortin, JK (corresponding author), US Geol Survey, Alaska Sci Ctr Anchorage, Anchorage, AK USA.	jennifer.fortin-noreus@umontana.edu		Rode, Karyn/0000-0002-3328-8202	US Geological Survey's National Park Service Natural Resources Preservation Program	US Geological Survey's National Park Service Natural Resources Preservation Program	This project was funded by the US Geological Survey's National Park Service Natural Resources Preservation Program.	ALBERT DM, 1991, WILDLIFE SOC B, V19, P339; Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Archibald W.R., 1987, INT C BEAR RES MAN, V7, P251; Atwood T.C., 2015, US GEOLOGICAL SURVEY, DOI [10.3133/ofr20141254, DOI 10.3133/OFR20141254]; Aumiller L. D, 1994, INT C BEAR RES MANAG, V9, P51; Barnes Jr V. G., 2000, BROWN BEAR ACTIVITY; Barnes Jr VG, 1994, INT C BEAR RES MAN, V9, P63; Barnes VGJ, 2006, BROWN BEAR USE DISTR; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; Beecham J., 1983, INT C BEAR RES MANAG, V5, P79; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; BOYLE SA, 1985, WILDLIFE SOC B, V13, P110; Cain J, 2001, PLANNING IMPROVEMENT; Cannon WB., BODILY CHANGES PAIN, DOI [10.1037/10013-000, DOI 10.1037/10013-000]; Chester J.M., 1980, Bear Biology Association Conference Series, P351; Chi Danielle K., 1999, Ursus, V11, P225; Ciarneillo LM, 2006, THESIS; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Coleman TH, 2013, URSUS, V24, P101, DOI 10.2192/URSUS-D-12-00024.1; Coleman TH, 2013, J WILDLIFE MANAGE, V77, P1311, DOI 10.1002/jwmg.602; Conroy M. J., 2013, DECISION MAKING NATU; Cordell HK, 2012, SRS150 US DEP AGR FO; CRAIGHEAD F C JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P84; Craighead J.J., 1982, P515; Craighead J.J., 1995, GRIZZLY BEARS YELLOW; Craighead JJ, 1974, INT C BEAR RES MANAG, V3, P357; Crupi Jr AP, 2003, THESIS; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Dalkey NC, 1967, DELPHI; DeBruyn TD, 2009, ECOTOURISM AND ENVIRONMENTAL SUSTAINABILITY: PRINCIPLES AND PRACTICE, P109; Delberq AL, 1975, GROUP TECHNIQUES PRO; Dood AR, 1986, FINAL PROGRAMMATIC E; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Egbert A.L., 1976, IUCN Publs (New Series), VNo. 40, P41; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; FAGEN JM, 1994, NAT AREA J, V14, P159; Federal Provincial and Territorial Governments of Canada, 2014, 2012 CAN NAT SURV AW; Fischbach A. S., 2005, BROWN BEAR USE PROPO; Flather Curtis H., 1995, P3; French HB, 2007, THESIS; Frid A, 2002, CONSERV ECOL, V6; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Gilbert BK, 1987, 970040019 NPS CX; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Glikman JA, 2012, EUR J WILDLIFE RES, V58, P295, DOI 10.1007/s10344-011-0579-x; Gonzalez LM, 2006, ANIM CONSERV, V9, P85, DOI 10.1111/j.1469-1795.2005.00016.x; GOODRICH JM, 1994, BIOL CONSERV, V67, P105, DOI 10.1016/0006-3207(94)90354-9; Graves TA, 2002, THESIS; Greve PMK, 2008, THESIS; GUNTHER K.A., 1990, P INT C BEAR RES MAN, V8, P73, DOI DOI 10.2307/3872904; Gunther K.A, 1994, INT C BEAR RES MANAG, V9, P549, DOI [10.2307/3872743, DOI 10.2307/3872743]; Gunther KA, 1984, ANN PROJECT TECHNICA, P185; Hamilton RJ, 1978, THESIS; Haroldson MA, 2004, J WILDLIFE MANAGE, V68, P129, DOI 10.2193/0022-541X(2004)068[0129:PEOEHO]2.0.CO;2; Harris RB, 2005, WILDLIFE MONOGR, V161, P57; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Herrero S, 1986, INT C BEAR RES MANAG, V6, P187; Herrero S, 1990, 8 INT C BEAR RES MAN; Herrero S., 1985, BEAR ATTACKS THEIR C; Herrero Stephen, 1999, Ursus, V11, P209; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Holcroft AC, 1986, THESIS; Holm Greg W., 1999, Ursus, V11, P99; Huber D., 1997, BEARS THEIR BIOL MAN, P79, DOI [DOI 10.2307/3872664, 10.2307/3872664]; Hussain A., 2012, Journal of Agricultural and Applied Economics, V44, P63; JOPE KL, 1985, WILDLIFE SOC B, V13, P32; KASWORM WF, 1990, INT C BEAR, V8, P79; Klinka DR, 2009, J MAMMAL, V90, P144, DOI 10.1644/07-MAMM-A-200.1; Klinka DR, 2002, CAN J ZOOL, V80, P1317, DOI 10.1139/Z02-123; Knight Richard L., 1995, P71; KNIGHT RR, 1988, WILDLIFE SOC B, V16, P121; Kuhnert PM, 2010, ECOL LETT, V13, P900, DOI 10.1111/j.1461-0248.2010.01477.x; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Mace RD, 1996, WILDLIFE SOC B, V24, P461; Machutchon AG, 1998, URSUS-SERIES, V10, P539; Manfredo Michael J., 1995, P17; Manning RE, 2012, MANAGING OUTDOOR RECREATION: CASE STUDIES IN THE NATIONAL PARKS, P1, DOI 10.1079/9781845939311.0000; Manning RE, 2014, KOEDOE, V56, DOI 10.4102/koedoe.v56i2.1159; Marcot BG, 2001, FOREST ECOL MANAG, V153, P29, DOI 10.1016/S0378-1127(01)00452-2; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Marcot BG, 2006, ECOL SOC, V11; Marcot BG, 2012, N AM J FISH MANAGE, V32, P450, DOI 10.1080/02755947.2012.675959; Marcot BG, 2012, ECOL MODEL, V230, P50, DOI 10.1016/j.ecolmodel.2012.01.013; Mattson D, 1985, 8144 INT GRIZZL BEAR; Mattson D. J., 1987, WYOMING URSUS, V7, P259, DOI DOI 10.2307/3872633; Mattson DJ, 1996, CONSERV BIOL, V10, P1013, DOI 10.1046/j.1523-1739.1996.10041013.x; MATTSON DJ, 1992, J WILDLIFE MANAGE, V56, P432, DOI 10.2307/3808855; MCLELLAN BN, 1989, WILDLIFE SOC B, V17, P269; McLellan BN, 1999, J WILDLIFE MANAGE, V63, P911, DOI 10.2307/3802805; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Miller Sterling D., 1999, Ursus, V11, P239; Moe TF, 2007, CAN J ZOOL, V85, P518, DOI 10.1139/Z07-034; Moen GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031699; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nadeau MS, 1989, P S MAN STRAT S HELD; Nadeau MS, 1987, THESIS; Neumann Wiebke, 2011, Alces, V47, P17; Nevin OT, 2005, BIOL CONSERV, V121, P611, DOI 10.1016/j.biocon.2004.06.011; Nevin OT, 2005, BIOL CONSERV, V123, P453, DOI 10.1016/j.biocon.2005.01.007; Noyce K. V., 1994, INT C BEAR RES MANAG, V9, P481, DOI DOI 10.2307/3872736; Olson T.L., 1994, URSUS, V9, P97; Olson TL, 1998, URSUS-SERIES, V10, P547; Olson TL, 2003, KATMNR0302 KATM NAT; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Proffitt K, 2003, KATMNR0301 KATM NAT; REINHART DP, 1990, INT C BEAR, V8, P343; Reynolds PC, 2001, TOURISM MANAGE, V22, P31, DOI 10.1016/S0261-5177(00)00018-2; Reynolds PE, 1986, INT C BEAR RES MANAG, V6, P169; Robbins CT, 2012, J MAMMAL, V93, P540, DOI 10.1644/11-MAMM-A-155.1; Rode KD, 2007, J WILDLIFE MANAGE, V71, P929, DOI 10.2193/2006-075; Rode KD, 2006, BIOL CONSERV, V133, P70, DOI 10.1016/j.biocon.2006.05.021; Rode KD, 2000, CAN J ZOOL, V78, P1640, DOI 10.1139/cjz-78-9-1640; RODE KD, 2006, ECOLOGY, V87, P2636, DOI DOI 10.1890/0012-9658(2006)87[2636:SDRSAH]2.0.CO;2; Ruth TK, 2003, WILDLIFE SOC B, V31, P1150; Sahlen V, 2013, THESIS; Sato CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064282; Schleyer BO, 1984, EFFECTS NONMOTORIZED; Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x; Schoen JW, 1987, INT C BEAR RES MANAG, V7, P293, DOI DOI 10.2307/3872636; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Shively KJ, 2005, J WILDLIFE MANAGE, V69, P1073, DOI 10.2193/0022-541X(2005)069[1073:ERRTRO]2.0.CO;2; Skibins Jeffrey C., 2012, Human Dimensions of Wildlife, V17, P112, DOI 10.1080/10871209.2012.627531; SMITH RB, 1990, INT C BEAR, V8, P93; Smith TS, 2005, URSUS, V16, P1, DOI 10.2192/1537-6176(2005)016[0001:ABBHAH]2.0.CO;2; Smith TS, 2002, URSUS, V13, P257; Smith TS, 2004, ARCTIC, V57, P160; Steven R, 2011, J ENVIRON MANAGE, V92, P2287, DOI 10.1016/j.jenvman.2011.05.005; Steyaert SMJG, 2013, J ANIM ECOL, V82, P836, DOI 10.1111/1365-2656.12055; Swenson J.E., 1999, BIOSPH CONS, V2, P1; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Swenson Jon E., 1999, Ursus, V11, P157; Swenson JE, 1997, WILDLIFE BIOL, V3, P35, DOI 10.2981/wlb.1997.005; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Tollefson TN, 2005, J WILDLIFE MANAGE, V69, P810, DOI 10.2193/0022-541X(2005)069[0810:QSOOAB]2.0.CO;2; Turner A.J., 2012, THESIS U YORK; [U.S. Fish and Wildlife Service U.S. Department of Commerce Bureau of the Census U.S. Department of the Interior], 1993, 1991 NAT SURV FISH H; United States Department of the Interior and United States Department of Commerce, 2012, 2011 NAT SURV FISH H; Van Dyke C, 2003, HUMAN BROWN BEAR USE; Warner S. H., 1987, INT C BEAR RES MAN, V7, P377; Weiss EW, 2012, MCNEIL RIVER STATE G; White D, 1999, WILDLIFE SOC B, V27, P146; Wilker GA, 1998, URSUS-SERIES, V10, P557; [No title captured]	148	36	38	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0141983	10.1371/journal.pone.0141983	http://dx.doi.org/10.1371/journal.pone.0141983			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731652	gold, Green Published			2022-12-27	WOS:000367801400003
J	Guerrera, F; Tabbo, F; Bessone, L; Maletta, F; Gaudiano, M; Ercole, E; Annaratone, L; Todaro, M; Boita, M; Filosso, PL; Solidoro, P; Delsedime, L; Oliaro, A; Sapino, A; Ruffini, E; Inghirami, G				Guerrera, Francesco; Tabbo, Fabrizio; Bessone, Luca; Maletta, Francesca; Gaudiano, Marcello; Ercole, Elisabetta; Annaratone, Laura; Todaro, Maria; Boita, Monica; Filosso, Pier Luigi; Solidoro, Paolo; Delsedime, Luisa; Oliaro, Alberto; Sapino, Anna; Ruffini, Enrico; Inghirami, Giorgio			The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank	PLOS ONE			English	Article							QUALITY; PANEL	Introduction Bio-repositories are invaluable resources to implement translational cancer research and clinical programs. They represent one of the most powerful tools for biomolecular studies of clinically annotated cohorts, but high quality samples are required to generate reliable molecular readouts and functional studies. The objective of our study was to define the impact of cancer tissue ischemia time on RNA and DNA quality, and for the generation of Patient-Derived Xenografts (PDXs). Methods One-hundred thirty-five lung cancer specimens were selected among our Institutional Bio-Bank samples. Associations between different warm (surgical) and cold (ex-vivo) ischemia time ranges and RNA quality or PDXs engraftment rates were assessed. RNA quality was determined by RNA integrity number (RINs) values. Fresh viable tissue fragments were implanted subcutaneously in NSG mice and serially transplanted. Results RNAs with a RIN>7 were detected in 51% of the sample (70/135), with values of RIN significantly lower (OR 0.08, P = 0.01) in samples preserved for more than 3 hours before cryopreservation. Higher quality DNA samples had a concomitant high RIN. Sixty-three primary tumors (41 adenocarcinoma) were implanted with an overall engraftment rate of 33%. Both prolonged warm (>2 hours) and ex-vivo ischemia time (>10 hours) were associated to a lower engraftment rate (OR 0.09 P = 0.01 and OR 0.04 P = 0.008, respectively). Conclusion RNA quality and PDXs engraftment rate were adversely affected by prolonged ischemia times. Proper tissue collection and processing reduce failure rate. Overall, NSCLC Bio-Banking represents an innovative modality, which can be successfully executed in routine clinical settings, when stringent Standard Operating Procedures are adopted.	[Guerrera, Francesco; Filosso, Pier Luigi; Oliaro, Alberto; Ruffini, Enrico] Univ Turin, Dept Thorac Surg, I-10126 Turin, Italy; [Tabbo, Fabrizio; Bessone, Luca; Gaudiano, Marcello; Ercole, Elisabetta; Todaro, Maria; Inghirami, Giorgio] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy; [Tabbo, Fabrizio; Bessone, Luca; Gaudiano, Marcello; Ercole, Elisabetta; Todaro, Maria; Inghirami, Giorgio] Univ Turin, Ctr Expt Res & Med Studies, I-10126 Turin, Italy; [Tabbo, Fabrizio; Gaudiano, Marcello; Todaro, Maria; Inghirami, Giorgio] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Maletta, Francesca; Annaratone, Laura; Delsedime, Luisa; Sapino, Anna] Univ Turin, Dept Med Sci, I-10126 Turin, Italy; [Boita, Monica] Univ Turin, Dept Med Sci Allergol & Immunol, I-10126 Turin, Italy; [Solidoro, Paolo] San Giovanni Battista Hosp, Unit Pulmonol, I-10126 Turin, Italy; [Inghirami, Giorgio] NYU, Sch Med, Dept Pathol, New York, NY USA; [Inghirami, Giorgio] NYU, Ctr Canc, New York, NY USA	University of Turin; University of Turin; University of Turin; Cornell University; University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; New York University; New York University	Guerrera, F (corresponding author), Univ Turin, Dept Thorac Surg, I-10126 Turin, Italy.	fra.guerrera@gmail.com	Maletta, Francesca/AAB-1496-2019; Annaratone, Laura/J-9261-2016; Guerrera, Francesco/L-4400-2019; Guerrera, Francesco/M-9391-2014; Sapino, Anna/J-4113-2018; Sapino, Anna/AGY-9901-2022; SOLIDORO, PAOLO/AAI-3040-2020	Annaratone, Laura/0000-0001-5750-1445; Guerrera, Francesco/0000-0002-4125-4379; Guerrera, Francesco/0000-0002-4125-4379; Sapino, Anna/0000-0003-3542-9571; Sapino, Anna/0000-0003-3542-9571; Maletta, Francesca/0000-0002-7877-030X				Annaratone L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075193; [Anonymous], 2015, NAT MED, V21, P99, DOI 10.1038/nm.3801; Asterand C, 2006, RNA QUALITY ASSURANC; Bao WG, 2013, ANN SURG ONCOL, V20, P1737, DOI 10.1245/s10434-012-2440-1; Bertilsson H, 2010, SCAND J CLIN LAB INV, V70, P45, DOI 10.3109/00365510903540815; Botti G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-204; Comanescu Maria, 2012, Recent Pat DNA Gene Seq, V6, P22; Dev H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-121; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Gundisch S, 2015, LAB INVEST, V95, P561, DOI 10.1038/labinvest.2015.37; Guerrera F, 2015, EUR J CARDIO-THORAC, V47, P1037, DOI 10.1093/ejcts/ezu410; Hao CC, 2015, CANCER LETT, V357, P179, DOI 10.1016/j.canlet.2014.11.024; Ilie M, 2015, CANCER MED-US, V4, P201, DOI 10.1002/cam4.357; Jewell SD, 2002, AM J CLIN PATHOL, V118, P733; Kristensen T, 2011, APPL IMMUNOHISTO M M, V19, P460, DOI 10.1097/PAI.0b013e318214e523; Nemati F, 2009, ANTI-CANCER DRUG, V20, P932, DOI 10.1097/CAD.0b013e32833009cc; Ohashi Y, 2004, EXP MOL PATHOL, V77, P98, DOI 10.1016/j.yexmp.2004.05.005; Rio D.C., 2010, COLD SPRING HARB PRO, V2010, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3944; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vaught J, 2012, CLIN CHIM ACTA, V413, P1569, DOI 10.1016/j.cca.2012.04.030	26	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145100	10.1371/journal.pone.0145100	http://dx.doi.org/10.1371/journal.pone.0145100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731692	Green Published, gold			2022-12-27	WOS:000367801400022
J	Latorre, R; Torres, JJ; Varona, P				Latorre, Roberto; Torres, Joaquin J.; Varona, Pablo			Interplay between Subthreshold Oscillations and Depressing Synapses in Single Neurons	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; NEOCORTICAL PYRAMIDAL NEURONS; ATTRACTOR NEURAL-NETWORKS; DYNAMIC SYNAPSES; ENTORHINAL CORTEX; NEUROTRANSMITTER RELEASE; FREQUENCY PREFERENCES; LESS-THAN-1 HZ; INFERIOR OLIVE; STELLATE CELLS	In this paper we analyze the interplay between the subthreshold oscillations of a single neuron conductance-based model and the short-term plasticity of a dynamic synapse with a depressing mechanism. In previous research, the computational properties of subthreshold oscillations and dynamic synapses have been studied separately. Our results show that dynamic synapses can influence different aspects of the dynamics of neuronal subthreshold oscillations. Factors such as maximum hyperpolarization level, oscillation amplitude and frequency or the resulting firing threshold are modulated by synaptic depression, which can even make subthreshold oscillations disappear. This influence reshapes the postsynaptic neuron's resonant properties arising from subthreshold oscillations and leads to specific input/output relations. We also study the neuron's response to another simultaneous input in the context of this modulation, and show a distinct contextual processing as a function of the depression, in particular for detection of signals through weak synapses. Intrinsic oscillations dynamics can be combined with the characteristic time scale of the modulatory input received by a dynamic synapse to build cost-effective cell/channel-specific information discrimination mechanisms, beyond simple resonances. In this regard, we discuss the functional implications of synaptic depression modulation on intrinsic subthreshold dynamics.	[Latorre, Roberto; Varona, Pablo] Univ Autonoma Madrid, Escuela Politecn Super, Dept Ingn Informat, Grp Neurocomputac Biol, E-28049 Madrid, Spain; [Torres, Joaquin J.] Univ Granada, Dept Electromagnetismo & Fis Mat, Granada, Spain; [Torres, Joaquin J.] Univ Granada, Inst Carlos Theoret & Computat Phys 1, Granada, Spain	Autonomous University of Madrid; University of Granada; University of Granada	Latorre, R (corresponding author), Univ Autonoma Madrid, Escuela Politecn Super, Dept Ingn Informat, Grp Neurocomputac Biol, E-28049 Madrid, Spain.	roberto.latorre@uam.es	Varona, Pablo/B-5583-2012; Torres, Joaquín J./C-1385-2012; Latorre, Roberto/F-9436-2012; Torres, Joaquín J./AAE-6228-2019	Varona, Pablo/0000-0002-1754-8991; Torres, Joaquín J./0000-0001-6175-9676; Latorre, Roberto/0000-0003-3835-7905; 	MINECO [TIN2012-30883, FIS2013-43201-P]	MINECO(Spanish Government)	This work was supported by MINECO TIN2012-30883 (RL and PV) and FIS2013-43201-P (JJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; Baroni F, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015023, DOI 10.1371/J0URNAL.P0NE.0015023]; Baroni F, 2007, NEUROCOMPUTING, V70, P1611, DOI 10.1016/j.neucom.2006.10.042; Baroni F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003574; Baroni F, 2010, J PHYSIOL-PARIS, V104, P91, DOI 10.1016/j.jphysparis.2009.11.007; Benita JM, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00064; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; Boehlen A, 2013, J NEUROPHYSIOL, V109, P445, DOI 10.1152/jn.00743.2011; Bressloff PC, 2011, SIAM J APPL MATH, V71, P379, DOI 10.1137/100799423; Bressloff PC, 1999, PHYS REV E, V60, P2160, DOI 10.1103/PhysRevE.60.2160; Brezina V, 1997, P NATL ACAD SCI USA, V94, P10444, DOI 10.1073/pnas.94.19.10444; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Cortes JM, 2006, NEURAL COMPUT, V18, P614, DOI 10.1162/089976606775623342; Cortes JM, 2004, NEUROCOMPUTING, V58, P67, DOI 10.1016/j.neucom.2004.01.024; de la Rocha J, 2005, J NEUROSCI, V25, P8416, DOI 10.1523/JNEUROSCI.0631-05.2005; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fung CCA, 2012, NEURAL COMPUT, V24, P1147, DOI 10.1162/NECO_a_00269; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Kilpatrick ZP, 2010, J COMPUT NEUROSCI, V28, P193, DOI 10.1007/s10827-009-0199-6; Kistler WM, 1999, NEURAL COMPUT, V11, P1579, DOI 10.1162/089976699300016151; Klug A, 2012, J NEUROSCI, V32, P14058, DOI 10.1523/JNEUROSCI.3348-12.2012; Latorre R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00138; Liaw JS, 1996, HIPPOCAMPUS, V6, P591; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Marro J, 2007, NEURAL NETWORKS, V20, P230, DOI 10.1016/j.neunet.2006.11.005; Mejias JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017255; Mohan A, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00041; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Natschlager T, 2001, NETWORK-COMP NEURAL, V12, P75, DOI 10.1088/0954-898X/12/1/305; O'Donnell C, 2011, TRENDS NEUROSCI, V34, P51, DOI 10.1016/j.tins.2010.10.003; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Pinamonti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051170; Reboreda A, 2003, J PHYSIOL-LONDON, V551, P191, DOI 10.1113/jphysiol.2003.039917; Romani S, 2015, HIPPOCAMPUS, V25, P94, DOI 10.1002/hipo.22355; Rotstein HG, 2015, J COMPUT NEUROSCI, V38, P325, DOI 10.1007/s10827-014-0544-2; Rotstein HG, 2014, J MATH NEUROSCI, V4, DOI 10.1186/2190-8567-4-11; Senn W, 1996, NEURAL NETWORKS, V9, P575, DOI 10.1016/0893-6080(95)00109-3; Senn W, 1998, NEURAL COMPUT, V10, P815, DOI 10.1162/089976698300017494; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tateno T, 2004, J NEUROPHYSIOL, V92, P2283, DOI 10.1152/jn.00109.2004; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Torres JJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053014; Torres JJ, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00030; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varona P, 2002, NEUROCOMPUTING, V44, P685, DOI 10.1016/S0925-2312(02)00458-7; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wu S, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00188; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	71	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145830	10.1371/journal.pone.0145830	http://dx.doi.org/10.1371/journal.pone.0145830			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730737	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400060
J	Martin-Fernandez, B; Rubio-Navarro, A; Cortegano, I; Ballesteros, S; Alia, M; Cannata-Ortiz, P; Olivares-Alvaro, E; Egido, J; de Andres, B; Gaspar, ML; de las Heras, N; Lahera, V; Moreno, JA				Martin-Fernandez, Beatriz; Rubio-Navarro, Alfonso; Cortegano, Isabel; Ballesteros, Sandra; Alia, Mario; Cannata-Ortiz, Pablo; Olivares-Alvaro, Elena; Egido, Jesus; de Andres, Belen; Luisa Gaspar, Maria; de las Heras, Natalia; Lahera, Vicente; Antonio Moreno, Juan			Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TISSUE GROWTH-FACTOR; ALTERNATIVELY ACTIVATED MACROPHAGES; POLARIZATION; CELLS; MICE; PROGRESSION; BLOCKADE; INJURY; HYPERTENSION	We aimed to evaluate macrophages heterogeneity and structural, functional and inflammatory alterations in rat kidney by aldosterone + salt administration. The effects of treatment with spironolactone on above parameters were also analyzed. Male Wistar rats received aldosterone (1 mgkg(-1)d(-1)) + 1% NaCl for 3 weeks. Half of the animals were treated with spironolactone (200 mg kg(-1)d(-1)). Systolic and diastolic blood pressures were elevated (p<0.05) in aldosterone + salt-treated rats. Relative kidney weight, collagen content, fibronectin, macrophage infiltrate, CTGF, Col I, MMP2, TNF-alpha, CD68, Arg2, and SGK-1 were increased (p<0.05) in aldosterone + salt-treated rats, being reduced by spironolactone (p<0.05). Increased iNOS and IFN-Upsilon mRNA gene expression (M1 macrophage markers) was observed in aldosterone + salt rats, whereas no significant differences were observed in IL-10 and gene ArgI mRNA expression or ED2 protein content (M2 macrophage markers). All the observed changes were blocked with spironolactone treatment. Macrophage depletion with liposomal clodronate reduced macrophage influx and inflammatory M1 markers (INF-Upsilon or iNOS), whereas interstitial fibrosis was only partially reduced after this intervention, in aldosterone plus salt-treated rats. In conclusion, aldosterone + salt administration mediates inflammatory M1 macrophage phenotype and increased fibrosis throughout mineralocorticoid receptors activation.	[Martin-Fernandez, Beatriz; Ballesteros, Sandra; Olivares-Alvaro, Elena; de las Heras, Natalia; Lahera, Vicente] Univ Complutense, Fac Med, Dept Physiol, E-28040 Madrid, Spain; [Rubio-Navarro, Alfonso; Egido, Jesus; Antonio Moreno, Juan] Autonoma Univ UAM, IIS Fdn Jimenez Diaz, Renal Vasc & Diabet Res Lab, Madrid 28040, Spain; [Cortegano, Isabel; Alia, Mario; de Andres, Belen; Luisa Gaspar, Maria] Inst Salud Carlos III, Ctr Nacl Microbiol, Dept Immunol, Madrid 28220, Spain; [Cannata-Ortiz, Pablo] Autonoma Univ UAM, IIS Fdn Jimenez Diaz, Dept Pathol, Madrid 28040, Spain	Complutense University of Madrid; Fundacion Jimenez Diaz; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Fundacion Jimenez Diaz	Martin-Fernandez, B (corresponding author), Univ Complutense, Fac Med, Dept Physiol, E-28040 Madrid, Spain.	bmartinfernandez@med.ucm.es; jamoreno@fjd.es	Rubio, Alfonso/ABH-5028-2020; de Andres, Belen/D-4712-2016; Moreno, Juan Antonio/B-3487-2018; Gaspar, Maria Luisa/P-5436-2014; Cortegano, Isabel/AAE-1500-2020; Alia, Mario/H-1382-2015	Rubio, Alfonso/0000-0001-5677-3123; Moreno, Juan Antonio/0000-0002-7468-2871; Gaspar, Maria Luisa/0000-0001-9858-3862; Alia, Mario/0000-0002-0695-4038; Lahera, Vicente/0000-0002-9688-4503; DE LAS HERAS, NATALIA/0000-0002-2960-6175; DE ANDRES, BELEN/0000-0002-7391-2823; Martin-Fernandez, Beatriz/0000-0002-1904-6194	Fondo de Investigaciones Sanitaria (FIS) [CP10/00479, PI13/00802, PI14/00883]; Spanish Society of Nephrology; Fundacion Conchita Rabago; Institute of Research Queen Sophia; Fundacion Renal Inigo Alvarez de Toledo (FRIAT); Instituto de Salud Carlos III (ISCIII) fund [PI14/00386]; VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana [SAF2011-30396]	Fondo de Investigaciones Sanitaria (FIS); Spanish Society of Nephrology; Fundacion Conchita Rabago; Institute of Research Queen Sophia; Fundacion Renal Inigo Alvarez de Toledo (FRIAT)(Fonds de la Recherche Scientifique - FNRS); Instituto de Salud Carlos III (ISCIII) fund; VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana	This work has been supported by grants from Fondo de Investigaciones Sanitaria (FIS, Programa Miguel Servet: CP10/00479, PI13/00802 and PI14/00883), Spanish Society of Nephrology to Juan Antonio Moreno, Fundacion Conchita Rabago to Alfonso Rubio-Navarro, Institute of Research Queen Sophia, Fundacion Renal Inigo Alvarez de Toledo (FRIAT) and Instituto de Salud Carlos III (ISCIII) fund PI14/00386 to Jesus Egido and VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana (SAF2011-30396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Belliere J, 2015, J AM SOC NEPHROL, V26, P1363, DOI 10.1681/ASN.2014040320; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; Bienvenu LA, 2012, ENDOCRINOLOGY, V153, P3416, DOI 10.1210/en.2011-2098; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Brem AS, 2011, AM J KIDNEY DIS, V58, P471, DOI 10.1053/j.ajkd.2011.03.029; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Carlos CP, 2010, TRANSPLANTATION, V89, P1362, DOI 10.1097/TP.0b013e3181da0587; Chantong B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-260; Chen YJ, 2015, J NEUROSCI RES, V93, P1526, DOI 10.1002/jnr.23612; Crowley SD, 2014, J CLIN INVEST, V124, P2341, DOI 10.1172/JCI72274; Delyani JA, 2000, KIDNEY INT, V57, P1408, DOI 10.1046/j.1523-1755.2000.00983.x; Drawz PE, 2013, KIDNEY INT SUPPL, V3, P372, DOI 10.1038/kisup.2013.80; Fu YL, 2014, NEPHRON PHYSIOL, V128, P8, DOI 10.1159/000368264; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Funder JW, 2000, KIDNEY INT, V57, P1358, DOI 10.1046/j.1523-1755.2000.00975.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greene EL, 1996, J CLIN INVEST, V98, P1063, DOI 10.1172/JCI118867; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Huang W, 2008, AM J PHYSIOL-RENAL, V294, pF1287, DOI 10.1152/ajprenal.00017.2008; Ikezumi Y, 2011, HISTOPATHOLOGY, V58, P198, DOI 10.1111/j.1365-2559.2011.03742.x; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lahera V, 2006, THESCIENTIFICWORLDJO, V6, P413, DOI 10.1100/tsw.2006.68; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Li C, 2015, CELL PHYSIOL BIOCHEM, V36, P358, DOI 10.1159/000430106; Mallavia B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066754; Martin-Fernandez B, 2011, J CARDIOVASC PHARM, V57, P114, DOI 10.1097/FJC.0b013e31820088ca; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Namsolleck P, 2014, NEPHROL DIAL TRANSPL, V29, pI62, DOI 10.1093/ndt/gft402; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Raesl G, 2007, CURR OPIN IMMUNOL, V19, P454, DOI 10.1016/j.coi.2007.05.007; Rogerson FM, 1999, J BIOL CHEM, V274, P36305, DOI 10.1074/jbc.274.51.36305; Salyer SA, 2013, BBA-MOL CELL RES, V1833, P2143, DOI 10.1016/j.bbamcr.2013.05.009; Sastre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083713; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Toto RD, 2005, SEMIN NEPHROL, V25, P435, DOI 10.1016/j.semnephrol.2005.05.016; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Volk MJ, 2011, CURR HYPERTENS REP, V13, P282, DOI 10.1007/s11906-011-0202-2; Wang SN, 2001, KIDNEY INT, V60, P96, DOI 10.1046/j.1523-1755.2001.00776.x	44	59	60	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145946	10.1371/journal.pone.0145946	http://dx.doi.org/10.1371/journal.pone.0145946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730742	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400069
J	Wu, ZK; Wang, B; Chen, X; Wu, JS; King, GJ; Xiao, YJ; Liu, KD				Wu, Zhikun; Wang, Bo; Chen, Xun; Wu, Jiangsheng; King, Graham J.; Xiao, Yingjie; Liu, Kede			Evaluation of Linkage Disequilibrium Pattern and Association Study on Seed Oil Content in Brassica napus Using ddRAD Sequencing	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; NATURAL VARIATION; AGRONOMIC TRAITS; EVOLUTION; INSIGHTS; MAP	High-density genetic markers are the prerequisite for understanding linkage disequilibrium (LD) and genome-wide association studies (GWASs) of complex traits in crops. To evaluate the LD pattern in oilseed rape, we sequenced a previous association panel containing 189 B. napus inbred lines using double-digested restriction-site associated DNA (ddRAD) and genotyped 19,327 RAD tags. A total of 15,921 RAD tags were assigned to a published genetic linkage map and the majority (71.1%) of these tags was uniquely mapped to the draft reference genome "Darmor-bzh." The distance of LD decay was 1,214 kb across the genome at the background level (r(2) = 0.26), with the distances of LD decay being 405 kb and 2,111 kb in the A and C subgenomes, respectively. A total of 361 haplotype blocks with length > 100 kb were identified in the entire genome. The association panel could be classified into two groups, P1 and P2, which are essentially consistent with the geographical origins of varieties. A large number of group-specific haplotypes were identified, reflecting that varieties in the P1 and P2 groups experienced distinct selection in breeding programs to adapt their different growth habitats. GWAS repeatedly detected two loci significantly associated with oil content of seeds based on the developed SNPs, suggesting that the high-density SNPs were useful for understanding the genetic determinants of complex traits in GWAS.	[Wu, Zhikun; Wang, Bo; Chen, Xun; Wu, Jiangsheng; Xiao, Yingjie; Liu, Kede] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [King, Graham J.] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia	Huazhong Agricultural University; Southern Cross University	Xiao, YJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	shanren0179@163.com; kdliu@mail.hzau.edu.cn	King, Graham J/AAW-3368-2020; Chen, Xun/K-9994-2019	King, Graham J/0000-0002-5975-6051; Chen, Xun/0000-0003-0327-1888	National Hi-Tech R&D Program of China [2013AA102602]; National Technology R&D Program of China [2012BAD49G00]; National Natural Science Foundation of China [31071452]	National Hi-Tech R&D Program of China(National High Technology Research and Development Program of China); National Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Hi-Tech R&D Program of China (2013AA102602), the National Technology R&D Program of China (2012BAD49G00), and the National Natural Science Foundation of China (31071452).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhardwaj HL, 2000, IND CROP PROD, V12, P33, DOI 10.1016/S0926-6690(99)00043-6; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen W, 2014, NAT GENET, V46, P714, DOI 10.1038/ng.3007; Chen X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-346; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gan Li, 2003, Scientia Agricultura Sinica, V36, P1609; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jiang CC, 2014, THEOR APPL GENET, V127, P957, DOI 10.1007/s00122-014-2271-5; Kim HU, 2005, PLANT CELL, V17, P1073, DOI 10.1105/tpc.104.030403; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036807; Liu H. L., 1984, Acta Agronomica Sinica, V10, P9; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian LW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1170; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Wang N, 2014, THEOR APPL GENET, V127, P1817, DOI 10.1007/s00122-014-2343-6; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080569; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096; Zou J, 2010, GENOME, V53, P908, DOI 10.1139/G10-075	45	34	38	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146383	10.1371/journal.pone.0146383	http://dx.doi.org/10.1371/journal.pone.0146383			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730738	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400167
J	Ying, H; Lu, Y; Dong, YN; Wang, DF				Ying, Hao; Lu, Yi; Dong, Yi-Nuo; Wang, De-Fen			Effect of Placenta Previa on Preeclampsia	PLOS ONE			English	Article							TROPHOBLAST INVASION; HYPERTENSION; MANAGEMENT; PREGNANCY; ONSET; PATHOGENESIS	Background The correlation between gestational hypertension-preeclampsia (GH-PE) and placenta previa (PP) is controversial. Specifically, it is unknown whether placenta previa has any effect on the various types of preeclampsia (PE), and the role PP with concurrent placenta accreta (PA) play in the occurrence of GH-PE are not well understood. Objective The aim of this study was to identify the effects of PP on GH, mild and severe preeclampsia (MPE and SPE), and early-and late-onset preeclampsia (EPE and LPE). Another aim of the study was to determine if concurrent PA impacts the relationship between PP and GH-PE. Methods A retrospective single-center study of 1,058 patients having singleton pregnancies with PP was performed, and 2,116 pregnant women were randomly included as controls. These cases were collected from a tertiary hospital and met the inclusion criteria for the study. Clinical information, including PP and the gestational age at the onset of GH-PE were collected. Binary and multiple logistic regression analyses were conducted after the confounding variables were controlled to assess the effects of PP on different types of GH-PE. Results There were 155 patients with GH-PE in the two groups. The incidences of GH-PE in the PP group and the control group were 2.5% (26/1058) and 6.1% (129/2116), respectively (P = 0.000). Binary and multiple regression analyses were conducted after controlling for confounding variables. Compared to the control group, in the PP group, the risk of GH-PE was reduced significantly by 78% (AOR: 0.216; 95% CI: 0.135-0.345); the risks of GH and PE were reduced by 55% (AOR: 0.451; 95% CI: 0.233-0.873) and 86% (AOR: 0.141; 95% CI: 0.073-0.271), respectively; the risks of MPE and SPE were reduced by 73% (AOR: 0.269; 95% CI: 0.087-0828) and 88% (AOR: 0.123; 95% CI: 0.055-0.279), respectively; and the risks of EPE and LPE were reduced by 95% (AOR: 0.047; 95% CI: 0.012-0.190) and 67% (AOR: 0.330; 95% CI: 0.153-0.715), respectively. The incidence of concurrent PA in women with PP was 5.86%; PP with PA did not significantly further reduce the incidence of GH-PE compared with PP without PA (1.64% vs. 2.51%, P>0.05). Binary logistic regression analyses were conducted after controlling for confounding variables, compared with the non-PP + GH-PE group, and the AOR of FGR in the non-PP + non-GH-PE group was 0.206 (0.124-0.342). Compared with the PP + GH-PE group, the AOR of FGR in the PP + non-GH-PE group was 0.430 (0.123-1.500). Conclusion PP is not only associated with a significant reduction in the incidence of GH-PE, but also is associated with a reduction in incidence of various types of PE. Concurrent PA and PP do not show association with a reduction in incidence of GH-PE.	[Ying, Hao; Lu, Yi; Dong, Yi-Nuo; Wang, De-Fen] Tongji Univ, Sch Med, Dept Obstet, Shanghai Matern & Infant Hosp 1, Shanghai 200092, Peoples R China	Tongji University	Ying, H (corresponding author), Tongji Univ, Sch Med, Dept Obstet, Shanghai Matern & Infant Hosp 1, Shanghai 200092, Peoples R China.	stephenying_2011@163.com			Health and Family Planning commission of Pudong District, Shanghai [PW2012D-10]; Key Program of Health and Family Planning commission of Shanghai [20124037]; Shanghai Hospital Development Center Grant [SHDC12012116]; Natural Science Foundation of Shanghai [13ZR1432900]; Shanghai Science and Technology Committee [134119a0800]; Industrial, Teaching and Research Cooperative Program in Medical Field, Science and Technology Commission of Shanghai Municipality [13DZ1931002]	Health and Family Planning commission of Pudong District, Shanghai; Key Program of Health and Family Planning commission of Shanghai; Shanghai Hospital Development Center Grant; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Industrial, Teaching and Research Cooperative Program in Medical Field, Science and Technology Commission of Shanghai Municipality	This work was supported by The Health and Family Planning commission of Pudong District, Shanghai (grant no. PW2012D-10); Key Program of Health and Family Planning commission of Shanghai (grant no. 20124037); Shanghai Hospital Development Center Grant (grant no. SHDC12012116); Natural Science Foundation of Shanghai (grant no. 13ZR1432900); Shanghai Science and Technology Committee (grant no. 134119a0800); Industrial, Teaching and Research Cooperative Program in Medical Field, Science and Technology Commission of Shanghai Municipality (grant no. 13DZ1931002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00032; Adler E, 2014, PLACENTA, V35, P1075, DOI 10.1016/j.placenta.2014.09.014; Ananth CV, 1997, AM J OBSTET GYNECOL, V177, P997, DOI 10.1016/S0002-9378(97)70003-6; BIENIARZ J, 1958, AM J OBSTET GYNECOL, V75, P444, DOI 10.1016/0002-9378(58)90411-3; Biswas R, 1999, ACTA OBSTET GYN SCAN, V78, P173, DOI 10.1034/j.1600-0412.1999.780301.x; Buchbinder A, 2002, AM J OBSTET GYNECOL, V186, P66, DOI 10.1067/mob.2002.120080; Corthorn J, 2006, ENDOCRINE, V29, P491, DOI 10.1385/ENDO:29:3:491; Dogan E, 2014, CLIN EXP OBSTET GYN, V41, P681; Gagnon R, 2009, J OBSTET GYNAECOL CA, V31, P748, DOI 10.1016/S1701-2163(16)34282-7; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Harper LM, 2010, AM J OBSTET GYNECOL, V203, p[e1, 330], DOI [10.1016/j.ajog.2010.05.014, DOI 10.1016/J.AJ0G.2010.05.014]; Hasegawa J, 2011, BJOG-INT J OBSTET GY, V118, P1464, DOI 10.1111/j.1471-0528.2011.03051.x; Hasegawa J, 2009, ULTRASOUND OBST GYN, V34, P80, DOI 10.1002/uog.6426; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; JELSEMA RD, 1991, J PERINAT MED, V19, P485, DOI 10.1515/jpme.1991.19.6.485; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; LEIBERMAN JR, 1991, OBSTET GYNECOL, V77, P83; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Myatt L, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0595-4; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Oppenheimer L, 2007, J OBSTET GYNAECOL CA, V29, P261, DOI 10.1016/S1701-2163(16)32401-X; Raisanen S, 2014, OBSTET GYNECOL, V124, P285, DOI 10.1097/AOG.0000000000000368; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Saito S, 2014, J REPROD IMMUNOL, V101, P80, DOI 10.1016/j.jri.2013.06.002; Sheiner E, 2001, J Matern Fetal Med, V10, P414, DOI 10.1080/714052784; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Yoder SR, 2009, AM J MED, V122, P890, DOI 10.1016/j.amjmed.2009.03.036; Yung HW, 2014, J PATHOL, V234, P262, DOI 10.1002/path.4394	34	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146126	10.1371/journal.pone.0146126	http://dx.doi.org/10.1371/journal.pone.0146126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731265	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400099
J	Lin, CF; Tsai, CC; Huang, WC; Wang, YC; Tseng, PC; Tsai, TT; Chen, CL				Lin, Chiou-Feng; Tsai, Cheng-Chieh; Huang, Wei-Ching; Wang, Yu-Chih; Tseng, Po-Chun; Tsai, Tsung-Ting; Chen, Chia-Ling			Glycogen Synthase Kinase-3 beta and Caspase-2 Mediate Ceramide- and Etoposide-Induced Apoptosis by Regulating the Lysosomal-Mitochondrial Axis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; CATHEPSIN-D; CANCER CELLS; MCL-1; ACTIVATION; CLEAVAGE; BAX; PERMEABILIZATION; UPSTREAM	Glycogen synthase kinase-3 beta (GSK-3 beta) regulates the sequential activation of caspase-2 and caspase-8 before mitochondrial apoptosis. Here, we report the regulation of Mcl-1 destabilization and cathepsin D-regulated caspase-8 activation by GSK-3 beta and caspase-2. Treatment with either the ceramide analogue C-2-ceramide or the topoisomerase II inhibitor etoposide sequentially induced lysosomal membrane permeabilization (LMP), the reduction of mitochondrial transmembrane potential, and apoptosis. Following LMP, cathepsin D translocated from lysosomes to the cytoplasm, whereas inhibiting cathepsin D blocked mitochondrial apoptosis. Furthermore, cathepsin D caused the activation of caspase-8 but not caspase-2. Inhibiting GSK-3 beta and caspase-2 blocked Mcl-1 destabilization, LMP, cathepsin D re-localization, caspase-8 activation, and mitochondrial apoptosis. Expression of Mcl-1 was localized to the lysosomes, and forced expression of Mcl-1 prevented apoptotic signaling via the lysosomal-mitochondrial pathway. These results demonstrate the importance of GSK-3 beta and caspase-2 in ceramide-and etoposide-induced apoptosis through mechanisms involving Mcl-1 destabilization and the lysosomal-mitochondrial axis.	[Lin, Chiou-Feng; Wang, Yu-Chih; Tsai, Tsung-Ting] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei 110, Taiwan; [Lin, Chiou-Feng] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Tsai, Cheng-Chieh] Chung Hwa Univ Med Technol, Dept Nursing, Tainan 717, Taiwan; [Huang, Wei-Ching; Tseng, Po-Chun] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 701, Taiwan; [Chen, Chia-Ling] Taipei Med Univ, Translat Res Ctr, Taipei 110, Taiwan	Taipei Medical University; Taipei Medical University; Chung Hua University; National Cheng Kung University; Taipei Medical University	Chen, CL (corresponding author), Taipei Med Univ, Translat Res Ctr, Taipei 110, Taiwan.	chialing66@tmu.edu.tw			Taipei Medical University, Taiwan [TMU103-AE1-B21]; Ministry of Science and Technology, Taiwan [MOST96-2320-B-006-018-MY3, MOST104-2320-B038-011-MY2]	Taipei Medical University, Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant TMU103-AE1-B21 from the Taipei Medical University, Taiwan and grants MOST96-2320-B-006-018-MY3 and MOST104-2320-B038-011-MY2 from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Cao XF, 2008, J BIOL CHEM, V283, P14490, DOI 10.1074/jbc.M801107200; Chen M, 2007, J BIOL CHEM, V282, P33888, DOI 10.1074/jbc.M702969200; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Darios F, 2003, J NEUROCHEM, V84, P643, DOI 10.1046/j.1471-4159.2003.01590.x; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Germain M, 2008, J BIOL CHEM, V283, P6384, DOI 10.1074/jbc.M707762200; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Guicciardi ME, 2005, GASTROENTEROLOGY, V129, P269, DOI 10.1053/j.gastro.2005.05.022; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Holman DH, 2008, CANCER CHEMOTH PHARM, V61, P231, DOI 10.1007/s00280-007-0465-0; Hong M, 1999, CANCER RES, V59, P2847; Hsing CH, 2012, ANESTHESIOLOGY, V116, P868, DOI 10.1097/ALN.0b013e31824af68a; Huang WC, 2009, J PHARMACOL EXP THER, V329, P524, DOI 10.1124/jpet.108.148122; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lin CF, 2006, CURR MED CHEM, V13, P1609, DOI 10.2174/092986706777441986; Lin CF, 2005, J BIOL CHEM, V280, P23758, DOI 10.1074/jbc.M412292200; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Mohan J, 2006, J BIOL CHEM, V281, P17599, DOI 10.1074/jbc.M602641200; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Tardy C, 2003, CELL DEATH DIFFER, V10, P1090, DOI 10.1038/sj.cdd.4401272; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4	41	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145460	10.1371/journal.pone.0145460	http://dx.doi.org/10.1371/journal.pone.0145460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727221	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500016
J	Liu, GH; Weston, CQ; Pham, LK; Waltz, S; Barnes, H; King, P; Sphar, D; Yamamoto, RT; Forsyth, RA				Liu, Guohong; Weston, Christopher Q.; Pham, Long K.; Waltz, Shannon; Barnes, Helen; King, Paula; Sphar, Dan; Yamamoto, Robert T.; Forsyth, R. Allyn			Epigenetic Segregation of Microbial Genomes from Complex Samples Using Restriction Endonucleases HpaII and McrB	PLOS ONE			English	Article							DNA METHYLATION; EPIGENOMICS; PHENOTYPE; SYSTEMS; CPG	We describe continuing work to develop restriction endonucleases as tools to enrich targeted genomes of interest from diverse populations. Two approaches were developed in parallel to segregate genomic DNA based on cytosine methylation. First, the methyl-sensitive endonuclease HpaII was used to bind non-CG methylated DNA. Second, a truncated fragment of McrB was used to bind CpG methylated DNA. Enrichment levels of microbial genomes can exceed 100-fold with HpaII allowing improved genomic detection and coverage of otherwise trace microbial genomes from sputum. Additionally, we observe interesting enrichment results that correlate with the methylation states not only of bacteria, but of fungi, viruses, a protist and plants. The methods presented here offer promise for testing biological samples for pathogens and global analysis of population methylomes.	[Liu, Guohong; Weston, Christopher Q.; Pham, Long K.; Waltz, Shannon; Barnes, Helen; King, Paula; Sphar, Dan; Forsyth, R. Allyn] FLIR Syst Inc, La Jolla, CA 92037 USA; [Weston, Christopher Q.; Waltz, Shannon; King, Paula; Forsyth, R. Allyn] Singlera Genom Inc, La Jolla, CA 92037 USA; [Yamamoto, Robert T.] Zova Syst LLC, San Diego, CA 92129 USA; [Waltz, Shannon; Forsyth, R. Allyn] San Diego State Univ, San Diego, CA 92182 USA	California State University System; San Diego State University	Forsyth, RA (corresponding author), FLIR Syst Inc, La Jolla, CA 92037 USA.	rforsyth@mail.sdsu.edu		King, Paula/0000-0002-3876-2655	Department of Homeland Security (DHS), Science and Technology Directorate (ST) [HSHQDC-10-C-00019]; FLIR Systems, Inc; Singlera Genomics Inc.; Zova Systems, LLC	Department of Homeland Security (DHS), Science and Technology Directorate (ST)(United States Department of Homeland Security (DHS)); FLIR Systems, Inc; Singlera Genomics Inc.; Zova Systems, LLC	Funding for this research was provided in full through contract HSHQDC-10-C-00019 to FLIR Systems, Inc., by the Department of Homeland Security (DHS), Science and Technology Directorate (S&T), http://www.dhs.gov/science-and-technology. DHS S&T reviewed and approved the manuscript for publication. DHS S&T had no additional roles in the study design, data collection, analysis or preparation of the manuscript. FLIR Systems, Inc., Singlera Genomics Inc. and Zova Systems, LLC, provided support in the form of salaries for authors GL, CQW, LKP, SW, HB, PK, DS, RTY and RAF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANTEQUERA F, 1984, J BIOL CHEM, V259, P8033; Barnes HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109061; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berger G, 2015, RAMBAM MAIMONIDES ME, V6, DOI 10.5041/RMMJ.10202; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Chen Q, 2008, J BACTERIOL, V190, P7885, DOI 10.1128/JB.00324-08; Chen XS, 2013, CURR OPIN PLANT BIOL, V16, P164, DOI 10.1016/j.pbi.2013.03.004; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011; De Meyer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059068; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fournier PE, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0114-2; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gissot M, 2008, EUKARYOT CELL, V7, P537, DOI 10.1128/EC.00448-07; Guo YQ, 2015, J CLIN MICROBIOL, V53, P641, DOI 10.1128/JCM.02962-14; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Huo WW, 2015, J BACTERIOL, V197, P1939, DOI 10.1128/JB.00130-15; KRUGER T, 1995, EMBO J, V14, P2661, DOI 10.1002/j.1460-2075.1995.tb07264.x; Lee DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002531; Lee WC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1585-2; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Liu SY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036406, 10.1371/journal.pone.0030349]; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231; Lopez-Cepero AA, 2015, P R HEALTH SCI J, V34, P60; MANN MB, 1977, NUCLEIC ACIDS RES, V4, P4211, DOI 10.1093/nar/4.12.4211; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Melli LCFL, 2016, ALLERGOL IMMUNOPATH, V44, P177, DOI 10.1016/j.aller.2015.01.013; Mensaert K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00016; Meyer P, 2011, FEBS LETT, V585, P2008, DOI 10.1016/j.febslet.2010.08.017; Mishra PK, 2011, P NATL ACAD SCI USA, V108, P11965, DOI 10.1073/pnas.1109631108; Priest NK, 2012, NAT REV MICROBIOL, V10, P791, DOI 10.1038/nrmicro2880; Ryan U, 2015, INT J PARASITOL, V45, P367, DOI 10.1016/j.ijpara.2015.01.009; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; Yigit E, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400064; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327	45	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146064	10.1371/journal.pone.0146064	http://dx.doi.org/10.1371/journal.pone.0146064			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727463	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500049
J	Soria-Saucedo, R; Xu, P; Newsom, J; Cabral, H; Kazis, LE				Soria-Saucedo, Rene; Xu, Peng; Newsom, Jack; Cabral, Howard; Kazis, Lewis E.			The Role of Geography in the Assessment of Quality: Evidence from the Medicare Advantage Program	PLOS ONE			English	Article							OF-CARE; BENEFICIARIES; EXPENDITURES; GROWTH; RATES; RISK	The Affordable Care Act set inmotion a renewed emphasis on quality of care evaluation. However, the evaluation strategies of quality by the Centers for Medicare and Medicaid Services do not consider geography when comparisons are made among plans. Using an overall measure of a plan's quality in the public sector-the Medicare Advantage (MA) star ratings-we explored the impact of geography in these ratings. We identified 2,872 U.S counties in 2010. The geographic factor predicted a larger fraction of the MA ratings' compared to sociodemographic factors which explained less. Also, after the risk adjustments, almost half of the U.S. states changed their ranked position in the star ratings. Further, lower MA star ratings were identified in the Southeastern region. These findings suggest that the geographic component effect on the ratings is not trivial and should be considered in future adjustments of the metric, which may enhance the transparency, accountability, and importantly level the playing field more effectively when comparing quality across health plans.	[Soria-Saucedo, Rene; Xu, Peng; Kazis, Lewis E.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, CAPP, Boston, MA 02140 USA; [Newsom, Jack] CenseoHealth, Dallas, TX USA; [Cabral, Howard] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Boston University; Boston University	Kazis, LE (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, CAPP, Boston, MA 02140 USA.	lek@bu.edu						Allen NB, 2010, NEUROEPIDEMIOLOGY, V34, P123, DOI 10.1159/000274804; Ashton CM, 1999, NEW ENGL J MED, V340, P32, DOI 10.1056/NEJM199901073400106; Atkinson R, 2001, URBAN STUD, V38, P2277, DOI 10.1080/00420980120087162; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Barnato AE, 2011, CRIT CARE MED, V39, P1663, DOI 10.1097/CCM.0b013e3182186e98; Brown JR, 2014, JAMA-J AM MED ASSOC, V311, P1009, DOI 10.1001/jama.2014.421; Burke JF, 2012, ANN NEUROL, V71, P179, DOI 10.1002/ana.22698; Centers for Medicare & Medicaid Services, 2014, ENH STAR RAT 2016; Congress of The United States Congressional Budget Office, 2008, GEOGR VAR HLTH CAR S; Curtis LH, 2010, CIRC CARDIOVASC QUAL; Daffner SD, 2010, SPINE, V35, P1165, DOI 10.1097/BRS.0b013e3181d88e78; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Goodney PP, 2010, CIRC-CARDIOVASC QUAL, V3, P15, DOI 10.1161/CIRCOUTCOMES.109.864736; Institute of Medicine, 2013, MAK SENS GEOGR VAR H; Institute of Medicine of the National Academies, 2013, VAR HLTH CAR SPEND T; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P70; Kazis LE, 2012, J AMBUL CARE MANAG, V35, P263, DOI 10.1097/JAC.0b013e318267468f; Likosky DS, 2013, JAMA INTERN MED, V173, P2055, DOI 10.1001/jamainternmed.2013.10789; Miller DC, 2011, HEALTH AFFAIR, V30, P2107, DOI 10.1377/hlthaff.2011.0783; Morden NE, 2013, NEW ENGL J MED, V369, P299, DOI 10.1056/NEJMp1301805; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Parker L, 2010, AM J ROENTGENOL, V194, P1034, DOI 10.2214/AJR.09.3528; Qato DM, 2013, J GEN INTERN MED, V28, P546, DOI 10.1007/s11606-012-2244-9; Reschovsky JD, 2014, HEALTH SERV RES, V49, P32, DOI 10.1111/1475-6773.12087; Rosenthal T, 2012, ANNU REV MED, V63, P493, DOI 10.1146/annurev-med-050710-134438; Schneider EC, 2005, AM J MED, V118, P1392, DOI 10.1016/j.amjmed.2005.05.032; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Xu P, 2015, ANN INTERN MED, V162, P353, DOI 10.7326/M14-0332	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145656	10.1371/journal.pone.0145656	http://dx.doi.org/10.1371/journal.pone.0145656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727371	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500028
J	Lei, PF; Sun, RX; Wang, L; Zhou, JL; Wan, LF; Zhou, TJ; Hu, YH				Lei, Pengfei; Sun, Rongxin; Wang, Long; Zhou, Jialin; Wan, Lifei; Zhou, Tianjian; Hu, Yihe			A New Method for Xenogeneic Bone Graft Deproteinization: Comparative Study of Radius Defects in a Rabbit Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CANCELLOUS BONE; BIO-OSS; COLLAGEN; IMPLANTATION; RECONSTRUCTION; OSTEOPOROSIS; CT	Background and Objectives Deproteinization is an indispensable process for the elimination of antigenicity in xenograft bones. However, the hydrogen peroxide (H2O2) deproteinized xenograft, which is commonly used to repair bone defect, exhibits limited osteoinduction activity. The present study was designed to develop a new method for deproteinization and compare the osteogenic capacities of new pepsin deproteinized xenograft bones with those of conventional H2O2 deproteinized ones. Methods Bones were deproteinized in H2O2 or pepsin for 8 hours. The morphologies were compared by HE staining. The content of protein and collagen I were measured by the Kjeldahl method and HPLC-MS, respectively. The physical properties were evaluated by SEM and mechanical tests. For in vivo study, X-ray, micro-CT and HE staining were employed to monitor the healing processes of radius defects in rabbit models transplanted with different graft materials. Results Compared with H2O2 deproteinized bones, no distinct morphological and physical changes were observed. However, pepsin deproteinized bones showed a lower protein content, and a higher collagen content were preserved. In vivo studies showed that pepsin deproteinized bones exhibited better osteogenic performance than H2O2 deproteinized bones, moreover, the quantity and quality of the newly formed bones were improved as indicated by micro-CT analysis. From the results of histological examination, the newly formed bones in the pepsin group were mature bones. Conclusions Pepsin deproteinized xenograft bones show advantages over conventional H2O2 deproteinized bones with respect to osteogenic capacity; this new method may hold potential clinical value in the development of new biomaterials for bone grafting.	[Lei, Pengfei; Wang, Long; Hu, Yihe] Cent S Univ, Xiangya Hosp, Dept Orthoped, Changsha, Hunan, Peoples R China; [Sun, Rongxin] Xinjiang Med Univ, Affiliated Hosp 6, Dept Orthoped, Urumqi, Peoples R China; [Zhou, Jialin] Thorac Hosp Hunan Prov, Dept Orthoped, Changsha, Hunan, Peoples R China; [Wan, Lifei] Ningxiang Peoples Hosp, Dept Orthoped, Ningxiang, Peoples R China; [Zhou, Tianjian] First Peoples Hosp Shenzhen, Dept Orthoped, Shenzhen, Peoples R China	Central South University; Xinjiang Medical University	Hu, YH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Orthoped, Changsha, Hunan, Peoples R China.	csuhuyihe@163.com		Wang, Long/0000-0002-2733-7370	Hunan Provincial Foundation for Science and Technology Planning Project [2011FJ6085]; Hunan Provincial Innovation Foundation for Postgraduates [CX2014B072]; Open-End Fund for the Valuable and Precision Instruments of Central South University [CSUZC2014046]	Hunan Provincial Foundation for Science and Technology Planning Project; Hunan Provincial Innovation Foundation for Postgraduates; Open-End Fund for the Valuable and Precision Instruments of Central South University	This work was supported by Hunan Provincial Foundation for Science and Technology Planning Project (2011FJ6085) to YH, Hunan Provincial Innovation Foundation for Postgraduates (CX2014B072) to PL and The Open-End Fund for the Valuable and Precision Instruments of Central South University (CSUZC2014046) to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Baldini N, 2011, DENT MATER, V27, P61, DOI 10.1016/j.dental.2010.10.017; Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9; Bi FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125900; Bi L, 2013, ARTIF ORGANS, V37, P629, DOI 10.1111/aor.12048; Borah B, 2001, ANAT RECORD, V265, P101, DOI 10.1002/ar.1060; Brennan TA, 2014, DIS MODEL MECH, V7, P583, DOI 10.1242/dmm.014928; Buchman SR, 1998, J CRANIOFAC SURG, V9, P48, DOI 10.1097/00001665-199801000-00011; Castro-Cesena AB, 2013, MAT SCI ENG C-MATER, V33, P4958, DOI 10.1016/j.msec.2013.08.022; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Clark DP, 2014, PHYS MEDICA, V30, P619, DOI 10.1016/j.ejmp.2014.05.011; David F, 2015, J TISSUE ENG REGEN M, V9, P1193, DOI 10.1002/term.2006; Day JS, 2000, BONE, V27, P715, DOI 10.1016/S8756-3282(00)00371-9; de Carmejane O, 2005, CALCIFIED TISSUE INT, V76, P207, DOI 10.1007/s00223-004-0168-z; DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; KATO Y, 1992, J BIOL CHEM, V267, P23646; Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; LANE JM, 1987, ORTHOP CLIN N AM, V18, P213; Li Q, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0028-2; Liu Lei, 2006, Chin J Traumatol, V9, P234; MAATZ R, 1957, J BONE JOINT SURG AM, V39, P153, DOI 10.2106/00004623-195739010-00014; Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824; Shahab U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031199; Shin SY, 2014, J PERIODONTAL IMPLAN, V44, P259, DOI 10.5051/jpis.2014.44.5.259; Stanko P, 2013, BRATISL MED J, V114, P50, DOI 10.4149/BLL_2013_012; Stone KR, 2007, ARTHROSCOPY, V23, P411, DOI 10.1016/j.arthro.2006.12.024; Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967; Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x; Wagner-Ecker M, 2013, ACTA BIOMATER, V9, P7298, DOI 10.1016/j.actbio.2013.03.037; Watson L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt439; Wei JQ, 2015, TISSUE ENG PT A, V21, P1810, DOI [10.1089/ten.tea.2014.0395, 10.1089/ten.TEA.2014.0395]; You TM, 2007, ORAL SURG ORAL MED O, V103, pE8, DOI 10.1016/j.tripleo.2006.11.042; Zhao JJ, 2013, GRAEF ARCH CLIN EXP, V251, P1325, DOI 10.1007/s00417-013-2300-0; Zhao Yao, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P1323	37	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146005	10.1371/journal.pone.0146005	http://dx.doi.org/10.1371/journal.pone.0146005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719896	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900032
J	Lin, CY; Gong, BW; Qu, X				Lin, Ciyun; Gong, Bowen; Qu, Xin			Low Emissions and Delay Optimization for an Isolated Signalized Intersection Based on Vehicular Trajectories	PLOS ONE			English	Article							VEHICLE FUEL CONSUMPTION; CAR-FOLLOWING MODEL; TRAFFIC FLOW; INSTANTANEOUS SPEED; ACCELERATION LEVELS; LATE ARRIVAL; TRIP COST; TIME; ROAD; TRANI,ANTONIO	A traditional traffic signal control system is established based on vehicular delay, queue length, saturation and other indicators. However, due to the increasing severity of urban environmental pollution issues and the development of a resource-saving and environmentally friendly social philosophy, the development of low-carbon and energy-efficient urban transport is required. This paper first defines vehicular trajectories and the calculation of vehicular emissions based on VSP. Next, a regression analysis method is used to quantify the relationship between vehicular emissions and delay, and a traffic signal control model is established to reduce emissions and delay using the enumeration method combined with saturation constraints. Finally, one typical intersection of Changchun is selected to verify the model proposed in this paper; its performance efficiency is also compared using simulations in VISSIM. The results of this study show that the proposed model can significantly reduce vehicle delay and traffic emissions simultaneously.	[Lin, Ciyun; Gong, Bowen] Jilin Univ, State Key Lab Automobile Dynam Simulat, Changchun 130022, Peoples R China; [Lin, Ciyun; Gong, Bowen; Qu, Xin] Jilin Univ, Coll Transportat, Changchun 130022, Peoples R China	Jilin University; Jilin University	Lin, CY (corresponding author), Jilin Univ, State Key Lab Automobile Dynam Simulat, Changchun 130022, Peoples R China.	linciyun@jlu.edu.cn; gongbowen@jlu.edu.cn; quxin14@mails.jlu.edu.cn	Lin, Ciyun/B-2086-2009; Lin, Ciyun/AAK-6489-2020	Lin, Ciyun/0000-0001-9098-2666; 	National Science Foundation of China [51408257, 51308248]; Chinese National High Technology Research and Development Program [2014BAG03B03]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120061120046]; National Science Foundation for Post-doctoral Scientists of China [2013T60331, 2012T50300]; Youth Scientific Research Fund of Jilin [20140520134JH]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Youth Scientific Research Fund of Jilin	This work was supported by the National Science Foundation of China (Grant No. 51408257 and No. 51308248), the Chinese National High Technology Research and Development Program (Grant No. 2014BAG03B03), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20120061120046), the National Science Foundation for Post-doctoral Scientists of China (Grant No. 2013T60331 and No. 2012T50300), and the Youth Scientific Research Fund of Jilin (Grant No. 20140520134JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2002, J TRANSP ENG, V128, P182, DOI 10.1061/(ASCE)0733-947X(2002)128:2(182); Ahn K., 1998, MICROSCOPIC FUEL CON; Board TR, 2000, 209 TRB; Cesme B, 2014, TRANSPORT RES C-EMER, V48, P1, DOI 10.1016/j.trc.2014.08.006; Dickinson MW, 2001, IEEE T ENG MANAGE, V48, P518, DOI 10.1109/17.969428; Edwardes W, 2014, TRANSPORT RES REC, P1, DOI 10.3141/2428-01; El-Tantawy S, 2014, J INTELL TRANSPORT S, V18, P227, DOI 10.1080/15472450.2013.810991; Ghafghazi G, 2014, TRANSPORTATION, V41, P633, DOI 10.1007/s11116-014-9513-x; Guo H, 2007, J ENVIRON SCI-CHINA, V19, P818, DOI 10.1016/S1001-0742(07)60137-5; Gupta AK, 2015, NONLINEAR DYNAM, V79, P663, DOI 10.1007/s11071-014-1693-6; Gupta AK, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114500454; Gupta AK, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183113500186; Lee CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026082; Li XG, 2004, TRANSPORT RES D-TR E, V9, P401, DOI 10.1016/j.trd.2004.05.001; Ma XL, 2014, TRANSPORT RES D-TR E, V32, P1, DOI 10.1016/j.trd.2014.06.013; Meszaros F, 2014, PERIOD POLYTECH, V42, P37, DOI [10.3311/PPtr.7183, DOI 10.3311/PPTR.7183]; Minocha VK, 2003, J TRANSP ENG, V129, P578, DOI 10.1061/(ASCE)0733-947X(2003)129:5(578); Morrison GM, 2015, CLIMATIC CHANGE, V131, P545, DOI 10.1007/s10584-015-1403-5; Niittymaki J, 2001, JOINT 9TH IFSA WORLD CONGRESS AND 20TH NAFIPS INTERNATIONAL CONFERENCE, PROCEEDINGS, VOLS. 1-5, P2870, DOI 10.1109/NAFIPS.2001.943682; Osorio C, 2015, TRANSPORT SCI, V49, P637, DOI 10.1287/trsc.2014.0554; Pandian S, 2009, TRANSPORT RES D-TR E, V14, P180, DOI 10.1016/j.trd.2008.12.001; Peng GH, 2014, PHYSICA A, V398, P76, DOI 10.1016/j.physa.2013.12.015; Rakha H, 2000, TRANSPORT RES REC, P56; Rakha H, 2003, J TRANSP ENG, V129, P579, DOI 10.1061/(ASCE)0733-947X(2003)129:5(579); Rakha HA, 2011, TRANSPORT RES D-TR E, V16, P492, DOI 10.1016/j.trd.2011.05.008; Redhu P, 2015, COMMUN NONLINEAR SCI, V27, P263, DOI 10.1016/j.cnsns.2015.03.015; Samra S, 2015, IEEE T INTELL TRANSP, V16, P387, DOI 10.1109/TITS.2014.2336657; Srinivasan D, 2006, IEEE T INTELL TRANSP, V7, P261, DOI 10.1109/TITS.2006.874716; Tang TQ, 2014, MEASUREMENT, V48, P63, DOI 10.1016/j.measurement.2013.10.035; Tang TQ, 2016, INT J MOD PHYS C, V27, DOI 10.1142/S012918311650011X; Tang TQ, 2016, PHYSICA A, V441, P221, DOI 10.1016/j.physa.2015.09.003; Tang TQ, 2015, PHYSICA A, V437, P55, DOI 10.1016/j.physa.2015.05.054; Tang TQ, 2015, PHYSICA A, V431, P52, DOI 10.1016/j.physa.2015.02.041; Tang TQ, 2015, PHYSICA A, V430, P148, DOI 10.1016/j.physa.2015.01.014; Tang TQ, 2015, MEASUREMENT, V64, P123, DOI 10.1016/j.measurement.2014.12.045; Tang TQ, 2015, PHYSICA A, V419, P293, DOI 10.1016/j.physa.2014.10.051; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2014, J ADV TRANSPORT, V48, P304, DOI 10.1002/atr.215; Tang TQ, 2013, SCI CHINA TECHNOL SC, V56, P1307, DOI 10.1007/s11431-013-5182-9; Wang JY, 2011, ATMOS ENVIRON, V45, P6923, DOI 10.1016/j.atmosenv.2011.09.045; Wei S, 2007, PHYSICA A, V381, P399, DOI 10.1016/j.physa.2007.02.106; Wu CX, 2011, TRANSPORT RES D-TR E, V16, P515, DOI 10.1016/j.trd.2011.06.002; Wu YZ, 2014, TRANSPORT RES D-TR E, V32, P193, DOI 10.1016/j.trd.2014.07.009; Xiao YY, 2012, COMPUT OPER RES, V39, P1419, DOI 10.1016/j.cor.2011.08.013; Xunan T., 2014, SIGNAL TIMING OPTIMI; Yu SW, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215500848; Yu SW, 2015, MEASUREMENT, V70, P137, DOI 10.1016/j.measurement.2015.03.031; Yu SW, 2015, PHYSICA A, V428, P206, DOI 10.1016/j.physa.2015.01.064; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036; Zhang LH, 2013, TRANSPORT RES C-EMER, V29, P55, DOI 10.1016/j.trc.2013.01.003; Zhang N, 2015, RENEW SUST ENERG REV, V41, P584, DOI 10.1016/j.rser.2014.08.076; Zhou P, 2010, ENERG ECON, V32, P194, DOI 10.1016/j.eneco.2009.10.003; Zhu WX, 2013, PHYSICA A, V392, P3301, DOI 10.1016/j.physa.2013.04.004	53	6	6	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146018	10.1371/journal.pone.0146018	http://dx.doi.org/10.1371/journal.pone.0146018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TR	26720095	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510900034
J	Roy-Zokan, EM; Dyer, KA; Meagher, RB				Roy-Zokan, Eileen M.; Dyer, Kelly A.; Meagher, Richard B.			Phylogenetic Patterns of Codon Evolution in the ACTIN-DEPOLYMERIZING FACTOR/COFILIN (ADF/CFL) Gene Family	PLOS ONE			English	Article							FACTOR HOMOLOGY DOMAIN; ADF/COFILIN FAMILY; GENOME; COFILIN; BINDING; ORIGIN; ADF	The actin-depolymerizing factor/cofilin (ADF/CFL) gene family encodes a diverse group of relatively small proteins. Once known strictly as modulators of actin filament dynamics, recent research has demonstrated that these proteins are involved in a variety of cellular processes, from signal transduction to the cytonuclear trafficking of actin. In both plant and animal lineages, expression patterns of paralogs in the ADF/CFL gene family vary among tissue types and developmental stages. In this study we use computational approaches to investigate the evolutionary forces responsible for the diversification of the ADF/CFL gene family. Estimating the rate of non-synonymous to synonymous mutations (dN/dS) across phylogenetic lineages revealed that the majority of ADF/CFL codon positions were under strong purifying selection, with rare episodic events of accelerated protein evolution. In both plants and animals these instances of accelerated evolution were ADF/CFL subclass specific, and all of the sites under selection were located in regions of the protein that could serve in new functional roles. We suggest these sites may have been important in the functional diversification of ADF/CFL proteins.	[Roy-Zokan, Eileen M.; Dyer, Kelly A.; Meagher, Richard B.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Roy-Zokan, EM (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	eileenmroy@gmail.com			National Institutes of Health [GM36397]; Alton Graduate Research Fellowship; National Science Foundation [DEB-1149350, 10-21-RR093-399]; Division Of Environmental Biology [1149350] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alton Graduate Research Fellowship; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (http://www.nih.gov) grant GM36397 to RBM, by the Alton Graduate Research Fellowship to E.R.Z, and by National Science Foundation (http://www.nsf.gov/) grant DEB-1149350 to KAD. Funds for publication are provided by Allen J. Moore through a National Science Foundation (http://www.nsf.gov/) grant 10-21-RR093-399. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Burgos-Rivera B, 2008, PLANT MOL BIOL, V68, P619, DOI 10.1007/s11103-008-9398-1; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Clement M, 2009, PLANT CELL, V21, P2963, DOI 10.1105/tpc.109.069104; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Estornes Y, 2007, INT J CANCER, V121, P2162, DOI 10.1002/ijc.22911; Feng Y, 2006, J PLANT PHYSIOL, V163, P69, DOI 10.1016/j.jplph.2005.01.015; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Guindon S, 2004, P NATL ACAD SCI USA, V101, P12957, DOI 10.1073/pnas.0402177101; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kandasamy MK, 2014, CYTOSKELETO IN PRESS; Kandasamy MK, 2012, PLANT CELL, V24, P2041, DOI 10.1105/tpc.111.095281; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin CH, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/328676; Maciver SK, 2002, GENOME BIOL, V3; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Nakashima K, 2005, J BIOCHEM, V138, P519, DOI 10.1093/jb/mvi152; Nylander JAA, 2004, MRMODELTEST, V2; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; Shan HY, 2009, MOL BIOL EVOL, V26, P2229, DOI 10.1093/molbev/msp129; Storz JF, 2008, GENETICS, V178, P1623, DOI 10.1534/genetics.107.080903; Susumu O., 1970, EVOLUTION GENE DUPLI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian MY, 2009, PLANT PHYSIOL, V150, P815, DOI 10.1104/pp.109.137604; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6	43	9	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145917	10.1371/journal.pone.0145917	http://dx.doi.org/10.1371/journal.pone.0145917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717562	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500094
J	Dutto, I; Sukhanova, M; Tillhon, M; Cazzalini, O; Stivala, LA; Scovassi, AI; Lavrik, O; Prosperi, E				Dutto, Ilaria; Sukhanova, Maria; Tillhon, Micol; Cazzalini, Ornella; Stivala, Lucia A.; Scovassi, A. Ivana; Lavrik, Olga; Prosperi, Ennio			p21(CDKN1A) Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates	PLOS ONE			English	Article							BASE EXCISION-REPAIR; STRAND BREAKS; DAMAGE; PARP-1; PCNA; BETA; SENESCENCE; INHIBITOR; PROTEINS; DOMAINS	The cell cycle inhibitor p21(CDKN1A) was previously found to interact directly with DNA nick-sensor poly(ADP-ribose) polymerase-1 (PARP-1) and to promote base excision repair (BER). However, the molecular mechanism responsible for this BER-related association of p21 with PARP-1 remains to be clarified. In this study we investigate the capability of p21 to influence PARP-1 binding to DNA repair intermediates in a reconstituted BER system in vitro. Using model photoreactive BER substrates containing single-strand breaks, we found that full-length recombinant GST-tagged p21 but not a C-terminal domain truncated form of p21 was able to stimulate the PARP-1 binding to BER intermediates with no significant influence on the catalytic activity of PARP-1. In addition, we investigate whether the activation of PARP-1 through poly(ADP-ribose) (PAR) synthesis, is required for its interaction with p21. We have found that in human fibroblasts and in HeLa cells treated with the DNA alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), the interaction of p21 with PARP-1 was greatly dependent on PAR synthesis. In fact, an anti-PAR antibody was able to coimmunoprecipitate p21 and PARP-1 from extracts of MNNG-treated cells, while blocking PAR synthesis with the PARP-1 inhibitor Olaparib, drastically reduced the amount of p21 co-immunoprecipitated by a PARP-1 antibody. Our results provide the first evidence that p21 can stimulate the binding of PARP-1 to DNA repair intermediates, and that this cooperation requires PAR synthesis.	[Dutto, Ilaria; Tillhon, Micol; Scovassi, A. Ivana; Prosperi, Ennio] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Sukhanova, Maria; Lavrik, Olga] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Cazzalini, Ornella; Stivala, Lucia A.] Univ Pavia, Dipartimento Med Mol Immunol & Patol, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; University of Pavia	Prosperi, E (corresponding author), CNR, Ist Genet Mol, Via Abbiategrasso 207, I-27100 Pavia, Italy.	prosperi@igm.cnr.it	Tillhon, Micol/AAQ-6994-2020; dutto, Ilaria/AAX-9097-2020; Prosperi, Ennio/A-3439-2014; Lavrik, Olga I/G-4641-2013	Prosperi, Ennio/0000-0001-5391-5157; Sukhanova, Mariya/0000-0002-8501-6946; Dutto, Ilaria/0000-0002-6987-6647	Associazione Italiana Ricerca sul Cancro [5126]; Russian Science Foundation [14-24-00038]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Grant no. 5126 to EP, Associazione Italiana Ricerca sul Cancro (www.airc.it), and Grant no. 14-24-00038 to OIL, Russian Science Foundation (www.rscf.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AAE, 2012, NAT STRUCT MOL BIOL, V19, P685, DOI 10.1038/nsmb.2335; Allinson SL, 2003, ACTA BIOCHIM POL, V50, P169; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Aredia F, 2014, BIOCHEM PHARMACOL, V92, P157, DOI 10.1016/j.bcp.2014.06.021; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Beck C, 2014, EXP CELL RES, V329, P18, DOI 10.1016/j.yexcr.2014.07.003; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cazzalini O, 2008, NUCLEIC ACIDS RES, V36, P1713, DOI 10.1093/nar/gkn014; Cazzalini O, 2003, CELL CYCLE, V2, P596, DOI 10.4161/cc.2.6.502; Cazzalini O, 2010, DNA REPAIR, V9, P627, DOI 10.1016/j.dnarep.2010.02.011; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Cistulli C, 2004, DNA REPAIR, V3, P581, DOI 10.1016/j.dnarep.2003.09.012; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; Dantzer F, 2013, FEBS J, V280, P3508, DOI 10.1111/febs.12368; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Frouin I, 2003, J BIOL CHEM, V278, P39265, DOI 10.1074/jbc.C300098200; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2005, TRENDS MOL MED, V11, P456, DOI 10.1016/j.molmed.2005.08.003; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kirkland JB, 2010, EXP BIOL MED, V235, P561, DOI 10.1258/ebm.2010.009280; Langelier MF, 2013, CURR OPIN STRUC BIOL, V23, P134, DOI 10.1016/j.sbi.2013.01.003; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Lavrik OI, 2001, J BIOL CHEM, V276, P25541, DOI 10.1074/jbc.M102125200; Lebedeva NA, 2002, BIOCHEM BIOPH RES CO, V297, P714, DOI 10.1016/S0006-291X(02)02338-0; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Li M, 2015, ONCOGENE, V34, P3349, DOI 10.1038/onc.2014.295; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mangerich A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/321653; Mansoorabadi SO, 2014, BIOCHEMISTRY-US, V53, P1779, DOI 10.1021/bi401439n; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Parsons JL, 2005, FEBS J, V272, P2012, DOI 10.1111/j.1742-4658.2005.04628.x; Pines A, 2013, TRENDS BIOCHEM SCI, V38, P321, DOI 10.1016/j.tibs.2013.03.002; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Prosperi Ennio, 2006, P67; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Scovassi A Ivana, 2006, Methods Mol Biol, V314, P457; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Sukhanova M, 2010, MUTAT RES-FUND MOL M, V685, P80, DOI 10.1016/j.mrfmmm.2009.08.009; Sukhanova MV, 2005, NUCLEIC ACIDS RES, V33, P1222, DOI 10.1093/nar/gki266; Tillhon M., 2013, NEW RES DIRECTIONS D, P249, DOI [10.5772/54173, DOI 10.5772/54173]; Tom S, 2001, J BIOL CHEM, V276, P48781, DOI 10.1074/jbc.M109626200; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017; Yao N, 2013, PLOS ONE, V8; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417	55	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146031	10.1371/journal.pone.0146031	http://dx.doi.org/10.1371/journal.pone.0146031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730949	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400079
J	Gschwendtner, S; Alatossava, T; Kublik, S; Fuka, MM; Schloter, M; Munsch-Alatossava, P				Gschwendtner, Silvia; Alatossava, Tapani; Kublik, Susanne; Fuka, Mirna Mrkonjic; Schloter, Michael; Munsch-Alatossava, Patricia			N-2 Gas Flushing Alleviates the Loss of Bacterial Diversity and Inhibits Psychrotrophic Pseudomonas during the Cold Storage of Bovine Raw Milk	PLOS ONE			English	Article							DAIRY-PRODUCTS; SP-NOV.; PHENOTYPIC CHARACTERIZATION; MICROBIAL COMMUNITIES; DNA EXTRACTION; COW MILK; CATTLE; QUALITY; LACTATION; BIAS	The quality and safety of rawmilk still remains a worldwide challenge. Culture-dependent methods indicated that the continuous N-2 gas-flushing of raw milk reduced the bacterial growth during cold storage by up to four orders of magnitude, compared to cold storage alone. This study investigated the influence of N-2 gas-flushing on bacterial diversity in bovine raw-milk samples, that were either cold stored at 6 degrees C or additionally flushed with pure N-2 for up to one week. Next-generation sequencing (NGS) of the V1-V2 hypervariable regions of 16S rRNA genes, derived fromamplified cDNA, which was obtained from RNA directly isolated from rawmilk samples, was performed. The reads, which were clustered into 2448 operational taxonomic units (OTUs), were phylogenetically classified. Our data revealed a drastic reduction in the diversity of OTUs in raw milk during cold storage at 6 C at 97% similarity level; but, the N-2-flushing treatment alleviated this reduction and substantially limited the loss of bacterial diversity during the same cold-storage period. Compared to cold-storedmilk, the initial raw-milk samples contained less Proteobacteria (mainly Pseudomonadaceae, Moraxellaceae and Enterobacteriaceae) but more Firmicutes (mainly Ruminococcaceaea, Lachnospiraceae and Oscillospiraceaea) and Bacteroidetes (mainly Bacteroidales). Significant differences between cold-stored and additionally N-2-flushed milk were mainly related to higher levels of Pseudomononadaceae (including the genera Pseudomonas and Acinetobacter) in cold-stored milk samples; furthermore, rare taxa were better preserved by the N-2 gas flushing compared to the cold storage alone. No major changes in bacterial composition with time were found regarding the distribution of themajor 9 OTUs, that dominated the Pseudomonas genus in N-2-flushed or non-flushedmilk samples, other than an intriguing predominance of bacteria related to P. veronii. Overall, this study established that neither bacteria causingmilk spoilage nor any wellknown human pathogen or anaerobe benefited from the N-2 gas flushing even though the N-2-flushed and non-flushed cold-stored milk differed in bacterial counts by up to 10(4)-fold.	[Gschwendtner, Silvia; Kublik, Susanne; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Neuherberg, Germany; [Alatossava, Tapani; Munsch-Alatossava, Patricia] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Fuka, Mirna Mrkonjic] Univ Zagreb, Fac Agr, Dept Microbiol, Zagreb 41000, Croatia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Helsinki; University of Zagreb	Munsch-Alatossava, P (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	patricia.munsch@helsinki.fi	Schloter, 1Michael/H-9151-2013; Alatossava, Tapani/HGE-8059-2022		Matti Sundberg quality research foundation; Finnish Cultural Foundation	Matti Sundberg quality research foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	TA was supported by a grant from the Matti Sundberg quality research foundation and by a personal grant from the Finnish Cultural Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Callon C, 2007, SYST APPL MICROBIOL, V30, P547, DOI 10.1016/j.syapm.2007.05.004; Cousin M. A., 1981, DAIRY MICROBIOLOGY M, P119; COUSIN MA, 1982, J FOOD PROTECT, V45, P172, DOI 10.4315/0362-028X-45.2.172; De Lima-Morales D, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00258.13, DOI 10.1128/GEN0MEA.00258.13]; Delbes C, 2007, APPL ENVIRON MICROB, V73, P1882, DOI 10.1128/AEM.01716-06; Delgado S, 2013, FOOD MICROBIOL, V36, P103, DOI 10.1016/j.fm.2013.04.015; Dogan B, 2003, APPL ENVIRON MICROB, V69, P130, DOI 10.1128/AEM.69.1.130-138.2003; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Elomari M, 1996, INT J SYST BACTERIOL, V46, P1138, DOI 10.1099/00207713-46-4-1138; Frank JF, 2002, ENCY DAIRY SCI, P1786; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; Fuka MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080734; Gill JJ, 2006, FEMS MICROBIOL ECOL, V56, P471, DOI 10.1111/j.1574-6941.2006.00091.x; Gomila M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00214; Gschwendtner S, 2015, MICROB ECOL, V69, P867, DOI 10.1007/s00248-014-0527-x; Hantsis-Zacharov E, 2008, INT J SYST EVOL MICR, V58, P1024, DOI 10.1099/ijs.0.65500-0; Hantsis-Zacharov E, 2007, APPL ENVIRON MICROB, V73, P7162, DOI 10.1128/AEM.00866-07; Hantsis-Zacharov E, 2007, INT J SYST EVOL MICR, V57, P2344, DOI 10.1099/ijs.0.65115-0; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Jayarao BM, 1999, J DAIRY SCI, V82, P2620, DOI 10.3168/jds.S0022-0302(99)75518-9; JOSEPHSON KL, 1993, APPL ENVIRON MICROB, V59, P3513, DOI 10.1128/AEM.59.10.3513-3515.1993; Jost T, 2013, BRIT J NUTR, V110, P1253, DOI 10.1017/S0007114513000597; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lafarge V, 2004, APPL ENVIRON MICROB, V70, P5644, DOI 10.1128/AEM.70.9.5644-5650.2004; Leriche F, 2012, J DAIRY SCI, V95, P2299, DOI 10.3168/jds.2011-4785; Li M, 2012, J NUTR, V142, P681, DOI 10.3945/jn.111.154427; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marchand S, 2009, ENVIRON MICROBIOL, V11, P467, DOI 10.1111/j.1462-2920.2008.01785.x; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Masoud W, 2012, INT J FOOD MICROBIOL, V153, P192, DOI 10.1016/j.ijfoodmicro.2011.11.014; Munsch-Alatossava P, 2007, MICROBIOL RES, V162, P115, DOI 10.1016/j.micres.2006.01.015; Munsch-Alatossava P, 2006, MICROBIOL RES, V161, P334, DOI 10.1016/j.micres.2005.12.004; Munsch-Alatossava P., 2010, J FOOD PROCESS TE-US, V1, P1, DOI [10.4172/2157-7110.1000101, DOI 10.4172/2157-7110.1000101]; Munsch-Alatossava P, 2012, ANTIBIOTIC RESISTANT BACTERIA - A CONTINUOUS CHALLENGE IN THE NEW MILLENNIUM, P105; Munsch-Alatossava P, 2010, MICROBIOL RES, V165, P122, DOI 10.1016/j.micres.2009.02.002; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Ogier JC, 2002, APPL ENVIRON MICROB, V68, P3691, DOI 10.1128/AEM.68.8.3691-3701.2002; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pajarillo EAB, 2014, J MICROBIOL, V52, P646, DOI 10.1007/s12275-014-4270-2; Park SJ, 2014, ANAEROBE, V28, P157, DOI 10.1016/j.anaerobe.2014.06.002; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; PEREIRA JN, 1957, J BACTERIOL, V74, P710, DOI 10.1128/JB.74.6.710-713.1957; Perkins NR, 2009, J DAIRY SCI, V92, P3714, DOI 10.3168/jds.2009-2030; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Quigley L, 2013, J DAIRY SCI, V96, P4928, DOI 10.3168/jds.2013-6688; Raats D, 2011, FOOD MICROBIOL, V28, P465, DOI 10.1016/j.fm.2010.10.009; Ramos C, 2000, APPL ENVIRON MICROB, V66, P801, DOI 10.1128/AEM.66.2.801-809.2000; Rasolofo EA, 2010, INT J FOOD MICROBIOL, V138, P108, DOI 10.1016/j.ijfoodmicro.2010.01.008; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; SHAH NP, 1994, MILCHWISSENSCHAFT, V49, P432; Sorhaug T, 1997, TRENDS FOOD SCI TECH, V8, P35, DOI 10.1016/S0924-2244(97)01006-6; Sydenham TV, 2014, J CLIN MICROBIOL, V52, P1304, DOI 10.1128/JCM.03128-13; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wiedmann M, 2000, APPL ENVIRON MICROB, V66, P2085, DOI 10.1128/AEM.66.5.2085-2095.2000; Yeung M, 2012, J DAIRY SCI, V95, P6831, DOI 10.3168/jds.2012-5677; Yoon JH, 2003, INT J SYST EVOL MICR, V53, P595, DOI 10.1099/ijs.0.02132-0	62	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146015	10.1371/journal.pone.0146015	http://dx.doi.org/10.1371/journal.pone.0146015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730711	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400078
J	Hanson, HI; Palmu, E; Birkhofer, K; Smith, HG; Hedlund, K				Hanson, Helena I.; Palmu, Erkki; Birkhofer, Klaus; Smith, Henrik G.; Hedlund, Katarina			Agricultural Land Use Determines the Trait Composition of Ground Beetle Communities	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; ECOSYSTEM SERVICES; CARABID BEETLES; SPECIES TRAITS; ARABLE FIELDS; COLEOPTERA; MANAGEMENT; HABITAT; CROP; ARTHROPODS	In order to improve biological control of agricultural pests, it is fundamental to understand which factors influence the composition of natural enemies in agricultural landscapes. In this study, we aimed to understand how agricultural land use affects a number of different traits in ground beetle communities to better predict potential consequences of land-use change for ecosystem functioning. We studied ground beetles in fields with different agricultural land use ranging from frequently managed sugar beet fields, winter wheat fields to less intensively managed grasslands. The ground beetles were collected in emergence tents that catch individuals overwintering locally in different life stages and with pitfall traps that catch individuals that could have a local origin or may have dispersed into the field. Community weighted mean values for ground beetle traits such as body size, flight ability and feeding preference were estimated for each land-use type and sampling method. In fields with high land-use intensity the average body length of emerging ground beetle communities was lower than in the grasslands while the average body length of actively moving communities did not differ between the land-use types. The proportion of ground beetles with good flight ability or a carnivorous diet was higher in the crop fields as compared to the grasslands. Our study highlights that increasing management intensity reduces the average body size of emerging ground beetles and the proportion of mixed feeders. Our results also suggest that the dispersal ability of ground beetles enables them to compensate for local management intensities.	[Hanson, Helena I.; Palmu, Erkki; Birkhofer, Klaus; Smith, Henrik G.; Hedlund, Katarina] Lund Univ, Dept Biol, Biodivers, S-22362 Lund, Sweden; [Hanson, Helena I.; Smith, Henrik G.; Hedlund, Katarina] Lund Univ, Ctr Environm & Climate Res, S-22362 Lund, Sweden	Lund University; Lund University	Hanson, HI (corresponding author), Lund Univ, Dept Biol, Biodivers, Ecol Bldg, S-22362 Lund, Sweden.	Helena.hanson@biol.lu.se	Hedlund, Katarina/AAC-3333-2022; Birkhofer, Klaus/AAA-2374-2021	Birkhofer, Klaus/0000-0002-9301-2443	Kungl Fysiografiska Sallskapet i Lund; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)	Kungl Fysiografiska Sallskapet i Lund; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	The project was funded by grants from Kungl Fysiografiska Sallskapet i Lund (to H. I. Hanson) and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) (to H. G. Smith and K. Hedlund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BAARS MA, 1979, OECOLOGIA, V44, P125, DOI 10.1007/BF00346411; Birkhofer K, 2014, BIOL CONSERV, V175, P25, DOI 10.1016/j.biocon.2014.04.014; Birkhofer K, 2015, ECOGRAPHY, V38, P889, DOI 10.1111/ecog.01141; Birkhofer K, 2014, INSECT CONSERV DIVER, V7, P274, DOI 10.1111/icad.12051; Birkhofer K, 2011, SOIL BIOL BIOCHEM, V43, P2200, DOI 10.1016/j.soilbio.2011.07.008; BLAKE S, 1994, PEDOBIOLOGIA, V38, P502; BRYAN KM, 1984, ECOL ENTOMOL, V9, P251, DOI 10.1111/j.1365-2311.1984.tb00849.x; Caballero-Lopez B, 2012, BIOL CONTROL, V63, P222, DOI 10.1016/j.biocontrol.2012.03.012; Chapman JW, 2005, ECOL ENTOMOL, V30, P264, DOI 10.1111/j.0307-6946.2005.00702.x; CHIVERTON PA, 1986, ANN APPL BIOL, V109, P49, DOI 10.1111/j.1744-7348.1986.tb03183.x; Dahms H, 2010, BASIC APPL ECOL, V11, P6, DOI 10.1016/j.baae.2009.06.004; de Vries FT, 2013, P NATL ACAD SCI USA, V110, P14296, DOI 10.1073/pnas.1305198110; den Boer P. J., 1970, Oecologia, V4, P1, DOI 10.1007/BF00390612; deVries HH, 1996, OECOLOGIA, V107, P332, DOI 10.1007/BF00328449; Diehl E, 2012, ARTHROPOD-PLANT INTE, V6, P75, DOI 10.1007/s11829-011-9153-4; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Eyre MD, 2013, AGR ECOSYST ENVIRON, V165, P60, DOI 10.1016/j.agee.2012.12.009; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gorley C.K., 2006, GETTING STARTED PRIM; Hendrickx F, 2009, GLOBAL ECOL BIOGEOGR, V18, P607, DOI 10.1111/j.1466-8238.2009.00473.x; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Holland JM, 2007, B ENTOMOL RES, V97, P89, DOI 10.1017/S0007485307004804; Holland JM, 2009, BIOCONTROL, V54, P19, DOI 10.1007/s10526-008-9152-2; Holland JM, 2004, B ENTOMOL RES, V94, P419, DOI 10.1079/BER2004323; HOLLIDAY NJ, 1978, CAN ENTOMOL, V110, P113, DOI 10.4039/Ent110113-2; Homburg K, 2014, INSECT CONSERV DIVER, V7, P195, DOI 10.1111/icad.12045; Jones TH, 1996, OECOLOGIA, V106, P317, DOI 10.1007/BF00334559; Klimes P, 2010, J APPL ENTOMOL, V134, P659, DOI 10.1111/j.1439-0418.2009.01463.x; Knapp M, 2012, J APPL ENTOMOL, V136, P225, DOI 10.1111/j.1439-0418.2011.01643.x; Lang A, 2000, ANZ SCHADL-J PEST SC, V73, P99; Lang A, 2003, OECOLOGIA, V134, P144, DOI 10.1007/s00442-002-1091-5; Lindroth C.H., 1985, CARABIDAE COLEOPTERA; Lindroth C. H., 1992, GROUND BEETLES CAR 1; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Luff ML, 2007, CARABIDAE GROUND BEE, P2007; LYS JA, 1992, OECOLOGIA, V92, P373, DOI 10.1007/BF00317463; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Palmu E, 2014, BASIC APPL ECOL, V15, P241, DOI 10.1016/j.baae.2014.03.001; Pfiffner L, 2000, AGR ECOSYST ENVIRON, V78, P215, DOI 10.1016/S0167-8809(99)00130-9; Purtauf T, 2005, OECOLOGIA, V142, P458, DOI 10.1007/s00442-004-1740-y; Purvis G, 2002, PEDOBIOLOGIA, V46, P452, DOI 10.1078/0031-4056-00152; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ribera I, 2001, ECOLOGY, V82, P1112, DOI 10.1890/0012-9658(2001)082[1112:EOLDAS]2.0.CO;2; Rusch A, 2015, BASIC APPL ECOL, V16, P250, DOI 10.1016/j.baae.2015.02.003; Rusch A, 2014, OECOLOGIA, V175, P971, DOI 10.1007/s00442-014-2949-z; Rusch A, 2013, AGR ECOSYST ENVIRON, V176, P63, DOI 10.1016/j.agee.2013.05.014; Rusch A, 2013, J APPL ECOL, V50, P345, DOI 10.1111/1365-2664.12055; Schellhorn NA, 2014, ANNU REV ENTOMOL, V59, P559, DOI 10.1146/annurev-ento-011613-161952; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; Thiele H, 1977, CARABID BEETLES THEI; TOPPING CJ, 1992, J APPL ECOL, V29, P485, DOI 10.2307/2404516; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Tsiafouli MA, 2015, GLOBAL CHANGE BIOL, V21, P973, DOI 10.1111/gcb.12752; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Williams A, 2014, APPL SOIL ECOL, V77, P1, DOI 10.1016/j.apsoil.2014.01.001; Winqvist C, 2014, J INSECT CONSERV, V18, P837, DOI 10.1007/s10841-014-9690-0; Wissinger SA, 1997, BIOL CONTROL, V10, P4, DOI 10.1006/bcon.1997.0543; Woodcock BA, 2010, AGR ECOSYST ENVIRON, V139, P181, DOI 10.1016/j.agee.2010.07.018	63	27	28	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146329	10.1371/journal.pone.0146329	http://dx.doi.org/10.1371/journal.pone.0146329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730734	Green Published, gold			2022-12-27	WOS:000367801400150
J	Murray, SG; Schmajuk, G; Trupin, L; Gensler, L; Katz, PP; Yelin, EH; Gansky, SA; Yazdany, J				Murray, Sara G.; Schmajuk, Gabriela; Trupin, Laura; Gensler, Lianne; Katz, Patricia P.; Yelin, Edward H.; Gansky, Stuart A.; Yazdany, Jinoos			National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; SYSTEMIC-LUPUS; MYCOPHENOLATE-MOFETIL; RHEUMATOID-ARTHRITIS; SERIOUS INFECTIONS; CARINII-PNEUMONIA; INTRAVENOUS CYCLOPHOSPHAMIDE; AUTOIMMUNE-DISEASES; ADMINISTRATIVE DATA; INDUCTION TREATMENT	Objective Infection is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). Therapeutic practices have evolved over the past 15 years, but effects on infectious complications of SLE are unknown. We evaluated trends in hospitalizations for severe and opportunistic infections in a population-based SLE study. Methods Data derive from the 2000 to 2011 United States National Inpatient Sample, including individuals who met a validated administrative definition of SLE. Primary outcomes were diagnoses of bacteremia, pneumonia, opportunistic fungal infection, herpes zoster, cytomegalovirus, or pneumocystis pneumonia (PCP). We used Poisson regression to determine whether infection rates were changing in SLE hospitalizations and used predictive marginals to generate annual adjusted rates of specific infections. Results We identified 361,337 SLE hospitalizations from 2000 to 2011 meeting study inclusion criteria. Compared to non-SLE hospitalizations, SLE patients were younger (51 vs. 62 years), predominantly female (89% vs. 54%), and more likely to be racial/ethnic minorities. SLE diagnosis was significantly associated with all measured severe and opportunistic infections. From 2000 to 2011, adjusted SLE hospitalization rates for herpes zoster increased more than non-SLE rates: 54 to 79 per 10,000 SLE hospitalizations compared with 24 to 29 per 10,000 non-SLE hospitalizations. Conversely, SLE hospitalizations for PCP disproportionately decreased: 5.1 to 2.5 per 10,000 SLE hospitalizations compared with 0.9 to 1.3 per 10,000 non-SLE hospitalizations. Conclusions Among patients with SLE, herpes zoster hospitalizations are rising while PCP hospitalizations are declining. These trends likely reflect evolving SLE treatment strategies. Further research is needed to identify patients at greatest risk for infectious complications.	[Murray, Sara G.; Schmajuk, Gabriela; Trupin, Laura; Gensler, Lianne; Katz, Patricia P.; Yelin, Edward H.; Yazdany, Jinoos] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Schmajuk, Gabriela] Vet Adm, Dept Med, San Francisco, CA USA; [Katz, Patricia P.; Yelin, Edward H.; Yazdany, Jinoos] Univ Calif San Francisco, Phillip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Gansky, Stuart A.] Univ Calif San Francisco, Div Oral Epidemiol & Dent Publ Hlth, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Murray, SG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA.	sara.murray@ucsf.edu			National Institutes for Health [3UL1RR024131-04S1]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23 AR060259, P60 AR053308]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS024412] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR060259, P60AR053308, K23AR063770] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Data for this study were provided by the Comparative Effectiveness Large Dataset Analysis Core (CELDAC), a program of the University of California, San Francisco's Clinical and Translational Science Institute. Funding for CELDAC is provided by the National Institutes for Health (grant 3UL1RR024131-04S1). This research was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases under award numbers K23 AR060259 and P60 AR053308 (JY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support came from the Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center at the University of California, San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel GB, 2009, J AM SOC NEPHROL, V20, P1103, DOI 10.1681/ASN.2008101028; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Barber C, 2011, CURR OPIN RHEUMATOL, V23, P358, DOI 10.1097/BOR.0b013e3283476cd8; Borba EF, 2010, JCR-J CLIN RHEUMATOL, V16, P119, DOI 10.1097/RHU.0b013e3181d52ed7; Chakravarty EF, 2013, LUPUS, V22, P238, DOI 10.1177/0961203312470186; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HH, 2011, CLINICS, V66, P1177, DOI 10.1590/S1807-59322011000700009; Dall'Era M, 2011, CURR OPIN RHEUMATOL, V23, P454, DOI 10.1097/BOR.0b013e328349a1e5; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Edwards CJ, 2003, LUPUS, V12, P672, DOI 10.1191/0961203303lu452oa; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Ginzler EM, 2005, NEW ENGL J MED, V353, P2219, DOI 10.1056/NEJMoa043731; Goldblatt F, 2009, LUPUS, V18, P682, DOI 10.1177/0961203308101019; Green H, 2007, MAYO CLIN PROC, V82, P1052, DOI 10.4065/82.9.1052; Grijalva CG, 2008, PHARMACOEPIDEM DR S, V17, P890, DOI 10.1002/pds.1625; Gupta D, 2008, JCR-J CLIN RHEUMATOL, V14, P267, DOI 10.1097/RHU.0b013e31817a7e30; Guthridge JM, 2013, J RHEUMATOL, V40, P1875, DOI 10.3899/jrheum.130170; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Hata A, 2011, INFECTION, V39, P537, DOI 10.1007/s15010-011-0162-0; Houssiau FA, 2010, ANN RHEUM DIS, V69, P61, DOI 10.1136/ard.2008.102533; Houssiau FA, 2002, ARTHRITIS RHEUM-US, V46, P2121, DOI 10.1002/art.10461; Husain S, 2002, CLIN INFECT DIS, V35, P53, DOI 10.1086/340867; Aceves-Avila FJ, 2008, JCR-J CLIN RHEUMATOL, V14, P261, DOI 10.1097/RHU.0b013e31817a241a; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Louie GH, 2010, ARTHRITIS RHEUM-US, V62, P3826, DOI 10.1002/art.27735; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; MANZI S, 1995, J RHEUMATOL, V22, P1254; McDonald JR, 2009, CLIN INFECT DIS, V48, P1364, DOI 10.1086/598331; Moores KG, 2013, VACCINE, V31, pK62, DOI 10.1016/j.vaccine.2013.06.104; Murray SG, 2014, ARTHRITIS CARE RES, pn/a; Navarro-Zarza JE, 2010, LUPUS, V19, P43, DOI 10.1177/0961203309345776; Oz HS, 1997, J INFECT DIS, V175, P901, DOI 10.1086/513988; Pope JE, 2004, J RHEUMATOL, V31, P274; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; Ritter ML, 2009, TRANSPL INFECT DIS, V11, P290, DOI 10.1111/j.1399-3062.2009.00407.x; Rondaan C, 2014, ARTHRITIS RHEUMATOL, V66, P3122, DOI 10.1002/art.38804; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011; Tektonidou MG, 2015, ARTHRIT CARE RES, V67, P1078, DOI 10.1002/acr.22575; Touma Z, 2011, J RHEUMATOL, V38, P69, DOI 10.3899/jrheum.100130; Tsai WP, 2012, RHEUMATOL INT, V32, P2901, DOI 10.1007/s00296-011-2131-4; Ward MM, 2008, ARTHRIT RHEUM-ARTHR, V59, P162, DOI 10.1002/art.23346; Ward MM, 1999, ARTHRITIS RHEUM, V42, P780, DOI 10.1002/1529-0131(199904)42:4&lt;780::AID-ANR23&gt;3.0.CO;2-M; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	44	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144918	10.1371/journal.pone.0144918	http://dx.doi.org/10.1371/journal.pone.0144918			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731012	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400017
J	Schubotz, W; Brand, T; Kollmeier, B; Ewert, SD				Schubotz, Wiebke; Brand, Thomas; Kollmeier, Birger; Ewert, Stephan D.			The Influence of High-Frequency Envelope Information on Low-Frequency Vowel Identification in Noise	PLOS ONE			English	Article							TEMPORAL FINE-STRUCTURE; FUNDAMENTAL-FREQUENCY; PERCEPTUAL SEPARATION; SPEECH RECOGNITION; COMPLEX TONES; PITCH; DISCRIMINATION; RECEPTION; MASKING; FUSION	Vowel identification in noise using consonant-vowel-consonant (CVC) logatomes was used to investigate a possible interplay of speech information from different frequency regions. It was hypothesized that the periodicity conveyed by the temporal envelope of a high frequency stimulus can enhance the use of the information carried by auditory channels in the low-frequency region that share the same periodicity. It was further hypothesized that this acts as a strobe-like mechanism and would increase the signal-to-noise ratio for the voiced parts of the CVCs. In a first experiment, different high-frequency cues were provided to test this hypothesis, whereas a second experiment examined more closely the role of amplitude modulations and intact phase information within the high-frequency region (4-8 kHz). CVCs were either natural or vocoded speech (both limited to a low-pass cutoff-frequency of 2.5 kHz) and were presented in stationary 3-kHz low-pass filtered masking noise. The experimental results did not support the hypothesized use of periodicity information for aiding low-frequency perception.	[Schubotz, Wiebke] Carl von Ossietzky Univ Oldenburg, Med Phys, D-26111 Oldenburg, Germany; Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Schubotz, W (corresponding author), Carl von Ossietzky Univ Oldenburg, Med Phys, D-26111 Oldenburg, Germany.	wiebke.schubotz@uni-oldenburg.de			Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich SFB/TRR31]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) within the Sonderforschungsbereich SFB/TRR31, "The Active Auditory System." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JB, 1994, IEEE T SPEECH AUDI P, V2, P567, DOI 10.1109/89.326615; American National Standards Institute (ANSI), 1997, S351997 ANSI; ASSMANN PF, 1990, J ACOUST SOC AM, V88, P680, DOI 10.1121/1.399772; Bird J., 1998, PSYCHOPHYSICAL PHYSL, P263; BREGMAN AS, 1978, CAN J PSYCHOL, V32, P19, DOI 10.1037/h0081664; BREGMAN AS, 1990, PERCEPT PSYCHOPHYS, V47, P68, DOI 10.3758/BF03208166; BREGMAN AS, 1985, PERCEPT PSYCHOPHYS, V37, P483, DOI 10.3758/BF03202881; BROADBENT DE, 1957, J ACOUST SOC AM, V29, P708, DOI 10.1121/1.1909019; BROKX JPL, 1982, J PHONETICS, V10, P23, DOI 10.1016/S0095-4470(19)30909-X; Carlyon RP, 1996, J ACOUST SOC AM, V99, P517, DOI 10.1121/1.414510; Cooke M, 2006, J ACOUST SOC AM, V119, P1562, DOI 10.1121/1.2166600; Coughlin M, 1998, J ACOUST SOC AM, V104, P3597, DOI 10.1121/1.423942; CULLING JF, 1993, J ACOUST SOC AM, V93, P3454, DOI 10.1121/1.405675; Darwin CJ, 1997, TRENDS COGN SCI, V1, P327, DOI 10.1016/S1364-6613(97)01097-8; Deeks JM, 2004, J ACOUST SOC AM, V115, P1736, DOI 10.1121/1.1675814; Dreschler WA, 2001, AUDIOLOGY, V40, P148; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; Ewert S.D., 2013, P INT C ACOUSTICS AI, P1326; Ghitza O., 2001, J ACOUST SOC AM, V88, P1725; Gordon PC, 2000, SPEECH COMMUN, V30, P197, DOI 10.1016/S0167-6393(99)00053-9; Gordon PC, 1997, PERCEPT PSYCHOPHYS, V59, P232, DOI 10.3758/BF03211891; HOUTSMA AJM, 1990, J ACOUST SOC AM, V87, P304, DOI 10.1121/1.399297; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Josupeit A, 2012, J ACOUST SOC AM, V132, pEL450, DOI 10.1121/1.4766274; Kong YY, 2007, J ACOUST SOC AM, V121, P3717, DOI 10.1121/1.2717408; Loizou P.C., 2013, SPEECH ENHANCEMENT T; Markel JE, 1982, LINEAR PREDICTION SP; Meddis R, 1997, J ACOUST SOC AM, V102, P1811, DOI 10.1121/1.420088; Moore BCJ, 2012, J ACOUST SOC AM, V132, P1542, DOI 10.1121/1.4739444; Moore BCJ, 2009, J ACOUST SOC AM, V125, P3186, DOI 10.1121/1.3106525; Moore GA, 2003, J ACOUST SOC AM, V113, P977, DOI 10.1121/1.1536631; Oxenham AJ, 2011, P NATL ACAD SCI USA, V108, P7629, DOI 10.1073/pnas.1015291108; Oxenham AJ, 2009, J ACOUST SOC AM, V125, P2189, DOI 10.1121/1.3089220; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Patzold M., 1997, ARBEITSBERICHTE INST, V32, P215; Plack CJ, 2006, PITCH NEURAL CODING, V24; Pompino-Marschall Bernd, 1995, EINFUHRUNG PHONETIK; Qin MK, 2006, J ACOUST SOC AM, V119, P2417, DOI 10.1121/1.2178719; Qin MK, 2003, J ACOUST SOC AM, V114, P446, DOI 10.1121/1.1579009; Stone MA, 2008, J ACOUST SOC AM, V124, P2272, DOI 10.1121/1.2968678; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; WARREN RM, 1995, PERCEPT PSYCHOPHYS, V57, P175, DOI 10.3758/BF03206503; Wesker T., 2005, P INT, P1273	45	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145610	10.1371/journal.pone.0145610	http://dx.doi.org/10.1371/journal.pone.0145610			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730702	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000367801400042
J	Wu, DWL; DiGiacomo, A; Lenkic, PJ; Wong, VK; Kingstone, A				Wu, David W. -L.; DiGiacomo, Alessandra; Lenkic, Peter J.; Wong, Vanessa K.; Kingstone, Alan			Being in a "Green" Building Elicits "Greener" Recycling, but Not Necessarily "Better" Recycling	PLOS ONE			English	Article							PRO-ENVIRONMENTAL BEHAVIOR; CHANGING BEHAVIOR; PSYCHOLOGY; SUSTAINABILITY; INTERVENTIONS; ARCHITECTURE; INFORMATION; FEEDBACK; CULTURE; IMPACTS	Previous observational work revealed that transient populations in a sustainable building disposed of waste more accurately when compared to patrons in a non-sustainable building. The current study uses an experimental design to replicate this observed effect and to investigate whether or not the built environment influences motivational factors to impact behavior. We find support that a building designed and built to communicate an atmosphere of sustainability can influence waste disposal behavior. Participants in the sustainable building used the garbage receptacle significantly less and compensated by tending to select the containers and organics receptacle more, which actually resulted in more errors overall. Our findings suggest that building atmospherics can motivate people to recycle more. However, atmospherics alone do not appear to be sufficient to elicit the desired performance outcome.	[Wu, David W. -L.; DiGiacomo, Alessandra; Lenkic, Peter J.; Wong, Vanessa K.; Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Wu, DWL (corresponding author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	david.wl.wu@gmail.com		Wu, David/0000-0002-6924-6047	National Sciences and Engineering Research Council of Canada [12R80338]; Social Sciences and Humanities Research Council of Canada [12R09579]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Work for this paper was supported by grants to AK from the National Sciences and Engineering Research Council of Canada (#12R80338; http://www.nserc-crsng.gc.ca) and the Social Sciences and Humanities Research Council of Canada (#12R09579; http://www.sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Abrahamse W, 2007, J ENVIRON PSYCHOL, V27, P265, DOI 10.1016/j.jenvp.2007.08.002; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ariely D, 2009, AM ECON REV, V99, P544, DOI 10.1257/aer.99.1.544; AUSTIN J, 1993, J APPL BEHAV ANAL, V26, P247, DOI 10.1901/jaba.1993.26-247; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; BROTHERS KJ, 1994, J APPL BEHAV ANAL, V27, P153, DOI 10.1901/jaba.1994.27-153; Brown Z, 2010, FACILITIES, V28, P225, DOI 10.1108/02632771011023168; Campbell-Arvai V, 2014, ENVIRON BEHAV, V46, P453, DOI 10.1177/0013916512469099; Cheung SF, 1999, ENVIRON BEHAV, V31, P587, DOI 10.1177/00139169921972254; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Codinhoto R, 2009, FACILITIES, V27, P138, DOI 10.1108/02632770910933152; Cole LB, 2014, ENVIRON EDUC RES, V20, P836, DOI 10.1080/13504622.2013.833586; DEYOUNG R, 1993, ENVIRON BEHAV, V25, P485, DOI 10.1177/0013916593253003; Ernst A, 2014, EUR PSYCHOL, V19, P118, DOI 10.1027/1016-9040/a000174; Garling T, 2014, EUR PSYCHOL, V19, P127, DOI 10.1027/1016-9040/a000184; Heschong L, 2002, J ILLUM ENG SOC, V31, P101, DOI 10.1080/00994480.2002.10748396; Kaiser FG, 2014, EUR PSYCHOL, V19, P81, DOI 10.1027/1016-9040/a000180; Kingstone A, 2010, BRIT J PSYCHOL, V99, P317; Klockner CA, 2013, GLOBAL ENVIRON CHANG, V23, P1028, DOI 10.1016/j.gloenvcha.2013.05.014; KOTLER P, 1974, J RETAILING, V49, P48; LEE YJ, 1995, ENVIRON BEHAV, V27, P380, DOI 10.1177/0013916595273006; Osbaldiston R, 2012, ENVIRON BEHAV, V44, P257, DOI 10.1177/0013916511402673; Risko EF, 2011, ATTEN PERCEPT PSYCHO, V73, P291, DOI 10.3758/s13414-010-0042-1; Schultz PW, 2014, EUR PSYCHOL, V19, P107, DOI 10.1027/1016-9040/a000163; SCHULTZ PW, 1995, J ENVIRON PSYCHOL, V15, P105, DOI 10.1016/0272-4944(95)90019-5; Schultz PW, 1999, BASIC APPL SOC PSYCH, V21, P25, DOI 10.1207/s15324834basp2101_3; Seibold-Bultmann U, 2007, INTERDISCIPL SCI REV, V32, P3, DOI 10.1179/030801807X183614; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Tanner C, 2003, PSYCHOL MARKET, V20, P883, DOI 10.1002/mar.10101; Tanner C.K., 2000, J EDUC ADMIN, V38, P309, DOI DOI 10.1108/09578230010373598; Tonglet M, 2004, RESOUR CONSERV RECY, V42, P27, DOI 10.1016/j.resconrec.2004.02.001; Turley LW, 2000, J BUS RES, V49, P193, DOI 10.1016/S0148-2963(99)00010-7; Verplanken B, 2006, J PUBLIC POLICY MARK, V25, P90, DOI 10.1509/jppm.25.1.90; Vischer J. C., 2008, ARCHIT SCI REV, V51, P97, DOI DOI 10.3763/ASRE.2008.5114; Wener R, 2006, TECHNOL SOC, V28, P157, DOI 10.1016/j.techsoc.2005.10.016; Werner CM, 1998, J ENVIRON PSYCHOL, V18, P373, DOI 10.1006/jevp.1998.0114; Wu DWL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053856; Yau Y, 2012, SUSTAIN DEV, V20, P115, DOI 10.1002/sd.468	40	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145737	10.1371/journal.pone.0145737	http://dx.doi.org/10.1371/journal.pone.0145737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731651	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400048
J	Al Khaldi, R; Mojiminiyi, O; AlMulla, F; Abdella, N				Al Khaldi, Rasha; Mojiminiyi, Olusegun; AlMulla, Fahd; Abdella, Nabila			Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus	PLOS ONE			English	Article							COMMON VARIANTS; ADIPONECTIN; DISEASE; EXPRESSION; BTB/POZ; LOCUS	Previous Studies have mapped putative loci that may probably regulate leukocyte telomere length (LTL). The strongest associations with LTL were reported for SNP rs12696304 and rs16847897 near the non-coding Ribose Nucleic Acid (RNA) molecule component (TERC) of telomerase enzyme on 3q26. It is unclear whether these identified loci coding functional components of telomerase, exert a similar effect on LTL in other populations or influence risk factors of Type 2 Diabetes Mellitus (T2DM). The present study was performed to: study the influence of TERC polymorphisms on LTL, human telomerase reverse transcriptase (hTERT), indices of obesity and explore the potential associations with T2DM. 225 T2DM patients and 245 age and sex matched controls were studied. Allelic Discrimination (AD) genotyping was utilized to determine TERC SNPs [rs12696304 and rs16847897]. hTERT, adiponectin, Insulin, Homeostasis Model Assessment (HOMA-IR), and LTL were measured. Body Mass Index (BMI) and waist circumference (WC) were recorded. [CC] genotype of rs16847897 was significantly associated with shorter LTL [OR = 1.6, p = 0.004], lower hTERT levels [OR = 0.4, p = 0.006], higher BMI [OR = 2.2, p = 0.006], larger WC [OR = 23.4, p = 0.007] and hypo-adiponectemia [OR = 0.6, p = 0.006]. [GG] genotype of rs12696304 was also significantly associated with shorter LTL [OR = 1.5, p = 0.004], lower hTERT [OR = 0.7, p = 0.006] but with larger WC[OR = 5.3, p = 0.004]. [CC] genotype of rs16847897 and [GG] genotype of rs12696304 together increased the risk of T2DM significantly [OR = 1.7, p = 0.004]. We provide insights connecting a structure that is critically involved in maintaining genomic stability with obesity and T2DM. Given the central role of telomere length in determining telomere function our findings may expand our understanding of the pathological mechanisms underlying age associated conditions such as T2DM.	[Al Khaldi, Rasha; Mojiminiyi, Olusegun; AlMulla, Fahd] Kuwait Univ, Fac Med, Dept Pathol, Kuwait, Kuwait; [Abdella, Nabila] Kuwait Univ, Fac Med, Deartment Med, Kuwait, Kuwait	Kuwait University; Kuwait University	Mojiminiyi, O (corresponding author), Kuwait Univ, Fac Med, Dept Pathol, Kuwait, Kuwait.	segunade@yahoo.com	Al-Mulla, Fahd/E-2068-2015	Al-Mulla, Fahd/0000-0001-5409-3829; Al Khaldi, Rasha/0000-0002-2028-8713	College of Graduate Studies [YM06/11]; General Facility KU Project [SRUL02/13]	College of Graduate Studies; General Facility KU Project	This research is supported by the College of Graduate Studies [Research Sector Grant-YM06/11]. We gratefully acknowledge the contribution of the General Facility KU Project [SRUL02/13].	Alliel PM, 2000, BIOCHEM BIOPH RES CO, V273, P385, DOI 10.1006/bbrc.2000.2862; [Anonymous], 1997, WORLD HEALTH FORUM, V18, P248; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Balasubramanyam M, 2007, INDIAN J MED RES, V125, P441; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chiodini BD, 2003, ARTERIOSCL THROM VAS, V23, P1863, DOI 10.1161/01.ATV.0000093281.10213.DB; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cifuentes-Diaz C, 2004, MUSCLE NERVE, V29, P59, DOI 10.1002/mus.10526; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cui Y, 2013, OBESITY, V21, P2582, DOI 10.1002/oby.20321; Hara Y, 2008, FEBS LETT, V582, P2998, DOI 10.1016/j.febslet.2008.07.058; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Meeker AK, 2006, UROL ONCOL-SEMIN ORI, V24, P122, DOI 10.1016/j.urolonc.2005.11.002; Mojiminiyi OA, 2007, INT J OBESITY, V31, P213, DOI 10.1038/sj.ijo.0803355; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; Sumida T, 2001, ORAL ONCOL, V37, P333, DOI 10.1016/S1368-8375(00)00132-9; Trudeau M. A., 2010, Current Pharmacogenomics & Personalized Medicine, V8, P7; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734	24	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145721	10.1371/journal.pone.0145721	http://dx.doi.org/10.1371/journal.pone.0145721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720590	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900021
J	Cousineau, M; Bidelman, GM; Peretz, I; Lehmann, A				Cousineau, Marion; Bidelman, Gavin M.; Peretz, Isabelle; Lehmann, Alexandre			On the Relevance of Natural Stimuli for the Study of Brainstem Correlates: The Example of Consonance Perception	PLOS ONE			English	Article							FREQUENCY-FOLLOWING RESPONSES; COMPLEX TONES; MUSICAL CONSONANCE; AUDITORY-NERVE; PHASE SENSITIVITY; COMPUTER-MODEL; VIRTUAL PITCH; REPRESENTATION; INFORMATION; SOUNDS	Some combinations of musical tones sound pleasing to Western listeners, and are termed consonant, while others sound discordant, and are termed dissonant. The perceptual phenomenon of consonance has been traced to the acoustic property of harmonicity. It has been repeatedly shown that neural correlates of consonance can be found as early as the auditory brainstem as reflected in the harmonicity of the scalp-recorded frequency-following response (FFR). "Neural Pitch Salience" (NPS) measured from FFRs-essentially a time-domain equivalent of the classic pattern recognition models of pitch-has been found to correlate with behavioral judgments of consonance for synthetic stimuli. Following the idea that the auditory system has evolved to process behaviorally relevant natural sounds, and in order to test the generalizability of this finding made with synthetic tones, we recorded FFRs for consonant and dissonant intervals composed of synthetic and natural stimuli. We found that NPS correlated with behavioral judgments of consonance and dissonance for synthetic but not for naturalistic sounds. These results suggest that while some form of harmonicity can be computed from the auditory brainstem response, the general percept of consonance and dissonance is not captured by this measure. It might either be represented in the brainstem in a different code (such as place code) or arise at higher levels of the auditory pathway. Our findings further illustrate the importance of using natural sounds, as a complementary tool to fully-controlled synthetic sounds, when probing auditory perception.	[Cousineau, Marion; Peretz, Isabelle; Lehmann, Alexandre] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Cousineau, Marion; Peretz, Isabelle; Lehmann, Alexandre] CRBLM, Montreal, PQ, Canada; [Cousineau, Marion; Peretz, Isabelle; Lehmann, Alexandre] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Bidelman, Gavin M.] Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA; [Bidelman, Gavin M.] Univ Memphis, Sch Commun Sci & Disorders, Memphis, TN 38152 USA; [Lehmann, Alexandre] McGill Univ, Dept Otolaryngol Head & Neck Surg, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Memphis; University of Memphis; McGill University	Cousineau, M (corresponding author), Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada.	marioncousineau@gmail.com	Bidelman, Gavin M/D-9998-2016	Bidelman, Gavin M/0000-0002-1821-3261	Auditory Cognitive Neuroscience (ACN)-create network; Grammy Foundation; Government of Quebec via the Fonds de Recherche Nature et Technologies and Societe et Culture	Auditory Cognitive Neuroscience (ACN)-create network; Grammy Foundation; Government of Quebec via the Fonds de Recherche Nature et Technologies and Societe et Culture	This study was supported by a Postdoctoral grant from the Auditory Cognitive Neuroscience (ACN)-create network to MC (http://www.acn-create.org); Grammy Foundation Award to GB (https://www.grammy.org/grammy-foundation/grants); EEG facilities are supported by The Centre for Research on Brain, Language and Music, a strategic cluster funded by the Government of Quebec via the Fonds de Recherche Nature et Technologies and Societe et Culture (www.crblm.ca); the Canadian Institutes of Health Research (CIHR) 133-608 for IP (http://www.cihr-irsc.gc.ca); a Canada Research Chair (CRC) for IP.	Aiken SJ, 2008, HEARING RES, V245, P35, DOI 10.1016/j.heares.2008.08.004; Bidelman GM, 2015, HEARING RES, V323, P68, DOI 10.1016/j.heares.2015.01.011; Bidelman GM, 2014, J AM ACAD AUDIOL, V25, P715, DOI 10.3766/jaaa.25.8.2; Bidelman GM, 2014, NEUROIMAGE, V101, P204, DOI 10.1016/j.neuroimage.2014.07.005; Bidelman GM, 2011, J ACOUST SOC AM, V130, P1488, DOI 10.1121/1.3605559; Bidelman GM, 2011, NEUROREPORT, V22, P212, DOI 10.1097/WNR.0b013e328344a689; Bidelman GM, 2009, J NEUROSCI, V29, P13165, DOI 10.1523/JNEUROSCI.3900-09.2009; Bones O, 2015, J NEUROSCI, V35, P4071, DOI 10.1523/JNEUROSCI.3214-14.2015; Bones O, 2014, NEUROPSYCHOLOGIA, V58, P23, DOI 10.1016/j.neuropsychologia.2014.03.011; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1717, DOI 10.1152/jn.1996.76.3.1717; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Cedolin L, 2005, J NEUROPHYSIOL, V94, P347, DOI 10.1152/jn.01114.2004; Cousineau M, 2012, P NATL ACAD SCI USA, V109, P19858, DOI 10.1073/pnas.1207989109; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Gockel HE, 2011, JARO-J ASSOC RES OTO, V12, P767, DOI 10.1007/s10162-011-0284-1; GOLDSTEIN JL, 1973, J ACOUST SOC AM, V54, P1496, DOI 10.1121/1.1914448; Hartmann W. M., 1997, SIGNALS SOUND SENSAT; Helmholtz HLF, 1954, SENSATIONS TONE; HOUTSMA AJM, 1972, J ACOUST SOC AM, V51, P520, DOI 10.1121/1.1912873; HOUTSMA AJM, 1979, J ACOUST SOC AM, V66, P87, DOI 10.1121/1.382943; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; HUTCHINSON W, 1978, INTERFACE-J NEW MUS, V7, P1, DOI 10.1080/09298217808570246; Itoh K, 2003, NEUROREPORT, V14, P2303, DOI 10.1097/00001756-200312190-00003; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1460, DOI 10.1121/1.1911624; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1451, DOI 10.1121/1.1911623; Larsen E, 2008, J NEUROPHYSIOL, V100, P1301, DOI 10.1152/jn.01361.2007; LICKLIDER JCR, 1951, J ACOUST SOC AM, V23, P147, DOI 10.1121/1.1917296; MARGOLIASH D, 1985, P NATL ACAD SCI USA, V82, P5997, DOI 10.1073/pnas.82.17.5997; McDermott JH, 2010, CURR BIOL, V20, P1035, DOI 10.1016/j.cub.2010.04.019; MEDDIS R, 1991, J ACOUST SOC AM, V89, P2866, DOI 10.1121/1.400725; MEDDIS R, 1991, J ACOUST SOC AM, V89, P2883, DOI 10.1121/1.400726; PERROTT DR, 1969, J ACOUST SOC AM, V46, P1477, DOI 10.1121/1.1911890; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Pressnitzer D, 2001, J ACOUST SOC AM, V109, P2074, DOI 10.1121/1.1359797; Pressnitzer D., 2001, PHYSL PSYCHOPHYSICAL, P97; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Schreiner CE, 1997, NATURE, V388, P383, DOI 10.1038/41106; SETHARES WA, 1993, J ACOUST SOC AM, V94, P1218, DOI 10.1121/1.408175; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; SMITH JC, 1975, ELECTROEN CLIN NEURO, V39, P465, DOI 10.1016/0013-4694(75)90047-4; Stumpf Carl, 1965, TONPSYCHOLOGIE; TERHARDT E, 1974, ACUSTICA, V30, P201; Theunissen FE, 2014, NAT REV NEUROSCI, V15, P355, DOI 10.1038/nrn3731; Tufts JB, 2007, J ACOUST SOC AM, V121, pEL161, DOI 10.1121/1.2710744; Vassilakis P., 2005, SELECTED REPORTS ETH, V12, P119; Vassilakis P., 2001, J ACOUST SOC AM, V110, P2755, DOI [10.1121/1.4777600, DOI 10.1121/1.4777600]; Vassilakis PN, 2005, SELECTED REPORTS ETH, P119	47	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145439	10.1371/journal.pone.0145439	http://dx.doi.org/10.1371/journal.pone.0145439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720000	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510900010
J	Katayama, N; Kishida, O; Sakai, R; Hayakashi, S; Miyoshi, C; Ito, K; Naniwa, A; Yamaguchi, A; Wada, K; Kowata, S; Koike, Y; Tsubakimoto, K; Ohiwa, K; Sato, H; Miyazaki, T; Oiwa, S; Oka, T; Kikuchi, S; Igarashi, C; Chiba, S; Akiyama, Y; Takahashi, H; Takagi, K				Katayama, Noboru; Kishida, Osamu; Sakai, Rei; Hayakashi, Shintaro; Miyoshi, Chikako; Ito, Kinya; Naniwa, Aiko; Yamaguchi, Aya; Wada, Katsunori; Kowata, Shiro; Koike, Yoshinobu; Tsubakimoto, Katsuhiro; Ohiwa, Kenichi; Sato, Hirokazu; Miyazaki, Toru; Oiwa, Shinichi; Oka, Tsubasa; Kikuchi, Shinya; Igarashi, Chikako; Chiba, Shiho; Akiyama, Yoko; Takahashi, Hiroyuki; Takagi, Kentaro			Response of a Wild Edible Plant to Human Disturbance: Harvesting Can Enhance the Subsequent Yield of Bamboo Shoots	PLOS ONE			English	Article							REGIME SHIFTS; HERBIVORY; TOLERANCE; RECOVERY; OVERCOMPENSATION; AVAILABILITY; ECOSYSTEMS; GRASSLAND; BENEFITS; ECOLOGY	Wild edible plants, ecological foodstuffs obtained from forest ecosystems, grow in natural fields, and their productivity depends on their response to harvesting by humans. Addressing exactly how wild edible plants respond to harvesting is critical because this knowledge will provide insights into how to obtain effective and sustainable ecosystem services from these plants. We focused on bamboo shoots of Sasa kurilensis, a popular wild edible plant in Japan. We examined the effects of harvesting on bamboo shoot productivity by conducting an experimental manipulation of bamboo shoot harvesting. Twenty experimental plots were prepared in the Teshio Experimental Forest of Hokkaido University and were assigned into two groups: a harvest treatment, in which newly emerged edible bamboo shoots were harvested (n = 10); and a control treatment, in which bamboo shoots were maintained without harvesting (n = 10). In the first year of harvesting (2013), bamboo shoot productivities were examined twice; i.e., the productivity one day after harvesting and the subsequent post-harvest productivity (2-46 days after harvesting), and we observed no difference in productivity between treatments. This means that there was no difference in original bamboo shoot productivity between treatments, and that harvesting did not influence productivity in the initial year. In contrast, in the following year (2014), the number of bamboo shoots in the harvested plots was 2.4-fold greater than in the control plots. These results indicate that over-compensatory growth occurred in the harvested plots in the year following harvesting. Whereas previous research has emphasized the negative impact of harvesting, this study provides the first experimental evidence that harvesting can enhance the productivity of a wild edible plant. This suggests that exploiting compensatory growth, which really amounts to less of a decline in productivity, may be s a key for the effective use of wild edible plants.	[Katayama, Noboru; Kishida, Osamu; Sakai, Rei; Hayakashi, Shintaro; Miyoshi, Chikako; Ito, Kinya; Naniwa, Aiko; Yamaguchi, Aya; Wada, Katsunori; Kowata, Shiro; Koike, Yoshinobu; Tsubakimoto, Katsuhiro; Ohiwa, Kenichi; Sato, Hirokazu; Miyazaki, Toru; Oiwa, Shinichi; Oka, Tsubasa; Kikuchi, Shinya; Igarashi, Chikako; Chiba, Shiho; Akiyama, Yoko; Takahashi, Hiroyuki; Takagi, Kentaro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Teshio Expt Forest, Horonobe, Hokkaido 0982943, Japan; [Katayama, Noboru; Kishida, Osamu] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Tomakomai Expt Forest, Tomakomai, Hokkaido 0530035, Japan; [Sakai, Rei] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Uryu Expt Forest, Horokanai, Hokkaido 0740741, Japan; [Naniwa, Aiko] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Fac Educ Res, Noyoro, Hokkaido 0960071, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Katayama, N (corresponding author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Teshio Expt Forest, Horonobe, Hokkaido 0982943, Japan.	noborukata1913@gmail.com	Takagi, Kentaro/C-2222-2012; Kishida, Osamu/B-7970-2011		Japan Society for the Promotion of Science [26740045, 24370004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI Grant Number 26740045 and 24370004 from Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, TRENDS PLANT SCI, V5, P309, DOI 10.1016/S1360-1385(00)01679-4; Briske DD, 1996, OECOLOGIA, V105, P151, DOI 10.1007/BF00328540; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Frank DA, 2002, ECOLOGY, V83, P602, DOI 10.1890/0012-9658(2002)083[0602:CCOGPP]2.0.CO;2; Gaoue OG, 2011, ECOL APPL, V21, P1604, DOI 10.1890/10-0422.1; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hobbs RJ, 2007, ECOL MONOGR, V77, P545, DOI 10.1890/06-1530.1; Karban R, 1997, ECOLOGY, V78, P1351; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; KOZUKUE E, 1989, J JPN SOC HORTIC SCI, V58, P719, DOI 10.2503/jjshs.58.719; KOZUKUE E, 1983, J FOOD SCI, V48, P935, DOI 10.1111/j.1365-2621.1983.tb14934.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lennartsson T, 1998, ECOLOGY, V79, P1061, DOI 10.1890/0012-9658(1998)079[1061:IOOITF]2.0.CO;2; Matsuo Ayumi, 2010, Japanese Journal of Ecology (Otsu), V60, P81; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Motomura H, 2002, ANN BOT-LONDON, V90, P149, DOI 10.1093/aob/mcf148; Nakamura M, 2003, FUNCT ECOL, V17, P851, DOI 10.1111/j.1365-2435.2003.00786.x; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Rock JH, 2004, BIOL CONSERV, V116, P227, DOI 10.1016/S0006-3207(03)00193-9; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Saitoh T, 2002, J ECOL, V90, P78, DOI 10.1046/j.0022-0477.2001.00631.x; Saitoh T, 2006, ANN BOT-LONDON, V98, P657, DOI 10.1093/aob/mcl147; Sasa K., 1991, Research Bulletins of the College Experiment Forests, Hokkaido University, V48, P355; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schoonhoven L. M., 2005, Insect-plant biology; Shimano K., 2000, J FOREST RES, V5, P103, DOI [10.1007/BF02762528, DOI 10.1007/BF02762528]; Small CJ, 2011, AM MIDL NAT, V166, P339, DOI 10.1674/0003-0031-166.2.339; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Toyooka H, 1983, HOKKAIDO BAMBOO GRAS; TRUMBLE JT, 1993, ANNU REV ENTOMOL, V38, P93, DOI 10.1146/annurev.en.38.010193.000521; Turner NJ, 2011, CRIT REV PLANT SCI, V30, P198, DOI 10.1080/07352689.2011.554492; Van der Voort ME, 2003, AM MIDL NAT, V149, P282, DOI 10.1674/0003-0031(2003)149[0282:ROPOGH]2.0.CO;2; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Yajima T., 1997, Journal of the Japanese Forestry Society, V79, P234	37	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146228	10.1371/journal.pone.0146228	http://dx.doi.org/10.1371/journal.pone.0146228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720274	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900052
J	Prasad, S; Hu, SX; Sheng, WS; Singh, A; Lokensgard, JR				Prasad, Sujata; Hu, Shuxian; Sheng, Wen S.; Singh, Amar; Lokensgard, James R.			Tregs Modulate Lymphocyte Proliferation, Activation, and Resident-Memory T-Cell Accumulation within the Brain during MCMV Infection	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; TISSUE; EFFECTOR; DIFFERENTIATION; NEUROINFLAMMATION; MIGRATION; RESPONSES; MICE; ICOS	Accumulation and retention of regulatory T-cells (Tregs) has been reported within post viral-encephalitic brains, however, the full extent to which these cells modulate neuroinflammation is yet to be elucidated. Here, we used Foxp3-DTR (diphtheria toxin receptor) knock-in transgenic mice, which upon administration of low dose diphtheria toxin (DTx) results in specific deletion of Tregs. We investigated the proliferation status of various immune cell subtypes within inflamed central nervous system (CNS) tissue. Depletion of Tregs resulted in increased proliferation of both CD8+ and CD4+ T-cell subsets within the brain at 14 d post infection (dpi) when compared to Treg-sufficient animals. At 30 dpi, while proliferation of CD8+ T-cells was controlled within brains of both Treg-depleted and undepleted mice, proliferation of CD4+ T-cells remained significantly enhanced with DTx-treatment. Previous studies have demonstrated that Treg numbers within the brain rebound following DTx treatment to even higher numbers than in untreated animals. Despite this rebound, CD8+ and CD4+ T-cells proliferated at a higher rate when compared to that of Treg-sufficient mice, thus maintaining sustained neuroinflammation. Furthermore, at 30 dpi we found the majority of CD8+ T-cells were CD127(hi) KLRG1-indicating that the cells were long lived memory precursor cells. These cells showed marked elevation of CD103 expression, a marker of tissue resident-memory T-cells (T-RM) in the CNS, in untreated animals when compared to DTx-treated animals suggesting that generation of T-RM is impaired upon Treg depletion. Moreover, the effector function of T-RM as indicated by granzyme B production in response to peptide re-stimulation was found to be more potent in Treg-sufficient animals. Taken together, our findings demonstrate that Tregs limit neuroinflammatory responses to viral infection by controlling cell proliferation and may direct a larger proportion of lymphocytes within the brain to be maintained as T-RM cells.	[Prasad, Sujata; Hu, Shuxian; Sheng, Wen S.; Singh, Amar; Lokensgard, James R.] Univ Minnesota, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Neuroimmunol Lab, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lokensgard, JR (corresponding author), Univ Minnesota, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Neuroimmunol Lab, Box 736 UMHC, Minneapolis, MN 55455 USA.	loken006@umn.edu	Prasad, Sujata/AAV-5950-2020	Prasad, Sujata/0000-0003-3254-5366	National Institute of Mental Health [MH066703]; National Institute of Neurological Disorders and Stroke [NS-038836]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038836] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by grants from the National Institute of Mental Health (MH066703) and the National Institute of Neurological Disorders and Stroke (NS-038836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Beura LK, 2015, J LEUKOCYTE BIOL, V97, P217, DOI 10.1189/jlb.1HI0314-154R; Brea D, 2014, J CELL MOL MED, V18, P1571, DOI 10.1111/jcmm.12304; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cheeran MCJ, 2007, VIRUS RES, V130, P96, DOI 10.1016/j.virusres.2007.05.022; Cheeran MCJ, 2005, J NEUROVIROL, V11, P274, DOI 10.1080/13550280590952808; Cheeran MCJ, 2004, J NEUROVIROL, V10, P152, DOI 10.1080/13550280490441130; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Duppach J, 2014, J VIROL, V88, P13892, DOI 10.1128/JVI.01941-14; Ertelt JM, 2011, J IMMUNOL, V187, P2569, DOI 10.4049/jimmunol.1100374; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; FORD AL, 1995, J IMMUNOL, V154, P4309; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Gebhardt T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00340; Graham JB, 2014, J IMMUNOL, V192, P683, DOI 10.4049/jimmunol.1202153; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Horste GMZ, 2010, J IMMUNOL METHODS, V354, P80, DOI 10.1016/j.jim.2010.01.012; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kastenmuller W, 2011, J IMMUNOL, V187, P3186, DOI 10.4049/jimmunol.1101649; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Liesz A, 2013, J NEUROSCI, V33, P17350, DOI 10.1523/JNEUROSCI.4901-12.2013; Lokensgard JR, 2015, GLIA, V63, P1982, DOI 10.1002/glia.22868; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Marten NW, 2003, J VIROL, V77, P2775, DOI 10.1128/JVI.77.4.2775-2778.2003; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Mutnal MB, 2014, J IMMUNOL, V193, P6070, DOI 10.4049/jimmunol.1400654; Mutnal MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033143; Mutnal MB, 2011, J NEUROVIROL, V17, P424, DOI 10.1007/s13365-011-0042-5; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; STODDART CA, 1994, J VIROL, V68, P6243, DOI 10.1128/JVI.68.10.6243-6253.1994; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Taams LS, 2006, IMMUNOLOGY, V118, P1, DOI 10.1111/j.1365-2567.2006.02348.x; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Veiga-Parga T, 2012, J IMMUNOL, V189, P5924, DOI 10.4049/jimmunol.1202322; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wang DH, 2004, J IMMUNOL, V172, P214, DOI 10.4049/jimmunol.172.1.214; Yuzefpolskiy Y, 2015, CELL MOL IMMUNOL, V12, P400, DOI 10.1038/cmi.2014.48; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	50	26	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145457	10.1371/journal.pone.0145457	http://dx.doi.org/10.1371/journal.pone.0145457			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720146	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900011
J	Shuryak, I				Shuryak, Igor			Mechanistic Modeling of Dose and Dose Rate Dependences of Radiation-Induced DNA Double Strand Break Rejoining Kinetics in Saccharomyces cerevisiae	PLOS ONE			English	Article							ION-BEAM IRRADIATION; X-RAY; YEAST-CELLS; REPAIR; INDUCTION; DAMAGE; CHROMATIN; PATHWAY; TRACK; DSB	Mechanistic modeling of DNA double strand break (DSB) rejoining is important for quantifying and medically exploiting radiation-induced cytotoxicity (e.g. in cancer radiotherapy). Most radiation-induced DSBs are quickly-rejoinable and are rejoined within the first 1-2 hours after irradiation. Others are slowly-rejoinable (persist for several hours), and yet others are essentially unrejoinable (persist for >24 hours). The dependences of DSB rejoining kinetics on radiation dose and dose rate remain incompletely understood. We hypothesize that the fraction of slowly-rejoinable and/or unrejoinable DSBs increases with increasing dose/dose rate. This radiation-dependent (RD) model was implemented using differential equations for three DSB classes: quickly-rejoinable, slowly-rejoinable and unrejoinable. Radiation converts quickly-rejoinable to slowly-rejoinable, and slowly-rejoinable to unrejoinable DSBs. We used large published data sets on DSB rejoining in yeast exposed to sparsely-ionizing (electrons and gamma-rays, single or split-doses, high or low dose rates) and densely-ionizing (alpha-particles) radiation to compare the performances of the proposed RD formalism and the established two-lesion kinetic (TLK) model. These yeast DSB rejoining data were measured within the radiation dose range relevant for clonogenic cell survival, whereas in mammalian cells DSB rejoining is usually measured only at supra-lethal doses for technical reasons. The RD model described both sparsely-ionizing and densely-ionizing radiation data much better than the TLK model: by 217 and 14 sample-size-adjusted Akaike information criterion units, respectively. This occurred because: the RD (but not the TLK) model reproduced the observed upwardly-curving dose responses for slowly-rejoinable/unrejoinable DSBs at long times after irradiation; the RD model adequately described DSB yields at both high and low dose rates using one parameter set, whereas the TLK model overestimated low dose rate data. These results support the hypothesis that DSB rejoining is progressively impeded at increasing radiation doses/dose rates.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA	Columbia University	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@cumc.columbia.edu						Andrae R., 2010, ARXIV10123754, DOI 1012.3754; Antonelli F, 2015, RADIAT RES, V183, P417, DOI 10.1667/RR13855.1; Bee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069061; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Brenner DJ, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130629; Brenner DJ, 2009, HEALTH PHYS, V97, P505, DOI 10.1097/HP.0b013e3181ad7f04; Brenner DJ, 1998, RADIAT RES, V150, P83, DOI 10.2307/3579648; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cao GZ, 2015, J RADIAT RES, V56, P294, DOI 10.1093/jrr/rru114; Carlson DJ, 2008, RADIAT RES, V169, P447, DOI 10.1667/RR1046.1; Cheng YL, 2015, RADIOTHER ONCOL, V116, P366, DOI 10.1016/j.radonc.2015.08.004; Chua MLK, 2014, RADIAT ENVIRON BIOPH, V53, P355, DOI 10.1007/s00411-014-0531-z; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; CURTIS SB, 1986, RADIAT RES, V106, P252, DOI 10.2307/3576798; Datta K, 2005, P NATL ACAD SCI USA, V102, P10569, DOI 10.1073/pnas.0503975102; Dobbs TA, 2008, DNA REPAIR, V7, P1372, DOI 10.1016/j.dnarep.2008.05.001; Dos Santos M, 2014, RADIAT PROT DOSIM, V161, P469, DOI 10.1093/rpd/ncu029; FRANKENBERG D, 1981, RADIAT RES, V88, P524, DOI 10.2307/3575641; FRANKENBERG D, 1986, INT J RADIAT BIOL, V50, P727, DOI 10.1080/09553008614551121; Frankenberg D, 2000, ADV SPACE RES, V25, P2085, DOI 10.1016/S0273-1177(99)01066-2; FRANKENBERGSCHWAGER M, 1980, INT J RADIAT BIOL, V37, P207, DOI 10.1080/09553008014550251; FRANKENBERGSCHWAGER M, 1981, RADIAT RES, V87, P710, DOI 10.2307/3575532; FRANKENBERGSCHWAGER M, 1994, RADIAT ENVIRON BIOPH, V33, P1, DOI 10.1007/BF01255269; FRANKENBERGSCHWAGER M, 1990, INT J RADIAT BIOL, V57, P1151, DOI 10.1080/09553009014551261; FRANKENBERGSCHWAGER M, 1980, RADIAT RES, V82, P498, DOI 10.2307/3575316; Friedland W, 2011, RADIAT PROT DOSIM, V143, P542, DOI 10.1093/rpd/ncq383; Friedrich T, 2012, RADIAT RES, V178, P385, DOI 10.1667/RR2964.1; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Guerrero M, 2002, PHYS MED BIOL, V47, P3197, DOI 10.1088/0031-9155/47/17/310; HAWKINS RB, 1994, RADIAT RES, V140, P366, DOI 10.2307/3579114; Herr L, 2015, RADIAT RES, V184, P280, DOI 10.1667/RR14060.1; ILIAKIS G, 1991, INT J RADIAT BIOL, V59, P927, DOI 10.1080/09553009114550821; Illner D, 2013, P NATL ACAD SCI USA, V110, P16027, DOI 10.1073/pnas.1306324110; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Lawrence CT, 2001, SIAM J OPTIMIZ, V11, P1092, DOI 10.1137/S1052623498344562; LECAM L, 1992, MATH BIOSCI, V112, P261, DOI 10.1016/0025-5564(92)90027-T; Li YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085816; Li YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044293; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; Lorat Y, 2015, DNA REPAIR, V28, P93, DOI 10.1016/j.dnarep.2015.01.007; Ma LQ, 2013, FUNGAL BIOL-UK, V117, P227, DOI 10.1016/j.funbio.2013.01.002; McQuarrie ADR, 1998, WORLD SCI, Vxxi; Mladenov E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00113; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Pater P, 2014, MED PHYS, V41, DOI 10.1118/1.4901555; Prise KM, 1998, INT J RADIAT BIOL, V74, P173, DOI 10.1080/095530098141564; Rief N, 2002, J BIOL CHEM, V277, P20572, DOI 10.1074/jbc.M200265200; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rube CE, 2011, DNA REPAIR, V10, P427, DOI 10.1016/j.dnarep.2011.01.012; Sachs RK, 1997, INT J RADIAT BIOL, V72, P351, DOI 10.1080/095530097143149; Sankaranarayanan K, 2011, INT J RADIAT BIOL, V87, P161, DOI 10.3109/09553002.2010.518214; Schipler A, 2013, NUCLEIC ACIDS RES, V41, P7589, DOI 10.1093/nar/gkt556; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sharma KK, 2016, CRIT REV BIOTECHNOL, V36, P743, DOI 10.3109/07388551.2015.1015959; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Somaiah N, 2013, RADIOTHER ONCOL, V108, P155, DOI 10.1016/j.radonc.2013.05.012; Spiess Andrej-Nikolai, 2010, BMC Pharmacology, V10, P6, DOI 10.1186/1471-2210-10-6; Sridharan DM, 2015, RADIAT RES, V184, P105, DOI 10.1667/RR13684.1; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Taleei R, 2013, RADIAT RES, V179, P530, DOI 10.1667/RR3123.1; TOBIAS CA, 1985, RADIAT RES, V104, pS77, DOI 10.2307/3576635; Tommasino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129416; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Wang RJ, 2015, CURR OPIN CELL BIOL, V34, P54, DOI 10.1016/j.ceb.2015.04.004; Xue L, 2015, DNA REPAIR, V25, P72, DOI 10.1016/j.dnarep.2014.11.004; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058	68	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146407	10.1371/journal.pone.0146407	http://dx.doi.org/10.1371/journal.pone.0146407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741137	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600039
J	Bekisz, M; Bogdan, W; Ghazaryan, A; Waleszczyk, WJ; Kublik, E; Wrobel, A				Bekisz, Marek; Bogdan, Wojciech; Ghazaryan, Anaida; Waleszczyk, Wioletta J.; Kublik, Ewa; Wrobel, Andrzej			The Primary Visual Cortex Is Differentially Modulated by Stimulus-Driven and Top-Down Attention	PLOS ONE			English	Article							BETA-ACTIVITY; RETINOTOPIC ORGANIZATION; SPATIOTEMPORAL PATTERNS; FREQUENCY OSCILLATIONS; SINGLE NEURONS; GAMMA; CATS; SYNCHRONIZATION; CONNECTIVITY; SYSTEM	Selective attention can be focused either volitionally, by top-down signals derived from task demands, or automatically, by bottom-up signals from salient stimuli. Because the brain mechanisms that underlie these two attention processes are poorly understood, we recorded local field potentials (LFPs) from primary visual cortical areas of cats as they performed stimulus-driven and anticipatory discrimination tasks. Consistent with our previous observations, in both tasks, we found enhanced beta activity, which we have postulated may serve as an attention carrier. We characterized the functional organization of taskrelated beta activity by (i) cortical responses (EPs) evoked by electrical stimulation of the optic chiasm and (ii) intracortical LFP correlations. During the anticipatory task, peripheral stimulation that was preceded by high-amplitude beta oscillations evoked large-amplitude EPs compared with EPs that followed low-amplitude beta. In contrast, during the stimulusdriven task, cortical EPs preceded by high-amplitude beta oscillations were, on average, smaller than those preceded by low-amplitude beta. Analysis of the correlations between the different recording sites revealed that beta activation maps were heterogeneous during the bottom-up task and homogeneous for the top-down task. We conclude that bottom-up attention activates cortical visual areas in a mosaic-like pattern, whereas top-down attentional modulation results in spatially homogeneous excitation.	[Bekisz, Marek; Bogdan, Wojciech; Ghazaryan, Anaida; Waleszczyk, Wioletta J.; Kublik, Ewa; Wrobel, Andrzej] Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Wrobel, A (corresponding author), Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland.	wrobel@nencki.gov.pl	Waleszczyk, Wioletta/F-6027-2010; Kublik, Ewa/S-5293-2016; Wrobel, Andrzej/R-4084-2016	Kublik, Ewa/0000-0001-6806-9707; Wrobel, Andrzej/0000-0002-9726-1164; Waleszczyk, Wioletta/0000-0002-7300-6193; Bekisz, Marek/0000-0002-2345-7746	Polish National Centre for Research and Development, ERA-NET Neuron project REVIS;  [N N401 533040]	Polish National Centre for Research and Development, ERA-NET Neuron project REVIS; 	This research was supported by the state donation to the Nencki Institute, Polish National Science Centre (https://www.ncn.gov.pl), grant number N N401 533040 to EK; and by the Polish National Centre for Research and Development (http://www.ncbr.gov.pl), ERA-NET Neuron project REVIS to WJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ayzenshtat I, 2010, J NEUROSCI, V30, P11232, DOI 10.1523/JNEUROSCI.5177-09.2010; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Bekisz M, 1999, NEUROREPORT, V10, P3589, DOI 10.1097/00001756-199911260-00023; Bekisz M, 2003, EUR J NEUROSCI, V17, P421, DOI 10.1046/j.1460-9568.2003.02454.x; Bekisz Marek, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharmauria V, 2014, NEUROSCIENCE, V268, P255, DOI 10.1016/j.neuroscience.2014.03.027; Buffalo EA, 2004, 7176 SOC NEUR; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buffalo EA, 2010, P NATL ACAD SCI USA, V107, P361, DOI 10.1073/pnas.0907658106; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Castro-Alamancos MA, 2002, J NEUROSCI, V22, P9651; Chalk M, 2010, NEURON, V66, P114, DOI 10.1016/j.neuron.2010.03.013; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Chica AB, 2013, BEHAV BRAIN RES, V237, P107, DOI 10.1016/j.bbr.2012.09.027; Chu CCJ, 2014, VISION RES, V96, P113, DOI 10.1016/j.visres.2014.01.008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cutzu F, 2003, VISION RES, V43, P205, DOI 10.1016/S0042-6989(02)00491-1; den Ouden HEM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00548; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; GAREY LJ, 1971, PROC R SOC SER B-BIO, V179, P21, DOI 10.1098/rspb.1971.0079; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Haenschel C, 2000, P NATL ACAD SCI USA, V97, P7645, DOI 10.1073/pnas.120162397; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Innocenti GM, 2002, CEREB CORTEX, V12, P411, DOI 10.1093/cercor/12.4.411; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kublik E, 2001, CLIN NEUROPHYSIOL, V112, P1720, DOI 10.1016/S1388-2457(01)00603-4; Lashgari R, 2012, J NEUROSCI, V32, P11396, DOI 10.1523/JNEUROSCI.0429-12.2012; Lee CC, 2011, NAT NEUROSCI, V14, P108, DOI 10.1038/nn.2713; Leopold DA, 2003, REV NEUROSCIENCE, V14, P195; LINDSTROM S, 1990, J PHYSIOL-LONDON, V429, P259, DOI 10.1113/jphysiol.1990.sp018255; LINDSTROM S, 1990, EXP BRAIN RES, V79, P313, DOI 10.1007/BF00608240; Maier A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00031; Maier A, 2011, J NEUROSCI, V31, P1971, DOI 10.1523/JNEUROSCI.5300-09.2011; Maris E, 2013, NEUROIMAGE, V74, P99, DOI 10.1016/j.neuroimage.2013.02.007; Martin AB, 2015, J NEUROSCI, V35, P6860, DOI 10.1523/JNEUROSCI.3590-14.2015; MITZDORF U, 1980, J PHYSIOL-LONDON, V304, P203, DOI 10.1113/jphysiol.1980.sp013320; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Ramalingam N, 2013, J NEUROSCI, V33, P1773, DOI 10.1523/JNEUROSCI.3825-12.2013; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roland PE, 2002, TRENDS NEUROSCI, V25, P183, DOI 10.1016/S0166-2236(00)02125-1; Roland PE, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00028; Ruff DA, 2014, NAT NEUROSCI, V17, P1591, DOI 10.1038/nn.3835; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schmiedt JT, 2014, J NEUROSCI, V34, P11857, DOI 10.1523/JNEUROSCI.0509-14.2014; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Siegel M, 2003, J NEUROSCI, V23, P4251; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; van Aerde KI, 2009, J PHYSIOL-LONDON, V587, P5177, DOI 10.1113/jphysiol.2009.178384; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247; WROBEL A, 1994, ACTA NEUROBIOL EXP, V54, P95; Wrobel A, 2000, PLASTICITY BARREL CO, P229; Wrobel A, 2007, J NEUROSCI, V27, P2230, DOI 10.1523/JNEUROSCI.4004-06.2007; Wrobel A, 2014, NEW VISUAL NEUROSCIENCES, P339; Zhang XL, 2012, NEURON, V73, P183, DOI 10.1016/j.neuron.2011.10.035	71	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145379	10.1371/journal.pone.0145379	http://dx.doi.org/10.1371/journal.pone.0145379			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730705	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400033
J	Buckner, LR; Amedee, AM; Albritton, HL; Kozlowski, PA; Lacour, N; McGowin, CL; Schust, DJ; Quayle, AJ				Buckner, Lyndsey R.; Amedee, Angela M.; Albritton, Hannah L.; Kozlowski, Pamela A.; Lacour, Nedra; McGowin, Chris L.; Schust, Danny J.; Quayle, Alison J.			Chlamydia trachomatis Infection of Endocervical Epithelial Cells Enhances Early HIV Transmission Events	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEMALE REPRODUCTIVE-TRACT; GENITAL-TRACT; SELECTIVE TRANSMISSION; MONOCLONAL-ANTIBODIES; ANTIMICROBIAL FACTORS; SEXUAL TRANSMISSION; VIRAL TRANSCYTOSIS; TYPE-1 INFECTION; NATURAL-HISTORY	Chlamydia trachomatis causes a predominantly asymptomatic, but generally inflammatory, genital infection that is associated with an increased risk for HIV acquisition. Endocervical epithelial cells provide the major niche for this obligate intracellular bacterium in women, and the endocervix is also a tissue in which HIV transmission can occur. The mechanism by which CT infection enhances HIV susceptibility at this site, however, is not well understood. Utilizing the A2EN immortalized endocervical epithelial cell line grown on cell culture inserts, we evaluated the direct role that CT-infected epithelial cells play in facilitating HIV transmission events. We determined that CT infection significantly enhanced the apical-tobasolateral migration of cell-associated, but not cell-free, HIVBaL, a CCR5-tropic strain of virus, across the endocervical epithelial barrier. We also established that basolateral super-natants from CT-infected A2EN cells significantly enhanced HIV replication in peripheral mononuclear cells and a CCR5+ T cell line. These results suggest that CT infection of endocervical epithelial cells could facilitate both HIV crossing the mucosal barrier and subsequent infection or replication in underlying target cells. Our studies provide a mechanism by which this common STI could potentially promote the establishment of founder virus populations and the maintenance of local HIV reservoirs in the endocervix. Development of an HIV/STI co-infection model also provides a tool to further explore the role of other sexually transmitted infections in enhancing HIV acquisition.	[Buckner, Lyndsey R.; Amedee, Angela M.; Albritton, Hannah L.; Kozlowski, Pamela A.; Lacour, Nedra; McGowin, Chris L.; Quayle, Alison J.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [McGowin, Chris L.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Infect Dis Sect, New Orleans, LA 70112 USA; [Schust, Danny J.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65201 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Missouri System; University of Missouri Columbia	Buckner, LR (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA.	lbuckn@lsuhsc.edu			National Institute of Health, National Institute of Allergy and Infectious Diseases [AI110373, AI087899]; Louisiana Vaccine Center - Louisiana Board of Regents; Louisiana Vaccine Center; Louisiana Board of Regents; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110373, R21AI087899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Institute of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Louisiana Vaccine Center - Louisiana Board of Regents; Louisiana Vaccine Center; Louisiana Board of Regents; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health, National Institute of Allergy and Infectious Diseases grants AI110373 and AI087899 (AJQ, AMA, and DJS), and the Louisiana Vaccine Center funded by the Louisiana Board of Regents (AJQ).; This work was supported by the Louisiana Vaccine Center and the Louisiana Board of Regents. The following reagents were obtained from the NIH AIDS Reagent Program: HIV<INF>LAI</INF>-infected J1.1 cells (contributed by Dr. Thomas Folks), HIV<INF>BaL</INF> (Drs. Suzanne Gartner, Mikulas Popovic and Robert Gallo), PM-1 cells (Drs. Paulo Lusso and Robert Gallo), TZM-bl cells (Drs. John Kappes and Xiaoyin Wu and Tranzyme Inc).	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; Anderson BL, 2012, AM J OBSTET GYNECOL, V207, pe1; Anderson DJ, 2014, J INFECT DIS, V210, pS648, DOI 10.1093/infdis/jiu537; Anderson DJ, 2014, J INFECT DIS, V210, pS606, DOI 10.1093/infdis/jiu538; Barreto-de-Souza V, 2014, AM J REPROD IMMUNOL, V71, P589, DOI 10.1111/aji.12240; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Belec L, 2001, J INFECT DIS, V184, P1412, DOI 10.1086/324375; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P15971, DOI 10.1073/pnas.2535394100; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Bouschbacher M, 2008, AIDS, V22, P1257, DOI 10.1097/QAD.0b013e3282f736f4; BRUNHAM RC, 1984, NEW ENGL J MED, V311, P1, DOI 10.1056/NEJM198407053110101; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Buckner LR, 2013, CYTOKINE, V63, P151, DOI 10.1016/j.cyto.2013.04.022; Buckner LR, 2011, J REPROD IMMUNOL, V92, P8, DOI 10.1016/j.jri.2011.08.002; Byams VR, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.010; Carreno MP, 2002, CYTOKINE, V20, P289, DOI 10.1006/cyto.2002.2009; Cavarelli M, 2013, EMBO MOL MED, V5, P776, DOI 10.1002/emmm.201202232; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Centers for Disease Control and Prevention (CDC), 2015, SEX TRANSM DIS SURV; Chomont N, 2008, VIROLOGY, V370, P246, DOI 10.1016/j.virol.2007.09.006; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Costiniuk CT, 2014, J GEN VIROL, V95, P2346, DOI 10.1099/vir.0.069641-0; Darville T, 2013, ADV EXP MED BIOL, V764, P109, DOI 10.1007/978-1-4614-4726-9_8; Dezzutti CS, 2001, J INFECT DIS, V183, P1204, DOI 10.1086/319676; Drannik AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052738; Eccleston A, 1997, NAT BIOTECHNOL, V15, P709, DOI 10.1038/nbt0897-709; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Ganor Y, 2010, MUCOSAL IMMUNOL, V3, P506, DOI 10.1038/mi.2010.32; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Giuliano AR, 2015, JAIDS-J ACQ IMM DEF, V68, P227, DOI 10.1097/QAI.0000000000000425; Gorodeski GI, 2001, FERTIL STERIL, V76, P753, DOI 10.1016/S0015-0282(01)02377-9; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Halldorsson S, 2007, IN VITRO CELL DEV-AN, V43, P283, DOI 10.1007/s11626-007-9050-4; HARRISON HR, 1985, AM J OBSTET GYNECOL, V153, P244, DOI 10.1016/S0002-9378(85)80105-8; Hein M, 2002, AM J OBSTET GYNECOL, V187, P137, DOI 10.1067/mob.2002.123034; Henning TR, 2009, J CLIN VIROL, V46, P309, DOI 10.1016/j.jcv.2009.08.015; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Ibana JA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-66; Kinlock BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096760; Kohli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098077; Krowicka H, 2008, AIDS RES HUM RETROV, V24, P956, DOI 10.1089/aid.2007.0242; Lewis ME, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00071; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; MCNEARNEY T, 1992, P NATL ACAD SCI USA, V89, P10247, DOI 10.1073/pnas.89.21.10247; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Ming L, 2007, HUM REPROD, V22, P1810, DOI 10.1093/humrep/dem128; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Morre SA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/095646202762226092; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Oravecz T, 1996, J IMMUNOL, V157, P1329; Paavonen J, 1988, Obstet Gynecol Surv, V43, P373, DOI 10.1097/00006254-198807000-00001; Pande V, 2003, CURR MED CHEM, V10, P1603, DOI 10.2174/0929867033457250; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Peterman TA, 2015, INT J STD AIDS, V26, P113, DOI 10.1177/0956462414531243; Phillips David M., 1994, Trends in Microbiology, V2, P454, DOI 10.1016/0966-842X(94)90804-4; PHILLIPS DM, 1994, AIDS, V8, P719, DOI 10.1097/00002030-199406000-00001; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Politch JA, 2014, J INFECT DIS, V210, pS609, DOI 10.1093/infdis/jiu390; Popovic M, 1989, RETROVIRUSES HUMAN A, P21; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; RANK RG, 1988, INFECT IMMUN, V56, P2243, DOI 10.1128/IAI.56.9.2243-2249.1988; Research DoRHa, 2012, GLOB INC PREV SEL CU; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Saidi H, 2009, AIDS RES HUM RETROV, V25, P497, DOI 10.1089/aid.2008.0156; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; SCHUMACHER GFB, 1977, AM J OBSTET GYNECOL, V129, P629, DOI 10.1016/0002-9378(77)90644-5; Schust DJ, 2012, CURR HIV RES, V10, P218, DOI 10.2174/157016212800618093; Stoddard E, 2009, J VIROL, V83, P8596, DOI 10.1128/JVI.00744-09; Strengert M, 2011, METHODS MOL BIOL, V763, P195, DOI 10.1007/978-1-61779-191-8_13; Ugolini S, 1997, J EXP MED, V186, P1287, DOI 10.1084/jem.186.8.1287; UNAIDS, 2010, WOM GIRLS GEND EQ HI; Van Herrewege Y, 2007, ANTIVIR RES, V74, P111, DOI 10.1016/j.antiviral.2006.10.010; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Venkatesh KK, 2011, INT J STD AIDS, V22, P218, DOI 10.1258/ijsa.2010.010385; Walsh C, 2000, J WOMEN HEALTH GEN-B, V9, P339, DOI 10.1089/15246090050020637; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Wira CR, 2011, MUCOSAL IMMUNOL, V4, P335, DOI 10.1038/mi.2010.72; Wira CR, 2011, AM J REPROD IMMUNOL, V65, P196, DOI 10.1111/j.1600-0897.2011.00970.x; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Yirenya-Tawiah Dzidzo, 2014, BMC Res Notes, V7, P349, DOI 10.1186/1756-0500-7-349; Yu MY, 2009, MINI-REV MED CHEM, V9, P60, DOI 10.2174/138955709787001677; Yuan SY., 2010, REGULATION ENDOTHELI; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	104	28	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146663	10.1371/journal.pone.0146663	http://dx.doi.org/10.1371/journal.pone.0146663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730599	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400202
J	Korner, Z; Durbeej, M				Korner, Zandra; Durbeej, Madeleine			Bortezomib Does Not Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin alpha 2 Chain-Deficient Muscular Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; LAMA2 GENE; MICE; INHIBITION; IMPROVES; MDC1A	Congenital muscular dystrophy with laminin alpha 2 chain-deficiency, also known as MDC1A, is a severe neuromuscular disorder for which there is no cure. Patients with complete laminin alpha 2 chain-deficiency typically have an early onset disease with a more severe muscle phenotype while patients with residual laminin alpha 2 chain expression usually have a milder disease course. Similar genotype-phenotype correlations can be seen in the dy(3K)/dy(3K) and dy(2J)/dy(2J) mouse models of MDC1A, respectively, with dy(3K)/dy(3K) mice presenting the more severe phenotype. Recently, we demonstrated that the proteasome inhibitor bortezomib partially improves muscle morphology and increases lifespan in dy(3K)/dy(3K) mice. Here, we explore the use of bortezomib in dy(2J)/dy(2J) animals. However, bortezomib neither improved histological hallmarks of disease nor increased muscle strength and locomotive activity in dy(2J)/dy(2J) mice. Altogether our data suggest that proteasome inhibition does not mitigate muscle dysfunction caused by partial laminin alpha 2 chain-deficiency. Still, it is possible that proteasome inhibition could be useful as a supportive therapy in patients with complete absence of laminin alpha 2 chain.	[Korner, Zandra; Durbeej, Madeleine] Lund Univ, Dept Expt Med Sci, Muscle Biol Unit, Lund, Sweden	Lund University	Durbeej, M (corresponding author), Lund Univ, Dept Expt Med Sci, Muscle Biol Unit, Lund, Sweden.	madeleine.durbeej-hjalt@med.lu.se		Durbeej Hjalt, Madeleine/0000-0002-5491-2457	Muscular Dystrophy Association; Association Francaise contre les Myopathies; Vetenskapsradet; Alfred Osterlund Foundation; Fanny Ekdahl Foundation; Greta and Johan Kock Foundation; Linnea and Josef Foundation	Muscular Dystrophy Association(Muscular Dystrophy Association); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Vetenskapsradet(Swedish Research Council); Alfred Osterlund Foundation; Fanny Ekdahl Foundation; Greta and Johan Kock Foundation; Linnea and Josef Foundation	Muscular Dystrophy Association, Association Francaise contre les Myopathies, Vetenskapsradet, Alfred Osterlund Foundation, Fanny Ekdahl Foundation, Greta and Johan Kock Foundation, Linnea and Josef Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allamand V, 2002, EUR J HUM GENET, V10, P91, DOI 10.1038/sj.ejhg.5200743; Carmignac V, 2011, HUM MOL GENET, V20, P541, DOI 10.1093/hmg/ddq499; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Gawlik KI, 2010, MUSCLE NERVE, V42, P30, DOI 10.1002/mus.21616; Gazzerro E, 2010, AM J PATHOL, V176, P1863, DOI 10.2353/ajpath.2010.090468; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Hemeryck A, 2007, CANCER CHEMOTH PHARM, V60, P777, DOI 10.1007/s00280-007-0424-9; Holmberg J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00155; Korner Z, 2014, AM J PATHOL, V184, P1518, DOI 10.1016/j.ajpath.2014.01.019; Lee SW, 2009, ANN RHEUM DIS, V68, P1761, DOI 10.1136/ard.2008.097709; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Quijano-Roy S, 1993, GENEREVIEWS R; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Xiong H, 2015, CLIN GENET, V87, P233, DOI 10.1111/cge.12366; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Yu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065468; Zhang L, 2015, J PHARMACOKINET PHAR, V42, P541, DOI 10.1007/s10928-015-9445-x	19	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146471	10.1371/journal.pone.0146471	http://dx.doi.org/10.1371/journal.pone.0146471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731667	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400182
J	Ornstein, P; Lyhagen, J				Ornstein, Petra; Lyhagen, Johan			Asymptotic Properties of Spearman's Rank Correlation for Variables with Finite Support	PLOS ONE			English	Article								The asymptotic variance and distribution of Spearman's rank correlation have previously been known only under independence. For variables with finite support, the population version of Spearman's rank correlation has been derived. Using this result, we show convergence to a normal distribution irrespectively of dependence, and derive the asymptotic variance. A small simulation study indicates that the asymptotic properties are of practical importance.	[Ornstein, Petra; Lyhagen, Johan] Uppsala Univ, Dept Stat, Uppsala, Sweden	Uppsala University	Lyhagen, J (corresponding author), Uppsala Univ, Dept Stat, Uppsala, Sweden.	Johan.Lyhagen@statistics.uu.se		Ornstein, Petra/0000-0003-2515-6995				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Cramer H., 1946, MATH METHODS STAT; Kendall M., 1938, NATURE, V142, P402, DOI [10.2307/2280246, DOI 10.2307/2280246]; Kotz S, 2006, ENCY STAT SCI; Neslehova J., 2004, DEPENDENCE NONCONTIN; Neslehova J, 2007, J MULTIVARIATE ANAL, V98, P544, DOI 10.1016/j.jmva.2005.11.007; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159	8	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145595	10.1371/journal.pone.0145595	http://dx.doi.org/10.1371/journal.pone.0145595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730491	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400041
J	Geenen, IL; Kolk, FF; Molin, DG; Wagenaar, A; Compeer, MG; Tordoir, JH; Schurink, GW; De Mey, JG; Post, MJ				Geenen, Irma L.; Kolk, Felix F.; Molin, Daniel G.; Wagenaar, Allard; Compeer, Mathijs G.; Tordoir, Jan H.; Schurink, Geert W.; De Mey, Jo G.; Post, Mark J.			Nitric Oxide Resistance Reduces Arteriovenous Fistula Maturation in Chronic Kidney Disease in Rats	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; ENDOTHELIUM-DEPENDENT RELAXATION; OXIDATIVE STRESS; MONOCYTE ACTIVATION; DYSFUNCTION; FAILURE; ACCESS; NO; HYPERTENSION; INFLAMMATION	Background Autologous arteriovenous (AV) fistulas are the first choice for vascular access but have a high risk of non-maturation due to insufficient vessel adaptation, a process dependent on nitric oxide (NO)-signaling. Chronic kidney disease (CKD) is associated with oxidative stress that can disturb NO-signaling. Here, we evaluated the influence of CKD on AV fistula maturation and NO-signaling. Methods CKD was established in rats by a 5/6th nephrectomy and after 6 weeks, an AV fistula was created between the carotid artery and jugular vein, which was followed up at 3 weeks with ultrasound and flow assessments. Vessel wall histology was assessed afterwards and vasoreactivity of carotid arteries was studied in a wire myograph. The soluble guanylate cyclase (sGC) activator BAY 60-2770 was administered daily to CKD animals for 3 weeks to enhance fistula maturation. Results CKD animals showed lower flow rates, smaller fistula diameters and increased oxidative stress levels in the vessel wall. Endothelium-dependent relaxation was comparable but vasorelaxation after sodium nitroprusside was diminished in CKD vessels, indicating NO resistance of the NO-receptor sGC. This was confirmed by stimulation with BAY 60-2770 resulting in increased vasorelaxation in CKD vessels. Oral administration of BAY 60-2770 to CKD animals induced larger fistula diameters, however; flow was not significantly different from vehicle-treated CKD animals. Conclusions CKD induces oxidative stress resulting in NO resistance that can hamper AV fistula maturation. sGC activators like BAY 60-2770 could offer therapeutic potential to increase AV fistula maturation.	[Geenen, Irma L.; Kolk, Felix F.; Molin, Daniel G.; Wagenaar, Allard; Post, Mark J.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Physiol, NL-6200 MD Maastricht, Netherlands; [Geenen, Irma L.; Tordoir, Jan H.; Schurink, Geert W.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Gen Surg, NL-6200 MD Maastricht, Netherlands; [Compeer, Mathijs G.; De Mey, Jo G.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Pharmacol, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Geenen, IL (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Physiol, NL-6200 MD Maastricht, Netherlands.	i.geenen@maastrichtuniversity.nl	Tordoir, Jan/AAE-4083-2020		Translational en Regenerative Medicine (TeRM) Smart Mix Program; Biomedical Materials Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; Interreg Euregio Meuse-Rhine IVa grant BioMIMedics; Interreg Flanders-the Netherlands IV grant VaRiA; TI Pharma [T2-301]	Translational en Regenerative Medicine (TeRM) Smart Mix Program; Biomedical Materials Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; Interreg Euregio Meuse-Rhine IVa grant BioMIMedics; Interreg Flanders-the Netherlands IV grant VaRiA; TI Pharma	ILG and FFK are supported by the Translational en Regenerative Medicine (TeRM) Smart Mix Program and the Biomedical Materials Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science, http://www.term.nu. DGMM is supported by the Interreg Euregio Meuse-Rhine IVa grant BioMIMedics and Interreg Flanders-the Netherlands IV grant VaRiA, http://www.euregio.eu/nl/subsidies/interreg. MGC and JGRDM were supported by TI Pharma project T2-301, http://www.tipharma.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Asif A, 2006, CLIN J AM SOC NEPHRO, V1, P332, DOI 10.2215/CJN.00850805; BenDriss A, 1997, AM J PHYSIOL-HEART C, V272, pH851, DOI 10.1152/ajpheart.1997.272.2.H851; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Corpataux JM, 2002, NEPHROL DIAL TRANSPL, V17, P1057, DOI 10.1093/ndt/17.6.1057; Dember LM, 2004, KIDNEY INT, V66, P390, DOI 10.1111/j.1523-1755.2004.00743.x; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dixon BS, 2006, KIDNEY INT, V70, P1413, DOI 10.1038/sj.ki.5001747; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Friedlander MA, 1996, CLIN NEPHROL, V45, P379; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GAGNON RF, 1988, UROL RES, V16, P119, DOI 10.1007/BF00261969; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hofmann F, 2000, J CELL SCI, V113, P1671; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Jolma P, 2002, EXP NEPHROL, V10, P348, DOI 10.1159/000065299; Knorr A, 2008, ARZNEIMITTEL-FORSCH, V58, P71, DOI 10.1055/s-0031-1296471; Kohler R, 2005, KIDNEY INT, V67, P2280, DOI 10.1111/j.1523-1755.2005.00331.x; Kokubo T, 2009, J AM SOC NEPHROL, V20, P1236, DOI 10.1681/ASN.2007121312; Langer S, 2010, KIDNEY INT, V78, P1312, DOI 10.1038/ki.2010.353; Lucas KA, 2000, PHARMACOL REV, V52, P375; Luksha L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036056; Mailloux LU, 1998, AM J KIDNEY DIS, V32, P705, DOI 10.1016/S0272-6386(98)70146-5; Mezzano D, 2001, KIDNEY INT, V60, P1844, DOI 10.1046/j.1523-1755.2001.00998.x; Radovits T, 2011, EUR J CARDIO-THORAC, V39, P248, DOI 10.1016/j.ejcts.2010.05.025; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothuizen TC, 2013, NEPHROL DIAL TRANSPL, V28, P1085, DOI 10.1093/ndt/gft068; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Schram MT, 2005, HORM METAB RES, V37, pS49, DOI 10.1055/s-2005-861363; Shinozaki K, 1999, DIABETES, V48, P2437, DOI 10.2337/diabetes.48.12.2437; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Tatematsu S, 2007, J AM SOC NEPHROL, V18, P741, DOI 10.1681/ASN.2006040367; Thuraisingham RC, 1999, NEPHROL DIAL TRANSPL, V14, P70, DOI 10.1093/ndt/14.1.70; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; Tordoir JHM, 2003, NEPHROL DIAL TRANSPL, V18, P378, DOI 10.1093/ndt/18.2.378; Tronc F, 1996, ARTERIOSCL THROM VAS, V16, P1256, DOI 10.1161/01.ATV.16.10.1256; VALLANCE P, 1992, LANCET, V339, P572; Vascular Access 2006 Work Group, 2006, AM J KIDNEY DIS S, V48, pS176, DOI [DOI 10.1053/J.AJKD.2006.04.029, 10.1053/j.ajkd.2006.04.029]; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Wang SP, 1996, SURGERY, V120, P328, DOI 10.1016/S0039-6060(96)80306-0; Windt WAKM, 2008, NEPHROL DIAL TRANSPL, V23, P3103, DOI 10.1093/ndt/gfn233; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Yamamizu K, 2007, J CARDIOVASC PHARM, V49, P131, DOI 10.1097/FJC.0b013e31802f9923	45	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146212	10.1371/journal.pone.0146212	http://dx.doi.org/10.1371/journal.pone.0146212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727368	gold, Green Submitted, Green Published			2022-12-27	WOS:000367681500068
J	Yang, CH; Lin, YD; Chiang, YC; Chuang, LY				Yang, Cheng-Hong; Lin, Yu-Da; Chiang, Yi-Cheng; Chuang, Li-Yeh			A Hybrid Approach for CpG Island Detection in the Human Genome	PLOS ONE			English	Article							DNA METHYLATION; PREDICTION	Background CpG islands have been demonstrated to influence local chromatin structures and simplify the regulation of gene activity. However, the accurate and rapid determination of CpG islands for whole DNA sequences remains experimentally and computationally challenging. Methodology/Principal Findings A novel procedure is proposed to detect CpG islands by combining clustering technology with the sliding-window method (PSO-based). Clustering technology is used to detect the locations of all possible CpG islands and process the data, thus effectively obviating the need for the extensive and unnecessary processing of DNA fragments, and thus improving the efficiency of sliding-window based particle swarm optimization (PSO) search. This proposed approach, named ClusterPSO, provides versatile and highly-sensitive detection of CpG islands in the human genome. In addition, the detection efficiency of ClusterPSO is compared with eight CpG island detection methods in the human genome. Comparison of the detection efficiency for the CpG islands in human genome, including sensitivity, specificity, accuracy, performance coefficient (PC), and correlation coefficient (CC), ClusterPSO revealed superior detection ability among all of the test methods. Moreover, the combination of clustering technology and PSO method can successfully overcome their respective drawbacks while maintaining their advantages. Thus, clustering technology could be hybridized with the optimization algorithm method to optimize CpG island detection. Conclusion/Significance The prediction accuracy of ClusterPSO was quite high, indicating the combination of CpGcluster and PSO has several advantages over CpGcluster and PSO alone. In addition, ClusterPSO significantly reduced implementation time.	[Yang, Cheng-Hong; Lin, Yu-Da; Chiang, Yi-Cheng] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 80778, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; I Shou University; I Shou University	Chuang, LY (corresponding author), I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan.	chuang@isu.edu.tw	Yang, Cheng-Hong/K-2438-2019; Lin, Yu-da/M-7946-2013	Lin, Yu-da/0000-0001-5100-6072				Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Chuang LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021036; Feldmann A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003994; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gudise VG, 2003, IEEE IJCNN, P468; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hackenberg M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-327; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Miller CA, 2008, NEURON, V59, DOI 10.1016/j.neuron.2008.09.015; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Su JZ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp882; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099	17	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0144748	10.1371/journal.pone.0144748	http://dx.doi.org/10.1371/journal.pone.0144748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727213	Green Submitted, gold, Green Published			2022-12-27	WOS:000367681500006
J	Zhai, YL; Chao, QL; Li, H; Wang, B; Xu, R; Wang, N; Han, YJ; He, XL; Jia, X; Wang, XM				Zhai, Yali; Chao, Qiuling; Li, Hong; Wang, Bo; Xu, Rong; Wang, Ning; Han, Yajun; He, Xiaole; Jia, Xin; Wang, Xiaoming			Application and Revision of Montreal Cognitive Assessment in China's Military Retirees with Mild Cognitive Impairment	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; ALZHEIMERS-DISEASE; ELDERLY POPULATION; PHYSICAL-ACTIVITY; SCREENING TOOL; WORKING GROUP; DEMENTIA; PREVALENCE; RISK; STROKE	Objective In an effort to accommodate MOCA to better fit for the Chinese context, this study was designed to employ the MOCA criteria to screen mild cognitive impairment (MCI) and analyze associated risk factors in military retirees. Methods Three hundred and four retired military cadres were recruited using a random cluster sampling technique with information collected including personal, prevalence, MOCA scale, and related neuropsychiatry scale. Thirty retirees were randomly chosen to be further analyzed one month later using the revised MOCA scale. Results Our data indicated an incidence rate of 64.8% for mild cognitive impairment in retired military cadres. The incidence rate for MCI was significantly higher in those aged 80 or above compared with those 80 years of age or younger (P<0.05). The incidence rate of MCI was significantly higher in those with fewer than 6 years of education compared with those with over 7 years of education (P<0.05). The MCI incidence was higher for those with little exercise than those taking regular exercise (P< 0.01). Moreover, the MCI incidence was higher in stroke patients than those who never had a stroke episode (P< 0.05).There was a significant correlation between MOCA and MMSE scale scores (r = 0.81). MOCA scale scores were negatively correlated with ADL and CES-D scores (although not PSQI scores). MOCA recension Cronbach's alpha value was 0.862. The related coefficient of MOCA and MOCA recension was 0.878(P< 0.01). When the Score of cut-off -point of the MOCA recension was 28, the area in ROC curve analyses was 0.859, as well as the largest area. Conclusion Retired cadres exhibited a greater incidence of MCI (than general population), which was closely associated with age, level of education and physical exercise and cerebral apoplexy. Revised MOCA scale displays a better validity and reaction degree of reliability and is more suitable for screening and diagnosis of MCI in the elderly in China.	[Zhai, Yali; Chao, Qiuling; Li, Hong; Xu, Rong; Wang, Ning; Han, Yajun; He, Xiaole; Jia, Xin; Wang, Xiaoming] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian 710032, Shaanxi, Peoples R China; [Chao, Qiuling] Xi An Jiao Tong Univ, Ctr Ageing & Hlth Res, Xian 710049, Shaanxi, Peoples R China; [Wang, Bo] Fourth Mil Med Univ, Dept Epidem, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University	Chao, QL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian 710032, Shaanxi, Peoples R China.	cql@mail.xjtu.edu.cn; xmwang@fmmu.edu.cn		Wang, Xiaoming/0000-0002-9671-6358	National Natural Science Foundation of China [81270169]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201302008]; National Social Science Foundation of China [15BRK024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation by Ministry of Health P. R. China; National Social Science Foundation of China	This study was supported by the National Natural Science Foundation of China (No. 81270169). National Department Public Benefit Research Foundation by Ministry of Health P. R. China (No. 201302008). National Social Science Foundation of China (No. 15BRK024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2011, AM J PSYCHIAT, V168, P1075, DOI 10.1176/appi.ajp.2011.10060853; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 2007, ZHONGHUA NEI KE ZA Z; Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; Chang YL, 2011, NEUROLOGY, V76, P652, DOI 10.1212/WNL.0b013e31820ce6a5; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Farina N, 2014, ARCH GERONTOL GERIAT, V59, P91, DOI 10.1016/j.archger.2014.03.016; Ferrer I, 2012, PROG NEUROBIOL, V97, P38, DOI 10.1016/j.pneurobio.2012.03.005; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Forlenza OV, 2013, REV BRAS PSIQUIATR, V35, P178, DOI 10.1590/1516-4446-2012-3503; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Geda YE, 2014, AM J PSYCHIAT, V171, P572, DOI 10.1176/appi.ajp.2014.13060821; Geda YE, 2010, ARCH NEUROL-CHICAGO, V67, P80, DOI 10.1001/archneurol.2009.297; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; Kramer AF, 2004, J GERONTOL A-BIOL, V59, P940; Landi F, 2010, BIOGERONTOLOGY, V11, P537, DOI 10.1007/s10522-010-9296-1; Launer LJ, 2005, NEUROBIOL AGING, V26, P335, DOI 10.1016/j.neurobiolaging.2004.03.016; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Li J, 2011, NEUROLOGY, V76, P1485, DOI 10.1212/WNL.0b013e318217e7a4; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2012, ARCH NEUROL-CHICAGO, V69, P700, DOI 10.1001/archneurol.2011.3152; Mortamais M, 2014, AM J GERIAT PSYCHIAT, V22, P1336, DOI 10.1016/j.jagp.2013.06.002; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nie HW, 2011, INT J GERIATR PSYCH, V26, P558, DOI 10.1002/gps.2579; Olson RA, 2008, SUPPORT CARE CANCER, V16, P1273, DOI 10.1007/s00520-008-0431-3; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Popovic IM, 2007, J NEUROL SCI, V257, P185, DOI 10.1016/j.jns.2007.01.029; Portet F, 2006, J NEUROL NEUROSUR PS, V77, P714, DOI 10.1136/jnnp.2005.085332; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Ramlall S, 2013, AFR J PSYCHIATRY, V16, P456, DOI [10.4314/ajpsy.v16i6.58, http://dx.doi.org/10.4314/ajpsy.v16i6.58]; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P661; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Sachdev PS, 2009, J INT NEUROPSYCH SOC, V15, P915, DOI 10.1017/S1355617709990579; Sasaki M, 2009, INT J GERIATR PSYCH, V24, P1119, DOI 10.1002/gps.2234; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Sosa AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001170; Srikanth VK, 2006, STROKE, V37, P2479, DOI 10.1161/01.STR.0000239666.46828.d7; Steenland K, 2012, J ALZHEIMERS DIS, V31, P265, DOI 10.3233/JAD-2012-111922; Stephan BCM, 2015, AGE AGEING, V44, P78, DOI 10.1093/ageing/afu085; Su XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083217; Tarawneh R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006148; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Vega JN, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0490-8; Visser PJ, 2006, INT PSYCHOGERIATR, V18, P402; Wen Hong-Bo, 2008, Zhonghua Nei Ke Za Zhi, V47, P36; Weuve J, 2010, ALZHEIMERS DEMENTI S, V6, pS125; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Xu SJ, 2014, NEUROEPIDEMIOLOGY, V42, P123, DOI 10.1159/000357374; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837; [张立秀 Zhang Lixiu], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P123; Zhang WenXu, 2001, Chinese Journal of Rice Science, V15, P327	63	7	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145547	10.1371/journal.pone.0145547	http://dx.doi.org/10.1371/journal.pone.0145547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727602	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500021
J	Friedlander, AM; Ballesteros, E; Caselle, JE; Gaymer, CF; Palma, AT; Petit, I; Varas, E; Wilson, AM; Sala, E				Friedlander, Alan M.; Ballesteros, Enric; Caselle, Jennifer E.; Gaymer, Carlos F.; Palma, Alvaro T.; Petit, Ignacio; Varas, Eduardo; Munoz Wilson, Alex; Sala, Enric			Marine Biodiversity in Juan Fernandez and Desventuradas Islands, Chile: Global Endemism Hotspots	PLOS ONE			English	Article							REEF FISH; ARCHIPELAGO; DIVERSITY; ORIGIN; COMMUNITIES; MORPHOLOGY; CORAL; PARK	The Juan Fernandez and Desventuradas islands are among the few oceanic islands belonging to Chile. They possess a unique mix of tropical, subtropical, and temperate marine species, and although close to continental South America, elements of the biota have greater affinities with the central and south Pacific owing to the Humboldt Current, which creates a strong biogeographic barrier between these islands and the continent. The Juan Fernandez Archipelago has similar to 700 people, with the major industry being the fishery for the endemic lobster, Jasus frontalis. The Desventuradas Islands are uninhabited except for a small Chilean military garrison on San Felix Island. We compared the marine biodiversity of these islands across multiple taxonomic groups. At San Ambrosio Island (SA), in Desventuradas, the laminarian kelp (Eisenia cokeri), which is limited to Desventuradas in Chile, accounted for >50% of the benthic cover at wave exposed areas, while more sheltered sites were dominated by sea urchin barrens. The benthos at Robinson Crusoe Island (RC), in the Juan Fernandez Archipelago, comprised a diverse mix of macroalgae and invertebrates, a number of which are endemic to the region. The biomass of commercially targeted fishes was >2 times higher in remote sites around RC compared to sheltered locations closest to port, and overall biomass was 35% higher around SA compared to RC, likely reflecting fishing effects around RC. The number of endemic fish species was extremely high at both islands, with 87.5% of the species surveyed at RC and 72% at SA consisting of regional endemics. Remarkably, endemics accounted for 99% of the numerical abundance of fishes surveyed at RC and 96% at SA, which is the highest assemblage-level endemism known for any individual marine ecosystem on earth. Our results highlight the uniqueness and global significance of these biodiversity hotspots exposed to very different fishing pressures.	[Friedlander, Alan M.; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Friedlander, Alan M.] Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Friedlander, Alan M.; Gaymer, Carlos F.] Millennium Nucleus Ecol & Sustainable Management, Coquimbo, Chile; [Ballesteros, Enric] CEAB CSIC, Ctr Estudis Avancats, Blanes, Spain; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Gaymer, Carlos F.; Petit, Ignacio] Univ Catolica Norte, Coquimbo, Chile; [Gaymer, Carlos F.] Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile; [Gaymer, Carlos F.] Inst Ecol & Biodiversidad, Coquimbo, Chile; [Palma, Alvaro T.; Varas, Eduardo] FisioAqua, Santiago, Chile; [Munoz Wilson, Alex] OCEANA SA, Santiago, Chile	National Geographic Society; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of California System; University of California Santa Barbara; Universidad Catolica del Norte	Friedlander, AM (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC USA.	alan.friedlander@hawaii.edu			Blancpain, Davidoff Cool Water; National Geographic Society; Oceana; Millennium Scientific Initiative [NC120030]	Blancpain, Davidoff Cool Water; National Geographic Society(National Geographic Society); Oceana; Millennium Scientific Initiative	ES received funding from Blancpain, Davidoff Cool Water and The National Geographic Society. Oceana provided funding to ATP. CFG was suported by Grant NC120030 from the Millennium Scientific Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACUNA HO, 1995, CAN J ZOOL, V73, P1444, DOI 10.1139/z95-170; Anderson A., 2002, 50 YEARS FIELD ESSAY, V25, P239; Arana E. P., 1987, ISLAS OCEANICAS CHIL, P319; Bahamonde N., 1987, ISLAS OCEANICAS CHIL, P85; BirdLife International, 2015, SPEC FACTSH PTER DEF; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Briggs JC, 2003, J BIOGEOGR, V30, P1, DOI 10.1046/j.1365-2699.2003.00810.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Castilla J. C., 1987, ISLAS OCEANICAS CHIL, P15; Castilla J. C., 1987, ISLAS OCEANICAS CHIL; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Delrieu-Trottin Erwan, 2015, Check List, V11, P1758; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Dyer BS, 2010, REV BIOL MAR OCEANOG, V45, P589, DOI 10.4067/S0718-19572010000400007; Eddy TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013670; Edgar GJ, 2010, AQUAT CONSERV, V20, P378, DOI 10.1002/aqc.1075; Ernst B, 2013, GLOBAL ENVIRON CHANG, V23, P1381, DOI 10.1016/j.gloenvcha.2013.08.002; Ernst B, 2010, B MAR SCI, V86, P315; Etcheverry H., 1960, REV BIOL MAR, V10, P83; Fernandez M, 2014, LAT AM J AQUAT RES, V42, P666, DOI 10.3856/vol42-issue4-fulltext-1; Francis Malcolm P., 1993, Pacific Science, V47, P136; Gonzalez-Ferran O., 1987, ISLAS OCEANICAS CHIL, P37; Green R., 1979, SAMPLING DESIGN STAT; Haberle S, 2009, ENCY ISLANDS; Hobbs JPA, 2011, CONSERV BIOL, V25, P1053, DOI 10.1111/j.1523-1739.2011.01698.x; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jones Geoffrey P., 2002, P81, DOI 10.1016/B978-012615185-5/50006-2; Lindsay MJ, 2008, MAR ECOL PROG SER, V353, P265, DOI 10.3354/meps07155; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Ludwig J. A., 1988, STAT ECOLOGY; Martinez C, 1980, CATALOGO RECURSOS PE; Medina JT, 1918, PILOTO JUAN FERNANDE; Meneses I., 1994, Pacific Science, V48, P464; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mortensen T., 1940, MONOGRAPH ECHINOIDEA, VII; NOAA NMFS SWFSC ERD, SST POES AVHRR GAC G; Osman LP, 2008, THESIS; Parravicini V, 2014, ECOL LETT, V17, P1101, DOI 10.1111/ele.12316; Pederson HG, 2006, J EXP MAR BIOL ECOL, V336, P120, DOI 10.1016/j.jembe.2006.04.010; Pequeno G, 2000, GLOBAL ECOL BIOGEOGR, V9, P431, DOI 10.1046/j.1365-2699.2000.00207.x; Pequeno R. German, 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P27; Perez-Matus A, 2014, LAT AM J AQUAT RES, V42, P814, DOI 10.3856/vol42-issue4-fulltext-9; Ramirez F, 2013, J MAR BIOL ASSOC UK, V93, P1457, DOI 10.1017/S0025315413000192; RAMIREZ M.E., 1991, MONOGRAFIAS BIOL PON, P437; Randall J.E., 2011, SHORE FISHES EASTER; Randall JE, 1973, ORSTOM TRAVAUXET DOC, P49; Randall JE, 2007, REEF SHORE FISHES HA; Rayner JCW, 2013, AUST NZ J STAT, V55, P305, DOI 10.1111/anzs.12041; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson DR, 2009, MAR ECOL PROG SER, V380, P1, DOI 10.3354/meps07925; Rodrigo C, 2014, LAT AM J AQUAT RES, V42, P907, DOI 10.3856/vol42-issue4-fulltext-15; Rodrigo C, 2014, LAT AM J AQUAT RES, V42, P857, DOI 10.3856/vol42-issue4-fulltext-12; Rodriguez-Ruiz MC, 2014, LAT AM J AQUAT RES, V42, P918, DOI 10.3856/vol42-issue4-fulltext-16; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Santelices B, 2000, REV CHIL HIST NAT, V73, P605; Sepulveda J. I., 1987, ISLAS OCEANICAS CHIL, P225; Silva PC, 2005, CRYPTOGAMIE ALGOL, V26, P103; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Tulke H., 1954, SCIENTIA, V21, P140; Valentine JP, 2010, CORAL REEFS, V29, P399, DOI 10.1007/s00338-010-0610-9; Vieira C, 2014, J PHYCOL, V50, P1101, DOI 10.1111/jpy.12243; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234	70	37	38	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145059	10.1371/journal.pone.0145059	http://dx.doi.org/10.1371/journal.pone.0145059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734732	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100019
J	Rasenack, M; Rychen, J; Andelova, M; Naegelin, Y; Stippich, C; Kappos, L; Lindberg, RLP; Sprenger, T; Derfuss, T				Rasenack, Maria; Rychen, Jonathan; Andelova, Michaela; Naegelin, Yvonne; Stippich, Christoph; Kappos, Ludwig; Lindberg, Raija L. P.; Sprenger, Till; Derfuss, Tobias			Efficacy and Safety of Fingolimod in an Unselected Patient Population	PLOS ONE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; VARICELLA-ZOSTER-VIRUS; INTERFERON-GAMMA; ORAL FINGOLIMOD; ENCEPHALITIS; INDUCTION	Background Fingolimod is a first in class oral compound approved for the treatment of relapsing-remitting multiple sclerosis (RR-MS). The aim of this study was to evaluate clinical and neuroradiological responses to fingolimod as well as the safety and tolerability in RR-MS patients in clinical practice. In addition, a panel of pro-inflammatory serum cytokines was explored as potential biomarker for treatment response. Methods We conducted a retrospective, non-randomized, open-label, observational study in 105 patients with RR-MS and measured cytokines in longitudinal serum samples. Results Compared to the year before fingolimod start the annualized relapse rate was reduced by 44%. Also, the percentage of patients with a worsening of the EDSS decreased. Accordingly, the fraction of patients with no evidence of disease activity (no relapse, stable EDSS, no new active lesions in MRI) increased from 11% to 38%. The efficacy and safety were comparable between highly active patients or patients with relevant comorbidities and our general patient population. Conclusions The efficacy in reducing relapses was comparable to that observed in the phase III trials. In our cohort fingolimod was safe and efficacious irrespective of comorbidities and previous treatment.	[Rasenack, Maria; Rychen, Jonathan; Andelova, Michaela; Naegelin, Yvonne; Kappos, Ludwig; Derfuss, Tobias] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Rasenack, Maria; Kappos, Ludwig; Lindberg, Raija L. P.; Derfuss, Tobias] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Andelova, Michaela; Stippich, Christoph] Div Neuroradiol, Dept Radiol, Basel, Switzerland; [Sprenger, Till] DKD Helios Klin Wiesbaden, Dept Neurol, Wiesbaden, Germany	University of Basel; University of Basel; Helios Kliniken	Derfuss, T (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	tobias.derfuss@usb.ch		Andelova, Michaela/0000-0002-3812-7483; Sprenger, Till/0000-0002-5390-819X; Derfuss, Tobias/0000-0001-8656-4250	Actelion; Addex; Allozyne; Bayer Health Care Pharmaceuticals; Bayer Schering Pharma; Biogen Idec; CLC Behring; GeNeuro SA; Genzyme; GlaxoSmithKline; Lilly; Merck Serono; Mitsubishi Pharma; Novartis; Octapharma; Ono Pharma; Praxicon; Roche; Sanofi-aventis; Santhera; Siemens; Teva; Xenoport; Swiss MS Society; Swiss National Research Foundation; European Union; Gianni Rubatto; Novartis Foundation; Roche Research Foundation; Swiss National Science Foundation; European FP6 program; IMI JU program; Roche Postdoc Fellowship Program (RPF-program); Biogen; ATI; Jansen; Mitsubishi Pharma Europe; Novartis Pharma; German Research Foundation	Actelion; Addex; Allozyne; Bayer Health Care Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); CLC Behring; GeNeuro SA; Genzyme(Sanofi-AventisGenzyme Corporation); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Merck Serono(Merck & Company); Mitsubishi Pharma; Novartis(Novartis); Octapharma; Ono Pharma; Praxicon; Roche(Roche Holding); Sanofi-aventis(Sanofi-Aventis); Santhera; Siemens(Siemens AG); Teva(Teva Pharmaceutical Industries); Xenoport; Swiss MS Society; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); European Union(European Commission); Gianni Rubatto; Novartis Foundation(Novartis); Roche Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European FP6 program(European Commission); IMI JU program; Roche Postdoc Fellowship Program (RPF-program); Biogen(Biogen); ATI; Jansen; Mitsubishi Pharma Europe; Novartis Pharma; German Research Foundation(German Research Foundation (DFG))	The authors of this manuscript have the following competing interests: L. Kappos participated in the last 24 months as principal investigator, member or chair of planning and steering committees or advisory boards in corporate-sponsored clinical trials in multiple sclerosis and other neurological diseases. The sponsoring pharmaceutical companies for these trials include Actelion, Addex, Allozyne, Bayer Health Care Pharmaceuticals, Bayer Schering Pharma, Biogen Idec, CLC Behring, GeNeuro SA, Genzyme, GlaxoSmithKline, Lilly, Merck Serono, Mitsubishi Pharma, Novartis, Octapharma, Ono Pharma, Praxicon, Roche, Sanofi-aventis, Santhera, Siemens, Teva, and Xenoport. He lectured at medical conferences or in public on various aspects of the diagnosis and management of multiple sclerosis. In many cases these talks have been sponsored by non-restricted educational grants to his institution from one or another of the above listed companies. Honoraria and other payments for all these activities have been exclusively used for funding of research of his department. Research and the clinical operations (nursing and patient care services) of the MS Center in Basel have been supported by non-restricted grants from one or more of these companies and by grants from the Swiss MS Society, the Swiss National Research Foundation, the European Union, the Gianni Rubatto, Novartis and Roche Research Foundations. RLP Lindberg has received research support from Swiss MS Society, Swiss National Science Foundation, European FP6 and IMI JU programs, Roche Postdoc Fellowship Program (RPF-program), unrestricted research grants from Novartis and Biogen. T. Sprenger has received no personal compensation. His employer, the University Hospital Basel, has received compensation for his serving on scientific advisory boards or speaking fees from Novartis, ATI, Genzyme, Actelion, Jansen, Teva, Mitsubishi Pharma Europe and Biogen Idec. These fees were used for funding of research. T. Derfuss serves on scientific advisory boards for Novartis Pharma, Merck Serono, Biogen Idec, Genzyme, Teva, GeNeuro, Mitsubishi Pharma and Bayer Schering Pharma; has received funding for travel and/or speaker honoraria from Biogen Idec, Novartis Pharma, Merck Serono, Genzyme, and Bayer Schering Pharma and received research support from Novartis Pharma, Merck Serono, the Swiss National Science Foundation, the German Research Foundation, the European Union and the Swiss MS Society. M. Rasenack reports no conflicts of interest. J. Rychen reports no conflicts of interest. M. Andelova reports no conflicts of interest. Y. Naegelin reports no conflicts of interest. C. Stippich reports no conflicts of interest.	Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Espinosa PS, 2011, MULT SCLER J, V17, P1387, DOI 10.1177/1352458511410344; Faber H, 2013, MULT SCLER J, V19, P126, DOI 10.1177/1352458512447596; Gold R, 2014, J NEUROL, V261, P267, DOI 10.1007/s00415-013-7115-8; Gran B, 2004, J NEUROIMMUNOL, V156, P123, DOI 10.1016/j.jneuroim.2004.07.019; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lindsey JW, 2012, MULT SCLER J, V18, P1507, DOI 10.1177/1352458512438456; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Mehling M, 2011, CURR NEUROL NEUROSCI, V11, P492, DOI 10.1007/s11910-011-0216-9; Nixon R, 2012, ENS 22 M EUR NEUR SO; PANITCH HS, 1987, LANCET, V1, P893; Ratchford JN, 2012, NEUROLOGY, V79, P2002, DOI 10.1212/WNL.0b013e3182735d00; Ricklin ME, 2013, NEUROLOGY, V81, P174, DOI 10.1212/WNL.0b013e31829a3311; SETHNA MP, 1991, J NEUROIMMUNOL, V34, P121, DOI 10.1016/0165-5728(91)90121-M; Suryani S, 2007, J NEUROIMMUNOL, V183, P96, DOI 10.1016/j.jneuroim.2006.11.023; Uccelli A, 2011, NEUROLOGY, V76, P1023, DOI 10.1212/WNL.0b013e31821043b5; Willenborg DO, 1996, J IMMUNOL, V157, P3223	17	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146190	10.1371/journal.pone.0146190	http://dx.doi.org/10.1371/journal.pone.0146190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734938	Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100038
J	Donovan, P; Chehreghanianzabi, Y; Rathinam, M; Zustiak, SP				Donovan, Preston; Chehreghanianzabi, Yasaman; Rathinam, Muruhan; Zustiak, Silviya Petrova			Homogenization Theory for the Prediction of Obstructed Solute Diffusivity in Macromolecular Solutions	PLOS ONE			English	Article							ANOMALOUS DIFFUSION; HINDERED DIFFUSION; GLOBULAR-PROTEINS; DRUG-DELIVERY; MODELS; MECHANISMS; RELEASE; FICOLL; POLYMERS; DEXTRAN	The study of diffusion inmacromolecular solutions is important in many biomedical applications such as separations, drug delivery, and cell encapsulation, and key for many biological processes such as protein assembly and interstitial transport. Not surprisingly, multiple models for the a-priori prediction of diffusion in macromolecular environments have been proposed. However, most models include parameters that are not readily measurable, are specific to the polymer-solute-solvent system, or are fitted and do not have a physical meaning. Here, for the first time, we develop a homogenization theory framework for the prediction of effective solute diffusivity in macromolecular environments based on physical parameters that are easily measurable and not specific to the macromolecule-solute-solvent system. Homogenization theory is useful for situations where knowledge of fine-scale parameters is used to predict bulk system behavior. As a first approximation, we focus on a model where the solute is subjected to obstructed diffusion via stationary spherical obstacles. We find that the homogenization theory results agree well with computationally more expensive Monte Carlo simulations. Moreover, the homogenization theory agrees with effective diffusivities of a solute in dilute and semi-dilute polymer solutions measured using fluorescence correlation spectroscopy. Lastly, we provide a mathematical formula for the effective diffusivity in terms of a non-dimensional and easily measurable geometric system parameter.	[Donovan, Preston; Rathinam, Muruhan] Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA; [Chehreghanianzabi, Yasaman; Zustiak, Silviya Petrova] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA	University System of Maryland; University of Maryland Baltimore County; Saint Louis University; Washington University (WUSTL)	Zustiak, SP (corresponding author), St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.	szustiak@slu.edu			Saint Louis University	Saint Louis University	Dr. Silviya Zustiak received start-up funds from Saint Louis University.	Alexanderian A, 2012, ACTA MATH SCI, V32, P129, DOI 10.1016/S0252-9602(12)60008-3; Amsden B, 2002, POLYMER, V43, P1623, DOI 10.1016/S0032-3861(01)00749-2; Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Ashley GW, 2013, P NATL ACAD SCI USA, V110, P2318, DOI 10.1073/pnas.1215498110; Bensoussan A., 2011, ASYMPTOTIC ANAL PERI, V374; BOHRER MP, 1984, MACROMOLECULES, V17, P1170, DOI 10.1021/ma00136a011; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5; Cheema U, 2012, J TISSUE ENG REGEN M, V6, P77, DOI 10.1002/term.402; Cioranescu D, 2012, HOMOGENIZATION RETIC, V136; DAVIDSON MG, 1988, MACROMOLECULES, V21, P3474, DOI 10.1021/ma00190a022; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DENOBEL JG, 1989, J GEN MICROBIOL, V135, P2077; Donato P, 2004, CHINESE ANN MATH B, V25, P143, DOI 10.1142/S0252959904000159; Donato P, 1999, OXFORD LECT SERIES M, V4, P118; Ellery AJ, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4864000; Ethier S. N., 2009, MARKOV PROCESSES CHA, V282; Fissell WH, 2010, AM J PHYSIOL-RENAL, V298, pF205, DOI 10.1152/ajprenal.00312.2009; Gardiner C, 1985, HDB STOCHASTIC METHO, V4; Hadjiev NA, 2015, J CONTROL RELEASE, V199, P10, DOI 10.1016/j.jconrel.2014.12.010; Jikov V.V., 2012, HOMOGENIZATION DIFFE; Khruslov EY, 2008, HOMOGENIZATION PARTI, V46; KIRKWOOD JG, 1948, J CHEM PHYS, V16, P565, DOI 10.1063/1.1746947; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Leier A, 2012, FEBS J, V279, P524; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7; Maxwell JC., 1873, TREATISE ELECT MAGNE; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Michelman-Ribeiro A, 2007, BIOMACROMOLECULES, V8, P1595, DOI 10.1021/bm061195r; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Ochab-Marcinek A, 2011, SOFT MATTER, V7, P7366, DOI 10.1039/c1sm05217a; Pavliotis GA, 2008, TEXTS APPL MATH, V53, P1; Peppas NA, 2014, J CONTROL RELEASE, V190, P75, DOI 10.1016/j.jconrel.2014.06.041; Petit JM, 1996, MACROMOLECULES, V29, P6031, DOI 10.1021/ma951159c; Price C, 2011, J BONE MINER RES, V26, P277, DOI 10.1002/jbmr.211; Raccis R, 2011, SOFT MATTER, V7, P7042, DOI 10.1039/c0sm01438a; Sahimi M, 2003, HETEROGENEOUS MAT 1, V1; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Siepmann J, 2012, J CONTROL RELEASE, V161, P351, DOI 10.1016/j.jconrel.2011.10.006; Sokolov IM, 2012, SOFT MATTER, V8, P9043, DOI 10.1039/c2sm25701g; SUNDELOF LO, 1979, BER BUNSEN PHYS CHEM, V83, P329, DOI 10.1002/bbpc.19790830408; Torquato S., 2013, RANDOM HETEROGENEOUS, V16; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Vilaseca E, 2011, PHYS CHEM CHEM PHYS, V13, P7396, DOI 10.1039/c0cp01218a; WIJMANS JG, 1995, J MEMBRANE SCI, V107, P1, DOI 10.1016/0376-7388(95)00102-I; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zustiak SP, 2011, BIOPHYS J, V101, P255, DOI 10.1016/j.bpj.2011.05.035; Zustiak SP, 2011, BIOTECHNOL BIOENG, V108, P197, DOI 10.1002/bit.22911; Zustiak SP, 2010, SOFT MATTER, V6, P3609, DOI [10.1039/C0SM00111B, 10.1039/c0sm00111b]	53	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146093	10.1371/journal.pone.0146093	http://dx.doi.org/10.1371/journal.pone.0146093			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731550	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400092
J	Huang, RH; Fang, PT; Hao, ZP; Kay, BK				Huang, Renhua; Fang, Pete; Hao, Zengping; Kay, Brian K.			Directed Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase	PLOS ONE			English	Article							SRC FAMILY KINASES; PROTEIN-PROTEIN INTERACTIONS; PROLINE-RICH PEPTIDES; MAST-CELL ACTIVATION; IN-VITRO SELECTION; ESCHERICHIA-COLI; BINDING-PROTEINS; PHAGE-DISPLAY; AFFINITY MATURATION; BIOTECHNOLOGICAL APPLICATIONS	Affinity reagents of high affinity and specificity are very useful for studying the subcellular locations and quantities of individual proteins. To generate high-quality affinity reagents for human Lyn tyrosine kinase, a phage display library of fibronectin type III (FN3) monobodies was affinity selected with a recombinant form of the Lyn SH3 domain. While a highly specific monobody, TA8, was initially isolated, we chose to improve its affinity through directed evolution. A secondary library of 1.2 x 10(9) variants was constructed and screened by affinity selection, yielding three variants, two of which have affinities of similar to 40 nM, a 130-fold increase over the original TA8 monobody. One of the variants, 2H7, displayed high specificity to the Lyn SH3 domain, as shown by ELISA and probing arrays of 150 SH3 domains. Furthermore, the 2H7 monobody was able to pull down endogenous Lyn from a lysate of Burkitt's lymphoma cells, thereby demonstrating its utility as an affinity reagent for detecting Lyn in a complex biological mixture.	[Huang, Renhua; Fang, Pete; Hao, Zengping; Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Huang, RH (corresponding author), Meso Scale Diagnost, Rockville, MD 20850 USA.	rhuang@meso-scale.com; bkay@uic.edu			National Institute of Health (NIH) [GM082288, DK093444]; US National Institutes of Health [GM082288]; Common Fund [DK093444]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK093444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082288] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Common Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research described in this study was conducted in University of Illiois at Chicago and was funded by two grants (GM082288 and DK093444) from National Institute of Health (NIH). R. Huang is currently employed by Meso Scale Diagnostics (MSD), which supports in the form of salaries for author R. Huang. But both NIH and MSD did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge funding from the US National Institutes of Health (GM082288) and the Common Fund (DK093444). We thank Dr. Arnon Lavie (UIC) for the SUMO pET14b vector, and Mr. Kevin Gorman and Leon Venegas for editorial comments on the manuscript.	ABRAMS CS, 1995, J BIOL CHEM, V270, P333, DOI 10.1074/jbc.270.1.333; Adachi T, 1999, J IMMUNOL, V162, P1496; Barua D, 2012, J IMMUNOL, V189, P646, DOI 10.4049/jimmunol.1102003; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bolen JB, 1997, ANNU REV IMMUNOL, V15, P371, DOI 10.1146/annurev.immunol.15.1.371; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chames P, 1998, J IMMUNOL, V161, P5421; Cochran JN, 2014, J BIOMOL SCREEN, V19, P1338, DOI 10.1177/1087057114547232; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Couchman JR, 2009, J HISTOCHEM CYTOCHEM, V57, P7, DOI 10.1369/jhc.2008.952820; de Marco A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-44; Douthwaite JA, 2015, MABS-AUSTIN, V7, P152, DOI 10.4161/19420862.2014.985158; Fagete S, 2009, MABS-AUSTIN, V1, P288, DOI 10.4161/mabs.1.3.8527; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gilbreth RN, 2011, P NATL ACAD SCI USA, V108, P7751, DOI 10.1073/pnas.1102294108; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Gulyani A, 2011, NAT CHEM BIOL, V7, P437, DOI [10.1038/NCHEMBIO.585, 10.1038/nchembio.585]; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Huang R, 2012, METHODS; Huang RH, 2012, NEW BIOTECHNOL, V29, P526, DOI 10.1016/j.nbt.2011.11.015; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Imai S, 2015, ANAL BIOCHEM, V473, P72, DOI 10.1016/j.ab.2014.12.003; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Jin LL, 2015, MOL CELL PROTEOMICS, V14, P695, DOI 10.1074/mcp.M114.044404; Karatan E, 2004, CHEM BIOL, V11, P835, DOI 10.1016/j.chembiol.2004.04.009; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Katagiri K, 1996, J BIOL CHEM, V271, P11557, DOI 10.1074/jbc.271.19.11557; Kay Brian K., 2009, V498, P185, DOI 10.1007/978-1-59745-196-3_13; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2002, P NATL ACAD SCI USA, V99, P1253, DOI 10.1073/pnas.032665299; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Liu BA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002105; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; LU ZJ, 1995, BIO-TECHNOL, V13, P366, DOI 10.1038/nbt0495-366; MALEK SN, 1993, J BIOL CHEM, V268, P22557; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Mayer BJ, 2001, J CELL SCI, V114, P1253; Miersch S, 2012, METHODS, V57, P486, DOI 10.1016/j.ymeth.2012.06.012; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Nilsson FY, 2007, CURR OPIN DRUG DISC, V10, P167; Olson CA, 2008, ACS CHEM BIOL, V3, P480, DOI 10.1021/cb800069c; Park SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132976; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pershad K, 2011, ANAL BIOCHEM, V412, P210, DOI 10.1016/j.ab.2011.02.006; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Pitt James J, 2009, Clin Biochem Rev, V30, P19; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; ROBERTS S, 1987, NATURE, V328, P731, DOI 10.1038/328731a0; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; SCHLESINGER MJ, 1968, ANN NY ACAD SCI, V151, P159, DOI 10.1111/j.1749-6632.1968.tb11886.x; Schweimer K, 2002, BIOCHEMISTRY-US, V41, P5120, DOI 10.1021/bi015986j; SEIDELDUGAN C, 1992, MOL CELL BIOL, V12, P1835, DOI 10.1128/MCB.12.4.1835; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Stauffer TP, 1997, BIOCHEMISTRY-US, V36, P9388, DOI 10.1021/bi970781p; Tabe Y, 2012, LEUKEMIA, V26, P883, DOI 10.1038/leu.2011.291; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tsantikos E, 2012, J IMMUNOL, V189, P1726, DOI 10.4049/jimmunol.1103427; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P10925, DOI 10.1021/bi00202a011; Vohidov F, 2015, CHEM SCI, V6, P4778, DOI 10.1039/c5sc01602a; Wang YH, 2012, LEUK LYMPHOMA; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Xiao WB, 2005, J IMMUNOL, V175, P6885, DOI 10.4049/jimmunol.175.10.6885; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	88	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145872	10.1371/journal.pone.0145872	http://dx.doi.org/10.1371/journal.pone.0145872			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731115	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400062
J	Olsen, E; Fay, G; Gaichas, S; Gamble, R; Lucey, S; Link, JS				Olsen, Erik; Fay, Gavin; Gaichas, Sarah; Gamble, Robert; Lucey, Sean; Link, Jason S.			Ecosystem Model Skill Assessment. Yes We Can!	PLOS ONE			English	Article							ECOLOGICAL INDICATORS; MARINE SYSTEM; MANAGEMENT; RESPONSES; DYNAMICS; STRATEGY; LESSONS; CLIMATE; FISH	Need to Assess the Skill of Ecosystem Models Accelerated changes to global ecosystems call for holistic and integrated analyses of past, present and future states under various pressures to adequately understand current and projected future system states. Ecosystem models can inform management of human activities in a complex and changing environment, but are these models reliable? Ensuring that models are reliable for addressing management questions requires evaluating their skill in representing real-world processes and dynamics. Skill has been evaluated for just a limited set of some biophysical models. A range of skill assessment methods have been reviewed but skill assessment of full marine ecosystem models has not yet been attempted. Northeast US Atlantis Marine Ecosystem Model We assessed the skill of the Northeast U.S. (NEUS) Atlantis marine ecosystem model by comparing 10-year model forecasts with observed data. Model forecast performance was compared to that obtained from a 40-year hindcast. Multiple metrics (average absolute error, root mean squared error, modeling efficiency, and Spearman rank correlation), and a suite of time-series (species biomass, fisheries landings, and ecosystem indicators) were used to adequately measure model skill. Overall, the NEUS model performed above average and thus better than expected for the key species that had been the focus of the model tuning. Model forecast skill was comparable to the hindcast skill, showing that model performance does not degenerate in a 10-year forecast mode, an important characteristic for an end-to-end ecosystem model to be useful for strategic management purposes. Skill Assessment Is Both Possible and Advisable We identify best-practice approaches for end-to-end ecosystem model skill assessment that would improve both operational use of other ecosystem models and future model development. We show that it is possible to not only assess the skill of a complicated marine ecosystem model, but that it is necessary do so to instill confidence in model results and encourage their use for strategic management. Our methods are applicable to any type of predictive model, and should be considered for use in fields outside ecology (e.g. economics, climate change, and risk assessment).	[Olsen, Erik] Inst Marine Res, N-5817 Bergen, Norway; [Olsen, Erik; Gaichas, Sarah; Gamble, Robert; Lucey, Sean] NOAA, Northeast Fisheries Sci Ctr, Woods Hole, MA 02543 USA; [Fay, Gavin] Univ Massachusetts Dartmouth, Sch Marine Sci & Technol, Fairhaven, MA 02719 USA; [Link, Jason S.] NOAA, Natl Marine Fisheries Serv, Woods Hole, MA 02543 USA	Institute of Marine Research - Norway; National Oceanic Atmospheric Admin (NOAA) - USA; University of Massachusetts System; University Massachusetts Dartmouth; National Oceanic Atmospheric Admin (NOAA) - USA	Olsen, E (corresponding author), Inst Marine Res, PB 1870 Nordnes, N-5817 Bergen, Norway.	eriko@imr.no		Olsen, Erik/0000-0002-7552-2335; Fay, Gavin/0000-0003-0425-9952; Link, Jason/0000-0003-2740-7161; Gaichas, Sarah/0000-0002-5788-3073	NOAA National Marine Fisheries Service; Institute of Marine Research	NOAA National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA); Institute of Marine Research	NOAA National Marine Fisheries Service and the Institute of Marine Research used their own funding to carry out this work.	Aanes S, 2007, CAN J FISH AQUAT SCI, V64, P1130, DOI 10.1139/F07-074; Allen JI, 2009, J MARINE SYST, V76, P83, DOI 10.1016/j.jmarsys.2008.05.009; Anav A, 2013, J CLIMATE, V26, P6801, DOI 10.1175/JCLI-D-12-00417.1; Azarovitz T.R., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P62; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Ciscar JC, 2011, P NATL ACAD SCI USA, V108, P2678, DOI 10.1073/pnas.1011612108; Cochran WG., 1963, SAMPLING TECHNIQUES; Dale Virginia H., 2008, Integrated Environmental Assessment and Management, V4, P306, DOI 10.1897/IEAM_2007-066.1; Dey CH, 1986, B AM METEOROLOGICAL, P67; Dickey-Collas M, 2014, ICES J MAR SCI, V71, P2300, DOI 10.1093/icesjms/fst215; Elliott G, 2008, J ECON LIT, V46, P3, DOI 10.1257/jel.46.1.3; Fay G, 2015, ICES J MAR SCI, V72, P1285, DOI 10.1093/icesjms/fsu214; Fay G, 2013, ECOL MODEL, V265, P45, DOI 10.1016/j.ecolmodel.2013.05.016; Fienen MN, 2015, ENVIRON MODELL SOFTW, V63, P14, DOI 10.1016/j.envsoft.2014.09.007; Fogarty MJ, 2014, CAN J FISH AQUAT SCI, V71, P479, DOI 10.1139/cjfas-2013-0203; Fogarty MJ, 1998, ECOL APPL, V8, pS6, DOI 10.2307/2641359; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Francis TB, 2011, MAR POLICY, V35, P675, DOI 10.1016/j.marpol.2011.02.008; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Hamill TM, 2006, Q J ROY METEOR SOC, V132, P2905, DOI 10.1256/qj.06.25; Harfoot MBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001841; Hendry DF, 2003, ECON MODEL, V20, P301, DOI 10.1016/S0264-9993(02)00055-X; Higdon D, 2012, ASSESSING RELIABILIT, P145; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Jolliff JK, 2009, J MARINE SYST, V76, P64, DOI 10.1016/j.jmarsys.2008.05.014; Kaplan IC, 2014, ICES J MAR SCI, V71, P308, DOI 10.1093/icesjms/fst114; Large SI, 2013, ICES J MAR SCI, V70, P755, DOI 10.1093/icesjms/fst067; Levin P. S., 2010, STANFORD J LAW SCI P, V1, P36; Levin PS, 2014, ICES J MAR SCI, V71, P1198, DOI 10.1093/icesjms/fst112; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; LEVINS R, 1966, AM SCI, V54, P421; Link JS, 2007, ECOL APPL, V17, P2037, DOI 10.1890/06-1154.1; Link JS, 2014, ICES J MAR SCI, V71, P1170, DOI 10.1093/icesjms/fsu026; Link JS, 2010, PROG OCEANOGR, V87, P214, DOI 10.1016/j.pocean.2010.09.020; Link JS, 2005, ICES J MAR SCI, V62, P569, DOI 10.1016/j.icesjms.2004.12.015; Link JS, 2010, 216 NOAA NMFS NE; Link JS, 2011, NE218 NOAA NE FISH S; Link JS, 2006, DOCUMENTATION FOR TH; Maunder MN, 2013, FISH RES, V142, P61, DOI 10.1016/j.fishres.2012.07.025; Methratta ET, 2006, ECOL INDIC, V6, P575, DOI 10.1016/j.ecolind.2005.08.022; Miller TJ, 2010, 105 NAT MAR FISH NE; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Morzaria-Luna HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042917; O'Reilly J.E, 1998, SEASONAL HORIZONTAL; Palmer TN, 2004, B AM METEOROL SOC, V85, P853, DOI 10.1175/BAMS-85-6-853; Punt AE, 2014, MANAGEMENT STRATEGY; R Core Team, 2013, R LANG ENV STAT COMP; Seferian R, 2013, CLIM DYNAM, V40, P2549, DOI 10.1007/s00382-012-1362-8; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; Sverdrup L., 2011, J INFORM; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Zhang A, 2010, J OPER OCEANOGR, V3, P11, DOI 10.1080/1755876X.2010.11020114; Zhang K, 2015, GLOBAL CHANGE BIOL, V21, P2569, DOI 10.1111/gcb.12903	60	67	67	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146467	10.1371/journal.pone.0146467	http://dx.doi.org/10.1371/journal.pone.0146467			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731540	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400181
J	Zeitouni, NE; Dersch, P; Naim, HY; von Kockritz-Blickwede, M				Zeitouni, Nathalie E.; Dersch, Petra; Naim, Hassan Y.; von Koeckritz-Blickwede, Maren			Hypoxia Decreases Invasin-Mediated Yersinia enterocolitica Internalization into Caco-2 Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; INDUCIBLE FACTOR-I; INFLAMMATORY-BOWEL-DISEASE; TRANSIENT MOSAIC PATTERNS; HUMAN ERYTHROPOIETIN GENE; CULTURED ANIMAL-CELLS; EPITHELIAL-CELLS; BACTERIAL-INFECTION; MAMMALIAN-CELLS; PROLYL HYDROXYLATION	Yersinia enterocolitica is a major cause of human yersiniosis, with enterocolitis being a typical manifestation. These bacteria can cross the intestinal mucosa, and invade eukaryotic cells by binding to host beta(1) integrins, a process mediated by the bacterial effector protein invasin. This study examines the role of hypoxia on the internalization of Y. enterocolitica into intestinal epithelial cells, since the gastrointestinal tract has been shown to be physiologically deficient in oxygen levels (hypoxic), especially in cases of infection and inflammation. We show that hypoxic pre-incubation of Caco-2 cells resulted in significantly decreased bacterial internalization compared to cells grown under normoxia. This phenotype was absent after functionally blocking host beta(1) integrins as well as upon infection with an invasin-deficient Y. enterocolitica strain. Furthermore, downstream phosphorylation of the focal adhesion kinase was also reduced under hypoxia after infection. In good correlation to these data, cells grown under hypoxia showed decreased protein levels of beta(1) integrins at the apical cell surface whereas the total protein level of the hypoxia inducible factor (HIF-1) alpha was elevated. Furthermore, treatment of cells with the HIF-1 alpha stabilizer dimethyloxalylglycine (DMOG) also reduced invasion and decreased beta(1) integrin protein levels compared to control cells, indicating a potential role for HIF-1 alpha in this process. These results suggest that hypoxia decreases invasin-integrin-mediated internalization of Y. enterocolitica into intestinal epithelial cells by reducing cell surface localization of host beta(1) integrins.	[Zeitouni, Nathalie E.; Naim, Hassan Y.; von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany; [Dersch, Petra] Helmholtz Ctr Infect Res, Braunschweig, Germany; [von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation	von Kockritz-Blickwede, M (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany.	mkoeckbl@tiho-hannover.de		Zeitouni, Nathalie/0000-0001-5525-6976	DFG [KO 3552/4-1]; German Academic Exchange Service (DAAD)	DFG(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was partially supported by DFG grant KO 3552/4-1 (MvK-B); N.Z. was funded by the German Academic Exchange Service (DAAD). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Aoyama K, 2004, AM J REPROD IMMUNOL, V52, P362, DOI 10.1111/j.1600-0897.2004.00236.x; BEAULIEU JF, 1992, J CELL SCI, V102, P427; Bhandari T, 2014, INFECT DIS THER, V3, P159, DOI 10.1007/s40121-014-0030-1; BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; BOTTONE EJ, 1974, APPL MICROBIOL, V27, P858, DOI 10.1128/AEM.27.5.858-861.1974; Bouvry D, 2006, AM J RESP CELL MOL, V35, P519, DOI 10.1165/rcmb.2005-0478OC; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Lima CBC, 2013, REV INST MED TROP SP, V55, P341, DOI 10.1590/S0036-46652013000500008; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; COCONNIER MH, 1994, DIFFERENTIATION, V58, P87, DOI 10.1046/j.1432-0436.1994.5810087.x; Colgan SP, 2013, INFLAMM BOWEL DIS, V19, P2238, DOI 10.1097/MIB.0b013e31828dcaaf; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; CURFS JHAJ, 1995, MED MICROBIOL IMMUN, V184, P123, DOI 10.1007/BF00224348; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FANDREY J, 1995, RESP PHYSIOL, V101, P1, DOI 10.1016/0034-5687(95)00013-4; FINLAY BB, 1988, BIOCHIMIE, V70, P1089, DOI 10.1016/0300-9084(88)90271-4; Finlay BB, 1996, INFECT IMMUN; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Giannasca PJ, 1999, INFECT IMMUN, V67, P946, DOI 10.1128/IAI.67.2.946-953.1999; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Haase VH, 2009, ANN NY ACAD SCI, V1177, P57, DOI 10.1111/j.1749-6632.2009.05030.x; Hamzaoui N, 2004, CELL MICROBIOL, V6, P817, DOI 10.1111/j.1462-5822.2004.00391.x; Hatoum OA, 2005, EUR J CLIN INVEST, V35, P599, DOI 10.1111/j.1365-2362.2005.01567.x; Hein Z, 2011, DIFFERENTIATION, V81, P243, DOI 10.1016/j.diff.2011.01.009; Horn F, 2010, GUT PATHOG, V2, P2; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KAISERLIAN D, 1991, EUR J IMMUNOL, V21, P2415, DOI 10.1002/eji.1830211018; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Keely S, 2009, FASEB J, V23, P1338, DOI 10.1096/fj.08-125344; Laura B, 2008, J CELL BIOCHEM, V105, P503, DOI 10.1002/jcb.21850; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lindner R, 2009, EXP CELL RES, V315, P2871, DOI 10.1016/j.yexcr.2009.07.020; Madara JL, 1988, MORPHOLOGY MUCOSA SM, P953; MANDELL GL, 1973, J CLIN INVEST, V52, P1673, DOI 10.1172/JCI107348; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; MILLER VL, 1990, J BACTERIOL, V172, P1062, DOI 10.1128/jb.172.2.1062-1069.1990; MILLER VL, 1988, INFECT IMMUN, V56, P1242, DOI 10.1128/IAI.56.5.1242-1248.1988; MILLER VL, 1988, CURR TOP MICROBIOL, V138, P15; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; Okumura CYM, 2012, J MOL MED, V90, P1079, DOI 10.1007/s00109-012-0882-3; PEPE JC, 1994, MOL MICROBIOL, V11, P123, DOI 10.1111/j.1365-2958.1994.tb00295.x; Pepe JC, 1995, INFECT IMMUN; Pereira SHM, 1997, MICROB PATHOGENESIS, V23, P249, DOI 10.1006/mpat.1997.0153; PINTO M, 1983, BIOL CELL, V47, P323; Rana MK, 2015, J CELL SCI, V128, P1083, DOI 10.1242/jcs.155036; Ren Y, 2014, MOL CELL PROTEOMICS, V13, P3126, DOI 10.1074/mcp.M114.038505; Riecken Hahn, 1988, MED MICROBIOL IMMUN, DOI [10.1007/BF00191063, DOI 10.1007/BF00191063]; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Schaffer K, 2015, FEBS J, V282, P2260, DOI 10.1111/febs.13270; Schaible B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056491; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHMITZ J, 1973, BIOCHIM BIOPHYS ACTA, V323, P98, DOI 10.1016/0005-2736(73)90434-3; Schreider C, 2002, J CELL SCI, V115, P543; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Srichai MB, 2010, CELL-EXTRACELLULAR MATRIX INTERACTIONS IN CANCER, P19, DOI 10.1007/978-1-4419-0814-8_2; Tafazoli F, 2000, INFECT IMMUN, V68, P5335, DOI 10.1128/IAI.68.9.5335-5343.2000; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Uliczka F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002117; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; Vachon PH, 1996, J CELL PHYSIOL, V166, P198, DOI 10.1002/(SICI)1097-4652(199601)166:1<198::AID-JCP21>3.0.CO;2-A; VACHON PH, 1993, ANAT REC, V235, P567, DOI 10.1002/ar.1092350409; VANDERKOOI JM, 1987, J BIOL CHEM, V262, P5476; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; WILSON PD, 1991, CELL BIOL INT REP, V15, P1243, DOI 10.1016/0309-1651(91)90096-2; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; YOUNG VB, 1990, MOL MICROBIOL, V4, P1119, DOI 10.1111/j.1365-2958.1990.tb00686.x; Yu B, 2009, J PERINAT MED, V37, P59, DOI 10.1515/JPM.2009.009; Zinkernagel AS, 2008, J INFECT DIS, V197, P214, DOI 10.1086/524843; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2; Zuk A, 1998, AM J PHYSIOL-CELL PH, V275, pC711, DOI 10.1152/ajpcell.1998.275.3.C711; ZWEIBAUM A, 1983, INT J CANCER, V32, P407, DOI 10.1002/ijc.2910320403	93	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146103	10.1371/journal.pone.0146103	http://dx.doi.org/10.1371/journal.pone.0146103			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731748	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400094
J	Zheng, F; Kasper, LH; Bedford, DC; Lerach, S; Teubner, BJW; Brindle, PK				Zheng, Fei; Kasper, Lawryn H.; Bedford, David C.; Lerach, Stephanie; Teubner, Brett J. W.; Brindle, Paul K.			Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice	PLOS ONE			English	Article							RUBINSTEIN-TAYBI-SYNDROME; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; RETT-SYNDROME; STRUCTURAL BASIS; MOUSE MODELS; CBP; MECP2; GENE; MEMORY	Autism spectrum disorders (ASDs) are a group of neurodevelopmental afflictions characterized by repetitive behaviors, deficits in social interaction, and impaired communication skills. For most ASD patients, the underlying causes are unknown. Genetic mutations have been identified in about 25 percent of ASD cases, including mutations in epigenetic regulators, suggesting that dysregulated chromatin or DNA function is a critical component of ASD. Mutations in the histone acetyltransferase CREB binding protein (CBP, CREBBP) cause Rubinstein-Taybi Syndrome (RTS), a developmental disorder that includes ASD-like symptoms. Recently, genomic studies involving large numbers of ASD patient families have theoretically modeled CBP and its paralog p300 (EP300) as critical hubs in ASD-associated protein and gene interaction networks, and have identified de novo missense mutations in highly conserved residues of the CBP acetyltransferase and CH1 domains. Here we provide animal model evidence that supports this notion that CBP and its CH1 domain are relevant to autism. We show that mice with a deletion mutation in the CBP CH1 (TAZ1) domain (CBP Delta CH1/Delta CH1) have an RTS-like phenotype that includes ASD-relevant repetitive behaviors, hyperactivity, social interaction deficits, motor dysfunction, impaired recognition memory, and abnormal synaptic plasticity. Our results therefore indicate that loss of CBP CH1 domain function contributes to RTS, and possibly ASD, and that this domain plays an essential role in normal motor function, cognition and social behavior. Although the key physiological functions affected by ASD-associated mutation of epigenetic regulators have been enigmatic, our findings are consistent with theoretical models involving CBP and p300 in ASD, and with a causative role for recently described ASD-associated CBP mutations.	[Zheng, Fei; Kasper, Lawryn H.; Bedford, David C.; Lerach, Stephanie; Brindle, Paul K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Teubner, Brett J. W.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Zheng, F (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	fei.zheng@stjude.org; paul.k.brindle1@gmail.com	Kasper, Lawryn/GWV-5700-2022	Brindle, Paul/0000-0001-7172-8478	NIH [R21 DE018183, R01 DC012833, R01 MH097742, R01 MH095810]; Cancer Center (CORE) [P30 CA021765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097742, R01MH095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012833] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants R21 DE018183 (P.B.), R01 DC012833, R01 MH097742 and R01 MH095810 (S.Z.), Cancer Center (CORE) support grant P30 CA021765, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank James Morgan, Sandra D'Azzo, Jennifer Parris, Peng Wei, Jing Yu, Ildar Bayazitov, Laurie Earls, Elida Gomero, and Stanislav Zakharenko for access to and help with equipment used in this study, Chris Calabrese in the Small Animal Imaging Core for microCT scans, Hiro Kimura for the Alcian Blue/Alizarin Red S staining protocol, Beisi Xu for statistics assistance, and Yunchao Chang and Trushar Jeevan for technical assistance. This work was supported by NIH grants R21 DE018183 (P.B.), R01 DC012833, R01 MH097742 and R01 MH095810 (S.Z), Cancer Center (CORE) support grant P30 CA021765, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Barnby G, 2005, AM J HUM GENET, V76, P950, DOI 10.1086/430454; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bedford DC, 2011, CELL METAB, V14, P219, DOI 10.1016/j.cmet.2011.06.010; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Cali F, 2013, GENET MOL RES, V12, P2809, DOI 10.4238/2013.January.7.2; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chung LY, 2012, KOREAN J PHYSIOL PHA, V16, P369, DOI 10.4196/kjpp.2012.16.6.369; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Crider A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-46; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Earls LR, 2010, J NEUROSCI, V30, P15843, DOI 10.1523/JNEUROSCI.1425-10.2010; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Galera C, 2009, J AUTISM DEV DISORD, V39, P1252, DOI 10.1007/s10803-009-0733-4; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hellings JA, 2002, AM J MED GENET, V114, P190, DOI 10.1002/ajmg.10156; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kaksonen M, 2002, MOL CELL NEUROSCI, V21, P158, DOI 10.1006/mcne.2002.1167; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Martin HGS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00023; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; Rose SA, 2013, DEV MED CHILD NEUROL, V55, P364, DOI 10.1111/dmcn.12085; Schaaf CP, 2011, NEURON, V70, P806, DOI 10.1016/j.neuron.2011.05.025; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Schorry EK, 2008, AM J MED GENET A, V146A, P2512, DOI 10.1002/ajmg.a.32424; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Wiley S, 2003, AM J MED GENET A, V119A, P101, DOI 10.1002/ajmg.a.10009; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Yasui DH, 2014, HUM MOL GENET, V23, P2447, DOI 10.1093/hmg/ddt640; Zocchi L, 2012, EPIGENETICS-US, V7, P695, DOI 10.4161/epi.20733	59	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146366	10.1371/journal.pone.0146366	http://dx.doi.org/10.1371/journal.pone.0146366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730956	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400160
J	Apostolico, JD; Boscardin, SB; Yamamoto, MM; de Oliveira, JN; Kalil, J; Cunha-Neto, E; Rosa, DS				Apostolico, Juliana de Souza; Boscardin, Silvia Beatriz; Yamamoto, Marcio Massao; de Oliveira-Filho, Jethe Nunes; Kalil, Jorge; Cunha-Neto, Edecio; Rosa, Daniela Santoro			HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost	PLOS ONE			English	Article							T-CELL RESPONSES; HEPATITIS-B-VACCINE; NEUTRALIZING ANTIBODIES; GLYCOPROTEIN TRIMERS; PRIMARY ISOLATE; PROTEIN; PHASE; DNA; IMMUNOGENICITY; TRIAL	The development of a preventive vaccine against human immunodeficiency virus (HIV-1) infection is the most efficient method to control the epidemic. The ultimate goal is to develop a vaccine able to induce specific neutralizing, non-neutralizing antibodies and cellular mediated immunity (CMI). Humoral and CMI responses can be directed to glycoproteins that are normally presented as a trimeric spike on the virus surface (gp140). Despite safer, subunit vaccines are normally less immunogenic/effective and need to be delivered together with an adjuvant. The choice of a suitable adjuvant can induce effective humoral and CMI that utterly lead to full protection against disease. In this report, we established a hierarchy of adjuvant potency on humoral and CMI when admixed with the recombinant HIV gp140 trimer. We show that vaccination with gp140 in the presence of different adjuvants can induce high-affinity antibodies, follicular helper T cells and germinal center B cells. The data show that poly (I:C) is the most potent adjuvant to induce specific CMI responses evidenced by IFN-gamma production and CD4(+)/CD8(+) T cell proliferation. Furthermore, we demonstrate that combining some adjuvants like MPL plus Alum and MPL plus MDP exert additive effects that impact on the magnitude and quality of humoral responses while mixing MDP with poly (I:C) or with R848 had no impact on total IgG titers but highly impact IgG subclass. In addition, heterologous DNA prime-protein boost yielded higher IgG titers when compare to DNA alone and improved the quality of humoral response when compare to protein immunization as evidenced by IgG1/IgG2a ratio. The results presented in this paper highlight the importance of selecting the correct adjuvant-antigen combination to potentiate desired cells for optimal stimulation.	[Apostolico, Juliana de Souza; de Oliveira-Filho, Jethe Nunes; Rosa, Daniela Santoro] Fed Univ Sao Paulo UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Boscardin, Silvia Beatriz; Yamamoto, Marcio Massao] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Kalil, Jorge; Cunha-Neto, Edecio; Rosa, Daniela Santoro] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Rosa, DS (corresponding author), Fed Univ Sao Paulo UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.	dsantororosa@gmail.com	Apostolico, Juliana/W-8804-2018; Rosa, Daniela S/D-2190-2012; Cunha-Neto, Edecio/B-4157-2009; Boscardin, Silvia Beatriz/C-3397-2012; KALIL, JORGE/C-8029-2012	Apostolico, Juliana/0000-0002-3507-3117; Rosa, Daniela S/0000-0003-4536-891X; Cunha-Neto, Edecio/0000-0002-3699-3345; Boscardin, Silvia Beatriz/0000-0002-7845-7110; KALIL, JORGE/0000-0001-8415-4274	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/10154-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [474729/2011-7]; FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant number: 2011/10154-0), url: http://www.fapesp.br, author responsible for funding DSR; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant number: 474729/2011-7), url: www.cnpq.br, author responsible for funding DSR, FAPESP fellowship JSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bansal GP, 2010, CURR OPIN MOL THER, V12, P39; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Baum Linda L, 2010, Curr HIV/AIDS Rep, V7, P11, DOI 10.1007/s11904-009-0036-6; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Blackbourn DJ, 1996, P NATL ACAD SCI USA, V93, P13125, DOI 10.1073/pnas.93.23.13125; Buffa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050529; Burke B, 2009, VIROLOGY, V387, P147, DOI 10.1016/j.virol.2009.02.005; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper CL, 2008, CLIN INFECT DIS, V46, P1310, DOI 10.1086/533467; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; De Rosa SC, 2008, CURR OPIN HIV AIDS, V3, P375, DOI 10.1097/COH.0b013e3282fbaaa7; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Demberg T, 2007, J VIROL, V81, P3414, DOI 10.1128/JVI.02453-06; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Douagi I, 2010, J VIROL, V84, P1683, DOI 10.1128/JVI.01896-09; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grundner C, 2004, VIROLOGY, V330, P233, DOI 10.1016/j.virol.2004.08.037; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hasegawa Hideki, 2009, Ther Clin Risk Manag, V5, P125; Hope TJ, 2011, NAT MED, V17, P1195, DOI 10.1038/nm.2528; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Jost S, 2012, MICROBES INFECT, V14, P904, DOI 10.1016/j.micinf.2012.05.001; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Kim SK, 2000, VACCINE, V19, P530, DOI 10.1016/S0264-410X(00)00195-X; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong NCT, 2008, KIDNEY INT, V73, P856, DOI 10.1038/sj.ki.5002725; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 2009, CELL HOST MICROBE, V6, P292, DOI 10.1016/j.chom.2009.09.008; Lai L, 2007, VIROLOGY, V369, P153, DOI 10.1016/j.virol.2007.07.017; Lai RPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035083; Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; MACDONALD RA, 1988, J IMMUNOL METHODS, V106, P191, DOI 10.1016/0022-1759(88)90196-2; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mouquet H, 2013, NATURE, V496, P441, DOI 10.1038/nature12091; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Nkolola JP, 2014, VACCINE, V32, P2109, DOI 10.1016/j.vaccine.2014.02.001; Park H, 2013, J IMMUNOL, V190, P4103, DOI 10.4049/jimmunol.1202958; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Ratto-Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115582; Ratto-Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045840; Rerks-Ngarm S, 2013, J INFECT DIS, V207, P1195, DOI 10.1093/infdis/jis478; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rosa DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016921; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Schonning K, 1998, AIDS RES HUM RETROV, V14, P1451, DOI 10.1089/aid.1998.14.1451; Sealy R, 2009, INT REV IMMUNOL, V28, P49, DOI 10.1080/08830180802495605; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Siegrist CA, 2004, VACCINE, V23, P615, DOI 10.1016/j.vaccine.2004.07.014; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Walker BD, 2011, NAT MED, V17, P1194, DOI 10.1038/nm.2529; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	86	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145637	10.1371/journal.pone.0145637	http://dx.doi.org/10.1371/journal.pone.0145637			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727218	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500026
J	Bibeau, K; Sicotte, B; Beland, M; Bhat, M; Gaboury, L; Couture, R; St-Louis, J; Brochu, M				Bibeau, Karine; Sicotte, Benoit; Beland, Melanie; Bhat, Menakshi; Gaboury, Louis; Couture, Rejean; St-Louis, Jean; Brochu, Michele			Placental Underperfusion in a Rat Model of Intrauterine Growth Restriction Induced by a Reduced Plasma Volume Expansion	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; UTEROPLACENTAL BLOOD-FLOW; FETAL-GROWTH; TROPHOBLAST INVASION; UTERINE ARTERIES; HORMONAL CHANGES; MYOGENIC TONE; LOW-SODIUM; EXPRESSION; PREGNANCY	Lower maternal plasma volume expansion was found in idiopathic intrauterine growth restriction (IUGR) but the link remains to be elucidated. An animal model of IUGR was developed by giving a low-sodium diet to rats over the last week of gestation. This treatment prevents full expansion of maternal circulating volume and the increase in uterine artery diameter, leading to reduced placental weight compared to normal gestation. We aimed to verify whether this is associated with reduced remodeling of uteroplacental circulation and placental hypoxia. Dams were divided into two groups: IUGR group and normal-fed controls. Blood velocity waveforms in the main uterine artery were obtained by Doppler sonography on days 14, 18 and 21 of pregnancy. On day 22 (term = 23 days), rats were sacrificed and placentas and uterine radial arteries were collected. Diameter and myogenic response of uterine arteries supplying placentas were determined while expression of hypoxia-modulated genes (HIF-1 alpha, VEGFA and VEGFR2), apoptotic enzyme (Caspase -3 and -9) and glycogen cells clusters were measured in control and IUGR term-placentas. In the IUGR group, impaired blood velocity in the main uterine artery along with increased resistance index was observed without alteration in umbilical artery blood velocity. Radial uterine artery diameter was reduced while myogenic response was increased. IUGR placentas displayed increased expression of hypoxia markers without change in the caspases and increased glycogen cells in the junctional zone. The present data suggest that reduced placental and fetal growth in our IUGR model may be mediated, in part, through reduced maternal uteroplacental blood flow and increased placental hypoxia.	[Bibeau, Karine; Sicotte, Benoit; Bhat, Menakshi; Couture, Rejean; Brochu, Michele] Univ Montreal, Dept Mol & Integrat Physiol, Montreal, PQ, Canada; [Beland, Melanie; Gaboury, Louis] Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ, Canada; [St-Louis, Jean] Univ Montreal, Dept Obstet Gynecol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Brochu, M (corresponding author), Univ Montreal, Dept Mol & Integrat Physiol, Montreal, PQ, Canada.	michele.brochu@umontreal.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research [MOP-37902]; NSERC; Fonds de la Recherche en Sante du Quebec	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (MOP-37902). Personal support was provided by NSERC and Fonds de la Recherche en Sante du Quebec to K.B. (studentships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain R, 2005, J ENDOCRINOL, V185, P253, DOI 10.1677/joe.1.06039; Bedard S, 2005, J PHYSIOL-LONDON, V562, P937, DOI 10.1113/jphysiol.2004.064683; BRUCE NW, 1976, J REPROD FERTIL, V46, P359; Caluwaerts S, 2005, PLACENTA, V26, P574, DOI 10.1016/j.placenta.2004.09.007; Carr DJ, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.008; Chauhan M, 2006, BIOL REPROD, V75, P940, DOI 10.1095/biolreprod.106.053322; Cipolla MJ, 1997, AM J OBSTET GYNECOL, V177, P215, DOI 10.1016/S0002-9378(97)70464-2; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; DANGELO G, 1993, AM J PHYSIOL, V264, pH78, DOI 10.1152/ajpheart.1993.264.1.H78; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; DOWELL RT, 1993, J APPL PHYSIOL, V74, P2079, DOI 10.1152/jappl.1993.74.5.2079; Dowell RT, 1997, METHOD FIND EXP CLIN, V19, P613; Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060; Ghidini A, 2008, SEMIN PERINATOL, V32, P258, DOI 10.1053/j.semperi.2008.04.019; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Hewitt DP, 2006, ENDOCRINOLOGY, V147, P5568, DOI 10.1210/en.2006-0825; Huppertz Berthold, 2005, Angiogenesis, V8, P157, DOI 10.1007/s10456-005-9007-8; Iriyama T, 2015, HYPERTENSION, V65, P1307, DOI 10.1161/HYPERTENSIONAHA.115.05314; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Kanaka-Gantenbein C, 2003, ANN NY ACAD SCI, V997, P150, DOI 10.1196/annals.1290.017; Knofler M, 2012, PLACENTA, V33, pS55, DOI 10.1016/j.placenta.2011.09.019; Leandro SM, 2008, PHYSIOL BEHAV, V95, P145, DOI 10.1016/j.physbeh.2008.05.011; Lyall F, 1997, PLACENTA, V18, P269, DOI 10.1016/S0143-4004(97)80061-6; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Moll W, 2003, EUR J OBSTET GYN R B, V110, pS19, DOI 10.1016/S0301-2115(03)00169-6; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; OSOL G, 1993, AM J OBSTET GYNECOL, V168, P268, DOI 10.1016/S0002-9378(12)90924-2; OSOL G, 1993, AM J OBSTET GYNECOL, V168, P697, DOI 10.1016/0002-9378(93)90519-O; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Polisca A, 2010, THERIOGENOLOGY, V73, P358, DOI 10.1016/j.theriogenology.2009.09.019; Pourageaud F, 1997, AM J PHYSIOL-HEART C, V273, pH1699, DOI 10.1152/ajpheart.1997.273.4.H1699; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Roh CR, 2005, PLACENTA, V26, P319, DOI 10.1016/j.placenta.2004.06.013; Roy-Clavel E, 1999, AM J OBSTET GYNECOL, V180, P608, DOI 10.1016/S0002-9378(99)70262-0; Salas SP, 2006, HYPERTENSION, V47, P203, DOI 10.1161/01.HYP.0000200042.64517.19; SALAS SP, 1993, OBSTET GYNECOL, V81, P1029; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Sciscione AC, 2009, AM J OBSTET GYNECOL, V201, P121, DOI 10.1016/j.ajog.2009.03.027; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026; Soares MJ, 2014, INT J DEV BIOL, V58, P247, DOI 10.1387/ijdb.140083ms; St-Louis J, 2006, REPRODUCTION, V131, P331, DOI 10.1530/rep.1.00565; St-Louis J, 1997, AM J PHYSIOL-HEART C, V273, pH1148, DOI 10.1152/ajpheart.1997.273.3.H1148; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Telezhkin V, 2008, AM J PHYSIOL-HEART C, V294, pH272, DOI 10.1152/ajpheart.00216.2007; Tse JYM, 2001, J SOC GYNECOL INVEST, V8, P77, DOI 10.1016/S1071-5576(01)00096-X; Urban G, 2007, SEMIN PERINATOL, V31, P232, DOI 10.1053/j.semperi.2007.06.002; Valensise H, 2008, ULTRASOUND OBST GYN, V31, P55, DOI 10.1002/uog.5234; Vercruysse L, 2006, PLACENTA, V27, P22, DOI 10.1016/j.placenta.2004.11.004; Whitehead C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-256; Zamudio S, 2007, AM J PATHOL, V170, P2171, DOI 10.2353/ajpath.2007.061185	55	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145982	10.1371/journal.pone.0145982	http://dx.doi.org/10.1371/journal.pone.0145982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727492	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500040
J	Kiiski, HSM; Riada, SN; Lalor, EC; Goncalves, NR; Nolan, H; Whelan, R; Lonergan, R; Kelly, S; O'Brien, MC; Kinsella, K; Bramham, J; Burke, T; Donnchadha, SO; Hutchinson, M; Tubridy, N; Reilly, RB				Kiiski, Hanni S. M.; Riada, Sinead Ni; Lalor, Edmund C.; Goncalves, Nuno R.; Nolan, Hugh; Whelan, Robert; Lonergan, Roisin; Kelly, Siobhan; O'Brien, Marie Claire; Kinsella, Katie; Bramham, Jessica; Burke, Teresa; Donnchadha, Sean O.; Hutchinson, Michael; Tubridy, Niall; Reilly, Richard B.			Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis	PLOS ONE			English	Article							CORTICAL GENERATORS; OUTCOME MEASURES; POTENTIALS; VESPA; DISABILITY; COMPONENTS; RESPONSES; IDENTIFICATION; CORTEX; V1	Conduction along the optic nerve is often slowed in multiple sclerosis (MS). This is typically assessed by measuring the latency of the P100 component of the Visual Evoked Potential (VEP) using electroencephalography. The Visual Evoked Spread Spectrum Analysis (VESPA) method, which involves modulating the contrast of a continuous visual stimulus over time, can produce a visually evoked response analogous to the P100 but with a higher signal-to-noise ratio and potentially higher sensitivity to individual differences in comparison to the VEP. The main objective of the study was to conduct a preliminary investigation into the utility of the VESPA method for probing and monitoring visual dysfunction in multiple sclerosis. The latencies and amplitudes of the P100-like VESPA component were compared between healthy controls and multiple sclerosis patients, and multiple sclerosis subgroups. The P100-like VESPA component activations were examined at baseline and over a 3-year period. The study included 43 multiple sclerosis patients (23 relapsing-remitting MS, 20 secondary-progressive MS) and 42 healthy controls who completed the VESPA at baseline. The follow-up sessions were conducted 12 months after baseline with 24 MS patients (15 relapsing-remitting MS, 9 secondary-progressive MS) and 23 controls, and again at 24 months post-baseline with 19 MS patients (13 relapsing-remitting MS, 6 secondary-progressive MS) and 14 controls. The results showed P100-like VESPA latencies to be delayed in multiple sclerosis compared to healthy controls over the 24-month period. Secondary-progressive MS patients had most pronounced delay in P100-like VESPA latency relative to relapsing-remitting MS and controls. There were no longitudinal P100-like VESPA response differences. These findings suggest that the VESPA method is a reproducible electrophysiological method that may have potential utility in the assessment of visual dysfunction in multiple sclerosis.	[Kiiski, Hanni S. M.; Riada, Sinead Ni; Lalor, Edmund C.; Goncalves, Nuno R.; Nolan, Hugh; Whelan, Robert; Reilly, Richard B.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Neural Engn Grp, Dublin 2, Ireland; [Kiiski, Hanni S. M.; Riada, Sinead Ni; Lalor, Edmund C.; Goncalves, Nuno R.; Nolan, Hugh; Reilly, Richard B.] Univ Dublin Trinity Coll, Sch Engn, Dublin 2, Ireland; [Reilly, Richard B.] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Lonergan, Roisin; Kelly, Siobhan; Kinsella, Katie; Hutchinson, Michael; Tubridy, Niall] St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland; [Whelan, Robert; O'Brien, Marie Claire; Bramham, Jessica; Burke, Teresa; Donnchadha, Sean O.] Univ Coll Dublin, Coll Human Sci, Sch Psychol, Cognit & Behav Neurosci Res Grp, Dublin 2, Ireland; [Burke, Teresa] Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Dublin City University	Kiiski, HSM (corresponding author), Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Neural Engn Grp, Dublin 2, Ireland.	hanni.kiiski@gmail.com	hutchinson, michael/H-3508-2019; Reilly, Richard/N-1080-2019; Reilly, Richard B/F-7034-2011; Whelan, Robert/E-5365-2010	Reilly, Richard/0000-0001-8578-1245; Reilly, Richard B/0000-0001-8578-1245; Whelan, Robert/0000-0002-2790-7281; Lalor, Edmund/0000-0002-2498-6631; O Donnchadha, Sean/0000-0002-7861-426X; Burke, Teresa/0000-0001-8093-9912; Goncalves, Nuno Reis/0000-0002-9494-9414	Enterprise Ireland; Science Foundation Ireland; Irish Research Council for Science, Engineering Technology	Enterprise Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering Technology(Irish Research Council for Science, Engineering and Technology)	This study was partly funded by an Enterprise Ireland grant to RBR (eBiomed: eHealthCare based on Biomedical Signal Processing and ICT for Integrated Diagnosis and Treatment of Disease, http://www.enterprise-ireland.com/en/), by a Science Foundation Ireland grant to RBR (Research Frontiers Program, http://www.sfi.ie), and by an Irish Research Council for Science, Engineering & Technology (www.ircset.ie) grant to HSMK. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ales JM, 2010, NEUROIMAGE, V52, P1401, DOI 10.1016/j.neuroimage.2010.05.016; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Balnyte R, 2011, MED LITH, V47, P263; BASELER HA, 1994, ELECTROEN CLIN NEURO, V90, P65, DOI 10.1016/0013-4694(94)90114-7; BUTLER SR, 1987, ELECTROEN CLIN NEURO, V68, P256, DOI 10.1016/0168-5597(87)90046-3; Cao DC, 2011, INVEST OPHTH VIS SCI, V52, P8900, DOI 10.1167/iovs.11-7644; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Donnchadha SO, 2013, MULT SCLER J, V19, P971; Donnchadha SO, 2013, MULT SCLER J, V19, P1349, DOI 10.1177/1352458513476742; Filippi M, 2011, NAT REV NEUROL, V7, P74, DOI 10.1038/nrneurol.2010.215; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Foxe JJ, 2008, BRAIN TOPOGR, V21, P11, DOI 10.1007/s10548-008-0063-4; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; Hagler DJ, 2009, HUM BRAIN MAPP, V30, P1290, DOI 10.1002/hbm.20597; HALLIDAY AM, 1973, BRIT MED J, V4, P661, DOI 10.1136/bmj.4.5893.661; HALLIDAY AM, 1972, LANCET, V1, P982; IBM Corp, 2011, IBM SPSS STAT WIND V; JEFFREYS DA, 1972, EXP BRAIN RES, V16, P1; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Kiiski H, 2011, J NEUROL SCI, V305, P45, DOI 10.1016/j.jns.2011.03.018; Kiiski H, 2010, EUROPEAN J NEUROLOGY; Kiiski H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045536; Ko KF, 2010, SINGAP MED J, V51, P716; Kolappan M, 2009, J NEUROL, V256, P305, DOI 10.1007/s00415-009-0123-z; Kurtzke JF, 2008, NEUROEPIDEMIOLOGY, V31, P1, DOI 10.1159/000136645; Lalor EC, 2012, NEUROSCIENCE, V218, P226, DOI 10.1016/j.neuroscience.2012.05.067; Lalor EC, 2008, SCHIZOPHR RES, V98, P256, DOI 10.1016/j.schres.2007.09.037; Lalor EC, 2006, NEUROIMAGE, V32, P1549, DOI 10.1016/j.neuroimage.2006.05.054; Lalor EC, 2009, VISION RES, V49, P127, DOI 10.1016/j.visres.2008.09.032; MathWorks Inc, 2012, MATLAB VERS R2012A; McEvoy LK, 2000, CLIN NEUROPHYSIOL, V111, P457, DOI 10.1016/S1388-2457(99)00258-8; Murphy JW, 2012, EXP BRAIN RES, V220, P191, DOI 10.1007/s00221-012-3129-1; Niklas A, 2009, MULT SCLER J, V15, P68, DOI 10.1177/1352458508095731; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pokryszko-Dragan A, 2015, NEUROL SCI, V36, P235, DOI 10.1007/s10072-014-1953-8; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rosser DA, 2001, BRIT J OPHTHALMOL, V85, P432, DOI 10.1136/bjo.85.4.432; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Schlaeger R, 2012, MULT SCLER J, V18, P31, DOI 10.1177/1352458511416836; Schlaeger R, 2012, CLIN NEUROPHYSIOL, V123, P406, DOI 10.1016/j.clinph.2011.06.021; Seki K, 1996, EVOKED POTENTIAL, V100, P436; Slotnick SD, 1999, CLIN NEUROPHYSIOL, V110, P1793, DOI 10.1016/S1388-2457(99)00135-2; WESTHEIMER G, 1979, ARCH OPHTHALMOL-CHIC, V97, P327; Whelan R, 2010, J NEUROL SCI; Whelan R, 2010, CLIN NEUROPHYSIOL; World Federation of Neurology, 2007, SEM CLIN NEUR	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146084	10.1371/journal.pone.0146084	http://dx.doi.org/10.1371/journal.pone.0146084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726800	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500052
J	Latchoumycandane, C; Hanouneh, M; Nagy, LE; McIntyre, TM				Latchoumycandane, Calivarathan; Hanouneh, Mohamad; Nagy, Laura E.; McIntyre, Thomas M.			Inflammatory PAF Receptor Signaling Initiates Hedgehog Signaling and Kidney Fibrogenesis During Ethanol Consumption	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; OXIDATIVELY TRUNCATED PHOSPHOLIPIDS; ALCOHOLIC LIVER-DISEASE; INJURY MOLECULE-1; ANIMAL-MODELS; RAT-KIDNEY; FIBROSIS; MICE; APOPTOSIS; PERICYTES	Acute inflammation either resolves or proceeds to fibrotic repair that replaces functional tissue. Pro-fibrotic hedgehog signaling and induction of its Gli transcription factor in pericytes induces fibrosis in kidney, but molecular instructions connecting inflammation to fibrosis are opaque. We show acute kidney inflammation resulting from chronic ingestion of the common xenobiotic ethanol initiates Gli1 transcription and hedgehog synthesis in kidney pericytes, and promotes renal fibrosis. Ethanol ingestion stimulated transcription of TGF-beta, collagens I and IV, and alpha-smooth muscle actin with accumulation of these proteins. This was accompanied by deposition of extracellular fibrils. Ethanol catabolism by CYP2E1 in kidney generates local reactive oxygen species that oxidize cellular phospholipids to phospholipid products that activate the Platelet-activating Factor receptor (PTAFR) for inflammatory phospholipids. Genetically deleting this ptafr locus abolished accumulation of mRNA for TGF-beta, collagen IV, and a-smooth muscle actin. Loss of PTAFR also abolished ethanol-stimulated Sonic (Shh) and Indian hedgehog (Ihh) expression, and abolished transcription and accumulation of Gli1. Shh induced in pericytes and Ihh in tubules escaped to urine of ethanol-fed mice. Neutrophil myeloperoxidase (MPO) is required for ethanol-induced kidney inflammation, and Shh was not present in kidney or urine of mpo(-/-) mice. Shh also was present in urine of patients with acute kidney injury, but not in normal individuals or those with fibrotic liver cirrhosis We conclude neither endogenous PTAFR signaling nor CYP2E1-generated radicals alone are sufficient to initiate hedgehog signaling, but instead PTAFR-dependent neutrophil infiltration with myeloperoxidase activation is necessary to initiate ethanol-induced fibrosis in kidney. We also show fibrogenic mediators escape to urine, defining a new class of urinary mechanistic biomarkers of fibrogenesis for an organ not commonly biopsied.	[Latchoumycandane, Calivarathan; McIntyre, Thomas M.] Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Hanouneh, Mohamad] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Nagy, Laura E.] Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	mcintyt@ccf.org	Latchoumycandane, Calivarathan/GPP-5175-2022	Latchoumycandane, Calivarathan/0000-0002-6637-369X	National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health and the National Institute on Alcohol Abuse and Alcoholism. TMM, LEN received this funding (www.niaaa.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano J, 2012, CLIN GASTROENTEROL H, V10, P65, DOI 10.1016/j.cgh.2011.09.011; Angulo P, 2015, SEMIN LIVER DIS, V35, P132, DOI 10.1055/s-0035-1550065; Bailly V, 2002, J BIOL CHEM, V277, P39739, DOI 10.1074/jbc.M200562200; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2009, J BIOL CHEM, V284, P26297, DOI 10.1074/jbc.M109.018978; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Choi SS, 2011, INT J BIOCHEM CELL B, V43, P238, DOI 10.1016/j.biocel.2010.10.015; Cummings BS, 1999, DRUG METAB DISPOS, V27, P542; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; DeSantis DA, 2013, ALCOHOL CLIN EXP RES, V37, P1668, DOI 10.1111/acer.12157; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GIRRE C, 1994, BIOCHEM PHARMACOL, V47, P1503, DOI 10.1016/0006-2952(94)90524-X; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Handa RK, 2003, AM J PHYSIOL-RENAL, V284, pF274, DOI 10.1152/ajprenal.00117.2002; HAUG CE, 1995, RENAL FAILURE, V17, P489, DOI 10.3109/08860229509037614; Horn A, 2012, ANN RHEUM DIS, V71, P785, DOI 10.1136/annrheumdis-2011-200883; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Ishii S, 2002, PROSTAG OTH LIPID M, V68-9, P599, DOI 10.1016/S0090-6980(02)00058-8; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Kramann R., 2013, CURR PATHOBIOL REP, V1; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Kramann R, 2014, SEMIN NEPHROL, V34, P374, DOI 10.1016/j.semnephrol.2014.06.004; Latchoumycandane C, 2015, FREE RADICAL BIO MED, V86, P179, DOI 10.1016/j.freeradbiomed.2015.05.020; Latchoumycandane C, 2014, FREE RADICAL BIO MED, V69, P403, DOI 10.1016/j.freeradbiomed.2014.01.001; Latchoumycandane C, 2012, J BIOL CHEM, V287, P17693, DOI 10.1074/jbc.M111.300012; Lieber C S, 2005, Rocz Akad Med Bialymst, V50, P7; LIEBER CS, 1994, METHOD ENZYMOL, V233, P585; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu H, 2003, KIDNEY INT, V63, P1687, DOI 10.1046/j.1523-1755.2003.00908.x; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Marathe GK, 2002, VASC PHARMACOL, V38, P193, DOI 10.1016/S1537-1891(02)00169-6; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; Mathews S, 2014, AM J PHYSIOL-GASTR L, V306, pG819, DOI 10.1152/ajpgi.00041.2014; McIntyre TM, 2012, BBA-BIOMEMBRANES, V1818, P2456, DOI 10.1016/j.bbamem.2012.03.004; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; PERICO N, 1990, AM J NEPHROL, V10, P98, DOI 10.1159/000168202; Pratap A, 2010, PHARM RES-DORDR, V27, P2492, DOI 10.1007/s11095-010-0246-z; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Rastogi P, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.08.032; Ronis MJJ, 1998, BIOCHEM PHARMACOL, V55, P123, DOI 10.1016/S0006-2952(97)00381-X; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Ruiz-Ortega M, 1998, NEPHROL DIAL TRANSPL, V13, P886, DOI 10.1093/ndt/13.4.886; Schrimpf C, 2011, CURR OPIN NEPHROL HY, V20, P297, DOI 10.1097/MNH.0b013e328344c3d4; SMILEY PL, 1991, J BIOL CHEM, V266, P11104; Smith SW, 2012, NEPHROL DIAL TRANSPL, V27, P2149, DOI 10.1093/ndt/gfs134; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Wang S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074141, 10.1371/journal.pone.0073946]; Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009; ZERILLI A, 1995, ALCOHOL ALCOHOLISM, V30, P357; Zhou XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044121	60	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145691	10.1371/journal.pone.0145691	http://dx.doi.org/10.1371/journal.pone.0145691			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720402	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510900020
J	Mansuri, A; Elmaghrabi, A; Legan, SK; Gattineni, J; Baum, M				Mansuri, Asifhusen; Elmaghrabi, Ayah; Legan, Susan K.; Gattineni, Jyothsna; Baum, Michel			Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion	PLOS ONE			English	Article							LOW BIRTH-WEIGHT; LOW-PROTEIN DIET; ADULT HYPERTENSION; BLOOD-PRESSURE; DEXAMETHASONE; INSUFFICIENCY; GROWTH; CAPTOPRIL; ORIGINS; KIDNEY	Maternal low protein diet programs offspring to develop hypertension as adults. Transient exposure to angiotensin converting enzyme inhibitors or angiotensin II receptor blockers can result in improvement in hypertension. Male rats whose mothers received a low protein diet during the last half of pregnancy were given either vehicle, continuous enalapril (CE) in their drinking water or were given transient enalapril exposure (TE) after weaning at 21 days of age. The TE group had enalapril in their drinking water for 21 days starting from day 21 of life. All rats were studied at 6 months of age. Vehicle treated rats whose mothers were fed a low protein diet were hypertensive, had albuminuria, and demonstrated upregulation of the intrarenal renin-angiotensin systemas evidenced by higher urinary angiotensinogen and urinary angiotensin II levels. In low protein rats both continuous and transient exposure to enalapril normalized blood pressure, urinary angiotensinogen and urinary angiotensin II levels at 6 months of age, but only continuous administration of enalapril decreased urinary albumin excretion. These data support the importance of the intrarenal renin-angiotensin system in mediating hypertension in programmed rats and transient exposure to enalapril can reprogram the hypertension and dysregulation of the intrarenal renin-angiotensin system.	[Mansuri, Asifhusen; Elmaghrabi, Ayah; Legan, Susan K.; Gattineni, Jyothsna; Baum, Michel] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Baum, Michel] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Baum, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	Michel.Baum@UTSouthwestern.edu		Elmaghrabi, Ayah/0000-0002-9065-1338	NIH [DK41612, DK78596]; Children's Medical Center; O'Brien Center [P30DK079328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, R01DK078596, R01DK041612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Center; O'Brien Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK41612 and DK78596 to MB, a grant from Children's Medical Center and the O'Brien Center P30DK079328.	Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 1996, J HYPERTENS, V14, pS117; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; Baum M, 2010, AM J PHYSIOL-RENAL, V298, pF235, DOI 10.1152/ajprenal.00288.2009; Cheng CJ, 2012, AM J PHYSIOL-RENAL, V302, pF674, DOI 10.1152/ajprenal.00633.2011; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Dagan A, 2008, AM J PHYSIOL-RENAL, V295, pF29, DOI 10.1152/ajprenal.00123.2008; Dagan A, 2010, AM J HYPERTENS, V23, P420, DOI 10.1038/ajh.2009.274; Dagan A, 2009, AM J PHYSIOL-REG I, V297, pR93, DOI 10.1152/ajpregu.91006.2008; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; Grigore D, 2007, AM J PHYSIOL-REG I, V293, pR804, DOI 10.1152/ajpregu.00725.2006; Habib S, 2011, NEPHRON EXTRA, V1, P157, DOI 10.1159/000333477; Habib S, 2011, AM J HYPERTENS, V24, P96, DOI 10.1038/ajh.2010.177; Ingelfinger JR, 2002, AM J HYPERTENS, V15, p46S, DOI 10.1016/S0895-7061(01)02302-0; Kett MM, 2011, AM J PHYSIOL-REG I, V300, pR791, DOI 10.1152/ajpregu.00791.2010; Kobori H, 2003, HYPERTENSION, V41, P42, DOI 10.1161/01.HYP.0000050102.90932.CF; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Langley-Evans SC, 1999, BIOCHEM SOC T, V27, P88, DOI 10.1042/bst0270088; LANGLEYEVANS SC, 1995, COMP BIOCHEM PHYS A, V110, P223, DOI 10.1016/0300-9629(94)00177-U; LAW CM, 1991, ARCH DIS CHILD, V66, P1291, DOI 10.1136/adc.66.11.1291; Lozano G, 2015, AM J PHYSIOL-RENAL, V308, pF411, DOI 10.1152/ajprenal.00593.2014; Manning J, 2005, AM J PHYSIOL-REG I, V288, pR80, DOI 10.1152/ajpregu.00309.2004; Manning J, 2001, PEDIATR NEPHROL, V16, P417, DOI 10.1007/s004670000560; Mizuno M, 2014, HYPERTENSION, V63, P324, DOI 10.1161/HYPERTENSIONAHA.113.02330; Mizuno M, 2013, HYPERTENSION, V61, P180, DOI 10.1161/HYPERTENSIONAHA.112.199356; Moritz KM, 2010, PLACENTA, V31, pS40, DOI 10.1016/j.placenta.2010.01.006; Moritz KM, 2009, J PHYSIOL-LONDON, V587, P2635, DOI 10.1113/jphysiol.2009.170407; Murano Y, 2015, PEDIATR RES, V78, P678, DOI 10.1038/pr.2015.153; Navar LG, 2003, CURR HYPERTENS REP, V5, P135, DOI 10.1007/s11906-003-0070-5; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; Quan A, 1996, J CLIN INVEST, V97, P2878, DOI 10.1172/JCI118745; Quan A, 2004, AM J PHYSIOL-RENAL, V287, pF452, DOI 10.1152/ajprenal.00188.2003; Sherman RC, 2000, CLIN SCI, V98, P269, DOI 10.1042/CS19990275; Sherman RC, 1998, CLIN SCI, V94, P373, DOI 10.1042/cs0940373; Suzue M, 2015, CLIN EXP NEPHROL, V19, P293, DOI 10.1007/s10157-014-0977-y; Tabacova S, 2003, PHARMACOEPIDEM DR S, V12, P633, DOI 10.1002/pds.796; Vehaskari VM, 2005, J AM SOC NEPHROL, V16, P2545, DOI 10.1681/ASN.2005030300; Vehaskari VM, 2004, AM J PHYSIOL-RENAL, V287, pF262, DOI 10.1152/ajprenal.00055.2004; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Wang Q, 2015, J RENIN-ANGIO-ALDO S, V16, P1010, DOI 10.1177/1470320315583777; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003	47	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146183	10.1371/journal.pone.0146183	http://dx.doi.org/10.1371/journal.pone.0146183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719973	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900049
J	Sandoval-Hernandez, AG; Buitrago, L; Moreno, H; Cardona-Gomez, GP; Arboleda, G				Sandoval-Hernandez, Adrian G.; Buitrago, Luna; Moreno, Herman; Patricia Cardona-Gomez, Gloria; Arboleda, Gonzalo			Role of Liver X Receptor in AD Pathophysiology	PLOS ONE			English	Article							AMYLOID BETA-PEPTIDE; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; WILD-TYPE; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; TRANSGENIC MODEL; DENTATE GYRUS; MOUSE MODEL	Alzheimer's disease (AD) is the major cause of dementia worldwide. The pharmacological activation of nuclear receptors (Liver X receptors: LXRs or Retinoid X receptors: RXR) has been shown to induce overexpression of the ATP-Binding Cassette A1 (ABCA1) and Apolipoprotein E (ApoE), changes that are associated with improvement in cognition and reduction of amyloid beta pathology in amyloidogenic AD mouse models (i.e. APP, PS1: 2tg-AD). Here we investigated whether treatment with a specific LXR agonist has a measurable impact on the cognitive impairment in an amyloid and Tau AD mouse model (3xTg-AD: 12-months-old; three months treatment). The data suggests that the LXR agonist GW3965 is associated with increased expression of ApoE and ABCA1 in the hippocampus and cerebral cortex without a detectable reduction of the amyloid load. We also report that most cells overexpressing ApoE (86 +/- 12%) are neurons localized in the granular cell layer of the hippocampus and entorhinal cortex. In the GW3965 treated 3xTg-AD mice we also observed reduction in astrogliosis and increased number of stem and proliferating cells in the subgranular zone of the dentate gyrus. Additionally, we show that GW3965 rescued hippocampus long term synaptic plasticity, which had been disrupted by oligomeric amyloid beta peptides. The effect of GW3965 on synaptic function was protein synthesis dependent. Our findings identify alternative functional/molecular mechanisms by which LXR agonists may exert their potential benefits as a therapeutic strategy against AD.	[Sandoval-Hernandez, Adrian G.; Arboleda, Gonzalo] Univ Nacl Colombia, Inst Genet, Grp Muerte Celular, Bogota, Colombia; [Buitrago, Luna; Moreno, Herman] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA; [Buitrago, Luna; Moreno, Herman] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol Pharmacol, Brooklyn, NY 11203 USA; [Patricia Cardona-Gomez, Gloria] Univ Antioquia, Grp Neurociencias Antioquia, Area Neurobiol Celular & Mol, Medellin, Colombia	Universidad Nacional de Colombia; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Universidad de Antioquia	Arboleda, G (corresponding author), Univ Nacl Colombia, Inst Genet, Grp Muerte Celular, Bogota, Colombia.	gharboledab@unal.edu.co	Cardona-Gomez, Gloria Patricia/D-8100-2016	Cardona-Gomez, Gloria Patricia/0000-0002-3814-4494; Sandoval-Hernandez, Adrian Gabriel/0000-0002-0661-6872	NIA/NIH [R01 AG029802-01]; Colciencias [110151928994]; NIH [AG027476]; NATIONAL INSTITUTE ON AGING [R01AG029802, K08AG027476] Funding Source: NIH RePORTER	NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We want to thank Dr. Jon Collins (GSK, Stevenage, UK) for providing the GW683965A. Dr. Sergio Angulo for his help with the hippocampal slice recordings, and Dr. Riccardo Bianchi for discussions-Funded by: R01 AG029802-01 NIA/NIH.2007-2012 Colciencias 110151928994, and NIH AG027476 to HM	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Annicotte JS, 2004, ANAT REC PART A, V277A, P312, DOI 10.1002/ar.a.20015; Arboleda GH, 2001, NEUROSCI LETT, V305, P135, DOI 10.1016/S0304-3940(01)01829-8; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Caruso D, 2013, NEUROBIOL AGING, V34, P1080, DOI 10.1016/j.neurobiolaging.2012.10.007; Cepeda-Prado E, 2012, J NEUROSCI, V32, P6456, DOI 10.1523/JNEUROSCI.0388-12.2012; Chabrier MA, 2014, NEUROBIOL DIS, V64, P107, DOI 10.1016/j.nbd.2014.01.007; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Chevallier NL, 2005, AM J PATHOL, V167, P151, DOI 10.1016/S0002-9440(10)62962-8; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Crespo-Biel Natalia, 2012, Int J Alzheimers Dis, V2012, P251426, DOI 10.1155/2012/251426; Do TD, 2014, J PHYS CHEM B, V118, P11220, DOI 10.1021/jp506258g; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Frisardi V, 2010, J AM GERIATR SOC, V58, P2429, DOI 10.1111/j.1532-5415.2010.03164.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045881; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; Hernandez-Ortega K, 2015, BRAIN PATHOL; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huang Z, 2009, MOL CELL NEUROSCI, V42, P11, DOI 10.1016/j.mcn.2009.06.003; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Ishikawa T, 2013, J CLIN INVEST, V123, P3488, DOI 10.1172/JCI66533; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Ly PTT, 2011, JOVE-J VIS EXP, DOI 10.3791/2831; Ma DKK, 2009, CELL STEM CELL, V5, P343, DOI 10.1016/j.stem.2009.09.001; Mandler M, 2014, ACTA NEUROPATHOL, V128, P67, DOI 10.1007/s00401-014-1296-9; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Moreno H, 2009, P NATL ACAD SCI USA, V106, P5901, DOI 10.1073/pnas.0900944106; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moutinho M, 2015, MOL NEUROBIOL, V51, P1489, DOI 10.1007/s12035-014-8828-0; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Otaegui-Arrazola A, 2010, FOOD CHEM TOXICOL, V48, P3289, DOI 10.1016/j.fct.2010.09.023; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Panzaa F, 2009, NEUROBIOL AGING, V30, P546, DOI 10.1016/j.neurobiolaging.2007.10.019; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rodriguez JJ, 2013, NEUROSCI LETT; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Theofilopoulos S, 2013, NAT CHEM BIOL, V9, P126, DOI [10.1038/NCHEMBIO.1156, 10.1038/nchembio.1156]; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Wen PH, 2002, NEUROBIOL DIS, V10, P8, DOI 10.1006/nbdi.2002.0490; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	78	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145467	10.1371/journal.pone.0145467	http://dx.doi.org/10.1371/journal.pone.0145467			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720273	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900012
J	Suwanthawornkul, T; Anothaisintawee, T; Sobhonslidsuk, A; Thakkinstian, A; Teerawattananon, Y				Suwanthawornkul, Thanthima; Anothaisintawee, Thunyarat; Sobhonslidsuk, Abhasnee; Thakkinstian, Ammarin; Teerawattananon, Yot			Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naive Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							FIXED-DOSE COMBINATION; INTERFERON-ALPHA 2A; PEGYLATED INTERFERON; DOUBLE-BLIND; PHASE-2 TRIAL; OPEN-LABEL; GENETIC-VARIATION; PLUS RIBAVIRIN; CHRONIC HCV; INFECTION	Background The treatment of hepatitis C (HCV) infections has significantly changed in the past few years due to the introduction of direct-acting antiviral agents (DAAs). DAAs could improve the sustained virological response compared to pegylated interferon with ribavirin (PR). However, there has been no evidence from randomized controlled trials (RCTs) that directly compare the efficacy among the different regimens of DAAs. Aim Therefore, we performed a systematic review and network meta-analysis aiming to compare the treatment efficacy between different DAA regimens for treatment naive HCV genotype 1. Methods Medline and Scopus were searched up to 25th May 2015. RCTs investigating the efficacy of second generation DAA regimens for treatment naive HCV genotype 1 were eligible for the review. Due to the lower efficacy and more side effects of first generation DAAs, this review included only second generation DAAs approved by the US or EU Food and Drug Administration, that comprised of simeprevir (SMV), sofosbuvir (SOF), daclatasvir (DCV), ledipasvir (LDV), and paritaprevir/ritonavir/ombitasvir plus dasabuvir (PrOD). Primary outcomes were sustained virological response at weeks 12 (SVR12) and 24 (SVR24) after the end of treatment and adverse drug events (i.e. serious adverse events, anemia, and fatigue). Efficacy of all treatment regimens were compared by applying a multivariate random effect meta-analysis. Incidence rates of SVR12 and SVR24, and adverse drug events of each treatment regimen were pooled using 'pmeta' command in STATA program. Results Overall, 869 studies were reviewed and 16 studies were eligible for this study. Compared with the PR regimen, SOF plus PR, SMV plus PR, and DVC plus PR regimens yielded significantly higher probability of having SVR24 with pooled risk ratios (RR) of 1.98 (95% CI 1.24, 3.14), 1.46 (95% CI: 1.22, 1.75), and 1.68 (95% CI: 1.14, 2.46), respectively. Pooled incidence rates of SVR12 and SVR24 in all treatment regimens without PR, i.e. SOF plus LDV with/without ribavirin, SOF plus SMV with/without ribavirin, SOF plus DCV with/without ribavirin, and PrOD with/without ribavirin, (pooled incidence of SVR12 ranging from 93% to 100%, and pooled incidence of SVR24 ranging from 89% to 96%) were much higher than the pooled incidence rates of SVR12 (51%) and SVR24 (48%) in PR alone. In comparing SOF plus LDV with ribavirin and SOF plus LDV without ribavirin, the chance of having SVR12 was not significantly different between these two regimens, with the pooled RR of 0.99 (95% CI: 0.97, 1.01). Regarding adverse drug events, risk of serious adverse drug events, anemia and fatigue were relatively higher in treatment regimens with PR than the treatment regimens without PR. The main limitation of our study is that a subgroup analysis according to dosages and duration of treatment could not be performed. Therefore, the dose and duration of recommended treatment have been suggested in range and not in definite value. Conclusions Both DAA plus PR and dual DAA regimens should be included in the first line drug for treatment naive HCV genotype 1 because of the significant clinical benefits over PR alone. However, due to high drug costs, an economic evaluation should be conducted in order to assess the value of the investment when making coverage decisions.	[Suwanthawornkul, Thanthima; Teerawattananon, Yot] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Nonthaburi, Thailand; [Anothaisintawee, Thunyarat] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Family Med, Bangkok 10400, Thailand; [Sobhonslidsuk, Abhasnee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Div Gastroenterol & Hepatol, Bangkok 10400, Thailand; [Thakkinstian, Ammarin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Sect Clin Epidemiol & Biostat, Bangkok 10400, Thailand	Ministry of Public Health - Thailand; Mahidol University; Mahidol University; Mahidol University	Anothaisintawee, T (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Family Med, Bangkok 10400, Thailand.	thunyarat.ano@mahidol.ac.th	Thakkinstian, Ammarin/J-4788-2019	Suwanthawornkul, Thanthima/0000-0002-1794-4863; Teerawattananon, Yot/0000-0003-2217-2930	Merck; Eisai; Biotin; Bristol-Myers Squibb	Merck(Merck & Company); Eisai(Eisai Co Ltd); Biotin; Bristol-Myers Squibb(Bristol-Myers Squibb)	Abhasnee Sobhonslidsuk has received grant/research support from Merck, Eisai, Biotin, and Bristol-Myers Squibb; acted as an advisor and speaker for Bristol-Myers Squibb. The other authors have no conflicts of interest to declare.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Bansal S, 2015, WORLD J HEPATOL, V7, P806, DOI 10.4254/wjh.v7.i5.806; Cooper C, 2013, QJM-INT J MED, V106, P153, DOI 10.1093/qjmed/hcs214; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Hezode C, 2014, GUT; Higgins JPT, COCHRANE COLLABORATI; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Lawitz E, 2014, LANCET; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Malone Daniel C, 2005, J Manag Care Pharm, V11, P687; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Pol S, 2012, LANCET INFECT DIS, V12, P671, DOI 10.1016/S1473-3099(12)70138-X; Pollack A., 2013, NY TIMES; Rodriguez-Torres M, 2013, J HEPATOL, V58, P663, DOI 10.1016/j.jhep.2012.11.018; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; World Health Organisation, 2014, CALL ACT SCAL GLOB H; World Health Organization, 2015, REC EX WHO GUID PREV, P87; World Health Organization, 2014, STRENGTH PALL CAR CO	31	48	49	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145953	10.1371/journal.pone.0145953	http://dx.doi.org/10.1371/journal.pone.0145953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720298	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900028
J	An, WL; Jackson, RE; Hunter, P; Gogel, S; van Diepen, M; Liu, KR; Meyer, MP; Eickholt, BJ				An, Wenlin; Jackson, Rachel E.; Hunter, Paul; Goegel, Stefanie; van Diepen, Michiel; Liu, Karen; Meyer, Martin P.; Eickholt, Britta J.			Engineering FKBP-Based Destabilizing Domains to Build Sophisticated Protein Regulation Systems	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PTEN; STABILITY; MEMBRANE; CIRCUITS; LINKERS	Targeting protein stability with small molecules has emerged as an effective tool to control protein abundance in a fast, scalable and reversible manner. The technique involves tagging a protein of interest (POI) with a destabilizing domain (DD) specifically controlled by a small molecule. The successful construction of such fusion proteins may, however, be limited by functional interference of the DD epitope with electrostatic interactions required for full biological function of proteins. Another drawback of this approach is the remaining endogenous protein. Here, we combined the Cre-LoxP system with an advanced DD and generated a protein regulation system in which the loss of an endogenous protein, in our case the tumor suppressor PTEN, can be coupled directly with a conditionally fine-tunable DD-PTEN. This new system will consolidate and extend the use of DD-technology to control protein function precisely in living cells and animal models.	[An, Wenlin; Jackson, Rachel E.; Hunter, Paul; van Diepen, Michiel; Meyer, Martin P.; Eickholt, Britta J.] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England; [An, Wenlin; Goegel, Stefanie; Eickholt, Britta J.] Charite, Cluster Excellence NeuroCure, D-10117 Berlin, Germany; [An, Wenlin; Goegel, Stefanie; Eickholt, Britta J.] Inst Biochem, D-10117 Berlin, Germany; [Liu, Karen] Kings Coll London, Dept Craniofacial Dev, London SE1 1UL, England	University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London	Eickholt, BJ (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England.	Britta.Eickholt@charite.de	Meyer, Martin/C-5472-2009; Liu, Karen/F-2870-2010; Hunter, Paul/J-7795-2013	Eickholt, Britta/0000-0001-7873-8687; Jackson, Rachel Emily/0000-0001-9454-0080; Liu, Karen/0000-0002-2483-2165; Hunter, Paul/0000-0003-4570-483X; van Diepen, Michiel/0000-0001-8156-4294; Meyer, Martin/0000-0001-8337-630X	Medical Research Council [G08022289/89617]; Deutsche Forschungsgemeinschaft [SFB665, TP11, SFB958, TP16]; Biotechnology and Biological Sciences Research Council [BB/I021922/1, BB/E013872/1, BB/L004992/1] Funding Source: researchfish; Medical Research Council [G0901899] Funding Source: researchfish; BBSRC [BB/E013872/1, BB/I021922/1, BB/L004992/1] Funding Source: UKRI; MRC [G0901899] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant from the Medical Research Council (G08022289/89617), the Deutsche Forschungsgemeinschaft (SFB665, TP11; SFB958, TP16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Carracedo A, 2011, CANCER RES, V71, P629, DOI 10.1158/0008-5472.CAN-10-2488; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Rodriguez S, 2012, CHEM BIOL, V19, P391, DOI 10.1016/j.chembiol.2011.12.022; Rouhi P, 2010, NAT PROTOC, V5, P1911, DOI 10.1038/nprot.2010.150; Runions J, 2006, J EXP BOT, V57, P43, DOI 10.1093/jxb/eri289; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yamada KM, 2001, J CELL SCI, V114, P2375	20	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145783	10.1371/journal.pone.0145783	http://dx.doi.org/10.1371/journal.pone.0145783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717575	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500070
J	Branche, E; Conzelmann, S; Parisot, C; Bedert, L; Levy, PL; Bartosch, B; Clement, S; Negro, F				Branche, Emilie; Conzelmann, Stephanie; Parisot, Clotilde; Bedert, Ludmila; Levy, Pierre L.; Bartosch, Birke; Clement, Sophie; Negro, Francesco			Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein	PLOS ONE			English	Article							B TYPE-I; LIPID DROPLET; CORE PROTEIN; RNA REPLICATION; LOW-DENSITY; HEPATOCELLULAR-CARCINOMA; SUPERINFECTION EXCLUSION; ENDOPLASMIC-RETICULUM; TRIGLYCERIDE LIPASE; RISK-FACTOR	The hepatitis C virus (HCV) life cycle is closely associated with lipid metabolism. In particular, HCV assembly initiates at the surface of lipid droplets. To further understand the role of lipid droplets in HCV life cycle, we assessed the relationship between HCV and the adipose differentiation-related protein (ADRP), a lipid droplet-associated protein. Different steps of HCV life cycle were assessed in HCV-infected human Huh-7 hepatoma cells overexpressing ADRP upon transduction with a lentiviral vector. HCV infection increased ADRP mRNA and protein expression levels by 2-and 1.5-fold, respectively. The overexpression of ADRP led to an increase of (i) the surface of lipid droplets, (ii) the total cellular neutral lipid content (2.5- and 5-fold increase of triglycerides and cholesterol esters, respectively), (iii) the cellular free cholesterol level (5-fold) and (iv) the HCV particle production and infectivity (by 2-and 3.5-fold, respectively). The investigation of different steps of the HCV life cycle indicated that the ADRP overexpression, while not affecting the viral replication, promoted both virion egress and entry (similar to 12-fold), the latter possibly via an increase of its receptor occludin. Moreover, HCV infection induces an increase of both ADRP and occludin expression. In HCV infected cells, the occludin upregulation was fully prevented by the ADRP silencing, suggesting a specific, ADRP-dependent mechanism. Finally, in HCV-infected human livers, occludin and ADRP mRNA expression levels correlated with each other. Alltogether, these findings show that HCV induces ADRP, which in turns appears to confer a favorable environment to viral spread.	[Branche, Emilie; Conzelmann, Stephanie; Parisot, Clotilde; Bedert, Ludmila; Levy, Pierre L.] Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Bartosch, Birke] Univ Lyon, INSERM, CNRS 5286, CRCL,U1052, Lyon, France; [Clement, Sophie; Negro, Francesco] Univ Hosp, Div Clin Pathol, Geneva, Switzerland; [Negro, Francesco] Univ Hosp, Gastroenterol & Hepatol, Geneva, Switzerland	University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); University of Geneva; University of Geneva	Clement, S (corresponding author), Univ Hosp, Div Clin Pathol, Geneva, Switzerland.	sophie.clement@unige.ch; Francesco.Negro@hcuge.ch	Negro, Francesco/E-2183-2012; Levy, Pierre/AAR-4370-2020; Bartosch, Birke/I-7255-2018	Levy, Pierre/0000-0003-3213-0080; Bartosch, Birke/0000-0001-6354-4660	Swiss National Science Foundation [314730-146991]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (314730-146991 to FN).; The authors wish to thank Prof R. Bartenschlager for providing the constructs pFK-J6/C3 (Jc1) and PFK_i389LucNS3. We are also grateful to Dr C. Rice and Dr D. Garcin for supplying the Huh-7.5 cells and the plasmid pTKrenilla_Luc respectively. We thank the Bioimagery Platform for the Metamorph journal for lipid droplet morphometric analyses (Geneva, Switzerland). This work was supported by the Swiss National Science Foundation (314730-146991) (to FN).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benedicto I, 2008, HEPATOLOGY, V48, P1044, DOI 10.1002/hep.22465; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bouchagier KA, 2014, IN VIVO, V28, P315; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Camus G, 2014, J BIOL CHEM, V289, P35770, DOI 10.1074/jbc.M114.587816; Clement S, 2008, HEPATOLOGY, V48, P799, DOI 10.1002/hep.22404; Clement S, 2013, J GEN VIROL, V94, P2208, DOI 10.1099/vir.0.054593-0; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Dai X, 2014, HEPATO-GASTROENTEROL, V61, P136, DOI 10.5754/hge12760; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Filipe A, 2015, TRENDS MOL MED, V21, P34, DOI 10.1016/j.molmed.2014.11.003; Fujii H, 2009, J ATHEROSCLER THROMB, V16, P893; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kurosaki M, 2010, HEPATOL RES, V40, P870, DOI 10.1111/j.1872-034X.2010.00692.x; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Mensa L, 2011, HEPATOLOGY, V53, P1436, DOI 10.1002/hep.24110; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakamuta M, 2011, J MED VIROL, V83, P921, DOI 10.1002/jmv.22042; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Peyrou M, 2013, J HEPATOL, V59, P420, DOI 10.1016/j.jhep.2013.04.012; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Ploen D, 2013, J HEPATOL, V58, P1081, DOI 10.1016/j.jhep.2013.01.022; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Ray Katrina, 2012, Nat Rev Gastroenterol Hepatol, V9, P124, DOI 10.1038/nrgastro.2012.4; Read SA, 2014, J GEN VIROL, V95, P1900, DOI 10.1099/vir.0.065300-0; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146000	10.1371/journal.pone.0146000	http://dx.doi.org/10.1371/journal.pone.0146000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731658	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400075
J	Gouda-Vossos, A; Dixson, BJ; Brooks, RC				Gouda-Vossos, Amany; Dixson, Barnaby J.; Brooks, Robert C.			Sexual Conflict and Gender Gap Effects: Associations between Social Context and Sex on Rated Attractiveness and Economic Status	PLOS ONE			English	Article							NONINDEPENDENT MATE CHOICE; PHYSICAL ATTRACTIVENESS; EVOLUTIONARY PSYCHOLOGY; PARENTAL INVESTMENT; PARTNER SELECTION; AGENTIC WOMEN; UNITED-STATES; BEAUTY; PREFERENCES; HUMANS	Human mate choice research often concerns sex differences in the importance of traits such as physical attractiveness and social status. A growing number of studies indicate that cues to social context, including other people who appear in stimulus photographs, can alter that individual's attractiveness. Fewer studies, however, consider judgements of traits other than physical attractiveness, such as wealth. Here we manipulate the presence/absence of other people in photographs of target models, and test the effects on judgments of both attractiveness and earnings (a proxy for status). Participants (N = 2044) rated either male or female models for either physical attractiveness or social/economic status when presented alone, with same sex others or with opposite sex others. We collectively refer to this manipulation as ` social context'. Male and female models received similar responses for physical attractiveness, but social context affected ratings of status differently for women and men. Males presented alongside other men received the highest status ratings while females presented alone were given the highest status ratings. Further, the status of females presented alongside a male was constrained by the rated status of that male. Our results suggests that high status may not directly lead to high attractiveness in men, but that status is more readily attributed to men than to women. This divide in status between the sexes is very clear when men and women are presented together, possibly reflecting one underlying mechanism of the modern day gender gap and sexist attitudes to women's economic participation. This adds complexity to our understanding of the relationship between attractiveness, status, and sex in the light of parental investment theory, sexual conflict and economic theory.	[Gouda-Vossos, Amany; Dixson, Barnaby J.; Brooks, Robert C.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Dixson, Barnaby J.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	University of New South Wales Sydney; University of Queensland	Gouda-Vossos, A (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	a.gouda-vossos@unsw.edu.au	Brooks, Robert/A-1251-2008	Brooks, Robert/0000-0001-6926-0781; Dixson, Barnaby/0000-0003-0911-1244; Gouda-Vossos, Amany/0000-0002-6142-9439	ARC Discovery Grant [DP120102076]	ARC Discovery Grant(Australian Research Council)	This work was supported by an ARC Discovery Grant, Number: DP120102076, URL: http://www.arc.gov.au/pdf/DP12/DP12_Listing_by_all_State_Organisation.pdf.	Aguiar F, 2009, EXP ECON, V12, P93, DOI 10.1007/s10683-008-9199-z; Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Alesina A, 2013, Q J ECON, V128, P469, DOI 10.1093/qje/qjt005; Anderson C, 2001, J PERS SOC PSYCHOL, V81, P116, DOI 10.1037//0022-3514.81.1.116; Andreoni J, 2008, J ECON PSYCHOL, V29, P73, DOI 10.1016/j.joep.2007.07.008; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Auld HL, 2009, BEHAV PROCESS, V82, P78, DOI 10.1016/j.beproc.2009.03.004; Bertrand M, 2013, NATL BUREAU EC RES W, DOI [10.3386w19023, DOI 10.3386/W19023]; Betzig LL, 1986, DESPOTISM DIFFERENTI, pxi; Bittman M, 2003, AM J SOCIOL, V109, P186, DOI 10.1086/378341; Brase GL, 2004, J APPL SOC PSYCHOL, V34, P2469, DOI 10.1111/j.1559-1816.2004.tb01987.x; Brooks R, 1998, TRENDS ECOL EVOL, V13, P45, DOI 10.1016/S0169-5347(97)01253-6; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Buss DM, 1994, EVOLUTION DESIRE STR, px; Cooke LP, 2006, AM J SOCIOL, V112, P442, DOI 10.1086/506417; DeWall CN, 2008, EVOL PSYCHOL, V6, P328, DOI 10.1177/147470490800600209; Dixson BJ, 2015, ARCH SEX BEHAV, V44, P1685, DOI 10.1007/s10508-015-0516-2; Dixson BJ, 2013, EVOL HUM BEHAV, V34, P236, DOI 10.1016/j.evolhumbehav.2013.02.003; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P43, DOI 10.1007/s10508-009-9523-5; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; Dunn M.J., 2010, J SOCIAL EVOLUTIONAR, V4, P1, DOI [10.1037/h0099305, DOI 10.1037/H0099305]; Dunn MJ, 2010, BRIT J PSYCHOL, V101, P69, DOI 10.1348/000712609X417319; Dunn MJ., 2014, J EVOL PSYCHOL, V12, P1, DOI [10.1556/jep.12.2014.1.1, DOI 10.1556/JEP.12.2014.1.1]; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Eastwick PW, 2006, SEX ROLES, V54, P603, DOI 10.1007/s11199-006-9027-x; Fisman R, 2006, Q J ECON, V121, P673, DOI 10.1162/qjec.2006.121.2.673; Galef BG, 1998, ANIM BEHAV, V55, P545, DOI 10.1006/anbe.1997.0616; Gibson RM, 1991, BEHAV ECOL, V2, P165, DOI 10.1093/beheco/2.2.165; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Hill AK, 2013, EVOL HUM BEHAV, V34, P334, DOI 10.1016/j.evolhumbehav.2013.05.004; Hill SE, 2008, PERS SOC PSYCHOL B, V34, P635, DOI 10.1177/0146167207313728; HOGLUND J, 1995, ANIM BEHAV, V49, P1627, DOI 10.1016/0003-3472(95)90085-3; Hopcroft RL, 2006, EVOL HUM BEHAV, V27, P104, DOI 10.1016/j.evolhumbehav.2005.07.004; West-Eberhard MJ, 2014, NEUROSCI BIOBEHAV R, V46, P501, DOI 10.1016/j.neubiorev.2014.06.015; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; Jones BC, 2007, P ROY SOC B-BIOL SCI, V274, P899, DOI 10.1098/rspb.2006.0205; KENRICK DT, 1992, BEHAV BRAIN SCI, V15, P75, DOI 10.1017/S0140525X00067595; KENRICK DT, 1990, J PERS, V58, P97, DOI 10.1111/j.1467-6494.1990.tb00909.x; Kinsey A. C., 1953, SEXUAL BEHAV HUMAN M; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Kray LJ, 2005, RES ORGAN BEHAV, V26, P103, DOI 10.1016/S0191-3085(04)26004-X; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Little AC, 2011, SOCIAL LEARNING HUMA, P366; Little AC, 2011, ARCH SEX BEHAV, V40, P1119, DOI 10.1007/s10508-011-9806-5; Marcinkowska UM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0850; McCord DM, 2010, AM J PSYCHOL RES, V6, P10; Mobius MM, 2006, AM ECON REV, V96, P222, DOI 10.1257/000282806776157515; Mueller U, 1997, BEHAV ECOL, V8, P569; Place SS, 2010, EVOL HUM BEHAV, V31, P320, DOI 10.1016/j.evolhumbehav.2010.02.001; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rosenblat TS, 2008, NEGOTIATION J, V24, P465, DOI 10.1111/j.1571-9979.2008.00198.x; Ross ML, 2008, AM POLIT SCI REV, V102, P107, DOI 10.1017/S0003055408080040; Rudman LA, 1999, J PERS SOC PSYCHOL, V77, P1004, DOI 10.1037/0022-3514.77.5.1004; Rudman LA, 2001, J SOC ISSUES, V57, P743, DOI 10.1111/0022-4537.00239; SCHEIN VE, 1992, J ORGAN BEHAV, V13, P439, DOI 10.1002/job.4030130502; Seabright P, 2011, CEPR DISCUSSION PAPE; Sherman Paul W., 1997, P69; Singh D, 2010, EVOL HUM BEHAV, V31, P176, DOI 10.1016/j.evolhumbehav.2009.09.001; Stewart-Williams S, 2013, PSYCHOL INQ, V24, P137, DOI 10.1080/1047840X.2013.804899; SYMON D, 1995, CHIC SEX HIST SOC, P80; Teachman J, 2010, J FAM ISSUES, V31, P1305, DOI 10.1177/0192513X10370108; The United States Department of Labour, 2013, LEAD OCC WOM US US D; The United States Department of Labour, 2013, WOM PART SEL OCC US; TOWNSEND JM, 1990, ARCH SEX BEHAV, V19, P149, DOI 10.1007/BF01542229; TOWNSEND JM, 1990, J PSYCHOL, V124, P371, DOI 10.1080/00223980.1990.10543232; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; von Rueden C, 2011, P ROY SOC B-BIOL SCI, V278, P2223, DOI 10.1098/rspb.2010.2145; WADE MJ, 1990, P NATL ACAD SCI USA, V87, P5749, DOI 10.1073/pnas.87.15.5749; Waynforth D, 2007, HUM NATURE-INT BIOS, V18, P264, DOI 10.1007/s12110-007-9004-2; Westneat DF, 2000, ANIM BEHAV, V59, P467, DOI 10.1006/anbe.1999.1341; Widmer ED, 1998, J SEX RES, V35, P349, DOI 10.1080/00224499809551953; Witte K, 2002, ANIM BEHAV, V63, P943, DOI 10.1006/anbe.2001.1982; Zentner M, 2012, PSYCHOL SCI, V23, P1176, DOI 10.1177/0956797612441004	75	3	3	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146269	10.1371/journal.pone.0146269	http://dx.doi.org/10.1371/journal.pone.0146269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731414	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400136
J	Kauke, T; Klimaschewski, S; Schoenermarck, U; Fischereder, M; Dick, A; Guba, M; Stangl, M; Werner, J; Meiser, B; Habicht, A				Kauke, Teresa; Klimaschewski, Sandra; Schoenermarck, Ulf; Fischereder, Michael; Dick, Andrea; Guba, Markus; Stangl, Manfred; Werner, Jens; Meiser, Bruno; Habicht, Antje			Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience	PLOS ONE			English	Article							BK VIRUS; RENAL-TRANSPLANTATION; CLINICAL-RELEVANCE; ANTIBODIES; NEPHROPATHY	Background The shortage of deceased donors led to an increase of living donor kidney (LDK) transplantations performed in the presence of donor-specific antibodies (DSA) or ABO incompatibility (ABOi) using various desensitization protocols. Methods We herein analyzed 26 ABOi and 8 Luminex positive DSA patients who were successfully desensitized by anti-CD20, antigen-specific immunoadsorption and/or plasmapheresis to receive an LDK transplant. Twenty LDK recipients with non-donor-specific HLA-antibodies (low risk) and 32 without anti-HLA antibodies (no risk) served as control groups. Results 1-year graft survival rate and renal function was similar in all 4 groups (creatinine: 1.63 +/- 0.5 vs 1.78 +/- 0.6 vs 1.64 +/- 0.5 vs 1.6 +/- 0.3 mg/dl in ABOi, DSA, low risk and no risk group). The incidence of acute T-cell mediated rejections did not differ between the 4 groups (15% vs 12, 5% vs 15% vs 22% in ABOi, DSA, low risk and no risk), while antibody-mediated rejections were only found in the DSA (25%) and ABOi (7.5%) groups. Incidence of BK nephropathy (BKVN) was significantly more frequent after desensitization as compared to controls (5/34 vs 0/52, p = 0.03). Conclusion We demonstrate favorable short-term allograft outcome in LDK transplant recipients after desensitization. However, the desensitization was associated with an increased risk of BKVN.	[Kauke, Teresa; Dick, Andrea] Univ Hosp LMU, Immunogenet Lab, Munich, Germany; [Kauke, Teresa; Guba, Markus; Stangl, Manfred; Werner, Jens] Univ Hosp LMU, Clin Gen Visceral Transplantat Vasc & Thorac Surg, Munich, Germany; [Klimaschewski, Sandra; Meiser, Bruno; Habicht, Antje] Univ Hosp LMU, Transplant Ctr, Munich, Germany; [Schoenermarck, Ulf; Fischereder, Michael] Univ Hosp LMU, Dept Internal Med 4, Div Renal, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Habicht, A (corresponding author), Univ Hosp LMU, Transplant Ctr, Munich, Germany.	antje.habicht@med.uni-muenchen.de	Guba, Markus/M-4309-2019	Schonermarck, Ulf/0000-0002-3266-9791				Bagnasco SM, 2014, TRANSPLANTATION, V97, P440, DOI 10.1097/01.TP.0000437177.40551.f4; Barbosa D, 2014, TRANSPLANTATION, V97, P755, DOI 10.1097/01.TP.0000437671.78716.f3; Bentall A, 2013, AM J TRANSPLANT, V13, P76, DOI 10.1111/j.1600-6143.2012.04291.x; Bielmann D, 2007, AM J TRANSPLANT, V7, P626, DOI 10.1111/j.1600-6143.2007.01667.x; Binet I, 1999, TRANSPLANTATION, V67, P918, DOI 10.1097/00007890-199903270-00022; Bressollette-Bodin C, 2005, AM J TRANSPLANT, V5, P1926, DOI 10.1111/j.1600-6143.2005.00934.x; de Freitas DG, 2011, AM J TRANSPLANT, V11, P56; Fishman JA, 2002, NEW ENGL J MED, V347, P527, DOI 10.1056/NEJMe020076; Habicht A, 2011, NEPHROL DIAL TRANSPL, V26, P4124, DOI 10.1093/ndt/gfr215; Hirsch HH, 2005, CLIN INFECT DIS, V41, P354, DOI 10.1086/431488; Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09; Hirsch HH, 2003, LANCET INFECT DIS, V3, P611, DOI 10.1016/S1473-3099(03)00770-9; Klein K, 2013, ATHEROSCLEROSIS SUPP, V14, P199, DOI 10.1016/j.atherosclerosissup.2012.10.030; Lee PC, 2009, TRANSPL P, V41, P95, DOI 10.1016/j.transproceed.2008.10.074; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Mengel M, 2003, NEPHROL DIAL TRANSPL, V18, P1190, DOI 10.1093/ndt/gfg072; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Mylonakis E, 2001, TRANSPLANTATION, V72, P1587, DOI 10.1097/00007890-200111270-00001; Patel AM, 2007, AM J TRANSPLANT, V7, P2371, DOI 10.1111/j.1600-6143.2007.01944.x; Phelan D, 2009, HUM IMMUNOL, V70, P584, DOI 10.1016/j.humimm.2009.05.007; Picascia A, 2012, CLIN EXP NEPHROL, V16, P373, DOI 10.1007/s10157-012-0635-1; Reinsmoen NL, 2012, CURR OPIN ORGAN TRAN, V17, P406, DOI 10.1097/MOT.0b013e328355f3c4; Roelen DL, 2012, TRANSPL INT, V25, P604, DOI 10.1111/j.1432-2277.2012.01491.x; Sharif A, 2012, CLIN J AM SOC NEPHRO, V7, P1320, DOI 10.2215/CJN.00770112; Smits JMA, 1998, TRANSPLANTATION, V66, P1146, DOI 10.1097/00007890-199811150-00006; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Susal C, 2011, TISSUE ANTIGENS, V77, P177, DOI 10.1111/j.1399-0039.2011.01638.x; Susal C, 2011, TRANSPLANTATION, V91, P883, DOI 10.1097/TP.0b013e3182100f77; Takahashi K, 2013, TRANSPLANT REV-ORLAN, V27, P1, DOI 10.1016/j.trre.2012.07.003; van den Berg-Loonen EM, 2008, TRANSPLANTATION, V85, P1086, DOI 10.1097/TP.0b013e31816b3ed1; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894	32	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146075	10.1371/journal.pone.0146075	http://dx.doi.org/10.1371/journal.pone.0146075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730981	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400088
J	Liu, MJ; Xiong, CH; Xiong, L; Huang, XL				Liu, Ming-Jin; Xiong, Cai-Hua; Xiong, Le; Huang, Xiao-Lin			RETRACTED: Biomechanical Characteristics of Hand Coordination in Grasping Activities of Daily Living (Retracted article. See vol. 11, e0151685, 2016)	PLOS ONE			English	Article; Retracted Publication							FINGER MOVEMENTS; CONSTRAINTS; SYNERGIES; EVOLUTION; MOTION; MODEL	Hand coordination can allow humans to have dexterous control with many degrees of freedom to perform various tasks in daily living. An important contributing factor to this important ability is the complex biomechanical architecture of the human hand. However, drawing a clear functional link between biomechanical architecture and hand coordination is challenging. It is not understood which biomechanical characteristics are responsible for hand coordination and what specific effect each biomechanical characteristic has. To explore this link, we first inspected the characteristics of hand coordination during daily tasks through a statistical analysis of the kinematic data, which were collected from thirty right-handed subjects during a multitude of grasping tasks. Then, the functional link between biomechanical architecture and hand coordination was drawn by establishing the clear corresponding causality between the tendinous connective characteristics of the human hand and the coordinated characteristics during daily grasping activities. The explicit functional link indicates that the biomechanical characteristic of tendinous connective architecture between muscles and articulations is the proper design by the Creator to perform a multitude of daily tasks in a comfortable way. The clear link between the structure and the function of the human hand also suggests that the design of a multifunctional robotic hand should be able to better imitate such basic architecture.	[Liu, Ming-Jin; Xiong, Cai-Hua] Huazhong Univ Sci & Technol, Inst Rehabil & Med Robot, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Hubei, Peoples R China; [Xiong, Le] Worcester Polytech Inst, Foisie Sch Business, Worcester, MA 01609 USA; [Huang, Xiao-Lin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Worcester Polytechnic Institute; Huazhong University of Science & Technology	Xiong, CH (corresponding author), Huazhong Univ Sci & Technol, Inst Rehabil & Med Robot, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Hubei, Peoples R China.	chxiong@hust.edu.cn			National Basic Research Program of China (973 Program) [2011CB013301]; National Natural Science Foundation of China [51335004]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Basic Research Program of China (973 Program, Grant No. 2011CB013301), and National Natural Science Foundation of China (Grant No. 51335004).	Braido P, 2004, HUM MOVEMENT SCI, V22, P661, DOI 10.1016/j.humov.2003.10.001; BROOK N, 1995, MED ENG PHYS, V17, P54, DOI 10.1016/1350-4533(95)90378-O; BUCHNER HJ, 1988, J BIOMECH, V21, P459, DOI 10.1016/0021-9290(88)90238-2; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Chang LY, 2006, IEEE INT CONF ROBOT, P1000, DOI 10.1109/ROBOT.2006.1641840; Chen WB, 2015, IEEE-ASME T MECH, V20, P1249, DOI 10.1109/TMECH.2014.2329006; Chen WB, 2010, GAIT POSTURE, V32, P475, DOI 10.1016/j.gaitpost.2010.07.005; CUTKOSKY MR, 1989, IEEE T ROBOTIC AUTOM, V5, P269, DOI 10.1109/70.34763; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Diogo R., 2012, COMP ANATOMY PHYLOGE; Diogo R, 2012, J HUM EVOL, V63, P64, DOI 10.1016/j.jhevol.2012.04.001; Doyle J. R., 2003, SURG ANATOMY HAND UP; Edwards S.J., 2002, DEV FUNCTIONAL HAND, P57; Feix T., 2009, P ROB SCI SYST C WOR; Fok KS, 2010, J BIOMECH, V43, P701, DOI 10.1016/j.jbiomech.2009.10.020; GARCIAELIAS M, 1991, J HAND SURG-AM, V16A, P1130, DOI 10.1016/S0363-5023(10)80079-6; Gray H., 1918, ANATOMY HUMAN BODY, V20th; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; HOLM S, 1979, SCAND J STAT, V6, P65; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Inman Mason, 2006, PLoS Biol, V4, pe196, DOI 10.1371/journal.pbio.0040196; Johnson RA., 2007, APPL MULTIVARIATE ST; Jolliffe L., 2005, PRINCIPAL COMPONENT; Kahle W, 2003, COLOR ATLAS HUMAN AN; KLATZKY RL, 1987, J MOTOR BEHAV, V19, P187; LANDSMEER JMF, 1963, J BONE JOINT SURG AM, V45, P1654, DOI 10.2106/00004623-196345080-00007; Leijnse JNAL, 2012, J BIOMECH, V45, P569, DOI 10.1016/j.jbiomech.2011.11.002; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079400; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; Mason CR, 2001, J NEUROPHYSIOL, V86, P2896, DOI 10.1152/jn.2001.86.6.2896; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALASTANGA N, 2006, ANATOMY HUMAN MOVEME; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Santello M, 1998, J NEUROSCI, V18, P10105; Santello M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00023; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Soechting JF, 1997, J COMPUT NEUROSCI, V4, P29, DOI 10.1023/A:1008812426305; Standring S, 2005, GRAYS ANATOMY ANATOM, V39th; van Duinen H, 2011, J PHYSIOL-LONDON, V589, P5583, DOI 10.1113/jphysiol.2011.217810; Xiong C. H., 2007, FUNDAMENTALS ROBOTIC; Xiong CH, 1999, INT J ROBOT RES, V18, P951, DOI 10.1177/02783649922066682	42	15	15	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146193	10.1371/journal.pone.0146193	http://dx.doi.org/10.1371/journal.pone.0146193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730579	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400113
J	Liu, X; Zhao, JX				Liu, Xia; Zhao, Jingxin			Chinese Migrant Adolescents' Perceived Discrimination and Psychological Well-Being: The Moderating Roles of Group Identity and the Type of School	PLOS ONE			English	Article							ETHNIC-IDENTITY; AFRICAN-AMERICAN; RACIAL-DISCRIMINATION; ADJUSTMENT; LATINO; IDENTIFICATION; DISTRESS; YOUNG; BLACK	Perceived discrimination can be harmful to migrant adolescents in China. However, little is known about the processes through which discrimination may be linked to decreased wellbeing in Chinese migrant adolescents. This study examined the relationship between perceived discrimination and three indices of psychological well-being (self-esteem, life satisfaction, collective self-esteem) in 798 Chinese migrant adolescents (49.4% from public schools). Group identity affirmation and belonging (GIAB) was examined as a protective factor that was expected to alleviate the negative effects of perceived discrimination on well-being, and the type of school was investigated as a potential moderator of the associations of interest. The results indicate that perceived discrimination was negatively linked to the three indices of psychological well-being and that the negative effects of perceived discrimination on psychological well-being were particularly salient for migrant adolescents attending public schools. Additionally, GIAB emerged as a protective buffer against perceived discrimination's negative effects on collective well-being.	[Liu, Xia] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China; [Zhao, Jingxin] Shandong Normal Univ, Sch Psychol, Jinan, Peoples R China	Beijing Normal University; Shandong Normal University	Liu, X (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China.	liuxia@bnu.edu.cn	Liu, Xia/AAL-7454-2021		National Social Science Fund of China [14BSH078]; Humanity and Social Science Youth Foundation of Ministry of Education of China [11YJC190015]	National Social Science Fund of China; Humanity and Social Science Youth Foundation of Ministry of Education of China	This research was supported by the National Social Science Fund of China (14BSH078) and the Humanity and Social Science Youth Foundation of Ministry of Education of China (11YJC190015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman A, 2010, THESIS, P5; Armenta BE, 2011, EUR J SOC PSYCHOL, V41, P107, DOI 10.1002/ejsp.742; Berkel C, 2010, J RES ADOLESCENCE, V20, P893, DOI 10.1111/j.1532-7795.2010.00668.x; Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037/0022-3514.77.1.135; Chen YY, 2013, CHINA ECON REV, V26, P75, DOI 10.1016/j.chieco.2013.04.007; Coll CG, 1996, CHILD DEV, V67, P1891, DOI 10.2307/1131600; Deng X., 2013, CHINESE J SPECIAL ED, V8, P48, DOI [10.3969/j.issn.1007-3728.2013.08.009, DOI 10.3969/J.ISSN.1007-3728.2013.08.009]; Duan C., 2013, S CHINA POPULATION, V28, P44; Eccles JS, 2006, J SCHOOL PSYCHOL, V44, P407, DOI 10.1016/j.jsp.2006.04.001; Edwards LM, 2008, HISPANIC J BEHAV SCI, V30, P24, DOI 10.1177/0739986307311431; ELLEMERS N, 1988, EUR J SOC PSYCHOL, V18, P497, DOI 10.1002/ejsp.2420180604; Ellemers Naomi, 1993, EUROPEAN REV SOCIAL, V4, P27, DOI DOI 10.1080/14792779343000013; [范兴华 Fan Xinghua], 2012, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V20, P539; [范兴华 Fan Xinghua], 2012, [心理学报, Acta Psychologica Sinica], V44, P647; Fang X. Y., 2011, J CHINESE ACAD GOVER, V3, P61; Fang XY., 2008, PSYCHOL DEV ED, V4, P93, DOI [10.16187/j.cnki.issn1001-4918.2008.04.011, DOI 10.16187/J.CNKI.ISSN1001-4918.2008.04.011, DOI 10.1371/J0URNAL.P0NE.0146559]; Fisher CB, 2000, J YOUTH ADOLESCENCE, V29, P679, DOI 10.1023/A:1026455906512; Flores E, 2008, HISPANIC J BEHAV SCI, V30, P401, DOI 10.1177/0739986308323056; Galliher RV, 2011, DEV PSYCHOL, V47, P509, DOI 10.1037/a0021061; Garstka TA, 2004, PSYCHOL AGING, V19, P326, DOI 10.1037/0882-7974.19.2.326; GONZALES NA, 1997, ISSUES CLIN CHILD PS, P481; Greene ML, 2006, DEV PSYCHOL, V42, P218, DOI 10.1037/0012-1649.42.2.218; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hou SD., 2011, PSYCHOL DEV ED, V27, P401, DOI 10.16187/j.cnki.issn1001-4918.2011.04.012; Hox J. J., 1998, CLASSIFICATION DATA, P147, DOI [DOI 10.1007/978-3-642-72087-1_17, 10.1007/978-3-642-72087-1_17]; Huebner E. S., 1991, SCHOOL PSYCHOL INT, V12, P231, DOI [10.1177/0143034391123010, DOI 10.1177/0143034391123010]; Lei YG, 2004, CHIN ED SCI RES, P27; [李小青 Li Xiaoqing], 2008, [心理科学, Psychological Science], V31, P909; [蔺秀云 LIN Xiu-Yun], 2009, [心理学报, Acta Psychologica Sinica], V41, P967; LUHTANEN R, 1992, PERS SOC PSYCHOL B, V18, P302, DOI 10.1177/0146167292183006; Masten AS, 1998, AM PSYCHOL, V53, P205, DOI 10.1037/0003-066X.53.2.205; Mesch GS, 2008, J YOUTH ADOLESCENCE, V37, P592, DOI 10.1007/s10964-007-9210-6; Miles J., 2001, APPL REGRESSION CORR; Park IJK, 2013, CULT DIVERS ETHN MIN, V19, P166, DOI 10.1037/a0028640; Phinney, 1992, J ADOLESCENT RES, V7, P156, DOI [10.1177/074355489272003, DOI 10.1177/074355489272003]; Phinney J., 2003, ACCULTURATION ADV TH, P63, DOI DOI 10.1037/10472-006; Phinney JS, 2007, J COUNS PSYCHOL, V54, P271, DOI 10.1037/0022-0167.54.3.271; Research Group of All China Womens Federation, 2013, CHIN WOMENS MOV, P30; Roberts RE, 1999, J EARLY ADOLESCENCE, V19, P301, DOI 10.1177/0272431699019003001; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Seaton EK, 2010, DEV PSYCHOL, V46, P1372, DOI 10.1037/a0019869; Seaton EK, 2010, J YOUTH ADOLESCENCE, V39, P694, DOI 10.1007/s10964-009-9438-4; Sellers RM, 2006, J RES ADOLESCENCE, V16, P187, DOI 10.1111/j.1532-7795.2006.00128.x; Shen, 2010, PSYCHOL SCI, V33, P693; Shen J., 2015, PSYCHOL DEV ED, V31, P108; Shen JL, 2008, CONT YOUTH RES, V27, P9; Shi BG, 2013, J CAP NORMAL U, P143; Smith TB, 2011, J COUNS PSYCHOL, V58, P42, DOI 10.1037/a0021528; Spencer M.B., 2006, HDB CHILD PSYCHOL, P829, DOI [10.1002/9780470147658.chpsy0115, DOI 10.1002/9780470147658.CHPSY0115]; Supple AJ, 2006, CHILD DEV, V77, P1427, DOI 10.1111/j.1467-8624.2006.00945.x; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tom DM, 2006, THESIS, P36; Toomey RB, 2013, J ADOLESCENCE, V36, P825, DOI 10.1016/j.adolescence.2013.06.004; Torres L, 2011, AM J ORTHOPSYCHIAT, V81, P526, DOI 10.1111/j.1939-0025.2011.01117.x; Umana-Taylor A. J., 2004, IDENTITY, V4, P9, DOI [10.1207/S1532706XID0401_2, DOI 10.1207/S1532706XID0401_2, 10.1207/s1532706xid0401_2]; Umana-Taylor A, 2012, J ADOLESCENCE, V35, P773, DOI 10.1016/j.adolescence.2011.11.003; Umana-Taylor AJ, 2011, J YOUTH ADOLESCENCE, V40, P140, DOI 10.1007/s10964-010-9511-z; Wang KQ., 2011, CHINA YOUTH STUDY, V3, P29; Wang XL, 1999, RATING SCALES MENTAL, P318; Wu QB, 2010, BRIT J SOC WORK, V40, P2578, DOI 10.1093/bjsw/bcq051; Xue S, 2007, CHIN J CLIN PSYCHOL, V15, P616; [薛松 XUE Song], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P612; Yuan X., 2012, PSYCHOL DEV ED, V28, P283, DOI [DOI 10.16187/J.CNKI.ISSN1001-4918.2012.03.004, 10.16187/j.cnki.issn1001-4918.2012.03.004]; [曾守锤 Zeng Shouchui], 2010, [心理科学, Psychological Science], V33, P456; Zhao Y, 2014, CHIN J CLIN PSYCHOL, V22, P521; [赵燕 Zhao Yan], 2014, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V22, P512	66	31	31	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146559	10.1371/journal.pone.0146559	http://dx.doi.org/10.1371/journal.pone.0146559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731529	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400190
J	Owusu, SA; Ross, AC				Owusu, Sarah A.; Ross, A. Catharine			Retinoid Homeostatic Gene Expression in Liver, Lung and Kidney: Ontogeny and Response to Vitamin A-Retinoic Acid (VARA) Supplementation from Birth to Adult Age	PLOS ONE			English	Article							NEONATAL-RATS; BINDING PROTEIN; ALVEOLAR DEVELOPMENT; PROXIMAL TUBULE; ESTER FORMATION; NEWBORN MICE; METABOLISM; INCREASES; MEGALIN; GROWTH	Vitamin A (VA, retinol) metabolism is homeostatically controlled, but little is known of its regulation in the postnatal period. Here, we determined the postnatal trajectory of VA storage and metabolism in major compartments of VA metabolism-plasma, liver, lung, and kidney from postnatal (P) day 1 to adulthood. We also investigated the response to supplementation with VARA, a combination of VA and 10% all-trans-retinoic acid that previously was shown to synergistically increase retinol uptake and storage in lung. Nursling pups of dams fed a VA-marginal diet received an oral dose of oil (placebo) or VARA on each of four neonatal days: P1, P4, P7, and P10; and again as adults. Tissues were collected 6 h after the final dosing on P1, P4, P10, and at adult age. Gene transcripts for Lrat and Rbp4 in liver and Raldh-1 and Raldh-3 in lung, did not differ in the neonatal period but were higher, P<0.05, in adults, while Cyp26B1, Stra6, megalin, and Raldh-2 in lung did not differ from perinatal to adult ages. VARA supplementation increased total retinol in plasma, liver and lung, with a dose-by-dose accumulation in neonatal liver and lung, while transcripts for Lrat in liver, megalin in kidney, Cyp26A1/B1 in liver and lung, respectively, and Stra6 in lung, were all increased, suggesting pathways of VA uptake, storage and RA oxidation were each augmented after VARA. VARA decreased hepatic expression of Rbp4, responsible for VA trafficking from liver to plasma, and, in lung, of Raldh-1 and Raldh-2, which function in RA production. Our results define retinoid homeostatic gene expression from neonatal and adult age and show that while supplementation with VARA acutely alters retinol content and retinoid homeostatic gene expression in neonatal and adult lung, liver and kidney, VARA supplementation of neonates increased adult-age VA content only in the liver.	[Owusu, Sarah A.] Penn State Univ, Grad Program Physiol, University Pk, PA 16802 USA; [Owusu, Sarah A.; Ross, A. Catharine] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Ross, A. Catharine] Penn State Univ, Huck Inst Life Sci, Ctr Mol & Cellular Immunol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ross, AC (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.	acr6@psu.edu			National Institute of Health [RO1 HD-066982]; Pennsylvania State University Bunton-Waller Fellowship; Pennsylvania State University Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD066982] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University Bunton-Waller Fellowship; Pennsylvania State University Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Health (RO1 HD-066982), the Pennsylvania State University Bunton-Waller Fellowship, and partial funding through Alfred P. Sloan Scholarship for PhD candidates through the Pennsylvania State University Center for Exemplary Mentoring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Christensen EI, 2002, PEDIATR NEPHROL, V17, P993, DOI 10.1007/s00467-002-0956-5; Christensen EI, 1999, J AM SOC NEPHROL, V10, P2224; James ML, 2013, AM J PHYSIOL-LUNG C, V304, pL803, DOI 10.1152/ajplung.00257.2012; James ML, 2010, PEDIATR RES, V67, P591, DOI 10.1203/PDR.0b013e3181dbac3d; Kumar VH, 2005, ADV CLIN CHEM, V40, P261, DOI 10.1016/S0065-2423(05)40007-4; Li RJ, 2008, ARCH ENVIRON CON TOX, V54, P748, DOI 10.1007/s00244-007-9054-9; Mactier H, 2005, ARCH DIS CHILD-FETAL, V90, P103, DOI 10.1136/adc.2004.057547; Maden M, 2004, CURR TOP DEV BIOL, V61, P153, DOI 10.1016/S0070-2153(04)61007-6; Maden M, 2004, PHILOS T R SOC B, V359, P799, DOI 10.1098/rstb.2004.1470; Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL305, DOI 10.1152/ajplung.1996.270.2.L305; Massaro GD, 2000, AM J PHYSIOL-LUNG C, V278, pL955, DOI 10.1152/ajplung.2000.278.5.L955; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; Raila J, 2000, VET RES, V31, P541, DOI 10.1051/vetres:2000138; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Ritter SJ, 1996, BBA-GEN SUBJECTS, V1291, P228, DOI 10.1016/S0304-4165(96)00070-0; Ross AC, 2007, J NUTR, V137, P2371, DOI 10.1093/jn/137.11.2371; Ross AC, 2007, NEONATOLOGY, V92, P26, DOI 10.1159/000100083; Ross AC, 2006, J NUTR, V136, P2803, DOI 10.1093/jn/136.11.2803; Ross AC, 2006, J LIPID RES, V47, P1844, DOI 10.1194/jlr.M600061-JLR200; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Ross AC, 2011, PHYSIOL GENOMICS, V43, P57, DOI 10.1152/physiolgenomics.00182.2010; Ross AC, 2004, J NUTR, V134, p269S, DOI 10.1093/jn/134.1.269S; Ross AC, 2003, J NUTR, V133, p271S, DOI 10.1093/jn/133.1.271S; Ross AC, 2005, INTRO VITAMIN A NUTR; Ross AC, 2012, BR J NUTR, P1; SHENAI JP, 1990, BIOL NEONATE, V57, P126, DOI 10.1159/000243172; SMITH JE, 1992, J NUTR, V122, P1999, DOI 10.1093/jn/122.10.1999; Tan LB, 2014, J LIPID RES, V55, P1738, DOI 10.1194/jlr.M050518; Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777; Vonend O, 2004, NEPHROL DIAL TRANSPL, V19, P2217, DOI 10.1093/ndt/gfh374; World Health Organization, 2009, REP WHO TECHN CONS V, Viv; World Health Organization,, 2011, GUID VIT A SUPPL INF; Wu LL, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-72; Wu LL, 2010, J LIPID RES, V51, P378, DOI 10.1194/jlr.M001222; ZACHMAN RD, 1995, J NUTR, V125, pS1634; Zhang Y, 2012, J NUTR, V142, P649, DOI 10.3945/jn.111.152660	43	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145924	10.1371/journal.pone.0145924	http://dx.doi.org/10.1371/journal.pone.0145924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731668	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400066
J	Pinto, RD; Roncalli, AG; Abreu, MHNG; Vargas, AMD				Pinto, Rafaela da Silveira; Roncalli, Angelo Giuseppe; Nogueira Guimaraes Abreu, Mauro Henrique; Duarte Vargas, Andrea Maria			Use of Public Oral Health Services by the Adult Population: A Multilevel Analysis	PLOS ONE			English	Article							DENTAL-CARE SERVICES; SOCIAL DETERMINANTS; OLDER-ADULTS; REGULAR USE; ACCESS; BRAZIL; PRIVATE; STATE; INEQUITY; PATTERNS	Background It is important to assess context to explain inequalities in oral health, particularly with regard to the type of service used; thus, this study aimed to identify the social determinants of public dental service use by adults and to assess whether, beyond the level individual, existing inequalities are also expressed in the context in which individuals are embedded. Methods A multilevel analysis with three levels of aggregation of variables was performed. The individual variables were derived from the database of the SB Minas Gerais project-a survey of oral health status of the population of Minas Gerais, a state of the Brazilian Southeast region. The variable at the neighborhood level came from the Census of 2010. The variables at the municipal level were obtained from available public databases relating to oral health services. At the municipal level, the Human Development Index (HDI) variable was chosen to represent quality of life in the municipalities. Results In the final model, the following individual variables were associated with greater use of public dental services: lower income (PR = 1.98, 95% CI = 1.53; 2.58), higher number of residents at home (PR = 1.37, 95% CI = 1.11; 1.68) and higher number of teeth requiring treatment (PR = 1.49, 95% CI = 1.20; 1.84). With regard to context variables, a poorer infrastructure (PR = 0.62, 95% CI = 0.40; 0.96) leads to a lower use of public services. Conclusion The use of public services is associated with family income, how this income is divided in households, the need for treatment presented by the individual and the organization of the existing oral health service infrastructure in the municipality.	[Pinto, Rafaela da Silveira] Minas Gerais State Hlth Dept, Oral Hlth Dept Minas Gerais, Belo Horizonte, MG, Brazil; [Pinto, Rafaela da Silveira; Nogueira Guimaraes Abreu, Mauro Henrique; Duarte Vargas, Andrea Maria] Univ Fed Minas Gerais, Sch Dent, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil; [Roncalli, Angelo Giuseppe] Univ Fed Rio Grande do Norte, Dept Dent, BR-59072970 Natal, RN, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Rio Grande do Norte	Pinto, RD (corresponding author), Minas Gerais State Hlth Dept, Oral Hlth Dept Minas Gerais, Belo Horizonte, MG, Brazil.	rafaelasilveirapinto@gmail.com	Abreu, Mauro Henrique/G-6502-2012	Abreu, Mauro Henrique/0000-0001-8794-5725; VARGAS, ANDREA/0000-0002-4371-9862; da Silveira Pinto, Rafaela/0000-0002-6169-7708	Research Support Foundation of the State of Minas Gerais (FAPEMIG); National Council of Scientific and Technological Development	Research Support Foundation of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council of Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This manuscript was funded by the Research Support Foundation of the State of Minas Gerais (FAPEMIG). National Council of Scientific and Technological Development - (http://www.cnpq.br) for its concession of grants to both RSP (SWP grant) and MHNGA (productivity in research - level 2). Minas Gerais State Health Department (SESMG) (http://www.saude.mg.gov.br) for their authorization of the use of their database. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript was funded by the Research Support Foundation of the State of Minas Gerais (FAPEMIG). The authors would like to thank the National Council of Scientific and Technological Development (CNPq) for its concession of grants to both RSP (SWP grant) and MHNGA (productivity in research-level 2). They also would like to thank the Minas Gerais State Health Department (SESMG) for their authorization for the use of their databank, which gave rise to this research project.	Agenda Nacional de Saude Suplementar, DAD IND SET BEN PLAN; Aguilera Sandra Lúcia Vieira Ulinski, 2014, Rev. bras. epidemiol., V17, P654, DOI 10.1590/1809-4503201400030007; Ajayi DM, 2012, AFR HEALTH SCI, V12, P507, DOI 10.4314/ahs.v12i4.17; ANDERSEN AS, 1983, MED CARE, V21, P266, DOI 10.1097/00005650-198303000-00002; Anikeeva O, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-432; Assis MMA, 2012, CIENC SAUDE COLETIVA, V17, P2865, DOI 10.1590/S1413-81232012001100002; Barros Aluísio J. D., 2002, Ciênc. saúde coletiva, V7, P709; Bos AMG, 2004, REV SAUDE PUBL, V38, P113, DOI 10.1590/S0034-89102004000100016; Pavao ALB, 2012, REV SAUDE PUBL, V46, P98, DOI 10.1590/S0034-89102012005000002; Brennan DS, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-1; Camargo MBJ, 2009, CAD SAUDE PUBLICA, V25, P1894, DOI 10.1590/S0102-311X2009000900004; Cohen-Carneiro F, 2009, CAD SAUDE PUBLICA, V25, P1827, DOI 10.1590/S0102-311X2009000800019; Miranda CDC, 2013, CAD SAUDE PUBLICA, V29, P2319, DOI [10.1590/0102-311x00139912, 10.1590/0102-311X00139912]; Martins AMEDL, 2008, CAD SAUDE PUBLICA, V24, P1651, DOI 10.1590/S0102-311X2008000700020; Martins AMEDL, 2007, REV PANAM SALUD PUBL, V22, P308, DOI 10.1590/S1020-49892007001000003; de Lacerda JT, 2004, REV SAUDE PUBL, V38, P453, DOI 10.1590/S0034-89102004000300017; Manhaes ALD, 2008, CAD SAUDE PUBLICA, V24, P207, DOI 10.1590/S0102-311X2008000100021; FDI World Dental Federation, 2014, OR HLTH WORLDW REP F; Gilbert GH, 1998, SOC SCI MED, V47, P727, DOI 10.1016/S0277-9536(98)00148-8; Gouveia Giselle Campozana, 2005, Cad. Saúde Pública, V21, pS109, DOI 10.1590/S0102-311X2005000700012; Guiotoku SK, 2012, REV PANAM SALUD PUBL, V31, P135, DOI 10.1590/S1020-49892012000200007; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Hancock M, 1999, J PUBLIC HEALTH MED, V21, P415, DOI 10.1093/pubmed/21.4.415; Instituto Brasileiro de Geografia e Estatistica, 2011, BAS INF CENS DEM 201; Instituto Brasileiro de Geografia e Estatistica, 2012, EST POP 1 JULH 2012; Instituto Brasileiro de Geografia e Estattstica, 2011, CENS DEM 2010 CAR PO; Chaves SCL, 2012, CIENC SAUDE COLETIVA, V17, P3115, DOI 10.1590/S1413-81232012001100027; Locker D, 2011, J PUBLIC HEALTH DENT, V71, P327, DOI 10.1111/j.1752-7325.2011.00277.x; Luzzi L, 2009, AUST DENT J, V54, P154, DOI 10.1111/j.1834-7819.2009.01109.x; Machado LP, 2012, REV SAUDE PUBL, V46, P526, DOI 10.1590/S0034-89102012000300015; Macinko James, 2012, Int J Equity Health, V11, P33, DOI [10.1186/1475-9276-11-80, 10.1186/1475-9276-11-33]; Matos D L, 2001, Cad Saude Publica, V17, P661, DOI 10.1590/S0102-311X2001000300020; Matos DL, 2007, CAD SAUDE PUBLICA, V23, P2740, DOI 10.1590/S0102-311X2007001100021; Mendoza-Sassi R, 2001, Cad Saude Publica, V17, P819, DOI 10.1590/S0102-311X2001000400016; Minayo MCS, 2000, CIENC SAUDE COLETIVA, V5, P7, DOI [10.1590/S1413-81232000000100002, DOI 10.1590/S1413-81232000000100002]; Ministerio da Saude, DATASUS CNES RECURSO; Ministerio da Saude, DATASUS PRODUCAO AMB; Narvai PC, 2010, CAD SAUDE PUBLICA, V26, P647, DOI 10.1590/S0102-311X2010000400002; Nguyen Lien, 2006, Eur J Health Econ, V7, P99, DOI 10.1007/s10198-006-0344-3; Peres KG, 2012, REV SAUDE PUBL, V46, P250, DOI 10.1590/S0034-89102012000200007; Pinheiro Rejane Sobrino, 2006, Ciênc. saúde coletiva, V11, P999, DOI 10.1590/S1413-81232006000400021; Pinto RD, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-100; Pinto RD, 2012, CIENC SAUDE COLETIVA, V17, P531, DOI 10.1590/S1413-81232012000200026; Programa das Naqoes Unidas para o Desenvolvimento, 2013, ATL DES HUM MUN 2013; Ribeiro Manoel Carlos Sampaio de Almeida, 2006, Ciênc. saúde coletiva, V11, P1011, DOI 10.1590/S1413-81232006000400022; Roberts-Thomson KF, 2008, AUST NZ J PUBL HEAL, V32, P444, DOI 10.1111/j.1753-6405.2008.00277.x; Roncalli AG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1097; Roncalli AG, 2012, CAD SAUDE PUBLICA, V28, pS40, DOI 10.1590/S0102-311X2012001300006; Secretaria de Estado de Saude de Minas Gerais, 2013, SB MIN GER PESQ COND; Sheiham A, 2011, Adv Dent Res, V23, P259, DOI 10.1177/0022034511402084; Slack-Smith L, 2010, GERODONTOLOGY, V27, P104, DOI 10.1111/j.1741-2358.2009.00320.x; Snijders T. A. B., 2003, MULTILEVEL ANAL INTR; TENNSTEDT SL, 1994, J PUBLIC HEALTH DENT, V54, P211, DOI 10.1111/j.1752-7325.1994.tb01217.x; [Um Panorama da Saude no Brasil Institute Brasileirode Geografiae Estattstica], 2010, PAN SAUD BRAS ACC UT; Wamala S, 2006, J EPIDEMIOL COMMUN H, V60, P1027, DOI 10.1136/jech.2006.046896; World Health Organisation, 2009, COUNTR COOP STRAT GL	56	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145149	10.1371/journal.pone.0145149	http://dx.doi.org/10.1371/journal.pone.0145149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26730714	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400024
J	Sarker, BK; Rahman, M; Rahman, T; Hossain, J; Reichenbach, L; Mitra, DK				Sarker, Bidhan Krishna; Rahman, Musfikur; Rahman, Tawhidur; Hossain, Jahangir; Reichenbach, Laura; Mitra, Dipak Kumar			Reasons for Preference of Home Delivery with Traditional Birth Attendants (TBAs) in Rural Bangladesh: A Qualitative Exploration	PLOS ONE			English	Article								Background and Objectives Although Bangladesh has made significant progress in reducing maternal and child mortality in the last decade, childbirth assisted by skilled attendants has not increased as much as expected. An objective of the Bangladesh National Strategy for Maternal Health 2014-2024 is to reduce maternal mortality to 50/100,000 live births. It also aims to increase deliveries with skilled birth attendants to more than 80% which remains a great challenge, especially in rural areas. This study explores the underlying factors for the major reliance on home delivery with Traditional Birth Attendants (TBA) in rural areas of Bangladesh. Methods This was a qualitative cross-sectional study. Data were collected between December 2012 and February 2013 in Sunamganj district of Sylhet division and data collection methods included key informant interviews (KII) with stakeholders; formal and informal health service providers and health managers; and in-depth interviews (IDI) with community women to capture a range of information. Key questions were asked of all the study participants to explore the question of why women and their families prefer home delivery by TBA and to identify the factors associated with this practice in the local community. Results The study shows that home delivery by TBAs remain the first preference for pregnant women. Poverty is the most frequently cited reason for preferring home delivery with a TBA. Other major reasons include; traditional views, religious fallacy, poor road conditions, limited access of women to decision making in the family, lack of transportation to reach the nearest health facility. Apart from these, community people also prefer home delivery due to lack of knowledge and awareness about service delivery points, fear of increased chance of having a caesarean delivery at hospital, and lack of female doctors in the health care facilities. Conclusions The study findings provide us a better understanding of the reasons for preference for home delivery with TBA among this population. These identified factors can inform policy makers and program implementers to adopt socially and culturally appropriate interventions that can improve deliveries with skilled attendants and thus contribute to the reduction of maternal and neonatal mortality and morbidity in rural Bangladesh.	[Sarker, Bidhan Krishna; Rahman, Musfikur; Rahman, Tawhidur; Reichenbach, Laura] Icddr b, Ctr Reprod Hlth, Dhaka, Bangladesh; [Hossain, Jahangir] Pragati Insurance Bhabhan, Care Bangladesh, Dhaka 1215, Bangladesh; [Reichenbach, Laura] Populat Council, Res, Evidence Project, Washington, DC USA; [Mitra, Dipak Kumar] Johns Hopkins Univ, Int Ctr Maternal & Newborn Hlth, Dept Int Hlth, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); Population Council; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sarker, BK (corresponding author), Icddr b, Ctr Reprod Hlth, GPO Box 1000, Dhaka, Bangladesh.	bidhan@icddrb.org	Hossain, Jahangir/AAD-5492-2020; Mitra, Dipak/W-9569-2018	Hossain, Jahangir/0000-0001-7602-3581; Mitra, Dipak/0000-0001-8680-4146	GlaxoSmithKline (GSK) through CARE Bangladesh [GR-01011]	GlaxoSmithKline (GSK) through CARE Bangladesh	This research protocol was funded by GlaxoSmithKline (GSK) through CARE Bangladesh, grant number GR-01011. icddr,b acknowledges with gratitude the commitment of GSK and CARE Bangladesh to its research efforts. The following are links of donor and recipient. http://www.carebangladesh.org/care_current_project.php; http://www.icddrb.org/protocols/display/protocol/799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INC EXP POV; [Anonymous], 2001, SKILL ATT DEL BANGL, P38; [Anonymous], 2014, WORK PAP BAS FIND QU; Ara Sharmin, 2013, AM J LIFE SCI, V1, P93, DOI 10.11648/j.ajls.20130103.13; Carter Alexandra, 2010, 82 ISP; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Imogie A O, 2002, Afr J Reprod Health, V6, P94, DOI 10.2307/3583135; Kkonde A, 2010, FACTORS INFLUENCE PR; Matsuoka S, 2010, HEALTH POLICY, V95, P255, DOI 10.1016/j.healthpol.2009.12.011; Mekonnen MG, 2012, PAN AFRICAN MED J S1, V13; Millennium Development Goals, 2014, MILL DEV GOALS BAGNL; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ICF International and ICBBRB, 2012, BANGL MAT MORT HLTH; Parkhurst JO, 2009, HEALTH POLICY PLANN, V24, P377, DOI 10.1093/heapol/czp023; Population and Housing Census, 2012, COMM REP SUN ZIL; Prasad K. Raghava, 2001, Journal of Human Ecology, V12, P357; Rajalakshmi TK, 2012, FRONTLINE INDIA 0908, V29; Rajesh Garg, 2010, Health and Population - Perspectives and Issues, V33, P23; Shah N, 2010, J PAK MED ASSOC, V60, P555; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Some TD, REPROD HLTH, V8, P2; Sychareun V, 2009, ASIAN PACIFIC RESOUR, P3; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43	25	94	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146161	10.1371/journal.pone.0146161	http://dx.doi.org/10.1371/journal.pone.0146161			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731276	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400108
J	Van Poucke, S; Zhang, ZH; Schmitz, M; Vukicevic, M; Vander Laenen, M; Celi, LA; De Deyne, C				Van Poucke, Sven; Zhang, Zhongheng; Schmitz, Martin; Vukicevic, Milan; Vander Laenen, Margot; Celi, Leo Anthony; De Deyne, Cathy			Scalable Predictive Analysis in Critically Ill Patients Using a Visual Open Data Analysis Platform	PLOS ONE			English	Article							ACUTE PHYSIOLOGY SCORE; SELECTION	With the accumulation of large amounts of health related data, predictive analytics could stimulate the transformation of reactive medicine towards Predictive, Preventive and Personalized (PPPM) Medicine, ultimately affecting both cost and quality of care. However, high-dimensionality and high-complexity of the data involved, prevents data-driven methods from easy translation into clinically relevant models. Additionally, the application of cutting edge predictive methods and data manipulation require substantial programming skills, limiting its direct exploitation by medical domain experts. This leaves a gap between potential and actual data usage. In this study, the authors address this problem by focusing on open, visual environments, suited to be applied by the medical community. Moreover, we review code free applications of big data technologies. As a showcase, a framework was developed for the meaningful use of data from critical care patients by integrating the MIMIC-II database in a data mining environment (RapidMiner) supporting scalable predictive analytics using visual tools (RapidMiner's Radoop extension). Guided by the CRoss-Industry Standard Process for Data Mining (CRISP-DM), the ETL process (Extract, Transform, Load) was initiated by retrieving data from the MIMIC-II tables of interest. As use case, correlation of platelet count and ICU survival was quantitatively assessed. Using visual tools for ETL on Hadoop and predictive modeling in RapidMiner, we developed robust processes for automatic building, parameter optimization and evaluation of various predictive models, under different feature selection schemes. Because these processes can be easily adopted in other projects, this environment is attractive for scalable predictive analytics in health research.	[Van Poucke, Sven; Vander Laenen, Margot; De Deyne, Cathy] Ziekenhuis Oost Limburg, Dept Anesthesiol Intens Care Emergency Med & Pain, Genk, Belgium; [Zhang, Zhongheng] Zhejiang Univ, Jinhua Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China; [Schmitz, Martin] RapidMiner GmbH, Dortmund, Germany; [Vukicevic, Milan] Univ Belgrade, Dept Org Sci, Belgrade, Serbia; [Celi, Leo Anthony] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [De Deyne, Cathy] Univ Hasselt, Fac Med, Limburg Clin Res Program, Hasselt, Belgium	East Limburg Hospital; Zhejiang University; University of Belgrade; Massachusetts Institute of Technology (MIT); Hasselt University	Van Poucke, S (corresponding author), Ziekenhuis Oost Limburg, Dept Anesthesiol Intens Care Emergency Med & Pain, Genk, Belgium.	svanpoucke@gmail.com	Vukicevic, Milan/GOH-2563-2022; Zhang, Zhongheng/E-1282-2011; Van Poucke, Sven/K-5999-2016; Vukicevic, Milan/X-3590-2019; PAN, ZEQIANG/X-6341-2018; zhang, zh/GWV-4677-2022	Vukicevic, Milan/0000-0002-1631-6531; Zhang, Zhongheng/0000-0002-2336-5323; Van Poucke, Sven/0000-0001-8070-8786; 	National Institutes of Health (NIH) through National Institute of Biomedical Imaging and Bioengineering [R01 EB01720501A1]; Vancis B.V. (Amsterdam, NL); Xomnia B.V. (Amsterdam, NL); RapidMiner; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017205] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vancis B.V. (Amsterdam, NL); Xomnia B.V. (Amsterdam, NL); RapidMiner; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	LAC was funded by the National Institutes of Health (NIH) through National Institute of Biomedical Imaging and Bioengineering grant R01 EB01720501A1. Access, licenses and support for Hadoop/Hiveare were provided by Vancis B.V. (Amsterdam, NL) and Xomnia B.V. (Amsterdam, NL). Licenses for RapidMiner/Radoop were provided by RapidMiner (Cambridge, MA, USA). RapidMiner provides free or substantially discounted use of the commercial version of its platform to students, professors, researchers and other academics at educational institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RapidMiner provided support in the form of salary for author [MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chao CM, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0106-1; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Davis J, P 23 INT C MACH LEAR, P230, DOI [http://doi.acm.org/10.1145/1143844.1143874J, DOI 10.1145/1143844.1143874J]; Druss BG, 2000, AM J PSYCHIAT, V157, P1485, DOI 10.1176/appi.ajp.157.9.1485; Edwards DD., 2003, ARTIF INTELL, V2; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Friedrichs F, 2005, NEUROCOMPUTING, V64, P107, DOI 10.1016/j.neucom.2004.11.022; Ghassemi M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0801-4; Goldberg DE, 1989, GENETIC ALGORITHMS S; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Golubnitschaja O, 2014, EPMA J, V5, DOI [10.1186/1878-5085-5-6, 10.1186/s13167-015-0026-2]; Grau J, 2015, PRECISION RECALL ROC; Hall M, 2013, WEKA AND HADOOP; Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Herschel G, MAGIC QUADRANT ADV A; Jovic A, 2014, 2014 37TH INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P1112, DOI 10.1109/MIPRO.2014.6859735; Kamkar I, 2015, J BIOMED INFORM, V53, P277, DOI 10.1016/j.jbi.2014.11.013; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Koliopoulos AK, 2015, IEEE INT CONGR BIG, P9, DOI 10.1109/BigDataCongress.2015.12; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Landset S., 2015, J BIG DATA-GER, V2, P1, DOI [10.1186/s40537-015-0032-1, DOI 10.1186/S40537-015-0032-1]; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Mao KZ, 2004, IEEE T SYST MAN CY B, V34, P629, DOI 10.1109/TSMCB.2002.804363; Mohammadzadeh Niloofar, 2014, Acta Inform Med, V22, P263, DOI 10.5455/aim.2014.22.263-267; Mohammed EA, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-22; Ni Z, 2013, THESIS; Nick RK, 2015, 18 INT C EXT DAT TEC, P671; Olston C., 2008, P 2008 ACM SIGMOD IN, P1099, DOI [10.1145/1376616.1376726, DOI 10.1145/1376616.1376726]; Post RM, 2015, COMPR PSYCHIAT, V56, P21, DOI 10.1016/j.comppsych.2014.08.050; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Radovanovic S, 2015, P 15 C ART INT MED 2; Riley RD, 2015, STAT MED, P1097, DOI DOI 10.1002/SIM.6471/ABSTRACT; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Rittho O., 2001, LLWA 01 TAG GI WORKS, P84; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; Scott DJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-9; Shearer C, 2000, J DATA WAREHOUSING, V15, P13; Sparks ER, 2013, IEEE DATA MINING, P1187, DOI 10.1109/ICDM.2013.158; Thusoo A, 2010, PROC INT CONF DATA, P996, DOI 10.1109/ICDE.2010.5447738; Ting H, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0094-1; Van Poucke S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0895-8; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wimmer H, 2015, COMP OPEN SOURCE TOO, P1; Wolfson J, 2014, NAIVE BAYES MACHINE; Zaharia M, 2012, USENIX LOGIN, V37, P45; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095204; Zheng J, 2014, IEEE INT CONF BIG DA, P952, DOI 10.1109/BigData.2014.7004327	56	29	29	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145791	10.1371/journal.pone.0145791	http://dx.doi.org/10.1371/journal.pone.0145791			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731286	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400054
J	Basto, MP; Santos-Reis, M; Simoes, L; Grilo, C; Cardoso, L; Cortes, H; Bruford, MW; Fernandes, C				Basto, Mafalda P.; Santos-Reis, Margarida; Simoes, Luciana; Grilo, Clara; Cardoso, Luis; Cortes, Helder; Bruford, Michael W.; Fernandes, Carlos			Assessing Genetic Structure in Common but Ecologically Distinct Carnivores: The Stone Marten and Red Fox	PLOS ONE			English	Article							ASSESSING POPULATION-STRUCTURE; MULTILOCUS GENOTYPE DATA; COMPUTER-PROGRAM; VULPES-VULPES; LANDSCAPE GENETICS; ASSIGNMENT METHODS; RECENT MIGRATION; CENTRAL SPAIN; MICROSATELLITE; DIFFERENTIATION	The identification of populations and spatial genetic patterns is important for ecological and conservation research, and spatially explicit individual-based methods have been recognised as powerful tools in this context. Mammalian carnivores are intrinsically vulnerable to habitat fragmentation but not much is known about the genetic consequences of fragmentation in common species. Stone martens (Martes foina) and red foxes (Vulpes vulpes) share a widespread Palearctic distribution and are considered habitat generalists, but in the Iberian Peninsula stone martens tend to occur in higher quality habitats. We compared their genetic structure in Portugal to see if they are consistent with their differences in ecological plasticity, and also to illustrate an approach to explicitly delineate the spatial boundaries of consistently identified genetic units. We analysed microsatellite data using spatial Bayesian clustering methods (implemented in the software BAPS, GENELAND and TESS), a progressive partitioning approach and a multivariate technique (Spatial Principal Components Analysis-sPCA). Three consensus Bayesian clusters were identified for the stone marten. No consensus was achieved for the red fox, but one cluster was the most probable clustering solution. Progressive partitioning and sPCA suggested additional clusters in the stone marten but they were not consistent among methods and were geographically incoherent. The contrasting results between the two species are consistent with the literature reporting stricter ecological requirements of the stone marten in the Iberian Peninsula. The observed genetic structure in the stone marten may have been influenced by landscape features, particularly rivers, and fragmentation. We suggest that an approach based on a consensus clustering solution of multiple different algorithms may provide an objective and effective means to delineate potential boundaries of inferred subpopulations. sPCA and progressive partitioning offer further verification of possible population structure and may be useful for revealing cryptic spatial genetic patterns worth further investigation.	[Basto, Mafalda P.; Santos-Reis, Margarida; Simoes, Luciana; Fernandes, Carlos] Univ Lisbon, Fac Ciencias, Ce3C, Lisbon, Portugal; [Basto, Mafalda P.; Bruford, Michael W.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Grilo, Clara] Univ Fed Lavras, Programa Posgrad Ecol Aplicada, Ctr Brasileiro Estudos Ecol Estradas, Lavras, MG, Brazil; [Cardoso, Luis] Univ Tras Os Montes & Alto Douro UTAD, Escola Ciencias Agr & Vet, Dept Ciencias Vet, Vila Real, Portugal; [Cortes, Helder] Univ Evora, ICAAM, Lab Parasitol Victor Caeiro, Evora, Portugal	Universidade de Lisboa; Cardiff University; Universidade Federal de Lavras; University of Tras-os-Montes & Alto Douro; University of Evora	Basto, MP (corresponding author), Univ Lisbon, Fac Ciencias, Ce3C, Lisbon, Portugal.	mafalda.basto@gmail.com	Fernandes, Carlos/AAB-5256-2019; Grilo, Clara/H-2002-2012; Santos-Reis, Margarida/H-4064-2011; Bruford, Michael/Y-7463-2019; Bruford, Michael W/D-3750-2009; Fernandes, Carlos/J-3045-2013; Cardoso, Luís/J-8310-2013	Fernandes, Carlos/0000-0002-1386-8103; Grilo, Clara/0000-0001-9870-3115; Bruford, Michael/0000-0001-6357-6080; Bruford, Michael W/0000-0001-6357-6080; Fernandes, Carlos/0000-0002-1386-8103; Cardoso, Luís/0000-0002-6145-7560; Santos-Reis, Margarida/0000-0002-0337-963X; Cortes, Helder/0000-0003-4644-2165	Fundacao para a Ciencia e Tecnologia [SFRH/BD/38410/2007, C2007-UL-342-CBA1, PTDC/BIA-BEC/101511/2008]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	MPB and CF acknowledge financial support from Fundacao para a Ciencia e Tecnologia through the PhD fellowship SFRH/BD/38410/2007, the Ciencia 2007 contract C2007-UL-342-CBA1, and the research project PTDC/BIA-BEC/101511/2008.	Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; [Anonymous], 2014, TRACER V1 6; [Anonymous], 1996, 5000 CNRS UMR; Atterby H, 2015, MAMMAL RES, V60, P9, DOI 10.1007/s13364-014-0209-6; Aurelle D, 2013, CONSERV GENET, V14, P705, DOI 10.1007/s10592-013-0464-0; Ball MC, 2010, CONSERV GENET, V11, P2131, DOI 10.1007/s10592-010-0099-3; Basto MP, 2010, CONSERV GENET RESOUR, V2, P317, DOI 10.1007/s12686-010-9217-2; Basto MP, 2014, THESIS; Benito G, 2003, CLIMATIC CHANGE, V58, P171, DOI 10.1023/A:1023417102053; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; BIVAND R, 2007, SPDEP SPATIAL DEPEND; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; Cegelski CC, 2003, MOL ECOL, V12, P2907, DOI 10.1046/j.1365-294X.2003.01969.x; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cohen TM, 2013, CONSERV GENET, V14, P55, DOI 10.1007/s10592-012-0423-1; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Costa A, 2011, LANDSCAPE URBAN PLAN, V102, P164, DOI 10.1016/j.landurbplan.2011.04.002; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Cullingham CI, 2009, MOL ECOL, V18, P43, DOI 10.1111/j.1365-294X.2008.03989.x; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Diaz-Ruiz F, 2013, MAMMAL REV, V43, P59, DOI 10.1111/j.1365-2907.2011.00206.x; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; DOW BD, 1995, THEOR APPL GENET, V91, P137, DOI 10.1007/BF00220870; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DURAND E, 2009, TESS VERSION 2 3 REF; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epperson BK, 2005, MOL ECOL, V14, P703, DOI 10.1111/j.1365-294X.2005.02429.x; Epperson BK, 2010, MOL ECOL, V19, P3549, DOI 10.1111/j.1365-294X.2010.04678.x; Estoup A, 1998, MOL ECOL, V7, P339, DOI 10.1046/j.1365-294X.1998.00362.x; Falush D, 2003, GENETICS, V164, P1567; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Fernandes CA, 2008, CONSERV GENET, V9, P681, DOI 10.1007/s10592-007-9364-5; Ferreira E, 2009, MAMM BIOL, V74, P274, DOI 10.1016/j.mambio.2008.05.009; Fogelqvist J, 2010, MOL ECOL RESOUR, V10, P314, DOI 10.1111/j.1755-0998.2009.02756.x; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Genovesi P, 1997, CAN J ZOOL, V75, P1966, DOI 10.1139/z97-828; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2012, POPULATION GENETIC M; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Guillot G, 2009, MOL ECOL RESOUR, V9, P1112, DOI 10.1111/j.1755-0998.2008.02496.x; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hapeman P, 2011, J HERED, V102, P251, DOI 10.1093/jhered/esr001; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hobbs GI, 2011, J APPL ECOL, V48, P1206, DOI 10.1111/j.1365-2664.2011.02028.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hunter M.L., 2007, FUNDAMENTALS CONSERV, V3rd; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; Kukekova AV, 2007, GENOME RES, V17, P387, DOI 10.1101/gr.5893307; Kyle CJ, 2003, CONSERV GENET, V4, P179, DOI 10.1023/A:1023334521996; Kyle CJ, 2001, MOL ECOL, V10, P2341, DOI 10.1046/j.1365-294X.2001.01351.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Loxterman JL, 2011, CONSERV GENET, V12, P1049, DOI 10.1007/s10592-011-0208-y; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Macdonald DW, 2008, IUCN 2011 IUCN RED L; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Manel S, 2002, CONSERV BIOL, V16, P650, DOI 10.1046/j.1523-1739.2002.00576.x; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Mucci N, 2010, CONSERV GENET, V11, P583, DOI 10.1007/s10592-010-0054-3; Mullins J, 2014, ACTA THERIOL, V59, P367, DOI 10.1007/s13364-014-0180-2; Nagai T, 2012, MAMM STUDY, V37, P353, DOI 10.3106/041.037.0410; Nystrom V, 2006, OIKOS, V114, P84, DOI 10.1111/j.2006.0030-1299.14701.x; Oishi T, 2011, J HERED, V102, P38, DOI 10.1093/jhered/esq091; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Palsboll PJ, 1999, GENETICS, V151, P285; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pease KM, 2009, MOL ECOL, V18, P1848, DOI 10.1111/j.1365-294X.2009.04112.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reding DM, 2012, MOL ECOL, V21, P3078, DOI 10.1111/j.1365-294X.2012.05595.x; REIG S, 1992, J MAMMAL, V73, P744, DOI 10.2307/1382193; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Rutledge LY, 2010, HEREDITY, V105, P520, DOI 10.1038/hdy.2010.6; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Sacks BN, 2004, MOL ECOL, V13, P1265, DOI 10.1111/j.1365-294X.2004.02110.x; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Santos MJ, 2010, EUR J WILDLIFE RES, V56, P275, DOI 10.1007/s10344-009-0317-9; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Tucker JM, 2014, CONSERV GENET, V15, P123, DOI 10.1007/s10592-013-0525-4; VALERIO N, 2001, ESTATISTICAS HIST PO, V1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vergara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134257; Virgos E, 2002, ACTA OECOL, V23, P231, DOI 10.1016/S1146-609X(02)01142-6; Vis GJ, 2010, J QUATERNARY SCI, V25, P1222, DOI 10.1002/jqs.1401; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whiteley AR, 2006, MOL ECOL, V15, P2767, DOI 10.1111/j.1365-294X.2006.02972.x; Whiteside HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022145; Wilson GA, 2003, GENETICS, V163, P1177; Wisely SM, 2004, J MAMMAL, V85, P640, DOI 10.1644/BEL-011; Zigouris J, 2012, CONSERV GENET, V13, P1543, DOI 10.1007/s10592-012-0399-x	130	10	11	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145165	10.1371/journal.pone.0145165	http://dx.doi.org/10.1371/journal.pone.0145165			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727497	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000367681500010
J	Buttet, M; Poirier, H; Traynard, V; Gaire, K; Tran, TTT; Sundaresan, S; Besnard, P; Abumrad, NA; Niot, I				Buttet, Marjorie; Poirier, Helene; Traynard, Veronique; Gaire, Kevin; Tran, Thi Thu Trang; Sundaresan, Sinju; Besnard, Philippe; Abumrad, Nada A.; Niot, Isabelle			Deregulated Lipid Sensing by Intestinal CD36 in Diet-Induced Hyperinsulinemic Obese Mouse Model	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; METABOLIC SYNDROME; LIPOPROTEIN METABOLISM; NONFASTING TRIGLYCERIDES; INSULIN-RESISTANCE; CHOLESTEROL UPTAKE; DISTAL INTESTINE; ABSORPTION; SECRETION; TRANSPORT	The metabolic syndrome (MetS) greatly increases risk of cardiovascular disease and diabetes and is generally associated with abnormally elevated postprandial triglyceride levels. We evaluated intestinal synthesis of triglyceride-rich lipoproteins (TRL) in a mouse model of the MetS obtained by feeding a palm oil-rich high fat diet (HFD). By contrast to control mice, MetS mice secreted two populations of TRL. If the smaller size population represented 44% of total particles in the beginning of intestinal lipid absorption in MetS mice, it accounted for only 17% after 4 h due to the secretion of larger size TRL. The MetS mice displayed accentuated postprandial hypertriglyceridemia up to 3 h due to a defective TRL clearance. These alterations reflected a delay in lipid induction of genes for key proteins of TRL formation (MTP, L-FABP) and blood clearance (ApoC2). These abnormalities associated with blunted lipid sensing by CD36, which is normally required to optimize jejunal formation of large TRL. In MetS mice CD36 was not downregulated by lipid in contrast to control mice. Treatment of controls with the proteosomal inhibitor MG132, which prevented CD36 downregulation, resulted in blunted lipid-induction of MTP, L-FABP and ApoC2 gene expression, as in MetS mice. Absence of CD36 sensing was due to the hyperinsulinemia in MetS mice. Acute insulin treatment of controls before lipid administration abolished CD36 downregulation, lipid-induction of TRL genes and reduced postprandial triglycerides (TG), while streptozotocin-treatment of MetS mice restored lipid-induced CD36 degradation and TG secretion. In vitro, insulin treatment abolished CD36-mediated up-regulation of MTP in Caco-2 cells. In conclusion, HFD treatment impairs TRL formation in early stage of lipid absorption via insulin-mediated inhibition of CD36 lipid sensing. This impairment results in production of smaller TRL that are cleared slowly from the circulation, which might contribute to the reported association of CD36 variants with MetS risk.	[Buttet, Marjorie; Poirier, Helene; Traynard, Veronique; Gaire, Kevin; Tran, Thi Thu Trang; Besnard, Philippe; Niot, Isabelle] Univ Bourgogne, AgroSup Dijon, INSERM, Physiol Nutr & Toxicol NUTox,UMR U866, F-21000 Dijon, France; [Sundaresan, Sinju] Univ Michigan, Div Gastroenterol, Dept Med, Ann Arbor, MI 48109 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, Dept Med, St Louis, MO 63110 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of Michigan System; University of Michigan; Washington University (WUSTL); Washington University (WUSTL)	Niot, I (corresponding author), Univ Bourgogne, AgroSup Dijon, INSERM, Physiol Nutr & Toxicol NUTox,UMR U866, F-21000 Dijon, France.	niot@u-bourgogne.fr			Fonds Unique Interministeriel (FUI SYMPPA); French Government [ANR-12-BSV1-0027]; Ministere de l'Enseignement Superieur et de la Recherche; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060022, P30DK056341] Funding Source: NIH RePORTER	Fonds Unique Interministeriel (FUI SYMPPA); French Government; Ministere de l'Enseignement Superieur et de la Recherche; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by: the Fonds Unique Interministeriel (FUI SYMPPA); a French Government grant managed by the National Research Agency (ANR) under the program "SensoFAT 2" (ANR-12-BSV1-0027). M.B. was financed by the Fonds Unique Interministeriel (FUI SYMPPA), and V.T. and T.T.T. were financed by the Ministere de l'Enseignement Superieur et de la Recherche.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Couture P, 2014, J LIPID RES, V55, P128, DOI 10.1194/jlr.M040071; de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, pG589, DOI 10.1152/ajpgi.00488.2011; de Wit NJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019145; Douglass JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00025; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Farook VS, 2012, OBESITY, V20, P2083, DOI 10.1038/oby.2012.74; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; Freire RD, 2005, DIABETES CARE, V28, P1779, DOI 10.2337/diacare.28.7.1779; Geloen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037633; Hayashi AA, 2011, AM J PHYSIOL-GASTR L, V301, pG326, DOI 10.1152/ajpgi.00425.2010; Hsieh J, 2009, GASTROENTEROLOGY, V137, P997, DOI 10.1053/j.gastro.2009.05.051; Jackson KG, 2013, METABOLISM, V62, P1065, DOI 10.1016/j.metabol.2013.03.001; Jia L, 2010, J LIPID RES, V51, P3135, DOI 10.1194/jlr.M006353; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kolovou GD, 2006, EUR J CARDIOV PREV R, V13, P661, DOI 10.1097/01.hjr.0000224490.10845.26; Kondo H, 2006, AM J PHYSIOL-ENDOC M, V291, pE1092, DOI 10.1152/ajpendo.00583.2005; Kuda O, 2013, J BIOL CHEM, V288, P15547, DOI 10.1074/jbc.M113.473298; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; Larsen MA, 2015, CLIN OBES; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; LIN MCM, 1994, J BIOL CHEM, V269, P29138; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Maljaars PWJ, 2008, PHYSIOL BEHAV, V95, P271, DOI 10.1016/j.physbeh.2008.07.018; Martins IJ, 1996, J LIPID RES, V37, P2696; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; Noel SE, 2010, ATHEROSCLEROSIS, V211, P210, DOI 10.1016/j.atherosclerosis.2010.02.009; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545; Pavlic M, 2010, DIABETES, V59, P580, DOI 10.2337/db09-1297; PETERSON J, 1990, P NATL ACAD SCI USA, V87, P909, DOI 10.1073/pnas.87.3.909; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Poirier H, 1997, AM J PHYSIOL-GASTR L, V273, pG289, DOI 10.1152/ajpgi.1997.273.2.G289; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Shojaee-Moradie F, 2013, DIABETES, V62, P4063, DOI 10.2337/db13-0935; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Sundaresan S, 2013, FASEB J, V27, P1191, DOI 10.1096/fj.12-217703; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; van der Veen JN, 2005, J LIPID RES, V46, P526, DOI 10.1194/jlr.M400400-JLR200; Wong ATY, 2014, J CLIN ENDOCR METAB, V99, pE122, DOI 10.1210/jc.2013-2477; Zhu SK, 2004, METABOLISM, V53, P1503, DOI 10.1016/j.metabol.2004.04.017	51	22	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145626	10.1371/journal.pone.0145626	http://dx.doi.org/10.1371/journal.pone.0145626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727015	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500024
J	Guo, J; Ren, XZ; Wang, XH; Qu, ZY; Zhou, QY; Ran, C; Wang, X; Hu, J				Guo, Jing; Ren, Xuezhu; Wang, Xiaohua; Qu, Zhiyong; Zhou, Qianyun; Ran, Chun; Wang, Xia; Hu, Juan			Depression among Migrant and Left-Behind Children in China in Relation to the Quality of Parent-Child and Teacher-Child Relationships	PLOS ONE			English	Article							BEHAVIORAL-ADJUSTMENT; STUDENT RELATIONSHIP; ATTACHMENT; INVENTORY; SUPPORT	The objective of this study was to examine rates of depression among migrant children (MC) and left-behind children (LBC) as compared to non-left-behind children (NLBC) and also to examine the relationship between depression among these children and the quality of their parent-child and teacher-child relationships. This study collected data from a large sample of 3,759 children aged from 8 to 17 years, including 824 who had been left behind by one parent (LBCO), 423 who had been left behind by both parents (LBCB), 568 MC and 1944 NLBC. Children's Depression Inventory-Short Form was used to measure child depression. Parent-Child Relationship Scale (PCRS) and Teacher-Child Relationship Scale (TCRS) were used to measure the quality of parent-child and teacher-child relationships, respectively. The results showed that the prevalence of depression was 10.5% among NLBC, 13.1% among LBCO, 16.1% among LBCB, and 20.1% among MC. Depression was related to parent-child relationship quality and teacher-child relationship quality. Negative parent-child relationship was more relevant to depression than negative teacher-child relationship among LBCB, while negative teacher-child relationship was the most correlated with depression among MC.	[Guo, Jing; Zhou, Qianyun] Huazhong Univ Sci & Technol, Dept Sociol, Wuhan 430074, Peoples R China; [Ren, Xuezhu] Huazhong Univ Sci & Technol, Sch Educ, Wuhan 430074, Peoples R China; [Wang, Xiaohua; Qu, Zhiyong; Ran, Chun] Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China; [Wang, Xia] Beijing Haidian Inst Educ Res, Beijing, Peoples R China; [Hu, Juan] Huazhong Univ Sci & Technol, Community Hlth Serv Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Beijing Normal University; Huazhong University of Science & Technology	Guo, J (corresponding author), Huazhong Univ Sci & Technol, Dept Sociol, Wuhan 430074, Peoples R China.	jing624218@163.com; wxh@bnu.edu.cn	guo, jing/A-6416-2018; Ren, Xuezhu/Z-4616-2019	Ren, Xuezhu/0000-0002-3703-3194	Fundamental Research Funds for the Central Universities [HUST: 2015AE004]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was only supported by "the Fundamental Research Funds for the Central Universities", HUST: 2015AE004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INFORMATION, V18, P8, DOI [DOI 10.3969/J.ISSN.1001-4918.2002.03.004, 10.3969/j.issn.1672-4623.2020, DOI 10.3969/J.ISSN.1672-4623.2020]; ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939; Birch SH, 1997, J SCHOOL PSYCHOL, V35, P61, DOI 10.1016/S0022-4405(96)00029-5; Cavell TA, 2009, J CLIN CHILD ADOLESC, V38, P185, DOI 10.1080/15374410802698420; Chen LH, 2014, HEALTH PSYCHOL BEHAV, V2, P713, DOI 10.1080/21642850.2014.919865; Cheng J, 2015, CHILD CARE HLTH DEV, V41, P515, DOI 10.1111/cch.12221; China Labour Bulletin, 2013, CHIN LAB B; Comiskey CM, 2012, J SCHOOL HEALTH, V82, P508, DOI 10.1111/j.1746-1561.2012.00730.x; Davanzo P, 2004, CHILD PSYCHIAT HUM D, V35, P75, DOI 10.1023/B:CHUD.0000039321.56041.cd; Federation Research group of the All-China Women's, 2013, STUD COND LEFT CHILD; George C, 2006, CHILD PSYCHIAT HUM D, V37, P163, DOI 10.1007/s10578-006-0026-5; Hu XJ, 2012, VACCINE, V30, P5721, DOI 10.1016/j.vaccine.2012.07.007; Kennedy JH, 2004, PSYCHOL SCHOOLS, V41, P247, DOI 10.1002/pits.10153; Knight J, 1999, J DEV STUD, V35, P73, DOI 10.1080/00220389908422574; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Li Xiaoming, 2007, World Health Popul, V9, P29; Liang Z., 2008, YALE CHINA HLTH J, V5, P25; Liu T, 2015, INT J INCLUSIVE EDUC, V19, P994, DOI 10.1080/13603116.2015.1024762; Liu Y, 2015, INT J PSYCHOL, V50, P354, DOI 10.1002/ijop.12112; McCarty CA, 2005, J DEV BEHAV PEDIATR, V26, P267, DOI 10.1097/00004703-200508000-00002; PIANTA RC, 1994, J SCHOOL PSYCHOL, V32, P15, DOI 10.1016/0022-4405(94)90026-4; Sabol TJ, 2012, ATTACH HUM DEV, V14, P213, DOI 10.1080/14616734.2012.672262; Sheeber LB, 2007, J ABNORM PSYCHOL, V116, P144, DOI 10.1037/0021-843X.116.1.144; Stevens GWJM, 2008, J CHILD PSYCHOL PSYC, V49, P276, DOI 10.1111/j.1469-7610.2007.01848.x; Verschueren K, 2012, ATTACH HUM DEV, V14, P205, DOI 10.1080/14616734.2012.672260; Wang MT, 2013, DEV PSYCHOL, V49, P690, DOI 10.1037/a0027916; Wang MT, 2009, SCHOOL PSYCHOL QUART, V24, P240, DOI 10.1037/a0017999; Wen M, 2012, CHILD DEV, V83, P120, DOI 10.1111/j.1467-8624.2011.01698.x; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Wong DFK, 2009, SOC PSYCH PSYCH EPID, V44, P815, DOI 10.1007/s00127-009-0003-y; Zhang X, 2011, EARLY CHILD RES Q, V26, P192, DOI 10.1016/j.ecresq.2010.09.001; Zhao J., 2008, PSYCHOL DEV ED, V1, P36, DOI DOI 10.1242/dev.042309; Zhou F., 2006, POPULATION J, V3, P60	33	42	45	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145606	10.1371/journal.pone.0145606	http://dx.doi.org/10.1371/journal.pone.0145606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TR	26719895	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510900016
J	Han, XS; Nguyen, BT; Drope, J; Jemal, A				Han, Xuesong; Nguyen, Binh T.; Drope, Jeffrey; Jemal, Ahmedin			Health-Related Outcomes among the Poor: Medicaid Expansion vs. Non-Expansion States	PLOS ONE			English	Article							AFFORDABLE CARE ACT; YOUNG-ADULTS; DEPENDENT COVERAGE; PREVENTIVE CARE; ACCESS; VALIDITY; RATIOS; SCALES	Introduction States' decisions not to expand Medicaid under the Affordable Care Act (ACA) could potentially affect access to care and health status among their low-income residents. Methods The 2010-2012 nationally representative Medical Expenditure Panel Survey data were analyzed in 2015 to compare 9755 low-income adults aged 18-64 years from Medicaid-expanding states with 7455 adults from nonexpanding states. Multivariate logistic regression models were fitted to evaluate the differences in access to care, receipt of preventive services, quality of care, attitudes about health and self-reported health status by Medicaid expansion status. The differences in care utilization and medical expenditures between the two groups were examined using a 2-part modeling approach. Results Compared to their counterparts in Medicaid expansion states, low income adults in the nonexpanding states were more likely to be black and reside in rural areas and were less likely to have a usual source of care (prevalence ratio[PR] 0.86, 95% confidence interval[CI] 0.82-0.91) and recommended preventive services such as dental checkups (PR = 0.86; CI = 0.79-0.94), routine checks (PR = 0.89; CI = 0.83-0.95), flu vaccinations (PR = 0.89; CI = 0.81-0.98), and blood pressure checks (PR = 0.96; CI = 0.94-0.99). They also had less care utilization, fewer prescriptions, and less medical expenditures, but more out-of-pocket expenditures (all p-value <0.05). Conclusions Low-income adults in Medicaid nonexpanding states, who are disproportionately represented by blacks and rural residents, were worse off for multiple health-related outcomes compared to their counterparts in Medicaid expanding states at the baseline of ACA implementation, suggesting that low income adults residing in nonexpanding states may benefit markedly from the expansion of Medicaid.	[Han, Xuesong; Nguyen, Binh T.; Drope, Jeffrey; Jemal, Ahmedin] Amer Canc Soc, Intramural Res, Atlanta, GA 30329 USA; [Han, Xuesong; Jemal, Ahmedin] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	American Cancer Society; Emory University; Rollins School Public Health	Han, XS (corresponding author), Amer Canc Soc, Intramural Res, Atlanta, GA 30329 USA.	xuesong.han@cancer.org						Agency for Healthcare Research and Quality, MEPSHC155 AG HEALTHC; Agency for Healthcare Research and Quality, MED EXP PAN SURV; [Anonymous], 2015, VACC REC ACIP; [Anonymous], 2014, USPSTF A B REC; Barbaresco S, 2015, J HEALTH ECON, V40, P54, DOI 10.1016/j.jhealeco.2014.12.004; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Fedewa SA, 2015, CANCER-AM CANCER SOC, V121, P3272, DOI 10.1002/cncr.29494; Han XS, 2014, NEW ENGL J MED, V371, P2341, DOI 10.1056/NEJMc1406586; Honeycutt AA, 2009, HEALTH SERV RES, V44, P303, DOI 10.1111/j.1475-6773.2008.00909.x; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; KESSLER RC, 2002, MENTAL HLTH US 2002, P155; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lau JS, 2014, JAMA PEDIATR, V168, P1101, DOI 10.1001/jamapediatrics.2014.1691; Rasmussen Petra W, 2015, Issue Brief (Commonw Fund), V7, P1; Sabik LM, 2015, AM J PREV MED, V48, P98, DOI 10.1016/j.amepre.2014.08.015; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Tsai J, 2014, J CLIN PSYCHIAT, V75, P1402, DOI 10.4088/JCP.13m08885; Tsai J, 2013, HEALTH AFFAIR, V32, P1552, DOI 10.1377/hlthaff.2013.0228; Ware J, 2002, USERS MANUAL SF 12V2, DOI DOI 10.1038/nrendo.2016.14; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	23	41	41	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0144429	10.1371/journal.pone.0144429	http://dx.doi.org/10.1371/journal.pone.0144429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TR	26720311	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900004
J	Kather, JN; Weis, CA; Marx, A; Schuster, AK; Schad, LR; Zollner, FG				Kather, Jakob Nikolas; Weis, Cleo-Aron; Marx, Alexander; Schuster, Alexander K.; Schad, Lothar R.; Zoellner, Frank Gerrit			New Colors for Histology: Optimized Bivariate Color Maps Increase Perceptual Contrast in Histological Images	PLOS ONE			English	Article							QUANTIFICATION; PATHOLOGY; IMMUNOHISTOCHEMISTRY; EXPERTISE; UTILITY; ISSUES; TOOL	Background Accurate evaluation of immunostained histological images is required for reproducible research in many different areas and forms the basis of many clinical decisions. The quality and efficiency of histopathological evaluation is limited by the information content of a histological image, which is primarily encoded as perceivable contrast differences between objects in the image. However, the colors of chromogen and counterstain used for histological samples are not always optimally distinguishable, even under optimal conditions. Methods and Results In this study, we present a method to extract the bivariate color map inherent in a given histological image and to retrospectively optimize this color map. We use a novel, unsupervised approach based on color deconvolution and principal component analysis to show that the commonly used blue and brown color hues in Hematoxylin-3,3'-Diaminobenzidine (DAB) images are poorly suited for human observers. We then demonstrate that it is possible to construct improved color maps according to objective criteria and that these color maps can be used to digitally re-stain histological images. Validation To validate whether this procedure improves distinguishability of objects and background in histological images, we re-stain phantom images and N = 596 large histological images of immunostained samples of human solid tumors. We show that perceptual contrast is improved by a factor of 2.56 in phantom images and up to a factor of 2.17 in sets of histological tumor images. Context Thus, we provide an objective and reliable approach to measure object distinguishability in a given histological image and to maximize visual information available to a human observer. This method could easily be incorporated in digital pathology image viewing systems to improve accuracy and efficiency in research and diagnostics.	[Kather, Jakob Nikolas; Weis, Cleo-Aron; Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Kather, Jakob Nikolas; Schad, Lothar R.; Zoellner, Frank Gerrit] Heidelberg Univ, Med Fac Mannheim, Comp Assisted Clin Med, Mannheim, Germany; [Schuster, Alexander K.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Zollner, FG (corresponding author), Heidelberg Univ, Med Fac Mannheim, Comp Assisted Clin Med, Mannheim, Germany.	frank.zoellner@medma.uni-heidelberg.de	Weis, Cleo-Aron/GVT-8400-2022; Zöllner, Frank G/A-2725-2012; Kather, Jakob Nikolas/D-4279-2015	Zöllner, Frank G/0000-0003-3405-1394; Kather, Jakob Nikolas/0000-0002-3730-5348	Studienstiftung des Deutschen Volkes (German National Academic Foundation)	Studienstiftung des Deutschen Volkes (German National Academic Foundation)	JNK received funding by Studienstiftung des Deutschen Volkes (German National Academic Foundation). CAW, AM, AKS, LRS, and FGZ received no specific funding for this work.	Bautista PA, 2015, J DIGIT IMAGING, V28, P283, DOI 10.1007/s10278-014-9766-0; Bautista Pinky A, 2014, J Pathol Inform, V5, P4, DOI 10.4103/2153-3539.126153; Birch J., 1993, DIAGNOSIS DEFECTIVE; Borland D, 2007, IEEE COMPUT GRAPH, V27, P14, DOI 10.1109/MCG.2007.323435; Brewer C. A., 1994, VISUALIZATION MODERN, V2, P123, DOI DOI 10.1016/B978-0-08-042415-6.50014-4; Cole BL, 2007, CLIN EXP OPTOM, V90, P157, DOI 10.1111/j.1444-0938.2007.00135.x; Cromey DW, 2010, SCI ENG ETHICS, V16, P639, DOI 10.1007/s11948-010-9201-y; Crowley RS, 2003, J AM MED INFORM ASSN, V10, P39, DOI 10.1197/jamia.M1123; EYTON JR, 1984, ANN ASSOC AM GEOGR, V74, P477, DOI 10.1111/j.1467-8306.1984.tb01469.x; Glatz-Krieger K, 2003, HUM PATHOL, V34, P968, DOI 10.1053/S0046-8177(03)00348-4; Gottwald E, 2013, Z MED PHYS, V23, P102, DOI 10.1016/j.zemedi.2013.01.003; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Horvat Denis, 2013, Human-Computer Interaction and Knowledge Discovery in Complex, Unstructured, Big Data. Third International Workshop, HCI-KDD 2013. Held at SouthCHI 2013. Proceedings: LNCS 7947, P386, DOI 10.1007/978-3-642-39146-0_36; Hutter M, 2014, INTERACTIVE MULTICRI; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Judd DB., 1975, WILEY SERIES PURE AP, V3rd, P388; Kather JN, 2015, ONCOTARGET, V6, P19163, DOI 10.18632/oncotarget.4383; Khan AM, 2014, IEEE T BIO-MED ENG, V61, P1729, DOI 10.1109/TBME.2014.2303294; Kimpe T, 2007, J DIGIT IMAGING, V20, P422, DOI 10.1007/s10278-006-1052-3; Krupinski EA, 2013, HUM PATHOL, V44, P357, DOI 10.1016/j.humpath.2012.05.024; Kumar V, 2013, SYM REL DIST SYST, P10, DOI 10.1109/SRDS.2013.10; Landini G, 2009, J MICROSC-OXFORD, V234, P293, DOI 10.1111/j.1365-2818.2009.03174.x; Machado GM, 2009, IEEE T VIS COMPUT GR, V15, P1291, DOI 10.1109/TVCG.2009.113; Martinez K, 2005, IEEE IMAGE PROC, P2485; Moreland K, 2009, LECT NOTES COMPUT SC, V5876, P92, DOI 10.1007/978-3-642-10520-3_9; Niccoli M., 2014, LEAD EDGE, V33, P910, DOI DOI 10.1190/TLE33080910.1; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Rabinovich A, 2004, ADV NEUR IN, V16, P667; Rasmussen OF, 2015, HDB PRACTICAL IMMUNO, P57; Reyes-Aldasoro CC, 2009, ELECTRON LETT, V45, P454, DOI 10.1049/el.2009.0320; Robertson M, 2014, METHOD APPARATUS STA; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Saba L, 2014, EUR J RADIOL, V83, P2288, DOI 10.1016/j.ejrad.2014.09.001; Silverstein JC, 2008, J BIOMED INFORM, V41, P927, DOI 10.1016/j.jbi.2008.02.008; Spalding J Anthony B, 2004, Clin Exp Optom, V87, P344; Stevens J, 2015, BIVARIATE CHOROPLETH; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; Teuling AJ, 2011, INT J CLIMATOL, V31, P1408, DOI 10.1002/joc.2153; Trahearn N, 2015, P SOC PHOTO-OPT INS, V9420; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Walker RA, 2006, HISTOPATHOLOGY, V49, P406, DOI 10.1111/j.1365-2559.2006.02514.x; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; Westland S., 2012, COMPUTATIONAL COLOUR; Xu J, 2015, COMPUT MED IMAG GRAP, V46, P20, DOI 10.1016/j.compmedimag.2015.04.002	47	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145572	10.1371/journal.pone.0145572	http://dx.doi.org/10.1371/journal.pone.0145572			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717571	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500046
J	Boucher, H; Vanneaux, V; Domet, T; Parouchev, A; Larghero, J				Boucher, Helene; Vanneaux, Valerie; Domet, Thomas; Parouchev, Alexandre; Larghero, Jerome			Circadian Clock Genes Modulate Human Bone Marrow Mesenchymal Stem Cell Differentiation, Migration and Cell Cycle	PLOS ONE			English	Article							IN-VIVO; TRANSCRIPTIONAL REGULATION; REGULATES ADIPOGENESIS; METABOLIC SYNDROME; MOLECULAR CLOCK; ADIPOSE-TISSUES; DOWN-REGULATION; BETA-CATENIN; EXPRESSION; RHYTHMS	Many of the components that regulate the circadian clock have been identified in organisms and humans. The influence of circadian rhythm (CR) on the regulation of stem cells biology began to be evaluated. However, little is known on the role of CR on human mesenchymal stem cell (hMSCs) properties. The objective of this study was to investigate the influence of CR on the differentiation capacities of bone marrow hMSCs, as well as the regulation of cell cycle and migration capabilities. To that, we used both a chemical approach with a GSK-3 beta specific inhibitor (2'E,3'Z-6-bromoindirubin-3'-oxime, BIO) and a knockdown of CLOCK and PER2, two of the main genes involved in CR regulation. In these experimental conditions, a dramatic inhibition of adipocyte differentiation was observed, while osteoblastic differentiation capacities were not modified. In addition, cell migration was decreased in PER2(-/-) cells. Lastly, downregulation of circadian clock genes induced a modification of the hMSCs cell cycle phase distribution, which was shown to be related to a change of the cyclin expression profile. Taken together, these data showed that CR plays a role in the regulation of hMSCs differentiation and division, and likely represent key factor in maintaining hMSCs properties.	[Boucher, Helene; Vanneaux, Valerie; Domet, Thomas; Parouchev, Alexandre; Larghero, Jerome] Hop St Louis, AP HP, Cell Therapy Unit, Paris, France; [Boucher, Helene] Univ Paris 05, Sch Pharm, Paris, France; [Vanneaux, Valerie; Domet, Thomas; Parouchev, Alexandre; Larghero, Jerome] Hop St Louis, INSERM, CIC Biotherapies CBT 501, Paris, France; [Vanneaux, Valerie; Domet, Thomas; Parouchev, Alexandre; Larghero, Jerome] Hop St Louis, Inst Univ Hematol, UMR1160, Paris, France; [Larghero, Jerome] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Larghero, J (corresponding author), Hop St Louis, AP HP, Cell Therapy Unit, Paris, France.	jerome.larghero@aphp.fr	Vanneaux, Valérie/D-7853-2017	Vanneaux, Valérie/0000-0003-0813-2318				Abramova MV, 2006, J BIOL CHEM, V281, P21040, DOI 10.1074/jbc.M511059200; Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Borgs L, 2009, CELL CYCLE, V8, P832, DOI 10.4161/cc.8.6.7869; Cao H., 2012, SPACECR RECOVER REMO, V3, P7, DOI DOI 10.1371/J0URNAL.P0NE.0031502; Chen YG, 2000, BIOCHEM BIOPH RES CO, V276, P724, DOI 10.1006/bbrc.2000.3536; Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Emery IF, 1997, P NATL ACAD SCI USA, V94, P4092, DOI 10.1073/pnas.94.8.4092; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Fu LN, 2006, PROG BRAIN RES, V153, P177, DOI 10.1016/S0079-6123(06)53010-9; Gambardella A, 2011, J BONE MINER RES, V26, P811, DOI 10.1002/jbmr.266; Garaulet M, 2010, J AM DIET ASSOC, V110, P917, DOI 10.1016/j.jada.2010.03.017; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gery S, 2010, CELL CYCLE, V9, P1097, DOI 10.4161/cc.9.6.11046; Gimble JM, 2009, J CELL BIOCHEM, V107, P569, DOI 10.1002/jcb.22153; Goldbeter A, 2008, CURR BIOL, V18, pR751, DOI 10.1016/j.cub.2008.06.044; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Guo BY, 2012, FASEB J, V26, P3453, DOI 10.1096/fj.12-205781; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Lee JH, 2011, P NATL ACAD SCI USA, V108, P12036, DOI 10.1073/pnas.1108125108; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Maronde E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011527; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Maury E, 2014, DIABETES METAB, V40, P338, DOI 10.1016/j.diabet.2013.12.005; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nicolaou KA, 2012, BIOCHEM BIOPH RES CO, V425, P76, DOI 10.1016/j.bbrc.2012.07.053; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen ED, 2000, GENE DEV, V14, P1293; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Shostak A, 2013, DIABETES, V62, P2195, DOI 10.2337/db12-1449; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wu XY, 2008, BONE, V42, P861, DOI 10.1016/j.bone.2007.12.226; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yang XM, 2009, BREAST CANCER RES TR, V117, P423, DOI 10.1007/s10549-008-0133-z; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	52	37	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146674	10.1371/journal.pone.0146674	http://dx.doi.org/10.1371/journal.pone.0146674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741371	gold, Green Published, Green Submitted			2022-12-27	WOS:000367810600061
J	Lai, CH; Wang, KC; Lee, FT; Tsai, HW; Ma, CY; Cheng, TL; Chang, BI; Yang, YJ; Shi, GY; Wu, HL				Lai, Chao-Han; Wang, Kuan-Chieh; Lee, Fang-Tzu; Tsai, Hung-Wen; Ma, Chih-Yuan; Cheng, Tsung-Lin; Chang, Bi-Ing; Yang, Yu-Jen; Shi, Guey-Yueh; Wu, Hua-Lin			Toll-Like Receptor 4 Is Essential in the Development of Abdominal Aortic Aneurysm	PLOS ONE			English	Article							INNATE IMMUNITY; INFLAMMATION; RAGE; PATHOGENESIS; S100A12; KINASE; CELLS; MICE; TLR	Toll-like receptor (TLR) family plays a key role in innate immunity and various inflammatory responses. TLR4, one of the well-characterized pattern-recognition receptors, can be activated by endogenous damage-associated molecular pattern molecules such as high mobility group box 1 (HMGB1) to sustain sterile inflammation. Evidence suggested that blockade of TLR4 signaling may confer protection against abdominal aortic aneurysm (AAA). Herein we aimed to obtain further insight into the mechanism by which TLR4 might promote aneurysm formation. Characterization of the CaCl2-induced AAA model in mice revealed that upregulation of TLR4 expression, localized predominantly to vascular smooth muscle cells (VSMCs), was followed by a late decline during a 28-day period of AAA development. In vitro, TLR4 expression was increased in VSMCs treated with HMGB1. Knockdown of TLR4 by siRNA attenuated HMGB1-enhanced production of proinflammatory cytokines, specifically interleukin-6 and monocyte chemoattractant protein-1 (MCP-1), and matrix-degrading matrix metalloproteinase (MMP)-2 from VSMCs. In vivo, two different strains of TLR4-deficient (C57BL/10ScNJ and C3H/HeJ) mice were resistant to CaCl2-induced AAA formation compared to their respective controls (C57BL/10ScSnJ and C3H/HeN). Knockout of TLR4 reduced interleukin-6 and MCP-1 levels and HMGB1 expression, attenuated macrophage accumulation, and eventually suppressed MMP production, elastin destruction and VSMC loss. Finally, human AAA exhibited higher TLR4 expression that was localized to VSMCs. These data suggest that TLR4 signaling contributes to AAA formation by promoting a proinflammatory status of VSMCs and by inducing proteinase release from VSMCs during aneurysm initiation and development.	[Lai, Chao-Han; Yang, Yu-Jen] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70101, Taiwan; [Lai, Chao-Han; Wang, Kuan-Chieh; Lee, Fang-Tzu; Ma, Chih-Yuan; Cheng, Tsung-Lin; Chang, Bi-Ing; Yang, Yu-Jen; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Coll Med, Cardiovasc Res Ctr, Tainan 70101, Taiwan; [Wang, Kuan-Chieh; Lee, Fang-Tzu; Ma, Chih-Yuan; Cheng, Tsung-Lin; Chang, Bi-Ing; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Tsai, Hung-Wen] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70101, Taiwan; [Cheng, Tsung-Lin] Kaohsiung Med Univ, Coll Med, Dept Physiol, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University	Shi, GY (corresponding author), Natl Cheng Kung Univ, Coll Med, Cardiovasc Res Ctr, Tainan 70101, Taiwan.	gyshi@mail.ncku.edu.tw; halnwu@mail.ncku.edu.tw		Cheng, Tsung-Lin/0000-0001-7080-8652; Lai, Chao-Han/0000-0002-1382-1495	National Science Council, Executive Yuan, Taiwan [NSC 101-2314-B-006-072]; National Cheng Kung University Hospital, Tainan, Taiwan [NCKUH-10306008]; National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital, Tainan, Taiwan; National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan	This work was supported by National Science Council, Executive Yuan, Taiwan (www.most.gov.tw, NSC 101-2314-B-006-072 to CHL), National Cheng Kung University Hospital, Tainan, Taiwan (www.hosp.ncku.edu.tw, NCKUH-10306008 to CHL), and a National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan (www.ncku.edu.tw, to GYS and HLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire E, 2002, J VASC SURG, V36, P1018, DOI 10.1067/mva.2002.127347; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Bowman MH, 2010, CIRC RES, V106, P145, DOI 10.1161/CIRCRESAHA.109.209486; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Curci JA, 2009, VASCULAR, V17, pS21, DOI 10.2310/6670.2008.00085; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Foell D, 2013, AM J RESP CRIT CARE, V187, P1324, DOI 10.1164/rccm.201209-1602OC; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Hua F, 2007, J IMMUNOL, V178, P7317, DOI 10.4049/jimmunol.178.11.7317; Ibrahim ZA, 2013, MOL IMMUNOL, V56, P739, DOI 10.1016/j.molimm.2013.07.008; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kohno T, 2012, J CARDIOL, V59, P299, DOI 10.1016/j.jjcc.2012.01.007; Lai CH, 2013, ANN SURG, V258, P1103, DOI 10.1097/SLA.0b013e31827df7cb; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Miyake T, 2009, CARDIOVASC RES, V83, P436, DOI 10.1093/cvr/cvp155; Morgan S, 2012, ARTERIOSCL THROM VAS, V32, P2493, DOI 10.1161/ATVBAHA.112.255661; Owens AP, 2011, ARTERIOSCL THROM VAS, V31, P2813, DOI 10.1161/ATVBAHA.111.238642; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pirianov G, 2012, ATHEROSCLEROSIS, V225, P69, DOI 10.1016/j.atherosclerosis.2012.07.034; Qin YW, 2013, FUTUR CARDIOL, V9, P89, DOI [10.2217/FCA.12.71, 10.2217/fca.12.71]; Qin ZX, 2015, J MOL CELL CARDIOL, V87, P160, DOI 10.1016/j.yjmcc.2015.08.014; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Riches K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-208; Salmon M, 2013, CIRCULATION, V128, pS163, DOI 10.1161/CIRCULATIONAHA.112.000238; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Schlederer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100822; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Shang T, 2014, VASA, V43, P39, DOI 10.1024/0301-1526/a000326; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Song Y, 2012, ARTERIOSCL THROM VAS, V32, P103, DOI 10.1161/ATVBAHA.111.236349; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Spirig R, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/181394; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724; Zhang F, 2009, ANN SURG, V250, P416, DOI [10.1097/SLA.0b013e3e181b41a18, 10.1097/SLA.0b013e3181b41a18]	42	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146565	10.1371/journal.pone.0146565	http://dx.doi.org/10.1371/journal.pone.0146565			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741694	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600056
J	Weeks, CA; Lambton, SL; Williams, AG				Weeks, Claire A.; Lambton, Sarah L.; Williams, Adrian G.			Implications for Welfare, Productivity and Sustainability of the Variation in Reported Levels of Mortality for Laying Hen Flocks Kept in Different Housing Systems: A Meta-Analysis of Ten Studies	PLOS ONE			English	Article							ENVIRONMENTAL IMPACTS; FEATHER PECKING; MANAGEMENT; FARM; PREVALENCE; END	Data from ten sources comprising 3,851 flocks were modelled to identify variation in levels of mortality in laying hens. The predicted increase with age was curvilinear with significant variation between the seven breed categories. Mortality was higher in loose housing systems than in cages and variable within system, confirming previous reports. Cumulative mortality (CM) was higher in flocks with intact beaks (chi 2 = 6.03; df 1; p = 0.014) than in those with trimmed beaks. Most data were available for free-range systems (2,823 flocks), where producer recorded CM at 60-80 weeks of age averaged 10% but with a range from 0% to 69.3%. Life cycle assessment showed that the main effect of increased levels of hen mortality is to increase the relative contribution of breeding overheads, so increasing environmental burdens per unit of production. Reducing CM to levels currently achieved by the 1st quartile could reduce flock greenhouse gas emissions by as much as 25%. Concurrently this would enhance hen welfare and better meet the expectation of egg consumers. More research to understand the genetic x environment interaction and detailed records of the causes of mortality is required so that improved genotypes can be developed for different systems and different breeds can be better managed within systems.	[Weeks, Claire A.; Lambton, Sarah L.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Williams, Adrian G.] Cranfield Univ, Sch Energy Environm & Agrifood, Bedford, England	University of Bristol; Cranfield University	Weeks, CA (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	claire.weeks@bristol.ac.uk	Weeks, Claire/C-9136-2012	Weeks, Claire/0000-0002-4280-9604; Williams, Adrian/0000-0003-2098-808X; Lambton, Sarah/0000-0001-5802-3465	Tubney Charitable Trust; EU; Tubney Trust; Defra; UFAW; RSPCA	Tubney Charitable Trust; EU(European Commission); Tubney Trust; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); UFAW; RSPCA	The authors received no specific funding for this work. Funds from the Tubney Charitable Trust will be used to support publication.; We are extremely grateful to those who supplied data for this analysis: Ashleigh Bright of FAI (with kind permission of The Lakes Free Range Egg Co., Noble Foods and McDonalds); Thea Fiks van Niekerk and Linda Keeling from Welfare Quality (R) (an EU-funded FP6 project). Additional datasets were used from work at the University of Bristol supported by The Tubney Trust, Defra, UFAW and the RSPCA. We are also grateful for helpful comments on a draft of the paper from Christine Nicol.	Aerni V, 2005, WORLD POULTRY SCI J, V61, P130, DOI 10.1079/WPS200450; [Anonymous], 2013, GREENHOUSE GAS EMISS; BAXTER MR, 1994, VET REC, V134, P614, DOI 10.1136/vr.134.24.614; Black H, 2009, 200918 MAF; Blokhuis HJ, 2007, WORLD POULTRY SCI J, V63, P101, DOI 10.1017/S0043933907001328; BSI, 2006, 140402006 BSI EN ISO; Dekker SEM, 2011, LIVEST SCI, V139, P109, DOI 10.1016/j.livsci.2011.03.011; Elson HA, 2015, WORLD POULTRY SCI J, V71, P449, DOI 10.1017/S0043933915002172; Green LE, 2000, VET REC, V147, P233, DOI 10.1136/vr.147.9.233; HOLT P. S., 2011, FEEDSTUFFS, V83, P12; Johnsen PF, 1998, APPL ANIM BEHAV SCI, V60, P25, DOI 10.1016/S0168-1591(98)00149-X; Lambton SL, 2013, VET REC, V172, P423, DOI 10.1136/vr.101067; Lay DC, 2011, POULTRY SCI, V90, P278, DOI 10.3382/ps.2010-00962; Leinonen I, 2012, POULTRY SCI, V91, P26, DOI 10.3382/ps.2011-01635; Matthews WA, 2015, POULTRY SCI, V94, P552, DOI 10.3382/ps/peu011; Nicol CJ, 2006, BRIT POULTRY SCI, V47, P135, DOI 10.1080/00071660600610609; Petrik MT, 2015, POULTRY SCI, V94, P579, DOI 10.3382/ps/pev039; Richards GJ, 2012, VET REC, V171, P474, DOI 10.1136/vr.100844; Sandars DL, 2003, BIOSYST ENG, V84, P267, DOI 10.1016/S1537-5110(02)00278-7; Sherwin CM, 2010, BRIT POULTRY SCI, V51, P488, DOI 10.1080/00071668.2010.502518; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Tauson Ragnar, 2005, Animal Science Papers and Reports, V23, P95; Van Sambeek F, PROGR LAYER GENETICS; Weeks CA, 2006, WORLD POULTRY SCI J, V62, P296, DOI 10.1079/WPS200598; Weeks CA, 2012, VET REC, V170, P647, DOI 10.1136/vr.100728; Whay HR, 2007, VET REC, V161, P119, DOI 10.1136/vr.161.4.119; Williams A. G., 2006, IS0205 DEFRA; Xin H, 2011, POULTRY SCI, V90, P263, DOI 10.3382/ps.2010-00877; Yngvesson J, 2004, BRIT POULTRY SCI, V45, P453, DOI 10.1080/00071660412331286163	29	43	44	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146394	10.1371/journal.pone.0146394	http://dx.doi.org/10.1371/journal.pone.0146394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734933	Green Published, gold			2022-12-27	WOS:000367805100047
J	Zhao, YS; Shen, B				Zhao, YingSi; Shen, Bo			Empirical Study of User Preferences Based on Rating Data of Movies	PLOS ONE			English	Article							RECOMMENDER; NETWORK; FRAMEWORK	User preference plays a prominent role in many fields, including electronic commerce, social opinion, and Internet search engines. Particularly in recommender systems, it directly influences the accuracy of the recommendation. Though many methods have been presented, most of these have only focused on how to improve the recommendation results. In this paper, we introduce an empirical study of user preferences based on a set of rating data about movies. We develop a simple statistical method to investigate the characteristics of user preferences. We find that the movies have potential characteristics of closure, which results in the formation of numerous cliques with a power- law size distribution. We also find that a user related to a small clique always has similar opinions on the movies in this clique. Then, we suggest a user preference model, which can eliminate the predictions that are considered to be impracticable. Numerical results show that the model can reflect user preference with remarkable accuracy when data elimination is allowed, and random factors in the rating data make prediction error inevitable. In further research, we will investigate many other rating data sets to examine the universality of our findings.	[Zhao, YingSi] Beijing Jiaotong Univ, Sch Econ & Management, Beijing 100044, Peoples R China; [Shen, Bo] Beijing Jiaotong Univ, Sch Elect & Informat Engn, Key Lab Commun & Informat Syst, Beijing Municipal Commiss Educ, Beijing 100044, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; Beijing Municipal Commission of Education	Zhao, YS (corresponding author), Beijing Jiaotong Univ, Sch Econ & Management, Beijing 100044, Peoples R China.	yszhao@bjtu.edu.cn			National Natural Science Foundation of China [61271308]; Fundamental Research Funds for the Central Universities [B15JB00220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partly supported by the National Natural Science Foundation of China under Grant 61271308 (URL: http://www.nsfc.gov.cn/) and the Fundamental Research Funds for the Central Universities under Grant B15JB00220 (URL: http://www.bjtu.edu.cn/). The sponsor of the former project was mainly in charge of the implement of software used in experiments and performing the experiments. The sponsor of the later project designed the experiments, analyzed the data and plotted the results. They both wrote the manuscript.	Agarwal S., 2006, P 23 INT C MACH LEAR, P17, DOI DOI 10.1145/1143844.1143847; Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; Al-Shamri MYH, 2008, EXPERT SYST APPL, V35, P1386, DOI 10.1016/j.eswa.2007.08.016; Barragans-Martinez AB, 2010, INFORM SCIENCES, V180, P4290, DOI 10.1016/j.ins.2010.07.024; Berge C., 1989, HYPERGRAPHS, V45; Blattner M, 2007, PHYSICA A, V373, P753, DOI 10.1016/j.physa.2006.04.121; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; Bobadilla J, 2011, EXPERT SYST APPL, V38, P14609, DOI 10.1016/j.eswa.2011.05.021; Bordogna CM, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/6/065144; Candillier L, 2007, LECT NOTES ARTIF INT, V4571, P548; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Choi K, 2013, KNOWL-BASED SYST, V37, P146, DOI 10.1016/j.knosys.2012.07.019; Colins K. D., CAYLEY MENGER DETERM; de Campos LM, 2010, INT J APPROX REASON, V51, P785, DOI 10.1016/j.ijar.2010.04.001; Ekstrand Michael D., 2010, Foundations and Trends in Human-Computer Interaction, V4, P81, DOI 10.1561/1100000009; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; GALLO G, 1993, DISCRETE APPL MATH, V42, P177, DOI 10.1016/0166-218X(93)90045-P; Gan MX, 2013, EXPERT SYST APPL, V40, P4044, DOI 10.1016/j.eswa.2013.01.004; Goel S, 2010, PNAS, V107; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Gritzmann P, 1994, POLYTOPES ABSTRACT C; Grujic J, 2008, LECT NOTES COMPUT SC, V5102, P576, DOI 10.1007/978-3-540-69387-1_66; Han J, 2012, MOR KAUF D, P1; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Hill W., 1995, Human Factors in Computing Systems. CHI'95 Conference Proceedings, P194; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056107; Johnson Jeffrey H., 2014, HYPERNETWORKS SCI CO; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Lambiotte R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066107; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lee SK, 2010, INFORM SCIENCES, V180, P2142, DOI 10.1016/j.ins.2010.02.004; Lemire D., 2005, SDM, P1; Leung CWK, 2006, KNOWL INF SYST, V10, P357, DOI 10.1007/s10115-006-0002-1; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Melville P, 2010, ENCY MACHINE LEARNIN, V1, P829; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Preis T, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140095; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Shang MS, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48006; Shinde SK, 2012, EXPERT SYST APPL, V39, P1381, DOI 10.1016/j.eswa.2011.08.020; Su X., 2009, ADV ARTIF INTELL, V2009, P19, DOI [10.1155/2009/421425, DOI 10.1155/2009/421425]; Takacs G., 2007, ACM SIGKDD EXPLOR NE, V9, P80, DOI DOI 10.1145/1345448.134546; Vozalis MG, 2007, INFORM SCIENCES, V177, P3017, DOI 10.1016/j.ins.2007.02.036; Wang J., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P501, DOI 10.1145/1148170.1148257; Yedidia JS, 2005, IEEE T INFORM THEORY, V51, P2282, DOI 10.1109/TIT.2005.850085; Zeng W, 2010, INT J MOD PHYS C, V21, P1217, DOI 10.1142/S0129183110015786; Zhou T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/58004; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123008; Zlatic V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036118	53	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146541	10.1371/journal.pone.0146541	http://dx.doi.org/10.1371/journal.pone.0146541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735847	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100052
J	Castelli, M; Amodeo, G; Negri, L; Lattanzi, R; Maftei, D; Gotti, C; Pistillo, F; Onnis, V; Congu, C; Panerai, AE; Sacerdote, P; Franchi, S				Castelli, Mara; Amodeo, Giada; Negri, Lucia; Lattanzi, Roberta; Maftei, Daniela; Gotti, Cecilia; Pistillo, Francesco; Onnis, Valentina; Congu, Cenzo; Panerai, Alberto E.; Sacerdote, Paola; Franchi, Silvia			Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes	PLOS ONE			English	Article							NMDA RECEPTOR; NR2B SUBUNIT; PROINFLAMMATORY CYTOKINES; NEUROPATHIC PAIN; DORSAL-HORN; SPINAL-CORD; BV8; SENSITIZATION; HYPERALGESIA; MODULATION	Neuropathic pain is a severe diabetes complication and its treatment is not satisfactory. It is associated with neuroinflammation-related events that participate in pain generation and chronicization. Prokineticins are a new family of chemokines that has emerged as critical players in immune system, inflammation and pain. We investigated the role of prokineticins and their receptors as modulators of neuropathic pain and inflammatory responses in experimental diabetes. In streptozotocin-induced-diabetes in mice, the time course expression of prokineticin and its receptors was evaluated in spinal cord and sciatic nerves, and correlated with mechanical allodynia. Spinal cord and sciatic nerve pro-and anti-inflammatory cytokines were measured as protein and mRNA, and spinal cord GluR subunits expression studied. The effect of preventive and therapeutic treatment with the prokineticin receptor antagonist PC1 on behavioural and biochemical parameters was evaluated. Peripheral immune activation was assessed measuring macrophage and T-helper cytokine production. An up-regulation of the Prokineticin system was present in spinal cord and nerves of diabetic mice, and correlated with allodynia. Therapeutic PC1 reversed allodynia while preventive treatment blocked its development. PC1 normalized prokineticin levels and prevented the up-regulation of GluN2B subunits in the spinal cord. The antagonist restored the pro-/anti-inflammatory cytokine balance altered in spinal cord and nerves and also reduced peripheral immune system activation in diabetic mice, decreasing macrophage proinflammatory cytokines and the T-helper 1 phenotype. The prokineticin system contributes to altered sensitivity in diabetic neuropathy and its inhibition blocked both allodynia and inflammatory events underlying disease.	[Castelli, Mara; Amodeo, Giada; Panerai, Alberto E.; Sacerdote, Paola; Franchi, Silvia] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Negri, Lucia; Lattanzi, Roberta; Maftei, Daniela] Univ Rome, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy; [Gotti, Cecilia; Pistillo, Francesco] CNR, Inst Neurosci, Milan, Italy; [Onnis, Valentina; Congu, Cenzo] Univ Cagliari, Dept Life & Environm Sci, Unit Pharmaceut Pharmacol & Nutraceut Sci, Cagliari, Italy	University of Milan; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari	Sacerdote, P (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	paola.sacerdote@unimi.it	Amodeo, Giada/AAO-7684-2021; Onnis, Valentina/B-1649-2008; , Franchi/AAK-5400-2020; Maftei, Daniela/AAY-1133-2021	Amodeo, Giada/0000-0002-4097-3195; Onnis, Valentina/0000-0002-2438-725X; Maftei, Daniela/0000-0002-8679-2840; LATTANZI, Roberta/0000-0002-6377-9256	Minister of University and Scientific Research of Italy, PRIN	Minister of University and Scientific Research of Italy, PRIN	This study was supported by the Minister of University and Scientific Research of Italy, PRIN 2008/2011.	Abou-Hamdan M, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000095; Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Aring AM, 2005, AM FAM PHYSICIAN, V71, P2123; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Balboni G, 2008, J MED CHEM, V51, P7635, DOI 10.1021/jm800854e; Barutta F, 2015, ENDOCRINE, V48, P730, DOI 10.1007/s12020-014-0437-1; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Canta A, 2009, J PAIN, V10, P961, DOI 10.1016/j.jpain.2009.04.003; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Clark AK, 2013, J PAIN RES, V6, P803, DOI 10.2147/JPR.S53660; Cline GW, 2011, BIOCHEM BIOPH RES CO, V412, P413, DOI 10.1016/j.bbrc.2011.07.077; Comelli F, 2009, PHYTOTHER RES, V23, P1678, DOI 10.1002/ptr.2806; Dormishian M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000411; Dorsch M, 2005, J LEUKOCYTE BIOL, V78, P426, DOI 10.1189/jlb.0205061; Franchi S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-60; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; Gonzalez-Clemente JM, 2005, CLIN ENDOCRINOL, V63, P525, DOI 10.1111/j.1365-2265.2005.02376.x; Gotti C, 2008, MOL PHARMACOL, V73, P1796, DOI 10.1124/mol.108.045203; Guida F, 2015, PHARMACOL RES, V91, P36, DOI 10.1016/j.phrs.2014.11.004; Guo W, 2002, J NEUROSCI, V22, P6208; Gupta M, 2003, METHOD FIND EXP CLIN, V25, P49, DOI 10.1358/mf.2003.25.1.772547; Iwata H, 2007, BRAIN RES, V1135, P92, DOI 10.1016/j.brainres.2006.12.014; Jiang XH, 2009, PANCREATOLOGY, V9, P165, DOI 10.1159/000178888; Kapur D, 2003, DIABETES-METAB RES, V19, pS9, DOI 10.1002/dmrr.359; Karlsson U, 2002, NEUROSCIENCE, V112, P861, DOI 10.1016/S0306-4522(02)00140-9; Kyoraku I, 2009, BIOCHEM BIOPH RES CO, V389, P405, DOI 10.1016/j.bbrc.2009.08.171; Lattanzi R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/301292; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; Maftei D, 2014, BRIT J PHARMACOL, V171, P4850, DOI 10.1111/bph.12793; Malcangio M, 1998, PAIN, V76, P151, DOI 10.1016/S0304-3959(98)00037-2; Martucci C, 2006, BRIT J PHARMACOL, V147, P225, DOI 10.1038/sj.bjp.0706467; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; Martucci C, 2007, J LEUKOCYTE BIOL, V81, P344, DOI 10.1189/jlb.0406237; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Moretti S, 2014, J LEUKOCYTE BIOL, V96, P523, DOI 10.1189/jlb.3HI0713-406RR; Negri L, 2012, CURR OPIN PHARMACOL, V12, P62, DOI 10.1016/j.coph.2011.10.023; Negri L, 2011, CURR PHARM BIOTECHNO, V12, P1720, DOI 10.2174/138920111798357410; Noh JR, 2013, INT J BIOCHEM CELL B, V45, P1538, DOI 10.1016/j.biocel.2013.05.004; Old EA, 2014, J CLIN INVEST, V124, P2023, DOI 10.1172/JCI71389; Old EA, 2015, HANDB EXP PHARMACOL, V227, P145, DOI 10.1007/978-3-662-46450-2_8; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; Qu XP, 2012, J BIOL CHEM, V287, P19574, DOI 10.1074/jbc.M111.326801; Rivero A, 2009, CLIN SCI, V116, P479, DOI 10.1042/CS20080394; Sacerdote P, 2000, BLOOD, V95, P2031, DOI 10.1182/blood.V95.6.2031; Sacerdote P, 2013, J NEUROIMMUNE PHARM, V8, P202, DOI 10.1007/s11481-012-9428-2; Skundric Dusanka S, 2003, Exp Diabesity Res, V4, P303, DOI 10.1155/EDR.2003.303; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Tan PH, 2005, GENE THER, V12, P59, DOI 10.1038/sj.gt.3302376; Taniguchi K, 1997, BRIT J PHARMACOL, V122, P809, DOI 10.1038/sj.bjp.0701445; Valsecchi AE, 2011, EUR J PHARMACOL, V650, P694, DOI 10.1016/j.ejphar.2010.10.060; Vellani V, 2006, J NEUROSCI, V26, P5109, DOI 10.1523/JNEUROSCI.3870-05.2006; VINIK AI, 1995, MUSCLE NERVE, V18, P574, DOI 10.1002/mus.880180603; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xin H, 2013, J BIOL CHEM, V288, P13842, DOI 10.1074/jbc.M113.450049	57	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146259	10.1371/journal.pone.0146259	http://dx.doi.org/10.1371/journal.pone.0146259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730729	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400132
J	Dey, A; Molodecky, NA; Verma, H; Sharma, P; Yang, JS; Saletti, G; Ahmad, M; Bahl, SK; Wierzba, TF; Nandy, RK; Deshpande, JM; Sutter, RW; Czerkinsky, C				Dey, Ayan; Molodecky, Natalie A.; Verma, Harish; Sharma, Prashant; Yang, Jae Seung; Saletti, Giulietta; Ahmad, Mohammad; Bahl, Sunil K.; Wierzba, Thomas F.; Nandy, Ranjan K.; Deshpande, Jagadish M.; Sutter, Roland W.; Czerkinsky, Cecil			Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus	PLOS ONE			English	Article							INTESTINAL IMMUNITY; FORMING-CELLS; VACCINE; RESPONSES; CHILDREN; IMMUNIZATIONS; INDUCTION; INDIA; LIVE	Background The "gold standard" for assessing mucosal immunity after vaccination with poliovirus vaccines consists in measuring virus excretion in stool after challenge with oral poliovirus vaccine (OPV). This testing is time and resource intensive, and development of alternative methods is a priority for accelerating polio eradication. We therefore evaluated circulating antibody-secreting cells (ASCs) as a potential means to evaluate mucosal immunity to poliovirus vaccine. Methods 199 subjects, aged 10 years, and previously immunized repeatedly with OPV, were selected. Subjects were assigned to receive either a booster dose of inactivated poliovirus vaccine (IPV), bivalent OPV (bOPV), or no vaccine. Using a micro-modified whole blood-based ELISPOT assay designed for field setting, circulating poliovirus type-specific IgA- and IgG-ASCs, including gut homing alpha 4 beta 7+ASCs, were enumerated on days 0 and 7 after booster immunization. In addition, serum samples collected on days 0, 28 and 56 were tested for neutralizing antibody titers against poliovirus types 1, 2, and 3. Stool specimens were collected on day 28 (day of bOPV challenge), and on days 31, 35 and 42 and processed for poliovirus isolation. Results An IPV dose elicited blood IgA- and IgG-ASC responses in 84.8 to 94.9% of subjects, respectively. In comparison, a bOPV dose evoked corresponding blood ASC responses in 20.0 to 48.6% of subjects. A significant association was found between IgA- and IgG-ASC responses and serum neutralizing antibody titers for poliovirus type 1, 2, 3 (p<0.001). In the IPV group, alpha 4 beta 7(+)ASCs accounted for a substantial proportion of IgA-ASCs and the proportion of subjects with a positive alpha 4 beta 7(+) IgA-ASC response to poliovirus types 1, 2 and 3 was 62.7%, 89.8% and 45.8%, respectively. A significant association was observed between virus excretion and alpha 4 beta 7(+) IgA-and/or IgG-ASC responses to poliovirus type 3 among immunized children; however, only a weak association was found for type 1 poliovirus. Discussion Our results suggest that virus-specific blood ASCs, especially for type 3 poliovirus, can serve as surrogate of mucosal immunity after vaccination. Further studies are needed to evaluate the duration of such memory responses and to assess the programmatic utility of this whole blood-based mucosal ASC testing for the polio eradication program.	[Dey, Ayan; Sharma, Prashant; Yang, Jae Seung; Saletti, Giulietta; Wierzba, Thomas F.; Czerkinsky, Cecil] Int Vaccine Inst, Seoul, South Korea; [Molodecky, Natalie A.; Verma, Harish; Sutter, Roland W.] WHO, CH-1211 Geneva, Switzerland; [Sharma, Prashant] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Ahmad, Mohammad; Bahl, Sunil K.] World Hlth Org, Natl Polio Surveillance Project, New Delhi, India; [Wierzba, Thomas F.] PATH, Vaccine Dev Global Program, Washington, DC USA; [Nandy, Ranjan K.] Natl Inst Cholera & Enter Dis, Kolkata, India; [Deshpande, Jagadish M.] Enterovirus Res Ctr, Bombay, Maharashtra, India; [Czerkinsky, Cecil] Univ Nice Sophia Antipolis, INSERM, CNRS, Inst Pharmacol Mol & Cellulaire, Valbonne, France	International Vaccine Institute; World Health Organization; Seoul National University (SNU); World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Dey, A (corresponding author), Int Vaccine Inst, Seoul, South Korea.	adey@ivi.int; adey@ivi.int; czerkinsky@ipmc.cnrs.fr	Dey, Ayan/I-4206-2019; Sharma, Prashant/I-1840-2019; CZERKINSKY, CECIL/G-6520-2015	Dey, Ayan/0000-0002-0718-7336; Sharma, Prashant/0000-0001-9353-9520; Deshpande, Jagadish/0000-0001-5194-0375; Nandy, Ranjan Kumar/0000-0002-0012-9803	Global Polio Eradication Initiative (GPEI), WHO, Geneva (through a grant from Rotary International); Bill & Melinda Gates Foundation; Swedish Agency for International Cooperation (SIDA); government of the Republic of Korea; government of the Sweden; National Research foundation of Korea [2013K1AZA1058633]; ADITEC grant, European Union Framework Program 7	Global Polio Eradication Initiative (GPEI), WHO, Geneva (through a grant from Rotary International); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Swedish Agency for International Cooperation (SIDA); government of the Republic of Korea(Korean Government); government of the Sweden; National Research foundation of Korea(National Research Foundation of Korea); ADITEC grant, European Union Framework Program 7	This work was technically and financially supported by the Global Polio Eradication Initiative (GPEI), WHO, Geneva (through a grant from Rotary International). Part of this study was funded by the Bill & Melinda Gates Foundation and the Swedish Agency for International Cooperation (SIDA). The International Vaccine Institute is supported by the governments of the Republic of Korea and Sweden. Support to AD through National Research foundation of Korea (http://www.nrf.re.kr), grant number 2013K1AZA1058633 is gratefully acknowledged. Support to CC through "ADITEC grant (http://www.aditecproject.eu), European Union Framework Program 7, is gratefully acknowledged.; We thank all volunteers who participated in this study and the entire team from the National Polio Surveillance Project (NPSP), World Health Organization (WHO), India, for setting up the field laboratory and providing field support in Moradabad and Sambhal, Uttar Pradesh, India. We are particularly grateful to Prof. Pearay Ogra for advice and inspiring discussions. Special thanks are extended to Drs Eugene Butcher (Stanford University) and Sanofi-Pasteur (France) for providing alpha 4 beta 7 antibody and purified poliovirus antigens respectively. This work was technically and financially supported by the Global Polio Eradication Initiative (GPEI), WHO, Geneva (through a grant from Rotary International). Part of this study was funded by the Bill & Melinda Gates Foundation and the Swedish Agency for International Cooperation (SIDA). The International Vaccine Institute is supported by the governments of the Republic of Korea and Sweden. Support to AD through National Research foundation of Korea (http://www.nrf.re.kr), grant number 2013K1AZA1058633 is gratefully acknowledged. Support to CC through "ADITEC grant (http://www.aditecproject.eu), European Union Framework Program 7, is gratefully acknowledged	[Anonymous], 2015, WKLY EPIDEMIOL REC, V90; Chen ZC, 2013, P NATL ACAD SCI USA, V110, P20242, DOI 10.1073/pnas.1320041110; CZERKINSKY C, 1987, P NATL ACAD SCI USA, V84, P2449, DOI 10.1073/pnas.84.8.2449; DEENEN GJ, 1993, INT IMMUNOL, V5, P735, DOI 10.1093/intimm/5.7.735; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Grassly NC, 2010, J INFECT DIS, V201, P1535, DOI 10.1086/651952; Greenwood BM, 1997, J INFECT DIS, V175, pS215; HAMMON WM, 1954, JAMA-J AM MED ASSOC, V156, P21, DOI 10.1001/jama.1954.02950010023009; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; Huang KYA, 2014, J INFECT DIS, V209, P1354, DOI 10.1093/infdis/jit650; Jafari H, 2014, SCIENCE, V345, P922, DOI 10.1126/science.1255006; John J, 2014, LANCET, V384, P1505, DOI 10.1016/S0140-6736(14)60934-X; Kantele A, 1999, VACCINE, V17, P229, DOI 10.1016/S0264-410X(98)00193-5; Krieg C, 2004, J GEN VIROL, V85, P1571, DOI 10.1099/vir.0.79919-0; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MESTECKY J, 1987, ANN ALLERGY, V59, P54; Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383; ONORATO IM, 1991, J INFECT DIS, V163, P1, DOI 10.1093/infdis/163.1.1; QUIDINGJARBRINK M, 1995, EUR J IMMUNOL, V25, P322, DOI 10.1002/eji.1830250203; QuidingJarbrink M, 1997, J CLIN INVEST, V99, P1281, DOI 10.1172/JCI119286; R Core Team, 2014, LANG ENV STAT COMP; Saletti G, 2013, NAT PROTOC, V8, P1073, DOI 10.1038/nprot.2013.058; STEVENS RH, 1978, J CLIN INVEST, V62, P1154, DOI 10.1172/JCI109234; Sutter R.W., 1993, VACCINES-BASEL, V6th ed., P598, DOI DOI 10.1016/B978-1-4557-0090-5.00035-5; SVENNERHOLM AM, 1981, J INFECT DIS, V143, P707, DOI 10.1093/infdis/143.5.707; UHLIG H, 1988, VIROLOGY, V163, P214, DOI 10.1016/0042-6822(88)90251-6; World Health Organization, 2004, WHOIVB0410; World Health Organization (WHO), 1991, EXPANDED PROGRAMME I; Wright PF, 2014, J INFECT DIS, V209, P1628, DOI 10.1093/infdis/jit671	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146010	10.1371/journal.pone.0146010	http://dx.doi.org/10.1371/journal.pone.0146010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730586	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400077
J	Boyle, MD; Payne-Sturges, DC; Sangaramoorthy, T; Wilson, S; Nachman, KE; Babik, K; Jenkins, CC; Trowell, J; Milton, DK; Sapkota, A				Boyle, Meleah D.; Payne-Sturges, Devon C.; Sangaramoorthy, Thurka; Wilson, Sacoby; Nachman, Keeve E.; Babik, Kelsey; Jenkins, Christian C.; Trowell, Joshua; Milton, Donald K.; Sapkota, Amir			Hazard Ranking Methodology for Assessing Health Impacts of Unconventional Natural Gas Development and Production: The Maryland Case Study	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; CONGESTIVE-HEART-FAILURE; BIRTH OUTCOMES; SHALE; MORTALITY; HOSPITALIZATION; CALIFORNIA; EXPOSURE; METHANE; ORIGIN	The recent growth of unconventional natural gas development and production (UNGDP) has outpaced research on the potential health impacts associated with the process. The Maryland Marcellus Shale Public Health Study was conducted to inform the Maryland Marcellus Shale Safe Drilling Initiative Advisory Commission, State legislators and the Governor about potential public health impacts associated with UNGDP so they could make an informed decision that considers the health and well-being of Marylanders. In this paper, we describe an impact assessment and hazard ranking methodology we used to assess the potential public health impacts for eight hazards associated with the UNGDP process. The hazard ranking included seven metrics: 1) presence of vulnerable populations (e.g. children under the age of 5, individuals over the age of 65, surface owners), 2) duration of exposure, 3) frequency of exposure, 4) likelihood of health effects, 5) magnitude/severity of health effects, 6) geographic extent, and 7) effectiveness of setbacks. Overall public health concern was determined by a color-coded ranking system (low, moderately high, and high) that was generated based on the overall sum of the scores for each hazard. We provide three illustrative examples of applying our methodology for air quality and health care infrastructure which were ranked as high concern and for water quality which was ranked moderately high concern. The hazard ranking was a valuable tool that allowed us to systematically evaluate each of the hazards and provide recommendations to minimize the hazards.	[Boyle, Meleah D.; Payne-Sturges, Devon C.; Wilson, Sacoby; Babik, Kelsey; Jenkins, Christian C.; Trowell, Joshua; Milton, Donald K.; Sapkota, Amir] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Sangaramoorthy, Thurka] Univ Maryland, Dept Anthropol, Coll Behav & Social Sci, College Pk, MD 20742 USA; [Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Livable Future, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sapkota, A (corresponding author), Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA.	amirsap@umd.edu	Sapkota, Amir/A-5968-2011; Sangaramoorthy, Thurka/AAZ-2730-2021; Babik, Kelsey/GYU-8346-2022; Milton, Donald K/G-3286-2010	Milton, Donald K/0000-0002-0550-7834; Payne-Sturges, Devon/0000-0001-7343-2814; Nachman, Keeve/0000-0003-4925-4151; Sangaramoorthy, Thurka/0000-0002-8467-5907; Trowell, Joshua/0000-0003-4311-4609; Babik, Kelsey/0000-0002-8084-6449	Maryland Department of Health and Mental Hygiene [DHMH: M00B4400326]	Maryland Department of Health and Mental Hygiene	The work presented in this manuscript was supported by the Maryland Department of Health and Mental Hygiene (DHMH: M00B4400326).	Adams M. B., 2011, NRS76 USDA; Adams MB, 2011, J ENVIRON QUAL, V40, P1340, DOI 10.2134/jeq2010.0504; Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; [Anonymous], OHIO IMP ASS; Bamberger M, 2012, NEW SOLUT, V22, P51, DOI 10.2190/NS.22.1.e; Brown D., 2014, ENV HLTH PERSPECT, V122, P50; Brown David, 2014, Reviews on Environmental Health, V29, P277, DOI 10.1515/reveh-2014-0002; Constantine S, MINING TOWNS DOES BO; Coussens C, 2014, HLTH IMPACT ASSESSME; Erny-Albrecht K, 2014, PHRIS POLICY ISSUE R; Farag AM, 2014, INT J COAL GEOL, V126, P157, DOI 10.1016/j.coal.2013.12.006; Finkel ML, 2011, AM J PUBLIC HEALTH, V101, P784, DOI 10.2105/AJPH.2010.300089; Franklin M, 2007, J EXPO SCI ENV EPID, V17, P279, DOI 10.1038/sj.jes.7500530; Hill E., 2013, INT SOC ENV EP ANN M; Jackson RB, 2013, P NATL ACAD SCI USA, V110, P11250, DOI 10.1073/pnas.1221635110; Kassotis CD, 2016, ENVIRON HEALTH PERSP, V124, P256, DOI 10.1289/ehp.1409535; Kassotis CD, 2014, ENDOCRINOLOGY, V155, P897, DOI 10.1210/en.2013-1697; Kettunen J, 2007, STROKE, V38, P918, DOI 10.1161/01.STR.0000257999.49706.3b; Li HS, 2014, ENVIRON SCI TECHNOL, V48, P1484, DOI 10.1021/es404668b; Maryland Department of the Environment, 2013, MARC SHAL SAF DRILL; Maryland Institute for Applied Environmental Health, 2014, POT PUBL HLTH IMP NA; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; MORRIS RD, 1995, AM J PUBLIC HEALTH, V85, P1361, DOI 10.2105/AJPH.85.10.1361; Myers T, 2012, GROUND WATER, V50, P872, DOI 10.1111/j.1745-6584.2012.00933.x; National Research Council, 2011, IMPR HLTH US ROL HLT; NYSDEC (New York State Department of Environmental Conservation), 2011, REV DRAFT SUPPL GEN; Occupational Safety and Health Administration (OSHA), SAF HLTH TOP DIES EX; Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Revesz KM, 2010, APPL GEOCHEM, V25, P1845, DOI 10.1016/j.apgeochem.2010.09.011; Rich AL, 2013, NEW SOLUT, V23, P117, DOI 10.2190/NS.23.1.h; Ritz B, 1999, ENVIRON HEALTH PERSP, V107, P17, DOI 10.2307/3434285; Rozell DJ, 2012, RISK ANAL, V32, P1382, DOI 10.1111/j.1539-6924.2011.01757.x; Sangaramoorthy T, 2015, SOCIAL SCI MED; Shandro JA, 2011, RESOUR POLICY, V36, P178, DOI 10.1016/j.resourpol.2011.01.004; Shonkoff SBC, 2014, ENVIRON HEALTH PERSP, V122, P787, DOI 10.1289/ehp.1307866; Steinzor N, 2013, NEW SOLUT, V23, P55, DOI 10.2190/NS.23.1.e; Trasande L, 2015, J CLIN ENDOCR METAB, V100, P1245, DOI 10.1210/jc.2014-4324; U.S. Department of Labor, 2010, OIL GAS IND FATAL NO; Vengosh A, 2014, ENVIRON SCI TECHNOL, V48, P8334, DOI 10.1021/es405118y; Venners SA, 2003, ENVIRON HEALTH PERSP, V111, P562, DOI 10.1289/ehp.5664; Vidic RD, 2013, SCIENCE, V340, DOI 10.1126/science.1235009; Warner NR, 2013, ENVIRON SCI TECHNOL, V47, P11849, DOI 10.1021/es402165b; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2005, AM J EPIDEMIOL, V161, P1030, DOI 10.1093/aje/kwi135; Wilhelm M, 2005, ENVIRON HEALTH PERSP, V113, P1212, DOI 10.1289/ehp.7751; Witter R., 2010, HLTH IMPACT ASSESSME	48	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145368	10.1371/journal.pone.0145368	http://dx.doi.org/10.1371/journal.pone.0145368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26726918	gold, Green Published			2022-12-27	WOS:000367681500013
J	Mastropasqua, R; Toto, L; Borrelli, E; Di Antonio, L; De Nicola, C; Mastrocola, A; Di Nicola, M; Carpineto, P				Mastropasqua, Rodolfo; Toto, Lisa; Borrelli, Enrico; Di Antonio, Luca; De Nicola, Chiara; Mastrocola, Alessandra; Di Nicola, Marta; Carpineto, Paolo			Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema	PLOS ONE			English	Article							VASCULAR LEAKAGE; CONTROLLED-TRIAL; RETINOPATHY; NEURODEGENERATION; LEUKOSTASIS; ASSOCIATION; RETINA	Background To investigate changes in macular morphology and function after an intravitreal dexamethasone implant for diabetic macular edema (DME). Methods Twenty-seven eyes in 27 treatment-naive patients affected by DME were treated with intravitreal Ozurdex (R) injections (IVOI) and followed up 12 months to evaluate morphological and functional changes by means of best-corrected visual acuity (BCVA), microperimetry (MP1), multifocal electroretinography (mfERG), pattern electroretinography (PERG) and spectral domain optical coherence tomography (SD-OCT). Results Both BCVA and retinal sensitivity improved significantly at one month after the IVOI (p = 0.031 and p<0.0001, respectively). After five months, the improvement of BCVA remained statistically significant compared with baseline values (p = 0.022); retinal sensitivity improvement was statistically significant for up to four months after the IVOI (p = 0.059). Moreover, central macular thickness significantly decreased for up to four months. Interestingly, PERG and mfERG values did not change significantly for up to four months post-IVOI, but then began to worsen. Conclusions In eyes with DME, intravitreal dexamethasone implant determined morphological and functional improvement as soon as one month and for up to four months after the treatment.	[Mastropasqua, Rodolfo] Univ Verona, Ophthalmol Clin, I-37100 Verona, Italy; [Toto, Lisa; Borrelli, Enrico; Di Antonio, Luca; De Nicola, Chiara; Mastrocola, Alessandra; Carpineto, Paolo] Univ G dAnnunzio, Dept Med & Sci Aging, Ophthalmol Clin, Chieti, Italy; [Di Nicola, Marta] Univ G DAnnunzio Chieti, Ctr Excellence Aging, Lab Biostat, Chieti, Italy; [Di Nicola, Marta] Univ G DAnnunzio Chieti, Dept Biomed Sci, Lab Biostat, Chieti, Italy	University of Verona; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Toto, L (corresponding author), Univ G dAnnunzio, Dept Med & Sci Aging, Ophthalmol Clin, Chieti, Italy.	l.toto@unich.it	Carpineto, Paolo/AAN-9688-2020; Borrelli, Enrico/AAR-3693-2020; Mastropasqua, Rodolfo/AAC-6453-2022; Toto, Lisa/K-3473-2018	Borrelli, Enrico/0000-0003-2815-5031; Toto, Lisa/0000-0001-5311-5184				Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Bandello F, 2010, OPHTHALMOLOGICA, V224, P41, DOI 10.1159/000315161; Bandello F., 2014, CLIN STRATEGIES MANA, V1st; Bearse MA, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0526-9; Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001; Boyer DS, 2014, OPHTHALMOLOGY, V121, P1904, DOI 10.1016/j.ophtha.2014.04.024; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; De Benedetto U, 2014, RETINA-J RET VIT DIS, V34, P2171, DOI 10.1097/IAE.0000000000000205; Dong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125329; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Haller JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P289, DOI 10.1001/archophthalmol.2010.21; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Pacella E, 2013, CLIN TER, V164, pE121, DOI 10.7417/CT.2013.1543; Pacella E, 2014, SENSES SCI, V1, P164; Pacella E, 2013, CLIN OPHTHALMOL, V7, P1423, DOI 10.2147/OPTH.S48364; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Querques G, 2014, OPTOMETRY VISION SCI, V91, P760, DOI 10.1097/OPX.0000000000000308; Querques G, 2014, RETINA-J RET VIT DIS, V34, P330, DOI 10.1097/IAE.0b013e31829f7495; Scaramuzzi M, 2015, RETINA-J RET VIT DIS, V35, P1216, DOI 10.1097/IAE.0000000000000443; Simo R, 2014, TRENDS ENDOCRIN MET, V25, P23, DOI 10.1016/j.tem.2013.09.005; Stem MS, 2013, CURR MED CHEM, V20, P3241, DOI 10.2174/09298673113209990027; Tamura H, 2005, INVEST OPHTH VIS SCI, V46, P1440, DOI 10.1167/iovs.04-0905; Vujosevic S, 2006, INVEST OPHTH VIS SCI, V47, P3044, DOI 10.1167/iovs.05-1141; Wang K, 2008, BIOL PHARM BULL, V31, P1541, DOI 10.1248/bpb.31.1541; Zitkus Bruce S, 2014, Nurse Pract, V39, P22, DOI 10.1097/01.NPR.0000451880.48790.50	27	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145663	10.1371/journal.pone.0145663	http://dx.doi.org/10.1371/journal.pone.0145663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720268	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900019
J	Graumann, F; Churin, Y; Tschuschner, A; Reifenberg, K; Glebe, D; Roderfeld, M; Roeb, E				Graumann, Franziska; Churin, Yuri; Tschuschner, Annette; Reifenberg, Kurt; Glebe, Dieter; Roderfeld, Martin; Roeb, Elke			Genomic Methylation Inhibits Expression of Hepatitis B Virus Envelope Protein in Transgenic Mice: A Non-Infectious Mouse Model to Study Silencing of HBV Surface Antigen Genes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HEPATOCELLULAR-CARCINOMA; CLONAL EXPANSION; LIVER; HEPATOCYTES; ACTIVATION; DNA; POLYPEPTIDE; SECRETION; CELLS	Objective The Hepatitis B virus genome persists in the nucleus of virus infected hepatocytes where it serves as template for viral mRNA synthesis. Epigenetic modifications, including methylation of the CpG islands contribute to the regulation of viral gene expression. The present study investigates the effects of spontaneous age dependent loss of hepatitis B surface protein-(HBs) expression due to HBV-genome specific methylation as well as its proximate positive effects in HBs transgenic mice. Methods Liver and serum of HBs transgenic mice aged 5-33 weeks were analyzed by Western blot, immunohistochemistry, serum analysis, PCR, and qRT-PCR. Results From the third month of age hepatic loss of HBs was observed in 20% of transgenic mice. The size of HBs-free area and the relative number of animals with these effects increased with age and struck about 55% of animals aged 33 weeks. Loss of HBs-expression was strongly correlated with amelioration of serum parameters ALT and AST. In addition lower HBs-expression went on with decreased ER-stress. The loss of surface protein expression started on transcriptional level and appeared to be regulated epigenetically by DNA methylation. The amount of the HBs-expression correlated negatively with methylation of HBV DNA in the mouse genome. Conclusions Our data suggest that methylation of specific CpG sites controls gene expression even in HBs-transgenic mice with truncated HBV genome. More important, the loss of HBs expression and intracellular aggregation ameliorated cell stress and liver integrity. Thus, targeted modulation of HBs expression may offer new therapeutic approaches. Furthermore, HBs-transgenic mice depict a non-infectious mouse model to study one possible mechanism of HBs gene silencing by hypermethylation.	[Graumann, Franziska; Churin, Yuri; Tschuschner, Annette; Roderfeld, Martin; Roeb, Elke] Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany; [Reifenberg, Kurt] Johannes Gutenberg Univ Mainz, Cent Lab, Anim Facil, D-55122 Mainz, Germany; [Glebe, Dieter] Univ Giessen, Inst Med Virol, Natl Reference Ctr Hepatitis B&D Viruses, D-35390 Giessen, Germany	Justus Liebig University Giessen; Johannes Gutenberg University of Mainz; Justus Liebig University Giessen	Roeb, E (corresponding author), Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany.	elke.roeb@innere.med.uni-giessen.de	, Martin/AHD-5202-2022	, Martin/0000-0002-3232-1277	DFG [RO 958-1]; von-Behring-Roentgen Foundation [58-0005, 60-0002]; University Medical Center Giessen and Marburg [21 2013, 7_2014]	DFG(German Research Foundation (DFG)); von-Behring-Roentgen Foundation; University Medical Center Giessen and Marburg	ER received the following funding: 1. DFG grant, #RO 958-1, http://www.dfg.der, 2. von-Behring-Roentgen Foundation, #58-0005, http://www.br-stiftung.de/, 3. University Medical Center Giessen and Marburg, #21 2013, http://www.ukgm.de/ugm 2/deu/906.html. MR received the following funding: 1. von-Behring-Roentgen Foundation, #60-0002, http://www.br-stiftung.de/, 2. University Medical Center Giessen and Marburg, #7_2014, http://www.ukgm.de/ugm_2/deu/906.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; Christen V, 2007, HEPATOLOGY, V46, P558, DOI 10.1002/hep.21611; Chua PK, 2005, J VIROL, V79, P13483, DOI 10.1128/JVI.79.21.13483-13496.2005; Churin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090608; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Glebe D, 2003, J VIROL, V77, P9511, DOI 10.1128/JVI.77.17.9511-9521.2003; Glebe D, 2013, SEMIN LIVER DIS, V33, P103, DOI 10.1055/s-0033-1345717; HEERMANN KH, 1984, J VIROL, V52, P396, DOI 10.1128/JVI.52.2.396-402.1984; Hofstetter JR, 1997, BIOCHEM MOL MED, V62, P197, DOI 10.1006/bmme.1997.2637; Kaur P, 2010, J INFECT DIS, V202, P700, DOI 10.1086/655398; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lazar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034169; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Mason WS, 2010, J VIROL, V84, P8308, DOI 10.1128/JVI.00833-10; Mason WS, 2009, J VIROL, V83, P8396, DOI 10.1128/JVI.00700-09; Mason WS, 2005, P NATL ACAD SCI USA, V102, P1139, DOI 10.1073/pnas.0409332102; Modrow S, 2010, MOLEKULARE VIROLOGIE; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Qiu Q, 2011, STEM CELLS DEV, V20, P2177, DOI 10.1089/scd.2010.0352; Riviere L, 2014, RECENT RESULTS CANC, V193, P59, DOI 10.1007/978-3-642-38965-8_4; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Vig P, 2006, HEPATOLOGY, V43, P316, DOI 10.1002/hep.21018; Vivekanandan P, 2008, J VIRAL HEPATITIS, V15, P103, DOI 10.1111/j.1365-2893.2007.00905.x; Vivekanandan P, 2009, J INFECT DIS, V199, P1286, DOI 10.1086/597614; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Yovchev MI, 2014, HEPATOLOGY, V59, P284, DOI 10.1002/hep.26615; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008	36	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146099	10.1371/journal.pone.0146099	http://dx.doi.org/10.1371/journal.pone.0146099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717563	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500134
J	Hojland, DH; Nauen, R; Foster, SP; Williamson, MS; Kristensen, M				Hojland, Dorte H.; Nauen, Ralf; Foster, Stephen P.; Williamson, Martin S.; Kristensen, Michael			Incidence, Spread and Mechanisms of Pyrethroid Resistance in European Populations of the Cabbage Stem Flea Beetle, Psylliodes chrysocephala L. (Coleoptera: Chrysomelidae)	PLOS ONE			English	Article							OILSEED RAPE; POLLEN BEETLE	Background Cabbage stem flea beetle (CSFB), Psylliodes chrysocephala L. (Coleoptera: Chrysomelidae) is a major early season pest of oilseed rape throughout Europe. Pyrethroids have been used for controlling this pest by foliar application, but in recent years control failures have occurred, particularly in Germany due to the evolution of knock-down resistance (kdr). The purpose of this study was to investigate the incidence and spread of pyrethroid resistance in CSFB collected in Germany, Denmark and the United Kingdom during 2014. The level of pyrethroid resistance was measured in adult vial tests and linked to the presence of kdr genotypes. Results Although kdr (L1014F) genotypes are present in all three countries, marked differences in pyrethroid efficacy were found in adult vial tests. Whereas Danish CSFB samples were in general susceptible to recommended label rates, those collected in the UK mostly resist such rates to some extent. Moderately resistant and susceptible samples were found in Germany. Interestingly, some of the resistant samples from the UK did not carry the kdr allele, which is in contrast to German CSFB. Pre-treatment with PBO, prior to exposure to lambda-cyhalothrin suggested involvement of metabolic resistance in UK samples. Conclusion Danish samples were mostly susceptible with very low resistance ratios, while most other samples showed reduced sensitivity in varying degrees. Likewise, there was a clear difference in the presence of the kdr mutation between the three countries. In the UK, the presence of kdr genotypes did not always correlate well with resistant phenotypes. This appears to be primarily conferred by a yet undisclosed, metabolic-based mechanism. Nevertheless our survey disclosed an alarming trend concerning the incidence and spread of CSFB resistance to pyrethroids, which is likely to have negative impacts on oilseed production in affected regions due to the lack of alternative modes of action for resistance management purposes.	[Hojland, Dorte H.; Kristensen, Michael] Aarhus Univ, Dept Agroecol, DK-4200 Slagelse, Denmark; [Nauen, Ralf] Bayer CropSci AG, Pest Control Biol, D-40789 Monheim, Germany; [Foster, Stephen P.; Williamson, Martin S.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England	Aarhus University; Bayer AG; Bayer CropScience; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Kristensen, M (corresponding author), Aarhus Univ, Dept Agroecol, Forsogsvej 1, DK-4200 Slagelse, Denmark.	mikr@agro.au.dk	Nauen, Ralf/AAG-5840-2019; Kristensen, Michael/F-5536-2016	Nauen, Ralf/0000-0002-7525-8589; Kristensen, Michael/0000-0001-7332-3490; Hojland, Dorte H./0000-0002-9758-5783	AHDB-HGCA; Innovation Fund Denmark [EvoPPM 0603-00516B]; Bayer CropScience; BBSRC [BBS/E/C/00005193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005193] Funding Source: researchfish	AHDB-HGCA; Innovation Fund Denmark; Bayer CropScience(Bayer AG); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AHDB-HGCA part-funded the work done at Rothamsted Research which is an institute of the Biotechnology and Biological Sciences Council of the United Kingdom. This project EvoPPM 0603-00516B was funded by Innovation Fund Denmark and Bayer CropScience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2011, SUSTAINABLE AGRICULTURE, VOL 2, P623, DOI 10.1007/978-94-007-0394-0_28; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Ferguson AW, 2003, AGR ECOSYST ENVIRON, V95, P509, DOI 10.1016/S0167-8809(02)00200-1; GRAHAM CW, 1981, PLANT PATHOL, V30, P141, DOI 10.1111/j.1365-3059.1981.tb01245.x; Hansen LM, 2003, PEST MANAG SCI, V59, P1057, DOI 10.1002/ps.737; Heimbach U, 2013, PEST MANAG SCI, V69, P209, DOI 10.1002/ps.3351; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Nauen R, 2012, PESTIC BIOCHEM PHYS, V103, P173, DOI 10.1016/j.pestbp.2012.04.012; Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007; SARINGER G, 1984, Z ANGEW ENTOMOL, V98, P50; Williams IH, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P181; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zimmer CT, 2014, INSECT BIOCHEM MOLEC, V45, P18, DOI 10.1016/j.ibmb.2013.11.008; Zimmer CT, 2014, PESTIC BIOCHEM PHYS, V108, P1, DOI 10.1016/j.pestbp.2013.11.005; Zimmer CT, 2011, PESTIC BIOCHEM PHYS, V100, P264, DOI 10.1016/j.pestbp.2011.04.011	16	26	26	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146045	10.1371/journal.pone.0146045	http://dx.doi.org/10.1371/journal.pone.0146045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717570	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510500126
J	Martinez, RM; Pinho-Ribeiro, FA; Steffen, VS; Silva, TCC; Caviglione, CV; Bottura, C; Fonseca, MJV; Vicentini, FTMC; Vignoli, JA; Baracat, MM; Georgetti, SR; Verri, WA; Casagrande, R				Martinez, Renata M.; Pinho-Ribeiro, Felipe A.; Steffen, Vinicius S.; Silva, Thais C. C.; Caviglione, Carla V.; Bottura, Carolina; Fonseca, Maria J. V.; Vicentini, Fabiana T. M. C.; Vignoli, Josiane A.; Baracat, Marcela M.; Georgetti, Sandra R.; Verri, Waldiceu A., Jr.; Casagrande, Rubia			Topical Formulation Containing Naringenin: Efficacy against Ultraviolet B Irradiation-Induced Skin Inflammation and Oxidative Stress in Mice	PLOS ONE			English	Article							PIMENTA-PSEUDOCARYOPHYLLUS EXTRACT; ANION-INDUCED PAIN; FACTOR-KAPPA-B; ANTIOXIDANT ACTIVITY; LEUKOCYTE RECRUITMENT; INDUCED GENERATION; HAIRLESS MICE; NADPH OXIDASE; NITRIC-OXIDE; EXPRESSION	Naringenin (NGN) exhibits anti-inflammatory and antioxidant activities, but it remains undetermined its topical actions against ultraviolet B (UVB)-induced inflammation and oxidative stress in vivo. The purpose of this study was to evaluate the physicochemical and functional antioxidant stability of NGN containing formulations, and the effects of selected NGN containing formulation on UVB irradiation-induced skin inflammation and oxidative damage in hairless mice. NGN presented ferric reducing power, ability to scavenge 2,2'-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and hydroxyl radical, and inhibited iron-independent and dependent lipid peroxidation. Among the three formulations containing NGN, only the F3 kept its physicochemical and functional stability over 180 days. Topical application of F3 in mice protected from UVB-induced skin damage by inhibiting edema and cytokine production (TNF-alpha, IL-1 beta, IL-6, and IL-10). Furthermore, F3 inhibited superoxide anion and lipid hydroperoxides production and maintained ferric reducing and ABTS scavenging abilities, catalase activity, and reduced glutathione levels. In addition, F3 maintained mRNA expression of cellular antioxidants glutathione peroxidase 1, glutathione reductase and transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2), and induced mRNA expression of heme oxygenase-1. In conclusion, a formulation containing NGN may be a promising approach to protecting the skin from the deleterious effects of UVB irradiation.	[Martinez, Renata M.; Steffen, Vinicius S.; Silva, Thais C. C.; Caviglione, Carla V.; Bottura, Carolina; Baracat, Marcela M.; Georgetti, Sandra R.; Casagrande, Rubia] Univ Estadual Londrina, Dept Ciencias Farmaceut, BR-86039440 Londrina, Parana, Brazil; [Pinho-Ribeiro, Felipe A.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Dept Ciencias Patol, BR-86057970 Londrina, Parana, Brazil; [Fonseca, Maria J. V.] Fac Ciencias Farmaceut Ribeirao Preto USP, Dept Ciencias Farmaceut, BR-14049903 Sao Paulo, Brazil; [Vicentini, Fabiana T. M. C.] Farmacore Biotecnol LTDA, BR-14095250 Sao Paulo, Brazil; [Vignoli, Josiane A.] Univ Estadual Londrina, Ctr Ciencias Exatas, Dept Bioquim & Biotecnol, BR-86057970 Londrina, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Londrina	Verri, WA (corresponding author), Univ Estadual Londrina, Dept Ciencias Patol, Rodovia Celso Garcia Cid,Km 380,PR445, BR-86057970 Londrina, Parana, Brazil.	waldiceujr@yahoo.com.br; rubiacasa@yahoo.com.br	MARTINEZ, RENATA M/L-5787-2016; Casagrande, Rubia/I-1377-2013; de Pinho Ribeiro, Felipe Almeida/AAI-8107-2020; WA, Verri/I-1330-2013; Casagrande, Rubia/U-6019-2019; Vignoli, Josiane/AFQ-1790-2022; Georgetti, Sandra/AAA-6576-2020; Vicentini, Fabiana T.M.C./F-8065-2012; Martinez, Renata Micheli/O-6097-2019	de Pinho Ribeiro, Felipe Almeida/0000-0003-4264-9839; WA, Verri/0000-0003-2756-9283; Casagrande, Rubia/0000-0002-2296-1668; Vignoli, Josiane/0000-0002-8615-8161; Vicentini, Fabiana T.M.C./0000-0002-0842-9130; Martinez, Renata Micheli/0000-0003-1096-0876; Georgetti, Sandra Regina/0000-0003-2580-8762	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Inovacao (SETI)/Fundacao Araucaria; Parana State Government; Farmacore Biotecnologia LTDA	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Inovacao (SETI)/Fundacao Araucaria; Parana State Government; Farmacore Biotecnologia LTDA	This work was supported by Brazilian grants from Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Inovacao (SETI)/Fundacao Araucaria, and Parana State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Farmacore Biotecnologia LTDA provided support in the form of salaries for authors [FTMCV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aebi H, 1984, Methods Enzymol, V105, P121; Afaq F, 2005, MUTAT RES-FUND MOL M, V571, P153, DOI 10.1016/j.mrfmmm.2004.07.019; Afaq F, 2011, MINI-REV MED CHEM, V11, P1200; Al-Rejaie SS, 2013, WORLD J GASTROENTERO, V19, P5633, DOI 10.3748/wjg.v19.i34.5633; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Azizi E, 2000, CANCER CAUSE CONTROL, V11, P513, DOI 10.1023/A:1008970224998; Beak SM, 2004, BIOCHIMIE, V86, P425, DOI 10.1016/j.biochi.2004.06.010; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Borghi SM, 2015, EXP PHYSIOL, V100, P531, DOI 10.1113/EP085026; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Buege J A, 1978, Methods Enzymol, V52, P302; Campanini MZ, 2014, AAPS PHARMSCITECH, V15, P86, DOI 10.1208/s12249-013-0049-8; Campanini MZ, 2013, J PHOTOCH PHOTOBIO B, V127, P153, DOI 10.1016/j.jphotobiol.2013.08.007; Casagrande R, 2006, J PHOTOCH PHOTOBIO B, V84, P21, DOI 10.1016/j.jphotobiol.2006.01.006; Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Dhanalakshmi S, 2004, CARCINOGENESIS, V25, P1459, DOI 10.1093/carcin/bgh152; El-Mahdy MA, 2008, PHOTOCHEM PHOTOBIOL, V84, P307, DOI 10.1111/j.1751-1097.2007.00255.x; Fattori V, 2015, INFLAMM RES, V64, P993, DOI 10.1007/s00011-015-0885-y; Fischer TW, 2013, J PINEAL RES, V54, P303, DOI 10.1111/jpi.12018; FLECHA BG, 1991, FREE RADICAL BIO MED, V10, P93; Fonseca YM, 2011, J PHARM SCI-US, V100, P2182, DOI 10.1002/jps.22438; Georgetti SR, 2006, EUR J PHARM BIOPHARM, V64, P99, DOI 10.1016/j.ejpb.2006.04.003; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Guazelli CFS, 2013, J NAT PROD, V76, P200, DOI 10.1021/np300670w; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hasegawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077308; Heck DE, 2003, J BIOL CHEM, V278, P22432, DOI 10.1074/jbc.C300048200; Hermenean A, 2013, CHEM-BIOL INTERACT, V205, P138, DOI 10.1016/j.cbi.2013.06.016; Hiramoto K, 2012, EXP DERMATOL, V21, P911, DOI 10.1111/exd.12032; Hwang H, 2006, INT J CANCER, V119, P2742, DOI 10.1002/ijc.22147; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Ivan ALM, 2014, J PHOTOCH PHOTOBIO B, V138, P124, DOI 10.1016/j.jphotobiol.2014.05.010; Johnson MK, 2000, MUTAT RES-DNA REPAIR, V459, P211, DOI 10.1016/S0921-8777(99)00074-9; Kam WWY, 2013, FREE RADICAL BIO MED, V65, P607, DOI 10.1016/j.freeradbiomed.2013.07.024; Khan MB, 2012, NEUROCHEM INT, V61, P1081, DOI 10.1016/j.neuint.2012.07.025; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kim SH, 2012, J PHOTOCH PHOTOBIO B, V117, P104, DOI 10.1016/j.jphotobiol.2012.08.013; KUKREJA RC, 1986, CIRC RES, V59, P612, DOI 10.1161/01.RES.59.6.612; Lee CH, 2001, BIOCHEM BIOPH RES CO, V284, P681, DOI 10.1006/bbrc.2001.5001; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Listopad J, 2007, EXP DERMATOL, V16, P661, DOI 10.1111/j.1600-0625.2007.00581.x; Maioli NA, 2015, BRAZ J MED BIOL RES, V48, P321, DOI [10.1590/1414-431X20144187, 10.1590/1414-431x20144187]; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martinez RM, 2015, J NAT PROD, V78, P1647, DOI 10.1021/acs.jnatprod.5b00198; Martinez RM, 2012, REV BRAS FARMACOGN, V22, P587, DOI 10.1590/S0102-695X2012005000006; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Mershiba SD, 2013, MOL BIOL REP, V40, P3681, DOI 10.1007/s11033-012-2444-8; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Okayama Yoshimichi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P517, DOI 10.2174/1568010054526386; Pari L, 2006, BASIC CLIN PHARMACOL, V98, P456, DOI 10.1111/j.1742-7843.2006.pto_351.x; Piskin G, 2005, ARCH DERMATOL RES, V296, P339, DOI 10.1007/s00403-004-0522-z; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Reeve VE, 2010, PHOTOCH PHOTOBIO SCI, V9, P601, DOI 10.1039/b9pp00177h; Renugadevi J, 2009, TOXICOLOGY, V256, P128, DOI 10.1016/j.tox.2008.11.012; Renugadevi J, 2010, EXP TOXICOL PATHOL, V62, P171, DOI 10.1016/j.etp.2009.03.010; Saw CL, 2011, MOL CARCINOGEN, V50, P479, DOI 10.1002/mc.20725; Saw CLL, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-39; Serafim KGG, 2015, N-S ARCH PHARMACOL, V388, P1211, DOI 10.1007/s00210-015-1160-z; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Strickland I, 1997, J INVEST DERMATOL, V108, P763, DOI 10.1111/1523-1747.ep12292156; Subburaman S, 2014, J ENVIRON PATHOL TOX, V33, P363, DOI 10.1615/JEnvironPatholToxicolOncol.2014010625; Sullivan NJ, 2012, J INVEST DERMATOL, V132, P695, DOI 10.1038/jid.2011.329; Tsai MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131026; Tsai MJ, 2015, INT J PHARMACEUT, V481, P84, DOI 10.1016/j.ijpharm.2015.01.034; Tulah AS, 2013, MITOCHONDRION, V13, P444, DOI 10.1016/j.mito.2012.11.007; Turkkan B, 2012, SPECTROCHIM ACTA A, V85, P235, DOI 10.1016/j.saa.2011.09.066; Vafeiadou K, 2009, ARCH BIOCHEM BIOPHYS, V484, P100, DOI 10.1016/j.abb.2009.01.016; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2012, STUD NAT PROD CHEM, V36, P297, DOI 10.1016/B978-0-444-53836-9.00026-8; Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002; Xu CW, 2013, BIOL PHARM BULL, V36, P1549, DOI 10.1248/bpb.b13-00247; Yamacita-Borin FY, 2015, NEUROSCI LETT, V605, P53, DOI 10.1016/j.neulet.2015.08.015; Yang J, 2011, MOL CELL BIOCHEM, V351, P29, DOI 10.1007/s11010-010-0708-y; Yasul H, 2006, BIOCHEM BIOPH RES CO, V347, P83, DOI 10.1016/j.bbrc.2006.06.046; Yen FL, 2009, PHARM RES-DORDR, V26, P893, DOI 10.1007/s11095-008-9791-0; Yen HR, 2015, CHEM-BIOL INTERACT, V235, P1, DOI 10.1016/j.cbi.2015.04.003; Yilma AN, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/102457; Yu J, 2005, J AGR FOOD CHEM, V53, P2009, DOI 10.1021/jf0484632; Zhang SY, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-4	85	108	114	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146296	10.1371/journal.pone.0146296	http://dx.doi.org/10.1371/journal.pone.0146296			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741806	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600029
J	Strifler, G; Tuboly, E; Szel, E; Kaszonyi, E; Cao, C; Kaszaki, J; Meszaros, A; Boros, M; Hartmann, P				Strifler, Gerda; Tuboly, Eszter; Szel, Edit; Kaszonyi, Eniko; Cao, Chun; Kaszaki, Jozsef; Meszaros, Andres; Boros, Mihaly; Hartmann, Petra			Inhaled Methane Limits the Mitochondrial Electron Transport Chain Dysfunction during Experimental Liver Ischemia-Reperfusion Injury	PLOS ONE			English	Article							METHANOGENIC FLORA; OXIDATIVE STRESS; CONSTIPATION; HYPOXIA; TRANSIT	Background Methanogenesis can indicate the fermentation activity of the gastrointestinal anaerobic flora. Methane also has a demonstrated anti-inflammatory potential. We hypothesized that enriched methane inhalation can influence the respiratory activity of the liver mitochondria after an ischemia-reperfusion (IR) challenge. Methods The activity of oxidative phosphorylation system complexes was determined after in vitro methane treatment of intact liver mitochondria. Anesthetized Sprague-Dawley rats subjected to standardized 60-min warm hepatic ischemia inhaled normoxic air (n = 6) or normoxic air containing 2.2% methane, from 50 min of ischemia and throughout the 60-min reperfusion period (n = 6). Measurement data were compared with those on sham-operated animals (n = 6 each). Liver biopsy samples were subjected to high-resolution respirometry; whole-blood superoxide and hydrogen peroxide production was measured; hepatocyte apoptosis was detected with TUNEL staining and in vivo fluorescence laser scanning microscopy. Results Significantly decreased complex II-linked basal respiration was found in the normoxic IR group at 55 min of ischemia and a lower respiratory capacity (similar to 60%) and after 5 min of reperfusion. Methane inhalation preserved the maximal respiratory capacity at 55 min of ischemia and significantly improved the basal respiration during the first 30 min of reperfusion. The IR-induced cytochrome c activity, reactive oxygen species (ROS) production and hepatocyte apoptosis were also significantly reduced. Conclusions The normoxic IR injury was accompanied by significant functional damage of the inner mitochondrial membrane, increased cytochrome c activity, enhanced ROS production and apoptosis. An elevated methane intake confers significant protection against mitochondrial dysfunction and reduces the oxidative damage of the hepatocytes.	[Strifler, Gerda; Tuboly, Eszter; Kaszonyi, Eniko; Cao, Chun; Kaszaki, Jozsef; Meszaros, Andres; Boros, Mihaly; Hartmann, Petra] Univ Szeged, Inst Surg Res, Szeged, Hungary; [Szel, Edit] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary	Szeged University; Szeged University	Hartmann, P (corresponding author), Univ Szeged, Inst Surg Res, Szeged, Hungary.	hartmann.petra@med.szote.u-szeged.hu	Hartmann, Petra/AAZ-7881-2021	Hartmann, Petra/0000-0002-4746-9792	Hungarian Science Research Fund [OTKA K75161]	Hungarian Science Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian Science Research Fund with the grant number OTKA K75161 (http://www.otka.hu/en). M.B. was the principle investigator, E.T., J.K., and A.M. were associated researchers of the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff F, 2010, CHEMOSPHERE, V80, P286, DOI 10.1016/j.chemosphere.2010.04.004; Attaluri A, 2010, AM J GASTROENTEROL, V105, P1407, DOI 10.1038/ajg.2009.655; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Boros M, 1999, SHOCK, V12, P56, DOI 10.1097/00024382-199911001-00174; Boros M, 2012, CRIT CARE MED, V40, P1269, DOI 10.1097/CCM.0b013e31823dae05; Carlisle SM, 2005, APPL RADIAT ISOTOPES, V62, P847, DOI 10.1016/j.apradiso.2005.01.010; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Cole NB, 2010, EXP GERONTOL, V45, P596, DOI 10.1016/j.exger.2010.01.016; DOUGHERT.RW, 1967, P SOC EXP BIOL MED, V124, P1155, DOI 10.3181/00379727-124-31949; Ferdinandy P, 2000, CIRC RES, V87, P241, DOI 10.1161/01.RES.87.3.241; Ghyczy M, 2008, CELL PHYSIOL BIOCHEM, V21, P251, DOI 10.1159/000113766; Gnaiger E, 2000, LIFE IN THE COLD, P431; Goetz M, 2011, AM J PHYSIOL-GASTR L, V301, pG764, DOI 10.1152/ajpgi.00175.2011; Hartmann P, 2014, J SURG RES, V189, P32, DOI 10.1016/j.jss.2013.12.025; Hutter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x; Keppler F, 2009, ENVIRON CHEM, V6, P459, DOI 10.1071/EN09137; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levitt MD, 2006, CLIN GASTROENTEROL H, V4, P123, DOI 10.1016/j.cgh.2005.11.006; Li ZH, 2012, METHODS MOL BIOL, V837, P63, DOI 10.1007/978-1-61779-504-6_5; Liu Ying, 2013, Zhonghua Yi Xue Za Zhi, V93, P459; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MEYER M, 1980, PFLUG ARCH EUR J PHY, V384, P131, DOI 10.1007/BF00584428; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Pimentel M, 2006, AM J PHYSIOL-GASTR L, V290, pG1089, DOI 10.1152/ajpgi.00574.2004; Pimentel M, 2014, DIGEST DIS SCI, V59, P1278, DOI 10.1007/s10620-014-3157-8; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Roccarina D, 2010, AM J GASTROENTEROL, V105, P1250, DOI 10.1038/ajg.2009.744; Szarka A, 2004, ARCH BIOCHEM BIOPHYS, V428, P73, DOI 10.1016/j.abb.2004.05.011; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Tuboly E, 2013, AM J PHYSIOL-CELL PH, V304, pC207, DOI 10.1152/ajpcell.00300.2012; Wang XD, 2001, GENE DEV, V15, P2922; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	33	26	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146363	10.1371/journal.pone.0146363	http://dx.doi.org/10.1371/journal.pone.0146363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741361	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000367810600033
J	Biderre-Petit, C; Dugat-Bony, E; Mege, M; Parisot, N; Adrian, L; Mone, A; Denonfoux, J; Peyretaillade, E; Debroas, D; Boucher, D; Peyret, P				Biderre-Petit, Corinne; Dugat-Bony, Eric; Mege, Mickael; Parisot, Nicolas; Adrian, Lorenz; Mone, Anne; Denonfoux, Jeremie; Peyretaillade, Eric; Debroas, Didier; Boucher, Delphine; Peyret, Pierre			Distribution of Dehalococcoidia in the Anaerobic Deep Water of a Remote Meromictic Crater Lake and Detection of Dehalococcoidia-Derived Reductive Dehalogenase Homologous Genes	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; MICROBIAL COMMUNITIES; VERTICAL-DISTRIBUTION; GENOME SEQUENCE; LAC PAVIN; TETRACHLOROETHENE; DIVERSITY; SEDIMENTS; BACTERIA; BIODEGRADATION	Here we describe the natural occurrence of bacteria of the class Dehalococcoidia (DEH) and their diversity at different depths in anoxic waters of a remote meromictic lake (Lake Pavin) using 16S rRNA gene amplicon sequencing and quantitative PCR. Detected DEH are phylogenetically diverse and the majority of 16S rRNA sequences have less than 91% similarity to previously isolated DEH 16S rRNA sequences. To predict the metabolic potential of detected DEH subgroups and to assess if they encode genes to transform halogenated compounds, we enriched DEH-affiliated genomic DNA by using a specific-gene capture method and probes against DEH-derived 16S rRNA genes, reductive dehalogenase genes and known insertion sequences. Two reductive dehalogenase homologous sequences were identified from DEH-enriched genomic DNA, and marker genes in the direct vicinity confirm that gene fragments were derived from DEH. The low sequence similarity with known reductive dehalogenase genes suggests yet-unknown catabolic potential in the anoxic zone of Lake Pavin.	[Biderre-Petit, Corinne; Mege, Mickael; Parisot, Nicolas; Mone, Anne; Debroas, Didier] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, F-63000 Clermont Ferrand, France; [Biderre-Petit, Corinne; Mege, Mickael; Parisot, Nicolas; Mone, Anne; Debroas, Didier] CNRS, UMR 6023, Lab Microorganismes Genome & Environm, F-63171 Aubiere, France; [Dugat-Bony, Eric] Univ Paris Saclay, INRA, AgroParisTech, UMR GMPA, F-78850 Thiverval Grignon, France; [Parisot, Nicolas; Denonfoux, Jeremie; Peyretaillade, Eric; Boucher, Delphine; Peyret, Pierre] Clermont Univ, Univ Auvergne, EA CIDAM 4678, F-63001 Clermont Ferrand, France; [Adrian, Lorenz] UFZ Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Clermont Auvergne (UCA); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Biderre-Petit, C (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, F-63000 Clermont Ferrand, France.	corinne.petit@univ-bpclermont.fr	Adrian, Lorenz/A-4443-2012; Parisot, Nicolas/C-8116-2012; Dugat-Bony, Eric/K-2455-2014	Adrian, Lorenz/0000-0001-8205-0842; Parisot, Nicolas/0000-0001-5217-8415; Dugat-Bony, Eric/0000-0002-5182-0063; boucher, delphine/0000-0002-6979-4094; PEYRET, Pierre/0000-0003-3114-0586	Deutsche Forschungsgemeinschaft FOR1530; Direction Generale de l'Armement (DGA); CNRS; Agence De l'Environnement et de la Maitrise de l'Energie (ADEME); French National Programme INSU-EC2CO (EChlore Project); ANR Programme PRECODD (EVASOL Project); Universite Blaise Pascal; Ministere de la Recherche et de la Technologie; Region Auvergne; l'Agence De l'Environnement et de la Maitrise de l'Energie (ADEME)	Deutsche Forschungsgemeinschaft FOR1530(German Research Foundation (DFG)); Direction Generale de l'Armement (DGA)(General Electric); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence De l'Environnement et de la Maitrise de l'Energie (ADEME); French National Programme INSU-EC2CO (EChlore Project); ANR Programme PRECODD (EVASOL Project)(French National Research Agency (ANR)); Universite Blaise Pascal; Ministere de la Recherche et de la Technologie; Region Auvergne(Region Auvergne-Rhone-Alpes); l'Agence De l'Environnement et de la Maitrise de l'Energie (ADEME)	This work was funded by the following: Deutsche Forschungsgemeinschaft FOR1530 (to LA), Direction Generale de l'Armement (DGA) (to NP), CNRS and Region Auvergne (to JD), Agence De l'Environnement et de la Maitrise de l'Energie (ADEME) (to EDB), French National Programme INSU-EC2CO (EChlore Project) (to CBP and PP), ANR Programme PRECODD (EVASOL Project) (to EDB, PP and CBP), Universite Blaise Pascal and Ministere de la Recherche et de la Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study includes results from PhD researches supported by various instances: Region Auvergne, CNRS, l'Agence De l'Environnement et de la Maitrise de l'Energie (ADEME), Direction Generale de l'Armement (DGA), Universite Blaise Pascal and Ministere de la Recherche et de la Technologie. The study was also granted from different sources: French National Programme INSU-EC2CO (EChlore Project) and ANR Programme PRECODD (EVASOL Project). The work of LA was supported by the Deutsche Forschungsgemeinschaft FOR1530. We are grateful to Najwa Taib for her technical support and to Cecile Lepere for her help in the English language correction. We thank Didier Jezequel for his data communication.	Aeschbach-Hertig W, 2002, HYDROBIOLOGIA, V487, P111, DOI 10.1023/A:1022942226198; Ahn YB, 2003, APPL ENVIRON MICROB, V69, P4159, DOI 10.1128/AEM.69.7.4159-4166.2003; Alberic P, 2000, LIMNOL OCEANOGR, V45, P1088, DOI 10.4319/lo.2000.45.5.1088; Alfreider A, 2002, SYST APPL MICROBIOL, V25, P232, DOI 10.1078/0723-2020-00111; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Assayag N, 2008, APPL GEOCHEM, V23, P2800, DOI 10.1016/j.apgeochem.2008.04.015; Baba D, 2007, WORLD J MICROB BIOT, V23, P1627, DOI 10.1007/s11274-007-9409-4; Bedard DL, 2008, ANNU REV MICROBIOL, V62, P253, DOI 10.1146/annurev.micro.62.081307.162733; Biderre-Petit C, 2011, FEMS MICROBIOL ECOL, V77, P533, DOI 10.1111/j.1574-6941.2011.01134.x; Biderre-Petit C, 2011, MICROB ECOL, V61, P313, DOI 10.1007/s00248-010-9769-4; Busigny V, 2014, GEOCHIM COSMOCHIM AC, V133, P443, DOI 10.1016/j.gca.2014.03.004; Comeau AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00604; Cosmidis J, 2014, GEOCHIM COSMOCHIM AC, V126, P78, DOI 10.1016/j.gca.2013.10.037; Daprato RC, 2007, ENVIRON SCI TECHNOL, V41, P2261, DOI 10.1021/es061544p; Denonfoux J, 2013, DNA RES, V20, P185, DOI 10.1093/dnares/dst001; Dugat-Bony E, 2012, MICROB BIOTECHNOL, V5, P642, DOI 10.1111/j.1751-7915.2012.00339.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Futagami T, 2009, APPL ENVIRON MICROB, V75, P6905, DOI 10.1128/AEM.01124-09; Gies EA, 2014, APPL ENVIRON MICROB, V80, P6807, DOI 10.1128/AEM.01774-14; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gregersen LH, 2009, FEMS MICROBIOL ECOL, V70, P30, DOI 10.1111/j.1574-6941.2009.00737.x; Gribble GW, 2004, AM SCI, V92, P342, DOI 10.1511/2004.4.342; Hiraishi A, 2008, MICROBES ENVIRON, V23, P1, DOI 10.1264/jsme2.23.1; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Hug LA, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-22; Hug LA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0322; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Inceoglu O, 2015, MICROB ECOL, V70, P596, DOI 10.1007/s00248-015-0612-9; Kaster AK, 2014, ISME J, V8, P1831, DOI 10.1038/ismej.2014.24; Kawai M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00080; Kittelmann S, 2008, ENVIRON MICROBIOL, V10, P31, DOI 10.1111/j.1462-2920.2007.01427.x; Krzmarzick MJ, 2014, APPL ENVIRON MICROB, V80, P1210, DOI 10.1128/AEM.03472-13; Krzmarzick MJ, 2013, FEMS MICROBIOL ECOL, V84, P248, DOI 10.1111/1574-6941.12059; Krzmarzick MJ, 2012, APPL ENVIRON MICROB, V78, P393, DOI 10.1128/AEM.06510-11; Kube M, 2005, NAT BIOTECHNOL, V23, P1269, DOI 10.1038/nbt1131; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lehours AC, 2005, APPL ENVIRON MICROB, V71, P7389, DOI 10.1128/AEM.71.11.7389-7400.2005; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; Loffler FE, 2006, CURR OPIN BIOTECH, V17, P274, DOI 10.1016/j.copbio.2006.05.001; Lopes F, 2011, APPL GEOCHEM, V26, P1919, DOI 10.1016/j.apgeochem.2011.06.021; Manchester MJ, 2012, APPL ENVIRON MICROB, V78, P5280, DOI 10.1128/AEM.00384-12; Maness AD, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-54; May HD, 2008, APPL ENVIRON MICROB, V74, P2089, DOI 10.1128/AEM.01450-07; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; McMurdie PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000714; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MICHARD G, 1994, CHEM GEOL, V115, P103, DOI 10.1016/0009-2541(94)90147-3; Milucka J, 2015, ISME J, V9, P1991, DOI 10.1038/ismej.2015.12; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Siddaramappa S, 2012, STAND GENOMIC SCI, V6, P251, DOI 10.4056/sigs.2806097; Smidt H, 2004, ANNU REV MICROBIOL, V58, P43, DOI 10.1146/annurev.micro.58.030603.123600; Song H, 2012, J APPL MICROBIOL, V112, P79, DOI 10.1111/j.1365-2672.2011.05187.x; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Taib N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058950; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van der Zaan B, 2009, WATER RES, V43, P3207, DOI 10.1016/j.watres.2009.04.042; Viollier E, 1997, CHEM GEOL, V142, P225, DOI 10.1016/S0009-2541(97)00093-4; Wagner A, 2009, APPL ENVIRON MICROB, V75, P1876, DOI 10.1128/AEM.01042-08; Wang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059178; Wasmund K, 2015, ENVIRON MICROBIOL, V17, P3540, DOI 10.1111/1462-2920.12510; Wasmund K, 2014, ISME J, V8, P383, DOI 10.1038/ismej.2013.143	63	27	28	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145558	10.1371/journal.pone.0145558	http://dx.doi.org/10.1371/journal.pone.0145558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734727	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100028
J	Cristiano, MP; Cardoso, DC; Fernandes-Salomao, TM; Heinze, J				Cristiano, Maykon Passos; Cardoso, Danon Clemes; Fernandes-Salomao, Tania Maria; Heinze, Juergen			Integrating Paleodistribution Models and Phylogeography in the Grass-Cutting Ant Acromyrmex striatus (Hymenoptera: Formicidae) in Southern Lowlands of South America	PLOS ONE			English	Article							GENETIC-STRUCTURE; RAIN-FOREST; DIVERSITY; PATTERNS; DIVERSIFICATION; EVOLUTION; SOFTWARE; ATTA	Past climate changes often have influenced the present distribution and intraspecific genetic diversity of organisms. The objective of this study was to investigate the phylogeography and historical demography of populations of Acromyrmex striatus (Roger, 1863), a leaf-cutting ant species restricted to the open plains of South America. Additionally, we modeled the distribution of this species to predict its contemporary and historic habitat. From the partial sequences of the mitochondrial gene cytochrome oxidase I of 128 A. striatus workers from 38 locations we estimated genetic diversity and inferred historical demography, divergence time, and population structure. The potential distribution areas of A. striatus for current and quaternary weather conditions were modeled using the maximum entropy algorithm. We identified a total of 58 haplotypes, divided into five main haplogroups. The analysis of molecular variance (AMOVA) revealed that the largest proportion of genetic variation is found among the groups of populations. Paleodistribution models suggest that the potential habitat of A. striatus may have decreased during the Last Interglacial Period (LIG) and expanded during the Last Maximum Glacial (LGM). Overall, the past potential distribution recovered by the model comprises the current potential distribution of the species. The general structuring pattern observed was consistent with isolation by distance, suggesting a balance between gene flow and drift. Analysis of historical demography showed that populations of A. striatus had remained constant throughout its evolutionary history. Although fluctuations in the area of their potential historic habitat occurred during quaternary climate changes, populations of A. striatus are strongly structured geographically. However, explicit barriers to gene flow have not been identified. These findings closely match those in Mycetophylax simplex, another ant species that in some areas occurs in sympatry with A. striatus. Ecophysiological traits of this species and isolation by distance may together have shaped the phylogeographic pattern.	[Cristiano, Maykon Passos; Cardoso, Danon Clemes; Fernandes-Salomao, Tania Maria] Univ Fed Vicosa, Dept Biol Geral, BR-36570000 Vicosa, MG, Brazil; [Cristiano, Maykon Passos] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Dept Biodiversidade Evolucao & Meio Ambiente, BR-35400000 Ouro Preto, MG, Brazil; [Cardoso, Danon Clemes] Univ Fed Parana, Setor Ciencias Biol, Dept Genet, BR-81530000 Curitiba, Parana, Brazil; [Cristiano, Maykon Passos; Cardoso, Danon Clemes; Heinze, Juergen] Univ Regensburg, Zool Evolutionary Biol, D-93040 Regensburg, Germany	Universidade Federal de Vicosa; Universidade Federal de Ouro Preto; Universidade Federal do Parana; University of Regensburg	Cristiano, MP (corresponding author), Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Dept Biodiversidade Evolucao & Meio Ambiente, Campus Morro Cruzeiro S-N, BR-35400000 Ouro Preto, MG, Brazil.	Maykon.Passos@biologie.uni-regensburg.de	Cristiano, Maykon Passos/H-7723-2012; Cardoso, Danon Clemes/D-2313-2009	Cristiano, Maykon Passos/0000-0001-7850-9155; Cardoso, Danon Clemes/0000-0002-2811-2536	FAPEMIG; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG [CRA-APQ-00935-11]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; FAPEMIG fellowship [CBB-22003/11]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG fellowship(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	MPC and DCC acknowledge the FAPEMIG for his doctoral fellowship. This research was majorly supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG (Process number: CRA-APQ-00935-11), and additional financial support was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES. This research forms part of the D.Sc. thesis of the first author, who was supported by FAPEMIG fellowship during his doctorate studies in Brazil at Universidade Federal de Vicosa and during the sandwich period at the Universitat Regensburg in Germany (CBB-22003/11).	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Azuma N, 2006, ECOL RES, V21, P126, DOI 10.1007/s11284-005-0101-6; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Behling H, 2001, QUATERNARY RES, V56, P383, DOI 10.1006/qres.2001.2264; BEHLING H, 2009, CAMPOS SULINOS CONSE, P13; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; CARDOSO DC, 2015, BMC EVOL BIOL, V15, P1, DOI DOI 10.1186/S12862-015-0383-4; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cristiano MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059784; Delabie JH, 2011, FORMIGAS CORTADEIRAS, P80; Diehl E., 2001, Brazilian Journal of Biology, V61, P667; Diehl-Fleig Elena, 1998, Anais da Sociedade Entomologica do Brasil, V27, P41, DOI 10.1590/S0301-80591998000100005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandes-Salomao TM, 2005, INSECT SOC, V52, P11, DOI 10.1007/s00040-004-0767-8; Fitzpatrick SW, 2009, MOL ECOL, V18, P2877, DOI 10.1111/j.1365-294X.2009.04245.x; FOWLER HG, 1983, REV BIOL TROP, V31, P213; Fregonezi JN, 2013, BOT J LINN SOC, V171, P140, DOI 10.1111/j.1095-8339.2012.01292.x; Freitas EM, 2010, REV BRAS BIOCIENC, V8, P112; Fu YX, 1997, GENETICS, V147, P915; Goncalves C. R., 1961, Studia Entomologica Petropolis (NS), V4, P113; Gonzalez J, 2010, IBIS, V152, P761, DOI 10.1111/j.1474-919X.2010.01060.x; Gonzalez S, 1998, MOL ECOL, V7, P47, DOI 10.1046/j.1365-294x.1998.00303.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; KUSNEZOV NICOLAS, 1963, ACTA ZOOL LILLOANA, V19, P25; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Mapelli FJ, 2012, J ZOOL, V286, P48, DOI 10.1111/j.1469-7998.2011.00849.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Mora MS, 2013, J MAMMAL, V94, P459, DOI 10.1644/11-MAMM-A-242.1; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Ojeda AA, 2010, J MAMMAL, V91, P302, DOI 10.1644/09-MAMM-A-177.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Porto TJ, 2013, DIVERS DISTRIB, V19, P330, DOI 10.1111/j.1472-4642.2012.00944.x; Ramos-Fregonezi AMC, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0363-8; Resende HC, 2010, BIOL J LINN SOC, V101, P949, DOI 10.1111/j.1095-8312.2010.01534.x; Seal JN, 2011, J BIOGEOGR, V38, P868, DOI 10.1111/j.1365-2699.2010.02447.x; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Solomon SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002738; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomazelli L.J., 2000, GEOLOGIA RIO GRANDE, P375; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Vanzolini P.E., 1981, Papeis Avulsos de Zoologia (Sao Paulo), V34, P251; Ward PS, 2005, SYST ENTOMOL, V30, P310, DOI 10.1111/j.1365-3113.2004.00281.x	59	16	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146734	10.1371/journal.pone.0146734	http://dx.doi.org/10.1371/journal.pone.0146734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734939	Green Submitted, gold, Green Published			2022-12-27	WOS:000367805100056
J	Handisurya, A; Kerscher, C; Tura, A; Herkner, H; Payer, BA; Mandorfer, M; Werzowa, J; Winnicki, W; Reiberger, T; Kautzky-Willer, A; Pacini, G; Saemann, M; Schmidt, A				Handisurya, Ammon; Kerscher, Corinna; Tura, Andrea; Herkner, Harald; Payer, Berit Anna; Mandorfer, Mattias; Werzowa, Johannes; Winnicki, Wolfgang; Reiberger, Thomas; Kautzky-Willer, Alexandra; Pacini, Giovanni; Saeemann, Marcus; Schmidt, Alice			Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients	PLOS ONE			English	Article							ONSET DIABETES-MELLITUS; CHRONIC HEPATITIS-C; BETA-CELL FUNCTION; INSULIN SENSITIVITY; CALCINEURIN INHIBITORS; KIDNEY-TRANSPLANTATION; RISK-FACTORS; SECRETION; METABOLISM; HEMODIALYSIS	Background Calcineurin-inhibitors and hepatitis C virus (HCV) infection increase the risk of post-transplant diabetes mellitus. Chronic HCV infection promotes insulin resistance rather than beta-cell dysfunction. The objective was to elucidate whether a conversion from tacrolimus to cyclosporine A affects fasting and/or dynamic insulin sensitivity, insulin secretion or all in HCV-positive renal transplant recipients. Methods In this prospective, single-center study 10 HCV-positive renal transplant recipients underwent 2h-75g-oral glucose tolerance tests before and three months after the conversion of immunosuppression from tacrolimus to cyclosporine A. Established oral glucose tolerance test-based parameters of fasting and dynamic insulin sensitivity and insulin secretion were calculated. Data are expressed as median (IQR). Results After conversion, both fasting and challenged glucose levels decreased significantly. This was mainly attributable to a significant amelioration of post-prandial dynamic glucose sensitivity as measured by the oral glucose sensitivity-index OGIS [422.17 (370.82-441.92) vs. 468.80 (414.27-488.57) mL/min/m(2), p = 0.005), which also resulted in significant improvements of the disposition index (p = 0.017) and adaptation index (p = 0.017) as markers of overall glucose tolerance and beta-cell function. Fasting insulin sensitivity (p = 0.721), insulinogenic index as marker of first-phase insulin secretion [0.064 (0.032-0.106) vs. 0.083 (0.054-0.144) nmol/mmol, p = 0.093) and hepatic insulin extraction (p = 0.646) remained unaltered. No changes of plasma HCV-RNA levels (p = 0.285) or liver stiffness (hepatic fibrosis and necroinflammation, p = 0.463) were observed after the conversion of immunosuppression. Conclusions HCV-positive renal transplant recipients show significantly improved glucose-stimulated insulin sensitivity and overall glucose tolerance after conversion from tacrolimus to cyclosporine A. Considering the HCV-induced insulin resistance, HCV-positive renal transplant recipients may benefit from a cyclosporine A-based immunosuppressive regimen.	[Handisurya, Ammon; Kerscher, Corinna; Werzowa, Johannes; Winnicki, Wolfgang; Saeemann, Marcus; Schmidt, Alice] Med Univ Vienna, Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria; [Tura, Andrea; Pacini, Giovanni] CNR, Inst Neurosci, Padua, Italy; [Herkner, Harald] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Payer, Berit Anna; Mandorfer, Mattias; Reiberger, Thomas] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria; [Kautzky-Willer, Alexandra] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria	Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Schmidt, A (corresponding author), Med Univ Vienna, Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria.	alice.schmidt@meduniwien.ac.at	Mandorfer, Mattias/H-7603-2019; Reiberger, Thomas/H-7613-2019; Winnicki, Wolfgang/ABB-1864-2021	Mandorfer, Mattias/0000-0003-2330-0017; Reiberger, Thomas/0000-0002-4590-3583; Winnicki, Wolfgang/0000-0002-0511-6120; Werzowa, Johannes/0000-0003-2507-1377; Herkner, Harald/0000-0003-1329-6149; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Schmidt, Alice/0000-0002-5275-0044				Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Ahren B, 1997, AM J PHYSIOL-ENDOC M, V273, pE701, DOI 10.1152/ajpendo.1997.273.4.E701; Baid-Agrawal S, 2009, AM J TRANSPLANT, V9, P2777, DOI 10.1111/j.1600-6143.2009.02843.x; Bloom RD, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000012382.97168.E0; Bose SK, 2014, WORLD J DIABETES, V5, P52, DOI 10.4239/wjd.v5.i1.52; Bulanowski M, 2012, ANN TRANSPL, V17, P61; Chakkera HA, 2013, TRANSPLANTATION, V95, P647, DOI 10.1097/TP.0b013e31826e592e; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; El-Zayadi AR, 2012, WORLD J GASTROENTERO, V18, P212, DOI 10.3748/wjg.v18.i3.212; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Ghisdal L, 2008, TRANSPL INT, V21, P146, DOI 10.1111/j.1432-2277.2007.00589.x; Goswami A, 2014, ANN GASTROENTEROL, V27, P237; Goto K, 2006, BIOCHEM BIOPH RES CO, V343, P879, DOI 10.1016/j.bbrc.2006.03.059; Hagen M, 2003, NEPHROL DIAL TRANSPL, V18, P2154, DOI 10.1093/ndt/gfg338; Handisurya A, 2008, CLIN ENDOCRINOL, V69, P963, DOI 10.1111/j.1365-2265.2008.03280.x; Hecking M, 2013, DIABETES CARE, V36, P2763, DOI 10.2337/dc12-2441; Hecking M, 2013, NEPHROL DIAL TRANSPL, V28, P550, DOI 10.1093/ndt/gfs583; Hornum M, 2010, CLIN J AM SOC NEPHRO, V5, P709, DOI 10.2215/CJN.05360709; HURAIB S, 1995, NEPHROL DIAL TRANSPL, V10, P470, DOI 10.1093/ndt/10.4.470; Inoue K, 2003, J GASTROENTEROL, V38, P567, DOI 10.1007/s00535-002-1104-5; Jadoul M, 2004, NEPHROL DIAL TRANSPL, V19, P904, DOI 10.1093/ndt/gfh012; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kaposztas Z, 2011, TRANSPL P, V43, P1375, DOI 10.1016/j.transproceed.2011.04.008; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Khattab M, 2010, LIVER INT, V30, P447, DOI 10.1111/j.1478-3231.2009.02171.x; Luan FL, 2008, AM J TRANSPLANT, V8, P1871, DOI 10.1111/j.1600-6143.2008.02328.x; Midtvedt K, 1998, NEPHROL DIAL TRANSPL, V13, P427, DOI 10.1093/oxfordjournals.ndt.a027841; Milner KL, 2010, GASTROENTEROLOGY, V138, P932, DOI 10.1053/j.gastro.2009.11.050; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Ozbay LA, 2012, DIABETIC MED, V29, pe440, DOI 10.1111/dme.12028; Ozbay LA, 2012, BRIT J CLIN PHARMACO, V73, P536, DOI 10.1111/j.1365-2125.2011.04118.x; Pacini G, 2003, BEST PRACT RES CL EN, V17, P305, DOI 10.1016/S1521-690X(03)00042-3; Prokai A, 2012, PEDIATR DIABETES, V13, P81, DOI 10.1111/j.1399-5448.2011.00782.x; Sawinski D, 2015, TRANSPLANTATION, V99, P2458, DOI 10.1097/TP.0000000000000847; Sharif A, 2014, AM J TRANSPLANT, V14, P1992, DOI 10.1111/ajt.12850; Sharif A, 2012, NAT REV NEPHROL, V8, P34, DOI 10.1038/nrneph.2011.174; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tura A, 2001, AM J PHYSIOL-ENDOC M, V281, pE966, DOI 10.1152/ajpendo.2001.281.5.E966; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005; Vincenti F, 2007, AM J TRANSPLANT, V7, P1506, DOI 10.1111/j.1600-6143.2007.01749.x; Wissing KM, 2014, TRANSPLANT REV-ORLAN, V28, P37, DOI 10.1016/j.trre.2013.12.004	41	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145319	10.1371/journal.pone.0145319	http://dx.doi.org/10.1371/journal.pone.0145319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735686	gold, Green Submitted, Green Published			2022-12-27	WOS:000367805100024
J	Abou Hammoud, A; Kirstein, N; Mournetas, V; Darracq, A; Broc, S; Blanchard, C; Zeineddine, D; Mortada, M; Boeuf, H				Abou Hammoud, Aya; Kirstein, Nina; Mournetas, Virginie; Darracq, Anais; Broc, Sabine; Blanchard, Camille; Zeineddine, Dana; Mortada, Mohamad; Boeuf, Helene			Murine Embryonic Stem Cell Plasticity Is Regulated through Klf5 and Maintained by Metalloproteinase MMP1 and Hypoxia	PLOS ONE			English	Article							MOUSE ES CELLS; GROUND-STATE PLURIPOTENCY; KRUPPEL-LIKE FACTORS; SELF-RENEWAL; ENDODERM DIFFERENTIATION; SIGNALING PATHWAYS; OXYGEN; MAINTENANCE; LIF; IDENTIFICATION	Mouse embryonic stem cells (mESCs) are expanded and maintained pluripotent in vitro in the presence of leukemia inhibitory factor (LIF), an IL6 cytokine family member which displays pleiotropic functions, depending on both cell maturity and cell type. LIF withdrawal leads to heterogeneous differentiation of mESCs with a proportion of the differentiated cells apoptosising. During LIF withdrawal, cells sequentially enter a reversible and irreversible phase of differentiation during which LIF addition induces different effects. However the regulators and effectors of LIF-mediated reprogramming are poorly understood. By employing a LIF-dependent 'plasticity' test, that we set up, we show that Klf5, but not JunB is a key LIF effector. Furthermore PI3K signaling, required for the maintenance of mESC pluripotency, has no effect on mESC plasticity while displaying a major role in committed cells by stimulating expression of the mesodermal marker Brachyury at the expense of endoderm and neuroectoderm lineage markers. We also show that the MMP1 metalloproteinase, which can replace LIF for maintenance of pluripotency, mimics LIF in the plasticity window, but less efficiently. Finally, we demonstrate that mESCs maintain plasticity and pluripotency potentials in vitro under hypoxic/physioxic growth conditions at 3% O-2 despite lower levels of Pluri and Master gene expression in comparison to 20% O-2.	[Abou Hammoud, Aya; Kirstein, Nina; Mournetas, Virginie; Darracq, Anais; Broc, Sabine; Blanchard, Camille; Boeuf, Helene] Univ Bordeaux, CIRID, UMR5164, F-33000 Bordeaux, France; [Abou Hammoud, Aya; Kirstein, Nina; Mournetas, Virginie; Darracq, Anais; Broc, Sabine; Blanchard, Camille; Boeuf, Helene] CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; [Abou Hammoud, Aya; Zeineddine, Dana; Mortada, Mohamad] Lebanese Univ, Beirut, Lebanon	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Lebanese University	Boeuf, H (corresponding author), Univ Bordeaux, CIRID, UMR5164, F-33000 Bordeaux, France.	helene.boeuf@u-bordeaux.fr	Mournetas, Virginie/X-2084-2019	Mournetas, Virginie/0000-0002-6557-4190; Kirstein, Nina/0000-0001-6030-6173	CNRS; University of Bordeaux; SIRIC BRIO program; Region Aquitaine; INCA; FR TransBiomed; foundation Hariri (Lebanon)	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux; SIRIC BRIO program; Region Aquitaine(Region Nouvelle-Aquitaine); INCA(Institut National du Cancer (INCA) France); FR TransBiomed; foundation Hariri (Lebanon)	This work was funded by CNRS, University of Bordeaux, the SIRIC BRIO program, the Region Aquitaine, the INCA and the FR TransBiomed. A.A.H. had a fellowship from the foundation Hariri (Lebanon) under a Franco-Lebanese co-supervision between the University of Bordeaux and the Lebanese University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4719; Andreev DE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0651-z; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Attia WA, 2014, STEM CELL REV REP, V10, P1, DOI 10.1007/s12015-013-9472-1; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Barbosa HSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038963; Boeuf H, 2001, J BIOL CHEM, V276, P46204, DOI 10.1074/jbc.M106718200; Bourillot PY, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-125; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8095; Coronado D, 2013, STEM CELL RES, V10, P118, DOI 10.1016/j.scr.2012.10.004; DELAGRANGE PB, 2013, STEM CELL RES, V11, P625, DOI DOI 10.1016/J.SCR.2013.04.003; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Doss MX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r56; Duval D, 2006, CELL DEATH DIFFER, V13, P564, DOI 10.1038/sj.cdd.4401789; Duval D, 2004, CELL DEATH DIFFER, V11, P331, DOI 10.1038/sj.cdd.4401337; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Fernandes TG, 2010, STEM CELL RES, V5, P76, DOI 10.1016/j.scr.2010.04.003; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gao Y, 2015, DEV DYNAM, V244, P1328, DOI 10.1002/dvdy.24310; Guitart AV, 2011, CELL DEATH DIFFER, V18, P174, DOI 10.1038/cdd.2010.85; Guitart AV, 2010, EXP HEMATOL, V38, P847, DOI 10.1016/j.exphem.2010.06.002; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hawkins KE, 2013, REGEN MED, V8, P771, DOI 10.2217/rme.13.71; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200; Jez M, 2015, J CELL PHYSIOL, V230, P1999, DOI 10.1002/jcp.24953; Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007; Lee SW, 2012, EMBO MOL MED, V4, P924, DOI 10.1002/emmm.201101107; Li L, 2014, J NEUROSCI, V34, P16713, DOI 10.1523/JNEUROSCI.4590-13.2014; Lu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040938; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Matheny RW, 2015, MOL CELL BIOL, V35, P1182, DOI 10.1128/MCB.00550-14; Mathieu J, 2013, STEM CELLS, V31, P1737, DOI 10.1002/stem.1446; Mathieu ME, 2013, DEVELOPMENT, V140, P3311, DOI 10.1242/dev.091082; Mathieu ME, 2012, STEM CELL REV REP, V8, P1, DOI 10.1007/s12015-011-9261-7; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Narva E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078847; Niebruegge S, 2009, BIOTECHNOL BIOENG, V102, P493, DOI 10.1002/bit.22065; Niwa H, 2010, DEV GROWTH DIFFER, V52, P275, DOI 10.1111/j.1440-169X.2009.01166.x; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Orlando L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030234; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Parisi S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-128; Petruzzelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108309; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Przybyla LM, 2013, STEM CELLS, V31, P1097, DOI 10.1002/stem.1360; Przybyla LM, 2012, P NATL ACAD SCI USA, V109, P835, DOI 10.1073/pnas.1103100109; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Sui L, 2013, INT J DEV BIOL, V57, P1, DOI [10.1387/ijdb.1201151s, 10.1387/ijdb.120115ls]; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Tong YX, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0031-z; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trouillas M, 2008, CELL DEATH DIFFER, V15, P1450, DOI 10.1038/cdd.2008.63; Trouillas M, 2009, EUR CYTOKINE NETW, V20, P51, DOI 10.1684/ecn.2009.0148; Trouillas M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-73; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vlaski M, 2014, J CELL PHYSIOL, V229, P2153, DOI 10.1002/jcp.24678; Welham MJ, 2011, BIOCHEM SOC T, V39, P674, DOI 10.1042/BST0390674; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zeineddine D, 2014, AM J STEM CELLS, V3, P74	76	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146281	10.1371/journal.pone.0146281	http://dx.doi.org/10.1371/journal.pone.0146281			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731538	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400137
J	Benitez-Malvido, J; Dattilo, W; Martinez-Falcon, AP; Duran-Barron, C; Valenzuela, J; Lopez, S; Lombera, R				Benitez-Malvido, Julieta; Dattilo, Wesley; Martinez-Falcon, Ana Paola; Duran-Barron, Cesar; Valenzuela, Jorge; Lopez, Sara; Lombera, Rafael			The Multiple Impacts of Tropical Forest Fragmentation on Arthropod Biodiversity and on their Patterns of Interactions with Host Plants	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; HISPINE BEETLES; DIVERSITY; CHRYSOMELIDAE; HELICONIACEAE; CONSERVATION; ARCHITECTURE; NESTEDNESS; RESPONSES; SPP.	Tropical rain forest fragmentation affects biotic interactions in distinct ways. Little is known, however, about how fragmentation affects animal trophic guilds and their patterns of interactions with host plants. In this study, we analyzed changes in biotic interactions in forest fragments by using a multitrophic approach. For this, we classified arthropods associated with Heliconia aurantiaca herbs into broad trophic guilds (omnivores, herbivores and predators) and assessed the topological structure of intrapopulation plant-arthropod networks in fragments and continuous forests. Habitat type influenced arthropod species abundance, diversity and composition with greater abundance in fragments but greater diversity in continuous forest. According to trophic guilds, coleopteran herbivores were more abundant in continuous forest and overall omnivores in fragments. Continuous forest showed a greater diversity of interactions than fragments. Only in fragments, however, did the arthropod community associated with H aurantiaca show a nested structure, suggesting novel and/or opportunistic host-arthropod associations. Plants, omnivores and predators contributed more to nestedness than herbivores. Therefore, Heliconia-arthropod network properties do not appear to be maintained in fragments mainly caused by the decrease of herbivores. Our study contributes to the understanding of the impact of fragmentation on the structure and dynamics of multitrophic arthropod communities associated with a particular plant species of the highly biodiverse tropical forests. Nevertheless, further replication of study sites is needed to strengthen the conclusion that forest fragmentation negatively affects arthropod assemblages.	[Benitez-Malvido, Julieta; Martinez-Falcon, Ana Paola] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Lab Ecol Habitat Alterado, Morelia, Michoacan, Mexico; [Dattilo, Wesley] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico; [Martinez-Falcon, Ana Paola] Univ Autonoma Estado Hidalgo, Ctr Invest Biol, Pachuca 42001, Hidalgo, Mexico; [Duran-Barron, Cesar; Lopez, Sara] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Valenzuela, Jorge] Inst Ecol AC, Red Ecol Func, Xalapa, Veracruz, Mexico; [Lombera, Rafael] Univ Intercultural Chiapas, Unidad Acad Multidisciplinaria Las Margaritas, Chiapas, Mexico	Universidad Nacional Autonoma de Mexico; Instituto de Ecologia - Mexico; Universidad Autonoma del Estado de Hidalgo; Universidad Nacional Autonoma de Mexico; Instituto de Ecologia - Mexico	Benitez-Malvido, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Lab Ecol Habitat Alterado, Morelia, Michoacan, Mexico.	jbenitez@cieco.unam.mx	, WD/A-6371-2012; Valenzuela-Gonzalez, Jorge E./R-4527-2018	, WD/0000-0002-4758-4379; Martinez-Falcon, Ana Paola/0000-0003-3307-3989; Valenzuela-Gonzalez, Jorge E./0000-0003-2106-6693	Universidad Nacional Autonoma de Mexico (UNAM) Project PAPIIT [IN214014]; CNPq [237339/2012-9]; UNAM	Universidad Nacional Autonoma de Mexico (UNAM) Project PAPIIT; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by financial and logistic support from Universidad Nacional Autonoma de Mexico (UNAM) Project PAPIIT IN214014 to JBM and for a sabbatical grant to JBM at the Instituto Mediterraneo de Estudios Avanzados (IMEDEA). WD was supported by CNPq grant 237339/2012-9, and APMF by a postdoctoral scholarship from UNAM. The Comision Nacional de Areas Naturales Protegidas (CONANP), permission number SGPA/DGVS/07830)) granted permits to work in the MABR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to JM Lobato-Garcia for technical assistance in the field and in the laboratory and to Dr. W Maddison for identifying Salticidae species. We appreciate the financial and logistic support from Universidad Nacional Autonoma de Mexico (UNAM) Project PAPIIT IN214014 to JBM and for a sabbatical grant to JBM at the Instituto Mediterraneo de Estudios Avanzados (IMEDEA), WD was supported by CNPq grant 237339/2012-9, and APMF by a postdoctoral scholarship from UNAM. The Comision Nacional de Areas Naturales Protegidas (CONANP), permission number SGPA/DGVS/07830)) granted permits to work in the MABR.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Aristizabal LF, 2013, FLA ENTOMOL, V96, P112, DOI 10.1653/024.096.0114; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2009, PHILOS T R SOC B, V364, P1781, DOI 10.1098/rstb.2008.0226; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Benitez-Malvido J, 2015, AM J BOT, V102, P512, DOI 10.3732/ajb.1400303; Benitez-Malvido J, 2014, GLOB ECOL CONSERV, V2, P107, DOI 10.1016/j.gecco.2014.08.007; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Burslem D., 2005, BIOTIC INTERACTIONS; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao A., 2010, PROGRAM SPADE SPECIE; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Crawley M. J, 2002, STAT COMPUTING INTRO; Crawley M.J., 2007, R BOOK; Dattilo W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121275; Dattilo W, 2013, ARTHROPOD-PLANT INTE, V7, P455, DOI 10.1007/s11829-013-9256-1; DeVries P.J., 1987, BUTTERFLIES COSTA RI; Dominy NJ, 2008, ANN BOT-LONDON, V101, P1363, DOI 10.1093/aob/mcn046; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Faveri SB, 2008, J TROP ECOL, V24, P57, DOI 10.1017/S0266467407004592; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Figueroa F, 2009, ENVIRON CONSERV, V36, P180, DOI 10.1017/S0376892909990221; GAGE DA, 1981, BIOCHEM SYST ECOL, V9, P79, DOI 10.1016/0305-1978(81)90063-6; Gonzalez-Di Pierro AM, 2011, BIOTROPICA, V43, P459, DOI 10.1111/j.1744-7429.2010.00734.x; Gorley RN, 2009, PRIMER V61 USER MANU; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Hsieh T. C., 2013, INEXT ONLINE INTERPO; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Lopez-Perez S, 2015, SOUTHWEST ENTOMOL, V40, P241, DOI 10.3958/059.040.0125; Magurran A.E., 2004, MEASURING BIOL DIVER; Mead R., 1990, DESIGN EXPT STAT PRI; Meave del Castillo J, 1990, COLECCION CIENTIFICA; MEDELLIN RA, 1994, CONSERV BIOL, V8, P780, DOI 10.1046/j.1523-1739.1994.08030780.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; R Core Team, 2021, R LANGUAGE ENV STAT; Rico-Gray V., 2007, ECOLOGY EVOLUTION AN; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Santos BA, 2011, THESIS; Santos BA, 2012, BIOTROPICA, V44, P53, DOI 10.1111/j.1744-7429.2011.00765.x; Santos BA, 2009, REV MEX BIODIVERS, V80, P857; SEIFERT RP, 1982, Q REV BIOL, V57, P1, DOI 10.1086/412573; SIEBE C, 1995, P INT C SOILS TROP F, P40; Staines CL, 2001, P CONS BIOL DIV KEY, P233; STRONG DR, 1977, BIOTROPICA, V9, P156, DOI 10.2307/2387878; STRONG DR, 1977, ECOLOGY, V58, P573, DOI 10.2307/1939006; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Uchida JY, 1995, RES EXTENSION SERIES, P159; Villa-Galaviz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053009; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wilf P, 2000, SCIENCE, V289, P291, DOI 10.1126/science.289.5477.291; WILSON E O, 1992; Wirth R, 2007, J TROP ECOL, V23, P501, DOI 10.1017/S0266467407004221	61	28	28	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146461	10.1371/journal.pone.0146461	http://dx.doi.org/10.1371/journal.pone.0146461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731271	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400179
J	Fukahori, M; Chitose, S; Sato, K; Sueyoshi, S; Kurita, T; Umeno, H; Monden, Y; Yamakawa, R				Fukahori, Mioko; Chitose, Shun-ichi; Sato, Kiminori; Sueyoshi, Shintaro; Kurita, Takashi; Umeno, Hirohito; Monden, Yu; Yamakawa, Ryoji			Regeneration of Vocal Fold Mucosa Using Tissue-Engineered Structures with Oral Mucosal Cells	PLOS ONE			English	Article							LASER CORDECTOMY; FIBROBLASTS; EPITHELIUM; THERAPY	Objectives Scarred vocal folds result in irregular vibrations during phonation due to stiffness of the vocal fold mucosa. To date, a completely satisfactory corrective procedure has yet to be achieved. We hypothesize that a potential treatment option for this disease is to replace scarred vocal folds with organotypic mucosa. The purpose of this study is to regenerate vocal fold mucosa using a tissue-engineered structure with autologous oral mucosal cells. Study Design Animal experiment using eight beagles (including three controls). Methods A 3 mm by 3 mm specimen of canine oral mucosa was surgically excised and divided into epithelial and subepithelial tissues. Epithelial cells and fibroblasts were isolated and cultured separately. The proliferated epithelial cells were co-cultured on oriented collagen gels containing the proliferated fibroblasts for an additional two weeks. The organotypic cultured tissues were transplanted to the mucosa-deficient vocal folds. Two months after transplantation, vocal fold vibrations and morphological characteristics were observed. Results A tissue-engineered vocal fold mucosa, consisting of stratified epithelium and lamina propria, was successfully fabricated to closely resemble the normal layered vocal fold mucosa. Laryngeal stroboscopy revealed regular but slightly small mucosal waves at the transplanted site. Immunohistochemically, stratified epithelium expressed cytokeratin, and the distributed cells in the lamina propria expressed vimentin. Elastic Van Gieson staining revealed a decreased number of elastic fibers in the lamina propria of the transplanted site. Conclusion The fabricated mucosa with autologous oral mucosal cells successfully restored the vocal fold mucosa. This reconstruction technique could offer substantial clinical advantages for treating intractable diseases such as scarring of the vocal folds.	[Fukahori, Mioko; Chitose, Shun-ichi; Sato, Kiminori; Sueyoshi, Shintaro; Kurita, Takashi; Umeno, Hirohito] Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kurume, Fukuoka 830, Japan; [Monden, Yu; Yamakawa, Ryoji] Kurume Univ, Sch Med, Dept Ophthalmol, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University	Chitose, S (corresponding author), Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kurume, Fukuoka 830, Japan.	yonekawa@med.kurume-u.ac.jp			JSPS KAKENHI Grant [25462696]; Ishibashi Foundation for the Promotion of Science, Kurume	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ishibashi Foundation for the Promotion of Science, Kurume	This work (SC) was supported by a JSPS KAKENHI Grant Number 25462696 from Grant-in-Aid for Scientific Research (C), Tokyo (http://www.jsps.go.jp/english/e-grants/), and a grant from the Ishibashi Foundation for the Promotion of Science, Kurume (http://www.ishibashi-foundation.or.jp/english/grant/).	Allen J, 2010, CURR OPIN OTOLARYNGO, V18, P475, DOI 10.1097/MOO.0b013e32833fecd1; CASIANO RR, 1991, OTOLARYNG HEAD NECK, V104, P831, DOI 10.1177/019459989110400611; Chhetri DK, 2004, OTOLARYNG HEAD NECK, V131, P864, DOI 10.1016/j.otohns.2004.07.010; DALE B A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P167; Dowdall JR, 2015, LARYNGOSCOPE, V125, pE313, DOI 10.1002/lary.25264; El Ghalbzouri A, 2004, LAB INVEST, V84, P102, DOI 10.1038/labinvest.3700014; Frank S, 2003, METH MOLEC MED, V78, P3; Hansen JK, 2006, J VOICE, V20, P110, DOI 10.1016/j.jvoice.2004.12.005; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Hirano M., 1975, OTOLOGY FUKUOKA, V21, P239; Hirano S, 2004, ANN OTO RHINOL LARYN, V113, P777, DOI 10.1177/000348940411301002; Hirano S, 2009, J VOICE, V23, P399, DOI 10.1016/j.jvoice.2007.12.002; Hirayama M, 2012, INVEST OPHTH VIS SCI, V53, P1602, DOI 10.1167/iovs.11-7847; Hu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092676; Isobe Y, 2012, MATERIALS, V5, P501, DOI 10.3390/ma5030501; Isshiki N, 1996, ANN OTO RHINOL LARYN, V105, P182, DOI 10.1177/000348949610500303; Isshiki N, 2000, ACTA OTO-LARYNGOL, V120, P120, DOI 10.1080/000164800750000748; Isshiki N, 1981, PHONOSURGERY THEORY; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kakita Y, 1985, COVER BODY THEORY VO; Kishimoto Y, 2010, LARYNGOSCOPE, V120, P1597, DOI 10.1002/lary.21016; Kurita S, 1983, COMP STUDY LAYER STR, P3; Mikami H, 2012, J UROLOGY, V187, P1882, DOI 10.1016/j.juro.2011.12.059; Mortensen MM, 2008, LARYNGOSCOPE, V118, P1884, DOI 10.1097/MLG.0b013e31817d7546; NEUMANN OG, 1976, HNO, V24, P248; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Paniello RC, 1998, OTOLARYNG HEAD NECK, V118, P512, DOI 10.1016/S0194-5998(98)70210-4; PHILLIPS GD, 1991, AM J ANAT, V192, P257, DOI 10.1002/aja.1001920305; Remacle M, 2000, EUR ARCH OTO-RHINO-L, V257, P227, DOI 10.1007/s004050050228; Roh JL, 2007, HEAD NECK-J SCI SPEC, V29, P1010, DOI 10.1002/hed.20625; Sataloff RT, 2010, CURR OPIN OTOLARYNGO, V18, P503, DOI 10.1097/MOO.0b013e32833f8c21; Sato K, 1998, ANN OTO RHINOL LARYN, V107, P1023, DOI 10.1177/000348949810701205; Sulica L, 2010, LARYNGOSCOPE, V120, P319, DOI 10.1002/lary.20737; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P285, DOI 10.1177/000348940611500406; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786	36	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146151	10.1371/journal.pone.0146151	http://dx.doi.org/10.1371/journal.pone.0146151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730600	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400104
J	Lo, C; Ilic, D; Teede, H; Cass, A; Fulcher, G; Gallagher, M; Johnson, G; Kerr, PG; Mathew, T; Murphy, K; Polkinghorne, K; Walker, R; Zoungas, S				Lo, Clement; Ilic, Dragan; Teede, Helena; Cass, Alan; Fulcher, Greg; Gallagher, Martin; Johnson, Greg; Kerr, Peter G.; Mathew, Tim; Murphy, Kerry; Polkinghorne, Kevan; Walker, Rowan; Zoungas, Sophia			The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study	PLOS ONE			English	Article							CLINICAL-PRACTICE; SELF-MANAGEMENT; RENAL-DISEASE; OF-LIFE; ADHERENCE; RISK; NEPHROPATHY; EMPOWERMENT; PROGRESSION; DEPRESSION	Background Multi-morbidity due to diabetes and chronic kidney disease (CKD) remains challenging for current health-systems, which focus on single diseases. As a first step toward health-care improvement, we explored the perspectives of patients and their carers on factors influencing the health-care of those with co-morbid diabetes and CKD. Methods In this qualitative study participants with co-morbid diabetes and CKD were purposively recruited using maximal variation sampling from 4 major tertiary health-services from 2 of Australia's largest cities. Separate focus groups were conducted for patients with CKD stages 3, 4 and 5. Findings were triangulated with semi-structured interviews of carers of patients. Discussions were transcribed verbatim and thematically analysed. Results Twelve focus groups with 58 participants and 8 semi-structured interviews of carers were conducted. Factors influencing health-care of co-morbid diabetes and CKD grouped into patient and health service level factors. Key patient level factors identified were patient self-management, socio-economic situation, and adverse experiences related to co-morbid diabetes and CKD and its treatment. Key health service level factors were prevention and awareness of co-morbid diabetes and CKD, poor continuity and coordination of care, patient and carer empowerment, access and poor recognition of psychological co-morbidity. Health-service level factors varied according to CKD stage with poor continuity and coordination of care and patient and carer empowerment emphasized by participants with CKD stage 4 and 5, and access and poor recognition of psychological co-morbidity emphasised by participants with CKD stage 5 and carers. Conclusions According to patients and their carers the health-care of co-morbid diabetes and CKD may be improved via a preventive, patient-centred health-care model which promotes self-management and that has good access, continuity and coordination of care and identifies and manages psychological morbidity.	[Lo, Clement; Teede, Helena; Zoungas, Sophia] Monash Univ, Monash Ctr Hlth Res & Implementat, Sch Publ Hlth & Prevent Med, Diabet & Vasc Res Program, Clayton, Vic, Australia; [Lo, Clement; Teede, Helena; Zoungas, Sophia] Monash Hlth, Diabet & Vasc Med Unit, Clayton, Vic, Australia; [Ilic, Dragan; Murphy, Kerry] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia; [Cass, Alan] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Cass, Alan; Gallagher, Martin; Zoungas, Sophia] George Inst Global Hlth, Camperdown, NSW, Australia; Royal N Shore Hosp, Dept Endocrinol & Diabet, St Leonards, NSW 2065, Australia; [Gallagher, Martin] Concord Hosp, Dept Nephrol, Concord, NSW, Australia; [Johnson, Greg] Diabet Australia, Canberra, ACT, Australia; [Kerr, Peter G.; Polkinghorne, Kevan] Monash Hlth, Dept Nephrol, Clayton, Vic, Australia; [Mathew, Tim] Kidney Hlth Australia, Adelaide, SA, Australia; [Walker, Rowan] Alfred Hlth, Dept Renal Med, Prahran, Vic, Australia	Monash University; Monash University; Charles Darwin University; Menzies School of Health Research; George Institute for Global Health; University of Sydney; Royal North Shore Hospital; Concord Repatriation General Hospital	Zoungas, S (corresponding author), Monash Univ, Monash Ctr Hlth Res & Implementat, Sch Publ Hlth & Prevent Med, Diabet & Vasc Res Program, Clayton, Vic, Australia.	Sophia.zoungas@monash.edu	Kerr, Peter G/I-1461-2013		National Health and Medical Research Council Partnership Grant [ID 1055175]; research institutes and national consumer stakeholder groups-Alfred Health; Concord Hospital; Royal North Shore Hospital; Monash Health; Monash Centre for Health Research and Implementation, Monash University; George Institute for Global Health, University of Sydney; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER	National Health and Medical Research Council Partnership Grant(National Health and Medical Research Council (NHMRC) of Australia); research institutes and national consumer stakeholder groups-Alfred Health; Concord Hospital; Royal North Shore Hospital; Monash Health(Monash University); Monash Centre for Health Research and Implementation, Monash University; George Institute for Global Health, University of Sydney; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by a National Health and Medical Research Council Partnership Grant (ID 1055175) between the following health services, research institutes and national consumer stakeholder groups-Alfred Health; Concord Hospital; Royal North Shore Hospital; Monash Health; Monash Centre for Health Research and Implementation, Monash University; The George Institute for Global Health, University of Sydney;	[Anonymous], 2015, 2015 US REN DAT SYST; [Anonymous], 2014, 2014 US REN DAT SYST; ANZDATA, 2014, 2014 ANZDATA REG 37; Atun R, 2015, LANCET; Cherryholmes C.H., 1992, ED RES, P13; Ciardullo AV, 2004, ACTA DIABETOL, V41, P9, DOI 10.1007/s00592-004-0137-z; Collins A. J., 2006, AM J KIDNEY DIS, V49, pS1; De Cosmo S., 2015, NEPHROL DIAL TRANSPL; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Garcia-Llana H, 2014, NEFROLOGIA, V34, P637, DOI 10.3265/Nefrologia.pre2014.Jun.11959; Gruen RL, 2004, COCHRANE DATABASE SY, DOI [DOI 10.1002/14651858.CD003798.PUB2, 10.1002/14651858.CD003798.pub2]; Harding J., 2018, QUALITATIVE DATA ANA, V2nd ed.; Hernandez-Tejada MA, 2012, DIABETES TECHNOL THE, V14, P630, DOI 10.1089/dia.2011.0287; Hill CJ, 2014, DIABETIC MED, V31, P448, DOI 10.1111/dme.12312; Jayapaul MK, 2006, QJM-INT J MED, V99, P153, DOI 10.1093/qjmed/hcl016; Joss N, 2002, QJM-INT J MED, V95, P41, DOI 10.1093/qjmed/95.1.41; Kazawa K., 2014, J NEPHROL; Kazawa K, 2013, NEPHROL NURS J, V40, P141; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Lee YJ, 2013, INT J CLIN PRACT, V67, P363, DOI 10.1111/ijcp.12020; Lenz Oliver, 2005, BMC Nephrol, V6, P11, DOI 10.1186/1471-2369-6-11; Li T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007374.pub2; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Morrow BD, 2010, CLIN EXP NEPHROL, V14, P137, DOI 10.1007/s10157-009-0247-6; Patel M, 2009, J EVAL CLIN PRACT, V15, P832, DOI 10.1111/j.1365-2753.2008.01097.x; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Penfornis A, 2014, VASC HEALTH RISK MAN, V10, P341, DOI 10.2147/VHRM.S60312; Rachmani R, 2005, DIABETIC MED, V22, P410, DOI 10.1111/j.1464-5491.2005.01428.x; Reid K, 2012, J RENAL CARE, V38, P30, DOI 10.1111/j.1755-6686.2012.00278.x; Renders CM, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD001481]; Sakraida TJ, 2009, WESTERN J NURS RES, V31, P627, DOI 10.1177/0193945909334096; Slade H, 2011, DIABETES RES CLIN PR, V92, P356, DOI 10.1016/j.diabres.2011.02.022; Stevens PE, 2010, KIDNEY BLOOD PRESS R, V33, P119, DOI 10.1159/000313595; Strauss A., 1990, BASICS QUALITATIVE R; Tsay SL, 2004, INT J NURS STUD, V41, P59, DOI 10.1016/S0020-7489(03)00095-6; Welch J.L., 2014, W J NURS RES; Wilkinson E, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-157; Wilkinson E, 2011, J RENAL CARE, V37, P2, DOI 10.1111/j.1755-6686.2011.00199.x; Williams AF, 2009, J ADV NURS, V65, P2108, DOI 10.1111/j.1365-2648.2009.05077.x; Williams AF, 2008, INT J NURS STUD, V45, P1742, DOI 10.1016/j.ijnurstu.2008.07.002; Young BA, 2010, GEN HOSP PSYCHIAT, V32, P119, DOI 10.1016/j.genhosppsych.2009.11.018; Yu IC, 2013, J ADV NURS, V69, P1943, DOI 10.1111/jan.12055	43	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146615	10.1371/journal.pone.0146615	http://dx.doi.org/10.1371/journal.pone.0146615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26730708	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400194
J	Malik, R; Deardon, R; Kwong, GPS				Malik, Rajat; Deardon, Rob; Kwong, Grace P. S.			Parameterizing Spatial Models of Infectious Disease Transmission that Incorporate Infection Time Uncertainty Using Sampling-Based Likelihood Approximations	PLOS ONE			English	Article							INDIVIDUAL-LEVEL MODELS; INFERENCE; SELECTION; SPREAD	A class of discrete-time models of infectious disease spread, referred to as individual-level models (ILMs), are typically fitted in a Bayesian Markov chain Monte Carlo (MCMC) framework. These models quantify probabilistic outcomes regarding the risk of infection of susceptible individuals due to various susceptibility and transmissibility factors, including their spatial distance from infectious individuals. The infectious pressure from infected individuals exerted on susceptible individuals is intrinsic to these ILMs. Unfortunately, quantifying this infectious pressure for data sets containing many individuals can be computationally burdensome, leading to a time-consuming likelihood calculation and, thus, computationally prohibitive MCMC-based analysis. This problem worsens when using data augmentation to allow for uncertainty in infection times. In this paper, we develop sampling methods that can be used to calculate a fast, approximate likelihood when fitting such disease models. A simple random sampling approach is initially considered followed by various spatially-stratified schemes. We test and compare the performance of our methods with both simulated data and data from the 2001 foot-and-mouth disease (FMD) epidemic in the U.K. Our results indicate that substantial computation savings can be obtained-albeit, of course, with some information loss-suggesting that such techniques may be of use in the analysis of very large epidemic data sets.	[Malik, Rajat; Deardon, Rob] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Deardon, Rob] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Deardon, Rob; Kwong, Grace P. S.] Univ Calgary, Dept Math & Stat, Calgary, AB T2N 1N4, Canada	University of Guelph; University of Calgary; University of Calgary	Malik, R (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	rmalik@uoguelph.ca; robert.deardon@ucalgary.ca; grace.kwong@ucalgary.ca	Malik, Rajat/AAK-9864-2021	Malik, Rajat/0000-0002-5106-3058	Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation via the Leading Edge Fund grant, "Centre for Public Health and Zoonoses (CPHAZ)"	Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation via the Leading Edge Fund grant, "Centre for Public Health and Zoonoses (CPHAZ)"	This research was funded by the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) and by the Natural Sciences and Engineering Research Council of Canada (NSERC). Computer equipment was provided by the Canada Foundation for Innovation via the Leading Edge Fund grant, "Centre for Public Health and Zoonoses (CPHAZ)."	Anderson I., 2002, FOOT MOUTH DIS 2001; Brown PE, 2014, J R STAT SOC C-APPL, V63, P467, DOI 10.1111/rssc.12036; Cauchemez S, 2012, J R SOC INTERFACE, V9, P456, DOI 10.1098/rsif.2011.0379; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Deardon R, 2010, STAT SINICA, V20, P239; Gamerman D, 2006, MARKOV CHAIN MONTE C; Gani J, 2001, EPIDEMIC MODELS INTR; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Jandarov R, 2014, J R STAT SOC C-APPL, V63, P423, DOI 10.1111/rssc.12042; Jewell CP, 2009, BAYESIAN ANAL, V4, P465, DOI 10.1214/09-BA417; Kwong GPS, 2012, B MATH BIOL, V74, P1912, DOI 10.1007/s11538-012-9739-8; Malik R, 2014, J APPL STAT, V41, P1578, DOI 10.1080/02664763.2014.881787; Manolopoulou I, 2010, BAYESIAN ANAL, V5, P429, DOI 10.1214/10-BA517; McKinley T, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1171; McKinley TJ, 2014, COMPUT STAT DATA AN, V71, P434, DOI 10.1016/j.csda.2012.12.012; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; O'Neill PD, 2010, STAT MED, V29, P2069, DOI 10.1002/sim.3968; Park HS, 2009, EXPERT SYST APPL, V36, P3336, DOI 10.1016/j.eswa.2008.01.039; Shekhar S, 2011, WIRES DATA MIN KNOWL, V1, P193, DOI 10.1002/widm.25; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2010, J THEOR BIOL, V264, P95, DOI 10.1016/j.jtbi.2010.01.006; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Vrbik I, 2012, BAYESIAN ANAL, V7, P615, DOI 10.1214/12-BA721	25	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146253	10.1371/journal.pone.0146253	http://dx.doi.org/10.1371/journal.pone.0146253			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731666	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400129
J	Porter, TM; Shokralla, S; Baird, D; Golding, GB; Hajibabaei, M				Porter, Teresita M.; Shokralla, Shadi; Baird, Donald; Golding, G. Brian; Hajibabaei, Mehrdad			Ribosomal DNA and Plastid Markers Used to Sample Fungal and Plant Communities from Wetland Soils Reveals Complementary Biotas	PLOS ONE			English	Article							LAND PLANTS; PHYLOGENETIC-RELATIONSHIPS; ECTOMYCORRHIZAL FUNGI; MYCORRHIZAL FUNGI; IDENTIFICATION; RDNA; DIVERSITY; DATABASE; BIODIVERSITY; SEQUENCES	Though the use of metagenomic methods to sample below-ground fungal communities is common, the use of similar methods to sample plants from their underground structures is not. In this study we use high throughput sequencing of the ribulose-bisphosphate carboxylase large subunit (rbcL) plastid marker to study the plant community as well as the internal transcribed spacer and large subunit ribosomal DNA (rDNA) markers to investigate the fungal community from two wetland sites. Observed community richness and composition varied by marker. The two rDNA markers detected complementary sets of fungal taxa and total fungal composition clustered according to primer rather than by site. The composition of the most abundant plants, however, clustered according to sites as expected. We suggest that future studies consider using multiple genetic markers, ideally generated from different primer sets, to detect a more taxonomically diverse suite of taxa compared with what can be detected by any single marker alone. Conclusions drawn from the presence of even the most frequently observed taxa should be made with caution without corroborating lines of evidence.	[Porter, Teresita M.; Golding, G. Brian] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; [Shokralla, Shadi; Hajibabaei, Mehrdad] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Shokralla, Shadi; Hajibabaei, Mehrdad] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Baird, Donald] Univ New Brunswick, Canadian Rivers Inst, Environm Canada, Fredericton, NB E3B 6E1, Canada	McMaster University; University of Guelph; University of Guelph; Environment & Climate Change Canada; University of New Brunswick	Porter, TM (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	terri@evol.mcmaster.ca	Porter, Teresita M/H-4072-2011		Government of Canada through Genome Canada; Ontario Genomics Institute [OGI-050]	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	All the coauthors were funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute through the Biomonitoring 2.0 (www.biomonitoring2.org) project (OGI-050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Anas MUM, 2014, CAN J FISH AQUAT SCI, V71, P719, DOI 10.1139/cjfas-2013-0472; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; BRUNS TD, 1991, ANNU REV ECOL SYST, V22, P525, DOI 10.1146/annurev.es.22.110191.002521; Bruns TD, 1998, MOL ECOL, V7, P257, DOI 10.1046/j.1365-294X.1998.00337.x; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; CLEGG MT, 1993, P NATL ACAD SCI USA, V90, P363, DOI 10.1073/pnas.90.2.363; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falgueras J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-38; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; GOODALL DW, 1966, BIOMETRICS, V22, P882, DOI 10.2307/2528080; Hajibabaei M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-28; Hall L, 2003, J CLIN MICROBIOL, V41, P5099, DOI 10.1128/JCM.41.11.5099-5102.2003; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett D, 2011, NEW PHYTOL, V191, P592, DOI 10.1111/j.1469-8137.2011.03819.x; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jackson RB, 1999, P NATL ACAD SCI USA, V96, P11387, DOI 10.1073/pnas.96.20.11387; Jumpponen A, 2003, NEW PHYTOL, V158, P569, DOI 10.1046/j.1469-8137.2003.00767.x; Jumpponen A, 2005, MYCOLOGIA, V97, P1177, DOI 10.3852/mycologia.97.6.1177; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Karen O, 1997, NEW PHYTOL, V136, P313, DOI 10.1046/j.1469-8137.1997.00742.x; Kendrick B., 2000, 5 KINGDOM; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kjoller R, 2003, MYCOLOGIA, V95, P603, DOI 10.2307/3761936; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Linder CR, 2000, MOL ECOL, V9, P1549, DOI 10.1046/j.1365-294x.2000.01034.x; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lynch MDJ, 2006, APPL ENVIRON MICROB, V72, P7050, DOI 10.1128/AEM.00826-06; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; Mitra S, 2010, ISME J, V4, P1236, DOI 10.1038/ismej.2010.51; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; Moncalvo JM, 2000, SYST BIOL, V49, P278, DOI 10.1093/sysbio/49.2.278; Nagy LG, 2011, NEW PHYTOL, V191, P789, DOI 10.1111/j.1469-8137.2011.03707.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2015, MICROBES ENVIRON, V30, P145, DOI 10.1264/jsme2.ME14121; Nilsson RH, 2014, FUNGAL DIVERS, V67, P11, DOI 10.1007/s13225-014-0291-8; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; O'Hanlon-Manners DL, 2004, ECOLOGY, V85, P284, DOI 10.1890/03-3030; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Porter TM, 2008, MOL ECOL, V17, P3037, DOI 10.1111/j.1365-294X.2008.03813.x; Porter TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035749; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schafer M, 2004, PLANT ECOL, V175, P19, DOI 10.1023/B:VEGE.0000048096.00772.23; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tedersoo L, 2015, MYCOKEYS, P1, DOI 10.3897/mycokeys.10.4852; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	82	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0142759	10.1371/journal.pone.0142759	http://dx.doi.org/10.1371/journal.pone.0142759			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731732	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400004
J	Rubio-Campillo, X				Rubio-Campillo, Xavier			Model Selection in Historical Research Using Approximate Bayesian Computation	PLOS ONE			English	Article							LANCHESTERS SQUARE LAW; CHAIN MONTE-CARLO; AHR-EXCHANGE; COMBAT; INFERENCE; MANIFESTO; EQUATIONS; BATTLES	Formal Models and History Computational models are increasingly being used to study historical dynamics. This new trend, which could be named Model-Based History, makes use of recently published datasets and innovative quantitative methods to improve our understanding of past societies based on their written sources. The extensive use of formal models allows historians to reevaluate hypotheses formulated decades ago and still subject to debate due to the lack of an adequate quantitative framework. The initiative has the potential to transform the discipline if it solves the challenges posed by the study of historical dynamics. These difficulties are based on the complexities of modelling social interaction, and the methodological issues raised by the evaluation of formal models against data with low sample size, high variance and strong fragmentation. Case Study This work examines an alternate approach to this evaluation based on a Bayesian-inspired model selection method. The validity of the classical Lanchester's laws of combat is examined against a dataset comprising over a thousand battles spanning 300 years. Four variations of the basic equations are discussed, including the three most common formulations (linear, squared, and logarithmic) and a new variant introducing fatigue. Approximate Bayesian Computation is then used to infer both parameter values and model selection via Bayes Factors. Impact Results indicate decisive evidence favouring the new fatigue model. The interpretation of both parameter estimations and model selection provides new insights into the factors guiding the evolution of warfare. At a methodological level, the case study shows how model selection methods can be used to guide historical research through the comparison between existing hypotheses and empirical evidence.	[Rubio-Campillo, Xavier] Barcelona Supercomp Ctr, Comp Applicat Sci & Engn Dept, Barcelona, Spain	Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS)	Rubio-Campillo, X (corresponding author), Barcelona Supercomp Ctr, Comp Applicat Sci & Engn Dept, Barcelona, Spain.	xavier.rubio@bsc.es	Rubio-Campillo, Xavier/O-4182-2014	Rubio-Campillo, Xavier/0000-0003-4428-4335	SimulPast Consolider Ingenio project of the former Ministry for Science and Innovation of the Spanish Government [CSD2010-00034]; European Research Council Advanced Grant EPNet [340828]	SimulPast Consolider Ingenio project of the former Ministry for Science and Innovation of the Spanish Government; European Research Council Advanced Grant EPNet	Funding for this work was provided by the SimulPast Consolider Ingenio project (CSD2010-00034) of the former Ministry for Science and Innovation of the Spanish Government and the European Research Council Advanced Grant EPNet (340828).	Abelson RP., 2012, STAT PRINCIPLED ARGU; Adams ES, 2003, BEHAV ECOL, V14, P719, DOI 10.1093/beheco/arg061; Allen CD, 1990, EVOLUTION MODERN BAT; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; [Anonymous], 2011, CREATING CONSILIENCE; [Anonymous], 2003, HIST DYNAMICS WHY ST; [Anonymous], 2014, HIST MANIFESTO; Armitage D, 2015, AM HIST REV, V120, P543, DOI 10.1093/ahr/120.2.543; Artelli MJ, 2008, J DEF MODEL SIMUL-AP, V5, P1, DOI 10.1177/154851290800500101; Ausloos M, 2010, PROCEEDINGS OF THE FIRST INTERDISCIPLINARY CHESS INTERACTIONS CONFERENCE, P157, DOI 10.1142/9789814295895_0009; Bankes SC, 2002, P NATL ACAD SCI USA, V99, P7199, DOI 10.1073/pnas.072081299; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bertrand JWM, 2002, INT J OPER PROD MAN, V22, P241, DOI 10.1108/01443570210414338; Bodart G., 1908, MILITAR HISTORISCHES; Cohen D, 2015, AM HIST REV, V120, P530, DOI 10.1093/ahr/120.2.530; COWGILL GL, 1977, AM ANTIQUITY, V42, P350, DOI 10.2307/279061; Crema ER, 2014, J ARCHAEOL SCI, V50, P160, DOI 10.1016/j.jas.2014.07.014; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; DEITCHMAN SJ, 1962, OPER RES, V10, P818, DOI 10.1287/opre.10.6.818; ENGEL JH, 1954, J OPER RES SOC AM, V2, P163, DOI 10.1287/opre.2.2.163; Epstein JM, 2008, JASSS-J ARTIF SOC S, V11; Eve SJ, 2014, J ARCHAEOL SCI, V43, P267, DOI 10.1016/j.jas.2013.12.019; Gliner JA, 2002, J EXP EDUC, V71, P83, DOI 10.1080/00220970209602058; Gonzalez E, 2011, EUR J OPER RES, V210, P706, DOI 10.1016/j.ejor.2010.11.009; HARTLEY DS, 1995, NAV RES LOG, V42, P609, DOI 10.1002/1520-6750(199506)42:4<609::AID-NAV3220420408>3.0.CO;2-W; Hernandez FX, 2014, REV U HIST MILITAR, V4, P255; Hoganson K, 2014, P 2014 ACM SE REG C, P1; Johnson DDP, 2015, EVOL HUM BEHAV, V36, P152, DOI 10.1016/j.evolhumbehav.2014.11.001; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kandler A, 2015, REPLACE NEANDERTHAL, P85, DOI 10.1007/978-4-431-55363-2_7; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kirkpatrick DLI, 1985, J ROYAL UNITED SERVI, V130, P25; Kovacevic M, 2015, REPLACE NEANDERTHAL, P103, DOI 10.1007/978-4-431-55363-2_8; Kruschke JK, 2014, JAGS STAN, V2nd, DOI DOI 10.1016/B978-0-12-405888-0.09996-7; Lanchester FW., 1956, WORLD MATH, V4, P2138; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; Litton C.D., 1995, ARCHAEOMETRY, V37, P1, DOI DOI 10.1111/J.1475-4754.1995.TB00723.X; Lucas TW, 2004, NAV RES LOG, V51, P95, DOI 10.1002/nav.10101; Maikov AS, 2014, CLIODYNAMICS J QUANT, V5; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; McGrayne S.B, 2011, THEORY WOULD NOT BAY; Meson B, 2015, WORLD ARCHAEOL, P1; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Pettit LI, 2003, EUR J OPER RES, V148, P152, DOI 10.1016/S0377-2217(02)00462-9; Plowes NJR, 2005, P ROY SOC B-BIOL SCI, V272, P1809, DOI 10.1098/rspb.2005.3162; Porcic M., 2015, ARCHAEOL ANTHROP SCI, P1, DOI [10.1007/s12520-014-0223-2, DOI 10.1007/S12520-014-0223-2]; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Rubio-Campillo X, 2013, J SIMUL, V7, P170, DOI 10.1057/jos.2012.25; Sabin Philip., 2014, SIMULATING WAR STUDY; Schich M, 2014, SCIENCE, V345, P558, DOI 10.1126/science.1240064; Scogings C, 2012, P WINT SIM C WINT SI, P207; Shelley EL, 2004, CONDOR, V106, P395, DOI 10.1650/7424; Sigue SP, 2015, DYNAMIC GAMES APPL; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; TAYLOR JG, 1974, OPER RES, V22, P756, DOI 10.1287/opre.22.4.756; Towner MC, 2007, EVOL ANTHROPOL, V16, P107, DOI 10.1002/evan.20134; Turchin P, 2012, CLIODYNAMICS, V3, P2; Turchin P, 2008, NATURE, V454, P34, DOI 10.1038/454034a; Turner BM, 2012, J MATH PSYCHOL, V56, P69, DOI 10.1016/j.jmp.2012.02.005; Waniek M, 2014, 2014 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCES ON WEB INTELLIGENCE (WI) AND INTELLIGENT AGENT TECHNOLOGIES (IAT), VOL 3, P412, DOI 10.1109/WI-IAT.2014.196; Wegmann D, 2009, GENETICS, V182, P1207, DOI 10.1534/genetics.109.102509; Weigley Russell F, 2004, AGE BATTLES QUEST DE; WEISS HK, 1966, OPER RES, V14, P759, DOI 10.1287/opre.14.5.759; Widmer ED, 2011, REDES REV HISPANA AN, V21, P0347; Wiper MP, 2000, NAV RES LOG, V47, P541, DOI 10.1002/1520-6750(200010)47:7<541::AID-NAV1>3.0.CO;2-0; Zucchini W, 2000, J MATH PSYCHOL, V44, P41, DOI 10.1006/jmps.1999.1276	70	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146491	10.1371/journal.pone.0146491	http://dx.doi.org/10.1371/journal.pone.0146491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DA4VZ	26730953	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400186
J	Sasaki, R; Kanda, T; Nakamura, M; Nakamoto, S; Haga, Y; Wu, S; Shirasawa, H; Yokosuka, O				Sasaki, Reina; Kanda, Tatsuo; Nakamura, Masato; Nakamoto, Shingo; Haga, Yuki; Wu, Shuang; Shirasawa, Hiroshi; Yokosuka, Osamu			Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; PROTEIN-KINASE; I EXPRESSION; ACTIVATION; PROMOTES; GROWTH; FIBROSIS; SERUM	Background The induction of apoptosis in hepatic stellate cells (HSCs) is a promising therapeutic strategy against hepatitis B virus (HBV)-related hepatic fibrosis. The underlying mechanisms of apoptosis in HSCs, however, are unknown under consideration of HBV infection. In this study, the effects of HBV on apoptosis and endoplasmic reticulum (ER) stress signaling in HSCs were examined. Methods The effects of conditioned media (CM) from HepG2.2.15 on apoptosis induced by the proteasome inhibitor MG132 in LX-2 and HHSteC were studied in regard to c-Jun. In combination with c-Fos, c-Jun forms the AP-1 early response transcription factor, leading to AP-1 activation, signal transduction, endoplasmic reticulum (ER) stress and apoptosis. Results In LX-2 cells, MG132 treatment was associated with the phosphorylation of c-Jun, activation of AP-1 and apoptosis. However, in the presence of CM from HepG2.2.15, these phenomena were attenuated. In HHSteC cells, similar results were observed. HBV genomic DNA is not involved in the process of HSC apoptosis. It is possible that HBeAg has an inhibitory effect on MG132-induced apoptosis in LX-2. We also observed the upregulation of several ER stress-associated genes, such as cAMP responsive element binding protein 3-like 3, inhibin-beta A and solute carrier family 17-member 2, in the presence of CM from HepG2.2.15, or CM from PXB cells infected with HBV. Conclusions HBV inhibits the activation of c-Jun/AP-1 in HSCs, contributing to the attenuation of apoptosis and resulting in hepatic fibrosis. HBV also up-regulated several ER stress genes associated with cell growth and fibrosis. These mechanistic insights might shed new light on a treatment strategy for HBV-associated hepatic fibrosis.	[Sasaki, Reina; Kanda, Tatsuo; Nakamura, Masato; Nakamoto, Shingo; Haga, Yuki; Wu, Shuang; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan; [Nakamoto, Shingo; Shirasawa, Hiroshi] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba 2608670, Japan	Chiba University; Chiba University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan.	kandat@aol.com		Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20345002]; Japan Agency for Medical Research and Development, AMED	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by a KAKEN Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (20345002 to TK, https://kaken.nii.ac.jp/d/r/20345002.ja.html). This research was (partially) supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS G, 1987, P NATL ACAD SCI USA, V84, P4641, DOI 10.1073/pnas.84.13.4641; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Bai QX, 2012, INT J MOL MED, V30, P1443, DOI 10.3892/ijmm.2012.1148; Basu A, 2006, APOPTOSIS, V11, P1391, DOI 10.1007/s10495-006-8312-z; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cheret C, 2002, J MOL BIOL, V322, P929, DOI 10.1016/S0022-2836(02)00816-1; Crawford LJ, 2011, J CELL COMMUN SIGNAL, V5, P101, DOI 10.1007/s12079-011-0121-7; Evans A, 2008, HEPATOLOGY, V48, P759, DOI 10.1002/hep.22419; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Ghavami S, 2005, MED SCI MONITOR, V11, pRA337; Han HL, 2003, WORLD J GASTROENTERO, V9, P117, DOI 10.3748/wjg.v9.i1.117; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Igaki N, 2003, J GASTROENTEROL, V38, P968, DOI 10.1007/s00535-003-1180-1; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548; Jiang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131973; Kanda T, 2006, CANCER LETT, V234, P143, DOI 10.1016/j.canlet.2005.03.030; Kanda T, 2015, WORLD J HEPATOL, V7, P1913, DOI [10.4254/wjh.v7.i15.1913, 10.4254/wjh.v7.i11.1541]; Kim WR, 2015, CANCER-AM CANCER SOC, V121, P3631, DOI 10.1002/cncr.29537; Lebensztejn DM, 2005, EUR J GASTROEN HEPAT, V17, P843, DOI 10.1097/00042737-200508000-00011; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liu XD, 2014, BIOMED REP, V2, P97, DOI 10.3892/br.2013.201; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Matsuda Y, 2013, SCI WORLD J, DOI 10.1155/2013/597095; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nuriya H, 2010, J CLIN MICROBIOL, V48, P3843, DOI 10.1128/JCM.00415-10; Panagopoulos I, 2007, GENE CHROMOSOME CANC, V46, P181, DOI 10.1002/gcc.20395; Pinzani M, 2015, DIGEST DIS, V33, P492, DOI 10.1159/000374096; Prasad S, 2014, TRENDS PHARMACOL SCI, V35, P520, DOI 10.1016/j.tips.2014.07.004; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Sasaki R, 2015, BIOCHEM BIOPH RES CO, V464, P1192, DOI 10.1016/j.bbrc.2015.07.102; Seifert O, 2008, WOUND REPAIR REGEN, V16, P254, DOI 10.1111/j.1524-475X.2007.00343.x; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shi H, 2009, LIVER INT, V29, P349, DOI 10.1111/j.1478-3231.2008.01835.x; SING GK, 1993, J VIROL, V67, P3454, DOI 10.1128/JVI.67.6.3454-3460.1993; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007; TABOR E, 1992, J MED VIROL, V37, P271, DOI 10.1002/jmv.1890370406; Weng TC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-78; Wong GLH, 2013, GASTROENTEROLOGY, V144, P933, DOI 10.1053/j.gastro.2013.02.002; Wu HM, 2002, AM J RESP CELL MOL, V27, P234, DOI 10.1165/ajrcmb.27.2.4792; Wu S, 2012, J INFECT DIS, V206, P415, DOI 10.1093/infdis/jis363; Wu S, 2011, CANCER LETT, V312, P33, DOI 10.1016/j.canlet.2011.07.025; Wu SA, 2010, VIRAL IMMUNOL, V23, P467, DOI 10.1089/vim.2010.0042; Wu XN, 2012, HEPATOL RES, V42, P911, DOI 10.1111/j.1872-034X.2012.01000.x; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Yapali S, 2014, CLIN GASTROENTEROL H, V12, P16, DOI 10.1016/j.cgh.2013.04.036; Zan YL, 2013, BIOCHEM BIOPH RES CO, V435, P391, DOI 10.1016/j.bbrc.2013.04.098; Zanotto A, 2012, INVEST NEW DRUG, V30, P2252, DOI 10.1007/s10637-012-9804-z; Zhao G, 2014, GUT, V63, P1159, DOI 10.1136/gutjnl-2013-305507	53	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146314	10.1371/journal.pone.0146314	http://dx.doi.org/10.1371/journal.pone.0146314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731332	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400145
J	Yang, TK; Woo, P; Yang, HJ; Chang, HC; Hsieh, JT; Huang, KH				Yang, Teng-Kai; Woo, Peter; Yang, Hung-Ju; Chang, Hong-Chiang; Hsieh, Ju-Ton; Huang, Kuo-How			Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-Up	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; BIOELECTRICAL-IMPEDANCE ANALYSIS; TRANSRECTAL ULTRASOUND; BODY-COMPOSITION; HYPERPLASIA; OBESITY; DIAGNOSIS; MANAGEMENT; STATEMENT; FAT	Objectives To investigate the impact of metabolic components and body composition indices on prostate volume (PV) in a population of middle-aged men receiving health check-ups. Methods Six hundred and sixteen men receiving health assessments were stratified to large and small prostates based on the cut-off of median PV. Their demographic data, health history, and international prostate symptoms scores (IPSS) were collected. Metabolic components and body composition indices were compared between subjects with large and small prostates. Moreover, the correlations between these parameters and PV were analyzed by multivariate logistic regression. Results The median PV was 27 mL and mean age was 54.8 years. Subjects with large PV were older (56.5 vs. 52.7 years) and had higher serum prostate specific antigen (PSA) level (1.73 vs. 0.96 ng/mL), higher IPSS score (8.37 vs. 6.16), and higher body fat, body mass, and waist circumference (all p<0.05). In multivariate analysis, age (OR, 2.45; 95% CI, 1.743.45), serum PSA (OR, 2.75; 95% CI, 1.96-3.86), waist circumference (OR, 1.45; 95% CI, 1.02-2.07), fatness (OR, 1.47; 95% CI, 1.04-2.09), and body fat mass (OR, 1.43; 95% CI, 1.00-2.03) were significantly correlated with PV of study subjects. In subgroup analysis, raised waist circumference (OR, 1.89; 95% CI, 1.00-3.59) was the independent predictor of PV in subjects with bothersome lower urinary tract symptoms. Conclusions Several metabolic components and body composition indices are significantly associated with PV of middle-aged men, including raised waist circumference, fatness, and body fat mass. Raised waist circumference is the only independent predictor of PV in middle-aged men with bothersome LUTS.	[Yang, Teng-Kai; Yang, Hung-Ju] Yonghe Cardinal Tien Hosp, Dept Surg, New Taipei, Taiwan; [Yang, Teng-Kai] Fu Jen Catholic Univ, Coll Med, New Taipei, Taiwan; [Woo, Peter] Yonghe Cardinal Tien Hosp, Dept Internal Med, New Taipei, Taiwan; [Chang, Hong-Chiang; Hsieh, Ju-Ton; Huang, Kuo-How] Natl Taiwan Univ, Coll Med, Dept Urol, Taipei 10764, Taiwan; [Chang, Hong-Chiang; Hsieh, Ju-Ton; Huang, Kuo-How] Natl Taiwan Univ Hosp, Taipei, Taiwan	Fu Jen Catholic University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Huang, KH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Urol, Taipei 10764, Taiwan.	khhuang123@ntu.edu.tw		HSIEH, JU-TON/0000-0001-7545-8487; CHANG, HONG-CHIANG/0000-0001-5411-6680				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Carballido J, 2011, INT J CLIN PRACT, V65, P989, DOI 10.1111/j.1742-1241.2011.02735.x; Chien KL, 2011, NUTR METAB CARDIOVAS, V21, P643, DOI 10.1016/j.numecd.2010.01.007; Choi YJ, 2009, AM J ROENTGENOL, V192, P444, DOI 10.2214/AJR.07.3617; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fitzpatrick JM, 2006, BJU INT, V97, P3, DOI 10.1111/j.1464-410X.2006.06097.x; Fowke JH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-23; Gacci M, 2015, BJU INT, V115, P24, DOI 10.1111/bju.12728; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hammarsten J, 2001, EUR UROL, V39, P151, DOI 10.1159/000052430; Kim JH, 2014, UROLOGY, V84, P665, DOI 10.1016/j.urology.2014.05.019; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; Mauras N, 2010, J CLIN ENDOCR METAB, V95, P1060, DOI 10.1210/jc.2009-1887; Misra A, 2009, J Assoc Physicians India, V57, P163; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Rohrmann S, 2005, INT J OBESITY, V29, P310, DOI 10.1038/sj.ijo.0802881; Russo GI, 2015, AGING MALE, V18, P133, DOI 10.3109/13685538.2015.1028353; Sarma AV, 2012, NEW ENGL J MED, V367, P248, DOI 10.1056/NEJMcp1106637; Sarma AV, 2009, J UROLOGY, V182, pS32, DOI 10.1016/j.juro.2009.07.088; Schafer H, 2002, CHEST, V122, P829, DOI 10.1378/chest.122.3.829; TERRIS MK, 1991, J UROLOGY, V145, P984, DOI 10.1016/S0022-5347(17)38508-7; Thorpe A, 2003, LANCET, V361, P1359, DOI 10.1016/S0140-6736(03)13073-5; Yang HJ, 2012, UROLOGY, V80, P187, DOI 10.1016/j.urology.2012.04.003; Yang TK, 2012, UROLOGY, V80, P1093, DOI 10.1016/j.urology.2012.08.002; Yim SJ, 2011, KOREAN J UROL, V52, P390, DOI 10.4111/kju.2011.52.6.390; Zou C, 2015, WORLD J UROL	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145050	10.1371/journal.pone.0145050	http://dx.doi.org/10.1371/journal.pone.0145050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731481	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400020
J	Liu, M; Xu, Y; Mohammed, AW				Liu, Ming; Xu, Yang; Mohammed, Abdul-Wahid			Decentralized Opportunistic Spectrum Resources Access Model and Algorithm toward Cooperative Ad-Hoc Networks	PLOS ONE			English	Article								Limited communication resources have gradually become a critical factor toward efficiency of decentralized large scale multi-agent coordination when both system scales up and tasks become more complex. In current researches, due to the agent's limited communication and observational capability, an agent in a decentralized setting can only choose a part of channels to access, but cannot perceive or share global information. Each agent's cooperative decision is based on the partial observation of the system state, and as such, uncertainty in the communication network is unavoidable. In this situation, it is a major challenge working out cooperative decision-making under uncertainty with only a partial observation of the environment. In this paper, we propose a decentralized approach that allows agents cooperatively search and independently choose channels. The key to our design is to build an up-to-date observation for each agent's view so that a local decision model is achievable in a large scale team coordination. We simplify the Dec-POMDP model problem, and each agent can jointly work out its communication policy in order to improve its local decision utilities for the choice of communication resources. Finally, we discuss an implicate resource competition game, and show that, there exists an approximate resources access tradeoff balance between agents. Based on this discovery, the tradeoff between real-time decision-making and the efficiency of cooperation using these channels can be well improved.	[Liu, Ming; Xu, Yang; Mohammed, Abdul-Wahid] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China	Xu, Y (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China.	xuyang@uestc.edu.cn	Liu, Ming/AAC-7186-2020	Liu, Ming/0000-0003-1349-7143; Mohammed, Abdul-Wahid/0000-0002-6263-9227	National Natural Science Foundation of China [61370151, 61202211]; National Science and Technology Major Project of China [2015ZX03003012]; Central University Basic Research Funds Foundation of China [ZYGX2014J055]; Science and Technology on Electronic Information Control Laboratory Project; NSFC [61370151, 61202211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Central University Basic Research Funds Foundation of China; Science and Technology on Electronic Information Control Laboratory Project; NSFC(National Natural Science Foundation of China (NSFC))	This research was sponsored by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) grants 61370151 and 61202211 to YX, the National Science and Technology Major Project of China (http://www.nmp.gov.cn/) grant 2015ZX03003012 to YX, the Central University Basic Research Funds Foundation of China grant ZYGX2014J055 to YX, and the Science and Technology on Electronic Information Control Laboratory Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was sponsored by the NSFC 61370151 and 61202211, the National Science and Technology Major Project of China 2015ZX03003012, the Central University Basic Research Funds Foundation of China ZYGX2014J055, and the Science and Technology on Electronic Information Control Laboratory Project.	Ab Wahab MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122827; Busoniu L, 2008, IEEE T SYST MAN CY C, V38, P156, DOI 10.1109/TSMCC.2007.913919; Capitan J, 2013, INT J ROBOT RES, V32, P650, DOI 10.1177/0278364913483345; Conti M, 2014, IEEE COMMUN MAG, V52, P85, DOI 10.1109/MCOM.2014.6710069; Feng MY, 2014, IEEE T CIRCUITS-I, V61, P2941, DOI 10.1109/TCSI.2014.2333677; Fernandez-Gauna B, 2015, INFORM SCIENCES, V317, P25, DOI 10.1016/j.ins.2015.04.005; Fernandez-Gauna B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127129; Halldorsson M. M., 2004, P 23 ANN ACM S PRINC, P107, DOI [10.1145/1011767.1011783., DOI 10.1145/1011767.1011783]; Hansen EA, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P709; Iqbal J, 2009, MULT C 2009 INMIC 20, DOI [10.1109/INMIC.2009.5383082, DOI 10.1109/INMIC.2009.5383082]; Kish LB, 2001, FLUCT NOISE LETT, V1, pL13, DOI 10.1142/S0219477501000093; Kulkarni RV, 2011, IEEE T SYST MAN CY C, V41, P262, DOI 10.1109/TSMCC.2010.2054080; Liu H, 2008, COMM WORKSH 2008 ICC, DOI [10.1109/ICCW.2008.98., DOI 10.1109/ICCW.2008.98]; Liu M, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/802387; Niyato D, 2009, IEEE T MOBILE COMPUT, V8, P1009, DOI 10.1109/TMC.2008.157; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Seuken S., 2012, ARXIV12065295; Tan L, 2011, WIR COMM NETW C WCNC, DOI [10.1109/WCNC.2011.5779338, DOI 10.1109/WCNC.2011.5779338]; Tang S, 2007, GLOB TEL C 2007 GLOB, DOI [10.1109/glocom.2007.880., DOI 10.1109/GLOCOM.2007.880]; Wang T, 2013, STUDIES MEDIA COMMUN, V1, P91, DOI 10.11114/smc.v1i1.124; Wang YC, 2011, IEICE T COMMUN, VE94B, P1621, DOI 10.1587/transcom.E94.B.1621; Xu YH, 2012, IEEE J-STSP, V6, P180, DOI 10.1109/JSTSP.2011.2176916; Xue Y, 2006, IEEE T MOBILE COMPUT, V5, P347, DOI 10.1109/TMC.2006.1599404; Yan Z, 2013, INT J ADV ROBOT SYST, V10, DOI 10.5772/57313; Zhang Y, 2014, INTELLIGENT INFORM P, VVII, P197; Zhao Q, 2007, IEEE SIGNAL PROC MAG, V24, P79, DOI 10.1109/MSP.2007.361604	26	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145526	10.1371/journal.pone.0145526	http://dx.doi.org/10.1371/journal.pone.0145526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727504	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500020
J	Stankewich, MC; Moeckel, GW; Ji, L; Ardito, T; Morrow, JS				Stankewich, Michael C.; Moeckel, Gilbert W.; Ji, Lan; Ardito, Thomas; Morrow, Jon S.			Isoforms of Spectrin and Ankyrin Reflect the Functional Topography of the Mouse Kidney	PLOS ONE			English	Article							AMMONIUM TRANSPORTER RHBG; HIPPO SIGNALING PATHWAY; INTESTINAL BRUSH-BORDER; EPITHELIAL-CELLS; LATERAL MEMBRANE; BETA-SPECTRIN; ALPHA-SUBUNIT; GENE FAMILY; NEPHROTIC SYNDROME; DISTAL NEPHRON	The kidney displays specialized regions devoted to filtration, selective reabsorption, and electrolyte and metabolite trafficking. The polarized membrane pumps, channels, and transporters responsible for these functions have been exhaustively studied. Less examined are the contributions of spectrin and its adapter ankyrin to this exquisite functional topography, despite their established contributions in other tissues to cellular organization. We have examined in the rodent kidney the expression and distribution of all spectrins and ankyrins by qPCR, Western blotting, immunofluorescent and immuno electron microscopy. Four of the seven spectrins (alpha II, beta I, beta II, and beta III) are expressed in the kidney, as are two of the three ankyrins (G and B). The levels and distribution of these proteins vary widely over the nephron. alpha II/beta II is the most abundant spectrin, found in glomerular endothelial cells; on the basolateral membrane and cytoplasmic vesicles in proximal tubule cells and in the thick ascending loop of Henle; and less so in the distal nephron. beta III spectrin largely replaces beta beta II spectrin in podocytes, Bowman's capsule, and throughout the distal tubule and collecting ducts. beta I spectrin is only marginally expressed; its low abundance hinders a reliable determination of its distribution. Ankyrin G is the most abundant ankyrin, found in capillary endothelial cells and all tubular segments. Ankyrin B populates Bowman's capsule, podocytes, the ascending thick loop of Henle, and the distal convoluted tubule. Comparison to the distribution of renal protein 4.1 isoforms and various membrane proteins indicates a complex relationship between the spectrin scaffold, its adapters, and various membrane proteins. While some proteins (e.g. ankyrin B, beta III spectrin, and aquaporin 2) tend to share a similar distribution, there is no simple mapping of different spectrins or ankyrins to most membrane proteins. The implications of this data are discussed.	[Stankewich, Michael C.; Moeckel, Gilbert W.; Ji, Lan; Ardito, Thomas; Morrow, Jon S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Morrow, Jon S.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	Yale University; Yale University	Stankewich, MC (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	Michael.stankewich@yale.edu		Moeckel, Gilbert/0000-0002-6059-0837	NIH [RO1-HL28560, RO1-DK43812]; National Ataxia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043812, P30DK079310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants RO1-HL28560 and RO1-DK43812 (JSM) and a Young Investigator Award from the National Ataxia Foundation (MCS).	Antolik C, 2007, NEUROSCIENCE, V145, P56, DOI 10.1016/j.neuroscience.2006.11.047; Bailey MA, 2004, J PHYSIOL-LONDON, V561, P765, DOI 10.1113/jphysiol.2004.074716; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Berghs S, 2001, P NATL ACAD SCI USA, V98, P6945, DOI 10.1073/pnas.121170798; Bialkowska K, 2005, J CELL SCI, V118, P381, DOI 10.1242/jcs.01625; CARBONI JM, 1987, AM J PATHOL, V129, P589; Cen J, 2015, INT J CLIN EXP MED, V8, P3629; De Matteis MA, 2000, J CELL SCI, V113, P2331; Deng H, 2015, ELIFE, V4, DOI 10.7554/eLife.06567; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; DRENCKHAHN D, 1985, SCIENCE, V230, P1287, DOI 10.1126/science.2933809; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; Fang LA, 2010, AM J PHYSIOL-RENAL, V299, pF1359, DOI 10.1152/ajprenal.00257.2010; Fath KR, 1997, J CELL BIOL, V139, P1169, DOI 10.1083/jcb.139.5.1169; Fletcher GC, 2015, EMBO J, V34, P940, DOI 10.15252/embj.201489642; HARRIS AS, 1986, J CELL BIOCHEM, V30, P51, DOI 10.1002/jcb.240300107; Hayashi M, 2000, EXP NEPHROL, V8, P215; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; HIROKAWA N, 1983, CELL, V32, P953, DOI 10.1016/0092-8674(83)90080-6; Hoock TC, 1997, J CELL BIOL, V136, P1059, DOI 10.1083/jcb.136.5.1059; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Igarashi P, 1996, J BIOL CHEM, V271, P9666, DOI 10.1074/jbc.271.16.9666; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Jenkins PM, 2013, J BIOL CHEM, V288, P14018, DOI 10.1074/jbc.M113.454439; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; JORDAN C, 1995, J BIOL CHEM, V270, P29971; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Kang QZ, 2009, J CELL SCI, V122, P1091, DOI 10.1242/jcs.039644; Kashgarian M, 1988, Prog Clin Biol Res, V268B, P245; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; KOOB R, 1988, EUR J CELL BIOL, V45, P230; Lee GS, 2009, AM J PHYSIOL-RENAL, V297, pF371, DOI 10.1152/ajprenal.90615.2008; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Lenkkeri U, 1999, AM J HUM GENET, V64, P51, DOI 10.1086/302182; Liu X, 2008, J BIOL CHEM, V283, P11461, DOI 10.1074/jbc.M706942200; LOMBARDO CR, 1994, J BIOL CHEM, V269, P29212; Lopez C, 2005, J BIOL CHEM, V280, P8221, DOI 10.1074/jbc.M413351200; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Magyar CE, 2002, AM J PHYSIOL-RENAL, V283, pF29, DOI 10.1152/ajprenal.00252.2000; MCINTOSH JE, 1986, ANAT REC, V215, P383, DOI 10.1002/ar.1092150408; Melo Z, 2013, AM J PHYSIOL-RENAL, V305, pF1402, DOI 10.1152/ajprenal.00390.2013; Meneton P, 2004, AM J PHYSIOL-RENAL, V287, pF593, DOI 10.1152/ajprenal.00454.2003; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Mohler PJ, 2005, CURR OPIN CARDIOL, V20, P189, DOI 10.1097/01.hco.0000160372.95116.3e; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Monette MY, AM J PHYSL RENAL PHY; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nedrelow JH, 2003, J BIOL CHEM, V278, P7735, DOI 10.1074/jbc.M210988200; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Piepenhagen PA, 1995, AM J PHYSIOL-CELL PH, V269, pC1417, DOI 10.1152/ajpcell.1995.269.6.C1417; Pradhan D, 2002, IMMUNITY, V17, P303, DOI 10.1016/S1074-7613(02)00396-5; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Ramez M, 2003, KIDNEY INT, V63, P1321, DOI 10.1046/j.1523-1755.2003.00870.x; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; Sohet F, 2008, J BIOL CHEM, V283, P26557, DOI 10.1074/jbc.M803120200; Stabach PR, 2008, AM J PHYSIOL-CELL PH, V295, pC1202, DOI 10.1152/ajpcell.00273.2008; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Stankewich MC, 2010, P NATL ACAD SCI USA, V107, P6022, DOI 10.1073/pnas.1001522107; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Wang YH, 2005, AM J PHYSIOL-RENAL, V289, pF850, DOI 10.1152/ajprenal.00011.2005; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Wong KKL, 2015, J BIOL CHEM, V290, P6397, DOI 10.1074/jbc.M114.629493; Woroniecki R, 2003, AM J PHYSIOL-RENAL, V284, pF358, DOI 10.1152/ajprenal.00100.2002; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	72	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0142687	10.1371/journal.pone.0142687	http://dx.doi.org/10.1371/journal.pone.0142687			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727517	Green Submitted, gold, Green Published			2022-12-27	WOS:000367681500001
J	Kato, Y; Terashima, M; Ohigashi, H; Tezuka, D; Ashikaga, T; Hirao, K; Isobe, M				Kato, Yoko; Terashima, Masahiro; Ohigashi, Hirokazu; Tezuka, Daisuke; Ashikaga, Takashi; Hirao, Kenzo; Isobe, Mitsuaki			Vessel Wall Inflammation of Takayasu Arteritis Detected by Contrast-Enhanced Magnetic Resonance Imaging: Association with Disease Distribution and Activity	PLOS ONE			English	Article							MACARONI SIGN; ANGIOGRAPHIC FINDINGS; CT; ULTRASONOGRAPHY; CLASSIFICATION; INVOLVEMENT	Aims The assessment of the distribution and activity of vessel wall inflammation is clinically important in patients with Takayasu arteritis. Magnetic resonance imaging (MRI) is a useful tool, but the clinical utility of late gadolinium enhancement (LGE) in Takayasu arteritis has yet to be determined. The aim of the present study was to evaluate the utility of LGE in assessing vessel wall inflammation and disease activity in Takayasu arteritis. Methods and Results We enrolled 49 patients with Takayasu arteritis who had undergone 1.5 T MRI. Patients were divided into Active (n = 19) and Inactive disease (n = 30) groups. The distribution of vessel wall inflammation using angiography and LGE was assessed by qualitative analysis. In 79% and 63% of patients in Active and Inactive groups, respectively, greater distribution of vessel wall inflammation was observed with LGE than with conventional angiography. MRI values of pre- and post-contrast signal-to-noise ratios (SNR), SNR increment (post-SNR minus pre-SNR), pre-and post-contrast contrast-to-noise ratios (CNR), and CNR increment (post-CNR minus pre-CNR) were evaluated at arterial wall sites with the highest signal intensity using quantitative analysis of post-contrast LGE images. No statistically significant differences in MRI parameters were observed between Active and Inactive groups. Contrast-enhanced MRI was unable to accurately detect active disease. Conclusion Contrast-enhanced MRI has utility in detecting the distribution of vessel wall inflammation but has less utility in assessing disease activity in Takayasu arteritis.	[Kato, Yoko; Ohigashi, Hirokazu; Tezuka, Daisuke; Ashikaga, Takashi; Hirao, Kenzo; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Kato, Yoko; Terashima, Masahiro] Cardiovasc Imaging Clin, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Isobe, M (corresponding author), Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan.	isobemi.cvm@gmail.com	Kato, Yoko/AFR-8287-2022	Kato, Yoko/0000-0002-4328-1987	Tokyo Medical and Dental University, Department of Cardiovascular medicine [1703]	Tokyo Medical and Dental University, Department of Cardiovascular medicine	This study was funded by Tokyo Medical and Dental University, Department of Cardiovascular medicine, Money of authorized accounting, number 1703. Receiver of the funding is MI. Funder's website: http://www.tmd.ac.jp/med/med3/cvm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Desai MY, 2005, AM J ROENTGENOL, V184, P1427, DOI 10.2214/ajr.184.5.01841427; Hata A, 1996, INT J CARDIOL, V54, pS155, DOI 10.1016/S0167-5273(96)02813-6; Ibrahim T, 2009, JACC-CARDIOVASC IMAG, V2, P580, DOI 10.1016/j.jcmg.2008.12.029; Isobe M, 2013, INT J CARDIOL, V168, P3, DOI 10.1016/j.ijcard.2013.01.022; Jiang LD, 2012, INT J CARDIOL, V155, P262, DOI 10.1016/j.ijcard.2010.10.002; Keo HH, 2013, J CLIN ULTRASOUND, V41, P59, DOI 10.1002/jcu.20894; KERR GS, 1994, ANN INTERN MED, V120, P919, DOI 10.7326/0003-4819-120-11-199406010-00004; Kosuge H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014523; MAEDA H, 1991, ULTRASOUND MED BIOL, V17, P695, DOI 10.1016/0301-5629(91)90101-2; Makowski MR, 2013, RADIOLOGY, V269, P33, DOI 10.1148/radiol.13102336; Makowski MR, 2012, INVEST RADIOL, V47, P438, DOI 10.1097/RLI.0b013e3182588263; Meini S, 2006, CIRCULATION, V114, pE544, DOI 10.1161/CIRCULATIONAHA.106.628206; Misra R, 2013, RHEUMATOLOGY, V52, P1795, DOI 10.1093/rheumatology/ket128; Moriwaki R, 1997, ANGIOLOGY, V48, P369, DOI 10.1177/000331979704800501; Nicoletti G, 2009, J RHEUMATOL, V36, P2042, DOI 10.3899/jrheum.081305; Ohigashi H, 2012, CIRC J, V76, P1004, DOI 10.1253/circj.CJ-11-1108; Ozaki S, 2011, CIRC J, V75, P474, DOI 10.1253/circj.CJ-88-0007; Papa M, 2012, AM J ROENTGENOL, V198, pW279, DOI 10.2214/AJR.11.7360; PARK JH, 1995, RADIOLOGY, V196, P89, DOI 10.1148/radiology.196.1.7784596; Park JH, 1996, INT J CARDIOL, V54, pS165, DOI 10.1016/S0167-5273(96)88785-7; Park SH, 2001, J ULTRAS MED, V20, P371; Schneeweis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050655; Spuentrup E, 2009, CIRCULATION, V119, P1768, DOI 10.1161/CIRCULATIONAHA.108.826388; Terashima M, 2011, BIOMATERIALS, V32, P1430, DOI 10.1016/j.biomaterials.2010.09.029; Tezuka D, 2012, JACC-CARDIOVASC IMAG, V5, P422, DOI 10.1016/j.jcmg.2012.01.013; Varma N, 2014, JACC-CARDIOVASC IMAG, V7, P762, DOI 10.1016/j.jcmg.2014.03.012	27	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145855	10.1371/journal.pone.0145855	http://dx.doi.org/10.1371/journal.pone.0145855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720837	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510900023
J	Liang, ZH; Duan, XJ; Su, C; Voss, L; Sleigh, J; Li, XL				Liang, Zhenhu; Duan, Xuejing; Su, Cui; Voss, Logan; Sleigh, Jamie; Li, Xiaoli			A Pharmacokinetics-Neural Mass Model (PK-NMM) for the Simulation of EEG Activity during Propofol Anesthesia	PLOS ONE			English	Article							GENERAL-ANESTHESIA; FUNCTIONAL ACTIVATION; PERMUTATION ENTROPY; BRAIN; ELECTROENCEPHALOGRAM; SLEEP; CONSCIOUSNESS; MECHANISMS; RECOVERY; SPECTRUM	Modeling the effects of anesthetic drugs on brain activity is very helpful in understanding anesthesia mechanisms. The aim of this study was to set up a combined model to relate actual drug levels to EEG dynamics and behavioral states during propofol-induced anesthesia. We proposed a new combined theoretical model based on a pharmacokinetics (PK) model and a neural mass model (NMM), which we termed PK-NMM-with the aim of simulating electroencephalogram (EEG) activity during propofol-induced general anesthesia. The PK model was used to derive propofol effect-site drug concentrations (C-eff) based on the actual drug infusion regimen. The NMM model took C-eff as the control parameter to produce simulated EEG-like (sEEG) data. For comparison, we used real prefrontal EEG (rEEG) data of nine volunteers undergoing propofol anesthesia from a previous experiment. To see how well the sEEG could describe the dynamic changes of neural activity during anesthesia, the rEEG data and the sEEG data were compared with respect to: power-frequency plots; nonlinear exponent (permutation entropy (PE)); and bispectral SynchFast-Slow (SFS) parameters. We found that the PK-NMM model was able to reproduce anesthesia EEG-like signals based on the estimated drug concentration and patients' condition. The frequency spectrum indicated that the frequency power peak of the sEEG moved towards the low frequency band as anesthesia deepened. Different anesthetic states could be differentiated by the PE index. The correlation coefficient of PE was 0.80 +/- 0.13 (mean +/- standard deviation) between rEEG and sEEG for all subjects. Additionally, SFS could track the depth of anesthesia and the SFS of rEEG and sEEG were highly correlated with a correlation coefficient of 0.77 +/- 0.13. The PK-NMM model could simulate EEG activity and might be a useful tool for understanding the action of propofol on brain activity.	[Liang, Zhenhu; Duan, Xuejing; Su, Cui] Yanshan Univ, Inst Elect Engn, Qinhuangdao, Peoples R China; [Voss, Logan; Sleigh, Jamie] Waikato Hosp, Dept Anesthesia, Hamilton, New Zealand; [Li, Xiaoli] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Xiaoli] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Li, Xiaoli] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China	Yanshan University; Waikato Hospital; Beijing Normal University; Beijing Normal University; Beijing Normal University	Li, XL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	xiaoli@bnu.edu.cn	Li, Xiaoli/B-6565-2016; Li, Xiaoli/GYQ-7384-2022	Li, Xiaoli/0000-0003-1359-5130; 	National Natural Science Foundation of China [61304247, 81230023]; China Postdoctoral Science Foundation [2014M551051]; Natural Science Foundation of Hebei Province of China [F2014203127]; Applied Basic Research Project in Hebei Province [12966120D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Applied Basic Research Project in Hebei Province	This research was supported by National Natural Science Foundation of China (61304247, 81230023), China Postdoctoral Science Foundation (2014M551051), Natural Science Foundation of Hebei Province of China (F2014203127) and Applied Basic Research Project in Hebei Province (12966120D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Austin VC, 2005, NEUROIMAGE, V24, P92, DOI 10.1016/j.neuroimage.2004.08.011; Bai DL, 1999, J NEUROSCI, V19, P10635, DOI 10.1523/JNEUROSCI.19-24-10635.1999; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Bojak I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041902; Bojak I, 2004, NEUROCOMPUTING, V58, P1197, DOI 10.1016/j.neucom.2004.01.185; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Bruhn J, 2001, ANESTHESIOLOGY, V95, P30, DOI 10.1097/00000542-200107000-00010; Cao YH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046217; Ching SN, 2014, CURR OPIN NEUROBIOL, V25, P116, DOI 10.1016/j.conb.2013.12.011; Ching SN, 2012, P NATL ACAD SCI USA, V109, P3095, DOI 10.1073/pnas.1121461109; Ching SN, 2010, P NATL ACAD SCI USA, V107, P22665, DOI 10.1073/pnas.1017069108; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; Dadok VM, 2014, J COMPUT NEUROSCI, V37, P105, DOI 10.1007/s10827-013-0489-x; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Feshchenko VA, 2004, NEUROPSYCHOBIOLOGY, V50, P257, DOI 10.1159/000079981; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Franks NP, 1997, NATURE, V389, P334, DOI 10.1038/38614; Freeman WJ, 1975, LANCET, P661; GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003; Grech R, 2008, J NEUROENG REHABIL, V5, P1419; Gugino LA, 2001, BRIT J ANAESTH, V87, P421, DOI 10.1093/bja/87.3.421; Hallez H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-46; Hashemi M, 2015, J COMPUT NEUROSCI, V39, P155, DOI 10.1007/s10827-015-0569-1; Hindriks R, 2012, NEUROIMAGE, V60, P2323, DOI 10.1016/j.neuroimage.2012.02.042; Hutt A, 2010, COGN NEURODYNAMICS, V4, P37, DOI 10.1007/s11571-009-9092-2; Ionescu CM, 2008, IEEE T BIO-MED ENG, V55, P2161, DOI 10.1109/TBME.2008.923142; Jameson Leslie C, 2006, J Clin Monit Comput, V20, P445, DOI 10.1007/s10877-006-9044-x; Jamsek J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.016201; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; Jospin M, 2007, IEEE T BIO-MED ENG, V54, P840, DOI 10.1109/TBME.2007.893453; Kramer MA, 2005, J R SOC INTERFACE, V2, P113, DOI 10.1098/rsif.2004.0028; Levitt David G, 2005, BMC Anesthesiol, V5, P4, DOI 10.1186/1471-2253-5-4; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; Li D, 2013, ANESTHESIOLOGY, V119, P81, DOI 10.1097/ALN.0b013e31828e894f; Li XL, 2010, NEUROIMAGE, V52, P497, DOI 10.1016/j.neuroimage.2010.05.003; Li XL, 2008, CLIN NEUROPHYSIOL, V119, P2465, DOI 10.1016/j.clinph.2008.08.006; Liang ZH, 2012, CLIN NEUROPHYSIOL, V123, P681, DOI 10.1016/j.clinph.2011.08.027; Liley DT, 2013, FRONTIERS COMPUTATIO, P7; Liley DTJ, 1999, NEUROCOMPUTING, V26-7, P795, DOI 10.1016/S0925-2312(98)00149-0; Liley DTJ, 2002, NETWORK-COMP NEURAL, V13, P67, DOI 10.1088/0954-898X/13/1/303; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McCarthy Michelle M, 2008, J Neurosci, V28, P13488, DOI 10.1523/JNEUROSCI.3536-08.2008; Minto CF, 2008, CLIN PHARMACOL THER, V84, P27, DOI 10.1038/clpt.2008.100; Mukamel EA, 2011, ENG MED BIOL SOC EMB; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Nakao Y, 2001, P NATL ACAD SCI USA, V98, P7593, DOI 10.1073/pnas.121179898; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Ohtahara S, 2003, J CLIN NEUROPHYSIOL, V20, P398, DOI 10.1097/00004691-200311000-00003; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Oppenheim A.V.B., 2001, DISCRETE TIME SIGNAL, VVolume 2; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; RAMSEY JC, 1984, TOXICOL APPL PHARM, V73, P159, DOI 10.1016/0041-008X(84)90064-4; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Schnider TW, 1999, ANESTHESIOLOGY, V90, P1502, DOI 10.1097/00000542-199906000-00003; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Stecker MM, 2007, J CLIN NEUROPHYSIOL, V24, P310; Stecker MM, 2001, ANN THORAC SURG, V71, P22, DOI 10.1016/S0003-4975(00)02021-X; Steyn-Ross DA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011918; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001; Steyn-Ross ML, 1999, PHYS REV E, V60, P7299, DOI 10.1103/PhysRevE.60.7299; Tsurugizawa T, 2010, NEUROSCIENCE, V165, P244, DOI 10.1016/j.neuroscience.2009.10.006; Vijayan S, 2013, J NEUROSCI, V33, P11070, DOI 10.1523/JNEUROSCI.5670-12.2013; Williams ML, 1999, ANAESTH INTENS CARE, V27, P265, DOI 10.1177/0310057X9902700307; Wilson MT, 2006, GEN ANESTHETIC INDUC; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006	68	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145959	10.1371/journal.pone.0145959	http://dx.doi.org/10.1371/journal.pone.0145959			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720495	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900029
J	Perovic, O; Iyaloo, S; Kularatne, R; Lowman, W; Bosman, N; Wadula, J; Seetharam, S; Duse, A; Mbelle, N; Bamford, C; Dawood, H; Mahabeer, Y; Bhola, P; Abrahams, S; Singh-Moodley, A				Perovic, Olga; Iyaloo, Samantha; Kularatne, Ranmini; Lowman, Warren; Bosman, Noma; Wadula, Jeannette; Seetharam, Sharona; Duse, Adriano; Mbelle, Nontombi; Bamford, Colleen; Dawood, Halima; Mahabeer, Yesholata; Bhola, Prathna; Abrahams, Shareef; Singh-Moodley, Ashika			Prevalence and Trends of Staphylococcus aureus Bacteraemia in Hospitalized Patients in South Africa, 2010 to 2012: Laboratory-Based Surveillance Mapping of Antimicrobial Resistance and Molecular Epidemiology	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; SUSCEPTIBILITY; INFECTION; EMERGENCE; CLONES; PCR	Introduction We aimed to obtain an in-depth understanding on recent antimicrobial resistance trends and molecular epidemiology trends of S. aureus bacteraemia (SAB). Methods Thirteen academic centres in South Africa were included from June 2010 until July 2012. S. aureus susceptibility testing was performed on the MicroScan Walkaway. Real-time PCR using the LightCycler 480 II was done for mecA and nuc. SCCmec and spa-typing were finalized with conventional PCR. We selected one isolate per common spa type per province for multilocus sequence typing (MLST). Results S. aureus from 2709 patients were included, and 1231 (46%) were resistant to methicillin, with a significant decline over the three-year period (p-value = 0.003). Geographical distribution of MRSA was significantly higher in Gauteng compared to the other provinces (P<0.001). Children <5 years were significantly associated with MRSA with higher rates compared to all other age groups (P = 0.01). The most prevalent SCCmec type was SCCmec type III (531 [41%]) followed by type IV (402 [31%]). Spa-typing discovered 47 different spa-types. The five (87%) most common spa-types were t037, t1257, t045, t064 and t012. Based on MLST, the commonest was ST612 clonal complex (CC8) (n = 7) followed by ST5 (CC5) (n = 4), ST36 (CC30) (n = 4) and ST239 (CC8) (n = 3). Conclusions MRSA rate is high in South Africa. Majority of the isolates were classified as SCCmec type III (41%) and type IV (31%), which are typically associated with hospital and community-acquired infections, respectively. Overall, this study reveals the presence of a variety of hospital-acquired MRSA clones in South Africa dominance of few clones, spa 037 and 1257. Monitoring trends in resistance and molecular typing is recommended to detect changing epidemiological trends in AMR patterns of SAB.	[Perovic, Olga; Iyaloo, Samantha; Singh-Moodley, Ashika] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Perovic, Olga; Kularatne, Ranmini; Lowman, Warren; Bosman, Noma; Wadula, Jeannette; Seetharam, Sharona; Duse, Adriano] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa; [Kularatne, Ranmini] Helen Joseph Hosp, Natl Hlth Lab Serv, Johannesburg, South Africa; [Lowman, Warren; Bosman, Noma; Duse, Adriano] Charlotte Maxeke Johannesburg Acad Hosp, Natl Hlth Lab Serv, Johannesburg, South Africa; [Wadula, Jeannette; Seetharam, Sharona] Chris Hani Baragwanath Acad Hosp, Natl Hlth Lab Serv, Johannesburg, South Africa; [Mbelle, Nontombi] Univ Pretoria, Dept Med Microbiol, ZA-0002 Pretoria, South Africa; [Bamford, Colleen] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Bamford, Colleen] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Dawood, Halima] Greys Hosp & Caprisa, Dept Med, Pietermaritzburg, South Africa; [Dawood, Halima] Univ KwaZulu Natal, Durban, South Africa; [Mahabeer, Yesholata; Bhola, Prathna] Inkosi Albert Luthuli Cent Hosp, Natl Hlth Lab Serv, Durban, South Africa; [Mahabeer, Yesholata; Bhola, Prathna] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Abrahams, Shareef] Univ Stellenbosch, Natl Hlth Lab Serv Stellenbosch, ZA-7600 Stellenbosch, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Health Laboratory Service; National Health Laboratory Service; University of Witwatersrand; National Health Laboratory Service; University of Pretoria; University of Cape Town; University of Cape Town; University of Kwazulu Natal; University of Kwazulu Natal; Stellenbosch University	Perovic, O (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.	olgap@nicd.ac.za	Dawood, Halima/AAF-6045-2020; Lowman, Warren/AAX-9477-2020; Dawood, Halima/AAO-6963-2020; Perovic, Olga/AAN-8276-2021	Lowman, Warren/0000-0002-6981-389X; Dawood, Halima/0000-0001-8180-6791; Iyaloo, Samantha/0000-0003-3332-9235; Mbelle, Nontombi/0000-0001-8890-2663				Boundy S, 2012, J CLIN MICROBIOL, V50, P469, DOI 10.1128/JCM.01063-11; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DAVIS M, 1994, JAMA-J AM MED ASSOC, V271, P341; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Essa ZI, 2009, S AFR J EPIDEMIOL IN, V4; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068024; File T. M., 2008, Southern African Journal of Epidemiology & Infection, V23, P13; Fortuin-de Smidt MC, 2015, INT J INFECT DIS, V30, P41, DOI 10.1016/j.ijid.2014.10.011; Harrison EM, 2014, J ANTIMICROB CHEMOTH, V69, P911, DOI 10.1093/jac/dkt452; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Marais E, 2009, SAMJ S AFR MED J, V99, P170; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Moodley A, 2010, J CLIN MICROBIOL, V48, P4608, DOI 10.1128/JCM.01704-10; Omuse G, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0669-y; Orth H., 2013, Southern African Journal of Epidemiology & Infection, V28, P22; Patel JB., 2015, M100S25 CLIN LAB STA; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; STYERS D, 2005, ANN CLIN MICROB ANTI, V5, P2; TECoAS Testing, 2015, TESTING TECOAS BREAK; Thomas LC, 2007, J MICROBIOL METH, V68, P296, DOI 10.1016/j.mimet.2006.09.003; van Rensburg MJJ, 2011, CLIN MICROBIOL INFEC, V17, P785, DOI 10.1111/j.1469-0691.2010.03373.x; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; Zhanel GG, 2013, J ANTIMICROB CHEMOTH, V68, pi7, DOI 10.1093/jac/dkt022	28	34	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145429	10.1371/journal.pone.0145429	http://dx.doi.org/10.1371/journal.pone.0145429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719975	gold, Green Published			2022-12-27	WOS:000367510900009
J	Elvira, B; Leal, S; Doadrio, I; Almodovar, A				Elvira, Benigno; Leal, Sheila; Doadrio, Ignacio; Almodovar, Ana			Current Occurrence of the Atlantic Sturgeon Acipenser oxyrinchus in Northern Spain: A New Prospect for Sturgeon Conservation in Western Europe	PLOS ONE			English	Article							THREATENED FISHES; SEA STURGEON; STURIO L; IDENTIFICATION; WORLD; HETEROPLASMY; DELINEATION; EXISTENCE; SPECIMENS; TAXONOMY	Acipenser oxyrinchus is considered extirpated in Europe, but numerous breeding populations still exist on the Atlantic coast of North America. An adult female A. oxyrinchus, 2500 mm total length and 120 kg wet weight, was accidentally fished on 24 November 2010 near the coast of Gijon, Asturias, Spain. The fish was identified by its morphological pattern as well as by mitochondrial and nuclear DNA analyses. Because the sturgeon was found far away from any known breeding area, it was considered a stray or vagrant specimen. It certainly has a natural origin, but its eventual birthplace could not be determined. Because its current occurrence was unknown in southwestern Europe until now, the species is not cataloged or protected in this area. Therefore, the residual European stocks of A. oxyrinchus ought to be listed as Critically Endangered (CR) according to the IUCN categories. Likewise, it is imperative for southwestern European countries with an historic or recent occurrence of A. oxyrinchus to protect the species through domestic and international legislation. The present sympatric occurrence of A. sturio and A. oxyrinchus raises new challenges about key questions, such as the species selection for restoration program in European countries. Accurate monitoring is mandatory to obtain appropriate information for an assessment of the current occurrence of A. oxyrinchus in southwestern Europe.	[Elvira, Benigno; Leal, Sheila; Almodovar, Ana] Univ Complutense Madrid, Fac Biol, Dept Zool, Madrid, Spain; [Doadrio, Ignacio] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Elvira, B (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Zool, Madrid, Spain.	belvira@bio.ucm.es	Almodóvar, Ana/L-5400-2014; Elvira, Benigno/A-9273-2009; Doadrio, Ignacio/F-8448-2016	Almodóvar, Ana/0000-0003-1465-3857; Elvira, Benigno/0000-0002-6127-5302; Doadrio, Ignacio/0000-0003-4863-9711				Almaca C., 2000, Boletin Instituto Espanol de Oceanografia, V16, P11; Almodovar A., 2000, Boletin Instituto Espanol de Oceanografia, V16, P17; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2006, BALTIC SEA ENV P, V109, P1; Balazik MT, 2010, BIOL LETTERS, V6, P708, DOI 10.1098/rsbl.2010.0144; Billard R, 2001, REV FISH BIOL FISHER, V10, P355; Birstein V. J., 2000, Boletin Instituto Espanol de Oceanografia, V16, P61; Birstein VJ, 1998, BIOL CONSERV, V84, P97, DOI 10.1016/S0006-3207(97)00091-8; Bronzi P, 2005, ENVIRON BIOL FISH, V72, P66, DOI 10.1007/s10641-004-1036-4; Bronzi P, ACIPENSER NACCARII; Chassaing O, 2011, J FISH BIOL, V78, P208, DOI 10.1111/j.1095-8649.2010.02852.x; Chassaing O, 2013, J BIOGEOGR, V40, P382, DOI 10.1111/j.1365-2699.2012.02785.x; Chassaing Olivier, 2011, P117; Dadswell MJ, 2006, FISHERIES, V31, P218, DOI 10.1577/1548-8446(2006)31[218:AROTSO]2.0.CO;2; de la Herran R, 2004, CONSERV GENET, V5, P545, DOI 10.1023/B:COGE.0000041023.59291.39; Debus L, 1999, J APPL ICHTHYOL, V15, P38, DOI 10.1111/j.1439-0426.1999.tb00203.x; Desse-Berset N, 2011, J APPL ICHTHYOL, V27, P263, DOI 10.1111/j.1439-0426.2010.01649.x; Desse-Berset N, 2011, BIOL CONSERVATION EU, P23, DOI [10.1007/978-3-642-20611-53, DOI 10.1007/978-3-642-20611-5_3]; Desse-Berset N, 2009, CR PALEVOL, V8, P717, DOI 10.1016/j.crpv.2009.06.001; Doukakis P, 2000, MAR BIOL, V136, P373, DOI 10.1007/s002270050695; Elvira B., 2000, Boletin Instituto Espanol de Oceanografia, V16, P89; ELVIRA B, 1991, ARCH HYDROBIOL, V121, P253; ELVIRA B, 1993, ARCH HYDROBIOL, V129, P253, DOI 10.1127/archiv-hydrobiol/129/1993/253; Elvira B., 1991, P337; Elvira B., 1999, Journal of Applied Ichthyology, V15, P278; Elvira B., 2000, Boletin Instituto Espanol de Oceanografia, V16, P1; Elvira B, 2000, FOLIA ZOOL, V49, P221; Elvira B, 2006, ENVIRON BIOL FISH, V76, P15, DOI DOI 10.1007/910641-006-9001-Z; Erickson DL, 2011, J APPL ICHTHYOL, V27, P356, DOI 10.1111/j.1439-0426.2011.01690.x; Findeis EK, 1997, ENVIRON BIOL FISH, V48, P73, DOI 10.1023/A:1007372832213; Fopp-Bayat D., 2015, Journal of Survey in Fisheries Sciences, V2, P1; Garrido-Ramos MA, 2009, FISH FISH SER, V29, P25; GarridoRamos MA, 1997, MAR BIOL, V129, P33, DOI 10.1007/s002270050143; Gesner J, ACIPENSER STURIO; Gessner J, 2011, J APPL ICHTHYOL, V27, P192, DOI 10.1111/j.1439-0426.2011.01697.x; Gessner Joern, 2011, P539; Grunwald C, 2008, CONSERV GENET, V9, P1111, DOI 10.1007/s10592-007-9420-1; Henderson-Arzapalo A, 2002, MOL ECOL NOTES, V2, P437, DOI 10.1046/j.1471-8286.2002.00262.x; Hoick J, 1989, FRESHWATER FISHES 2, V1, P167; Holcik J., 1989, FRESHWATER FISHES 2, P18; Houben B, 2012, ATLANTISCHE STEUR KR; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; Kolman R, 2011, J APPL ICHTHYOL, V27, P186, DOI 10.1111/j.1439-0426.2011.01680.x; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Kottelat M, 2009, ICHTHYOL EXPLOR FRES, V20, P75; Lassalle G, 2010, BIOL CONSERV, V143, P2441, DOI 10.1016/j.biocon.2010.06.008; LEPAGE M, 1995, ENVIRON BIOL FISH, V43, P28, DOI 10.1007/BF00001813; Loza A, 2010, BOL CIEN NAT RIDEA, V51, P385; Ludwig A, 2000, GENETICS, V156, P1933; Ludwig A, 2000, ANIM GENET, V31, P153, DOI 10.1046/j.1365-2052.2000.00606.x; Ludwig A, 2002, NATURE, V419, P447, DOI 10.1038/419447a; Ludwig A, 2009, J APPL ICHTHYOL, V25, P5, DOI 10.1111/j.1439-0426.2009.01184.x; Ludwig A, 2007, AM FISH S S, V56, P285; Ludwig Arne, 2011, P131; Ludwig A, 2009, ARCHAEOFAUNA, V18, P185; Ludwig A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-221; May B, 1997, CAN J FISH AQUAT SCI, V54, P1542, DOI 10.1139/cjfas-54-7-1542; Nelson TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071552; Oliver MJ, 2013, FISHERIES, V38, P210, DOI 10.1080/03632415.2013.782861; Otto Z, 2006, NATUR CYMRU, V18, P47; Paaver T, 1999, J APPL ICHTHYOL, V15, P129, DOI 10.1111/j.1439-0426.1999.tb00221.x; Pages M, 2009, CONSERV GENET, V10, P217, DOI 10.1007/s10592-008-9549-6; Parauka FM, ACIPENSER OXYRINCHUS; Popovic D, 2014, J BIOGEOGR, V41, P1590, DOI 10.1111/jbi.12307; Prie Vincent, 2010, MalaCo, V6, P270; Rincon P. A., 2000, Boletin Instituto Espanol de Oceanografia, V16, P217; Rincon PA, 2000, MAR BIOL, V136, P715, DOI 10.1007/s002270050731; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thieren E, 2012, BOUQUET ARCHAEOZOOLO, P197; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiedemann R, 2007, NATURWISSENSCHAFTEN, V94, P213, DOI 10.1007/s00114-006-0175-1; Vecsei P, 2000, ENVIRON BIOL FISH, V59, P98, DOI 10.1023/A:1007640622624; Waldman John, 2011, P517; Williot Patrick, 2011, P499; Wirgin I, 2007, N AM J FISH MANAGE, V27, P1214, DOI 10.1577/M06-269.1; Wuertz Sven, 2011, P53	76	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145728	10.1371/journal.pone.0145728	http://dx.doi.org/10.1371/journal.pone.0145728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717564	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500062
J	Feierabend, D; Kielland, K				Feierabend, Dashiell; Kielland, Knut			Seasonal Effects of Habitat on Sources and Rates of Snowshoe Hare Predation in Alaskan Boreal Forests	PLOS ONE			English	Article							CYCLIC POPULATION; LEPUS-AMERICANUS; SURVIVAL; LYNX; COYOTES; DYNAMICS; DEMOGRAPHY; MORTALITY; RESPONSES; SELECTION	Survival and predation of snowshoe hares (Lepus americanus) has been widely studied, yet there has been little quantification of the changes in vulnerability of hares to specific predators that may result from seasonal changes in vegetation and cover. We investigated survival and causes of mortalities of snowshoe hares during the late increase, peak, and decline of a population in interior Alaska. From June 2008 to May 2012, we radio-tagged 288 adult and older juvenile hares in early successional and black spruce (Picea mariana) forests and, using known-fate methods in program MARK, evaluated 85 survival models that included variables for sex, age, and body condition of hares, as well as trapping site, month, season, year, snowfall, snow depth, and air temperature. We compared the models using Akaike's information criterion with correction for small sample size. Model results indicated that month, capture site, and body condition were the most important variables in explaining survival rates. Survival was highest in July, and more generally during summer, when alternative prey was available to predators of hares. Low survival rates coincided with molting periods, breeding activity in the spring, and the introduction of juveniles to the sample population in the fall. We identified predation as the cause of mortality in 86% of hare deaths. When the source of predation could be determined, hares were killed more often by goshawks (Accipiter gentilis) than other predators in early successional forest (30%), and more often by lynx (Lynx canadensis) than other predators in black spruce forest (31%). Great horned owls (Bubo virginianus) and coyotes (Canis latrans) represented smaller proportions of hare predation, and non-predatory causes were a minor source (3%) of mortality. Because hares rely on vegetative cover for concealment from predators, we measured cover in predation sites and habitats that the hares occupied and concluded that habitat type had a greater influence on the sources of predation than the amount of cover in any given location within a habitat. Our observations illustrate the vulnerability of hares to predators in even the densest coniferous habitat available in the boreal forest, and indicate strong seasonal changes in the rates and sources of predation.	[Feierabend, Dashiell; Kielland, Knut] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Kielland, Knut] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Feierabend, D (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA.	dsfeierabend@gmail.com			Bonanza Creek Long Term Ecological Research grant [DEB-10226415]; Institute of Arctic Biology; University of Alaska Fairbanks	Bonanza Creek Long Term Ecological Research grant; Institute of Arctic Biology; University of Alaska Fairbanks	KK received funding for this research through the Bonanza Creek Long Term Ecological Research grant #DEB-10226415. DSF received research stipends and awards from the Institute of Arctic Biology and University of Alaska Fairbanks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele SL, 2013, J WILDLIFE MANAGE, V77, P84, DOI 10.1002/jwmg.426; Alaska Department of Fish and Game, 2012, ANN REPORT; Bonanza Creek Long-Term Ecological Research, 2013, WINT SNOWSH HAR PELL; BOUTIN S, 1985, CAN J ZOOL, V63, P106, DOI 10.1139/z85-019; BOUTIN S, 1995, OIKOS, V74, P69, DOI 10.2307/3545676; BOUTIN S, 1986, CAN J ZOOL, V64, P606, DOI 10.1139/z86-090; BRAND CJ, 1975, J WILDLIFE MANAGE, V39, P741, DOI 10.2307/3800236; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carreker RG, 1985, HABITAT SUITABILITY, P21; Chapin F.S., 2006, ALASKAS CHANGING BOR, P100, DOI DOI 10.1093/OSO/9780195154313.001.0001; Crawford JA, 2010, J MAMMAL, V91, P838, DOI 10.1644/09-MAMM-A-068.1; Doyle FI, 2000, TIMING REPROD RED TA; Feierabend D, 2014, J MAMMAL, V95, P525, DOI 10.1644/13-MAMM-A-199; FERRON J, 1992, CAN J ZOOL, V70, P2178, DOI 10.1139/z92-294; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gillis EA, 1998, CAN J ZOOL, V76, P1949, DOI 10.1139/cjz-76-10-1949; Griffin PC, 2009, OIKOS, V118, P1487, DOI 10.1111/j.1600-0706.2009.17621.x; Griffin PC, 2005, BEHAV ECOL, V16, P938, DOI 10.1093/beheco/ari074; HEARN BJ, 1987, CAN J ZOOL, V65, P852, DOI 10.1139/z87-136; Hodges Karen E., 2000, P163; Hodges Karen E., 2000, P117; Hodges KE, 2006, J ANIM ECOL, V75, P1, DOI 10.1111/j.1365-2656.2005.01018.x; Hodges KE, 1999, ECOSCIENCE, V6, P487, DOI 10.1080/11956860.1999.11682558; Hodges KE, 2001, ECOSYSTEM DYNAMICS OF THE BOREAL FOREST, P141; Hodges KE, 2001, CAN J ZOOL, V79, P1878, DOI 10.1139/cjz-79-10-1878; Hodson J, 2010, J MAMMAL, V91, P607, DOI 10.1644/09-MAMM-A-289.1; Keith L.B., 1990, Current Mammalogy, V2, P119; Keith L.B., 1977, INT C GAME BIOLOGIST, V13, P151; KEITH LB, 1993, CAN J ZOOL, V71, P1385, DOI 10.1139/z93-191; KEITH LB, 1984, WILDLIFE MONOGR, P1; Kielland K, 2010, CAN J FOREST RES, V40, P1265, DOI 10.1139/X10-053; Krebs C.J., 2001, ECOSYSTEM DYNAMICS B; KREBS CJ, 1986, J ANIM ECOL, V55, P963, DOI 10.2307/4427; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; LITVAITIS JA, 1991, CAN FIELD NAT, V105, P275; LITVAITIS JA, 1985, J WILDLIFE MANAGE, V49, P866, DOI 10.2307/3801359; Mills LS, 2013, P NATL ACAD SCI USA, V110, P7360, DOI 10.1073/pnas.1222724110; Mowat G, 2000, ECOLOGY CONSERVATION; MURRAY DL, 1995, ANIM BEHAV, V50, P1203, DOI 10.1016/0003-3472(95)80037-9; MURRAY DL, 1994, CAN J ZOOL, V72, P1444, DOI 10.1139/z94-191; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; O'Donoghue M, 2001, ECOSYSTEM DYNAMICS OF THE BOREAL FOREST, P275; O'Donoghue M, 1998, OIKOS, V82, P169, DOI 10.2307/3546927; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; O'Farrell T. P., 1965, Journal of Mammalogy, V46, P406, DOI 10.2307/1377626; ODonoghue M, 1997, OIKOS, V80, P150, DOI 10.2307/3546526; ODONOGHUE M, 1994, ECOLOGY, V75, P1582, DOI 10.2307/1939619; PARKER GR, 1983, CAN J ZOOL, V61, P770, DOI 10.1139/z83-102; PIETZ PJ, 1983, J WILDLIFE MANAGE, V47, P686, DOI 10.2307/3808604; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Rohner C, 1996, OECOLOGIA, V108, P303, DOI 10.1007/BF00334655; Sheriff MJ, 2009, CAN J ZOOL, V87, P956, DOI 10.1139/Z09-087; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Sheriff MJ, 2009, J MAMMAL, V90, P761, DOI 10.1644/08-MAMM-A-247R.1; SIEVERT PR, 1985, J WILDLIFE MANAGE, V49, P854, DOI 10.2307/3801358; Squires JR, 2010, J WILDLIFE MANAGE, V74, P1648, DOI 10.2193/2009-184; Squires JR, 2000, WILSON BULL, V112, P536, DOI 10.1676/0043-5643(2000)112[0536:FHONGN]2.0.CO;2; Stefan CI, 2001, CAN J ZOOL, V79, P2101, DOI 10.1139/cjz-79-11-2101; TROSTEL K, 1987, OECOLOGIA, V74, P185, DOI 10.1007/BF00379358; White G.C., 1990, ANAL WILDLIFE RADIO; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wirsing AJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P489, DOI 10.1086/342798; Wirsing AJ, 2002, CAN J ZOOL, V80, P169, DOI 10.1139/Z01-214; WOLFF JO, 1980, ECOL MONOGR, V50, P111, DOI 10.2307/2937249; [No title captured]	65	15	16	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0143543	10.1371/journal.pone.0143543	http://dx.doi.org/10.1371/journal.pone.0143543			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717577	gold, Green Published			2022-12-27	WOS:000367510500006
J	Setegn, T; Lakew, Y; Deribe, K				Setegn, Tesfaye; Lakew, Yihunie; Deribe, Kebede			Geographic Variation and Factors Associated with Female Genital Mutilation among Reproductive Age Women in Ethiopia: A National Population Based Survey	PLOS ONE			English	Article							HEALTH; PREVALENCE; CONSEQUENCES	Background Female genital mutilation (FGM) is a common traditional practice in developing nations including Ethiopia. It poses complex and serious long-term health risks for women and girls and can lead to death. In Ethiopia, the geographic distribution and factors associated with FGM practices are poorly understood. Therefore, we assessed the spatial distribution and factors associated with FGM among reproductive age women in the country. Method We used population based national representative surveys. Data from two (2000 and 2005) Ethiopian demographic and health surveys (EDHS) were used in this analysis. Briefly, EDHS used a stratified, two-stage cluster sampling design. A total of 15,367 (from EDHS 2000) and 14,070 (from EDHS 2005) women of reproductive age (15-49 years) were included in the analysis. Three outcome variables were used (prevalence of FGM among women, prevalence of FGM among daughters and support for the continuation of FGM). The data were weighted and descriptive statistics (percentage change), bivariate and multivariable logistic regression analyses were carried out. Multicollinearity of variables was assessed using variance inflation factors (VIF) with a reference value of 10 before interpreting the final output. The geographic variation and clustering of weighted FGM prevalence were analyzed and visualized on maps using ArcGIS. Z-scores were used to assess the statistical difference of geographic clustering of FGM prevalence spots. Result The trend of FGM weighted prevalence has been decreasing. Being wealthy, Muslim and in higher age categories are associated with increased odds of FGM among women. Similarly, daughters from Muslim women have increased odds of experiencing FGM. Women in the higher age categories have increased odds of having daughters who experience FGM. The odds of FGM among daughters decrease with increased maternal education. Mass media exposure, being wealthy and higher paternal and maternal education are associated with decreased odds of women's support of FGM continuation. FGM prevalence and geographic clustering showed variation across regions in Ethiopia. Conclusion Individual, economic, socio-demographic, religious and cultural factors played major roles in the existing practice and continuation of FGM. The significant geographic clustering of FGM was observed across regions in Ethiopia. Therefore, targeted and integrated interventions involving religious leaders in high FGM prevalence spot clusters and addressing the socio-economic and geographic inequalities are recommended to eliminate FGM.	[Setegn, Tesfaye] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth, Bahir Dar, Ethiopia; [Lakew, Yihunie] Ethiopian Publ Hlth Assoc, Addis Ababa, Ethiopia; [Deribe, Kebede] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Deribe, Kebede] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Bahir Dar University; University of Brighton; University of Sussex; Addis Ababa University	Setegn, T (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth, Bahir Dar, Ethiopia.	tesfayesetegn@yahoo.com	Deribe, Kebede/K-7055-2019; Mengistu, Tesfaye S./AAI-4027-2021; Mengistu, Tesfaye Setegn/AFQ-0237-2022; Deribe, Kebede/I-5422-2019	Mengistu, Tesfaye S./0000-0001-8276-5143; Deribe, Kebede/0000-0002-8526-6996	Wellcome Trust [099876]	Wellcome Trust(Wellcome TrustEuropean Commission)	KD is supported by a Wellcome Trust PHATIC fellowship (099876). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achia TNO, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-276; Andro A, 2014, SOC SCI MED, V106, P177, DOI 10.1016/j.socscimed.2014.02.003; [Anonymous], 2010, LANCET, V376, P1800, DOI 10.1016/S0140-6736(10)62149-6; [Anonymous], 2006, ETH DEM HLTH SURV 20; [Anonymous], FEM GEN MUT CUTT DAT; [Anonymous], 2014, FEMALE GENITAL MUTIL; [Anonymous], 2001, ETH DEM HLTH SURV 20; Authority CS, 2007, POP HOUS CENS ETH; Meseguer CB, 2014, GAC SANIT, V28, P287, DOI 10.1016/j.gaceta.2014.02.006; Berg R. C., 2010, FACTORS PROMOTING HI; Bjalkander O, 2012, INT J WOMENS HEALTH, V4, P321, DOI 10.2147/IJWH.S32670; Bogale D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1076; Central Statistical Agency (CSA) Ethiopia, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV 20; CentralStatisticalAuthority[Ethiopia]andORCMacro, 2001, ETH DEM HLTH SURV 20; Fikrie Z, 2010, ETHIOP J HEALTH SCI, V20, P49; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hussein MA, 2013, EUR J THER, V19, P164, DOI 10.5455/GMJ-30-2013-157; Kaplan A, 2013, INT J WOMENS HEALTH, V5, P323, DOI 10.2147/IJWH.S42064; Karmaker B, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-20; Masho SW, 2009, INT J GYNECOL OBSTET, V107, P232, DOI 10.1016/j.ijgo.2009.07.022; Mitike G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-264; Modrek S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-921; Plo K, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/837471; Richards S, 2011, CONFLICT IN THE SOMA; Sagna ML, 2014, CULT HEALTH SEX, V16, P603, DOI 10.1080/13691058.2014.896474; Teufel K, 2013, INT UROGYNECOL J, V24, P2021, DOI 10.1007/s00192-013-2160-5; UNFPA, 2013, TECHNICAL REPORT; UNICEF, 2013, POL BRIEF AB FGM C F; Vissandjee B, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-13; World Health Organization, 2008, EL FEM GEN MUT INT S; Yasin BA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-809; Yirga WS, 2012, INT J WOMENS HEALTH, V4, P45, DOI 10.2147/IJWH.S28805	34	33	33	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145329	10.1371/journal.pone.0145329	http://dx.doi.org/10.1371/journal.pone.0145329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741488	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000367810600006
J	Abdi, A; Idris, N; Alguliyev, RM; Aliguliyev, RM				Abdi, Asad; Idris, Norisma; Alguliyev, Rasim M.; Aliguliyev, Ramiz M.			An Automated Summarization Assessment Algorithm for Identifying Summarizing Strategies	PLOS ONE			English	Article							COMPREHENSION	Background Summarization is a process to select important information from a source text. Summarizing strategies are the core cognitive processes in summarization activity. Since summarization can be important as a tool to improve comprehension, it has attracted interest of teachers for teaching summary writing through direct instruction. To do this, they need to review and assess the students' summaries and these tasks are very time-consuming. Thus, a computer-assisted assessment can be used to help teachers to conduct this task more effectively. Design/Results This paper aims to propose an algorithm based on the combination of semantic relations between words and their syntactic composition to identify summarizing strategies employed by students in summary writing. An innovative aspect of our algorithm lies in its ability to identify summarizing strategies at the syntactic and semantic levels. The efficiency of the algorithm is measured in terms of Precision, Recall and F-measure. We then implemented the algorithm for the automated summarization assessment system that can be used to identify the summarizing strategies used by students in summary writing.	[Abdi, Asad; Idris, Norisma] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Artificial Intelligence, Kuala Lumpur 50603, Malaysia; [Alguliyev, Rasim M.; Aliguliyev, Ramiz M.] Azerbaijan Natl Acad Sci, Inst Informat Technol, AZ-1141 Baku, Azerbaijan	Universiti Malaya; Azerbaijan National Academy of Sciences (ANAS); Institute of Information Technology of the Azerbaijan National Academy of Sciences	Abdi, A (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Dept Artificial Intelligence, Kuala Lumpur 50603, Malaysia.	asadabdi55@gmail.com	IDRIS, NORISMA/B-9373-2010; Abdi, Asad/AAG-3374-2019; Abdi, Asad/F-6492-2012; Aliguliyev, Ramiz/A-1072-2013; Abdi, Asad/L-4984-2019; Alguliyev, Rasim/V-7265-2018	Aliguliyev, Ramiz/0000-0001-9795-1694; Abdi, Asad/0000-0001-5667-730X; Alguliyev, Rasim/0000-0003-1223-7411	University Malaya (UM) [PG184-2014B]	University Malaya (UM)	This research is supported by the postgraduate research grant (PPP)-research, grant no: PG184-2014B, University Malaya (UM).	Abdi A, 2015, EXPERT SYSTEMS APPL; Abdi A., 2015, SOFT COMPUT, P1; Abdi A, 2015, INFORM PROCESS MANAG, V51, P340, DOI 10.1016/j.ipm.2015.02.001; Achananuparp P, 2008, LECT NOTES COMPUT SC, V5182, P305, DOI 10.1007/978-3-540-85836-2_29; Alguliev RM, 2011, SWARM EVOL COMPUT, V1, P213, DOI 10.1016/j.swevo.2011.06.006; Aliguliyev RM, 2009, EXPERT SYST APPL, V36, P7764, DOI 10.1016/j.eswa.2008.11.022; Alonso L., 2004, INTELIGENCIA ARTIFIC, V8, P22; Aytar Y, 2008, UTILIZING SEMANTIC W; Bawakid A, 2008, SEMANTIC SUMMARIZATI; BROWN AL, 1983, J VERB LEARN VERB BE, V22, P1, DOI 10.1016/S0022-5371(83)80002-4; Chiu CH, 2013, COMPUT EDUC, V67, P229, DOI 10.1016/j.compedu.2013.04.015; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; de Marneffe M.-C., 2006, INT C LANG RES EV; Fan Y-C, 2010, ASIAN SOCIAL SCI, V6; Fattah MA, 2009, COMPUT SPEECH LANG, V23, P126, DOI 10.1016/j.csl.2008.04.002; Franzke M, 2006, BUILDING STUDENT SUM; Fraser B, 1999, J PRAGMATICS, V31, P931, DOI 10.1016/S0378-2166(98)00101-5; Galgani F, 2014, INT J HUM-COMPUT ST, V72, P584, DOI 10.1016/j.ijhcs.2014.03.002; Gupta Vishal, 2010, J EMERGING TECHNOLOG, V2; Hirschberg J., 1993, Computational Linguistics, V19, P501; Idris N, 2009, COMPUTER INFORM SCI, V2, pP200; Johnson NS, 1983, CHILDRENS LANGUAGE, V4, P315; Kanejiya D, 2003, AUTOMATIC EVALUATION; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Kupiec J, 1995, TRAINABLE DOCUMENT S; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lemaire B, 2005, COMPUTATIONAL COGNIT; Li S, 2006, PEKING U DUC 2006; Li YH, 2006, IEEE T KNOWL DATA EN, V18, P1138, DOI 10.1109/TKDE.2006.130; Lin D, 1998, INFORM THEORETIC DEF; Lin Rouge, 2004, PACKAGE AUTOMATIC EV; Mihalcea R, 2006, CORPUS BASED KNOWLED; Mohler M., 2011, LEARNING GRADE SHORT; Perez D, 2005, AUTOMATIC ASSESSMENT; Perez Gliozzo AM, 2005, AUTOMATIC ASSESSMENT; Ponce HR, 2012, COMPUT EDUC, V59, P1170, DOI 10.1016/j.compedu.2012.05.013; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Teufel S., 1997, SENTENCE EXTRACTION; Tian Y, 2010, MEASURING SIMILARITY; Tseng JCR, 2008, COMPUT EDUC, V51, P776, DOI 10.1016/j.compedu.2007.08.002; Warin M., 2004, USING WORDNET SEMANT, V25, P2008; Westby C, 2010, TOP LANG DISORD, V30, P275, DOI 10.1097/TLD.0b013e3181ff5a88; Wiemer-Hastings P, 2001, RULES SYNTAX VECTORS; Wiemer-Hastings P, 2000, ADDING SYNTACTIC INF; Xie S, 2008, EVALUATING EFFECTIVE; Xie S, 2008, USING CORPUS KNOWLED; Xie SS, 2010, COMPUT SPEECH LANG, V24, P495, DOI 10.1016/j.csl.2009.04.007; Yang GB, 2013, COMPUT EDUC, V68, P233, DOI 10.1016/j.compedu.2013.05.012; Zhang J, 2005, CUE BASED HUB AUTHOR; Zipitria I, 2004, HUMAN AUTOMATIC SUMM	52	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145809	10.1371/journal.pone.0145809	http://dx.doi.org/10.1371/journal.pone.0145809			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735139	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100030
J	McGuinness, D; Leierer, J; Shapter, O; Mohammed, S; Gingell-Littlejohn, M; Kingsmore, DB; Little, AM; Kerschbaum, J; Schneeberger, S; Maglione, M; Nadalin, S; Wagner, S; Konigsrainer, A; Aitken, E; Whalen, H; Clancy, M; McConnachie, A; Koppelstaetter, C; Stevenson, KS; Shiels, PG				McGuinness, Dagmara; Leierer, Johannes; Shapter, Olivier; Mohammed, Suhaib; Gingell-Littlejohn, Marc; Kingsmore, David B.; Little, Ann-Margaret; Kerschbaum, Julia; Schneeberger, Stefan; Maglione, Manuel; Nadalin, Silvio; Wagner, Sylvia; Koenigsrainer, Alfred; Aitken, Emma; Whalen, Henry; Clancy, Marc; McConnachie, Alex; Koppelstaetter, Christian; Stevenson, Karen S.; Shiels, Paul G.			Identification of Molecular Markers of Delayed Graft Function Based on the Regulation of Biological Ageing	PLOS ONE			English	Article							KIDNEY-TRANSPLANT OUTCOMES; CIT-INDUCED DGF; GENE-EXPRESSION; CELLULAR SENESCENCE; MICRORNA FUNCTION; RENAL-ALLOGRAFT; ADHESION; STRESS	Introduction Delayed graft function is a prevalent clinical problem in renal transplantation for which there is no objective system to predict occurrence in advance. It can result in a significant increase in the necessity for hospitalisation post-transplant and is a significant risk factor for other post-transplant complications. Methodology The importance of microRNAs (miRNAs), a specific subclass of small RNA, have been clearly demonstrated to influence many pathways in health and disease. To investigate the influence of miRNAs on renal allograft performance post-transplant, the expression of a panel of miRNAs in pre-transplant renal biopsies was measured using qPCR. Expression was then related to clinical parameters and outcomes in two independent renal transplant cohorts. Results Here we demonstrate, in two independent cohorts of pre-implantation human renal allograft biopsies, that a novel pre-transplant renal performance scoring system (GRPSS), can determine the occurrence of DGF with a high sensitivity (>90%) and specificity (>60%) for donor allografts pre-transplant, using just three senescence associated microRNAs combined with donor age and type of organ donation. Conclusion These results demonstrate a relationship between pre-transplant microRNA expression levels, cellular biological ageing pathways and clinical outcomes for renal transplantation. They provide for a simple, rapid quantitative molecular pre-transplant assay to determine post-transplant allograft function and scope for future intervention. Furthermore, these results demonstrate the involvement of senescence pathways in ischaemic injury during the organ transplantation process and an indication of accelerated bio-ageing as a consequence of both warm and cold ischaemia.	[McGuinness, Dagmara; Shapter, Olivier; Mohammed, Suhaib; Gingell-Littlejohn, Marc; Whalen, Henry; Shiels, Paul G.] Univ Glasgow, Coll Med Vet & Life Sci, Wolfson Wohl Translat Res Ctr, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland; [Kingsmore, David B.; Aitken, Emma; Clancy, Marc; Stevenson, Karen S.] South Glasgow Univ Hosp, NHS Greater Glasgow & Clyde, Renal Transplant Unit, Glasgow G51 4TF, Lanark, Scotland; [Little, Ann-Margaret] Gartnavel Royal Hosp, NHS Greater Glasgow & Clyde, Histocompatibil & Immunogenet, Lab Med Bldg, Glasgow G12 0XL, Lanark, Scotland; [Leierer, Johannes; Kerschbaum, Julia; Schneeberger, Stefan; Maglione, Manuel; Koppelstaetter, Christian] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Ctr Operat Med, A-6020 Innsbruck, Austria; [Nadalin, Silvio] Univ Klinikum Tubingen, Univ Klin Allgemeine Viszeral & Transplantat Chir, D-72076 Tubingen, Germany; [Wagner, Sylvia] Univ Klinikum Tubingen, Klin AllgemeineViszeral & Transplantat Chirurg, Chirurg Studienzentale, D-72076 Tubingen, Germany; [Koenigsrainer, Alfred] Univ Klinikum Tubingen, Univ Klin Allgemeine Viszeral & Transplantat Chir, CRONA, D-72076 Tubingen, Germany; [McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Glasgow; Gartnavel Royal Hospital; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Glasgow	Shiels, PG (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Wolfson Wohl Translat Res Ctr, Inst Canc Sci, Garscube Estate,Switchback Rd, Glasgow G61 1QH, Lanark, Scotland.	paul.shiels@glasgow.ac.uk	Schneeberger, Stefan/S-9329-2019; Aitken, Emma/AAV-8554-2021; Maglione, Manuel/AAK-8599-2020; Aitken, Emma/AAW-4473-2020	Schneeberger, Stefan/0000-0002-2619-8639; Maglione, Manuel/0000-0003-1479-6129; Aitken, Emma/0000-0001-8939-7478; Leierer, Johannes/0000-0002-7884-9827; Clancy, Marc/0000-0002-1709-9743; Shiels, Paul/0000-0002-7577-9843; Stevenson, Karen/0000-0002-2170-511X; McGuinness, Dagmara/0000-0001-9057-3504; Mohammed, Suhaib/0000-0003-1772-8690	Cunningham Trust; Darlinda's Charity for Renal Research; NHS Greater Glasgow and Clyde Endowment grant; European Community [241544]	Cunningham Trust; Darlinda's Charity for Renal Research; NHS Greater Glasgow and Clyde Endowment grant; European Community(European Commission)	This work was supported by Cunningham Trust, Darlinda's Charity for Renal Research and NHS Greater Glasgow and Clyde Endowment grant (PS, DM). For the analysis of the validation cohort funding has been received from the European Community's Seventh Framework Programme under the grant agreement No. 241544.	Aitken E, 2015, EXP CLIN TRANSPLANT, V13, P19, DOI 10.6002/ect.2014.0024; Akkina S, 2011, TRANSL RES, V157, P236, DOI 10.1016/j.trsl.2011.01.011; Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; BRADY HR, 1994, KIDNEY INT, V45, P1285, DOI 10.1038/ki.1994.169; Cassidy Hilary, 2012, J Signal Transduct, V2012, P463617, DOI 10.1155/2012/463617; Drakaki Alexandra, 2013, Biomed J, V36, P200, DOI 10.4103/2319-4170.119690; Gingell-Littlejohn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068133; Goldfarb DA, 2012, J UROLOGY, V188, P231, DOI 10.1016/j.juro.2012.02.2513; Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kayler LK, 2011, AM J TRANSPLANT, V11, P2657, DOI 10.1111/j.1600-6143.2011.03817.x; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Kwon O, 1998, J CLIN INVEST, V101, P2054, DOI 10.1172/JCI772; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lant B, 2010, INT J BIOL SCI, V6, P9; Livak KJ, 2013, METHODS, V59, P71, DOI 10.1016/j.ymeth.2012.10.004; Malhas A, 2010, CELL CYCLE, V9, P531, DOI 10.4161/cc.9.3.10511; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Naesens M, 2011, DISCOV MED, V11, P65; Saj A, 2011, CURR OPIN GENET DEV, V21, P504, DOI 10.1016/j.gde.2011.04.010; Stokman G, 2011, J AM SOC NEPHROL, V22, P859, DOI 10.1681/ASN.2010040423; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Tejani A H, 1999, Pediatr Transplant, V3, P293, DOI 10.1034/j.1399-3046.1999.00057.x; Watson CJE, 2012, TRANSPLANTATION, V93, P314, DOI 10.1097/TP.0b013e31823f14d4; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yarlagadda SG, 2008, ADV CHRONIC KIDNEY D, V15, P248, DOI 10.1053/j.ackd.2008.04.005	29	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146378	10.1371/journal.pone.0146378	http://dx.doi.org/10.1371/journal.pone.0146378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734715	gold, Green Accepted, Green Published			2022-12-27	WOS:000367805100046
J	Pattinson, CL; Allan, AC; Staton, SL; Thorpe, KJ; Smith, SS				Pattinson, Cassandra L.; Allan, Alicia C.; Staton, Sally L.; Thorpe, Karen J.; Smith, Simon S.			Environmental Light Exposure Is Associated with Increased Body Mass in Children	PLOS ONE			English	Article							HIGH-FAT DIET; SLEEP DURATION; DIM LIGHT; SOCIOECONOMIC-STATUS; CIRCADIAN-RHYTHMS; POTENTIAL ROLE; BRIGHT LIGHT; WEIGHT-GAIN; FOOD-INTAKE; NIGHT	The timing, intensity, and duration of exposure to both artificial and natural light have acute metabolic and physiological effects in mammals. Recent research in human adults suggests exposure to moderate intensity light later in the day is concurrently associated with increased body mass; however, no studies have investigated the effect of light exposure on body mass in young children. We examined objectively measured light exposure and body mass of 48 preschool-aged children at baseline, and measured their body mass again 12 months later. At baseline, moderate intensity light exposure earlier in the day was associated with increased body mass index (BMI). Increased duration of light exposure at baseline predicted increased BMI 12-months later, even after controlling for baseline sleep duration, sleep timing, BMI, and activity. The findings identify that light exposure may be a contributor to the obesogenic environment during early childhood.	[Pattinson, Cassandra L.; Staton, Sally L.; Thorpe, Karen J.; Smith, Simon S.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Ctr Childrens Hlth Res, Kelvin Grove, Qld, Australia; [Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, CARRS Q, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Pattinson, CL (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Ctr Childrens Hlth Res, Kelvin Grove, Qld, Australia.	cassandra.pattinson@qut.edu.au; simon.smith@qut.edu.au	Thorpe, Karen/N-1159-2017; Staton, Sally L/N-9415-2018; Smith, Simon/P-1859-2017; Pattinson, Cassandra/AAY-5974-2020; Pattinson, Cassandra/A-5543-2019	Thorpe, Karen/0000-0001-8927-4064; Staton, Sally L/0000-0002-9741-8010; Smith, Simon/0000-0002-0362-9045; Pattinson, Cassandra/0000-0002-5975-7935	Financial Markets Foundation for Children (Australia) [2012-213]	Financial Markets Foundation for Children (Australia)	This work was supported by the Financial Markets Foundation for Children (Australia) Grant (2012-213).	Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Australian Bureau of Statistics, 2013, 2033 0 55 001 CENS P; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bedrosian TA, 2013, MOL PSYCHIATR, V18, P751, DOI 10.1038/mp.2013.70; Bell JF, 2010, ARCH PEDIAT ADOL MED, V164, P840, DOI 10.1001/archpediatrics.2010.143; Borbely AA, 1998, HORM RES, V49, P114, DOI 10.1159/000023156; Borniger JC, 2014, CHRONOBIOL INT, V31, P917, DOI 10.3109/07420528.2014.926911; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Brooks E, 2013, NEUROSCI BIOBEHAV R, V37, P551, DOI 10.1016/j.neubiorev.2013.02.012; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Cao RF, 2015, NAT NEUROSCI, V18, P855, DOI 10.1038/nn.4010; Coomans CP, 2013, FASEB J, V27, P1721, DOI 10.1096/fj.12-210898; Cox R, 2013, J PAEDIATR CHILD H, V49, pE108, DOI 10.1111/jpc.12041; Danilenko KV, 2013, OBESITY FACTS, V6, P28, DOI 10.1159/000348549; Dauchy RT, 2014, CANCER RES, V74, P4099, DOI 10.1158/0008-5472.CAN-13-3156; de Moira AP, 2010, AM J EPIDEMIOL, V171, P1289, DOI 10.1093/aje/kwq083; Dennison BA, 2002, PEDIATRICS, V109, P1028, DOI 10.1542/peds.109.6.1028; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dunai A, 2007, OBESITY, V15, P1749, DOI 10.1038/oby.2007.208; Ebling FJP, 2014, HORM BEHAV, V66, P56, DOI 10.1016/j.yhbeh.2014.03.009; Eisenmann JC, 2004, OBES RES, V12, P1633, DOI 10.1038/oby.2004.203; Evans WR, 2012, N AM BIRDS, V60, P476; Figueiro M, 2016, LIGHTING RES TECHNOL, V48, P966, DOI 10.1177/1477153515584979; Figueiro MG, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/530726; Fonken LK, 2013, OBESITY, V21, P1159, DOI 10.1002/oby.20108; Fonken LK, 2013, ENDOCRINOLOGY, V154, P3817, DOI 10.1210/en.2013-1121; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Gaston KJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0133; Gaston KJ, 2014, OECOLOGIA, V176, P917, DOI 10.1007/s00442-014-3088-2; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Gooley JJ, 2011, J CLIN ENDOCR METAB, V96, pE463, DOI 10.1210/jc.2010-2098; Hiscock H, 2011, ARCH DIS CHILD, V96, P735, DOI 10.1136/adc.2010.204925; Holker F, 2010, ECOL SOC, V15; Irwin M, 2008, UNDERSTANDING THE LO; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; Klingenberg L, 2013, PEDIATR OBES, V8, pe14, DOI 10.1111/j.2047-6310.2012.00109.x; Koninklijke Philips Electronics, 2008, CHAR LIGHT SENS PERF; Kooijman S, 2015, P NATL ACAD SCI USA, V112, P6748, DOI 10.1073/pnas.1504239112; Liu D, 2014, J INVEST DERMATOL, V134, P1839, DOI 10.1038/jid.2014.27; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Dea JA, 2012, PEDIATR OBES, V7, P295, DOI 10.1111/j.2047-6310.2012.00054.x; Obayashi K, 2013, J CLIN ENDOCR METAB, V98, P337, DOI 10.1210/jc.2012-2874; Pattinson CL, 2014, EARLY CHILD RES Q, V29, P660, DOI 10.1016/j.ecresq.2014.07.009; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Reid KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092251; Scharf RJ, 2015, PEDIATR OBES, V10, P141, DOI 10.1111/ijpo.229; Simmen B, 2015, PHYSIOL BEHAV, V138, P193, DOI 10.1016/j.physbeh.2014.10.018; Stevens RG, 2001, CANCER CAUSE CONTROL, V12, P279, DOI 10.1023/A:1011237000609; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; The International Commission on Illumination, 1994, 1081994 CIE; The International Organization of Standardization, 2009, 80000 QUANT UN; Turner PL, 2010, SLEEP MED REV, V14, P269, DOI 10.1016/j.smrv.2009.11.002; World Health Organisation, 1995, PHYS STAT UINT ANT; World Health Organization, 2000, WHO TECHN REP SER, V894; Wyse CA, 2011, MED HYPOTHESES, V77, P1139, DOI 10.1016/j.mehy.2011.09.023; Wyse CA, 2014, ANN MED, V46, P253, DOI 10.3109/07853890.2014.913422; Yamauchi M, 2014, SLEEP BREATH, V18, P829, DOI 10.1007/s11325-014-0951-7	61	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0143578	10.1371/journal.pone.0143578	http://dx.doi.org/10.1371/journal.pone.0143578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735299	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100004
J	Whisson, DA; Dixon, V; Taylor, ML; Melzer, A				Whisson, Desley A.; Dixon, Victoria; Taylor, Megan L.; Melzer, Alistair			Failure to Respond to Food Resource Decline Has Catastrophic Consequences for Koalas in a High-Density Population in Southern Australia	PLOS ONE			English	Article							HOME-RANGE; TREE USE; HABITAT; PATTERNS	Understanding the ability of koalas to respond to changes in their environment is critical for conservation of the species and their habitat. We monitored the behavioural response of koalas to declining food resources in manna gum (Eucalyptus viminalis) woodland at Cape Otway, Victoria, Australia, from September 2011 to November 2013. Over this period, koala population density increased from 10.1 to 18.4 koalas. ha(-1). As a result of the high browsing pressure of this population, manna gum canopy condition declined with 71.4% manna gum being completely or highly defoliated in September 2013. Despite declining food resources, radio collared koalas (N = 30) exhibited high fidelity to small ranges (0.4-1.2 ha). When trees became severely defoliated in September 2013, koalas moved relatively short distances from their former ranges (mean predicted change in range centroid = 144 m) and remained in areas of 0.9 to 1.0 ha. This was despite the high connectivity of most manna gum woodland, and close proximity of the study site (< 3 km) to the contiguous mixed forest of the Great Otway National Park. Limited movement had catastrophic consequences for koalas with 71% (15/21) of radio collared koalas dying from starvation or being euthanased due to their poor condition between September and November 2013.	[Whisson, Desley A.; Dixon, Victoria; Taylor, Megan L.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia; [Melzer, Alistair] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia	Deakin University; Central Queensland University	Whisson, DA (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia.	desley.whisson@deakin.edu.au	Whisson, Desley/V-9422-2019; Whisson, Desley A/H-9578-2013	Whisson, Desley/0000-0002-4221-0706; Whisson, Desley A/0000-0002-4221-0706	Earthwatch Institute Australia; Earthwatch Institute	Earthwatch Institute Australia; Earthwatch Institute	DAW and AM received funding from the Earthwatch Institute Australia (http://au.earthwatch.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to Cyril and Pat Marriner for allowing us to conduct this study on their property, and to Frank and Katrina Fotinas of Bimbi Park for their logistical support. This project was funded in part by the generous support of the Earthwatch Institute. We thank the numerous Earthwatch participants and other volunteers who assisted us with data collection.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; BELL WJ, 1979, J INSECT PHYSIOL, V25, P631, DOI 10.1016/0022-1910(79)90112-4; Beyer H. L, 2012, GEOSPATIAL MODELLING; CALHOUN J B, 1958, Public Health Monogr, V55, P1; Callaghan J, 2011, WILDLIFE RES, V38, P89, DOI 10.1071/WR07177; Campbell TA, 2004, FOREST ECOL MANAG, V199, P371, DOI 10.1016/j.foreco.2004.05.051; Cimino L, 2003, J ZOOL, V261, P299, DOI 10.1017/S0952836903004229; Cork SJ, 2000, CONSERV BIOL, V14, P660, DOI 10.1046/j.1523-1739.2000.99389.x; DANIELSON BJ, 1987, J MAMMAL, V68, P160, DOI 10.2307/1381066; de Oliveira SM, 2014, AUST MAMMAL, V36, P45, DOI 10.1071/AM12046; Department of Environment Land Water and Planning (DELWP), 2015, KOAL AT CAP OTW; Di Stefano J, 2007, FOREST ECOL MANAG, V253, P128, DOI 10.1016/j.foreco.2007.07.010; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; ESRI, 2018, ARCGIS DESKTOP RELEA; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Hindell M.A., 1990, P117; Jackson S., 1994, KOALA PHASCOLARCTOS; Kavanagh RP, 2007, WILDLIFE RES, V34, P94, DOI 10.1071/WR06126; Kershaw J.A., 1934, VICTORIAN NAT, V51, P76; MARTIN RW, 1985, AUST WILDLIFE RES, V12, P355; McLean N, 2003, THESIS; McLean N, 2006, AUST J ZOOL, V54, P385, DOI 10.1071/ZO06015; Menkhorst P, 2008, TOO CLOSE FOR COMFORT : CONTENTIOUS ISSUES IN HUMAN-WILDLIFE ENCOUNTERS, P73; Mitchell P., 1990, P97; Mitchell P., 1990, P171; Moore BD, 2005, NATURE, V435, P488, DOI 10.1038/nature03551; Moore BD, 2010, ECOLOGY, V91, P3165, DOI 10.1890/09-1714.1; MUNGER JC, 1984, OECOLOGIA, V62, P351, DOI 10.1007/BF00384267; Natural Resource Management Ministerial Council, 2009, NAT KOAL CONS MAN ST; Newell GR, 1999, BIOL CONSERV, V91, P181, DOI 10.1016/S0006-3207(99)00083-X; R Core Team, 2012, R LANG ENV STAT COMP; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Signer J., 2014, RHR R PACKAGE REPROD; SPENCER SR, 1990, ECOLOGY, V71, P1817, DOI 10.2307/1937590; SWITZER PV, 1993, EVOL ECOL, V7, P533, DOI 10.1007/BF01237820; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; TYNDALEBISCOE CH, 1969, J ANIM ECOL, V38, P651, DOI 10.2307/3041; Walter WD, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0039-4; Whisson DA, 2010, J MAMMAL, V91, P1160, DOI 10.1644/09-MAMM-A-384.1; White NA, 1994, THESIS	40	31	31	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144348	10.1371/journal.pone.0144348	http://dx.doi.org/10.1371/journal.pone.0144348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735846	gold, Green Published			2022-12-27	WOS:000367805100007
J	Castany, S; Carcole, M; Leanez, S; Pol, O				Castany, Silvia; Carcole, Mireia; Leanez, Sergi; Pol, Olga			The Induction of Heme Oxygenase 1 Decreases Painful Diabetic Neuropathy and Enhances the Antinociceptive Effects of Morphine in Diabetic Mice	PLOS ONE			English	Article							MU-OPIOID RECEPTORS; COUNTERACTS MULTIPLE MANIFESTATIONS; MONOXIDE-RELEASING MOLECULES; SPINAL-CORD; NOCICEPTIVE RESPONSE; SIGNALING PATHWAY; RATS; MODELS; INDUCER; GLIA	Painful diabetic neuropathy is a common complication of diabetes mellitus which is poorly controlled by conventional analgesics. This study investigates if treatment with an heme oxygenase 1 (HO-1) inducer, cobalt protoporphyrin IX (CoPP), could modulate the allodynia and hyperalgesia induced by diabetes and enhanced the antinociceptive effects of morphine. In a diabetic mice model induced by the injection of streptozotocin (STZ), we evaluated the antiallodynic and antihyperalgesic effects produced by the intraperitoneal administration of 5 and 10 mg/kg of CoPP at several days after its administration. The antinociceptive actions produced by the systemic administration of morphine alone or combined with CoPP were also evaluated. In addition, the effects of CoPP treatment on the expression of HO-1, the microglial activation marker (CD11b/c), the inducible nitric oxide synthase (NOS2) and mu-opioid receptors (MOR), were also assessed. Our results showed that the administration of 10 mg/kg of CoPP during 5 consecutive days completely blocked the mechanical and thermal hypersensitivity induced by diabetes. These effects are accompanied by the increased spinal cord, dorsal root ganglia and sciatic nerve protein levels of HO-1. In addition, the STZ-induced activation of microglia and overexpression of NOS2 in the spinal cord were inhibited by CoPP treatment. Furthermore, the antinociceptive effects of morphine were enhanced by CoPP treatment and reversed by the administration of an HO-1 inhibitor, tin protoporphyrin IX (SnPP). The spinal cord expression of MOR was also increased by CoPP treatment in diabetic mice. In conclusion, our data provide the first evidence that the induction of HO-1 attenuated STZ-induced painful diabetic neuropathy and enhanced the antinociceptive effects of morphine via inhibition of microglia activation and NOS2 overexpression as well as by increasing the spinal cord levels of MOR. This study proposes the administration of CoPP alone or combined with morphine as an interesting therapeutic approach for the treatment of painful diabetic neuropathy.	[Pol, Olga] Univ Autonoma Barcelona, Inst Invest Biomed St Pau, Grp Neurofarmacol Mol, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Pol, O (corresponding author), Univ Autonoma Barcelona, Inst Invest Biomed St Pau, Grp Neurofarmacol Mol, E-08193 Barcelona, Spain.	opol@santpau.es	Quintana, Sílvia Castany/N-6261-2019; Pol, Olga/O-2146-2019	Quintana, Sílvia Castany/0000-0002-9530-2647; Pol, Olga/0000-0002-4621-8457	Ministerio de Economia y Competitividad; Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER); Union Europea [PS0900968, PI1400927]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Union Europea	This work was supported by Ministerio de Economia y Competitividad, Instituto de Salud Carlos III, and Fondo Europeo de Desarrollo Regional (FEDER), Union Europea [Grant numbers: PS0900968 (OP) and PI1400927 (OP)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Biessels GJ, 2014, J PERIPHER NERV SYST, V19, P77, DOI 10.1111/jns5.12072; Calcutt NA, 2004, J NEUROL SCI, V220, P137, DOI 10.1016/j.jns.2004.03.015; Carcole M, 2014, J PHARMACOL EXP THER, V351, P224, DOI 10.1124/jpet.114.215681; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen SR, 2003, ANESTHESIOLOGY, V99, P1409, DOI 10.1097/00000542-200312000-00026; Chen SR, 2002, ANESTHESIOLOGY, V97, P1602, DOI 10.1097/00000542-200212000-00037; Colleoni M, 2010, BBA-MOL BASIS DIS, V1802, P924, DOI 10.1016/j.bbadis.2009.10.012; Courteix C, 1998, J PHARMACOL EXP THER, V285, P63; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gou G, 2014, EUR J PHARMACOL, V737, P41, DOI 10.1016/j.ejphar.2014.05.004; Gul H, 2000, PAIN, V89, P39, DOI 10.1016/S0304-3959(00)00343-2; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hervera A, 2013, PSYCHOPHARMACOLOGY, V228, P463, DOI 10.1007/s00213-013-3053-5; Hervera A, 2013, ANESTHESIOLOGY, V118, P1180, DOI 10.1097/ALN.0b013e318286d085; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; Hervera A, 2012, EUR J PHARMACOL, V685, P42, DOI 10.1016/j.ejphar.2012.04.009; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Kong Q, 2012, NEURAL REGEN RES, V7, P2305, DOI 10.3969/j.issn.1673-5374.2012.29.010; Li M, 2007, CELL CYCLE, V6, P567, DOI 10.4161/cc.6.5.3917; Megias J, 2009, BIOCHEM PHARMACOL, V77, P1806, DOI 10.1016/j.bcp.2009.03.009; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Motterlini R, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-28; Mousa SA, 2013, DIABETES, V62, P1308, DOI 10.2337/db12-0590; Nascimento CGO, 2008, EUR J PHARMACOL, V581, P71, DOI 10.1016/j.ejphar.2007.11.036; Nascimento CGO, 2007, EUR J PHARMACOL, V556, P55, DOI 10.1016/j.ejphar.2006.10.009; Negi G, 2011, CURR NEUROVASC RES, V8, P294, DOI 10.2174/156720211798120972; Nielsen CK, 2007, PAIN, V132, P289, DOI 10.1016/j.pain.2007.03.022; Ohsawa M, 2000, EUR J PHARMACOL, V401, P55, DOI 10.1016/S0014-2999(00)00408-8; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Park TS, 2004, DIABETES RES CLIN PR, V66, pS53, DOI 10.1016/j.diabres.2003.12.009; Ptilovanciv EON, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-3; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shaqura M, 2013, J PAIN, V14, P720, DOI 10.1016/j.jpain.2013.01.776; Shen Y, 2015, NEUROBIOL DIS, V79, P100, DOI 10.1016/j.nbd.2015.04.012; Vareniuk I, 2008, DIABETOLOGIA, V51, P2126, DOI 10.1007/s00125-008-1136-3; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; Wang Y, 2014, VASC PHARMACOL, V61, P16, DOI 10.1016/j.vph.2014.02.001; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771; Zurek JR, 2001, PAIN, V90, P57, DOI 10.1016/S0304-3959(00)00386-9; Zychowska M, 2013, J NEUROIMMUNOL, V262, P35, DOI 10.1016/j.jneuroim.2013.06.005	43	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146427	10.1371/journal.pone.0146427	http://dx.doi.org/10.1371/journal.pone.0146427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730587	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400175
J	Chang, YC; Lee, WF; Feng, SW; Huang, HM; Lin, CT; Teng, NC; Chang, WJ				Chang, Yu-Chi; Lee, Wei-Fang; Feng, Sheng-Wei; Huang, Haw-Ming; Lin, Che-Tong; Teng, Nai-Chia; Chang, Wei Jen			In Vitro Analysis of Fibronectin-Modified Titanium Surfaces	PLOS ONE			English	Article							DISCHARGE PLASMA TREATMENT; CELL-ADHESION; PRETREATMENT; HEAT; DIFFERENTIATION; PROLIFERATION; COMPATIBILITY; EXPRESSION; ROUGHNESS; IMPLANTS	Background Glow discharge plasma (GDP) procedure is an effective method for grafting various proteins, including albumin, type I collagen, and fibronectin, onto a titanium surface. However, the behavior and impact of titanium (Ti) surface modification is yet to be unraveled. Purpose The purpose of this study is to evaluate and analyze the biological properties of fibronectingrafted Ti surfaces treated by GDP. Materials and Methods Grade II Ti discs were initially cleaned and autoclaved to obtain original specimens. Subsequently, the specimens were GDP treated and grafted with fibronectin to form Ar-GDP (Argon GDP treatment only) and GDP-fib (fibronectin coating following GDP treatment) groups. Blood coagulation test and MG-63 cell culture were performed to evaluate the biological effects on the specimen. Results There was no significant difference between Ar-GDP and GDP-fib groups in blood compatibility analysis. While in the MTT test, cellular proliferation was benefited from the presence of fibronectin coating. The numbers of cells on Ar-GDP and GDP-fib specimens were greater than those in the original specimens after 24 h of culturing. Conclusions GDP treatment combined with fibronectin grafting favored MG-63 cell adhesion, migration, and proliferation on titanium surfaces, which could be attributed to the improved surface properties.	[Chang, Yu-Chi; Feng, Sheng-Wei; Huang, Haw-Ming; Lin, Che-Tong; Teng, Nai-Chia; Chang, Wei Jen] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan; [Lee, Wei-Fang] Taipei Med Univ, Coll Oral Med, Sch Dent Technol, Taipei, Taiwan; [Huang, Haw-Ming] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Lin, Che-Tong; Teng, Nai-Chia] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan; [Chang, Wei Jen] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital	Chang, WJ (corresponding author), Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan.	m8404006@tmu.edu.tw						Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010; Aronsson BO, 1997, J BIOMED MATER RES, V35, P49; BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2; Chang WJ, 2008, DENT MATER J, V27, P340, DOI 10.4012/dmj.27.340; Chang Y.C., 2013, CLIN IMPLANT DENT RE; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Cools P, 2014, PLASMA CHEM PLASMA P, V34, P917, DOI 10.1007/s11090-014-9552-2; Czarnowska E, 1999, J MATER SCI-MATER M, V11, P73; Durual S, 2011, CLIN ORAL IMPLAN RES, V22, P552, DOI 10.1111/j.1600-0501.2010.02033.x; Duske K., 2015, PLASMA PROCESSES POL; Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044; Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606; Huang HM, 2011, MED BIOL ENG COMPUT, V49, P701, DOI 10.1007/s11517-011-0742-2; Kawai H, 2004, BIOMATERIALS, V25, P1805, DOI 10.1016/j.biomaterials.2003.08.032; Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3; Kurachi T, 1997, ARCH ORAL BIOL, V42, P465, DOI 10.1016/S0003-9969(97)00019-8; Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E; Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117; Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025; MacDonald DE, 2013, J CELL BIOCHEM, V114, P2363, DOI 10.1002/jcb.24585; Oshida Y., 1994, Bio-Medical Materials and Engineering, V4, P397; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; da Silva JSP, 2011, INT J ORAL MAX IMPL, V26, P237; Rapuano BE, 2013, J CELL BIOCHEM, V114, P1917, DOI 10.1002/jcb.24536; Rapuano BE, 2012, J PERIODONTAL IMPLAN, V42, P95, DOI 10.5051/jpis.2012.42.3.95; Rapuano BE, 2012, EUR J ORAL SCI, V120, P185, DOI 10.1111/j.1600-0722.2012.954.x; Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233; Sharma C P, 1991, J Biomater Appl, V6, P72, DOI 10.1177/088532829100600105; Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771; Singh RG, 2011, INT J ORAL MAX IMPL, V26, P998; Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4; Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x; Yamamoto H, 2005, J DENT RES, V84, P668, DOI 10.1177/154405910508400717	36	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146219	10.1371/journal.pone.0146219	http://dx.doi.org/10.1371/journal.pone.0146219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731536	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400119
J	Chea, R; Grenouillet, G; Lek, S				Chea, Ratha; Grenouillet, Gael; Lek, Sovan			Evidence of Water Quality Degradation in Lower Mekong Basin Revealed by Self-Organizing Map	PLOS ONE			English	Article							SURFACE-WATER; RIVER DELTA; POLLUTION; CHALLENGES; SECURITY; SEDIMENT; IMPACTS; VIETNAM; NETWORK; THREATS	To reach a better understanding of the spatial variability of water quality in the Lower Mekong Basin (LMB), the Self-Organizing Map (SOM) was used to classify 117 monitoring sites and hotspots of pollution within the basin identified according to water quality indicators and US-EPA guidelines. Four different clusters were identified based on their similar physicochemical characteristics. The majority of sites in upper (Laos and Thailand) and middle part (Cambodia) of the basin were grouped in two clusters, considered as good quality water with high DO and low nutrient levels. The other two clusters were mostly composed of sites in Mekong delta (Vietnam) and few sites in upstream tributaries (i.e., northwestern Thailand, Tonle Sap Lake, and swamps close to Vientiane), known for moderate to poor quality of water and characterized by high nutrient and dissolved solid levels. Overall, we found that the water in the mainstream was less polluted than its tributaries; eutrophication and salinity could be key factors affecting water quality in LMB. Moreover, the seasonal variation of water quality seemed to be less marked than spatial variation occurring along the longitudinal gradient of Mekong River. Significant degradations were mainly associated with human disturbance and particularly apparent in sites distributed along the man-made canals in Vietnam delta where population growth and agricultural development are intensive.	[Chea, Ratha; Grenouillet, Gael; Lek, Sovan] Univ Toulouse 3, CNRS, Lab Evolut & Divers Biol, ENFA,UMR5174,EDB, F-31062 Toulouse, France; [Chea, Ratha] Univ Battambang, Fac Agr & Food Proc, Battambang City, Cambodia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Chea, R (corresponding author), Univ Toulouse 3, CNRS, Lab Evolut & Divers Biol, ENFA,UMR5174,EDB, 118 Route Narbonne, F-31062 Toulouse, France.	chearatha@rocketmail.com	Grenouillet, Gael/E-6518-2019		Erasmus Mundus TECHNO Program; Belmont Forum; "Investissement d'Avenir" grants [ANR-10-LABX-0025, ANR-10-LABX-41]; National Research Agency France [ANR-13-JCLI-0003-01]; Tonle Sap Climate Change (TLSCC) project [ANR-13-JCLI-0003-01]	Erasmus Mundus TECHNO Program; Belmont Forum; "Investissement d'Avenir" grants(French National Research Agency (ANR)); National Research Agency France; Tonle Sap Climate Change (TLSCC) project	The authors are grateful to the Erasmus Mundus TECHNO Program and the Belmont Forum for providing funds to support the studies, which were a part of the Tonle Sap Climate Change (TLSCC) project (ANR-13-JCLI-0003-01). EDB lab was supported by "Investissement d'Avenir" grants (CEBA, ref. ANR-10-LABX-0025; TULIP, ref. ANR-10-LABX-41). SL was supported by grant number ANR-13-JCLI-0003-01 from the National Research Agency France (http://www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Erasmus Mundus TECHNO Program and the Belmont Forum for providing funds to support our studies, which are a part of the Tonle Sap Climate Change (TLSCC) project. Great thanks to the Mekong River Commission (MRC) for providing the water quality data used in this study. We thank to University of Battambang for the data request and our colleagues at the Laboratory of Evolution and Biological Diversity (EDB) for their support and discussion concerning data preparation and analysis. EDB lab was supported by "Investissement d'Avenir" grants (CEBA, ref. ANR-10-LABX-0025; TULIP, ref. ANR-10-LABX-41).	Alongi DM, 1999, AQUACULTURE, V175, P121, DOI 10.1016/S0044-8486(99)00078-2; [Anonymous], 2008, ASS WAT QUAL LOW MEK, P70; Arias ME, 2011, 34 IAHR WORLD C BAL, P3018; Belay A.A., 2010, J WATER RESOURCE PRO, V2, P61; Bui TM, 2010, AQUACULTURE, V306, P92, DOI 10.1016/j.aquaculture.2010.06.016; Campbell IC, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005130; Campbell IC, 2003, P INT C ENV FLOWS RI; Chau NDG, 2015, ENVIRON SCI POLLUT R, V22, P9042, DOI 10.1007/s11356-014-4034-x; Claridge GF, 1996, INVENTORY WETLANDS L, P317; Dise N.B., 2011, EUROPEAN NITROGEN AS; Dudgeon D, 2005, ECOL SOC, V10; Dudgeon D, 2011, J FISH BIOL, V79, P1487, DOI 10.1111/j.1095-8649.2011.03086.x; Phung D, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4474-x; Evans AEV, 2012, INT J WATER RESOUR D, V28, P195, DOI 10.1080/07900627.2012.669520; Fedra K, 2004, ENV PROBLEMS WATER R; Fu KD, 2012, J GEOGR SCI, V22, P874, DOI 10.1007/s11442-012-0969-3; Gamble A, 2012, ENVIRON MONIT ASSESS, V184, P845, DOI 10.1007/s10661-011-2005-y; Gerrard P., 2004, INTEGRATING WETLAND; Grumbine RE, 2012, FRONT ECOL ENVIRON, V10, P91, DOI 10.1890/110146; Hart BT, 2001, TRANSBOUNDARY WATER; Iida T, 2011, HYDROL PROCESS, V25, P3590, DOI 10.1002/hyp.8084; Johnston R, 2014, WATER RESOUR MANAG, V28, P2695, DOI 10.1007/s11269-014-0637-8; Komany S, 2008, 3 WEPA INT FORUM WAT; Kummu M, 2008, QUATERN INT, V186, P100, DOI 10.1016/j.quaint.2007.10.015; Lek S, 1999, ECOL MODEL, V120, P65, DOI 10.1016/S0304-3800(99)00092-7; Li SY, 2014, SCI TOTAL ENVIRON, V472, P162, DOI 10.1016/j.scitotenv.2013.11.027; Liljestrom I, 2012, INT J WATER RESOUR D, V28, P373, DOI 10.1080/07900627.2012.668649; Lu XX, 2006, HYDROL EARTH SYST SC, V10, P181, DOI 10.5194/hess-10-181-2006; Lu XX, 2014, QUATERN INT, V336, P145, DOI 10.1016/j.quaint.2014.02.006; Lu XX, 2014, EARTH SURF PROC LAND, V39, P1855, DOI 10.1002/esp.3573; MacQuarrie PR, 2013, THE 3S RIVER BASIN, P12; Mekong River Commission (MRC), 2005, OV HYDR MEK BAS, P73; Minh LQ, 1997, AGR ECOSYST ENVIRON, V61, P19, DOI 10.1016/S0167-8809(96)01084-5; Minh NH, 2007, CHEMOSPHERE, V67, P1794, DOI 10.1016/j.chemosphere.2006.05.144; MNRE, 2010, CLIM CHANG MEK DELT; MRC, 2010, MEK RIV REP WAT QUAL, P16; MRC, 2007, DIAGN STUD WAT QUAL DIAGN STUD WAT QUAL, P57; Phong ND, 2014, J ENVIRON MANAGE, V140, P14, DOI 10.1016/j.jenvman.2013.11.049; Lan NTP, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-675; Nguyen TD, 2008, 3 WEPA INT FORUM WAT; Olkowska E, 2014, SCI TOTAL ENVIRON, V476, P477, DOI 10.1016/j.scitotenv.2014.01.044; Ongley ED, 2006, WATER QUALITY GUIDEL; Ozaki H, 2014, ENVIRON MONIT ASSESS, V186, P845, DOI 10.1007/s10661-013-3421-y; Phet P, 2008, 3 WEPA INT FORUM WAT; Phong ND, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1765-0; Piman T, 2013, J WATER RES PLAN MAN, V139, P723, DOI 10.1061/(ASCE)WR.1943-5452.0000286; Prathumratana L, 2008, ENVIRON INT, V34, P860, DOI 10.1016/j.envint.2007.10.011; Qin BQ, 2006, SCI CHINA SER D, V49, P1, DOI 10.1007/s11430-006-8101-0; Resh VH, 2007, ENVIRON MANAGE, V39, P737, DOI 10.1007/s00267-006-0151-8; Ribolzi O, 2011, ENVIRON MANAGE, V47, P291, DOI 10.1007/s00267-010-9593-0; Sarkkula J., 2003, ECOSYSTEM PROCESSES, P1; Sebesvari Z, 2012, ENVIRON SCI ENG, P331, DOI 10.1007/978-94-007-3962-8_13; Sengsoulichanh P, 2008, 3 WEPA INT FORUM WAT; SEQ-Eau, 2003, SYST EV QUAL EAU COU, P40; Stephan EC, 1985, GUIDELINES DERIVING, P104; Tang Hong Qu, 2009, [Korean Journal of Ecology and Environment, 생태와 환경], V42, P303; Teng SK, 2006, GLOBAL INT WATER ASS, P75; Tudesque L, 2008, WATER RES, V42, P732, DOI 10.1016/j.watres.2007.08.001; US-EPA, 1976, QUAL CRIT WAT, P34; US-EPA, 2010, COND IN MEAS WAT QUA; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wang JJ, 2011, RIVER RES APPL, V27, P33, DOI 10.1002/rra.1337; Weber-Scannell Phyllis K., 2007, American Journal of Environmental Sciences, V3, P1; Wilbers GJ, 2014, SCI TOTAL ENVIRON, V485, P653, DOI 10.1016/j.scitotenv.2014.03.049; WWF, 2007, FRESHW TOX PROGR, P33; Yadav NS., 2014, J INTEGR SCI TECHNOL, V2, P52; Ye C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121210; Yoshimura C, 2009, SCI TOTAL ENVIRON, V407, P5356, DOI 10.1016/j.scitotenv.2009.06.026; Ziegler AD, 2013, PLOS NEGLECT TROP D, V7, P5; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	71	66	71	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145527	10.1371/journal.pone.0145527	http://dx.doi.org/10.1371/journal.pone.0145527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731522	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400038
J	Delgadillo, RF; Parker, ML; Lebrun, M; Boulanger, MJ; Douguet, D				Delgadillo, Roberto F.; Parker, Michelle L.; Lebrun, Maryse; Boulanger, Martin J.; Douguet, Dominique			Stability of the Plasmodium falciparum AMA1-RON2 Complex Is Governed by the Domain II (DII) Loop	PLOS ONE			English	Article							MEMBRANE ANTIGEN 1; MALARIA PARASITE INVASION; APICOMPLEXAN PARASITES; ERYTHROCYTE INVASION; MOVING JUNCTION; CELL INVASION; AMA1; PLASTICITY; VACCINE; EVENTS	Plasmodium falciparum is an obligate intracellular protozoan parasite that employs a highly sophisticated mechanism to access the protective environment of the host cells. Key to this mechanism is the formation of an electron dense ring at the parasite-host cell interface called the Moving Junction (MJ) through which the parasite invades. The MJ incorporates two key parasite components: the surface protein Apical Membrane Antigen 1 (AMA1) and its receptor, the Rhoptry Neck Protein (RON) complex, the latter one being targeted to the host cell membrane during invasion. Crystal structures of AMA1 have shown that a partially mobile loop, termed the DII loop, forms part of a deep groove in domain I and overlaps with the RON2 binding site. To investigate the mechanism by which the DII loop influences RON2 binding, we measured the kinetics of association and dissociation and binding equilibria of a PfRON2sp1 peptide with both PfAMA1 and an engineered form of PfAMA1 where the flexible region of the DII loop was replaced by a short Gly-Ser linker (Delta DII-PfAMA1). The reactions were tracked by fluorescence anisotropy as a function of temperature and concentration and globally fitted to acquire the rate constants and corresponding thermodynamic profiles. Our results indicate that both PfAMA1 constructs bound to the PfRON2sp1 peptide with the formation of one intermediate in a sequential reversible reaction: ABC. Consistent with Isothermal Titration Calorimetry measurements, final complex formation was enthalpically driven and slightly entropically unfavorable. Importantly, our experimental data shows that the DII loop lengthened the complex half-life time by 18-fold (900 s and 48 s at 25o C for Pf and.DII-Pf complex, respectively). The longer half-life of the Pf complex appeared to be driven by a slower dissociation process. These data highlight a new influential role for the DII loop in kinetically locking the functional binary complex to enable host cell invasion.	[Delgadillo, Roberto F.; Douguet, Dominique] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR 7275, F-06560 Valbonne, France; [Parker, Michelle L.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Lebrun, Maryse] Univ Montpellier, CNRS, UMR 5235, F-34095 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; University of Victoria; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Douguet, D (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	douguet@ipmc.cnrs.fr	Lebrun, Maryse/I-7728-2016; douguet, dominique/D-5644-2017	Delgadillo, Roberto F./0000-0002-5743-9781; Lebrun, Maryse/0000-0002-0962-0156	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche [ANR-12-BSV3-0012-03]; l'Institut National de la Sante et de la Recherche Medicale (INSERM); Canadian Institutes of Health Research (CIHR) [MOP82915]; Canada Research Chair program; CONACYT [130994, 162809]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); l'Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Agence Nationale de la Recherche (ANR-12-BSV3-0012-03), l'Institut National de la Sante et de la Recherche Medicale (INSERM) to DD and by the Canadian Institutes of Health Research (CIHR) grant MOP82915 to MJB. MJB also acknowledges the Canada Research Chair program for salary support. The authors thank CONACYT postdoctoral fellowships (130994, 162809) and Veracruz scholarship for RFD. RFD also acknowledges Infectiopole Sud for salary support.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; AKAIKE H, 1970, ANN I STAT MATH, V22, P203, DOI 10.1007/BF02506337; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bright AT, 2013, NATURE, V498, P446, DOI 10.1038/498446b; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Dahl G, 2013, DRUG DISCOV TODAY, V18, P697, DOI 10.1016/j.drudis.2013.02.010; Delgadillo RF, 2009, AAI3388957359 ETD CO; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Ge XP, 2014, J MED CHEM, V57, P6419, DOI 10.1021/jm500390g; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Gupta A, 2005, PROTEIN EXPRES PURIF, V41, P186, DOI 10.1016/j.pep.2005.01.005; Harris KS, 2009, J BIOL CHEM, V284, P9361, DOI 10.1074/jbc.M808762200; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Lim SS, 2014, BIOCHEMISTRY-US, V53, P7310, DOI 10.1021/bi5012089; Moore, 1981, KINETICS MECH; O'Donnell RA, 2005, CURR OPIN MICROBIOL, V8, P422, DOI 10.1016/j.mib.2005.06.018; OTTO MR, 1994, BIOPHYS J, V67, P2511, DOI 10.1016/S0006-3495(94)80741-6; Parker ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126206; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Tonkin ML, 2013, PROTEIN SCI, V22, P114, DOI 10.1002/pro.2193; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Vulliez-Le Normand B, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0123567, DOI 10.1371/J0URNAL.P0NE.0123567]; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; Yap A, 2014, CELL MICROBIOL, V16, P642, DOI 10.1111/cmi.12287	38	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144764	10.1371/journal.pone.0144764	http://dx.doi.org/10.1371/journal.pone.0144764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731670	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400012
J	Kelley, ST; Skarra, DV; Rivera, AJ; Thackray, VG				Kelley, Scott T.; Skarra, Danalea V.; Rivera, Alissa J.; Thackray, Varykina G.			The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; INTESTINAL MICROBIOTA; MICE; DIVERSITY; HEALTH; PCOS; AUTOIMMUNITY; RESILIENCE; METAGENOME	Women with polycystic ovary syndrome (PCOS) have reproductive and metabolic abnormalities that result in an increased risk of infertility, diabetes and cardiovascular disease. The large intestine contains a complex community of microorganisms (the gut microbiome) that is dysregulated in humans with obesity and type 2 diabetes. Using a letrozole-induced PCOS mouse model, we demonstrated significant diet-independent changes in the gut microbial community, suggesting that gut microbiome dysbiosis may also occur in PCOS women. Letrozole treatment was associated with a time-dependent shift in the gut microbiome and a substantial reduction in overall species and phylogenetic richness. Letrozole treatment also correlated with significant changes in the abundance of specific Bacteroidetes and Firmicutes previously implicated in other mouse models of metabolic disease in a time-dependent manner. Our results suggest that the hyperandrogenemia observed in PCOS may significantly alter the gut microbiome independently of diet.	[Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Skarra, Danalea V.; Rivera, Alissa J.; Thackray, Varykina G.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Thackray, Varykina G.] Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego	Thackray, VG (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.	vthackray@ucsd.edu			National Institute of Child Health and Human Development [R01 HD067448]; University of California, San Diego [U54 HD012303]; University of Virginia Ligand Assay and Analysis Core [U54 HD28934]; National Institute of General Medical Sciences [K12 GM068524];  [T32 HD007203];  [F32 HD074414]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067448, P50HD012303, U54HD012303, R01HD082567, F32HD074414, P50HD028934, U54HD028934, T32HD007203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of California, San Diego(University of California System); University of Virginia Ligand Assay and Analysis Core; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of Child Health and Human Development through R01 HD067448 to V.G.T., a cooperative agreement as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research U54 HD012303 (University of California, San Diego) and U54 HD28934 (University of Virginia Ligand Assay and Analysis Core) as well as a T32 HD007203, F32 HD074414 to D.V.S. D.V.S. was also funded by the National Institute of General Medical Sciences (K12 GM068524).	Abbott DH, 2013, FERTIL STERIL, V100, P2, DOI 10.1016/j.fertnstert.2013.05.023; Anderson AD, 2014, SEMIN REPROD MED, V32, P202, DOI 10.1055/s-0034-1371092; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Carmina E, 2012, OBSTET GYNECOL, V119, P263, DOI 10.1097/AOG.0b013e31823f7135; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CHAO A, 1984, SCAND J STAT, V11, P265; Chassaing B, 2012, ADV IMMUNOL, V116, P93, DOI 10.1016/B978-0-12-394300-2.00003-X; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; Diamanti-Kandarakis E, 2012, CURR PHARM DESIGN, V18, P5569, DOI 10.2174/138161212803307590; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Jorgensen BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103398; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kauffman AS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131631; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moghetti P, 2013, J CLIN ENDOCR METAB, V98, pE628, DOI 10.1210/jc.2012-3908; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walker AW, 2013, PHARMACOL RES, V69, P75, DOI 10.1016/j.phrs.2012.09.008; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27	53	85	104	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146509	10.1371/journal.pone.0146509	http://dx.doi.org/10.1371/journal.pone.0146509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731268	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400188
J	Lee, S; Hwang, S; Yu, HJ; Oh, D; Choi, YJ; Kim, MC; Kim, Y; Ryu, DY				Lee, Seungwoo; Hwang, Seungwoo; Yu, Hee Jeong; Oh, Dayoung; Choi, Yu Jung; Kim, Myung-Chul; Kim, Yongbaek; Ryu, Doug-Young			Expression of microRNAs in Horse Plasma and Their Characteristic Nucleotide Composition	PLOS ONE			English	Article							CIRCULATING MICRORNAS; REVEALS; CLASSIFICATION; IDENTIFICATION; POPULATION; VESICLES; ORIGIN; MIRNAS	MicroRNAs (miRNAs) in blood plasma are stable under high levels of ribonuclease activity and could function in tissue-to-tissue communication, suggesting that they may have distinctive structural characteristics compared with non-circulating miRNAs. In this study, the expression of miRNAs in horse plasma and their characteristic nucleotide composition were examined and compared with non-plasma miRNAs. Highly expressed plasma miRNA species were not part of the abundant group of miRNAs in non-plasma tissues, except for the eca-let-7 family. eca-miR-486-5p, -92a, and -21 were among the most abundant plasma miRNAs, and their human orthologs also belong to the most abundant group of miRNAs in human plasma. Uracil and guanine were the most common nucleotides of both plasma and non-plasma miRNAs. Cytosine was the least common in plasma and non-plasma miRNAs, although levels were higher in plasma miRNAs. Plasma miRNAs also showed higher expression levels of miRNAs containing adenine and cytosine repeats, compared with non-plasma miRNAs. These observations indicate that miRNAs in the plasma have a unique nucleotide composition.	[Lee, Seungwoo; Yu, Hee Jeong; Oh, Dayoung; Choi, Yu Jung; Kim, Myung-Chul; Kim, Yongbaek; Ryu, Doug-Young] Seoul Natl Univ, Res Inst Vet Sci, Plus Program Creat Vet Sci Res BK21, Seoul 08826, South Korea; [Lee, Seungwoo; Yu, Hee Jeong; Oh, Dayoung; Choi, Yu Jung; Kim, Myung-Chul; Kim, Yongbaek; Ryu, Doug-Young] Seoul Natl Univ, Coll Vet Med, Seoul 08826, South Korea; [Hwang, Seungwoo] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Daejeon 34141, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Ryu, DY (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, Plus Program Creat Vet Sci Res BK21, 1 Gwanak Ro, Seoul 08826, South Korea.	dyryu@snu.ac.kr		Oh, Dayoung/0000-0002-1694-2620	Bio-industry Technology Development Program of iPET (http://www.ipet.re.kr/; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries) [1111594]; Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	Bio-industry Technology Development Program of iPET (http://www.ipet.re.kr/; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries); Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This study was supported by Bio-industry Technology Development Program (Grant no. 1111594) of iPET (http://www.ipet.re.kr/; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barrey E, 2010, EQUINE VET J, V42, P561, DOI 10.1111/j.2042-3306.2010.00267.x; Buechli ME, 2013, STEM CELLS DEV, V22, P1288, DOI 10.1089/scd.2012.0411; Carmel I, 2012, RNA, V18, P1947, DOI 10.1261/rna.032185.111; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Donadeu FX, 2013, DOMEST ANIM ENDOCRIN, V45, P122, DOI 10.1016/j.domaniend.2013.06.006; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gu YQ, 2014, INT J MOL MED, V33, P1243, DOI 10.3892/ijmm.2014.1677; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kim MC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093662, 10.1371/journal.pone.0101486]; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lukiw Walter J., 2013, Frontiers in Genetics, V3, P327, DOI 10.3389/fgene.2012.00327; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Servant Nicolas, 2010, BMC Res Notes, V3, P277, DOI 10.1186/1756-0500-3-277; Sun JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090244; Sun JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-42; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang B, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/951570; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Xie FL, 2010, BIOINFORMATICS, V26, P3002, DOI 10.1093/bioinformatics/btq568; Yuan LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115251; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027	38	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146374	10.1371/journal.pone.0146374	http://dx.doi.org/10.1371/journal.pone.0146374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731407	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400163
J	Men, P; Li, HB; Zhai, SD; Zhao, RS				Men, Peng; Li, Hui-Bo; Zhai, Suo-Di; Zhao, Rong-Sheng			Association between the AUC(0-24)/MIC Ratio of Vancomycin and Its Clinical Effectiveness: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMIC PROPERTIES; BACTEREMIA; TIME; INFECTIONS; CURVE; MORTALITY; OUTCOMES; TARGETS	Background A target AUC(0-24)/MIC ratio of 400 has been associated with its clinical success when treating Staphylococcus aureus infections but is not currently supported by state-of-the-art evidence-based research. Objective This current systematic review aimed to evaluate the available evidence for the association between the AUC(0-24)/MIC ratio of vancomycin and its clinical effectiveness on hospitalized patients and to confirm the existing target value of 400. Methods PubMed, Embase, Web of Sciences, the Cochrane Library and two Chinese literature databases (CNKI, CBM) were systematically searched. Manual searching was also applied. Both RCTs and observational studies comparing the clinical outcomes of high AUC(0-24)/MIC groups versus low AUC(0-24)/MIC groups were eligible. Two reviewers independently extracted the data. The primary outcomes were mortality and infection treatment failure. Risk ratios (RRs) with 95% confidence intervals (95% CIs) were calculated. Results No RCTs were retrieved. Nine cohort studies were included in the meta-analysis. Mortality rates were significantly lower in high AUC(0-24)/MIC groups (RR = 0.47, 95% CI = 0.31-0.70, p<0.001). The rates of infection treatment failure were also significantly lower in high AUC/MIC groups and were consistent after correcting for heterogeneity (RR = 0.39, 95% CI = 0.28-0.55, p = 0.001). Subgroup analyses showed that results were consistent whether MIC values were determined by broth microdilution (BMD) method or Etest method. In studies using the BMD method, breakpoints of AUC(0-24)/MIC all fell within 85% to 115% of 400. Conclusions This meta-analysis demonstrated that achieving a high AUC(0-24)/MIC of vancomycin could significantly decrease mortality rates by 53% and rates of infection treatment failure by 61%, with 400 being a reasonable target.	[Men, Peng; Li, Hui-Bo; Zhai, Suo-Di; Zhao, Rong-Sheng] Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China; [Men, Peng; Li, Hui-Bo] Peking Univ, Dept Pharm Adm & Clin Pharm, Sch Pharmaceut Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Zhai, SD (corresponding author), Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China.	zhaisuodi@163.com	Men, Peng/AAF-8875-2019; Hegde, Nagendra/J-5920-2014	MEN, PENG/0000-0003-4429-3792; Hegde, Nagendra/0000-0001-5260-2159				ACKERMAN BH, 1992, ANTIMICROB AGENTS CH, V36, P1766, DOI 10.1128/AAC.36.8.1766; Ampe E, 2013, INT J ANTIMICROB AG, V41, P439, DOI 10.1016/j.ijantimicag.2013.01.009; Brown J, 2012, ANTIMICROB AGENTS CH, V56, P634, DOI 10.1128/AAC.05609-11; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Craig WA, 2003, INFECT DIS CLIN N AM, V17, P479, DOI 10.1016/S0891-5520(03)00065-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gawronski KM, 2013, CLIN THER, V35, P772, DOI 10.1016/j.clinthera.2013.05.008; Ghosh N, 2014, CLIN MICROBIOL INFEC, V20, pO1098, DOI 10.1111/1469-0691.12695; Giulano C, 2010, EXPERT REV ANTI-INFE, V8, P95, DOI [10.1586/eri.09.123, 10.1586/ERI.09.123]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holland TL, 2011, J INFECT DIS, V204, P329, DOI 10.1093/infdis/jir275; Holmes NE, 2013, ANTIMICROB AGENTS CH, V57, P1654, DOI 10.1128/AAC.01485-12; Jung Y, 2014, INT J ANTIMICROB AG, V43, P179, DOI 10.1016/j.ijantimicag.2013.10.017; Kullar R, 2011, CLIN INFECT DIS, V52, P975, DOI 10.1093/cid/cir124; Lodise TP, 2009, CLIN INFECT DIS, V49, P507, DOI 10.1086/600884; Lowdin E, 1998, ANTIMICROB AGENTS CH, V42, P2739, DOI 10.1128/AAC.42.10.2739; Moise PA, 2000, AM J HEALTH-SYST PH, V57, pS4, DOI 10.1093/ajhp/57.suppl_2.S4; Moise-Broder PA, 2004, CLIN PHARMACOKINET, V43, P925, DOI 10.2165/00003088-200443130-00005; Neely MN, 2014, ANTIMICROB AGENTS CH, V58, P309, DOI 10.1128/AAC.01653-13; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; Sader HS, 2009, ANTIMICROB AGENTS CH, V53, P3162, DOI 10.1128/AAC.00093-09; Vandecasteele SJ, 2013, J ANTIMICROB CHEMOTH, V68, P743, DOI 10.1093/jac/dks495; Ye ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077169; Zelenitsky S, 2013, INT J ANTIMICROB AG, V41, P255, DOI 10.1016/j.ijantimicag.2012.10.015	25	70	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146224	10.1371/journal.pone.0146224	http://dx.doi.org/10.1371/journal.pone.0146224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731739	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400121
J	Smith, ML; Lopez, MF; Archer, KJ; Wolen, AR; Becker, HC; Miles, MF				Smith, Maren L.; Lopez, Marcelo F.; Archer, Kellie J.; Wolen, Aaron R.; Becker, Howard C.; Miles, Michael F.			Time-Course Analysis of Brain Regional Expression Network Responses to Chronic Intermittent Ethanol and Withdrawal: Implications for Mechanisms Underlying Excessive Ethanol Consumption	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NEURAL STEM-CELLS; GENE-EXPRESSION; ALCOHOL-CONSUMPTION; RAT HIPPOCAMPUS; SYNAPTIC PLASTICITY; MICROARRAY ANALYSIS; NUCLEUS-ACCUMBENS; BINDING PROTEIN; NEUROGENESIS	Long lasting abusive consumption, dependence, and withdrawal are characteristic features of alcohol use disorders (AUD). Mechanistically, persistent changes in gene expression are hypothesized to contribute to brain adaptations leading to ethanol toxicity and AUD. We employed repeated chronic intermittent ethanol (CIE) exposure by vapor chamber as a mouse model to simulate the cycles of ethanol exposure and withdrawal commonly seen with AUD. This model has been shown to induce progressive ethanol consumption in rodents. Brain CIE-responsive expression networks were identified by microarray analysis across five regions of the mesolimbic dopamine system and extended amygdala with tissue harvested from 0-hours to 7-days following CIE. Weighted Gene Correlated Network Analysis (WGCNA) was used to identify gene networks over-represented for CIE-induced temporal expression changes across brain regions. Differential gene expression analysis showed that long-lasting gene regulation occurred 7-days after the final cycle of ethanol exposure only in prefrontal cortex (PFC) and hippocampus. Across all brain regions, however, ethanol- responsive expression changes occurred mainly within the first 8-hours after removal from ethanol. Bioinformatics analysis showed that neuroinflammatory responses were seen across multiple brain regions at early time-points, whereas co-expression modules related to neuroplasticity, chromatin remodeling, and neurodevelopment were seen at later timepoints and in specific brain regions (PFC or HPC). In PFC a module containing Bdnf was identified as highly CIE responsive in a biphasic manner, with peak changes at 0 hours and 5 days following CIE, suggesting a possible role in mechanisms underlying long-term molecular and behavioral response to CIE. Bioinformatics analysis of this network and several other modules identified Let-7 family microRNAs as potential regulators of gene expression changes induced by CIE. Our results suggest a complex temporal and regional pattern of widespread gene network responses involving neuroinflammatory and neuroplasticity related genes as contributing to physiological and behavioral responses to chronic ethanol.	[Wolen, Aaron R.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Smith, Maren L.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Archer, Kellie J.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, VCU Alcohol Res Ctr, Richmond, VA USA; [Lopez, Marcelo F.; Becker, Howard C.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Becker, Howard C.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Becker, Howard C.] Vet Affairs Med Ctr, RHJ Dept, Charleston, SC 29403 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Miles, MF (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA.	Michael.Miles@vcuhealth.org		Archer, Kellie/0000-0003-1555-5781	NIH [RC1 AA019138, U01 AA016667, P50 AA022537, P20 AA017828, F31AA023134, U01 AA014095, P50 AA010761]; VA BLRD Merit Award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017828, F31AA023134, RC1AA019138, U01AA014095, U01AA016667, P50AA010761, P50AA022537, R01AA020634, U01AA020929] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA BLRD Merit Award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grants RC1 AA019138 (HCB and MFM), U01 AA016667 (MFM), P50 AA022537 (MFM), P20 AA017828 (MFM), F31AA023134 (MS), U01 AA014095 (HCB), P50 AA010761 (HCB), and a VA BLRD Merit Award (HCB).	Abernathy K, 2010, INT REV NEUROBIOL, V91, P289, DOI 10.1016/S0074-7742(10)91009-X; Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson ML, 2012, NEUROSCIENCE, V224, P202, DOI 10.1016/j.neuroscience.2012.08.018; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Barkley-Levenson AM, 2012, ALCOHOL RES-CURR REV, V34, P325; Batel P, 2008, ALCOHOL CLIN EXP RES, V32, P567, DOI 10.1111/j.1530-0277.2008.00618.x; Becker HC, 2004, ALCOHOL CLIN EXP RES, V28, P1829, DOI 10.1097/01.ALC.0000149977.95306.3A; Becker HC, 2014, NEUROBIOLOGY ALCOHOL; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beresford TP, 2006, ALCOHOL CLIN EXP RES, V30, P1866, DOI 10.1111/j.1530-0277.2006.00223.x; Bleich S, 2003, ALCOHOL ALCOHOLISM, V38, P40, DOI 10.1093/alcalc/agg017; Blencowe BJ, 2000, RNA, V6, P111, DOI 10.1017/S1355838200991982; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; CHAN AWK, 1985, EPILEPSIA, V26, P323, DOI 10.1111/j.1528-1157.1985.tb05658.x; Chen G, 2009, ALCOHOL, V43, P411, DOI 10.1016/j.alcohol.2009.05.003; Council NR., 2011, GUIDE CARE USE LAB A; Cui CH, 2015, ALCOHOL, V49, P435, DOI 10.1016/j.alcohol.2015.04.006; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Daniels GM, 2002, GENES BRAIN BEHAV, V1, P35, DOI 10.1046/j.1601-1848.2001.00008.x; Darcq E, 2015, MOL PSYCHIATR, V20, P1240, DOI 10.1038/mp.2014.120; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fan CL, 2014, NEURAL REGEN RES, V9, P318, DOI 10.4103/1673-5374.128231; Farris SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082435; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GRANT KA, 1990, EUR J PHARMACOL, V176, P289, DOI 10.1016/0014-2999(90)90022-X; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Griffin WC, 2014, NEUROPSYCHOPHARMACOL, V39, P707, DOI 10.1038/npp.2013.256; Griffin WC, 2009, ALCOHOL CLIN EXP RES, V33, P1893, DOI 10.1111/j.1530-0277.2009.01027.x; Guirado R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-5; Gustafson EA, 2010, BIOCHEM BIOPH RES CO, V395, P1, DOI 10.1016/j.bbrc.2010.02.172; HAUSER WA, 1988, EPILEPSIA, V29, pS66, DOI 10.1111/j.1528-1157.1988.tb05800.x; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwase K, 2014, J NEUROCHEM, V128, P233, DOI 10.1111/jnc.12467; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Khisti RT, 2006, ALCOHOL, V40, P119, DOI 10.1016/j.alcohol.2006.12.003; Kim DJ, 2007, BIOCHEM BIOPH RES CO, V357, P1135, DOI 10.1016/j.bbrc.2007.04.074; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; Klugmann M, 2006, MOL CELL NEUROSCI, V31, P303, DOI 10.1016/j.mcn.2005.09.019; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; Kruman II, 2012, EXP BIOL MED, V237, P740, DOI 10.1258/ebm.2012.011421; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Melendez RI, 2012, ADDICT BIOL, V17, P351, DOI 10.1111/j.1369-1600.2011.00357.x; MELLO NK, 1972, PSYCHOSOM MED, V34, P139, DOI 10.1097/00006842-197203000-00007; Miller R, 2002, BRAIN RES, V950, P137, DOI 10.1016/S0006-8993(02)03014-7; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mizutani A, 2000, J BIOL CHEM, V275, P9823, DOI 10.1074/jbc.275.13.9823; Moonat S, 2013, BIOL PSYCHIAT, V73, P763, DOI 10.1016/j.biopsych.2013.01.012; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Nakamura-Palacios EM, 2014, ALCOHOL CLIN EXP RES, V38, P1126, DOI 10.1111/acer.12308; NG SKC, 1988, NEW ENGL J MED, V319, P666; Nixon K, 2010, ALCOHOL, V44, P39, DOI 10.1016/j.alcohol.2009.11.001; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Orenbuch A, 2012, J NEUROSCI, V32, P3969, DOI 10.1523/JNEUROSCI.5058-11.2012; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Plaisier CL, 2011, NUCLEIC ACIDS RES, V39, pW125, DOI 10.1093/nar/gkr374; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rapanelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014713; Robinson G, 2014, INT REV NEUROBIOL, V118, P13, DOI 10.1016/B978-0-12-801284-0.00002-6; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Saito M, 2002, NEUROCHEM RES, V27, P1221, DOI 10.1023/A:1020937728506; Sawada Y, 2000, BBA-GENE STRUCT EXPR, V1492, P191, DOI 10.1016/S0167-4781(00)00065-8; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soumier A, 2010, EUR NEUROPSYCHOPHARM, V20, P336, DOI 10.1016/j.euroneuro.2009.11.007; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Staffend NA, 2014, DEV NEUROBIOL, V74, P633, DOI 10.1002/dneu.22160; Stepanyan TD, 2008, ALCOHOL CLIN EXP RES, V32, P2128, DOI 10.1111/j.1530-0277.2008.00801.x; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Tapia-Arancibia L, 2001, J NEUROSCI RES, V63, P200, DOI 10.1002/1097-4547(20010115)63:2<200::AID-JNR1012>3.0.CO;2-Q; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Tapocik JD, 2014, J NEUROSCI, V34, P4581, DOI 10.1523/JNEUROSCI.0445-14.2014; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tillo M, 2012, CELL ADHES MIGR, V6, P541, DOI 10.4161/cam.22408; Wang HD, 2004, NEUROPSYCHOPHARMACOL, V29, P1230, DOI 10.1038/sj.npp.1300449; Wang J, 2007, ALCOHOL CLIN EXP RES, V31, P357, DOI 10.1111/j.1530-0277.2006.00331.x; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weitlauf C, 2008, ALCOHOL CLIN EXP RES, V32, P690, DOI 10.1111/j.1530-0277.2008.00625.x; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021100; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107	113	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146257	10.1371/journal.pone.0146257	http://dx.doi.org/10.1371/journal.pone.0146257			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730594	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400131
J	Wang, WJ; Ma, XT; Han, JC; Zhou, MJ; Ren, HH; Pan, QW; Zheng, CL; Zheng, QS				Wang, Wenjuan; Ma, Xiaotang; Han, Jichun; Zhou, Mingjie; Ren, Huanhuan; Pan, Qunwen; Zheng, Chunli; Zheng, Qiusheng			Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor	PLOS ONE			English	Article							BLOOD-FLOW; OXIDATIVE STRESS; ARTERY OCCLUSION; STROKE; INHIBITION; BRAIN; RATS; APOPTOSIS; INFILTRATION; HYPERTENSION	Background and Purpose Previous studies have demonstrated that angiotensin-converting enzyme (ACE) is involved in brain ischemic injury. In the present study, we investigated whether Scutellarin (Scu) exerts neuroprotective effects by down-regulating the Expression of Angiotensin-Converting Enzyme and AT1 receptor in a rat model of permanent focal cerebral ischemia. Methods Adult Sprague-Dawley rats were administrated with different dosages of Scu by oral gavage for 7 days and underwent permanent middle cerebral artery occlusion (pMCAO). Blood pressure was measured 7 days after Scu administration and 24 h after pMCAO surgery by using a noninvasive tail cuff method. Cerebral blood flow (CBF) was determined by Laser Doppler perfusion monitor and the neuronal dysfunction was evaluated by analysis of neurological deficits before being sacrificed at 24 h after pMCAO. Histopathological change, cell apoptosis and infarct area were respectively determined by hematoxylin-eosin staining, terminal deoxynucleotidyl transfer-mediated dUTP nick end labeling (TUNEL) analysis and 2,3,5-triphenyltetrazolium chloride staining. Tissue angiotensin II (Ang II) and ACE activity were detected by enzyme-linked immunosorbent assays. The expression levels of ACE, Ang II type 1 receptor (AT1R), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) were measured by Western blot and real-time PCR. ACE inhibitory activity of Scu in vitro was detected by the photometric determination. Results Scu treatment dose-dependently decreased neurological deficit score, infarct area, cell apoptosis and morphological changes induced by pMCAO, which were associated with reductions of ACE and AT1R expression and the levels of Ang II, TNF-alpha, IL-6, and IL-1 beta in ischemic brains. Scu has a potent ACE inhibiting activity. Conclusion Scu protects brain from acute ischemic injury probably through its inhibitory effect on the ACE/Ang II/AT1 axis, CBF preservation and proinflammation inhibition.	[Wang, Wenjuan; Han, Jichun; Ren, Huanhuan; Zheng, Qiusheng] Shihezi Univ, Sch Pharm, Shihezi, Peoples R China; [Wang, Wenjuan] Hosp Xinjiang Prod & Construct Corps, Div 1, Dept Pharm, Aksu, Xinjiang, Peoples R China; [Zheng, Chunli] Northwest A&F Univ, Coll Life Sci, Yangling, Shanxi, Peoples R China; [Zheng, Qiusheng] Binzhou Med Univ, Yantai, Peoples R China; [Ma, Xiaotang; Pan, Qunwen] Zhanjiang Med Coll, Inst Neurol Dis, Zhanjiang, Guangdong, Peoples R China; [Zhou, Mingjie] Weifang Med Univ, Weifang, Peoples R China	Shihezi University; Northwest A&F University - China; Binzhou Medical University; Weifang Medical University	Zheng, QS (corresponding author), Shihezi Univ, Sch Pharm, Shihezi, Peoples R China.	zqsyt@sohu.com	pan, qunwen/Y-1522-2019; Zheng, Qiusheng/E-1643-2013	Zheng, Qiusheng/0000-0001-6413-9878; Zheng, Qiusheng/0000-0002-5676-1736	National Natural Science Foundation of China [31471338]; Xinjiang Production and Construction Corps for innovation team in key areas [2015BD005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang Production and Construction Corps for innovation team in key areas	This study was supported by the National Natural Science Foundation of China (No. 31471338) to Zheng QS. The authors are especially thankful for funds from the Xinjiang Production and Construction Corps for innovation team in key areas (2015BD005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Tao Lin from the Medical School of Shihezi University for helpful discussions on this work. We especially thank funds of the Xinjiang Production and Construction Corps for innovation team in key areas (2015BD005).	Abdel-Wahab BA, 2014, CHEM-BIOL INTERACT, V216, P43, DOI 10.1016/j.cbi.2014.03.012; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Brdon J, 2007, J HYPERTENS, V25, P187, DOI 10.1097/01.hjh.0000254376.80864.d3; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Chai LJ, 2013, J ETHNOPHARMACOL, V150, P100, DOI 10.1016/j.jep.2013.08.011; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chen SZ, 2009, AM J PHYSIOL-REG I, V297, pR1526, DOI 10.1152/ajpregu.91040.2008; Chrysant Steven G, 2007, J Clin Hypertens (Greenwich), V9, P454, DOI 10.1111/j.1524-6175.2007.06602.x; Della-Morte D, 2011, NEUROSCI LETT, V487, P158, DOI 10.1016/j.neulet.2010.10.013; Elkins JS, 2003, STROKE, V34, P2109, DOI 10.1161/01.STR.0000085829.60324.DE; Guimond MO, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/351758; Guo H, 2011, CHINESE J PHYSIOL, V54, P399, DOI 10.4077/CJP.2011.AMM059; Han JC, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/134862; Iadecola C, 2004, STROKE, V35, P348, DOI 10.1161/01.STR.0000115162.16321.AA; Ilieva I, 2006, EXP EYE RES, V83, P651, DOI 10.1016/j.exer.2006.03.005; Iwanami J, 2007, EUR J PHARMACOL, V566, P153, DOI 10.1016/j.ejphar.2007.03.043; Kobayashi T, 1998, EUR J PHARMACOL, V363, P1, DOI 10.1016/S0014-2999(98)00774-2; LARTAUD I, 1994, AM J PHYSIOL, V267, pR687, DOI 10.1152/ajpregu.1994.267.3.R687; Lee RMKW, 1996, J HYPERTENS, V14, pS29; Li F, 2012, FREE RADICAL RES, V46, P286, DOI 10.3109/10715762.2011.652628; Li SJ, 2012, MOLECULES, V17, P13403, DOI 10.3390/molecules171113403; Li WL, 2008, DEV NEUROBIOL, V68, P1474, DOI 10.1002/dneu.20674; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Lin LL, 2007, J CARDIOVASC PHARM, V50, P327, DOI 10.1097/FJC.0b013e3180cbd0e7; Linz W, 1997, CIRCULATION, V96, P3164, DOI 10.1161/01.CIR.96.9.3164; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maud P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/802539; Miners JS, 2008, NEUROPATH APPL NEURO, V34, P181, DOI 10.1111/j.1365-2990.2007.00885.x; Nag S, 1997, STROKE, V28, P1028, DOI 10.1161/01.STR.28.5.1028; Panahpour Hamdollah, 2012, Iranian Biomedical Journal, V16, P202, DOI 10.6091/IBJ.1096.2012; Park JB, 2011, PHARMACOL REP, V63, P1145; Porritt MJ, 2010, J CEREBR BLOOD F MET, V30, P1520, DOI 10.1038/jcbfm.2010.57; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Rudzinski W, 2007, NUCL MED REV, V10, P29; Saavedra JM, 2007, STRESS, V10, P185, DOI 10.1080/10253890701350735; Saavedra JM, 2012, CELL MOL NEUROBIOL, V32, P667, DOI 10.1007/s10571-011-9754-6; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Scott NJA, 2012, AM J PHYSIOL-ENDOC M, V302, pE576, DOI 10.1152/ajpendo.00222.2011; Shaw L, 2014, EMERG MED J, V31, P994, DOI 10.1136/emermed-2013-202536; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Tanahpour H, 2010, DARU, V18, P35; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Uzar E, 2012, PROG NEURO-PSYCHOPH, V36, P22, DOI 10.1016/j.pnpbp.2011.08.011; Wang S, 2011, NEUROSCIENCE, V185, P150, DOI 10.1016/j.neuroscience.2011.04.005; Wilms Henrik, 2005, Am J Cardiovasc Drugs, V5, P245, DOI 10.2165/00129784-200505040-00004; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zhang HF, 2009, PLANTA MED, V75, P121, DOI 10.1055/s-0028-1088368; Zhao HR, 2015, NEUROCHEM RES, V40, P854, DOI 10.1007/s11064-015-1536-y; Zhao JY, 2014, J NEUROL SCI, V345, P37, DOI 10.1016/j.jns.2014.07.023; Zheng CL, 2014, MOL DIVERS, V18, P621, DOI 10.1007/s11030-014-9521-y; Zhou J, 2006, STROKE, V37, P1271, DOI 10.1161/01.STR.0000217404.64352.d7	53	31	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146197	10.1371/journal.pone.0146197	http://dx.doi.org/10.1371/journal.pone.0146197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730961	Green Published, gold			2022-12-27	WOS:000367801400115
J	Yang, ZT; Yeo, SY; Yin, YX; Lin, ZH; Lee, HM; Xuan, YH; Cui, Y; Kim, SH				Yang, Zhao-Ting; Yeo, So-Young; Yin, Yong-Xue; Lin, Zhen-Hua; Lee, Hak-Min; Xuan, Yan-Hua; Cui, Yan; Kim, Seok-Hyung			Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							EXPRESSION; GROWTH	Background Tenascin-C, an adhesion modulatory extracellular matrix molecule, is highly expressed in numerous human malignancies; thus, it may contribute to carcinogenesis and tumor progression. We explored the clinicopathological significance of Tenascin-C as a prognostic determinant of esophageal squamous cell carcinoma (ESCC). Methods In ESCC patient tissues and cell lines, the presence of isoforms were examined using western blotting. We then investigated Tenascin-C immunohistochemical expression in 136 ESCC tissue samples. The clinical relevance of Tenascin-C expression and the correlation between Tenascin-C expression and expression of other factors related to cancer-associated fibroblasts (CAFs) were also determined. Results Both 250 and 350 kDa sized isoforms of Tenascin-C were expressed only in esophageal cancer tissue not in normal tissue. Furthermore, both isoforms were also identified in all of four CAFs derived from esophageal cancer tissues. Tenascin-C expression was remarkably higher in ESCC than in adjacent non-tumor esophageal epithelium (p < 0.001). Tenascin-C expression in ESCC stromal fibroblasts was associated with patient's age, tumor (pT) stage, lymph node metastasis, clinical stage, and cancer recurrence. Tenascin-C expression in cancer cells was correlated with an increase in tumor-associated macrophage (TAM) population, cancer recurrence, and hypoxia inducible factor1 alpha (HIF1 alpha) expression. Moreover, Tenascin-C overexpression in cancer cells and stromal fibroblasts was an independent poor prognostic factor for overall survival (OS) and disease-free survival (DFS). In the Cox proportional hazard regression model, Tenascin-C overexpression in cancer cells and stromal fibroblasts was a significant independent hazard factor for OS and DFS in ESCC patients in both univariate and multivariate analyses. Furthermore, Tenascin-C expression in stromal fibroblasts of the ESCC patients was positively correlated with platelet-derived growth factor alpha (PDGFR alpha), PDGFR beta, and smooth muscle actin (SMA) expression. The 5-year OS and DFS rates were remarkably lower in patients with positive expressions of both Tenascin-C and PDGFR alpha (p < 0.001), Tenascin-C and PDGFR beta (p < 0.001), Tenascin-C and SMA (p < 0.001), Tenascin-C and fibroblast activation protein (FAP) (p < 0.001), and Tenascin-C and fibroblast-stimulating protein-1 (FSP1) (p < 0.001) in ESCC stromal fibroblasts than in patients with negative expressions of both Tenascin-C and one of the abovementioned CAF markers. Conclusion Our results show that Tenascin-C is a reliable and significant prognostic factor in ESCC. Tenascin-C may thus be a potent ESCC therapeutic target.	[Yang, Zhao-Ting; Yin, Yong-Xue; Lin, Zhen-Hua; Xuan, Yan-Hua] Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji 133002, Peoples R China; [Yang, Zhao-Ting; Lin, Zhen-Hua; Xuan, Yan-Hua] Yanbian Univ, Coll Med, Dept Pathol, Yanji 133002, Peoples R China; [Yeo, So-Young; Lee, Hak-Min; Kim, Seok-Hyung] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul 110745, South Korea; [Yeo, So-Young; Lee, Hak-Min; Kim, Seok-Hyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 110745, South Korea; [Yin, Yong-Xue] Yanbian Univ, Coll Sci, Dept Math, Yanji 133002, Peoples R China; [Cui, Yan] Yanbian Univ, Affiliated Hosp, Dept Oncol, Yanji 133002, Peoples R China	Yanbian University; Yanbian University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yanbian University; Yanbian University	Xuan, YH (corresponding author), Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji 133002, Peoples R China.	xuanyh1@ybu.edu.cn; cuiyan2005@hotmail.com; platoshkim@daum.net			National Natural Science Funds of China [81160315, 81460390, 61371067]; Samsung Biomedical Research Institute Funds [SBRI-CB0-212-1]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C2517]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Samsung Biomedical Research Institute Funds(Samsung); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by grants from National Natural Science Funds of China (81160315 (YHX), 81460390 (YHX) and 61371067 (ZHL)) and Samsung Biomedical Research Institute Funds (SBRI-CB0-212-1(SHK)). And this study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (HI14C2517) Website: www.nsfc.gov.cnhttp://sbri.or.kr; This study was supported by grants from National Natural Science Funds of China (81160315, 81460390). And this study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (HI14C2517)	Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Brellier F, 2012, J CELL MOL MED, V16, P32, DOI 10.1111/j.1582-4934.2011.01360.x; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Gebb SA, 2003, ADV EXP MED BIOL, V543, P117; Ghert MA, 2001, CELL STRUCT FUNCT, V26, P179; Ha SY, 2014, PLOS ONE, V9, P1; Hindermann W, 1999, J PATHOL, V189, P475; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Nong YH, 2015, AM J CANCER RES, V5, P782; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Parekh K, 2005, LUNG CANCER, V47, P17, DOI 10.1016/j.lungcan.2004.05.016; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tastekin D, 2014, TUMOR BIOL, V35, P6619, DOI 10.1007/s13277-014-1875-3; Tsunoda T, 2003, AM J PATHOL, V162, P1857, DOI 10.1016/S0002-9440(10)64320-9; Ueno H, 2015, ANN SURG ONCOL, V22, P1504, DOI 10.1245/s10434-014-4149-9; vanDiest PJ, 1997, J CLIN PATHOL, V50, P801, DOI 10.1136/jcp.50.10.801; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Wu SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023303	21	78	79	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145807	10.1371/journal.pone.0145807	http://dx.doi.org/10.1371/journal.pone.0145807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731558	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400056
J	Florez, AB; Campedelli, I; Delgado, S; Alegria, A; Salvetti, E; Felis, GE; Mayo, B; Torriani, S				Belen Florez, Ana; Campedelli, Ilenia; Delgado, Susana; Alegria, Angel; Salvetti, Elisa; Felis, Giovanna E.; Mayo, Baltasar; Torriani, Sandra			Antibiotic Susceptibility Profiles of Dairy Leuconostoc, Analysis of the Genetic Basis of Atypical Resistances and Transfer of Genes In Vitro and in a Food Matrix	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; COMPLETE GENOME SEQUENCE; MACROLIDE-LINCOSAMIDE-STREPTOGRAMIN; ANTIMICROBIAL SUSCEPTIBILITY; MOLECULAR CHARACTERIZATION; SAFETY ASSESSMENT; SP NOV.; LACTOBACILLUS; TETRACYCLINE; STRAINS	In spite of a global concern on the transfer of antibiotic resistances (AR) via the food chain, limited information exists on this issue in species of Leuconostoc and Weissella, adjunct cultures used as aroma producers in fermented foods. In this work, the minimum inhibitory concentration was determined for 16 antibiotics in 34 strains of dairy origin, belonging to Leuconostoc mesenteroides (18), Leuconostoc citreum (11), Leuconostoc lactis (2), Weissella hellenica (2), and Leuconostoc carnosum (1). Atypical resistances were found for kanamycin (17 strains), tetracycline and chloramphenicol (two strains each), and erythromycin, clindamycin, virginiamycin, ciprofloxacin, and rifampicin (one strain each). Surprisingly, L. mesenteroides subsp. mesenteroides LbE16, showed resistance to four antibiotics, kanamycin, streptomycin, tetracycline and virginiamycin. PCR analysis identified tet(S) as responsible for tetracycline resistance in LbE16, but no gene was detected in a second tetracycline-resistant strain, L. mesenteroides subsp. cremoris LbT16. In Leuconostoc mesenteroides subsp. dextranicum LbE15, erythromycin and clindamycin resistant, an erm(B) gene was amplified. Hybridization experiments proved erm(B) and tet(S) to be associated to a plasmid of approximate to 35 kbp and to the chromosome of LbE15 and LbE16, respectively. The complete genome sequence of LbE15 and LbE16 was used to get further insights on the makeup and genetic organization of AR genes. Genome analysis confirmed the presence and location of erm(B) and tet(S), but genes providing tetracycline resistance in LbT16 were again not identified. In the genome of the multi-resistant strain LbE16, genes that might be involved in aminoglycoside (aadE, aphA-3, sat4) and virginiamycin [vat(E)] resistance were further found. The erm(B) gene but not tet(S) was transferred from Leuconostoc to Enterococcus faecalis both under laboratory conditions and in cheese. This study contributes to the characterization of AR in the Leuconostoc-Weissella group, provides evidence of the genetic basis of atypical resistances, and demonstrates the inter-species transfer of erythromycin resistance.	[Belen Florez, Ana; Delgado, Susana; Alegria, Angel; Mayo, Baltasar] CSIC, IPLA, Dept Microbiol & Bioquim, Villaviciosa, Asturias, Spain; [Campedelli, Ilenia; Alegria, Angel; Salvetti, Elisa; Felis, Giovanna E.; Torriani, Sandra] Univ Verona, Dipartimento Biotecnol, I-37100 Verona, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Verona	Torriani, S (corresponding author), Univ Verona, Dipartimento Biotecnol, I-37100 Verona, Italy.	sandra.torriani@univr.it	Felis, Giovanna/AAX-7268-2020; Felis, Giovanna/ABC-9038-2020; Mayo, Baltasar/D-4855-2011; Delgado, Susana/H-9844-2012; Torriani, Sandra/K-6147-2019	Felis, Giovanna/0000-0002-6506-6911; Mayo, Baltasar/0000-0001-5634-6543; Delgado, Susana/0000-0002-1081-2614; Campedelli, Ilenia/0000-0002-6495-3172; Salvetti, Elisa/0000-0002-7428-8268; Torriani, Sandra/0000-0002-2565-7557; Alegria Gonzalez, Angel/0000-0002-3379-9168	Ministerio de Education y Ciencia [IT2009-0080]; Ministerio dell'Istruzione, dell'Univesita e della Ricerca [IT105MD12L]	Ministerio de Education y Ciencia(Spanish Government); Ministerio dell'Istruzione, dell'Univesita e della Ricerca	This research was partially supported by a Spain-Italy bilateral collaboration program (Ref. Ministerio de Education y Ciencia IT2009-0080, and Ministerio dell'Istruzione, dell'Univesita e della Ricerca IT105MD12L), aiming at the research mobility, to ST and BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimpong DB, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-75; AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Alegria A, 2013, DAIRY SCI TECHNOL, V93, P657, DOI 10.1007/s13594-013-0128-3; Alifano P, 2015, J BIOTECHNOL, V202, P60, DOI 10.1016/j.jbiotec.2014.11.024; Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; Ammor MS, 2008, J MOL MICROB BIOTECH, V14, P6, DOI 10.1159/000106077; [Anonymous], 2009, ENVIRON HEALTH PERSP, V117, pA244, DOI 10.1289/ehp.117-a244; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; Barlow S, 2007, EFSA J, V5, DOI 10.2903/j.efsa.2007.587; Bellanger X, 2014, FEMS MICROBIOL REV, V38, P720, DOI 10.1111/1574-6976.12058; Bjorkroth J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P267, DOI 10.1007/0-387-30744-3_9; BRYAN LE, 1981, J ANTIMICROB CHEMOTH, V8, P1; Campedelli I, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01018-15; Munoz MDC, 2014, INT J FOOD MICROBIOL, V172, P110, DOI 10.1016/j.ijfoodmicro.2013.11.025; CLSI, 2011, M100S21 CLSI, V31; Cocconcelli PS, 2003, INT J FOOD MICROBIOL, V88, P315, DOI 10.1016/S0168-1605(03)00194-6; Danielsen M, 2003, INT J FOOD MICROBIOL, V82, P1, DOI 10.1016/S0168-1605(02)00254-4; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; De Bruyne K, 2007, INT J SYST EVOL MICR, V57, P2952, DOI 10.1099/ijs.0.65292-0; Deng Y, 2012, J MED MICROBIOL, V61, P1621, DOI 10.1099/jmm.0.045161-0; Devirgiliis C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00301; Economou V, 2015, INFECT DRUG RESIST, V8, P49, DOI 10.2147/IDR.S55778; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Florez AB, 2005, CAN J MICROBIOL, V51, P51, DOI 10.1139/W04-114; Florez AB, 2008, INT J FOOD MICROBIOL, V121, P189, DOI 10.1016/j.ijfoodmicro.2007.11.029; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gazzola S, 2012, FOOD MICROBIOL, V30, P348, DOI 10.1016/j.fm.2011.12.005; Geenen PL, 2010, 330334001 RIVM; Gevers D, 2003, APPL ENVIRON MICROB, V69, P1270, DOI 10.1128/AEM.69.2.1270-1275.2003; Giedraitiene A, 2011, MEDICINA-LITHUANIA, V47, P137, DOI 10.3390/medicina47030019; Gomez JAL, 2011, INT J MED MICROBIOL, V301, P165, DOI 10.1016/j.ijmm.2010.08.015; Gu CT, 2012, INT J SYST EVOL MICR, V62, P1548, DOI 10.1099/ijs.0.031203-0; Hemme D, 2004, INT DAIRY J, V14, P467, DOI 10.1016/j.idairyj.2003.10.005; Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820; Hummel A, 2007, SYST APPL MICROBIOL, V30, P1, DOI 10.1016/j.syapm.2006.02.004; Hummel AS, 2007, APPL ENVIRON MICROB, V73, P730, DOI 10.1128/AEM.02105-06; Huys G, 2010, ANTIMICROB AGENTS CH, V54, P2567, DOI 10.1128/AAC.00407-10; Jung JY, 2012, J BACTERIOL, V194, P6672, DOI 10.1128/JB.01805-12; Katla AK, 2001, INT J FOOD MICROBIOL, V67, P147, DOI 10.1016/S0168-1605(00)00522-5; Kim JF, 2008, J BACTERIOL, V190, P3093, DOI 10.1128/JB.01862-07; Klare I, 2005, APPL ENVIRON MICROB, V71, P8982, DOI 10.1128/AEM.71.12.8982-8986.2005; Lampkowska J, 2008, INT J FOOD MICROBIOL, V127, P172, DOI 10.1016/j.ijfoodmicro.2008.06.017; Lee SH, 2012, INT J SYST EVOL MICR, V62, P1098, DOI 10.1099/ijs.0.032367-0; Liu LC, 2008, J ANTIMICROB CHEMOTH, V61, P453, DOI 10.1093/jac/dkm500; Lyhs U, 2015, INT J SYST EVOL MICR, V65, P2586, DOI 10.1099/ijs.0.000305; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marcobal AM, 2008, J BACTERIOL, V190, P564, DOI 10.1128/JB.01457-07; McSweeney PLH, 2000, LAIT, V80, P293, DOI 10.1051/lait:2000127; Morandi S, 2013, J DAIRY RES, V80, P457, DOI 10.1017/S0022029913000447; Nawaz M, 2011, CURR MICROBIOL, V62, P1081, DOI 10.1007/s00284-010-9856-2; Nesmelova IV, 2010, ADV DRUG DELIVER REV, V62, P1187, DOI 10.1016/j.addr.2010.06.006; Nieto-Arribas P, 2010, FOOD MICROBIOL, V27, P85, DOI 10.1016/j.fm.2009.08.006; Ogier JC, 2008, INT J FOOD MICROBIOL, V126, P286, DOI 10.1016/j.ijfoodmicro.2007.08.012; Oh HM, 2010, J BACTERIOL, V192, P3844, DOI 10.1128/JB.00508-10; OSULLIVAN DJ, 1993, APPL ENVIRON MICROB, V59, P2730, DOI 10.1128/AEM.59.8.2730-2733.1993; Ouoba LII, 2008, INT J FOOD MICROBIOL, V121, P217, DOI 10.1016/j.ijfoodmicro.2007.11.018; Punina NV, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0037-z; Qin SS, 2012, ANTIMICROB AGENTS CH, V56, P5332, DOI 10.1128/AAC.00809-12; Rahkila R, 2014, INT J SYST EVOL MICR, V64, P1290, DOI 10.1099/ijs.0.058263-0; Riveros-Mckay F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01130-14; Rizzotti L, 2005, J FOOD PROTECT, V68, P955, DOI 10.4315/0362-028X-68.5.955; Rizzotti L, 2009, ANTON LEEUW INT J G, V96, P43, DOI 10.1007/s10482-009-9334-7; Rizzotti L, 2009, APPL ENVIRON MICROB, V75, P4224, DOI 10.1128/AEM.01380-08; Roberts MC, 2008, FEMS MICROBIOL LETT, V282, P147, DOI 10.1111/j.1574-6968.2008.01145.x; Rodriguez-Alonso P, 2009, J FOOD SCI, V74, pM284, DOI 10.1111/j.1750-3841.2009.01217.x; Rodriguez-Rojas A, 2013, INT J MED MICROBIOL, V303, P293, DOI 10.1016/j.ijmm.2013.02.004; Rojo-Bezares B, 2006, INT J FOOD MICROBIOL, V111, P234, DOI 10.1016/j.ijfoodmicro.2006.06.007; Rossi F, 2014, FOOD MICROBIOL, V42, P232, DOI 10.1016/j.fm.2014.04.004; Ammor MS, 2007, FOOD MICROBIOL, V24, P559, DOI 10.1016/j.fm.2006.11.001; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sambrook J., 2001, MOL CLONING LAB MANU; Sasirekha B, 2014, 3 BIOTECH, V4, P85, DOI 10.1007/s13205-013-0133-5; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taskapilioglu O, 2011, CLIN NEURORADIOL, V21, P235, DOI 10.1007/s00062-011-0054-9; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Thumu SCR, 2012, INDIAN J MICROBIOL, V52, P530, DOI 10.1007/s12088-012-0296-5; Toomey N, 2010, RES MICROBIOL, V161, P127, DOI 10.1016/j.resmic.2009.12.010; Toomey N, 2009, J MICROBIOL METH, V77, P23, DOI 10.1016/j.mimet.2008.12.002; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; van Reenen CA, 2011, ARCH MICROBIOL, V193, P157, DOI 10.1007/s00203-010-0668-3; Vannuffel P, 1996, DRUGS, V51, P20, DOI 10.2165/00003495-199600511-00006; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; Wang HH, 2006, FEMS MICROBIOL LETT, V254, P226, DOI 10.1111/j.1574-6968.2005.00030.x	84	33	33	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145203	10.1371/journal.pone.0145203	http://dx.doi.org/10.1371/journal.pone.0145203			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726815	Green Submitted, gold, Green Published			2022-12-27	WOS:000367681500012
J	Bertuzzi, R; Melegati, J; Bueno, S; Ghiarone, T; Pasqua, LA; Gaspari, AF; Lima-Silva, AE; Goldman, A				Bertuzzi, Romulo; Melegati, Jorge; Bueno, Salomao; Ghiarone, Thaysa; Pasqua, Leonardo A.; Gaspari, Arthur Fernandes; Lima-Silva, Adriano E.; Goldman, Alfredo			GEDAE-LaB: A Free Software to Calculate the Energy System Contributions during Exercise	PLOS ONE			English	Article							PULMONARY OXYGEN-UPTAKE; MUSCLE; COST; EXPENDITURE; RESYNTHESIS; PHOSPHATES; ENERGETICS; INTENSITY; KINETICS; OLDER	Purpose The aim of the current study is to describe the functionality of free software developed for energy system contributions and energy expenditure calculation during exercise, namely GEDAE-LaB. Methods Eleven participants performed the following tests: 1) a maximal cycling incremental test to measure the ventilatory threshold and maximal oxygen uptake ((V)over dot O(2)max); 2) a cycling workload constant test at moderate domain (90% ventilatory threshold); 3) a cycling workload constant test at severe domain (110% (V)over dot O(2)max). Oxygen uptake and plasma lactate were measured during the tests. The contributions of the aerobic (A(MET)), anaerobic lactic (LA(MET)), and anaerobic alactic (AL(MET)) systems were calculated based on the oxygen uptake during exercise, the oxygen energy equivalents provided by lactate accumulation, and the fast component of excess post-exercise oxygen consumption, respectively. In order to assess the intra-investigator variation, four different investigators performed the analyses independently using GEDAE-LaB. A direct comparison with commercial software was also provided. Results All subjects completed 10 min of exercise at moderate domain, while the time to exhaustion at severe domain was 144 +/- 65 s. The A(MET), LA(MET), and AL(MET) contributions during moderate domain were about 93, 2, and 5%, respectively. The A(MET), LA(MET), and AL(MET) contributions during severe domain were about 66, 21, and 13%, respectively. No statistical differences were found between the energy system contributions and energy expenditure obtained by GEDAE-LaB and commercial software for both moderate and severe domains (P > 0.05). The ICC revealed that these estimates were highly reliable among the four investigators for both moderate and severe domains (all ICC >= 0.94). Conclusion These findings suggest that GEDAE-LaB is a free software easily comprehended by users minimally familiarized with adopted procedures for calculations of energetic profile using oxygen uptake and lactate accumulation during exercise. By providing availability of the software and its source code we hope to facilitate future related research.	[Bertuzzi, Romulo; Bueno, Salomao; Pasqua, Leonardo A.; Gaspari, Arthur Fernandes] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp GEDAE USP, Sao Paulo, Brazil; [Ghiarone, Thaysa; Lima-Silva, Adriano E.] Univ Fed Pernambuco, Dept Phys Educ & Sports Sci CAV, Sports Sci Res Grp, Recife, PE, Brazil; [Melegati, Jorge; Goldman, Alfredo] Univ Sao Paulo, Dept Comp Sci, Syst & Software Grp, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Pernambuco; Universidade de Sao Paulo	Bertuzzi, R (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp GEDAE USP, Sao Paulo, Brazil.	bertuzzi@usp.br	Lima-Silva, Adriano/Y-2404-2019; Lima-Silva, Adriano Eduardo/C-2800-2013; Bertuzzi, Romulo/E-7048-2012; Melegati, Jorge/AAG-3925-2021; Goldman, Alfredo/J-3739-2017	Lima-Silva, Adriano/0000-0002-0613-5104; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; Melegati, Jorge/0000-0003-1303-4173; Goldman, Alfredo/0000-0001-5746-4154	NAPSoL; CAPES; CNPq	NAPSoL; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by NAPSoL, CAPES, and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneke R, 2004, EUR J APPL PHYSIOL, V92, P518, DOI 10.1007/s00421-004-1073-x; Beneke R, 2002, EUR J APPL PHYSIOL, V87, P388, DOI 10.1007/s00421-002-0622-4; Bertuzzi RCM, 2010, INT J SPORTS MED, V31, P477, DOI 10.1055/s-0030-1253375; Bertuzzi R, 2013, J SPORT SCI MED, V12, P454; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Bertuzzi RCD, 2007, EUR J APPL PHYSIOL, V101, P293, DOI 10.1007/s00421-007-0501-0; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Fernandes AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109954; FRANCESCATO MP, 1995, EUR J APPL PHYSIOL, V71, P355, DOI 10.1007/BF00240417; Gastin P. B., 1994, Scandinavian Journal of Medicine and Science in Sports, V4, P91; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; GREEN S, 1995, SPORTS MED, V19, P32, DOI 10.2165/00007256-199519010-00003; Guidetti L, 2008, EUR J APPL PHYSIOL, V103, P315, DOI 10.1007/s00421-008-0705-y; Guidetti L, 2007, EUR J APPL PHYSIOL, V99, P275, DOI 10.1007/s00421-006-0348-9; Hall KS, 2014, MED SCI SPORT EXER, V46, P2335, DOI 10.1249/MSS.0000000000000356; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Hunter GR, 2003, J STRENGTH COND RES, V17, P76, DOI 10.1519/00124278-200302000-00013; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kent Beck, 2000, EXTREME PROGRAMMING; Margaria R, 1933, AM J PHYSIOL, V106, P689, DOI 10.1152/ajplegacy.1933.106.3.689; Mazzetti S, 2007, MED SCI SPORT EXER, V39, P1291, DOI 10.1249/mss.0b013e318058a603; McCreary CR, 1996, J APPL PHYSIOL, V81, P1331, DOI 10.1152/jappl.1996.81.3.1331; McMahon S, 2002, SPORTS MED, V32, P761, DOI 10.2165/00007256-200232120-00002; MEDBO JI, 1988, J APPL PHYSIOL, V64, P50, DOI 10.1152/jappl.1988.64.1.50; Neder JA, 2006, MED SCI SPORT EXER, V38, P1007, DOI 10.1249/01.mss.0000218141.90442.6c; Ozyener F, 2001, J PHYSIOL-LONDON, V533, P891, DOI 10.1111/j.1469-7793.2001.t01-1-00891.x; PIIPER J, 1970, J APPL PHYSIOL, V28, P657, DOI 10.1152/jappl.1970.28.5.657; Scott CB, 2006, J STRENGTH COND RES, V20, P404; Silva-Batista C, 2013, J STRENGTH COND RES, V27, P3481, DOI 10.1519/JSC.0b013e31828f1efa; Silva-Cavalcante MD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075399, 10.1371/journal.pone.0072025]; VANDEWALLE H, 1987, SPORTS MED, V4, P268, DOI 10.2165/00007256-198704040-00004	32	23	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145733	10.1371/journal.pone.0145733	http://dx.doi.org/10.1371/journal.pone.0145733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727499	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500030
J	Ikuta, T; Sellak, H; Odo, N; Adekile, AD; Gaensler, KML				Ikuta, Tohru; Sellak, Hassan; Odo, Nadine; Adekile, Adekunle D.; Gaensler, Karin M. L.			Nitric Oxide-cGMP Signaling Stimulates Erythropoiesis through Multiple Lineage-Specific Transcription Factors: Clinical Implications and a Novel Target for Erythropoiesis	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; SOLUBLE GUANYLATE-CYCLASE; GLOBIN GENE-EXPRESSION; CAMP-DEPENDENT PATHWAY; SMOOTH-MUSCLE-CELLS; RED-BLOOD-CELLS; FETAL-HEMOGLOBIN; IN-VITRO; TRANSGENIC MICE; HYDROXYUREA	Much attention has been directed to the physiological effects of nitric oxide (NO)-cGMP signaling, but virtually nothing is known about its hematologic effects. We reported for the first time that cGMP signaling induces human gamma-globin gene expression. Aiming at developing novel therapeutics for anemia, we examined here the hematologic effects of NO-cGMP signaling in vivo and in vitro. We treated wild-type mice with NO to activate soluble guanylate cyclase (sGC), a key enzyme of cGMP signaling. Compared to untreated mice, NO-treated mice had higher red blood cell counts and total hemoglobin but reduced leukocyte counts, demonstrating that when activated, NO-cGMP signaling exerts hematopoietic effects on multiple types of blood cells in vivo. We next generated mice which overexpressed rat sGC in erythroid and myeloid cells. The forced expression of sGCs activated cGMP signaling in both lineage cells. Compared with non-transgenic littermates, sGC mice exhibited hematologic changes similar to those of NO-treated mice. Consistently, a membrane-permeable cGMP enhanced the differentiation of hematopoietic progenitors toward erythroid-lineage cells but inhibited them toward myeloid-lineage cells by controlling multiple lineage-specific transcription factors. Human gamma-globin gene expression was induced at low but appreciable levels in sGC mice carrying the human beta-globin locus. Together, these results demonstrate that NO-cGMP signaling is capable of stimulating erythropoiesis in both in vitro and vivo settings by controlling the expression of multiple lineage-specific transcription factors, suggesting that cGMP signaling upregulates erythropoiesis at the level of gene transcription. The NO-cGMP signaling axis may constitute a novel target to stimulate erythropoiesis in vivo.	[Ikuta, Tohru; Sellak, Hassan; Odo, Nadine] Georgia Regents Univ, Med Coll Georgia, Dept Anesthesiol & Perioperat Med, Augusta, GA 30912 USA; [Adekile, Adekunle D.] Kuwait Univ, Fac Med, Dept Paediat, Safat, Kuwait; [Gaensler, Karin M. L.] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA USA	University System of Georgia; Augusta University; Kuwait University; University of California System; University of California San Francisco	Ikuta, T (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Anesthesiol & Perioperat Med, Augusta, GA 30912 USA.	tikuta@gru.edu	Odo, Nadine/AAV-5466-2021	Odo, Nadine/0000-0003-4103-1404	National Institutes of Health USA [DK61806, HL73452, MD003383]; American Heart Association USA [15GRNT25710387]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061806] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD003383] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association USA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants from National Institutes of Health USA (DK61806, HL73452, and MD003383 to T.I.) and from the American Heart Association USA (15GRNT25710387 to T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Almeida CB, 2012, BLOOD, V120, P2879, DOI 10.1182/blood-2012-02-409524; Anstey NM, 1999, AM J TROP MED HYG, V61, P249, DOI 10.4269/ajtmh.1999.61.249; Ashmore T, 2015, FASEB J, V29, P1102, DOI 10.1096/fj.14-263004; Bailey L, 2007, BRIT J HAEMATOL, V138, P382, DOI 10.1111/j.1365-2141.2007.06673.x; Blaylock MG, 1998, FREE RADICAL BIO MED, V25, P748, DOI 10.1016/S0891-5849(98)00108-7; Brawley OW, 2008, ANN INTERN MED, V148, P932, DOI 10.7326/0003-4819-148-12-200806170-00220; Carlstrom M, 2010, P NATL ACAD SCI USA, V107, P17716, DOI 10.1073/pnas.1008872107; CHARACHE S, 1992, BLOOD, V79, P2555; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Choi JW, 2002, ANN HEMATOL, V81, P1, DOI 10.1007/s00277-001-0409-4; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; Conran N, 2004, BRIT J HAEMATOL, V124, P547, DOI 10.1111/j.1365-2141.2004.04810.x; Conran N, 2007, ANN HEMATOL, V86, P255, DOI 10.1007/s00277-006-0246-6; DELEO VA, 1976, AM J MED, V60, P8, DOI 10.1016/0002-9343(76)90528-3; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; Filippov G, 1997, J CLIN INVEST, V100, P942, DOI 10.1172/JCI119610; Fisher JW, 2003, EXP BIOL MED, V228, P1; Fukumoto S, 1999, CIRC RES, V85, P985; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Ghoshal P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099363; Ghoshal P, 2009, CANCER RES, V69, P4380, DOI 10.1158/0008-5472.CAN-08-3467; Gladwin MT, 2002, BRIT J HAEMATOL, V116, P436, DOI 10.1046/j.1365-2141.2002.03274.x; Gutsaeva DR, 2014, BLOOD, V123, P1917, DOI 10.1182/blood-2013-06-510180; Head CA, 1997, J CLIN INVEST, V100, P1193, DOI 10.1172/JCI119631; HIRSCH RE, 1991, AM J HEMATOL, V36, P147, DOI 10.1002/ajh.2830360215; Ho JA, 2003, EXP HEMATOL, V31, P586, DOI 10.1016/S0301-472X(03)00086-9; Hobbs AJ, 1997, TRENDS PHARMACOL SCI, V18, P484, DOI 10.1016/S0165-6147(97)01137-1; Ignarro L J, 1994, Adv Pharmacol, V26, P35, DOI 10.1016/S1054-3589(08)60050-2; IGNARRO LJ, 1984, J BIOL CHEM, V259, P6201; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Ignarro LJ, 1996, KIDNEY INT, pS2; Ikuta T, 1999, BLOOD, V94, p615A; Ikuta T, 2001, P NATL ACAD SCI USA, V98, P1847, DOI 10.1073/pnas.041599798; Ikuta T, 2011, BLOOD CELL MOL DIS, V47, P235, DOI 10.1016/j.bcmd.2011.08.005; Ikuta T, 2011, ARCH BIOCHEM BIOPHYS, V510, P53, DOI 10.1016/j.abb.2011.03.013; Jiang JJ, 1997, MOL PHARMACOL, V52, P1081, DOI 10.1124/mol.52.6.1081; Jin RC, 2010, J BLOOD MED, V1, P147; King SB, 2004, FREE RADICAL BIO MED, V37, P737, DOI 10.1016/j.freeradbiomed.2004.02.073; Kuroyanagi Y, 2006, BIOCHEM BIOPH RES CO, V344, P1038, DOI 10.1016/j.bbrc.2006.03.203; Lanaro C, 2009, J LEUKOCYTE BIOL, V85, P235, DOI 10.1189/jlb.0708445; Lutton JD, 1997, P NATL ACAD SCI USA, V94, P1432, DOI 10.1073/pnas.94.4.1432; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Manodori AB, 2002, J LAB CLIN MED, V140, P161, DOI 10.1067/mlc.2002.126504; Manwani D, 2013, BLOOD, V122, P3892, DOI 10.1182/blood-2013-05-498311; Martinez-Ruiz R, 2001, ANESTHESIOLOGY, V94, P1113, DOI 10.1097/00000542-200106000-00028; MONCADA S, 1991, PHARMACOL REV, V43, P109; Pacelli R, 1996, LANCET, V347, P900, DOI 10.1016/S0140-6736(96)91378-1; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; Reeves PG, 2005, J NUTR, V135, P92, DOI 10.1093/jn/135.1.92; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; RODGERS GP, 1990, NEW ENGL J MED, V322, P1037, DOI 10.1056/NEJM199004123221504; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; TEITZ T, 1994, DNA CELL BIOL, V13, P705, DOI 10.1089/dna.1994.13.705; Tsui AKY, 2011, P NATL ACAD SCI USA, V108, P17544, DOI 10.1073/pnas.1114026108; YARBRO JW, 1992, SEMIN ONCOL, V19, P1	61	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0144561	10.1371/journal.pone.0144561	http://dx.doi.org/10.1371/journal.pone.0144561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727002	Green Submitted, gold, Green Published			2022-12-27	WOS:000367681500004
J	Liu, J; Dong, M; Sun, XR; Li, WW; Xing, LG; Yu, JM				Liu, Jing; Dong, Min; Sun, Xiaorong; Li, Wenwu; Xing, Ligang; Yu, Jinming			Prognostic Value of F-18-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; TOTAL LESION GLYCOLYSIS; METABOLIC TUMOR BURDEN; STAGE-I; VOLUMETRIC PARAMETERS; FDG PET/CT; F-18-FLUORODEOXYGLUCOSE UPTAKE; DISEASE PROGRESSION; SURVIVAL	Background The identification of surgical non-small cell lung cancer (NSCLC) patients with poor prognosis is a priority in clinical oncology because of their high 5-year mortality. This meta-analysis explored the prognostic value of maximal standardized uptake value (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) on disease-free survival (DFS) and overall survival (OS) in surgical NSCLC patients. Materials and Methods MEDLINE, EMBASE and Cochrane Libraries were systematically searched until August 1, 2015. Prospective or retrospective studies that evaluated the prognostic roles of preoperative 18F-FDG PET/CT with complete DFS and OS data in surgical NSCLC patients were included. The impact of SUVmax, MTV or TLG on survival was measured using hazard ratios (HR). Sub-group analyses were performed based on disease stage, pathological classification, surgery only and cut-off values. Results Thirty-six studies comprised of 5807 patients were included. The combined HRs for DFS were 2.74 (95% CI 2.33-3.24, unadjusted) and 2.43 (95% CI: 1.76-3.36, adjusted) for SUVmax, 2.27 (95% CI 1.77-2.90, unadjusted) and 2.49 (95% CI 1.23-5.04, adjusted) for MTV, and 2.46 (95% CI 1.91-3.17, unadjusted) and 2.97 (95% CI 1.68-5.28, adjusted) for TLG. The pooled HRs for OS were 2.54 (95% CI 1.86-3.49, unadjusted) and 1.52 (95% CI 1.16-2.00, adjusted) for SUVmax, 2.07 (95% CI 1.16-3.69, unadjusted) and 1.91 (95% CI 1.13-3.22, adjusted) for MTV, and 2.47 (95% CI 1.38-4.43, unadjusted) and 1.94 (95% CI 1.12-3.33, adjusted) for TLG. Begg's test detected publication bias, the trim and fill procedure was performed, and similar HRs were obtained. The prognostic role of SUVmax, MTV and TLG remained similar in the sub-group analyses. Conclusions High values of SUVmax, MTV and TLG predicted a higher risk of recurrence or death in patients with surgical NSCLC. We suggest the use of FDG PET/CT to select patients who are at high risk of disease recurrence or death and may benefit from aggressive treatments.	[Liu, Jing; Xing, Ligang; Yu, Jinming] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China; [Liu, Jing; Xing, Ligang; Yu, Jinming] Shandong Canc Hosp & Inst, Shandong Key Lab Radiat Oncol, Jinan, Shandong, Peoples R China; [Dong, Min] Peoples Hosp Pingyi Cty, Dept Oncol, Pingyi, Shandong, Peoples R China; [Sun, Xiaorong; Li, Wenwu] Shandong Canc Hosp & Inst, Dept Radiol, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Xing, LG (corresponding author), Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China.	xinglg@medmail.com.cn			National Health and Family Planning Commission Institutes of the People's Republic of China [201402011]; National Natural Science Foundation of China [81272502, L1322016]	National Health and Family Planning Commission Institutes of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the grant from National Health and Family Planning Commission Institutes of the People's Republic of China (201402011), and the grants from National Natural Science Foundation of China (81272502 and L1322016) to LX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2010, EUR J NUCL MED MOL I, V37, P691, DOI 10.1007/s00259-009-1291-x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berghmans T, 2008, J THORAC ONCOL, V3, P6, DOI 10.1097/JTO.0b013e31815e6d6b; Bille A, 2013, CLIN LUNG CANCER, V14, P149, DOI 10.1016/j.cllc.2012.04.007; Boellaard R, 2004, J NUCL MED, V45, P1519; Cistaro A, 2013, RADIOL ONCOL, V47, P219, DOI 10.2478/raon-2013-0023; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Davison J, 2013, AM J ROENTGENOL, V200, P635, DOI 10.2214/AJR.12.9138; Dhital K, 2000, EUR J CARDIO-THORAC, V18, P425, DOI 10.1016/S1010-7940(00)00535-2; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Domachevsky L, 2015, EUR RADIOL, V25, P3361, DOI 10.1007/s00330-015-3754-8; Dooms C, 2009, J THORAC ONCOL, V4, P822, DOI 10.1097/JTO.0b013e3181a97df7; Downey RJ, 2007, J THORAC CARDIOV SUR, V133, P1419, DOI 10.1016/j.jtcvs.2007.01.041; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goodgame B, 2008, J THORAC ONCOL, V3, P130, DOI 10.1097/JTO.0b013e318160c122; Hanin FX, 2008, EUR J CARDIO-THORAC, V33, P819, DOI 10.1016/j.ejcts.2008.02.005; Higashi K, 2002, J NUCL MED, V43, P39; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hyun SH, 2013, ANN SURG, V257, P364, DOI 10.1097/SLA.0b013e318262a6ec; Im HJ, 2015, EUR J NUCL MED MOL I, V42, P241, DOI 10.1007/s00259-014-2903-7; Kang SR, 2014, NUCL MED MOLEC IMAG, V48, P16, DOI 10.1007/s13139-013-0231-7; Kim DH, 2014, ANN SURG ONCOL, V21, P589, DOI 10.1245/s10434-013-3270-5; Kim HR, 2009, EUR J CARDIO-THORAC, V35, P712, DOI 10.1016/j.ejcts.2008.12.030; Kim K, 2012, NUCL MED COMMUN, V33, P613, DOI 10.1097/MNM.0b013e328351d4f5; Kim YS, 2011, NEOPLASMA, V58, P245, DOI 10.4149/neo_2011_03_245; Ko KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000434; Koo HK, 2011, LUNG CANCER, V73, P222, DOI 10.1016/j.lungcan.2010.11.013; Lee P, 2007, INT J RADIAT ONCOL, V69, P328, DOI 10.1016/j.ijrobp.2007.04.036; Lin Y, 2012, ANTICANCER RES, V32, P5087; Machtay M, 2013, J CLIN ONCOL, V31, P3823, DOI 10.1200/JCO.2012.47.5947; Melloni G, 2013, EJSO-EUR J SURG ONC, V39, P1254, DOI 10.1016/j.ejso.2013.07.092; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moon SH, 2013, KOREAN J RADIOL, V14, P1, DOI 10.3348/kjr.2013.14.1.1; Motono N, 2014, ASIAN PAC J CANCER P, V15, P10171, DOI 10.7314/APJCP.2014.15.23.10171; Na FF, 2014, J THORAC ONCOL, V9, P834, DOI 10.1097/JTO.0000000000000185; Nair VS, 2009, J THORAC ONCOL, V4, P1473, DOI 10.1097/JTO.0b013e3181bccbc6; Nair VS, 2010, CHEST, V137, P1150, DOI 10.1378/chest.09-2356; Naruke T, 2001, ANN THORAC SURG, V71, P1759, DOI 10.1016/S0003-4975(00)02609-6; Ohtaka K, 2013, ANTICANCER RES, V33, P5193; Ohtsuka T, 2006, CANCER, V107, P2468, DOI 10.1002/cncr.22268; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Paidpally Vasavi, 2012, Imaging Med, V4, P633; Pak K, 2014, J NUCL MED, V55, P884, DOI 10.2967/jnumed.113.133801; Pan LL, 2009, EUR J GASTROEN HEPAT, V21, P1008, DOI 10.1097/MEG.0b013e328323d6fa; Park SY, 2015, J NUCL MED, V56, P45, DOI 10.2967/jnumed.114.147561; Pelosi E, 2011, Q J NUCL MED MOL IM, V55, P72; Shimizu K, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-343; Shiono S, 2011, J THORAC ONCOL, V6, P43, DOI 10.1097/JTO.0b013e3181f9abca; Stahl A, 2004, EUR J NUCL MED MOL I, V31, P1471, DOI 10.1007/s00259-004-1626-6; Stiles BM, 2013, ANN THORAC SURG, V95, P397, DOI 10.1016/j.athoracsur.2012.07.038; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tixier F, 2014, J NUCL MED, V55, P1235, DOI 10.2967/jnumed.113.133389; Tomita M, 2012, ASIA-PAC J CLIN ONCO, V8, P244, DOI 10.1111/j.1743-7563.2012.01549.x; Tsutani Y, 2011, JPN J CLIN ONCOL, V41, P890, DOI 10.1093/jjco/hyr062; Um SW, 2009, J THORAC ONCOL, V4, P1331, DOI 10.1097/JTO.0b013e3181b6be3e; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; van Baardwijk A, 2007, EUR J CANCER, V43, P1392, DOI 10.1016/j.ejca.2007.03.027; Vesselle H, 2007, CLIN CANCER RES, V13, P3255, DOI 10.1158/1078-0432.CCR-06-1128; Yoo IR, 2014, BIO-MED MATER ENG, V24, P3091, DOI 10.3233/BME-141131; Zhang H, 2013, ACAD RADIOL, V20, P32, DOI 10.1016/j.acra.2012.07.002; Zhang ZJ, 2007, CHINESE MED J-PEKING, V120, P125, DOI 10.1097/00029330-200701020-00010; Zheng XP, 2014, INT J RADIAT ONCOL, V90, P603, DOI 10.1016/j.ijrobp.2014.05.055; Zhu AZ, 2011, SEMIN ONCOL, V38, P55, DOI 10.1053/j.seminoncol.2010.11.012	66	109	114	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146195	10.1371/journal.pone.0146195	http://dx.doi.org/10.1371/journal.pone.0146195			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727114	Green Published, gold			2022-12-27	WOS:000367681500065
J	Slade, J; Hall, JV; Kintner, J; Schoborg, RV				Slade, Jessica; Hall, Jennifer V.; Kintner, Jennifer; Schoborg, Robert V.			Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; IMMUNE-RESPONSES; TYPE-2 INFECTION; GLYCOPROTEIN-D; SEX WORKERS; NK CELLS; TRACHOMATIS; MICE; HIV; RECOGNITION	Chlamydia trachomatis and Herpes Simplex Virus-2 (HSV-2) genital tract co-infections have been reported in humans and studied in vitro but the clinical consequences are unknown. Limited epidemiologic evidence suggests that these co-infections could be more severe than single infections of either pathogen, but the host-pathogen interactions during co-infection remain uncharacterized. To determine whether disease progression and/or pathogen shedding differs between singly-infected and super-infected animals, we developed an in vivo super-infection model in which female BALB/c mice were vaginally infected with Chlamydia muridarum (Cm) followed later by HSV-2. Pre-infection with Chlamydia 3 or 9 days prior to HSV-2 super-infection conferred significant protection from HSV-2-induced neurologic disease and significantly reduced viral recovery compared to HSV-2 singly-infected controls. Neither protection from mortality nor reduced viral recovery were observed when mice were i) super-infected with HSV-2 on day 27 post Cm; ii) infected with UV-irradiated Cm and super-infected with HSV-2; or iii) azithromycin-treated prior to HSV-2 super-infection. Therefore, protection from HSV-2-induced disease requires active infection with viable chlamydiae and is not observed after chlamydial shedding ceases, either naturally or due to antibiotic treatment. Thus, Chlamydia-induced protection is transient and requires the continued presence of chlamydiae or their components. These data demonstrate that chlamydial pre-infection can alter progression of subsequent HSV-2 infection, with implications for HSV-2 transmission from co-infected humans.	[Slade, Jessica; Hall, Jennifer V.; Kintner, Jennifer; Schoborg, Robert V.] E Tennessee State Univ, Dept Biomed Sci, Ctr Inflammat Infect Dis & Immun, James H Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University	Schoborg, RV (corresponding author), E Tennessee State Univ, Dept Biomed Sci, Ctr Inflammat Infect Dis & Immun, James H Quillen Coll Med, Johnson City, TN 37614 USA.	schoborg@etsu.edu			National Institutes of Health, National Institute of Allergy and Infectious Diseases [5R01AI095637-04]; ETSU Biomedical Sciences Graduate Program; National Institutes of Health, National Center for Research Resources [1C06RR030651-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095637] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ETSU Biomedical Sciences Graduate Program; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health, National Institute of Allergy and Infectious Diseases grant number 5R01AI095637-04 awarded to RVS. We would also like to thank the ETSU Biomedical Sciences Graduate Program for providing financial support to JS. This work was also supported by the National Institutes of Health, National Center for Research Resources grant number 1C06RR030651-01 awarded to Dr. Gregory Ordway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006; Bochud PY, 2007, J INFECT DIS, V196, P505, DOI 10.1086/519693; Brunham RC, 1996, J INFECT DIS, V173, P950, DOI 10.1093/infdis/173.4.950; Campbell RP, 2012, MICROBES INFECT, V14, P1177, DOI 10.1016/j.micinf.2012.07.017; Centers for Disease Control and Prevention, 2012, SEX TRANSM DIS SURV; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 2001, INFECT IMMUN, V69, P3556, DOI 10.1128/IAI.69.6.3556-3561.2001; Deka S, 2006, CELL MICROBIOL, V8, P149, DOI 10.1111/j.1462-5822.2005.00608.x; Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714; Derbigny WA, 2012, INFECT IMMUN, V80, P254, DOI 10.1128/IAI.05549-11; Docherty JJ, 2005, ANTIVIR RES, V67, P155, DOI 10.1016/j.antiviral.2005.06.008; DOMKEOPITZ I, 1986, J VIROL, V60, P37, DOI 10.1128/JVI.60.1.37-42.1986; Fageeh Wafa M K, 2013, BMC Res Notes, V6, P301, DOI 10.1186/1756-0500-6-301; Finan RR, 2006, CLIN MICROBIOL INFEC, V12, P927, DOI 10.1111/j.1469-0691.2006.01479.x; Gill N, 2011, CELL IMMUNOL, V269, P29, DOI 10.1016/j.cellimm.2011.03.007; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Herbst-Kralovetz MM, 2006, J VIROL, V80, P9988, DOI 10.1128/JVI.01099-06; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kajaia D, 2006, GEORGIAN MED NEWS, P27; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kimani J, 1996, J INFECT DIS, V173, P1437, DOI 10.1093/infdis/173.6.1437; LEHTINEN M, 1985, J MED VIROL, V16, P245, DOI 10.1002/jmv.1890160305; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Linehan MM, 2004, J VIROL, V78, P2530, DOI 10.1128/JVI.78.5.2530-2536.2004; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Malhotra M, 2013, INDIAN J MED RES, V138, P303; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Milligan GN, 1997, VIROLOGY, V229, P259, DOI 10.1006/viro.1997.8441; MORAHAN PS, 1977, J IMMUNOL, V119, P2030; Morrison SG, 2000, INFECT IMMUN, V68, P2870, DOI 10.1128/IAI.68.5.2870-2879.2000; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; O'Meara CP, 2014, CURR MOL MED, V14, P396, DOI 10.2174/15665240113136660078; Paavonen J, 1999, HUM REPROD UPDATE, V5, P433, DOI 10.1093/humupd/5.5.433; Page KR, 2005, INFECT IMMUN, V73, P8369, DOI 10.1128/IAI.73.12.8369-8380.2005; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; PAROLI E, 1990, EUR J EPIDEMIOL, V6, P329, DOI 10.1007/BF00150443; Phillips-Campbell R, 2014, ANTIMICROB AGENTS CH, V58, P1782, DOI 10.1128/AAC.02097-13; Prantner D, 2011, INFECT IMMUN, V79, P3922, DOI 10.1128/IAI.00140-11; Qi ZM, 2013, TOHOKU J EXP MED, V229, P87, DOI 10.1620/tjem.229.87; Ramsey KH, 2009, INFECT IMMUN, V77, P3284, DOI 10.1128/IAI.00147-09; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Roizman B, 2001, FIELDS VIROLOGY, P2399; Santiago HC, 1999, INFECT IMMUN, V67, P4939, DOI 10.1128/IAI.67.9.4939-4944.1999; SARTIN JS, 1995, J AM ACAD DERMATOL, V32, P255, DOI 10.1016/0190-9622(95)90136-1; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Shaw SY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S4; Stiles KM, 2010, VIROLOGY, V399, P109, DOI 10.1016/j.virol.2009.12.034; Sun JR, 2009, MICROBES INFECT, V11, P12, DOI 10.1016/j.micinf.2008.10.001; Tsay Cynthia J., 2013, Yale Journal of Biology and Medicine, V86, P245; Tseng CTK, 1998, INFECT IMMUN, V66, P5867, DOI 10.1128/IAI.66.12.5867-5875.1998; Vanover J, 2010, MICROBIOL-SGM, V156, P1294, DOI 10.1099/mic.0.036566-0; Vanover J, 2008, MICROBIOL-SGM, V154, P971, DOI 10.1099/mic.0.2007/012161-0; VETTER KM, 1990, GENITOURIN MED, V66, P182; Wira CR, 2011, AM J REPROD IMMUNOL, V65, P196, DOI 10.1111/j.1600-0897.2011.00970.x; World Health Organization, 2011, GLOB INC PREV SEL CU; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Yao XD, 2011, J GEN VIROL, V92, P1981, DOI 10.1099/vir.0.030296-0	63	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146186	10.1371/journal.pone.0146186	http://dx.doi.org/10.1371/journal.pone.0146186			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726882	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500063
J	Zhao, J; Li, P; Zhou, XZ				Zhao, Jing; Li, Peng; Zhou, Xizhao			Capacity Estimation Model for Signalized Intersections under the Impact of Access Point	PLOS ONE			English	Article							CAR-FOLLOWING MODEL; TRAFFIC FLOW MODEL; CRUISE CONTROL-SYSTEMS; LATTICE MODEL; FUEL CONSUMPTION; DRIVERS ANTICIPATION; DRIVING BEHAVIOR; LATE ARRIVAL; MACRO MODEL; DYNAMIC USE	Highway Capacity Manual 2010 provides various factors to adjust the base saturation flow rate for the capacity analysis of signalized intersections. No factors, however, is considered for the potential change of signalized intersections capacity caused by the access point closeing to the signalized intersection. This paper presented a theoretical model to estimate the lane group capacity at signalized intersections with the consideration of the effects of access points. Two scenarios of access point locations, upstream or downstream of the signalized intersection, and impacts of six types of access traffic flow are taken into account. The proposed capacity model was validated based on VISSIM simulation. Results of extensive numerical analysis reveal the substantial impact of access point on the capacity, which has an inverse correlation with both the number of major street lanes and the distance between the intersection and access point. Moreover, among the six types of access traffic flows, the access traffic flow 1 (right-turning traffic from major street), flow 4 (left-turning traffic from access point), and flow 5 (left-turning traffic from major street) cause a more significant effect on lane group capacity than others. Some guidance on the mitigation of the negative effect is provided for practitioners.	[Zhao, Jing; Zhou, Xizhao] Univ Shanghai Sci & Technol, Dept Transportat Engn, Shanghai, Peoples R China; [Li, Peng] Univ Wisconsin, Dept Civil Engn & Mech, Milwaukee, WI 53201 USA; [Zhou, Xizhao] Shanghai Maritime Univ, Sch Econ & Management, Shanghai, Peoples R China	University of Shanghai for Science & Technology; University of Wisconsin System; University of Wisconsin Milwaukee; Shanghai Maritime University	Zhao, J (corresponding author), Univ Shanghai Sci & Technol, Dept Transportat Engn, Shanghai, Peoples R China.	jing_zhao_traffic@163.com	Zhao, Jing/AAW-9779-2020; Li, Peng/ABE-8933-2020	Zhao, Jing/0000-0003-0741-4911; Li, Peng/0000-0003-0810-3947	Science and Technology Commission [13510501700]	Science and Technology Commission	This work received support from the Science and Technology Commission of (http://www.stcsm.gov.cn/, grant number 13510501700, XZ).	AASHTO, 2011, POLICY GEOMETRIC DES; Aghdashi S, 2014, TRANSPORT RES REC, P58, DOI 10.3141/2461-08; Bonneson J.A., 1997, CAPACITY OPERATIONAL; Burrow IJ, 1986, TRAFFIC ENG CONTROL, V27, P597; Chen Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133951; Courage KG, 1996, CAPACITY ANAL TRAFFI; Darbha S, 1999, TRANSPORT RES C-EMER, V7, P329, DOI 10.1016/S0968-090X(99)00024-8; FHWA, 2012, REV MON TRAFF FLOW T; Gupta AK, 2006, PHYSICA A, V368, P551, DOI 10.1016/j.physa.2005.12.036; Gupta AK, 2006, PHYSICA A, V371, P674, DOI 10.1016/j.physa.2006.03.061; Gupta AK, 2005, J PHYS A-MATH GEN, V38, P4069, DOI 10.1088/0305-4470/38/19/002; Gupta AK, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114500454; Gupta AK, 2014, NONLINEAR DYNAM, V76, P1001, DOI 10.1007/s11071-013-1183-2; Gupta AK, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/11/110503; Hu HJ, 2009, TRANSPORT RES REC, P75, DOI 10.3141/2138-11; Karoonsoontawong A, 2011, COMPUT-AIDED CIV INF, V26, P632, DOI 10.1111/j.1467-8667.2011.00722.x; Li PY, 2002, TRANSPORT RES C-EMER, V10, P275, DOI 10.1016/S0968-090X(02)00004-9; Lindsey R, 2014, TRANSPORT RES B-METH, V67, P187, DOI 10.1016/j.trb.2014.05.006; Ng KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114406; O'shea JK, 2000, DESIGN GUIDELINES PR; Papayannoulis V, 2000, EC019 TRANSP RES, VE-C019, P1; Peng GH, 2013, PHYSICA A, V392, P3563, DOI 10.1016/j.physa.2013.04.011; Peng GH, 2013, NONLINEAR DYNAM, V73, P1035, DOI 10.1007/s11071-013-0850-7; Peng GH, 2013, COMMUN NONLINEAR SCI, V18, P2801, DOI 10.1016/j.cnsns.2013.03.007; Peng GH, 2013, COMMUN NONLINEAR SCI, V18, P559, DOI 10.1016/j.cnsns.2012.07.015; Prevedouros PD, 2005, J TRANSP ENG, V131, P898, DOI 10.1061/(ASCE)0733-947X(2005)131:12(898); Rahman MM, 2008, J TRANSP ENG, V134, P532, DOI 10.1061/(ASCE)0733-947X(2008)134:12(532); Redhu P, 2015, COMMUN NONLINEAR SCI, V27, P263, DOI 10.1016/j.cnsns.2015.03.015; Redhu P, 2015, PHYSICA A, V421, P249, DOI 10.1016/j.physa.2014.11.037; Sharma S, 2015, NONLINEAR DYNAM, V81, P991, DOI 10.1007/s11071-015-2046-9; Sharma S, 2015, PHYSICA A, V421, P401, DOI 10.1016/j.physa.2014.11.003; Sun HJ, 2014, INFORM SCIENCES, V287, P121, DOI 10.1016/j.ins.2014.07.036; Tang TQ, 2013, PHYSICA A, V392, P3537, DOI 10.1016/j.physa.2013.03.056; Tang TQ, 2015, TRANSPORT RES D-TR E, V41, P423, DOI 10.1016/j.trd.2015.10.016; Tang TQ, 2015, PHYSICA A, V437, P55, DOI 10.1016/j.physa.2015.05.054; Tang TQ, 2015, PHYSICA A, V431, P52, DOI 10.1016/j.physa.2015.02.041; Tang TQ, 2015, PHYSICA A, V430, P148, DOI 10.1016/j.physa.2015.01.014; Tang TQ, 2015, MEASUREMENT, V64, P123, DOI 10.1016/j.measurement.2014.12.045; Tang TQ, 2015, PHYSICA A, V419, P293, DOI 10.1016/j.physa.2014.10.051; Tang TQ, 2014, NETW SPAT ECON, V14, P465, DOI 10.1007/s11067-014-9244-8; Tang TQ, 2015, MEASUREMENT, V59, P30, DOI 10.1016/j.measurement.2014.09.031; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2012, COMMUN THEOR PHYS, V58, P300, DOI 10.1088/0253-6102/58/2/23; Tang TQ, 2014, NONLINEAR DYNAM, V76, P2017, DOI 10.1007/s11071-014-1265-9; Tian ZZ, 2006, J TRANSP ENG, V132, P205, DOI 10.1061/(ASCE)0733-947X(2006)132:3(205); Torbic D, 2000, EC018 TRANSP RES, VE-C018, P336; TRB (Transportation Research Board), 2010, HIGHW CAP MAN 2010; Williams K. M., 2014, ACCESS MANAGEMENT MA; Wu N, 1994, P 2 INT S HIGHW CAP, P1; Wu N, 2007, TRANSPORT RES REC, P19, DOI 10.3141/2027-03; Yang XG, 2008, INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTATION TECHNOLOGY AND AUTOMATION, VOL 2, PROCEEDINGS, P377, DOI 10.1109/ICICTA.2008.422; Yu SW, 2015, PHYSICA A, V428, P206, DOI 10.1016/j.physa.2015.01.064; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036; Zhao J, 2015, ACCIDENT ANAL PREV, V81, P107, DOI 10.1016/j.aap.2015.04.028; Zhao J, 2015, TRANSPORT RES C-EMER, V51, P196, DOI 10.1016/j.trc.2014.11.010; Zhao J, 2014, TRANSPORT RES REC, P71, DOI 10.3141/2439-07; Zhao J, 2014, TRANSPORTMETRICA B, V2, P130, DOI 10.1080/21680566.2014.908751; Zhao J, 2013, PROCD SOC BEHV, V96, P1745, DOI 10.1016/j.sbspro.2013.08.199; Zhao J, 2013, TRANSPORT RES REC, P39, DOI 10.3141/2355-05; Zhao J, 2013, TRANSPORT RES REC, P49, DOI 10.3141/2355-06	60	10	11	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145989	10.1371/journal.pone.0145989	http://dx.doi.org/10.1371/journal.pone.0145989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726998	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500044
J	Scroyen, I; Bauters, D; Vranckx, C; Lijnen, HR				Scroyen, Ilse; Bauters, Dries; Vranckx, Christine; Lijnen, H. Roger			The Anti-Adipogenic Potential of COUP-TFII Is Mediated by Downregulation of the Notch Target Gene Hey1	PLOS ONE			English	Article							ADIPOSE-TISSUE DEVELOPMENT; ADIPOCYTE DIFFERENTIATION; ENDOTHELIAL-CELLS; FUNCTIONAL-ROLE; PPAR-GAMMA; STEM-CELLS; FAT-CELLS; PREADIPOCYTES; ANGIOGENESIS; EXPRESSION	Background Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) belongs to the steroid/thyroid hormone receptor superfamily and may contribute to the pathogenesis of obesity. It has not conclusively been established, however, whether its role is pro-or anti-adipogenic. Methods and Results Gene silencing of Coup-tfII in 3T3-F442A preadipocytes resulted in enhanced differentiation into mature adipocytes. This was associated with upregulation of the Notch signaling target gene Hey1. A functional role of Hey1 was confirmed by gene silencing in 3T3-F442A preadipocytes, resulting in impaired differentiation. In vivo, de novo fat pad formation in NUDE mice was significantly stimulated following injection of preadipocytes with Coup-tfII gene silencing, but impaired with Hey1 gene silencing. Moreover, expression of Coup-tfII was lower and that of Hey1 higher in isolated adipocytes of obese as compared to lean adipose tissue. Conclusions These in vitro and in vivo data support an anti-adipogenic role of COUP-TFII via downregulating the Notch signaling target gene Hey1.	[Scroyen, Ilse; Bauters, Dries; Vranckx, Christine; Lijnen, H. Roger] Univ Leuven, KU Leuven, Ctr Mol & Vasc Biol, Dept Cardiovasc Sci, B-3000 Leuven, Belgium	KU Leuven	Lijnen, HR (corresponding author), Univ Leuven, KU Leuven, Ctr Mol & Vasc Biol, Dept Cardiovasc Sci, B-3000 Leuven, Belgium.	roger.lijnen@med.kuleuven.be	Lijnen, Roger/AAA-4085-2020	Scroyen, Ilse/0000-0001-5290-7219	Programmafinanciering KU Leuven [PF/10/014]; Research Foundation-Flanders (FWO-Vlaanderen) [G.0972.11N]	Programmafinanciering KU Leuven(KU Leuven); Research Foundation-Flanders (FWO-Vlaanderen)(FWO)	The Center for Molecular and Vascular Biology is supported by the "Programmafinanciering KU Leuven" (PF/10/014). This study was supported financially by grant G.0972.11N from Research Foundation-Flanders (FWO-Vlaanderen). I. Scroyen is a post-doctoral fellow of the Research Foundation-Flanders (FWO-Vlaanderen).	Aranguren XL, 2013, J CELL SCI, V126, P1164, DOI 10.1242/jcs.116293; Ba K, 2012, CELL PROLIFERAT, V45, P538, DOI 10.1111/j.1365-2184.2012.00850.x; Chen XP, 2012, MOL ENDOCRINOL, V26, P1268, DOI 10.1210/me.2011-1305; Christiaens V, 2012, BBA-GEN SUBJECTS, V1820, P949, DOI 10.1016/j.bbagen.2012.04.001; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Demeulemeester D, 2006, THROMB HAEMOSTASIS, V95, P1019, DOI 10.1160/TH05-11-0742; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Garces C, 1997, J BIOL CHEM, V272, P29729, DOI 10.1074/jbc.272.47.29729; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Huang Y, 2010, CELL PROLIFERAT, V43, P147, DOI 10.1111/j.1365-2184.2009.00661.x; Jung SR, 2011, NUTR RES, V31, P723, DOI 10.1016/j.nutres.2011.08.010; Kajimoto K, 2010, J IMMUNOL METHODS, V357, P43, DOI 10.1016/j.jim.2010.03.011; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Neels JG, 2004, FASEB J, V18, P983, DOI 10.1096/fj.03-1101fje; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ross DA, 2006, MOL ENDOCRINOL, V20, P698, DOI 10.1210/me.2005-0325; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Scroyen I, 2007, J THROMB HAEMOST, V5, P139, DOI 10.1111/j.1538-7836.2006.02284.x; Scroyen I, 2010, OBESITY, V18, P638, DOI 10.1038/oby.2009.279; Scroyen I, 2009, THROMB RES, V124, P578, DOI 10.1016/j.thromres.2009.06.020; Sera Y, 2009, EXP HEMATOL, V37, P1108, DOI 10.1016/j.exphem.2009.06.008; Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	32	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145608	10.1371/journal.pone.0145608	http://dx.doi.org/10.1371/journal.pone.0145608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719988	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900017
J	Ye, YY; Wu, CW; Li, JJ				Ye, Ying Ying; Wu, Chang Wen; Li, Ji Ji			Genetic Population Structure of Macridiscus multifarius (Mollusca: Bivalvia) on the Basis of Mitochondrial Markers: Strong Population Structure in a Species with a Short Planktonic Larval Stage	PLOS ONE			English	Article							DNA; DISPERSAL; FLOW; DISTANCE; LIMITS	The clam Macridiscus multifarius with a planktonic larval stage of about 10 days is an ecologically and economically important species in the coastal regions of China. In this study, 3 mt-DNA markers (COI, 12S rRNA, and ND1) were used to investigate the population structure and demography of wild M. multifarius populations in 3 coastal localities of the East China Sea (ZS and ZP populations) and Beibu Gulf in the South China Sea (BH population). Sequences of 685 bp in COI, 350 bp in 12S rRNA, and 496 bp in ND1 were determined. High level and significant F-ST values were obtained among the different localities on the basis of either COI (F-ST = 0.100-0.444, p < 0.05) or 12S rRNA (F-ST = 0.199-0.742, p < 0.05) gene, indicating a high degree of genetic differentiation among the populations. F-ST values were significant but weak for the ND1 gene because it is highly conservative. The median-joining network suggested an obvious genetic differentiation between ZS and BH populations, and the finding is consistent with the results of our demographic analyses using the unweighted pair group method with arithmetic mean. Our study unraveled the extant population genetic structure of M. multifarius and explained the strong population structure of a species with a short planktonic larval stage species; this information could be useful for fishery management measures, including artificial breeding and conservation.	[Ye, Ying Ying; Wu, Chang Wen; Li, Ji Ji] Zhejiang Ocean Univ, Coll Marine Sci & Technol, Natl Engn Res Ctr Maricultural Facil China, Zhoushan, Peoples R China; [Ye, Ying Ying] Burapha Univ, Fac Sci, Dept Aquat Sci, Chon Buri, Thailand; [Li, Ji Ji] Univ Naples Federico II, Naples, Italy	Zhejiang Ocean University; Burapha University; University of Naples Federico II	Wu, CW (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci & Technol, Natl Engn Res Ctr Maricultural Facil China, Zhoushan, Peoples R China.	wucw2013@126.com	Li, Jiji/AAA-1042-2022		National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2011BAD13B08]; Open Foundation from Marine Sciences in the Most Important Subjects of Zhejiang [20140203]	National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China(Ministry of Science and Technology, China); Open Foundation from Marine Sciences in the Most Important Subjects of Zhejiang	This work was supported by the National Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (No. 2011BAD13B08): http://www.most.gov.cn/ received by CWW and the Open Foundation from Marine Sciences in the Most Important Subjects of Zhejiang (No. 20140203): http://www.zjou.edu.cn/ received by YYY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Dupont L, 2007, MAR ECOL PROG SER, V349, P125, DOI 10.3354/meps07098; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gao Ru-cheng, 2006, Xiamen Daxue Xuebao (Ziran Kexue Ban), V45, P195; Gu Z, 2010, J ANHUI AGR SCI, V32; Guo Xin-hong, 2004, Acta Genetica Sinica, V31, P983; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Huang BX, 2000, MAR BIOL, V136, P207, DOI 10.1007/s002270050678; Jing Zhang, 2008, Journal of Electrical Engineering & Technology, V3, P8, DOI 10.5370/JEET.2008.3.1.008; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kong LF, 2012, J MOLLUS STUD, V78, P1, DOI 10.1093/mollus/eyr024; Li JJ, 2013, BIOCHEM SYST ECOL, V50, P30, DOI 10.1016/j.bse.2013.03.033; Michalakis Y, 1996, GENETICS, V142, P1061; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shanks AL, 2003, ECOL APPL, V13, pS159; Shen YB, 2011, MARINE SCI B, V4, P013; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang S., 2009, THESIS; Weir BS, 1996, SINAUER ASS SUNDERL; White C, 2010, P ROY SOC LOND B BIO; WRIGHT S, 1978, P580; Xu XD, 2012, GENE, V494, P17, DOI 10.1016/j.gene.2011.12.002; Yuan JY, 2014, J ZHEJIANG OCEAN U N, V33, P368; Yuan T, 2009, AQUACULTURE, V289, P19, DOI 10.1016/j.aquaculture.2009.01.004	36	14	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146260	10.1371/journal.pone.0146260	http://dx.doi.org/10.1371/journal.pone.0146260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720602	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900054
J	Anelli, F; Candini, M; Cappelletti, M; Oliveri, M; Frassinetti, F				Anelli, Filomena; Candini, Michela; Cappelletti, Marinella; Oliveri, Massimiliano; Frassinetti, Francesca			The Remapping of Time by Active Tool-Use	PLOS ONE			English	Article							FAR SPACE; PERIPERSONAL SPACE; BODY; NEGLECT; ARM; REPRESENTATION; PERCEPTION; MORPHOLOGY; DISTANCE	Multiple, action-based space representations are each based on the extent to which action is possible toward a specific sector of space, such as near/reachable and far/unreachable. Studies on tool-use revealed how the boundaries between these representations are dynamic. Space is not only multidimensional and dynamic, but it is also known for interacting with other dimensions of magnitude, such as time. However, whether time operates on similar action-driven multiple representations and whether it can be modulated by tool-use is yet unknown. To address these issues, healthy participants performed a time bisection task in two spatial positions (near and far space) before and after an active tool-use training, which consisted of performing goal-directed actions holding a tool with their right hand (Experiment 1). Before training, perceived stimuli duration was influenced by their spatial position defined by action. Hence, a dissociation emerged between near/reachable and far/unreachable space. Strikingly, this dissociation disappeared after the active tool-use training since temporal stimuli were now perceived as nearer. The remapping was not found when a passive tool-training was executed (Experiment 2) or when the active tool-training was performed with participants' left hand (Experiment 3). Moreover, no time remapping was observed following an equivalent active hand-training but without a tool (Experiment 4). Taken together, our findings reveal that time processing is based on action-driven multiple representations. The dynamic nature of these representations is demonstrated by the remapping of time, which is action- and effector-dependent.	[Anelli, Filomena; Candini, Michela; Frassinetti, Francesca] Univ Bologna, Dept Psychol, Bologna, Italy; [Anelli, Filomena; Frassinetti, Francesca] Fdn Salvatore Maugeri Hosp IRCCS, Castel Goffredo, Italy; [Cappelletti, Marinella] UCL, Inst Cognit Neurosci, London, England; [Cappelletti, Marinella] Univ London, Goldsmiths Coll, Dept Psychol, London, England; [Oliveri, Massimiliano] Univ Palermo, Dept Psychol, Palermo, Italy; [Oliveri, Massimiliano] NeuroTeam Life & Sci, Palermo, Italy	University of Bologna; Istituti Clinici Scientifici Maugeri IRCCS; University of London; University College London; University of London; Goldsmiths University London; University of Palermo	Anelli, F (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	filomena.anelli@unibo.it	Candini, Michela/AAB-4163-2020; Anelli, Filomena/K-1468-2016; Oliveri, Massimiliano/HDO-5602-2022; FRASSINETTI, FRANCESCA/ABI-1533-2020; Frassinetti, Francesca/K-1474-2016	Candini, Michela/0000-0003-3197-4062; Anelli, Filomena/0000-0002-3971-0101; FRASSINETTI, FRANCESCA/0000-0001-6810-2861; Frassinetti, Francesca/0000-0001-6810-2861	Fondazione Del Monte of Bologna and Ravenna (Italy); Fondazione Maugeri; RFO (Ricerca Fondamentale Orientata, Ministry of University and Research)	Fondazione Del Monte of Bologna and Ravenna (Italy); Fondazione Maugeri; RFO (Ricerca Fondamentale Orientata, Ministry of University and Research)	This work was supported by Fondazione Del Monte of Bologna and Ravenna (Italy), by Fondazione Maugeri, and by RFO (Ricerca Fondamentale Orientata, Ministry of University and Research) to FF. No grant number is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; Bonato M, 2012, NEUROSCI BIOBEHAV R, V36, P2257, DOI 10.1016/j.neubiorev.2012.08.007; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Canzoneri E, 2013, EXP BRAIN RES, V228, P25, DOI 10.1007/s00221-013-3532-2; Cardinali L, 2011, NEUROPSYCHOLOGIA, V49, P3750, DOI 10.1016/j.neuropsychologia.2011.09.033; Cardinali L., 2011, TOOL USE CAUSAL COGN, P202, DOI DOI 10.1093/ACPROF:OSO/9780199571154.003.0011; Cardinali L, 2009, CURR BIOL, V19, pR478, DOI 10.1016/j.cub.2009.05.009; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; de Grave DDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016697; de Vignemont F, 2015, NEUROPSYCHOLOGIA, V70, P327, DOI 10.1016/j.neuropsychologia.2014.11.018; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Frassinetti F, 2009, PSYCHOL SCI, V20, P949, DOI 10.1111/j.1467-9280.2009.02390.x; Gallese V, 2010, NEUROPSYCHOLOGIA, V48, P746, DOI 10.1016/j.neuropsychologia.2009.09.038; Garbarini F, 2015, NEUROPSYCHOLOGIA, V70, P402, DOI 10.1016/j.neuropsychologia.2014.11.008; Gavazzi G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01168; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Holmes NP, 2012, EXP BRAIN RES, V218, P273, DOI 10.1007/s00221-012-3042-7; Holmes NP, 2004, NEUROSCI LETT, V372, P62, DOI 10.1016/j.neulet.2004.09.024; Iriki A, 1996, NEUROREPORT, V7, P2325; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Lakoff G, 2008, CAMB HANDB PSYCHOL, P17; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George., 1999, PHILOS FLESH EMBODIE; Lakoff George, 1993, METAPHOR THOUGHT, V2nd, P202, DOI DOI 10.1017/CBO9781139173865.013; Lane AR, 2013, HUM BRAIN MAPP, V34, P356, DOI 10.1002/hbm.21433; Longo MR, 2007, EXP BRAIN RES, V177, P285, DOI 10.1007/s00221-007-0855-x; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Magnani Barbara, 2010, Behav Neurol, V23, P213, DOI 10.3233/BEN-2010-0298; Magnani B, 2011, NEUROPSYCHOLOGIA, V49, P1016, DOI 10.1016/j.neuropsychologia.2010.12.014; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Maravita A, 2002, COGNITION, V83, pB25, DOI 10.1016/S0010-0277(02)00003-3; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; Miller LE, 2014, J EXP PSYCHOL HUMAN, V40, P2143, DOI 10.1037/a0037777; Neppi-Modona M, 2007, CORTEX, V43, P397, DOI 10.1016/S0010-9452(08)70465-9; Oliveri M, 2013, CORTEX, V49, P120, DOI 10.1016/j.cortex.2011.11.010; Oliveri M, 2009, EXP BRAIN RES, V195, P489, DOI 10.1007/s00221-009-1834-1; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Rossetti A, 2015, NEUROPSYCHOLOGIA, V70, P486, DOI 10.1016/j.neuropsychologia.2015.01.019; Sposito A, 2012, NEUROPSYCHOLOGIA, V50, P2187, DOI 10.1016/j.neuropsychologia.2012.05.022; Tversky B, 2000, LECT NOTES ARTIF INT, V1849, P72; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Vicario CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001716; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; Witt JK, 2011, CURR DIR PSYCHOL SCI, V20, P201, DOI 10.1177/0963721411408770; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880; Zach P, 2008, COGN BEHAV NEUROL, V21, P8, DOI 10.1097/WNN.0b013e31815f237c	52	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146175	10.1371/journal.pone.0146175	http://dx.doi.org/10.1371/journal.pone.0146175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717521	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500141
J	Di Luca, M; Toma, L; Boccolini, D; Severini, F; La Rosa, G; Minelli, G; Bongiorno, G; Montarsi, F; Arnoldi, D; Capelli, G; Rizzoli, A; Romi, R				Di Luca, Marco; Toma, Luciano; Boccolini, Daniela; Severini, Francesco; La Rosa, Giuseppe; Minelli, Giada; Bongiorno, Gioia; Montarsi, Fabrizio; Arnoldi, Daniele; Capelli, Gioia; Rizzoli, Annapaola; Romi, Roberto			Ecological Distribution and CQ11 Genetic Structure of Culex pipiens Complex (Diptera: Culicidae) in Italy	PLOS ONE			English	Article							WEST-NILE-VIRUS; SPECIES DIPTERA; MOSQUITOS; MOLESTUS; IDENTIFICATION; TORRENTIUM; HYBRIDIZATION; POPULATIONS; HYBRIDS; FORMS	Mosquitoes in the Culex pipiens complex are considered to be involved in the transmission of a range of pathogens, including West Nile virus (WNV). Although its taxonomic status is still debated, the complex includes species, both globally distributed or with a more limited distribution, morphologically similar and characterised by different physiological and behavioural traits, which affect their ability as vectors. In many European countries, Cx. pipiens and its sibling species Culex torrentium occur in sympatry, exhibiting similar bionomic and morphological characters, but only Cx. pipiens appears to play a vector role in WNV transmission. This species consists of two biotypes, pipiens and molestus, which can interbreed when in sympatry, and their hybrids can act as WNV-bridge vectors, due to intermediate ecological features. Considering the yearly WNV outbreaks since 2008 and given the morphological difficulties in recognising species and biotypes, our aim was to molecularly identify and characterised Cx. pipiens and Cx. torrentium in Italy, using recently developed molecular assays. Culex torrentium was not detected; as in other European countries, the pipiens and molestus biotypes were widely found in sympatry with hybrids in most environments. The UPGMA cluster analysis applied to CQ11 genotypic frequencies mainly revealed two groups of Cx. pipiens populations that differed in ecological features. The high propensity of the molestus biotype to exist in hypogean environments, where the habitat's physical characteristics hinder and preclude the gene flow, was shown. These results confirmed the CQ11 assay as a reliable diagnostic method, consistent with the ecological and physiological aspects of the populations analysed. Since the assessment of the actual role of three biotypes in the WNV circulation remains a crucial point to be elucidated, this extensive molecular screening of Cx. pipiens populations can provide new insights into the ecology of the species and may give useful indications to plan and implement WNV surveillance activities in Italy.	[Di Luca, Marco; Toma, Luciano; Boccolini, Daniela; Severini, Francesco; La Rosa, Giuseppe; Bongiorno, Gioia; Romi, Roberto] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Minelli, Giada] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy; [Montarsi, Fabrizio; Capelli, Gioia] Ist Zooprofilatt Sperimentale Venezie, Parasitol Lab, I-35020 Padua, Italy; [Arnoldi, Daniele; Rizzoli, Annapaola] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, Trento, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IZS delle Venezie; Fondazione Edmund Mach	Di Luca, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	marco.diluca@iss.it	SEVERINI, FRANCESCO/C-4978-2016; TOMA, LUCIANO/C-4979-2016; Di Luca, Marco/C-4966-2016; Minelli, Giada/AAC-2787-2021; Rizzoli, Annapaola/J-2439-2012	SEVERINI, FRANCESCO/0000-0002-0179-5277; TOMA, LUCIANO/0000-0003-2109-6331; Di Luca, Marco/0000-0003-1442-3672; Minelli, Giada/0000-0002-2752-9989; Rizzoli, Annapaola/0000-0003-3997-6783; La Rosa, Giuseppe/0000-0002-9906-3137	7th Framework Program: European West Nile collaborative research project [261391]	7th Framework Program: European West Nile collaborative research project	This work was funded by the 7th Framework Program: European West Nile collaborative research project (Grant agreement n. 261391; www.eurowestnile.org).	Amraoui F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-83; Aranda Carlos, 2000, European Mosquito Bulletin, V8, P7; Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Byrne K, 1999, HEREDITY, V82, P7, DOI 10.1038/sj.hdy.6884120; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; CHEVILLON C, 1995, GENET RES, V66, P147, DOI 10.1017/S0016672300034492; Ciota AT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-305; Clements A.N., 1999, BIOL MOSQUITOES, V2; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Danabalan R, 2012, J AM MOSQUITO CONTR, V28, P68, DOI 10.2987/8756-971X-28.0.68; Di Sabatino D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907852; Esteves A, 2005, VECTOR-BORNE ZOONOT, V5, P410, DOI 10.1089/vbz.2005.5.410; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Fyodorova MV, 2006, J MED ENTOMOL, V43, P552, DOI 10.1603/0022-2585(2006)43[552:EOPWNV]2.0.CO;2; GILLIES M T, 1982, Mosquito Systematics, V14, P127; Gomes B, 2013, INFECT GENET EVOL, V16, P218, DOI 10.1016/j.meegid.2013.02.006; Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HARBACH RE, 1985, P ENTOMOL SOC WASH, V87, P1; HARBACH RE, 1984, P ENTOMOL SOC WASH, V86, P521; Hesson JC, 2014, MED VET ENTOMOL, V28, P179, DOI 10.1111/mve.12024; Hesson JC, 2010, MED VET ENTOMOL, V24, P142, DOI 10.1111/j.1365-2915.2010.00871.x; Hesson JC, 2011, VECTOR-BORNE ZOONOT, V11, P1383, DOI 10.1089/vbz.2011.0630; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Huang SM, 2009, VECTOR-BORNE ZOONOT, V9, P637, DOI 10.1089/vbz.2008.0146; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415; Knight KL, 1978, CATALOG MOSQUITOES S, P6; Kothera L, 2010, J MED ENTOMOL, V47, P805, DOI 10.1603/ME10031; Krida G, 2015, MED VET ENTOMOL, V29, P124, DOI 10.1111/mve.12107; MATTINGL.PF, 1967, B WORLD HEALTH ORGAN, V37, P257; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Osorio HC, 2014, MED VET ENTOMOL, V28, P103, DOI 10.1111/mve.12020; Reusken CBEM, 2010, J VECTOR ECOL, V35, P210, DOI 10.1111/j.1948-7134.2010.00050.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rudolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071832; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; Savage HM, 2000, AM J TROP MED HYG, V62, P162; SERVICE MW, 1968, J ZOOL, V156, P313; Severini Francesco, 2009, Fragmenta Entomologica, V41, P213; Shaikevich E. V., 2007, European Mosquito Bulletin, P25; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Snow Keith, 1999, European Mosquito Bulletin, V3, P14; SPIELMAN A, 1964, AM J HYG, V80, P175, DOI 10.1093/oxfordjournals.aje.a120466; SPIELMAN A, 1967, B WORLD HEALTH ORGAN, V37, P271; Talbalaghi A, 2011, EUR J ENTOMOL, V108, P35, DOI 10.14411/eje.2011.004; Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123; Vinogradova EB, 2007, COMP CYTOGENET, V1, P129; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weitzel T, 2009, J AM MOSQUITO CONTR, V25, P6, DOI 10.2987/08-5699.1; Werblow A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102158	52	22	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146476	10.1371/journal.pone.0146476	http://dx.doi.org/10.1371/journal.pone.0146476			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741494	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600048
J	Gupta, Y; Pasupuleti, V; Du, WN; Welford, SM				Gupta, Yashi; Pasupuleti, Vinay; Du, Weinan; Welford, Scott M.			Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells	PLOS ONE			English	Article							D-DOPACHROME TAUTOMERASE; FACTOR MIF; HYDROGEN-PEROXIDE; IN-VITRO; HYPOXIA; RECRUITMENT; ACTIVATION; EXPRESSION; CARCINOMA; PATHWAY	The macrophage migration inhibitory factor (MIF) has been increasingly implicated in cancer development and progression by promoting inflammation, angiogenesis, tumor cell survival and immune suppression. MIF is overexpressed in a variety of solid tumor types in part due to its responsiveness to hypoxia inducible factor (HIF) driven transcriptional activation. MIF secretion, however, is a poorly understood process owing to the fact that MIF is a leaderless polypeptide that follows a non-classical secretory pathway. Better understanding of MIF processing and release could have therapeutic implications. Here, we have discovered that ionizing radiation (IR) and other DNA damaging stresses can induce robust MIF secretion in several cancer cell lines. MIF secretion by IR appears independent of ABCA1, a cholesterol efflux pump that has been implicated previously in MIF secretion. However, MIF secretion is robustly induced by oxidative stress. Importantly, MIF secretion can be observed both in cell culture models as well as in tumors in mice in vivo. Rapid depletion of MIF from tumor cells observed immunohistochemically is coincident with elevated circulating MIF detected in the blood sera of irradiated mice. Given the robust tumor promoting activities of MIF, our results suggest that an innate host response to genotoxic stress may mitigate the beneficial effects of cancer therapy, and that MIF inhibition may improve therapeutic responses.	[Gupta, Yashi; Pasupuleti, Vinay; Du, Weinan; Welford, Scott M.] Case Western Reserve Univ, Dept Radiat Oncol, Cleveland, OH 44106 USA; [Gupta, Yashi] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Welford, SM (corresponding author), Case Western Reserve Univ, Dept Radiat Oncol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	scott.welford@case.edu	Pasupuleti, Vinay/G-1316-2013		NCI [CA178157]; American Cancer Society [RSG-12-097-01-CCG]; AACR [14-60-36WELF];  [P30CA043703]; NATIONAL CANCER INSTITUTE [R21CA178157, P30CA043703] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); AACR; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the NCI (CA178157), the American Cancer Society (RSG-12-097-01-CCG), and the AACR (14-60-36WELF). Core facilities at the Case Comprehensive Cancer Center were supported by P30CA043703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher M, 1997, AM J PATHOL, V150, P235; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brock SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099795; Bucala R, 2012, THE MIF HDB; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Dahm-Daphi J, 2000, INT J RADIAT BIOL, V76, P67, DOI 10.1080/095530000139023; de Souza MB, 2014, ONCOL LETT, V8, P2267, DOI 10.3892/ol.2014.2513; Du W, 2013, ONCOGENE, V32, P1469, DOI 10.1038/onc.2012.143; Dumitru CA, 2011, INT J CANCER, V129, P859, DOI 10.1002/ijc.25991; Fallica J, 2014, AM J RESP CELL MOL, V51, P94, DOI 10.1165/rcmb.2013-0371OC; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Finke J, 2011, INT IMMUNOPHARMACOL, V11, P856, DOI 10.1016/j.intimp.2011.01.030; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fukuzawa J, 2002, J BIOL CHEM, V277, P24889, DOI 10.1074/jbc.M112054200; Grieb G, 2014, MINI-REV MED CHEM, V14, P1125; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; Heise R, 2012, PHOTOCHEM PHOTOBIOL, V88, P1157, DOI 10.1111/j.1751-1097.2012.01108.x; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Ietta F, 2010, AM J PHYSIOL-ENDOC M, V298, pE411, DOI 10.1152/ajpendo.00522.2009; Jayasooriya RGPT, 2014, ENVIRON TOXICOL PHAR, V38, P959, DOI 10.1016/j.etap.2014.10.012; Ji SQ, 2014, UROL ONCOL-SEMIN ORI, V32, P153, DOI 10.1016/j.urolonc.2012.09.013; Kanzler I, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0310-4; Kawczyk-Krupka A, 2015, PHOTODIAGN PHOTODYN, V12, P27, DOI 10.1016/j.pdpdt.2014.12.013; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Larsen M, 2008, CANCER LETT, V265, P239, DOI 10.1016/j.canlet.2008.02.012; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li J, 2015, AM J CANCER RES, V5, P1000; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Meyer-Siegler KL, 2002, CANCER-AM CANCER SOC, V94, P1449, DOI 10.1002/cncr.10354; Mitchell RA, 2014, CELL SIGNAL, V26, P2969, DOI 10.1016/j.cellsig.2014.09.012; Multhoff G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00058; Najjar YG, 2012, THER ADV MED ONCOL, V4, P183, DOI 10.1177/1758834012443725; Oliveira CS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-630; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Piccioli P, 2013, SEMIN IMMUNOL, V25, P425, DOI 10.1016/j.smim.2013.10.007; Polajeva J, 2014, MOL ONCOL, V8, P50, DOI 10.1016/j.molonc.2013.09.002; Robinson CM, 2014, FEBS LETT, V588, P2704, DOI 10.1016/j.febslet.2014.02.026; Sakamoto W, 2002, INT IMMUNOPHARMACOL, V2, P1123, DOI 10.1016/S1567-5769(02)00063-2; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Szekanecz Z, 2010, CURR OPIN RHEUMATOL, V22, P299, DOI 10.1097/BOR.0b013e328337c95a; Tan LP, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-92; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Yadav N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.305; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Youn H, 2015, J CELL BIOCH; Youn H, 2015, J CELL BIOCHEM, V116, P2504, DOI 10.1002/jcb.25195	51	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146482	10.1371/journal.pone.0146482	http://dx.doi.org/10.1371/journal.pone.0146482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741693	Green Submitted, Green Published, gold			2022-12-27	WOS:000367810600049
J	Eggenberger, N; Preisig, BC; Schumacher, R; Hopfner, S; Vanbellingen, T; Nyffeler, T; Gutbrod, K; Annoni, JM; Bohlhalter, S; Cazzoli, D; Muri, RM				Eggenberger, Noemi; Preisig, Basil C.; Schumacher, Rahel; Hopfner, Simone; Vanbellingen, Tim; Nyffeler, Thomas; Gutbrod, Klemens; Annoni, Jean-Marie; Bohlhalter, Stephan; Cazzoli, Dario; Mueri, Rene M.			Comprehension of Co-Speech Gestures in Aphasic Patients: An Eye Movement Study	PLOS ONE			English	Article							AUDITORY VIGILANCE; VISUAL EXPLORATION; SPATIAL NEGLECT; ICONIC GESTURES; LIMB APRAXIA; NEURAL BASIS; INDIVIDUALS; LANGUAGE; COMMUNICATION; PERCEPTION	Background Co-speech gestures are omnipresent and a crucial element of human interaction by facilitating language comprehension. However, it is unclear whether gestures also support language comprehension in aphasic patients. Using visual exploration behavior analysis, the present study aimed to investigate the influence of congruence between speech and co-speech gestures on comprehension in terms of accuracy in a decision task. Method Twenty aphasic patients and 30 healthy controls watched videos in which speech was either combined with meaningless (baseline condition), congruent, or incongruent gestures. Comprehension was assessed with a decision task, while remote eye-tracking allowed analysis of visual exploration. Results In aphasic patients, the incongruent condition resulted in a significant decrease of accuracy, while the congruent condition led to a significant increase in accuracy compared to baseline accuracy. In the control group, the incongruent condition resulted in a decrease in accuracy, while the congruent condition did not significantly increase the accuracy. Visual exploration analysis showed that patients fixated significantly less on the face and tended to fixate more on the gesturing hands compared to controls. Conclusion Co-speech gestures play an important role for aphasic patients as they modulate comprehension. Incongruent gestures evoke significant interference and deteriorate patients' comprehension. In contrast, congruent gestures enhance comprehension in aphasic patients, which might be valuable for clinical and therapeutic purposes.	[Eggenberger, Noemi; Preisig, Basil C.; Schumacher, Rahel; Hopfner, Simone; Vanbellingen, Tim; Nyffeler, Thomas; Bohlhalter, Stephan; Mueri, Rene M.] Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Eggenberger, Noemi; Preisig, Basil C.; Schumacher, Rahel; Hopfner, Simone; Vanbellingen, Tim; Nyffeler, Thomas; Bohlhalter, Stephan; Mueri, Rene M.] Univ Hosp Bern, Inselspital, Dept Clin Res, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Eggenberger, Noemi; Preisig, Basil C.; Schumacher, Rahel; Hopfner, Simone; Vanbellingen, Tim; Nyffeler, Thomas; Gutbrod, Klemens; Bohlhalter, Stephan; Mueri, Rene M.] Univ Bern, Bern, Switzerland; [Schumacher, Rahel; Gutbrod, Klemens; Mueri, Rene M.] Univ Hosp Bern, Inselspital, Dept Neurol, Div Cognit & Restorat Neurol, CH-3010 Bern, Switzerland; [Vanbellingen, Tim; Nyffeler, Thomas; Bohlhalter, Stephan] Luzerner Kantonsspital, Dept Internal Med, Neurol & Neurorehabil Ctr, Luzern, Switzerland; [Annoni, Jean-Marie] Univ Fribourg, Lab Cognit & Neurol Sci, Dept Med, Neurol Unit,Fac Sci, CH-1700 Fribourg, Switzerland; [Cazzoli, Dario] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; Lucerne Cantonal Hospital; University of Fribourg; University of Bern	Muri, RM (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland.	rene.mueri@insel.ch	Preisig, Basil/P-6823-2019; Muri, Rene/E-9320-2012	Preisig, Basil/0000-0002-8148-3555; Schumacher, Rahel/0000-0001-7500-7491; Vanbellingen, Tim/0000-0002-0884-2005; Nyffeler, Thomas/0000-0003-2504-8935; Muri, Rene/0000-0001-6990-4188; Bohlhalter, Stephan/0000-0002-0723-8164; Gutbrod, Klemens/0000-0002-5723-3468; Cazzoli, Dario/0000-0001-7217-7153	Swiss National Science Foundation (SNF) [320030_138532/1]; Swiss National Science Foundation	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was entirely funded by the Swiss National Science Foundation (SNF). The grant (grant number 320030_138532/1) was received by Rene Muri (RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Swiss National Science Foundation (Grant no. 320030_138532/1). The authors would like to thank the speech therapists Sandra Perny, Susanne Zurrer, Julia Renggli, Marianne Tschirren, Corina Wyss, Carmen Schmid, Gabriella Steiner, Monica Koenig-Bruhin, and Nicole Williams for their assistance.	AHLSEN E, 1991, J COMMUN DISORD, V24, P1, DOI 10.1016/0021-9924(91)90029-I; Ahlsen E, 2011, P 3 NORD S MULT COMM; Beattie G, 1999, J LANG SOC PSYCHOL, V18, P438, DOI 10.1177/0261927X99018004005; Beattie G, 2010, J LANG SOC PSYCHOL, V29, P194, DOI 10.1177/0261927X09359589; BEESON PM, 1993, BRAIN LANG, V45, P253, DOI 10.1006/brln.1993.1045; Burgio F, 1997, NEUROPSYCHOLOGIA, V35, P759, DOI 10.1016/S0028-3932(97)00014-6; Buxbaum LJ, 2005, COGNITIVE BRAIN RES, V25, P226, DOI 10.1016/j.cogbrainres.2005.05.014; Campana E, 2005, ANN C COGN SCI SOC S; Caplan D, 2013, BRAIN LANG, V127, P21, DOI 10.1016/j.bandl.2013.07.007; Carpenter RHS, 1988, MOVEMENTS EYES; Cassell J., 1999, PRAGMAT COGN, V7, P1, DOI [DOI 10.1075/PC.7.1.03CAS, 10.1075/pc.7.1.03cas]; CICONE M, 1979, BRAIN LANG, V8, P324, DOI 10.1016/0093-934X(79)90060-9; Cocks N, 2009, INT J LANG COMM DIS, V44, P795, DOI 10.1080/13682820802256965; DAMASIO AR, 1992, NEW ENGL J MED, V326, P531, DOI 10.1056/NEJM199202203260806; Dick AS, 2009, HUM BRAIN MAPP, V30, P3509, DOI 10.1002/hbm.20774; Ehrenstein WH, 2005, GRAEF ARCH CLIN EXP, V243, P926, DOI 10.1007/s00417-005-1128-7; Erickson RJ, 1996, BRAIN COGNITION, V30, P244, DOI 10.1006/brcg.1996.0016; Everdell IT, 2007, PERCEPTION, V36, P1535, DOI 10.1068/p5852; FEYEREISEN P, 1983, INT J PSYCHOL, V18, P545, DOI 10.1080/00207598308247500; FEYEREISEN P, 1987, PSYCHOL REV, V94, P493, DOI 10.1037/0033-295X.94.4.493; Feyereisen P., 2006, ADV SPEECH LANGUAGE, V8, P128, DOI [10.1080/14417040600667293, DOI 10.1080/14417040600667293]; Goldenberg Georg, 2008, Handb Clin Neurol, V88, P323, DOI 10.1016/S0072-9752(07)88016-X; Gullberg M., 2002, Gesture and Sign Language in Human-Computer Interaction. International Gesture Workshop, GW 2001. Revised Papers (Lecture Notes in Artificial Intelligence Vol.2298), P206; Gullberg M., 1999, PRAGMAT COGN, V7, P35, DOI [10.1075/pc.7.1.04gul, DOI 10.1075/PC.7.1.04GUL]; Gullberg M, 2009, J NONVERBAL BEHAV, V33, P251, DOI 10.1007/s10919-009-0073-2; Hadar U, 1998, BRAIN LANG, V62, P107, DOI 10.1006/brln.1997.1890; HAGOORT P, 1993, BRAIN LANG, V45, P189, DOI 10.1006/brln.1993.1043; Halsband U, 2001, NEUROPSYCHOLOGIA, V39, P200, DOI 10.1016/S0028-3932(00)00088-9; Helm-Estabrooks N, 2002, J COMMUN DISORD, V35, P171, DOI 10.1016/S0021-9924(02)00063-1; Heuer S, 2015, J COMMUN DISORD, V55, P15, DOI 10.1016/j.jcomdis.2015.01.005; Hickok G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00649; Hogrefe K, 2012, CORTEX, V48, P952, DOI 10.1016/j.cortex.2011.02.022; Holmqvist K., 2011, EYE TRACKING COMPREH; Hostetter AB, 2011, PSYCHOL BULL, V137, P297, DOI 10.1037/a0022128; Huber W, 1984, Adv Neurol, V42, P291; Jefferies E, 2006, BRAIN, V129, P2132, DOI 10.1093/brain/awl153; Jefferies E, 2013, CORTEX, V49, P611, DOI 10.1016/j.cortex.2012.10.008; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kelly SD, 2004, BRAIN LANG, V89, P253, DOI 10.1016/S0093-934X(03)00335-3; Kelly SD, 1999, J MEM LANG, V40, P577, DOI 10.1006/jmla.1999.2634; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; Kendon A., 1994, RES LANG SOC INTERAC, V27, P175, DOI [10.1207/s15327973rlsi2703_2, DOI 10.1207/S15327973RLSI2703_2]; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; LAPOINTE LL, 1991, APHASIOLOGY, V5, P511, DOI 10.1080/02687039108248556; Marangolo P, 2010, NEUROPSYCHOLOGIA, V48, P3824, DOI 10.1016/j.neuropsychologia.2010.09.025; MCNEILL D, 1985, PSYCHOL REV, V92, P350, DOI 10.1037/0033-295X.92.3.350; McNeill D., 1992, HAND MIND WHAT HANDS; McNeill David., 1994, RES LANG SOC INTERAC, V27, P223, DOI [10.1207/s15327973rlsi2703_4, DOI 10.1207/S15327973RLSI2703_4]; Morsella E, 2004, AM J PSYCHOL, V117, P411, DOI 10.2307/4149008; Murray Laura L., 2002, Seminars in Speech and Language, V23, P107, DOI 10.1055/s-2002-24987; Murray LL, 1997, J SPEECH LANG HEAR R, V40, P792, DOI 10.1044/jslhr.4004.792; Nelissen N, 2010, J NEUROSCI, V30, P6334, DOI 10.1523/JNEUROSCI.0321-10.2010; Pazzaglia M, 2008, J NEUROSCI, V28, P3030, DOI 10.1523/JNEUROSCI.5748-07.2008; Preisig BC, 2015, CORTEX, V64, P157, DOI 10.1016/j.cortex.2014.10.013; RECORDS NL, 1994, J SPEECH HEAR RES, V37, P1086, DOI 10.1044/jshr.3705.1086; Rogalsky C, 2013, APHASIOLOGY, V27, P1147, DOI 10.1080/02687038.2013.812779; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rose M., 2006, ADV SPEECH LANGUAGE, V8, P92, DOI DOI 10.1080/14417040600657948; Rothi L. J. G., 1997, APRAXIA NEUROPSYCHOL; Rousseaux M, 2010, J NEUROL, V257, P1099, DOI 10.1007/s00415-010-5469-8; SALTHOUSE TA, 1980, AM J PSYCHOL, V93, P207, DOI 10.2307/1422228; Saygin AP, 2004, NEUROPSYCHOLOGIA, V42, P1788, DOI 10.1016/j.neuropsychologia.2004.04.016; Schmid G, 2006, NEUROPSYCHOLOGIA, V44, P546, DOI 10.1016/j.neuropsychologia.2005.07.002; Seniow J, 2009, J NEUROL SCI, V283, P91, DOI 10.1016/j.jns.2009.02.315; Vanbellingen T, 2010, EUR J NEUROL, V17, P59, DOI 10.1111/j.1468-1331.2009.02741.x; Vanbellingen T, 2015, NEUROPSYCHOLOGIA, V71, P158, DOI 10.1016/j.neuropsychologia.2015.04.001; Wernicke C., 1970, ARCH NEUROL-CHICAGO, V22, P280, DOI DOI 10.1001/ARCHNEUR.1970.00480210090013; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; WILLMES K, 1980, NERVENARZT, V51, P553; Wu YC, 2007, BRAIN LANG, V101, P234, DOI 10.1016/j.bandl.2006.12.003	72	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146583	10.1371/journal.pone.0146583	http://dx.doi.org/10.1371/journal.pone.0146583			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26735917	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000367805100053
J	Mosseri, J; Trinquart, L; Nizard, R; Ravaud, P				Mosseri, Jonathan; Trinquart, Ludovic; Nizard, Remy; Ravaud, Philippe			Meta-Analysis of a Complex Network of Non-Pharmacological Interventions: The Example of Femoral Neck Fracture	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; DISPLACED INTRACAPSULAR FRACTURE; SLIDING SCREW PLATE; INTERNAL-FIXATION; ELDERLY-PATIENTS; BIPOLAR HEMIARTHROPLASTY; RANDOMIZED-TRIAL; HOOK-PINS; FOLLOW-UP; PREDICTIVE-DISTRIBUTIONS	Background Surgical interventions raise specific methodological issues in network meta-analysis (NMA). They are usually multi-component interventions resulting in complex networks of randomized controlled trials (RCTs), with multiple groups and sparse connections. Purpose To illustrate the applicability of the NMA in a complex network of surgical interventions and to prioritize the available interventions according to a clinically relevant outcome. Methods We considered RCTs of treatments for femoral neck fracture in adults. We searched CENTRAL, MEDLINE, EMBASE and ClinicalTrials.gov up to November 2015. Two reviewers independently selected trials, extracted data and used the Cochrane Collaboration's tool for assessing the risk of bias. A group of orthopedic surgeons grouped similar but not identical interventions under the same node. We synthesized the network using a Bayesian network meta-analysis model. We derived posterior odds ratios (ORs) and 95% credible intervals (95% CrIs) for all possible pairwise comparisons. The primary outcome was all-cause revision surgery. Results Data from 27 trials were combined, for 4,186 participants (72% women, mean age 80 years, 95% displaced fractures). The median follow-up was 2 years. With hemiarthroplasty (HA) and total hip arthroplasty (THA) as a comparison, risk of surgical revision was significantly higher with the treatments unthreaded cervical osteosynthesis (OR 8.0 [95% CrI 3.6-15.5] and 5.9 [2.4-12.0], respectively), screw (9.4 [6.0-16.5] and 6.7 [3.9-13.6]) and plate (12.5 [5.8-23.8] and 7.8 [3.8-19.4]). Conclusions In older women with displaced femoral neck fractures, arthroplasty (HA and THA) is the most effective treatment in terms of risk of revision surgery.	[Mosseri, Jonathan; Trinquart, Ludovic; Ravaud, Philippe] INSERM, U1153, Paris, France; [Mosseri, Jonathan; Nizard, Remy] Hop Lariboisiere, AP HP, Serv Chirurg Orthoped & Traumatol, F-75475 Paris, France; [Mosseri, Jonathan; Nizard, Remy] Univ Paris Diderot, Paris, France; [Trinquart, Ludovic; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Trinquart, Ludovic; Ravaud, Philippe] French Cochrane Ctr, Paris, France; [Trinquart, Ludovic; Ravaud, Philippe] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Trinquart, Ludovic; Ravaud, Philippe] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Trinquart, L (corresponding author), INSERM, U1153, Paris, France.	ludovic.trinquart@htd.aphp.fr	Trinquart, Ludovic/H-4961-2019; Nizard, Remy/R-5845-2019; ravaud, philippe/C-1694-2009	Trinquart, Ludovic/0000-0002-3028-4900; Ravaud, Philippe/0000-0001-8264-9206	Fondation pour la Recherche Medicale [DEQ20101221475]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	JM was supported by an academic grant for Masters of Research 2012 from the Fondation pour la Recherche Medicale. The team of PR was supported by an academic grant (DEQ20101221475) for the programme "Equipe espoir de la Recherche" from the Fondation pour la Recherche Medicale. The funding agency had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation and review of the manuscript.	Ahn J, 2008, CLIN ORTHOP RELAT R, V466, P2513, DOI 10.1007/s11999-008-0368-3; Bafeta Aida, 2013, BMJ, V347, pf3675, DOI 10.1136/bmj.f3675; Baker RP, 2006, J BONE JOINT SURG AM, V88A, P2583, DOI 10.2106/JBJS.E.01373; Benterud JG, 1997, ANN CHIR GYNAECOL FE, V86, P338; Bhandari M, 2005, J BONE JOINT SURG AM, V87A, P2122, DOI 10.2106/JBJS.E.00535; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Blomfeldt R, 2005, J BONE JOINT SURG BR, V87B, P523, DOI 10.1302/0301-620X.87B4; Boutron I., 2012, RANDOMIZED CLIN TRIA; Burgers PTPW, 2012, INT ORTHOP, V36, P1549, DOI 10.1007/s00264-012-1569-7; Butler M, 2011, J BONE JOINT SURG AM, V93A, P1104, DOI [10.2106/JBJSJ.00296, 10.2106/JBJS.J.00296]; Cadossi M, 2013, BONE JOINT J, V95B, P609, DOI 10.1302/0301-620X.95B5.31083; Caldwell DM, 2015, VALUE HEALTH, V18, P673, DOI 10.1016/j.jval.2015.03.1792; Cao LH, 2014, CHIN J TRAUMATOL, V17, P63, DOI 10.3760/cma.j.issn.1008-1275.2014.02.001; Carroll C, 2011, HEALTH TECHNOL ASSES, V15, pI, DOI 10.3310/hta15360; CHRISTIE J, 1988, J BONE JOINT SURG BR, V70, P199, DOI 10.1302/0301-620X.70B2.3346287; Chua D, 1997, CAN J SURG, V40, P271; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dai ZY, 2011, J SURG RES, V165, P68, DOI 10.1016/j.jss.2009.03.029; Davison JNS, 2001, J BONE JOINT SURG BR, V83B, P206, DOI 10.1302/0301-620X.83B2.11128; De Laet CEDH, 2000, BEST PRACT RES CL EN, V14, P171, DOI 10.1053/beem.2000.0067; Del Giovane C, 2013, STAT MED, V32, P25, DOI 10.1002/sim.5512; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; DICKSON JA, 1953, J BONE JOINT SURG AM, V35-A, P805, DOI 10.2106/00004623-195335040-00001; Efthimiou O, 2014, BIOSTATISTICS; Efthimiou O, 2014, STAT MED, V33, P2275, DOI 10.1002/sim.6117; Elmerson S, 1995, ACTA ORTHOP SCAND, V66, P507, DOI 10.3109/17453679509002303; Frihagen F, 2007, BMJ-BRIT MED J, V335, P1251, DOI 10.1136/bmj.39399.456551.25; Gao HW, 2012, CLIN ORTHOP RELAT R, V470, P1782, DOI 10.1007/s11999-012-2250-6; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; Gjertsen JE, 2010, J BONE JOINT SURG AM, V92A, P619, DOI 10.2106/JBJS.H.01750; Goh SK, 2009, J ARTHROPLASTY, V24, P400, DOI 10.1016/j.arth.2007.12.009; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Handoll HHG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000337.pub2; Hedbeck CJ, 2011, J BONE JOINT SURG AM, V93A, P445, DOI 10.2106/JBJS.J.00474; Hedbeck CJ, 2013, J ORTHOP TRAUMA, V27, P690, DOI 10.1097/BOT.0b013e318291f544; HERNGREN B, 1992, ACTA ORTHOP SCAND, V63, P41, DOI 10.3109/17453679209154847; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hopley C, 2010, BMJ-BRIT MED J, V340, pc2332, DOI DOI 10.1136/BMJ.C2332; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Iorio R, 2006, J ARTHROPLASTY, V21, P1124, DOI 10.1016/j.arth.2005.12.008; Johansson T, 2000, ACTA ORTHOP SCAND, V71, P597, DOI 10.1080/000164700317362235; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Jonsson B, 1996, ACTA ORTHOP SCAND, V67, P431, DOI 10.3109/17453679608996662; Kakar S, 2007, J TRAUMA, V63, P641, DOI 10.1097/01.ta.0000249296.55245.97; Keating JF, 2005, HEALTH TECHNOL ASSES, V9, P1; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; Lykke N, 2003, J BONE JOINT SURG BR, V85B, P426, DOI 10.1302/0301-620X.85B3.13788; Macaulay W, 2008, J ARTHROPLASTY, V23, P2, DOI 10.1016/j.arth.2008.05.013; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Mjorud J, 2006, INJURY, V37, P768, DOI 10.1016/j.injury.2006.01.001; Mouzopoulos G, 2008, INT ORTHOP, V32, P367, DOI 10.1007/s00264-007-0321-1; Murphy DK, 2013, CLIN ORTHOP RELAT R, V471, P2691, DOI 10.1007/s11999-013-3020-9; Neuman Mark D, 2013, Am J Orthop (Belle Mead NJ), V42, pE42; Oakes DA, 2003, CLIN ORTHOP RELAT R, P232, DOI 10.1097/01.blo.0000059583.08469.e5; Oliver D., 2010, BMJ CLIN EVID, V2010, P1110; Parker MJ, 2015, BONE JOINT J, V97B, P992, DOI 10.1302/0301-620X.97B7.35524; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Parker MJ, 2002, J BONE JOINT SURG BR, V84B, P1150, DOI 10.1302/0301-620X.84B8.13522; Puolakka TJS, 2001, ANN CHIR GYNAECOL, V90, P225; Rhodes KM, 2015, J CLIN EPIDEMIOL, V68, P52, DOI 10.1016/j.jclinepi.2014.08.012; ROBINSON CM, 1995, CLIN ORTHOP RELAT R, P238; Roden M, 2003, ACTA ORTHOP SCAND, V74, P42, DOI 10.1080/00016470310013635; SIKORSKI JM, 1981, J BONE JOINT SURG BR, V63, P357, DOI 10.1302/0301-620X.63B3.7263746; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Tidermark J, 2003, J BONE JOINT SURG BR, V85B, P380, DOI 10.1302/0301-620X.85B3.13609; Turner RM, 2015, STAT MED, V34, P984, DOI 10.1002/sim.6381; van den Bekerom MPJ, 2010, J BONE JOINT SURG BR, V92B, P1422, DOI 10.1302/0301-620X.92B10.24899; Van Embden D, 2012, ORTHOP TRAUMATOL-SUR, V98, P405, DOI 10.1016/j.otsr.2012.02.003; Watson A, 2013, ANZ J SURG, V83, P679, DOI 10.1111/j.1445-2197.2012.06256.x	75	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146336	10.1371/journal.pone.0146336	http://dx.doi.org/10.1371/journal.pone.0146336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735922	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100044
J	Yang, CY; Delproposto, J; Chinnaswamy, K; Brown, WC; Wang, SY; Stuckey, JA; Wang, XQ				Yang, Chao-Yie; Delproposto, James; Chinnaswamy, Krishnapriya; Brown, William Clay; Wang, Shuying; Stuckey, Jeanne A.; Wang, Xinquan			Conformational Sampling and Binding Site Assessment of Suppression of Tumorigenicity 2 Ectodomain	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; X-RAY-SCATTERING; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; IL-1 RECEPTOR; STRUCTURAL INSIGHTS; MEAN SHIFT; PROTEIN; INTERLEUKIN-1; CYTOKINE	Suppression of Tumorigenicity 2 (ST2), a member of the interleukin-1 receptor (IL-1R) family, activates type 2 immune responses to pathogens and tissue damage via binding to IL-33. Dysregulated responses contribute to asthma, graft-versus-host and autoinflammatory diseases and disorders. To study ST2 structure for inhibitor development, we performed the principal component (PC) analysis on the crystal structures of IL1-1R1, IL1-1R2, ST2 and the refined ST2 ectodomain (ST2(ECD)) models, constructed from previously reported small-angle X-ray scattering data. The analysis facilitates mapping of the ST2(ECD) conformations to PC subspace for characterizing structural changes. Extensive coverage of ST2(ECD) conformations was then obtained using the accelerated molecular dynamics simulations started with the IL-33 bound ST2(ECD) structure as instructed by their projected locations on the PC subspace. Cluster analysis of all conformations further determined representative conformations of ST2(ECD) ensemble in solution. Alignment of the representative conformations with the ST2/IL-33 structure showed that the D3 domain of ST2(ECD) (containing D1-D3 domains) in most conformations exhibits no clashes with IL-33 in the crystal structure. Our experimental binding data informed that the D1-D2 domain of ST2(ECD) contributes predominantly to the interaction between ST2(ECD) and IL-33 underscoring the importance of the D1-D2 domain in binding. Computational binding site assessment revealed one third of the total detected binding sites in the representative conformations may be suitable for binding to potent small molecules. Locations of these sites include the D1-D2 domain ST2(ECD) and modulation sites conformed to ST2(ECD) conformations. Our study provides structural models and analyses of ST2(ECD) that could be useful for inhibitor discovery.	[Yang, Chao-Yie] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA; [Delproposto, James; Chinnaswamy, Krishnapriya; Brown, William Clay; Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Wang, Shuying] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan; [Wang, Shuying] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Stuckey, Jeanne A.] Univ Michigan, Biol Chem, Ann Arbor, MI 48109 USA; [Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Cheng Kung University; National Cheng Kung University; University of Michigan System; University of Michigan; Tsinghua University	Yang, CY (corresponding author), Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA.	chaoyie@umich.edu	Yang, Chao-Yie/A-3930-2015; wang, shuying/HHZ-4516-2022	Yang, Chao-Yie/0000-0002-5445-0109; 	National Institute of Health, National Cancer Institute, USA [R01 CA174667]; National Institutes of Health through the University of Michigan's Cancer Center Support Grant [P30 CA046592]; NATIONAL CANCER INSTITUTE [R01CA174667, P30CA046592] Funding Source: NIH RePORTER	National Institute of Health, National Cancer Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through the University of Michigan's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the generous computational resources support in part by the National Science Foundation through Extreme Science and Engineering Discovery Environment (XSEDE) Science Gateway (to C.Y.). The authors are also grateful for the financial support in part from the National Institute of Health, National Cancer Institute, USA, (R01 CA174667 to C.Y.) and from the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (P30 CA046592) by the use of the following Cancer Center Core: Center of Structural Biology.; We acknowledge the generous computational resources support in part by the National Science Foundation through Extreme Science and Engineering Discovery Environment (XSEDE) Science Gateway (to C.Y.). We are also grateful for the financial support in part from the National Institute of Health, National Cancer Institute, USA, (R01 CA174667 to C.Y.) and from the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (P30 CA046592) by the use of the following Cancer Center Core: Center of Structural Biology. We thank Shaomeng Wang for providing computing resources for this work and helpful comments on the manuscript from Denzil Bernard and Sophie Paczesny.	Akeson AL, 1996, J BIOL CHEM, V271, P30517, DOI 10.1074/jbc.271.48.30517; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowman GR, 2015, P NATL ACAD SCI USA, V112, P2734, DOI 10.1073/pnas.1417811112; Bowman GR, 2012, P NATL ACAD SCI USA, V109, P11681, DOI 10.1073/pnas.1209309109; Broughton SE, 2012, CURR OPIN STRUC BIOL, V22, P350, DOI 10.1016/j.sbi.2012.03.015; Brown WC, 2011, PROTEIN EXPRES PURIF, V77, P34, DOI 10.1016/j.pep.2011.01.007; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; Case D.A., 2012, AMBER; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fleischmann RM, 2006, ANN RHEUM DIS, V65, P1006, DOI 10.1136/ard.2005.048371; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Herbert C, 2013, CANCER CELL, V23, P489, DOI 10.1016/j.ccr.2013.02.018; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Hou JZ, 2013, P NATL ACAD SCI USA, V110, P3913, DOI 10.1073/pnas.1217996110; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kirchmair J, 2008, J MED CHEM, V51, P7021, DOI 10.1021/jm8005977; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Molofsky AB, 2015, IMMUNITY, V42, P1005, DOI 10.1016/j.immuni.2015.06.006; Nelson RP, 2014, BIOL BLOOD MARROW TR, V20, P1861, DOI 10.1016/j.bbmt.2014.06.039; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Vidler LR, 2012, J MED CHEM, V55, P7346, DOI 10.1021/jm300346w; Vigers GPA, 2000, J BIOL CHEM, V275, P36927, DOI 10.1074/jbc.M006071200; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wassman CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2361; Xu D, 2015, METHODS MOL BIOL, V1278, P77, DOI 10.1007/978-1-4939-2425-7_5; YANAGISAWA K, 1993, FEBS LETT, V318, P83, DOI 10.1016/0014-5793(93)81333-U; Yang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118671	68	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146522	10.1371/journal.pone.0146522	http://dx.doi.org/10.1371/journal.pone.0146522			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735493	Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100050
J	Canales, E; Coll, Y; Hernandez, I; Portieles, R; Garcia, MR; Lopez, Y; Aranguren, M; Alonso, E; Delgado, R; Luis, M; Batista, L; Paredes, C; Rodriguez, M; Pujol, M; Ochagavia, ME; Falcon, V; Terauchi, R; Matsumura, H; Ayra-Pardo, C; Llauger, R; Perez, MD; Nunez, M; Borrusch, MS; Walton, JD; Silva, Y; Pimentel, E; Borroto, C; Borras-Hidalgo, O				Canales, Eduardo; Coll, Yamilet; Hernandez, Ingrid; Portieles, Roxana; Rodriguez Garcia, Mayra; Lopez, Yunior; Aranguren, Miguel; Alonso, Eugenio; Delgado, Roger; Luis, Maritza; Batista, Lochy; Paredes, Camilo; Rodriguez, Meilyn; Pujol, Merardo; Elena Ochagavia, Maria; Falcon, Viviana; Terauchi, Ryohei; Matsumura, Hideo; Ayra-Pardo, Camilo; Llauger, Raixa; Perez, Maria del Carmen; Nunez, Mirian; Borrusch, Melissa S.; Walton, Jonathan D.; Silva, Yussuan; Pimentel, Eulogio; Borroto, Carlos; Borras-Hidalgo, Orlando			'Candidatus Liberibacter asiaticus', Causal Agent of Citrus Huanglongbing, Is Reduced by Treatment with Brassinosteroids	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; STRESS TOLERANCE; GENE-EXPRESSION; DISEASE; PATHOGEN; AMERICANUS; INFECTION; BACTERIUM; RESPONSES	Huanglongbing (HLB) constitutes the most destructive disease of citrus worldwide, yet no established efficient management measures exist for it. Brassinosteroids, a family of plant steroidal compounds, are essential for plant growth, development and stress tolerance. As a possible control strategy for HLB, epibrassinolide was applied to as a foliar spray to citrus plants infected with the causal agent of HLB, 'Candidatus Liberibacter asiaticus'. The bacterial titers were reduced after treatment with epibrassinolide under both greenhouse and field conditions but were stronger in the greenhouse. Known defense genes were induced in leaves by epibrassinolide. With the SuperSAGE technology combined with next generation sequencing, induction of genes known to be associated with defense response to bacteria and hormone transduction pathways were identified. The results demonstrate that epibrassinolide may provide a useful tool for the management of HLB.	[Canales, Eduardo; Hernandez, Ingrid; Portieles, Roxana; Rodriguez Garcia, Mayra; Lopez, Yunior; Rodriguez, Meilyn; Pujol, Merardo; Elena Ochagavia, Maria; Falcon, Viviana; Ayra-Pardo, Camilo; Pimentel, Eulogio; Borroto, Carlos; Borras-Hidalgo, Orlando] Ctr Genet Engn & Biotechnol, Dept Plant Sci, Havana, Cuba; [Coll, Yamilet] Univ Havana, Fac Chem, Havana, Cuba; [Aranguren, Miguel; Luis, Maritza; Batista, Lochy; Paredes, Camilo; Llauger, Raixa] Inst Invest Fruticultura Trop, Grp Phytopathol, Havana, Cuba; [Alonso, Eugenio; Delgado, Roger] Empresa Agroind Victoria Giron, Jaguey Grande, Matanzas, Cuba; [Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Dept Genom & Breeding, Kitakami, Iwate, Japan; [Matsumura, Hideo] Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan; [Perez, Maria del Carmen; Nunez, Mirian] Natl Inst Agr Sci, Dept Physiol, Mayabeque, Cuba; [Borrusch, Melissa S.; Walton, Jonathan D.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Silva, Yussuan] Tobacco Res Inst, Grp Phytopathol, Havana, Cuba	Centro de Ingenieria Genetica y Biotecnologia; Universidad de la Habana; Iwate Biotechnology Research Center; Shinshu University; Michigan State University	Borras-Hidalgo, O (corresponding author), Ctr Genet Engn & Biotechnol, Dept Plant Sci, Havana, Cuba.	orlando.borras@cigb.edu.cu	AYRA-PARDO, CAMILO/AAM-5623-2020; Borras-Hidalgo, Orlando/S-2231-2017; Terauchi, Ryohei/Y-2992-2019	AYRA-PARDO, CAMILO/0000-0001-5579-677X; Borras-Hidalgo, Orlando/0000-0002-1424-2022; Terauchi, Ryohei/0000-0002-0095-4651; Falcon, Viviana/0000-0002-3795-9966; Matsumura, Hideo/0000-0003-4849-1016	"Empresa Agroindustrial Victoria de Giron", Cuba; "Instituto de Investigaciones en Fruticultura Tropical", Cuba; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG02-91ER20021]	"Empresa Agroindustrial Victoria de Giron", Cuba; "Instituto de Investigaciones en Fruticultura Tropical", Cuba; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	The authors thank "Empresa Agroindustrial Victoria de Giron", Cuba and the "Instituto de Investigaciones en Fruticultura Tropical", Cuba, for providing all the support for the experiments. Work in J.D.W.'s lab was supported in part by Grant DE-FG02-91ER20021 to the Plant Research Laboratory from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank "Empresa Agroindustrial Victoria de Giron", Cuba and the "Instituto de Investigaciones en Fruticultura Tropical", Cuba, for providing all the support for the experiments. Work in J.D.W.'s lab was supported in part by Grant DE-FG02-91ER20021 to the Plant Research Laboratory from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy.	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Ali SS, 2013, PHYTOPATHOLOGY, V103, P1260, DOI 10.1094/PHYTO-05-13-0111-R; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aritua V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073742; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Bishop GJ, 2001, PLANT CELL PHYSIOL, V42, P114, DOI 10.1093/pcp/pce018; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Conrath U, 2006, PLANT SIGNAL BEHAV, V1, P179, DOI 10.4161/psb.1.4.3221; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; Ding J, 2009, HORTSCIENCE, V44, P1340, DOI 10.21273/HORTSCI.44.5.1340; Divi UK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-151; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Gottwald TR, 2012, CROP PROT, V36, P73, DOI 10.1016/j.cropro.2012.01.004; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Khripach V, 2000, ANN BOT-LONDON, V86, P441, DOI 10.1006/anbo.2000.1227; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Li PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066582; Lin CK, 1963, ACTA PHYTOPHYLACT SI, V2, P243; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mafra V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-247; Martinelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074256; MARTINEZ A. L., 1967, PLANT DIS REPORT, V51, P692; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Nwugo CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067442; Oberholzer PCJ, 1965, S AFR J AGR SCI, V8, P287; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pieterse CMJ, 2003, SYMBIOSIS, V35, P39; SCHWARZ RE, 1973, FAO PLANT PROTECT B, V21, P132; Smith-Becker J, 1998, PLANT PHYSIOL, V116, P231, DOI 10.1104/pp.116.1.231; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZY, 2012, P NATL ACAD SCI USA, V109, P7, DOI 10.1073/pnas.1118600109; Xia XJ, 2011, NEW PHYTOL, V191, P706, DOI 10.1111/j.1469-8137.2011.03745.x; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Yokota T, 1997, TRENDS PLANT SCI, V2, P137, DOI 10.1016/S1360-1385(97)01017-0; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	49	43	49	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146223	10.1371/journal.pone.0146223	http://dx.doi.org/10.1371/journal.pone.0146223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731660	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400120
J	Duyck, J; Vandamme, K; Krausch-Hofmann, S; Boon, L; De Keersmaecker, K; Jalon, E; Teughels, W				Duyck, Joke; Vandamme, Katleen; Krausch-Hofmann, Stefanie; Boon, Lies; De Keersmaecker, Katrien; Jalon, Eline; Teughels, Wim			Impact of Denture Cleaning Method and Overnight Storage Condition on Denture Biofilm Mass and Composition: A Cross-Over Randomized Clinical Trial	PLOS ONE			English	Article							ORAL MUCOSAL LESIONS; STOMATITIS; CANDIDA; HEALTH; MICROORGANISMS; COLONIZATION; INDIVIDUALS; POPULATION; PREVALENCE; EDENTULISM	Background Appropriate oral hygiene is required to maintain oral health in denture wearers. This study aims to compare the role of denture cleaning methods in combination with overnight storage conditions on biofilm mass and composition on acrylic removable dentures. Methods In a cross-over randomized controlled trial in 13 older people, 4 conditions with 2 different mechanical cleaning methods and 2 overnight storage conditions were considered: (i) brushing and immersion in water without a cleansing tablet, (ii) brushing and immersion in water with a cleansing tablet, (iii) ultrasonic cleaning and immersion in water without a cleansing tablet, and (iv) ultrasonic cleaning and immersion in water with a cleansing tablet. Each test condition was performed for 5 consecutive days, preceded by a 2-days wash-out period. Biofilm samples were taken at baseline (control) and at the end of each test period from a standardized region. Total and individual levels of selected oral bacteria (n = 20), and of Candida albicans were identified using the Polymerase Chain Reaction (PCR) technique. Denture biofilm coverage was scored using an analogue denture plaque score. Paired t-tests and Wilcoxon-signed rank tests were used to compare the test conditions. The level of significance was set at alpha<5%. Results Overnight denture storage in water with a cleansing tablet significantly reduced the total bacterial count (p<0.01). The difference in total bacterial level between the two mechanical cleaning methods was not statistically significant. No significant effect was observed on the amount of Candida albicans nor on the analogue plaque scores. Conclusions The use of cleansing tablets during overnight denture storage in addition to mechanical denture cleaning did not affect Candida albicans count, but reduced the total bacterial count on acrylic removable dentures compared to overnight storage in water. This effect was more pronounced when combined with ultrasonic cleaning compared to brushing.	[Duyck, Joke; Vandamme, Katleen; Krausch-Hofmann, Stefanie; Boon, Lies; De Keersmaecker, Katrien; Jalon, Eline] Katholieke Univ Leuven, Dept Oral Hlth Sci, BIOMAT & Prosthet Sect, Leuven, Belgium; [Duyck, Joke; Vandamme, Katleen; Krausch-Hofmann, Stefanie; Boon, Lies; De Keersmaecker, Katrien; Jalon, Eline; Teughels, Wim] Univ Hosp Leuven, Leuven, Belgium; [Teughels, Wim] Katholieke Univ Leuven, Dept Oral Hlth Sci, Periodontol Sect, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven	Duyck, J (corresponding author), Katholieke Univ Leuven, Dept Oral Hlth Sci, BIOMAT & Prosthet Sect, Leuven, Belgium.	Joke.Duyck@uzleuven.be	Teughels, Wim/F-4337-2014	Teughels, Wim/0000-0001-7675-5643	GlaxoSmithKline Consumer Healthcare	GlaxoSmithKline Consumer Healthcare(GlaxoSmithKline)	GlaxoSmithKline Consumer Healthcare funded this study, but they had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional funding for the project. The authors had full academic freedom to design and perform the study, to collect, analyze, and interpret the data, to prepare the manuscript, and to submit for publication.	AUGSBURGER RH, 1982, J PROSTHET DENT, V47, P356, DOI 10.1016/S0022-3913(82)80079-6; Bernabe E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104808; Bhatti MA, 2000, CLIN INFECT DIS, V31, P839, DOI 10.1086/314046; Brondani AM, 2012, GERODONTOLOGY, V29, P6; Byrd WC, 2014, MOL BIOSYST, V10, P2299, DOI 10.1039/c4mb00185k; Coco BJ, 2008, ORAL MICROBIOL IMMUN, V23, P377, DOI 10.1111/j.1399-302X.2008.00439.x; Compagnoni MA, 2007, J ORAL REHABIL, V34, P600, DOI 10.1111/j.1365-2842.2007.01754.x; Cone LA, 2003, EMERG INFECT DIS, V9, P1629, DOI 10.3201/eid0912.020646; Coulthwaite L, 2007, BRIT J BIOMED SCI, V64, P180, DOI 10.1080/09674845.2007.11732784; Cross LJ, 2004, ORAL SURG ORAL MED O, V97, P351, DOI 10.1016/j.tripleo.2003.10.006; Cruz PC, 2011, J APPL ORAL SCI, V19, P668, DOI 10.1590/S1678-77572011000600021; Cueto A, 2013, GERODONTOLOGY, V30, P201, DOI 10.1111/j.1741-2358.2012.00663.x; de Souza RF, 2009, COCHRANE DB SYST REV, V7; De Visschere Luc M, 2006, Gerodontology, V23, P195, DOI 10.1111/j.1741-2358.2006.00139.x; Duyck J, 2013, J DENT, V41, P1281, DOI 10.1016/j.jdent.2013.08.002; Emami E, 2014, J DENT, V42, P99, DOI 10.1016/j.jdent.2013.11.021; Felton D, 2011, J PROSTHODONT, V20, pS1, DOI 10.1111/j.1532-849X.2010.00683.x; Felton DA, 2009, J PROSTHODONT, V18, P88, DOI 10.1111/j.1532-849X.2009.00437.x; Frenkel H, 2000, Gerodontology, V17, P33, DOI 10.1111/j.1741-2358.2000.00033.x; Gasparoto TH, 2012, GERODONTOLOGY, V29, pE331, DOI 10.1111/j.1741-2358.2011.00476.x; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Hugoson A, 2005, SWED DENT J, V29, P139; Iinuma T, 2015, J DENT RES, V94, p28S, DOI 10.1177/0022034514552493; Jainkittivong A, 2010, GERODONTOLOGY, V27, P26, DOI 10.1111/j.1741-2358.2009.00289.x; Kawasaki K, 2014, GERODONTOLOGY, DOI [10.1111/ger.12149, DOI 10.1111/GER.12149.]; Kulak-Ozkan Y, 2002, J ORAL REHABIL, V29, P300, DOI 10.1046/j.1365-2842.2002.00816.x; McNally ME, 2014, GERODONTOLOGY, V31, P123, DOI 10.1111/ger.12022; Mollaoglu N, 2005, CLIN ORAL INVEST, V9, P137, DOI 10.1007/s00784-005-0307-6; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; Murray JJ, 2011, BRIT DENT J, V211, P407, DOI 10.1038/sj.bdj.2011.903; Neppelenbroek KH, 2008, J ORAL REHABIL, V35, P836, DOI 10.1111/j.1365-2842.2008.01874.x; Nishi Y, 2014, GERODONTOLOGY, V31, P202, DOI 10.1111/ger.12027; Paranhos HFO, 2007, J ORAL REHABIL, V34, P606, DOI 10.1111/j.1365-2842.2007.01753.x; Pereira CA, 2013, DIAGN MICR INFEC DIS, V76, P419, DOI 10.1016/j.diagmicrobio.2013.05.001; Polzer I, 2010, INT DENT J, V60, P143, DOI 10.1922/IDJ_2184Polzer13; Salerno C, 2011, MED ORAL PATOL ORAL, V16, pE139, DOI 10.4317/medoral.16.e139; Semba RD, 2006, J NUTR HEALTH AGING, V10, P161; Shi Z, 2013, COCHRANE DB SYST REV, V13, DOI DOI 10.1002/14651858.CD008367.PUB2.REVIEW; Shimazaki Y, 2001, J DENT RES, V80, P340, DOI 10.1177/00220345010800010801; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; STAFFORD GD, 1986, J DENT, V14, P52, DOI 10.1016/0300-5712(86)90051-5; Strydonck DAC, 2012, J CLIN PERIODONTOL, V39, P1042, DOI 10.1111/j.1600-051X.2012.01883.x; Takamiya AS, 2011, GERODONTOLOGY, V28, P91, DOI 10.1111/j.1741-2358.2010.00369.x; van der Maarel-Wierink CD, 2013, GERODONTOLOGY, V30, P3, DOI 10.1111/j.1741-2358.2012.00637.x; Zissis A, 2006, INT J PROSTHODONT, V19, P621	45	32	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145837	10.1371/journal.pone.0145837	http://dx.doi.org/10.1371/journal.pone.0145837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730967	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400061
J	Garver, KA; Johnson, SC; Polinski, MP; Bradshaw, JC; Marty, GD; Snyman, HN; Morrison, DB; Richard, J				Garver, Kyle A.; Johnson, Stewart C.; Polinski, Mark P.; Bradshaw, Julia C.; Marty, Gary D.; Snyman, Heindrich N.; Morrison, Diane B.; Richard, Jon			Piscine Orthoreovirus from Western North America Is Transmissible to Atlantic Salmon and Sockeye Salmon but Fails to Cause Heart and Skeletal Muscle Inflammation	PLOS ONE			English	Article							SALAR L.; BRITISH-COLUMBIA; REOVIRUS PRV; VIRUS; OUTBREAK	Heart and skeletal muscle inflammation (HSMI) is a significant and often fatal disease of cultured Atlantic salmon in Norway. The consistent presence of Piscine orthoreovirus (PRV) in HSMI diseased fish along with the correlation of viral load and antigen with development of lesions has supported the supposition that PRV is the etiologic agent of this condition; yet the absence of an in vitro culture system to demonstrate disease causation and the widespread prevalence of this virus in the absence of disease continues to obfuscate the etiological role of PRV with regard to HSMI. In this study, we explore the infectivity and disease causing potential of PRV from western North America-a region now considered endemic for PRV but without manifestation of HSMI-in challenge experiments modeled upon previous reports associating PRV with HSMI. We identified that western North American PRV is highly infective by intraperitoneal injection in Atlantic salmon as well as through cohabitation of both Atlantic and Sockeye salmon. High prevalence of viral RNA in peripheral blood of infected fish persisted for as long as 59 weeks post-challenge. Nevertheless, no microscopic lesions, disease, or mortality could be attributed to the presence of PRV, and only a minor transcriptional induction of the antiviral Mx gene occurred in blood and kidney samples during log-linear replication of viral RNA. Comparative analysis of the S1 segment of PRV identified high similarity between this North American sequence and previous sequences associated with HSMI, suggesting that factors such as viral co-infection, alternate PRV strains, host condition, or specific environmental circumstances may be required to cause this disease.	[Garver, Kyle A.; Johnson, Stewart C.; Polinski, Mark P.; Bradshaw, Julia C.; Marty, Gary D.; Richard, Jon] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada; [Marty, Gary D.; Snyman, Heindrich N.] Minist Agr, Ctr Anim Hlth, Abbotsford, BC, Canada; [Morrison, Diane B.] Marine Harvest Canada, Campbell River, BC, Canada	Fisheries & Oceans Canada	Garver, KA (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada.	Kyle.Garver@dfo-mpo.gc.ca	Snyman, Heindrich N./J-8938-2019	Polinski, Mark/0000-0001-7237-3808	Aquaculture Coordinated Research and Development Program of Fisheries and Oceans Canada [P-13-02-001]; Marine Harvest Canada (MHC)	Aquaculture Coordinated Research and Development Program of Fisheries and Oceans Canada; Marine Harvest Canada (MHC)	Financial support was provided through the Aquaculture Coordinated Research and Development Program of Fisheries and Oceans Canada project #P-13-02-001 (http://www.dfompo.gc.ca/science/enviro/aquaculture/acrdp-pcrda/index-eng.htm) and Marine Harvest Canada (MHC). MHC provided support in the form of fish for virus exposure studies and salary for author DBM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bjorgen H, 2015, VET RES, V46, DOI 10.1186/s13567-015-0244-6; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Dahle MK, 2015, FISH SHELLFISH IMMUN, V45, P780, DOI 10.1016/j.fsi.2015.05.049; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garseth AH, 2012, HEART SKELETAL MUSCL; Garver KA, 2016, J FISH DIS, V39, P117, DOI 10.1111/jfd.12329; Garver KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082296; Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10; Kibenge MJ, 2013, VIROL J, V10, P10; Kongtorp RT, 2009, J FISH DIS, V32, P253, DOI 10.1111/j.1365-2761.2008.00983.x; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Kristoffersen AB, 2013, PREV VET MED, V109, P136, DOI 10.1016/j.prevetmed.2012.08.012; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; Lyngstad TM, 2012, DIS AQUAT ORGAN, V101, P197, DOI 10.3354/dao02520; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Mikalsen AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107132; Mikalsen AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037269; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Olsen AB, 2012, HLTH SITUATION NORWE; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Pennacchi Y, 2014, FISH SHELLFISH IMMUN, V36, P563, DOI 10.1016/j.fsi.2013.12.013; Polinski M, 2013, MOL BIOCHEM PARASIT, V191, P7, DOI 10.1016/j.molbiopara.2013.07.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe K, 2006, DIS AQUAT ORGAN, V70, P183, DOI 10.3354/dao070183; Wessel O, 2015, VET RES, V46, DOI 10.1186/s13567-015-0154-7; Wiik-Nielsen CR, 2012, DIS AQUAT ORGAN, V97, P255, DOI 10.3354/dao02425; Withler RE, 2005, ANIM GENET, V36, P43, DOI 10.1111/j.1365-2052.2004.01220.x	33	51	53	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146229	10.1371/journal.pone.0146229	http://dx.doi.org/10.1371/journal.pone.0146229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730591	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400122
J	Huang, CW; Lin, HC; Chou, CY; Kao, WC; Chou, WY; Lee, HJ				Huang, Chih-Wei; Lin, Hui-Chen; Chou, Chi-Yuan; Kao, Wei-Chuo; Chou, Wei-Yuan; Lee, Hwei-Jen			Lys-315 at the Interfaces of Diagonal Subunits of delta-Crystallin Plays a Critical Role in the Reversibility of Folding and Subunit Assembly	PLOS ONE			English	Article							GUANIDINE-HYDROCHLORIDE; ARGININOSUCCINATE LYASE; DUCK DELTA-2-CRYSTALLIN; AMYLOID FIBRILS; TRANSTHYRETIN; DENATURATION; AGGREGATION; RECRUITMENT; PRECIPITATION; INTERMEDIATE	delta-Crystallin is the major structural protein in avian eye lenses and is homologous to the urea cycle enzyme argininosuccinate lyase. This protein is structurally assembled as double dimers. Lys-315 is the only residue which is arranged symmetrically at the diagonal subunit interfaces to interact with each other. This study found that wild-type protein had both dimers and monomers present in 2-4 M urea whilst only monomers of the K315A mutant were observed under the same conditions, as judged by sedimentation velocity analysis. The assembly of monomeric K315A mutant was reversible in contrast to wild-type protein. Molecular dynamics simulations showed that the dissociation of primary dimers is prior to the diagonal dimers in wild-type protein. These results suggest the critical role of Lys-315 in stabilization of the diagonal dimer structure. Guanidinium hydrochloride (GdmCl) denatured wild-type or K315A mutant protein did not fold into functional protein. However, the urea dissociated monomers of K315A mutant protein in GdmCl were reversible folding through a multiple steps mechanism as measured by tryptophan and ANS fluorescence. Two partly unfolded intermediates were detected in the pathway. Refolding of the intermediates resulted in a conformation with greater amounts of hydrophobic regions exposed which was prone to the formation of protein aggregates. The formation of aggregates was not prevented by the addition of alpha-crystallin. These results highlight that the conformational status of the monomers is critical for determining whether reversible oligomerization or aggregate formation occurs.	[Lin, Hui-Chen; Kao, Wei-Chuo; Chou, Wei-Yuan; Lee, Hwei-Jen] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Huang, Chih-Wei] Kaohsiung Armed Forces Gen Hosp, Pharm Div, Kaohsiung, Taiwan; [Huang, Chih-Wei] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chou, Chi-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Defense Medical Center; National Defense Medical Center; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, HJ (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan.	hjlee@mail.ndmctsgh.edu.tw		Chou, Chi-Yuan/0000-0002-3400-171X	National Defense Medical Bureau [MAB104-031]; Tri-Service General Hospital [TSGH-C103-147]	National Defense Medical Bureau; Tri-Service General Hospital	This work was supported by the National Defense Medical Bureau (MAB104-031), and Tri-Service General Hospital (TSGH-C103-147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuAbed M, 1997, BIOCHEMISTRY-US, V36, P14012, DOI 10.1021/bi971407s; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chang HP, 2007, BIOPHYS J, V92, P1374, DOI 10.1529/biophysj.106.091736; Chen YH, 2011, BIOCHIMIE, V93, P314, DOI 10.1016/j.biochi.2010.10.003; Dignam JD, 2001, J BIOL CHEM, V276, P4028, DOI 10.1074/jbc.M006840200; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; Fukuhara S, 2012, BIOCHEMISTRY-US, V51, P5394, DOI 10.1021/bi3004236; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Huang CW, 2009, FEBS J, V276, P5126, DOI 10.1111/j.1742-4658.2009.07209.x; Kannan R, 2013, BIOCHEMISTRY-US, V52, P3638, DOI 10.1021/bi301662w; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Konno T, 2001, BIOCHEMISTRY-US, V40, P2148, DOI 10.1021/bi002156h; Lai ZH, 1997, BIOCHEMISTRY-US, V36, P10230, DOI 10.1021/bi963195p; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lee HJ, 2000, EUR J BIOCHEM, V267, P3979, DOI 10.1046/j.1432-1327.2000.01429.x; Lee HJ, 2005, BIOCHEM J, V392, P545, DOI 10.1042/BJ20050860; Lee HJ, 2003, EUR J BIOCHEM, V270, P3988, DOI 10.1046/j.1432-1033.2003.03787.x; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Pace C N, 1986, Methods Enzymol, V131, P266; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; PIATIGORSKY J, 1992, J BIOL CHEM, V267, P4277; Ratner S, 1970, METHODS ENZYMOLOGY A, V17A, P304; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; Sampaleanu LM, 2001, BIOCHEMISTRY-US, V40, P2732, DOI 10.1021/bi002272k; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; SIMPSON A, 1994, NAT STRUCT BIOL, V1, P724, DOI 10.1038/nsb1094-724; Turner MA, 1997, P NATL ACAD SCI USA, V94, P9063, DOI 10.1073/pnas.94.17.9063; Vallee F, 1999, BIOCHEMISTRY-US, V38, P2425, DOI 10.1021/bi982149h; WISTOW G, 1990, P NATL ACAD SCI USA, V87, P6277, DOI 10.1073/pnas.87.16.6277; WISTOW G, 1993, TRENDS BIOCHEM SCI, V18, P301, DOI 10.1016/0968-0004(93)90041-K; Yin FY, 2007, BIOPHYS J, V93, P1235, DOI 10.1529/biophysj.107.104604; Yu BM, 2004, J BIOL CHEM, V279, P40972, DOI 10.1074/jbc.M405300200	37	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145957	10.1371/journal.pone.0145957	http://dx.doi.org/10.1371/journal.pone.0145957			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731266	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400072
J	Kahle, LQ; Flannery, ME; Dumbacher, JP				Kahle, Logan Q.; Flannery, Maureen E.; Dumbacher, John P.			Bird-Window Collisions at a West-Coast Urban Park Museum: Analyses of Bird Biology and Window Attributes from Golden Gate Park, San Francisco	PLOS ONE			English	Article							AVIAN MORTALITY; UNITED-STATES; UNIVERSITY	Bird-window collisions are a major and poorly-understood generator of bird mortality. In North America, studies of this topic tend to be focused east of the Mississippi River, resulting in a paucity of data from the Western flyways. Additionally, few available data can critically evaluate factors such as time of day, sex and age bias, and effect of window pane size on collisions. We collected and analyzed 5 years of window strike data from a 3-story building in a large urban park in San Francisco, California. To evaluate our window collision data in context, we collected weekly data on local bird abundance in the adjacent parkland. Our study asks two overarching questions: first-what aspects of a bird's biology might make them more likely to fatally strike windows; and second, what characteristics of a building's design contribute to bird-window collisions. We used a dataset of 308 fatal bird strikes to examine the relationships of strikes relative to age, sex, time of day, time of year, and a variety of other factors, including mitigation efforts. We found that actively migrating birds may not be major contributors to collisions as has been found elsewhere. We found that males and young birds were both significantly overrepresented relative to their abundance in the habitat surrounding the building. We also analyzed the effect of external window shades as mitigation, finding that an overall reduction in large panes, whether covered or in some way broken up with mullions, effectively reduced window collisions. We conclude that effective mitigation or design will be required in all seasons, but that breeding seasons and migratory seasons are most critical, especially for low-rise buildings and other sites away from urban migrant traps. Finally, strikes occur throughout the day, but mitigation may be most effective in the morning and midday.	[Kahle, Logan Q.; Flannery, Maureen E.; Dumbacher, John P.] Calif Acad Sci, Dept Ornithol & Mammal, Inst Biodivers Sci & Sustainabil, San Francisco, CA 94118 USA	California Academy of Sciences	Dumbacher, JP (corresponding author), Calif Acad Sci, Dept Ornithol & Mammal, Inst Biodivers Sci & Sustainabil, Golden Gate Pk,55 Mus Concourse Dr, San Francisco, CA 94118 USA.	jdumbacher@calacademy.org	Dumbacher, John/B-5280-2009	Dumbacher, John/0000-0001-8942-1554	California Academy of Sciences	California Academy of Sciences	LQK was supported by a Student Science Fellowship awarded by the California Academy of Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borden W. Calvin, 2010, Ohio Journal of Science, V110, P44; Bracey AM, 2011, THESIS; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; Fair J., 2010, ORNITHOLOGICAL COUNC; Gauthreaux SA, 2003, AVIAN MIGRATION, P335; Gelb Y, 2009, NORTHEAST NAT, V16, P455, DOI 10.1656/045.016.n312; Graham DL, 1997, J FIELD ORNITHOL, V68, P98; Hager SB, 2008, WILSON J ORNITHOL, V120, P550, DOI 10.1676/07-075.1; Hager SB, 2014, PEERJ, V2, DOI 10.7717/peerj.460; Hager SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053371; Hager SB, 2012, J FIELD ORNITHOL, V83, P203, DOI 10.1111/j.1557-9263.2012.00370.x; Klem D, 2004, WILSON BULL, V116, P69, DOI 10.1676/0043-5643(2004)116[0069:EOWAFP]2.0.CO;2; KLEM D, 1989, WILSON BULL, V101, P606; KLEM D, 1990, J FIELD ORNITHOL, V61, P120; Klem D, 2006, BIRD OBSERVER, V34, P73; Klem Jr. D, 2009, TUNDRA TROPICS CONNE; Klem Jr Daniel, 1991, GLASS BIRD KILLS OVE, P99; Longcore T, 2013, BIOL CONSERV, V158, P410, DOI 10.1016/j.biocon.2012.09.019; Longcore T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034025; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Mayfield H., 1967, AUDUBON MAGAZINE, V69, P61; Milius S., 2013, SCI NEWS, V184, P20; O'connell Timothy J., 2001, Raven, V72, P141; Pyle P, 1997, IDENTIFICATION GUIDE; PYLE P, 2008, IDENTIFICATION GUI 2; Ralph CJ, 1993, HDB FIELD METHODS MO; Rawlings Cynthia M., 2010, Transactions of the Illinois State Academy of Science, V103, P153; Sokal R. R, 1981, BIOMETRY; Stienen EWM, 2008, CONDOR, V110, P154, DOI 10.1525/cond.2008.110.1.154; Townsend CW, 1931, AUK, V48, P602	32	33	38	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144600	10.1371/journal.pone.0144600	http://dx.doi.org/10.1371/journal.pone.0144600			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731417	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400010
J	Mattyasovszky, SG; Wollstadter, J; Martin, A; Ritz, U; Baranowski, A; Ossendorf, C; Rommens, PM; Hofmann, A				Mattyasovszky, Stefan G.; Wollstaedter, Jochen; Martin, Anne; Ritz, Ulrike; Baranowski, Andreas; Ossendorf, Christian; Rommens, Pol M.; Hofmann, Alexander			Inhibition of Contractile Function in Human Joint Capsule Myofibroblasts by Targeting the TGF-beta 1 and PDGF Pathways	PLOS ONE			English	Article							GRANULATION-TISSUE; EXTRACELLULAR-MATRIX; ELBOW CAPSULES; MUSCLE; SURAMIN; ALPHA; CELLS	Background Contractile myofibroblasts (MFs) accumulate in the joint capsules of patients suffering from posttraumatic joint stiffness. MF activation is controlled by a complex local network of growth factors and cytokines, ending in the increased production of extracellular matrix components followed by soft tissue contracture. Despite the tremendous growth of knowledge in this field, inconsistencies remain in practice and prevention. Methods and Findings In this in vitro study, we isolated and cultured alpha-smooth muscle actin (alpha-SMA) positive human joint capsule MFs from biopsy specimens and investigated the effect of profibrotic and antifibrotic agents on MF function. Both TGF-beta 1 and PDGF significantly induced proliferation and increased extracellular matrix contraction in an established 3D collagen gel contraction model. Furthermore, both growth factors induced a-SMA and collagen type I gene expression in MFs. TGF-beta 1 down-regulated TGF-beta 1 and TGF-beta receptor (R) 1 and receptor (R) 2 gene expression, while PDGF selectively down-regulated TGF-beta receptor 2 gene expression. These effects were blocked by suramin. Interestingly, the anti-oxidant agent superoxide dismutase (SOD) blocked TGF-beta 1 induced proliferation and collagen gel contraction without modulating the gene expression of a-SMA, collagen type I, TGF-beta 1, TGF-beta R1 and TGF-beta R2. Conclusions Our results provide evidence that targeting the TGF-beta 1 and PDGF pathways in human joint capsule MFs affects their contractile function. TGF-beta 1 may modulate MF function in the joint capsule not only via the receptor signalling pathway but also by regulating the production of profibrotic reactive oxygen species (ROS). In particular, anti-oxidant agents could offer promising options in developing strategies for the prevention and treatment of post-traumatic joint stiffness in humans.	[Mattyasovszky, Stefan G.; Wollstaedter, Jochen; Martin, Anne; Ritz, Ulrike; Baranowski, Andreas; Ossendorf, Christian; Rommens, Pol M.; Hofmann, Alexander] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Orthopaed & Traumatol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Hofmann, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Orthopaed & Traumatol, D-55122 Mainz, Germany.	hofmann.trauma-surgery@gmx.net	Hofmann, Alexander/C-3943-2013; Ritz, Ulrike/N-6871-2016	Ritz, Ulrike/0000-0001-8936-3227; Baranowski, Andreas/0000-0001-7954-5289				Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Chan YS, 2005, AM J SPORT MED, V33, P43, DOI 10.1177/0363546504265190; Chan YS, 2003, J APPL PHYSIOL, V95, P771, DOI 10.1152/japplphysiol.00915.2002; Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Doornberg Job N, 2014, J Bone Joint Surg Am, V96, pe36, DOI 10.2106/JBJS.M.00388; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Germscheid NM, 2006, CLIN ORTHOP RELAT R, P219, DOI 10.1097/01.blo.0000194681.94882.9a; Hildebrand KA, 2004, CLIN ORTHOP RELAT R, P189, DOI 10.1097/01.blo.0000122664.95703.79; Hildebrand KA, 2007, CLIN ORTHOP RELAT R, P85, DOI 10.1097/BLO.0b013e3180312c01; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Levy O, 2008, J SHOULDER ELB SURG, V17, P410, DOI 10.1016/j.jse.2007.11.014; Lindenhovius ALC, 2007, J HAND SURG-AM, V32A, P1605, DOI 10.1016/j.jhsa.2007.09.015; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Mattyasovszky SG, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2902; Micallef L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S5; Morishima Y, 2001, AM J RESP CELL MOL, V24, P1; Novo E, 2006, GUT, V55, P90, DOI 10.1136/gut.2005.069633; O'DRISCOLL S W, 1990, Arthroscopy, V6, P100, DOI 10.1016/0749-8063(90)90007-Z; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9; Soneja A, 2005, PHARMACOL REP, V57, P108; Soren A, 1996, ARCH ORTHOP TRAUM SU, V115, P270, DOI 10.1007/BF00439051; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; TOMASEK JJ, 1987, J BONE JOINT SURG AM, V69A, P1400; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wipff PJ, 2009, J BODYW MOV THER, V13, P121, DOI 10.1016/j.jbmt.2008.04.031; Wu YJ, 2007, WOUND REPAIR REGEN, V15, pS18, DOI 10.1111/j.1524-475X.2007.00221.x	35	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145948	10.1371/journal.pone.0145948	http://dx.doi.org/10.1371/journal.pone.0145948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730954	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400070
J	Nigro, LM; Angel, MV; Blachowiak-Samolyk, K; Hopcroft, RR; Bucklin, A				Nigro, Lisa M.; Angel, Martin V.; Blachowiak-Samolyk, Katarzyna; Hopcroft, Russell R.; Bucklin, Ann			Identification, Discrimination, and Discovery of Species of Marine Planktonic Ostracods Using DNA Barcodes	PLOS ONE			English	Article							PELAGIC OSTRACODS; HALOCYPRIDIDAE; ATLANTIC; CONSEQUENCES; ZOOPLANKTON; DIVERGENCE; EVOLUTION; TAXONOMY; GULF	The Ostracoda (Crustacea; Class Ostracoda) is a diverse, frequently abundant, and ecologically important component of the marine zooplankton assemblage. There are more than 200 described species of marine planktonic ostracods, many of which (especially conspecific species) can be identified only by microscopic examination and dissection of fragile morphological characters. Given the complexity of species identification and increasing lack of expert taxonomists, DNA barcodes (short DNA sequences for species discrimination and identification) are particularly useful and necessary. Results are reported from analysis of 210 specimens of 78 species of marine planktonic ostracods, including two novel species, and 51 species for which barcodes have not been previously published. Specimens were collected during 2006 to 2008 from the Atlantic, Indian, and Southern Oceans, Greenland Sea and Gulf of Alaska. Samples were collected from surface to 5,000 m using various collection devices. DNA sequence variation was analyzed for a 598 base-pair region of the mitochondrial cytochrome oxidase subunit I (COI) gene. Kimura-2-Parameter (K2P) genetic distances within described species (mean = 0.010 +/- 0.017 SD) were significantly smaller than between species (0.260 + 0.080), excluding eight taxa hypothesized to comprise cryptic species due to morphological variation (especially different size forms) and/or collection from different geographic regions. These taxa showed similar K2P distance values within (0.014 + 0.026) and between (0.221 +/- 0.068) species. All K2P distances > 0.1 resulted from comparisons between identified or cryptic species, with no overlap between intra-and interspecific genetic distances. A Neighbor Joining tree resolved nearly all described species analyzed, with multiple sequences forming monophyletic clusters with high bootstrap values (typically 99%). Based on taxonomically and geographically extensive sampling and analysis (albeit with small sample sizes), the COI barcode region was shown to be a valuable character for discrimination, recognition, identification, and discovery of species of marine planktonic ostracods.	[Nigro, Lisa M.; Bucklin, Ann] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Angel, Martin V.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Blachowiak-Samolyk, Katarzyna] Polish Acad Sci, Inst Oceanol, Arctic Ecol Grp, Sopot, Poland; [Hopcroft, Russell R.] Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA	University of Connecticut; NERC National Oceanography Centre; University of Southampton; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; University of Alaska System; University of Alaska Fairbanks	Bucklin, A (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	ann.bucklin@uconn.edu	Hopcroft, Russell R/I-6286-2012	Bucklin, Ann/0000-0003-3750-9348; Blachowiak-Samolyk, Katarzyna/0000-0001-8076-2168	National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration and Research [NA050AR4601079]; NOAA Arctic Research Office [NA17RJ1224]; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010009] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R13AR046010] Funding Source: NIH RePORTER	National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration and Research; NOAA Arctic Research Office; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was partially funded by the National Oceanic and Atmospheric Administration (NOAA) Office of Ocean Exploration and Research (http://explore.noaa.gov/; Award No. NA050AR4601079). Funding was also provided by the NOAA Arctic Research Office (http://www.arctic.noaa.gov/index.shtml) through a cooperative agreement with the Cooperative Institute for Arctic Research (CIFAR) at the University of Alaska (Award No. NA17RJ1224). The authors gratefully acknowledge programmatic support from the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANGEL M V, 1969, Crustaceana (Leiden), V17, P45, DOI 10.1163/156854069X00051; Angel M.V., 1982, P327; ANGEL M V, 1970, Crustaceana (Leiden), V18, P147, DOI 10.1163/156854070X00761; Angel M. V., 2008, ATLAS ATLANTIC PLANK; Angel MV, 2007, PROG OCEANOGR, V73, P60, DOI 10.1016/j.pocean.2006.11.002; Angel MV, 2013, ZOOTAXA, V3709, P401; Angel MV, 2010, DEEP-SEA RES PT II, V57, P2173, DOI 10.1016/j.dsr2.2010.09.020; Angel MV, 1993, SYNOPSES BRIT FAUNA, V48; Angel MV., 1983, APPL OSTRACODA, P529; Baczewska A, 2012, HYDROBIOLOGIA, V688, P75, DOI 10.1007/s10750-011-0808-z; Blachowiak-Samolyk K, 2003, ATLAS SO OCEAN PLANK; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Bucklin A, 2007, J PLANKTON RES, V29, P483, DOI 10.1093/plankt/fbm031; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P40, DOI 10.1016/j.dsr2.2009.08.005; Chavtur VG, 2007, RUSS J MAR BIOL+, V33, P75, DOI 10.1134/S1063074007020010; Chavtur VG, 2015, ZOOTAXA, V4013, P151, DOI 10.11646/zootaxa.4013.2.1; Chavtur VG, 2011, ZOOTAXA, P1; Chavtur Vladimir G., 2008, Publications of the Seto Marine Biological Laboratory, V40, P55; Cheng Fangping, 2013, Advances in Polar Science, V24, P119, DOI 10.3724/SP.J.1085.2013.00119; Claus C, 1891, ARB ZOOL I WIEN, V9, P1; Cornils A, 2015, J PLANKTON RES, V37, P6, DOI 10.1093/plankt/fbu105; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; DEEVEY G B, 1980, Bulletin of the Florida State Museum Biological Sciences, V26, P37; DEEVEY G B, 1974, Proceedings of the Biological Society of Washington, V87, P351; FASHAM MJR, 1975, J MAR BIOL ASSOC UK, V55, P739, DOI 10.1017/S0025315400017380; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goulletquer P, 2014, BIODIVERSITY MARINE; Graves C, 2012, J NAT HIST, V46, P517, DOI 10.1080/00222933.2011.649017; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jennings RM, 2010, DEEP-SEA RES PT II, V57, P2199, DOI 10.1016/j.dsr2.2010.09.022; Jennings RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009949; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; MARTENS J M, 1979, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V76, P303; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Muller GW, 1906, WISSENSCHAFTLICHE ER, V8, P29; Ortman BD, 2010, DEEP-SEA RES PT II, V57, P2148, DOI 10.1016/j.dsr2.2010.09.017; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Poulsen E.M., 1973, Dana Reports, VNo. 84, P1; Radulovici Adriana E., 2010, Diversity, V2, P450; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Raupach MJ, 2015, ZOOKEYS, P53, DOI 10.3897/zookeys.539.6530; Raupach MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139421; Reygondeau G, 2011, GLOBAL CHANGE BIOL, V17, P756, DOI 10.1111/j.1365-2486.2010.02310.x; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Sars G. O., 1865, Vidensk. Selsk. Forh., P1; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Stepien A, 2015, ZOOTAXA, V3995, P66, DOI 10.11646/zootaxa.3995.1.9; Stoeckle MY, 2008, SCI AM, V299, P82; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka H, 2016, MAR BIODIVERS, V46, P625, DOI 10.1007/s12526-015-0412-y; Wiebe PH, 2010, DEEP-SEA RES PT II, V57, P2157, DOI 10.1016/j.dsr2.2010.09.018; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811	61	20	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146327	10.1371/journal.pone.0146327	http://dx.doi.org/10.1371/journal.pone.0146327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730595	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400149
J	Park, MS; Patel, MM; Sarezky, D; Rojas, C; Choo, C; Choi, M; Liu, DC; Rademaker, AW; Tanna, AP				Park, Meghan S.; Patel, Marguerite M.; Sarezky, Daniel; Rojas, Carin; Choo, Clara; Choi, Michael; Liu, Dachao; Rademaker, Alfred W.; Tanna, Angelo P.			Inter-Rater Agreement in the Assessment of Video Recordings of Eye Drop Instillation by Glaucoma Patients	PLOS ONE			English	Article							MEDICATIONS; SEVERITY; EYEDROPS	Purpose To create a standardized method for evaluating the video recordings of patients self-instilling eye drops and to determine the level of agreement of eye drop instillation efficacy, safety and efficiency ratings by three masked graders. Design Prospective cross-sectional study. Participants 78 patients with open-angle glaucoma or ocular hypertension who had at least 6 months of experience with the use of eye drop medications. Methods Participants were video recorded while self-instilling artificial tears sequentially to both eyes. Three masked observers graded these video recordings on three criteria: efficacy (the determination of whether an eye drop was instilled on the ocular surface), safety (assessment of whether the tip of the medication bottle made contact with the ocular surface or eyelids), and efficiency (the number of eye drops expressed from the bottle). Main Outcome Measures After grading the video recordings based on efficacy, safety, and efficiency, kappa statistics were used to estimate inter-rater agreement. Results The mean kappa level of agreement for efficacy, safety, and efficiency was 0.64 (95% confidence interval (CI), 0.42-0.87), 0.73 (95% CI, 0.58-0.88), and 0.62 (95% CI, 0.42-0.81), respectively. Conclusions We demonstrated good inter-rater reproducibility of the masked analysis of video recordings of patients self-instilling eye drops based on three criteria: efficiency, safety, and efficacy.	[Park, Meghan S.; Patel, Marguerite M.; Rojas, Carin; Tanna, Angelo P.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Sarezky, Daniel] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Choo, Clara] Univ Arizona, Dept Ophthalmol, Tucson, AZ USA; [Choi, Michael] Mayo Clin, Dept Ophthalmol, Rochester, MN USA; [Liu, Dachao; Rademaker, Alfred W.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Arizona; Mayo Clinic; Northwestern University; Feinberg School of Medicine	Tanna, AP (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	atanna@northwestern.edu		Tanna, Angelo/0000-0003-3089-6664	Research to Prevent Blindness, New York, NY; Department of Ophthalmology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER	Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Department of Ophthalmology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	APT is supported by an unrestricted grant to Northwestern University from Research to Prevent Blindness, New York, NY. The Northwestern University Biostatistics Consultation Service received funding from the Department of Ophthalmology to carry out the statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm A, 2008, SURV OPHTHALMOL, V53, pS93, DOI 10.1016/j.survophthal.2008.08.004; Aptel F, 2009, BRIT J OPHTHALMOL, V93, P700, DOI 10.1136/bjo.2008.139840; BROWN MM, 1984, CAN J OPHTHALMOL, V19, P2; BURNS E, 1992, AGE AGEING, V21, P168, DOI 10.1093/ageing/21.3.168; Dickinson C, 2007, INVEST OPHTH VIS SCI, V48, P4368, DOI 10.1167/iovs.07-0001; GEYER O, 1995, BRIT J OPHTHALMOL, V79, P376, DOI 10.1136/bjo.79.4.376; Hennessy AL, 2011, AM J OPHTHALMOL, V152, P982, DOI 10.1016/j.ajo.2011.05.015; Hennessy AL, 2010, OPHTHALMOLOGY, V117, P2345, DOI 10.1016/j.ophtha.2010.03.040; KASS MA, 1982, ANN OPHTHALMOL, V14, P889; Sleath B, 2006, OPHTHALMOLOGY, V113, P431, DOI 10.1016/j.ophtha.2005.10.034; Sleath B, 2011, OPHTHALMOLOGY, V118, P2398, DOI 10.1016/j.ophtha.2011.05.013; Stone JL, 2009, ARCH OPHTHALMOL-CHIC, V127, P732, DOI 10.1001/archophthalmol.2009.96; WINFIELD AJ, 1990, BRIT J OPHTHALMOL, V74, P477, DOI 10.1136/bjo.74.8.477	13	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145764	10.1371/journal.pone.0145764	http://dx.doi.org/10.1371/journal.pone.0145764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730605	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400050
J	Sajo, M; Sugiyama, H; Yamamoto, H; Tanii, T; Matsuki, N; Ikegaya, Y; Koyama, R				Sajo, Mari; Sugiyama, Hiroki; Yamamoto, Hideaki; Tanii, Takashi; Matsuki, Norio; Ikegaya, Yuji; Koyama, Ryuta			Neuraminidase-Dependent Degradation of Polysialic Acid Is Required for the Lamination of Newly Generated Neurons	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; DENTATE GYRUS; ADULT-RAT; PROGENITOR CELLS; GRANULE CELLS; NCAM; HIPPOCAMPUS; MIGRATION; DIFFERENTIATION; NEUROGENESIS	Hippocampal granule cells (GCs) are generated throughout the lifetime and are properly incorporated into the innermost region of the granule cell layer (GCL). Hypotheses for the well-regulated lamination of newly generated GCs suggest that polysialic acid (PSA) is present on the GC surface to modulate GC-to-GC interactions, regulating the process of GC migration; however, direct evidence of this involvement is lacking. We show that PSA facilitates the migration of newly generated GCs and that the activity of N-acetyl-a-neuraminidase 1 (NEU1, sialidase 1) cleaves PSA from immature GCs, terminating their migration in the innermost GCL. Developing a migration assay of immature GCs in vitro, we found that the pharmacological depletion of PSA prevents the migration of GCs, whereas the inhibition of PSA degradation with a neuraminidase inhibitor accelerates this migration. We found that NEU1 is highly expressed in immature GCs. The knockdown of NEU1 in newly generated GCs in vivo increased PSA presence on these cells, and attenuated the proper termination of GC migration in the innermost GCL. In conclusion, this study identifies a novel mechanism that underlies the proper lamination of newly generated GCs through the modulation of PSA presence by neuronal NEU1.	[Sajo, Mari; Sugiyama, Hiroki; Matsuki, Norio; Ikegaya, Yuji; Koyama, Ryuta] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan; [Yamamoto, Hideaki] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Tanii, Takashi] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	University of Tokyo; Tohoku University; Waseda University	Koyama, R (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan.	rkoyama@mol.f.u-tokyo.ac.jp		Ikegaya, Yuji/0000-0003-2260-8191; Yamamoto, Hideaki/0000-0003-3362-5376	JSPS [21790059, 26460094, 26117504]; Japan Society for the Promotion of Science [10592]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part supported by JSPS KAKENHI Grant Numbers 21790059, 26460094, and 26117504 and in part by the grants for iPS Non-clinical Experiments for Nervous System (iNCENS) project in AMED. MS was supported by a Grant-in-Aid for JSPS Fellows (No. 10592) from the Japan Society for the Promotion of Science. The authors declare no conflict of interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; MEINDL P, 1974, VIROLOGY, V58, P457, DOI 10.1016/0042-6822(74)90080-4; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Rottier RJ, 1998, HUM MOL GENET, V7, P313, DOI 10.1093/hmg/7.2.313; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seki T, 2002, J NEUROSCI RES, V69, P772, DOI 10.1002/jnr.10366; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; Tamura M, 2011, J NEUROSCI, V31, P11505, DOI 10.1523/JNEUROSCI.3447-10.2011; Thomas G.H., METABOLIC MOL BASES, V3, P3507; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamada RX, 2008, J NEUROSCI, V28, P4613, DOI 10.1523/JNEUROSCI.0019-08.2008; YANG PF, 1992, J CELL BIOL, V116, P1487, DOI 10.1083/jcb.116.6.1487	30	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146398	10.1371/journal.pone.0146398	http://dx.doi.org/10.1371/journal.pone.0146398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731280	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400170
J	Whitehead, J; Shaver, J; Stephenson, R				Whitehead, J.; Shaver, John; Stephenson, Rob			Outness, Stigma, and Primary Health Care Utilization among Rural LGBT Populations	PLOS ONE			English	Article							SEXUAL RISK BEHAVIOR; MENTAL-HEALTH; SUBSTANCE USE; LATINO GAY; TRANSGENDER; ORIENTATION; DISCLOSURE; EXPERIENCES; PREJUDICE; PATTERNS	Background Prior studies have noted significant health disadvantages experienced by LGBT (lesbian, gay, bisexual, and transgender) populations in the US. While several studies have identified that fears or experiences of stigma and disclosure of sexual orientation and/or gender identity to health care providers are significant barriers to health care utilization for LGBT people, these studies have concentrated almost exclusively on urban samples. Little is known about the impact of stigma specifically for rural LGBT populations, who may have less access to quality, LGBT-sensitive care than LGBT people in urban centers. Methodology LBGT individuals residing in rural areas of the United States were recruited online to participate in a survey examining the relationship between stigma, disclosure and "outness," and utilization of primary care services. Data were collected and analyzed regarding LGBT individuals' demographics, health care access, health risk factors, health status, outness to social contacts and primary care provider, and anticipated, internalized, and enacted stigmas. Results Higher scores on stigma scales were associated with lower utilization of health services for the transgender & non-binary group, while higher levels of disclosure of sexual orientation were associated with greater utilization of health services for cisgender men. Conclusions The results demonstrate the role of stigma in shaping access to primary health care among rural LGBT people and point to the need for interventions focused towards decreasing stigma in health care settings or increasing patients' disclosure of orientation or gender identity to providers. Such interventions have the potential to increase utilization of primary and preventive health care services by LGBT people in rural areas.	[Whitehead, J.] Northwestern Univ, Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Shaver, John; Stephenson, Rob] Univ Michigan, Sch Nursing, Dept Hlth & Biol Sci, Ann Arbor, MI 48109 USA	Northwestern University; University of Michigan System; University of Michigan	Stephenson, R (corresponding author), Univ Michigan, Sch Nursing, Dept Hlth & Biol Sci, Ann Arbor, MI 48109 USA.	rbsteph@umich.edu						[Anonymous], 2015, 10 THINGS INCL HLGH; [Anonymous], 2014, LESBIAN GAY BISEXUAL; Austin A, 2015, PROF PSYCHOL-RES PR, V46, P21, DOI 10.1037/a0038642; Austin EL, 2013, WOMEN HEALTH, V53, P41, DOI 10.1080/03630242.2012.743497; Austin SB, 2013, CANCER CAUSE CONTROL, V24, P539, DOI 10.1007/s10552-012-9991-0; Behavioral Risk Factor Surveillance System, 2012, 2013 BEH RISK FACT S; Bradford J, 2013, AM J PUBLIC HEALTH, V103, P1820, DOI 10.2105/AJPH.2012.300796; Bruce D, 2008, J DRUG ISSUES, V38, P235, DOI 10.1177/002204260803800111; Calonge N, 2005, ANN FAM MED, V3, P263, DOI 10.1370/afm.337; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Calonge N, 2007, ANN INTERN MED, V147, P783, DOI 10.7326/0003-4819-147-11-200712040-00009; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carpenter JS, 1998, PSYCHOMETRICS 2 SHOR; Case P, 2004, J WOMENS HEALTH, V13, P1033, DOI 10.1089/jwh.2004.13.1033; Centers for Disease Control and Prevention, 2012, SEX TRANSM DIS SURV; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities Board on the Health of Select Populations & Institute of Medicine, 2011, HLTH LESB GAY BIS TR; Crisp C, 2007, CHILD ADOLESC SOC WO, V24, P403, DOI 10.1007/s10560-007-0091-z; Croghan CF, 2015, J GERONTOL SOC WORK, V58, P637, DOI 10.1080/01634372.2015.1072759; Diamant AL, 2000, AM J PREV MED, V19, P141, DOI 10.1016/S0749-3797(00)00192-6; Diamant AL, 2000, ARCH FAM MED, V9, P1043, DOI 10.1001/archfami.9.10.1043; Durso L, 2014, MOVING NEEDLE IMPACT, V1, P1; Durso LE, 2013, SEX RES SOC POLICY, V10, P35, DOI 10.1007/s13178-012-0105-2; Facione NC, 2007, NURS RES, V56, P175, DOI 10.1097/01.NNR.0000270026.90359.4c; Fisher CM, 2011, MIDLANDS LGBT NEEDS; Ford JD, 2005, SOC SCI MED, V61, P1618, DOI 10.1016/j.socscimed.2005.03.017; Gates G. J, 2014, LGBT MORE LIKELY NON; Grulich A, 2013, NATL AIDS B, V11, P33; Harding R, 2007, FEM PSYCHOL, V17, P277, DOI 10.1177/0959353507076563; Hatzenbuehler ML, 2013, AM J PREV MED, V44, P612, DOI 10.1016/j.amepre.2013.01.027; Hendricks ML, 2012, PROF PSYCHOL-RES PR, V43, P460, DOI 10.1037/a0029597; Herek GM, 2007, J SOC ISSUES, V63, P905, DOI 10.1111/j.1540-4560.2007.00544.x; Herek GM, 2009, J COUNS PSYCHOL, V56, P32, DOI 10.1037/a0014672; Hernandez-Romieu AC, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3342; Horvath KJ, 2014, J HOMOSEXUAL, V61, P1117, DOI 10.1080/00918369.2014.872502; Housing Assistance Council, 2012, RAC ETHN RUR AM; Jeffries WL, 2013, AIDS BEHAV, V17, P1442, DOI 10.1007/s10461-012-0189-y; Kecojevic A, 2012, ADDICT BEHAV, V37, P1289, DOI 10.1016/j.addbeh.2012.06.006; King Brian A, 2012, Am J Public Health, V102, pe93, DOI 10.2105/AJPH.2012.301002; Klitzman RL, 2002, J HOMOSEXUAL, V42, P65, DOI 10.1300/J082v42n04_04; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Kosenko K, 2013, MED CARE, V51, P819, DOI 10.1097/MLR.0b013e31829fa90d; LeFevre ML, 2014, ANN INTERN MED, V161, P281, DOI 10.7326/M14-1204; Lehavot K, 2011, J CONSULT CLIN PSYCH, V79, P159, DOI 10.1037/a0022839; Madison M, 2012, J RURAL HEALTH, V28, P4, DOI 10.1111/j.1748-0361.2011.00383.x; McCambridge SA, 2014, EMOTION, V14, P407, DOI 10.1037/a0035209; McElroy J. A., 2015, PSYCHOL SEX IN PRESS; Meyer I, 2006, PROJECT STRIDE INTER; Meyer I.H., 2006, PROJECT STRIDE METHO; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Mohr J, 2000, MEAS EVAL COUNS DEV, V33, P66, DOI 10.1080/07481756.2000.12068999; Mosack KE, 2013, WOMEN HEALTH ISS, V23, pE341, DOI 10.1016/j.whi.2013.07.004; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Nakamura N, 2010, CULT HEALTH SEX, V12, P73, DOI 10.1080/13691050903089961; Nelson W, 2010, CAMB Q HEALTHC ETHIC, V19, P510, DOI 10.1017/S096318011000040X; Papworth E, 2014, EXAMINING RISK FACTO; Petroll AE, 2011, SEX TRANSM DIS, V38, P63, DOI 10.1097/OLQ.0b013e3181ebd50f; Preston DB., 2002, J PRIM PREV, V23, P199, DOI DOI 10.1023/A:1019968315959; Preston DB, 2007, AIDS EDUC PREV, V19, P218, DOI 10.1521/aeap.2007.19.3.218; Rosario V. A., 2015, PSYCHIAT TIMES, V32, P24; Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Services and Advocacy for GLBT Elders (SAGE), 2012, INCL SERV LGBT OLD A; Swank E, 2013, SOCIOL INQ, V83, P238, DOI 10.1111/soin.12004; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; The Joint Commission, 2011, ADV EFF COMM CULT CO; Thomas Hertz Beth, 2015, LONG TERM LIVING, V64, P28; Tracy JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-442; U.S. Department of Health and Human Services, 2014, REC AD IMM SCH; U.S. Preventive Services Task Force, 2014, SCREENING FOR LIPID; U.S. Preventive Services Task Force, 2013, ANN INTERN MED, P1; U.S. Preventive Services Task Force, 2013, ANN INTERNAL MED; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; Ward BW, 2013, 77 US DEP HLTH HUM S; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WILSON KG, 1995, ARCH PHYS MED REHAB, V76, P899, DOI 10.1016/S0003-9993(95)80063-8; Womach J., 2005, AGR GLOSSARY TERMS P	77	203	207	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146139	10.1371/journal.pone.0146139	http://dx.doi.org/10.1371/journal.pone.0146139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731405	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400100
J	Yu, LD; Wang, XW; Lin, XJ; Wang, Y				Yu, Liedao; Wang, Xuanwei; Lin, Xiangjin; Wang, Yue			The Use of Lumbar Spine Magnetic Resonance Imaging in Eastern China: Appropriateness and Related Factors	PLOS ONE			English	Article							LOW-BACK-PAIN; PRIMARY-CARE; DECISION-SUPPORT; PREVALENCE; GUIDELINES; OVERUSE	Back pain is common and costly. While a general scene of back pain related practice in China remains unknown, there are signs of excessive use of lumbar spine magnetic resonance (MR). We retrospectively studied 3107 lumbar spine MRIs in Eastern China to investigate the appropriateness of lumbar spine MR use. Simple back pain is the most common chief complaint for ordering a lumbar MR study. Only 41.3% of lumbar spine MR studies identified some findings that may have potential clinical significance. Normal lumbar spine is the most common diagnosis (32.7%), followed by lumbar disc bulging and lumbar disc herniation. Walk difficulties, back injury and referred leg pain as chief complaints were associated with greater chance of detecting potentially clinically positive lumbar MR image findings, as compare with simple back pain. There was no difference in positive rates among orthopedic surgeon and specialists of other disciplines. Lumbar spine MR imaging was generally overused in Eastern China by various specialists, particularly at health assessment centers. For appropriate use of lumbar spine MR, orthopedic surgeons are no better than physicians of other disciplines. Professional training and clinical guidelines are needed to facilitate evidence-based back pain practice in China.	[Yu, Liedao; Wang, Xuanwei; Lin, Xiangjin; Wang, Yue] Zhejiang Univ, Affiliated Hosp 1, Dept Orthoped Surg, Spine Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Lin, XJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Orthoped Surg, Spine Lab, Hangzhou 310003, Zhejiang, Peoples R China.	doclinxj@126.com; wangyuespine@gmail.com			National Natural Science Foundation of China (NSFC) [81371995]; Education Bureau of Zhejiang Province [491010-G21333]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Education Bureau of Zhejiang Province	This study was supported by National Natural Science Foundation of China (NSFC, 81371995, www.nsfc.gov.cn, receiver: YW) and Education Bureau of Zhejiang Province (491010-G21333, www.zjedu.gov.cn, YW is the receiver). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; BATTIE MC, 1990, J SPINAL DISORD, V3, P195; Blackmore CC, 2011, J AM COLL RADIOL, V8, P19, DOI 10.1016/j.jacr.2010.07.009; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; Carragee Eugene, 2006, Spine J, V6, P624, DOI 10.1016/j.spinee.2006.03.005; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Davis Patricia C, 2009, J Am Coll Radiol, V6, P401, DOI 10.1016/j.jacr.2009.02.008; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Deyo RA, 2009, ARCH INTERN MED, V169, P921, DOI 10.1001/archinternmed.2009.124; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Emery DJ, 2013, JAMA INTERN MED, V173, P823, DOI 10.1001/jamainternmed.2013.3804; Findlay JM, 2010, CAN J NEUROL SCI, V37, P843, DOI 10.1017/S0317167100051544; Flynn TW, 2011, J ORTHOP SPORT PHYS, V41, P838, DOI 10.2519/jospt.2011.3618; Graves JM, 2012, SPINE, V37, P1708, DOI 10.1097/BRS.0b013e31823a03cc; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kovacs FM, 2013, EUR J RADIOL, V82, P1008, DOI 10.1016/j.ejrad.2013.01.017; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.010; Lu YW, 2013, CHINESE J ORTHOPAEDI, V33, P6; Modic MT, 2007, RADIOLOGY, V245, P43, DOI 10.1148/radiol.2451051706; Rao JK, 2002, AM J MANAG CARE, V8, P27; Sistrom CL, 2009, RADIOLOGY, V251, P637, DOI 10.1148/radiol.2513080636; Stadnik TW, 1998, RADIOLOGY, V206, P49, DOI 10.1148/radiology.206.1.9423651; Weishaupt D, 1998, RADIOLOGY, V209, P661, DOI 10.1148/radiology.209.3.9844656	26	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146369	10.1371/journal.pone.0146369	http://dx.doi.org/10.1371/journal.pone.0146369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731106	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400161
J	Zhao, D; Kim, MH; Pastor-Barriuso, R; Chang, Y; Ryu, S; Zhang, YY; Rampal, S; Shin, H; Kim, JM; Friedman, DS; Guallar, E; Cho, J				Zhao, Di; Kim, Myung Hun; Pastor-Barriuso, Roberto; Chang, Yoosoo; Ryu, Seungho; Zhang, Yiyi; Rampal, Sanjay; Shin, Hocheol; Kim, Joon Mo; Friedman, David S.; Guallar, Eliseo; Cho, Juhee			A Longitudinal Study of Association between Adiposity Markers and Intraocular Pressure: The Kangbuk Samsung Health Study	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; AGE-RELATED-CHANGES; BODY-MASS INDEX; BLOOD-PRESSURE; INSULIN-RESISTANCE; GLAUCOMA; EPIDEMIOLOGY; HYPERTENSION; POPULATION; OBESITY	Importance Intraocular pressure (IOP) reduction or stabilization is the only proven method for glaucoma management. Identifying risk factors for IOP is crucial to understand the pathophysiology of glaucoma. Objective To examine the associations of change in body mass index (BMI), waist circumference, and percent fat mass with change in intraocular pressure (IOP) in a large sample of Korean adults. Design, setting and participants Cohort study of 274,064 young and middle age Korean adults with normal fundoscopic findings who attended annual or biennial health exams from January 1, 2002 to Feb 28, 2010 (577,981 screening visits). Exposures BMI, waist circumference, and percent fat mass. Main Outcome Measure(s) At each visit, IOP was measured in both eyes with automated noncontact tonometers. Results In multivariable-adjusted models, the average increase in IOP (95% confidence intervals) over time per interquartile increase in BMI (1.26 kg/m(2)), waist circumference (6.20 cm), and percent fat mass (3.40%) were 0.18 mmHg (0.17 to 0.19), 0.27 mmHg (0.26 to 0.29), and 0.10 mmHg (0.09 to 0.11), respectively (all P < 0.001). The association was stronger in men compared to women (P < 0.001) and it was only slightly attenuated after including diabetes and hypertension as potential mediators in the model. Conclusions and Relevance Increases in adiposity were significantly associated with an increase in IOP in a large cohort of Korean adults attending health screening visits, an association that was stronger for central obesity. Further research is needed to understand better the underlying mechanisms of this association, and to establish the role of weight gain in increasing IOP and the risk of glaucoma and its complications.	[Zhao, Di; Chang, Yoosoo; Ryu, Seungho; Zhang, Yiyi; Rampal, Sanjay; Guallar, Eliseo; Cho, Juhee] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Zhao, Di; Chang, Yoosoo; Ryu, Seungho; Zhang, Yiyi; Rampal, Sanjay; Guallar, Eliseo; Cho, Juhee] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Kim, Myung Hun] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea; [Pastor-Barriuso, Roberto] Carlos III Inst Hlth, Natl Ctr Epidemiol, Madrid, Spain; [Pastor-Barriuso, Roberto] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea; [Rampal, Sanjay] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Shin, Hocheol] Kangbuk Samsung Hosp, Dept Family Med, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Sch Med, Seoul, South Korea; [Kim, Joon Mo] Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Kangbuk Samsung Hosp, Seoul, South Korea; [Friedman, David S.; Guallar, Eliseo] Johns Hopkins Univ, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21218 USA; [Cho, Juhee] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Seoul National University (SNU); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Universiti Malaya; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Ryu, S (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	sh703.yoo@gmail.com; jcho@skku.edu	Pastor-Barriuso, Roberto/AAA-6746-2019; Cho, Juhee/ABD-2280-2021; Rampal, Sanjay/B-9691-2010	Pastor-Barriuso, Roberto/0000-0002-7325-3960; Rampal, Sanjay/0000-0002-0105-6407; Friedman, David/0000-0002-2055-5797; Chang, Yoosoo/0000-0002-6945-9050; Ryu, Seungho/0000-0002-3927-8646				BULPITT CJ, 1975, BRIT J OPHTHALMOL, V59, P717, DOI 10.1136/bjo.59.12.717; Caballero M, 2003, BIOCHEM BIOPH RES CO, V308, P346, DOI 10.1016/S0006-291X(03)01385-8; Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Chang Y, 2013, ARTERIOSCL THROM VAS, V33, P2026, DOI 10.1161/ATVBAHA.113.301587; DAVID R, 1987, BRIT J OPHTHALMOL, V71, P766, DOI 10.1136/bjo.71.10.766; Diggle Diggle P, 2013, ANAL LONGITUDINAL DA; Elm EV, 2007, STRENGTHENING REPORT, DOI [10.1136/bmj.39335.541782.AD, DOI 10.1136/BMJ.39335.541782.AD]; Fan Q, 2011, INVEST OPHTH VIS SCI, V52, P6059, DOI 10.1167/iovs.10-7108; Foster PJ, 2003, INVEST OPHTH VIS SCI, V44, P3885, DOI 10.1167/iovs.03-0012; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gupta PD, 2005, SURV OPHTHALMOL, V50, P274, DOI 10.1016/j.survophthal.2005.02.005; Hennis A, 2003, OPHTHALMOLOGY, V110, P908, DOI 10.1016/S0161-6420(03)00075-7; Hoehn R, 2013, OPHTHALMOLOGY, V120, P961, DOI 10.1016/j.ophtha.2012.10.031; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Khachatryan N, 2015, AM J OPHTHALMOL, DOI [10.1016/j.ajo.2015.01.011, DOI 10.1016/J.AJ0.2015.01.011]; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; MAPSTONE R, 1985, BRIT MED J, V291, P93, DOI 10.1136/bmj.291.6488.93; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; Musch DC, 2011, OPHTHALMOLOGY, V118, P1766, DOI 10.1016/j.ophtha.2011.01.047; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Ogbuehi KC, 2006, CLIN EXP OPTOM, V89, P310, DOI 10.1111/j.1444-0938.2006.00068.x; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Park Sang-shin, 2010, J Prev Med Public Health, V43, P125, DOI 10.3961/jpmph.2010.43.2.125; Qureshi IA, 1997, CLIN PHYSIOL, V17, P247, DOI 10.1111/j.1365-2281.1997.tb00004.x; Rabe-Hesketh S, 2009, CH CRC HANDB MOD STA, P79; Raudenbush SW, 2002, HIERARCHICAL LINEAR; SHIOSE Y, 1984, ARCH OPHTHALMOL-CHIC, V102, P883; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; Wang DD, 2011, AM J OPHTHALMOL, V152, P454, DOI 10.1016/j.ajo.2011.03.005; Wang S, 2009, OPHTHALMOLOGY, V116, P2373, DOI 10.1016/j.ophtha.2009.05.041; WANG Y, 2013, PLOS ONE, V2013; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Williams AL, 2013, J GLAUCOMA, V22, P215, DOI 10.1097/IJG.0b013e318237bfb8; Wong TT, 2009, INVEST OPHTH VIS SCI, V50, P4097, DOI 10.1167/iovs.08-2822; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Wu SY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1631, DOI 10.1001/archopht.124.11.1631; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; Yoshida M, 2003, JPN J OPHTHALMOL, V47, P191, DOI 10.1016/S0021-5155(02)00666-4; Yoshida M, 2014, ACTA MED OKAYAMA, V68, P27; Yudkin JS, 2005, LANCET, V365, P1817, DOI 10.1016/S0140-6736(05)66585-3; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051; Zhao D, 2014, INVEST OPHTH VIS SCI, V55, P6244, DOI 10.1167/iovs.14-14151; Zhao D, 2014, AM J OPHTHALMOL, V158, P615, DOI 10.1016/j.ajo.2014.05.029	49	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146057	10.1371/journal.pone.0146057	http://dx.doi.org/10.1371/journal.pone.0146057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731527	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400083
J	Balaguer, A; Monforte-Royo, C; Porta-Sales, J; Alonso-Babarro, A; Altisent, R; Aradilla-Herrero, A; Bellido-Perez, M; Breitbart, W; Centeno, C; Cuervo, MA; Deliens, L; Frerich, G; Gastmans, C; Lichtenfeld, S; Limonero, JT; Maier, MA; Materstvedt, LJ; Nabal, M; Rodin, G; Rosenfeld, B; Schroepfer, T; Tomas-Sabado, J; Trelis, J; Villavicencio-Chavez, C; Voltz, R				Balaguer, Albert; Monforte-Royo, Cristina; Porta-Sales, Josep; Alonso-Babarro, Alberto; Altisent, Rogelio; Aradilla-Herrero, Amor; Bellido-Perez, Mercedes; Breitbart, William; Centeno, Carlos; Angel Cuervo, Miguel; Deliens, Luc; Frerich, Gerrit; Gastmans, Chris; Lichtenfeld, Stephanie; Limonero, Joaqun T.; Maier, Markus A.; Johan Materstvedt, Lars; Nabal, Maria; Rodin, Gary; Rosenfeld, Barry; Schroepfer, Tracy; Tomas-Sabado, Joaquin; Trelis, Jordi; Villavicencio-Chavez, Christian; Voltz, Raymond			An International Consensus Definition of the Wish to Hasten Death and Its Related Factors	PLOS ONE			English	Article							ILL CANCER-PATIENTS; TERMINALLY-ILL; ASSISTED SUICIDE; PALLIATIVE CARE; DELPHI TECHNIQUE; OLDER-PEOPLE; DESIRE; DIE; EUTHANASIA; DEPRESSION	Background The desire for hastened death or wish to hasten death (WTHD) that is experienced by some patients with advanced illness is a complex phenomenon for which no widely accepted definition exists. This lack of a common conceptualization hinders understanding and cooperation between clinicians and researchers. The aim of this study was to develop an internationally agreed definition of the WTHD. Methods Following an exhaustive literature review, a modified nominal group process and an international, modified Delphi process were carried out. The nominal group served to produce a preliminary definition that was then subjected to a Delphi process in which 24 experts from 19 institutions from Europe, Canada and the USA participated. Delphi responses and comments were analysed using a pre-established strategy. Findings All 24 experts completed the three rounds of the Delphi process, and all the proposed statements achieved at least 79% agreement. Key concepts in the final definition include the WTHD as a reaction to suffering, the fact that such a wish is not always expressed spontaneously, and the need to distinguish the WTHD from the acceptance of impending death or from a wish to die naturally, although preferably soon. The proposed definition also makes reference to possible factors related to the WTHD. Conclusions This international consensus definition of the WTHD should make it easier for clinicians and researchers to share their knowledge. This would foster an improved understanding of the phenomenon and help in developing strategies for early therapeutic intervention.	[Balaguer, Albert; Porta-Sales, Josep; Villavicencio-Chavez, Christian] Univ Int Catalunya, Sch Med & Hlth Sci, Barcelona, Spain; [Monforte-Royo, Cristina; Bellido-Perez, Mercedes] Univ Int Catalunya, Sch Med & Hlth Sci, Dept Nursing, Barcelona, Spain; [Porta-Sales, Josep; Trelis, Jordi; Villavicencio-Chavez, Christian] Bellvitge Biomed Res Inst IDIBELL, Inst Catala Oncol, Palliat Care Serv, Barcelona, Spain; [Alonso-Babarro, Alberto] Hosp Univ La Paz, Unidad Cuidados Paliat, Madrid, Spain; [Altisent, Rogelio] Univ Zaragoza, Inst Hlth Res Aragon, Catedra Profesionalismo & Et Clin, Zaragoza, Spain; [Aradilla-Herrero, Amor; Tomas-Sabado, Joaquin] Autonomous Univ Barcelona, Escola Univ Infermeria Gimbernat, Barcelona, Spain; [Breitbart, William] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Centeno, Carlos] Univ Navarra, Univ Navarra Clin, Inst Culture & Soc, ATLANTES Res Program, Navarra, Spain; [Centeno, Carlos] Univ Navarra, Univ Navarra Clin, Palliat Med Dept, Navarra, Spain; [Angel Cuervo, Miguel] Complejo Hosp Infanta Cristina, Badajoz, Spain; [Deliens, Luc] Univ Ghent, End Of Life Care Res Grp, Brussels, Belgium; [Deliens, Luc] Vrije Univ Brussel, Brussels, Belgium; [Frerich, Gerrit] Univ Hosp Cologne, Dept Palliat Med, Cologne, Germany; [Gastmans, Chris] Katholieke Univ Leuven, Leuven, Belgium; [Lichtenfeld, Stephanie; Maier, Markus A.] Univ Munich, Munich, Germany; [Limonero, Joaqun T.] Univ Autonoma Barcelona, Fac Psychol, Stress & Res Grp, E-08193 Barcelona, Spain; [Johan Materstvedt, Lars] Norwegian Univ Sci & Technol NTNU, Fac Humanities, Dept Philosophy & Religious Studies, Trondheim, Norway; [Nabal, Maria] Hosp Arnau Vilanova, Inst Catala Salut, IRB, Palliat Care Support Team, Lleida, Spain; [Rodin, Gary] Univ Toronto, Dept Psychiat, Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON M5S 1A1, Canada; [Rodin, Gary] Univ Toronto, GIPPEC, Toronto, ON M5S 1A1, Canada; [Rosenfeld, Barry] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; [Schroepfer, Tracy] Univ Wisconsin, Sch Social Work, Madison, WI 53706 USA	Universitat Internacional de Catalunya (UIC); Universitat Internacional de Catalunya (UIC); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Universitario La Paz; University of Zaragoza; Autonomous University of Barcelona; Memorial Sloan Kettering Cancer Center; University of Navarra; University of Navarra; Ghent University; Vrije Universiteit Brussel; University of Cologne; KU Leuven; University of Munich; Autonomous University of Barcelona; Norwegian University of Science & Technology (NTNU); Institut de Recerca Biomedica - IRB Lleida; University Hospital Arnau de Vilanova; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Fordham University; University of Wisconsin System; University of Wisconsin Madison	Balaguer, A (corresponding author), Univ Int Catalunya, Sch Med & Hlth Sci, Barcelona, Spain.	abalaguer@uic.es	Gastmans, Chris/GWZ-3728-2022; Centeno, Carlos/H-3430-2013; Balaguer, Albert/B-3530-2011; Aradilla Herrero, Amor/C-3336-2013; Limonero, Joaquín T./G-8639-2011; Gastmans, Chris/Y-5504-2019; Monforte-Royo, Cristina/B-5016-2013; Balaguer, Albert/AAG-8678-2020; Tomas-Sabado, Joaquin/B-7368-2015	Centeno, Carlos/0000-0003-3395-7039; Balaguer, Albert/0000-0002-5222-8635; Aradilla Herrero, Amor/0000-0003-1916-2803; Limonero, Joaquín T./0000-0003-0573-791X; Gastmans, Chris/0000-0002-5522-0639; Monforte-Royo, Cristina/0000-0001-8334-4623; Balaguer, Albert/0000-0002-5222-8635; Deliens, Luc/0000-0002-8158-2422; Tomas-Sabado, Joaquin/0000-0002-7156-7843; Rodin, Gary/0000-0002-6626-6974; Bellido-Perez, Mercedes/0000-0002-1644-439X; Lichtenfeld, Stephanie/0000-0003-3485-9078	Instituto de Salud Carlos III [PI14/00263]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Instituto de Salud Carlos III (grant number: PI14/00263): Main researcher Albert Balaguer; Other researchers: Cristina Monforte-Royo, Joaquin Tomas-Sabado, Christian Villavicencio-Chavez, Mercedes Bellido-Perez; aecc-Catalunya contra el Cancer of Barcelona (Investigacio 2014): Main researcher: Albert Balaguer; Other researchers: Cristina Monforte-Royo, Josep Porta-Sales, Joaquin Tomas-Sabado, Christian Villavicencio-Chavez, Mercedes Bellido-Perez, Amor Aradilla-Herrero; WeCare Chair: End-of-life care at the Universitat Internacional de Catalunya and ALTIMA: Main researchers: Cristina Monforte-Royo; Josep Porta-Sales; Albert Balaguer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert SM, 2005, NEUROLOGY, V65, P68, DOI 10.1212/01.wnl.0000168161.54833.bb; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; BROWN JH, 1986, AM J PSYCHIAT, V143, P208; Bruce A, 2011, J ADV NURS, V67, P2732, DOI 10.1111/j.1365-2648.2011.05711.x; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chochinov HM, 2005, PSYCHOSOMATICS, V46, P7, DOI 10.1176/appi.psy.46.1.7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Coyle N, 2004, ONCOL NURS FORUM, V31, P699, DOI 10.1188/04.ONF.699-709; Cresswell KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001554; de Casterle BD, 2006, J MED ETHICS, V32, P187, DOI 10.1136/jme.2005.011783; Gastmans C, 2004, J MED ETHICS, V30, P212, DOI 10.1136/jme.2003.005082; Gordon M, 2014, MED TEACH, V22, P1; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hudson PL, 2006, PALLIATIVE MED, V20, P693, DOI 10.1177/0269216306071799; Johansen S, 2005, PALLIATIVE MED, V19, P454, DOI 10.1191/0269216305pm1048oa; Kelly B, 2003, PSYCHOL MED, V33, P75, DOI 10.1017/S0033291702006827; Kelly B, 2002, PALLIATIVE MED, V16, P339, DOI 10.1191/0269216302pm538oa; Kissane DW, 2012, ARCH INTERN MED, V172, P1501, DOI 10.1001/archinternmed.2012.3633; Kissane DW, 2001, J PALLIAT CARE, V17, P12, DOI 10.1177/082585970101700103; Lavery JV, 2001, LANCET, V358, P362, DOI 10.1016/S0140-6736(01)05555-6; Mak YYW, 2005, PALLIATIVE MED, V19, P343, DOI 10.1191/0269216305pm1019oa; Malpas PJ, 2012, NEW ZEAL MED J, V125, P9; McClain-Jacobson C, 2004, GEN HOSP PSYCHIAT, V26, P484, DOI 10.1016/j.genhosppsych.2004.08.002; Mishara BL, 1999, OMEGA-J DEATH DYING, V39, P1, DOI 10.2190/5YED-YKMY-V60G-L5U5; Monforte-Royo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037117; Monforte-Royo C, 2011, PSYCHO-ONCOLOGY, V20, P795, DOI 10.1002/pon.1839; Morita T, 2004, J PAIN SYMPTOM MANAG, V27, P44, DOI 10.1016/j.jpainsymman.2003.05.001; Mystakidou K, 2005, GEN HOSP PSYCHIAT, V27, P258, DOI 10.1016/j.genhosppsych.2005.02.004; Nissim R, 2009, SOC SCI MED, V69, P165, DOI 10.1016/j.socscimed.2009.04.021; Ohnsorge K, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-38; Ohnsorge K, 2012, NURS ETHICS, V19, P629, DOI 10.1177/0969733011436206; Owen C., 1992, PSYCHO-ONCOLOGY, V1, P79, DOI [10.1002/pon.2960010205, DOI 10.1002/PON.2960010205]; Pearlman RA, 2005, J GEN INTERN MED, V20, P234, DOI 10.1111/j.1525-1497.2005.40225.x; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Raijmakers NJH, 2015, J MED ETHICS, V41, DOI 10.1136/medethics-2012-101304; Rodin G, 2007, J PAIN SYMPTOM MANAG, V33, P661, DOI 10.1016/j.jpainsymman.2006.09.034; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; Rosenfeld B, 2000, PSYCHOL PUBLIC POL L, V6, P467, DOI 10.1037//1076-8971.6.2.467; Rosenfeld B, 2000, PSYCHOL PUBLIC POL L, V6, P559, DOI 10.1037//1076-8971.6.2.559; Rosenfeld B., 2004, ASSISTED SUICIDE RIG; Rurup ML, 2011, CRISIS, V32, P204, DOI 10.1027/0227-5910/a000078; Sanduleanu S, 2014, GUT; Schroepfer TA, 2006, J GERONTOL B-PSYCHOL, V61, pS129, DOI 10.1093/geronb/61.3.S129; Simon ST, 2014, J PAIN SYMPTOM MANAG, V47, P828, DOI 10.1016/j.jpainsymman.2013.06.013; Tastle WJ, 2007, P N AM FUZZ INF PROC; Van Loon RA, 1999, HEALTH SOC WORK, V24, P260, DOI 10.1093/hsw/24.4.260; van Wijngaarden E, 2014, OMEGA-J DEATH DYING, V69, P191, DOI 10.2190/OM.69.2.f; VANDEVEN AH, 1972, AM J PUBLIC HEALTH N, V62, P337, DOI 10.2105/AJPH.62.3.337; Villavicencio-Chavez C, 2014, PSYCHO-ONCOLOGY, V23, P1125, DOI 10.1002/pon.3536; Viola R, 2014, J PALLIAT CARE, V30, P294, DOI 10.1177/082585971403000410; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x	52	55	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146184	10.1371/journal.pone.0146184	http://dx.doi.org/10.1371/journal.pone.0146184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26726801	Green Accepted, Green Published, gold			2022-12-27	WOS:000367681500062
J	Basaran, KE; Villongco, M; Ho, B; Ellis, E; Zarndt, R; Antonova, J; Hopkins, SR; Powell, FL				Basaran, Kemal Erdem; Villongco, Michael; Ho, Baran; Ellis, Erika; Zarndt, Rachel; Antonova, Julie; Hopkins, Susan R.; Powell, Frank L.			Ibuprofen Blunts Ventilatory Acclimatization to Sustained Hypoxia in Humans	PLOS ONE			English	Article							CAROTID-BODY; ANTIINFLAMMATORY DRUGS; INNATE IMMUNITY; ALTITUDE; HIF-1-ALPHA; EXPRESSION; INTERMITTENT; INFLAMMATION; CONTRIBUTE; RESPONSES	Ventilatory acclimatization to hypoxia is a time-dependent increase in ventilation and the hypoxic ventilatory response (HVR) that involves neural plasticity in both carotid body chemoreceptors and brainstem respiratory centers. The mechanisms of such plasticity are not completely understood but recent animal studies show it can be blocked by administering ibuprofen, a nonsteroidal anti-inflammatory drug, during chronic hypoxia. We tested the hypothesis that ibuprofen would also block the increase in HVR with chronic hypoxia in humans in 15 healthy men and women using a double-blind, placebo controlled, cross-over trial. The isocapnic HVR was measured with standard methods in subjects treated with ibuprofen (400mg every 8 hrs) or placebo for 48 hours at sea level and 48 hours at high altitude (3,800 m). Subjects returned to sea level for at least 30 days prior to repeating the protocol with the opposite treatment. Ibuprofen significantly decreased the HVR after acclimatization to high altitude compared to placebo but it did not affect ventilation or arterial O-2 saturation breathing ambient air at high altitude. Hence, compensatory responses prevent hypoventilation with decreased isocapnic ventilatory O-2-sensitivity from ibuprofen at this altitude. The effect of ibuprofen to decrease the HVR in humans provides the first experimental evidence that a signaling mechanism described for ventilatory acclimatization to hypoxia in animal models also occurs in people. This establishes a foundation for the future experiments to test the potential role of different mechanisms for neural plasticity and ventilatory acclimatization in humans with chronic hypoxemia from lung disease.	[Basaran, Kemal Erdem; Villongco, Michael; Ho, Baran; Ellis, Erika; Zarndt, Rachel; Antonova, Julie; Hopkins, Susan R.; Powell, Frank L.] Univ Calif San Diego, Dept Med, Div Physiol, San Diego, CA 92103 USA; [Basaran, Kemal Erdem] Erciyes Univ, Fac Med, Dept Med Physiol, Kayseri, Turkey; [Hopkins, Susan R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA	University of California System; University of California San Diego; Erciyes University; University of California System; University of California San Diego	Powell, FL (corresponding author), Univ Calif San Diego, Dept Med, Div Physiol, San Diego, CA 92103 USA.	fpowell@ucsd.edu	BASARAN, KEMAL ERDEM/AFJ-0278-2022	BASARAN, KEMAL ERDEM/0000-0001-6035-9398; Hopkins, Susan/0000-0002-8672-0986; Ellis, Erika/0000-0002-8851-0157	National Heart Lung and Blood Institute [2R01HL081823, 5R01HL081171, 1P01HL098053, T32HL098062]; UC White Mountain Research Station; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053, T32HL098062, R01HL081823, R01HL081171] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UC White Mountain Research Station; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart Lung and Blood Institute 2R01HL081823 (FLP, MV), 5R01HL081171 (SRH), 1P01HL098053 (FLP), T32HL098062 (RZ), and UC White Mountain Research Station graduate student grant (BH, EE, JA).	Accorsi-Mendonca D, 2015, J NEUROSCI, V35, P6903, DOI 10.1523/JNEUROSCI.4598-14.2015; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; Dempsey JA, 2014, J APPL PHYSIOL, V116, P858, DOI 10.1152/japplphysiol.01126.2013; Donoghue S, 2005, J APPL PHYSIOL, V98, P1587, DOI 10.1152/japplphysiol.01019.2004; Dwinell MR, 1999, J APPL PHYSIOL, V87, P817, DOI 10.1152/jappl.1999.87.2.817; Garcia N, 2000, RESP PHYSIOL, V124, P11, DOI 10.1016/S0034-5687(00)00183-3; Garcia N, 2000, WILD ENVIRON MED, V11, P172, DOI 10.1580/1080-6032(2000)011[0172:IVCHEO]2.3.CO;2; Gertsch JH, 2012, WILD ENVIRON MED, V23, P307, DOI 10.1016/j.wem.2012.08.001; Hupperets MDW, 2004, RESP PHYSIOL NEUROBI, V142, P145, DOI 10.1016/j.resp.2004.06.011; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; Koehle MS, 2005, RESP PHYSIOL NEUROBI, V145, P33, DOI 10.1016/j.resp.2004.09.004; Kumar P, 2012, COMPR PHYSIOL, V2, P141, DOI 10.1002/cphy.c100069; Liu X, 2011, RESP PHYSIOL NEUROBI, V178, P362, DOI 10.1016/j.resp.2011.03.006; Pamenter ME, 2014, J PHYSIOL-LONDON, V592, P1839, DOI 10.1113/jphysiol.2013.268706; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Popa D, 2011, RESP PHYSIOL NEUROBI, V178, P381, DOI 10.1016/j.resp.2011.03.024; Powell FL, 1998, RESP PHYSIOL, V112, P123, DOI 10.1016/S0034-5687(98)00026-7; Rebuck AS, REGULATION BREATHI 2, P745; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; SATO M, 1994, J APPL PHYSIOL, V77, P313, DOI 10.1152/jappl.1994.77.1.313; SATO M, 1992, J APPL PHYSIOL, V73, P101, DOI 10.1152/jappl.1992.73.1.101; Stuhlmeier KM, 1999, BIOCHEM PHARMACOL, V57, P313, DOI 10.1016/S0006-2952(98)00301-3; Teppema LJ, 2010, PHYSIOL REV, V90, P675, DOI 10.1152/physrev.00012.2009; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Yamaya Y, 2002, J APPL PHYSIOL, V92, P162, DOI 10.1152/japplphysiol.00409.2001; Zhang S, 2000, J APPL PHYSIOL, V88, P1924, DOI 10.1152/jappl.2000.88.5.1924; Zhang WR, 2009, J NEUROSCI, V29, P3093, DOI 10.1523/JNEUROSCI.2648-08.2009; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	33	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146087	10.1371/journal.pone.0146087	http://dx.doi.org/10.1371/journal.pone.0146087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726885	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500053
J	Chruewkamlow, N; Mahasongkram, K; Pata, S; Chaiwarith, R; Salee, P; Supparatpinyo, K; Kasinrerk, W				Chruewkamlow, Nuttapol; Mahasongkram, Kodchakorn; Pata, Supansa; Chaiwarith, Romanee; Salee, Parichart; Supparatpinyo, Khuanchai; Kasinrerk, Watchara			Immune Alterations in Patients with AntiInterferon-gamma Autoantibodies	PLOS ONE			English	Article							HUMAN T-CELLS; INTERFERON-GAMMA; ACQUIRED-IMMUNODEFICIENCY; INTERLEUKIN-2 RECEPTOR; INFECTIONS; ALPHA; AUTOIMMUNITY; DISEASES; INNATE; AGE	Autoantibodies against interferon-gamma (IFN-gamma) can cause immunodeficiency and are associated with various opportunistic infections. In the present study, we investigated other cellular immune parameters for a better understanding of the immunodeficiency condition in the patients. The numbers of WBC, monocytes and NK cells were increased in patients with anti-IFN-gamma autoantibodies (AAbs). Upon TCR activation, T cell proliferation and IL-2 receptor of the patients remained intact. Nonetheless, the Th1 cytokine (IFN-gamma and TNF-alpha) production was up-regulated. The production of Th2 (IL-4) and Th17 (IL-17) cytokines was unchanged. We suggest that, in addition to the presence of anti-IFN-gamma autoantibodies, alterations in the cellular immune functions may also contribute to this immunodeficiency.	[Chruewkamlow, Nuttapol; Mahasongkram, Kodchakorn; Pata, Supansa; Kasinrerk, Watchara] Chiang Mai Univ, Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy, Biomed Technol Res Ctr,Fac Associated Med Sci, Chiang Mai 50000, Thailand; [Pata, Supansa; Kasinrerk, Watchara] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Div Clin Immunol, Chiang Mai 50000, Thailand; [Chaiwarith, Romanee; Salee, Parichart; Supparatpinyo, Khuanchai] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50000, Thailand; [Supparatpinyo, Khuanchai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand	Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chiang Mai University; Chiang Mai University; Chiang Mai University	Kasinrerk, W (corresponding author), Chiang Mai Univ, Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy, Biomed Technol Res Ctr,Fac Associated Med Sci, Chiang Mai 50000, Thailand.	wkasinrerk@gmail.com		Chaiwarith, Romanee/0000-0002-1241-5954	National Research University Project under Thailand's Office of the Higher Education Commission for Chiang Mai University; Chiang Mai University Center of Excellence grant for Biomedical Technology Research Center; Thailand Research Fund [TRG5780017]; Chiang Mai University at the Biomedical Technology Research Center	National Research University Project under Thailand's Office of the Higher Education Commission for Chiang Mai University; Chiang Mai University Center of Excellence grant for Biomedical Technology Research Center; Thailand Research Fund(Thailand Research Fund (TRF)); Chiang Mai University at the Biomedical Technology Research Center	This work was supported by the National Research University Project under Thailand's Office of the Higher Education Commission for Chiang Mai University to KS, Chiang Mai University Center of Excellence grant for Biomedical Technology Research Center to KW, and Thailand Research Fund [TRG5780017] to SP. NC is a postdoctoral researcher supported by Chiang Mai University at the Biomedical Technology Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2012, CELLULAR MOL IMMUNOL, P225; Abbas AK, 2010, CELLULAR MOL IMMUNOL, P3; Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Browne SK, 2014, ANNU REV IMMUNOL, V32, P635, DOI 10.1146/annurev-immunol-032713-120222; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Browne SK, 2010, CURR OPIN ALLERGY CL, V10, P534, DOI 10.1097/ACI.0b013e3283402b41; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; CHOPRA RK, 1989, IMMUNOLOGY, V66, P54; Crum NF, 2005, MEDICINE, V84, P291, DOI 10.1097/01.md.0000180044.19285.9a; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Desai A, 2010, J LEUKOCYTE BIOL, V87, P1001, DOI 10.1189/jlb.0809542; Doffinger R, 2005, CURR OPIN RHEUMATOL, V17, P440, DOI 10.1097/01.bor.0000166387.70475.dd; Haverkamp MH, 2006, MICROBES INFECT, V8, P1157, DOI 10.1016/j.micinf.2005.10.029; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Koya T, 2009, J INFECT CHEMOTHER, V15, P118, DOI 10.1007/s10156-008-0662-8; Meager A, 2003, CLIN EXP IMMUNOL, V132, P128, DOI 10.1046/j.1365-2249.2003.02113.x; NAGEL JE, 1989, CLIN EXP IMMUNOL, V75, P286; NAGEL JE, 1988, J CLIN INVEST, V81, P1096, DOI 10.1172/JCI113422; Pollard KM, 2013, DISCOV MED, V16, P123; Poulin S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-24; PRUMMER O, 1994, BONE MARROW TRANSPL, V14, P483; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Tang BSF, 2010, CLIN VACCINE IMMUNOL, V17, P1132, DOI 10.1128/CVI.00053-10; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; Whisler RL, 1996, CELL IMMUNOL, V169, P185, DOI 10.1006/cimm.1996.0109; Wipasa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110276; Wongkulab P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076371	31	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145983	10.1371/journal.pone.0145983	http://dx.doi.org/10.1371/journal.pone.0145983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727515	gold, Green Submitted, Green Published			2022-12-27	WOS:000367681500041
J	Kim, S; Kim, S; Khalid, A; Jeong, Y; Jeong, B; Lee, ST; Jung, KH; Chu, K; Lee, SK; Jeon, D				Kim, Shinheun; Kim, Sangwoo; Khalid, Arshi; Jeong, Yong; Jeong, Bumseok; Lee, Soon-Tae; Jung, Keun-Hwa; Chu, Kon; Lee, Sang Kun; Jeon, Daejong			Rhythmical Photic Stimulation at Alpha Frequencies Produces Antidepressant-Like Effects in a Mouse Model of Depression	PLOS ONE			English	Article							LIGHT THERAPY; BEHAVIORAL DESPAIR; BLOOD-FLOW; NONSEASONAL DEPRESSION; MATERNAL SEPARATION; MAJOR DEPRESSION; ANIMAL-MODEL; EEG-ALPHA; BRAIN; MOOD	Current therapies for depression consist primarily of pharmacological agents, including antidepressants, and/or psychiatric counseling, such as psychotherapy. However, light therapy has recently begun to be considered as an effective tool for the treatment of the neuropsychiatric behaviors and symptoms of a variety of brain disorders or diseases, including depression. One methodology employed in light therapy involves flickering photic stimulation within a specific frequency range. The present study investigated whether flickering and flashing photic stimulation with light emitting diodes (LEDs) could improve depression-like behaviors in a corticosterone (CORT)-induced mouse model of depression. Additionally, the effects of the flickering and flashing lights on depressive behavior were compared with those of fluoxetine. Rhythmical flickering photic stimulation at alpha frequencies from 9-11 Hz clearly improved performance on behavioral tasks assessing anxiety, locomotor activity, social interaction, and despair. In contrast, fluoxetine treatment did not strongly improve behavioral performance during the same period compared with flickering photic stimulation. The present findings demonstrated that LED-derived flickering photic stimulation more rapidly improved behavioral outcomes in a CORT-induced mouse model of depression compared with fluoxetine. Thus, the present study suggests that rhythmical photic stimulation at alpha frequencies may aid in the improvement of the quality of life of patients with depression.	[Kim, Shinheun; Khalid, Arshi; Jeong, Yong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Yuseong, Daejeon, South Korea; [Kim, Sangwoo; Lee, Soon-Tae; Jung, Keun-Hwa; Chu, Kon; Lee, Sang Kun; Jeon, Daejong] Seoul Natl Univ Hosp, Biomed Res Inst, Comprehens Epilepsy Ctr, Lab Neurotherapeut,Dept Neurol, Seoul 110744, South Korea; [Jeong, Bumseok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Yuseong, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Chu, K (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Comprehens Epilepsy Ctr, Lab Neurotherapeut,Dept Neurol, Seoul 110744, South Korea.	stemcell.snu@gmail.com; sangkun2923@gmail.com; clark.jeon@gmail.com	Jeong, Yong/C-1677-2011; Jeong, Bumseok/G-2722-2011	Jeong, Yong/0000-0002-5907-3787; Jeong, Bumseok/0000-0001-6805-6535; Lee, Soon-Tae/0000-0003-4767-7564; Jung, Keun-Hwa/0000-0003-1433-8005; Jeon, Daejong/0000-0002-6998-7603; Chu, Kon/0000-0001-5863-0302	Mid-career Researcher Program - Ministry of Science, ICT and Future Planning [NRF-2014R1A2A1A11052709]; Basic Science Research Program - Ministry of Science, ICT and Future Planning [NRF-2014R1A2A2A01002608]	Mid-career Researcher Program - Ministry of Science, ICT and Future Planning; Basic Science Research Program - Ministry of Science, ICT and Future Planning	This work was supported by the Mid-career Researcher Program (NRF-2014R1A2A1A11052709) and the Basic Science Research Program grants (NRF-2014R1A2A2A01002608) funded by Ministry of Science, ICT and Future Planning.	AASLID R, 1987, STROKE, V18, P771, DOI 10.1161/01.STR.18.4.771; Adrian ED, 1934, J PHYSIOL-LONDON, V81, P440, DOI 10.1113/jphysiol.1934.sp003147; Ardayfio P, 2006, BEHAV NEUROSCI, V120, P249, DOI 10.1037/0735-7044.120.2.249; BARLOW JS, 1960, ELECTROEN CLIN NEURO, V12, P317, DOI 10.1016/0013-4694(60)90005-5; Baskaran A, 2012, NEUROPHARMACOLOGY, V63, P507, DOI 10.1016/j.neuropharm.2012.04.021; Bedrosian TA, 2013, MOL PSYCHIATR, V18, P751, DOI 10.1038/mp.2013.70; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Canbeyli R, 2010, BEHAV BRAIN RES, V207, P249, DOI 10.1016/j.bbr.2009.11.002; Canbeyli R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00428; Cantero JL, 2005, REV NEUROSCIENCE, V16, P69, DOI 10.1515/REVNEURO.2005.16.1.69; Compston A, 2010, BRAIN, V133, P1, DOI 10.1093/brain/awp330; Correa-Lacarcel J, 2000, J CHEM NEUROANAT, V18, P135, DOI 10.1016/S0891-0618(00)00038-7; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Diehl B, 1998, ELECTROEN CLIN NEURO, V107, P8, DOI 10.1016/S0013-4694(98)00036-4; Dimatelis JJ, 2013, J MOL NEUROSCI, V51, P835, DOI 10.1007/s12031-013-0071-z; Dimatelis JJ, 2012, BRAIN RES, V1480, P61, DOI 10.1016/j.brainres.2012.07.013; Dowling GA, 2007, WESTERN J NURS RES, V29, P961, DOI 10.1177/0193945907303083; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; ESPIRITU RC, 1994, BIOL PSYCHIAT, V35, P403, DOI 10.1016/0006-3223(94)90007-8; Even C, 2008, J AFFECT DISORDERS, V108, P11, DOI 10.1016/j.jad.2007.09.008; Fink A, 2014, NEUROSCI BIOBEHAV R, V44, P111, DOI 10.1016/j.neubiorev.2012.12.002; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Gonzalez MMC, 2008, P NATL ACAD SCI USA, V105, P4898, DOI 10.1073/pnas.0703615105; Gourley SL, 2008, ANN NY ACAD SCI, V1148, P509, DOI 10.1196/annals.1410.076; Hache G, 2012, NEUROREPORT, V23, P525, DOI 10.1097/WNR.0b013e328353d70a; Hanford N, 2013, J ALZHEIMERS DIS, V33, P913, DOI 10.3233/JAD-2012-121645; Heim M, 1990, Psychiatr Neurol Med Psychol (Leipz), V42, P146; Huang TL, 2008, ALTERN THER HEALTH M, V14, P38; INOUYE T, 1980, ELECTROEN CLIN NEURO, V49, P135, DOI 10.1016/0013-4694(80)90359-4; Iosifescu DV, 2011, HARVARD REV PSYCHIAT, V19, P144, DOI 10.3109/10673229.2011.586549; Iyilikci O, 2009, BEHAV BRAIN RES, V203, P65, DOI 10.1016/j.bbr.2009.04.013; Jean-Louis G, 2005, PHYSIOL BEHAV, V84, P479, DOI 10.1016/j.physbeh.2005.01.011; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Jin Y, 1997, BIOL PSYCHIAT, V41, P496, DOI 10.1016/S0006-3223(96)00473-8; Jung S, 2013, BEHAV BRAIN RES, V236, P23, DOI 10.1016/j.bbr.2012.08.029; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khalid A, 2014, NEUROIMAGE, V101, P351, DOI 10.1016/j.neuroimage.2014.07.040; Klauser P, 2015, J AFFECT DISORDERS, V173, P45, DOI 10.1016/j.jad.2014.10.041; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kumano H, 1997, APPL PSYCHOPHYS BIOF, V22, P193, DOI 10.1023/A:1026215910176; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Molina-Hernandez M, 2000, PROG NEURO-PSYCHOPH, V24, P105, DOI 10.1016/S0278-5846(99)00084-6; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; NOGAWA T, 1976, ELECTROEN CLIN NEURO, V40, P78, DOI 10.1016/0013-4694(76)90181-4; Nomura T, 2006, J GASTROEN HEPATOL, V21, P54, DOI 10.1111/j.1440-1746.2005.04204.x; Ossebaard HC, 2000, APPL PSYCHOPHYS BIOF, V25, P93, DOI 10.1023/A:1009514824951; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; Parry Barbara L, 2003, Dialogues Clin Neurosci, V5, P353; Pastor MA, 2003, J NEUROSCI, V23, P11621; Patten SB, 2001, J AFFECT DISORDERS, V63, P35, DOI 10.1016/S0165-0327(00)00186-5; PHELPS ME, 1981, SCIENCE, V211, P1445, DOI 10.1126/science.6970412; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prasko J, 2008, NEUROENDOCRINOL LETT, V29, P33; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; RAO ML, 1992, ACTA PSYCHIAT SCAND, V86, P127, DOI 10.1111/j.1600-0447.1992.tb03240.x; RAO ML, 1990, PHARMACOPSYCHIATRY, V23, P155, DOI 10.1055/s-2007-1014499; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rosenfeld JP, 1997, APPL PSYCHOPHYS BIOF, V22, P3, DOI 10.1023/A:1026233624772; Rush AJ, 1997, J CLIN PSYCHIAT, V58, P14; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schulz D, 2008, PROG NEURO-PSYCHOPH, V32, P1257, DOI 10.1016/j.pnpbp.2008.03.019; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Seo J, 2013, EXP NEUROL, V241, P38, DOI 10.1016/j.expneurol.2012.11.024; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; SINGH UB, 1967, J NEUROCHEM, V14, P675, DOI 10.1111/j.1471-4159.1967.tb09572.x; Skjerve A, 2004, PSYCHIAT CLIN NEUROS, V58, P343, DOI 10.1111/j.1440-1819.2004.01265.x; Soares JC, 1997, J PSYCHIATR RES, V31, P393, DOI 10.1016/S0022-3956(97)00016-2; Stain-Malmgren R, 1998, PSYCHIAT RES, V78, P163, DOI 10.1016/S0165-1781(98)00017-1; TALWAR GP, 1966, J NEUROCHEM, V13, P109, DOI 10.1111/j.1471-4159.1966.tb03338.x; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; THALEN BE, 1995, ACTA PSYCHIAT SCAND, V92, P274, DOI 10.1111/j.1600-0447.1995.tb09583.x; TOWNSEND RE, 1975, ELECTROEN CLIN NEURO, V39, P515, DOI 10.1016/0013-4694(75)90053-X; Tsai YF, 2004, INT J GERIATR PSYCH, V19, P545, DOI 10.1002/gps.1125; van der Staay FJ, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-11; WALTER VJ, 1949, ELECTROEN CLIN NEURO, V1, P57, DOI 10.1016/0013-4694(49)90164-9; WALTER WG, 1956, NATURE, V177, P710, DOI 10.1038/177710a0; Williams J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-21; Williams JH, 2001, NEUROSCIENCE, V104, P283, DOI 10.1016/S0306-4522(00)00579-0; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Yilmaz A, 2004, PROG NEURO-PSYCHOPH, V28, P1261, DOI 10.1016/j.pnpbp.2004.06.011	96	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145374	10.1371/journal.pone.0145374	http://dx.doi.org/10.1371/journal.pone.0145374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727023	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500014
J	Kumar, NP; Banurekha, VV; Nair, D; Babu, S				Kumar, Nathella Pavan; Banurekha, Vaithilingam V.; Nair, Dina; Babu, Subash			Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LYMPHANGIOGENESIS; GRANULOMA; INFLAMMATION; RECEPTORS; VEGF	Background Angiogenesis and lymphangiogenesis are classical features of granuloma formation in pulmonary tuberculosis (PTB). In addition, the angiogenic factor-VEGF-A is a known biomarker for PTB. Aims/Methodology To examine the association of circulating angiogenic factors with PTB, we examined the systemic levels of VEGF-A, VEGF-C, VEGF-D, VEGF-R1, VEGF-R2 and VEGF-R3in individuals with PTB, latent TB (LTB) or no TB infection (NTB). Results Circulating levels of VEGF-A, VEGF-C andVEGF-R2 were significantly higher in PTB compared to LTB or NTB individuals. Moreover, the levels of VEGF-A, VEGF-C and VEGF-R2 were significantly higher in PTB with bilateral and/or cavitary disease. The levels of these factors also exhibited a significant positive relationship with bacterial burdens in PTB. ROC analysis revealed VEGF-A and VEGF-R2 as markers distinguishing PTB from LTB or NTB. Finally, the circulating levels of all the angiogenic factors examined were significantly reduced following successful chemotherapy. Conclusion Therefore, our data demonstrate that PTB is associated with elevated levels of circulating angiogenic factors, possibly reflecting vascular and endothelial dysfunction. In addition, some of these circulating angiogenic factors could prove useful as biomarkers to monitor disease severity, bacterial burden and therapeutic responses.	[Kumar, Nathella Pavan; Banurekha, Vaithilingam V.; Babu, Subash] Int Ctr Excellence Res, NIRT, Natl Inst Hlth, Madras, Tamil Nadu, India; [Nair, Dina] Natl Inst Res TB, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Babu, S (corresponding author), Int Ctr Excellence Res, NIRT, Natl Inst Hlth, Madras, Tamil Nadu, India.	sbabu@mail.nih.gov	Babu, Subash/GXG-4746-2022; Kumar, Nathella Pavan/AAU-2328-2021		Division of Intramural Research, NIAID (National Institute of Allergy and Infectious Diseases), NIH (National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID (National Institute of Allergy and Infectious Diseases), NIH (National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Division of Intramural Research, NIAID (National Institute of Allergy and Infectious Diseases), NIH (National Institutes of Health). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe Y, 2001, RESPIRATION, V68, P496, DOI 10.1159/000050557; Aebischer D, 2014, ANGIOGENESIS, V17, P383, DOI 10.1007/s10456-013-9404-3; Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Coso S, 2014, BLOOD, V123, P2614, DOI 10.1182/blood-2013-12-297317; Datta M, 2015, P NATL ACAD SCI USA, V112, P1827, DOI 10.1073/pnas.1424563112; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Franco D, 2012, AESTHET PLAST SURG, V36, P1254, DOI 10.1007/s00266-012-9957-3; Harding J, 2015, AM J PATHOL, V185, P432, DOI 10.1016/j.ajpath.2014.09.020; Ho VC, 2012, CIRCULATION, V126, P741, DOI 10.1161/CIRCULATIONAHA.112.091603; Jeltsch M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009183; Kim H, 2012, TRENDS IMMUNOL, V33, P350, DOI 10.1016/j.it.2012.03.006; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lee WL, 2011, CURR OPIN HEMATOL, V18, P191, DOI 10.1097/MOH.0b013e328345a3d1; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; Matty MA, 2015, IMMUNOL REV, V264, P276, DOI 10.1111/imr.12273; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Ota MOC, 2014, EUR RESPIR J, V44, P254, DOI 10.1183/09031936.00209913; Pagan A. J., 2014, COLD SPRING HARB PER; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Park HY, 2012, YONSEI MED J, V53, P369, DOI 10.3349/ymj.2012.53.2.369; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sakaguchi I, 2000, INFECT IMMUN, V68, P2043, DOI 10.1128/IAI.68.4.2043-2052.2000; Tammela T, 2005, TRENDS CELL BIOL, V15, P434, DOI 10.1016/j.tcb.2005.06.004; Walzl G, 2014, COLD SPRING HARB PER, V5; Webb NJA, 1998, CLIN SCI, V94, P395, DOI 10.1042/cs0940395; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603	29	25	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146318	10.1371/journal.pone.0146318	http://dx.doi.org/10.1371/journal.pone.0146318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727122	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000367681500075
J	Misra, N; Panda, PK; Parida, BK; Mishra, BK				Misra, Namrata; Panda, Prasanna Kumar; Parida, Bikram Kumar; Mishra, Barada Kanta			dEMBF: A Comprehensive Database of Enzymes of Microalgal Biofuel Feedstock	PLOS ONE			English	Article							HIDDEN MARKOV MODEL; LIPID PRODUCTION; DIACYLGLYCEROL ACYLTRANSFERASE; PROTEIN; BIOSYNTHESIS; SEQUENCE; ACCUMULATION; METABOLISM; PREDICTION; ALIGNMENT	Microalgae have attracted wide attention as one of the most versatile renewable feedstocks for production of biofuel. To develop genetically engineered high lipid yielding algal strains, a thorough understanding of the lipid biosynthetic pathway and the underpinning enzymes is essential. In this work, we have systematically mined the genomes of fifteen diverse algal species belonging to Chlorophyta, Heterokontophyta, Rhodophyta, and Haptophyta, to identify and annotate the putative enzymes of lipid metabolic pathway. Consequently, we have also developed a database, dEMBF (Database of Enzymes of Microalgal Biofuel Feedstock), which catalogues the complete list of identified enzymes along with their computed annotation details including length, hydrophobicity, amino acid composition, subcellular location, gene ontology, KEGG pathway, orthologous group, Pfam domain, intron-exon organization, transmembrane topology, and secondary/tertiary structural data. Furthermore, to facilitate functional and evolutionary study of these enzymes, a collection of built-in applications for BLAST search, motif identification, sequence and phylogenetic analysis have been seamlessly integrated into the database. dEMBF is the first database that brings together all enzymes responsible for lipid synthesis from available algal genomes, and provides an integrative platform for enzyme inquiry and analysis. This database will be extremely useful for algal biofuel research. It can be accessed at http://bbprof.immt.res.in/embf.	[Misra, Namrata; Panda, Prasanna Kumar; Mishra, Barada Kanta] CSIR, Inst Minerals & Mat Technol, Acad Sci & Innovat Res, Bhubaneswar, Odisha, India; [Misra, Namrata; Panda, Prasanna Kumar; Parida, Bikram Kumar] CSIR, Inst Minerals & Mat Technol, Bioresources Engn Dept, Bhubaneswar, Odisha, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Minerals & Materials Technology (IMMT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Minerals & Materials Technology (IMMT)	Panda, PK (corresponding author), CSIR, Inst Minerals & Mat Technol, Acad Sci & Innovat Res, Bhubaneswar, Odisha, India.	pkpanda@immt.res.in		Misra, Namrata/0000-0003-1813-6478	Department of Biotechnology, Government of India; CSIR; CSIR, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by the Department of Biotechnology, Government of India. NM acknowledges CSIR for the award of Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NM acknowledges CSIR, Government of India for the award of Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2015, PLANT BIOTECHNOL J, V13, P540, DOI 10.1111/pbi.12278; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birney E, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P56; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Cao BQ, 2006, BIOINFORMATICS, V22, P303, DOI 10.1093/bioinformatics/bti784; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen JE, 2012, J BIOTECHNOL, V162, P28, DOI 10.1016/j.jbiotec.2012.05.009; Childs KL, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar061; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; De Bhowmick G, 2015, RENEW SUST ENERG REV, V50, P1239, DOI 10.1016/j.rser.2015.04.131; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekstrom A, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau079; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Girke T, 2004, PLANT PHYSIOL, V136, P3003, DOI 10.1104/pp.104.049965; Guiheneuf F, 2011, FEBS J, V278, P3651, DOI 10.1111/j.1742-4658.2011.08284.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han SF, 2015, CRIT REV BIOTECHNOL, V35, P255, DOI 10.3109/07388551.2013.835301; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hsieh HJ, 2012, J MICROBIOL, V50, P526, DOI 10.1007/s12275-012-2041-5; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huerlimann R, 2013, CRIT REV BIOTECHNOL, V33, P49, DOI 10.3109/07388551.2012.668671; Khozin-Goldberg I, 2011, BIOCHIMIE, V93, P91, DOI 10.1016/j.biochi.2010.07.020; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu J, 2011, ENERG ENVIRON SCI, V4, P2451, DOI 10.1039/c0ee00593b; Mao FL, 2009, BIOENERG RES, V2, P209, DOI 10.1007/s12155-009-9052-z; Medipally SR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/519513; Misra N, 2012, EVOL BIOINFORM, V8, P545, DOI 10.4137/EBO.S10159; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; Niu YF, 2013, MAR DRUGS, V11, P4558, DOI 10.3390/md11114558; Parida BK, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-014-2563-3; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Reijnders MJMF, 2014, TRENDS BIOTECHNOL, V32, P617, DOI 10.1016/j.tibtech.2014.10.003; Sato N, 2007, EUKARYOT CELL, V6, P1006, DOI 10.1128/EC.00393-06; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smits SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012267; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wagner M, 2010, PLANT PHYSIOL BIOCH, V48, P407, DOI 10.1016/j.plaphy.2010.03.008; Wilkins MR, 1999, METH MOL B, V112, P531	49	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146158	10.1371/journal.pone.0146158	http://dx.doi.org/10.1371/journal.pone.0146158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727469	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500059
J	Shibata, Y; Hara, T; Nagano, J; Nakamura, N; Ohno, T; Ninomiya, S; Ito, H; Tanaka, T; Saito, K; Seishima, M; Shimizu, M; Moriwaki, H; Tsurumi, H				Shibata, Yuhei; Hara, Takeshi; Nagano, Junji; Nakamura, Nobuhiko; Ohno, Tomohiko; Ninomiya, Soranobu; Ito, Hiroyasu; Tanaka, Takuji; Saito, Kuniaki; Seishima, Mitsuru; Shimizu, Masahito; Moriwaki, Hisataka; Tsurumi, Hisashi			The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; HEPATOCELLULAR-CARCINOMA; TRYPTOPHAN CATABOLISM; PRENEOPLASTIC LESIONS; CHRONIC INFLAMMATION; COLORECTAL-CANCER; EXPRESSION; IDO; INHIBITION	Indoleamine 2,3-dioxygenase (IDO), a tryptophan-catabolizing intracellular enzyme of the L-kynurenine pathway, causes preneoplastic cells and tumor cells to escape the immune system by inducing immune tolerance; this mechanism might be associated with the development and progression of human malignancies. In the present study, we investigated the role of IDO in diethylnitrosamine (DEN)-induced hepatocarcinogenesis by using IDO-knockout (KO) mice. To induce hepatocellular carcinoma (HCC), hepatic adenoma, and preneoplastic hepatocellular lesions termed foci of cellular alteration (FCA), male IDO-wild-type (WT) and IDO-KO mice with a C57BL/6J background received a single intraperitoneal injection of DEN at 2 weeks of age. The mice were sacrificed to evaluate the development of FCA and hepatocellular neoplasms. HCC overexpressed IDO and L-kynurenine compared to surrounding normal tissue in the DEN-treated IDO-WT mice. The number and cell proliferative activity of FCAs, and the incidence and multiplicity of HCC were significantly greater in the IDO-WT than in the IDO-KO mice. The expression levels of the IDO protein, of L-kynurenine, and of IFN-gamma, COX-2, TNF-alpha, and Foxp3 mRNA were also significantly increased in the DEN-induced hepatic tumors that developed in the IDO-WT mice. The mRNA expression levels of CD8, perforin and granzyme B were markedly increased in hepatic tumors developed in IDO-KO mice. Moreover, Foxp3-positive inflammatory cells had infiltrated into the livers of DEN-treated IDO-WT mice, whereas fewer cells had infiltrated into the livers of IDO-KO mice. Induction of IDO and elevation of L-kynurenine might play a critical role in both the early and late phase of liver carcinogenesis. Our findings suggest that inhibition of IDO might offer a promising strategy for the prevention of liver cancer.	[Shibata, Yuhei; Hara, Takeshi; Nagano, Junji; Nakamura, Nobuhiko; Ohno, Tomohiko; Ninomiya, Soranobu; Shimizu, Masahito; Moriwaki, Hisataka; Tsurumi, Hisashi] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan; [Ito, Hiroyasu; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu, Japan; [Tanaka, Takuji] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan; [Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Saito, Kuniaki] Kyoto Univ, Fac Med, Kyoto, Japan	Gifu University; Gifu University; Gifu University; Kyoto University; Kyoto University	Tsurumi, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan.	htsuru@gifu-u.ac.jp		Shibata, Yuhei/0000-0003-2040-8903				Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Cesario A, 2011, CURR MED CHEM, V18, P2263, DOI 0929-8673/11 $58.00+.00; Chung KT, 2011, ENVIRON MOL MUTAGEN, V52, P81, DOI 10.1002/em.20588; Curti A, 2007, BLOOD, V109, P2871, DOI 10.1182/blood-2006-07-036863; D Basu G, 2006, J IMMUNOL, V177, P2391, DOI 10.4049/jimmunol.177.4.2391; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Feng X, 2011, ARCH IMMUNOL THER EX, V59, P309, DOI 10.1007/s00005-011-0127-0; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frith C H, 1994, IARC Sci Publ, P223; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fujigaki H, 2006, J BIOCHEM, V139, P655, DOI 10.1093/jb/mvj072; Fujigaki S, 2002, INFECT IMMUN, V70, P779, DOI 10.1128/IAI.70.2.779-786.2002; Fukuno K, 2015, LEUKEMIA LYMPHOMA, V56, P1398, DOI 10.3109/10428194.2014.953150; Higashitani K, 2013, J GASTROENTEROL, V48, P660, DOI 10.1007/s00535-012-0667-z; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Ito H, 2010, J IMMUNOL, V185, P4554, DOI 10.4049/jimmunol.0904173; Iwasa J, 2010, CANCER SCI, V101, P460, DOI 10.1111/j.1349-7006.2009.01402.x; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Koblish HK, 2010, MOL CANCER THER, V9, P489, DOI 10.1158/1535-7163.MCT-09-0628; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Leithauser F, 2006, AM J PATHOL, V168, P1898, DOI 10.2353/ajpath.2006.050228; Li TJ, 2012, CANCER LETT, V318, P154, DOI 10.1016/j.canlet.2011.12.020; Mabuchi R, 2016, LEUKEMIA LYMPHOMA, V57, P92, DOI 10.3109/10428194.2015.1041388; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Marotta F, 2004, Clin Ter, V155, P187; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nagano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073404; Nakamura N, 2015, INT J HEMATOL; Ninomiya S, 2012, LEUKEMIA LYMPHOMA, V53, P1143, DOI 10.3109/10428194.2011.643472; Ninomiya S, 2011, ANN HEMATOL, V90, P409, DOI 10.1007/s00277-010-1093-z; Nishikawa H, 2005, P NATL ACAD SCI USA, V102, P9253, DOI 10.1073/pnas.0503852102; Ogawa K, 2012, ONCOL LETT, V4, P546, DOI 10.3892/ol.2012.761; Ogawa K, 2012, CANCER SCI, V103, P951, DOI 10.1111/j.1349-7006.2012.02237.x; Ohtaki H, 2014, BBA-MOL BASIS DIS, V1842, P1464, DOI 10.1016/j.bbadis.2014.04.015; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Pan K, 2008, J CANCER RES CLIN, V134, P1247, DOI 10.1007/s00432-008-0395-1; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Terakura D, 2012, CARCINOGENESIS, V33, P2499, DOI 10.1093/carcin/bgs303; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Yoshikawa T, 2010, EUR J HAEMATOL, V84, P304, DOI 10.1111/j.1600-0609.2009.01393.x; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	54	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146279	10.1371/journal.pone.0146279	http://dx.doi.org/10.1371/journal.pone.0146279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727596	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500071
J	Pugni, L; Pietrasanta, C; Milani, S; Vener, C; Ronchi, A; Falbo, M; Arghittu, M; Mosca, F				Pugni, Lorenza; Pietrasanta, Carlo; Milani, Silvano; Vener, Claudia; Ronchi, Andrea; Falbo, Mariella; Arghittu, Milena; Mosca, Fabio			Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; EMERGENCY-DEPARTMENT; SCD14-ST PRESEPSIN; DIAGNOSTIC-VALUE; SEPTIC SHOCK; ONSET SEPSIS; MULTICENTER; NEWBORNS; PREDICTION; BACTEREMIA	Objective Presepsin (soluble CD14 subtype) has been shown to be beneficial as a sepsis marker in adults. Nevertheless, very few data are available in neonates. The aim of the present study was to determine reference ranges of presepsin in term and preterm neonates. Methods Healthy term neonates and preterm neonates without clinical signs of infection admitted to the Neonatal Unit were consecutively enrolled. Presepsin concentrations in whole blood were measured using a point-of-care assay system located in the Unit. Demographic data, antenatal and perinatal variables commonly affecting C-reactive protein and procalcitonin values were considered. Results Of the 684 neonates enrolled in the study, 484 (70.8%) were born at termand 200 (29.2%) were preterm (24-36 weeks' gestation). In term infants, presepsin median value was 603.5 pg/mL (interquartile range: 466.5-791 pg/mL; 5th and 95th centiles: 315 and 1178 pg/mL respectively). In preterm infants, presepsin median value was slightly higher, equal to 620 pg/mL (interquartile range: 503-864 pg/mL; 5th and 95th centiles: 352 and 1370 pg/mL respectively). The reference ranges of presepsin we determined were much higher than those seen in healthy adults. No correlation between presepsin levels and postnatal age was observed, as well as no significant difference was demonstrated in preterm neonates at different gestational ages. None of the variables analyzed affected presepsin levels at a clinical significant extent. Conclusion For the first time, this study provides reference ranges of presepsin in term and preterm neonates. Having reliable reference values is crucial for obtaining an adequate diagnostic accuracy. Based on our results, most variables commonly affecting C-reactive protein and procalcitonin values do not affect presepsin levels, which suggests that presepsin could be an effective sepsis marker. Further investigations in large groups of neonates with sepsis are needed to determine the diagnostic and prognostic value of this biomarker.	[Pugni, Lorenza; Pietrasanta, Carlo; Ronchi, Andrea; Falbo, Mariella; Mosca, Fabio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Dept Clin Sci & Community Hlth, Milan, Italy; [Milani, Silvano; Vener, Claudia] Univ Milan, Dept Clin Sci & Community Hlth, Lab GA Maccacaro, Milan, Italy; [Arghittu, Milena] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Microbiol Lab, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Pugni, L (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Dept Clin Sci & Community Hlth, Milan, Italy.	lorenza.pugni@mangiagalli.it	Mosca, Fabio/C-5826-2017; pietrasanta, carlo/K-5786-2018	Mosca, Fabio/0000-0001-6477-0299; pietrasanta, carlo/0000-0002-1019-4422; VENER, CLAUDIA/0000-0001-7351-8634				Ackland GL, 2015, INTENS CARE MED, V41, P351, DOI 10.1007/s00134-014-3642-8; Behnes M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0507-z; Bertino E, 2010, J PEDIATR GASTR NUTR, V51, P353, DOI 10.1097/MPG.0b013e3181da213e; Casani A, 2012, JPNIM, V1, P152, DOI DOI 10.7363/010106; Chenevier-Gobeaux C, 2015, CLIN CHIM ACTA, V450, P97, DOI 10.1016/j.cca.2015.06.026; Chenevier-Gobeaux C, 2014, CLIN CHIM ACTA, V427, P34, DOI 10.1016/j.cca.2013.09.019; Chiesa C, 2011, CLIN CHIM ACTA, V412, P1053, DOI 10.1016/j.cca.2011.02.020; Romualdo LGD, 2014, CLIN BIOCHEM, V47, P505, DOI 10.1016/j.clinbiochem.2014.02.011; Endo S, 2014, J INFECT CHEMOTHER, V20, P30, DOI 10.1016/j.jiac.2013.07.005; Endo S, 2012, J INFECT CHEMOTHER, V18, P891, DOI 10.1007/s10156-012-0435-2; Giavarina D, 2015, BIOCHEM MEDICA, V25, P64, DOI 10.11613/BM.2015.007; Hofer N, 2012, NEONATOLOGY, V102, P25, DOI 10.1159/000336629; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jopling J, 2009, PEDIATRICS, V123, pE333, DOI 10.1542/peds.2008-2654; Kellogg JA, 2000, J CLIN MICROBIOL, V38, P2181; Klinger G, 2010, PEDIATRICS, V125, pE736, DOI 10.1542/peds.2009-2017; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kotera A, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0063-2; Kweon OJ, 2014, J CRIT CARE, V29, P965, DOI 10.1016/j.jcrc.2014.06.014; Levy E, 2009, PEDIATR RES, V66, P179, DOI 10.1203/PDR.0b013e3181a9f41b; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu B, 2013, CRIT CARE, V17, DOI 10.1186/cc13070; Marete I K, 2011, East Afr Med J, V88, P18; Masson S, 2015, INTENS CARE MED, V41, P12, DOI 10.1007/s00134-014-3514-2; Masson S, 2014, CRIT CARE, V18, DOI 10.1186/cc13183; Mathai Elizabeth, 2004, Indian Pediatr, V41, P895; Meem Mahbuba, 2011, J Glob Health, V1, P201; Mussap M, 2013, SEMIN FETAL NEONAT M, V18, P56, DOI 10.1016/j.siny.2012.10.006; Mussap M, 2007, J Chemother, V19 Suppl 2, P35; Mussap M, 2015, CLIN CHIM ACTA, V451, P65, DOI 10.1016/j.cca.2015.07.025; Mussap M, 2012, J MATERN-FETAL NEO M, V25, P51, DOI 10.3109/14767058.2012.717462; Nagata T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129159; Okamura Y, 2011, CLIN CHIM ACTA, V412, P2157, DOI 10.1016/j.cca.2011.07.024; Palazzi DL, 2006, INFECT DIS FETUS NEW, P247, DOI DOI 10.1016/B0-72-160537-0/50008-6; Palmiere C, 2013, INT J LEGAL MED, V127, P799, DOI 10.1007/s00414-012-0804-5; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Poggi C, 2015, PEDIATRICS, V135, P68, DOI 10.1542/peds.2014-1755; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; Shozushima T, 2011, J INFECT CHEMOTHER, V17, P764, DOI 10.1007/s10156-011-0254-x; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Topcuoglu S, 2016, J MATERN-FETAL NEO M, V29, P1834, DOI 10.3109/14767058.2015.1064885; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Werdan K, 2012, ADV CLIN CHEM LAB ME, P129; Wu JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133057; Yaegashi Yasunori, 2005, Journal of Infection and Chemotherapy, V11, P234, DOI 10.1007/s10156-005-0400-4	45	41	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146020	10.1371/journal.pone.0146020	http://dx.doi.org/10.1371/journal.pone.0146020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720209	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900035
J	Sakaguchi, H; Muramatsu, H; Okuno, Y; Makishima, H; Xu, YY; Furukawa-Hibi, Y; Wang, XN; Narita, A; Yoshida, K; Shiraishi, Y; Doisaki, S; Yoshida, N; Hama, A; Takahashi, Y; Yamada, K; Miyano, S; Ogawa, S; Maciejewski, JP; Kojima, S				Sakaguchi, Hirotoshi; Muramatsu, Hideki; Okuno, Yusuke; Makishima, Hideki; Xu, Yinyan; Furukawa-Hibi, Yoko; Wang, Xinan; Narita, Atsushi; Yoshida, Kenichi; Shiraishi, Yuichi; Doisaki, Sayoko; Yoshida, Nao; Hama, Asahito; Takahashi, Yoshiyuki; Yamada, Kiyofumi; Miyano, Satoru; Ogawa, Seishi; Maciejewski, Jaroslaw P.; Kojima, Seiji			Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PEDIATRIC MYELODYSPLASTIC SYNDROME; ACUTE MYELOID-LEUKEMIA; PROMOTER METHYLATION; MUTATIONS; GENE; MALIGNANCIES; PROFILE; SETBP1; P16	Juvenile myelomonocytic leukemia (JMML), an overlap of myelodysplastic / myeloproliferative neoplasm, is an intractable pediatric myeloid neoplasm. Epigenetic regulation of transcription, particularly by CpG methylation, plays an important role in tumor progression, mainly by repressing tumor-suppressor genes. To clarify the clinical importance of aberrant DNA methylation, we studied the hypermethylation status of 16 target genes in the genomes of 92 patients with JMML by bisulfite conversion and the pryosequencing technique. Among 16 candidate genes, BMP4, CALCA, CDKN2A, and RARB exhibited significant hypermethylation in 72%(67/92) of patients. Based on the number of hypermethylated genes, patients were stratified into three cohorts based on an aberrant methylation score (AMS) of 0, 1-2, or 3-4. In the AMS 0 cohort, the 5-year overall survival (OS) and transplantation-free survival (TFS) were good (69% and 76%, respectively). In the AMS 1-2 cohort, the 5-year OS was comparable to that in the AMS 0 cohort (68%), whereas TFS was poor (6%). In the AMS 3-4 cohort, 5-year OS and TFS weremarkedly low (8% and 0%, respectively). Epigenetic analysis provides helpful information for clinicians to select treatment strategies for patients with JMML. For patients with AMS 3-4 in whom hematopoietic stem cell transplantation does not improve the prognosis, alternative therapies, including DNA methyltransferase inhibitors and new molecular-targeting agents, should be established as treatment options.	[Sakaguchi, Hirotoshi; Muramatsu, Hideki; Okuno, Yusuke; Xu, Yinyan; Wang, Xinan; Narita, Atsushi; Doisaki, Sayoko; Hama, Asahito; Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Sakaguchi, Hirotoshi; Yoshida, Nao] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Makishima, Hideki; Maciejewski, Jaroslaw P.] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA; [Makishima, Hideki; Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Furukawa-Hibi, Yoko; Yamada, Kiyofumi] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4648601, Japan; [Shiraishi, Yuichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan	Nagoya University; Red Cross Nagoya Daiichi Hospital; Cleveland Clinic Foundation; Kyoto University; Nagoya University; University of Tokyo	Kojima, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan.	kojimas@nagoya-med.ac.jp	Ogawa, Seishi/AAE-7088-2019; Okuno, Yusuke/C-9082-2009; Muramatsu, Hideki/ABA-3376-2021; Sokabe, Masahiro/I-1565-2012; Muramatsu, Hideki/I-3763-2012; NARITA, Atsushi/AAC-5449-2021	Okuno, Yusuke/0000-0003-3139-9272; Muramatsu, Hideki/0000-0002-8801-0021; Miyano, Satoru/0000-0002-1753-6616; Yoshida, Kenichi/0000-0003-4612-2778	Japan Society for the Promotion of Science KAKENHI [22790975]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 22790975, and the "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Chim CS, 2003, BRIT J HAEMATOL, V122, P571, DOI 10.1046/j.1365-2141.2003.04462.x; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Hasegawa D, 2005, BRIT J HAEMATOL, V128, P805, DOI 10.1111/j.1365-2141.2005.05392.x; Hasle H, 2003, LEUKEMIA, V17, P277, DOI 10.1038/sj.leu.2402765; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Johan MF, 2005, BRIT J HAEMATOL, V129, P60, DOI 10.1111/j.1365-2141.2005.05412.x; Lehmann U, 2004, ANN HEMATOL, V83, P137, DOI 10.1007/s00277-003-0798-7; Loh ML, 2011, BRIT J HAEMATOL, V152, P677, DOI 10.1111/j.1365-2141.2010.08525.x; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Muramatsu H, 2010, BLOOD, V115, P1969, DOI 10.1182/blood-2009-06-226340; Niemeyer CM, 1997, BLOOD, V89, P3534; OGAWA S, 1994, BLOOD, V84, P2431, DOI 10.1182/blood.V84.8.2431.bloodjournal8482431; OKUDA T, 1995, BLOOD, V85, P2321, DOI 10.1182/blood.V85.9.2321.bloodjournal8592321; Olk-Batz C, 2011, BLOOD, V117, P4871, DOI 10.1182/blood-2010-08-298968; Paulsson K, 2009, BRIT J HAEMATOL, V144, P838, DOI 10.1111/j.1365-2141.2008.07523.x; Perez B, 2010, BRIT J HAEMATOL, V151, P460, DOI 10.1111/j.1365-2141.2010.08393.x; Roman-Gomez J, 2003, J CLIN ONCOL, V21, P1472, DOI 10.1200/JCO.2003.08.166; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Stieglitz E, 2015, BLOOD, V125, P516, DOI 10.1182/blood-2014-09-601690; Tessema M, 2005, INT J ONCOL, V26, P499; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Vidal DO, 2007, LEUKEMIA RES, V31, P175, DOI 10.1016/j.leukres.2006.06.013; Voso MT, 2004, BLOOD, V103, P698, DOI 10.1182/blood-2003-07-2249; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yoshida N, 2012, PEDIATR DRUGS, V14, P157, DOI 10.2165/11631360-000000000-00000	32	18	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145394	10.1371/journal.pone.0145394	http://dx.doi.org/10.1371/journal.pone.0145394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720758	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900007
J	Scott, HM; Irvin, R; Wilton, L; Tieu, HV; Watson, C; Magnus, M; Chen, I; Gaydos, C; Hussen, SA; Mannheimer, S; Mayer, K; Hessol, NA; Buchbinder, S				Scott, Hyman M.; Irvin, Risha; Wilton, Leo; Hong Van Tieu; Watson, Chauncey; Magnus, Manya; Chen, Iris; Gaydos, Charlotte; Hussen, Sophia A.; Mannheimer, Sharon; Mayer, Kenneth; Hessol, Nancy A.; Buchbinder, Susan			Sexual Behavior and Network Characteristics and Their Association with Bacterial Sexually Transmitted Infections among Black Men Who Have Sex with Men in the United States	PLOS ONE			English	Article							HIV-INFECTION; HEALTH-CARE; WHITE MEN; PERCEIVED DISCRIMINATION; PARTNER CHARACTERISTICS; RACIAL-DISCRIMINATION; SOCIAL DISCRIMINATION; RISK; DISPARITIES; MSM	Background Black men who have sex with men (MSM) have a high prevalence of bacterial sexually transmitted infections (STIs), and individual risk behavior does not fully explain the higher prevalence when compared with other MSM. Using the social-ecological framework, we evaluated individual, social and sexual network, and structural factors and their association with prevalent STIs among Black MSM. Methods The HIV Prevention Trials Network 061 was a multi-site cohort study designed to determine the feasibility and acceptability of a multi-component intervention for Black MSM in six US cities. Baseline assessments included demographics, risk behavior, and social and sexual network questions collected information about the size, nature and connectedness of their sexual network. Logistic regression was used to estimate the odds of having any prevalent sexually transmitted infection (gonorrhea, chlamydia, or syphilis). Results A total of 1,553 Black MSM were enrolled in this study. In multivariate analysis, older age (aOR = 0.57; 95% CI 0.49-0.66, p<0.001) was associated with a lower odds of having a prevalent STI. Compared with reporting one male sexual partner, having 2-3 partners (aOR = 1.74; 95% CI 1.08-2.81, p<0.024) or more than 4 partners (aOR = 2.29; 95% CI 1.43-3.66, p<0.001) was associated with prevalent STIs. Having both Black and non-Black sexual partners (aOR = 0.67; 95% CI 0.45-0.99, p = 0.042) was the only sexual network factor associated with prevalent STIs. Conclusions Age and the number and racial composition of sexual partners were associated with prevalent STIs among Black MSM, while other sexual network factors were not. Further studies are needed to evaluate the effects of the individual, network, and structural factors on prevalent STIs among Black MSM to inform combination interventions to reduce STIs among these men.	[Scott, Hyman M.; Buchbinder, Susan] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA 94102 USA; [Irvin, Risha; Gaydos, Charlotte] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Wilton, Leo] SUNY Binghamton, Dept Human Dev, Binghamton, NY USA; [Wilton, Leo] Univ Johannesburg, Fac Humanities, Johannesburg, South Africa; [Hong Van Tieu] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA; [Hong Van Tieu] Columbia Univ, Med Ctr, Div Infect Dis, New York, NY USA; [Watson, Chauncey; Magnus, Manya] George Washington Univ, Dept Epidemiol & Biostat, Washington, DC USA; [Chen, Iris] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Hussen, Sophia A.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Mannheimer, Sharon] Columbia Univ, Harlem Hosp, Dept Med, New York, NY USA; [Mannheimer, Sharon] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Mayer, Kenneth] Fenway Inst, Boston, MA USA; [Hessol, Nancy A.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA	San Francisco Department of Public Health; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Johannesburg; New York Blood Center; Columbia University; George Washington University; Johns Hopkins University; Emory University; Rollins School Public Health; Columbia University; Columbia University; University of California System; University of California San Francisco	Scott, HM (corresponding author), San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA 94102 USA.	hyman.scott@sfdph.org	DSILVA, BROOKE/HCI-4879-2022; Gaydos, Charlotte A./E-9937-2010		National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) [UM1 AI068619, UM1 AI068617, UM1 AI068613]; Fenway Institute CRS: Harvard University CFAR [P30 AI060354]; CTU for HIV Prevention and Microbicide Research [UM1 AI069480]; George Washington University CRS: District of Columbia Developmental CFAR [P30 AI087714]; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU [5U01 AI069466]; ARRA funding [3U01 AI069466-03S1]; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU [5U01 AI069418]; CFAR [P30 AI050409]; CTSA [UL1 RR025008]; San Francisco Vaccine and Prevention CRS: ARRA [3U01 AI069496-03S1, 3U01 AI069496-03S2]; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU [U01 AI069424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069412, P30AI060354, U01AI069424, UM1AI069470, UM1AI068619, P30AI050409, UM1AI069480, U01AI069496, P30AI087714, UM1AI068617, U01AI069466, U01AI069418, UM1AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, K23MH104116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031035] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fenway Institute CRS: Harvard University CFAR; CTU for HIV Prevention and Microbicide Research; George Washington University CRS: District of Columbia Developmental CFAR; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU; ARRA funding; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU; CFAR; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); San Francisco Vaccine and Prevention CRS: ARRA; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	HPTN 061 grant support was provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding was provided by the Fenway Institute CRS: Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480). Further support came from the George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1). This project received support from the Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008). Finally, this paper was also supported by the San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2) in addition to the UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles R, 1999, MULT MEAREL SPIR U; Ayala G, 2012, AM J PUBLIC HEALTH, V102, pS242, DOI 10.2105/AJPH.2011.300641; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Barrera M, 1996, J COMMUNITY PSYCHOL, P413; Berry M, 2007, AIDS, V21, P2349, DOI 10.1097/QAD.0b013e3282f12f41; Bohl DD, 2009, SEX TRANSM INFECT, V85, P367, DOI 10.1136/sti.2009.036723; Bowleg L, 2013, AIDS BEHAV, V17, P407, DOI 10.1007/s10461-012-0179-0; Burgess DJ, 2008, J HEALTH CARE POOR U, V19, P894, DOI 10.1353/hpu.0.0063; Carnegie N. B., 2012, PLoS ONE, V7, pe43048, DOI 10.1371/journal.pone.0043048; CDC, 2013, SEX TRANSM DIS SURV; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Flores SA, 2009, AIDS EDUC PREV, V21, P91, DOI 10.1521/aeap.2009.21.2.91; Ford CL, 2009, AM J PUBLIC HEALTH, V99, pS137, DOI 10.2105/AJPH.2007.120865; Fujimoto K, 2014, AIDS BEHAV; Gorbach PM, 2009, J URBAN HEALTH, V86, pS63, DOI 10.1007/s11524-009-9370-7; Halkitis PN, 2013, AM J PUBLIC HEALTH, V103, P889, DOI 10.2105/AJPH.2012.300963; Hampton MC, 2013, AIDS BEHAV, V17, P931, DOI 10.1007/s10461-012-0139-8; Hausmann LRM, 2008, J GEN INTERN MED, V23, P1679, DOI 10.1007/s11606-008-0730-x; HEREK GM, 1988, J SEX RES, V25, P451, DOI 10.1080/00224498809551476; Tieu HV, 2014, SEX TRANSM DIS, V41, P200, DOI 10.1097/OLQ.0000000000000090; Irvin R, 2014, AIDS BEHAV, V18, P1272, DOI 10.1007/s10461-014-0734-y; Knowlton AR, 2011, AIDS BEHAV, V15, P1429, DOI 10.1007/s10461-010-9749-1; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Latkin Carl, 2011, Am J Public Health, V101, pe18, DOI 10.2105/AJPH.2011.300281; Latkin C, 2010, AIDS BEHAV, V14, P1137, DOI 10.1007/s10461-010-9676-1; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Maulsby C, 2012, AIDS BEHAV, V16, P543, DOI 10.1007/s10461-011-0046-4; Mayer KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087298; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mimiaga MJ, 2009, J URBAN HEALTH, V86, P602, DOI 10.1007/s11524-009-9363-6; Newcomb ME, 2013, JAIDS-J ACQ IMM DEF, V62, P329, DOI 10.1097/QAI.0b013e31827e5f8c; Newman LM, 2008, SEX TRANSM DIS, V35, pS4, DOI 10.1097/OLQ.0b013e31818eb90e; Oster AM, 2013, SEX TRANSM DIS, V40, P206, DOI 10.1097/OLQ.0b013e3182840373; Parrish DD, 2008, SEX TRANSM DIS, V35, pS19, DOI 10.1097/OLQ.0b013e31818f2ae1; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Peters PJ, 2014, MMWR-MORBID MORTAL W, V63, P90; Peterson JL, 2014, JAIDS-J ACQ IMM DEF, V66, P538, DOI 10.1097/QAI.0000000000000203; Phipps W, 2009, SEX TRANSM DIS, V36, P331, DOI 10.1097/OLQ.0b013e3181990c85; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; SAS, 2010, SAS STAT US GUID VER; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Shah NS, 2014, AIDS BEHAV, V18, P335, DOI 10.1007/s10461-013-0677-8; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012; Smith AMA, 2004, SEX TRANSM INFECT, V80, P455, DOI 10.1136/sti.2004.010355; Sullivan PS, 2015, ANN EPIDEMIOL, V25, P445, DOI 10.1016/j.annepidem.2015.03.006; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Tao GY, 2013, SEX HEALTH, V10, P363, DOI 10.1071/SH13017; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; Turner AN, 2013, SEX TRANSM DIS, V40, P433, DOI 10.1097/OLQ.0b013e31828fd163; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878	54	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146025	10.1371/journal.pone.0146025	http://dx.doi.org/10.1371/journal.pone.0146025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TR	26720332	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900036
J	Kamikawa, N; Taito, S; Takahashi, M; Sekikawa, K; Hamada, H				Kamikawa, Norimichi; Taito, Shunsuke; Takahashi, Makoto; Sekikawa, Kiyokazu; Hamada, Hironobu			Effect of Different Levels of Pressure Relieving Air-Mattress Firmness on Cough Strength	PLOS ONE			English	Article							RESPIRATORY MUSCLE STRENGTH; CAPACITY	Cough is an important host-defense mechanism. The elderly and patients who are severely ill cannot cough effectively when lying in the supine position. Furthermore, pressure relieving air-mattresses are recommended for preventing the development of pressure ulcers. In this study, we clarified whether or not the cough peak flow (CPF), an index of cough strength, is affected by different firmness levels of a pressure relieving air-mattress in healthy volunteers in the supine position. Fifty-two healthy young men participated. All the measurements were carried out on each participant in the supine position on a pressure relieving air-mattress. The participants were assessed at two firmness levels, a "hard" and "soft" mode. The CPF, forced vital capacity (FVC), maximal expiratory pressure (PEmax), and maximal inspiratory pressure (PImax) were determined for each mode. The sinking distance of the body into the mattress was measured without any activity and the difference between the sinking distances of the two firmness levels was determined. The CPF, FVC, PEmax, and PImax were determined for each mode. The sinking distance of the body into the mattress was measured and the difference between the sinking distances of the two firmness levels was determined. The CPF, FVC, PEmax and PImax values of the participants coughing on the mattress were significantly lower when the mattress was in "soft" than in "hard" mode. The differences between the sinking distances of the mattress in "soft" and "hard" modes were larger for the anterior superior iliac spine. A harder mattress may lead to increased CPF in healthy young men lying in the supine position, and increased CPF may be important for host defense.	[Kamikawa, Norimichi; Takahashi, Makoto; Sekikawa, Kiyokazu; Hamada, Hironobu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan; [Kamikawa, Norimichi] Hiroshima Coll Rehabil, Hiroshima, Japan; [Taito, Shunsuke] Hiroshima Univ Hosp, Dept Clin Support, Hiroshima, Japan	Hiroshima University; Hiroshima University	Hamada, H (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan.	hirohamada@hiroshima-u.ac.jp	kiyokazu, sekikawa/AAC-1498-2020; Hamada, Hironobu/A-6489-2018; Takahashi, Makoto/AAT-5262-2020; Taito, Shunsuke/V-3664-2019	Hamada, Hironobu/0000-0002-7979-0708; 	Fundamental Budget for Education and Research	Fundamental Budget for Education and Research	This work was supported by Fundamental Budget for Education and Research.	Bach JR, 1997, RESP CARE, V42, P403; Badr C, 2002, AUST J PHYSIOTHER, V48, P95, DOI 10.1016/S0004-9514(14)60203-8; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; CULHAM EG, 1994, SPINE, V19, P1250, DOI 10.1097/00007632-199405310-00010; Cullum N, 1995, Qual Health Care, V4, P289, DOI 10.1136/qshc.4.4.289; DETROYER A, 1980, THORAX, V35, P603, DOI 10.1136/thx.35.8.603; Fink JB, 2007, RESP CARE, V52, P1210; FISHER LR, 1990, ANN RHEUM DIS, V49, P921, DOI 10.1136/ard.49.11.921; Fontana GA, 2006, RESP PHYSIOL NEUROBI, V152, P266, DOI 10.1016/j.resp.2006.02.016; Grey JE, 2006, BMJ-BRIT MED J, V332, P472, DOI 10.1136/bmj.332.7539.472; Hadjikoutis S, 1999, QJM-MON J ASSOC PHYS, V92, P487, DOI 10.1093/qjmed/92.9.487; HOFMAN A, 1994, LANCET, V343, P568, DOI 10.1016/S0140-6736(94)91521-0; Kang SW, 2006, YONSEI MED J, V47, P184, DOI 10.3349/ymj.2006.47.2.184; Kang SW, 2000, CHEST, V118, P61, DOI 10.1378/chest.118.1.61; Kera T, 2001, J PHYS THER SCI, V13, P153; Lin F, 2006, ARCH PHYS MED REHAB, V87, P504, DOI 10.1016/j.apmr.2005.11.031; McCool FD, 2006, CHEST, V129, p48S, DOI 10.1378/chest.129.1_suppl.48S; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; NISHIMURA Y, 1989, TOHOKU J EXP MED, V159, P57, DOI 10.1620/tjem.159.57; Park JH, 2010, YONSEI MED J, V51, P392, DOI 10.3349/ymj.2010.51.3.392; Polkey MI, 1998, AM J RESP CRIT CARE, V158, P734, DOI 10.1164/ajrccm.158.3.9710072; Srour N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056676; SZEINBERG A, 1988, CHEST, V94, P1232, DOI 10.1378/chest.94.6.1232; Yamamoto Y, 2011, J JPN WOUND OSTOMY C, V15, P239	24	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146714	10.1371/journal.pone.0146714	http://dx.doi.org/10.1371/journal.pone.0146714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741497	Green Published, gold			2022-12-27	WOS:000367810600062
J	Chen, YY; Wang, WJ; Wang, HK; Li, YJ; Shi, MM; Li, HW; Yan, JQ				Chen, Yunyang; Wang, Weijie; Wang, Huakai; Li, Yongjian; Shi, Minmin; Li, Hongwei; Yan, Jiqi			Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPERDYNAMIC SPLANCHNIC CIRCULATION; LIVER-CIRRHOSIS; MAMMALIAN TARGET; SPLEEN; MECHANISMS; FIBROSIS; ANGIOGENESIS; EXPRESSION; HYPERSPLENISM	Background Spleen enlargement is often detected in patients with liver cirrhosis, but the precise pathogenetic mechanisms behind the phenomenon have not been clearly elucidated. We investigated the pathogenetic mechanisms of splenomegaly in both portal hypertensive patients and rats, and tried to identify the possible therapy for this disease. Methods Spleen samples were collected from portal hypertensive patients after splenectomy. Rat models of portal hypertension were induced by common bile duct ligation and partial portal vein ligation. Spleen samples from patients and rats were used to study the characteristics of splenomegaly by histological, immunohistochemical, and western blot analyses. Rapamycin or vehicle was administered to rats to determine the contribution of mTOR signaling pathway in the development of splenomegaly. Results We found that not only spleen congestion, but also increasing angiogenesis, fibrogenesis, inflammation and proliferation of splenic lymphoid tissue contributed to the development of splenomegaly in portal hypertensive patients and rats. Intriguingly, splenomegaly developed time-dependently in portal hypertensive rat that accompanied with progressive activation of mTOR signaling pathway. mTOR blockade by rapamycin profoundly ameliorated splenomegaly by limiting lymphocytes proliferation, angiogenesis, fibrogenesis and inflammation as well as decreasing portal pressure. Conclusions This study provides compelling evidence indicating that mTOR signaling activation pathway plays a key role in the pathogenesis of splenomegaly in both portal hypertensive patients and rats. Therapeutic intervention targeting mTOR could be a promising strategy for patients with portal hypertension and splenomegaly.	[Chen, Yunyang; Wang, Weijie; Wang, Huakai; Li, Yongjian; Li, Hongwei; Yan, Jiqi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Chen, Yunyang; Wang, Huakai; Li, Yongjian; Shi, Minmin; Yan, Jiqi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China; [Wang, Weijie] Zhengzhou Univ, Dept Surg, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Zhengzhou University	Yan, JQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	jiqiyan@yahoo.com			National Natural Science Foundation of China [81070358]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81070358), http://www.nsfc.gov.cn/, to JQY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; Araujo NC, 2014, TRANSPL P, V46, P1319, DOI 10.1016/j.transproceed.2014.03.011; Arduini A, 2011, AM J PHYSIOL-GASTR L, V301, pG119, DOI 10.1152/ajpgi.00253.2010; Biecker E, 2005, J PHARMACOL EXP THER, V313, P952, DOI 10.1124/jpet.104.079616; Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8; Boyer TD, 2015, LIVER INT, V35, P1492, DOI 10.1111/liv.12702; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Fernandez M, 2005, J HEPATOL, V43, P98, DOI 10.1016/j.jhep.2005.02.022; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Geerts AM, 2008, HEPATOL RES, V38, P1130, DOI 10.1111/j.1872-034X.2008.00369.x; Gerlach C, 1997, LAB INVEST, V77, P697; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jaeschke Hartmut, 2002, Hepatology, V35, P964, DOI 10.1053/jhep.2002.0350964; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Liu HQ, 2012, EXP PHYSIOL, V97, P999, DOI 10.1113/expphysiol.2012.064485; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manenti A, 1992, PATHOLOGICA, V85, P721; MANENTI F, 1966, GUT, V7, P175, DOI 10.1136/gut.7.2.175; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; McCormick PA, 2000, BEST PRACT RES CL GA, V14, P1009, DOI 10.1053/bega.2000.0144; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mejias M, 2010, J HEPATOL, V52, P529, DOI 10.1016/j.jhep.2010.01.004; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Neef M, 2006, J HEPATOL, V45, P786, DOI 10.1016/j.jhep.2006.07.030; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Wang WJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083908, 10.1371/journal.pone.0084654]; Yamaguchi S, 2007, LIFE SCI, V80, P2036, DOI 10.1016/j.lfs.2007.03.009	39	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0141159	10.1371/journal.pone.0141159	http://dx.doi.org/10.1371/journal.pone.0141159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734934	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100002
J	Firnhaber, C; Goeieman, B; Faesen, M; Levin, S; Williams, S; Rameotshela, S; Swarts, A; Michelow, P; Omar, T; Williamson, AL; Allan, B; Schnippel, K; Smith, JS				Firnhaber, Cynthia; Goeieman, Bridgette; Faesen, Mark; Levin, Simon; Williams, Sophie; Rameotshela, Sibongile; Swarts, Avril; Michelow, Pam; Omar, Tanvier; Williamson, Anna-Lise; Allan, Bruce; Schnippel, Kate; Smith, Jennifer S.			Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; ANTIRETROVIRAL THERAPY; REGRESSION; PREVENTION; SOWETO; RISK	Background Cervical cancer is the most common cancer in Sub-Saharan Africa. There are little of HIV-infected women one-year after screening using visual inspection with acetic acid (VIA), HPV or cytology in sub-Saharan Africa. Methods HIV-infected women in Johannesburg South Africa were screened one year later by Pap smear, VIA and human papillomavirus (HPV) testing. Women qualified for the 12 month follow-up visit if they had a negative or cervical intra-epithelial neoplasia (CIN) 1 results at the baseline visit. Modified Poisson regression was used to analyse associations between patient baseline characteristics and progression. Results A total of 688 of 1,202 enrolled at baseline study who were CIN-2+ negative and qualified for a 12 month follow-up visit. Progression to CIN-2+ was higher in women with positive VIA results (12.6%; 24/191) than those VIA-negative (4.4%; 19/432). HPV-positive women at baseline were more likely to progress to CIN-2+ (12.3%; 36/293) than those HPV-negative (2.1%; 7/329). Cytology-positive women at baseline were more likely to progress to CIN-2+ (9.6%; 37/384) than cytology-negative women (2.5%; 6/237). Approximately 10% (10.4%; 39/376) of women with CIN 1 at baseline progressed to CIN 2+. Women who were VIA or HPV positive at baseline were more likely to progress aIRR 1.85, CI 95% (1.46 to 2.36), aIRR 1.41 CI 95% (1.14 to 1.75) respectively. Conclusion Progression to CIN-2+ in HIV-infected women is significant when measured by baseline positive VIA, HPV or Pap and yearly screening by any method should be considered in this population if possible.	[Firnhaber, Cynthia; Swarts, Avril] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Clin HIV Res Unit, Johannesburg, South Africa; [Firnhaber, Cynthia; Goeieman, Bridgette; Faesen, Mark; Levin, Simon; Williams, Sophie; Rameotshela, Sibongile; Schnippel, Kate] Right Care, Johannesburg, South Africa; [Levin, Simon] Univ Witwatersrand, Coronat Hosp, Dept OB GYN, Johannesburg, South Africa; [Michelow, Pam] Univ Witwatersrand, Fac Hlth Sci, Dept Anat Pathol, Cytol Unit, Johannesburg, South Africa; [Michelow, Pam; Omar, Tanvier] Natl Hlth Lab Serv, Johannesburg, South Africa; [Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis, ZA-7925 Cape Town, South Africa; [Williamson, Anna-Lise] Univ Cape Town, Div Med Virol, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Williamson, Anna-Lise; Allan, Bruce] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Smith, Jennifer S.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Smith, Jennifer S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Cape Town; University of Cape Town; University of Cape Town; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Firnhaber, C (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Clin HIV Res Unit, Johannesburg, South Africa.	Cindy.firnhaber@righttocare.org		Schnippel, Kathryn/0000-0003-0757-4325; Williamson, Anna-Lise/0000-0002-5467-1200	United States Aid for International Development Public Health Evaluation [ZA.09.0265]; United States Aid for International Development Presidents Emergency Plan For AIDs Relief (PEPFAR) [674-A-00-08-00007-00]; University of North Carolina Center for AIDS Research [P30-AI50410]; African Research Chairs Initiative of the Department of Science and Technology; South African Research Chairs Initiative of the Department of Science and Technology; Nation Research Foundation (NRF), South Africa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	United States Aid for International Development Public Health Evaluation; United States Aid for International Development Presidents Emergency Plan For AIDs Relief (PEPFAR); University of North Carolina Center for AIDS Research; African Research Chairs Initiative of the Department of Science and Technology; South African Research Chairs Initiative of the Department of Science and Technology; Nation Research Foundation (NRF), South Africa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded under United States Aid for International Development Public Health Evaluation ZA.09.0265 grant awarded to CF. United States Aid for International Development Presidents Emergency Plan For AIDs Relief (PEPFAR) 674-A-00-08-00007-00 helped fund CF, BG, MF, SL, SW, SR and KS. University of North Carolina Center for AIDS Research P30-AI50410 was awarded to JSS. African Research Chairs Initiative of the Department of Science and Technology was awarded to ALW and BA. A small portion of this work is based on the research supported by the South African Research Chairs Initiative of the Department of Science and Technology and Nation Research Foundation (NRF), South Africa awarded to ALW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Y, 2013, SAMJ S AFR MED J, V103, P34, DOI [10.7196/samj.6124, 10.7196/SAMJ.6124]; Adler DH, 2012, AIDS, V26, P1645, DOI 10.1097/QAD.0b013e32835536a3; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Belhadj H, 2013, INT J GYNECOL OBSTET, V121, pS29, DOI 10.1016/j.ijgo.2013.02.002; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Firnhaber C, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17382; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA; Kuhn L, 2010, AIDS, V24, P2545, DOI 10.1097/QAD.0b013e32833e163e; Mabeya H, 2012, J LOW GENIT TRACT DI, V16, P92, DOI 10.1097/LGT.0b013e3182320f0c; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Nayar R, 2001, BETHESDA SYSTEM REPO; Omar T, 2011, AIDS, V25, P87, DOI 10.1097/QAD.0b013e328340fd99; Paramsothy P, 2009, OBSTET GYNECOL, V113, P26, DOI 10.1097/AOG.0b013e31819225cb; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS; WHO, 2014, COMPR CERV CANC CONT; Williamson AL, 2015, J CLIN MED, V4, P579, DOI 10.3390/jcm4040579; World Health Organization, 2005, INT WHO CLIN STAG HI; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	23	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144905	10.1371/journal.pone.0144905	http://dx.doi.org/10.1371/journal.pone.0144905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730710	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400015
J	Iuchi, H; Sakamoto, M; Suzuki, H; Kayama, Y; Ohashi, K; Hayashi, T; Ishizawa, S; Yokota, T; Tojo, K; Yoshimura, M; Utsunomiya, K				Iuchi, Hiroyuki; Sakamoto, Masaya; Suzuki, Hirofumi; Kayama, Yosuke; Ohashi, Kennosuke; Hayashi, Takeshi; Ishizawa, Sho; Yokota, Tamotsu; Tojo, Katsuyoshi; Yoshimura, Michihiro; Utsunomiya, Kazunori			Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes	PLOS ONE			English	Article							TO-VISIT VARIABILITY; BAROREFLEX SENSITIVITY; CIRCADIAN-RHYTHM; ANGIOTENSIN-II; SODIUM-INTAKE; COMPLICATIONS; MELLITUS; NEUROPATHY; NONDIPPER; REDUCTION	Background Increased short-term blood pressure (BP) variability on 24-hour ambulatory BP monitoring (ABPM) is known to be a risk factor for cardiovascular events. However, very few studies have evaluated the effect of salt restriction on BP variability particularly in hypertensive patients with type 2 diabetes. This study aimed to investigate the effect of salt restriction on systolic BP (SBP) variability. Methods and Results 10 hypertensive patients with type 2 diabetes and not receiving antihypertensive agents were enrolled in the study. After admission, all patients received a salt-restricted diet and appropriate anti-diabetic treatments and were followed up for 7 consecutive days using ABPM. After the 7-day treatment, the median [interquartile range (IQR)] coefficient of variation (CV) for diurnal SBP variability changed from day 1 to day 7-13.0 [10.8 to 16.8] % to 13.3 [9.1 to 18.9]%(P = 0.959)-and the median [IQR] change between days 1 and 7 was -0.3 [-3.2 to 2.9] %. In addition, CV for BP variability and circadian rhythm of BP varied greatly on a day-by-day basis for 7 days, compared to mean BP values. Interestingly, increased SBP variability was associated with greater day-by-day changes in circadian rhythm of BP. Conclusions Salt restriction during 7-day hospitalization led to a -0.3 [-3.2 to 2.9] (median [IQR]) % change from baseline in CV for diurnal SBP variability in 10 hypertensive patients with type 2 diabetes not receiving antihypertensive agents.	[Iuchi, Hiroyuki; Sakamoto, Masaya; Suzuki, Hirofumi; Ohashi, Kennosuke; Hayashi, Takeshi; Ishizawa, Sho; Yokota, Tamotsu; Tojo, Katsuyoshi; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Kayama, Yosuke; Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Jikei University; Jikei University	Sakamoto, M (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan.	m-sakamoto@umin.ac.jp		Iuchi, Hiroyuki/0000-0003-2638-5167				American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Chen GM, 2011, HYPERTENSION, V57, P891, DOI 10.1161/HYPERTENSIONAHA.110.162446; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DELEEUW PW, 1980, POSTGRAD MED J, V56, P704, DOI 10.1136/pgmj.56.660.704; Diaz KM, 2014, J HYPERTENS, V32, P840, DOI 10.1097/HJH.0000000000000080; Eguchi K, 2009, AM J HYPERTENS, V22, P46, DOI 10.1038/ajh.2008.294; Feltcio JS, 2006, CARDIOVASC DIABETOL, V5, P19; Frattola A, 1997, DIABETOLOGIA, V40, P1470, DOI 10.1007/s001250050851; Hanefeld M, 2012, J HYPERTENS, V30, P1440, DOI 10.1097/HJH.0b013e328354663c; Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717; Horikawa C, 2014, J CLIN ENDOCR METAB, V99, P3635, DOI 10.1210/jc.2013-4315; HOSSMANN V, 1981, HYPERTENSION, V3, P113, DOI 10.1161/01.HYP.3.1.113; Imai E, 2011, CLIN EXP NEPHROL, V15, P861, DOI 10.1007/s10157-011-0523-0; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; MANCIA G, 1986, HYPERTENSION, V8, P147, DOI 10.1161/01.HYP.8.2.147; Maser RE, 2005, J CLIN ENDOCR METAB, V90, P5896, DOI 10.1210/jc.2005-0754; Masuda S, 2009, HYPERTENS RES, V32, P950, DOI 10.1038/hr.2009.131; Narkiewicz K, 2002, HYPERTENSION, V39, P168, DOI 10.1161/hy1201.097302; Ozawa M, 2008, CLIN EXP HYPERTENS, V30, P213, DOI 10.1080/10641960802068477; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Ruiz J, 2005, HYPERTENSION, V46, P162, DOI 10.1161/01.HYP.0000169053.14440.7d; Stolarz-Skrzypek K, 2010, HYPERTENS RES, V33, P757, DOI 10.1038/hr.2010.110; Trevisan R, 1998, DIABETES, V47, P1347, DOI 10.2337/diabetes.47.8.1347; Uzu T, 1997, CIRCULATION, V96, P1859, DOI 10.1161/01.CIR.96.6.1859; Uzu T, 1999, CIRCULATION, V100, P1635, DOI 10.1161/01.CIR.100.15.1635; Verdecchia P, 2007, AM J HYPERTENS, V20, P154, DOI 10.1016/j.amjhyper.2006.07.017; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144921	10.1371/journal.pone.0144921	http://dx.doi.org/10.1371/journal.pone.0144921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731185	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400018
J	Lee, L; Genge, CE; Cua, M; Sheng, XY; Rayani, K; Beg, MF; Sarunic, MV; Tibbits, GF				Lee, Ling; Genge, Christine E.; Cua, Michelle; Sheng, Xiaoye; Rayani, Kaveh; Beg, Mirza F.; Sarunic, Marinko V.; Tibbits, Glen F.			Functional Assessment of Cardiac Responses of Adult Zebrafish (Danio rerio) to Acute and Chronic Temperature Change Using High-Resolution Echocardiography	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; COLD-ACCLIMATION; DOPPLER-ECHOCARDIOGRAPHY; YELLOWFIN TUNA; TROPONIN-C; HEART; PERFORMANCE; FISH; INCREASE	The zebrafish (Danio rerio) is an important organism as a model for understanding vertebrate cardiovascular development. However, little is known about adult ZF cardiac function and how contractile function changes to cope with fluctuations in ambient temperature. The goals of this study were to: 1) determine if high resolution echocardiography (HRE) in the presence of reduced cardiodepressant anesthetics could be used to accurately investigate the structural and functional properties of the ZF heart and 2) if the effect of ambient temperature changes both acutely and chronically could be determined non-invasively using HRE in vivo. Heart rate (HR) appears to be the critical factor in modifying cardiac output (CO) with ambient temperature fluctuation as it increases from 78 +/- 5.9 bpm at 18 degrees C to 162 +/- 9.7 bpm at 28 degrees C regardless of acclimation state (cold acclimated CA-18 degrees C; warm acclimated WA- 28 degrees C). Stroke volume (SV) is highest when the ambient temperature matches the acclimation temperature, though this difference did not constitute a significant effect (CA 1.17 +/- 0.15 mu L at 18 degrees C vs 1.06 +/- 0.14 mu l at 28 degrees C; WA 1.10 +/- 0.13 mu L at 18 degrees C vs 1.12 +/- 0.12 mu l at 28 degrees C). The isovolumetric contraction time (IVCT) was significantly shorter in CA fish at 18 degrees C. The CA group showed improved systolic function at 18 degrees C in comparison to the WA group with significant increases in both ejection fraction and fractional shortening and decreases in IVCT. The decreased early peak (E) velocity and early peak velocity / atrial peak velocity (E/A) ratio in the CA group are likely associated with increased reliance on atrial contraction for ventricular filling.	[Lee, Ling; Sheng, Xiaoye; Rayani, Kaveh; Tibbits, Glen F.] Simon Fraser Univ, Mol Cardiac Physiol Grp, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Lee, Ling; Genge, Christine E.; Sheng, Xiaoye; Tibbits, Glen F.] Child & Family Res Inst, Dept Cardiovasc Sci, Vancouver, BC V5Z 4H4, Canada; [Cua, Michelle; Beg, Mirza F.; Sarunic, Marinko V.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Child & Family Research Institute; Simon Fraser University	Tibbits, GF (corresponding author), Simon Fraser Univ, Mol Cardiac Physiol Grp, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	tibbits@sfu.ca		Sarunic, Marinko/0000-0002-5636-9056; Beg, Mirza Faisal/0000-0001-6706-8630; Tibbits, Glen/0000-0002-2586-3115	Natural Science and Engineering Research Council of Canada Discovery grant [RGPIN03724]; Canada Foundation for Innovation grant [219586]; Collaborative Health Research Program grant; NSERC Discovery grant	Natural Science and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation grant(Canada Foundation for Innovation); Collaborative Health Research Program grant; NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	These studies were supported by a Natural Science and Engineering Research Council of Canada Discovery grant (#RGPIN03724) to GFT, a Canada Foundation for Innovation grant (#219586) to GFT, and a Collaborative Health Research Program grant to GFT and MVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; These studies were supported by an NSERC Discovery grant to GFT, a Collaborative Health Research Program grant to GFT and MVS and a Canada Foundation for Innovation to GFT. MVS and MFB are Michael Smith Foundation for Health Research Scholars and GFT is a Tier 1 Canada Research Chair. The assistance of Bruce Leighton for set up of the fish acclimation system as well as Haruyo Kashihara for assistance with fish care and transport is greatly appreciated. Thanks to Dr. Charles Stevens for feedback on this manuscript.	Alderman SL, 2012, AM J PHYSIOL-REG I, V303, pR168, DOI 10.1152/ajpregu.00127.2012; Altimiras J, 2004, J EXP BIOL, V207, P195, DOI 10.1242/jeb.00742; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Blank JM, 2002, J EXP BIOL, V205, P1881; Brodeur JC, 2001, J FISH BIOL, V58, P439, DOI 10.1111/j.1095-8649.2001.tb02263.x; Clark TD, 2008, AM J PHYSIOL-REG I, V295, pR1631, DOI 10.1152/ajpregu.90461.2008; Cotter PA, 2008, J EXP ZOOL PART A, V309A, P243, DOI 10.1002/jez.453; Coucelo J, 2000, J EXP ZOOL, V286, P585, DOI 10.1002/(SICI)1097-010X(20000501)286:6<585::AID-JEZ5>3.0.CO;2-Z; DRIEDZIC WR, 1994, PHYSIOL REV, V74, P221, DOI 10.1152/physrev.1994.74.1.221; Driedzic WR, 1996, J EXP ZOOL, V275, P186, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<186::AID-JEZ10>3.3.CO;2-T; Farrell AP, 2007, J EXP BIOL, V210, P1216, DOI 10.1242/jeb.002881; Farrell AP, 1996, J EXP BIOL, V199, P663; Farrell AP, 1998, J EXP BIOL, V201, P2183; FARRELL AP, 1988, CAN J ZOOL, V66, P2368, DOI 10.1139/z88-351; Farrell AP aJD, 1992, HEART FISH PHYSL CAR, P1; FRANKLIN CE, 1992, J EXP BIOL, V166, P47; Garofalo F, 2012, COMP BIOCHEM PHYS A, V163, P215, DOI 10.1016/j.cbpa.2012.05.206; Genge CE, 2013, PHYSIOL GENOMICS, V45, P866, DOI 10.1152/physiolgenomics.00074.2013; Gollock MJ, 2006, J EXP BIOL, V209, P2961, DOI 10.1242/jeb.02319; Hein SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122665; HILTUNEN KM, 1992, EUR J SURG, V158, P607; Ho YL, 2002, ULTRASOUND MED BIOL, V28, P1137, DOI 10.1016/S0301-5629(02)00564-1; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Huang LX, 2014, CHEMOSPHERE, V108, P55, DOI 10.1016/j.chemosphere.2014.02.078; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Icardo JM, 2005, J EXP ZOOL PART A, V303A, P665, DOI 10.1002/jez.a.195; Johansen K., 1986, P71; Johnson AC, 2014, J EXP BIOL, V217, P1868, DOI 10.1242/jeb.101196; Kang BJ, 2015, J R SOC INTERFACE, V12; Klaiman JM, 2014, J EXP BIOL, V217, P4132, DOI 10.1242/jeb.109041; Korsmeyer KE, 1997, J EXP BIOL, V200, P1975; LAI NC, 1990, J COMP PHYSIOL B, V160, P259; Lee HC, 2014, FEBS J; Lee J, 2014, ZEBRAFISH, V11, P447, DOI 10.1089/zeb.2014.1016; Leet JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104190; Li Q, 2014, PSYCHOPHARMACOLOGY B; Lin E, 2014, AM J PHYSIOL-REG I, V306, pR823, DOI 10.1152/ajpregu.00002.2014; Mendonca PC, 2010, COMP BIOCHEM PHYS A, V155, P245, DOI 10.1016/j.cbpa.2009.11.006; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Nemtsas P, 2010, J MOL CELL CARDIOL, V48, P161, DOI 10.1016/j.yjmcc.2009.08.034; Ohte N, 2009, CIRC J, V73, P1595, DOI 10.1253/circj.CJ-09-0523; Paajanen V, 2004, AM J PHYSIOL-REG I, V286, pR405, DOI 10.1152/ajpregu.00500.2003; Sandblom E, 2007, AM J PHYSIOL-REG I, V292, pR2292, DOI 10.1152/ajpregu.00884.2006; Seebacher F, 2013, J EXP BIOL; Shiels HA, 2002, COMP BIOCHEM PHYS A, V132, P811, DOI 10.1016/S1095-6433(02)00050-8; Sidhu R, 2014, J FISH BIOL, V84, P982, DOI 10.1111/jfb.12339; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Steinhausen MF, 2008, J EXP BIOL, V211, P3915, DOI 10.1242/jeb.019281; Stenslokken KO, 2006, AM J PHYSIOL-REG I, V290, pR852, DOI 10.1152/ajpregu.00618.2004; SUDAK FN, 1965, COMP BIOCHEM PHYSIOL, V14, P689, DOI 10.1016/0010-406X(65)90255-0; Sun L, 2008, ULTRASOUND MED BIOL, V34, P31, DOI 10.1016/j.ultrasmedbio.2007.07.002; Tiitu V, 2002, J EXP BIOL, V205, P1597; Verkerk AO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00255	53	28	28	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145163	10.1371/journal.pone.0145163	http://dx.doi.org/10.1371/journal.pone.0145163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730947	Green Published, gold			2022-12-27	WOS:000367801400025
J	Moura, JF; Acevedo-Trejos, E; Tavares, DC; Meirelles, ACO; Silva, CPN; Oliveira, LR; Santos, RA; Wickert, JC; Machado, R; Siciliano, S; Merico, A				Moura, Jailson F.; Acevedo-Trejos, Esteban; Tavares, Davi C.; Meirelles, Ana C. O.; Silva, Cristine P. N.; Oliveira, Larissa R.; Santos, Roberta A.; Wickert, Janaina C.; Machado, Rodrigo; Siciliano, Salvatore; Merico, Agostino			Stranding Events of Kogia Whales along the Brazilian Coast	PLOS ONE			English	Article							PYGMY SPERM-WHALES; CETACEAN STRANDINGS; EASTERN BRAZIL; BREVICEPS; ATLANTIC; DOLPHINS; VARIABILITY; EVOLUTION; HABITAT; DIET	The genus Kogia, which comprises only two extant species, Kogia sima and Kogia breviceps, represents one of the least known groups of cetaceans in the global ocean. In some coastal regions, however, stranding events of these species have been relatively common over the last decades. Stranding provides the opportunity to investigate the biology of these cetaceans and to explore the epidemiological aspects associated with the mortality of the organisms found on the beach. A number of disturbances (including pelagic fisheries, chemical pollution, boat strikes, and noise pollution) have been confirmed to pose a particular threat to the Kogia species. However, no study has yet investigated potential relationships between environmental conditions and stranding events. Here we analyse how a collection of environmental, physical, and biological variables, such as wind, sea surface temperature (SST), water depth, and chlorophyll-a, correlate to Kogia stranding events along the Brazilian coast. The results of our statistical analyses suggest that K. sima is more likely found in warm tropical waters, which provide an explanation for the high frequency of stranding in northeastern Brazilian coast. In contrast, K. breviceps appears to have a preference for temperate and productive waters. Wind speed results to be also an important factor for predicting Kogia strandings in Brazilian coast. Additionally, literature information in combination with our own data and analyses of stomach contents confirms that oceanic cephalopods constitute the primary nutritional source of both Kogia species. By using the available information as a qualitative proxy for habitat preference and feeding ecology, our study provides a novel and comprehensive assessment of Kogia stranding data in relation to environmental conditions along the Brazilian coast.	[Moura, Jailson F.; Acevedo-Trejos, Esteban; Merico, Agostino] Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany; [Tavares, Davi C.] Univ Estadual N Fluminen, Lab Ciencias Ambientais, Programa Posgrad Ecol & Recursos Nat, Campos dos Goytacazes, RJ, Brazil; [Tavares, Davi C.; Siciliano, Salvatore] Fundacao Oswaldo Cruz Fiocruz, Grp Estudos Mamiferos Marinhos Regiao Lagos GEMM, Dept Endemias, ENSP, Rio De Janeiro, RJ, Brazil; [Meirelles, Ana C. O.; Silva, Cristine P. N.] SESC Iparana, Assoc Pesquisa & Preservacao Ecossistemas Aquat A, Caucaia, CE, Brazil; [Oliveira, Larissa R.; Wickert, Janaina C.; Machado, Rodrigo] Univ Vale Rio Sinos UNISINOS, Lab Ecol Mamiferos, Sao Leopoldo, RS, Brazil; [Oliveira, Larissa R.] Grp Estudos Mamiferos Aquat Rio Grande do Sul GEM, Osorio, RS, Brazil; [Santos, Roberta A.] Inst Chico Mendes Conservacao Biodiversidade ICMB, Ctr Pesquisa & Gestao Recursos Pesqueiros Litoral, Itajai, SC, Brazil; [Wickert, Janaina C.] Univ Fed Rio Grande do Sul, Dept Zool, Lab Sistemat & Ecol Aves & Mamiferos Marinhos LAB, Porto Alegre, RS, Brazil; [Machado, Rodrigo] Univ Fed Rio Grande do Sul, Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Merico, Agostino] Jacobs Univ Bremen, Fac Phys & Earth Sci, D-28759 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Fundacao Oswaldo Cruz; Universidade do Vale do Rio dos Sinos (Unisinos); Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Jacobs University	Moura, JF (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany.	jailson.moura@leibniz-zmt.de	Oliveira Meirelles A Campos, Ana Carolina/AFR-3399-2022; Siciliano, Salvatore/ABD-3352-2020; Moura, Jailson F./O-4315-2019; Tavares, Davi Castro/H-7960-2015; Siciliano, Salvatore/H-7670-2015; Merico, Agostino/C-1103-2013; Acevedo-Trejos, Esteban/N-1705-2013	Oliveira Meirelles A Campos, Ana Carolina/0000-0001-5879-3064; Siciliano, Salvatore/0000-0002-0124-8070; Moura, Jailson F./0000-0003-3601-3957; Tavares, Davi Castro/0000-0002-6811-9572; Merico, Agostino/0000-0001-8095-8056; Acevedo-Trejos, Esteban/0000-0003-4222-7062; Oliveira, Larissa/0000-0002-5735-3697	Alexander von Humboldt Foundation and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 0128/14-7]; "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq); Fundacao Grupo Boticario de Protecao a Natureza; Programa Petrobras Ambiental	Alexander von Humboldt Foundation and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Grupo Boticario de Protecao a Natureza; Programa Petrobras Ambiental	JFM and AM were supported by the Alexander von Humboldt Foundation and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, project number BEX 0128/14-7). LRO was supported by the "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) and "Fundacao Grupo Boticario de Protecao a Natureza". ACOM and CPNS were sponsored by the "Programa Petrobras Ambiental". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barlow J, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P209; Bastida R., 2003, MAMIFEROS MARINOS PA; Baumgartner MF, 2001, FISH B-NOAA, V99, P219; Beatson E, 2007, REV FISH BIOL FISHER, V17, P295, DOI 10.1007/s11160-007-9039-9; Bermudez-Villapol L.A., 2008, REV CIENTIFICA UDO A, V8, P154; BISBAL GA, 1995, MAR POLICY, V19, P21, DOI 10.1016/0308-597X(95)92570-W; Bloodworth Brian E., 2008, Mammalian Species, P1, DOI 10.1644/819.1; Borzone CA, 1999, MAR ECOL-P S Z N I, V20, P131, DOI 10.1046/j.1439-0485.1999.00070.x; Brabyn MW, 1991, SCI RES SERIES, V29; Byrd BL, 2014, FISH B-NOAA, V112, P1, DOI 10.7755/FB.112.1.1; Calado L, 2008, OCEAN MODEL, V25, P48, DOI 10.1016/j.ocemod.2008.06.007; Caldwell D.K., 1989, P235; Carmichael RH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041155, DOI 10.1371/J0URNAL.P0NE.0041155]; Chivers SJ, 2005, MAR MAMMAL SCI, V21, P619, DOI 10.1111/j.1748-7692.2005.tb01255.x; Clarke M.R, 1986, HDB IDENTIFICATION C; Davis RW, 1998, MAR MAMMAL SCI, V14, P490, DOI 10.1111/j.1748-7692.1998.tb00738.x; Santos MCD, 2010, BRAZ J OCEANOGR, V58, P123, DOI 10.1590/S1679-87592010000200004; dos Santos RA, 2001, FISH RES, V52, P99; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; Fertl D, 2003, MAMMAL REV, V33, P253, DOI 10.1046/j.1365-2907.2003.00033.x; Garcia CAE, 2004, DEEP-SEA RES PT II, V51, P159, DOI 10.1016/j.dsr2.2003.07.016; Garrison LP, 2003, NMFSSEFSC492 NOAA; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gulland FMD, 2007, ECOHEALTH, V4, P135, DOI 10.1007/s10393-007-0097-1; Gurjao LM, 2003, ARQUIVOS CIENCIAS MA, V36, P67; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jefferson TA, 2008, MARINE MAMMALS WORLD, DOI [10.1578/AM.35.3.2009.414, DOI 10.1578/AM.35.3.2009.414]; Jefferson TA, 2009, MAR BIOL, V156, P1109, DOI 10.1007/s00227-009-1152-y; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Limpus C, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094849.g005, DOI 10.1371/J0URNAL.P0NE.0094849.G005]; Lopes XM, 2012, J MAR BIOL ASSOC UK, V92, P1723, DOI 10.1017/S0025315412000495; Machado I, 2013, CONT SHELF RES, V53, P102, DOI 10.1016/j.csr.2012.11.014; Maia-Nogueira Rodrigo, 2001, Bioikos (Campinas), V15, P50; Maldini Daniela, 2005, Pacific Science, V59, P55, DOI 10.1353/psc.2005.0009; McAlpine DF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P936; Mead JG, 1979, ANAL CETACEAN STRAND, P54; Meirelles ACO, 2009, J MAR BIOL ASSOC UK, V89, P1083, DOI 10.1017/S0025315409002215; Moreno IB, 2005, MAR ECOL PROG SER, V300, P229, DOI 10.3354/meps300229; Munoz-Hincapie Milton F., 1998, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V22, P433; NAGORSEN D, 1985, Mammalian Species, P1, DOI 10.2307/3503937; Norris K, 1966, WHALES DOLPHINS PORP, P63; Palma ED, 2009, CONT SHELF RES, V29, P1525, DOI 10.1016/j.csr.2009.04.002; Peltier H, 2014, ECOL INDIC, V39, P203, DOI 10.1016/j.ecolind.2013.12.019; Plon S, 2004, STATUS NATURAL HIST; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reynolds John E. III, 2009, Endangered Species Research, V7, P23, DOI 10.3354/esr00179; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Ross GJB, 1979, ANN CAPE PROV MUS NA, V11, P259; Sampaio Claudio Luis Santos, 2000, Bioikos, V14, P28; Santos CP, 1998, MEM I OSWALDO CRUZ, V93, P187, DOI 10.1590/S0074-02761998000200028; Santos MB, 2006, MAR MAMMAL SCI, V22, P600, DOI 10.1111/j.1748-7692.2006.00038.x; Pereira MPS, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/12/124013; Santos RA, 1999, THESIS; Secchi ER, 1994, 4 REUN TRAB ESP MAM, P244; Siciliano S, 2008, ARQUIVOS MUSEU NACL, V66, P1; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; Soto JM, 1999, 12 SEMANA NACL OCEAN, P319; Souto Luciano Raimundo Alardo, 2009, Latin American Journal of Aquatic Mammals, V7, P105; Souto Luciano Raimundo Alardo, 2009, Sitientibus Serie Ciencias Biologicas, V9, P129; Souto Luciano Raimundo Alardo, 2007, Biotemas, V20, P19; Staudinger MD, 2014, MAR MAMMAL SCI, V30, P626, DOI 10.1111/mms.12064; Truchon MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059311; Valentin JL, 2001, ECOL STU AN, V144, P97; Vicente A, 1998, 8 REUN TRAB ESP MAM, P222; Waring GT, 2012, NMFSNE221 NOAA; West KL, 2009, MAR MAMMAL SCI, V25, P931, DOI 10.1111/j.1748-7692.2009.00295.x; Wilkinson Dean, 1999, P396; Willis PM, 1998, CAN FIELD NAT, V112, P114; Wright AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055553; Xavier J. C, 2009, CEPHALOPOD BEAK GUID; Zanellato RC, 1996, 7 REUN TRAB ESP MAM, P82	72	16	17	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146108	10.1371/journal.pone.0146108	http://dx.doi.org/10.1371/journal.pone.0146108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730951	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400097
J	Mysterud, A; Austrheim, G				Mysterud, Atle; Austrheim, Gunnar			The Role of Individual Traits and Environmental Factors for Diet Composition of Sheep	PLOS ONE			English	Article							HABITAT SELECTION; POSTINGESTIVE FEEDBACK; PHYSIOLOGICAL-STATE; SEXUAL SEGREGATION; PLANT-COMMUNITIES; DENSITY; FOOD; DEER; BEHAVIOR; HERBIVORES	Large herbivore consumption of forage is known to affect vegetation composition and thereby ecosystem functions. It is thus important to understand how diet composition arises as a mixture of individual variation in preferences and environmental drivers of availability, but few studies have quantified both. Based on 10 years of data on diet composition by aid of microhistological analysis for sheep kept at high and low population density, we analysed how both individual traits (sex, age, body mass, litter size) linked to preference and environmental variation (density, climate proxies) linked to forage availability affected proportional intake of herbs (high quality/low availability) and Avenella flexuosa (lower quality/high availability). Environmental factors affecting current forage availability such as population density and seasonal and annual variation in diet had the most marked impact on diet composition. Previous environment of sheep (switch between high and low population density) had no impact on diet, suggesting a comparably minor role of learning for density dependent diet selection. For individual traits, only the difference between lambs and ewes affected proportion of A. flexuosa, while body mass better predicted proportion of herbs in diet. Neither sex, body mass, litter size, ewe age nor mass of ewe affected diet composition of lambs, and there was no effect of age, body mass or litter size on diet composition of ewes. Our study highlights that diet composition arises from a combination of preferences being predicted by lamb and ewes' age and/or body mass differences, and the immediate environment in terms of population density and proxies for vegetation development.	[Mysterud, Atle] Univ Oslo, CEES, Dept Biosci, NO-0316 Oslo, Norway; [Austrheim, Gunnar] Norwegian Univ Sci & Technol, Museum Nat Hist & Archaeol, Sect Nat Hist, NO-7491 Trondheim, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU)	Mysterud, A (corresponding author), Univ Oslo, CEES, Dept Biosci, POB 1066 Blindern, NO-0316 Oslo, Norway.	atle.mysterud@ibv.uio.no	Mysterud, Atle/AAQ-2864-2020	Mysterud, Atle/0000-0001-8993-7382	Research Council of Norway, Miljo program [183268/S30]; Norwegian Environmental Agency	Research Council of Norway, Miljo program(Research Council of Norway); Norwegian Environmental Agency	This work was funded by the Research Council of Norway, Miljo 2015 program (Project 183268/S30) (http://www.forskningsradet.no/no/Forsiden/1173185591033), and the Norwegian Environmental Agency (http://www.miljodirektoratet.no/).	Agreil C, 2005, APPL ANIM BEHAV SCI, V91, P35, DOI 10.1016/j.applanim.2004.08.029; ALLDEN WG, 1970, AUST J AGR RES, V21, P755, DOI 10.1071/AR9700755; Armstrong HM, 1997, J APPL ECOL, V34, P186, DOI 10.2307/2404858; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Austrheim G, 2005, PLANT ECOL, V179, P217, DOI 10.1007/s11258-005-0197-3; Austrheim G, 2008, OIKOS, V117, P837, DOI 10.1111/j.0030-1299.2008.16543.x; Barboza PS, 2000, J MAMMAL, V81, P473, DOI 10.1644/1545-1542(2000)081&lt;0473:SSIDDA&gt;2.0.CO;2; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Blix AW, 2014, OIKOS, V123, P933, DOI 10.1111/oik.01069; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHOQUENOT D, 1991, ECOLOGY, V72, P805, DOI 10.2307/1940583; Cortes A, 2003, ACTA THERIOL, V48, P229, DOI 10.1007/BF03194162; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; duToit JT, 1995, S AFR J WILDL RES, V25, P127; Ergon T, 2001, NATURE, V411, P1043, DOI 10.1038/35082553; Ergon T, 2001, OIKOS, V95, P185, DOI 10.1034/j.1600-0706.2001.950201.x; Evju M, 2009, OECOLOGIA, V161, P77, DOI 10.1007/s00442-009-1358-1; Framstad E, 1997, P ROY SOC B-BIOL SCI, V264, P31, DOI 10.1098/rspb.1997.0005; Gaillard JM, 2003, ECOSCIENCE, V10, P412, DOI 10.1080/11956860.2003.11682789; Gibb MJ, 1999, APPL ANIM BEHAV SCI, V63, P269, DOI 10.1016/S0168-1591(99)00014-3; HANLEY TA, 1982, J RANGE MANAGE, V35, P146, DOI 10.2307/3898379; Illius AW, 1999, ECOLOGY, V80, P1008, DOI 10.1890/0012-9658(1999)080[1008:DSIGAT]2.0.CO;2; ILLIUS AW, 1992, J ANIM ECOL, V61, P183, DOI 10.2307/5521; Illius AW, 1995, FUNCT ECOL, V9, P894, DOI 10.2307/2389988; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; JEFFERIES RL, 1994, OIKOS, V71, P193, DOI 10.2307/3546267; Kausrud K, 2006, J ZOOL, V270, P63, DOI 10.1111/j.1469-7998.2006.00118.x; KENNEY PA, 1984, AUST J AGR RES, V35, P551, DOI 10.1071/AR9840551; Mobaek R, 2009, OIKOS, V118, P209, DOI 10.1111/j.1600-0706.2008.16935.x; Mobaek R, 2013, OIKOS, V122, P421, DOI 10.1111/j.1600-0706.2012.20888.x; Mobaek R, 2012, BASIC APPL ECOL, V13, P466, DOI 10.1016/j.baae.2012.06.009; Muller DWH, 2013, COMP BIOCHEM PHYS A, V164, P129, DOI 10.1016/j.cbpa.2012.09.018; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Mysterud A, 1997, WILDLIFE BIOL, V3, P27, DOI 10.2981/wlb.1997.004; Mysterud A, 2014, J ANIM ECOL, V83, P712, DOI 10.1111/1365-2656.12166; Mysterud A, 2011, BASIC APPL ECOL, V12, P195, DOI 10.1016/j.baae.2011.03.002; PARSONS AJ, 1994, J ANIM ECOL, V63, P465, DOI 10.2307/5563; Provenza FD, 1996, J ANIM SCI, V74, P2010; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; STAINES BW, 1982, J APPL ECOL, V19, P65, DOI 10.2307/2402991; Steen H, 2005, OECOLOGIA, V143, P357, DOI 10.1007/s00442-004-1792-z; Stenseth NC, 1998, P NATL ACAD SCI USA, V95, P15430, DOI 10.1073/pnas.95.26.15430; STEWART D R M, 1970, Zoologica Africana, V5, P115; Takatsuki S, 2003, ECOL RES, V18, P331, DOI 10.1046/j.1440-1703.2003.00558.x; Veiberg V, 2009, J ZOOL, V278, P15, DOI 10.1111/j.1469-7998.2008.00538.x; Villalba JJ, 1999, APPL ANIM BEHAV SCI, V63, P145, DOI 10.1016/S0168-1591(98)00238-X; Villalba JJ, 2000, APPL ANIM BEHAV SCI, V66, P49, DOI 10.1016/S0168-1591(99)00081-7; Villalba JJ, 2004, OIKOS, V107, P100, DOI 10.1111/j.0030-1299.2004.12983.x; Villalba JJ, 2009, RANGELAND ECOL MANAG, V62, P399, DOI 10.2111/08-076.1; WESTON RH, 1988, AUST J AGR RES, V39, P671, DOI 10.1071/AR9880671	52	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146217	10.1371/journal.pone.0146217	http://dx.doi.org/10.1371/journal.pone.0146217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731411	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400118
J	Taira, W; Otaki, JM				Taira, Wataru; Otaki, Joji M.			Butterfly Wings Are Three-Dimensional: Pupal Cuticle Focal Spots and Their Associated Structures in Junonia Butterflies	PLOS ONE			English	Article							COLOR-PATTERN-ANALYSIS; EYESPOT PATTERNS; EVOLUTION; ELEMENTS	Butterfly wing color patterns often contain eyespots, which are developmentally determined at the late larval and early pupal stages by organizing activities of focal cells that can later form eyespot foci. In the pupal stage, the focal position of a future eyespot is often marked by a focal spot, one of the pupal cuticle spots, on the pupal surface. Here, we examined the possible relationships of the pupal focal spots with the underneath pupal wing tissues and with the adult wing eyespots using Junonia butterflies. Large pupal focal spots were found in two species with large adult eyespots, J. orithya and J. almana, whereas only small pupal focal spots were found in a species with small adult eyespots, J. hedonia. The size of five pupal focal spots on a single wing was correlated with the size of the corresponding adult eyespots in J. orithya. A pupal focal spot was a three-dimensional bulge of cuticle surface, and the underside of the major pupal focal spot exhibited a hollowed cuticle in a pupal case. Cross sections of a pupal wing revealed that the cuticle layer shows a curvature at a focal spot, and a positional correlation was observed between the cuticle layer thickness and its corresponding cell layer thickness. Adult major eyespots of J. orithya and J. almana exhibited surface elevations and depressions that approximately correspond to the coloration within an eyespot. Our results suggest that a pupal focal spot is produced by the organizing activity of focal cells underneath the focal spot. Probably because the focal cell layer immediately underneath a focal spot is thicker than that of its surrounding areas, eyespots of adult butterfly wings are three-dimensionally constructed. The color-height relationship in adult eyespots might have an implication in the developmental signaling for determining the eyespot color patterns.	[Taira, Wataru; Otaki, Joji M.] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Nishihara, Okinawa 9030213, Japan	University of the Ryukyus	Otaki, JM (corresponding author), Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Nishihara, Okinawa 9030213, Japan.	otaki@sci.u-ryukyu.ac.jp			University of the Ryukyus	University of the Ryukyus	This study was supported by the International Research Hub Project for the Coral Reef/Island Dynamics from the University of the Ryukyus, and by the basic research fund from the University of the Ryukyus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Dhungel B, 2014, ENTOMOL SCI, V17, P207, DOI 10.1111/ens.12046; FRENCH V, 1992, DEVELOPMENT, V116, P103; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; Iwata M, 2015, ZOOL SCI, V32, P233, DOI 10.2108/zs140249; Iwata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089500; Kusaba K, 2009, J INSECT PHYSIOL, V55, P174, DOI 10.1016/j.jinsphys.2008.11.006; Matayoshi R, 2011, NEUROSCI RES, V69, P258, DOI 10.1016/j.neures.2010.12.006; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; Nijhout HF, 2001, J EXP ZOOL, V291, P213, DOI 10.1002/jez.1099; Ohno Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128332; Ohno Y, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0067-8; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; Otaki JM, 2005, ZOOL SCI, V22, P21, DOI 10.2108/zsj.22.21; Otaki JM, 2008, J INSECT PHYSIOL, V54, P1099, DOI 10.1016/j.jinsphys.2008.05.006; Otaki JM, 2012, ZOOL SCI, V29, P568, DOI 10.2108/zsj.29.568; Otaki JM, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-17; Otaki JM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00111; Otaki JM, 2011, ZOOL SCI, V28, P817, DOI 10.2108/zsj.28.817; Otaki JM, 2011, ZOOL SCI, V28, P403, DOI 10.2108/zsj.28.403; Otaki JM, 2009, ENTOMOL SCI, V12, P74, DOI 10.1111/j.1479-8298.2009.00306.x; Reed RD, 2004, CURR BIOL, V14, P1159, DOI 10.1016/j.cub.2004.06.046; Shirai LT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-21; Taira W, 2015, ZOOL SCI, V32, P38, DOI 10.2108/zs140058	27	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146348	10.1371/journal.pone.0146348	http://dx.doi.org/10.1371/journal.pone.0146348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731532	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400155
J	Varma, SR; Sivaprakasam, TO; Mishra, A; Kumar, LMS; Prakash, NS; Prabhu, S; Ramakrishnan, S				Varma, Sandeep R.; Sivaprakasam, Thiyagarajan O.; Mishra, Abheepsa; Kumar, L. M. Sharath; Prakash, N. S.; Prabhu, Sunil; Ramakrishnan, Shyam			Protective Effects of Triphala on Dermal Fibroblasts and Human Keratinocytes	PLOS ONE			English	Article							OXIDATIVE STRESS; IN-VITRO; SCAVENGING ACTIVITY; RAT ERYTHROCYTES; STRAND BREAKS; NITRIC-OXIDE; HUMAN SKIN; ANTIOXIDANT; TYROSINASE; EXTRACT	Human skin is body's vital organ constantly exposed to abiotic oxidative stress. This can have deleterious effects on skin such as darkening, skin damage, and aging. Plant-derived products having skin-protective effects are well-known traditionally. Triphala, a formulation of three fruit products, is one of the most important rasayana drugs used in Ayurveda. Several skin care products based on Triphala are available that claim its protective effects on facial skin. However, the skin protective effects of Triphala extract (TE) and its mechanistic action on skin cells have not been elucidated in vitro. Gallic acid, ellagic acid, and chebulinic acid were deduced by LC-MS as the major constituents of TE. The identified key compounds were docked with skin-related proteins to predict their binding affinity. The IC50 values for TE on human dermal fibroblasts (HDF) and human keratinocytes (HaCaT) were 204.90 +/- 7.6 and 239.13 +/- 4.3 mu g/mL respectively. The antioxidant capacity of TE was 481.33 +/- 1.5 mM Trolox equivalents in HaCaT cells. Triphala extract inhibited hydrogen peroxide (H2O2) induced RBC haemolysis (IC50 64.95 mu g/mL), nitric oxide production by 48.62 +/- 2.2%, and showed high reducing power activity. TE also rescued HDF from H2O2-induced damage; inhibited H2O2 induced cellular senescence and protected HDF from DNA damage. TE increased collagen-I, involucrin and filaggrin synthesis by 70.72 +/- 2.3%, 67.61 +/- 2.1% and 51.91 +/- 3.5% in HDF or HaCaT cells respectively. TE also exhibited anti-tyrosinase and melanin inhibition properties in a dose-dependent manner. TE increased the mRNA expression of collagen-I, elastin, superoxide dismutase (SOD-2), aquaporin-3 (AQP-3), filaggrin, involucrin, transglutaminase in HDF or HaCaT cells, and decreased the mRNA levels of tyrosinase in B16F10 cells. Thus, Triphala exhibits protective benefits on skin cells in vitro and can be used as a potential ingredient in skin care formulations.	[Varma, Sandeep R.; Sivaprakasam, Thiyagarajan O.; Mishra, Abheepsa; Kumar, L. M. Sharath; Prakash, N. S.; Prabhu, Sunil; Ramakrishnan, Shyam] Himalaya Drug Co, Res & Dev, Bangalore 562162, Karnataka, India	Himalaya Drug Company	Varma, SR (corresponding author), Himalaya Drug Co, Res & Dev, Bangalore 562162, Karnataka, India.	dr.sandeepvarma@himalayawellness.com	Mishra, Abheepsa/I-6872-2019	Mishra, Abheepsa/0000-0002-8242-6800	Himalaya Drug Company, India	Himalaya Drug Company, India	The funding for this project was done by The Himalaya Drug Company, India. All the authors of this study are regular employees of the Himalaya Drug Company. The study was conducted as part of the project work funded by the Himalaya drug Company, India. The company provided all the support to the study which include author salaries, study design, data collection, decision to publish, and preparation of the manuscript.	Ajila CM, 2008, FOOD CHEM TOXICOL, V46, P303, DOI 10.1016/j.fct.2007.08.024; Anusuya N.A., 2012, INT J PHARMA PHARM S, V4, P714; Azhar-ul-Haq, 2006, PHYTOMEDICINE, V13, P255, DOI 10.1016/j.phymed.2004.09.001; Bag A, 2013, INDIAN J EXP BIOL, V51, P709; Baliga MS, 2012, CHIN J INTEGR MED, V18, P946, DOI 10.1007/s11655-012-1299-x; Baurin N, 2002, J ETHNOPHARMACOL, V82, P155, DOI 10.1016/S0378-8741(02)00174-5; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bernard P., 2000, International Journal of Cosmetic Science, V22, P219, DOI 10.1046/j.1467-2494.2000.00019.x; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Chen QM, 2000, BIOGERONTOLOGY, V1, P335, DOI 10.1023/A:1026590501344; Chung YC, 2002, J AGR FOOD CHEM, V50, P2454, DOI 10.1021/jf011369q; Coleman JW, 2002, CLIN EXP IMMUNOL, V129, P4, DOI 10.1046/j.1365-2249.2002.01918.x; Cuppett SL, 1997, ANTIOXIDANT METHODOL, P41; Deep G, 2005, J EXP CLIN CANC RES, V24, P555; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding HY, 2011, J MED PLANTS RES, V5, P237; Duncan EL, 2000, BIOGERONTOLOGY, V1, P103, DOI 10.1023/A:1010000132671; Fulop T, 2012, PATHOL BIOL, V60, P28, DOI 10.1016/j.patbio.2011.10.006; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Gopaul R, 2011, INT J COSMETIC SCI, V33, P416, DOI 10.1111/j.1468-2494.2011.00645.x; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Hitomi K, 2005, EUR J DERMATOL, V15, P313; Jagetia GC, 2004, PHYTOTHER RES, V18, P561, DOI 10.1002/ptr.1494; Jagetia GC, 2002, PHYTOMEDICINE, V9, P99, DOI 10.1078/0944-7113-00095; Janjetovic Z, 2014, J PINEAL RES, V57, P90, DOI 10.1111/jpi.12146; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kaczvinsky JR, 2009, J DRUGS DERMATOL, V8, pS15; Kim YJ, 2006, BIOSCI BIOTECH BIOCH, V70, P532, DOI 10.1271/bbb.70.532; Kim YJ, 2013, BIOL PHARM BULL, V36, P1341, DOI 10.1248/bpb.b13-00276; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kumar KJS, 2010, PHYTOTHER RES, V24, P1158, DOI 10.1002/ptr.3018; Kurtz A, 2012, PREV MED, V54, pS50, DOI 10.1016/j.ypmed.2012.01.003; Lee K. T., 1997, International Journal of Cosmetic Science, V19, P291, DOI 10.1046/j.1467-2494.1997.171725.x; Li J, 2010, AUSTRALAS J DERMATOL, V51, P106, DOI 10.1111/j.1440-0960.2010.00629.x; Lloyd DR, 1999, MUTAT RES-FUND MOL M, V424, P23, DOI 10.1016/S0027-5107(99)00005-6; Lu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043934; Manayi A, 2014, EXPERT OPIN DRUG DIS, V9, P383, DOI 10.1517/17460441.2014.885014; Mensah AY, 2001, J ETHNOPHARMACOL, V77, P219, DOI 10.1016/S0378-8741(01)00297-5; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Mishra A, 2014, PEPTIDES, V54, P148, DOI 10.1016/j.peptides.2014.01.023; Mora P.C., 2000, POLYM BIOMATERIALS, V2nd ed., P459; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; Naik GH, 2006, CURR SCI INDIA, V90, P1100; Nakayama H, 2000, COSMET SCI TECHNOL S, P123; Pawar V, 2009, INDIAN J PHARM SCI, V71, P382, DOI 10.4103/0250-474X.57286; Pellati F, 2013, J ETHNOPHARMACOL, V147, P277, DOI 10.1016/j.jep.2013.02.025; Prota G, 1996, COSMET TOILETRIES, V111, P43; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P1690, DOI 10.1016/j.biortech.2007.04.005; Rajesh KP, 2013, IND CROP PROD, V47, P186, DOI 10.1016/j.indcrop.2013.03.008; Reddy CSSS, 2007, TOXICOL IN VITRO, V21, P1355, DOI 10.1016/j.tiv.2007.06.010; Robinson MK, 2009, J DRUGS DERMATOL, V8, pS8; ROSS WM, 1982, CAN J OPHTHALMOL, V17, P61; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sandeep RV, 2014, SCI PHARM, V82, P375, DOI [10.3797/scipharm.1310-25, DOI 10.3797/SCIPHARM.1310-25]; Shimogaki H., 2000, International Journal of Cosmetic Science, V22, P291, DOI 10.1046/j.1467-2494.2000.00023.x; Shimogaki H, 1996, AM AC DERM 54 ANN M, P280; SHINDO Y, 1994, J INVEST DERMATOL, V102, P122, DOI 10.1111/1523-1747.ep12371744; Singh DP, 2008, PHYTOCHEM ANALYSIS, V19, P164, DOI 10.1002/pca.1032; Sivanandham V., 2011, PHARMACOLOGYONLINE, V1, P1062; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; SLOMINSKI AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI DOI 10.2174/18715206113139990308; SNYDER LM, 1985, J CLIN INVEST, V76, P1971, DOI 10.1172/JCI112196; Sung JH, 2009, BIOSCI BIOTECH BIOCH, V73, P552, DOI 10.1271/bbb.80601; Svobodova Alena, 2003, Biomedical Papers (Olomouc), V147, P137; Tanaka Y, 2001, PIGMENT CELL RES, V14, P495; Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566; Tierra M, 1996, WONDERS TRIPHALA AYU; Tiwari AK, 2004, CURR SCI INDIA, V86, P1092; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P859, DOI 10.1016/0891-5849(95)02184-1; Treiber N, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.21819; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vasile E, 2001, FASEB J, V15, P458, DOI 10.1096/fj.00-0051com; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a; Zheng Q, 2013, CLIN COSMET INVESTI, V6, P317, DOI 10.2147/CCID.S51958; Zheng ZP, 2009, J AGR FOOD CHEM, V57, P6649, DOI 10.1021/jf9014685	83	29	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145921	10.1371/journal.pone.0145921	http://dx.doi.org/10.1371/journal.pone.0145921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731545	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400065
J	Wolwer, CB; Pase, LB; Russell, SM; Humbert, PO				Woelwer, Christina B.; Pase, Luke B.; Russell, Sarah M.; Humbert, Patrick O.			Calcium Signaling Is Required for Erythroid Enucleation	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; CALMODULIN ANTAGONISTS; CYTOKINESIS; ACTIN; KINASE; PHOSPHORYLATION; CELLS; ERYTHROBLASTS; INHIBITION; DYNAMICS	Although erythroid enucleation, the property of erythroblasts to expel their nucleus, has been known for 7ore than a century, surprisingly little is known regarding the molecular mechanisms governing this unique developmental process. Here we show that similar to cytokinesis, nuclear extrusion requires intracellular calcium signaling and signal transduction through the calmodulin (CaM) pathway. However, in contrast to cytokinesis we found that orthochromatic erythroblasts require uptake of extracellular calcium to enucleate. Together these functional studies highlight a critical role for calcium signaling in the regulation of erythroid enucleation.	[Woelwer, Christina B.; Pase, Luke B.; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet, Melbourne, Vic, Australia; [Woelwer, Christina B.; Pase, Luke B.; Russell, Sarah M.; Humbert, Patrick O.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Russell, Sarah M.] Peter MacCallum Canc Ctr, Immune Signaling Lab, Melbourne, Vic, Australia; [Russell, Sarah M.] Swinburne Univ Technol, Ctr Microphoton, Fac Engn & Ind Sci, Melbourne, Vic, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Swinburne University of Technology; University of Melbourne; University of Melbourne	Humbert, PO (corresponding author), Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet, Melbourne, Vic, Australia.	Patrick.Humbert@petermac.org	Russell, Sarah M/B-9341-2009; Humbert, Patrick O/L-4264-2016	Russell, Sarah M/0000-0001-5826-9641; Humbert, Patrick O/0000-0002-1366-6691	Australian Postgraduate Award; NHMRC; NH&MRC of Australia	Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC of Australia(National Health and Medical Research Council (NHMRC) of Australia)	C.B.W. was supported by the Australian Postgraduate Award. P.O.H. and S.M.R. are supported by a Senior Research Fellowship from the NH&MRC and the work by a project grant from the NH&MRC of Australia.	ASANO M, 1989, J PHARMACOL EXP THER, V251, P764; Atilla-Gokcumen GE, 2010, ACS CHEM BIOL, V5, P79, DOI 10.1021/cb900256m; Cantu C, 2012, HAEMATOL-HEMATOL J, V97, P980, DOI 10.3324/haematol.2011.052522; Day D, 2009, IMMUNOL CELL BIOL, V87, P154, DOI 10.1038/icb.2008.79; Hoffman L, 2013, BIOCHEMISTRY-US, V52, P1198, DOI 10.1021/bi3016586; ITOH H, 1984, J BIOCHEM-TOKYO, V96, P1721, DOI 10.1093/oxfordjournals.jbchem.a135004; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Keerthivasan G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/139851; Kimura M, 1999, AM J PHYSIOL-HEART C, V277, pH911, DOI 10.1152/ajpheart.1999.277.3.H911; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Lee KW, 2003, INT J DEV BIOL, V47, P411; Li CJ, 1999, J CELL SCI, V112, P1567; LIU TY, 1992, MOL BIOL CELL, V3, P1403, DOI 10.1091/mbc.3.12.1403; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Muto A, 1996, J CELL BIOL, V135, P181, DOI 10.1083/jcb.135.1.181; OHTA Y, 1986, FEBS LETT, V208, P423, DOI 10.1016/0014-5793(86)81061-4; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Sanabria H, 2009, J BIOL CHEM, V284, P9770, DOI 10.1074/jbc.M809518200; Ubukawa K, 2012, BLOOD, V119, P1036, DOI 10.1182/blood-2011-06-361907; Webb SE, 2008, PHILOS T R SOC B, V363, P1363, DOI 10.1098/rstb.2007.2253; Wolwer CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142655; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964	27	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146201	10.1371/journal.pone.0146201	http://dx.doi.org/10.1371/journal.pone.0146201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731108	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400116
J	Yang, JY; Bindels, LB; Munoz, RRS; Martinez, I; Walter, J; Ramer-Tait, AE; Rose, DJ				Yang, Junyi; Bindels, Laure B.; Munoz, Rafael R. Segura; Martinez, Ines; Walter, Jens; Ramer-Tait, Amanda E.; Rose, Devin J.			Disparate Metabolic Responses in Mice Fed a High-Fat Diet Supplemented with Maize-Derived Non-Digestible Feruloylated Oligoand Polysaccharides Are Linked to Changes in the Gut Microbiota	PLOS ONE			English	Article							AKKERMANSIA-MUCINIPHILA; LIPID-METABOLISM; FIBER; FERMENTATION; PERSPECTIVE; PREBIOTICS; BENEFITS; GLUCOSE; WEIGHT; HEALTH	Studies have suggested links between colonic fermentation of dietary fibers and improved metabolic health. The objectives of this study were to determine if non-digestible feruloylated oligo-and polysaccharides (FOPS), a maize-derived dietary fiber, could counteract the deleterious effects of high-fat (HF) feeding in mice and explore if metabolic benefits were linked to the gut microbiota. C57BL/6J mice (n = 8/group) were fed a low-fat (LF; 10 kcal% fat), HF (62 kcal% fat), or HF diet supplemented with FOPS (5%, w/w). Pronounced differences in FOPS responsiveness were observed: four mice experienced cecal enlargement and enhanced short chain fatty acid production, indicating increased cecal fermentation (F-FOPS). Only these mice displayed improvements in glucose metabolism compared with HF-fed mice. Blooms in the gut microbial genera Blautia and Akkermansia were observed in three of the F-FOPS mice; these shifts were associated with reductions in body and adipose tissue weights compared with the HF-fed control mice. No improvements in metabolic markers or weights were detected in the four mice whose gut microbiota did not respond to FOPS. These findings demonstrate that FOPS-induced improvements in weight gain and metabolic health in mice depended on the ability of an individual's microbiota to ferment FOPS.	[Yang, Junyi; Bindels, Laure B.; Munoz, Rafael R. Segura; Ramer-Tait, Amanda E.; Rose, Devin J.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Martinez, Ines; Walter, Jens] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Walter, Jens] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Rose, Devin J.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Alberta; University of Alberta; University of Nebraska System; University of Nebraska Lincoln	Rose, DJ (corresponding author), Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA.	drose3@unl.edu	Munoz, Rafael R. Segura/AAY-6320-2020; Bindels, Laure/T-7846-2019; Walter, Jens/AAA-7636-2020	Munoz, Rafael R. Segura/0000-0001-7330-8549; Bindels, Laure/0000-0003-3747-3234; Walter, Jens/0000-0003-1754-172X; Ramer-Tait, Amanda/0000-0003-0950-7548	Nebraska Research Initiative Fund; NIH NIGMS [1P20GM104320]; Fonds Special de Recherche, Universite catholique de Louvain; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER	Nebraska Research Initiative Fund; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fonds Special de Recherche, Universite catholique de Louvain; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Nebraska Research Initiative Fund (to DJR) and by NIH NIGMS 1P20GM104320 (to AERT). LBB was supported by a post-doctoral grant awarded by the Fonds Special de Recherche, Universite catholique de Louvain.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chou CJ, 2009, Patent Publication Number, Patent No. [WO2009024429 A3, 2009024429]; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fava F, 2006, CURR MED CHEM, V13, P3005, DOI 10.2174/092986706778521814; Frosig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062338; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Hamaker BR, 2014, J MOL BIOL, V426, P3838, DOI 10.1016/j.jmb.2014.07.028; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jakobsdottir G, 2014, NUTRITION, V30, P497, DOI 10.1016/j.nut.2013.08.013; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Kellow NJ, 2014, BRIT J NUTR, V111, P1147, DOI 10.1017/S0007114513003607; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kosugi A, 2002, J BACTERIOL, V184, P6859, DOI 10.1128/JB.184.24.6859-6865.2002; Krumbeck JA, 2015, APPL ENVIRON MICROB, V81, P2455, DOI 10.1128/AEM.03903-14; Leach JD, 2007, EUR J CLIN NUTR, V61, P140, DOI 10.1038/sj.ejcn.1602486; Li P, 2010, NATURE, V464, P1287, DOI 10.1038/4641287a; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Rocha BS, 2014, FOOD FUNCT, V5, P1646, DOI [10.1039/c4fo00124a, 10.1039/C4FO00124A]; Rose DJ, 2007, NUTR REV, V65, P51, DOI [10.1111/j.1753-4887.2007.tb00282.x, 10.1301/nr.2007.feb.51-62]; Rose DJ, 2011, ACS SYM SER, V1089, P111; Rose DJ, 2010, J AGR FOOD CHEM, V58, P493, DOI 10.1021/jf9020416; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; SAULNIER L, 1995, CARBOHYD POLYM, V26, P279, DOI 10.1016/0144-8617(95)00020-8; Tuohy Kieran M., 2002, Microbial Ecology in Health and Disease, V14, P165, DOI 10.1080/089106002320644357; Walter J, 2015, CELL HOST MICROBE, V17, P3, DOI 10.1016/j.chom.2014.12.004; Woting A, 2014, MBIO, V5, DOI 10.1128/mBio.01530-14; Yang JY, 2014, NUTR RES, V34, P749, DOI 10.1016/j.nutres.2014.08.006; Yang JY, 2014, J AGR FOOD CHEM, V62, P159, DOI 10.1021/jf404305y; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhou J, 2009, J AGR FOOD CHEM, V57, P8844, DOI 10.1021/jf901548e	47	38	43	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146144	10.1371/journal.pone.0146144	http://dx.doi.org/10.1371/journal.pone.0146144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731528	gold, Green Published			2022-12-27	WOS:000367801400101
J	Maside, X; Gomez-Moracho, T; Jara, L; Martin-Hernandez, R; De la Rua, P; Higes, M; Bartolome, C				Maside, Xulio; Gomez-Moracho, Tamara; Jara, Laura; Martin-Hernandez, Raquel; De la Rua, Pilar; Higes, Mariano; Bartolome, Carolina			Population Genetics of Nosema apis and Nosema ceranae: One Host (Apis mellifera) and Two Different Histories	PLOS ONE			English	Article							MICROSPORIDIAN POLAR TUBE; EUROPEAN HONEY-BEE; PHYLOGENETIC ANALYSIS; RECOMBINATION EVENTS; WIDESPREAD DISPERSAL; GENOME SEQUENCE; SPP. INFECTION; PARASITE; DNA; DIVERSITY	Two microsporidians are known to infect honey bees: Nosema apis and Nosema ceranae. Whereas population genetics data for the latter have been released in the last few years, such information is still missing for N. apis. Here we analyze the patterns of nucleotide polymorphism at three single-copy loci (PTP2, PTP3 and RPB1) in a collection of Apis mellifera isolates from all over the world, naturally infected either with N. apis (N = 22) or N. ceranae (N = 23), to provide new insights into the genetic diversity, demography and evolution of N. apis, as well as to compare them with evidence from N. ceranae. Neutral variation in N. apis and N. ceranae is of the order of 1%. This amount of diversity suggests that there is no substantial differentiation between the genetic content of the two nuclei present in these parasites, and evidence for genetic recombination provides a putative mechanism for the flow of genetic information between chromosomes. The analysis of the frequency spectrum of neutral variants reveals a significant surplus of low frequency variants, particularly in N. ceranae, and suggests that the populations of the two pathogens are not in mutation-drift equilibrium and that they have experienced a population expansion. Most of the variation in both species occurs within honey bee colonies (between 62%-90% of the total genetic variance), although in N. apis there is evidence for differentiation between parasites isolated from distinct A. mellifera lineages (20%-34% of the total variance), specifically between those collected from lineages A and C (or M). This scenario is consistent with a long-term host-parasite relationship and contrasts with the lack of differentiation observed among host-lineages in N. ceranae (<4% of the variance), which suggests that the spread of this emergent pathogen throughout the A. mellifera worldwide population is a recent event.	[Maside, Xulio; Gomez-Moracho, Tamara; Bartolome, Carolina] Univ Santiago de Compostela, CIMUS, Med Xenom, Santiago De Compostela, Galicia, Spain; IDIS, Xenom Comparada Parasitos Humanos, Santiago De Compostela, Galicia, Spain; Univ Santiago de Compostela, Dept Anat Patolox & Ciencias Forenses, Santiago De Compostela, Galicia, Spain; [Gomez-Moracho, Tamara; Martin-Hernandez, Raquel; Higes, Mariano] Consejeria Agr Junta Comunidades Castilla La Manc, Inst Reg Invest & Desarrollo Agroalimentario & Fo, Ctr Invest Apicola & Agroambiental CIAPA, Lab Patol Apicola, Marchamalo, Guadalajara, Spain; [Jara, Laura; De la Rua, Pilar] Univ Murcia, Fac Vet, Dept Zool & Antropol Fis, Murcia, Spain; [Martin-Hernandez, Raquel] Fdn Parque Cient & Tecnol Albacete, Inst Recursos Humanos Ciencia & Tecnol INCRECYT F, Albacete, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Murcia	Bartolome, C (corresponding author), Univ Santiago de Compostela, CIMUS, Med Xenom, Santiago De Compostela, Galicia, Spain.	carolina.bartolome@usc.es	Martin-Hernandez, Raquel/J-7507-2013; Maside, Xulio/AAA-6551-2019; Gomez-Moracho, Tamara/AAB-2294-2020; Bartolomé, Carolina/AAA-6581-2019; Maside, Xulio/AAU-8864-2020; De la Rúa, Pilar/A-4578-2009; Higes, Mariano/N-9380-2017	Martin-Hernandez, Raquel/0000-0002-1730-9368; Gomez-Moracho, Tamara/0000-0002-3063-8617; Bartolomé, Carolina/0000-0002-6989-3797; De la Rúa, Pilar/0000-0002-0058-1402; Higes, Mariano/0000-0001-7338-5851; Maside, Xulio/0000-0002-4494-8616	Instituto Nacional de Investigacion y Tecnologia Agraria (INIA) [RTA2013-00042-C10-05, RTA2013-00042-C10-06]; Regional Government of Murcia (Fundacion Seneca) [19908/GERM/2015]; Ministerio de Agricultura, Alimentacion y Medio Ambiente (MAGRAMA; Plan Apicola Nacional); COST Action [FA1307]	Instituto Nacional de Investigacion y Tecnologia Agraria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Regional Government of Murcia (Fundacion Seneca)(Fundacion Seneca); Ministerio de Agricultura, Alimentacion y Medio Ambiente (MAGRAMA; Plan Apicola Nacional); COST Action(European Cooperation in Science and Technology (COST))	This study was supported by funds from the Instituto Nacional de Investigacion y Tecnologia Agraria (INIA; http://www.inia.es/; grant numbers RTA2013-00042-C10-05 and 06), the Regional Government of Murcia (Fundacion Seneca; http://fseneca.es/; grant number 19908/GERM/2015) and the Ministerio de Agricultura, Alimentacion y Medio Ambiente (MAGRAMA; Plan Apicola Nacional 2014; http://www.magrama.gob.es). PDR is presently a member and receives support from COST Action FA1307, Sustainable pollination in Europe: joint research on bees and other pollinators, SUPER-B (http://www.cost.eu/COST_Actions/fa/Actions/FA1307).	Alaux C, 2014, J EXP BIOL, V217, P3416, DOI 10.1242/jeb.105783; Bailey L, 1955, ANN APPL BIOL, V43, P379, DOI 10.1111/j.1744-7348.1955.tb02488.x; Birky CW, 2010, TRENDS PARASITOL, V26, P70, DOI 10.1016/j.pt.2009.11.007; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Botias C, 2012, ENVIRON MICROBIOL, V14, P845, DOI 10.1111/j.1462-2920.2011.02647.x; Botias C, 2012, J INVERTEBR PATHOL, V110, P108, DOI 10.1016/j.jip.2012.02.014; Burgher-MacLellan KL, 2010, CAN ENTOMOL, V142, P271, DOI 10.4039/n10-010; Chaimanee V, 2011, J INVERTEBR PATHOL, V107, P229, DOI 10.1016/j.jip.2011.05.012; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chen Y.P., 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.4.11, DOI 10.3896/IBRA.1.52.4.11]; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J EUKARYOT MICROBIOL, V56, P142, DOI 10.1111/j.1550-7408.2008.00374.x; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Crane E., 1999, WORLD HIST BEEKEEPIN; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Desjardins CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8121; Drake JW, 1998, GENETICS, V148, P1667; Dussaubat C, 2013, J INVERTEBR PATHOL, V113, P42, DOI 10.1016/j.jip.2013.01.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; FRIES I, 1992, APIDOLOGIE, V23, P61, DOI 10.1051/apido:19920107; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Fu YX, 1997, GENETICS, V147, P915; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Gatehouse HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/jipa.1997.4737; Gatehouse HS, 1999, J APICULT RES, V38, P79; Giersch T, 2009, APIDOLOGIE, V40, P117, DOI 10.1051/apido/2008065; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Gomez-Moracho T, 2015, INFECT GENET EVOL, V31, P87, DOI 10.1016/j.meegid.2015.01.002; Gomez-Moracho T, 2014, ENV MICROBIOL; Gomez-Moracho T, 2014, PARASITOLOGY, V141, P475, DOI 10.1017/S0031182013001790; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; GRAY FH, 1969, J INVERTEBR PATHOL, V14, P391, DOI 10.1016/0022-2011(69)90167-0; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; GUPTA RS, 1993, J MOL EVOL, V37, P573; Haag KL, 2013, MOL ECOL, V22, P314, DOI 10.1111/mec.12126; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han F, 2012, ECOL EVOL, V2, P1949, DOI 10.1002/ece3.312; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Higes M, 2009, J APICULT RES, V48, P217, DOI 10.3896/IBRA.1.48.3.12; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Huang WF, 2007, APIDOLOGIE, V38, P30, DOI 10.1051/apido:2006054; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Ironside JE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-48; Ironside JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055878; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Medici SK, 2012, PARASITOL RES, V110, P859, DOI 10.1007/s00436-011-2566-2; Keeling P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000489; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Krebes L, 2014, INFECT GENET EVOL, V21, P259, DOI 10.1016/j.meegid.2013.11.007; Kudo R., 1920, Journal of Parasitology Urbana, V7, DOI 10.2307/3270960; LEE SJ, 2010, PLOS GENET, V6, DOI DOI 10.1371/JOURNAL.PONE.0010539; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; Martin-Hernandez R, 2012, ENVIRON MICROBIOL, V14, P2127, DOI 10.1111/j.1462-2920.2011.02645.x; McVean G, 2002, GENETICS, V160, P1231; Myers SR, 2003, GENETICS, V163, P375; Nei M., 1987, MOL EVOLUTIONARY GEN; OIE-WHO, 2014, MANUAL DIAGNOSTIC TE; Pelin A, 2015, ENV MICROBIOL; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Polonais V, 2005, FUNGAL GENET BIOL, V42, P791, DOI 10.1016/j.fgb.2005.05.005; Pombert JF, 2013, EUKARYOT CELL, V12, P503, DOI 10.1128/EC.00312-12; Roudel M, 2013, PARASITOLOGY, V140, P1346, DOI 10.1017/S0031182013001133; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sagastume S, 2014, J EUKARYOT MICROBIOL, V61, P42, DOI 10.1111/jeu.12084; Sagastume S, 2011, ENVIRON MICROBIOL, V13, P84, DOI 10.1111/j.1462-2920.2010.02311.x; Schmid-Hempel R, 1998, PARASITES SOCIAL INS; Selman M, 2013, EUKARYOT CELL, V12, P496, DOI 10.1128/EC.00307-12; Singh R. N., 2005, Karnataka Journal of Agricultural Sciences, V18, P398; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Van der Zee R, 2014, ENV MICROBIOL REP, V6, P401, DOI 10.1111/1758-2229.12133; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Webster T. C., 1993, American Bee Journal, V133, P869; Weedall GD, 2015, PARASITOLOGY, V142, pS120, DOI 10.1017/S0031182014001693; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Xu YJ, 2005, INT J PARASITOL, V35, P941, DOI 10.1016/j.ijpara.2005.04.003; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	104	15	16	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145609	10.1371/journal.pone.0145609	http://dx.doi.org/10.1371/journal.pone.0145609			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720131	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900018
J	Luo, CW; Wang, QY; Schyns, PG; Kingdom, FAA; Xu, H				Luo, Chengwen; Wang, Qingyun; Schyns, Philippe G.; Kingdom, Frederick A. A.; Xu, Hong			Facial Expression Aftereffect Revealed by Adaption to Emotion-Invisible Dynamic Bubbled Faces	PLOS ONE			English	Article							TEMPORAL INTEGRATION; ADAPTATION DEPENDS; MOTION ADAPTATION; ATTENTION; RECOGNITION; INFORMATION; PERCEPTION; ACTIVATION; FEARFUL; HAPPY	Visual adaptation is a powerful tool to probe the short-term plasticity of the visual system. Adapting to local features such as the oriented lines can distort our judgment of subsequently presented lines, the tilt aftereffect. The tilt aftereffect is believed to be processed at the low-level of the visual cortex, such as Vi. Adaptation to faces, on the other hand, can produce significant aftereffects in high-level traits such as identity, expression, and ethnicity. However, whether face adaptation necessitate awareness of face features is debatable. In the current study, we investigated whether facial expression aftereffects (FEAE) can be generated by partially visible faces. We first generated partially visible faces using the bubbles technique, in which the face was seen through randomly positioned circular apertures, and selected the bubbled faces for which the subjects were unable to identify happy or sad expressions. When the subjects adapted to static displays of these partial faces, no significant FEAE was found. However, when the subjects adapted to a dynamic video display of a series of different partial faces, a significant FEAE was observed. In both conditions, subjects could not identify facial expression in the individual adapting faces. These results suggest that our visual system is able to integrate unrecognizable partial faces over a short period of time and that the integrated percept affects our judgment on subsequently presented faces. We conclude that FEAE can be generated by partial face with little facial expression cues, implying that our cognitive system fills-in the missing parts during adaptation, or the subcortical structures are activated by the bubbled faces without conscious recognition of emotion during adaptation.	[Luo, Chengwen; Wang, Qingyun; Xu, Hong] Nanyang Technol Univ, Div Psychol, Singapore 639798, Singapore; [Schyns, Philippe G.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Kingdom, Frederick A. A.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Glasgow; McGill University	Xu, H (corresponding author), Nanyang Technol Univ, Div Psychol, Singapore 639798, Singapore.	xuhong@ntu.edu.sg	Schyns, Philippe/AAT-6989-2020; Xu, Hong/M-5173-2017	Xu, Hong/0000-0003-1389-5408; Schyns, Philippe/0000-0002-8542-7489	Nanyang Technological University Research Scholarship; Singapore Ministry of Education Academic Research Fund (AcRF); Natural Science and Engineering Research Council of Canada [RGPIN 121713-11]	Nanyang Technological University Research Scholarship(Nanyang Technological University); Singapore Ministry of Education Academic Research Fund (AcRF)(Ministry of Education, Singapore); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by Nanyang Technological University Research Scholarship to C.L., Singapore Ministry of Education Academic Research Fund (AcRF) Tier 1 to H.X., and a Natural Science and Engineering Research Council of Canada grant #RGPIN 121713-11 given to F.K.	Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; Anaki D, 2007, J EXP PSYCHOL HUMAN, V33, P1, DOI 10.1037/0096-1523.33.1.1; Anaki D, 2007, VIS COGN, V15, P741, DOI 10.1080/13506280601130883; Blake R, 2006, P NATL ACAD SCI USA, V103, P4783, DOI 10.1073/pnas.0509634103; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burra N, 2013, J NEUROSCI, V33, P10483, DOI 10.1523/JNEUROSCI.3994-12.2013; Carbon CC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00003; Cheadle S, 2014, NEURON, V81, P1429, DOI 10.1016/j.neuron.2014.01.020; Chen MY, 2010, VISION RES, V50, P1814, DOI 10.1016/j.visres.2010.06.002; Gheorghiu E, 2011, J VISION, V11, DOI 10.1167/11.14.18; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Harvey Jr LO, 2003, PSYCHOLOGY, P4165; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hegde J, 2008, J VISION, V8, DOI 10.1167/8.4.16; Hsu SM, 2004, VIS COGN, V11, P871, DOI 10.1080/13506280444000030; James TW, 2010, BRAIN COGNITION, V74, P112, DOI 10.1016/j.bandc.2010.07.007; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Kadosh KC, 2011, SOC COGN AFFECT NEUR, V6, P58, DOI 10.1093/scan/nsq015; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Keysers C, 2002, TRENDS COGN SCI, V6, P120, DOI 10.1016/S1364-6613(00)01852-0; Kouider S, 2011, PSYCHOL SCI, V22, P184, DOI 10.1177/0956797610396226; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; LeDoux J, 1996, EMOTIONAL BRAIN SIMO; Lee Y, 2012, NEUROIMAGE, V61, P1287, DOI 10.1016/j.neuroimage.2012.02.073; Lin ZC, 2012, PSYCHOL SCI, V23, P1534, DOI 10.1177/0956797612446348; Liu P, 2014, VISION RES, V105, P189, DOI 10.1016/j.visres.2014.10.014; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maior RS, 2010, BEHAV BRAIN RES, V215, P129, DOI 10.1016/j.bbr.2010.07.009; Nguyen MN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00085; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Morgan MJ, 2012, VISION RES, V55, P47, DOI 10.1016/j.visres.2011.12.009; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pitcher D, 2011, NEUROIMAGE, V56, P2356, DOI 10.1016/j.neuroimage.2011.03.067; Rajimehr R, 2003, PERCEPTION, V32, P1199, DOI 10.1068/p5076; Rezec A, 2004, VISION RES, V44, P3035, DOI 10.1016/j.visres.2004.07.020; Rhodes G, 2011, VISION RES, V51, P1811, DOI 10.1016/j.visres.2011.06.008; Rolfs M, 2005, EXP BRAIN RES, V166, P427, DOI 10.1007/s00221-005-2382-y; Rutishauser U, 2011, CURR BIOL, V21, P1654, DOI 10.1016/j.cub.2011.08.035; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; Sweeny TD, 2011, PSYCHOL SCI, V22, P943, DOI 10.1177/0956797611413292; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Treisman A, 1999, NEURON, V24, P105, DOI 10.1016/S0896-6273(00)80826-0; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Van den Stock J, 2011, P NATL ACAD SCI USA, V108, P16188, DOI 10.1073/pnas.1107214108; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Wu CT, 2011, J COGNITIVE NEUROSCI, V23, P4094, DOI 10.1162/jocn_a_00045; Xu H, 2008, J NEUROSCI, V28, P3374, DOI 10.1523/JNEUROSCI.0182-08.2008; Xu H, 2012, VISION RES, V72, P42, DOI 10.1016/j.visres.2012.09.003; Yang E, 2010, J VISION, V10, DOI 10.1167/10.12.24	55	6	6	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145877	10.1371/journal.pone.0145877	http://dx.doi.org/10.1371/journal.pone.0145877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717572	Green Accepted, Green Published, gold			2022-12-27	WOS:000367510500086
J	Mason, JB; Terry, BC; Merchant, SS; Mason, HM; Nazokkarmaher, M				Mason, Jeffrey B.; Terry, Boston C.; Merchant, Samer S.; Mason, Holly M.; Nazokkarmaher, Mahdi			Manipulation of Ovarian Function Significantly Influenced Trabecular and Cortical Bone Volume, Architecture and Density in Mice at Death	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MIDDLE-AGED RATS; MENOPAUSAL TRANSITION; FOLLICLE DEVELOPMENT; HORMONE DEPRIVATION; YOUNG OVARIES; ER-ALPHA; TURNOVER; STRENGTH; MEMORY	Previously, transplantation of ovaries from young, cycling mice into old, postreproductive-age mice increased life span and decreased cardiomyopathy at death. We anticipated that the same factors that increased life span and decreased cardiomyopathy could also influence the progression of orthopedic disease. At 11 months of age, prepubertally ovariectomized and ovary-intact mice (including reproductively cycling and acyclic mice) received new 60-day-old ovaries. At death, epiphyseal bone in the proximal tibia and the distal femur and mid-shaft tibial and femoral diaphyseal bone was analyzed with micro-computed tomography. For qualitative analysis of osteophytosis, we also included mineralized connective tissue within the stifle joint. Prepubertal ovariectomy had the greatest influence on bone volume, ovarian transplantation had the greatest influence on bone architecture and both treatments influenced bone density. Ovarian transplantation increased cortical, but not trabecular bone density and tended to increase osteophytosis and heterotopic mineralization, except in acyclic recipients. These effects may have been dictated by the timing of the treatments, with ovariectomy appearing to influence early development and ovarian transplantation limited to influencing only the postreproductive period. However, major differences observed between cycling, acyclic and ovariectomized recipients of new ovaries may have been, in part due to differences in the levels of hormone receptors present and the responsiveness of specific bone processes to hormone signaling. Changes that resulted from these treatments may represent a compensatory response to normal age-associated, negative, orthopedic changes. Alternatively, differences between treatments may simply be the 'preservation' of unblemished orthopedic conditions, prior to the influence of negative, age-associated effects. These findings may suggest that in women, tailoring hormone replacement therapy to the patient's current reproductive status may improve therapy effectiveness and that beginning therapy earlier may help preserve trabecular bone mineral density that would otherwise be lost during perimenopause.	[Mason, Jeffrey B.; Mason, Holly M.; Nazokkarmaher, Mahdi] Utah State Univ, Sch Vet Med, Ctr Integrated BioSyst, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Terry, Boston C.; Merchant, Samer S.] Univ Utah, Coll Engn, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; University of Utah	Mason, JB (corresponding author), Utah State Univ, Sch Vet Med, Ctr Integrated BioSyst, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	Jeff.Mason@USU.edu	Mason, jeffrey B/I-8601-2017	Mason, jeffrey B/0000-0003-2459-1186	Utah State University, Office of Research and Graduate Studies, the Research Catalyst Program Grant; University of Utah, Undergraduate Research Opportunities Program	Utah State University, Office of Research and Graduate Studies, the Research Catalyst Program Grant; University of Utah, Undergraduate Research Opportunities Program	This work was supported by Utah State University, Office of Research and Graduate Studies, the Research Catalyst Program Grant to JBM, and the University of Utah, Undergraduate Research Opportunities Program to BCT.	AARON JE, 1987, CLIN ORTHOP RELAT R, P260; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Barnett KR, 2006, HUM REPROD UPDATE, V12, P537, DOI 10.1093/humupd/dml022; Bohacek J, 2009, J NEUROENDOCRINOL, V21, P640, DOI 10.1111/j.1365-2826.2009.01882.x; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Cargill SL, 1999, BIOL REPROD, V61, P283, DOI 10.1095/biolreprod61.1.283; Carneiro RM, 2010, J CLIN ENDOCR METAB, V95, P1767, DOI 10.1210/jc.2009-1518; COOPER C, 1993, CALCIFIED TISSUE INT, V53, pS23, DOI 10.1007/BF01673397; Daniel JM, 2006, ENDOCRINOLOGY, V147, P607, DOI 10.1210/en.2005-0998; Ebeling PR, 1996, J CLIN ENDOCR METAB, V81, P3366, DOI 10.1210/jc.81.9.3366; FADDY MJ, 1987, CELL TISSUE KINET, V20, P551, DOI 10.1111/j.1365-2184.1987.tb01364.x; Farrokhi S, 2012, CLIN BIOMECH, V27, P384, DOI 10.1016/j.clinbiomech.2011.10.009; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; GOSDEN RG, 1978, EXP GERONTOL, V13, P159, DOI 10.1016/0531-5565(78)90008-6; Greising SM, 2011, EXP GERONTOL, V46, P685, DOI 10.1016/j.exger.2011.04.006; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Hernandez CJ, 2006, J BONE MINER RES, V21, P1248, DOI 10.1359/JBMR.060514; Iqbal J, 2012, ENDOCRINE, V41, P171, DOI 10.1007/s12020-012-9626-y; Jarvinen TLN, 2003, BONE, V32, P642, DOI 10.1016/S8756-3282(03)00100-5; JONES EC, 1961, J ENDOCRINOL, V21, P469, DOI 10.1677/joe.0.0210469; Kim BT, 2003, J BONE MINER RES, V18, P150, DOI 10.1359/jbmr.2003.18.1.150; Kontulainen SA, 2006, J CLIN ENDOCR METAB, V91, P2555, DOI 10.1210/jc.2006-0136; Lim SK, 1999, J BONE MINER RES, V14, P1189, DOI 10.1359/jbmr.1999.14.7.1189; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mason JB, 2011, AGING CELL, V10, P448, DOI 10.1111/j.1474-9726.2011.00691.x; Mason JB, 2010, EXP GERONTOL, V45, P435, DOI 10.1016/j.exger.2010.03.010; Mason JB, 2009, J GERONTOL A-BIOL, V64, P1207, DOI 10.1093/gerona/glp134; Olson EJ, 2007, BONE, V41, P282, DOI 10.1016/j.bone.2007.04.175; Onoe Y, 1997, ENDOCRINOLOGY, V138, P4509, DOI 10.1210/en.138.10.4509; Prior JC, 1998, ENDOCR REV, V19, P397, DOI 10.1210/er.19.4.397; Roman-Bias JA, 2009, ARTHRITIS RES THER, V11, P14; Roman-Blas JA, 2014, SEMIN ARTHRITIS RHEU, V43, P421, DOI 10.1016/j.semarthrit.2013.07.012; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Stenstrom M, 2000, J BIOMECH, V33, P289, DOI 10.1016/S0021-9290(99)00181-5; Syed FA, 2010, J BONE MINER RES, V25, P2438, DOI 10.1002/jbmr.129; THUNG PJ, 1956, ACTA ENDOCRINOL-COP, V23, P8, DOI 10.1530/acta.0.0230008; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504	40	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145821	10.1371/journal.pone.0145821	http://dx.doi.org/10.1371/journal.pone.0145821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717576	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500078
J	Gschwantler-Kaulich, D; Grunt, TW; Muhr, D; Wagner, R; Kolbl, H; Singer, CF				Gschwantler-Kaulich, Daphne; Grunt, Thomas W.; Muhr, Daniela; Wagner, Renate; Koelbl, Heinz; Singer, Christian F.			HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; IRREVERSIBLE INHIBITOR; EGF RECEPTOR; BIBW 2992; IN-VITRO; GROWTH; RESISTANCE; ACTIVATION; EXPRESSION; BLOCKER	Background HER-targeted tyrosine kinase inhibitors (TKIs) have demonstrated pro-apoptotic and antiproliferative effects in vitro and in vivo. The exact pathways through which TKIs exert their antineoplastic effects are, however, still not completely understood. Methods Using Milliplex assays, we have investigated the effects of the three panHER-TKIs lapatinib, canertinib and afatinib on signal transduction cascade activation in SKBR3, T47D and Jurkat neoplastic cell lines. The growth-inhibitory effect of blockade of HER and of JNK and STAT5 signaling was measured by proliferation-and apoptosis-assays using formazan dye labeling of viable cells, Western blotting for cleaved PARP-1 and immunolabeling for active caspase 3, respectively. Results All three HER-TKIs clearly inhibited proliferation and increased apoptosis in HER2 overexpressing SKBR3 cells, while their effect was less pronounced on HER2 moderately expressing T47D cells where they exerted only a weak antiproliferative and essentially no pro-apoptotic effect. Remarkably, phosphorylation/activation of JNK and STAT5A/B were inhibited by HER-TKIs only in the sensitive, but not in the resistant cells. In contrast, phosphorylation/activation of ERK/MAPK, STAT3, CREB, p70 S6 kinase, IkBa, and p38 were equally affected by HER-TKIs in both cell lines. Moreover, we demonstrated that direct pharmacological blockade of JNK and STAT5 abrogates cell growth in both HER-TKI-sensitive as well as -resistant breast cancer cells, respectively. Conclusion We have shown that HER-TKIs exert a HER2 expression-dependent anti-cancer effect in breast cancer cell lines. This involves blockade of JNK and STAT5A/B signaling, which have been found to be required for in vitro growth of these cell lines.	[Gschwantler-Kaulich, Daphne; Muhr, Daniela; Koelbl, Heinz; Singer, Christian F.] Med Univ Vienna, Dept OB GYN, Div Gynecol, Vienna, Austria; [Gschwantler-Kaulich, Daphne; Grunt, Thomas W.; Muhr, Daniela; Wagner, Renate; Koelbl, Heinz; Singer, Christian F.] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Grunt, Thomas W.; Wagner, Renate] Med Univ Vienna, Div Oncol, Signaling Networks Program, Dept Med 1, Vienna, Austria; [Grunt, Thomas W.] Ludwig Boltzmann Cluster Oncol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute	Gschwantler-Kaulich, D (corresponding author), Med Univ Vienna, Dept OB GYN, Div Gynecol, Vienna, Austria.	daphne.gschwantler-kaulich@meduniwien.ac.at		Grunt, Thomas/0000-0002-9899-5063				Brunner-Kubath C, 2011, BREAST CANCER RES TR, V129, P387, DOI 10.1007/s10549-010-1232-1; Brufsky A, 2010, AM J CLIN ONCOL-CANC, V33, P186, DOI 10.1097/COC.0b013e318191bfb0; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Grunt TW, 2005, BIOCHEM BIOPH RES CO, V329, P1253, DOI 10.1016/j.bbrc.2005.02.104; Kolb A, 2007, INT J CANCER, V120, P514, DOI 10.1002/ijc.22360; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Le XF, 2002, APOPTOSIS, V7, P483, DOI 10.1023/A:1020682807922; Lin NU, 2012, BREAST CANCER RES TR, V133, P1057, DOI 10.1007/s10549-012-2003-y; Maiello MR, 2007, BREAST CANCER RES TR, V102, P275, DOI 10.1007/s10549-006-9340-7; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Mendelsohn J, 2009, J CLIN ONCOL, V20, P1; Moasser MM, 2001, CANCER RES, V61, P7184; Moulder SL, 2001, CANCER RES, V61, P8887; Ocana A, 2009, CANCER TREAT REV, V35, P685, DOI 10.1016/j.ctrv.2009.08.001; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Puricelli L, 2002, INT J CANCER, V100, P642, DOI 10.1002/ijc.10533; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Rixe O, 2009, CANCER CHEMOTH PHARM, V64, P1139, DOI 10.1007/s00280-009-0975-z; Rocha-Lima Caio M, 2007, Cancer Control, V14, P295; Rubin BP, 2006, LAB INVEST, V86, P981, DOI 10.1038/labinvest.3700466; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Schuler M, 2012, BREAST CANCER RES TR, V134, P1149, DOI 10.1007/s10549-012-2126-1; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Sequist LV, 2007, ONCOLOGIST, V12, P325, DOI 10.1634/theoncologist.12-3-325; Slichenmyer WJ, 2001, SEMIN ONCOL; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Trinks C, 2011, BIOCHEM BIOPH RES CO, V410, P422, DOI 10.1016/j.bbrc.2011.05.148; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Wu CJ, 1999, DNA CELL BIOL, V18, P731, DOI 10.1089/104454999314872; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	36	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146311	10.1371/journal.pone.0146311	http://dx.doi.org/10.1371/journal.pone.0146311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735495	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100041
J	Olivero, J; Fa, JE; Farfan, MA; Lewis, J; Hewlett, B; Breuer, T; Carpaneto, GM; Fernandez, M; Germi, F; Hattori, S; Head, J; Ichikawa, M; Kitanaishi, K; Knights, J; Matsuura, N; Migliano, A; Nese, B; Noss, A; Ekoumou, DO; Paulin, P; Real, R; Riddell, M; Stevenson, EGJ; Toda, M; Vargas, JM; Yasuoka, H; Nasi, R				Olivero, Jesus; Fa, John E.; Farfan, Miguel A.; Lewis, Jerome; Hewlett, Barry; Breuer, Thomas; Carpaneto, Giuseppe M.; Fernandez, Maria; Germi, Francesco; Hattori, Shiho; Head, Josephine; Ichikawa, Mitsuo; Kitanaishi, Koichi; Knights, Jessica; Matsuura, Naoki; Migliano, Andrea; Nese, Barbara; Noss, Andrew; Ekoumou, Dieudonne Ongbwa; Paulin, Pascale; Real, Raimundo; Riddell, Mike; Stevenson, Edward G. J.; Toda, Mikako; Vargas, J. Mario; Yasuoka, Hirokazu; Nasi, Robert			Distribution and Numbers of Pygmies in Central African Forests	PLOS ONE			English	Article							CONSERVATION; MODELS; IMPACTS	Pygmy populations occupy a vast territory extending west-to-east along the central African belt from the Congo Basin to Lake Victoria. However, their numbers and actual distribution is not known precisely. Here, we undertake this task by using locational data and population sizes for an unprecedented number of known Pygmy camps and settlements (n = 654) in five of the nine countries where currently distributed. With these data we develop spatial distribution models based on the favourability function, which distinguish areas with favourable environmental conditions from those less suitable for Pygmy presence. Highly favourable areas were significantly explained by presence of tropical forests, and by lower human pressure variables. For documented Pygmy settlements, we use the relationship between observed population sizes and predicted favourability values to estimate the total Pygmy population throughout Central Africa. We estimate that around 920,000 Pygmies (over 60% in DRC) is possible within favourable forest areas in Central Africa. We argue that fragmentation of the existing Pygmy populations, alongside pressure from extractive industries and sometimes conflict with conservation areas, endanger their future. There is an urgent need to inform policies that can mitigate against future external threats to these indigenous peoples' culture and lifestyles.	[Olivero, Jesus; Farfan, Miguel A.; Real, Raimundo; Vargas, J. Mario] Univ Malaga, Fac Ciencias, Dept Biol Anim, Grp Biogeog Diversidad & Conservac, E-29071 Malaga, Spain; [Fa, John E.] Manchester Metropolitan Univ, Div Biol & Conservat Ecol, Sch Sci & Environm, Manchester M15 6BH, Lancs, England; [Fa, John E.] CIFOR Headquarters, Ctr Int Forestry Res CIFOR, Bogor, Indonesia; [Lewis, Jerome; Knights, Jessica; Migliano, Andrea] UCL, Dept Anthropol, London, England; [Hewlett, Barry] Washington State Univ, Dept Anthropol, Vancouver, WA USA; [Breuer, Thomas] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA; [Carpaneto, Giuseppe M.] Univ Rome Tre, Dipartimento Sci, I-00146 Rome, Italy; [Fernandez, Maria] Asociac Zerca & Lejos, Madrid, Spain; [Germi, Francesco] 46 Elm Row, Edinburgh, Midlothian, Scotland; [Hattori, Shiho] Tenri Univ, Fac Int Studies, Tenri, Nara, Japan; [Head, Josephine] Chameleon Strategy, London, England; [Kitanaishi, Koichi] Yamaguchi Univ, Fac Educ, Yamaguchi, Japan; [Matsuura, Naoki; Toda, Mikako] Kyoto Univ, Grad Sch Asian & African Area Studies, Sakyo Ku, Kyoto, Japan; [Nese, Barbara] COOPI Cooperaz Int ONG Onlus, Milan, Italy; [Noss, Andrew] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Ekoumou, Dieudonne Ongbwa] Univ Quebec, Inst Sante & Soc, Montreal, PQ H3C 3P8, Canada; [Paulin, Pascale] Univ Lyon 2, CNRS, DDL Lab, Lyon, France; [Riddell, Mike] Bioclimate Res & Dev, Edinburgh, Midlothian, Scotland; [Stevenson, Edward G. J.] Univ Durham, Dept Anthropol, Durham, England; [Yasuoka, Hirokazu] Hosei Univ, Fac Humanity & Environm, Chiyoda Ku, Tokyo, Japan; [Nasi, Robert] CIFOR Headquarters, CGIAR, Bogor, Indonesia	Universidad de Malaga; Manchester Metropolitan University; CGIAR; Center for International Forestry Research (CIFOR); University of London; University College London; Washington State University; Wildlife Conservation Society; Roma Tre University; Yamaguchi University; Kyoto University; State University System of Florida; University of Florida; University of Quebec; University of Quebec Montreal; Centre National de la Recherche Scientifique (CNRS); Universite Lyon 2; Durham University; Hosei University; CGIAR; Center for International Forestry Research (CIFOR)	Fa, JE (corresponding author), Univ Malaga, Fac Ciencias, Dept Biol Anim, Grp Biogeog Diversidad & Conservac, E-29071 Malaga, Spain.	jfa949@gmail.com	Olivero, Jesús/K-8727-2014; Real, Raimundo/E-6559-2010; Nasi, Robert/P-2382-2019; Farfan Aguilar, Miguel Angel/K-8783-2014	Olivero, Jesús/0000-0003-1714-0360; Real, Raimundo/0000-0002-6642-1284; Nasi, Robert/0000-0001-9739-3135; Stevenson, Edward/0000-0003-2018-8920; CARPANETO, Giuseppe Maria/0000-0002-6874-3463; Migliano, Andrea/0000-0003-4364-2735; YASUOKA, Hirokazu/0000-0001-5066-1534; Farfan Aguilar, Miguel Angel/0000-0002-4617-6517; FA, Julia Elizabeth/0000-0002-1572-9828	United States Agency for International Development (USAID); Department for International Development (DFID); Leverhulme Trust [RP2011-R-045]; Grants-in-Aid for Scientific Research [15H02598] Funding Source: KAKEN	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Department for International Development (DFID); Leverhulme Trust(Leverhulme Trust); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the United States Agency for International Development (USAID), Department for International Development (DFID) and the Leverhulme Trust (grant RP2011-R-045).	Acevedo P, 2012, NATURWISSENSCHAFTEN, V99, P515, DOI 10.1007/s00114-012-0926-0; [Anonymous], 2008, INT WORKSH UNESCO PA; [Anonymous], 2009, 51108ZR WORLD BANK; Bahuchet S., 1996, ALIMENTATION FORET T, P97; Barbosa AM, 2009, ECOL MODEL, V220, P747, DOI 10.1016/j.ecolmodel.2008.12.004; Beltran J., 2000, BEST PRACT PROTECT A, V4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Caruana R, 2004, P 10 ACM SIGKDD INT, P69, DOI 10.1145/1014052; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; Dounias E., 2006, Unasylva (English ed.), V57, P26; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P4765, DOI 10.1073/pnas.0611197104; Happold David, 2013, P57; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HART JA, 1978, HUM ECOL, V6, P325, DOI 10.1007/BF00889029; HEWLETT B, 1982, MAN, V17, P418, DOI 10.2307/2801706; Hewlett B. S., 2014, HUNTER GATHERERS CON; Hewlett BS, 2011, OXFORD HDB ARCHAEOLO, P936; Hoare AL, 2007, RESOURCE RIGHTS TIMB; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kesler DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125113; Knight J, 2003, AFR STUDY MONOGR S, V28, P81; Kohler A., 2002, ETHNICITY HUNTER GAT, P276; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Legendre P., 2012, NUMERICAL ECOLOGY; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MacDonald DH, 1999, CURR ANTHROPOL, V40, P501, DOI 10.1086/200047; Barbosa AM, 2013, DIVERS DISTRIB, V19, P1333, DOI 10.1111/ddi.12100; Ministere de l'Economie, 2014, EMPL DEV DUR CADR PL; Munoz AR, 2015, DIVERS DISTRIB, V21, P1388, DOI 10.1111/ddi.12352; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Njounan Tegomo O., 2012, AFR STUDY MONOGR, V43, P45; Papworth SK, 2012, METHODS ECOL EVOL, V3, P584, DOI 10.1111/j.2041-210X.2012.00189.x; Pourtier R., 1989, ESPACE HIST SOC; Rainforest Foundation-UK, 2015, MAPP RIGHTS PUTT COM; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Riddell M, 2013, CONSERV SOC, V11, P199, DOI 10.4103/0972-4923.121002; RUPP S, 2003, AFRICAN STUDY MONO S, V28, P37; Schnaiberg J, 2002, ENVIRON MANAGE, V30, P24, DOI 10.1007/s00267-002-2450-z; Sokal R. R, 1981, BIOMETRY; Tukey JW, 1977, EXPLORATORY DATA ANA; Turrero P, 2013, J ARCHAEOL SCI, V40, P4127, DOI 10.1016/j.jas.2013.06.003; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Verdu P, 2010, BIOL LETTERS, V6, P858, DOI 10.1098/rsbl.2010.0192; Wodon Q, 2012, INDIGENOUS PEOPLES, POVERTY, AND DEVELOPMENT, P118; Yasuoka H, 2006, HUM ECOL, V34, P275, DOI 10.1007/s10745-006-9017-1	49	16	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144499	10.1371/journal.pone.0144499	http://dx.doi.org/10.1371/journal.pone.0144499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26735953	gold, Green Published, Green Accepted			2022-12-27	WOS:000367805100009
J	Arefian, H; Vogel, M; Kwetkat, A; Hartmann, M				Arefian, Habibollah; Vogel, Monique; Kwetkat, Anja; Hartmann, Michael			Economic Evaluation of Interventions for Prevention of Hospital Acquired Infections: A Systematic Review	PLOS ONE			English	Review							CARE-ASSOCIATED INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; URINARY-TRACT-INFECTIONS; SURGICAL SITE INFECTION; NOSOCOMIAL INFECTIONS; URETHRAL CATHETERS; COST-EFFECTIVENESS; SURGERY; EFFICACY; QUALITY	Objective This systematic review sought to assess the costs and benefits of interventions preventing hospital-acquired infections and to evaluate methodological and reporting quality. Methods We systematically searched Medline via PubMed and the National Health Service Economic Evaluation Database from 2009 to 2014. We included quasi-experimental and randomized trails published in English or German evaluating the economic impact of interventions preventing the four most frequent hospital-acquired infections (urinary tract infections, surgical wound infections, pneumonia, and primary bloodstream infections). Characteristics and results of the included articles were extracted using a standardized data collection form. Study and reporting quality were evaluated using SIGN and CHEERS checklists. All costs were adjusted to 2013 US$. Savings-to-cost ratios and difference values with interquartile ranges (IQRs) per month were calculated, and the effects of study characteristics on the cost-benefit results were analyzed. Results Our search returned 2067 articles, of which 27 met the inclusion criteria. The median savings- to-cost ratio across all studies reporting both costs and savings values was US $7.0 (IQR 4.2-30.9), and the median net global saving was US $13,179 (IQR 5,106-65,850) per month. The studies' reporting quality was low. Only 14 articles reported more than half of CHEERS items appropriately. Similarly, an assessment of methodological quality found that only four studies (14.8%) were considered high quality. Conclusions Prevention programs for hospital acquired infections have very positive cost-benefit ratios. Improved reporting quality in health economics publications is required.	[Arefian, Habibollah; Hartmann, Michael] Jena Univ Hosp, CSCC, Jena, Germany; [Arefian, Habibollah; Hartmann, Michael] Jena Univ Hosp, Hosp Pharm, Jena, Germany; [Vogel, Monique] Jena Univ Hosp, Ctr Clin Studies, Jena, Germany; [Kwetkat, Anja] Jena Univ Hosp, Dept Geriatr Med, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Arefian, H (corresponding author), Jena Univ Hosp, CSCC, Jena, Germany.	Habibollah.Arefian@med.uni-jena.de	Hartmann, Michael/Y-2331-2019; Arefian, Habib/AAK-3701-2020	Arefian, Habib/0000-0002-8838-084X; Hartmann, Michael/0000-0002-6777-4540	German Ministry of Education and Research (BMBF) [01-E0-1002]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Funded by the German Ministry of Education and Research (BMBF) grant 01-E0-1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burden AR, 2012, J CLIN ANESTH, V24, P555, DOI 10.1016/j.jclinane.2012.04.006; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Clarke K, 2013, INT J QUAL HEALTH C, V25, P43, DOI 10.1093/intqhc/mzs077; Cohen ER, 2010, SIMUL HEALTHC, V5, P98, DOI 10.1097/SIH.0b013e3181bc8304; Dijksman LM, 2012, DIGEST SURG, V29, P384, DOI 10.1159/000343095; European Centre for Disease Prevention and Control, 2008, ANNUAL EPIDEMIOLOGIC; Farbman L, 2013, CLIN MICROBIOL INFEC, V19, pE582, DOI 10.1111/1469-0691.12280; Fraher MH, 2009, J HOSP INFECT, V73, P129, DOI 10.1016/j.jhin.2009.06.005; Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2; Gibsons Harbour Ferries, 2021, GIBS HARB FERR; Gulluoglu BM, 2013, ANN SURG, V257, P37, DOI 10.1097/SLA.0b013e31826d832d; HALEY RW, 1991, AM J MED, V91, pS32, DOI 10.1016/0002-9343(91)90341-T; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Harris BD, 2011, HEALTH AFFAIR, V30, P1751, DOI 10.1377/hlthaff.2010.1282; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Liau KH, 2010, SURG INFECT, V11, P151, DOI 10.1089/sur.2008.081; Liu Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009413.pub2; Mathur P, 2013, INDIAN J MED RES, V137, P111; Mian Amir, 2012, J Ark Med Soc, V109, P128; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nakamura T, 2013, SURGERY, V153, P576, DOI 10.1016/j.surg.2012.11.018; Nicolle L, WHO PREVENTION HOSP; Nthumba PM, 2010, BRIT J SURG, V97, P1621, DOI 10.1002/bjs.7213; Nyman MH, 2013, INT J NURS STUD, V50, P1589, DOI 10.1016/j.ijnurstu.2013.05.007; Granda MJP, 2013, J HOSP INFECT, V85, P312, DOI 10.1016/j.jhin.2013.08.006; Phillips P, 2009, LEVELS EVIDENCE GRAD; Pickard R, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI [10.3310/hta16470, 10.3310/jta16470]; Piednoir E, 2011, CRIT CARE MED, V39, P2672, DOI 10.1097/CCM.0b013e31822827e0; Raschka S, 2013, AM J INFECT CONTROL, V41, P773, DOI 10.1016/j.ajic.2012.10.026; Schwebel C, 2012, CRIT CARE MED, V40, P11, DOI 10.1097/CCM.0b013e31822f0604; Scott R.D., 2009, DIRECT MED COSTS HEA; Singh S, 2012, INT J QUAL HEALTH C, V24, P641, DOI 10.1093/intqhc/mzs059; Sona Carrie S, 2009, J Intensive Care Med, V24, P54, DOI 10.1177/0885066608326972; Speroni KG, 2011, NURS ECON, V29, P15; Stone PW, 2002, AM J INFECT CONTROL, V30, P145, DOI 10.1067/mic.2002.121099; Teshima H, 2009, SURG TODAY, V39, P848, DOI 10.1007/s00595-008-3974-5; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912; van den Broek PJ, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-10; Waters HR, 2011, AM J MED QUAL, V26, P333, DOI 10.1177/1062860611410685; Weight CJ, 2010, UROLOGY, V76, P15, DOI 10.1016/j.urology.2010.01.017; Zhou ZJ, 2011, CHINESE MED J-PEKING, V124, P699, DOI 10.3760/cma.j.issn.0366-6999.2011.05.012; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	44	31	44	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146381	10.1371/journal.pone.0146381	http://dx.doi.org/10.1371/journal.pone.0146381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731736	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400165
J	Honda, Y; Imajo, K; Kato, T; Kessoku, T; Ogawa, Y; Tomeno, W; Kato, S; Mawatari, H; Fujita, K; Yoneda, M; Saito, S; Nakajima, A				Honda, Yasushi; Imajo, Kento; Kato, Takayuki; Kessoku, Takaomi; Ogawa, Yuji; Tomeno, Wataru; Kato, Shingo; Mawatari, Hironori; Fujita, Koji; Yoneda, Masato; Saito, Satoru; Nakajima, Atsushi			The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; TRIGLYCERIDE TRANSFER PROTEIN; TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; LIPID-METABOLISM; PPAR-ALPHA; INFLAMMATION	Background & Aims In recent years, nonalcoholic steatohepatitis (NASH) has become a considerable healthcare burden worldwide. Pathogenesis of NASH is associated with type 2 diabetes mellitus (T2DM) and insulin resistance. However, a specific drug to treat NASH is lacking. We investigated the effect of the selective sodium glucose cotransporter 2 inhibitor (SGLT2I) ipragliflozin on NASH in mice. Methods We used the Amylin liver NASH model (AMLN), which is a diet-induced model of NASH that results in obesity and T2DM. AMLN mice were fed an AMLN diet for 20 weeks. SGLT2I mice were fed an AMLN diet for 12 weeks and an AMLN diet with 40 mg ipragliflozin/kg for 8 weeks. Results AMLN mice showed steatosis, inflammation, and fibrosis in the liver as well as obesity and insulin resistance, features that are recognized in human NASH. Ipragliflozin improved insulin resistance and liver injury. Ipragliflozin decreased serum levels of free fatty acids, hepatic lipid content, the number of apoptotic cells, and areas of fibrosis; it also increased lipid outflow from the liver. Conclusions Ipragliflozin improved the pathogenesis of NASH by reducing insulin resistance and lipotoxicity in NASH-model mice. Our results suggest that ipragliflozin has a therapeutic effect on NASH with T2DM.	[Honda, Yasushi; Imajo, Kento; Kato, Takayuki; Kessoku, Takaomi; Ogawa, Yuji; Tomeno, Wataru; Kato, Shingo; Mawatari, Hironori; Fujita, Koji; Yoneda, Masato; Saito, Satoru; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa 232, Japan	Yokohama City University	Nakajima, A (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa 232, Japan.	nakajima-tky@umin.ac.jp	Imajo, Kento/AAF-5744-2020	Imajo, Kento/0000-0002-1931-6326; Kessoku, Takaomi/0000-0002-5587-1386				Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Brunt EM, 2009, CLIN LIVER DIS, V13, P533, DOI 10.1016/j.cld.2009.07.008; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Corey KE, 2014, CLIN LIVER DIS, V18, P1, DOI 10.1016/j.cld.2013.09.019; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Dunn Winston, 2008, Curr Gastroenterol Rep, V10, P67, DOI 10.1007/s11894-008-0011-1; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fonseca VA, 2013, J DIABETES COMPLICAT, V27, P268, DOI 10.1016/j.jdiacomp.2012.11.005; Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094; Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; Grasselli E, 2014, J PHYSIOL BIOCHEM, V70, P341, DOI 10.1007/s13105-013-0308-x; Hayashizaki-Someya Y, 2015, EUR J PHARMACOL, V754, P19, DOI 10.1016/j.ejphar.2015.02.009; Imamura M, 2012, BIOORGAN MED CHEM, V20, P3263, DOI 10.1016/j.bmc.2012.03.051; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Kashiwagi A, 2015, DIABETES OBES METAB, V17, P304, DOI 10.1111/dom.12331; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lattuada G, 2011, CURR DIABETES REP, V11, P167, DOI 10.1007/s11892-011-0190-2; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Navasa M, 1998, J LIPID RES, V39, P1220; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Susca M, 2001, DIGEST LIVER DIS, V33, P768, DOI 10.1016/S1590-8658(01)80694-0; Tahara A, 2014, J PHARM PHARMACOL, V66, P975, DOI 10.1111/jphp.12223; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Tahara A, 2012, J PHARMACOL SCI, V120, P36, DOI 10.1254/jphs.12089FP; Tahara A, 2012, N-S ARCH PHARMACOL, V385, P423, DOI 10.1007/s00210-011-0713-z; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Yilmaz Y, 2014, CLIN LIVER DIS, V18, P19, DOI 10.1016/j.cld.2013.09.018; Yokono M, 2014, EUR J PHARMACOL, V727, P66, DOI 10.1016/j.ejphar.2014.01.040; Zhang L, 2010, DIABETES OBES METAB, V12, P510, DOI 10.1111/j.1463-1326.2010.01216.x	55	114	126	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146337	10.1371/journal.pone.0146337	http://dx.doi.org/10.1371/journal.pone.0146337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731267	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400153
J	Park, JY; Murakami, T; Lee, JY; Zhang, Y; Hoffman, RM; Bouvet, M				Park, Jeong Youp; Murakami, Takashi; Lee, Jin Young; Zhang, Yong; Hoffman, Robert M.; Bouvet, Michael			Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models	PLOS ONE			English	Article							CONJUGATED QUANTUM DOTS; PANCREATIC-CANCER; CEA ANTIBODY; COLORECTAL-CANCER; GUIDED SURGERY; TUMOR; EXPRESSION; RESECTION; IGF-1R; POLYPS	Fluorescent-antibody targeting of metastatic cancer has been demonstrated by our laboratory to enable tumor visualization and effective fluorescence-guided surgery. The goal of the present study was to determine whether insulin-like growth factor-1 receptor (IGF-1R) antibodies, conjugated with bright fluorophores, could enable visualization of metastatic colon cancer in orthotopic nude mouse models. IGF-1R antibody (clone 24-31) was conjugated with 550 nm, 650 nm or PEGylated 650 nm fluorophores. Subcutaneous, orthotopic, and liver metastasis models of colon cancer in nude mice were targeted with the fluorescent IGF-1R antibodies. Western blotting confirmed the expression of IGF-1R in HT-29 and HCT 116 human colon cancer cell lines, both expressing green fluorescent protein (GFP). Labeling with fluorophore-conjugated IGF-1R antibody demonstrated fluorescent foci on the membrane of colon cancer cells. Subcutaneously-and orthotopically-transplanted HT-29GFP and HCT 116-GFP tumors brightly fluoresced at the longer wavelengths after intravenous administration of fluorescent IGF-1R antibodies. Orthotopically-transplanted HCT 116-GFP tumors were brightly labeled by fluorescent IGF-1R antibodies such that they could be imaged non-invasively at the longer wavelengths. In an experimental liver metastasis model, IGF-1R antibodies conjugated with PEGylated 650 nm fluorophores selectively highlighted the liver metastases, which could then be non-invasively imaged. The IGF-1R fluorescent-antibody labeled liver metastases were very bright compared to the normal liver and the fluorescent-antibody label co-located with green fluorescent protein (GFP) expression of the colon cancer cells. The present study thus demonstrates that fluorophore-conjugated IGF-1R antibodies selectively visualize metastatic colon cancer and have clinical potential for improved diagnosis and fluorescence-guided surgery.	[Park, Jeong Youp; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Park, Jeong Youp; Murakami, Takashi; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Park, Jeong Youp; Lee, Jin Young] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Murakami, Takashi] Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan; [Bouvet, Michael] VA San Diego Healthcare Syst, Surg Serv, San Diego, CA USA	University of California System; University of California San Diego; Anti Cancer Inc; Yonsei University; Yonsei University Health System; Yokohama City University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	mbouvet@ucsd.edu		Murakami, Takashi/0000-0002-9429-5705; Park, Jeong Youp/0000-0003-0110-8606	National Cancer Institute [CA142669, CA132971]; AntiCancer, Inc.; Korea Research Foundation under the basic research promotion fund of the Ministry of Education and Health Resources Development of Korea [2010-0022990]; National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AntiCancer, Inc.(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Korea Research Foundation under the basic research promotion fund of the Ministry of Education and Health Resources Development of Korea(Ministry of Education (MOE), Republic of Korea); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Cancer Institute CA142669 and CA132971, to MB and AntiCancer, Inc., and a grant from the Korea Research Foundation under the basic research promotion fund of the Ministry of Education and Health Resources Development of Korea 2010-0022990 to JYP. The National Cancer Institute provided support in the form of salaries for author MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Aloia TA, 2006, ARCH SURG-CHICAGO, V141, P460, DOI 10.1001/archsurg.141.5.460; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Cao HST, 2012, HEPATO-GASTROENTEROL, V59, P1994, DOI 10.5754/hge11836; Donadon Matteo, 2007, Gastrointest Cancer Res, V1, P20; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; Heskamp S, 2012, MOL PHARMACEUT, V9, P2314, DOI 10.1021/mp300232n; Hiroshima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114310; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Koda M, 2004, ANN NY ACAD SCI, V1030, P377, DOI 10.1196/annals.1329.047; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Maawy AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121989; Maawy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097965; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, J AM COLL SURGEONS, V219, P132, DOI 10.1016/j.jamcollsurg.2014.02.021; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Metildi CA, 2013, ANN SURG ONCOL, V20, pS693, DOI 10.1245/s10434-013-3172-6; Metildi CA, 2012, J AM COLL SURGEONS, V214, P997, DOI 10.1016/j.jamcollsurg.2012.02.009; Park JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122100; Peters G, 2003, VIRCHOWS ARCH, V443, P139, DOI 10.1007/s00428-003-0856-5; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Shan HB, 2011, TECHNOL CANCER RES T, V10, P381, DOI 10.7785/tcrt.2012.500215; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Takahari D, 2009, ONCOLOGY-BASEL, V76, P42, DOI 10.1159/000178164; Uchugonova A, 2013, J CELL BIOCHEM, V114, P99, DOI 10.1002/jcb.24305; van der Vorst JR, 2013, CANCER-AM CANCER SOC, V119, P3411, DOI 10.1002/cncr.28203; Wilky BA, 2015, BRIT J CANCER, V112, P24, DOI 10.1038/bjc.2014.515; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yang M, 2007, CANCER RES, V67, P5195, DOI 10.1158/0008-5472.CAN-06-4590; Zhang H, 2009, BRIT J CANCER, V101, P71, DOI 10.1038/sj.bjc.6605103; Zhang H, 2009, BREAST CANCER RES TR, V114, P277, DOI 10.1007/s10549-008-0014-5	40	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146504	10.1371/journal.pone.0146504	http://dx.doi.org/10.1371/journal.pone.0146504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731105	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400187
J	Smith, RC; Amiaz, R; Si, TM; Maayan, L; Jin, H; Boules, S; Sershen, H; Li, CB; Ren, JJ; Liu, YH; Youseff, M; Lajtha, A; Guidotti, A; Weiser, M; Davis, JM				Smith, Robert C.; Amiaz, Revital; Si, Tian-Mei; Maayan, Lawrence; Jin, Hua; Boules, Sylvia; Sershen, Henry; Li, Chunbo; Ren, Juanjuan; Liu, Yanhong; Youseff, Mary; Lajtha, Abel; Guidotti, Alessandro; Weiser, Mark; Davis, John M.			Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial	PLOS ONE			English	Article							RECEPTOR PARTIAL AGONIST; SUSTAINED-RELEASE BUPROPION; NICOTINE NASAL SPRAY; ACETYLCHOLINE-RECEPTOR; TRANSDERMAL NICOTINE; CIGARETTE-SMOKING; GENERAL-PRACTICE; CESSATION; PLACEBO; ALPHA-4-BETA-2	Schizophrenic patients have a high rate of smoking and cognitive deficits which may be related to a decreased number or responsiveness of nicotinic receptors in their brains. Varenicline is a partial nicotinic agonist which is effective as an antismoking drug in cigarette smokers, although concerns have been raised about potential psychiatric side-effects. We conducted a double-blind placebo controlled study in 87 schizophrenic smokers to evaluate the effects of varenicline (2 mg/day) on measures of smoking, cognition, psychiatric symptoms, and side-effects in schizophrenic patients who were cigarette smokers. Varenicline significantly decreased cotinine levels (P<0.001), and other objective and subjective measures of smoking (P < .01), and responses on a smoking urges scale (P = .02), more than placebo. Varenicline did not improve scores on a cognitive battery designed to test the effect of drugs on cognitive performance in schizophrenia (the MATRICS battery), either in overall MATRICS battery Composite or individual Domain scores, more than placebo. There were no significant differences between varenicline vs. placebo effects on total symptom scores on psychiatric rating scales, PANSS, SANS, or Calgary Depression scales, and there were no significant drug effects in any of these scales sub-scores when we used Benjamin-Hochberg corrected significance levels (alpha = .05). Varenicline patients did not show greater side-effects than placebo treated patients at any time point when controlled for baseline side-effect scores. Our study supports the use of varenicline as a safe drug for smoking reduction in schizophrenia but not as a cognitive enhancer.	[Smith, Robert C.; Boules, Sylvia; Sershen, Henry; Youseff, Mary; Lajtha, Abel] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Smith, Robert C.; Sershen, Henry; Lajtha, Abel] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Amiaz, Revital; Weiser, Mark] Chaim Sheba Med Ctr, Ramat Gan, Israel; [Amiaz, Revital; Weiser, Mark] Sackler Sch Med, Tel Aviv, Israel; [Si, Tian-Mei; Liu, Yanhong] Peking Univ, Inst Mental Hlth, Key Lab Mental Hlth, Minist Hlth, Beijing 100871, Peoples R China; [Guidotti, Alessandro; Davis, John M.] Univ Illinois, Inst Psychiat, Chicago, IL USA; [Jin, Hua] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Jin, Hua] VA San Diego Healthcare Syst, San Diego, CA USA; [Li, Chunbo; Ren, Juanjuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China; [Maayan, Lawrence] Albany Med Ctr, Albany, NY USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Peking University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Shanghai Jiao Tong University; Albany Medical College	Smith, RC (corresponding author), Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.	rsmith@nki.rfmh.org	Amiaz, Revital/AAK-4576-2021; liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; jin, hua/AAX-1569-2020	Li, Chunming/0000-0002-4159-7048	Stanley Medical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093348] Funding Source: NIH RePORTER	Stanley Medical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from Stanley Medical Research Foundation (www.stanelyresearch.org). Pfizer Pharmaceuticals (Pfizer.com) supplied active and placebo varenicline. The design of the study and analysis of the data was done independently by the principal investigator. The Stanley Foundation and Pfizer received reports of the analysis of the study but had no other role in the presentation of data at meetings or writing of the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Anthenelli RM, 2013, ANN INTERN MED, V159, P390, DOI 10.7326/0003-4819-159-6-201309170-00005; Atbasoglu EC, 2003, PSYCHOPATHOLOGY, V36, P263, DOI 10.1159/000073452; Barr RS, 2008, NEUROPSYCHOPHARMACOL, V33, P480, DOI 10.1038/sj.npp.1301423; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buggy Y, 2013, DRUG SAFETY, V36, P521, DOI 10.1007/s40264-013-0046-6; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Depatie L, 2002, NEUROPSYCHOPHARMACOL, V27, P1056, DOI 10.1016/S0893-133X(02)00372-X; Etter JF, 2003, NEUROPSYCHOPHARMACOL, V28, P359, DOI 10.1038/sj.npp.1300030; Evins AE, 2008, J CLIN PSYCHIAT, V69, P1016, DOI 10.4088/JCP.v69n0620a; Evins AE, 2007, J CLIN PSYCHOPHARM, V27, P380, DOI 10.1097/01.jcp.0b013e3180ca86fa; Evins AE, 2014, JAMA-J AM MED ASSOC, V311, P145, DOI 10.1001/jama.2013.285113; Evins AE, 2005, J CLIN PSYCHOPHARM, V25, P218, DOI 10.1097/01.jcp.0000162802.54076.18; Foulds J, 2013, NICOTINE TOB RES, V21, P21; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Freedman R, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07020326; George TP, 2002, NEUROPSYCHOPHARMACOL, V26, P75, DOI 10.1016/S0893-133X(01)00296-2; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hong LE, 2011, ARCH GEN PSYCHIAT, V68, P1195, DOI 10.1001/archgenpsychiatry.2011.83; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Jubelt LE, 2008, PSYCHOPHARMACOLOGY, V199, P89, DOI 10.1007/s00213-008-1133-8; Kasliwal R, 2009, DRUG SAFETY, V32, P499, DOI 10.2165/00002018-200932060-00006; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2011, SCHIZOPHR RES, V125, P161, DOI 10.1016/j.schres.2010.09.015; Kern R, 2008, MATRICS CONSENSUS 2; Kern RS, 2008, AM J PSYCHIAT, V165, P214, DOI 10.1176/appi.ajp.2007.07010043; Lancon C, 2000, SCHIZOPHR RES, V42, P231, DOI 10.1016/S0920-9964(99)00129-2; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Levin ED, 1996, NEUROPSYCHOPHARMACOL, V15, P429, DOI 10.1016/S0893-133X(96)00018-8; Liu ME, 2011, PSYCHIAT RES, V190, P79, DOI 10.1016/j.psychres.2011.04.018; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Morstad AE, 2008, ANN PHARMACOTHER, V42, P288, DOI 10.1345/aph.1K511; Nides M, 2006, ARCH INTERN MED, V166, P1561, DOI 10.1001/archinte.166.15.1561; Pachas GN, 2012, J DUAL DIAGN, V8, P117, DOI 10.1080/15504263.2012.663675; Patterson F, 2009, BIOL PSYCHIAT, V65, P144, DOI 10.1016/j.biopsych.2008.08.028; Philip NS, 2009, J CLIN PSYCHIAT, V70, P1026, DOI 10.4088/JCP.08m04441; Rajji TK, 2013, AM J GERIAT PSYCHIAT, V21, P108, DOI 10.1016/j.jagp.2012.10.011; Roh S, 2014, PSYCHOPHARMACOLOGY, V231, P765, DOI 10.1007/s00213-013-3286-3; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Roseberry JE, 2014, SCHIZOPHR RES, V159, P188, DOI 10.1016/j.schres.2014.08.004; Shim JC, 2012, NEUROPSYCHOPHARMACOL, V37, P660, DOI 10.1038/npp.2011.238; Smith RC, 2006, NEUROPSYCHOPHARMACOL, V31, P637, DOI 10.1038/sj.npp.1300881; Smith RC, 2002, NEUROPSYCHOPHARMACOL, V27, P479, DOI 10.1016/S0893-133X(02)00324-X; Smith RC, 2002, SUBST ABUS, V22, P479; Smith RC, 2009, SCHIZOPHR RES, V110, P149, DOI 10.1016/j.schres.2009.02.001; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; Wallace TL, 2013, EXPERT OPIN THER TAR, V17, P139, DOI 10.1517/14728222.2013.736498; Weiner E, 2010, NEUROPSYCHOPHARMACOL, V35, P2274, DOI 10.1038/npp.2010.101; Williams JM, 2012, J CLIN PSYCHIAT, V73, P654, DOI 10.4088/JCP.11m07522; Wing VC, 2013, SCHIZOPHR RES, V149, P190, DOI 10.1016/j.schres.2013.06.032	57	48	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0143490	10.1371/journal.pone.0143490	http://dx.doi.org/10.1371/journal.pone.0143490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730716	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400006
J	Szokoli, F; Sabaneyeva, E; Castelli, M; Krenek, S; Schrallhammer, M; Soares, CAG; da Silva-Neto, ID; Berendonk, TU; Petroni, G				Szokoli, Franziska; Sabaneyeva, Elena; Castelli, Michele; Krenek, Sascha; Schrallhammer, Martina; Soares, Carlos A. G.; da Silva-Neto, Inacio D.; Berendonk, Thomas U.; Petroni, Giulio			"Candidatus Fokinia solitaria", a Novel "Stand-Alone" Symbiotic Lineage of Midichloriaceae (Rickettsiales)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; TARGETED OLIGONUCLEOTIDE PROBES; TICK IXODES-RICINUS; BACTERIAL ENDOSYMBIONTS; HARD TICKS; IN-SITU; ESCHERICHIA-COLI; GENOME SEQUENCE; AUTOPHAGY; MITOCHONDRII	Recently, the family Midichloriaceae has been described within the bacterial order Rickettsiales. It includes a variety of bacterial endosymbionts detected in different metazoan host species belonging to Placozoa, Cnidaria, Arthropoda and Vertebrata. Representatives of Midichloriaceae are also considered possible etiological agents of certain animal diseases. Midichloriaceae have been found also in protists like ciliates and amoebae. The present work describes a new bacterial endosymbiont, "Candidatus Fokinia solitaria", retrieved from three different strains of a novel Paramecium species isolated from a wastewater treatment plant in Rio de Janeiro (Brazil). Symbionts were characterized through the full-cycle rRNA approach: SSU rRNA gene sequencing and fluorescence in situ hybridization (FISH) with three species-specific oligonucleotide probes. In electron micrographs, the tiny rod-shaped endosymbionts (1.2 x 0.25-0.35 mu m in size) were not surrounded by a symbiontophorous vacuole and were located in the peripheral host cytoplasm, stratified in the host cortex in between the trichocysts or just below them. Frequently, they occurred inside autolysosomes. Phylogenetic analyses of Midichloriaceae apparently show different evolutionary pathways within the family. Some genera, such as "Ca. Midichloria" and "Ca. Lariskella", have been retrieved frequently and independently in different hosts and environmental surveys. On the contrary, others, such as Lyticum, "Ca. Anadelfobacter", "Ca. Defluviella" and the presently described "Ca. Fokinia solitaria", have been found only occasionally and associated to specific host species. These last are the only representatives in their own branches thus far. Present data do not allow to infer whether these genera, which we named "stand-alone lineages", are an indication of poorly sampled organisms, thus under-represented in GenBank, or represent fast evolving, highly adapted evolutionary lineages.	[Szokoli, Franziska; Krenek, Sascha; Berendonk, Thomas U.] Tech Univ Dresden, Inst Hydrobiol, D-01062 Dresden, Germany; [Szokoli, Franziska; Castelli, Michele; Petroni, Giulio] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Sabaneyeva, Elena] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg 199034, Russia; [Schrallhammer, Martina] Univ Freiburg, Inst Biol 2, Mikrobiol, Freiburg, Germany; [Soares, Carlos A. G.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [da Silva-Neto, Inacio D.] Univ Fed Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil	Technische Universitat Dresden; University of Pisa; Saint Petersburg State University; University of Freiburg; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Petroni, G (corresponding author), Univ Pisa, Dipartimento Biol, Pisa, Italy.	giulio.petroni@unipi.it	Krenek, Sascha/M-7294-2015; Petroni, Giulio/B-6086-2008; Schrallhammer, Martina/AAZ-5894-2020; Castelli, Michele/CAF-8503-2022; Soares, Carlos A G/H-9464-2016; Sabaneyeva, Elena/AAP-1699-2020	Krenek, Sascha/0000-0002-5062-4140; Petroni, Giulio/0000-0001-9572-9897; Schrallhammer, Martina/0000-0003-2061-2998; Soares, Carlos A G/0000-0001-9058-9266; Silva-Neto, Inacio Domingos/0000-0003-0431-7681; Sabaneyeva, Elena/0000-0002-7939-8263; Castelli, Michele/0000-0003-2177-5772	European Commission FP7-PEOPLE-IRSES project CINAR PATHOBACTER [247658]; European Commission FP7-PEOPLE-IRSES project CARBALA [295176]; COST action [BM1102]; PRIN fellowship from the Italian Research Ministry (MIUR) [2012A4F828_002]; Volkswagen foundation [84816]; RFFI [15-04-06410]; SPbU grant [1.42.1454.2015]	European Commission FP7-PEOPLE-IRSES project CINAR PATHOBACTER; European Commission FP7-PEOPLE-IRSES project CARBALA; COST action(European Cooperation in Science and Technology (COST)); PRIN fellowship from the Italian Research Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR)); Volkswagen foundation(Volkswagen); RFFI(Russian Foundation for Basic Research (RFBR)); SPbU grant	This work was supported by: European Commission FP7-PEOPLE-2009-IRSES project CINAR PATHOBACTER (247658): mobility support to GP ES FS MS SK; European Commission FP7-PEOPLE-2011-IRSES project CARBALA (295176): mobility support to ES; COST action BM1102: mobility support to FS; PRIN fellowship (protocol 2012A4F828_002) from the Italian Research Ministry (MIUR) to GP, Volkswagen foundation (project number 84816) to MS, RFFI grant number 15-04-06410 and the SPbU grant 1.42.1454.2015 to ES: general research costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Ahantarig A, 2013, FOLIA MICROBIOL, V58, P419, DOI 10.1007/s12223-013-0222-1; AMANN R, 1991, NATURE, V351, P161, DOI 10.1038/351161a0; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Bazzocchi C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-350; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Boscaro V, 2013, SCI REP-UK, V3, DOI 10.1038/srep03305; Boscaro V, 2013, MICROB ECOL, V65, P302, DOI 10.1007/s00248-012-0170-3; Boscaro V, 2013, MICROB ECOL, V65, P255, DOI 10.1007/s00248-012-0110-2; Cafiso A, 2016, J FISH DIS, V39, P497, DOI 10.1111/jfd.12371; Campoy E, 2009, CURR TOP MICROBIOL, V335, P227, DOI 10.1007/978-3-642-00302-8_11; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CURDS CR, 1982, ANNU REV MICROBIOL, V36, P27, DOI 10.1146/annurev.mi.36.100182.000331; CURDS CR, 1963, J GEN MICROBIOL, V33, P357, DOI 10.1099/00221287-33-3-357; CURDS CR, 1969, WATER RES, V3, P853, DOI 10.1016/0043-1354(69)90054-2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dergousoff SJ, 2011, VET MICROBIOL, V150, P100, DOI 10.1016/j.vetmic.2011.01.018; Dowd SE, 1998, APPL ENVIRON MICROB, V64, P3332; Driscoll T, 2013, GENOME BIOL EVOL, V5, P621, DOI 10.1093/gbe/evt036; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Emelyanov VV, 2001, BIOSCIENCE REP, V21, P1, DOI 10.1023/A:1010409415723; Epis S, 2008, PARASITOLOGY, V135, P485, DOI 10.1017/S0031182007004052; Erickson DL, 2009, J MED ENTOMOL, V46, P1532, DOI 10.1603/033.046.0642; Eschbach E, 2009, SYST APPL MICROBIOL, V32, P490, DOI 10.1016/j.syapm.2009.07.004; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Ferrantini F, 2009, J EUKARYOT MICROBIOL, V56, P119, DOI 10.1111/j.1550-7408.2008.00377.x; Fok A.K., 1988, P301; Fokin Sergei I., 2011, Protistology, V6, P227; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Friedman CS, 2000, INT J SYST EVOL MICR, V50, P847, DOI 10.1099/00207713-50-2-847; Friedrich N, 2012, MICROBIOL MOL BIOL R, V76, P707, DOI 10.1128/MMBR.00024-12; Fritsche TR, 1999, APPL ENVIRON MICROB, V65, P206; Fujishima M, 2009, MICROBIOL MONOGR, V12, P201, DOI 10.1007/978-3-540-92677-1_8; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024857; Gerba CP, 2005, J ENVIRON QUAL, V34, P42; Gillespie JJ, 2012, INTERCELLULAR PATHOGENS II: RICKETTSIALES, P84, DOI 10.1128/9781555817336.ch3; Gortz HD, 2009, MICROBIOL MONOGR, V12, P131, DOI 10.1007/978-3-540-92677-1_6; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; GORTZ HD, 1991, ENDOCYT CELL RES, V8, P45; Gray MW, 2001, GENOME BIOL, V2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harrus S, 2011, CLIN MICROBIOL INFEC, V17, P459, DOI 10.1111/j.1469-0691.2010.03316.x; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; Hilbi H, 2011, ENV MICROBIOL REP, V3, P286, DOI 10.1111/j.1758-2229.2011.00247.x; Hine PM, 2002, DIS AQUAT ORGAN, V49, P207, DOI 10.3354/dao049207; Hoffmann C, 2014, CELL MICROBIOL, V16, P15, DOI 10.1111/cmi.12235; Hollants J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2659; Hornok S, 2008, VET PARASITOL, V154, P354, DOI 10.1016/j.vetpar.2008.03.019; Kang YJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0167-2; Kawafune K, 2014, PHYCOLOGIA, V53, P95, DOI 10.2216/13-193.1; Kawafune K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031749; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Kim E, 2010, ISME J, V4, P1108, DOI 10.1038/ismej.2010.40; Kodama Y, 2010, MICROBIOLOGY SERIES, P95; Krenek S, 2011, EUR J PROTISTOL, V47, P124, DOI 10.1016/j.ejop.2010.12.001; Kuo RC, 2013, PROTIST, V164, P60, DOI 10.1016/j.protis.2012.08.004; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Liu LM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-310; Lloyd SJ, 2008, DIS AQUAT ORGAN, V82, P111, DOI 10.3354/dao01969; Lo N, 2006, ENVIRON MICROBIOL, V8, P1280, DOI 10.1111/j.1462-2920.2006.01024.x; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Pareja MEM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00054; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Mariconti M, 2012, PATHOG GLOB HEALTH, V106, P391, DOI 10.1179/2047773212Y.0000000050; Martijn J, 2015, ISME J, V9, P2373, DOI 10.1038/ismej.2015.46; Matsuura Y, 2012, APPL ENVIRON MICROB, V78, P4149, DOI 10.1128/AEM.00673-12; McQuiston JH, 2012, INTERCELLULAR PATHOGENS II: RICKETTSIALES, P40, DOI 10.1128/9781555817336.ch2; Mediannikov O Iu, 2004, Zh Mikrobiol Epidemiol Immunobiol, P7; Mediannikov O, 2014, STAND GENOMIC SCI, V9, DOI 10.1186/1944-3277-9-9; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Mura M, 2006, APPL ENVIRON MICROB, V72, P854, DOI 10.1128/AEM.72.1.854-859.2006; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Petroni G, 2002, MOL PHYLOGENET EVOL, V22, P118, DOI 10.1006/mpev.2001.1030; PREER JR, 1974, BACTERIOL REV, V38, P113, DOI 10.1128/MMBR.38.2.113-163.1974; PREER JR, 1982, INT J SYST BACTERIOL, V32, P140, DOI 10.1099/00207713-32-1-140; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Richard S, 2009, CLIN MICROBIOL INFEC, V15, P84, DOI 10.1111/j.1469-0691.2008.02244.x; Rikihisa Y, 2003, J CLIN MICROBIOL, V41, P5294, DOI 10.1128/JCM.41.11.5294-5297.2003; Rikihisa Y, 2003, ANN NY ACAD SCI, V990, P548, DOI 10.1111/j.1749-6632.2003.tb07425.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Sabaneyeva EV, 2009, PROTIST, V160, P205, DOI 10.1016/j.protis.2008.11.006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; Sassera D, 2011, MOL BIOL EVOL, V28, P3285, DOI 10.1093/molbev/msr159; Schmidt EW, 2013, PLOS ONE, DOI [10.1371/journal.pone.0080822, DOI 10.1371/J0URNAL.P0NE.0080822]; Schrallhammer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072581; Schrallhammer M, 2011, MICROB ECOL, V61, P455, DOI 10.1007/s00248-010-9772-9; Schulz F, 2016, ENVIRON MICROBIOL, V18, P2326, DOI 10.1111/1462-2920.12881; Senra MVX, 2016, MICROB ECOL, V71, P505, DOI 10.1007/s00248-015-0668-6; Skarphedinsson S, 2005, EMERG INFECT DIS, V11, P1055, DOI 10.3201/eid1107.041265; Sonneborn T.M., 1959, ADV VIRUS RES, V6, P229; Spitalska E, 2008, ACTA VIROL, V52, P175; SPRINGER N, 1993, P NATL ACAD SCI USA, V90, P9892, DOI 10.1073/pnas.90.21.9892; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Subramanian G, 2012, TICKS TICK-BORNE DIS, V3, P405, DOI 10.1016/j.ttbdis.2012.10.001; Sun HY, 2009, APPL ENVIRON MICROB, V75, P7445, DOI 10.1128/AEM.00850-09; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Vannini C, 2005, MICROB ECOL, V49, P434, DOI 10.1007/s00248-004-0055-1; Vannini C, 2004, INT J SYST EVOL MICR, V54, P1151, DOI 10.1099/ijs.0.02759-0; Vannini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087718; Vannini C, 2010, APPL ENVIRON MICROB, V76, P4047, DOI 10.1128/AEM.03105-09; Varela AR, 2013, ENVIRON SCI POLLUT R, V20, P3550, DOI 10.1007/s11356-013-1594-0; Venzal JM, 2008, EXP APPL ACAROL, V44, P49, DOI 10.1007/s10493-007-9126-6; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Williams-Newkirk AJ, 2012, EXP APPL ACAROL, V58, P291, DOI 10.1007/s10493-012-9582-5; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wu M, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00791-14, DOI 10.1128/GEN0MEA.00791-14]; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yilmaz LS, 2006, APPL ENVIRON MICROB, V72, P733, DOI 10.1128/AEM.72.1.733-744.2006	125	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145743	10.1371/journal.pone.0145743	http://dx.doi.org/10.1371/journal.pone.0145743			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731731	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400049
J	Sato, KA; Hachiya, T; Iwaya, T; Kume, K; Matsuo, T; Kawasaki, K; Abiko, Y; Akasaka, R; Matsumoto, T; Otsuka, K; Nishizuka, SS				Sato, Kei A.; Hachiya, Tsuyoshi; Iwaya, Takeshi; Kume, Kohei; Matsuo, Teppei; Kawasaki, Keisuke; Abiko, Yukito; Akasaka, Risaburo; Matsumoto, Takayuki; Otsuka, Koki; Nishizuka, Satoshi S.			Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel	PLOS ONE			English	Article							CELL-FREE DNA; ACQUIRED-RESISTANCE; RARE MUTATIONS; COLON-CANCER; COPY-NUMBER; DIGITAL PCR; PLASMA DNA; QUANTIFICATION; EVOLUTION; TRIAL	Background Circulating tumor DNA (ctDNA) carries information on tumor burden. However, the mutation spectrum is different among tumors. This study was designed to examine the utility of ctDNA for monitoring tumor burden based on an individual mutation profile. Methodology DNA was extracted from a total of 176 samples, including pre-and post-operational plasma, primary tumors, and peripheral blood mononuclear cells (PBMC), from 44 individuals with colorectal tumor who underwent curative resection of colorectal tumors, as well as nine healthy individuals. Using a panel of 50 cancer-associated genes, tumor-unique mutations were identified by comparing the single nucleotide variants (SNVs) from tumors and PBMCs with an Ion PGM sequencer. A group of the tumor-unique mutations from individual tumors were designated as individual marker mutations (MMs) to trace tumor burden by ctDNA using droplet digital PCR (ddPCR). From these experiments, three major objectives were assessed: (a) Tumor-unique mutations; (b) mutation spectrum of a tumor; and (c) changes in allele frequency of the MMs in ctDNA after curative resection of the tumor. Results A total of 128 gene point mutations were identified in 27 colorectal tumors. Twenty-six genes were mutated in at least 1 sample, while 14 genes were found to be mutated in only 1 sample, respectively. An average of 2.7 genes were mutated per tumor. Subsequently, 24 MMs were selected from SNVs for tumor burden monitoring. Among the MMs found by ddPCR with > 0.1% variant allele frequency in plasma DNA, 100% (8 out of 8) exhibited a decrease in post-operation ctDNA, whereas none of the 16 MMs found by ddPCR with < 0.1% variant allele frequency in plasma DNA showed a decrease. Conclusions This panel of 50 cancer-associated genes appeared to be sufficient to identify individual, tumor-unique, mutated ctDNA markers in cancer patients. The MMs showed the clinical utility in monitoring curatively-treated colorectal tumor burden if the allele frequency of MMs in plasma DNA is above 0.1%.	[Sato, Kei A.; Kume, Kohei; Nishizuka, Satoshi S.] Iwate Med Univ, Sch Med, Dept Surg, Mol Therapeut Lab, Morioka, Iwate 020, Japan; [Sato, Kei A.; Iwaya, Takeshi; Kume, Kohei; Matsuo, Teppei; Otsuka, Koki; Nishizuka, Satoshi S.] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; [Hachiya, Tsuyoshi] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biomed Informat Anal, Yahaba, Iwate, Japan; [Kume, Kohei; Nishizuka, Satoshi S.] Iwate Med Univ Sch, MIAST Med Innovat Adv Sci & Technol Project, Morioka, Iwate, Japan; [Kume, Kohei; Nishizuka, Satoshi S.] Iwate Med Univ, Inst Biomed Sci, Yahaba, Iwate, Japan; [Kawasaki, Keisuke; Abiko, Yukito; Akasaka, Risaburo; Matsumoto, Takayuki] Iwate Med Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Morioka, Iwate 020, Japan; [Nishizuka, Satoshi S.] Iwate Med Univ, Sch Dent, Dept Surg, Morioka, Iwate 020, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University	Nishizuka, SS (corresponding author), Iwate Med Univ, Sch Med, Dept Surg, Mol Therapeut Lab, Morioka, Iwate 020, Japan.	snishizu@iwate-med.ac.jp	Hachiya, Tsuyoshi/AAM-8691-2021	Hachiya, Tsuyoshi/0000-0002-5274-3266	Keiryoukai Research Foundation of Iwate Medical University [KAS] [125]; Ministry of Education, Culture, Sports, Science and Technology, Japan [S1001001]; Grants-in-Aid for Scientific Research [25462034] Funding Source: KAKEN	Keiryoukai Research Foundation of Iwate Medical University [KAS]; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Keiryoukai Research Foundation No. 125 of Iwate Medical University [KAS]; and Ministry of Education, Culture, Sports, Science and Technology, Japan for MIAST (Medical Innovation by Advanced Science and Technology) project of the grant-in-Aid for Strategic Research Foundation at Private Universities [S1001001 to SSN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dickinson BT, 2015, GUT, V64, P1485, DOI 10.1136/gutjnl-2014-308075; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Elbeik T, 2005, J CLIN MICROBIOL, V43, P3769, DOI 10.1128/JCM.43.8.3769-3771.2005; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gevensleben H, 2013, CLIN CANCER RES, V19, P3276, DOI 10.1158/1078-0432.CCR-12-3768; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; McArdle C, 2000, BMJ-BRIT MED J, V321, P1121, DOI 10.1136/bmj.321.7269.1121; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Mutch MG, 2007, J SURG ONCOL, V96, P693, DOI 10.1002/jso.20915; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Narayan A, 2012, CANCER RES, V72, P3492, DOI 10.1158/0008-5472.CAN-11-4037; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Perkins G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047020; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Salimnia H, 2005, J CLIN MICROBIOL, V43, P4635, DOI 10.1128/JCM.43.9.4635-4639.2005; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Spindler KLG, 2014, INT J CANCER, V135, P2984, DOI 10.1002/ijc.28946; Spindler KLG, 2014, INT J CANCER, V135, P2215, DOI 10.1002/ijc.28863; Spindler KLG, 2012, CLIN CANCER RES, V18, P1177, DOI 10.1158/1078-0432.CCR-11-0564; Tomasetti C, 2014, P NATL ACAD SCI US; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539; Yu JS, 2008, PHARMACOGENOMICS, V9, P1459, DOI 10.2217/14622416.9.10.1459; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622	36	44	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146275	10.1371/journal.pone.0146275	http://dx.doi.org/10.1371/journal.pone.0146275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727500	gold, Green Submitted, Green Published			2022-12-27	WOS:000367681500070
J	Cheng, X; Pinsky, PM				Cheng, Xi; Pinsky, Peter M.			The Balance of Fluid and Osmotic Pressures across Active Biological Membranes with Application to the Corneal Endothelium	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; VOLUME REGULATION; ELECTRIC CURRENT; CELL-VOLUME; TRANSPORT; PERMEABILITY; FLOW; METABOLISM; PHYSIOLOGY; EQUATIONS	The movement of fluid and solutes across biological membranes facilitates the transport of nutrients for living organisms and maintains the fluid and osmotic pressures in biological systems. Understanding the pressure balances across membranes is crucial for studying fluid and electrolyte homeostasis in living systems, and is an area of active research. In this study, a set of enhanced Kedem-Katchalsky (KK) equations is proposed to describe fluxes of water and solutes across biological membranes, and is applied to analyze the relationship between fluid and osmotic pressures, accounting for active transport mechanisms that propel substances against their concentration gradients and for fixed charges that alter ionic distributions in separated environments. The equilibrium analysis demonstrates that the proposed theory recovers the Donnan osmotic pressure and can predict the correct fluid pressure difference across membranes, a result which cannot be achieved by existing KK theories due to the neglect of fixed charges. The steady-state analysis on active membranes suggests a new pressure mechanism which balances the fluid pressure together with the osmotic pressure. The source of this pressure arises from active ionic fluxes and from interactions between solvent and solutes in membrane transport. We apply the proposed theory to study the transendothelial fluid pressure in the in vivo cornea, which is a crucial factor maintaining the hydration and transparency of the tissue. The results show the importance of the proposed pressure mechanism in mediating stromal fluid pressure and provide a new interpretation of the pressure modulation mechanism in the in vivo cornea.	[Cheng, Xi; Pinsky, Peter M.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University	Pinsky, PM (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	pinsky@stanford.edu			Stanford University Bio-X Interdisciplinary Initiatives Program (IIP)	Stanford University Bio-X Interdisciplinary Initiatives Program (IIP)	This research was supported by the Stanford University Bio-X Interdisciplinary Initiatives Program (IIP).	BLUMENTHAL R, 1967, BIOPHYS J, V7, P735, DOI 10.1016/S0006-3495(67)86620-7; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Cheng X, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0241; Cheng X, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0512; Chhabra M, 2009, OPTOMETRY VISION SCI, V86, P454, DOI 10.1097/OPX.0b013e31819f9e70; Demirel Y, 2002, BIOPHYS CHEM, V97, P87, DOI 10.1016/S0301-4622(02)00069-8; Elliott GF, 1998, REP PROG PHYS, V61, P1325, DOI 10.1088/0034-4885/61/10/001; Fraser JA, 2004, J PHYSIOL-LONDON, V559, P459, DOI 10.1113/jphysiol.2004.065706; HODSON S, 1993, J THEOR BIOL, V163, P173, DOI 10.1006/jtbi.1993.1115; HODSON S, 1971, J THEOR BIOL, V33, P419, DOI 10.1016/0022-5193(71)90090-7; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; HOSHKO T, 1967, J GEN PHYSIOL, V50, P729, DOI 10.1085/jgp.50.3.729; Jakobsson E, 1980, AM J PHYSIOL, V238, P196; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Kargol A, 2000, J MEMBRANE SCI, V174, P43, DOI 10.1016/S0376-7388(00)00367-7; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; KEDEM O, 1963, T FARADAY SOC, V59, P1918, DOI 10.1039/tf9635901918; KEDEM O, 1961, J GEN PHYSIOL, V45, P143, DOI 10.1085/jgp.45.1.143; KLYCE SD, 1979, J PHYSIOL-LONDON, V292, P107, DOI 10.1113/jphysiol.1979.sp012841; Leung BK, 2011, PROG RETIN EYE RES, V30, P471, DOI 10.1016/j.preteyeres.2011.07.001; Li LY, 2004, PHIL MAG LETT, V84, P593, DOI 10.1080/09500830512331325767; NILES WD, 1989, J GEN PHYSIOL, V93, P211, DOI 10.1085/jgp.93.2.211; OVERBEEK J T, 1956, Prog Biophys Biophys Chem, V6, P57; Pinsky PM, 2014, INVEST OPHTH VIS SCI, V55, P3093, DOI [10.1167/iovs.13-13844, 10.1167/iovs.14-13844]; Prigogine I., 1967, INTRO THERMODYNAMICS; Schultz SG, 1980, IUPAB BIOPHYSICS SER; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Titze J, 2013, KIDNEY INT, V84, P869, DOI 10.1038/ki.2013.287; URBAN JPG, 1979, BIORHEOLOGY, V16, P447; WIETH JO, 1982, PHILOS T ROY SOC B, V299, P383, DOI 10.1098/rstb.1982.0139; ZEUTHEN T, 1995, INT REV CYTOL, V160, P99, DOI 10.1016/S0074-7696(08)61554-5	33	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145422	10.1371/journal.pone.0145422	http://dx.doi.org/10.1371/journal.pone.0145422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719894	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510900008
J	Liu, W; Shahid, MQ; Bai, L; Lu, ZZ; Chen, YH; Jiang, L; Diao, MY; Liu, XD; Lu, YG				Liu, Wen; Shahid, Muhammad Qasim; Bai, Lin; Lu, Zhenzhen; Chen, Yuhong; Jiang, Lan; Diao, Mengyang; Liu, Xiangdong; Lu, Yonggen			Evaluation of Genetic Diversity and Development of a Core Collection of Wild Rice (Oryza rufipogon Griff.) Populations in China	PLOS ONE			English	Article							CONSERVATION GENETICS; MOLECULAR MARKER; CULTIVATED RICE; SATIVA; DOMESTICATION; DIFFERENTIATION; ESTABLISHMENT; RESISTANCE; GERMPLASM; JAPONICA	Common wild rice (Oryza rufipogon Griff.), the progenitor of Asian cultivated rice (O. sativa L.), is endangered due to habitat loss. The objectives of this research were to evaluate the genetic diversity of wild rice species in isolated populations and to develop a core collection of representative genotypes for ex situ conservation. We collected 885 wild rice accessions from eight geographically distinct regions and transplanted these accessions in a protected conservation garden over a period of almost two decades. We evaluated these accessions for 13 morphological or phenological traits and genotyped them for 36 DNA markers evenly distributed on the 12 chromosomes. The coefficient of variation of quantitative traits was 0.56 and ranged from 0.37 to 1.06. SSR markers detected 206 different alleles with an average of 6 alleles per locus. The mean polymorphism information content (PIC) was 0.64 in all populations, indicating that the marker loci have a high level of polymorphism and genetic diversity in all populations. Phylogenetic analyses based on morphological and molecular data revealed remarkable differences in the genetic diversity of common wild rice populations. The results showed that the Zengcheng, Gaozhou, and Suixi populations possess higher levels of genetic diversity, whereas the Huilai and Boluo populations have lower levels of genetic diversity than do the other populations. Based on their genetic distance, 130 accessions were selected as a core collection that retained over 90% of the alleles at the 36 marker loci. This genetically diverse core collection will be a useful resource for genomic studies of rice and for initiatives aimed at developing rice with improved agronomic traits.	[Liu, Wen; Shahid, Muhammad Qasim; Bai, Lin; Lu, Zhenzhen; Chen, Yuhong; Jiang, Lan; Diao, Mengyang; Liu, Xiangdong; Lu, Yonggen] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Liu, XD (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	xdliu@scau.edu.cn; yglu@scau.edu.cn	Shahid, Muhammad Qasim/F-2908-2013; Shahid, Muhammad Qasim/K-2304-2019	Shahid, Muhammad Qasim/0000-0002-6767-4355; Shahid, Muhammad Qasim/0000-0002-6767-4355	Natural Science Key Foundation of Guangdong Province [2014A030311042]; Project of Protection and Exploitation of Wild Rice of Guangdong [2003-360]; Joint Fund of the National Natural Science Foundation of China-Guangdong Province [U0631003]; Project to protect agricultural wild plants of China; Funds to state key laboratory for conservation and utilization of subtropical agrobioresources [SKLCUSA-a201506]	Natural Science Key Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Project of Protection and Exploitation of Wild Rice of Guangdong; Joint Fund of the National Natural Science Foundation of China-Guangdong Province; Project to protect agricultural wild plants of China; Funds to state key laboratory for conservation and utilization of subtropical agrobioresources	This work was supported by the Natural Science Key Foundation of Guangdong Province (Grant No. 2014A030311042 to XD Liu, http://pro.gdstc.gov.cn/egrantweb/), Project of Protection and Exploitation of Wild Rice of Guangdong (2003-360, to YG Lu), the Joint Fund of the National Natural Science Foundation of China-Guangdong Province (Grant No. U0631003 to YG Lu, http://isisn.nsfc.gov.cn/egrantweb/contract/index), Project to protect agricultural wild plants of China (2013), and Funds to state key laboratory for conservation and utilization of subtropical agrobioresources (SKLCUSA-a201506 to XD Liu, http://web.scau.edu.cn/sys/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Bhattacharjee R, 2007, EUPHYTICA, V155, P35, DOI 10.1007/s10681-006-9298-x; Bhattacharjee R, 2012, PLANT GENET RESOUR-C, V10, P119, DOI 10.1017/S1479262112000093; Bisht IS, 1998, GENET RESOUR CROP EV, V45, P325, DOI 10.1023/A:1008652420477; Cai HW, 2004, HEREDITY, V92, P409, DOI 10.1038/sj.hdy.6800435; Chen Yu, 2009, Acta Agronomica Sinica, V35, P459, DOI 10.3724/SP.J.1006.2009.00459; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dong YB, 2010, GENET RESOUR CROP EV, V57, P915, DOI 10.1007/s10722-009-9523-2; Elizabeth AV, 2008, BRAZ ARCH BIOL TECHN, V51, P95; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Gao L., 2000, ACTA AGRON SIN, V26, P210; Gao LH, 2004, MOL ECOL, V13, P1009, DOI 10.1111/j.1365-294X.2004.02108.x; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Gao LZ, 2006, BIODIVERS CONSERV, V15, P4059, DOI 10.1007/s10531-005-3135-8; Gao LZ, 2002, EUPHYTICA, V124, P273, DOI 10.1023/A:1015740331079; Gao LZ, 2000, HEREDITAS, V133, P47, DOI 10.1111/j.1601-5223.2000.00047.x; Holbrook CC, 2000, CROP SCI, V40, P1172, DOI 10.2135/cropsci2000.4041172x; Huang P, 2012, MOL ECOL, V21, P4593, DOI 10.1111/j.1365-294X.2012.05625.x; 时培建, 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P75; Le Dien S, 2003, REV STAT APPL, V51, P47; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li XB, 2010, GENETICA, V138, P1221, DOI 10.1007/s10709-010-9521-5; [李晓玲 LI Xiaoling], 2007, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V38, P681; Li ZiChao, 2003, Acta Agronomica Sinica, V29, P20; Liu XQ, 2010, INT J PLANT SCI, V171, P235, DOI 10.1086/650158; Ma F, 2010, NEW PHYTOL, V185, P204, DOI 10.1111/j.1469-8137.2009.03037.x; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Nagy S, 2012, BIOCHEM GENET, V50, P670, DOI 10.1007/s10528-012-9509-1; NEI M, 1978, GENETICS, V89, P583; Ngu MeeSiing, 2010, Tropical Plant Biology, V3, P227, DOI 10.1007/s12042-010-9060-3; Norby J, 1990, SCI GRAPH SYSTEM; OKA HI, 1982, EUPHYTICA, V31, P41, DOI 10.1007/BF00028305; Oliveira MF, 2010, FIELD CROP RES, V119, P277, DOI 10.1016/j.fcr.2010.07.021; Pinon A, 2010, J R STAT SOC A STAT, V173, P464, DOI 10.1111/j.1467-985X.2009.00634_6.x; Putcha V, 2008, J ROY STAT SOC A STA, V171, P317, DOI 10.1111/j.1467-985X.2007.00521_10.x; Raj RD, 2010, CURR SCI INDIA, V98, P65; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Song ZP, 2005, PLANT SPEC BIOL, V20, P83, DOI 10.1111/j.1442-1984.2005.00128.x; Sun QM, 2012, SCI HORTIC-AMSTERDAM, V146, P29, DOI 10.1016/j.scienta.2012.08.012; Sun XiPing, 2009, Acta Agronomica Sinica, V35, P679, DOI 10.3724/SP.J.1006.2009.00679; Tan LB, 2008, GENOME, V51, P692, DOI 10.1139/G08-054; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; van Heerwaarden J, 2013, THEOR APPL GENET, V126, P763, DOI 10.1007/s00122-012-2016-2; Wang F, 2006, PLANT BIOTECHNOL J, V4, P667, DOI 10.1111/j.1467-7652.2006.00210.x; Wang JC, 2007, RICE SCI, V14, P101, DOI 10.1016/S1672-6308(07)60015-8; Wang Jing, 2004, Journal of South China Agricultural University, V25, P63; Wang MX, 2008, HEREDITY, V101, P527, DOI 10.1038/hdy.2008.61; Wang YZ, 2011, SCI HORTIC-AMSTERDAM, V128, P311, DOI 10.1016/j.scienta.2011.01.025; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Wu JW, 2014, PLANT REPROD, V27, P181, DOI 10.1007/s00497-014-0250-2; Xie J, 2010, GENET RESOUR CROP EV, V57, P597, DOI 10.1007/s10722-009-9498-z; Yang YX, 2009, CHINESE SCI BULL, V54, P3258, DOI 10.1007/s11434-009-0466-y; Yeh FC, 2000, POPGENE 32 MICROSOFT; Zhang HL, 2011, THEOR APPL GENET, V122, P49, DOI 10.1007/s00122-010-1421-7; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhou HF, 2003, THEOR APPL GENET, V107, P332, DOI 10.1007/s00122-003-1251-y; 李晨, 2006, [科学通报, Chinese science bulletin], V51, P551	60	32	33	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145990	10.1371/journal.pone.0145990	http://dx.doi.org/10.1371/journal.pone.0145990			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720755	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900031
J	Carvalho, LP; Di Thommazo-Luporini, L; Aubertin-Leheudre, M; Bonjorno, JC; de Oliveira, CR; Luporini, RL; Mendes, RG; Zangrando, KTL; Trimer, R; Arena, R; Borghi-Silva, A				Carvalho, Livia Pinheiro; Di Thommazo-Luporini, Luciana; Aubertin-Leheudre, Mylene; Bonjorno Junior, Jose Carlos; de Oliveira, Claudio Ricardo; Luporini, Rafael Luis; Mendes, Renata Goncalves; Lopes Zangrando, Katiany Thais; Trimer, Renata; Arena, Ross; Borghi-Silva, Audrey			Prediction of Cardiorespiratory Fitness by the Six-Minute Step Test and Its Association with Muscle Strength and Power in Sedentary Obese and Lean Young Women: A Cross-Sectional Study	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; INSULIN SENSITIVITY; SKELETAL-MUSCLE; ELDERLY-WOMEN; WALK TEST; QUADRICEPS; VALIDITY; INDIVIDUALS; OVERWEIGHT; HEALTHY	Impaired cardiorespiratory fitness (CRF) is a hallmark characteristic in obese and lean sedentary young women. Peak oxygen consumption (VO2peak) prediction from the six-minute step test (6MST) has not been established for sedentary females. It is recognized that lower-limb muscle strength and power play a key role during functional activities. The aim of this study was to investigate cardiorespiratory responses during the 6MST and CPX and to develop a predictive equation to estimate VO2peak in both lean and obese subjects. Additionally we aim to investigate how muscle function impacts functional performance. Lean (LN = 13) and obese (OB = 18) women, aged 20-45, underwent a CPX, two 6MSTs, and isokinetic and isometric knee extensor strength and power evaluations. Regression analysis assessed the ability to predict VO2peak from the 6MST, age and body mass index (BMI). CPX and 6MST main outcomes were compared between LN and OB and correlated with strength and power variables. CRF, functional capacity, and muscle strength and power were lower in the OB compared to LN (<0.05). During the 6MST, LN and OB reached similar to 90% of predicted maximal heart rate and similar to 80% of the VO2peak obtained during CPX. BMI, age and number of step cycles (NSC) explained 83% of the total variance in VO2peak. Moderate to strong correlations between VO2peak at CPX and VO2peak at 6MST (r = 0.86), VO2peak at CPX and NSC (r = 0.80), as well as between VO2peak, NSC and muscle strength and power variables were found (p<0.05). These findings indicate the 6MST, BMI and age accurately predict VO2peak in both lean and obese young sedentary women. Muscle strength and power were related to measures of aerobic and functional performance.	[Carvalho, Livia Pinheiro; Di Thommazo-Luporini, Luciana; Mendes, Renata Goncalves; Lopes Zangrando, Katiany Thais; Trimer, Renata; Borghi-Silva, Audrey] Univ Fed Sao Carlos, Physiotherapy Dept, Cardiopulm Physiotherapy Lab, Sao Paulo, Brazil; [Aubertin-Leheudre, Mylene] Univ Quebec, Kinanthropol Dept, Montreal, PQ H3C 3P8, Canada; [Bonjorno Junior, Jose Carlos; de Oliveira, Claudio Ricardo] Univ Fed Sao Carlos, Dept Med, Sao Paulo, Brazil; [Luporini, Rafael Luis] Santa Casa Misericordia Sao Carlos, Sao Carlos, SP, Brazil; [Arena, Ross] Univ Illinois, Coll Appl Hlth Sci, Phys Therapy Dept, Integrat Physiol Lab, Chicago, IL USA	Universidade Federal de Sao Carlos; University of Quebec; University of Quebec Montreal; Universidade Federal de Sao Carlos; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Borghi-Silva, A (corresponding author), Univ Fed Sao Carlos, Physiotherapy Dept, Cardiopulm Physiotherapy Lab, Sao Paulo, Brazil.	audrey@ufscar.br	Arena, Ross/AAY-7646-2020; Carvalho, Livia/AAB-3173-2022; Arena, Ross/A-3141-2008; aubertin, rebeckah/R-6437-2017; Mendes, Renata Gonçalves/E-9284-2013; Borghi-Silva, Audrey/F-5702-2012; Luporini, Rafael Luis/AAI-2257-2021	Carvalho, Livia/0000-0002-0870-4278; Arena, Ross/0000-0002-6675-1996; aubertin, rebeckah/0000-0002-0558-7571; Mendes, Renata Gonçalves/0000-0003-4683-2657; Borghi-Silva, Audrey/0000-0002-3891-6941; Luporini, Rafael Luis/0000-0003-2757-8104	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/15681-3, 2009/01842-0, 2015/12751-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)-2013/15681-3, 2009/01842-0 and 2015/12751-6 (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison O, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/309570; Arcuri JF, 2015, CLIN J SPOR IN PRESS; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baillot A, 2015, INT J SPORT IN PRESS; Baldon RD, 2012, MED SCI SPORT EXER, V44, P135, DOI 10.1249/MSS.0b013e31822a51bb; Bandyopadhyay Amit, 2013, Indian J Physiol Pharmacol, V57, P77; Barbat-Artigas S, 2014, J AM MED DIR ASSOC, V15, pe1; Barbat-Artigas S, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.003; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Borghi-Silva A, 2009, RESPIROLOGY, V14, P537, DOI 10.1111/j.1440-1843.2009.01515.x; Capodaglio P, 2010, INT J OCCUP SAF ERGO, V16, P507, DOI 10.1080/10803548.2010.11076863; Capodaglio P, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-47; Cataneo DC, 2010, ACTA CIR BRAS, V25, P194, DOI 10.1590/S0102-86502010000200013; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; da Costa JNF, 2014, RESP CARE, V59, P538, DOI 10.4187/respcare.02743; Di Thommazo-Luporini L, 2015, EUR J PHYS IN PRESS; Di Thommazo-Luporini L, 2012, REV BRAS FISIOTER, V16, P469; Dourado Victor Zuniga, 2013, J. bras. pneumol., V39, P190, DOI 10.1590/S1806-37132013000200010; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; Ekblom-Bak E, 2014, SCAND J MED SCI SPOR, V24, P319, DOI 10.1111/sms.12014; Eriksson JS, 2012, EUR J APPL PHYSIOL, V112, P345, DOI 10.1007/s00421-011-1985-1; Florindo AA, 2003, REV BRAS MED ESPORTE, V9, P121, DOI DOI 10.1590/S1517-86922003000300002; Gonzalez-Gross M, 2013, NUTR HOSP, V28, P89, DOI 10.3305/nh.2013.28.sup5.6923; Guazzi M, 2012, EUR HEART J, V33, P2917, DOI 10.1093/eurheartj/ehs221; Guetta V, 1996, CIRCULATION, V93, P1928, DOI 10.1161/01.CIR.93.10.1928; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Hulens M, 2002, J ORTHOP SPORT PHYS, V32, P347, DOI 10.2519/jospt.2002.32.7.347; Hulens M, 2001, INT J OBESITY, V25, P676, DOI 10.1038/sj.ijo.0801560; Karelis AD, 2007, APPL PHYSIOL NUTR ME, V32, P297, DOI 10.1139/H07-002; Karelis AD, 2013, APPL PHYSIOL NUTR ME, V38, P27, DOI 10.1139/apnm-2012-0129; Labruna G, 2011, OBESITY, V19, P1492, DOI 10.1038/oby.2010.309; Lafortuna CL, 2002, J ENDOCRINOL INVEST, V25, P134, DOI 10.1007/BF03343977; Lafortuna CL, 2013, J ENDOCRINO IN PRESS; Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3; Lerner ZF, 2014, GAIT POSTURE, V39, P978, DOI 10.1016/j.gaitpost.2013.12.020; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; Maffiuletti NA, 2008, EUR J APPL PHYSIOL, V103, P481, DOI 10.1007/s00421-008-0737-3; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; Marcus RL, 2012, J AGING RES IN PRESS; Messier V, 2008, METABOLISM, V57, P1293, DOI 10.1016/j.metabol.2008.04.026; Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364; Neves CDC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117563; OLSEN GN, 1991, CHEST, V99, P587, DOI 10.1378/chest.99.3.587; Paolillo FR, 2012, MENOPAUSE, V19, P556, DOI 10.1097/gme.0b013e3182364e80; Pereira CAC, 2002, J BRAS PNEUMOL, V28, P1, DOI DOI 10.1590/1414-431X20175700; Petrella RJ, 2001, J AM GERIATR SOC, V49, P632, DOI 10.1046/j.1532-5415.2001.49124.x; Quinart S, 2014, J SCI MED SPORT, V17, P521, DOI 10.1016/j.jsams.2013.07.010; Rolland Y, 2004, AM J CLIN NUTR, V79, P552; Rolland Y, 2009, AM J CLIN NUTR, V89, P1895, DOI 10.3945/ajcn.2008.26950; Rosdahl H, 2010, EUR J APPL PHYSIOL, V109, P159, DOI 10.1007/s00421-009-1326-9; SICONOLFI SF, 1985, AM J EPIDEMIOL, V121, P382, DOI 10.1093/oxfordjournals.aje.a114010; Weber J., 1970, STAT RES PHYS ED; WHO, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2014, WORLD HLTH STAT 2014	55	19	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145960	10.1371/journal.pone.0145960	http://dx.doi.org/10.1371/journal.pone.0145960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717568	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500102
J	Boggs, K; Venkatesan, N; Mederacke, I; Komatsu, Y; Stice, S; Schwabe, RF; Mistretta, CM; Mishina, Y; Liu, HX				Boggs, Kristin; Venkatesan, Nandakumar; Mederacke, Ingmar; Komatsu, Yoshihiro; Stice, Steve; Schwabe, Robert F.; Mistretta, Charlotte M.; Mishina, Yuji; Liu, Hong-Xiang			Contribution of Underlying Connective Tissue Cells to Taste Buds in Mouse Tongue and Soft Palate	PLOS ONE			English	Article							NEURAL CREST CELLS; FUNGIFORM PAPILLA; STEM/PROGENITOR CELLS; RECEPTOR-CELLS; RAT; LINEAGE; SYSTEM; IMMUNOREACTIVITY; MORPHOGENESIS; LOCALIZATION	Taste buds, the sensory organs for taste, have been described as arising solely from the surrounding epithelium, which is in distinction from other sensory receptors that are known to originate from neural precursors, i.e., neural ectoderm that includes neural crest (NC). Our previous study suggested a potential contribution of NC derived cells to early immature fungiform taste buds in late embryonic (E18.5) and young postnatal (P1-10) mice. In the present study we demonstrated the contribution of the underlying connective tissue (CT) to mature taste buds in mouse tongue and soft palate. Three independent mouse models were used for fate mapping of NC and NC derived connective tissue cells: (1) P0-Cre/R26-tdTomato (RFP) to label NC, NC derived Schwann cells and derivatives; (2) Dermo1-Cre/ RFP to label mesenchymal cells and derivatives; and (3) Vimentin-CreER/mGFP to label Vimentin-expressing CT cells and derivatives upon tamoxifen treatment. Both P0-Cre/RFP and Dermo1-Cre/RFP labeled cells were abundant in mature taste buds in lingual taste papillae and soft palate, but not in the surrounding epithelial cells. Concurrently, labeled cells were extensively distributed in the underlying CT. RFP signals were seen in the majority of taste buds and all three types (I, II, III) of differentiated taste bud cells, with the neuronal- like type III cells labeled at a greater proportion. Further, Vimentin-CreER labeled cells were found in the taste buds of 3-month-old mice whereas Vimentin immunoreactivity was only seen in the CT. Taken together, our data demonstrate a previously unrecognized origin of taste bud cells from the underlying CT, a conceptually new finding in our knowledge of taste bud cell derivation, i.e., from both the surrounding epithelium and the underlying CT that is primarily derived from NC.	[Boggs, Kristin; Venkatesan, Nandakumar; Stice, Steve; Liu, Hong-Xiang] Univ Georgia, Dept Anim & Dairy Sci, Coll Agr & Environm Sci, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Mederacke, Ingmar; Schwabe, Robert F.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Komatsu, Yoshihiro] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA; [Mistretta, Charlotte M.; Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University System of Georgia; University of Georgia; Columbia University; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Liu, HX (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Coll Agr & Environm Sci, Regenerat Biosci Ctr, Athens, GA 30602 USA.	lhx@uga.edu	Venkatesan, Nandakumar/AAX-7940-2020; Schwabe, Robert/AAY-6506-2021	Venkatesan, Nandakumar/0000-0002-2073-9887; 	National Institutes of Health [R00DE021054, 5U54CA163111-05, R01DC000456, R01DE020843, R03 DC009055, R01 DC012308]; NATIONAL CANCER INSTITUTE [U54CA163111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE021054, R01DE020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009055, R01DC012308, R01DC000456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by the National Institutes of Health R00DE021054 to YK, http://grants.nih.gov/grants/oer.htm; National Institutes of Health 5U54CA163111-05 to RFS, http://grants.nih.gov/grants/oer.htm; National Institutes of Health R01DC000456 to CMM, http://grants.nih.gov/grants/oer.htm; National Institutes of Health R01DE020843 to YM, http://grants.nih.gov/grants/oer.htm; National Institutes of Health R03 DC009055 to HXL, http://grants.nih.gov/grants/oer.htm; National Institutes of Health R01 DC012308 to HXL, http://grants.nih.gov/grants/oer.htm.	Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Boughter JD, 1997, J NEUROSCI, V17, P2852; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286; FARBMAN AI, 1991, J COMP NEUROL, V304, P172, DOI 10.1002/cne.903040203; FARBMAN AI, 1965, DEV BIOL, V11, P110, DOI 10.1016/0012-1606(65)90040-0; FARBMAN AI, 1965, J ULTRA MOL STRUCT R, V12, P328, DOI 10.1016/S0022-5320(65)80103-4; Feltri ML, 1999, EUR J NEUROSCI, V11, P1577, DOI 10.1046/j.1460-9568.1999.00568.x; Gao N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-20; Kawakami M, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-68; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Lewis AE, 2013, DEV BIOL, V379, P229, DOI 10.1016/j.ydbio.2013.04.026; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Liu HX, 2013, DEV BIOL, V382, P82, DOI 10.1016/j.ydbio.2013.07.022; Liu HX, 2012, DEV BIOL, V368, P294, DOI 10.1016/j.ydbio.2012.05.028; Liu HX, 2012, DEV BIOL, V361, P39, DOI 10.1016/j.ydbio.2011.10.009; Mii S, 2014, J CELL BIOCHEM, V115, P1070, DOI 10.1002/jcb.24696; Miura H, 2014, DEV DYNAM, V243, P1286, DOI [10.1002/DVDY.24121, 10.1002/dvdy.24121]; MURRAY RG, 1993, MICROSC RES TECHNIQ, V26, P209, DOI 10.1002/jemt.1070260304; Murray RG, 1970, CONTRIB SENS PHYSL, V5, P47; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; NODEN DM, 1993, J NEUROBIOL, V24, P248, DOI 10.1002/neu.480240210; NODEN DM, 1991, BRAIN BEHAV EVOLUT, V38, P190, DOI 10.1159/000114388; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Olaopa M, 2011, DEV BIOL, V356, P308, DOI 10.1016/j.ydbio.2011.05.583; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; Smith DV, 2001, SCI AM, V284, P32, DOI 10.1038/scientificamerican0301-32; Stone LM, 2002, J NEUROSCI, V22, P4522, DOI 10.1523/JNEUROSCI.22-11-04522.2002; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; STONE LM, 1994, CHEM SENSES, V19, P725, DOI 10.1093/chemse/19.6.725; Thirumangalathu S, 2009, DEVELOPMENT, V136, P1519, DOI 10.1242/dev.029090; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Tzahor E, 2015, HEAD MUSCLE DEV VERT, P123; Vandenbeuch Aurelie, 2009, Journal of Biology (London), V8, P42, DOI 10.1186/jbiol138; Wang SK, 2011, BIOCHEM BIOPH RES CO, V415, P114, DOI 10.1016/j.bbrc.2011.10.026; Witt M, 2000, PHILOS T ROY SOC B, V355, P1233, DOI 10.1098/rstb.2000.0674; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	51	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146475	10.1371/journal.pone.0146475	http://dx.doi.org/10.1371/journal.pone.0146475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741369	gold, Green Published			2022-12-27	WOS:000367810600047
J	Compaore, TR; Soubeiga, ST; Ouattara, AK; Obiri-Yeboah, D; Tchelougou, D; Maiga, M; Assih, M; Bisseye, C; Bakouan, D; Compaore, IP; Dembele, A; Martinson, J; Simpore, J				Compaore, Tegwinde Rebeca; Soubeiga, Serge Theophile; Ouattara, Abdoul Karim; Obiri-Yeboah, Dorcas; Tchelougou, Damehan; Maiga, Mamoudou; Assih, Maleki; Bisseye, Cyrille; Bakouan, Didier; Compaore, Issaka Pierre; Dembele, Augustine; Martinson, Jeremy; Simpore, Jacques			APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; GENETIC-VARIANTS; VIF; AIDS; ASSOCIATION; PROGRESSION; RESISTANCE; CRF06-CPX; PROTEINS; SUBTYPES	Studies on host factors, particularly the APOBEC3G gene, have previously found an association with AIDS progression in some populations and against some HIV-1 strains but not others. Our study had two main objectives: firstly, to screen a population from Burkina Faso for three variants of APOBEC3G previously described, and secondly to analyze the effect of these three variants and their haplotypes on HIV-1 infection with Circulating Recombinant Forms (CRFs) present in Burkina Faso. This case control study involved 708 seropositive and seronegative individuals. Genotyping was done by the TaqMan allelic discrimination method. Minor allele frequencies of rs6001417 (p<0.05), rs8177832 (P<0.05), and rs35228531 (P<0.001) were higher in seronegative subjects. The rs6001417 and rs8177832 SNPs were associated with HIV-1 infection in an additive model (P<0.01). Furthermore the SNP rs35228531 was also associated with HIV-1 infection in a dominant model (P<0.001). Odds ratio analysis of genotypes and alleles of the different APOBEC3G variants showed that there is a strong association between the minor genetic variants, genotype of the three SNPs, and HIV-1 status. Haplotype analysis demonstrated that rs6001417, rs8177832, and rs35228531 are in linkage disequilibrium. The haplotype GGT from the rs6001417, rs8177832 and rs35228531 respectively has a protective effect OR = 0.54 [0.43-0.68] with P < 0.001. There was also associations between the haplotypes GGC OR = 1.6 [1.1;-2.3] P < 0.05, and CGC OR = 5.21 [2.4-11.3] P < 0.001, which increase the risk of infection by HIV-1 from almost two (2) to five (5) fold. This study demonstrates an association of rs6001417, rs8177832, and rs35228531 of APOBEC3G with HIV-1 infection in a population from Burkina Faso.	[Compaore, Tegwinde Rebeca; Soubeiga, Serge Theophile; Ouattara, Abdoul Karim; Tchelougou, Damehan; Maiga, Mamoudou; Assih, Maleki; Compaore, Issaka Pierre; Simpore, Jacques] Univ Ouagadougou, Pietro Annigoni Biomol Res Ctr CERBA LABIOGENE, Ouagadougou, Burkina Faso; [Obiri-Yeboah, Dorcas] Univ Cape Coast, Sch Med Sci, Dept Microbiol, Cape Coast, Ghana; [Bisseye, Cyrille] USTM, Lab Mol & Cellular Biol, Franceville, Gabon; [Bakouan, Didier; Dembele, Augustine] Permanent Secretary AIDS & Sexually Transmitted D, Ouagadougou, Burkina Faso; [Martinson, Jeremy] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA	University of Cape Coast; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Simpore, J (corresponding author), Univ Ouagadougou, Pietro Annigoni Biomol Res Ctr CERBA LABIOGENE, Ouagadougou, Burkina Faso.	jacques.simpore@yahoo.fr	OUATTARA, Abdoul Karim/P-5542-2018; Bisseye, C./AFO-0118-2022; Obiri-Yeboah, Dorcas/AAE-7672-2019; SIMPORE, Jacques/ABA-4873-2020; Bisseye, Cyrille/AGP-8782-2022	OUATTARA, Abdoul Karim/0000-0002-9767-0646; SIMPORE, Jacques/0000-0002-0415-9161; Bisseye, Cyrille/0000-0002-6888-6317; OBIRI-YEBOAH, DORCAS/0000-0003-4562-9294; TCHELOUGOU, Damehan/0000-0002-2123-6632; Martinson, Jeremy/0000-0003-4673-7238; Soubeiga, PhD, Serge Theophile/0000-0002-9741-2428	Conseil National de Lutte contre le SIDA et les IST/Secretariat permanent [2014/003/PRES/CNLS-IST/SP/UGF]; West African Economic and Monetary Union (WAEMU), PACER2	Conseil National de Lutte contre le SIDA et les IST/Secretariat permanent; West African Economic and Monetary Union (WAEMU), PACER2	This work was supported by Conseil National de Lutte contre le SIDA et les IST/Secretariat permanent, No2014/003/PRES/CNLS-IST/SP/UGF; West African Economic and Monetary Union (WAEMU), PACER2. The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Binka M, 2012, J VIROL, V86, P49, DOI 10.1128/JVI.06082-11; Do H, 2005, J INFECT DIS, V191, P159, DOI 10.1086/426826; Donfack J, 2006, AIDS RES HUM RETROV, V22, P925, DOI 10.1089/aid.2006.22.925; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Farrow MA, 2008, FUTURE MICROBIOL, V3, P145, DOI 10.2217/17460913.3.2.145; Fonjungo PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092423; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Kagone T S, 2011, Pak J Biol Sci, V14, P392, DOI 10.3923/pjbs.2011.392.398; Kagone TS, 2014, ASIAN PAC J TROP MED, V7, pS93, DOI 10.1016/S1995-7645(14)60211-X; Liddament MT, 2004, NATURE REV IMMUNOLOG, V4, P10; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Montavon C, 2002, J ACQ IMMUN DEF SYND, V29, P522, DOI 10.1097/00126334-200204150-00014; Nadembega WM, 2006, J MED VIROL, V78, P1385, DOI 10.1002/jmv.20709; Ouedraogo-Traore R, 2003, AIDS, V17, P441, DOI 10.1097/00002030-200302140-00019; Reddy K, 2010, AIDS, V24, P195, DOI 10.1097/QAD.0b013e3283353bba; Shastry BS, 2009, SNPS IMPACT GENE FUN; Simpore J, 2007, J MED VIROL, V79, P873, DOI 10.1002/jmv.20913; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tan EK, 2005, J EXP MED, V62, P14; Valcke HS, 2006, AIDS, V20, P1984, DOI 10.1097/01.aids.0000247124.35129.e1	25	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146386	10.1371/journal.pone.0146386	http://dx.doi.org/10.1371/journal.pone.0146386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741797	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000367810600036
J	Pacheco, JM; Lee, KN; Eschbaumer, M; Bishop, EA; Hartwig, EJ; Pauszek, SJ; Smoliga, GR; Kim, SM; Park, JH; Ko, YJ; Lee, HS; Tark, D; Cho, IS; Kim, B; Rodriguez, LL; Arzt, J				Pacheco, Juan M.; Lee, Kwang-Nyeong; Eschbaumer, Michael; Bishop, Elizabeth A.; Hartwig, Ethan J.; Pauszek, Steven J.; Smoliga, George R.; Kim, Su-Mi; Park, Jong-Hyeon; Ko, Young-Joon; Lee, Hyang-Sim; Tark, Dongseob; Cho, In-Soo; Kim, Byounghan; Rodriguez, Luis L.; Arzt, Jonathan			Evaluation of Infectivity, Virulence and Transmission of FDMV Field Strains of Serotypes O and A Isolated In 2010 from Outbreaks in the Republic of Korea	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; CONTACT TRANSMISSION; PATHOGENESIS; DIAGNOSIS; PIGS; ERADICATION; SPREAD; ASSAY	Since the early 2000s outbreaks of foot-and-mouth disease (FMD) have been described in several previously FMD-free Asian nations, including the Republic of Korea (South Korea). One outbreak with FMD virus (FDMV) serotype A and two with serotype O occurred in South Korea in 2010/2011. The causative viruses belonged to lineages that had been spreading in South East Asia, far East and East Asia since 2009 and presented a great threat to the countries in that region. Most FMDV strains infect ruminants and pigs, as it happened during the outbreaks of FMDV serotype O in South Korea. Contrastingly, the strain of serotype A affected only ruminants. Based upon these findings, the intention of the work described in the current report was to characterize and compare the infectivity, virulence and transmission of both strains under laboratory conditions in cattle and pigs, by direct inoculation and contact exposure. As expected, FMDV serotype O was highly virulent in both cattle and swine by contact exposure and direct inoculation. Surprisingly, FMDV serotype A was highly virulent in swine, but was less infectious in cattle by contact exposure to infected swine or cattle. Interestingly, similar quantities of aerosolized FMDV RNA were detected during experiments with viruses of serotypes O and A. Specific virus-host interaction of A/SKR/2010 could affect the transmission of this strain to cattle, and this may explain in part the limited spread of the serotype A epizootic.	[Pacheco, Juan M.; Eschbaumer, Michael; Bishop, Elizabeth A.; Hartwig, Ethan J.; Pauszek, Steven J.; Smoliga, George R.; Rodriguez, Luis L.; Arzt, Jonathan] ARS, Plum Isl Anim Dis Ctr, Foreign Anim Dis Res Unit, USDA, Plum Isl, NY 11957 USA; [Lee, Kwang-Nyeong; Kim, Su-Mi; Park, Jong-Hyeon; Ko, Young-Joon; Lee, Hyang-Sim; Tark, Dongseob; Cho, In-Soo; Kim, Byounghan] Anim & Plant Quarantine Agcy, Dept Anim & Plant Hlth Res, Anyang Si, Gyeonggi Do, South Korea; [Eschbaumer, Michael] Oak Ridge Inst Sci & Educ, PIADC Res Participat Program, Oak Ridge, TN USA	United States Department of Agriculture (USDA); Animal & Plant Quarantine Agency; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Pacheco, JM (corresponding author), ARS, Plum Isl Anim Dis Ctr, Foreign Anim Dis Res Unit, USDA, Plum Isl, NY 11957 USA.	juanmanuelpacheco@hotmail.com		Kim, Su-Mi/0000-0002-9242-2731; Pacheco, Juan/0000-0001-5477-0201; Arzt, Jonathan/0000-0002-7517-7893	USDA-ARS CRIS project [8064-32000-057-00D]; Agricultural Research Service (ARS), USDA [58-1940-1-034F]; National Veterinary Research and Quarantine Service (NVRQS), Republic of Korea [58-1940-1-034F]; Animal and Plant Quarantine Agency (QIA), Republic of Korea; PIADC Research Participation Program fellowships; Animal Research Branch at PIADC	USDA-ARS CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Agricultural Research Service (ARS), USDA; National Veterinary Research and Quarantine Service (NVRQS), Republic of Korea; Animal and Plant Quarantine Agency (QIA), Republic of Korea; PIADC Research Participation Program fellowships; Animal Research Branch at PIADC	This project was funded by USDA-ARS CRIS project 8064-32000-057-00D. Additional funding came from collaborative agreement 58-1940-1-034F between Agricultural Research Service (ARS), USDA and National Veterinary Research and Quarantine Service (NVRQS), Republic of Korea with support from the Animal and Plant Quarantine Agency (QIA), Republic of Korea.; We would like to thank the Animal Research Branch at PIADC for assistance and support during animal studies. Michael Eschbaumer is a recipient of a PIADC Research Participation Program fellowships, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement with the U.S. Department of Energy.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; BURROWS R, 1966, J HYG-CAMB, V64, P419, DOI 10.1017/S0022172400040729; Donaldson AI, 2002, REV SCI TECH OIE, V21, P569, DOI 10.20506/rst.21.3.1362; Dunn CS, 1997, VET REC, V141, P174, DOI 10.1136/vr.141.7.174; Fray MD, 2001, J IMMUNOL METHODS, V249, P235, DOI 10.1016/S0022-1759(00)00359-8; Gloster J, 2008, VET J, V177, P374, DOI 10.1016/j.tvjl.2007.06.014; GRAVES JH, 1971, J INFECT DIS, V123, P386, DOI 10.1093/infdis/123.4.386; Henderson WM, 1949, REPORT SERIES AGR RE; Joo YS, 2002, CAN J VET RES, V66, P122; Knowles NJ, 2012, EMERG INFECT DIS, V18, P499, DOI 10.3201/eid1803.110908; Kweon CH, 2002, VIRUS RES, V90, P15, DOI 10.1016/S0168-1702(02)00139-9; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Lin YL, 2014, J VET MED SCI, V76, P1479, DOI 10.1292/jvms.14-0167; Malirat V, 2007, VIRUS RES, V124, P22, DOI 10.1016/j.virusres.2006.09.006; Mason PW, 2003, J GEN VIROL, V84, P1583, DOI 10.1099/vir.0.18669-0; Mattion N, 2004, VACCINE, V22, P4149, DOI 10.1016/j.vaccine.2004.06.040; Oem JK, 2008, J COMP PATHOL, V138, P204, DOI 10.1016/j.jcpa.2008.01.007; Oem Jae Ku, 2005, J Vet Sci, V6, P117; Oem JK, 2004, VIRUS GENES, V29, P63, DOI 10.1023/B:VIRU.0000032789.31134.eb; Pacheco JM, 2012, VET J, V193, P456, DOI 10.1016/j.tvjl.2012.01.012; Pacheco JM, 2010, J VET SCI, V11, P133, DOI 10.4142/jvs.2010.11.2.133; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Park JH, 2014, TRANSBOUND EMERG DIS, V61, P277, DOI 10.1111/tbed.12029; Park JH, 2013, TRANSBOUND EMERG DIS, V60, P188, DOI 10.1111/j.1865-1682.2012.01333.x; Quan M, 2009, J COMP PATHOL, V140, P225, DOI 10.1016/j.jcpa.2008.12.002; Sakamoto K, 2002, REV SCI TECH OIE, V21, P459, DOI 10.20506/rst.21.3.1347; Sorensen JH, 2000, EPIDEMIOL INFECT, V124, P577, DOI 10.1017/S095026889900401X; Sur JungHyang, 2000, Korean Journal of Veterinary Research, V40, P719; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731; Yoon H, 2012, TRANSBOUND EMERG DIS, V59, P517, DOI 10.1111/j.1865-1682.2011.01304.x; Yoon H, 2013, TRANSBOUNDARY EMERGI	33	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146445	10.1371/journal.pone.0146445	http://dx.doi.org/10.1371/journal.pone.0146445			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735130	Green Submitted, gold, Green Published			2022-12-27	WOS:000367805100048
J	Wang, Y; Lv, Y; Gao, SJ; Zhang, YY; Sun, JJ; Gong, CL; Chen, XJ; Li, GP				Wang, Yu; Lv, Yang; Gao, Shujun; Zhang, Yuanyuan; Sun, Jiajia; Gong, Chunling; Chen, Xiujuan; Li, Guangpeng			MicroRNA Profiles in Spontaneous Decidualized Menstrual Endometrium and Early Pregnancy Decidua with Successfully Implanted Embryos	PLOS ONE			English	Article							EXPRESSION; RNA; PATHWAY; WOMEN	To comparatively analyze the human microRNA (miRNA) profiles between spontaneous decidualized menstrual endometrium and early pregnancy decidua by an in-depth sequencing of miRNAs. The specific miRNAs expressed at conception might be involved in pregnancy establishment and expression of let-7f-5p and let-7g-5p was experimentally up-regulated or inhibited to assess the effect on the expression of IGF2BP-1 and IGF2R in vitro, respectively. Samples of endometria and deciduas were obtained from 25 women who suffered from tubal or male factor subfertility and from 35 early pregnant women who underwent pregnancy termination at 6-8 weeks gestation were irrespectively collected and comparatively analyzed by miRNA sequencing and differential expression of known and novel miRNAs was analyzed using bioinformatics. The 2042 miRNA expression was analyzed in the study and the differential expression of six miRNAs was validated by qRT-PCR. The expression of four miRNAs in decidua samples was down-regulated (miR-34c, miR-92a, miR-181a-5p, and miR-191), whereas the expression of miR-10a-5p and let-7f-5p was significantly up-regulated. The expression of IGF2BP-1 and IGF2R declined and increased with overexpression and inhibition of let-7f-5p and let-7g-5p, respectively. Changes in the expression of particular miRNAs might play a role in the physiology of decidualization following successful embryo implantation, ultimately resulting in continuous decidualization.	[Wang, Yu; Lv, Yang; Sun, Jiajia; Gong, Chunling; Li, Guangpeng] Inner Mongolia Univ, Minist Mammalian Reprod Biol & Biotechnol, Key Lab Natl Educ, Hohhot, Peoples R China; [Wang, Yu; Chen, Xiujuan] Inner Mongolia Med Univ, Dept Gynecol & Obstet, Affiliated Hosp, Hohhot, Peoples R China; [Gao, Shujun; Zhang, Yuanyuan] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia Medical University; Inner Mongolia University	Chen, XJ (corresponding author), Inner Mongolia Med Univ, Dept Gynecol & Obstet, Affiliated Hosp, Hohhot, Peoples R China.	chenxiujuan616@163.com; gpengli@imu.edu.cn	zhang, yuanyuan/GYA-4428-2022		Ministry of Science and Technology of China 973 Basic Science Project [2012CB722306]; National Natural Science Foundation of China [81560260]; Inner Mongolia Natural Science Foundation of China [2014MS0346, 2015MS08125]; MERCK CREAT Project; Open Research Fund of the State Key Laboratory of Inner Mongolia University [20130902]	Ministry of Science and Technology of China 973 Basic Science Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Natural Science Foundation of China; MERCK CREAT Project; Open Research Fund of the State Key Laboratory of Inner Mongolia University	This work was supported by a Ministry of Science and Technology of China 973 Basic Science Project Grant (2012CB722306) to GPL, http://www.most.gov.cn/; the National Natural Science Foundation of China (81560260) to YW, http://www.nsfc.gov.cn/; the Inner Mongolia Natural Science Foundation of China (2014MS0346, 2015MS08125) to YW, http://nsbr.nmkjt.gov.cn/index.aspx; the MERCK CREAT Project (2014) to YW, http://www.medsci.cn/merckserono_create/; and the Open Research Fund of the State Key Laboratory of Inner Mongolia University (20130902) to GPL, http://www.imu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Ministry of Science and Technology of China 973 Basic Science Project Grant (2012CB722306), the National Natural Science Foundation of China(81560260), the Inner Mongolia Natural Science Foundation of China (2014MS0346, 2015MS08125), the MERCK CREAT Project (2014), and the Open Research Fund of the State Key Laboratory of Inner Mongolia University (20130902).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Altmae S, 2013, REPROD SCI, V20, P308, DOI 10.1177/1933719112453507; Basile N, 2015, CURR OPIN OBSTET GYN, V27, P193, DOI 10.1097/GCO.0000000000000166; Burney RO, 2009, MOL HUM REPROD, V15, P625, DOI 10.1093/molehr/gap068; Carrington B, 2005, CURR OPIN OBSTET GYN, V17, P591, DOI 10.1097/01.gco.0000194112.86051.26; Chan HW, 2013, PLACENTA, V34, P443, DOI 10.1016/j.placenta.2013.02.008; Dai L, 2012, MOL HUM REPROD, V18, P136, DOI 10.1093/molehr/gar066; Dior UP, 2014, SEMIN REPROD MED, V32, P402, DOI 10.1055/s-0034-1376359; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Farmer WT, 2013, ANIM REPROD SCI, V138, P64, DOI 10.1016/j.anireprosci.2013.01.009; Filigheddu N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/369549; Fisher SJ, 2011, NAT MED, V17, P1348, DOI 10.1038/nm.2549; Flemr M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.118703; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Haouzi D, 2011, HUM REPROD, V26, P1440, DOI 10.1093/humrep/der075; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Leach RE, 2012, HUM REPROD, V27, P814, DOI 10.1093/humrep/der436; Lin SC, 2012, J CLIN ENDOCR METAB, V97, pE1515, DOI 10.1210/jc.2012-1450; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JE, 2007, GENE, V388, P125, DOI 10.1016/j.gene.2006.10.014; Lozoya T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087698; Maslova MA, 2015, B EXP BIOL MED+, V158, P781, DOI 10.1007/s10517-015-2861-5; Miese-Looy G, 2012, J REPROD DEVELOP, V58, P51, DOI 10.1262/jrd.09-191K; Miravet-Valenciano JA, 2015, CURR OPIN OBSTET GYN, V27, P187, DOI 10.1097/GCO.0000000000000173; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Ramon LA, 2011, HUM REPROD, V26, P1082, DOI 10.1093/humrep/der025; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Siristatidis C, 2015, IN VIVO, V29, P169; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Toloubeydokhti T, 2008, REPROD SCI, V15, P993, DOI 10.1177/1933719108324132; Wang Y, 2015, FERTIL STERIL, V103, P980, DOI 10.1016/j.fertnstert.2015.01.003; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566	40	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0143116	10.1371/journal.pone.0143116	http://dx.doi.org/10.1371/journal.pone.0143116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735129	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100003
J	Fianu, A; Bourse, L; Naty, N; Le Moullec, N; Lepage, B; Lang, T; Favier, F				Fianu, Adrian; Bourse, Lea; Naty, Nadege; Le Moullec, Nathalie; Lepage, Benoit; Lang, Thierry; Favier, Francois			Long-Term Effectiveness of a Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes in a Low Socio-Economic Community - An Intervention Follow-Up Study on Reunion Island	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ENERGY; RISK; RECOMMENDATIONS; PREVALENCE; REDUCTION	In type 2 diabetes (T2D) prevention research, evidence for maintenance of risk factor reduction after three years of follow-up is needed. The objective of this study was to evaluate the long-term effectiveness of a combined lifestyle intervention aiming at controlling body weight (BW) and waist circumference (WC) in non-diabetic, overweight/obese adults living in a low socio-economic community. On Reunion Island, 445 adults living in deprived areas, aged 18-40 and at high-risk for T2D, were included in an intervention versus control trial for primary prevention (2001-2002). The intervention promoted a healthy diet and moderate regular physical activity, through actions strengthening individuals or community and improving living conditions. The control group received a one-shot medical information and nutritional advices. After the end of the trial (2003), 259 of the subjects participated in a follow-up study (20102011). The outcomes were the nine-year changes from baseline in BW, body mass index (BMI) and WC measurements, separately. Statistical analyses were performed on an intention-to-treat basis, using available and imputed datasets. At inclusion, T2D risk factors were prevalent: family history of diabetes in first-degree relatives (42%), women with a personal history of gestational diabetes (11%), total obesity (43%, median BMI 29.1 kg/m(2)) and central obesity (71%). At follow-up, the adjusted effect on imputed dataset was significant for WC -2.4 cm (95% confidence interval: -4.7 to -0.0 cm, p = 0.046), non-significant for BW -2.2 kg (-4.6 to +0.2 kg, p = 0.073) and BMI -0.81 kg/m(2) (-1.69 to +0.08 kg/m(2), p = 0.074). A specific long-term effect was the increased likelihood of reduction in adiposity: BW loss, BMI reduction, and WCreduction were more frequent in the intervention group. In the context of low	[Fianu, Adrian; Bourse, Lea; Naty, Nadege; Favier, Francois] INSERM, Ctr Invest Clin Reunion CIC 1410, St Pierre, Reunion, France; [Fianu, Adrian; Bourse, Lea; Naty, Nadege; Favier, Francois] CHU Reunion, Ctr Invest Clin Reunion CIC 1410, St Pierre, Reunion, France; [Fianu, Adrian; Lepage, Benoit; Lang, Thierry] Univ Toulouse 3, UMR1027, F-31062 Toulouse, France; [Fianu, Adrian; Lepage, Benoit; Lang, Thierry] Fac Med Toulouse, INSERM, UMR1027, F-31073 Toulouse, France; [Le Moullec, Nathalie] CHU Reunion, Serv Endocrinol Diabetol & Nutr, St Pierre, Reunion, France; [Lang, Thierry] Ctr Hosp Univ Toulouse, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion; CHU de Toulouse	Fianu, A (corresponding author), INSERM, Ctr Invest Clin Reunion CIC 1410, St Pierre, Reunion, France.	adrian.fianu@chu-reunion.fr	Lang, Thierry/C-1686-2009; LANG, THIERRY/ABC-4576-2021; Lepage, Benoit/AAD-6193-2021; LEPAGE, Benoit/R-4715-2019; LEPAGE, Benoit/C-1228-2011	LANG, THIERRY/0000-0003-3406-8970; LEPAGE, Benoit/0000-0002-1586-2055	National Institute for Health and Medical Research (INSERM); INPES (the National Institute for Prevention and Health Education)	National Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); INPES (the National Institute for Prevention and Health Education)	This work was supported by The National Institute for Health and Medical Research (INSERM) was the study sponsor. The REDIA-prev1 cohort study was carried out with financial support from INPES (the National Institute for Prevention and Health Education). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absetz P, 2009, DIABETES CARE, V32, P1418, DOI 10.2337/dc09-0039; Actif N, 2013, INSEE PARTENAIRES, P1; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2000, WHO TECH REP SER, P894; Basdevant A, 2002, DIABETES METAB, V28, P146; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Black AE, 1996, EUR J CLIN NUTR, V50, P72; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dellagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025738; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Enders C. K., 2010, APPL MISSING DATA AN; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; Favier F, 2005, DIABETES RES CLIN PR, V67, P234, DOI 10.1016/j.diabres.2004.07.013; Favier F, 2002, COMPORTEMENTS ALIMEN; Favier F, 2005, REV MED ASSUR MAL, V36, P5; Fiche profil-quartiers de la politique de la ville, 2012, FICH PROF QUART POL; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Harati H, 2010, AM J PREV MED, V38, P628, DOI 10.1016/j.amepre.2010.03.003; Janiszewski PM, 2007, DIABETES CARE, V30, P3105, DOI 10.2337/dc07-0945; Jiang LH, 2013, DIABETES CARE, V36, P2027, DOI 10.2337/dc12-1250; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Lepage B, 2015, EPIDEMIOLOGY, V26, P122, DOI 10.1097/EDE.0000000000000192; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2008, LANCET, V371, P1731, DOI 10.1016/S0140-6736(08)60740-0; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; National Institute for Health and Clinical Excellence, 2011, PREV TYP 2 DIAB POP, V35; O'Brien MJ, 2015, PREV MED, V77, P125, DOI 10.1016/j.ypmed.2015.05.017; Papoz L, 2002, DIABETES METAB, V28, P72; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Satterfield DW, 2003, DIABETES CARE, V26, P2643, DOI 10.2337/diacare.26.9.2643; Secretariat General du CIV, 2011, OBS NAT ZON URB SENS, P1; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Tuomilehto J, 2011, DIABETES CARE, V34, pS210, DOI 10.2337/dc11-s222; Walker CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131681; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whitehead M, 2007, J EPIDEMIOL COMMUN H, V61, P473, DOI 10.1136/jech.2005.037242; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	44	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146095	10.1371/journal.pone.0146095	http://dx.doi.org/10.1371/journal.pone.0146095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731676	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400093
J	Friedrichs, A; Spies, M; Harter, M; Buchholz, A				Friedrichs, Anke; Spies, Maren; Haerter, Martin; Buchholz, Angela			Patient Preferences and Shared Decision Making in the Treatment of Substance Use Disorders: A Systematic Review of the Literature	PLOS ONE			English	Article							NONRANDOM ASSIGNMENT; PROBLEM DRINKERS; PRIMARY-CARE; DRUG-USE; PARTICIPATION; SMOKING; CHOICE; IMPACT; INTERVENTION; DEPRESSION	Background Shared Decision Making (SDM) as means to the involvement of patients in medical decision making is increasingly demanded by treatment guidelines and legislation. Also, matching of patients' preferences to treatments has been shown to be effective regarding symptom reduction. Despite promising results for patients with substance use disorders (SUD) no systematic evaluation of the literature has been provided. The aim is therefore to give a systematic overview of the literature of patient preferences and SDM in the treatment of patients with SUD. Methods An electronic literature search of the databases Medline, Embase, Psyndex and Clinical Trials Register was performed. Variations of the search terms substance use disorders, patient preferences and SDM were used. For data synthesis the populations, interventions and outcomes were summarized and described according to the PRISMA statement. Methodological quality of the included articles was assessed with the Mixed Methods Appraisal Tool. Results N = 25 trials were included in this review. These were conducted between 1986 and 2014 with altogether n = 8.729 patients. Two studies found that patients with SUD preferred to be actively involved in treatment decisions. Treatment preferences were assessed in n = 18 studies, where the majority of patients preferred outpatient compared with inpatient treatment. Matching patients to preferences resulted in a reduction on substance use (n = 3 studies), but the majority of studies found no significant effect. Interventions for SDM differed across patient populations and optional therapeutic techniques. Discussion Patients with substance use disorders should be involved in medical treatment decisions, as patients with other health conditions. A suitable approach is Shared Decision Making, emphasizing the patients' preferences. However, due to the heterogeneity of the included studies, results should be interpreted with caution. Further research is needed regarding SDM interventions in patient populations with substance use disorders.	[Friedrichs, Anke; Spies, Maren; Haerter, Martin; Buchholz, Angela] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Friedrichs, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	an.friedrichs@uke.de		Harter, Martin/0000-0001-7443-9890	Federal Ministry of Education and Research (BMBF) [01GY1114]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The present study (project number No. 01GY1114) was funded by the Federal Ministry of Education and Research (BMBF; http://www.bmbf.de/en/). The sponsor had no further role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; or in the decision to submit the paper for publication.; The study was funded by the Federal Ministry of Education and Research (BMBF; registration code 01GY1114). The authors wish to thank Aisha Boettcher and Miriam Bartsch for their assistance with the data collection process, as well as Sarah Kissel and Benjamin Kahl for their assistance with the preparation of the manuscript.	Adamson SJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1864; Adamson SJ, 2005, DRUG ALCOHOL REV, V24, P209, DOI 10.1080/09595230500167502; Amann K, S3 LEITLINIE SCREENI; Beitinger R, 2014, CURR OPIN PSYCHIATR, V27, P222, DOI 10.1097/YCO.0000000000000057; Bernstein SM, 1999, J SUBST ABUSE TREAT, V17, P167, DOI 10.1016/S0740-5472(98)00071-3; Brener L, 2009, DRUG ALCOHOL DEPEN, V105, P172, DOI 10.1016/j.drugalcdep.2009.06.016; Brown TG, 2002, ADDICT BEHAV, V27, P585, DOI 10.1016/S0306-4603(01)00195-2; Centre for Reviews Dissemination, SYSTEMATIC REV CRDS, V009; Charles C, 1999, BRIT MED J, V319, P780, DOI 10.1136/bmj.319.7212.780; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Coulter A, 1997, J Health Serv Res Policy, V2, P112; Coulter A., IMPLEMENTING SHARED; Crawford MJ, 2003, ACTA PSYCHIAT SCAND, V107, P410, DOI 10.1034/j.1600-0447.2003.00049.x; Dillworth TM, 2009, BEHAV THER, V40, P72, DOI 10.1016/j.beth.2008.01.002; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Elwyn G, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-75; Enggasser JL, 2015, ADDICT BEHAV, V42, P63, DOI 10.1016/j.addbeh.2014.10.036; Flach SD, 2004, ADDICT BEHAV, V29, P791, DOI 10.1016/j.addbeh.2004.02.008; Friedmann PD, 2004, ADDICTION, V99, P962, DOI 10.1111/j.1360-0443.2004.00772.x; Frosch DL, 1999, AM J PREV MED, V17, P285, DOI 10.1016/S0749-3797(99)00097-5; Goebert D, 2011, J SUBST USE, V16, P161, DOI 10.3109/14659891.2011.554594; GOSSOP M, 1986, BRIT MED J, V293, P103, DOI 10.1136/bmj.293.6539.103; Graff FS, 2009, AM J ADDICTION, V18, P277, DOI 10.1080/10550490902925540; Green KE, 2011, ALCOHOL TREAT Q, V29, P45, DOI 10.1080/07347324.2011.538311; Guadagnoli E, 1998, SOC SCI MED, V47, P329, DOI 10.1016/S0277-9536(98)00059-8; Harter M, 2011, Z EVIDENZ FORTBILD Q, V105, P263, DOI 10.1016/j.zefq.2011.04.002; Harter M, 2011, Z EVIDENZ FORTBILD Q, V105, P229, DOI 10.1016/j.zefq.2011.04.018; Hamann J, 2006, ACTA PSYCHIAT SCAND, V114, P265, DOI 10.1111/j.1600-0447.2006.00798.x; Hamann J, 2007, HEALTH EXPECT, V10, P358, DOI 10.1111/j.1369-7625.2007.00458.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hser YI, 1999, J SUBST ABUSE TREAT, V16, P299, DOI 10.1016/S0740-5472(98)00037-3; Joosten EAG, 2011, INT J SOC PSYCHIATR, V57, P263, DOI 10.1177/0020764009354835; Joosten EAG, 2009, PSYCHOTHER PSYCHOSOM, V78, P245, DOI 10.1159/000219524; Joosten Eag, 2008, Patient Prefer Adherence, V2, P277; Joosten EAG, 2011, SUBST USE MISUSE, V46, P1037, DOI 10.3109/10826084.2011.552931; Kwan BM, 2010, BEHAV RES THER, V48, P799, DOI 10.1016/j.brat.2010.04.003; Legare F, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-144; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Lieberman DZ, 2014, INT J PSYCHIAT MED, V47, P231, DOI 10.2190/PM.47.3.d; Liebherz S, PATIENT PRE IN PRESS; Loh A, 2007, PATIENT EDUC COUNS, V67, P324, DOI 10.1016/j.pec.2007.03.023; Loh A, 2007, PATIENT EDUC COUNS, V65, P69, DOI 10.1016/j.pec.2006.05.007; Luty J., 2004, PSYCHIATRIC B, V28, P47, DOI [DOI 10.1192/PB.28.2.47, 10.1192/pb.28.2.47]; MAGURA S, 1988, INT J ADDICT, V23, P253, DOI 10.3109/10826088809033072; Marlowe DB, 2003, ADDICT BEHAV, V28, P387, DOI 10.1016/S0306-4603(01)00248-9; Marshall M, 2001, Health Technol Assess, V5, P1; McCarty D, 2014, PSYCHIAT SERV, V65, P718, DOI 10.1176/appi.ps.201300249; McCrady BS, 2011, PSYCHOL ADDICT BEHAV, V25, P521, DOI 10.1037/a0024037; McKay JR, 1998, J CONSULT CLIN PSYCH, V66, P697, DOI 10.1037/0022-006X.66.4.697; MCKAY JR, 1995, J CONSULT CLIN PSYCH, V63, P70, DOI 10.1037/0022-006X.63.1.70; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x; National Collaborating Centre for Mental Health, 2011, ALC US DIS NIC GUID; Neumann T, 2006, J TRAUMA, V61, P805, DOI 10.1097/01.ta.0000196399.29893.52; Neuner B, 2007, J INT MED RES, V35, P609, DOI 10.1177/147323000703500505; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Pace R, 2012, INT J NURS STUD, V49, P47, DOI 10.1016/j.ijnurstu.2011.07.002; Pluye P, PROPOSAL MIXED METHO; Silverstone P, 2015, J ADDICT PREV, V3, P1; SOBELL MB, 1992, BEHAV THER, V23, P43, DOI 10.1016/S0005-7894(05)80307-7; Sterling RC, 1997, AM J ADDICTION, V6, P168; Swift JK, 2009, J CLIN PSYCHOL, V65, P368, DOI 10.1002/jclp.20553; Tuten M, 2007, AM J DRUG ALCOHOL AB, V33, P547, DOI 10.1080/00952990701407454; Von Korff M, 2003, PSYCHOSOM MED, V65, P938, DOI 10.1097/01.PSY.0000097336.95046.0C; White R, 2007, J SUBST USE, V12, P365; Willemsen MC, 2006, ADDICTION, V101, P441, DOI 10.1111/j.1360-0443.2006.01349.x	67	68	69	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145817	10.1371/journal.pone.0145817	http://dx.doi.org/10.1371/journal.pone.0145817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731679	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400057
J	Li, BT; Lou, E; Hsu, M; Yu, HA; Naidoo, J; Zauderer, MG; Sima, C; Johnson, ML; Daras, M; DeAngelis, LM; Fleisher, M; Kris, MG; Azzoli, CG				Li, Bob T.; Lou, Emil; Hsu, Meier; Yu, Helena A.; Naidoo, Jarushka; Zauderer, Marjorie G.; Sima, Camelia; Johnson, Melissa L.; Daras, Mariza; DeAngelis, Lisa M.; Fleisher, Martin; Kris, Mark G.; Azzoli, Christopher G.			Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers	PLOS ONE			English	Article							EGFR MUTATION STATUS; TUMOR-MARKERS; CARCINOEMBRYONIC ANTIGEN; PROGNOSTIC-FACTORS; RADIATION-THERAPY; DIAGNOSIS; CYFRA-21-1; CARCINOMA; SURVIVAL; SCC	Background Lung cancers account for the majority of brain metastases which pose major therapeutic challenges. Biomarkers prognosticating for the development of brain metastases in patients with non-small cell lung cancers (NSCLC) may improve personalized care. Six serum proteomic biomarkers were previously investigated at Memorial Sloan Kettering but their associations with brain metastases were unknown. Methods Serum NSE, CYFRA 21-1, ProGRP, SCC-Ag, TIMP1, and HE4 by ELISA-based proteomic assays were prospectively collected from consecutive patients with stage IV NSCLC. Pretreatment serum biomarker levels as well as age, histology, and epidermal growth factor receptor (EGFR) mutation status were evaluated for association with the baseline presence of brain metastases using logistic regression and multivariable analysis. For patients without brain metastases at baseline, the cumulative incidence of subsequent brain metastases were compared according to baseline biomarkers and clinical factors using Gray's test. Results A total of 118 patients were enrolled, 31 (26%; 95% CI 0.19-0.35) had brain metastases at baseline and a further 26 (22%; 95% CI 0.15-0.30) developed brain metastases subsequently. Pre-treatment serum biomarker levels were available in 104 patients. There was no significant association between the six serum biomarkers and the baseline presence or subsequent development of brain metastases. Age younger than 65 years was the only clinical factor significantly associated with brain metastasis at baseline (OR 3.00; 95% CI 1.22-7.34, P = 0.02) by multivariable analysis. A trend toward increased cumulative incidence of subsequent brain metastases was observed in patients with EGFR mutation (p = 0.2), but this was not statistically significant possibly due to small sample size. Conclusions Serum NSE, CYFRA 21-1, Pro-GRP, SCC-Ag, TIMP1, and HE4 are not significantly associated with brain metastases. Our methods taking into account follow-up time may be applied to independent datasets to identify a patient cohort with a higher biologic propensity for developing brain metastases. Such information may be useful for the study of agents targeting the development of brain metastases.	[Li, Bob T.; Yu, Helena A.; Naidoo, Jarushka; Zauderer, Marjorie G.; Johnson, Melissa L.; Kris, Mark G.] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, Div Solid Tumor Oncol,Dept Med, New York, NY 10065 USA; [Li, Bob T.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lou, Emil] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Hsu, Meier; Sima, Camelia] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10017 USA; [Daras, Mariza; DeAngelis, Lisa M.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Fleisher, Martin] Mem Sloan Kettering Canc Ctr, Clin Chem Serv, Dept Lab Med, New York, NY 10065 USA; [Azzoli, Christopher G.] Massachusetts Gen Hosp, Ctr Canc, Thorac Oncol Program, Boston, MA 02114 USA	Cornell University; Memorial Sloan Kettering Cancer Center; University of Sydney; University of Minnesota System; University of Minnesota Twin Cities; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital	Li, BT (corresponding author), Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, Div Solid Tumor Oncol,Dept Med, 300 E 66th St,12th Floor, New York, NY 10065 USA.	lib1@mskcc.org		Zauderer, Marjorie/0000-0002-6109-5790; Kris, Mark/0000-0002-7317-5341; Lou, Emil/0000-0002-1607-1386; Naidoo, Jarushka/0000-0002-3470-8686; Li, Bob/0000-0001-6661-8733; DeAngelis, Lisa/0000-0002-6290-7818	Core Grant at Memorial Sloan Kettering Cancer Center from the National Institutes of Health, USA [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Core Grant at Memorial Sloan Kettering Cancer Center from the National Institutes of Health, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Unrestricted philanthropic funding to the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center was used to support the study, as received by MGK. This study was supported by the Core Grant (P30 CA008748) at Memorial Sloan Kettering Cancer Center from the National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardizzoni A, 2006, CANCER-AM CANCER SOC, V107, P2842, DOI 10.1002/cncr.22330; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Bhatt VR, 2013, J CLIN ONCOL, V31, P3162, DOI 10.1200/JCO.2013.49.8915; Burel-Vandenbos F, 2013, J NEURO-ONCOL, V111, P1, DOI 10.1007/s11060-012-0990-5; Chau CH, 2008, CLIN CANCER RES, V14, P5967, DOI 10.1158/1078-0432.CCR-07-4535; Daniele L, 2009, J THORAC ONCOL, V4, P684, DOI 10.1097/JTO.0b013e3181a52359; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Eichler AF, 2010, NEURO-ONCOLOGY, V12, P1193, DOI 10.1093/neuonc/noq076; Gaspar LE, 2005, J CLIN ONCOL, V23, P2955, DOI 10.1200/JCO.2005.08.026; Gore EM, 2011, J CLIN ONCOL, V29, P272, DOI 10.1200/JCO.2010.29.1609; Heon S, 2010, CLIN CANCER RES, V16, P5873, DOI 10.1158/1078-0432.CCR-10-1588; Hubbs JL, 2010, CANCER-AM CANCER SOC, V116, P5038, DOI 10.1002/cncr.25254; Jacot W, 2001, BRIT J CANCER, V84, P903, DOI 10.1054/bjoc.2000.1706; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lamy PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128836; Lee DS, 2012, TUMOR BIOL, V33, P1065, DOI 10.1007/s13277-012-0344-0; Lou E, 2014, CANCER BIOMARK, V14, P207, DOI 10.3233/CBM-140399; Mehta MP, 2003, J CLIN ONCOL, V21, P2529, DOI 10.1200/JCO.2003.12.122; Molina R, 2005, ANTICANCER RES, V25, P1773; Molina R, 2003, TUMOR BIOL, V24, P209, DOI 10.1159/000074432; Molina R, 2008, TUMOR BIOL, V29, P371, DOI 10.1159/000181180; Pintilie M, 2007, COMPETING RISKS A PR; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Sun MH, 2009, CLIN CANCER RES, V15, P4829, DOI 10.1158/1078-0432.CCR-08-2921; Tas F, 2000, J EXP CLIN CANC RES, V19, P477; VANDEPOL M, 1994, J NEURO-ONCOL, V19, P149, DOI 10.1007/BF01306456; Welsh JW, 2013, J CLIN ONCOL, V31, P895, DOI 10.1200/JCO.2011.40.1174; WIESKOPF B, 1995, CHEST, V108, P163, DOI 10.1378/chest.108.1.163	28	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146063	10.1371/journal.pone.0146063	http://dx.doi.org/10.1371/journal.pone.0146063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730601	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400086
J	Munoz-Gutierrez, I; de Ora, LO; Grinberg, IR; Garty, Y; Bayer, EA; Shoham, Y; Lamed, R; Borovok, I				Munoz-Gutierrez, Ivan; de Ora, Lizett Ortiz; Grinberg, Inna Rozman; Garty, Yuval; Bayer, Edward A.; Shoham, Yuval; Lamed, Raphael; Borovok, Ilya			Decoding Biomass-Sensing Regulons of Clostridium thermocellum Alternative Sigma-I Factors in a Heterologous Bacillus subtilis Host System	PLOS ONE			English	Article							QUANTITATIVE PROTEOMIC ANALYSIS; CELLULOSOME COMPONENTS; THERMOPHILIC BACTERIA; XYLANASE GENES; EXPRESSION; BINDING; IDENTIFICATION; ENDOGLUCANASE; RESISTANCE; ENZYMES	The Gram-positive, anaerobic, cellulolytic, thermophile Clostridium (Ruminiclostridium) thermocellum secretes a multi-enzyme system called the cellulosome to solubilize plant cell wall polysaccharides. During the saccharolytic process, the enzymatic composition of the cellulosome is modulated according to the type of polysaccharide(s) present in the environment. C. thermocellum has a set of eight alternative RNA polymerase sigma (s) factors that are activated in response to extracellular polysaccharides and share sequence similarity to the Bacillus subtilis sigma(I) factor. The aim of the present work was to demonstrate whether individual C. thermocellum sI-like factors regulate specific cellulosomal genes, focusing on C. thermocellum sigma(I6) and sigma(I3) factors. To search for putative sigma(I6)-and sigma(I3)-dependent promoters, bioinformatic analysis of the upstream regions of the cellulosomal genes was performed. Because of the limited genetic tools available for C. thermocellum, the functionality of the predicted sigma(I6)-and sigma(I3)-dependent promoters was studied in B. subtilis as a heterologous host. This system enabled observation of the activation of 10 predicted sigma(I6)-dependent promoters associated with the C. thermocellum genes: sigI6 (itself, Clo1313_2778), xyn11B (Clo1313_0522), xyn10D (Clo1313_0177), xyn10Z (Clo1313_2635), xyn10Y (Clo1313_1305), cel9V (Clo1313_0349), cseP (Clo1313_2188), sigI1 (Clo1313_2174), cipA (Clo1313_0627), and rsgI5 (Clo1313_0985). Additionally, we observed the activation of 4 predicted sigma(I3)-dependent promoters associated with the C. thermocellum genes: sigI3 (itself, Clo1313_1911), pl11 (Clo1313_1983), ce12 (Clo1313_0693) and cipA. Our results suggest possible regulons of sigma(I6) and sigma(I3) in C. thermocellum, as well as the sigma(I6) and sigma(I3) promoter consensus sequences. The proposed -35 and -10 promoter consensus elements of sigma(I6) are CNNAAA and CGAA, respectively. Additionally, a less conserved CGA sequence next to the C in the -35 element and a highly conserved AT sequence three bases	[Munoz-Gutierrez, Ivan; de Ora, Lizett Ortiz; Grinberg, Inna Rozman; Garty, Yuval; Lamed, Raphael; Borovok, Ilya] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Shoham, Yuval] Technion IIT, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel	Tel Aviv University; Weizmann Institute of Science; Technion Israel Institute of Technology	Borovok, I (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	ilyabo@tauex.tau.ac.il	Shoham, Yuval/M-4409-2013; Munoz-Gutierrez, Ivan/M-9493-2019; BOROVOK, ILYA/ABB-7370-2022	Munoz-Gutierrez, Ivan/0000-0002-9307-5073; BOROVOK, ILYA/0000-0003-1602-4499	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [238334]; Israel Science Foundation [24/11, 715/12, 500/10, 1349/13]; Sidney E. Frank Foundation through the ISF	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Israel Science Foundation(Israel Science Foundation); Sidney E. Frank Foundation through the ISF	IMG was supported with a postdoctoral fellowship by the Consejo Nacional de Ciencia y Tecnologia (CONACyT proposal number 238334) [http://www.conacyt.mx/]. This research was supported by the Israel Science Foundation (grant No. 24/11 to RL and IB; grant Nos. 715/12, 500/10 to YS, and 1349/13 to EAB) [http://www.isf.org.il/] with additional support issued to RL and IB by The Sidney E. Frank Foundation through the ISF. The authors	Akinosho H, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00066; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asai K, 2007, MICROBIOL-SGM, V153, P92, DOI 10.1099/mic.0.29239-0; Bahari L, 2011, J IND MICROBIOL BIOT, V38, P825, DOI 10.1007/s10295-010-0848-9; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1985, J BACTERIOL, V163, P552, DOI 10.1128/JB.163.2.552-559.1985; BAYER EA, 1983, J BACTERIOL, V156, P818, DOI 10.1128/JB.156.2.818-827.1983; BEGUIN P, 1986, MOL GEN GENET, V202, P251, DOI 10.1007/BF00331645; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dror TW, 2003, J BACTERIOL, V185, P5109, DOI 10.1128/JB.185.17.5109-5116.2003; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Fang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093169; FONTES CMGA, 1995, BIOCHEM J, V307, P151, DOI 10.1042/bj3070151; Gebhard S, 2014, ANTIMICROB AGENTS CH, V58, P1425, DOI 10.1128/AAC.02111-13; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; GREPINET O, 1988, J BACTERIOL, V170, P4576, DOI 10.1128/jb.170.10.4576-4581.1988; Hartl B, 2001, J BACTERIOL, V183, P2696, DOI 10.1128/JB.183.8.2696-2699.2001; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hayashi H, 1999, APPL MICROBIOL BIOT, V51, P348, DOI 10.1007/s002530051401; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Ho TD, 2011, INFECT IMMUN, V79, P3229, DOI 10.1128/IAI.00019-11; Hong W, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-80; Huang XJ, 1998, J BACTERIOL, V180, P3765, DOI 10.1128/JB.180.15.3765-3770.1998; Jindou S, 2006, FEMS MICROBIOL LETT, V254, P308, DOI 10.1111/j.1574-6968.2005.00040.x; Kahel-Raifer H, 2010, FEMS MICROBIOL LETT, V308, P84, DOI 10.1111/j.1574-6968.2010.01997.x; Kato S, 2004, INT J SYST EVOL MICR, V54, P2043, DOI 10.1099/ijs.0.63148-0; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Lamed R, 1983, BIOTECHNOL BIOENG S, V13, P163; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mascher T, 2007, J BACTERIOL, V189, P6919, DOI 10.1128/JB.00904-07; Mascher T, 2013, CURR OPIN MICROBIOL, V16, P148, DOI 10.1016/j.mib.2013.02.001; MISHRA S, 1991, J BACTERIOL, V173, P80, DOI 10.1128/jb.173.1.80-85.1991; MORAG E, 1993, APPL BIOCHEM BIOTECH, V43, P147, DOI 10.1007/BF02916439; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Paget MS, 2015, BIOMOLECULES, V5, P1245, DOI 10.3390/biom5031245; Radeck J, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-29; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Rigden DJ, 2004, TRENDS BIOCHEM SCI, V29, P335, DOI 10.1016/j.tibs.2004.05.002; SALAMITOU S, 1992, FEBS LETT, V304, P89, DOI 10.1016/0014-5793(92)80595-8; Sambrook J., 2001, MOL CLONING LAB MANU; Sand A, 2015, FEBS LETT, V589, P3133, DOI 10.1016/j.febslet.2015.08.026; TOKATLIDIS K, 1991, FEBS LETT, V291, P185, DOI 10.1016/0014-5793(91)81279-H; Tseng CL, 2008, J BACTERIOL, V190, P1561, DOI 10.1128/JB.01497-07; Viljoen JA, 1926, J AGR SCI, V16, P1, DOI 10.1017/S0021859600088249; Wei H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00142; Yaniv O, 2014, ACTA CRYSTALLOGR D, V70, P522, DOI 10.1107/S139900471302926X; Yaniv O, 2013, ACTA CRYSTALLOGR F, V69, P733, DOI 10.1107/S174430911301614X; Yano K, 2011, BIOSCI BIOTECH BIOCH, V75, P966, DOI 10.1271/bbb.110035; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1; Yuki M, 2014, GENOME ANNOUNC, V2, P5, DOI [10.1128/genomeA.00110-14, DOI 10.1128/GEN0MEA.00110-14]; Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199; Zverlov VV, 2005, MICROBIOL-SGM, V151, P3395, DOI 10.1099/mic.0.28206-0; Zverlov VV, 2003, MICROBIOL-SGM, V149, P515, DOI 10.1099/mic.0.25959-0; Zverlov VV, 2002, APPL ENVIRON MICROB, V68, P3176, DOI 10.1128/AEM.68.6.3176-3179.2002	57	20	21	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146316	10.1371/journal.pone.0146316	http://dx.doi.org/10.1371/journal.pone.0146316			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731480	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400146
J	Souho, T; El Fatemi, H; Karim, S; El Rhazi, K; Bouchikhi, C; Banani, A; Melhouf, MA; Benlemlih, M; Bennani, B				Souho, Tiatou; El Fatemi, Hinde; Karim, Safae; El Rhazi, Karima; Bouchikhi, Chahrazed; Banani, Abdelaziz; Melhouf, Moulay Abdelilah; Benlemlih, Mohamed; Bennani, Bahia			Distribution of Carcinogenic Human Papillomavirus Genotypes and Association to Cervical Lesions among Women in Fez (Morocco)	PLOS ONE			English	Article							PREVALENCE; CANCER; HPV; INFECTION; PROVINCE; IMPLEMENTATION; CYTOLOGY; CHINA	Objectives To determine the distribution of cervical high-risk human papillomavirus genotypes and their association to cellular abnormalities in women from Fez and its neighborhood. Methods Women attending the Hassan II University Hospital for cervical pap smears were recruited after an informed consent. Interviews and two cervical samples were performed for each woman. Cervical samples were used for cytological analysis and HPV DNA detection. HPV was typed using a method based on multiplex PCR with fluorescently labeled specific primers followed by capillary electrophoresis. The study was approved by the ethics committee of the Faculty of Medicine and Pharmacy of Fez. Results The HPV prevalence in the studied population was 43.1% and the most prevalent types were HPV 53 (23 cases); HPV 16 (20 cases); HPV 35 (18 cases); HPV 51 (10 cases) and HPV 56 (7 cases). From the 619 confirmed pap smears, 20% were abnormal. The cytological abnormalities were significantly associated to HPV infection, women age, number of pregnancies and parity (p < 0.05). Conclusion More attention should be given to HPV in Morocco because it represents an important public health concern. The distribution of carcinogenic HPV types in the studied population is different from the data in other regions but epidemiological studies in other Moroccan regions are required.	[Souho, Tiatou; Karim, Safae] USMBA, FMPF, Lab Microbiol & Biol Mol, Fes, Morocco; [Souho, Tiatou; Karim, Safae; Benlemlih, Mohamed; Bennani, Bahia] USMBA, Fac Sci Dhar El Mahraz, Biotechnol Lab, Fes, Morocco; [El Fatemi, Hinde] CHU Hassan II, Lab Cent Anal Med, Fes, Morocco; [El Rhazi, Karima] USMBA, FMPF, Lab Epidemiol Rech Clin & Sante Communautaire, Fes, Morocco; [Bouchikhi, Chahrazed; Banani, Abdelaziz] CHU Hassan II, Serv Gynecol Obstet 1, Fes, Morocco; [Melhouf, Moulay Abdelilah] CHU Hassan II, Serv Gynecol Obstet 2, Fes, Morocco; [Bennani, Bahia] USMBA, FMPF, Equipe Microorganismes Genom & Facteurs Oncogenes, Lab Pathol Humaine Biomed & Environm, Fes, Morocco	Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Hassan II University Hospital Center of Fez; Sidi Mohamed Ben Abdellah University of Fez	Bennani, B (corresponding author), USMBA, FMPF, Lab Microbiol & Biol Mol, Fes, Morocco.	bahia.bennani@usmba.ac.ma		Souho, Tiatou/0000-0002-8288-1643; , bahia/0000-0002-5509-3991; KARIM, Safae/0000-0003-3518-632X				Al-Ahdal MN, 2014, J INFECT DEV COUNTR, V8, P320, DOI 10.3855/jidc.4220; Alhamany Z, 2010, J INFECT DEV COUNTR, V4, P732, DOI 10.3855/jidc.781; AlObaid A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0643-8; Andrae B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e900; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Bennani B, 2012, J INFECT DEV COUNTR, V6, P543, DOI 10.3855/jidc.1675; Bigoni J, 2014, INT J CANC; Cochand-Priollet B, 2006, ANN PATHOL, V26, P382; de Kok IMCM, 2011, INT J CANCER, V128, P2174, DOI 10.1002/ijc.25553; el Khair MM, 2009, J MED VIROL, V81, P678, DOI 10.1002/jmv.21279; Ghosh M, 2014, J STEROID BIOCHEM, V142, P171, DOI 10.1016/j.jsbmb.2013.09.003; Guettiti H, 2014, ASIAN PAC J CANCER P, V15, P9361, DOI 10.7314/APJCP.2014.15.21.9361; Halec G, 2014, J PATHOL, V234, P441, DOI 10.1002/path.4405; HUSMAN AMD, 1995, BRIT J CANCER, V72, P412, DOI 10.1038/bjc.1995.347; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; IARC Working Group, 2005, IARC HDB CANC PREV; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100E; Jing LP, 2014, SEX TRANSM DIS, V41, P725, DOI 10.1097/OLQ.0000000000000201; Jumaan AO, 2013, VACCINE, V31, pG58, DOI 10.1016/j.vaccine.2012.06.097; Liu XX, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0708-8; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Perlman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090912; Qmichou Z, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-378; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Ribassin-Majed L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032251; Salcedo M, 2014, ASIAN PAC J CANCER P, V15, P10061, DOI 10.7314/APJCP.2014.15.23.10061; Si-Mohamed A, 2005, J MED VIROL, V77, P430, DOI 10.1002/jmv.20472; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Souho T, 2014, J VIROL METHODS, V196, P45, DOI 10.1016/j.jviromet.2013.10.024; Tabrizi SN, 2014, J CLIN VIROL, V60, P250, DOI 10.1016/j.jcv.2014.04.013; Tshomo U, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-408; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang LQ, 2015, J MED VIROL, V87, P516, DOI 10.1002/jmv.24094; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	34	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146246	10.1371/journal.pone.0146246	http://dx.doi.org/10.1371/journal.pone.0146246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731415	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400127
J	Ulitzky, L; Lafer, MM; KuKuruga, MA; Silberstein, E; Cehan, N; Taylor, DR				Ulitzky, Laura; Lafer, Manuel M.; KuKuruga, Mark A.; Silberstein, Erica; Cehan, Nicoleta; Taylor, Deborah R.			A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TIGHT JUNCTIONAL RESISTANCE; PROTEIN-COUPLED RECEPTOR; HEPATOMA-CELLS; BREAST-CANCER; ENTRY; POLARIZATION; INFECTION; DISEASE; PROGRESSION	Poor outcome in response to hepatitis C virus, including higher viral load, hepatocellular carcinoma and cirrhosis, is more associated with men and postmenopausal women than with premenopausal women and women receiving hormone replacement therapy, suggesting that a-estradiol plays an innate role in preventing viral infection and liver disease. Consequently, most research in the field has concluded that estrogen affects HCV replication through viral interactions with estrogen receptor-a. Previously, estrogen-like antagonists, including Tamoxifen, were shown to reduce HCV RNA production and prevent viral entry, although the authors did not identify host factors involved. Estrogen can act alternatively through the membrane-bound G-protein-coupled estrogen receptor, GPR30. Here, human hepatoma Huh7.5 cells were infected with HCV J6/JFH-1 and treated with estrogen or Tamoxifen, resulting in a marked decrease in detectable virus. The effect was mimicked by G1, a GPR30-specific agonist, and was reversed by the GPR30-specific antagonist, G15. While previous studies have demonstrated that estrogen down-regulated occludin in cervical cancer cells, its action on liver cells was unknown. Occludin is a tight junction protein and HCV receptor and here we report that activation and cellular export of MMP-9 led to the cleavage of occludin upon estrogen treatment of liver cells. This is the first report of the cleavage of an HCV receptor in response to estrogen. We also identify the occludin cleavage site in extracellular Domain D; the motif required for HCV entry and spread. This pathway gives new insight into a novel innate antiviral pathway and the suboptimal environment that estrogen provides for the proliferation of the virus. It may also explain the disparate host-virus responses to HCV demonstrated by the two sexes. Moreover, these data suggest that hormone replacement therapy may have beneficial antiviral enhancement properties for HCV-infected postmenopausal women and show promise for new antiviral treatments for both men and women.	[Ulitzky, Laura; Lafer, Manuel M.; KuKuruga, Mark A.; Silberstein, Erica; Cehan, Nicoleta; Taylor, Deborah R.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Taylor, DR (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Deborah.Taylor@fda.hhs.gov			Office of Women's Health, U.S. Food and Drug Administration	Office of Women's Health, U.S. Food and Drug Administration	This work was funded by the Office of Women's Health, U.S. Food and Drug Administration.; We gratefully acknowledge funding by the Office of Women's Health, U.S. Food and Drug Administration. We thank C.M. Rice for virus and cells and special thanks to German Anez for helpful discussions and invaluable input. The findings and conclusions in this article have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.	Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Benedicto I, 2011, WORLD J GASTROENTERO, V17, P2683, DOI 10.3748/wjg.v17.i22.2683; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Capone F, 2012, CLIN BIOCHEM, V45, P525, DOI 10.1016/j.clinbiochem.2012.02.004; Collins BM, 1997, STEROIDS, V62, P365, DOI 10.1016/S0039-128X(96)00246-2; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Di Martino V, 2004, HEPATOLOGY, V40, P1426, DOI 10.1002/hep.20463; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Finamore A, 2008, J NUTR, V138, P1664, DOI 10.1093/jn/138.9.1664; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; Gorodeski GI, 2007, ENDOCRINOLOGY, V148, P218, DOI 10.1210/en.2006-1120; Hayashi J, 1998, ARCH INTERN MED, V158, P177, DOI 10.1001/archinte.158.2.177; Hayashida K, 2010, MICROBIOL IMMUNOL, V54, P684, DOI 10.1111/j.1348-0421.2010.00268.x; Huet E, 2011, AM J PATHOL, V179, P1278, DOI 10.1016/j.ajpath.2011.05.036; IWAMURA K, 1979, ACTA HEPATO-GASTRO, V26, P267; Kashima H, 2009, ENDOCR-RELAT CANCER, V16, P113, DOI 10.1677/ERC-08-0117; Kim DH, 2008, J NEUROSCI, V28, P208, DOI 10.1523/JNEUROSCI.3674-07.2008; Kohaar I, 2010, J VIROL, V84, P6987, DOI 10.1128/JVI.00196-10; Li W, 2009, J MED CHEM, V52, P1799, DOI 10.1021/jm900093d; Li YX, 2012, J VIROL, V86, P12531, DOI 10.1128/JVI.01136-12; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2010, VIROLOGY, V407, P160, DOI 10.1016/j.virol.2010.08.009; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; McKenna N, 2000, NAT MED, V6, P960, DOI 10.1038/79637; Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Mekky RY, 2012, TRANSL RES, V159, P190, DOI 10.1016/j.trsl.2011.08.002; Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Murakami Y, 2013, MICROBES INFECT, V15, P45, DOI 10.1016/j.micinf.2012.10.003; Naito Y, 2004, INFLAMM RES, V53, P462, DOI 10.1007/s00011-004-1281-1; NEWMAN KM, 1994, ARTERIOSCLER THROMB, V14, P1315, DOI 10.1161/01.ATV.14.8.1315; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x; Shimizu I, 2001, INTERNAL MED, V40, P100, DOI 10.2169/internalmedicine.40.100; Silberstein E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000910; Steenbergen RH, 2013, HEPATOLOGY, V58, P1907, DOI 10.1002/hep.26566; Stevenson BR, 1998, ANNU REV CELL DEV BI, V14, P89, DOI 10.1146/annurev.cellbio.14.1.89; SUTHERLAND RL, 1980, NATURE, V288, P273, DOI 10.1038/288273a0; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Voloshenyuk TG, 2010, AM J PHYSIOL-REG I, V299, pR683, DOI 10.1152/ajpregu.00162.2010; Zeng R, 2004, J CLIN ENDOCR METAB, V89, P5145, DOI 10.1210/jc.2004-0823; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104	48	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145212	10.1371/journal.pone.0145212	http://dx.doi.org/10.1371/journal.pone.0145212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731262	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400027
J	Vanterpool, SF; Been, JV; Houben, ML; Nikkels, PGJ; De Krijger, RR; Zimmermann, LJI; Kramer, BW; Progulske-Fox, A; Reyes, L				Vanterpool, Sizzle F.; Been, Jasper V.; Houben, Michiel L.; Nikkels, Peter G. J.; De Krijger, Ronald R.; Zimmermann, Luc J. I.; Kramer, Boris W.; Progulske-Fox, Ann; Reyes, Leticia			Porphyromonas gingivalis within Placental Villous Mesenchyme and Umbilical Cord Stroma Is Associated with Adverse Pregnancy Outcome	PLOS ONE			English	Article							AMNIOTIC-FLUID; PRETERM BIRTH; PERIODONTAL PATHOGENS; INFECTION; DISEASE; TERM; TRANSMISSION; INFLAMMATION; DELIVERY; INVASION	Intrauterine presence of Porphyromonas gingivalis (Pg), a common oral pathobiont, is implicated in preterm birth. Our aim was to determine if the location of Pg within placental and/or umbilical cord sections was associated with a specific delivery diagnosis at preterm delivery (histologic chorioamnionitis, chorioamnionitis with funisitis, preeclampsia, and preeclampsia with HELLP-syndrome, small for gestational age). The prevalence and location of Pg within archived placental and umbilical cord specimens from preterm (25 to 32 weeks gestation) and term control cohorts were evaluated by immunofluorescent histology. Detection of Pg was performed blinded to pregnancy characteristics. Multivariate analyses were performed to evaluate independent effects of gestational age, being small for gestational age, specific preterm delivery diagnosis, antenatal steroids, and delivery mode, on the odds of having Pg in the preterm tissue. Within the preterm cohort, 49 of 97 (51%) placentas and 40 of 97 (41%) umbilical cord specimens were positive for Pg. Pg within the placenta was significantly associated with shorter gestation lengths (OR 0.63 (95% CI: 0.48-0.85; p = 0.002) per week) and delivery via caesarean section (OR 4.02 (95% CI: 1.15-14.04; p = 0.03), but not with histological chorioamnionitis or preeclampsia. However, the presence of Pg in the umbilical cord was significantly associated with preeclampsia: OR 6.73 (95% CI: 1.31-36.67; p = 0.02). In the term cohort, 2 of 35 (6%) placentas and no umbilical cord term specimens were positive for Pg. The location of Pg within the placenta was different between preterm and term groups in that Pg within the villous mesenchyme was only detected in the preterm cohort, whereas Pg associated with syncytiotrophoblasts was found in both preterm and term placentas. Taken together, our results suggest that the presence of Pg within the villous stroma or umbilical cord may be an important determinant in Pg-associated adverse pregnancy outcomes.	[Vanterpool, Sizzle F.; Been, Jasper V.; Zimmermann, Luc J. I.; Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, NL-6200 MD Maastricht, Netherlands; [Vanterpool, Sizzle F.; Kramer, Boris W.] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, NL-6200 MD Maastricht, Netherlands; [Been, Jasper V.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, NL-6200 MD Maastricht, Netherlands; [Been, Jasper V.] Erasmus Univ, Div Neonatol, Med Center, Sophia Childrens Hosp, Rotterdam, Netherlands; [Houben, Michiel L.] Univ Med Ctr Utrecht, Dept Pediat, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [De Krijger, Ronald R.] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Zimmermann, Luc J. I.; Kramer, Boris W.] Maastricht Univ, Sch Oncol & Dev Biol GROW, NL-6200 MD Maastricht, Netherlands; [Progulske-Fox, Ann; Reyes, Leticia] Univ Florida, Dept Oral Biol, Ctr Mol Microbiol, Gainesville, FL 32610 USA; [Reyes, Leticia] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	Maastricht University; Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Maastricht University; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison	Reyes, L (corresponding author), Univ Florida, Dept Oral Biol, Ctr Mol Microbiol, Gainesville, FL 32610 USA.	lreyes2@wisc.edu	Kramer, Boris/AAO-3183-2021; Reyes, Leticia/H-7338-2019; de Krijger, Ronald/J-2564-2019		Revolving Fund Erasmus MC Rotterdam; Wilhelmina Children's Hospital Research Fund [2004.02]; Catharijne Stichting; University of Florida, College of Dentistry; AXA doctoral research grant; Maastricht University Kootstra Talent Fellowship	Revolving Fund Erasmus MC Rotterdam; Wilhelmina Children's Hospital Research Fund; Catharijne Stichting; University of Florida, College of Dentistry(University of Florida); AXA doctoral research grant(AXA Research Fund); Maastricht University Kootstra Talent Fellowship	This work was supported by the Revolving Fund Erasmus MC Rotterdam; the Wilhelmina Children's Hospital Research Fund (2004.02); the Catharijne Stichting; departmental funding from the University of Florida, College of Dentistry. Sizzle Vanterpool is supported by an AXA doctoral research grant and a Maastricht University Kootstra Talent Fellowship. The study sponsors were not involved in study design; in the collection, analysis or interpretation of data; in the writing of the report; nor in the decision to submit the article for publication.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ao M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137249; Arce RM, 2009, PLACENTA, V30, P156, DOI 10.1016/j.placenta.2008.11.017; Barak S, 2007, J PERIODONTOL, V78, P670, DOI 10.1902/jop.2007.060362; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Been JV, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001596; Been JV, 2013, EUR J EPIDEMIOL, V28, P525, DOI 10.1007/s10654-013-9804-0; Been JV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.025; Belanger M, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.067; Bernischke K, 2006, PATHOLOGY HUMAN PLAC, P44; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chaparro A, 2013, J PERIODONTAL RES, V48, P802, DOI 10.1111/jre.12074; Dorn BR, 2000, FEMS MICROBIOL LETT, V187, P139, DOI 10.1016/S0378-1097(00)00191-9; Duryea EL, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.038; Ercan E, 2013, ACTA ODONTOL SCAND, V71, P553, DOI 10.3109/00016357.2012.697576; Geusens N, 2010, PLACENTA, V31, P320, DOI 10.1016/j.placenta.2010.01.011; Gonzales-Marin C, 2011, MOL ORAL MICROBIOL, V26, P277, DOI 10.1111/j.2041-1014.2011.00616.x; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Han YW, 2011, J DENT RES, V90, P289, DOI 10.1177/0022034510381905; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Han YPW, 2006, J CLIN MICROBIOL, V44, P1475, DOI 10.1128/JCM.44.4.1475-1483.2006; Houben ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006572; Howsen C, 2012, BORN TOO SOON GLOBAL; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; Inaba H, 2009, CELL MICROBIOL, V11, P1517, DOI 10.1111/j.1462-5822.2009.01344.x; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Kim JY, 2015, J PATHOL TRANSL MED, V49, P462, DOI 10.4132/jptm.2015.10.23; Leon R, 2007, J PERIODONTOL, V78, P1249, DOI 10.1902/jop.2007.060368; Li L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-26; Lin DM, 2003, INFECT IMMUN, V71, P5156, DOI 10.1128/IAI.71.9.5156-5162.2003; Lin DM, 2003, INFECT IMMUN, V71, P5163, DOI 10.1128/IAI.71.9.5163-5168.2003; Lopez E, 2010, CLIN MICROBIOL INFEC, V16, P1539, DOI [10.1111/j.1469-0691.2009.03151.x, 10.1111/j.1469-0691.2010.03151.x]; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Marchesan JT, 2012, MOL ORAL MICROBIOL, V27, P483, DOI 10.1111/omi.12001; Mendz GL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00058; Michelin MCAN, 2012, ORAL DIS, V18, P648, DOI 10.1111/j.1601-0825.2012.01917.x; Redline RW, 2015, SEMIN PERINATOL, V39, P2, DOI 10.1053/j.semperi.2014.10.002; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732; Rodrigues PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052606; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Sanz M, 2013, J PERIODONTOL, V84, pS164, DOI [10.1902/jop.2013.1340016, 10.1111/jcpe.12083]; Swati P, 2012, ARCH GYNECOL OBSTET, V285, P613, DOI 10.1007/s00404-011-2012-9; TAKECHI K, 1993, PLACENTA, V14, P235, DOI 10.1016/S0143-4004(05)80264-4; Tribble GD, 2013, FUTURE MICROBIOL, V8, P607, DOI [10.2217/FMB.13.30, 10.2217/fmb.13.30]; Wang M, 2009, ORAL MICROBIOL IMMUN, V24, P478, DOI 10.1111/j.1399-302X.2009.00545.x; Wu F, 2016, AM J REPROD IMMUNOL, V76, P258, DOI 10.1111/aji.12454; Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821	49	47	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146157	10.1371/journal.pone.0146157	http://dx.doi.org/10.1371/journal.pone.0146157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731111	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400107
J	Gratia, M; Vende, P; Charpilienne, A; Baron, HC; Laroche, C; Sarot, E; Pyronnet, S; Duarte, M; Poncet, D				Gratia, Matthieu; Vende, Patrice; Charpilienne, Annie; Baron, Hilma Carolina; Laroche, Cecile; Sarot, Emeline; Pyronnet, Stephane; Duarte, Mariela; Poncet, Didier			Challenging the Roles of NSP3 and Untranslated Regions in Rotavirus mRNA Translation	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN NSP3; EUKARYOTIC TRANSLATION; CONSENSUS SEQUENCE; INITIATION; EXPRESSION; RECOGNITION; BINDING; GENOME; CAP; EIF4G	Rotavirus NSP3 is a translational surrogate of the PABP-poly(A) complex for rotavirus mRNAs. To further explore the effects of NSP3 and untranslated regions (UTRs) on rotavirus mRNAs translation, we used a quantitative in vivo assay with simultaneous cytoplasmic NSP3 expression (wild-type or deletion mutant) and electroporated rotavirus-like and standard synthetic mRNAs. This assay shows that the last four GACC nucleotides of viral mRNA are essential for efficient translation and that both the NSP3 eIF4G-and RNA-binding domains are required. We also show efficient translation of rotavirus-like mRNAs even with a 5'UTR as short as 5 nucleotides, while more than eleven nucleotides are required for the 3'UTR. Despite the weak requirement for a long 5'UTR, a good AUG environment remains a requirement for rotavirus mRNAs translation.	[Gratia, Matthieu; Vende, Patrice; Charpilienne, Annie; Baron, Hilma Carolina; Laroche, Cecile; Duarte, Mariela; Poncet, Didier] USC INRA 1358, Dept Virol, UMR 9198, I2BC, Gif Sur Yvette, France; [Duarte, Mariela] Univ Evry Val dEssonne, Dept Biol, Evry, France; [Sarot, Emeline; Pyronnet, Stephane] Univ Toulouse 3, INSERM UMR 1037, Lab Excellence Toulouse Canc TOUCAN, Equipe Labellisee Ligue Canc Toulouse, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Poncet, D (corresponding author), USC INRA 1358, Dept Virol, UMR 9198, I2BC, Gif Sur Yvette, France.	didier.poncet@i2bc.paris-saclay.fr	Poncet, Didier/AAV-6583-2021; Pyronnet, Stéphane/P-2419-2014	Poncet, Didier/0000-0001-7689-0175; Pyronnet, Stephane/0000-0002-9562-5112	INRA (Institut National de la recherche agronomique); INSERM Institut National de la sante et de la recherche medicale; Universite d'evry;  [ANR-09-MIEN-04]	INRA (Institut National de la recherche agronomique); INSERM Institut National de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite d'evry; 	This work was supported by ANR-09-MIEN-04 "Trans-Inf-Rot" (http://www.agence-nationale-recherche.fr/), INRA (Institut National de la recherche agronomique) (http://www.inra.fr/), INSERM Institut National de la sante et de la recherche medicale (http://www.inserm.fr/), and Universite d'evry (http://www.univ-evry.fr/fr/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Au H. H., 2014, REV RNA, V5, P779, DOI [10.1002/wrna.1246, DOI 10.1002/WRNA.1246]; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Barreau C, 2006, RNA, V12, P1790, DOI 10.1261/rna.191706; Bath AJ, 2002, J BIOL CHEM, V277, P4024, DOI 10.1074/jbc.M108441200; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P18077, DOI 10.1073/pnas.0608212103; Chizhikov V, 2000, RNA, V6, P814, DOI 10.1017/S1355838200992264; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Elfakess R, 2011, NUCLEIC ACIDS RES, V39, P7598, DOI 10.1093/nar/gkr484; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gratia M, 2015, J VIROL, V89, P8773, DOI 10.1128/JVI.01402-15; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Harb M, 2008, J VIROL, V82, P11283, DOI 10.1128/JVI.00872-08; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kearney K, 2004, EMBO J, V23, P4072, DOI 10.1038/sj.emboj.7600408; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1977, NATURE, V269, P390, DOI 10.1038/269390a0; KOZAK M, 1991, GENE EXPRESSION, V1, P111; LAZAROWITZ SG, 1977, J BIOL CHEM, V252, P7842; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; Martin F, 2011, MOL CELL, V41, P197, DOI 10.1016/j.molcel.2010.12.019; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Montero H, 2006, J VIROL, V80, P9031, DOI 10.1128/JVI.00437-06; Paek KY, 2015, P NATL ACAD SCI USA, V112, P1041, DOI 10.1073/pnas.1416883112; Patton JT, 2001, J VIROL, V75, P2076, DOI 10.1128/JVI.75.5.2076-2086.2001; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; PONCET D, 1993, J VIROL, V67, P3159, DOI 10.1128/JVI.67.6.3159-3165.1993; Richards JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074328; Rong M, 1998, J BIOL CHEM, V273, P10253, DOI 10.1074/jbc.273.17.10253; Rubio RM, 2013, J VIROL, V87, P6336, DOI 10.1128/JVI.00361-13; Rydzik AM, 2009, ORG BIOMOL CHEM, V7, P4763, DOI 10.1039/b911347a; Sen A, 2012, P NATL ACAD SCI USA, V109, P20667, DOI 10.1073/pnas.1212188109; Stepinski J, 2001, RNA, V7, P1486; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Troupin C, 2010, J VIROL, V84, P6711, DOI 10.1128/JVI.00547-10; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Vende P, 2013, VIRUS RES, V176, P144, DOI 10.1016/j.virusres.2013.05.018; Vitour D, 2004, J VIROL, V78, P3851, DOI 10.1128/JVI.78.8.3851-3862.2004; Yang AD, 2004, ARCH VIROL, V149, P303, DOI 10.1007/s00705-003-0211-9	51	13	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145998	10.1371/journal.pone.0145998	http://dx.doi.org/10.1371/journal.pone.0145998			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727111	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500045
J	Leemann, A; Kolly, MJ; Purves, R; Britain, D; Glaser, E				Leemann, Adrian; Kolly, Marie-Jose; Purves, Ross; Britain, David; Glaser, Elvira			Crowdsourcing Language Change with Smartphone Applications	PLOS ONE			English	Article							DATA-COLLECTION; SOCIOLINGUISTICS; AUTHENTICITY; ELEPHANT; ROOM	Crowdsourcing linguistic phenomena with smartphone applications is relatively new. In linguistics, apps have predominantly been developed to create pronunciation dictionaries, to train acoustic models, and to archive endangered languages. This paper presents the first account of how apps can be used to collect data suitable for documenting language change: we created an app, Dialakt App (DA), which predicts users' dialects. For 16 linguistic variables, users select a dialectal variant from a drop-down menu. DA then geographically locates the user's dialect by suggesting a list of communes where dialect variants most similar to their choices are used. Underlying this prediction are 16 maps from the historical Linguistic Atlas of German-speaking Switzerland, which documents the linguistic situation around 1950. Where users disagree with the prediction, they can indicate what they consider to be their dialect's location. With this information, the 16 variables can be assessed for language change. Thanks to the playfulness of its functionality, DA has reached many users; our linguistic analyses are based on data from nearly 60,000 speakers. Results reveal a relative stability for phonetic variables, while lexical and morphological variables seem more prone to change. Crowdsourcing large amounts of dialect data with smartphone apps has the potential to complement existing data collection techniques and to provide evidence that traditional methods cannot, with normal resources, hope to gather. Nonetheless, it is important to emphasize a range of methodological caveats, including sparse knowledge of users' linguistic backgrounds (users only indicate age, sex) and users' self-declaration of their dialect. These are discussed and evaluated in detail here. Findings remain intriguing nevertheless: as a means of quality control, we report that traditional dialectological methods have revealed trends similar to those found by the app. This underlines the validity of the crowdsourcing method. We are presently extending DA architecture to other languages.	[Leemann, Adrian] Univ Cambridge, Dept Theoret & Appl Linguist, Phonet Lab, Cambridge, England; [Kolly, Marie-Jose] CNRS, Lab Informat Mecan & Sci Ingn, F-91405 Orsay, France; [Kolly, Marie-Jose] Univ Zurich, Dept Comparat Linguist, Zurich, Switzerland; [Purves, Ross] Univ Zurich, Dept Geog, Zurich, Switzerland; [Britain, David] Univ Bern, Dept English, Bern, Switzerland; [Glaser, Elvira] Univ Zurich, German Dept, Zurich, Switzerland	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; University of Zurich; University of Bern; University of Zurich	Leemann, A (corresponding author), Univ Cambridge, Dept Theoret & Appl Linguist, Phonet Lab, Cambridge, England.	al764@cam.ac.uk		Leemann, Adrian/0000-0001-9401-8938				BFS = Bundesamt fur Statistik, 2012, AMTL GEM SCHW; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Brabham DC, 2009, PLAN THEOR, V8, P242, DOI 10.1177/1473095209104824; Britain D., 2010, LANGUAGE IDENTITIES, P193; Britain David, 2015, RES NO ENGLISH, P417; BRITAIN DAVID, 2009, INT J SOCIOLOGY LANG, V2009, P121, DOI [DOI 10.1515/IJSL.2009.019, 10.1515/IJSL.2009.019]; Brown HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100662; Brupbacher M, 2015, GRUEZI MOIN SERVUS; Bry F, 2013, P 2 INT WORKSH SOC M, P4; Bucholtz M, 2003, J SOCIOLING, V7, P398, DOI 10.1111/1467-9481.00232; Callison-Burch C, 2010, P NAACL HLT 2010 WOR, P1; Chambers J., 1980, DIALECTOLOGY; Chambers J. K., 1994, ENGL WORLD-WIDE, V15, P35, DOI DOI 10.1075/EWW.15.1.03CHA; CHAMBERS JK, 1992, LANGUAGE, V68, P673, DOI 10.2307/416850; Christen H., 2013, KLEINER SPRACHATLAS; Christen H, 1988, FOLIA LINGUIST, V32, P53; Christen Helen, 2001, Z DIALEKTOL LINGUIST, V1, P16; Clopper CG, 2005, BLACKW HBK LINGUIST, P313; Cooke M., 2013, CROWDSOURCING SPEECH, V137, P172; de Vries NJ, 2014, SPEECH COMMUN, V56, P119, DOI 10.1016/j.specom.2013.07.001; Eckert P, 2003, J SOCIOLING, V7, P392, DOI 10.1111/1467-9481.00231; Eskenazi M, 1991, COROWDSOURCING SPEEC, P1; Eskenazi M., 2013, CROWDSOURCING SPEECN, P8; Glaser E, 2008, WORTSCHATZ SCHWEIZER; Godwin-Jones R, 2011, LANG LEARN TECHNOL, V15, P2; Goldman JP, 2014, P LREC 2014 REYKJ; Goncalves B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112074; Guntern M, 2011, Z DIALEKTOL LINGUIST, V78, P155; Hennig Beate, 2001, KLEINES MITTELHOCHDE; Hotzenkocherle Rudolf, 1984, SPRACHLANDSCHAFTEN D; Juska-Bacher B, 2012, LINGUISTIK ONLINE, V61, P7; JUSKABACHER B, 2010, LINGUISTIK ONLINE, V42, P19; Katz J, 2013, SODA POP OR COKE; Katz J, 2013, NEW YORK TIMES ONLIN; Kehrein R, 2010, PERCEPTUAL DIALECTOL, P351; Kolly M.J., 2015, TRENDS PHONETICS PHO, P271, DOI DOI 10.5167/UZH-117114; Kolly MJ, 2014, P DIG HUM 2014 LAUS, P231; Labov W., 1996, PAPERS PARASESSION T, P77; Labov W., 2005, ATLAS N AM ENGLISH; Labov William, 1979, SOCIOLINGUISTIC PATT; LAUGWITZ B, 2001, DIMENSIONS INTERNET, P131; Leemann A, 2014, LANG VAR CHANGE, V26, P191, DOI 10.1017/S0954394514000076; Leemann A, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P524; Leemann Adrian, 2013, DIALAKT APP; Lotscher A, 1983, SCHWEIZEREDEUTCH GES; McGraw I., 2013, CROWDSOURCING SPEECH, P38; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Milroy L., 2003, SOCIOLINGUISTICS MET; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Rozovskaya Alla, 2011, P 49 ANN M ASS COMP, P508; Sauer J. R., 1996, CHRISTMAS BIRD COUNT; Sayers D, 2014, J SOCIOLING, V18, P185, DOI 10.1111/josl.12069; Schilling Natalie, 2013, SOCIOLINGUISTIC FIEL; Schlippe T, 2014, SPEECH COMMUN, V56, P101, DOI 10.1016/j.specom.2013.06.015; Stuart-Smith J, 2013, LANGUAGE, V89, P501, DOI 10.1353/lan.2013.0041; Trudgill P., 1983, ON DIALECT; Trudgill Peter, 1986, DIALECTS CONTACT; Vaux B., 2003, HARVARD DIALECT SURV; Vaux B, 2014, US DIALECT APP; Wenker Georg, 1881, SPRACH ATLAS NORD MI; Wolfensberger H, 1967, DARGESTELLT AUSSCHNI; Wrede F, 1956, DTSCH SPRACHTALTS GR	62	29	29	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0143060	10.1371/journal.pone.0143060	http://dx.doi.org/10.1371/journal.pone.0143060			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DA3FF	26726775	Green Published, gold, Green Accepted			2022-12-27	WOS:000367681500002
J	Kim, SY; Park, SE; Shim, SM; Park, S; Kim, KK; Jeong, SY; Choi, EK; Hwang, JJ; Jin, DH; Chung, CD; Kim, I				Kim, So-Young; Park, Sang Eun; Shim, Sang-Mi; Park, Sojung; Kim, Kyung Kon; Jeong, Seong-Yun; Choi, Eun Kyung; Hwang, Jung Jin; Jin, Dong-Hoon; Chung, Christopher Doosoon; Kim, Inki			Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; KINASE INHIBITOR; LIGAND TRAIL; BETA-TRCP; RESISTANCE; PATHWAY; DEATH; SYK; CHEMOSENSITIZATION; TRANSCRIPTION	Breast cancer cells generally develop resistance to TNF-Related Apoptosis-Inducing Ligand (TRAIL) and, therefore, assistance from sensitizers is required. In our study, we have demonstrated that Spleen tyrosine kinase (Syk) inhibitor Bay 61-3606 was identified as a TRAIL sensitizer. Amplification of TRAIL-induced apoptosis by Bay 61-3606 was accompanied by the strong activation of Bak, caspases, and DNA fragmentation. In mechanism of action, Bay 61-3606 sensitized cells to TRAIL via two mechanisms regulating myeloid cell leukemia sequence-1 (Mcl-1). First, Bay 61-3606 triggered ubiquitin-dependent degradation of Mcl-1 by regulating Mcl-1 phosphorylation. Second, Bay 61-3606 down-regulates Mcl-1 expression at the transcription level. In this context, Bay 61-3606 acted as an inhibitor of Cyclin-Dependent Kinase (CDK) 9 rather than Syk. In summary, Bay 61-3606 downregulates Mcl-1 expression in breast cancer cells and sensitizes cancer cells to TRAIL-mediated apoptosis.	[Kim, So-Young; Park, Sang Eun; Park, Sojung; Kim, Kyung Kon; Jeong, Seong-Yun; Hwang, Jung Jin; Chung, Christopher Doosoon; Kim, Inki] ASAN Med Ctr, ASAN Inst Life Sci, Seoul, South Korea; [Shim, Sang-Mi] Seoul Natl Univ, Dept Biomed Sci, Seoul, South Korea; [Choi, Eun Kyung] Univ Ulsan, Coll Med, ASAN Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Kyung Kon; Jeong, Seong-Yun; Hwang, Jung Jin; Jin, Dong-Hoon; Kim, Inki] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Jeong, Seong-Yun; Choi, Eun Kyung; Hwang, Jung Jin; Jin, Dong-Hoon] ASAN Med Ctr, Inst Innovat Canc Res, Seoul, South Korea	University of Ulsan; Asan Medical Center; Seoul National University (SNU); University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center	Kim, I (corresponding author), ASAN Med Ctr, ASAN Inst Life Sci, Seoul, South Korea.	ik.kim@amc.seoul.kr	Hwang, Jung Jin/F-3424-2014		National Research Foundation of Korea (NRF) - Ministry of Science, Information & Communication Technology (ICT) and Future Planning [NRF-2014R1A1A1003831]; Center for Women in Science, Engineering and Technology (WISET) - Ministry of Science, ICT & Future Planning of Korea (MSIP) under the Program for Returners into RD, Korea [KW-2015-PPD-0134]	National Research Foundation of Korea (NRF) - Ministry of Science, Information & Communication Technology (ICT) and Future Planning; Center for Women in Science, Engineering and Technology (WISET) - Ministry of Science, ICT & Future Planning of Korea (MSIP) under the Program for Returners into RD, Korea	New Scientist Funding in Basic Science Research Program (NRF-2014R1A1A1003831) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information & Communication Technology (ICT) and Future Planning (90% CONTRIBUTION RATE). Center for Women in Science, Engineering and Technology (WISET) grant funded by the Ministry of Science, ICT & Future Planning of Korea (MSIP) under the Program for Returners into R&D (KW-2015-PPD-0134), Korea (10% CONTRIBUTION RATE).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Beranova L, 2013, APOPTOSIS, V18, P739, DOI 10.1007/s10495-013-0823-9; Bettayeb Karima, 2010, Genes Cancer, V1, P369, DOI 10.1177/1947601910369817; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; den Hollander MW, 2013, CANCER LETT, V332, P194, DOI 10.1016/j.canlet.2012.04.007; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Gururajan M, 2007, J IMMUNOL, V178, P111, DOI 10.4049/jimmunol.178.1.111; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Han Y, 2014, ONCOL REP, V31, P456, DOI 10.3892/or.2013.2838; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lau KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041343; Leahomschi S, 2013, NEOPLASMA, V60, P223, DOI 10.4149/neo_2013_030; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oh B, 2012, BIOCHEM BIOPH RES CO, V422, P42, DOI 10.1016/j.bbrc.2012.04.093; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Ren H, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-146; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Walczak H, 2001, TRENDS BIOCHEM SCI, V26, P452, DOI 10.1016/S0968-0004(01)01895-3; Walsby E, 2014, ONCOTARGET, V5, P375, DOI 10.18632/oncotarget.1568; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Wirth T, 2005, CANCER RES, V65, P7393, DOI 10.1158/0008-5472.CAN-04-3664; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	35	9	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146073	10.1371/journal.pone.0146073	http://dx.doi.org/10.1371/journal.pone.0146073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720004	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900042
J	Abu Khweek, A; Kanneganti, A; Guttridge, DC; Amer, AO				Abu Khweek, Arwa; Kanneganti, Apurva; Guttridge D, Denis C.; Amer, Amal O.			The Sphingosine-1-Phosphate Lyase (LegS2) Contributes to the Restriction of Legionella pneumophila in Murine Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; EFFECTOR PROTEIN DRRA; MOUSE MODEL; IFN-GAMMA; RECOGNITION; PHAGOSOME; RESPONSES; ACTIVATION; INFECTION	L. pneumophila is the causative agent of Legionnaires' disease, a human illness characterized by severe pneumonia. In contrast to those derived from humans, macrophages derived from most mouse strains restrict L. pneumophila replication. The restriction of L. pneumophila replication has been shown to require bacterial flagellin, a component of the type IV secretion system as well as the cytosolic NOD-like receptor (NLR) Nlrc4/Ipaf. These events lead to caspase-1 activation which, in turn, activates caspase-7. Following caspase-7 activation, the phagosome-containing L. pneumophila fuses with the lysosome, resulting in the restriction of L. pneumophila growth. The LegS2 effector is injected by the type IV secretion system and functions as a sphingosine 1-phosphate lyase. It is homologous to the eukaryotic sphingosine lyase (SPL), an enzyme required in the terminal steps of sphingolipid metabolism. Herein, we show that mice Bone Marrow-Derived Macrophages (BMDMs) and human Monocyte-Derived Macrophages (hMDMs) are more permissive to L. pneumophila legS2 mutants than wild-type (WT) strains. This permissiveness to L. pneumophila legS2 is neither attributed to abolished caspase-1, caspase-7 or caspase-3 activation, nor due to the impairment of phagosome-lysosome fusion. Instead, an infection with the legS2 mutant resulted in the reduction of some inflammatory cytokines and their corresponding mRNA; this effect is mediated by the inhibition of the nuclear transcription factor kappa-B (NF-kappa B). Moreover, BMDMs infected with L. pneumophila legS2 mutant showed elongated mitochondria that resembles mitochondrial fusion. Therefore, the absence of LegS2 effector is associated with reduced NF-kappa B activation and atypical morphology of mitochondria.	[Abu Khweek, Arwa] Birzeit Univ, Dept Biol & Biochem, West Bank, Palestine; [Kanneganti, Apurva; Amer, Amal O.] Ohio State Univ, Coll Med, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Guttridge D, Denis C.] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA	Birzeit University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Abu Khweek, A (corresponding author), Birzeit Univ, Dept Biol & Biochem, West Bank, Palestine.	arwakhweek@gmail.com	Amer, Amal/E-2643-2011	Kanneganti, Apurva/0000-0002-0834-7207; Guttridge, Denis/0000-0002-7276-6609	Birzeit University; Ohio State University (OSU) Bridge funds; Public Health Preparedness for Infectious Diseases (PHPID); Center for Clinical and Translational Science (CCTS) [R21 AI113477, R01 HL094586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113477] Funding Source: NIH RePORTER	Birzeit University; Ohio State University (OSU) Bridge funds; Public Health Preparedness for Infectious Diseases (PHPID); Center for Clinical and Translational Science (CCTS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Studies in Dr. Arwa Abu Khweek's laboratory are supported by Birzeit University. Studies in Dr. Amal Amer's laboratory are supported by Ohio State University (OSU) Bridge funds, Public Health Preparedness for Infectious Diseases (PHPID), Center for Clinical and Translational Science (CCTS), R21 AI113477, and R01 HL094586). Dr. Amer provided cell lines, bacteria, some kits and working space for some of the conducted work and helped in revising the manuscript [http://cmib.osu.edu/people/faculty/amalamer/]. Dr. Arwa Abu Khweek does not have funding.	Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Akhter A, 2012, IMMUNITY; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Amer AO, 2010, CELL MICROBIOL, V12, P140, DOI 10.1111/j.1462-5822.2009.01401.x; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Archer KA, 2010, INFECT IMMUN, V78, P2477, DOI 10.1128/IAI.00243-10; Archer KA, 2009, CELL MICROBIOL, V11, P21, DOI 10.1111/j.1462-5822.2008.01234.x; Bartfeld S, 2009, CELL MICROBIOL, V11, P1638, DOI 10.1111/j.1462-5822.2009.01354.x; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Bhan U, 2008, INFECT IMMUN, V76, P2895, DOI 10.1128/IAI.01489-07; BLANCHARD DK, 1987, INFECT IMMUN, V55, P433, DOI 10.1128/IAI.55.2.433-437.1987; BRIELAND JK, 1995, INFECT IMMUN, V63, P3253, DOI 10.1128/IAI.63.9.3253-3258.1995; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen Y, 2010, DIAGN MICR INFEC DIS, V66, P253, DOI 10.1016/j.diagmicrobio.2009.11.001; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Degtyar E, 2009, CELL MICROBIOL, V11, P1219, DOI 10.1111/j.1462-5822.2009.01328.x; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Fernandez-Serrano S, 2003, CLIN DIAGN LAB IMMUN, V10, P813, DOI 10.1128/CDLI.10.5.813-820.2003; Finsel I, 2015, CELL MICROBIOL, V17, P935, DOI 10.1111/cmi.12450; Fuse ET, 2007, J MED MICROBIOL, V56, P305, DOI 10.1099/jmm.0.46913-0; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Gomes LC, 2011, AUTOPHAGY, V7, P1251, DOI 10.4161/auto.7.10.16771; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Habyarimana F, 2008, ENVIRON MICROBIOL, V10, P1460, DOI 10.1111/j.1462-2920.2007.01560.x; Hervet E, 2011, INFECT IMMUN, V79, P1936, DOI 10.1128/IAI.00805-10; Hilbi H, 2006, CELL MICROBIOL, V8, P1697, DOI 10.1111/j.1462-5822.2006.00793.x; Hilbi H, 2012, TRAFFIC, V13, P1187, DOI 10.1111/j.1600-0854.2012.01344.x; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Jeschke A, 2015, P NATL ACAD SCI USA, V112, P4636, DOI 10.1073/pnas.1423456112; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Khweek AA, 2013, EUR J IMMUNOL, V43, P1333, DOI 10.1002/eji.201242835; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; McHugh SL, 2000, P SOC EXP BIOL MED, V224, P191, DOI 10.1046/j.1525-1373.2000.22420.x; McPhee JB, 2010, INFECT IMMUN, V78, P3529, DOI 10.1128/IAI.00269-10; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Park DR, 1996, J IMMUNOL, V157, P2528; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Price CTD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00131; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Rothmeier E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003598; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Santic M, 2005, INFECT IMMUN, V73, P3166, DOI 10.1128/IAI.73.5.3166-3171.2005; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Schmeck B, 2007, EUR RESPIR J, V29, P25, DOI 10.1183/09031936.00141005; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Stavru F, 2013, P NATL ACAD SCI USA, V110, P16003, DOI 10.1073/pnas.1315784110; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tateda K, 1998, CLIN DIAGN LAB IMMUN, V5, P401, DOI 10.1128/CDLI.5.3.401-403.1998; Tilney LG, 2001, J CELL SCI, V114, P4637; Urwyler Simon, 2009, Commun Integr Biol, V2, P107; Weber S, 2014, MBIO, V5, DOI 10.1128/mBio.00839-13; Yoshizawa S, 2005, INFECT IMMUN, V73, P2709, DOI 10.1128/IAI.73.5.2709-2717.2005; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	74	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146410	10.1371/journal.pone.0146410	http://dx.doi.org/10.1371/journal.pone.0146410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741365	gold, Green Published, Green Submitted			2022-12-27	WOS:000367810600040
J	Adams, SC; Garner, JP; Felt, SA; Geronimo, JT; Chu, DK				Adams, Sean C.; Garner, Joseph P.; Felt, Stephen A.; Geronimo, Jerome T.; Chu, David K.			A "Pedi" Cures All: Toenail Trimming and the Treatment of Ulcerative Dermatitis in Mice	PLOS ONE			English	Article							C57BL/6 MICE; LABORATORY MICE; VITAMIN-E; DISEASE; INFLAMMATION; BEHAVIOR; DEVELOP; DIET; UVB	Ulcerative Dermatitis (UD) is the most common cause of unplanned euthanasia in mice used in research, with prevalence rates reported between 4 and 21%. UD is characterized by a deep, ulcerative lesion that appears most commonly over the dorsal neck and is attendant with an intense pruritus. The underlying cause of UD is currently unknown, and as a consequence, there are no directed therapies that resolve lesions reliably. However, there is a growing body of evidence that suggests a behavioral component to the onset, maintenance, and progression of UD lesions. Scratching behavior in response to the intense pruritus associated with UD lesions may be an effective target for interventional therapies. We hypothesized that interfering with scratching behavior by trimming the toenails of mice with UD, would resolve UD lesions. To test this hypothesis, we first evaluated the efficacy of toenail trims with a single application of Vetericyn at the time of treatment versus our previous standard of care, topical Tresaderm applied daily. We found that toenail trims were significantly more effective at resolving lesions (n = 39 toenail trims, n = 100 Tresaderm, p<0.0001) with 93.3% of animals healing by 14 days (median time to lesion resolution). Furthermore, dorsal neck lesions did not recur by 42 days after a single toenail trim (n = 54); however, flank lesions did not resolve and the outcome of the two lesion distributions following treatment were significantly different (p<0.0001). Finally, we implemented toenail trims at an institutional level and found similar efficacies (approximately 90%) for toenail trims regardless of one-time topical supplement used (triple antibiotic ointment, Tresaderm, and Vetericyn, n = 55, 58, 18, p = 0.63). This is the first report of a highly effective treatment for one of the most serious welfare issues in laboratory mice.	[Adams, Sean C.; Garner, Joseph P.; Felt, Stephen A.; Geronimo, Jerome T.; Chu, David K.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Garner, Joseph P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Adams, SC (corresponding author), Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA.	Adamssc@stanford.edu	Garner, Joseph P/C-8422-2009	Felt, Stephen/0000-0001-7030-717X	NIH Grant [R25OD010452]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R25OD010452] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH Grant R25OD010452 to SAF and philanthropic donations to JPG for research in mouse welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by NIH Grant R25OD010452 to SAF and philanthropic donations to JPG for research in mouse welfare.	Andoh T, 1998, J PHARMACOL EXP THER, V286, P1140; ANDREWS AG, 1994, VET PATHOL, V31, P293, DOI 10.1177/030098589403100301; BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503; BLAZAR BR, 1993, J IMMUNOL, V151, P5726; Corsini E, 1997, PHOTODERMATOL PHOTO, V13, P147, DOI 10.1111/j.1600-0781.1997.tb00219.x; Duarte-Vogel SM, 2011, COMPARATIVE MED, V61, P13; Dufour BD, 2010, NUTR NEUROSCI, V13, P256, DOI 10.1179/147683010X12611460764688; Ezell PC, 2012, J AM ASSOC LAB ANIM, V51, P609; Forlow SB, 2002, J IMMUNOL, V169, P4797, DOI 10.4049/jimmunol.169.9.4797; Garner JP, 2011, BEHAV BRAIN RES, V219, P189, DOI 10.1016/j.bbr.2011.01.002; Garner JP, 2004, COMPARATIVE MED, V54, P216; George NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132092; Hampton AL, 2012, J AM ASSOC LAB ANIM, V51, P586; Han L, 2014, ANNU REV BIOPHYS, V43, P331, DOI 10.1146/annurev-biophys-051013-022826; Inagaki N, 2010, EUR J PHARMACOL, V626, P283, DOI 10.1016/j.ejphar.2009.09.043; Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8; Kwan KY, 2001, P NATL ACAD SCI USA, V98, P5717, DOI 10.1073/pnas.101132498; Lawson GW, 2005, CONTEMP TOP LAB ANIM, V44, P18; MacDonald MLE, 2009, ARTERIOSCL THROM VAS, V29, P341, DOI 10.1161/ATVBAHA.108.181099; Mallow C, 2014, LAB ANIMAL SCI PROFE, V2, P46; MARTEL N, 2011, TECH TALK, V16, P2; Marx JO, 2013, J AM ASSOC LAB ANIM, V52, P782; MILLER CC, 1994, J BIOL CHEM, V269, P3529; Mufford T, 2009, J AM ASSOC LAB ANIM, V48, P546; Rainsford K. D., 2009, Inflammopharmacology, V17, P275, DOI 10.1007/s10787-009-0016-x; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Seta S, 2009, J AM ASSOC LAB ANIM, V48, P608; Thornton VB, 2003, CONTEMP TOP LAB ANIM, V42, P49; Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379; Vieira G., 2014, THESIS; Williams-Fritze MJ, 2011, J AM ASSOC LAB ANIM, V50, P221; Wu D, 1998, AM J PHYSIOL-CELL PH, V275, pC661, DOI 10.1152/ajpcell.1998.275.3.C661	34	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144871	10.1371/journal.pone.0144871	http://dx.doi.org/10.1371/journal.pone.0144871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735497	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100014
J	Ximenez-Embun, MG; Ortego, F; Castanera, P				Ximenez-Embun, Miguel G.; Ortego, Felix; Castanera, Pedro			Drought-Stressed Tomato Plants Trigger Bottom-Up Effects on the Invasive Tetranychus evansi	PLOS ONE			English	Article							2-SPOTTED SPIDER-MITE; INSECT HERBIVORES; WATER-STRESS; CONTRASTING RESPONSES; ABIOTIC STRESSES; RESISTANCE; URTICAE; CONSEQUENCES; INHIBITORS; NITROGEN	Climate change will bring more drought periods that will have an impact on the irrigation practices of some crops like tomato, from standard water regime to deficit irrigation. This will promote changes in plant metabolism and alter their interactions with biotic stressors. We have tested if mild or moderate drought-stressed tomato plants (simulating deficit irrigation) have an effect on the biological traits of the invasive tomato red spider mite, Tetranychus evansi. Our data reveal that T evansi caused more leaf damage to drought-stressed tomato plants (>= 1.5 fold for both drought scenarios). Mite performance was also enhanced, as revealed by significant increases of eggs laid (>= 2 fold) at 4 days post infestation (dpi), and of mobile forms (>= 2 fold and 1.5 fold for moderate and mild drought, respectively) at 10 dpi. The levels of several essential amino acids (histidine, isoleucine, leucine, tyrosine, valine) and free sugars in tomato leaves were significantly induced by drought in combination with mites. The non-essential amino acid proline was also strongly induced, stimulating mite feeding and egg laying when added to tomato leaf disks at levels equivalent to that estimated on drought-infested tomato plants at 10 dpi. Tomato plant defense proteins were also affected by drought and/or mite infestation, but T. evansi was capable of circumventing their potential adverse effects. Altogether, our data indicate that significant increases of available free sugars and essential amino acids, jointly with their phagostimulant effect, created a favorable environment for a better T. evansi performance on drought-stressed tomato leaves. Thus, drought-stressed tomato plants, even at mild levels, may be more prone to T evansi outbreaks in a climate change scenario, which might negatively affect tomato production on area-wide scales.	[Ximenez-Embun, Miguel G.; Ortego, Felix; Castanera, Pedro] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Castanera, P (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid, Spain.	castan@cib.csic.es	Ortego, Félix/F-9402-2011; Ximenez-Embun, Miguel/AAE-4290-2021	Ortego, Félix/0000-0002-7778-8508; Ximenez-Embun, Miguel/0000-0002-2137-7937	INIA grant: GENOMITE [618105]	INIA grant: GENOMITE	This work was funded by an INIA grant: GENOMITE, Proposal No 618105 FACCE Era Net Plus-Food security, Agriculture, Climate Change (new generation sustainable tools to control emerging mite pests under climate change).	Akimov IA, 1997, ENTOMOL OBOZR, V56, P912; Alba JM, 2015, NEW PHYTOL, V205, P828, DOI 10.1111/nph.13075; Atkinson NJ., 2015, COMBINED STRESSES PL, P181, DOI [DOI 10.1007/978-3-319-07899-1_9, 10.1007/978-3-319-07899-1_9]; Azandeme-Hounmalon GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095071; Bauer D, 1997, PHYSIOL PLANTARUM, V99, P241, DOI 10.1034/j.1399-3054.1997.990205.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrillo L, 2011, PLANT CELL REP, V30, P101, DOI 10.1007/s00299-010-0948-z; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; DABROWSKI ZT, 1978, ENTOMOL EXP APPL, V24, P317, DOI 10.1007/BF02385080; EnglishLoeb G, 1997, OIKOS, V79, P456, DOI 10.2307/3546888; ENGLISHLOEB GM, 1990, ECOLOGY, V71, P1401, DOI 10.2307/1938277; EPPO, 2004, 052004 EPPO; Santamaria ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043011; Fitter A.H., 2002, ENV PHYSL PLANTS; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Guo HJ, 2013, GLOBAL CHANGE BIOL, V19, P3210, DOI 10.1111/gcb.12260; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Hacham Y, 2002, PLANT PHYSIOL, V128, P454, DOI 10.1104/pp.010819; Han P, 2015, ECOL EVOL, V5, P5468, DOI 10.1002/ece3.1788; Han P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04455; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Inbar M, 2001, OIKOS, V94, P228, DOI 10.1034/j.1600-0706.2001.940203.x; Johnson SN, 2014, ANN APPL BIOL, V165, P62, DOI 10.1111/aab.12115; Kant MR, 2015, ANN BOT-LONDON, V115, P1015, DOI 10.1093/aob/mcv054; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; LANGE WH, 1981, ANNU REV ENTOMOL, V26, P345, DOI 10.1146/annurev.en.26.010181.002021; Maness N, 2010, METHODS MOL BIOL, V639, P341, DOI 10.1007/978-1-60761-702-0_22; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Meynard CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066445; Migeon A, 2009, EXP APPL ACAROL, V48, P199, DOI 10.1007/s10493-008-9229-8; Mishra KB, 2012, PLANT SCI, V182, P79, DOI 10.1016/j.plantsci.2011.03.022; Mody K, 2009, ECOL ENTOMOL, V34, P133, DOI 10.1111/j.1365-2311.2008.01053.x; Mosolov VV, 2011, APPL BIOCHEM MICRO+, V47, P453, DOI 10.1134/S0003683811050097; Navajas M, 2013, EXP APPL ACAROL, V59, P43, DOI 10.1007/s10493-012-9590-5; Ortego Felix, 2012, P75; Ripoll J, 2014, J EXP BOT, V65, P4097, DOI 10.1093/jxb/eru197; RODRIGUEZ JG, 1966, J INSECT PHYSIOL, V12, P1209, DOI 10.1016/0022-1910(66)90012-6; Sadras VO, 1998, ANN BOT-LONDON, V81, P273, DOI 10.1006/anbo.1997.0551; Santamaria ME, 2015, J INSECT PHYSIOL, V78, P69, DOI 10.1016/j.jinsphys.2015.05.002; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Saunyama I. G. M., 2003, African Crop Science Journal, V11, P269; Seagraves MP, 2011, J INSECT BEHAV, V24, P132, DOI 10.1007/s10905-010-9242-8; Showler AT, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P387, DOI 10.5772/53125; Stocker T. F., 2013, CLIMATE CHANGE 2013; TULISALO U, 1971, Annales Entomologici Fennici, V37, P155; Valencia A, 2000, INSECT BIOCHEM MOLEC, V30, P207, DOI 10.1016/S0965-1748(99)00115-0; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; WERMELINGER B, 1991, EXP APPL ACAROL, V12, P259, DOI 10.1007/BF01193472; White TCR, 2009, OIKOS, V118, P807, DOI 10.1111/j.1600-0706.2009.17495.x; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Zhu-Salzman K, 2015, ANNU REV ENTOMOL, V60, P233, DOI 10.1146/annurev-ento-010814-020816	52	39	42	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145275	10.1371/journal.pone.0145275	http://dx.doi.org/10.1371/journal.pone.0145275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735490	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100023
J	Ban, JW; Emparanza, JI; Urreta, I; Burls, A				Ban, Jong-Wook; Ignacio Emparanza, Jose; Urreta, Iratxe; Burls, Amanda			Design Characteristics Influence Performance of Clinical Prediction Rules in Validation: A Meta-Epidemiological Study	PLOS ONE			English	Article							EXTERNAL VALIDATION; DIAGNOSTIC-ACCURACY; METHODOLOGICAL STANDARDS; EMPIRICAL-EVIDENCE; CONTROLLED-TRIALS; DECISION RULES; RHEUMATOID-ARTHRITIS; SYSTEMATIC REVIEWS; PROGNOSTIC MODELS; SEARCH STRATEGIES	Background Many new clinical prediction rules are derived and validated. But the design and reporting quality of clinical prediction research has been less than optimal. We aimed to assess whether design characteristics of validation studies were associated with the overestimation of clinical prediction rules' performance. We also aimed to evaluate whether validation studies clearly reported important methodological characteristics. Methods Electronic databases were searched for systematic reviews of clinical prediction rule studies published between 2006 and 2010. Data were extracted from the eligible validation studies included in the systematic reviews. A meta-analytic meta-epidemiological approach was used to assess the influence of design characteristics on predictive performance. From each validation study, it was assessed whether 7 design and 7 reporting characteristics were properly described. Results A total of 287 validation studies of clinical prediction rule were collected from 15 systematic reviews (31 meta-analyses). Validation studies using case-control design produced a summary diagnostic odds ratio (DOR) 2.2 times (95% CI: 1.2-4.3) larger than validation studies using cohort design and unclear design. When differential verification was used, the summary DOR was overestimated by twofold (95% CI: 1.2-3.1) compared to complete, partial and unclear verification. The summary RDOR of validation studies with inadequate sample size was 1.9 (95% CI: 1.2-3.1) compared to studies with adequate sample size. Study site, reliability, and clinical prediction rule was adequately described in 10.1%, 9.4%, and 7.0% of validation studies respectively. Conclusion Validation studies with design shortcomings may overestimate the performance of clinical prediction rules. The quality of reporting among studies validating clinical prediction rules needs to be improved.	[Ban, Jong-Wook] Univ Oxford, Dept Continuing Educ, Kellogg Coll, Evidence Based Hlth Care Programme, Oxford OX1 2JA, England; [Ignacio Emparanza, Jose; Urreta, Iratxe] Hosp Univ Donostia, Clin Epidemiol Unit, CIBER ESP, CASPe, San Sebastian, Spain; [Burls, Amanda] City Univ London, Sch Hlth Sci, London EC1V 0HB, England	University of Oxford; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; City University London	Ban, JW (corresponding author), Univ Oxford, Dept Continuing Educ, Kellogg Coll, Evidence Based Hlth Care Programme, Oxford OX1 2JA, England.	jong-wook.ban@conted.ox.ac.uk	Ban, Jong-Wook/N-4285-2019; Urreta Barallobre, Iratxe/ABB-2468-2021	Ban, Jong-Wook/0000-0002-6433-1250; Urreta Barallobre, Iratxe/0000-0003-0498-6033				Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Banal F, 2009, ANN RHEUM DIS, V68, P1184, DOI 10.1136/ard.2008.093187; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Dowling S, 2009, ACAD EMERG MED, V16, P277, DOI 10.1111/j.1553-2712.2008.00333.x; Geomini P, 2009, OBSTET GYNECOL, V113, P384, DOI 10.1097/AOG.0b013e318195ad17; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Giles MF, 2010, STROKE, V41, P667, DOI 10.1161/STROKEAHA.109.571174; Harrington L, 2010, J NURS ADMIN, V40, P483, DOI 10.1097/NNA.0b013e3181f88fbd; Hendriksen JMT, 2013, J THROMB HAEMOST, V11, P129, DOI 10.1111/jth.12262; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Holland Jennifer L, 2005, BMC Med Inform Decis Mak, V5, P11, DOI 10.1186/1472-6947-5-11; Hulsemann JL, 1999, ANN RHEUM DIS, V58, P278, DOI 10.1136/ard.58.5.278; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kontopantelis E, 2010, STATA J, V10, P395, DOI 10.1177/1536867X1001000307; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-21; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; McPhail MJW, 2010, J HEPATOL, V53, P492, DOI 10.1016/j.jhep.2010.03.023; Mitchell AJ, 2010, AM J GERIAT PSYCHIAT, V18, P1066, DOI 10.1097/JGP.0b013e3181f60f81; Mitchell AJ, 2010, J AFFECT DISORDERS, V125, P10, DOI 10.1016/j.jad.2009.08.019; Mitchell AJ, 2010, J AFFECT DISORDERS, V126, P335, DOI 10.1016/j.jad.2010.01.067; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Odgaard-Jensen J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub3; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutjes AWS, 2005, CLIN CHEM, V51, P1335, DOI 10.1373/clinchem.2005.048595; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Serrano LA, 2010, ANN EMERG MED, V56, P362, DOI 10.1016/j.annemergmed.2010.05.013; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stengel D, 2005, RADIOLOGY, V236, P102, DOI 10.1148/radiol.2361040791; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2009, CLIN PREDICTION MODE, Vxxviii; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Warnick EM, 2008, CHILD ADOL MENT H-UK, V13, P140, DOI 10.1111/j.1475-3588.2007.00461.x; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2013, J CLIN EPIDEMIOL, V66, P1093, DOI 10.1016/j.jclinepi.2013.05.014; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilczynski NL, 2007, J CLIN EPIDEMIOL, V60, P29, DOI 10.1016/j.jclinepi.2006.04.001; Wong Sharon S -L, 2003, AMIA Annu Symp Proc, P728; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	59	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145779	10.1371/journal.pone.0145779	http://dx.doi.org/10.1371/journal.pone.0145779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730980	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000367801400052
J	Buss, O; Jager, S; Dold, SM; Zimmermann, S; Hamacher, K; Schmitz, K; Rudat, J				Buss, O.; Jager, S.; Dold, S-M.; Zimmermann, S.; Hamacher, K.; Schmitz, K.; Rudat, J.			Statistical Evaluation of HTS Assays for Enzymatic Hydrolysis of beta-Keto Esters	PLOS ONE			English	Article							DIRECTED EVOLUTION; QUALITY-CONTROL; PH-INDICATORS; HYDROLASE LIBRARIES; SCREENING ASSAYS; LIPASE; SUBSTRATE; PURIFICATION; CRYSTALLIZATION; IDENTIFICATION	beta-keto esters are used as precursors for the synthesis of beta-amino acids, which are building blocks for some classes of pharmaceuticals. Here we describe the comparison of screening procedures for hydrolases to be used for the hydrolysis of beta-keto esters, the first step in the preparation of beta-amino acids. Two of the tested high throughput screening (HTS) assays depend on coupled enzymatic reactions which detect the alcohol released during ester hydrolysis by luminescence or absorption. The third assay detects the pH shift due to acid formation using an indicator dye. To choose the most efficient approach for screening, we assessed these assays with different statistical methods-namely, the classical Z'-factor, standardized mean difference (SSMD), the Kolmogorov-Smirnov-test, and t-statistics. This revealed that all three assays are suitable for HTS, the pH assay performing best. Based on our data we discuss the explanatory power of different statistical measures. Finally, we successfully employed the pH assay to identify a very fast hydrolase in an enzyme-substrate screening.	[Jager, S.; Hamacher, K.] Tech Univ Darmstadt, Computat Biol & Simulat, Darmstadt, Germany; [Zimmermann, S.] Karlsruhe Inst Technol, Biomol Separat Engn, D-76021 Karlsruhe, Germany; [Buss, O.; Dold, S-M.; Rudat, J.] Karlsruhe Inst Technol, Tech Biol, D-76021 Karlsruhe, Germany; [Schmitz, K.] Tech Univ Darmstadt, Biol Chem, Darmstadt, Germany	Technical University of Darmstadt; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Technical University of Darmstadt	Buss, O (corresponding author), Karlsruhe Inst Technol, Tech Biol, D-76021 Karlsruhe, Germany.	oliver.buss@kit.edu; jager@bio.tu-darmstadt.de	Schmitz, Katja/B-9342-2008	Schmitz, Katja/0000-0001-9023-318X	Federal Ministry of Education and Research (Germany) [031A095B]; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	This work was supported by Federal Ministry of Education and Research (Germany) funding code 031A095B, project: Molecular Interaction Engineering MIE (http://www.forschungmie.de/english/index.php). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology.	Andruska N, 2012, J BIOMOL SCREEN, V17, P921, DOI 10.1177/1087057112442960; [Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 2014, CHEMBIODRAW, V14; [Anonymous], 2003, ROMPP ONLINE; ARAKAWA H, 1981, STEROIDS, V38, P453, DOI 10.1016/0039-128X(81)90079-9; Azevedo AM, 2005, BIOSENS BIOELECTRON, V21, P235, DOI 10.1016/j.bios.2004.09.030; Banyai E., 1972, INDICATORS; Beisson F, 2000, EUR J LIPID SCI TECH, V102, P133, DOI 10.1002/(SICI)1438-9312(200002)102:2<133::AID-EJLT133>3.3.CO;2-O; BEUTLER HO, 1977, FRESEN Z ANAL CHEM, V284, P113, DOI 10.1007/BF00447345; Birner-Grunberger R, 2004, BIOTECHNOL BIOENG, V85, P147, DOI 10.1002/bit.10894; Borcard D, 2008, J STAT COMP UNPUB; Bornscheuer UT, 2004, ENG LIFE SCI, V4, P539, DOI 10.1002/elsc.200402157; Bornscheuer UT, 1999, BIOORGAN MED CHEM, V7, P2169, DOI 10.1016/S0968-0896(99)00147-9; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; Cao JZ, 2015, ANTIVIR RES, V114, P1, DOI 10.1016/j.antiviral.2014.11.010; Carroll SS, 2004, MOL CANCER THER, P119, DOI [http://dx.doi.org/10.1002/047165616X.ch7, DOI 10.1002/047165616X.CH7]; Cordova J, 2008, ENZYME MICROB TECH, V42, P278, DOI 10.1016/j.enzmictec.2007.10.007; COUDERC R, 1980, AGR BIOL CHEM TOKYO, V44, P2279, DOI 10.1080/00021369.1980.10864320; Crismaru CG, 2013, APPL ENVIRON MICROB, V79, P185, DOI 10.1128/AEM.02525-12; CROUT DHG, 1989, MOD SYN MET, V5, P1; Daiha KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131624; Dalal S, 2008, BIOTECHNOL APPL BIOC, V51, P23, DOI 10.1042/BA20070186; Demirjian DC, 1999, TOP CURR CHEM, V200, P1; Dyke KV, 2001, LUMINESCENCE BIOTECH; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Goddard JP, 2004, CURR OPIN BIOTECH, V15, P314, DOI 10.1016/j.copbio.2004.06.008; GROCHULSKI P, 1993, J BIOL CHEM, V268, P12843; HARTLEY BS, 1954, BIOCHEM J, V56, P288, DOI 10.1042/bj0560288; He N, 2011, ADV SYNTH CATAL, V353, P2384, DOI 10.1002/adsc.201100412; Hotta Y, 2002, APPL ENVIRON MICROB, V68, P3925, DOI 10.1128/AEM.68.8.3925-3931.2002; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; ISHIHARA H, 1975, BIOCHIM BIOPHYS ACTA, V388, P413; Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610; Janes LE, 1998, CHEM-EUR J, V4, P2324, DOI 10.1002/(SICI)1521-3765(19981102)4:11<2324::AID-CHEM2324>3.0.CO;2-I; JANSSEN FW, 1968, BIOCHIM BIOPHYS ACTA, V151, P330, DOI 10.1016/0005-2744(68)90100-9; KALTWASS.H, 1966, ANAL BIOCHEM, V16, P132, DOI 10.1016/0003-2697(66)90088-1; Kazlauskas RJ, 2005, ENZYME ASSAYS HIGH T, P15, DOI [http://dx.doi.org/10.1002/3527607846.ch1, DOI 10.1002/3527607846.CH1]; Keesey J, 1987, BOEHRINGER MANNHEIM, P56; Kudo F, 2014, NAT PROD REP, V31, P1056, DOI 10.1039/c4np00007b; Levine MN, 2008, MOLECULES, V13, P204, DOI 10.3390/molecules13020204; Li N, 2009, J BIOTECHNOL, V140, P250, DOI 10.1016/j.jbiotec.2009.02.003; Liljeblad A, 2006, TETRAHEDRON, V62, P5831, DOI 10.1016/j.tet.2006.03.109; Liu M, 2002, TETRAHEDRON, V58, P7991, DOI 10.1016/S0040-4020(02)00991-2; MAIN AR, 1961, BIOCHEM J, V78, P769, DOI 10.1042/bj0780769; MARSHALL RW, 1992, ANAL CHIM ACTA, V266, P309, DOI 10.1016/0003-2670(92)85057-D; MENGER FM, 1987, J AM CHEM SOC, V109, P3145, DOI 10.1021/ja00244a047; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Moris-Varas F, 1999, BIOORGAN MED CHEM, V7, P2183, DOI 10.1016/S0968-0896(99)00149-2; Oelmeier SA, 2011, BIOTECHNOL BIOENG, V108, P69, DOI 10.1002/bit.22900; Persson M, 2008, ANAL BIOCHEM, V378, P1, DOI 10.1016/j.ab.2008.03.006; Petersen Steffen B., 2001, Journal of Biomedicine and Biotechnology, V1, P62, DOI 10.1155/S1110724301000249; Petunin Yl, 1980, THEORY PROBABILITY M, V21, P25; PRATT RF, 1985, ANAL BIOCHEM, V144, P204, DOI 10.1016/0003-2697(85)90106-X; Putz A, 2006, ISOLIERUNG IDENTIFIZ; Reetz MT, 1997, ANGEW CHEM INT EDIT, V36, P2830, DOI 10.1002/anie.199728301; Reetz MT, 2001, APPL MICROBIOL BIOT, V55, P531, DOI 10.1007/s002530100597; Reetz MT, 2005, ENZYME ASSAYS, P41, DOI [http://dx.doi.org/10.1002/3527607846.ch2, DOI 10.1002/3527607846.CH2]; Rehm S, 2010, PROTEIN SCI, V19, P2122, DOI 10.1002/pro.493; Reymond JL, 2009, CHEM COMMUN, P34, DOI 10.1039/b813732c; Reymond JL, 2005, ENZYME ASSAYS, P1, DOI [http://dx.doi.org/10.1002/3527607846.ch, DOI 10.1002/3527607846.CH]; RODBARD D, 1974, CLIN CHEM, V20, P1255; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Rudat J, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-11; Schmidt M, 2005, BIOMOL ENG, V22, P51, DOI 10.1016/j.bioeng.2004.09.004; Schmidt-Dannert Claudia, 1999, Trends in Biotechnology, V17, P135, DOI 10.1016/S0167-7799(98)01283-9; Sharpe A, 2005, INORGAIC CHEM; Smirnov N., 1939, B MOSCOW U, V2, P3; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Sugawara T, 1998, J ANTIBIOT, V51, P435, DOI 10.7164/antibiotics.51.435; SUGIURA M, 1977, BIOCHIM BIOPHYS ACTA, V488, P353, DOI 10.1016/0005-2760(77)90194-1; Tasnadi G, 2008, TETRAHEDRON-ASYMMETR, V19, P2072, DOI 10.1016/j.tetasy.2008.08.009; Team RDC, 2019, R LANG ENV STAT COMP; THORPE GHG, 1985, CLIN CHEM, V31, P1335; Tunon I, 2015, ARCH BIOCHEM BIOPHYS, V582, P42, DOI 10.1016/j.abb.2015.06.004; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; Walla PJ, 2014, MODERN BIOPHYSICAL CHEMISTRY: DETECTION AND ANALYSIS OF BIOMOLECULES, 2ND EDITION, P323; Weiner B, 2010, CHEM SOC REV, V39, P1656, DOI 10.1039/b919599h; Woodfork K, 2001, LUMINESCENCE BIOTECH, P2, DOI [http://dx.doi.org/10.1201/9781420041804.ch1, DOI 10.1201/9781420041804.CH1]; You L, 1996, PROTEIN ENG, V9, P77, DOI 10.1093/protein/9.1.77; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	84	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146104	10.1371/journal.pone.0146104	http://dx.doi.org/10.1371/journal.pone.0146104			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730596	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400095
J	Guardiola-Avila, I; Acedo-Felix, E; Sifuentes-Romero, I; Yepiz-Plascencia, G; Gomez-Gil, B; Noriega-Orozco, L				Guardiola-Avila, Iliana; Acedo-Felix, Evelia; Sifuentes-Romero, Itzel; Yepiz-Plascencia, Gloria; Gomez-Gil, Bruno; Noriega-Orozco, Lorena			Molecular and Genomic Characterization of Vibrio mimicus Isolated from a Frozen Shrimp Processing Facility in Mexico	PLOS ONE			English	Article							VIRULENCE-ASSOCIATED GENES; CLINICAL STRAINS; CHOLERAE STRAINS; IDENTIFICATION; SEQUENCE; PROTEIN; FAMILY; TOXIN	Vibrio mimicus is a gram-negative bacterium responsible for diseases in humans. Three strains of V. mimicus identified as V. mimicus 87, V. mimicus 92 and V. mimicus 93 were isolated from a shrimp processing facility in Guaymas, Sonora, Mexico. The strains were analyzed using several molecular techniques and according to the cluster analysis they were different, their similarities ranged between 51.3% and 71.6%. ERIC-PCR and RAPD (vmh390R) were the most discriminatory molecular techniques for the differentiation of these strains. The complete genomes of two strains (V. mimicus 87, renamed as CAIM 1882, and V. mimicus 92, renamed as CAIM 1883) were sequenced. The sizes of the genomes were 3.9 Mb in both strains, with 2.8 Mb in ChI and 1.1 Mb in ChII. A 12.7% difference was found in the proteome content (BLAST matrix). Several virulence genes were detected (e.g. capsular polysaccharide, an accessory colonization factor and genes involved in quorum-sensing) which were classified in 16 categories. Variations in the gene content between these genomes were observed, mainly in proteins and virulence genes (e.g., hemagglutinin, mobile elements and membrane proteins). According to these results, both strains were different, even when they came from the same source, giving an insight of the diversity of V. mimicus. The identification of various virulence genes, including a not previously reported V. mimicus gene (acfD) in ChI in all sequenced strains, supports the pathogenic potential of this species. Further analysis will help to fully understand their potential virulence, environmental impact and evolution.	[Guardiola-Avila, Iliana; Acedo-Felix, Evelia; Yepiz-Plascencia, Gloria] Ctr Invest Alimentac & Desarrollo, Ac Hermosillo, Sonora, Mexico; [Sifuentes-Romero, Itzel; Gomez-Gil, Bruno] Ctr Invest Alimentac & Desarrollo, Mazatlan Unit Aquaculture & Environm Management, Ac Mazatlan, Sonora, Mexico; [Noriega-Orozco, Lorena] Ctr Invest Alimentac & Desarrollo, Guaymas Unit Qual Assurance & Management Nat Reso, Ac Guaymas, Sonora, Mexico	CIAD - Centro de Investigacion en Alimentacion y Desarrollo; CIAD - Centro de Investigacion en Alimentacion y Desarrollo; CIAD - Centro de Investigacion en Alimentacion y Desarrollo	Noriega-Orozco, L (corresponding author), Ctr Invest Alimentac & Desarrollo, Guaymas Unit Qual Assurance & Management Nat Reso, Ac Guaymas, Sonora, Mexico.	lnoriega@ciad.mx	Gomez-Gil, Bruno/AAD-8658-2020; Avila, Iliana Guardiola/P-3905-2019; Noriega-Orozco, Lorena O/O-9466-2014; Yepiz, Gloria/ABE-1101-2020	Gomez-Gil, Bruno/0000-0002-3695-3597; Avila, Iliana Guardiola/0000-0003-4996-0478; Noriega-Orozco, Lorena O/0000-0002-9855-0865; Sifuentes-Romero, Itzel/0000-0001-8000-9256; Yepiz-Plascencia, Gloria/0000-0001-5730-4011	CONACYT (National Council for Scinece and Technology) [98245]; CIAD-Guaymas; CIAD-Hermosillo	CONACYT (National Council for Scinece and Technology); CIAD-Guaymas; CIAD-Hermosillo	This work received funding from CONACYT (National Council for Scinece and Technology) for a student scholarship (98245). This work also received internal institutional funding from CIAD-Guaymas and CIAD-Hermosillo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleye I.A., 2010, INTERNET J FOOD SAF, V12, P1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Begum Anowara, 2001, Microbes and Environments, V16, P19, DOI 10.1264/jsme2.2001.19; Bi K, 2000, MICROBIOL IMMUNOL, V44, P149, DOI 10.1111/j.1348-0421.2000.tb01258.x; Bi KW, 2001, MICROBIOL IMMUNOL, V45, P613, DOI 10.1111/j.1348-0421.2001.tb01292.x; Campos E, 1996, APPL ENVIRON MICROB, V62, P1141, DOI 10.1128/AEM.62.4.1141-1144.1996; Chitov T, 2009, EUR J CLIN MICROBIOL, V28, P421, DOI 10.1007/s10096-008-0639-7; Dale J.W., 2004, MOL GENETICS BACTERI; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DAVIS BR, 1981, J CLIN MICROBIOL, V14, P631, DOI 10.1128/JCM.14.6.631-639.1981; DOLL L, 1993, RES MICROBIOL, V144, P17, DOI 10.1016/0923-2508(93)90211-J; Egan ES, 2005, MOL MICROBIOL, V56, P1129, DOI 10.1111/j.1365-2958.2005.04622.x; EVERISS KD, 1994, INFECT IMMUN, V62, P3289, DOI 10.1128/IAI.62.8.3289-3298.1994; Eyisi OAL, 2013, J HEALTH POPUL NUTR, V31, P314; Faruque SM, 2006, BIOLOGY OF VIBRIOS, P385; Field Dawn, 2004, Methods Mol Biol, V266, P261; Gomez-Gil B, 2004, MICROBIOL-SGM, V150, P1769, DOI 10.1099/mic.0.26797-0; Gonzalez Vazquez E, 2005, REV DIGIT U, V6, P1; Groisman EA, 2001, PRINCIPLES BACTERIAL, P41, DOI [10.1016/B978-012304220-0/50002-9, DOI 10.1016/B978-012304220-0/50002-9]; Guardiola-Avila I, 2013, GENOME ANNOUNC, V1, P3, DOI [10.1073/pnas.1013825107.8, DOI 10.1073/PNAS.1013825107.8]; Guardiola-Avila I, 2015, BIOTECNIA, V17, P38, DOI 10.18633/bt.v17i2.178; Hallin PF, 2009, STAND GENOMIC SCI, V1, P204, DOI 10.4056/sigs.28177; Hasan NA, 2010, P NATL ACAD SCI USA, V107, P21134, DOI 10.1073/pnas.1013825107; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Jensen RV, 2013, GENOME ANNOUNC, V1, P1, DOI [10.1128/genomeA.00159-14.Copyright, DOI 10.1128/GEN0MEA.00002-12]; Kimes NE, 2012, ISME J, V6, P835, DOI 10.1038/ismej.2011.154; Lee KH, 2014, INFECT CHEMOTHER, V46, P106, DOI 10.3947/ic.2014.46.2.106; Liu XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119026; Mala E, 2013, INT J BASIC APPL SCI, V3, P35, DOI [10.14419/ijbas.v3i1.1735, DOI 10.14419/IJBAS.V3I1.1735]; Noriega-Orozco L, 2007, REV LATINOAM MICROBI, V49, P60; Okada K, 2005, J BACTERIOL, V187, P752, DOI 10.1128/JB.187.2.752-757.2005; OKUJO N, 1994, FEMS MICROBIOL LETT, V118, P187, DOI 10.1016/0378-1097(94)90617-3; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Peterson Kenneth M, 2002, Curr Issues Intest Microbiol, V3, P29; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Provenzano D, 2000, INFECT IMMUN, V68, P1491, DOI 10.1128/IAI.68.3.1491-1497.2000; RAMAMURTHY T, 1994, J MED MICROBIOL, V40, P194, DOI 10.1099/00222615-40-3-194; RIVERA IG, 1995, APPL ENVIRON MICROB, V61, P2898, DOI 10.1128/AEM.61.8.2898-2904.1995; Roberts L, 1998, METHOD MICROBIOL, V27, P467; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; Shinoda S, 2004, MICROBIOL IMMUNOL, V48, P547, DOI 10.1111/j.1348-0421.2004.tb03551.x; Sultan Z, 2007, J HEALTH SCI, V53, P430, DOI 10.1248/jhs.53.430; Sultan Z, 2006, MICROBIOL IMMUNOL, V50, P407, DOI 10.1111/j.1348-0421.2006.tb03808.x; Tercero-Alburo JJ, 2014, MICROB PATHOGENESIS, V76, P77, DOI 10.1016/j.micpath.2014.09.012; Thompson FL, 2003, J CLIN MICROBIOL, V41, P1946, DOI 10.1128/JCM.41.5.1946-1950.2003; Thompson JR, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P29; TRUCKSIS M, 1993, P NATL ACAD SCI USA, V90, P5267, DOI 10.1073/pnas.90.11.5267; Urakawa H, 1997, FEMS MICROBIOL LETT, V152, P125, DOI 10.1016/S0378-1097(97)00191-2; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Vesth T, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060120, DOI 10.1371/J0URNAL.P0NE.0060120]; Waturangi DE, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-2; Wibbenmeyer JA, 2002, INFECT IMMUN, V70, P121, DOI 10.1128/IAI.70.1.121-126.2002; Wright AC, 1999, INFECT IMMUN, V67, P2250, DOI 10.1128/IAI.67.5.2250-2257.1999; Wu YN, 2014, FOOD CONTROL, V46, P197, DOI 10.1016/j.foodcont.2014.05.023; YUAN P, 1994, WORLD J MICROB BIOT, V10, P59, DOI 10.1007/BF00357565; Zamudio ML, 2005, B I NAC SAL PERU, V11, P75; Zhang XH, 2005, J APPL MICROBIOL, V98, P1011, DOI 10.1111/j.1365-2672.2005.02583.x	57	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144885	10.1371/journal.pone.0144885	http://dx.doi.org/10.1371/journal.pone.0144885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730584	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400014
J	Brickle, P; Schuchert, PC; Arkhipkin, AI; Reid, MR; Randhawa, HS				Brickle, Paul; Schuchert, Pia C.; Arkhipkin, Alexander I.; Reid, Malcolm R.; Randhawa, Haseeb S.			Otolith Trace Elemental Analyses of South American Austral Hake, Merluccius australis (Hutton, 1872) Indicates Complex Salinity Structuring on their Spawning/Larval Grounds	PLOS ONE			English	Article							MACRURONUS-MAGELLANICUS; PATAGONIAN GRENADIER; SR/CA RATIOS; MARINE FISH; FRESH-WATER; CHEMISTRY; STRONTIUM; MIGRATIONS; MECHANISMS; ESTUARINE	Trace element signatures of otolith edges and cores from 335 austral hake (Merluccius autralis) were analysed using LA-ICPMS from samples collected in Chilean and Falkland Islands' waters, in order to provide potential insights into stock discrimination and migrations. Fish were caught in two locations in Chile and four locations in the south-west of the Falkland Islands Shelf. Univariate and multivariate analyses of trace element signatures in the edges of otoliths, representing adult fish, were not able to distinguish between samples collected in Chile and the Falkland Islands. Cluster analyses based on Ward's similarity/distance metric suggested that it was possible to identify two groups from core signatures. Further analyses of this perceived clustering of the core concentrations revealed that this was largely due to the wide spread of Sr/Ca ratios in the otoliths' cores. Gaussian finite mixtures using MCMC methods confirmed that Sr/Ca ratios form two separate distributions with significantly different mean values while concentrations of other elements showed no evidence of the presence of two or more distributions. The results suggest that there is only one spawning stock of austral hake with spawning situated in and around the Chilean fjords (43 degrees 30'S-47 degrees S) and the variation in Sr/Ca ratios likely suggests complex salinity structuring in this area.	[Brickle, Paul; Arkhipkin, Alexander I.] Falkland Isl Govt, Directorate Nat Resources, Dept Fisheries, Stanley, Falkland Island, Iceland; [Brickle, Paul] South Atlantic Environm Res Inst, Stanley, Falkland Island, Iceland; [Brickle, Paul] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 2TZ, Scotland; [Schuchert, Pia C.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Reid, Malcolm R.] Univ Otago, Dept Chem, Dunedin 9054, New Zealand; [Randhawa, Haseeb S.] Univ Otago, Dept Bot, Ecol Degree Programme, Dunedin 9054, New Zealand	University of Aberdeen; Newcastle University - UK; University of Otago; University of Otago	Brickle, P (corresponding author), Falkland Isl Govt, Directorate Nat Resources, Dept Fisheries, Stanley, Falkland Island, Iceland.	pbrickle@env.institute.ac.fk	Randhawa, Haseeb/AAC-3272-2019; Randhawa, Haseeb/A-8621-2013	Randhawa, Haseeb/0000-0001-6262-970X; Randhawa, Haseeb/0000-0001-6262-970X; Reid, Malcolm/0000-0002-4129-0214; Brickle, Paul/0000-0002-9870-3518	Falkland Islands Government	Falkland Islands Government	This study was funded by the Falkland Islands Government.	Aguayo M, 1989, CAPTURA TOTAL PERMIS; Aguayo M, 1990, 9012 AP I FOM PESQ C; Anderson MJ, 2008, J EXP MAR BIOL ECOL, V366, P16, DOI 10.1016/j.jembe.2008.07.006; Arkhipkin A, 2012, J FISH BIOL, V81, P882, DOI 10.1111/j.1095-8649.2012.03359.x; Arkhipkin AI, 2003, AQUAT LIVING RESOUR, V16, P487, DOI 10.1016/S0990-7440(03)00086-X; Arkhipkin AI, 2009, FISH RES, V96, P188, DOI 10.1016/j.fishres.2008.11.002; Ashford JR, 2005, CAN J FISH AQUAT SCI, V62, P2832, DOI 10.1139/F05-191; Ashford JR, 2008, CAN J FISH AQUAT SCI, V65, P135, DOI 10.1139/F07-158; Ashford JR, 2012, FISH RES, V121, P144, DOI 10.1016/j.fishres.2012.01.023; Babaluk JA, 1997, ARCTIC, V50, P224; Balbontin Fernando, 1993, Revista de Biologia Marina, V28, P111; Barrows TT, 2007, SCIENCE, V318, P86, DOI 10.1126/science.1145873; Basten J, 1999, REV CIEN TEC MAR, V22, P31; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Brown RJ, 2009, CAN J FISH AQUAT SCI, V66, P1790, DOI 10.1139/F09-112; Bustos CA, 2007, FISH RES, V83, P23, DOI 10.1016/j.fishres.2006.08.010; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Cubillos LA, 2014, NEW ZEAL J MAR FRESH, V48, P284, DOI 10.1080/00288330.2013.846920; D'Amato ME, 2005, ICES J MAR SCI, V62, P247, DOI 10.1016/j.icesjms.2004.11.002; Elsdon TS, 2003, REV FISH BIOL FISHER, V13, P219; Elsdon TS, 2004, J EXP MAR BIOL ECOL, V313, P269, DOI 10.1016/j.jembe.2004.08.010; Galleguillos G, 1996, 9630 FIP IFOP; George-Nascimento M., 1994, BIOL PESQ, V23, P31; Gillanders BM, 2005, AQUAT LIVING RESOUR, V18, P291, DOI 10.1051/alr:2005033; Grun B., 2004, BAYESMIX R PACKAGE B; HO JS, 1990, FISH B-NOAA, V88, P95; Inada T, 1981, B FAR SEAS FISH RES, V18, P1; KALISH JM, 1990, FISH B-NOAA, V88, P657; Legendre P., 1998, NUMERICAL ECOLOGY DE, V20; Lillo S, 2009, FIPIT200714; Machado-Schiaffino G, 2009, MOL PHYLOGENET EVOL, V53, P351, DOI 10.1016/j.ympev.2009.02.017; Medina G, FISH RES IN PRESS; Miller JA, 2011, J EXP MAR BIOL ECOL, V405, P42, DOI 10.1016/j.jembe.2011.05.017; Milton DA, 2005, MAR ECOL PROG SER, V301, P279, DOI 10.3354/meps301279; Niklitschek EJ, 2014, ICES J MAR SCI, V71, P374, DOI 10.1093/icesjms/fst129; Ojeda C. V., 1986, Investigacion Pesquera (Santiago), V33, P47; Panfili J, 2012, AQUAT BIOL, V15, P175, DOI 10.3354/ab00414; Panfili J, 2015, J EXP MAR BIOL ECOL, V467, P65, DOI 10.1016/j.jembe.2015.03.007; Paya I, 2005, B MAR SCI, V76, P261; Pearce NJG, 1997, GEOSTANDARD NEWSLETT, V21, P115, DOI 10.1111/j.1751-908X.1997.tb00538.x; PETERSON RG, 1989, J GEOPHYS RES-OCEANS, V94, P10817, DOI 10.1029/JC094iC08p10817; Rooker JR, 2004, ESTUARIES, V27, P334, DOI 10.1007/BF02803389; Rubilar P, 2002, FIPIT2000M13; Sagar MW, 2011, NEW ZEAL J GEOL GEOP, V54, P273, DOI 10.1080/00288306.2011.562904; Schuchert PC, 2010, FISH RES, V102, P80, DOI 10.1016/j.fishres.2009.10.012; Secor DH, 2001, MAR ECOL PROG SER, V211, P245, DOI 10.3354/meps211245; Silva N., 1997, CIENC TECNOL MAR, V20, P23; Silva-S. Nelson, 1995, Revista de Biologia Marina, V30, P207; Strub P.T., 1998, SEA, P273; Sturrock AM, 2012, J FISH BIOL, V81, P766, DOI 10.1111/j.1095-8649.2012.03372.x; Swearer SE, 2003, ESTUAR COAST SHELF S, V56, P1111, DOI 10.1016/S0272-7714(02)00317-7; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Tzeng WN, 2007, MAR ECOL PROG SER, V348, P285, DOI 10.3354/meps07022; Walther BD, 2010, CAN J FISH AQUAT SCI, V67, P1699, DOI 10.1139/F10-086; Wohler O. C., 2001, MERLUZA COLA MACRURO	55	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145479	10.1371/journal.pone.0145479	http://dx.doi.org/10.1371/journal.pone.0145479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727274	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500017
J	Dziarski, R; Park, SY; Kashyap, DR; Dowd, SE; Gupta, D				Dziarski, Roman; Park, Shin Yong; Kashyap, Des Raj; Dowd, Scot E.; Gupta, Dipika			Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PEPTIDOGLYCAN RECOGNITION PROTEINS; FECAL MICROBIOTA TRANSPLANTATION; MUCOSA-ASSOCIATED MICROBIOTA; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTESTINAL INFLAMMATION; T-CELLS; IMMUNE-SYSTEM; HOST-GENOTYPE	Dysbiosis is a hallmark of inflammatory bowel disease (IBD), but it is unclear which specific intestinal bacteria predispose to and which protect from IBD and how they are regulated. Peptidoglycan recognition proteins (Pglyrps) are antibacterial, participate in maintaining intestinal microflora, and modulate inflammatory responses. Mice deficient in any one of the four Pglyrp genes are more sensitive to dextran sulfate sodium (DSS)-induced colitis, and stools from Pglyrp-deficient mice transferred to wild type (WT) germ-free mice predispose them to much more severe colitis than stools from WT mice. However, the identities of these Pglyrp-regulated bacteria that predispose Pglyrp-deficient mice to colitis or protect WT mice from colitis are not known. Here we identified significant changes in beta-diversity of stool bacteria in Pglyrp-deficient mice compared with WT mice. The most consistent changes in microbiome in all Pglyrp-deficient mice were in Bacteroidales, from which we selected four species, two with increased abundance (Prevotella falsenii and Parabacteroides distasonis) and two with decreased abundance (Bacteroides eggerthii and Alistipes finegoldii). We then gavaged WT mice with stock type strains of these species to test the hypothesis that they predispose to or protect from DSS-induced colitis. P. falsenii, P. distasonis, and B. eggerthii all enhanced DSS-induced colitis in both WT mice with otherwise undisturbed intestinal microflora and in WT mice with antibiotic-depleted intestinal microflora. By contrast, A. finegoldii (which is the most abundant species in WT mice) attenuated DSS-induced colitis both in WT mice with otherwise undisturbed intestinal microflora and in WT mice with antibiotic-depleted intestinal microflora, similar to the colitis protective effect of the entire normal microflora. These results identify P. falsenii, P. distasonis, and B. eggerthii as colitis-promoting species and A. finegoldii as colitis-protective species.	[Dziarski, Roman; Park, Shin Yong; Kashyap, Des Raj; Gupta, Dipika] Indiana Univ Sch Med Northwest, Gary, IN 46409 USA; [Dowd, Scot E.] MR DNA Mol Res LP, Shallowater, TX USA		Dziarski, R (corresponding author), Indiana Univ Sch Med Northwest, Gary, IN 46409 USA.	rdziar@iun.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Kashyap, Des/0000-0002-7151-2404	United State Public Health Service National Institutes of Health [AI028797, AI073290]; MR; DNA Molecular Research LP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028797, R01AI073290] Funding Source: NIH RePORTER	United State Public Health Service National Institutes of Health; MR; DNA Molecular Research LP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United State Public Health Service National Institutes of Health AI028797 and AI073290 (to RD) and MR; DNA Molecular Research LP (to SED). The funders provided support in the form of salaries for authors (RD, SYP, DRK, SED, and DG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brinkman BM, 2013, INFLAMM BOWEL DIS, V19, P2560, DOI 10.1097/MIB.0b013e3182a8759a; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006; Comstock LE, 2009, CELL HOST MICROBE, V5, P522, DOI 10.1016/j.chom.2009.05.010; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; De Cruz P, 2015, J GASTROEN HEPATOL, V30, P268, DOI 10.1111/jgh.12694; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erdman SE, 2009, P NATL ACAD SCI USA, V106, P1027, DOI 10.1073/pnas.0812347106; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gowda RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137129; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Ianiro G, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000097; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jing X, 2014, J IMMUNOL, V193, P3055, DOI 10.4049/jimmunol.1301548; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kainu K, 2009, EXP DERMATOL, V18, P109, DOI 10.1111/j.1600-0625.2008.00769.x; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Kashyap DR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004280; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Larmonier CB, 2013, AM J PHYSIOL-GASTR L, V305, pG667, DOI 10.1152/ajpgi.00189.2013; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Li XN, 2006, J BIOL CHEM, V281, P20738, DOI 10.1074/jbc.M601017200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Machiels Kathleen, 2014, Gut, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mizoguchi A, 2012, PROG MOL BIOL TRANSL, V105, P263, DOI 10.1016/B978-0-12-394596-9.00009-3; Noor SO, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-134; Park SY, 2011, J IMMUNOL, V187, P5813, DOI 10.4049/jimmunol.1101068; Park SY, 2013, J IMMUNOL, V190, P3480, DOI 10.4049/jimmunol.1202675; Park SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024961; Rautio M, 2003, SYST APPL MICROBIOL, V26, P182, DOI 10.1078/072320203322346029; Read CB, 2015, J IMMUNOL, V194, P1417, DOI 10.4049/jimmunol.1402303; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Sakamoto M, 2009, INT J SYST EVOL MICR, V59, P319, DOI 10.1099/ijs.0.002626-0; Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06; Shanahan F, 2014, GASTROENTEROLOGY, V146, P1554, DOI 10.1053/j.gastro.2014.01.050; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Sun C, 2006, HUM GENET, V119, P113, DOI 10.1007/s00439-005-0115-8; TSAI HH, 1995, GUT, V36, P570, DOI 10.1136/gut.36.4.570; Tydell CC, 2006, J IMMUNOL, V176, P1154, DOI 10.4049/jimmunol.176.2.1154; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wright DP, 2000, FEMS MICROBIOL LETT, V190, P73, DOI 10.1016/S0378-1097(00)00324-4; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zitomersky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063686; Zulfiqar F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067393	80	167	175	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146162	10.1371/journal.pone.0146162	http://dx.doi.org/10.1371/journal.pone.0146162			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727498	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500060
J	Gonzalez-Aldaco, K; Pinho, JRR; Roman, S; Gleyzer, K; Fierro, NA; Oyakawa, L; Ramos-Lopez, O; Santana, RAF; Sitnik, R; Panduro, A				Gonzalez-Aldaco, Karina; Rebello Pinho, Joao R.; Roman, Sonia; Gleyzer, Ketti; Fierro, Nora A.; Oyakawa, Leticia; Ramos-Lopez, Omar; Santana, Rubia A. Ferraz; Sitnik, Roberta; Panduro, Arturo			Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico	PLOS ONE			English	Article							VIRUS-INFECTION; TRANSIENT ELASTOGRAPHY; GENOMIC MEDICINE; INTERFERON-ALPHA; APOLIPOPROTEIN-E; IL28B GENOTYPE; IN-VIVO; FIBROSIS; EXPRESSION; EPIDEMIOLOGY	Aim To analyze the genetic heterogeneity of the Amerindian and admixed population (Mestizos) based on the IL28B (rs12979860, rs8099917) and IFNL4 (rs368234815) haplotypes, and their association with spontaneous clearance (SC) and liver damage in patients with hepatitis C infection from West Mexico. Methods A total of 711 subjects from West Mexico (181 Amerindians and 530 Mestizos) were studied for the prevalence of IL28B (rs12979860C/T, rs8099917G/T) and IFNL4 (rs368234815.G/TT) genotypes. A caseq-control study was performed in 234 treatmentq-naive HCV Mestizos (149 chronic hepatitis C and 85 with SC) for the association of haplotypes with SC and liver damage. A realq-time PCR assay was used for genotyping, and transitional elastography staged liver damage. Results Significant Fstq-values indicated differentiation between the studied populations. The frequencies of the protective C, T, TT alleles were significantly lower in the Amerindians than in Mestizos (p < 0.05). The r(2) measure of linkage disequilibrium was significant for all variants and the T/G/Delta G risk haplotype predominated in Amerindians and secondly in Mestizos. The protective C/T/TT haplotype was associated with SC (OR = 0.46, 95% IC 0.22q-0.95, p = 0.03) and less liver damage (OR = 0.32, 95% IC 0.10q-0.97, p = 0.04) in chronic patients. The Structure software analysis demonstrated no significant differences in ancestry among SC and chronic patients. Conclusions West Mexico's population is genetically heterogeneous at the IL28B/IFNL4 polymorphisms. The T/G/Delta G high-risk haplotype predominated in Amerindians and the beneficial alternative haplotype in Mestizos. The C/T/TT haplotype was associated with SC and less liver damage in chronically infected Mestizo patients.	[Gonzalez-Aldaco, Karina; Roman, Sonia; Fierro, Nora A.; Ramos-Lopez, Omar; Panduro, Arturo] Civil Hosp Guadalajara, Dept Mol Biol Med, Guadalajara, Jalisco, Mexico; [Gonzalez-Aldaco, Karina; Roman, Sonia; Fierro, Nora A.; Ramos-Lopez, Omar; Panduro, Arturo] Univ Guadalajara, Hlth Sci Ctr, Guadalajara 44430, Jalisco, Mexico; [Rebello Pinho, Joao R.; Oyakawa, Leticia; Santana, Rubia A. Ferraz; Sitnik, Roberta] Hosp Israelita Albert Einstein, Albert Einstein Med Diagnost, Sao Paulo, SP, Brazil; [Rebello Pinho, Joao R.] Univ Sao Paulo, Fac Med, Dept Gastroenterol, Lab Gastroenterol & Hepatol Trop,Inst Med Trop, Sao Paulo, SP, Brazil; [Gleyzer, Ketti] Hosp Israelita Albert Einstein, Dept Patol Clin & Anat Patol, Sao Paulo, SP, Brazil	Universidad de Guadalajara; Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Panduro, A (corresponding author), Civil Hosp Guadalajara, Dept Mol Biol Med, Guadalajara, Jalisco, Mexico.	apanduro@prodigy.net.mx	Panduro, Arturo/AAO-7392-2020; Pinho, Joao R. R./G-2850-2012; Sitnik, Roberta/N-4740-2017; LÓPEZ, OSCAR OMAR RAMOS/ABH-6978-2020	Pinho, Joao R. R./0000-0003-3999-0489; Sitnik, Roberta/0000-0002-6243-8118; LÓPEZ, OSCAR OMAR RAMOS/0000-0002-2505-1555	Promep-University of Guadalajara [UDG-CA-478]; Sao Paulo Research Foundation (FAPESP)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2010/10549-1]; Hospital Israelita Albert Einstein, Sao Paulo, Brasil	Promep-University of Guadalajara; Sao Paulo Research Foundation (FAPESP)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Hospital Israelita Albert Einstein, Sao Paulo, Brasil	The study was supported by Promep-University of Guadalajara (UDG-CA-478) to AP and by the Sao Paulo Research Foundation (FAPESP)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant 2010/10549-1) and the Hospital Israelita Albert Einstein, Sao Paulo, Brasil to JRRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves D, 2006, HUM BIOL, V78, P65, DOI 10.1353/hub.2006.0021; Akcam FZ, 2012, J INTERF CYTOK RES, V32, P570, DOI 10.1089/jir.2012.0048; Fierro NA, 2011, MEM I OSWALDO CRUZ, V106, P1007, DOI 10.1590/S0074-02762011000800018; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Asselah T, 2010, J PATHOL, V221, P264, DOI 10.1002/path.2703; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; de Ledinghen V, 2008, GASTROEN CLIN BIOL, V32, P58, DOI 10.1016/S0399-8320(08)73994-0; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; Estrabaud E, 2014, J VIROL, V88, P6394, DOI 10.1128/JVI.00016-14; Falush D, 2003, GENETICS, V164, P1567; Fernandez-Mestre MT, 2005, DIS MARKERS, V21, P15, DOI 10.1155/2005/625182; Fierro NA, 2015, MEM I OSWALDO CRUZ, V110, P267, DOI 10.1590/0074-02760140377; Fierro NA, 2014, WORLD J GASTROENTERO, V20, P3443, DOI 10.3748/wjg.v20.i13.3443; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gonzalez Stevan A, 2011, Gastroenterol Hepatol (N Y), V7, P366; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Halfon P, 2011, EUR J GASTROEN HEPAT, V23, P931, DOI 10.1097/MEG.0b013e328349d0ef; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hayes CN, 2015, J FORMOS MED ASSOC, V114, P204, DOI 10.1016/j.jfma.2014.09.001; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hsu CS, 2013, HEPATOL INT, V7, P171, DOI 10.1007/s12072-012-9390-3; Jimenez-Mendez R, 2010, ANN HEPATOL, V9, P33, DOI 10.1016/S1665-2681(19)31676-X; Katsounas A, 2012, J VIRAL HEPATITIS, V19, P128, DOI 10.1111/j.1365-2893.2011.01503.x; Katsounas A, 2011, INT REV IMMUNOL, V30, P366, DOI 10.3109/08830185.2011.593105; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Kitson MT, 2014, J GASTROEN HEPATOL, V29, P1458, DOI 10.1111/jgh.12544; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Liu Y, 2013, TRANSFUSION, V53, P2498, DOI 10.1111/trf.12305; Luna-Ruiz J., PUEBLOS INDIGENAS ME; Lundbo LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115882; Martinez-Cortes G, 2012, J HUM GENET, V57, P568, DOI 10.1038/jhg.2012.67; Martinez-Gomez LE, 2012, ANN HEPATOL, V11, P876, DOI 10.1016/S1665-2681(19)31413-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miyamura T, 2014, INT J HEPATOL, V2014, DOI 10.1155/2014/723868; Munoz-Espinosa LE, 2015, ANN HEPATOL, V14, P642, DOI 10.1016/S1665-2681(19)30758-6; Murguia-Romero M, 2012, GEOSPATIAL HEALTH, V6, pS43; Neurath J., PUEBLOS INDIGENAS DE; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Panduro A, 2010, VIRUS RES, V151, P19, DOI 10.1016/j.virusres.2010.03.009; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Ramos-Lopez O, 2015, ANN HEPATOL, V14, P729, DOI 10.1016/S1665-2681(19)30768-9; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Rojas A, 2014, J VIRAL HEPATITIS, V21, P19, DOI 10.1111/jvh.12209; Roman S, 2015, WORLD J GASTROENTERO, V21, P8227, DOI 10.3748/wjg.v21.i27.8227; Roman S, 2014, WORLD J GASTROENTERO, V20, P7181, DOI 10.3748/wjg.v20.i23.7181; Roman S, 2013, WORLD J GASTROENTERO, V19, P7972, DOI 10.3748/wjg.v19.i44.7972; Roman S, 2010, J MED VIROL, V82, P1527, DOI 10.1002/jmv.21846; Sixtos-Alonso MS, 2015, ARCH MED RES, V46, P448, DOI 10.1016/j.arcmed.2015.07.001; Stattermayer AF, 2012, J HEPATOL, V57, P492, DOI 10.1016/j.jhep.2012.04.036; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Trinks J, 2014, PHARMACOGENOMICS J, V14, P549, DOI 10.1038/tpj.2014.20; Vergara M, 2015, EUR J GASTROEN HEPAT, V27, P826, DOI 10.1097/MEG.0000000000000346; Zhang Q, 2014, J VIRAL HEPATITIS, V21, P525, DOI 10.1111/jvh.12177; Zheng MH, 2013, GENE, V518, P479, DOI 10.1016/j.gene.2012.12.067	61	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146258	10.1371/journal.pone.0146258	http://dx.doi.org/10.1371/journal.pone.0146258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741362	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600026
J	Tang, JY; Jimenez, SCA; Chakraborty, S; Schultz, SR				Tang, Jiaying; Jimenez, Silvia C. Ardila; Chakraborty, Subhojit; Schultz, Simon R.			Visual Receptive Field Properties of Neurons in the Mouse Lateral Geniculate Nucleus	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; STRIATE CORTEX; ORIENTATION SELECTIVITY; CONTRAST SENSITIVITY; MACAQUE MONKEY; RELAY CELLS; CAT; RESPONSES; MODULATION; IDENTIFICATION	The lateral geniculate nucleus (LGN) is increasingly regarded as a "smart-gating" operator for processing visual information. Therefore, characterizing the response properties of LGN neurons will enable us to better understand how neurons encode and transfer visual signals. Efforts have been devoted to study its anatomical and functional features, and recent advances have highlighted the existence in rodents of complex features such as direction/orientation selectivity. However, unlike well-researched higher-order mammals such as primates, the full array of response characteristics vis-a-vis its morphological features have remained relatively unexplored in the mouse LGN. To address the issue, we recorded from mouse LGN neurons using multisite-electrode-arrays (MEAs) and analysed their discharge patterns in relation to their location under a series of visual stimulation paradigms. Several response properties paralleled results from earlier studies in the field and these include centre-surround organization, size of receptive field, spontaneous firing rate and linearity of spatial summation. However, our results also revealed "high-pass" and "low-pass" features in the temporal frequency tuning of some cells, and greater average contrast gain than reported by earlier studies. In addition, a small proportion of cells had direction/orientation selectivity. Both "high-pass" and "low-pass" cells, as well as direction and orientation selective cells, were found only in small numbers, supporting the notion that these properties emerge in the cortex. ON-and OFF-cells showed distinct contrast sensitivity and temporal frequency tuning properties, suggesting parallel projections from the retina. Incorporating a novel histological technique, we created a 3-D LGN volume model explicitly capturing the morphological features of mouse LGN and localising individual cells into anterior/middle/posterior LGN. Based on this categorization, we show that the ON/OFF, DS/OS and linear response properties are not regionally restricted. Our study confirms earlier findings of spatial pattern selectivity in the LGN, and builds on it to demonstrate that relatively elaborate features are computed early in the visual pathway.	[Schultz, Simon R.] Univ London Imperial Coll Sci Technol & Med, Ctr Neurotechnol, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England	Imperial College London; Imperial College London	Schultz, SR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Neurotechnol, London SW7 2AZ, England.	s.schultz@imperial.ac.uk		Zou, Yajie/0000-0002-3505-168X	China Scholarship Council; BBSRC [BB/K001817/1, BB/K015540/1]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/K001817/1, BB/K015540/1] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a China Scholarship Council studentship to JT, by BBSRC grants BB/K001817/1 and BB/K015540/1 to SRS and by a Royal Society Industry Fellowship to SRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Chalupa LM, 2008, EYE RETINA VISUAL SY; Cheong SK, 2013, J NEUROSCI, V33, P6864, DOI 10.1523/JNEUROSCI.5208-12.2013; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Ibbotson MR, 2008, J NEUROSCI, V28, P10952, DOI 10.1523/JNEUROSCI.3950-08.2008; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; Latawiec D, 2000, J COMP NEUROL, V419, P306, DOI 10.1002/(SICI)1096-9861(20000410)419:3<306::AID-CNE4>3.0.CO;2-2; Lemmens MAM, 2010, J CHEM NEUROANAT, V40, P199, DOI 10.1016/j.jchemneu.2010.06.005; LIVINGSTONE MS, 1982, P NATL ACAD SCI-BIOL, V79, P6098, DOI 10.1073/pnas.79.19.6098; Maheswaran S, 2009, NEUROIMAGE, V44, P692, DOI 10.1016/j.neuroimage.2008.10.016; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; METIN C, 1988, EXP BRAIN RES, V69, P594; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Paxinos G, 2012, PAXINOS FRANKLINS MO; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; RODIECK RW, 1967, SCIENCE, V157, P90, DOI 10.1126/science.157.3784.90; Rucci M, 2000, J NEUROSCI, V20, P4708, DOI 10.1523/JNEUROSCI.20-12-04708.2000; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Scholl B, 2013, J NEUROSCI, V33, P10616, DOI 10.1523/JNEUROSCI.0404-13.2013; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Sincich LC, 2007, J NEUROSCI, V27, P2683, DOI 10.1523/JNEUROSCI.5077-06.2007; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SO YT, 1981, J NEUROPHYSIOL, V45, P107, DOI 10.1152/jn.1981.45.1.107; Solomon SG, 1999, J PHYSIOL-LONDON, V517, P907, DOI 10.1111/j.1469-7793.1999.0907s.x; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P168, DOI 10.1152/jn.1985.54.1.168; Tailby C, 2007, VISUAL NEUROSCI, V24, P99, DOI 10.1017/S0952523807070022; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; van Alphen B, 2009, INVEST OPHTH VIS SCI, V50, P2451, DOI 10.1167/iovs.08-2594; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; Wang LP, 2010, J NEUROSCI, V30, P16573, DOI 10.1523/JNEUROSCI.3305-10.2010; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085; Xu XM, 2001, J PHYSIOL-LONDON, V531, P203, DOI 10.1111/j.1469-7793.2001.0203j.x; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhao XY, 2013, J NEUROSCI, V33, P12751, DOI 10.1523/JNEUROSCI.0095-13.2013	55	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146017	10.1371/journal.pone.0146017	http://dx.doi.org/10.1371/journal.pone.0146017			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741374	Green Submitted, Green Published, gold			2022-12-27	WOS:000367810600019
J	Heise, R; Amann, PM; Ensslen, S; Marquardt, Y; Czaja, K; Joussen, S; Beer, D; Abele, R; Plewnia, G; Tampe, R; Merk, HF; Hermanns, HM; Baron, JM				Heise, Ruth; Amann, Philipp M.; Ensslen, Silke; Marquardt, Yvonne; Czaja, Katharina; Joussen, Sylvia; Beer, Daniel; Abele, Rupert; Plewnia, Gabriele; Tampe, Robert; Merk, Hans F.; Hermanns, Heike M.; Baron, Jens M.			Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma	PLOS ONE			English	Article							COOPERATIVE-ONCOLOGY-GROUP; STAGE-III MELANOMA; HIGH-RISK MELANOMA; ADJUVANT THERAPY; DOWN-REGULATION; CUTANEOUS MELANOMA; ABC TRANSPORTER; TUMOR-CELLS; EXPRESSION; MODULATION	Introduction Interferon alpha (IFN alpha) is routinely used in the clinical practice for adjuvant systemic melanoma therapy. Understanding the molecular mechanism of IFN alpha effects and prediction of response in the IFN alpha therapy regime allows initiation and continuation of IFN alpha treatment for responder and exclusion of non-responder to avoid therapy inefficacy and side-effects. The transporter protein associated with antigen processing-1 (TAP1) is part of the MHC class I peptide-loading complex, and important for antigen presentation in tumor and antigen presenting cells. In the context of personalized medicine, we address this potential biomarker TAP1 as a target of IFN alpha signalling. Results We could show that IFN alpha upregulates TAP1 expression in peripheral blood mononuclear cells (PBMCs) of patients with malignant melanoma receiving adjuvant high-dose immunotherapy. IFN alpha also induced expression of TAP1 in mouse blood and tumor tissue and suppressed the formation of melanoma metastasis in an in vivo B16 tumor model. Besides its expression, TAP binding affinity and transport activity is induced by IFN alpha in human monocytic THP1 cells. Furthermore, our data revealed that IFN alpha clearly activates phosphorylation of STAT1 and STAT3 in THP1 and A375 melanoma cells. Inhibition of Janus kinases abrogates the IFN alpha-induced TAP1 expression. These results suggest that the JAK/STAT pathway is a crucial mediator for TAP1 expression elicited by IFN alpha treatment. Conclusion We suppose that silencing of TAP1 expression provides tumor cells with a mechanism to escape cytotoxic T-lymphocyte recognition. The observed benefit of IFN alpha treatment could be mediated by the shown dual effect of TAP1 upregulation in antigen presenting cells on the one hand, and of TAP1 upregulation in 'silent' metastatic melanoma cells on the other hand. In conclusion, this work contributes to a better understanding of the mode of action of IFN alpha which is essential to identify markers to predict, assess and monitor therapeutic response of IFN alpha treatment in the future.	[Heise, Ruth; Amann, Philipp M.; Marquardt, Yvonne; Czaja, Katharina; Joussen, Sylvia; Beer, Daniel; Merk, Hans F.; Baron, Jens M.] Rhein Westfal TH Aachen, Dept Dermatol & Allergol, Aachen, Germany; [Ensslen, Silke] Rhein Westfal TH Aachen, IZKF, Aachen, Germany; [Abele, Rupert; Plewnia, Gabriele; Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60054 Frankfurt, Germany; [Hermanns, Heike M.] Univ Hosp Wurzburg, Med Clin & Policlin 2, Hepatol, Wurzburg, Germany	RWTH Aachen University; RWTH Aachen University; Goethe University Frankfurt; University of Wurzburg	Baron, JM (corresponding author), Rhein Westfal TH Aachen, Dept Dermatol & Allergol, Aachen, Germany.	JensMalte.Baron@post.rwth-aachen.de	Baron, Jens M/N-2934-2016; Tampé, Robert/H-2953-2015	Baron, Jens M/0000-0002-1174-6946; Tampé, Robert/0000-0002-0403-2160	Medical Faculty of the RWTH Aachen University	Medical Faculty of the RWTH Aachen University	This work was supported by START grants (to R.H. and J.M.B.) of the Medical Faculty of the RWTH Aachen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research project was supported by the START-Program (to RH) of the Medical Faculty of the RWTH Aachen University.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Abuzahra F, 2004, LANCET ONCOL, V5, P250, DOI 10.1016/S1470-2045(04)01429-9; Arina A, 2002, EXP HEMATOL, V30, P1355, DOI 10.1016/S0301-472X(02)00956-6; Baron J. M., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P393, DOI 10.2174/1568011033482224; Baron JM, 2004, LANCET, V364, P395, DOI 10.1016/S0140-6736(04)16780-9; Caraglia M, 2005, J CELL PHYSIOL, V202, P323, DOI 10.1002/jcp.20137; Cresswell AC, 2001, MELANOMA RES, V11, P275, DOI 10.1097/00008390-200106000-00009; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dissemond J, 2003, MELANOMA RES, V13, P253, DOI 10.1097/00008390-200306000-00005; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Eggermont AMM, 2005, LANCET, V366, P1189, DOI 10.1016/S0140-6736(05)67482-X; Enk A, 2001, Praxis (Bern 1994), V90, P403; FLEISCHMANN CM, 1994, CANCER IMMUNOL IMMUN, V39, P148, DOI 10.1007/BF01533379; Halama N, 2010, J ONCOL, V2010, DOI 10.1155/2010/689893; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Herget M, 2011, P NATL ACAD SCI USA, V108, P1349, DOI 10.1073/pnas.1012355108; Hermanns HM, 2000, J BIOL CHEM, V275, P40742, DOI 10.1074/jbc.M005408200; Humpolikova-Adamkova L, 2009, EUR J CANCER, V45, P1315, DOI 10.1016/j.ejca.2009.01.009; Ito N, 2007, J CLIN ONCOL, V25, P2785, DOI 10.1200/JCO.2006.09.8897; Jimeno A, 2006, MOL CANCER THER, V5, P787, DOI 10.1158/1535-7163.MCT-06-0005; Johnsen AK, 1999, J IMMUNOL, V163, P4224; Kamarashev J, 2001, INT J CANCER, V95, P23, DOI 10.1002/1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4; Kaur S, 2005, J INTERF CYTOK RES, V25, P780, DOI 10.1089/jir.2005.25.780; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Kirkwood JM, 1999, MOL MED, V5, P11, DOI 10.1007/BF03402135; Kreil S, 2010, HAEMATOL-HEMATOL J, V95, P148, DOI 10.3324/haematol.2009.011510; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lens M, 2006, DERMATOL THER, V19, P9, DOI 10.1111/j.1529-8019.2005.00051.x; Lesinski GB, 2005, CANCER IMMUNOL IMMUN, V54, P815, DOI 10.1007/s00262-004-0649-y; Lou YM, 2007, VACCINE, V25, P2331, DOI 10.1016/j.vaccine.2006.11.064; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Riese A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050944; Rouyez MC, 2005, J IMMUNOL, V174, P3948, DOI 10.4049/jimmunol.174.7.3948; Sebastian K, 2014, PLOS ONE, V8; Skazik C, 2008, EXP DERMATOL, V17, P739, DOI 10.1111/j.1600-0625.2008.00745.x; Tao J, 2008, BRIT J DERMATOL, V158, P88, DOI 10.1111/j.1365-2133.2007.08294.x; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Wald M, 2001, CANCER CHEMOTH PHARM, V47, pS16, DOI 10.1007/s002800170004; Wang WJ, 2008, CANCER IMMUNOL IMMUN, V57, P1315, DOI 10.1007/s00262-008-0466-9; Wang WJ, 2007, CLIN CANCER RES, V13, P1523, DOI 10.1158/1078-0432.CCR-06-1387; WEIERGRABER O, 1995, EUR J BIOCHEM, V234, P661, DOI 10.1111/j.1432-1033.1995.661_b.x; Zhang QJ, 2007, INT J CANCER, V120, P1935, DOI 10.1002/ijc.22371; Zhao LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-157	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146325	10.1371/journal.pone.0146325	http://dx.doi.org/10.1371/journal.pone.0146325			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735690	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100042
J	Akbar, N; Giorgio, A; Till, C; Sled, JG; Doesburg, SM; De Stefano, N; Banwell, B				Akbar, Nadine; Giorgio, Antonio; Till, Christine; Sled, John G.; Doesburg, Sam M.; De Stefano, Nicola; Banwell, Brenda			Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis	PLOS ONE			English	Article							WHITE-MATTER CHANGES; COGNITIVE IMPAIRMENT; DIFFUSION; CHILDHOOD; DAMAGE; ACTIVATION; SCALE; MRI; NETWORKS; CHILDREN	Background Reduced white matter (WM) integrity is a fundamental aspect of pediatric multiple sclerosis (MS), though relations to resting-state functional MRI (fMRI) connectivity remain unknown. The objective of this study was to relate diffusion-tensor imaging (DTI) measures of WM microstructural integrity to resting-state network (RSN) functional connectivity in pediatric-onset MS to test the hypothesis that abnormalities in RSN reflects changes in structural integrity. Methods This study enrolled 19 patients with pediatric-onset MS (mean age = 19, range 13-24 years, 14 female, mean disease duration = 65 months, mean age of disease onset = 13 years) and 16 age-and sex-matched healthy controls (HC). All subjects underwent 3.0T anatomical and functional MRI which included DTI and resting-state acquisitions. DTI processing was performed using Tract-Based Spatial Statistics (TBSS). RSNs were identified using Independent Components Analysis, and a dual regression technique was used to detect between-group differences in the functional connectivity of RSNs. Correlations were investigated between DTI measures and RSN connectivity. Results Lower fractional anisotropy (FA) was observed in the pediatric-onset MS group compared to HC group within the entire WM skeleton, and particularly the corpus callosum, posterior thalamic radiation, corona radiata and sagittal stratum (all p <.01, corrected). Relative to HCs, MS patients showed higher functional connectivity involving the anterior cingulate cortex and right precuneus of the default-mode network, as well as involving the anterior cingulate cortex and left middle frontal gyrus of the frontoparietal network (all p <.005 uncorrected, k >= 30 voxels). Higher functional connectivity of the right precuneus within the default-mode network was associated with lower FA of the entire WM skeleton (r = -.525, p =.02), genu of the corpus callosum (r = -.553, p = .014), and left (r = -.467, p = .044) and right (r = -.615, p = .005) sagittal stratum. Conclusions Loss of WM microstructural integrity is associated with increased resting-state functional connectivity in pediatric MS, which may reflect a diffuse and potentially compensatory activation early in MS.	[Akbar, Nadine; Doesburg, Sam M.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Akbar, Nadine; Doesburg, Sam M.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Giorgio, Antonio; De Stefano, Nicola] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Till, Christine] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada; [Sled, John G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sled, John G.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1X8, Canada; [Banwell, Brenda] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Siena; York University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Akbar, N (corresponding author), Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	nadine.akbar@utoronto.ca	Akbar, Nadine/D-4452-2019; Sled, John G/D-8268-2012	Sled, John G/0000-0002-4461-283X; Till, Christine/0000-0001-5030-3155; Akbar, Nadine/0000-0001-9983-0861; De Stefano, Nicola/0000-0003-4930-7639	Scottish Rite Charitable Foundation of Canada; Multiple Sclerosis Society of Canada	Scottish Rite Charitable Foundation of Canada; Multiple Sclerosis Society of Canada	This work was supported by the Scottish Rite Charitable Foundation of Canada (Research Grant 2011-2012). It was also supported by a Studentship from the Multiple Sclerosis Society of Canada (National Bank Financial Group Doctoral Studentship Award 2012-2015), and MS International Federation Du Pre Grant for NA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absinta M, 2010, J NEUROL NEUROSUR PS, V81, P1357, DOI 10.1136/jnnp.2010.205682; Akbar N, 2015, MULT SCLER IN PRESS; Aubert-Broche B, 2013, NEUROIMAGE, V82, P393, DOI 10.1016/j.neuroimage.2013.05.065; Aung Wint Yan, 2013, Imaging Med, V5, P427; Barratt W, 2006, BARRATT SIMPLIFED ME; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bethune A, 2011, J NEUROL SCI, V309, P68, DOI 10.1016/j.jns.2011.07.019; Blaschek A, 2013, AM J NEURORADIOL, V34, P2015, DOI 10.3174/ajnr.A3581; Chitnis T, 2009, MULT SCLER, V15, P627, DOI 10.1177/1352458508101933; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; FAULSTICH ME, 1986, AM J PSYCHIAT, V143, P1024; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Ghassemi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085741; Ghezzi A, 1997, MULT SCLER, V3, P43, DOI 10.1177/135245859700300105; Harding KE, 2013, J NEUROL NEUROSUR PS, V84, P141, DOI 10.1136/jnnp-2012-303996; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lenzi D, 2007, HUM BRAIN MAPP, V28, P636, DOI 10.1002/hbm.20305; Louapre C, 2014, HUM BRAIN MAPP, V35, P4706, DOI 10.1002/hbm.22505; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Manson SC, 2008, EXP BRAIN RES, V187, P25, DOI 10.1007/s00221-008-1276-1; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Renoux C, 2007, NEW ENGL J MED, V356, P2603, DOI 10.1056/NEJMoa067597; Rocca MA, 2014, HUM BRAIN MAPP, V35, P4180, DOI 10.1002/hbm.22469; Rocca MA, 2014, NEUROLOGY, V82, P1314, DOI 10.1212/WNL.0000000000000309; Rocca MA, 2010, RADIOLOGY, V254, P541, DOI 10.1148/radiol.09090463; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Till C, 2011, NEUROREPORT, V22, P1005, DOI 10.1097/WNR.0b013e32834dc301; Tillema JM, 2012, MULT SCLER J, V18, P1754, DOI 10.1177/1352458512447527; Todorow M, 2014, J CLIN EXP NEUROPSYC, V36, P111, DOI 10.1080/13803395.2013.867013; Tortorella P, 2006, J NEUROL, V253, P903, DOI 10.1007/s00415-006-0129-8; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Van Strien J, 2002, DUTCH HANDEDNESS QUE; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Vishwas MS, 2013, AM J NEURORADIOL, V34, P417, DOI 10.3174/ajnr.A3216; Vishwas MS, 2010, AM J NEURORADIOL, V31, P121, DOI 10.3174/ajnr.A1776; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zhou FQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101198	50	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145906	10.1371/journal.pone.0145906	http://dx.doi.org/10.1371/journal.pone.0145906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731278	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400063
J	Bell, SA; Shen, C; Brown, A; Hunt, AG				Bell, Stephen A.; Shen, Chi; Brown, Alishea; Hunt, Arthur G.			Experimental Genome-Wide Determination of RNA Polyadenylation in Chlamydomonas reinhardtii	PLOS ONE			English	Article							EXTENSIVE ALTERNATIVE POLYADENYLATION; POLY(A) SITE CHOICE; MESSENGER-RNA; PLANTS; CLEAVAGE; ARABIDOPSIS; EXPRESSION; DEGRADATION; SIGNALS; CONSERVATION	The polyadenylation of RNA is a near-universal feature of RNA metabolism in eukaryotes. This process has been studied in the model alga Chlamydomonas reinhardtii using low-throughput (gene-by-gene) and high-throughput (transcriptome sequencing) approaches that recovered poly(A)-containing sequence tags which revealed interesting features of this critical process in Chlamydomonas. In this study, RNA polyadenylation has been studied using the so-called Poly(A) Tag Sequencing (PAT-Seq) approach. Specifically, PAT-Seq was used to study poly(A) site choice in cultures grown in four different media types-Tris-Phosphate (TP), Tris-Phosphate-Acetate (TAP), High-Salt (HS), and High-Salt-Acetate (HAS). The results indicate that: 1. As reported before, the motif UGUAA is the primary, and perhaps sole, cis-element that guides mRNA polyadenylation in the nucleus; 2. The scope of alternative polyadenylation events with the potential to change the coding sequences of mRNAs is limited; 3. Changes in poly(A) site choice in cultures grown in the different media types are very few in number and do not affect protein-coding potential; 4. Organellar polyadenylation is considerable and affects primarily ribosomal RNAs in the chloroplast and mitochondria; and 5. Organellar RNA polyadenylation is a dynamic process that is affected by the different media types used for cell growth.	[Bell, Stephen A.; Hunt, Arthur G.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Shen, Chi; Brown, Alishea] Kentucky State Univ, Div Comp Sci, Frankfort, KY USA	University of Kentucky; Kentucky State University	Hunt, AG (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	aghunt00@uky.edu		Hunt, Arthur/0000-0002-0008-4158	US National Science Foundation [MCB-1243849]; NSF [IOS-0817818]; Div Of Molecular and Cellular Bioscience [1243849] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the US National Science Foundation (www.nsf.gov) Award MCB-1243849 and an REU Supplement to NSF Award IOS-0817818. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Chan SL, 2014, GENE DEV, V28, P2370, DOI 10.1101/gad.250993.114; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; de Almeida SF, 2010, EPIGENOMICS-UK, V2, P449, DOI 10.2217/EPI.10.21; De Rocher EJ, 1998, PLANT PHYSIOL, V117, P1445, DOI 10.1104/pp.117.4.1445; Diehn S H, 1996, Genet Eng (N Y), V18, P83; Diehn SH, 1998, PLANT PHYSIOL, V117, P1433, DOI 10.1104/pp.117.4.1433; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Hunt AG, 2008, CURR TOP MICROBIOL, V326, P151; Hunt AG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-641; Iannacone R, 1997, PLANT MOL BIOL, V34, P485, DOI 10.1023/A:1005876323398; Jinkerson RE, 2015, PLANT J, V82, P393, DOI 10.1111/tpj.12801; Komine Y, 2000, RNA, V6, P598, DOI 10.1017/S1355838200992252; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; Lenasi T, 2013, WIRES RNA, V4, P139, DOI 10.1002/wrna.1148; Li XQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0162-7; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Ma LY, 2014, METHODS, V67, P74, DOI 10.1016/j.ymeth.2013.06.037; Maes A, 2012, MOL MICROBIOL, V83, P436, DOI 10.1111/j.1365-2958.2011.07943.x; Maivali U, 2013, BIOL CHEM, V394, P845, DOI 10.1515/hsz-2013-0133; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mussgnug JH, 2015, APPL MICROBIOL BIOT, V99, P5407, DOI 10.1007/s00253-015-6698-7; OHMETAKAGI M, 1993, P NATL ACAD SCI USA, V90, P11811, DOI 10.1073/pnas.90.24.11811; Pati Pratap Kumar, 2015, Methods Mol Biol, V1255, P159, DOI 10.1007/978-1-4939-2175-1_14; Rasala BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043349; Rasala BA, 2011, PLANT BIOTECHNOL J, V9, P674, DOI 10.1111/j.1467-7652.2011.00620.x; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Scaife MA, 2015, PLANT J, V82, P532, DOI 10.1111/tpj.12781; Schonemann L, 2014, GENE DEV, V28, P2381, DOI 10.1101/gad.250985.114; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; Scranton MA, 2015, PLANT J, V82, P523, DOI 10.1111/tpj.12780; Shen YJ, 2008, GENETICS, V179, P167, DOI 10.1534/genetics.108.088971; Sherstnev A, 2012, NAT STRUCT MOL BIOL, V19, P845, DOI 10.1038/nsmb.2345; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; Torzillo G, 2015, CRIT REV BIOTECHNOL, V35, P485, DOI 10.3109/07388551.2014.900734; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wang YJ, 2015, PLANT J, V82, P429, DOI 10.1111/tpj.12829; Wodniok S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-65; Wu Xiaohui, 2015, Methods Mol Biol, V1255, P3, DOI 10.1007/978-1-4939-2175-1_1; Wu XH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-615; Wu XH, 2011, P NATL ACAD SCI USA, V108, P12533, DOI 10.1073/pnas.1019732108; Zhao ZX, 2014, G3-GENES GENOM GENET, V4, P871, DOI 10.1534/g3.114.010249; Zimmer SL, 2009, PLANT J, V59, P88, DOI 10.1111/j.1365-313X.2009.03853.x	51	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146107	10.1371/journal.pone.0146107	http://dx.doi.org/10.1371/journal.pone.0146107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730730	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400096
J	Bultitude, JH; Juravle, G; Spence, C				Bultitude, Janet H.; Juravle, Georgiana; Spence, Charles			Tactile Gap Detection Deteriorates during Bimanual Symmetrical Movements under Mirror Visual Feedback	PLOS ONE			English	Article							RUBBER-HAND ILLUSION; SENSORIMOTOR INCONGRUENCE; MULTISENSORY INTEGRATION; FIBROMYALGIA PATIENTS; HEALTHY-VOLUNTEERS; PAIN; TOUCH; BODY; DISCRIMINATION; PERCEPTION	It has been suggested that incongruence between signals for motor intention and sensory input can cause pain and other sensory abnormalities. This claim is supported by reports that moving in an environment of induced sensorimotor conflict leads to elevated pain and sensory symptoms in those with certain painful conditions. Similar procedures can lead to reports of anomalous sensations in healthy volunteers too. In the present study, we used mirror visual feedback to investigate the effects of sensorimotor incongruence on responses to stimuli that arise from sources external to the body, in particular, touch. Incongruence between the sensory and motor signals for the right arm was manipulated by having the participants make symmetrical or asymmetrical movements while watching a reflection of their left arm in a parasagittal mirror, or the left hand surface of a similarly positioned opaque board. In contrast to our prediction, sensitivity to the presence of gaps in tactile stimulation of the right forearm was not reduced when participants made asymmetrical movements during mirror visual feedback, as compared to when they made symmetrical or asymmetrical movements with no visual feedback. Instead, sensitivity was reduced when participants made symmetrical movements during mirror visual feedback relative to the other three conditions. We suggest that small discrepancies between sensory and motor information, as they occur during mirror visual feedback with symmetrical movements, can impair tactile processing. In contrast, asymmetrical movements with mirror visual feedback may not impact tactile processing because the larger discrepancies between sensory and motor information may prevent the integration of these sources of information. These results contrast with previous reports of anomalous sensations during exposure to both low and high sensorimotor conflict, but are nevertheless in agreement with a forward model interpretation of perceptual modulations during goal directed movement.	[Bultitude, Janet H.] Univ Bath, Dept Psychol, Bath BA2 7AY, North East Some, England; [Bultitude, Janet H.] Univ Oxford, Ctr Funct Magnet Resonance Imaging Brain, Oxford, Oxon, England; [Juravle, Georgiana] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Spence, Charles] Univ Oxford, Crossmodal Res Lab, Dept Expt Psychol, Oxford, Oxon, England	University of Bath; University of Oxford; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oxford	Bultitude, JH (corresponding author), Univ Bath, Dept Psychol, Bath BA2 7AY, North East Some, England.	j.bultitude@bath.ac.uk	Juravle, Georgiana/N-7762-2016	Juravle, Georgiana/0000-0001-5810-6973; Bultitude, Janet/0000-0003-4648-6184	Oxford University Press John Fell Fund [121/461]	Oxford University Press John Fell Fund	This study was supported by a grant from the Oxford University Press John Fell Fund to JHB (Grant number 121/461; https://www.admin.ox.ac.uk/pras/jff/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen EL, 2004, COGN AFFECT BEHAV NE, V4, P170, DOI 10.3758/CABN.4.2.170; Bara-Jimenez W, 2000, NEUROLOGY, V55, P1869, DOI 10.1212/WNL.55.12.1869; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buckingham G, 2010, EXP BRAIN RES, V201, P411, DOI 10.1007/s00221-009-2050-8; Burrack Anna, 2005, Body Image, V2, P307, DOI 10.1016/j.bodyim.2005.04.002; Colino FL, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.267; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Daenen L, 2014, PAIN PRACT, V14, P588, DOI 10.1111/papr.12113; Daenen L, 2012, RHEUMATOLOGY, V51, P1492, DOI 10.1093/rheumatology/kes050; Daenen L, 2010, RHEUMATOLOGY, V49, P1281, DOI 10.1093/rheumatology/keq067; Davidson PR, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S11; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Foell J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00310; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Forster B, 2005, EXP BRAIN RES, V165, P8, DOI 10.1007/s00221-005-2274-1; Freund W, 2010, CLIN J PAIN, V26, P339, DOI 10.1097/AJP.0b013e3181cb4055; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Green DM, 1966, SIGNAL DETECTION THE; Greening J, 2003, PAIN, V104, P275, DOI 10.1016/S0304-3959(03)00010-1; Haans A, 2012, ACTA PSYCHOL, V141, P169, DOI 10.1016/j.actpsy.2012.07.016; Harris AJ, 1999, LANCET, V354, P1464, DOI 10.1016/S0140-6736(99)05003-5; Holle H, 2011, COGN NEUROSCI-UK, V2, P171, DOI 10.1080/17588928.2011.603828; HOLM S, 1979, SCAND J STAT, V6, P65; HONORE J, 1989, NEUROPSYCHOLOGIA, V27, P367, DOI 10.1016/0028-3932(89)90025-0; Juravle G, 2012, EXP BRAIN RES, V223, P109, DOI 10.1007/s00221-012-3245-y; Juravle G, 2011, EXP BRAIN RES, V213, P87, DOI 10.1007/s00221-011-2780-2; Kalckert A, 2014, CONSCIOUS COGN, V30, P118, DOI 10.1016/j.concog.2014.08.022; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kosek E, 1996, PAIN, V68, P375, DOI 10.1016/S0304-3959(96)03188-0; Krause P, 2006, CLIN NEUROPHYSIOL, V117, P169, DOI 10.1016/j.clinph.2005.09.012; Lewis JS, 2012, EUR J PAIN, V16, P1320, DOI 10.1002/j.1532-2149.2012.00120.x; Macmillan NA, 2005, DETECTION THEORY USE; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; McCabe CS, 2008, RHEUMATOLOGY, V47, P1612, DOI 10.1093/rheumatology/ken254; McCabe CS, 2007, RHEUMATOLOGY, V46, P1587, DOI 10.1093/rheumatology/kem204; McCabe CS, 2008, CURR PAIN HEADACHE R, V12, P103, DOI 10.1007/s11916-008-0020-7; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; McLoughlin MJ, 2011, J PAIN, V12, P640, DOI 10.1016/j.jpain.2010.12.004; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Nishigami T, 2014, RHEUMATOLOGY, V53, P1194, DOI 10.1093/rheumatology/ket494; Pantev C, 2001, ANN NY ACAD SCI, V930, P300, DOI 10.1111/j.1749-6632.2001.tb05740.x; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Rommel O, 1999, PAIN, V80, P95, DOI 10.1016/S0304-3959(98)00202-4; Rumelhart D, 1992, FORWARD MODELS SUPER; Scontrini A, 2009, J NEUROL NEUROSUR PS, V80, P1315, DOI 10.1136/jnnp.2009.178236; Scott D, 2005, CLIN J PAIN, V21, P175, DOI 10.1097/00002508-200503000-00009; Spence C, 2013, ANN NY ACAD SCI, V1296, P31, DOI 10.1111/nyas.12121; Tame L, 2013, CORTEX, V49, P1340, DOI 10.1016/j.cortex.2012.03.016; Tinazzi M, 1999, NEUROREPORT, V10, P1547, DOI 10.1097/00001756-199905140-00028; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Wand BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093701; Yantis S, 2008, CURR DIR PSYCHOL SCI, V17, P86, DOI 10.1111/j.1467-8721.2008.00554.x	63	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146077	10.1371/journal.pone.0146077	http://dx.doi.org/10.1371/journal.pone.0146077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731117	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400089
J	Du, HX; Zhang, SB; Song, MY; Wang, YX; Zeng, L; Chen, Y; Xiong, W; Yang, JJ; Yao, FK; Wu, Y; Wang, DY; Hu, YL; Liu, JG				Du, Hongxu; Zhang, Shuaibing; Song, Meiyun; Wang, Yixuan; Zeng, Ling; Chen, Yun; Xiong, Wen; Yang, Jingjing; Yao, Fangke; Wu, Yi; Wang, Deyun; Hu, Yuanliang; Liu, Jiaguo			Assessment of a Flavone-Polysaccharide Based Prescription for Treating Duck Virus Hepatitis	PLOS ONE			English	Article							ACUTE LIVER-INJURY; CELLULAR INFECTIVITY; SULFATED MODIFICATION; ANTIOXIDANT ACTIVITY; HYPERICUM-JAPONICUM; REHMANNIA-GLUTINOSA; ANTIVIRAL ACTIVITY; SALVIA-PLEBEIA; MODIFIERS; EFFICACY	Because polysaccharide and flavone ingredients display good antiviral activity, we developed a flavone/polysaccharide-containing prescription that would be effective against duck viral hepatitis (DVH) and investigated its hepatoprotective effects. Flavones were derived from Hypericum japonicum (HJF) (entire herb of Hypericum japonicum Thunb) and Salvia plebeia (SPF) (entire herb of Salvia plebeia R.Br.), and polysaccharides were derived from Radix Rehmanniae Recens (RRRP) (dried root of Rehmannia glutinosa Libosch). This prescription combination was based on the theory of syndrome differentiation and treatment in traditional Chinese veterinary medicine. In vitro and in vivo experiments were conducted using the three single ingredients compared to the combined HRS prescription to determine their anti-duck hepatitis A viral (anti-DHAV) activity. The results showed that all experimental conditions displayed anti-DHAV activity, but the HRS prescription presented the best effect. To further investigate the hepatoprotective effect of the HRS prescription on DHAV-induced hepatic injury, we tested the mortality rate, the hepatic pathological severity score, plasma biochemical indexes of hepatic function, blood DHAV gene expression levels and peroxidation damage evaluation indexes and then analyzed correlations among these indexes. The results demonstrated that the HRS prescription significantly decreased the mortality rate, reduced the severity of hepatic injury, decreased the hepatic pathological severity score, depressed blood DHAV gene expression levels, and returned the indexes of hepatic function and peroxidation almost to a normal level. These results indicate that the HRS prescription confers an outstanding hepatoprotective effect, and we expect that it will be developed into a new candidate anti-DHAV drug.	[Du, Hongxu; Zhang, Shuaibing; Song, Meiyun; Wang, Yixuan; Zeng, Ling; Chen, Yun; Xiong, Wen; Yang, Jingjing; Yao, Fangke; Wu, Yi; Wang, Deyun; Hu, Yuanliang; Liu, Jiaguo] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, JG (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Jiangsu, Peoples R China.	liujiaguo@njau.edu.cn	Wang, Yixuan/GZK-6559-2022; wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022; wang, yi/GVT-8516-2022		National Natural Science Foundation of China [31172355]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Funds for Agro-scientific Research of Public Interest [201303040, 201403051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Funds for Agro-scientific Research of Public Interest	This work was supported by the National Natural Science Foundation of China (Grant No. 31172355, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), Project Funds from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Special Funds for Agro-scientific Research of Public Interest (201303040 and 201403051, http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V60, P211, DOI 10.1016/j.freeradbiomed.2013.02.018; Agbenorhevi JK, 2010, CARBOHYD POLYM, V81, P849, DOI 10.1016/j.carbpol.2010.03.056; Ahn B, 1999, CARCINOGENESIS, V20, P1337, DOI 10.1093/carcin/20.7.1337; Bourne N, 2005, ANTIVIR RES, V67, P76, DOI 10.1016/j.antiviral.2005.03.006; CHANG RS, 1988, ANTIVIR RES, V9, P163, DOI 10.1016/0166-3542(88)90001-0; Chen Y, 2014, CARBOHYD POLYM, V102, P333, DOI 10.1016/j.carbpol.2013.11.065; Chiang CH, 2012, OBES RES CLIN PRACT, V6, pE31, DOI 10.1016/j.orcp.2011.04.005; Fan YP, 2011, INT J BIOL MACROMOL, V48, P439, DOI 10.1016/j.ijbiomac.2011.01.005; Gui SY, 2005, WORLD J GASTROENTERO, V11, P2984, DOI 10.3748/wjg.v11.i19.2984; HAIDER SA, 1979, AVIAN DIS, V23, P715, DOI 10.2307/1589748; Haleagrahara N., 2014, BIOMED PREV NUTR, V4, P589, DOI [DOI 10.1016/J.BIONUT.2014.07.006, 10.1016/J.BIONUT.2014.07.006]; Harvala H, 2014, J CLIN VIROL, V59, P184, DOI 10.1016/j.jcv.2014.01.001; Huang XY, 2008, INT J BIOL MACROMOL, V42, P166, DOI 10.1016/j.ijbiomac.2007.10.019; Huang Y, 2013, CARBOHYD POLYM, V96, P516, DOI 10.1016/j.carbpol.2013.04.018; Ishiguro K., 1986, PLANTA MED, V52, P288; Jang YH, 2014, VACCINE, V32, P1808, DOI 10.1016/j.vaccine.2014.01.088; Jin XF, 2008, J PHARMACEUT BIOMED, V48, P100, DOI 10.1016/j.jpba.2008.05.027; Li T, 2013, ANTIVIR RES, V97, P1, DOI 10.1016/j.antiviral.2012.10.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loguercio C, 2003, FREE RADICAL BIO MED, V34, P1, DOI 10.1016/S0891-5849(02)01167-X; Lu YR, 2002, PHYTOCHEMISTRY, V59, P117, DOI 10.1016/S0031-9422(01)00415-0; Lu Y, 2008, CARBOHYD POLYM, V71, P180, DOI 10.1016/j.carbpol.2007.05.024; Pan M, 2012, J VIROL, V86, P1129, DOI 10.1128/JVI.00306-11; Qu XJ, 2009, FOOD CHEM TOXICOL, V47, P1710, DOI 10.1016/j.fct.2009.04.032; Reshi ML, 2014, INT J CELL BIOL, V2014, P467; Shireen KF, 2008, FOOD CHEM TOXICOL, V46, P3290, DOI 10.1016/j.fct.2008.07.015; Soon DKW, 2004, J HEPATOL, V41, P852, DOI 10.1016/j.jhep.2004.07.028; Sui ZF, 2013, CARBOHYD POLYM, V92, P283, DOI 10.1016/j.carbpol.2012.08.087; Szweda PA, 2002, FREE RADICAL BIO MED, V33, P29, DOI 10.1016/S0891-5849(02)00837-7; TAKEUCHI H, 1991, J VIROL METHODS, V33, P61, DOI 10.1016/0166-0934(91)90008-N; TOTH TE, 1969, AVIAN DIS, V13, P834, DOI 10.2307/1588590; Vinay Kumar, 2013, Journal of Pharmacy Research, V6, P620; Wang HW, 2012, ANAL BIOCHEM, V421, P324, DOI 10.1016/j.ab.2011.10.043; Wang N, 2008, J ETHNOPHARMACOL, V116, P1, DOI 10.1016/j.jep.2007.08.031; Weng XC, 2000, FOOD CHEM, V71, P489, DOI 10.1016/S0308-8146(00)00191-6; Wheeler MD, 2001, FREE RADICAL BIO MED, V31, P1544, DOI 10.1016/S0891-5849(01)00748-1; Wu QL, 1998, PHYTOCHEMISTRY, V49, P1395, DOI 10.1016/S0031-9422(98)00116-2; Zhang J, 2005, LIVESTOCK POULTRY IN, V3, P56; Zhang RX, 2008, J ETHNOPHARMACOL, V117, P199, DOI 10.1016/j.jep.2008.02.018; Zhang ZS, 2014, CARBOHYD POLYM, V112, P578, DOI 10.1016/j.carbpol.2014.06.030; Zhao XN, 2011, INT J BIOL MACROMOL, V49, P44, DOI 10.1016/j.ijbiomac.2011.03.010; ZHENG M, 1989, Journal of Traditional Chinese Medicine, V9, P113	42	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146046	10.1371/journal.pone.0146046	http://dx.doi.org/10.1371/journal.pone.0146046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731101	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400080
J	Han, W; Cao, F; Chen, MB; Lu, RZ; Wang, HB; Yu, M; Shi, CT; Ding, HZ				Han, Wei; Cao, Fang; Chen, Min-bin; Lu, Rong-zhu; Wang, Hua-bing; Yu, Min; Shi, Chun-tao; Ding, Hou-zhong			Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NAB-PACLITAXEL; ABERRANT METHYLATION; GASTRIC-CANCER; MESSENGER-RNA; EXPRESSION; ADENOCARCINOMA; SURVIVAL; GEMCITABINE; OSTEONECTIN; PROGRESSION	Objective There is a heated debate on whether the prognostic value of SPARC is favorable or unfavorable. Thus, we carried out a meta-analysis evaluating the relationship between SPARC expression and the prognosis of patients with pancreatic cancer. Methods We searched PubMed, EMBASE and Web of Science for relevant articles. The pooled hazard ratios (HRs) and corresponding 95% CI of overall survival (OS) were calculated to evaluate the prognostic value of SPARC expression in patients with pancreatic cancer. We also performed subgroup analyses. Results With 1623 patients pooled from 10 available studies, the incorporative HR showed an unfavorable prognosis of patients with pancreatic cancer in the multivariate analysis (HR = 1.55, 95% CI: 1.11-2.17, P = 0.01), but not in univariate analysis (HR = 1.41, 95% CI: 0.47-4.21, P = 0.54) and estimate (HR = 1.24, 95% CI: 0.72-2.13, P = 0.44). And this adverse impact could also be found in the subgroup analyses in multivariate analysis, especially in the stroma (HR = 1.53, 95% CI: 1.05-2.24, P = 0.03). However, the combined HR had the highly significant heterogeneity. No obvious publication bias was found. Conclusions SPARC might be an unfavorable indicator in patients with pancreatic cancer, especially in the stroma. More and further researches should be conducted to reveal the prognostic value of SPARC.	[Han, Wei; Cao, Fang; Wang, Hua-bing; Yu, Min; Shi, Chun-tao; Ding, Hou-zhong] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Gen Surg, Kunshan 215300, Jiangsu, Peoples R China; [Chen, Min-bin] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Radiotherapy & Oncol, Kunshan 215300, Jiangsu, Peoples R China; [Lu, Rong-zhu] Jiangsu Univ, Sch Med, Dept Prevent Med, Zhenjiang 212001, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University	Ding, HZ (corresponding author), Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Gen Surg, Kunshan 215300, Jiangsu, Peoples R China.	dinghouzhong@163.com		Lu, Rongzhu/0000-0002-8633-8453				Arnold SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031384; Bhoopathi P, 2011, CANCER RES, V71, P4908, DOI 10.1158/0008-5472.CAN-10-3395; Bloomston M, 2006, LAB INVEST, V86, p268A; Bloomston M, 2007, ANN SURG ONCOL, V14, P211, DOI 10.1245/s10434-006-9128-3; Bochatay Laurent, 2014, Rev Med Suisse, V10, P1582; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Chetty C, 2012, CANCER LETT, V323, P188, DOI 10.1016/j.canlet.2012.04.014; Chew A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022047; DeRosa CA, 2012, PROSTATE CANCER P D, V15, P150, DOI 10.1038/pcan.2011.61; Desai N, 2009, EJC SUPPL, V7, P88, DOI 10.1016/S1359-6349(09)70297-6; Desai NP, 2008, ANTI-CANCER DRUG, V19, P899, DOI 10.1097/CAD.0b013e32830f9046; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Gundewar C, 2015, SCAND J GASTROENTERO, V50, P1170, DOI 10.3109/00365521.2015.1024281; Guweidhi A, 2005, ANN SURG, V242, P224, DOI 10.1097/01.sla.0000171866.45848.68; Hartley ML, 2014, HUM VACC IMMUNOTHER, V10, P3347, DOI 10.1080/21645515.2014.1004017; Hidalgo M., 2015, CLIN CANC RES; Hohenester E, 1996, NAT STRUCT BIOL, V3, P67, DOI 10.1038/nsb0196-67; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jeung HC, 2011, CANCER-AM CANCER SOC, V117, P2050, DOI 10.1002/cncr.25729; Kurtul N, 2014, ASIAN PAC J CANCER P, V15, P8911, DOI 10.7314/APJCP.2014.15.20.8911; Liu QZ, 2015, EUR REV MED PHARMACO, V19, P1803; Lopes GL, 2010, ANN ACAD MED SING S1, V39, pS112; Mantoni TS, 2008, CANCER BIOL THER, V7, P1806, DOI 10.4161/cbt.7.11.6846; Mao ZF, 2014, TUMOR BIOL, V35, P10185, DOI 10.1007/s13277-014-2315-0; Miyoshi K, 2010, ANTICANCER RES, V30, P867; Nagaraju GP, 2014, CARCINOGENESIS, V35, P967, DOI 10.1093/carcin/bgu072; Ormanns S, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.e15264; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Prenzel KL, 2006, ONCOL REP, V15, P1397; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Reitz D, 2015, J CLIN PATHOL, V68, P427, DOI 10.1136/jclinpath-2014-202451; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Sato N, 2006, CANCER-AM CANCER SOC, V107, P251, DOI 10.1002/cncr.21977; Sinn M, 2014, ANN ONCOL, V25, P1025, DOI 10.1093/annonc/mdu084; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vogel A, 2014, IN VIVO, V28, P1135; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wang ZS, 2014, ARCH MED SCI, V10, P863, DOI 10.5114/aoms.2014.46207; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; Xue Li-Yan, 2011, Chin J Cancer, V30, P69; Yin J, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-59; Zhou YB, 2010, CANCER BIOL THER, V9, P507, DOI 10.4161/cbt.9.7.11106	46	32	33	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145803	10.1371/journal.pone.0145803	http://dx.doi.org/10.1371/journal.pone.0145803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731428	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400055
J	Ng, KM; Reaz, MBI				Ng, Kok Mun; Reaz, Mamun Bin Ibne			Platoon Interactions and Real-World Traffic Simulation and Validation Based on the LWR-IM	PLOS ONE			English	Article							CAR-FOLLOWING MODEL; DYNAMICS; WAVES; FLOW	Platoon based traffic flow models form the underlying theoretical framework in traffic simulation tools. They are essentially important in facilitating efficient performance calculation and evaluation in urban traffic networks. For this purpose, a new platoon-based macroscopic model called the LWR-IM has been developed in [1]. Preliminary analytical validation conducted previously has proven the feasibility of the model. In this paper, the LWR-IM is further enhanced with algorithms that describe platoon interactions in urban arterials. The LWR-IM and the proposed platoon interaction algorithms are implemented in the real-world class I and class II urban arterials. Another purpose of the work is to perform quantitative validation to investigate the validity and ability of the LWR-IM and its underlying algorithms to describe platoon interactions and simulate performance indices that closely resemble the real traffic situations. The quantitative validation of the LWR-IM is achieved by performing a two-sampled t-test on queues simulated by the LWR-IM and real queues observed at these real-world locations. The results reveal insignificant differences of simulated queues with real queues where the p-values produced concluded that the null hypothesis cannot be rejected. Thus, the quantitative validation further proved the validity of the LWR-IM and the embedded platoon interactions algorithm for the intended purpose.	[Ng, Kok Mun] Univ Teknol Mara, Fac Elect Engn, Shah Alam, Selangor, Malaysia; [Reaz, Mamun Bin Ibne] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Ukm Bangi, Selangor, Malaysia	Universiti Teknologi MARA; Universiti Kebangsaan Malaysia	Ng, KM (corresponding author), Univ Teknol Mara, Fac Elect Engn, Shah Alam, Selangor, Malaysia.	kokmun77@yahoo.com.sg	Bin Ibne Reaz, Mamun/E-7221-2010	Bin Ibne Reaz, Mamun/0000-0002-0459-0365; Ng, Kok Mun/0000-0003-1765-9488	Ministry of Higher Education (MOHE) [FRGS/1/2014/TK07/UKM/01/1]	Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR))	The authors thank the Ministry of Higher Education (MOHE) for supporting this research project through its FRGS grant no: FRGS/1/2014/TK07/UKM/01/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcelik R, 2015, 33 C AUSTR I TRANSP; Akcelik R, 2014, 26 ARRB C SYDN AUSTR; CHANDLER RE, 1958, OPER RES, V6, P165, DOI 10.1287/opre.6.2.165; DAGANZO CF, 1994, TRANSPORT RES B-METH, V28, P269, DOI 10.1016/0191-2615(94)90002-7; Di Francesco M, 2015, ARCH RATION MECH AN, V217, P831, DOI 10.1007/s00205-015-0843-4; Dotoli M, 2005, 2005 IEEE INT C SYST; Dotoli M, 2006, CONTROL ENG PRACT, V14, P1213, DOI 10.1016/j.conengprac.2006.02.005; Geroliminis N, 2005, TRANSPORT RES REC, P116, DOI 10.3141/1934-12; Hanabusa H, 2010, LECT NOTES ARTIF INT, V6279, P308, DOI 10.1007/978-3-642-15384-6_33; LIGHTHILL MJ, 1955, PROC R SOC LON SER-A, V229, P281, DOI 10.1098/rspa.1955.0088; Liu HX, 2009, TRANSPORT RES C-EMER, V17, P412, DOI 10.1016/j.trc.2009.02.003; Marinica N, 2012, P AMER CONTR CONF, P6563; McDonald JH., 2008, HDB BIOL STAT; Nagel K, 1996, PHYS REV E, V53, P4655, DOI 10.1103/PhysRevE.53.4655; Nakayama A, 2002, PHYS REV E, V65, P116; Ni DH, 2004, TRANSPORT RES REC, P20; Nordiana M, 2014, JURNAL TEKNOLOGI, V71, P7; Rakha H, 2001, J TRANSP ENG-ASCE, V127, P418, DOI 10.1061/(ASCE)0733-947X(2001)127:5(418); Rao L, 1998, 1998 WINTER SIMULATION CONFERENCE PROCEEDINGS, VOLS 1 AND 2, P1079, DOI 10.1109/WSC.1998.745856; Reaz MBI, 2015, PLOS ONE, V10, P1; RICHARDS PI, 1956, OPER RES, V4, P42, DOI 10.1287/opre.4.1.42; Robertson DI, 1969, 253 LR ROAD RES LAB; Sharma A, 2007, TRANSP RES RECORD, P69, DOI 10.3141/2035-08; Tang TQ, 2010, PHYS LETT A, V374, P3951, DOI 10.1016/j.physleta.2010.07.062; Tang TQ, 2010, PHYS LETT A, V374, P1668, DOI 10.1016/j.physleta.2010.02.001; Tang TQ, 2009, INT J MOD PHYS B, V23, P743, DOI 10.1142/S0217979209051966; Transportation Research Board (TRB), 2016, HIGHWAY CAPACITY MAN; Yu SW, 2015, MEASUREMENT, V70, P137, DOI 10.1016/j.measurement.2015.03.031; Yu SW, 2013, COMMUN NONLINEAR SCI, V18, P1229, DOI 10.1016/j.cnsns.2012.09.014	29	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144798	10.1371/journal.pone.0144798	http://dx.doi.org/10.1371/journal.pone.0144798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731745	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400013
J	Guerin, A; Mody, R; Carter, V; Ayas, C; Patel, H; Lasch, K; Wu, E				Guerin, Annie; Mody, Reema; Carter, Valerie; Ayas, Charles; Patel, Haridarshan; Lasch, Karen; Wu, Eric			Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication	PLOS ONE			English	Article							FOUNDATION TASK-FORCE; ANTIPLATELET THERAPY; PLATELET REACTIVITY; OMEPRAZOLE; ESOMEPRAZOLE; PANTOPRAZOLE; PHARMACOKINETICS; PHARMACODYNAMICS; LANSOPRAZOLE; RABEPRAZOLE	Objectives In 2009, the FDA issued a warning that omeprazole-a proton pump inhibitor (PPI)-reduces the antithrombotic effect of clopidogrel by almost half when taken concomitantly. This study aims to analyze the impact of the FDA Safety Communications on prescribing clopidogrel together with PPIs. Methods This retrospective study identified clopidogrel users from the Truven Health Analytics Market-Scan Databases (01/2006-12/2012). Rates of clopidogrel-PPI combination therapy were estimated in 6-month intervals for patients with >= 1 clopidogrel prescription fill, then were analyzed pre-and post-safety communication (11/17/2009). Analyses were also conducted by grouping PPIs into CYP2C19 inhibitors (omeprazole and esomeprazole) and CYP2C19 non-inhibitors (pantoprazole, lansoprazole, dexlansoprazole, and rabeprazole). Results Overall, 483,074 patients met the selection criteria; of these, 157,248 used a clopidogrel-PPI combination. On average, 30.5% of patients in the pre-and 19.9% in the post-communication period used a clopidogrel-PPI combination therapy. Among clopidogrel users, the probability of using clopidogrel-PPI combinations fell by over 40% in the post-communication period (OR = 0.57; p<0.001); the proportion of patients using esomeprazole fell from 12.9% to 5.3%, and the proportion using omeprazole fell from 10.1% to 6.3%. Among combination therapy users, the probability of patients using a combination with a CYP2C19 inhibitor decreased by 53% (OR = 0.47; p<0.001); however, 31.5% of patients were still prescribed a clopidogrel-PPI combination therapy. Trends were similar for all and newly treated patients, regardless of clopidogrel indication and physician specialty. Conclusions The FDA Safety Communication resulted in a reduction in the number of patients undergoing combination therapy; however approximately one-third of patients still used combination therapy post-communication.	[Guerin, Annie; Carter, Valerie; Ayas, Charles] Anal Grp Inc, Montreal, PQ, Canada; [Mody, Reema; Lasch, Karen] Takeda Pharmaceut Int Inc, Hlth Econ & Outcomes Res, Deerfield, IL USA; [Patel, Haridarshan] Immens Consulting Inc, Chicago, IL USA; [Wu, Eric] Anal Grp Inc, Boston, MA USA	Analysis Group Inc.; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Analysis Group Inc.	Guerin, A (corresponding author), Anal Grp Inc, Montreal, PQ, Canada.	annie.guerin@analysisgroup.com			Takeda Pharmaceuticals International; Analysis Group, Inc.	Takeda Pharmaceuticals International; Analysis Group, Inc.	Research for this article was funded by the sponsor, Takeda Pharmaceuticals International. The study was designed by the senior authors (A.G., E. W., and H.P.) and the sponsor employees (R.M. and K.L.). Data were collected by Analysis Group authors V.C. and C.A. and analyzed and interpreted in collaboration with all authors. Manuscript drafts were prepared by the authors with editorial assistance from a professional medical writer paid by the sponsor. All authors participated in the design of the study and contributed to the manuscript development. Although Sponsor employees R.M. and K.L. were involved in the design, collection, analysis, and interpretation of information, the content of this manuscript, the ultimate interpretation, and the decision to submit it for publication were made by each of the authors independently. All the authors vouch for the accuracy and completeness of the data reported and for the adherence of the study to the protocol. Takeda Pharmaceuticals International, Inc. and Analysis Group, Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angiolillo DJ, 2011, CLIN PHARMACOL THER, V89, P65, DOI 10.1038/clpt.2010.219; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bristol-Myers Squibb, 2009, DRUG LABEL, P1; Cardoso RN, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000248; Depta JP, 2010, CLEV CLIN J MED, V77, P113, DOI 10.3949/ccjm.77a.09173; Ehrenpreis ED, 2013, AM J GASTROENTEROL, V108, P866, DOI 10.1038/ajg.2012.300; Food and Drug Administration, 2009, EARL COMM ONG SAF RE; Food and Drug Administration, 2009, FOLL UP JAN 26 2009; Food and Drug Administration, 2010, FDA REM AV CONC US P; Frelinger AL, 2012, J AM COLL CARDIOL, V59, P1304, DOI 10.1016/j.jacc.2011.12.024; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Habib AS, 2008, J CLIN ANESTH, V20, P35, DOI 10.1016/j.jclinane.2007.08.003; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; *IMS HLTH, 2008, TOP 15 GLOB PROD; Laine L, 2010, AM J GASTROENTEROL, V105, P34, DOI 10.1038/ajg.2009.638; Lettino M, 2010, EUR J INTERN MED, V21, P484, DOI 10.1016/j.ejim.2010.08.004; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Melloni C, 2015, CIRC-CARDIOVASC QUAL, V8, P47, DOI 10.1161/CIRCOUTCOMES.114.001177; Neubauer H, 2010, J CARDIOVASC PHARM, V56, P91, DOI 10.1097/FJC.0b013e3181e19739; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Pfizer Inc, 2011, DRUG LAB, P1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Sahara S, 2013, ALIMENT PHARM THER, V38, P1129, DOI 10.1111/apt.12492; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; Singh Tanvir, 2009, Psychiatry (Edgmont), V6, P30; Southworth MR, 2010, NEW ENGL J MED, V363, P1977, DOI 10.1056/NEJMc1012022; Takeda Pharmaceuticals America, 2011, DRUG LAB, P1; Thompson JC, 2013, PEDIATR BLOOD CANCER, V60, pE149, DOI 10.1002/pbc.24633; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; Tran M, 2010, J CARDIOVASC PHARM T, V15, P326, DOI 10.1177/1074248410369109; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Weingart SN, 2009, ARCH INTERN MED, V169, P1465, DOI 10.1001/archinternmed.2009.252; Wood S., 2009, MEDSCAPE; Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e	37	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145504	10.1371/journal.pone.0145504	http://dx.doi.org/10.1371/journal.pone.0145504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727382	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500018
J	Zhou, FQ; Zhuang, Y; Gong, HH; Zhan, J; Grossman, M; Wang, Z				Zhou, Fuqing; Zhuang, Ying; Gong, Honghan; Zhan, Jie; Grossman, Murray; Wang, Ze			Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; COMPLEXITY ANALYSIS; ATROPHY; DISEASE	Brain entropy (BEN) mapping provides a novel approach to characterize brain temporal dynamics, a key feature of human brain. Using resting state functional magnetic resonance imaging (rsfMRI), reliable and spatially distributed BEN patterns have been identified in normal brain, suggesting a potential use in clinical populations since temporal brain dynamics and entropy may be altered in disease conditions. The purpose of this study was to characterize BEN in multiple sclerosis (MS), a neurodegenerative disease that affects millions of people. Since currently there is no cure for MS, developing treatment or medication that can slow down its progression represents a high research priority, for which validating a brain marker sensitive to disease and the related functional impairments is essential. Because MS can start long time before any measurable symptoms and structural deficits, assessing the dynamic brain activity and correspondingly BEN may provide a critical way to study MS and its progression. Because BEN is new to MS, we aimed to assess BEN alterations in the relapsing-remitting MS (RRMS) patients using a patient versus control design, to examine the correlation of BEN to clinical measurements, and to check the correlation of BEN to structural brain measures which have been more often used inMS studies. As compared to controls, RRMS patients showed increased BEN in motor areas, executive control area, spatial coordinating area, and memory system. Increased BEN was related to greater disease severity as measured by the expanded disability status scale (EDSS) and greater tissue damage as indicated by the mean diffusivity. Patients also showed decreased BEN in other places, which was associated with less disability or fatigue, indicating a disease-related BEN re-distribution. Our results suggest BEN as a novel and useful tool for characterizing RRMS.	[Zhou, Fuqing; Gong, Honghan; Zhan, Jie] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Wang, Ze] Hangzhou Normal Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Zhou, Fuqing; Gong, Honghan; Zhan, Jie] Jiangxi Prov Med Imaging Res Inst, Nanchang, Jiangxi, Peoples R China; [Zhuang, Ying] Second Hosp Nanchang, Dept Oncol, Nanchang, Jiangxi, Peoples R China; [Grossman, Murray] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Wang, Ze] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Nanchang University; Hangzhou Normal University; Nanchang University; University of Pennsylvania	Zhou, FQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.	fq.chou@yahoo.com; redhatw@gmail.com			National Natural Science Foundation of China [81101041, 81260217, 81460263, 81560284]; Natural Science Foundation of Jiangxi, China [2013BAB215008]; JiangXi Province science and technology [20151BBG70224]; Science and Technology Project of Jiangxi Provincial Education Department, China [GJJ13136]; Hangzhou Qianjiang Endowed Professor Program; Youth 1000 Talent Program of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi, China(Natural Science Foundation of Jiangxi Province); JiangXi Province science and technology; Science and Technology Project of Jiangxi Provincial Education Department, China; Hangzhou Qianjiang Endowed Professor Program; Youth 1000 Talent Program of China	This study was supported by the National Natural Science Foundation of China (grant no. 81101041, 81260217, 81460263, 81560284), the Natural Science Foundation of Jiangxi, China (2013BAB215008), the JiangXi Province science and technology support program (grant no. 20151BBG70224), the Science and Technology Project of Jiangxi Provincial Education Department, China (grant no. GJJ13136), and the Hangzhou Qianjiang Endowed Professor Program and the Youth 1000 Talent Program of China. The funders had not role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen AK, 2010, NEUROIMAGE, V50, P608, DOI 10.1016/j.neuroimage.2009.12.118; Benedict RHB, 2002, J NEUROPSYCH CLIN N, V14, P44, DOI 10.1176/appi.neuropsych.14.1.44; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Charil A, 2007, NEUROIMAGE, V34, P509, DOI 10.1016/j.neuroimage.2006.10.006; Chwastiak LA, 2007, PSYCHIAT CLIN N AM, V30, P803, DOI 10.1016/j.psc.2007.07.003; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Filippi M, 2013, J NEUROL, V260, P1709, DOI 10.1007/s00415-012-6695-z; Goto M, 2013, NEURORADIOLOGY, V55, P869, DOI 10.1007/s00234-013-1193-2; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lukas C, 2013, RADIOLOGY, V269, P541, DOI 10.1148/radiol.13122566; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Roosendaal SD, 2010, RADIOLOGY, V255, P595, DOI 10.1148/radiol.10091433; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Sbardella E, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/671730; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Smith RX, 2014, BRAIN IMAGING BEHAV, V8, P284, DOI 10.1007/s11682-013-9276-6; Sokunbi MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095146; Sokunbi MO, 2013, PSYCHIAT RES-NEUROIM, V214, P341, DOI 10.1016/j.pscychresns.2013.10.001; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Yao Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02853; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhou FQ, 2014, CLIN IMAG, V38, P605, DOI 10.1016/j.clinimag.2014.05.006; Zivadinov R, 2007, INT REV NEUROBIOL, V79, P449, DOI 10.1016/S0074-7742(07)79020-7; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	35	39	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146080	10.1371/journal.pone.0146080	http://dx.doi.org/10.1371/journal.pone.0146080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727514	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500051
J	Bakker, RS; Selen, LPJ; Medendorp, WP				Bakker, Romy S.; Selen, Luc P. J.; Medendorp, W. Pieter			Stability of Phase Relationships While Coordinating Arm Reaches with Whole Body Motion	PLOS ONE			English	Article							POINTING MOVEMENTS; VISUAL FEEDBACK; SELF-MOTION; ENERGY-COST; TASK; TRUNK; INTEGRATION; DYNAMICS; SYSTEM; TARGET	The human movement repertoire is characterized by the smooth coordination of several body parts, including arm movements and whole body motion. The neural control of this coordination is quite complex because the various body parts have their own kinematic and dynamic properties. Behavioral inferences about the neural solution to the coordination problem could be obtained by examining the emerging phase relationship and its stability. Here, we studied the phase relationships that characterize the coordination of arm-reaching movements with passively-induced whole-body motion. Participants were laterally translated using a vestibular chair that oscillated at a fixed frequency of 0.83 Hz. They were instructed to reach between two targets that were aligned either parallel or orthogonal to the whole body motion. During the first cycles of body motion, a metronome entrained either an in-phase or an anti-phase relationship between hand and body motion, which was released at later cycles to test phase stability. Results suggest that inertial forces play an important role when coordinating reaches with cyclic whole-body motion. For parallel reaches, we found a stable in-phase and an unstable anti-phase relationship. When the latter was imposed, it readily transitioned or drifted back toward an in-phase relationship at cycles without metronomic entrainment. For orthogonal reaches, we did not find a clear difference in stability between in-phase and anti-phase relationships. Computer simulations further show that cost models that minimize energy expenditure (i.e. net torques) or endpoint variance of the reach cannot fully explain the observed coordination patterns. We discuss how predictive control and impedance control processes could be considered important mechanisms underlying the rhythmic coordination of arm reaches and body motion.	[Bakker, Romy S.; Selen, Luc P. J.; Medendorp, W. Pieter] Radboud Univ Nijmegen, Donders Ctr Cognit, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bakker, RS (corresponding author), Radboud Univ Nijmegen, Donders Ctr Cognit, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	r.s.bakker@donders.ru.nl	Medendorp, W. Pieter/A-7369-2010; Selen, Luc/A-6066-2009	Medendorp, W. Pieter/0000-0001-9615-4220; Selen, Luc/0000-0001-5774-5415	European Research Council [EU-ERC-283567]; EU-FP7-FET grant [SpaceCog 600785]; Netherlands Organization for Scientific Research [NWO-VICI: 453-11-001, NWO-VENI: 451-10-017]	European Research Council(European Research Council (ERC)European Commission); EU-FP7-FET grant; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the European Research Council (http://erc.europa.eu/):(EU-ERC-283567) WPM and EU-FP7-FET grant (http://www.spacecog.eu) (SpaceCog 600785) WPM, and the Netherlands Organization for Scientific Research (http://www.nwo.nl/en) (NWO-VICI: 453-11-001), WPM and RSB, and (NWO-VENI: 451-10-017) LPJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 1997, BIOL CYBERN, V76, P97, DOI 10.1007/s004220050324; Balasubramanian R, 2009, IEEE T BIO-MED ENG, V56, P1310, DOI 10.1109/TBME.2008.2006683; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bernstein NA., 1967, COORDINATION REGULAT; Bresciani JP, 2005, EXP BRAIN RES, V164, P431, DOI 10.1007/s00221-005-2263-4; Bresciani JP, 2002, CAH PSYCHOL COGN, V21, P263; Christou EA, 2003, J APPL PHYSIOL, V95, P373, DOI 10.1152/japplphysiol.00060.2003; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Daffertshofer A, 2004, BIOL CYBERN, V90, P157, DOI 10.1007/s00422-004-0462-x; Duchateau J, 2008, J PHYSIOL-LONDON, V586, P5853, DOI 10.1113/jphysiol.2008.160747; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Huys R, 2003, BIOL CYBERN, V88, P302, DOI 10.1007/s00422-002-0379-1; KELSO JAS, 1994, HUM MOVEMENT SCI, V13, P393, DOI 10.1016/0167-9457(94)90047-7; Kelso JAS, 1984, AM J PHYSL REGUL INT; Kistemaker DA, 2014, J NEUROPHYSIOL, V112, P1815, DOI 10.1152/jn.00291.2014; Kistemaker DA, 2010, J NEUROPHYSIOL, V104, P2985, DOI 10.1152/jn.00483.2010; MA S, 1995, J NEUROPHYSIOL, V73, P2120, DOI 10.1152/jn.1995.73.5.2120; Medendorp WP, 1999, EXP BRAIN RES, V125, P50, DOI 10.1007/s002210050657; Moreau-Debord I, 2014, J NEUROPHYSIOL, V111, P1903, DOI 10.1152/jn.00419.2013; Neggers SFW, 1999, EXP BRAIN RES, V125, P97, DOI 10.1007/s002210050663; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Pigeon P, 2000, EXP BRAIN RES, V131, P336, DOI 10.1007/s002219900267; Pigeon P, 1998, BRAIN RES, V802, P274, DOI 10.1016/S0006-8993(98)00616-7; Prsa M, 2015, J NEUROPHYSIOL, V113, P1400, DOI 10.1152/jn.00755.2014; Ridderikhoff A, 2005, J NEUROPHYSIOL, V94, P3112, DOI 10.1152/jn.01077.2004; Ridderikhoff A, 2006, NEUROSCI LETT, V399, P71, DOI 10.1016/j.neulet.2006.01.026; Roerdink M, 2013, ANN BIOMED ENG, V41, P1726, DOI 10.1007/s10439-012-0680-7; Ronsse R, 2010, J NEUROPHYSIOL, V103, P2482, DOI 10.1152/jn.00600.2009; Rosenbaum DA, 2008, PSYCHON B REV, V15, P1100, DOI 10.3758/PBR.15.6.1100; Sarwary AME, 2013, J NEUROPHYSIOL, V110, P1269, DOI 10.1152/jn.00914.2012; Schaal S, 1996, J MOTOR BEHAV, V28, P165, DOI 10.1080/00222895.1996.9941743; SCHOLZ JP, 1989, J MOTOR BEHAV, V21, P122; Selen LPJ, 2005, BIOL CYBERN, V93, P373, DOI 10.1007/s00422-005-0015-y; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; STERNAD D, 2000, PHYS REV E, V63, DOI DOI 10.1103/PHYSREVE.63.011902; SWINNEN SP, 1995, EXP BRAIN RES, V105, P439; Thoroughman KA, 2007, J NEUROPHYSIOL, V98, P870, DOI 10.1152/jn.01126.2006; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593	42	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146231	10.1371/journal.pone.0146231	http://dx.doi.org/10.1371/journal.pone.0146231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TR	26720413	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900053
J	Bwana, P; Vojnov, L; Adhiambo, M; Akinyi, C; Mwende, J; Prescott, M; Mwau, M				Bwana, Priska; Vojnov, Lara; Adhiambo, Maureen; Akinyi, Catherine; Mwende, Joy; Prescott, Marta; Mwau, Matilu			The BD FACSPresto Point of Care CD4 Test Accurately Enumerates CD4+T Cell Counts	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RETENTION; CLINICS	Objective Currently 50% of ART eligible patients are not yet receiving life-saving antiretroviral therapy (ART). Financial constraints do not allow most developing countries to adopt a universal test and offer ART strategy. Decentralizing CD4+ T cell testing may, therefore, provide greater access to testing, ART, and better patient management. We evaluated the technical performance of a new point-of-care CD4+ T cell technology, the BD FACSPresto, in a field methods comparison study. Methods 264 HIV-positive patients were consecutively enrolled and included in the study. The BD FACSPresto POC CD4+ T cell technology was placed in two rural health care facilities and operated by health care facility staff. We compared paired finger-prick and venous samples using the BD FACSPresto and several existing reference technologies, respectively. Results The BD FACSPresto had a mean bias of 67.29 cells/ul and an r(2) of 0.9203 compared to the BD FACSCalibur. At ART eligibility thresholds of 350 and 500 cells/ul, the sensitivity to define treatment eligibility were 81.5% and 77.2% and the specificities were 98.9% and 100%, respectively. Similar results were observed when the BD FACSPresto was compared to the BD FACSCount and Alere Pima. The coefficient of variation (CV) was less than 7% for both the BD FACSCalibur and BD FACSPresto. CD4+ T cell testing by nurses using the BD FACSPresto at rural health care facilities showed high technical similarity to test results generated by laboratory technicians using the BD FACSPresto in a high functioning laboratory. Conclusions The BD FACSPresto performed favorably in the laboratory setting compared to the conventional reference standard technologies; however, the lower sensitivities indicated that up to 20% of patients tested in the field in need of treatment would be missed. The BD FACSPresto is a technology that can allow for greater decentralization and wider access to CD4+ T cell testing and ART.	[Bwana, Priska; Adhiambo, Maureen; Akinyi, Catherine; Mwende, Joy; Mwau, Matilu] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Vojnov, Lara; Prescott, Marta] Clinton Hlth Access Initiat, Boston, MA USA	Kenya Medical Research Institute	Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	matilu.mwau@gmail.com		Vojnov, Lara/0000-0003-0488-1012	UNITAID	UNITAID	This work was supported by UNITAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107410; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; UNAIDS, 2014, THE GAP REP; UNITAID, 2014, HIV AIDS DIAGN TECHN; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2015, WHO LIST PREQ VITR D; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809	15	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145586	10.1371/journal.pone.0145586	http://dx.doi.org/10.1371/journal.pone.0145586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720601	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900014
J	Kabiri, D; Hants, Y; Yarkoni, TR; Shaulof, E; Friedman, SE; Paltiel, O; Nir-Paz, R; Aljamal, WE; Ezra, Y				Kabiri, Doron; Hants, Yael; Yarkoni, Tom Raz; Shaulof, Esther; Friedman, Smadar Eventov; Paltiel, Ora; Nir-Paz, Ran; Aljamal, Wesam E.; Ezra, Yossef			Antepartum Membrane Stripping in GBS Carriers, Is It Safe? (The STRIP-G Study)	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; GROUP-B STREPTOCOCCUS; PREVENTION; DISEASE	Objective Stripping of the membranes is an established and widely utilized obstetric procedure associated with higher spontaneous vaginal delivery rates, reduced need for formal induction of labor and a lower likelihood of post-term pregnancy. Due to the theoretical concern of bacterial seeding during the procedure many practitioners choose not to sweep the membranes in Group B Streptococcus (GBS) colonized patients. We conducted 'the STRIP-G study' in order to determine whether maternal and neonatal outcomes are affected by GBS carrier status in women undergoing membrane stripping. Study design We conducted a prospective study in a tertiary referral center, comparing maternal and neonatal outcomes following membrane stripping among GBS-positive, GBS-negative, and GBS-unknown patients. We compared the incidence of composite adverse neonatal outcomes (primary outcome) among the three study groups, while secondary outcome measure was composite adverse maternal outcomes. Results A total of 542 women were included in the study, of which 135 were GBS-positive, 361 GBS-negative, and 46 GBS-unknown status. Demographic, obstetric, and intra-partum characteristics were similar for all groups. Adverse neonatal outcomes were observed in 8 (5.9%), 31 (8.6%), and 2 (4.3%) in the GBS-positive, GBS-negative, and unknown groups, respectively (P = 0.530), (Odds Ratio between GBS-Positive vs. GBS-Negative groups 0.67 (95%, CI = 0.30-1.50)); while composite adverse maternal outcomes occurred in 9 (6.66%), 31 (8.59%), and 5 (10.87%) in the GBS-positive, GBS-negative, and unknown groups, respectively (P = 0.617). Conclusions Antepartum membrane stripping in GBS carriers appears to be a safe obstetrical procedure that does not adversely affect maternal or neonatal outcomes.	[Kabiri, Doron; Hants, Yael; Yarkoni, Tom Raz; Shaulof, Esther; Aljamal, Wesam E.; Ezra, Yossef] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel; [Friedman, Smadar Eventov] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Neonatol, Jerusalem, Israel; [Paltiel, Ora] Hebrew Univ Jerusalem, Hadassah Med Ctr, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel; [Nir-Paz, Ran] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Kabiri, D (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel.	doronkabiri@gmail.com	Nir-Paz, Ran/Q-6244-2019; Kabiri, Doron/K-1339-2019; Nir-Paz, Ran/GYA-4148-2022	Nir-Paz, Ran/0000-0002-1567-2550; Kabiri, Doron/0000-0002-6527-7866; 				[Anonymous], 2011, Obstet Gynecol, V117, P1019, DOI 10.1097/AOG.0b013e318219229b; [Anonymous], ANT EARL ONS NEON IN; Arnold W, 2006, OBG MANAGEMENT; BAKER CJ, 1973, J PEDIATR-US, V83, P919, DOI 10.1016/S0022-3476(73)80524-4; Boulvain M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000451.pub2; Carbonell-Estrany X, 2008, ARCH DIS CHILD-FETAL, V93, pF85, DOI 10.1136/adc.2007.119958; Crago MS, 2012, J FAMILY PRACTICE, V61, p60a; de Miranda E, 2006, BJOG-INT J OBSTET GY, V113, P402, DOI 10.1111/j.1471-0528.2006.00870.x; Gabbe SG, 2012, OBSTET NORMAL PROBLE; Hill MJ, 2008, OBSTET GYNECOL, V111, P1313, DOI 10.1097/AOG.0b013e31816fdcf3; Induction of Labour, 2008, NICE CLIN GUID NO 70; Kabiri D, AM J OBSTET GYNECOLO, V212, pS163; Laughon SK, 2011, OBSTET GYNECOL, V117, P805, DOI 10.1097/AOG.0b013e3182114ad2; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Luck S, 2003, LANCET, V361, P1953, DOI 10.1016/S0140-6736(03)13553-2; MCCOLGIN SW, 1993, AM J OBSTET GYNECOL, V169, P71, DOI 10.1016/0002-9378(93)90134-5; National Guideline C, 2014, NAT GUID C; Netta D VP, 2002, AM J OBSTET GYNECOL, V187, pS210; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1; SWANN RO, 1958, OBSTET GYNECOL, V11, P74; Tan PC, 2006, OBSTET GYNECOL, V107, P569, DOI 10.1097/01.AOG.0000200094.89388.70; Thiery M BC, 2000, EFFECTIVE CARE PREGN; Van Dyke MK, 2009, NEW ENGL J MED, V360, P2626, DOI 10.1056/NEJMoa0806820; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1	25	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145905	10.1371/journal.pone.0145905	http://dx.doi.org/10.1371/journal.pone.0145905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719985	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900025
J	Bovery, CM; Wyneken, J				Bovery, Caitlin M.; Wyneken, Jeanette			Seasonal Variation in Sea Turtle Density and Abundance in the Southeast Florida Current and Surrounding Waters	PLOS ONE			English	Article							CARETTA-CARETTA; KEMPS RIDLEY; LOGGERHEAD TURTLES; DIVING BEHAVIOR; ATLANTIC WATERS; STABLE-ISOTOPES; HABITAT SHIFTS; MARINE TURTLES; NORTH PACIFIC; GREEN TURTLES	Assessment and management of sea turtle populations is often limited by a lack of available data pertaining to at-sea distributions at appropriate spatial and temporal resolutions. Assessing the spatial and temporal distributions of marine turtles in an open system poses both observational and analytical challenges due to the turtles' highly migratory nature. Surface counts of marine turtles in waters along the southern part of Florida's east coast were made in and adjacent to the southeast portion of the Florida Current using standard aerial surveys during 2011 and 2012 to assess their seasonal presence. This area is of particular concern for sea turtles as interest increases in offshore energy developments, specifically harnessing the power of the Florida Current. While it is understood that marine turtles use these waters, here we evaluate seasonal variation in sea turtle abundance and density over two years. Density of sea turtles observed within the study area ranged from 0.003 turtles km(-2) in the winter of 2011 to 0.064 turtles km(-2) in the spring of 2012. This assessment of marine turtles in the waters off southeast Florida quantifies their in-water abundance across seasons in this area to establish baselines and inform future management strategies of these protected species.	[Bovery, Caitlin M.; Wyneken, Jeanette] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Wyneken, J (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.	jwyneken@fau.edu			U.S. Department of Energy [DE-EE0000319]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, #DE-EE0000319 (http://energy.gov/eere/office-energy-efficiency-renewable-energy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt MD, 2012, MAR BIOL, V159, P127, DOI 10.1007/s00227-011-1829-x; Arendt MD, 2012, MAR BIOL, V159, P101, DOI 10.1007/s00227-011-1793-5; Arendt MD, 2012, MAR BIOL, V159, P113, DOI 10.1007/s00227-011-1826-0; BOLTEN AB, 2002, BIOL SEA TURTLES, V2, P243, DOI DOI 10.1201/9781420040807.CH9; Bovery Caitlin M., 2013, U S National Marine Fisheries Service Marine Fisheries Review, V75, P1; Braun-McNeill Joanne, 2002, U S National Marine Fisheries Service Marine Fisheries Review, V64, P50; Bresette Michael J., 2010, Endangered Species Research, V9, P105, DOI 10.3354/esr00245; Buckland S.T., 2001, pi; Casale P, 2008, MAR ECOL PROG SER, V372, P265, DOI 10.3354/meps07702; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; de Segura AG, 2006, ANIM CONSERV, V9, P199, DOI 10.1111/j.1469-1795.2005.00014.x; Dodd C.K., 1988, US FISH WILDLIFE SER, V88, P110; Dodd Jr KC, 2003, CHELONIAN CONSERV BI, V4, P1; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Ehrhart L.M., 2003, LOGGERHEAD SEA TURTL, P157; Ehrhart Llewellyn M., 2007, Florida Scientist, V70, P415; EPPERLY SP, 1995, FISH B-NOAA, V93, P254; Florida Fish and Wildlife Conservation Commission, 1989, IND NEST BEACH SURV; Fritts T. H., 1983, FWSOBS8265, P455; Fuentes MMPB, 2015, J EXP MAR BIOL ECOL, V471, P77, DOI 10.1016/j.jembe.2015.05.003; Girard C, 2009, MAR BIOL, V156, P1827, DOI 10.1007/s00227-009-1216-z; Gitschlag GR, 1996, J EXP MAR BIOL ECOL, V205, P115, DOI 10.1016/S0022-0981(96)02602-0; Hanson H. P., 2011, EOS T AGU, V92, P29, DOI [10.1029/2011EO040001, DOI 10.1029/2011E0040001]; Hanson HP, 2010, B AM METEOROL SOC, V91, P861, DOI 10.1175/2010BAMS3021.1; Hart KM, 2012, BIOL CONSERV, V145, P185, DOI 10.1016/j.biocon.2011.10.030; Hatase H, 2006, OECOLOGIA, V149, P52, DOI 10.1007/s00442-006-0431-2; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; HENWOOD T A, 1987, Northeast Gulf Science, V9, P153; HOFFMAN W, 1982, HERPETOLOGICA, V38, P405; Jean C, 2010, ORYX, V44, P223, DOI 10.1017/S003060530999072X; Johnson Steve A., 1999, Florida Scientist, V62, P194; Kenney RD, 2012, REPTILE BIODIVERSITY, P264; Kobayashi DR, 2008, J EXP MAR BIOL ECOL, V356, P96, DOI 10.1016/j.jembe.2007.12.019; Lambardi P, 2008, MAR ECOL PROG SER, V353, P289, DOI 10.3354/meps07118; Lauriano G, 2011, MAR ECOL PROG SER, V437, P291, DOI 10.3354/meps09261; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Makowski C, 2006, MAR BIOL, V148, P1167, DOI 10.1007/s00227-005-0150-y; Mansfield KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3039; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Mansfield KL., 2006, THESIS; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; McClellan CM, 2007, BIOLOGY LETT, V3, P592, DOI 10.1098/rsbl.2007.0355; McClellan D.B., 1996, NOAA TECHNICAL MEMOR, V42; Meylan AB, 2006, 26 ANN S SEA TURTL B, P306; Meylan Anne, 1995, Florida Marine Research Publications, V52, P1; Meylan Anne, 2006, Chelonian Research Monographs, V3, P105; Morreale SJ, 2005, CHELONIAN CONSERV BI, V4, P872; Musick John A., 1997, P137; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Putman NF, 2010, INTEGR COMP BIOL, V50, P305, DOI 10.1093/icb/icq041; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Schmid JR, 2005, CHELONIAN CONSERV BI, V4, P828; Schroeder BA, 1985, ECOLOGY E FLORIDA SE; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Shoop C.R., 1992, Herpetological Monographs, P43; Snover ML, 2008, B MAR SCI, V83, P53; Snover Melissa L., 2010, Endangered Species Research, V13, P25, DOI 10.3354/esr00311; Stewart K, 2011, ECOL APPL, V21, P263, DOI 10.1890/09-1838.1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thomson JA, 2012, METHODS ECOL EVOL, V3, P378, DOI 10.1111/j.2041-210X.2011.00163.x; Turtle Expert Working Group, 2007, NMFSSEFSC555 NOAA TU; Turtle Expert Working Group, 2009, NMFSSEFSC575 NOAA TU; Witherington B, 2012, MAR ECOL PROG SER, V463, P1, DOI 10.3354/meps09970; Witherington Blair, 2006, Chelonian Research Monographs, V3, P90; Witzell WN, 2002, FISH B-NOAA, V100, P624; Wood LD, 2006, 26 ANN S SEA TURTL B, P336	68	4	4	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145980	10.1371/journal.pone.0145980	http://dx.doi.org/10.1371/journal.pone.0145980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717520	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500109
J	Kim, JH; Kim, JH; Wang, P; Park, BS; Han, MS				Kim, Joo-Hwan; Kim, Jin Ho; Wang, Pengbin; Park, Bum Soo; Han, Myung-Soo			An Improved Quantitative Real-Time PCR Assay for the Enumeration of Heterosigma akashiwo (Raphidophyceae) Cysts Using a DNA Debris Removal Method and a Cyst-Based Standard Curve	PLOS ONE			English	Article							MARINE-SEDIMENTS; CHATTONELLA RAPHIDOPHYCEAE; ALEXANDRIUM-TAMARENSE; EXTRACELLULAR DNA; NUCLEIC-ACIDS; QUANTIFICATION; SURVIVAL; SOIL; GERMINATION; ALGAE	The identification and quantification of Heterosigma akashiwo cysts in sediments by light microscopy can be difficult due to the small size and morphology of the cysts, which are often indistinguishable from those of other types of algae. Quantitative real-time PCR (qPCR) based assays represent a potentially efficient method for quantifying the abundance of H. akashiwo cysts, although standard curves must be based on cyst DNA rather than on vegetative cell DNA due to differences in gene copy number and DNA extraction yield between these two cell types. Furthermore, qPCR on sediment samples can be complicated by the presence of extracellular DNA debris. To solve these problems, we constructed a cyst-based standard curve and developed a simple method for removing DNA debris from sediment samples. This cyst-based standard curve was compared with a standard curve based on vegetative cells, as vegetative cells may have twice the gene copy number of cysts. To remove DNA debris from the sediment, we developed a simple method involving dilution with distilled water and heating at 75 degrees C. A total of 18 sediment samples were used to evaluate this method. Cyst abundance determined using the qPCR assay without DNA debris removal yielded results up to 51-fold greater than with direct counting. By contrast, a highly significant correlation was observed between cyst abundance determined by direct counting and the qPCR assay in conjunction with DNA debris removal (r(2) = 0.72, slope = 1.07, p < 0.001). Therefore, this improved qPCR method should be a powerful tool for the accurate quantification of H. akashiwo cysts in sediment samples.	[Kim, Joo-Hwan; Kim, Jin Ho; Wang, Pengbin; Park, Bum Soo; Han, Myung-Soo] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Park, Bum Soo; Han, Myung-Soo] Hanyang Univ, Res Inst Nat Sci, Seoul 133791, South Korea	Hanyang University; Hanyang University	Han, MS (corresponding author), Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea.	hanms@hanyang.ac.kr	Park, Bum Soo/W-3178-2017; Wang, Pengbin/J-2436-2014	Park, Bum Soo/0000-0002-5441-6779; Wang, Pengbin/0000-0001-7116-3227; , Jin Ho/0000-0001-7657-5351	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT and future Planning [NRF-2015R1A2A2A01008115]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT and future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2015R1A2A2A01008115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENHOLTZ I, 1994, ARCH MICROBIOL, V161, P176, DOI 10.1007/s002030050039; Anderson D.M., 2003, Monographs on Oceanographic Methodology, V11, P165; Band-Schmidt CJ, 2004, HYDROBIOLOGIA, V515, P79, DOI 10.1023/B:HYDR.0000027320.00977.8b; BLACK EA, 1991, J APPL ICHTHYOL, V7, P168, DOI 10.1111/j.1439-0426.1991.tb00523.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bowers HA, 2006, HARMFUL ALGAE, V5, P342, DOI 10.1016/j.hal.2005.09.005; BUZER JS, 1985, PHYCOLOGIA, V24, P249, DOI 10.2216/i0031-8884-24-2-249.1; Coyne KJ, 2005, LIMNOL OCEANOGR-METH, V3, P381, DOI 10.4319/lom.2005.3.381; Dell'Anno A, 1998, APPL ENVIRON MICROB, V64, P3238; Dell'Anno A, 2002, LIMNOL OCEANOGR, V47, P899, DOI 10.4319/lo.2002.47.3.0899; Dell'Anno A, 1999, APPL ENVIRON MICROB, V65, P4451; Dyhrman ST, 2006, HARMFUL ALGAE, V5, P242, DOI 10.1016/j.hal.2005.07.005; England LS, 1997, SOIL BIOL BIOCHEM, V29, P1521, DOI 10.1016/S0038-0717(97)00013-8; Erdner DL, 2010, DEEP-SEA RES PT II, V57, P279, DOI 10.1016/j.dsr2.2009.09.006; FISHER JB, 1981, HYDROBIOLOGIA, V79, P277, DOI 10.1007/BF00006325; Galluzzi L, 2010, J APPL PHYCOL, V22, P1, DOI 10.1007/s10811-009-9411-3; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; Han MS, 2002, J PHYCOL, V38, P304, DOI 10.1046/j.1529-8817.2002.01087.x; HARA Y, 1987, BOT MAG TOKYO, V100, P151, DOI 10.1007/BF02488320; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Imai I, 1999, MAR BIOL, V133, P755, DOI 10.1007/s002270050517; Imai I., 1991, Bulletin of Japanese Society of Microbial Ecology, V6, P1; IMAI I, 1993, NIPPON SUISAN GAKK, V59, P1669; Imai I, 1998, HARMFUL ALGAE, P163; ITAKURA S, 1991, NIPPON SUISAN GAKK, V57, P1079; Kamikawa R, 2005, FISHERIES SCI, V71, P987, DOI 10.1111/j.1444-2906.2005.01055.x; Kamikawa R, 2007, HARMFUL ALGAE, V6, P413, DOI 10.1016/j.hal.2006.12.004; Kim JH, 2015, PHYCOLOGIA, V54, P435, DOI 10.2216/15-26.1; Lee JY, 2012, JBIO, V2, P30; LORENZ MG, 1981, MAR BIOL, V64, P225, DOI 10.1007/BF00397113; MEKSUMPUN S, 1994, PHYCOLOGIA, V33, P275, DOI 10.2216/i0031-8884-33-4-275.1; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Ning J, 2009, APPL MICROBIOL BIOT, V82, P983, DOI 10.1007/s00253-009-1912-0; O'Halloran C, 2006, HARMFUL ALGAE, V5, P124, DOI 10.1016/j.hal.2005.06.009; Park BS, 2014, HARMFUL ALGAE, V37, P133, DOI 10.1016/j.hal.2014.04.019; Park BS, 2012, J APPL PHYCOL, V24, P1555, DOI 10.1007/s10811-012-9816-2; Park TG, 2010, HARMFUL ALGAE, V9, P59, DOI 10.1016/j.hal.2009.08.002; Portune KJ, 2009, AQUAT MICROB ECOL, V55, P229, DOI 10.3354/ame01292; Shikata T, 2008, LIMNOL OCEANOGR, V53, P2503, DOI 10.4319/lo.2008.53.6.2503; Shikata T, 2007, HARMFUL ALGAE, V6, P700, DOI 10.1016/j.hal.2007.02.008; TRAINOR FR, 1983, PHYCOLOGIA, V22, P201, DOI 10.2216/i0031-8884-22-2-201.1; TRAINOR FR, 1995, PHYCOLOGIA, V34, P191, DOI 10.2216/i0031-8884-34-3-191.1; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; YAMAGUCHI M, 1994, PHYCOLOGIA, V33, P163, DOI 10.2216/i0031-8884-33-3-163.1; YAMAGUCHI M, 1995, PHYCOLOGIA, V34, P207, DOI 10.2216/i0031-8884-34-3-207.1; YANG CZ, 1995, DIS AQUAT ORGAN, V23, P101, DOI 10.3354/dao023101; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	48	11	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145712	10.1371/journal.pone.0145712	http://dx.doi.org/10.1371/journal.pone.0145712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741648	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600007
J	Matta, S; Park, J; Shantha, GPS; Khanna, RC; Rao, GN				Matta, Sumathi; Park, Jiwon; Shantha, Ghanshyam Palamaner Subash; Khanna, Rohit C.; Rao, Gullapalli N.			Cataract Surgery Visual Outcomes and Associated Risk Factors in Secondary Level Eye Care Centers of L V Prasad Eye Institute, India	PLOS ONE			English	Article							CHAMBER LENS IMPLANTATION; DEVELOPING-COUNTRY; CLINICAL-OUTCOMES; RURAL CHINA; VISION LOSS; EXTRACTION; PREVALENCE; AFRICA; COMMUNITY; CAMPAIGN	Purpose To evaluate cataract surgery visual outcomes and associated risk factors in rural secondary level eye care centers of L V Prasad Eye Institute (LVPEI), India. Methods The Eye Health pyramid of LVPEI has a network of rural secondary care centres (SCs) and attached vision centres (VCs) that provide high quality comprehensive eye care with permanent infrastructure to the most disadvantaged sections of society. The most common procedure performed at SCs is cataract surgery. We audited the outcome of a random sample of 2,049 cataract surgeries done from October 2009-March 2010 at eight rural SCs. All patients received a comprehensive ophthalmic examination, both before and after surgery. The World Health Organization recommended cataract surgical record was used for data entry. Visual outcomes were measured at discharge, 1-3 weeks and 4-11 weeks follow up visits. Poor outcome was defined as best corrected visual acuity < 6/18. Results Mean age was 61.8 years (SD: 8.9 years) and 1,133 (55.3%) surgeries were performed on female patients. Pre-existing ocular co-morbidity was present in 165 patients (8.1%). The most common procedure was small incision cataract surgery (SICS) with intraocular lens (IOL) implantation (91.8%). Intraoperative complications were seen in 29 eyes (1.4%). At the 4-11 weeks follow-up visit, based on presenting visual acuity (PVA), 61.8% had a good outcome and based on best-corrected visual acuity (BCVA), 91.7% had a good outcome. Based on PVA and BCVA, those with less than 6/60 were only 2.9% and 1.6% respectively. Using multivariable analysis, poor visual outcomes were significantly higher in patients aged >= 70 (OR 4.63; 95% CI 1.61, 13.30), in females (OR 1.58; 95% CI 1.04, 2.41), those with preoperative comorbidities (odds ratio 4.68; 95% CI 2.90, 7.57), with intraoperative complications (OR 8.01; 95% CI 2.91, 22.04), eyes that underwent no IOL or anterior chamber- IOL (OR 12.63; 95% CI 2.65, 60.25) and those undergoing extracapsular cataract extraction (OR 9.39; 95% CI 1.18, 74.78). Conclusions This study demonstrates that quality cataract surgeries can be achieved at rural SCs. The concept of the LVPEI SCs can be applied to other developing countries, allowing rural patients to attain better vision through cataract surgery. Despite improvements in quality of cataract surgery, gender discrimination in terms of outcome continues to be an issue and needs further investigation.	[Matta, Sumathi] Andhra Pradesh Right Sight Soc, Hyderabad, Andhra Pradesh, India; [Park, Jiwon] MIT, Cambridge, MA USA; [Shantha, Ghanshyam Palamaner Subash] Univ Iowa Hosp & Clin, Dept Internal Med, Iowa City, IA 52242 USA; [Khanna, Rohit C.; Rao, Gullapalli N.] LV Prasad Eye Inst, Allen Foster Res Ctr Community Eye Hlth, Gullapalli Pratibha Rao Int Ctr Adv Rural Eye Car, Hyderabad, Andhra Pradesh, India; [Khanna, Rohit C.; Rao, Gullapalli N.] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Hyderabad, Andhra Pradesh, India	Massachusetts Institute of Technology (MIT); University of Iowa; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Khanna, RC (corresponding author), LV Prasad Eye Inst, Allen Foster Res Ctr Community Eye Hlth, Gullapalli Pratibha Rao Int Ctr Adv Rural Eye Car, Hyderabad, Andhra Pradesh, India.	rohit@lvpei.org		Park, Jiwon/0000-0003-4446-4707				Baranano AE, 2008, OPHTHALMOLOGY, V115, P815, DOI 10.1016/j.ophtha.2007.05.052; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Chuo JY, 2012, CAN J OPHTHALMOL, V47, P284, DOI 10.1016/j.jcjo.2012.03.051; Cook NJ, 1996, BRIT J OPHTHALMOL, V80, P698, DOI 10.1136/bjo.80.8.698; Desai P, 1999, BRIT J OPHTHALMOL, V83, P1336, DOI 10.1136/bjo.83.12.1336; EGBERT PR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1764, DOI 10.1001/archopht.1991.01080120148046; Ezegwui Ifeoma Regina, 2009, International Ophthalmology, V29, P7, DOI 10.1007/s10792-007-9182-2; Gogate P, 2011, J CATARACT REFR SURG, V37, P328, DOI 10.1016/j.jcrs.2010.08.034; Hashemi H, 2012, OPHTHAL EPIDEMIOL, V19, P242, DOI 10.3109/09286586.2012.691600; Huang WY, 2013, CLIN EXP OPHTHALMOL, V41, P463, DOI 10.1111/ceo.12021; Jonas JB, 2014, BRIT J OPHTHALMOL, V98, P592, DOI 10.1136/bjophthalmol-2013-303998; Kandel RP, 2010, OPHTHAL EPIDEMIOL, V17, P276, DOI 10.3109/09286586.2010.508355; Lai FHP, 2014, J AM GERIATR SOC, V62, P165, DOI 10.1111/jgs.12590; Lam DSC, 2007, ARCH OPHTHALMOL-CHIC, V125, P1539, DOI 10.1001/archopht.125.11.eeb70013; Limburg H, 1999, B WORLD HEALTH ORGAN, V77, P455; Lindfield R, 2009, BRIT J OPHTHALMOL, V93, P875, DOI 10.1136/bjo.2008.152744; Lindfield R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038483; Muller A, 2011, OPHTHAL EPIDEMIOL, V18, P103, DOI 10.3109/09286586.2010.545932; Murthy GVS, 2009, OPHTHAL EPIDEMIOL, V16, P400, DOI 10.3109/09286580903315809; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Rao GN, 2012, INDIAN J OPHTHALMOL, V60, P396, DOI 10.4103/0301-4738.100533; Signes-Soler I, 2013, OPTOMETRY VISION SCI, V90, P185, DOI 10.1097/OPX.0b013e31827d0717; StataCorp, 2009, STAT STAT SOFTW REL; Venkatesh R, 2005, BRIT J OPHTHALMOL, V89, P1079, DOI 10.1136/bjo.2004.063479; Vijaya L, 2010, INDIAN J OPHTHALMOL, V58, P223, DOI 10.4103/0301-4738.62648; Xiao BX, 2013, OPHTHAL EPIDEMIOL, V20, P288, DOI 10.3109/09286586.2013.794901; Yan XX, 2013, OPHTHAL EPIDEMIOL, V20, P294, DOI 10.3109/09286586.2013.821136; Yorston D, 2002, BRIT J OPHTHALMOL, V86, P543, DOI 10.1136/bjo.86.5.543; Yorston D, 1999, BRIT J OPHTHALMOL, V83, P897, DOI 10.1136/bjo.83.8.897	29	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0144853	10.1371/journal.pone.0144853	http://dx.doi.org/10.1371/journal.pone.0144853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741363	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600005
J	Valentin, S; Licka, TF				Valentin, Stephanie; Licka, Theresia F.			Spinal Motion and Muscle Activity during Active Trunk Movements - Comparing Sheep and Humans Adopting Upright and Quadrupedal Postures	PLOS ONE			English	Article							LUMBAR SPINE; OLDER-ADULTS; IN-VITRO; HEALTHY-SUBJECTS; SKELETAL-MUSCLE; TREADMILL; RANGE; FLEXION; MODEL; KINEMATICS	Sheep are used as models for the human spine, yet comparative in vivo data necessary for validation is limited. The purpose of this study was therefore to compare spinal motion and trunk muscle activity during active trunk movements in sheep and humans. Three-dimensional kinematic data as well as surface electromyography (sEMG) of spinal flexion and extension was compared in twenty-four humans in upright (UR) and 4-point kneeling (KN) postures and in 17 Austrian mountain sheep. Kinematic markers were attached over the sacrum, posterior iliac spines, and spinous and transverse processes of T5, T8, T11, L2 and L5 in humans and over the sacrum, tuber sacrale, T5, T8, T12, L3 and L7 in sheep. The activity of erector spinae (ES), rectus abdominis (RA), obliquus externus (OE), and obliquus internus (OI) were collected. Maximum sEMG (MOE) was identified for each muscle and trial, and reported as a percentage (MOE%) of the overall maximally observed sEMG from all trials. Spinal range of motion was significantly smaller in sheep compared to humans (UR/KN) during flexion (sheep: 6-11 degrees; humans 12-34 degrees) and extension (sheep: 4 degrees; humans: 11-17 degrees). During extension, MOE% of ES was greater in sheep (median: 77.37%) than UR humans (24.89%), and MOE% of OE and OI was greater in sheep (OE 76.20%; OI 67.31%) than KN humans (OE 21.45%; OI 19.34%), while MOE% of RA was lower in sheep (21.71%) than UR humans (82.69%). During flexion, MOE% of RA was greater in sheep (83.09%) than humans (KN 47.42%; UR 41.38%), and MOE% of ES in sheep (45.73%) was greater than KN humans (14.45%), but smaller than UR humans (72.36%). The differences in human and sheep spinal motion and muscle activity suggest that caution is warranted when ovine data are used to infer human spine biomechanics.	[Valentin, Stephanie; Licka, Theresia F.] Univ Vet Med Vienna, Equine Clin, Vienna, Austria; [Licka, Theresia F.] Univ Edinburgh, Royal Dick Sch Vet Studies, Large Anim Hosp, Roslin, Midlothian, Scotland	University of Veterinary Medicine Vienna; University of Edinburgh	Valentin, S (corresponding author), Univ Vet Med Vienna, Equine Clin, Vienna, Austria.	stephanie.valentin@vetmeduni.ac.at		Licka, Theresia/0000-0001-7651-5180; Valentin, Stephanie/0000-0002-8568-3458	Austrian Science Fund (FWF) [P24020]; Austrian Science Fund (FWF) [P 24020] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Austrian Science Fund (FWF), P24020, principal investigator Theresia Licka, https://www.fwf.ac.at/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedoyin RA, 2011, J BACK MUSCULOSKELET, V24, P101, DOI [10.3233/BMR-2011-0282, 10.3233/BMR20110282]; Balshaw G, 2012, J ELECTROMYOGR KINES, V22, P308, DOI 10.1016/j.jelekin.2011.11.009; Beith ID, 2001, MANUAL THER, V6, P82, DOI 10.1054/math.2000.0376; Bible JE, 2008, SPINE, V33, P1793, DOI 10.1097/BRS.0b013e31817b8f3a; Boccia G, 2014, J ELECTROMYOGR KINES, V24, P25, DOI 10.1016/j.jelekin.2013.10.017; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Busscher I, 2009, SPINE, V34, P2858, DOI 10.1097/BRS.0b013e3181b4c75d; Clayton HM, 2010, EQUINE VET J, V42, P688, DOI 10.1111/j.2042-3306.2010.00196.x; Cockram MS, 2012, ANIMAL, V6, P1491, DOI 10.1017/S1751731112000638; Cort JA, 2013, J ELECTROMYOGR KINES, V23, P1334, DOI 10.1016/j.jelekin.2013.09.006; Cuesta-Vargas AI, 2013, J ELECTROMYOGR KINES, V23, P1446, DOI 10.1016/j.jelekin.2013.06.001; D'hooge R, 2013, J ELECTROMYOGR KINES, V23, P173, DOI 10.1016/j.jelekin.2012.09.003; Dvorak J, 1995, Eur Spine J, V4, P18, DOI 10.1007/BF00298413; Ebert R, 2014, MANUAL THER, V19, P114, DOI 10.1016/j.math.2013.08.004; Ekstrom RA, 2007, J ORTHOP SPORT PHYS, V37, P754, DOI 10.2519/jospt.2007.2471; Faber GS, 2013, J BIOMECH, V46, P2745, DOI 10.1016/j.jbiomech.2013.07.029; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080987; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; Hashemirad F, 2009, J ELECTROMYOGR KINES, V19, P746, DOI 10.1016/j.jelekin.2008.02.004; Hasler C, 2010, SPINE, V35, pE1262, DOI 10.1097/BRS.0b013e3181e24196; Heineck J, 2010, J ORTHOP RES, V28, P773, DOI 10.1002/jor.21057; Hodges PW, 2011, J ELECTROMYOGR KINES, V21, P220, DOI 10.1016/j.jelekin.2011.01.002; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Iida Y, 2012, EUR J APPL PHYSIOL, V112, P2223, DOI 10.1007/s00421-011-2199-2; Intolo P, 2009, MANUAL THER, V14, P596, DOI 10.1016/j.math.2009.08.006; Kandziora F, 2001, SPINE, V26, P1028, DOI 10.1097/00007632-200105010-00008; Kanekar N, 2014, EXP BRAIN RES, V232, P1127, DOI 10.1007/s00221-014-3822-3; Kubosch D, 2010, INJURY, V41, P768, DOI 10.1016/j.injury.2009.08.014; Kuo FC, 2014, CLIN BIOMECH, V29, P14, DOI 10.1016/j.clinbiomech.2013.10.020; Kuo YL, 2009, MANUAL THER, V14, P618, DOI 10.1016/j.math.2008.12.006; Lehmann W, 2008, EUR SPINE J, V17, P857, DOI 10.1007/s00586-008-0652-7; Licka T, 2009, VET J, V180, P71, DOI 10.1016/j.tvjl.2007.11.001; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; MacWilliams BA, 2014, SPINE, V39, pE1560, DOI 10.1097/BRS.0000000000000646; Melrose J, 2009, EUR SPINE J, V18, P479, DOI 10.1007/s00586-008-0871-y; Morl F, 2006, EUR SPINE J, V15, P742, DOI 10.1007/s00586-005-0960-0; Olson MW, 2010, J ELECTROMYOGR KINES, V20, P17, DOI 10.1016/j.jelekin.2009.04.006; Peach JP, 1998, ARCH PHYS MED REHAB, V79, P663, DOI 10.1016/S0003-9993(98)90041-7; Robert C, 2002, EQUINE VET J, V34, P295; Robert C, 2001, EQUINE VET J, V33, P466, DOI 10.2746/042516401776254745; Rozumalski A, 2008, GAIT POSTURE, V28, P378, DOI 10.1016/j.gaitpost.2008.05.005; Shahvarpour A, 2014, J ELECTROMYOGR KINES, V24, P394, DOI 10.1016/j.jelekin.2014.03.007; Singh DKA, 2011, MUSCLE NERVE, V44, P74, DOI 10.1002/mus.21998; Sions JM, 2012, J GERIATR PHYS THER, V35, P155, DOI 10.1519/JPT.0b013e318236db92; Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346; Sugiyama S, 2012, SPINE, V37, P763, DOI 10.1097/BRS.0b013e31822ffa05; SULLIVAN MS, 1994, SPINE, V19, P682, DOI 10.1097/00007632-199403001-00007; Valentin S, 2015, COMP EXERC PHYSIOL, V11, P95, DOI 10.3920/CEP150008; Valentin S, 2012, J BIOMECH, V45, P2506, DOI 10.1016/j.jbiomech.2012.07.022; Valentin S, 2015, COMP EXERC IN PRESS; Wade M, 2012, J APPL BIOMECH, V28, P677, DOI 10.1123/jab.28.6.677; Wakeling J. M., 2007, Equine and Comparative Exercise Physiology, V4, P95, DOI 10.1017/S1478061507812126; Wike HJ, 1997, EUR SPINE J, V6, P129; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009; WILKE HJ, 1995, SPINE, V20, P192, DOI 10.1097/00007632-199501150-00011; Zemp R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095426; Zsoldos RR, 2014, COMP EXERC PHYSIOL, V10, P75, DOI 10.3920/CEP140001; Zsoldos RR, 2010, EQUINE VET J, V42, P523, DOI 10.1111/j.2042-3306.2010.00230.x; Zsoldos RR, 2010, EQUINE VET J, V42, P455, DOI 10.1111/j.2042-3306.2010.00263.x	61	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146362	10.1371/journal.pone.0146362	http://dx.doi.org/10.1371/journal.pone.0146362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741136	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600032
J	Xu, JH; Wang, RX; Li, XX; Miclaus, M; Messing, J				Xu, Jian-Hong; Wang, Ruixian; Li, Xinxin; Miclaus, Mihai; Messing, Joachim			Locus- and Site-Specific DNA Methylation of 19 kDa Zein Genes in Maize	PLOS ONE			English	Article							TISSUE-CULTURE; RETROTRANSPOSON TOS17; ARABIDOPSIS-THALIANA; CYTOSINE METHYLATION; GENOME; PLANTS; RICE; TRANSCRIPTION; EXPRESSION; ENDOSPERM	An interesting question in maize development is why only a single zein gene is highly expressed in each of the 19-kDa zein gene clusters (A and B types), z1A2-1 and z1B4, in the immature endosperm. For instance, epigenetic marks could provide a structural difference. Therefore, we investigated the DNA methylation of the arrays of gene copies in both promoter and gene body regions of leaf (non-expressing tissue as a control), normal endosperm, and cultured endosperm. Although we could show that expressed genes have much lower methylation levels in promoter regions than silent ones in both leaf and normal endosperm, there was surprisingly also a difference in the pattern of the z1A and z1B gene clusters. The expression of z1B gene is suppressed by increased DNA methylation and activated with reduced DNA methylation, whereas z1A gene expression is not. DNA methylation in gene coding regions is higher in leaf than in endosperm, whereas no significant difference is observed in gene bodies between expressed and non-expressed gene copies. A median CHG methylation (25-30%) appears to be optimal for gene expression. Moreover, tissue-cultured endosperm can reset the DNA methylation pattern and tissue-specific gene expression. These results reveal that DNA methylation changes of the 19-kDa zein genes is subject to plant development and tissue culture treatment, but varies in different chromosomal locations, indicating that DNA methylation changes do not apply to gene expression in a uniform fashion. Because tissue culture is used to produce transgenic plants, these studies provide new insights into variation of gene expression of integrated sequences.	[Xu, Jian-Hong; Wang, Ruixian; Li, Xinxin] Zhejiang Univ, Inst Crop Sci, Zhejiang Key Lab Crop Germplasm, Hangzhou 310058, Zhejiang, Peoples R China; [Miclaus, Mihai] Natl Inst Res & Dev Biol Sci, Cluj Napoca, Romania; [Messing, Joachim] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Rutgers State University New Brunswick	Xu, JH (corresponding author), Zhejiang Univ, Inst Crop Sci, Zhejiang Key Lab Crop Germplasm, Hangzhou 310058, Zhejiang, Peoples R China.	jhxu@zju.edu.cn	Miclaus, Mihai/G-5571-2011; Miclăuș, Mihai/L-1340-2019; Xu, Jianhong/F-1489-2013	Miclaus, Mihai/0000-0001-7969-2393; Miclăuș, Mihai/0000-0001-7969-2393; Messing, Joachim/0000-0001-8260-2643; Xu, Jianhong/0000-0002-5620-0410	National Natural Science Foundation of China [31171165]; Fundamental Research Funds for the Central Universities [2014QNA6019]; Waksman Chair in Molecular Genetics	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Waksman Chair in Molecular Genetics	This work was supported by grants from the National Natural Science Foundation of China (31171165) and the Fundamental Research Funds for the Central Universities (2014QNA6019) to JHX and the Waksman Chair in Molecular Genetics to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZDEK M, 1992, FEBS LETT, V300, P268, DOI 10.1016/0014-5793(92)80860-J; BIANCHI MW, 1988, PLANT MOL BIOL, V11, P203, DOI 10.1007/BF00015672; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gavery MR, 2013, PEERJ, V1, DOI 10.7717/peerj.215; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Goettel W, 2013, GENE, V516, P8, DOI 10.1016/j.gene.2012.12.034; Goettel W, 2013, THEOR APPL GENET, V126, P159, DOI 10.1007/s00122-012-1970-z; Gonzalez A, 2013, PLANT GROWTH REGUL, V70, P227, DOI 10.1007/s10725-013-9794-7; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; HIROCHIKA H, 1993, EMBO J, V12, P2521, DOI 10.1002/j.1460-2075.1993.tb05907.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jeddeloh JA, 1996, PLANT J, V9, P579, DOI 10.1046/j.1365-313X.1996.9050579.x; KAEPPLER SM, 1993, P NATL ACAD SCI USA, V90, P8773, DOI 10.1073/pnas.90.19.8773; KODRZYCKI R, 1989, PLANT CELL, V1, P105, DOI 10.1105/tpc.1.1.105; Krizova K, 2009, PLANT PHYSIOL, V149, P1493, DOI 10.1104/pp.108.133165; La HG, 2011, P NATL ACAD SCI USA, V108, P15498, DOI 10.1073/pnas.1112704108; Lin CJ, 2012, PLANT CELL REP, V31, P2057, DOI 10.1007/s00299-012-1316-y; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Miclaus M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002131; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Park JY, 2013, LUNG CANCER, V79, P198, DOI 10.1016/j.lungcan.2012.11.019; PESCHKE VM, 1991, THEOR APPL GENET, V82, P121, DOI 10.1007/BF00226202; Reddy MSS, 2003, PLANT CELL REP, V21, P676, DOI 10.1007/s00299-002-0567-4; Rhee Y, 2010, GENETICS, V186, P843, DOI 10.1534/genetics.110.117929; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shibukawa T, 2009, GENE, V437, P22, DOI 10.1016/j.gene.2009.02.011; Stelpflug SC, 2014, GENETICS, V198, P209, DOI 10.1534/genetics.114.165480; Stroud H, 2013, ELIFE, V2, DOI 10.7554/eLife.00354; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Temel A, 2013, ACTA BIOL HUNG, V64, P86, DOI 10.1556/ABiol.64.2013.1.8; UEDA T, 1991, THEOR APPL GENET, V82, P93, DOI 10.1007/BF00231282; VicenteCarbajosa J, 1997, P NATL ACAD SCI USA, V94, P7685, DOI 10.1073/pnas.94.14.7685; Wang X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003872; Wang YP, 2013, NEW PHYTOL, V198, P274, DOI 10.1111/nph.12137; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xu JH, 2009, THEOR APPL GENET, V119, P1397, DOI 10.1007/s00122-009-1143-x; Yu X, 2011, ANN APPL BIOL, V158, P237, DOI 10.1111/j.1744-7348.2011.00458.x; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	51	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146416	10.1371/journal.pone.0146416	http://dx.doi.org/10.1371/journal.pone.0146416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741504	gold, Green Published, Green Submitted			2022-12-27	WOS:000367810600041
J	Bromage, TG; Idaghdour, Y; Lacruz, RS; Crenshaw, TD; Ovsiy, O; Rotter, B; Hoffmeier, K; Schrenk, F				Bromage, Timothy G.; Idaghdour, Youssef; Lacruz, Rodrigo S.; Crenshaw, Thomas D.; Ovsiy, Olexandra; Rotter, Bjoern; Hoffmeier, Klaus; Schrenk, Friedemann			The Swine Plasma Metabolome Chronicles "Many Days" Biological Timing and Functions Linked to Growth	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; CIRCADIAN CLOCK; TRANSCRIPTOME; COORDINATION; RHYTHMS; TISSUE; MOUSE; BONE; SIZE; TIME	The paradigm of chronobiology is based almost wholly upon the daily biological clock, or circadian rhythm, which has been the focus of intense molecular, cellular, pharmacological, and behavioral, research. However, the circadian rhythm does not explain biological timings related to fundamental aspects of life history such as rates of tissue/organ/body size development and control of the timing of life stages such as gestation length, age at maturity, and lifespan. This suggests that another biological timing mechanism is at work. Here we focus on a "many days" (multidien) chronobiological period first observed as enigmatic recurring growth lines in developing mammalian tooth enamel that is strongly associate with all adult tissue, organ, and body masses as well as life history attributes such as gestation length, age at maturity, weaning, and lifespan, particularly among the well studied primates. Yet, knowledge of the biological factors regulating the patterning of mammalian life, such as the development of body size and life history structure, does not exist. To identify underlying molecular mechanisms we performed metabolome and genome analyses from blood plasma in domestic pigs. We show that blood plasma metabolites and small non-coding RNA (sncRNA) drawn from 33 domestic pigs over a two-week period strongly oscillate on a 5-day multidien rhythm, as does the pig enamel rhythm. Metabolomics and genomics pathway analyses actually reveal two 5-day rhythms, one related to growth in which biological functions include cell proliferation, apoptosis, and transcription regulation/protein synthesis, and another 5-day rhythm related to degradative pathways that follows three days later. Our results provide experimental confirmation of a 5-day multidien rhythm in the domestic pig linking the periodic growth of enamel with oscillations of the metabolome and genome. This association reveals a new class of chronobiological rhythm and a snapshot of the biological bases that regulate mammalian growth, body size, and life history.	[Bromage, Timothy G.; Ovsiy, Olexandra] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA; [Bromage, Timothy G.; Lacruz, Rodrigo S.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA; [Bromage, Timothy G.; Schrenk, Friedemann] Senckenberg Res Inst, Dept Palaeoanthropol, Frankfurt, Germany; [Idaghdour, Youssef] New York Univ Abu Dhabi, Dept Biol, Abu Dhabi, U Arab Emirates; [Crenshaw, Thomas D.] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Rotter, Bjoern; Hoffmeier, Klaus] GenXPro GmbH, Frankfurt, Germany; [Schrenk, Friedemann] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60054 Frankfurt, Germany	New York University; New York University; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Wisconsin System; University of Wisconsin Madison; Goethe University Frankfurt	Bromage, TG (corresponding author), NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.	tim.bromage@nyu.edu	Lacruz, Rodrigo/AGY-8090-2022; Crenshaw, Thomas/H-1073-2013; bromage, timothy/H-8621-2015	Crenshaw, Thomas/0000-0001-8886-0264; bromage, timothy/0000-0002-9843-7993	Max Planck Research Award; Alexander von Humboldt Foundation in respect of the Hard Tissue Research Program in Human Paleobiomics	Max Planck Research Award(Max Planck Society); Alexander von Humboldt Foundation in respect of the Hard Tissue Research Program in Human Paleobiomics(Alexander von Humboldt Foundation)	Research support was provided by the 2010 Max Planck Research Award to TGB, endowed by the German Federal Ministry of Education and Research to the Max Planck Society (http://www.mpg.de/en) and the Alexander von Humboldt Foundation (http://www.humboldt-foundation.de/) in respect of the Hard Tissue Research Program in Human Paleobiomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors BR and KH are employees of the commercial company "GenXPro GmbH", which performed the sncRNA genomics for the study, contributing their expertise as indicated in the Author Contributions.	BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Bjarnason GA, 2000, PROG CELL CYC RES, V4, P193; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; BROMAGE TG, 1985, NATURE, V317, P525, DOI 10.1038/317525a0; Bromage TG, 2014, BIOL J LINN SOC, V112, P649, DOI 10.1111/bij.12269; Bromage TG, 2012, J THEOR BIOL, V305, P131, DOI 10.1016/j.jtbi.2012.04.007; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chai J, 2015, TUMOR BIOL, V36, P1313, DOI 10.1007/s13277-014-2766-3; CHARNOV EL, 1991, P NATL ACAD SCI USA, V88, P1134, DOI 10.1073/pnas.88.4.1134; Chen H, 2014, FEBS LETT, V588, P429, DOI 10.1016/j.febslet.2013.12.002; Chua ECP, 2013, P NATL ACAD SCI USA, V110, P14468, DOI 10.1073/pnas.1222647110; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; de Magalhaes JP, 2008, BIOESSAYS, V30, P567, DOI 10.1002/bies.20760; DEAN MC, 1987, J HUM EVOL, V16, P157, DOI 10.1016/0047-2484(87)90074-1; Dubman E, 2012, BIOL LETT, V305, P131; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; HARVEY PH, 1991, NATURE, V350, P23, DOI 10.1038/350023a0; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Hogg RT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134210; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Kerschnitzki M, 2013, J BONE MINER RES, V28, P1837, DOI 10.1002/jbmr.1927; Koukkari W.L., 2006, INTRO BIOL RHYTHMS; Lacruz RS, 2012, J BIOL RHYTHM, V27, P237, DOI 10.1177/0748730412442830; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P10314, DOI 10.1073/pnas.1005862107; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schibler U, 2005, EMBO REP, V6, pS9, DOI 10.1038/sj.embor.7400424; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; Thompson CB, 2011, COLD SH Q B, V76, P23, DOI 10.1101/sqb.2012.76.010496; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005	43	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							0145919	10.1371/journal.pone.0145919	http://dx.doi.org/10.1371/journal.pone.0145919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735517	Green Submitted, gold, Green Published			2022-12-27	WOS:000367805100032
J	Chen, CH; Lin, CL; Kao, CH				Chen, Chien-Hua; Lin, Cheng-Li; Kao, Chia-Hung			Irritable Bowel Syndrome Is Associated with an Increased Risk of Dementia: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BRAIN; NEUROINFLAMMATION; EPIDEMIOLOGY; INFLAMMATION; COMORBIDITY; DYSFUNCTION; SYMPTOMS	Purpose Abnormal interaction in the brain-gut axis has emerged as one of the relevant pathophysiological mechanisms for the development of irritable bowel syndrome (IBS). Moreover, the brain-gut axis has recently been demonstrated to be crucial for the maintenance of cognitive performance. Therefore, we assessed the risk of dementia following diagnosis of IBS. Methods Using the Taiwan National Health Insurance Research Database (NHIRD) to obtain medical claims data from 2000 to 2011, we employed a random sampling method to enroll32 298 adult patients with IBS and frequency-matched them according to sex, age, and baseline year with 129 192 patients without IBS. Results The patients with IBS exhibited an increased risk of dementia [adjusted hazard ratio (aHR) = 1.26, 95% confidence interval (CI) = 1.17-1.35] after adjustment for age, sex, diabetes, hypertension, stroke, coronary artery disease (CAD), head injury, depression, and epilepsy, and the overall incidence of dementia for the cohorts with and without IBS was 4.86 and 3.41 per 1000 person-years, respectively. IBS was associated with an increased risk of dementia in patients older than 50 years in both male and female, and in those with comorbidity or without comorbidity. After adjustment for age, sex, and comorbidity, patients with IBS were also more likely to develop either non-Alzheimer's disease (AD) dementia (aHR = 1.24, 95% CI = 1.15-1.33) or AD (aHR = 1.76, 95% CI = 1.28-2.43). Conclusions IBS is associated with an increased risk of dementia, and this effect is obvious only in patients who are >= 50 years old.	[Chen, Chien-Hua] Show Chwan Mem Hosp, Ctr Digest Dis, Changhua, Taiwan; [Chen, Chien-Hua] Hungkuang Univ, Taichung, Taiwan; [Chen, Chien-Hua] Meiho Univ Technol, Pingtung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Show Chwan Memorial Hospital; Hungkuang University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agarwal N, 2011, GASTROENTEROL CLIN N, V40, P11, DOI 10.1016/j.gtc.2010.12.013; Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Bauer K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-10; Canavan C, 2014, CLIN EPIDEMIOL, V6, P71, DOI 10.2147/CLEP.S40245; Chey WD, 2015, JAMA-J AM MED ASSOC, V313, P949, DOI 10.1001/jama.2015.0954; Clarke G, 2009, TRENDS MOL MED, V15, P478, DOI 10.1016/j.molmed.2009.08.001; Daulatzai, 2014, J MOL GENET MED S, V1, DOI DOI 10.4172/1747-0862.S1-005; Daulatzai MA, 2014, NEUROCHEM RES, V39, P624, DOI 10.1007/s11064-014-1266-6; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; Frings L, 2013, J NUCL MED, V54, P1909, DOI 10.2967/jnumed.113.120378; Gwee KA, 2010, J GASTROEN HEPATOL, V25, P1189, DOI 10.1111/j.1440-1746.2010.06353.x; Gwee KA, 2009, J GASTROEN HEPATOL, V24, P1601, DOI 10.1111/j.1440-1746.2009.05984.x; Hansen MK, 1998, J NEUROSCI, V18, P2247; Hansen MK, 2000, AUTON NEUROSCI-BASIC, V85, P119, DOI 10.1016/S1566-0702(00)00230-7; Heaton KW, 1992, GASTROENTEROLOGY, V304, P87; Hogan AM, 2009, BRIT J SURG, V96, P817, DOI 10.1002/bjs.6612; Kennedy PJ, 2014, PSYCHOL MED, V44, P1553, DOI 10.1017/S0033291713002171; Kennedy PJ, 2014, WORLD J GASTROENTERO, V20, P14105, DOI 10.3748/wjg.v20.i39.14105; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Longstreth GF, 2003, AM J GASTROENTEROL, V98, P600, DOI 10.1016/S0002-9270(02)06018-5; Lu CL, 2003, ALIMENT PHARM THERAP, V18, P1159, DOI 10.1046/j.1365-2036.2003.01711.x; Luyer MD, 2005, J EXP MED, V202, P1023, DOI 10.1084/jem.20042397; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Piche M, 2013, J PAIN, V14, P1217, DOI 10.1016/j.jpain.2013.05.009; Rosenberger C, 2013, CEREBELLUM, V12, P194, DOI 10.1007/s12311-012-0413-3; Sanoja R, 2005, PAIN, V118, P243, DOI 10.1016/j.pain.2005.08.021; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Tang YR, 2012, EUR J GASTROEN HEPAT, V24, P702, DOI 10.1097/MEG.0b013e328351b2c2; Thakur A.K., 2014, J PHARM CLIN TOXICOL, V2, P1016; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Vandvik PO, 2004, ALIMENT PHARM THER, V20, P1195, DOI 10.1111/j.1365-2036.2004.02250.x; WHITEHEAD WE, 1988, GASTROENTEROLOGY, V95, P709, DOI 10.1016/S0016-5085(88)80018-0	34	62	63	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0144589	10.1371/journal.pone.0144589	http://dx.doi.org/10.1371/journal.pone.0144589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731277	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400009
J	Franz, J; Brinkmann, BF; Konig, M; Huve, J; Stock, C; Ebnet, K; Riethmuller, C				Franz, Jonas; Brinkmann, Benjamin F.; Koenig, Michael; Hueve, Jana; Stock, Christian; Ebnet, Klaus; Riethmueller, Christoph			Nanoscale Imaging Reveals a Tetraspanin-CD9 Coordinated Elevation of Endothelial ICAM-1 Clusters	PLOS ONE			English	Article							LEUKOCYTE TRANSENDOTHELIAL MIGRATION; MEDIATES NEUTROPHIL TRANSMIGRATION; JUNCTIONAL ADHESION MOLECULE; TRANSCELLULAR DIAPEDESIS; ADHERENT LEUKOCYTES; CELL PERMEABILITY; DOCKING STRUCTURE; SEQUENTIAL ROLES; TNF-ALPHA; IN-VIVO	Endothelial barriers have a central role in inflammation as they allow or deny the passage of leukocytes from the vasculature into the tissue. To bind leukocytes, endothelial cells form adhesive clusters containing tetraspanins and ICAM-1, so-called endothelial adhesive platforms (EAPs). Upon leukocyte binding, EAPs evolve into docking structures that emanate from the endothelial surface while engulfing the leukocyte. Here, we show that TNF-alpha is sufficient to induce apical protrusions in the absence of leukocytes. Using advanced quantitation of atomic force microscopy (AFM) recordings, we found these structures to protrude by 160 +/- 80 nm above endothelial surface level. Confocal immunofluorescence microscopy proved them positive for ICAM-1, JAM-A, tetraspanin CD9 and f-actin. Microvilli formation was inhibited in the absence of CD9. Our findings indicate that stimulation with TNF-a induces nanoscale changes in endothelial surface architecture and that-via a tetraspanin CD9 depending mechanism-the EAPs rise above the surface to facilitate leukocyte capture.	[Franz, Jonas; Koenig, Michael] Univ Munster, Fac Med, D-48149 Munster, Germany; [Brinkmann, Benjamin F.; Ebnet, Klaus] ZMBE, Inst Med Biochem, Inst Associated Res Grp Cell Adhes & Cell Polar, D-48419 Munster, Germany; [Hueve, Jana] Univ Munster, Ctr Nanotechnol, Inst Med Phys & Biophys, Fluorescence Microscopy Facil Munster, D-48149 Munster, Germany; [Stock, Christian] Hannover Med Sch, Ctr Internal Med, Hannover, Germany; [Riethmueller, Christoph] Serend Ip GmbH, Ctr Nanotechnol, Munster, Germany	University of Munster; University of Munster; Hannover Medical School	Riethmuller, C (corresponding author), Serend Ip GmbH, Ctr Nanotechnol, Munster, Germany.	info@nanostic.org	Ebnet, Klaus T/C-8314-2009	Ebnet, Klaus T/0000-0002-0417-7888; Franz, Jonas/0000-0001-7523-6622	German Ministry of Research, BMBF [01DJ13022A]; Deutsche Forschungsgemeinschaft DFG [SFBs 629, 944]; University Munster [EB 160/4-1, -/4-2, IZKF Eb2/028/09, Eb2/020/14]; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of University of Muenster	German Ministry of Research, BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); University Munster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of University of Muenster	The work was financially supported by the German Ministry of Research, BMBF grant 01DJ13022A to CR, by grants from the Deutsche Forschungsgemeinschaft DFG (SFBs 629 and 944) to Jurgen Klingauf, and (EB 160/4-1 and -/4-2) and from the University Munster (IZKF Eb2/028/09 and Eb2/020/14) to KE. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. Serend-ip GmbH provided support in the form of salaries for authors CR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adami JG, 1909, INFLAMMATION; Adams JC, 1997, MOL BIOL CELL, V8, P2345, DOI 10.1091/mbc.8.11.2345; Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Dvorak AM, 2001, J HISTOCHEM CYTOCHEM, V49, P419, DOI 10.1177/002215540104900401; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Heemskerk N, 2014, CELL ADHES MIGR, V8, P67, DOI 10.4161/cam.28244; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Isac L, 2011, ANAL BIOANAL CHEM, V399, P2351, DOI 10.1007/s00216-010-3978-z; Maddugoda MP, 2011, CELL HOST MICROBE, V10, P464, DOI 10.1016/j.chom.2011.09.014; Mamdouh Z, 2009, J EXP MED, V206, P2795, DOI 10.1084/jem.20082745; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Ozaki H, 1999, J IMMUNOL, V163, P553; Peddibhotla SSD, 2013, MOL BIOL CELL, V24, P933, DOI 10.1091/mbc.E12-06-0481; Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Riethmuller C, 2008, PFLUG ARCH EUR J PHY, V456, P71, DOI 10.1007/s00424-007-0412-2; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Saito H, 1998, J IMMUNOL, V161, P1533; Schenk GJ, 2013, GLIA, V61, P1890, DOI 10.1002/glia.22565; Schmidt S, 2013, MOL IMMUNOL, V55, P49, DOI 10.1016/j.molimm.2012.11.006; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Stock C, 2011, CELL IMMUNOL, V271, P180, DOI 10.1016/j.cellimm.2011.06.022; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; TAYLOR AC, 1966, J CELL BIOL, V28, P155, DOI 10.1083/jcb.28.2.155; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Buul JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011336; van Buul JD, 2009, THROMB HAEMOSTASIS, V101, P649, DOI 10.1160/TH08-11-0714; van Rijssel J, 2012, MOL BIOL CELL, V23, P2831, DOI 10.1091/mbc.E11-11-0907; Wang HX, 2011, J CELL SCI, V124, P2702, DOI 10.1242/jcs.085449; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Woodfin A, 2007, BLOOD, V110, P1848, DOI 10.1182/blood-2006-09-047431; Woodfin A, 2009, BLOOD, V113, P6246, DOI 10.1182/blood-2008-11-188375; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zink T, 2008, ULTRAMICROSCOPY, V109, P22, DOI 10.1016/j.ultramic.2008.07.007	56	17	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146598	10.1371/journal.pone.0146598	http://dx.doi.org/10.1371/journal.pone.0146598			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731655	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400191
J	Gonzalez-Dominguez, J; Liu, YC; Schmidt, B				Gonzalez-Dominguez, Jorge; Liu, Yongchao; Schmidt, Bertil			Parallel and Scalable Short-Read Alignment on Multi-Core Clusters Using UPC plus	PLOS ONE			English	Article							ACCURATE; ALIGNER	The growth of next-generation sequencing (NGS) datasets poses a challenge to the alignment of reads to reference genomes in terms of alignment quality and execution speed. Some available aligners have been shown to obtain high quality mappings at the expense of long execution times. Finding fast yet accurate software solutions is of high importance to research, since availability and size of NGS datasets continue to increase. In this work we present an efficient parallelization approach for NGS short-read alignment on multi-core clusters. Our approach takes advantage of a distributed shared memory programming model based on the new UPC++ language. Experimental results using the CUSHAW3 aligner show that our implementation based on dynamic scheduling obtains good scalability on multi-core clusters. Through our evaluation, we are able to complete the single-end and paired-end alignments of 246 million reads of length 150 base-pairs in 11.54 and 16.64 minutes, respectively, using 32 nodes with four AMD Opteron 6272 16-core CPUs per node. In contrast, the multi-threaded original tool needs 2.77 and 5.54 hours to perform the same alignments on the 64 cores of one node. The source code of our parallel implementation is publicly available at the CUSHAW3 homepage (http://cushaw3.sourceforge.net).	[Gonzalez-Dominguez, Jorge; Schmidt, Bertil] Johannes Gutenberg Univ Mainz, Parallel & Distributed Architectures Grp, D-55122 Mainz, Germany; [Liu, Yongchao] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA	Johannes Gutenberg University of Mainz; University System of Georgia; Georgia Institute of Technology	Schmidt, B (corresponding author), Johannes Gutenberg Univ Mainz, Parallel & Distributed Architectures Grp, D-55122 Mainz, Germany.	bertil.schmidt@uni-mainz.de	González-Domínguez, Jorge/H-7371-2016; Liu, Yong/GWQ-6163-2022	González-Domínguez, Jorge/0000-0002-2602-4874; Liu, Yongchao/0000-0003-3440-9675				Abuin JM, 2015, BIOINFORMAT IN PRESS, DOI [10.1093/bioinformatics, DOI 10.1093/BI0INF0RMATICS/BTV506]; Bell C., 2006, P 20 IEEE INT PAR DI; Chen Y, 2013, BMC BIOINFORMATICS, V14; Georganas E., 2014, 26 ACM IEEE INT C HI; Georganas E., 2015, P 29 IEEE INT PAR DI; Gonz'lez-Dominguez J., 2012, 2012 IEEE 10th International Symposium on Parallel and Distributed Processing with Applications (ISPA), P40, DOI 10.1109/ISPA.2012.14; Gonzalez-Dominguez J, 2012, CONCURR COMP-PRACT E, V24, P1645, DOI 10.1002/cpe.1914; Herzeel C, 2013, P 10 INT C PAR PROC, P227; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Kassens J. C., 2014, P 15 IEEE INT C CLUS; Klus Petr, 2012, BMC Res Notes, V5, P27, DOI 10.1186/1756-0500-5-27; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H., 2013, ARXIV13033997QBIOGN; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu YC, 2014, IEEE DES TEST, V31, P31, DOI 10.1109/MDAT.2013.2284198; Liu YC, 2012, BIOINFORMATICS, V28, P1830, DOI 10.1093/bioinformatics/bts276; Liu Yu-Qiang, 2014, J Anal Methods Chem, V2014, P617367, DOI 10.1155/2014/617367; Luo RB, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S7-S10; Luo RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065632; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Mu JC, 2012, BIOINFORMATICS, V28, P2366, DOI 10.1093/bioinformatics/bts450; Nishtala R., 2009, P 23 IEEE INT PAR DI; Nishtala R, 2011, PARALLEL COMPUT, V37, P576, DOI 10.1016/j.parco.2011.05.006; Peters D., 2012, J APPL BIOINFORM COM, V1, P1, DOI 10.4172/2329-9533.1000101; Pireddu L, 2011, BIOINFORMATICS, V27, P2159, DOI 10.1093/bioinformatics/btr325; Reid J, 1998, ACM FORTRAN FORUM, P1, DOI [10.1145/289918.289920, DOI 10.1145/289918.289920]; Rizk G, 2010, BIOINFORMATICS, V26, P2534, DOI 10.1093/bioinformatics/btq485; Spence JM, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0147-1; UPC Consortium, UPC LANG SPEC V1 2; Yelick K, 1998, CONCURRENCY-PRACT EX, V10, P825, DOI 10.1002/(SICI)1096-9128(199809/11)10:11/13<825::AID-CPE383>3.0.CO;2-H; Zheng Y., 2014, P 28 IEEE INT PAR DI	31	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145490	10.1371/journal.pone.0145490	http://dx.doi.org/10.1371/journal.pone.0145490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731399	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400037
J	Kim, HJ; Koh, HY				Kim, Hea-Jin; Koh, Hae-Young			Impaired Reality Testing in Mice Lacking Phospholipase C beta 1: Observed by Persistent Representation-Mediated Taste Aversion	PLOS ONE			English	Article							AUDITORY VERBAL HALLUCINATIONS; EVENT REPRESENTATION; KNOCKOUT MICE; SCHIZOPHRENIA; MODEL; ENDOPHENOTYPES; STIMULUS; DISEASE; MEMORY; BRAIN	Hallucinations and delusions are the most prominent symptoms of schizophrenia and characterized by impaired reality testing. Representation-mediated taste aversion (RMTA) has been proposed as a potential behavioral assessment of reality testing and has been applied to a neurodevelopmental rat model of schizophrenia. However, the theory underlying this approach has not been generalized yet with any demonstration of impaired reality testing in other animal models of schizophrenia, such as genetically-modified mice. We devised a RMTA procedure for mice that combines a Pavlovian association protocol pairing odor conditioned stimulus (CS) with sugar reward unconditioned stimulus (US), and a conditioned taste aversion (CTA) method. In this RMTA paradigm, we compared performances of wildtype (PLC beta 1(+/+)) mice and phospholipase C beta 1 knock-out (PLC beta 1(-/-)) mice which are known as one of the genetic models for schizophrenia. With a minimal amount of initial odor-sugar associative training, both PLC beta 1(+/+) and PLC beta 1(-/-) mice were able to form an aversion to the sugar reward when the odor CS predicting sugar was paired with nausea. With an extended initial training, however, only PLC beta 1(-/-) mice could form a RMTA. This persistent RMTA displayed by PLC beta 1(-/-) mice shows their inability to distinguish real sugar from the CS-evoked representation of sugar at a stage in associative learning where wild-type mice normally could differentiate the two. These results demonstrate an impaired reality testing first observed in a genetic mouse model of schizophrenia, and suggest that RMTA paradigm may, with general applicability, allow diverse biological approaches to impaired reality testing.	[Kim, Hea-Jin; Koh, Hae-Young] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neurosci, Seoul 136791, South Korea; [Kim, Hea-Jin; Koh, Hae-Young] Korea Univ Sci & Technol UST, Dept Neurosci, Daejon 305333, South Korea	Korea Institute of Science & Technology (KIST); University of Science & Technology (UST)	Koh, HY (corresponding author), Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neurosci, Seoul 136791, South Korea.	hykkoh@kist.re.kr			KIST (Korea Institute of Science and Technology) [2E24210]	KIST (Korea Institute of Science and Technology)(Korea Institute of Science & Technology (KIST))	This work was supported by the KIST (Korea Institute of Science and Technology) (www.kist.re.kr) Institutional Program (Project No. 2E24210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson-Day B, 2015, NEUROSCI BIOBEHAV R, V55, P78, DOI 10.1016/j.neubiorev.2015.04.016; Amad A, 2014, MOL PSYCHIATR, V19, P184, DOI 10.1038/mp.2012.181; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Beavan V, 2011, J MENT HEALTH, V20, P281, DOI 10.3109/09638237.2011.562262; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Dwyer DM, 2001, Q J EXP PSYCHOL-B, V54, P145, DOI 10.1080/02724990042000146; Dwyer DM, 2006, J NEUROSCI, V26, P8305, DOI 10.1523/JNEUROSCI.1647-06.2006; El Haj M, 2015, COGN NEUROPSYCHIATRY, V20, P281, DOI 10.1080/13546805.2015.1023392; Holland P, 1998, NEUROPHARMACOLOGY, V37, P461, DOI 10.1016/S0028-3908(98)00038-0; Holland PC, 2005, LEARN BEHAV, V33, P464, DOI 10.3758/BF03193185; HOLLAND PC, 1982, LEARN MOTIV, V13, P454, DOI 10.1016/0023-9690(82)90004-2; HOLLAND PC, 1990, COGNITION, V37, P105, DOI 10.1016/0010-0277(90)90020-K; Holland PC, 2008, CONDITIONED TASTE AV, P196; Holland PC, 2008, LEARN BEHAV, V36, P227, DOI 10.3758/LB.36.3.227; Kerfoot EC, 2007, LEARN MEMORY, V14, P581, DOI 10.1101/lm.627007; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Koh HY, 2008, GENES BRAIN BEHAV, V7, P120, DOI 10.1111/j.1601-183X.2007.00351.x; Koh Hae-Young, 2013, Advances in Biological Regulation, V53, P242, DOI 10.1016/j.jbior.2013.08.002; Krishnan RR, 2011, PSYCHIAT CLIN NEUROS, V65, P305, DOI 10.1111/j.1440-1819.2011.02203.x; Lenka A, 2015, PARKINSONISM RELAT D, V21, P683, DOI 10.1016/j.parkreldis.2015.04.005; McDannald M, 2009, SCHIZOPHRENIA BULL, V35, P664, DOI 10.1093/schbul/sbp050; McDannald MA, 2011, BIOL PSYCHIAT, V70, P1122, DOI 10.1016/j.biopsych.2011.06.014; McOmish CE, 2008, MOL PSYCHIATR, V13, P661, DOI 10.1038/sj.mp.4002046; McOmish CE, 2008, HIPPOCAMPUS, V18, P824, DOI 10.1002/hipo.20443; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Pickens CL, 2004, NEUROSCI BIOBEHAV R, V28, P651, DOI 10.1016/j.neubiorev.2004.09.003; Saddoris MP, 2009, J NEUROSCI, V29, P15386, DOI 10.1523/JNEUROSCI.3233-09.2009; Schellinck HM, 2001, CHEM SENSES, V26, P663, DOI 10.1093/chemse/26.6.663; Shin J, 2005, P NATL ACAD SCI USA, V102, P18165, DOI 10.1073/pnas.0505498102; Toh WL, 2015, J AFFECT DISORDERS, V184, P18, DOI 10.1016/j.jad.2015.05.040; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Wheeler DS, 2013, NEUROBIOL LEARN MEM, V101, P1, DOI 10.1016/j.nlm.2012.12.015	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146376	10.1371/journal.pone.0146376	http://dx.doi.org/10.1371/journal.pone.0146376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731530	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400164
J	Kuhnlenz, F; Nardelli, PHJ				Kuhnlenz, Florian; Nardelli, Pedro H. J.			Dynamics of Complex Systems Built as Coupled Physical, Communication and Decision Layers	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; POWER; MANAGEMENT; DEMAND; ENERGY; MODELS	This paper proposes a simple model to capture the complexity of multilayer systems where their constituent layers affect, and are affected by, each other. The physical layer is a circuit composed by a power source and resistors in parallel. Every individual agent aims at maximizing its own delivered power by adding, removing or keeping the resistors it has; the delivered power is in turn a non-linear function that depends on the other agents' behavior, its own internal state, its global state perception, the information received from its neighbors via the communication network and a randomized selfishness. We develop an agent-based simulation to analyze the effects of number of agents (system size), communication network topology, communication errors and the minimum power gain that triggers a behavioral change on the system dynamic. Our results show that a wave-like behavior at macro-level (caused by individual changes in the decision layer) can only emerge for a specific system size. The ratio between cooperators and defectors depends on the minimum gain assumed-lower minimal gains lead to less cooperation, and vice-versa. Different communication network topologies imply different levels of power utilization and fairness at the physical layer, and a certain level of error in the communication layer induces more cooperation.	[Kuhnlenz, Florian; Nardelli, Pedro H. J.] Univ Oulu, Dept Commun Engn, FI-90014 Oulu, Finland	University of Oulu	Kuhnlenz, F (corresponding author), Univ Oulu, Dept Commun Engn, FI-90014 Oulu, Finland.	fkhnlenz@ee.oulu.fi	Nardelli, Pedro H J/C-7574-2012	Nardelli, Pedro H J/0000-0002-7398-1802	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [(BR)[312146/2012-4]]; Academy of Finland; project A Theory for Sustainable Smart Grids: Combining Communication Theory, Power Systems, Signal Processing and Economics from a Complexity Science Perspective (SUSTAIN); Strategic Research Council/Finnish Academy BC-DC project [292854]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Academy of Finland(Academy of Finland); project A Theory for Sustainable Smart Grids: Combining Communication Theory, Power Systems, Signal Processing and Economics from a Complexity Science Perspective (SUSTAIN); Strategic Research Council/Finnish Academy BC-DC project	Funding support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR)[312146/2012-4] (http://cnpq.br/); the Academy of Finland (http://www.aka.fi/en); the joint funded project A Theory for Sustainable Smart Grids: Combining Communication Theory, Power Systems, Signal Processing and Economics from a Complexity Science Perspective (SUSTAIN), which covers the authors' salary costs, and the Strategic Research Council/Finnish Academy BC-DC project (n.292854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061876; [Anonymous], 2011, AAMAS; Archetti M, 2012, J THEOR BIOL, V299, P9, DOI 10.1016/j.jtbi.2011.06.018; Arthur WB., 2014, COMPLEXITY EC; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bale CSE, 2015, APPL ENERG, V138, P150, DOI 10.1016/j.apenergy.2014.10.057; Batty M., 2007, CITIES COMPLEXITY UN; Batty M., 2013, NEW SCI CITIES; Bush SF, 2014, SMART GRID: COMMUNICATION-ENABLED INTELLIGENCE FOR THE ELECTRIC POWER GRID, DOI 10.1002/9781118820216; Carreras BA, 2004, IEEE T CIRCUITS-I, V51, P1733, DOI 10.1109/TCSI.2004.834513; Casazza J, 1954, P AM POW C, V16; Dam V, 2012, AGENT BASED MODELLIN, V9; Divenyi D, 2013, IEEE T SUSTAIN ENERG, V4, P886, DOI 10.1109/TSTE.2013.2253811; Dorf R. C., 2010, INTRO ELECT CIRCUITS; Lima GZD, 2012, PHYS LETT A, V376, P753, DOI 10.1016/j.physleta.2011.12.026; Filatrella G, 2008, EUR PHYS J B, V61, P485, DOI 10.1140/epjb/e2008-00098-8; Florian D, 2010, SYNCHRONIZATION TRAN, P930; Gianetto DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09340; Gini C, 1912, VARIABILITA MUTABILI; Hahn W, 1931, GEN ELECT REV SCHENE, V34, P444; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Hernandez L, 2013, IEEE COMMUN MAG, V51, P106, DOI 10.1109/MCOM.2013.6400446; Herrmann C, 2014, INT J PR ENG MAN-GT, V1, P283, DOI 10.1007/s40684-014-0034-z; Hodgson G.M., 1997, EC EVOLUTION BRINGIN; Hodgson GM., 2012, PLEASURE MACHINES MO; Holmgren AJ, 2006, RISK ANAL, V26, P955, DOI 10.1111/j.1539-6924.2006.00791.x; Hossain E, 2014, IEEE WIREL COMMUN, V21, P118, DOI 10.1109/MWC.2014.6845056; Huang Z, 2013, C IND ELECT APPL, P1023; Iarosz KC, 2012, PHYSICA A, V391, P819, DOI 10.1016/j.physa.2011.09.014; Krause SM, 2013, ECONOPHYSICS ADAPTIV, P5; Kremers EA., 2013, MODELLING SIMULATION; Kremers E, 2013, ENERG CONVERS MANAGE, V75, P643, DOI 10.1016/j.enconman.2013.07.050; Kremers E, 2013, APPL ENERG, V101, P709, DOI 10.1016/j.apenergy.2012.07.021; Marsic I, 2010, COMPUTER NETWORKS PE; Menck PJ, 2014, NATURE COMMUNICATION, V5, DOI [10.1038/ncomms4969, DOI 10.1038/NC0MMS4969]; Miranda L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039188; Mitchell M., 2009, COMPLEXITY GUIDED TO; Nardelli PHJ, 2014, EUR PHYS J-SPEC TOP, V223, P2423, DOI 10.1140/epjst/e2014-02219-6; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nikolic I, 2009, COEVOLUTIONARY METHO; Nishikawa T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/015012; Ott E, 2002, CHAOS DYNAMICAL SYST; Pipattanasomporn M., 2009, IEEEPES POWER SYSTEM, P1, DOI DOI 10.1109/PSCE.2009.4840087; Purchala K, USEFULNESS DC POWER; Rohden M, 2014, CHAOS, V24, DOI 10.1063/1.4865895; Sakowski PAM, 2014, FALL, V1, P3; Schuster P, 2015, COMPLEXITY, V21, P6, DOI 10.1002/cplx.21729; Stott B, 2009, IEEE T POWER SYST, V24, P1290, DOI 10.1109/TPWRS.2009.2021235; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Traag VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060063; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wang DQ, 2014, APPL MECH MATER, V513-517, P3287, DOI 10.4028/www.scientific.net/AMM.513-517.3287; Wolf WP, 2000, BRAZ J PHYS, V30, P794, DOI 10.1590/S0103-97332000000400030; WOLFRAM S, 1984, PHYSICA D, V10, P1, DOI 10.1016/0167-2789(84)90245-8; Wolfram S., 2002, NEW KIND SCI	57	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145135	10.1371/journal.pone.0145135	http://dx.doi.org/10.1371/journal.pone.0145135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730590	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400023
J	Li, M; Zhong, N; Lu, SF; Wang, G; Feng, L; Hu, B				Li, Mi; Zhong, Ning; Lu, Shengfu; Wang, Gang; Feng, Lei; Hu, Bin			Cognitive Behavioral Performance of Untreated Depressed Patients with Mild Depressive Symptoms	PLOS ONE			English	Article							MOOD-CONGRUENT MEMORY; WORKING-MEMORY; MAJOR DEPRESSION; NEUROPSYCHOLOGICAL DEFICITS; BIPOLAR DISORDER; FUNCTIONAL MRI; CONNECTIVITY; DYSFUNCTION; RECALL; CORTEX	This study evaluated the working memory performance of 18 patients experiencing their first onset of mild depression without treatment and 18 healthy matched controls. The results demonstrated that working memory impairment in patients with mild depression occurred when memorizing the position of a picture but not when memorizing the pictures themselves. There was no significant difference between the two groups in the emotional impact on the working memory, indicating that the attenuation of spatial working memory was not affected by negative emotion; however, cognitive control selectively affected spatial working memory. In addition, the accuracy of spatial working memory in the depressed patients was not significantly reduced, but the reaction time was significantly extended compared with the healthy controls. This finding indicated that there was no damage to memory encoding and function maintenance in the patients but rather only impaired memory retrieval, suggesting that the extent of damage to the working memory system and cognitive control abilities was associated with the corresponding depressive symptoms. The development of mild to severe depressive symptoms may be accompanied by spatial working memory damage from the impaired memory retrieval function extending to memory encoding and memory retention impairments. In addition, the impaired cognitive control began with an inadequate capacity to automatically process internal negative emotions and further extended to impairment of the ability to regulate and suppress external emotions. The results of the mood-congruent study showed that the memory of patients with mild symptoms of depression was associated with a mood-congruent memory effect, demonstrating that mood-congruent memory was a typical feature of depression, regardless of the severity of depression. This study provided important information for understanding the development of cognitive dysfunction.	[Li, Mi; Zhong, Ning; Lu, Shengfu] Beijing Univ Technol, Int WIC Inst, Beijing, Peoples R China; [Li, Mi; Zhong, Ning; Lu, Shengfu] Beijing Int Collaborat Base Brain Informat & Wisd, Beijing, Peoples R China; [Li, Mi; Zhong, Ning; Lu, Shengfu] Beijing Key Lab MRI & Brain Informat, Beijing, Peoples R China; [Zhong, Ning] Maebashi Inst Technol, Maebashi, Gunma, Japan; [Wang, Gang; Feng, Lei] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Wang, Gang; Feng, Lei] Capital Med Univ, Beijing Anding Hosp, China Clin Res Ctr Mental Disorders, Beijing, Peoples R China; [Wang, Gang] Beijing Inst Brain Disorders, Ctr Depress, Beijing, Peoples R China; [Hu, Bin] Lanzhou Univ, Ubiquitous Awareness & Intelligent Solut Lab, Lanzhou 730000, Peoples R China	Beijing University of Technology; Capital Medical University; Capital Medical University; Lanzhou University	Zhong, N (corresponding author), Beijing Univ Technol, Int WIC Inst, Beijing, Peoples R China.	zhong@maebashi-it.ac.jp; lusf@bjut.edu.cn		Zhong, Ning/0000-0001-7882-8340	National Basic Research Program of China [2014CB744600]; International Science & Technology Cooperation Program of China [2013DFA32180]; National Natural Science Foundation of China [61272345, 61420106005]; Beijing Natural Science Foundation [4132023]; Japan Society for the Promotion of Science [26350994]; Open Research Fund of Beijing Key Lab of Magnetic Resonance Imaging and Brain Informatics [2014CGZC03]; Beijing Outstanding Talent Training Foundation [2014000020124G039]	National Basic Research Program of China(National Basic Research Program of China); International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Open Research Fund of Beijing Key Lab of Magnetic Resonance Imaging and Brain Informatics; Beijing Outstanding Talent Training Foundation	This work was supported by National Basic Research Program of China (http://www.973.gov.cn/AreaAppl.aspx) (2014CB744600, authors who received the funding: ML NZ SL GW LF BH); International Science & Technology Cooperation Program of China (http://www.istcp.org.cn/index.html) (2013DFA32180, authors who received the funding: ML NZ SL GW LF); National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/) (61272345, authors who received the funding: ML NZ SL); National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/) (61420106005, authors who received the funding: ML NZ SL); Beijing Natural Science Foundation (http://www.bjnsf.org/) (4132023, authors who received the funding: ML NZ SL); Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/egrants/index.html) (26350994, authors who received the funding: ML NZ SL); Open Research Fund of Beijing Key Lab of Magnetic Resonance Imaging and Brain Informatics (2014CGZC03, authors who received the funding: ML NZ SL); and Beijing Outstanding Talent Training Foundation (2014000020124G039, authors who received the funding: ML NZ SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Basic Research Program of China (2014CB744600), the International Science & Technology Cooperation Program of China (2013DFA32180), the National Natural Science Foundation of China (61272345), the National Natural Science Foundation of China (61420106005), the Beijing Natural Science Foundation (4132023), the Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (26350994), the Open Research Fund of Beijing Key Lab of Magnetic Resonance Imaging and Brain Informatics (2014CGZC03), and the Beijing Outstanding Talent Training Foundation (2014000020124G039).	[Anonymous], 2004, MEM EM NON EV DEPR Q; Arnett PA, 1999, NEUROPSYCHOLOGY, V13, P546, DOI 10.1037/0894-4105.13.4.546; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beevers CG, 2010, NEUROSCIENCE, V167, P97, DOI 10.1016/j.neuroscience.2010.01.047; Berryhill ME, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00031; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Burianova L, 2012, NEUROIMAGE, V63, P1343, DOI 10.1016/j.neuroimage.2012.07.057; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Casey BJ, 1998, NEUROIMAGE, V8, P249, DOI 10.1006/nimg.1998.0360; Cohen J.E., 1988, STAT POWER ANAL BEHA; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Den Hartog HM, 2003, PSYCHOL MED, V33, P1443, DOI 10.1017/S003329170300833X; Eich E, 2000, PSYCHOL SCI, V11, P244, DOI 10.1111/1467-9280.00249; Elderkin-Thompson V, 2003, ARCH CLIN NEUROPSYCH, V18, P529, DOI 10.1016/S0887-6177(03)00022-2; Ellwart T, 2003, DEPRESS ANXIETY, V17, P197, DOI 10.1002/da.10102; Fossati P, 2002, J AFFECT DISORDERS, V68, P261, DOI 10.1016/S0165-0327(00)00362-1; Gilboa-Schechtman E, 2002, PSYCHIAT RES, V113, P279, DOI 10.1016/S0165-1781(02)00266-4; Gorlyn M, 2008, J NEURAL TRANSM, V115, P1213, DOI 10.1007/s00702-008-0084-x; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; Harvey PO, 2004, J PSYCHIATR RES, V38, P567, DOI 10.1016/j.jpsychires.2004.03.003; Holmes AJ, 2008, ARCH GEN PSYCHIAT, V65, P179, DOI 10.1001/archgenpsychiatry.2007.19; Joormann J, 2004, J ABNORM PSYCHOL, V113, P179, DOI 10.1037/0021-843X.113.2.179; Joormann J, 2007, J ABNORM PSYCHOL, V116, P484, DOI 10.1037/0021-843X.116.3.484; Kittler Jennifer E, 2007, Eat Behav, V8, P115, DOI 10.1016/j.eatbeh.2006.02.006; Lavric A, 2003, COGNITIVE THER RES, V27, P489, DOI 10.1023/A:1026300619569; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Liao C, 2012, NEUROSCIENCE, V201, P231, DOI 10.1016/j.neuroscience.2011.10.053; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; Monks PJ, 2004, BIPOLAR DISORD, V6, P550, DOI 10.1111/j.1399-5618.2004.00147.x; Moses-Kolko EL, 2010, AM J PSYCHIAT, V167, P1373, DOI 10.1176/appi.ajp.2010.09081235; Ortiz T, 2003, ACTAS ESP PSIQUIATRI, V31, P177; Pelosi L, 2000, CLIN NEUROPHYSIOL, V111, P1531, DOI 10.1016/S1388-2457(00)00354-0; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; Rose EJ, 2006, J AFFECT DISORDERS, V90, P149, DOI 10.1016/j.jad.2005.11.003; ROTHKOPF JS, 1991, COGNITION EMOTION, V5, P53, DOI 10.1080/02699939108411023; Schatzberg AF, 2000, AM J PSYCHIAT, V157, P1095, DOI 10.1176/appi.ajp.157.7.1095; Sergerie K, 2005, NEUROIMAGE, V24, P580, DOI 10.1016/j.neuroimage.2004.08.051; Shackman AJ, 2006, EMOTION, V6, P40, DOI 10.1037/1528-3542.6.1.40; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Storbeck J, 2005, PSYCHOL SCI, V16, P785, DOI 10.1111/j.1467-9280.2005.01615.x; WATKINS PC, 1992, J ABNORM PSYCHOL, V101, P581, DOI 10.1037/0021-843X.101.3.581; Weiland-Fiedler P, 2004, J AFFECT DISORDERS, V82, P253, DOI 10.1016/j.jad.2003.10.009	44	13	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146356	10.1371/journal.pone.0146356	http://dx.doi.org/10.1371/journal.pone.0146356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26730597	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400158
J	Lisowska, B; Siewruk, K; Lisowski, A				Lisowska, Barbara; Siewruk, Katarzyna; Lisowski, Aleksander			Substance P and Acute Pain in Patients Undergoing Orthopedic Surgery	PLOS ONE			English	Article							ANTAGONIST; RECEPTOR; RELEASE; INHIBITION; INCREASE; WOUNDS	Objective There is a limited information about the role of Substance P (SP) in acute pain nociception following surgical stimulation in patients with a chronic inflammatory state not to mention the link between this neuropeptide level changes and intensity of pain. The goal of the research was to find the correlation between SP level changes and acute pain intensity in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Material and Methods Patients with rheumatoid arthritis (RA) were enrolled in the study. The correlation between acute pain intensity and concentration of SP in serum as well as in drainage fluid from postoperative wound was assessed in patients with RA who underwent Total Knee Replacement (TKA) under spinal anesthesia. Results In patients with RA a correlation between intensity of acute pain and serum SP was found postoperatively, whereas there was no correlation between intensity of acute pain and concentration of SP in drainage fluid. Conclusions 1. The correlation between acute pain intensity and SP serum concentration was found postoperatively in patients with RA. 2. The correlation between acute pain intensity and SP concentration in drainage fluid was not found postoperatively in patients with RA.	[Lisowska, Barbara] CMKP Otwock, Med Ctr Postgrad Educ Clin Hosp Adam Gruca, Dept Anaesthesiol, Otwock, Poland; [Siewruk, Katarzyna] Warsaw Univ Life Sci, Fac Vet Med, Warsaw, Poland; [Lisowski, Aleksander] Warsaw Univ Life Sci, Fac Prod Engn, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences	Siewruk, K (corresponding author), Warsaw Univ Life Sci, Fac Vet Med, Warsaw, Poland.	siewruk.katarzyna@gmail.com	Lisowski, Aleksander/R-4884-2017; Lisowska, Barbara/R-5045-2017	Lisowski, Aleksander/0000-0001-8394-0396; Lisowska, Barbara/0000-0002-1964-5330				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Carvalho B, 2008, J PAIN, V9, P650, DOI 10.1016/j.jpain.2008.02.004; Carvalho B, 2010, ANESTH ANALG, V111, P1452, DOI 10.1213/ANE.0b013e3181f579de; Dalby PL, 1997, PAIN, V69, P263, DOI 10.1016/S0304-3959(96)03258-7; DIEKMANN O, 1994, BRAZ J MED BIOL RES, V27, P1865; Keeble JE, 2004, NEUROSCI LETT, V361, P176, DOI 10.1016/j.neulet.2003.12.020; Largent-Milnes TM, 2010, BRIT J PHARMACOL, V161, P986, DOI 10.1111/j.1476-5381.2010.00824.x; Lisowska B., 2008, REUMATOLOGIA, V46, P11; Matalinska J, 2013, FOLIA NEUROPATHOL, V51, P132, DOI 10.5114/fn.2013.35956; Michaels LA, 1998, BLOOD, V92, P3148, DOI 10.1182/blood.V92.9.3148.421k12_3148_3151; O'Shaughnessy MC, 2006, INFLAMM RES, V55, P236, DOI 10.1007/s00011-006-0079-8; Powell KJ, 2003, EUR J NEUROSCI, V18, P1572, DOI 10.1046/j.1460-9568.2003.02887.x; Sahbaie P, 2009, PAIN, V145, P341, DOI 10.1016/j.pain.2009.06.037; Tumati S, 2012, EUR J PHARMACOL, V684, P64, DOI 10.1016/j.ejphar.2012.03.025; Turchanyi B, 2005, PHYSIOL RES, V54, P25, DOI 10.33549/physiolres.930545; Zhou HY, 2008, J PHARMACOL EXP THER, V327, P375, DOI 10.1124/jpet.108.141226	16	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146400	10.1371/journal.pone.0146400	http://dx.doi.org/10.1371/journal.pone.0146400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731421	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400171
J	Pais-Morales, J; Betanzos, A; Garcia-Rivera, G; Chavez-Munguia, B; Shibayama, M; Orozco, E				Pais-Morales, Jonnatan; Betanzos, Abigail; Garcia-Rivera, Guillermina; Chavez-Munguia, Bibiana; Shibayama, Mineko; Orozco, Esther			Resveratrol Induces Apoptosis-Like Death and Prevents In Vitro and In Vivo Virulence of Entamoeba histolytica	PLOS ONE			English	Article							PHILASTERIDES-DICENTRARCHI; SCUTICOCILIATE PARASITE; SULFATE ACTIVATION; CYSTEINE PROTEASE; CELL-DEATH; AUTOPHAGY; MECHANISMS; MITOSOMES; IDENTIFICATION; PROLIFERATION	Entamoeba histolytica causes amoebiasis, an infection that kills 100,000 individuals each year. Metronidazole and its derivatives are currently used against this protozoan, but these drugs present adverse effects on human health. Here, we investigated the effect of resveratrol (a natural compound) on E. histolytica trophozoites viability, as well as its influence on the parasite virulence. Trophozoites growth was arrested by 72 mu M resveratrol and the IC50 was determined as 220 mu M at 48 h. Cells appeared smaller, rounded and in clusters, with debris-containing vacuoles and with abnormally condensed chromatin. Resveratrol triggered reactive oxygen species production. It caused lipid peroxidation and produced phosphatidylserine externalization and DNA fragmentation this latter evidenced by TUNEL assays. It also provoked an increase of intracellular Ca2+ concentration, activated calpain and decreased superoxide dismutase activity, indicating that an apoptosis-like event occurred; however, autophagy was not detected. Cytopathic activity, phagocytosis, encystment and in vivo virulence were diminished dramatically by pre-incubation of trophozoites with resveratrol, evidencing that resveratrol attenuated the trophozoite virulence in vitro. Interestingly, after the inoculation of virulent trophozoites, animals treated with the drug did not develop or developed very small abscesses. Our findings propose that resveratrol could be an alternative to contend amoebiasis.	[Pais-Morales, Jonnatan; Betanzos, Abigail; Garcia-Rivera, Guillermina; Chavez-Munguia, Bibiana; Shibayama, Mineko; Orozco, Esther] Ctr Invest & Estudios Avanzados IPN, Dept Infectom & Patogenesis Mol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Orozco, E (corresponding author), Ctr Invest & Estudios Avanzados IPN, Dept Infectom & Patogenesis Mol, Mexico City, DF, Mexico.	esther@cinvestav.mx		Betanzos, Abigail/0000-0003-1761-0481	Consejo Nacional de Ciencia y Tecnologia [220049, 4462, 226952]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx), No. 220049 (EO), No. 4462 (AB), No. 226952 (JPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeel Y, 2012, EXP PARASITOL, V132, P519, DOI 10.1016/j.exppara.2012.09.007; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bendesky A., 2001, REV FAC MED-CARACAS, V44, P255; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Budino B, 2012, PARASITOL RES, V110, P1573, DOI 10.1007/s00436-011-2664-1; CERBON J, 1981, COMP BIOCHEM PHYS B, V69, P487, DOI 10.1016/0305-0491(81)90339-4; Chavez-Munguia B., 2003, Journal of Submicroscopic Cytology and Pathology, V35, P235; Cordel H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002333; Villalba-Magdaleno JD, 2011, MICROBIOL-SGM, V157, P1489, DOI 10.1099/mic.0.047183-0; Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dobrzynska Malgorzata M, 2013, Rocz Panstw Zakl Hig, V64, P255; Eichinger D, 2001, J EUKARYOT MICROBIOL, V48, P17, DOI 10.1111/j.1550-7408.2001.tb00411.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Faust DM, 2011, EUR J MICROBIOL IMMU, V1, P10, DOI 10.1556/EuJMI.1.2011.1.4; Garcia-Rivera G, 1999, MOL MICROBIOL, V33, P556, DOI 10.1046/j.1365-2958.1999.01500.x; GARCIARIVERA G, 1982, ARCH INVEST MED, V13, P129; Ghosh AS, 2010, PARASITOL INT, V59, P166, DOI 10.1016/j.parint.2010.01.001; Hebbar V, 2005, LIFE SCI, V76, P2299, DOI 10.1016/j.lfs.2004.10.039; Huston CD, 2001, CURR OPIN GASTROEN, V17, P17, DOI 10.1097/00001574-200101000-00004; Joachim J, 2015, METHODS, V75, P96, DOI 10.1016/j.ymeth.2015.02.002; Kalsoom H, 2014, WORLD J MICROB BIOT, V30, P2337, DOI 10.1007/s11274-014-1658-4; Kaminskyy VO, 2014, ANTIOXID REDOX SIGN, V21, P86, DOI 10.1089/ars.2013.5746; Kohli V, 1997, P NATL ACAD SCI USA, V94, P9354, DOI 10.1073/pnas.94.17.9354; Kumar B, 2015, BIOCHIMIE; Lamas J, 2009, VET PARASITOL, V161, P307, DOI 10.1016/j.vetpar.2008.12.025; Leon-Avila G, 2004, MICROBIOL-SGM, V150, P1245, DOI 10.1099/mic.0.26923-0; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Lucas IK, 2013, PLANTA MED, V79, P20, DOI 10.1055/s-0032-1328020; Mableson HE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002800; Mallo N, 2013, ANTIMICROB AGENTS CH, V57, P2476, DOI 10.1128/AAC.00009-13; Mi-ichi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001263; Mi-ichi F, 2009, P NATL ACAD SCI USA, V106, P21731, DOI 10.1073/pnas.0907106106; Miki H, 2012, INT J ONCOL, V40, P1020, DOI 10.3892/ijo.2012.1325; Morais P, 2013, PROTIST, V164, P206, DOI 10.1016/j.protis.2012.07.002; Mortimer L, 2010, EXP PARASITOL, V126, P366, DOI 10.1016/j.exppara.2010.03.005; Muench H, 1938, AM J HYG, V27; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Nandi N, 2010, MICROBIOL-SGM, V156, P1926, DOI 10.1099/mic.0.034066-0; Njoya EM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002607; Nyunt KS, 2012, NAT PROD COMMUN, V7, P609; Ocadiz R, 2005, CELL MICROBIOL, V7, P221, DOI 10.1111/j.1462-5822.2004.00453.x; Ogas T, 2013, ANN NY ACAD SCI, V1290, P21, DOI 10.1111/nyas.12196; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; OROZCO E, 1994, MUTAT RES, V305, P229, DOI 10.1016/0027-5107(94)90243-7; Ozkoc S, 2009, PARASITOL RES, V105, P1139, DOI 10.1007/s00436-009-1533-7; Pezzuto JM, 2015, BIOCH BIOPHYS ACTA; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Preet S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001386; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Robb EL, 2008, BIOCHEM BIOPH RES CO, V367, P406, DOI 10.1016/j.bbrc.2007.12.138; Rodriguez MA, 1998, MICROB PATHOGENESIS, V25, P1, DOI 10.1006/mpat.1998.0202; ROE FJC, 1983, SURGERY, V93, P158; SANCHEZ L, 1994, MOL BIOCHEM PARASIT, V67, P125, DOI 10.1016/0166-6851(94)90102-3; Shibayama M, 1998, EXP PARASITOL, V88, P20, DOI 10.1006/expr.1998.4218; Solis F, 2002, MOL GENET GENOMICS, V267, P622, DOI 10.1007/s00438-002-0693-2; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stauffer W, 2003, CURR OPIN INFECT DIS, V16, P479, DOI 10.1097/00001432-200310000-00016; Villalba JD, 2007, MICROBIOL-SGM, V153, P3852, DOI 10.1099/mic.0.2007/008599-0; Wassmann C, 1999, J BIOL CHEM, V274, P26051, DOI 10.1074/jbc.274.37.26051; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Wink M, 2012, MOLECULES, V17, P12771, DOI 10.3390/molecules171112771; Yaeger R. G, 1996, MED MICROBIOLOGY	65	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146287	10.1371/journal.pone.0146287	http://dx.doi.org/10.1371/journal.pone.0146287			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731663	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400138
J	Pence, CH				Pence, Charles H.			RLetters: A Web-Based Application for Text Analysis of Journal Articles	PLOS ONE			English	Article								While textual analysis of the journal literature is a burgeoning field, there is still a profound lack of user-friendly software for accomplishing this task. RLetters is a free, open-source web application which provides researchers with an environment in which they can select sets of journal articles and analyze them with cutting-edge textual analysis tools. RLetters allows users without prior expertise in textual analysis to analyze word frequency, collocations, cooccurrences, term networks, and more. It is implemented in Ruby and scripts are provided to automate deployment.	[Pence, Charles H.] Louisiana State Univ, Dept Philosophy & Religious Studies, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Pence, CH (corresponding author), Louisiana State Univ, Dept Philosophy & Religious Studies, Baton Rouge, LA 70803 USA.	charles@charlespence.net	Pence, Charles H./A-1074-2012	Pence, Charles H./0000-0002-6836-6047	National Science Foundation, NSF [SES-1456573]; National Evolutionary Synthesis Center (NESCent), NSF [EF-0905606]; Direct For Social, Behav & Economic Scie [1456573] Funding Source: National Science Foundation	National Science Foundation, NSF(National Science Foundation (NSF)); National Evolutionary Synthesis Center (NESCent), NSF(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Work on RLetters was supported by the National Science Foundation, NSF 215 #SES-1456573, and the National Evolutionary Synthesis Center (NESCent), NSF 216 #EF-0905606.; Many thanks to Grant Ramsey, my collaborator on the evoText project, which uses RLetters as its backend. Thanks as well to David L. Hoover, who introduced me to many of these algorithms at the Digital Humanities Summer Institute (DHSI) 2012, and to the editor and two anonymous referees at this journal for helpful comments. Work on RLetters was supported by the National Science Foundation, NSF #SES-1456573, and the National Evolutionary Synthesis Center (NESCent), NSF #EF-0905606.	Apache Software Foundation, 2014, AP SOLR; Ashton AT, 2011, DIGITAL HUMANITIES 2, P270; Beck Jeffrey, 2011, Journal of Electronic Publishing, V14, DOI 10.3998/3336451.0014.106; Burns J, 2009, LECT NOTES COMPUT SC, V5714, P416, DOI 10.1007/978-3-642-04346-8_48; Burrows J., 2007, Literary & Linguistic Computing, V22. no 1, P27, DOI 10.1093/llc/fqi067; Craig Hugh, 2012, SHAKESPEARE COMPUTER, P78; Elsevier, 2014, TEXT AND DATA MINING; Franz A., 2006, GOOGLE WEB 1T 5 GRAM; He Q, 1999, LIBR TRENDS, V48, P133; Kumar A, 2009, JCDL 09; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Manning C.D., 1999, FDN STAT NATURAL LAN; Manning CD, 2014, P 52 ANN M ASS COMP, P55, DOI DOI 10.3115/V1/P14-5010; Nature Chemistry Editorial Board, 2011, NATURE CHEM, V3, P649, DOI [10.1038/nchem.1141, DOI 10.1038/NCHEM.1141]; Orduna-Malea E., 2014, EC3 WORKING PAPERS, V18; Roberts RJ, 2001, P NATL ACAD SCI USA, V98, P381, DOI 10.1073/pnas.98.2.381; Rockwell G, 2006, MIND TECHNOLOGIES HU, P285; Tsukamoto S, 2002, LANG COMPUT, P327; Veronis J, 1995, TEXT ENCODING INITIA	19	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146004	10.1371/journal.pone.0146004	http://dx.doi.org/10.1371/journal.pone.0146004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731738	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400076
J	Wu, J; Liu, Q; Wang, L; Chu, GQ; Liu, JQ				Wu, Jing; Liu, Qiang; Wang, Luo; Chu, Guo-qiang; Liu, Jia-qi			Vegetation and Climate Change during the Last Deglaciation in the Great Khingan Mountain, Northeastern China	PLOS ONE			English	Article							NORTH-ATLANTIC; HOLOCENE VEGETATION; TIBETAN PLATEAU; MODERN POLLEN; EVENT STRATIGRAPHY; MILLENNIAL-SCALE; GLACIAL MAXIMUM; INNER-MONGOLIA; CENTRAL JAPAN; QAIDAM BASIN	The Great Khingan Mountain range, Northeast China, is located on the northern limit of modern East Asian Summer Monsoon (EASM) and thus highly sensitive to the extension of the EASM from glacial to interglacial modes. Here, we present a high-resolution pollen record covering the last glacial maximum and the early Holocene from a closed crater Lake Moon to reconstruct vegetation history during the glacial-interglacial transition and thus register the evolution of the EASM during the last deglaciation. The vegetation history has gone through distinct changes from subalpine meadow in the last glacial maximum to dry steppe dominated by Artemisia from 20.3 to 17.4 ka BP, subalpine meadow dominated by Cyperaceae and Artemisia between 17.4 and 14.4 ka BP, and forest steppe dominated by Betula and Artemisia after 14.4 ka BP. The pollen-based temperature index demonstrates a gradual warming trend started at around 20.3 ka BP with interruptions of several brief events. Two cold conditions occurred around at 17.2-16.6 ka BP and 12.8-11.8 ka BP, temporally correlating to the Henrich 1 and the Younger Dryas events respectively, 1and abrupt warming events occurred around at 14.4 ka BP and 11.8 ka BP, probably relevant to the beginning of the Bolling-Allerod stages and the Holocene. The pollen-based moisture proxy shows distinct drought condition during the last glacial maximum (20.3-18.0 ka BP) and the Younger Dryas. The climate history based on pollen record of Lake Moon suggests that the regional temperature variability was coherent with the classical climate in the North Atlantic, implying the dominance of the high latitude processes on the EASM evolution from the Last Glacial Maximum (LGM) to early Holocene. The local humidity variability was influenced by the EASM limitedly before the Bolling-Allerod warming, which is mainly controlled by the summer rainfall due to the EASM front covering the Northeast China after that.	[Wu, Jing; Liu, Qiang; Wang, Luo; Chu, Guo-qiang; Liu, Jia-qi] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS	Wu, J (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China.	wujing@mail.iggcas.ac.cn; liujq@mail.iggcas.ac.cn	Wang, Luo/A-1430-2009	Wang, Luo/0000-0003-2217-8478	National Natural Science Foundation of China [41202259, 41272392, 40872206, 41320104006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by 41202259, www.nsfc.gov.cn, National Natural Science Foundation of China, JW; 41272392, www.nsfc.gov.cn, National Natural Science Foundation of China, QL; 40872206, www.nsfc.gov.cn, National Natural Science Foundation of China, QL; 41320104006, www.nsfc.gov.cn, National Natural Science Foundation of China, JQL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley RB, 2002, QUATERNARY SCI REV, V21, P431, DOI 10.1016/S0277-3791(01)00072-5; Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bjorck S, 1998, J QUATERNARY SCI, V13, P283, DOI 10.1002/(SICI)1099-1417(199807/08)13:4<283::AID-JQS386>3.0.CO;2-A; Blockley SPE, 2012, QUATERNARY SCI REV, V36, P2, DOI 10.1016/j.quascirev.2011.09.017; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Broecker WS, 1989, ROUTING MELTWATER LA; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Demske D, 2005, GLOBAL PLANET CHANGE, V46, P255, DOI 10.1016/j.gloplacha.2004.09.020; Exner A., 2004, Hacquetia, V3, P27; Fan QC, 2011, ACTA PETROL SIN, V27, P2827; Grachev AM, 2005, QUATERNARY SCI REV, V24, P513, DOI 10.1016/j.quascirev.2004.10.016; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Herzschuh U, 2006, QUATERNARY RES, V66, P133, DOI 10.1016/j.yqres.2006.03.001; Herzschuh U, 2010, J BIOGEOGR, V37, P752, DOI 10.1111/j.1365-2699.2009.02245.x; Hori M, 2013, CHEM GEOL, V347, P190, DOI 10.1016/j.chemgeo.2013.03.005; Jiang WY, 2008, PALAEOGEOGR PALAEOCL, V261, P47, DOI 10.1016/j.palaeo.2008.01.007; Kiefer T, 2005, QUATERNARY SCI REV, V24, P1063, DOI 10.1016/j.quascirev.2004.02.021; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Li CH, 2011, QUATERN INT, V229, P67, DOI 10.1016/j.quaint.2009.12.015; Li YC, 2011, HOLOCENE, V21, P997, DOI 10.1177/0959683611400202; Liu HY, 1999, REV PALAEOBOT PALYNO, V105, P237, DOI 10.1016/S0034-6667(98)00074-8; [刘强 Liu Qiang], 2010, [第四纪研究, Quaternary Sciences], V30, P1069; Lu HY, 2011, QUATERNARY SCI REV, V30, P947, DOI 10.1016/j.quascirev.2011.01.008; Ma YZ, 2008, J BIOGEOGR, V35, P1512, DOI 10.1111/j.1365-2699.2007.01871.x; Ma YZ, 2013, QUATERN INT, V311, P25, DOI 10.1016/j.quaint.2013.08.037; Moore P.D., 1991, BLACKWELL SCI PUBLI; Nakagawa T, 2003, SCIENCE, V299, P688, DOI 10.1126/science.1078235; Nakagawa T, 2005, QUATERNARY SCI REV, V24, P1691, DOI 10.1016/j.quascirev.2004.06.022; Nakagawa T, 2002, QUATERNARY SCI REV, V21, P2099, DOI 10.1016/S0277-3791(02)00014-8; Prokopenko AA, 2006, QUATERNARY SCI REV, V25, P3431, DOI 10.1016/j.quascirev.2006.10.002; Rasmussen SO, 2008, QUATERNARY SCI REV, V27, P18, DOI 10.1016/j.quascirev.2007.01.016; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Shen CC, 2010, QUATERNARY SCI REV, V29, P3327, DOI 10.1016/j.quascirev.2010.08.012; Shichi K, 2013, PALAEOGEOGR PALAEOCL, V375, P70, DOI 10.1016/j.palaeo.2013.02.015; Sinha A, 2005, GEOLOGY, V33, P813, DOI 10.1130/G21498.1; Stebich M, 2009, GLOBAL PLANET CHANGE, V65, P56, DOI 10.1016/j.gloplacha.2008.10.010; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Tarasov P E, 2009, CLIM PAST, V5, P127, DOI DOI 10.5194/CPD-5-127-2009; Tarasov PE, 1999, CLIM DYNAM, V15, P227, DOI 10.1007/s003820050278; Wang FX, 1995, POLLEN FLORA CHINA; Wang XZ, 1983, PALYNOLOGY OUTLINE; Wang YF, 1979, ACTA BOT SIN, V21, P274; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YB, 2011, REV PALAEOBOT PALYNO, V168, P31, DOI 10.1016/j.revpalbo.2011.09.004; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wen RL, 2010, BOREAS, V39, P262, DOI 10.1111/j.1502-3885.2009.00125.x; Wu Jing, 2012, Earth Science - Journal of China University of Geosciences, V37, P947, DOI 10.3799/dqkx.2012.103; Xu DK, 2013, P NATL ACAD SCI USA, V110, P9657, DOI 10.1073/pnas.1300025110; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Yue YF, 2012, PALAEOGEOGR PALAEOCL, V365, P115, DOI 10.1016/j.palaeo.2012.09.018; Zhao Y, 2007, REV PALAEOBOT PALYNO, V145, P275, DOI 10.1016/j.revpalbo.2006.12.002; Zhao Y, 2009, VEG HIST ARCHAEOBOT, V18, P245, DOI 10.1007/s00334-008-0201-7	61	28	33	11	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146261	10.1371/journal.pone.0146261	http://dx.doi.org/10.1371/journal.pone.0146261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730966	gold, Green Submitted, Green Published			2022-12-27	WOS:000367801400133
J	Radomska, KJ; Sager, J; Farnsworth, B; Tellgren-Roth, A; Tuveri, G; Peuckert, C; Kettunen, P; Jazin, E; Emilsson, LS				Radomska, Katarzyna J.; Sager, Jonathan; Farnsworth, Bryn; Tellgren-Roth, Asa; Tuveri, Giulia; Peuckert, Christiane; Kettunen, Petronella; Jazin, Elena; Emilsson, Lina S.			Characterization and Expression of the Zebrafish qki Paralogs	PLOS ONE			English	Article							RNA-BINDING PROTEIN; GLIOBLASTOMA-MULTIFORME; EMBRYONIC-DEVELOPMENT; SEQUENCE ALIGNMENTS; MUSCLE DEVELOPMENT; CANDIDATE GENE; STAR PROTEIN; QUAKING GENE; MUTANT MICE; SCHIZOPHRENIA	Quaking (QKI) is an RNA-binding protein involved in post-transcriptional mRNA processing. This gene is found to be associated with several human neurological disorders. Early expression of QKI proteins in the developing mouse neuroepithelium, together with neural tube defects in Qk mouse mutants, suggest the functional requirement of Qk for the establishment of the nervous system. As a knockout of Qk is embryonic lethal in mice, other model systems like the zebrafish could serve as a tool to study the developmental functions of qki. In the present study we sought to characterize the evolutionary relationship and spatiotemporal expression of qkia, qki2, and qkib; zebrafish homologs of human QKI. We found that qkia is an ancestral paralog of the single tetrapod Qk gene that was likely lost during the fin-to-limb transition. Conversely, qkib and qki2 are orthologs, emerging at the root of the vertebrate and teleost lineage, respectively. Both qki2 and qkib, but not qkia, were expressed in the progenitor domains of the central nervous system, similar to expression of the single gene in mice. Despite having partially overlapping expression domains, each gene has a unique expression pattern, suggesting that these genes have undergone subfunctionalization following duplication. Therefore, we suggest the zebrafish could be used to study the separate functions of qki genes during embryonic development.	[Radomska, Katarzyna J.; Sager, Jonathan; Farnsworth, Bryn; Tellgren-Roth, Asa; Tuveri, Giulia; Jazin, Elena; Emilsson, Lina S.] Uppsala Univ, Dept Evolut & Dev, Evolutionary Biol Ctr, Uppsala, Sweden; [Peuckert, Christiane] Uppsala Univ, Uppsala Biomed Ctr, Dept Neurosci, Uppsala, Sweden; [Kettunen, Petronella] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Kettunen, Petronella] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Dept Neuropathol, Oxford OX3 9DU, England	Uppsala University; Uppsala University; University of Gothenburg; University of Oxford	Emilsson, LS (corresponding author), Uppsala Univ, Dept Evolut & Dev, Evolutionary Biol Ctr, Uppsala, Sweden.	lina.emilsson@ebc.uu.se	Kettunen, Petronella/AAF-7606-2019; Peuckert, Christiane/G-1528-2018; Peuckert, Christiane/I-5958-2016	Kettunen, Petronella/0000-0002-2510-3423; Peuckert, Christiane/0000-0002-5973-1241; Peuckert, Christiane/0000-0002-5973-1241; Jazin, Elena/0000-0002-0363-3466; Radomska, Katarzyna/0000-0001-8243-0669	Goran Gustavsson's Foundation [1152]; Carl Trygger's Foundation [CTS12:116, CTS13:116, CTS14:128]; Zoologiska Foundation; Brain Foundation; Torsten Soderberg's Foundation [M237/12]; Magnus Bergvall's Foundation; Lars Hierta Memorial Foundation	Goran Gustavsson's Foundation; Carl Trygger's Foundation; Zoologiska Foundation; Brain Foundation; Torsten Soderberg's Foundation; Magnus Bergvall's Foundation; Lars Hierta Memorial Foundation	This project was supported by Goran Gustavsson's Foundation (Grant number: 1152) (LSE), Carl Trygger's Foundation (Grant number: CTS12:116; CTS13:116; CTS14:128) (LSE), The Zoologiska Foundation (LSE, EJ, BF, KR, JJ), The Brain Foundation (EJ), Torsten Soderberg's Foundation (Grant number: M237/12) (PK), Magnus Bergvall's Foundation (LSE), and the Lars Hierta Memorial Foundation (LSE). The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Aberg K, 2006, AM J MED GENET B, V141B, P84, DOI 10.1002/ajmg.b.30243; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doukhanine E, 2010, MOL BIOL CELL, V21, P3029, DOI 10.1091/mbc.E10-04-0305; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Edenfeld G, 2006, NEURON, V52, P969, DOI 10.1016/j.neuron.2006.10.029; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hardy RJ, 1998, J NEUROSCI RES, V51, P417, DOI 10.1002/(SICI)1097-4547(19980215)51:4<417::AID-JNR1>3.0.CO;2-F; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; Ichimura K, 2006, ONCOGENE, V25, P1261, DOI 10.1038/sj.onc.1209156; Justice MJ, 2010, ADV EXP MED BIOL, V693, P82; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klempan TA, 2009, BIOL PSYCHIAT, V66, P824, DOI 10.1016/j.biopsych.2009.05.010; Kondo T, 1999, MAMM GENOME, V10, P662; Lauriat TL, 2008, J NEUROSCI RES, V86, P785, DOI 10.1002/jnr.21534; Le-Niculescu H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.9; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Li ZZ, 2002, JPN J CANCER RES, V93, P167, DOI 10.1111/j.1349-7006.2002.tb01255.x; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Lobbardi R, 2011, DEVELOPMENT, V138, P1783, DOI 10.1242/dev.059121; Lu ZF, 2003, NUCLEIC ACIDS RES, V31, P4616, DOI 10.1093/nar/gkg635; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Mulholland PJ, 2006, CELL CYCLE, V5, P783, DOI 10.4161/cc.5.7.2631; Noveroske JK, 2005, MAMM GENOME, V16, P672, DOI 10.1007/s00335-005-0035-x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Schulte-Merker S., 2002, ZEBRAFISH PRACTICAL; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tanaka H, 1997, MECH DEVELOP, V69, P209, DOI 10.1016/S0925-4773(97)00164-0; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Wu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036351; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146155	10.1371/journal.pone.0146155	http://dx.doi.org/10.1371/journal.pone.0146155			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727370	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500058
J	Rha, EY; Han, K; Park, Y; Yoo, G				Rha, Eun Young; Han, Kyungdo; Park, Yongkyu; Yoo, Gyeol			Socioeconomic Disparities in the Prevalence of Blepharoptosis in the South Korean Adult Population Based on a Nationwide Cross-Sectional Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; METABOLIC SYNDROME; PTOSIS; HEALTH; DYSLIPIDEMIA; MANAGEMENT; MORTALITY; INJURY; GENDER; INCOME	Purpose We investigated the association between socioeconomic status (SES) and the prevalence of blepharoptosis in a representative South Korean population. Methods This cross-sectional study was based on data obtained in the Korea National Health and Nutrition Examination Survey from 2010 to 2012. In total, 17,178 Korean adults (7,261 men and 9,917 women) aged 19 years or older were enrolled. Blepharoptosis was defined as a marginal reflex distance 1 (MDR 1) lower than 2 mm. Household income and education level were used as indicators of SES. Univariate and multiple logistic regression analyses were conducted to analyze the relationship between SES and the prevalence of blepharoptosis. Results Household income was inversely associated with the prevalence of blepharoptosis in women [adjusted odds ratio (aOR) and corresponding 95% confidence interval (95% CI) was 1.894 (1.336, 2.685)], and educational level was inversely associated with blepharoptosis in both men and women [aORs and 95% CIs were 1.572 (1.113, 2.219) and 1.973 (1.153, 3.376), respectively]. After adjusting for household income and educational level, low SES was associated with a high prevalence of blepharoptosis in women only. Conclusions Socioeconomic disparities in the prevalence of blepharoptosis were found among women. Indeed, future research using a prospective design to determine the causal relationship between SES and blepharoptosis may identify SES as a risk factor for this condition.	[Rha, Eun Young] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Plast & Reconstruct Surg, Seoul, South Korea; [Han, Kyungdo; Park, Yongkyu] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Yoo, Gyeol] Catholic Univ Korea, Coll Med, Yeouido St Marys Hosp, Dept Plast & Reconstruct Surg, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Yoo, G (corresponding author), Catholic Univ Korea, Coll Med, Yeouido St Marys Hosp, Dept Plast & Reconstruct Surg, Seoul, South Korea.	psyg@catholic.ac.kr						Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; BEARD C, 1989, INT OPHTHALMOL CLIN, V29, P214, DOI 10.1097/00004397-198902940-00002; BURNLEY IH, 1995, SOC SCI MED, V41, P687, DOI 10.1016/0277-9536(94)00378-7; Chang SZ, 2012, PLAST RECONSTR SURG, V129, P149, DOI 10.1097/PRS.0b013e318230a1c7; Chao CY, 2014, OBES RES CLIN PRACT, V8, pE212, DOI 10.1016/j.orcp.2012.07.002; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; Dallongeville J, 2005, DIABETES CARE, V28, P409, DOI 10.2337/diacare.28.2.409; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Finsterer J, 2003, AESTHET PLAST SURG, V27, P193, DOI 10.1007/s00266-003-0127-5; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hur Inyoung, 2011, Osong Public Health Res Perspect, V2, P192, DOI 10.1016/j.phrp.2011.11.044; Kim S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002122; Kim SK, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/2052-4374-26-1; Lamina S, 2008, AFR HEALTH SCI, V8, P253; Larrimore J, 2011, MILBANK Q, V89, P694, DOI 10.1111/j.1468-0009.2011.00647.x; LOOMIS DP, 1991, AM J PUBLIC HEALTH, V81, P733, DOI 10.2105/AJPH.81.6.733; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Moon SS, 2015, ENDOCRINE, V48, P504, DOI 10.1007/s12020-014-0279-x; Nam GE, 2013, PREV MED, V57, P304, DOI 10.1016/j.ypmed.2013.06.008; Park MJ, 2007, ANN EPIDEMIOL, V17, P320, DOI 10.1016/j.annepidem.2006.10.007; Shirado M, 2012, J PLAST RECONSTR AES, V65, pE146, DOI 10.1016/j.bjps.2012.01.009; Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850; WAGENER DK, 1991, AM J PUBLIC HEALTH, V81, P1408, DOI 10.2105/AJPH.81.11.1408; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145069	10.1371/journal.pone.0145069	http://dx.doi.org/10.1371/journal.pone.0145069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727468	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500009
J	Warne, RW; LaBumbard, B; LaGrange, S; Vredenburg, VT; Catenazzi, A				Warne, Robin W.; LaBumbard, Brandon; LaGrange, Seth; Vredenburg, Vance T.; Catenazzi, Alessandro			Co-Infection by Chytrid Fungus and Ranaviruses in Wild and Harvested Frogs in the Tropical Andes	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; LIFE-HISTORY; TELMATOBIUS ANURA; POPULATION DECLINES; INFECTION; AMPHIBIANS; MORTALITY; DISEASE; CHYTRIDIOMYCOSIS; STRESS	While global amphibian declines are associated with the spread of Batrachochytrium dendrobatidis (Bd), undetected concurrent co-infection by other pathogens may be little recognized threats to amphibians. Emerging viruses in the genus Ranavirus (Rv) also cause dieoffs of amphibians and other ectotherms, but the extent of their distribution globally, or how co-infections with Bd impact amphibians are poorly understood. We provide the first report of Bd and Rv co-infection in South America, and the first report of Rv infections in the amphibian biodiversity hotspot of the Peruvian Andes, where Bd is associated with extinctions. Using these data, we tested the hypothesis that Bd or Rv parasites facilitate co-infection, as assessed by parasite abundance or infection intensity within individual adult frogs. Co-infection occurred in 30% of stream-dwelling frogs; 65% were infected by Bd and 40% by Rv. Among terrestrial, direct-developing Pristimantis frogs 40% were infected by Bd, 35% by Rv, and 20% co-infected. In Telmatobius frogs harvested for the live-trade 49% were co-infected, 92% were infected by Bd, and 53% by Rv. Median Bd and Rv loads were similar in both wild (Bd = 10(1.2) Ze, Rv = 10(2.3) viral copies) and harvested frogs (Bd = 10(3.1) Ze, Rv = 10(2.7) viral copies). While neither parasite abundance nor infection intensity were associated with co-infection patterns in adults, these data did not include the most susceptible larval and metamorphic life stages. These findings suggest Rv distribution is global and that co-infection among these parasites may be common. These results raise conservation concerns, but greater testing is necessary to determine if parasite interactions increase amphibian vulnerability to secondary infections across differing life stages, and constitute a previously undetected threat to declining populations. Greater surveillance of parasite interactions may increase our capacity to contain and mitigate the impacts of these and other wildlife diseases.	[Warne, Robin W.; LaBumbard, Brandon; LaGrange, Seth; Catenazzi, Alessandro] So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA; [Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	Southern Illinois University System; Southern Illinois University; California State University System; San Francisco State University	Warne, RW (corresponding author), So Illinois Univ, Dept Zool, 1125 Lincoln Dr,MC6501, Carbondale, IL 62901 USA.	rwarne@siu.edu	Catenazzi, Alessandro/C-8615-2009; Warne, Robin/A-8978-2013	Catenazzi, Alessandro/0000-0002-3650-4783; Vredenburg, Vance/0000-0002-9682-1190; LaBumbard, Brandon/0000-0001-9182-8388	SIUC; Amazon Conservation Association; Disney Worldwide Conservation Fund; Rufford Small Grants Foundation; National Science Foundation [1120283]	SIUC; Amazon Conservation Association; Disney Worldwide Conservation Fund; Rufford Small Grants Foundation; National Science Foundation(National Science Foundation (NSF))	This research was funded by SIUC Startup grants to RWW and AC, the Amazon Conservation Association to AC, the Disney Worldwide Conservation Fund, the Rufford Small Grants Foundation to AC and VTV, and National Science Foundation, Grant 1120283 to VTV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AJ, 2013, J GEN VIROL, V94, P2082, DOI 10.1099/vir.0.052837-0; Allender MC, 2013, J COMP PATHOL, V149, P356, DOI 10.1016/j.jcpa.2013.01.007; Angulo A, 2008, CONSERV SOC, V6, P328, DOI DOI 10.4103/0972-4923.49196; Bandin I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-67; Barrionuevo JS, 2008, HERPETOLOGICA, V64, P47, DOI 10.1655/06-057.1; Barrionuevo S, 2006, DIS AQUAT ORGAN, V73, P171, DOI 10.3354/dao073171; Beaupre SJ., 2004, HERP AN CAR US COMM; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blair C, 2009, COPEIA, P303, DOI 10.1643/CH-08-062; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brunner JL, 2004, ECOLOGY, V85, P560, DOI 10.1890/02-0374; Catenazzi A, 2014, CONSERV BIOL, V28, P509, DOI 10.1111/cobi.12194; Catenazzi A, 2013, BIOL CONSERV, V159, P413, DOI 10.1016/j.biocon.2012.11.023; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Catenazzi A, 2010, DIS AQUAT ORGAN, V92, P187, DOI 10.3354/dao02250; Chen GC, 2011, VIRUSES-BASEL, V3, P2065, DOI 10.3390/v3112065; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Crespi EJ, 2013, INTEGR COMP BIOL, V53, P989, DOI 10.1093/icb/ict087; Currylow AF, 2014, J HERPETOL, V48, P117, DOI 10.1670/12-235; De la Riva Ignacio, 2011, Herpetological Review, V42, P372; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P255; Duffus ALJ, 2009, RANAVIRUS ECOLOGY CO; Fey SB, 2015, P NATL ACAD SCI USA, V112, P1083, DOI 10.1073/pnas.1414894112; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Fox SF, 2006, DIS AQUAT ORGAN, V72, P87, DOI 10.3354/dao072087; Gahl MK, 2008, BIOL CONSERV, V141, P2679, DOI 10.1016/j.biocon.2008.08.003; GARCIAR JC, 2012, PLOS ONE, V0007; Goldberg TL, 2003, J VIROL, V77, P8812, DOI 10.1128/JVI.77.16.8812-8818.2003; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Gray M. J., 2013, WILDLIFE PROFESSIONA, V7, P51; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Greer AL, 2007, J WILDLIFE DIS, V43, P525, DOI 10.7589/0090-3558-43.3.525; Haislip NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022307; Hoverman JT, 2012, ECOHEALTH, V9, P288, DOI 10.1007/s10393-012-0778-2; Hoverman JT, 2012, ECOHEALTH, V9, P36, DOI 10.1007/s10393-011-0731-9; Hoverman JT, 2011, ECOHEALTH, V8, P301, DOI 10.1007/s10393-011-0717-7; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jancovich JK, 2005, MOL ECOL, V14, P213, DOI 10.1111/j.1365-294X.2004.02387.x; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Kerby JL, 2011, ECOHEALTH, V8, P46, DOI 10.1007/s10393-011-0682-1; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lehr Edgar, 2005, Monografias de Herpetologia, V7, P39; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Mao JH, 1999, VIRUS RES, V63, P45, DOI 10.1016/S0168-1702(99)00057-X; Mavian C, 2012, J VIROL, V86, P3617, DOI 10.1128/JVI.07108-11; Merino-Viteri A, 2005, STUDIES ANDEAN FROGS, P9; Moore IT, 2003, HORM BEHAV, V43, P39, DOI 10.1016/S0018-506X(02)00038-7; Morales HD, 2007, J VIROL, V81, P2240, DOI 10.1128/JVI.01104-06; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Picco AM, 2008, CONSERV BIOL, V22, P1582, DOI 10.1111/j.1523-1739.2008.01025.x; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Robert J, 2012, DEV COMP IMMUNOL, V36, P259, DOI 10.1016/j.dci.2011.08.008; Rodriguez M, 1999, PARASITE IMMUNOL, V21, P177, DOI 10.1046/j.1365-3024.1999.00218.x; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Schock DM, 2008, COPEIA, P133, DOI 10.1643/CP-06-134; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Souza MJ, 2012, J WILDLIFE DIS, V48, P560, DOI 10.7589/0090-3558-48.3.560; Stark T, 2014, ACTA HERPETOL, V9, P125; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Une Y, 2009, EMERG INFECT DIS, V15, P1146, DOI 10.3201/eid1507.081636; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; von May R, 2008, TROP CONSERV SCI, V1, P376, DOI 10.1177/194008290800100406; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Warne RW, 2015, J EXP ZOOL PART A, V323, P191, DOI 10.1002/jez.1911; Warne RW, 2015, ECOL EVOL, V5, P557, DOI 10.1002/ece3.1360; Warne RW, 2014, INTEGR COMP BIOL, V54, P864, DOI 10.1093/icb/icu071; Warne RW, 2012, AM NAT, V180, P130, DOI 10.1086/665995; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; Whitfield SM, 2013, DIS AQUAT ORGAN, V104, P173, DOI 10.3354/dao02598; Woolhouse MEJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400026	77	44	46	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145864	10.1371/journal.pone.0145864	http://dx.doi.org/10.1371/journal.pone.0145864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726999	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500034
J	Liang, YC; Wang, W; Huang, JM; Tan, H; Liu, TY; Shang, CL; Liu, D; Guo, LY; Yao, SZ				Liang, Yanchun; Wang, Wei; Huang, Jiaming; Tan, Hao; Liu, Tianyu; Shang, Chunliang; Liu, Duo; Guo, Luyan; Yao, Shuzhong			Potential Role of Semaphorin 3A and Its Receptors in Regulating Aberrant Sympathetic Innervation in Peritoneal and Deep Infiltrating Endometriosis	PLOS ONE			English	Article							NERVE-FIBERS; GROWTH; EXPRESSION; METASTASIS; REPELLENT; COMPLEXES; RESPONSES; SYNOVIUM; NEURONS; OVARIAN	Previous studies have demonstrated the involvement of nerve repellent factors in regulation of the imbalanced innervation of endometriosis. This prospective study aims to explore the role of Sema 3A in regulating aberrant sympathetic innervation in peritoneal and deep infiltrating endometriosis. Ectopic endometriotic lesion were collected from patients with peritoneal endometriosis (n = 24) and deep infiltrating endometriosis of uterosacral ligament (n = 20) undergoing surgery for endometriosis. Eutopic endometrial samples were collected from patients with endometriosis (n = 22) or without endometriosis (n = 26). Healthy peritoneum (n = 13) from the lateral pelvic wall and healthy uterosacral ligament (n = 13) were obtained from patients who had no surgical and histological proof of endometriosis during hysterectomy for uterine fibroids. Firstly, we studied the immunostaining of Sema 3A, Plexin A1 and NRP-1 in all the tissues described above. Then we studied the nerve fiber density (NFD) of endometriosis-associated (sympathetic) nerve and para-endometriotic (sympathetic) nerve by double immunofluorescence staining. Finally we analyzed the relationship between expression of Sema 3A in stromal cells of endometriotic lesion and the aberrant innervation of endometriosis. Semi-quantitative immunostaining demonstrated that (1) Higher immunostaining of Sema 3A were found in the eutopic endometrial glandular epithelial cells from patients with endometriosis (p = 0.041) than those without endometriosis; (2) Sema 3A immunostaining was higher in glandular epithelial cells of peritoneal endometriosis (P<0.001) and deep infiltrating endometriotic lesions of uterosacral ligament (P = 0.028) compared with glandular epithelial cells of the endometrium from women with endometriosis, while its expression in ectopic stormal cells in both groups were significantly lower than that from eutopic endometrium of women without endometirosis (P<0.001, P<0.001, respectively). NFDs of Anti-TH (+) endometriosis-associated sympathetic nerve of peritoneal endometriosis (p<0.001) and deep endometriosis of uterosacral ligament (p<0.001) were significantly lower than NFDs of para-endometriotic sympathetic nerve. Our results suggest that Sema 3A may contribute to the regulation of aberrant sympathetic innervation in peritoneal and deep infiltrating endometriosis.	[Liang, Yanchun; Wang, Wei; Huang, Jiaming; Tan, Hao; Liu, Tianyu; Shang, Chunliang; Liu, Duo; Guo, Luyan; Yao, Shuzhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University	Yao, SZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 58 2nd Zhongshan Rd, Guangzhou 510080, Guangdong, Peoples R China.	yszlfy@163.com		Yao, Shuzhong/0000-0002-5145-5705; Liang, Yanchun/0000-0001-7756-1621				Arnold J, 2013, NEUROIMMUNOMODULAT, V20, P9, DOI 10.1159/000342163; Ballester M, 2012, HUM REPROD, V27, P3179, DOI 10.1093/humrep/des304; Berkley KJ, 2005, SCIENCE, V308, P1587, DOI 10.1126/science.1111445; Berkley KJ, 2004, P NATL ACAD SCI USA, V101, P11094, DOI 10.1073/pnas.0403663101; Bos JL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002913; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Fassold A, 2009, ARTHRITIS RHEUM-US, V60, P2892, DOI 10.1002/art.24860; Ferrero S, 2010, FERTIL STERIL, V94, P2817, DOI 10.1016/j.fertnstert.2010.06.069; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Graf N, 2012, NEUROGASTROENT MOTIL, V24, P120, DOI 10.1111/j.1365-2982.2011.01818.x; Hashimoto M, 2004, ACTA NEUROPATHOL, V107, P250, DOI 10.1007/s00401-003-0805-z; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kawasaki T, 2002, DEVELOPMENT, V129, P671; Koeck FX, 2009, J ORTHOP RES, V27, P736, DOI 10.1002/jor.20807; Long JB, 2009, DEV BIOL, V334, P119, DOI 10.1016/j.ydbio.2009.07.023; Marzioni D, 2004, DEV DYNAM, V231, P839, DOI 10.1002/dvdy.20178; McKinnon B, 2012, FERTIL STERIL, V97, P373, DOI 10.1016/j.fertnstert.2011.11.011; Mechsner S, 2007, FERTIL STERIL, V88, P581, DOI 10.1016/j.fertnstert.2006.12.087; Mechsner S, 2009, FERTIL STERIL, V92, P1856, DOI 10.1016/j.fertnstert.2008.09.006; Miller LE, 2004, ARTHRITIS RHEUM-US, V50, P1156, DOI 10.1002/art.20110; Nangle MR, 2011, BRIT J PHARMACOL, V162, P1083, DOI 10.1111/j.1476-5381.2010.01108.x; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Rehman M, 2013, SEMIN CELL DEV BIOL, V24, P179, DOI 10.1016/j.semcdb.2012.10.005; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Sakurai A, 2012, CELL RES, V22, P23, DOI 10.1038/cr.2011.198; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Serini G, 2013, J INTERN MED, V273, P138, DOI 10.1111/joim.12017; Serini G, 2009, ANGIOGENESIS, V12, P187, DOI 10.1007/s10456-009-9138-4; Straub RH, 2008, GUT, V57, P911, DOI 10.1136/gut.2007.125401; Straub RH, 2008, ARTHRITIS RHEUM, V58, P3450, DOI 10.1002/art.24030; Straub RH, 2011, ARTHRITIS RHEUM-US, V63, P3234, DOI 10.1002/art.30516; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tolofari SK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2898; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Vercellini P, 2007, HUM REPROD, V22, P266, DOI 10.1093/humrep/del339; Wang GY, 2009, HUM REPROD, V24, P827, DOI 10.1093/humrep/den464; Wang YX, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002636; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Zhang GH, 2008, AM J PHYSIOL-REG I, V294, pR162, DOI 10.1152/ajpregu.00649.2007; Zhang XM, 2010, HUM REPROD, V25, P392, DOI 10.1093/humrep/dep427	44	15	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146027	10.1371/journal.pone.0146027	http://dx.doi.org/10.1371/journal.pone.0146027			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720585	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510900037
J	Rienstra, W; Blikman, T; Mensink, FB; van Raay, JJAM; Dijkstra, B; Bulstra, SK; Stevens, M; van den Akker-Scheek, I				Rienstra, Wietske; Blikman, Tim; Mensink, Frans B.; van Raay, Jos J. A. M.; Dijkstra, Baukje; Bulstra, Sjoerd K.; Stevens, Martin; van den Akker-Scheek, Inge			The Modified painDETECT Questionnaire for Patients with Hip or Knee Osteoarthritis: Translation into Dutch, Cross-Cultural Adaptation and Reliability Assessment	PLOS ONE			English	Article							NEUROPATHIC PAIN SYMPTOMS; CENTRAL-NERVOUS-SYSTEM; CENTRAL SENSITIZATION; ASSESSMENT TOOLS; UNITED-STATES; COHORT; ARTHROPLASTY; PREVALENCE; AGREEMENT; ARTHRITIS	There is a growing amount of evidence that alteration in pain processing by the peripheral and central nervous system play a role in osteoarthritis pain, leading to neuropathic-like symptoms. It is essential to identify knee and hip osteoarthritis patients with a neuropathic pain profile in order to offer such patients education and additional treatment options besides conventional pain treatment. The painDETECT Questionnaire is a self-report questionnaire developed to discriminate between nociceptive and neuropathic pain. This questionnaire was modified to fit patients suffering from knee osteoarthritis. The aim of this study was to translate and cross-culturally adapt the modified painDETECT Questionnaire to the Dutch language and to provide a modified version to fit patients with hip osteoarthritis. Reliability for internal consistency, repeatability and floor and ceiling effects were subsequently assessed. A total of 278 patients were included in the reliability study and 123 patients in the repeatability analysis. The Dutch modified painDETECT Questionnaire shows good internal consistency and small relative measurement errors, represented by a good intra-class correlation coefficient. Absolute measurement error, represented by the Standard Error of Measurement, was acceptable. However, a measurement bias might be present when it comes to repeatability. To our knowledge, this study is the first to provide a Dutch modified painDETECT Questionnaire to fit hip and knee osteoarthritis patients and to assess internal consistency, reliability and agreement. International guidelines were followed in the translation process and this study has ample sample size with an adequate time interval for repeatability. Based on this study, the Dutch modified painDETECT Questionnaire seems to be fit as a discriminative tool to identify knee and hip osteoarthritis patients with a neuropathic pain profile. Whether it is also suitable as an evaluative tool to record changes over time or after an intervention remains open to further investigation.	[Rienstra, Wietske; Blikman, Tim; Mensink, Frans B.; Bulstra, Sjoerd K.; Stevens, Martin; van den Akker-Scheek, Inge] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, NL-9713 AV Groningen, Netherlands; [van Raay, Jos J. A. M.] Martini Hosp Groningen, Dept Orthoped, Groningen, Netherlands; [Dijkstra, Baukje] Med Ctr Leeuwarden, Dept Orthoped, Leeuwarden, Netherlands	University of Groningen; Martini Hospital; Medical Center Leeuwarden	Rienstra, W (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, NL-9713 AV Groningen, Netherlands.	w.rienstra@umcg.nl	Stevens, Martin/A-5196-2013; Mensink, Frans/X-5566-2019	Stevens, Martin/0000-0001-8183-6894; van den Akker-Scheek, Inge/0000-0002-1614-8419; Rienstra, Wietske/0000-0001-6718-3129	Dutch Arthritis Foundation (Reumafonds NL)	Dutch Arthritis Foundation (Reumafonds NL)	This study was funded by the Dutch Arthritis Foundation (Reumafonds NL) (www.reumafonds.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan H, 2013, PAIN MED, V14, P1933, DOI 10.1111/pme.12222; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bennett MI, 2006, PAIN, V122, P289, DOI 10.1016/j.pain.2006.02.002; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Centers for Disease Control and Prevention (CDC), 2015, OSTEOARTHRITIS, V05, P21; Cruccu G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000045; De Andres J, 2012, CLIN J PAIN, V28, P243, DOI 10.1097/AJP.0b013e31822bb35b; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; de Vet HW, 2011, MEASUREMENT MED PRAC; Deyo RA, 1991, CONTROL CLIN TRIALS, P12; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Hochman JR, 2013, OSTEOARTHR CARTILAGE, V21, P1236, DOI 10.1016/j.joca.2013.06.023; Hochman JR, 2011, OSTEOARTHR CARTILAGE, V19, P647, DOI 10.1016/j.joca.2011.03.007; Hochman JR, 2010, ARTHRIT CARE RES, V62, P1019, DOI 10.1002/acr.20142; Jones RCW, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0363-6; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Matsubayashi Yoshitaka Y, 2013, PLOS ONE, V8; Mease PJ, 2011, J RHEUMATOL, V38, P1546, DOI 10.3899/jrheum.100759; Mulvey MR, 2014, PAIN MANAG, V4, P233, DOI [10.2217/PMT.14.8, 10.2217/pmt.14.8]; Murphy SL, 2012, CURR RHEUMATOL REP, V14, P576, DOI 10.1007/s11926-012-0285-z; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Neogi T, 2013, ANN RHEUM DIS; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Ohtori S, 2012, YONSEI MED J, V53, P801, DOI 10.3349/ymj.2012.53.4.801; Otten Renee, 2010, Ned Tijdschr Geneeskd, V154, pA1534; Shigemura T, 2011, EUR ORTHOP TRAUMATOL, V2, P73; Staud R, 2011, CURR RHEUMATOL REP, V13, P513, DOI 10.1007/s11926-011-0206-6; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thakur M, 2014, NAT REV RHEUMATOL, V10, P374, DOI 10.1038/nrrheum.2014.47; Valdes AM, 2012, SEMIN ARTHRITIS RHEU, V41, P568, DOI 10.1016/j.semarthrit.2011.07.002; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	36	18	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146117	10.1371/journal.pone.0146117	http://dx.doi.org/10.1371/journal.pone.0146117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720417	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900045
J	Sridharan, B; Lin, SM; Hwu, AT; Laflin, AD; Detamore, MS				Sridharan, BanuPriya; Lin, Staphany M.; Hwu, Alexander T.; Laflin, Amy D.; Detamore, Michael S.			Stem Cells in Aggregate Form to Enhance Chondrogenesis in Hydrogels	PLOS ONE			English	Article							HUMAN UMBILICAL-CORD; MESENCHYMAL STROMAL CELLS; WHARTONS JELLY CELLS; IN-VITRO; CARTILAGE FORMATION; HYALURONIC-ACID; CHONDROCYTES; DIFFERENTIATION; SCAFFOLDS; AGAROSE	There are a variety of exciting hydrogel technologies being explored for cartilage regenerative medicine. Our overall goal is to explore whether using stem cells in an aggregate form may be advantageous in these applications. 3D stem cell aggregates hold great promise as they may recapitulate the in vivo skeletal tissue condensation, a property that is not typically observed in 2D culture. We considered two different stem cell sources, human umbilical cord Wharton's jelly cells (hWJCs, currently being used in clinical trials) and rat bone marrow-derived mesenchymal stem cells (rBMSCs). The objective of the current study was to compare the influence of cell phenotype, aggregate size, and aggregate number on chondrogenic differentiation in a generic hydrogel (agarose) platform. Despite being differing cell sources, both rBMSC and hWJC aggregates were consistent in outperforming cell suspension control groups in biosynthesis and chondrogenesis. Higher cell density impacted biosynthesis favorably, and the number of aggregates positively influenced chondrogenesis. Therefore, we recommend that investigators employing hydrogels consider using cells in an aggregate form for enhanced chondrogenic performance.	[Sridharan, BanuPriya; Detamore, Michael S.] Univ Kansas, Bioengn Grad Program, Lawrence, KS 66045 USA; [Lin, Staphany M.; Hwu, Alexander T.; Laflin, Amy D.; Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Detamore, MS (corresponding author), Univ Kansas, Bioengn Grad Program, Lawrence, KS 66045 USA.	detamore@ku.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01 AR056347]; Kansas Bioscience Authority Rising Star Award; State of Kansas Umbilical Cord Matrix Project; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056347] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Kansas Bioscience Authority Rising Star Award; State of Kansas Umbilical Cord Matrix Project; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01 AR056347 supported research reported in this publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would also like to recognize support from the Kansas Bioscience Authority Rising Star Award, as well as the State of Kansas Umbilical Cord Matrix Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey MM, 2007, TISSUE ENG, V13, P2003, DOI 10.1089/ten.2006.0150; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Batsali AK, 2013, CURR STEM CELL RES T, V8, P144; Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004; Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030; Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111; Centola M, 2013, STEM CELLS DEV, V22, P2849, DOI 10.1089/scd.2013.0216; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Dang PN, 2014, TISSUE ENG PT A, V20, P3163, DOI [10.1089/ten.TEA.2012.0551, 10.1089/ten.tea.2012.0551]; Declercq HA, 2013, BIOMATERIALS, V34, P1004, DOI 10.1016/j.biomaterials.2012.10.051; DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761; Detamore MS, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt353; Devarajan K, 2013, CELL REPROGRAM, V15, P43, DOI 10.1089/cell.2011.0097; Dikina AD, 2015, BIOMATERIALS, V52, P452, DOI 10.1016/j.biomaterials.2015.01.073; Dormer NH, 2010, ANN BIOMED ENG, V38, P2167, DOI 10.1007/s10439-010-0028-0; DuRaine GD, 2015, ANN BIOMED ENG, V43, P543, DOI 10.1007/s10439-014-1161-y; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021; Florine EM, 2013, CARTILAGE, V4, P63, DOI 10.1177/1947603512455196; Goude MC, 2014, CELLS TISSUES ORGANS, V199, P117, DOI 10.1159/000365966; Huang CC, 2013, BIOMATERIALS, V34, P9441, DOI 10.1016/j.biomaterials.2013.09.010; Huey DJ, 2013, CELL TRANSPLANT, V22, P331, DOI 10.3727/096368912X657648; Lei J, 2014, BIOMATER SCI-UK, V2, P666, DOI 10.1039/c3bm60271k; Levato R, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035020; Lima AC, 2013, TISSUE ENG PT A, V19, P1175, DOI [10.1089/ten.tea.2012.0249, 10.1089/ten.TEA.2012.0249]; Liu SY, 2014, J BIOSCI BIOENG, V117, P229, DOI 10.1016/j.jbiosc.2013.07.001; Mellott AJ, 2015, TISSUE ENG PT A, V21, P1795, DOI [10.1089/ten.tea.2014.0340, 10.1089/ten.TEA.2014.0340]; Mellott AJ, 2014, CELL REPROGRAM, V16, P91, DOI 10.1089/cell.2013.0069; Moriguchi Y, 2013, BIOMATERIALS, V34, P2185, DOI 10.1016/j.biomaterials.2012.11.039; Raghothaman D, 2014, BIOMATERIALS, V35, P2607, DOI 10.1016/j.biomaterials.2013.12.008; Rettinger CL, 2014, CELL TISSUE RES, V358, P395, DOI 10.1007/s00441-014-1939-0; Ruan DK, 2012, TISSUE ENG PT A, V18, P167, DOI [10.1089/ten.tea.2011.0186, 10.1089/ten.TEA.2011.0186]; Sart S, 2013, TISSUE ENG B; Skaalure SC, 2014, ACTA BIOMATER, V10, P3409, DOI 10.1016/j.actbio.2014.04.013; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Teixeira LSM, 2012, EUR CELLS MATER, V23, P387, DOI 10.22203/eCM.v023a30; Wang Limin, 2013, Recent Pat Regen Med, V3, P182, DOI 10.2174/22102965113039990020; Wang LM, 2011, REGEN MED, V6, P95, DOI [10.2217/rme.10.98, 10.2217/RME.10.98]; Wang LM, 2009, TISSUE ENG PT A, V15, P2259, DOI 10.1089/ten.tea.2008.0393; Winter A, 2003, ARTHRITIS RHEUM-US, V48, P418, DOI 10.1002/art.10767; Yu Y, 2012, LIVER TRANSPLANT, V18, P9, DOI 10.1002/lt.22467	41	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0141479	10.1371/journal.pone.0141479	http://dx.doi.org/10.1371/journal.pone.0141479			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719986	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900001
J	Cui, QN; Lv, HN; Qi, ZZ; Jiang, B; Xiao, B; Liu, LD; Ge, YH; Hu, XM				Cui, Qinna; Lv, Huinan; Qi, Zhuangzhuang; Jiang, Bei; Xiao, Bo; Liu, Linde; Ge, Yihe; Hu, Xiaomei			Cross-Regulation between the phz1 and phz2 Operons Maintain a Balanced Level of Phenazine Biosynthesis in Pseudomonas aeruginosa PAO1	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; PHENAZINE-1-CARBOXYLIC ACID; FLUORESCENS CHA0; SECONDARY METABOLITES; BIOLOGICAL-CONTROL; SP M18; PYOCYANIN; EXPRESSION; VIRULENCE; GENES	Gene duplication often provides selective advantages for the survival of microorganisms in adapting to varying environmental conditions. P. aeruginosa PAO1 possesses two sevengene operons [ phz1 (phzA1B1C1D1E1F1G1) and phz2 (phzA2B2C2D2E2F2G2)] that are involved in the biosynthesis of phenazine-1-carboxylic acid and its derivatives. Although the two operons are highly homologous and their functions are well known, it is unclear how the two phz operons coordinate their expressions to maintain the phenazine biosynthesis. By constructing single and double deletion mutants of the two phz operons, we found that the phz1-deletion mutant produced the same or less amount of phenazine-1-carboxylic acid and pyocyanin in GA medium than the phz2-knockout mutant while the phz1-phz2 double knockout mutant did not produce any phenazines. By generating phzA1 and phzA2 translational and transcriptional fusions with a truncated lacZ reporter, we found that the expression of the phz1 operon increased significantly at the post-transcriptional level and did not alter at the transcriptional level in the absence of the phz2 operon. Surprisingly, the expression the phz2 operon increased significantly at the post-transcriptional level and only moderately at the transcriptional level in the absence of the phz1 operon. Our findings suggested that a complex cross-regulation existed between the phz1 and phz2 operons. By mediating the upregulation of one phz operon expression while the other was deleted, this crosstalk would maintain the homeostatic balance of phenazine biosynthesis in P. aeruginosa PAO1.	[Cui, Qinna; Lv, Huinan; Qi, Zhuangzhuang; Xiao, Bo; Liu, Linde; Ge, Yihe] Ludong Univ, Sch Biol Sci, Dept Appl & Environm Microbiol, Yantai, Peoples R China; [Cui, Qinna; Jiang, Bei; Hu, Xiaomei] Third Mil Med Univ, Dept Microbiol, Coll Basic Med Sci, Chongqing, Peoples R China	Ludong University; Army Medical University	Ge, YH (corresponding author), Ludong Univ, Sch Biol Sci, Dept Appl & Environm Microbiol, Yantai, Peoples R China.	geyihe@ldu.edu.cn; hxmay2008@163.com	Lv, Haibin/AAX-7696-2020	Lv, Haibin/0000-0003-1059-4765; GE, YIHE/0000-0002-7938-8292	Natural Science Fundation in Shandong Province [ZR2011CL003]	Natural Science Fundation in Shandong Province	All the works were supported by the Natural Science Fundation in Shandong Province (No. ZR2011CL003).	Baehler E, 2005, J APPL MICROBIOL, V99, P24, DOI 10.1111/j.1365-2672.2005.02597.x; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Chieda Y, 2005, FEMS MICROBIOL LETT, V244, P181, DOI 10.1016/j.femsle.2005.01.032; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Daval S, 2011, MOL PLANT PATHOL, V12, P839, DOI [10.1111/J.1364-3703.2011.00715.X, 10.1111/j.1364-3703.2011.00715.x]; Denning GM, 2003, AM J PHYSIOL-LUNG C, V285, pL584, DOI 10.1152/ajplung.00086.2003; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; FRANK LH, 1959, J BACTERIOL, V77, P776, DOI 10.1128/JB.77.6.776-782.1959; Ge YH, 2007, CURR MICROBIOL, V54, P277, DOI 10.1007/s00284-006-0317-x; Ge YH, 2007, FEMS MICROBIOL LETT, V268, P81, DOI 10.1111/j.1574-6968.2006.00562.x; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Hao YH, 2012, CELL MICROBIOL, V14, P401, DOI 10.1111/j.1462-5822.2011.01727.x; Hazan R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000810; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kidarsa TA, 2011, MOL MICROBIOL, V81, P395, DOI 10.1111/j.1365-2958.2011.07697.x; Kim KJ, 2000, J BIOCHEM MOL BIOL, V33, P332; Kurachi M., 1958, B I CHEM RES, V36, P163; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; LATIFI A, 1995, MOL MICROBIOL, V17, P333, DOI 10.1111/j.1365-2958.1995.mmi_17020333.x; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lauredo IT, 1998, J APPL PHYSIOL, V85, P2298, DOI 10.1152/jappl.1998.85.6.2298; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; Lequette Y, 2006, J BACTERIOL, V188, P3365, DOI 10.1128/JB.188.9.3365-3370.2006; Li YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019413; Liang HH, 2008, J BACTERIOL, V190, P6217, DOI 10.1128/JB.00428-08; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Look DC, 2005, J IMMUNOL, V175, P4017, DOI 10.4049/jimmunol.175.6.4017; Lundgren BR, 2013, J BACTERIOL, V195, P2087, DOI 10.1128/JB.02205-12; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; MARKIE D, 1986, Proceedings of the University of Otago Medical School, V64, P69; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2012, APPL ENVIRON MICROB, V78, P804, DOI 10.1128/AEM.06784-11; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MINTON NP, 1984, GENE, V31, P31, DOI 10.1016/0378-1119(84)90192-6; Mousa WK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00065; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Rampioni G, 2012, APPL ENVIRON MICROB, V78, P726, DOI 10.1128/AEM.06442-11; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Ren B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089653; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Smirnov V, 1990, BACTERIA PSEUDOMONAS; SMITH AW, 1989, NUCLEIC ACIDS RES, V17, P10509, DOI 10.1093/nar/17.24.10509; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Turner KH, 2015, P NATL ACAD SCI USA, V112, P4110, DOI 10.1073/pnas.1419677112; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559	58	29	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144447	10.1371/journal.pone.0144447	http://dx.doi.org/10.1371/journal.pone.0144447			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735915	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100008
J	Godoy-Lorite, A; Guimera, R; Sales-Pardo, M				Godoy-Lorite, Antonia; Guimera, Roger; Sales-Pardo, Marta			Long-Term Evolution of Email Networks: Statistical Regularities, Predictability and Stability of Social Behaviors	PLOS ONE			English	Article							SCALING BEHAVIOR; DYNAMICS; GROWTH	In social networks, individuals constantly drop ties and replace them by new ones in a highly unpredictable fashion. This highly dynamical nature of social ties has important implications for processes such as the spread of information or of epidemics. Several studies have demonstrated the influence of a number of factors on the intricate microscopic process of tie replacement, but the macroscopic long-term effects of such changes remain largely unexplored. Here we investigate whether, despite the inherent randomness at the microscopic level, there are macroscopic statistical regularities in the long-term evolution of social networks. In particular, we analyze the email network of a large organization with over 1,000 individuals throughout four consecutive years. We find that, although the evolution of individual ties is highly unpredictable, the macro-evolution of social communication networks follows well-defined statistical patterns, characterized by exponentially decaying log-variations of the weight of social ties and of individuals' social strength. At the same time, we find that individuals have social signatures and communication strategies that are remarkably stable over the scale of several years.	[Godoy-Lorite, Antonia; Guimera, Roger; Sales-Pardo, Marta] Univ Rovira & Virgili, Dept Engn Quim, Tarragona 43006, Catalonia, Spain; [Guimera, Roger] ICREA, Barcelona 08010, Catalonia, Spain	Universitat Rovira i Virgili; ICREA	Guimera, R (corresponding author), Univ Rovira & Virgili, Dept Engn Quim, Tarragona 43006, Catalonia, Spain.	roger.guimera@urv.cat	Guimera, Roger/M-9808-2019; Guimera, Roger/C-1727-2008; Sales-Pardo, Marta/O-9797-2019; Sales-Pardo, Marta/C-1725-2008	Guimera, Roger/0000-0002-3597-4310; Guimera, Roger/0000-0002-3597-4310; Sales-Pardo, Marta/0000-0002-8140-6525; Sales-Pardo, Marta/0000-0002-8140-6525	James S. McDonnell Foundation Research Award; Spanish Ministerio de Economia y Comptetitividad (MINECO) [FIS2010- 18639, FIS2013-47532-C3]; European Union [PIRG-GA-2010-277166, PIRG-GA-2010-268342]; European Union FET Grant [317532]; ICREA Funding Source: Custom	James S. McDonnell Foundation Research Award; Spanish Ministerio de Economia y Comptetitividad (MINECO); European Union(European Commission); European Union FET Grant; ICREA(ICREA)	This work was supported by a James S. McDonnell Foundation Research Award, Spanish Ministerio de Economia y Comptetitividad (MINECO) Grants FIS2010- 18639 and FIS2013-47532-C3, European Union Grant PIRG-GA-2010-277166 (to RG), European Union Grant PIRG-GA-2010-268342 (to MSP), and European Union FET Grant 317532 (MULTIPLEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 1997, J PHYS I, V7, P621; Amaral LAN, 1998, PHYS REV LETT, V80, P1385, DOI 10.1103/PhysRevLett.80.1385; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Buldyrev SV, 1997, J PHYS I, V7, P635, DOI 10.1051/jp1:1997181; Dunbar RIM, 2015, SOC NETWORKS, V43, P39, DOI 10.1016/j.socnet.2015.04.005; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Easley D., 2010, NETWORKS CROWDS MARK; Gautreau A, 2009, P NATL ACAD SCI USA, V106, P8847, DOI 10.1073/pnas.0811113106; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Iribarren JL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038702; Malmgren RD, 2010, NATURE, V465, P622, DOI 10.1038/nature09040; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Miritello G, 2013, SOC NETWORKS, V35, P89, DOI 10.1016/j.socnet.2013.01.003; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Plerou V, 1999, NATURE, V400, P433, DOI 10.1038/22719; Saramaki J, 2015, EUR PHYS J B, V88, DOI [10.1140/epjb/e2015-60106-6, 10.1140/epjb/e2015-60660-9]; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026972	32	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146113	10.1371/journal.pone.0146113	http://dx.doi.org/10.1371/journal.pone.0146113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26735853	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100034
J	Jalgaonkar, SV; Bhide, SS; Tripathi, RK; Shetty, YC; Marathe, PA; Katkar, J; Thatte, UM				Jalgaonkar, Sharmila V.; Bhide, Shruti S.; Tripathi, Raakhi K.; Shetty, Yashashri C.; Marathe, Padmaja A.; Katkar, Janhavi; Thatte, Urmila M.			An Audit of Protocol Deviations Submitted to an Institutional Ethics Committee of a Tertiary Care Hospital	PLOS ONE			English	Article							ENROLLMENT	Protocol deviations (PDs) may jeopardize safety, rights, and welfare of subjects and data integrity. There is scarce literature and no guidelines for Institutional Ethics Committees (IECs) to process PD reports. The PD reports submitted to IECs from Jan 2011 to August 2014 were analyzed retrospectively. Types of studies reporting PDs, category and type of PDs, PD rate per participant, time of reporting PD since its occurrence and corrective actions stated by principal investigator (PI) for major deviations were noted. Out of 447 PDs from 73/1387 total studies received during study period, 402 were from 126 pharma studies. Investigator initiated studies and dissertations reported negligible PDs. Median number of PDs was 4 per protocol. Out of 447 PDs, 304 were related to study procedure, 87, 47 and 9 were from safety, informed consent document (ICD) and eligibility category respectively. The most common reason for PDs was incomplete ICD (22/47). Maximum study procedure related PDs were due to patient visiting outside window period (126/304). Thirty five of 87 PDs were due to missed safety assessment. The overall PD reporting rate per participant was 0.08. In 90% of reports, date of occurrence of PD was not specified. The median delay for reporting PDs after occurrence was 94 days. PDs classified as Major were 73% (323/447). The most common corrective actions stated by PI were participant counseling (85/323) and caution in future (70/323). The study findings emphasize the need for GCP training at regular interval of study team members. IEC have to be vigilant and visit sites frequently, take initiative and formulate guidelines regarding PD reporting.	[Jalgaonkar, Sharmila V.; Bhide, Shruti S.; Tripathi, Raakhi K.; Shetty, Yashashri C.; Marathe, Padmaja A.] Seth GS Med Coll & KEM Hosp, Dept Pharmacol & Therapeut, Bombay, Maharashtra, India; [Katkar, Janhavi] Seth GS Med Coll & KEM Hosp, Inst Eth Comm, Bombay, Maharashtra, India; [Thatte, Urmila M.] Seth GS Med Coll & KEM Hosp, Dept Clin Pharmacol, Bombay, Maharashtra, India	Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Jalgaonkar, SV (corresponding author), Seth GS Med Coll & KEM Hosp, Dept Pharmacol & Therapeut, Bombay, Maharashtra, India.	sharmila_jalgaonkar@rediffmail.com						CDSCO.Good Clinical Practice Guidelines, 2001, GOOD CLIN PRACT GUID; Fleming TR, 2011, ANN INTERN MED, V154, P113, DOI 10.7326/0003-4819-154-2-201101180-00010; Gogtay N J, 2011, Indian J Med Ethics, V8, P211; Harel O, 2012, AIDS BEHAV, V16, P1382, DOI 10.1007/s10461-011-0125-6; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, GUID GOOD CLIN PRACT; Kuyare SS, 2014, J POSTGRAD MED, V60, P46, DOI 10.4103/0022-3859.128808; Lamberti MJ, 2012, DRUG INF J, V46, P573, DOI 10.1177/0092861512453040; Lele C, 2013, J CLIN STUDIES, V5, P51; Mandava A, 2013, HASTINGS CENT REP, V43, P38, DOI 10.1002/hast.144; Murthy V, 2012, J CANCER RES THER, V8, P94, DOI 10.4103/0973-1482.92221; NIH IRB Professional Administrators Committee, 2005, REG PROC WORKGR VERS; Shetty YC, 2015, J MED ETHICS, V41, P398, DOI 10.1136/medethics-2013-101829; Shetty Yashashri C, 2012, Indian J Med Ethics, V9, P22; Sweetman EA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-214; USFDA, COMPL PROGR GUID MAN; Yao Bin, 2013, Pharmaceutics, V5, P94, DOI 10.3390/pharmaceutics5010094	16	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146334	10.1371/journal.pone.0146334	http://dx.doi.org/10.1371/journal.pone.0146334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26735850	Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100043
J	Ottosson-Laakso, E; Tuomi, T; Forsen, B; Gullstrom, M; Groop, PH; Groop, L; Vikman, P				Ottosson-Laakso, Emilia; Tuomi, Tiinamaija; Forsen, Bjorn; Gullstrom, Monika; Groop, Per-Henrik; Groop, Leif; Vikman, Petter			Influence of Familial Renal Glycosuria Due to Mutations in the SLC5A2 Gene on Changes in Glucose Tolerance over Time	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; INSULIN SENSITIVITY; SGLT2; DNA; DAPAGLIFLOZIN; INHIBITION; FRAMEWORK; PATIENT; GENOME	Familial renal glycosuria is an inherited disorder resulting in glucose excretion in the urine despite normal blood glucose concentrations. It is most commonly due to mutations in the SLC5A2 gene coding for the glucose transporter SGLT2 in the proximal tubule. Several drugs have been introduced as means to lower glucose in patients with type 2 diabetes targeting SGLT2 resulting in renal glycosuria, but no studies have addressed the potential effects of decreased renal glucose reabsorption and chronic glycosuria on the prevention of glucose intolerance. Here we present data on a large pedigree with renal glycosuria due to two mutations (c.300-303+2del and p.A343V) in the SLC5A2 gene. The mutations, which in vitro affected glucose transport in a cell line model, and the ensuing glycosuria were not associated with better glycemic control during a follow-up period of more than 10 years. One individual, who was compound heterozygous for mutations in the SLC5A2 gene suffered from severe urogenital candida infections and postprandial hypoglycemia. In conclusion, in this family with familial glycosuria we did not find any evidence that chronic loss of glucose in the urine would protect from deterioration of the glucose tolerance over time.	[Ottosson-Laakso, Emilia; Groop, Leif; Vikman, Petter] Lund Univ, Dept Clin Sci, Diabet & Endocrinol, Malmo, Sweden; [Tuomi, Tiinamaija; Groop, Per-Henrik] Folkhalsan Inst Genet, Folkhalsan Res Ctr, Biomedicum, Helsinki, Finland; [Tuomi, Tiinamaija; Groop, Per-Henrik] Univ Helsinki, Res Program Unit, Diabet & Obes, Helsinki, Finland; [Forsen, Bjorn; Gullstrom, Monika] Narpes Hlth Care Ctr, Narpes, Finland; [Groop, Per-Henrik] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland; [Groop, Per-Henrik] Helsinki Univ Hosp, Helsinki, Finland; [Groop, Per-Henrik] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland	Lund University; Folkhalsan Research Center; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Baker Heart and Diabetes Institute; University of Helsinki	Ottosson-Laakso, E (corresponding author), Lund Univ, Dept Clin Sci, Diabet & Endocrinol, Malmo, Sweden.	emilia.ottosson_laakso@med.lu.se		Tuomi, Tiinamaija/0000-0002-8306-6202	Sigrid Juselius Foundation; Folkhalsan Research Foundation; Signe and Ane Gyllenberg Foundation; Swedish Cultural Foundation in Finland; Finnish Diabetes Research Foundation; Foundation for Life and Health in Finland; Paavo Nurmi Foundation; Helsinki University Central Hospital Research Foundation; Perklen Foundation; Ollqvist Foundation; Narpes Health Care Foundation; Ahokas Foundation; FiDiPro grant [263401]; Academy of Finland [267882]; Municipal Heath Care Center and Hospital in Jakobstad and Health Care Center in Vasa; Municipal Heath Care Center and Hospital in Jakobstad and Health Care Center in Narpes; Municipal Heath Care Center and Hospital in Jakobstad and Health Care Center in Korsholm; Lund University [2010-3490]; Linnaeus Centre of Excellence grant [2006-237]; European Research Council Advanced Researcher Grant [GA 269045]; Novo Nordisk Fonden [NNF14OC0010995] Funding Source: researchfish	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Folkhalsan Research Foundation; Signe and Ane Gyllenberg Foundation; Swedish Cultural Foundation in Finland; Finnish Diabetes Research Foundation; Foundation for Life and Health in Finland; Paavo Nurmi Foundation; Helsinki University Central Hospital Research Foundation; Perklen Foundation; Ollqvist Foundation; Narpes Health Care Foundation; Ahokas Foundation; FiDiPro grant; Academy of Finland(Academy of Finland); Municipal Heath Care Center and Hospital in Jakobstad and Health Care Center in Vasa; Municipal Heath Care Center and Hospital in Jakobstad and Health Care Center in Narpes; Municipal Heath Care Center and Hospital in Jakobstad and Health Care Center in Korsholm; Lund University; Linnaeus Centre of Excellence grant; European Research Council Advanced Researcher Grant(European Research Council (ERC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants to the Botnia Study from the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/stiftelse), Folkhalsan Research Foundation (http//www.folkhalsan.fi/ startsida/Var-verksamhet/Forskning/), Signe and Ane Gyllenberg Foundation (http://gyllenbergs.fi/en/signe-och-ane-gyllenbergs-stiftelse-en/), Swedish Cultural Foundation in Finland (http://www.kulturfonden.fi/sv/start/), Finnish Diabetes Research Foundation, Foundation for Life and Health in Finland (http://www.livochhalsa.fi/), Finnish Medical Society (http://www.duodecimfil/web/svenska/hemsida), Paavo Nurmi Foundation, Helsinki University Central Hospital Research Foundation, Perklen Foundation, Ollqvist Foundation, Narpes Health Care Foundation, Ahokas Foundation, a FiDiPro grant (263401) and a Project Grant (267882) from the Academy of Finland (http://www.aka.fi/sv). The study has also been supported by the Municipal Heath Care Center and Hospital in Jakobstad and Health Care Centers in Vasa, Narpes and Korsholm. The research at Lund University is supported by grants to LG: Swedish Research Council (http://www.vr.se/) project grant (2010-3490) and Linnaeus Centre of Excellence grant (2006-237), as well as a European Research Council Advanced Researcher Grant (GA 269045) (http://www.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2014, J INTERN MED, V276, P352, DOI 10.1111/joim.12244; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bailey CJ, 2011, TRENDS PHARMACOL SCI, V32, P63, DOI 10.1016/j.tips.2010.11.011; Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Calado J, 2004, HUM GENET, V114, P314, DOI 10.1007/s00439-003-1054-x; Calado J, 2011, KIDNEY INT, V79, pS7, DOI 10.1038/ki.2010.510; Calado J, 2008, NEPHROL DIAL TRANSPL, V23, P3874, DOI 10.1093/ndt/gfn386; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diamant M, 2013, LANCET; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Francis J, 2004, NEPHROL DIAL TRANSPL, V19, P2893, DOI 10.1093/ndt/gfh426; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Kanwal A, 2012, ANAL BIOCHEM, V429, P70, DOI 10.1016/j.ab.2012.07.003; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee HJ, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0034318; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Magen D, 2005, KIDNEY INT, V67, P34, DOI 10.1111/j.1523-1755.2005.00053.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Santer R, 2003, J AM SOC NEPHROL, V14, P2873, DOI 10.1097/01.ASN.0000092790.89332.D2; Santer R, 2010, CLIN J AM SOC NEPHRO, V5, P133, DOI 10.2215/CJN.04010609; Scholl-Burgi S, 2004, NEPHROL DIAL TRANSPL, V19, P2394, DOI 10.1093/ndt/gfh366; Sha S, 2014, DIABETES OBES METAB, V16, P1087, DOI 10.1111/dom.12322; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stenlof K, 2013, DIABETES OBES METAB, V15, P372, DOI 10.1111/dom.12054; van den Heuvel LP, 2002, HUM GENET, V111, P544, DOI 10.1007/s00439-002-0820-5; Wilding JPH, 2014, METABOLISM, V63, P1228, DOI 10.1016/j.metabol.2014.06.018; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yu L, 2011, HUM GENET, V129, P335, DOI 10.1007/s00439-010-0927-z	41	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146114	10.1371/journal.pone.0146114	http://dx.doi.org/10.1371/journal.pone.0146114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735923	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100035
J	Angelieri, CCS; Adams-Hosking, C; Ferraz, KMPMD; de Souza, MP; McAlpine, CA				Silva Angelieri, Cintia Camila; Adams-Hosking, Christine; Micchi de Barros Ferraz, Katia Maria Paschoaletto; de Souza, Marcelo Pereira; McAlpine, Clive Alexander			Using Species Distribution Models to Predict Potential Landscape Restoration Effects on Puma Conservation	PLOS ONE			English	Article							JAGUAR PANTHERA-ONCA; LIVESTOCK PREDATION; TROPHIC CASCADES; EXTINCTION RISK; ATLANTIC FOREST; CONCOLOR; HABITAT; COUGARS; DISPERSAL; BRAZIL	A mosaic of intact native and human-modified vegetation use can provide important habitat for top predators such as the puma (Puma concolor), avoiding negative effects on other species and ecological processes due to cascade trophic interactions. This study investigates the effects of restoration scenarios on the puma's habitat suitability in the most developed Brazilian region (Sao Paulo State). Species Distribution Models incorporating restoration scenarios were developed using the species' occurrence information to (1) map habitat suitability of pumas in Sao Paulo State, Southeast, Brazil; (2) test the relative contribution of environmental variables ecologically relevant to the species habitat suitability and (3) project the predicted habitat suitability to future native vegetation restoration scenarios. The Maximum Entropy algorithm was used (Test AUC of 0.84 +/- 0.0228) based on seven environmental non-correlated variables and non-autocorrelated presence-only records (n = 342). The percentage of native vegetation (positive influence), elevation (positive influence) and density of roads (negative influence) were considered the most important environmental variables to the model. Model projections to restoration scenarios reflected the high positive relationship between pumas and native vegetation. These projections identified new high suitability areas for pumas (probability of presence >0.5) in highly deforested regions. High suitability areas were increased from 5.3% to 8.5% of the total State extension when the landscapes were restored for >= the minimum native vegetation cover rule (20%) established by the Brazilian Forest Code in private lands. This study highlights the importance of a landscape planning approach to improve the conservation outlook for pumas and other species, including not only the establishment and management of protected areas, but also the habitat restoration on private lands. Importantly, the results may inform environmental policies and land use planning in Sao Paulo State, Brazil.	[Silva Angelieri, Cintia Camila] Univ Sao Paulo, Water Resources & Environm Studies Ctr, Sao Carlos Sch Engn, Sao Carlos, SP, Brazil; [Silva Angelieri, Cintia Camila; Adams-Hosking, Christine; McAlpine, Clive Alexander] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Micchi de Barros Ferraz, Katia Maria Paschoaletto] Univ Sao Paulo, Dept Forest Sci, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil; [de Souza, Marcelo Pereira] Univ Sao Paulo, Dept Biol, Ribeirao Preto Sch Philosophy Sci & Literature, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; University of Queensland; Universidade de Sao Paulo; Universidade de Sao Paulo	Angelieri, CCS (corresponding author), Univ Sao Paulo, Water Resources & Environm Studies Ctr, Sao Carlos Sch Engn, Sao Carlos, SP, Brazil.	cintiacamila.angelieri@gmail.com	Ferraz, Katia Maria P. M. B./D-7244-2012; Angelieri, Cintia/K-8064-2016; Souza, Marcelo Marini Pereira de/C-6345-2012	Ferraz, Katia Maria P. M. B./0000-0002-7870-8696; Angelieri, Cintia/0000-0003-2247-1244; Souza, Marcelo Marini Pereira de/0000-0002-5682-2973; McAlpine, Clive/0000-0003-0457-8144	Sao Paulo Research Foundation [11/11091-1, 12/03514-2]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CCSA was funded by the Sao Paulo Research Foundation (http://www.fapesp.br) grants: 11/11091-1 and 12/03514-2.	Abade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096261; Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Beyer H. L, 2012, GEOSPATIAL MODELLING; Booth G, 1994, INT470 USDA FOR SERV; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Caso A, 2008, PANTHERA ONCA IUCN R; Castilho CS, 2011, MAMM BIOL, V76, P476, DOI 10.1016/j.mambio.2010.08.002; Chapron G, 2003, CR BIOL, V326, P575, DOI 10.1016/S1631-0691(03)00148-3; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Clements GR, 2012, INTEGR ZOOL, V7, P400, DOI 10.1111/j.1749-4877.2012.00314.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Da Silva FR, 2011, SCIENCE, V332, P1033, DOI 10.1126/science.332.6033.1033-a; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; Dean Warren, 1995, BROADAX FIREBRAND DE; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dickson BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081898; Dotta Graziela, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000200031; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J., 2009, SPATIAL CONSERVATION, P70; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith Jane, 2002, P39; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Galetti M, 2013, SCIENCE, V342, P930, DOI 10.1126/science.342.6161.930-a; Gontier M, 2010, ENVIRON IMPACT ASSES, V30, P8, DOI 10.1016/j.eiar.2009.05.003; Goulart FVB, 2009, MAMM BIOL, V74, P182, DOI 10.1016/j.mambio.2009.02.006; Gould SF, 2014, ECOL EVOL, V4, P4798, DOI 10.1002/ece3.1319; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hernandez-Santin L, 2012, SOUTHWEST NAT, V57, P314, DOI 10.1894/0038-4909-57.3.314; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2013, NOT EST POP RES COM; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Larue MA, 2011, ECOL MODEL, V222, P897, DOI 10.1016/j.ecolmodel.2010.11.017; Lemes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054323; Lyra-Jorge MC, 2010, EUR J WILDLIFE RES, V56, P359, DOI 10.1007/s10344-009-0324-x; Maehr DS, 2002, BIOL CONSERV, V106, P187, DOI 10.1016/S0006-3207(01)00245-2; Magioli M, 2014, BIOTROPICA, V46, P451, DOI 10.1111/btp.12115; Mantovani JE, 2001, THESIS; Maron M, 2013, CONSERV LETT, V6, P359, DOI 10.1111/conl.12007; Marques Emilena Muzolon, 2012, Ambient. soc., V15, P131, DOI 10.1590/S1414-753X2012000100009; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Mazzolli M., 2012, Journal of Ecology and the Natural Environment, V4, P344; Mazzolli M, 2010, ENVIRON MANAGE, V46, P237, DOI 10.1007/s00267-010-9528-9; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Metzger JP, 2010, SCIENCE, V329, P276, DOI 10.1126/science.329.5989.276-b; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Ferraz KMPMD, 2012, ENVIRON CONSERV, V39, P316, DOI 10.1017/S0376892912000094; Michalski F, 2010, SCIENCE, V329, P1282, DOI 10.1126/science.329.5997.1282-a; Miotto RA, 2014, ORYX, V48, P250, DOI 10.1017/S0030605312000841; Miotto RA, 2012, BIOTROPICA, V44, P98, DOI 10.1111/j.1744-7429.2011.00772.x; MMA-Ministerio do Meio Ambiente Brasileiro, 2012, AR ESP UN CONS UCS P; Palmeira FBL, 2008, BIOL CONSERV, V141, P118, DOI 10.1016/j.biocon.2007.09.015; Paviolo A, 2009, J MAMMAL, V90, P926, DOI 10.1644/08-MAMM-A-128.1; Pearson RG, 2010, AM MUSEUM NATURAL HI, V3, P54; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Penteado MJF, 2012, THESIS; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ripple WJ, 2008, BIOL CONSERV, V141, P1249, DOI 10.1016/j.biocon.2008.02.028; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Sollmann R, 2012, MAMM BIOL, V77, P41, DOI 10.1016/j.mambio.2011.06.011; Sparovek G, 2010, ENVIRON SCI TECHNOL, V44, P6046, DOI 10.1021/es1007824; SpLink-Species Link network, EL DAT FREE OP ACC D; Stahl P, 2001, BIOL CONSERV, V101, P15, DOI 10.1016/S0006-3207(01)00054-4; Stoner DC, 2013, WILDLIFE BIOL, V19, P289, DOI 10.2981/12-124; Sweanor LL, 2008, J WILDLIFE MANAGE, V72, P1076, DOI 10.2193/2007-024; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; Torres N.M., 2008, CAT NEWS, V4, P4; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Weber E., 2004, ADAPTACAO MODELO DIG; Whitehead AL, 2014, CONSERV BIOL, V28, P992, DOI 10.1111/cobi.12257; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007	91	81	82	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145232	10.1371/journal.pone.0145232	http://dx.doi.org/10.1371/journal.pone.0145232			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735128	Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100021
J	Staats, H; Jahncke, H; Herzog, TR; Hartig, T				Staats, Henk; Jahncke, Helena; Herzog, Thomas R.; Hartig, Terry			Urban Options for Psychological Restoration: Common Strategies in Everyday Situations	PLOS ONE			English	Article							ENVIRONMENTAL PREFERENCES; STRESS RECOVERY; SOCIAL-CONTEXT; EXPERIENCE; CITY; MOTIVATION; COMPONENTS; EXPOSURE; BENEFITS; FATIGUE	Objectives Given the need for knowledge on the restorative potential of urban settings, we sought to estimate the effects of personal and contextual factors on preferences and restoration likelihood assessments for different urban activities-in-environments. We also sought to study the generality of these effects across different countries. Methods We conducted a true experiment with convenience samples of university students in the Netherlands (n = 80), Sweden (n = 100), and the USA (n = 316). In each country, the experiment had a mixed design with activities-in-environments (sitting in a park, sitting in a cafe, walking in a shopping mall, walking along a busy street) manipulated within-subjects and the need for restoration (attentional fatigue, no attentional fatigue) and immediate social context (in company, alone) manipulated between-subjects. The manipulations relied on previously tested scenarios describing everyday situations that participants were instructed to remember and imagine themselves being in. For each imagined situation (activity-in-environment with antecedent fatigue condition and immediate social context), subjects provided two criterion measures: general preference and the likelihood of achieving psychological restoration. Results The settings received different preference and restoration likelihood ratings as expected, affirming that a busy street, often used in comparisons with natural settings, is not representative of the restorative potential of urban settings. Being with a close friend and attentional fatigue both moderated ratings for specific settings. Findings of additional moderation by country of residence caution against broad generalizations regarding preferences for and the expected restorative effects of different urban settings. Conclusions Preferences and restoration likelihood ratings for urban activity-environment combinations are subject to multiple personal and contextual determinants, including level of attentional fatigue, being alone versus in company, and broader aspects of the urban context that vary across cities and countries. Claims regarding a lack of restorative quality in urban environments are problematic.	[Staats, Henk] Leiden Univ, Dept Social & Org Psychol, Leiden, Netherlands; [Jahncke, Helena] Univ Gavle, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Herzog, Thomas R.] Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA; [Hartig, Terry] Uppsala Univ, Inst Housing & Urban Res, Uppsala, Sweden	Leiden University; Leiden University - Excl LUMC; University of Gavle; Grand Valley State University; Uppsala University	Staats, H (corresponding author), Leiden Univ, Dept Social & Org Psychol, Leiden, Netherlands.	Staats@fsw.leidenuniv.nl	Hartig, Terry/AAC-5676-2021; Jahncke, Helena/N-8583-2013	Jahncke, Helena/0000-0002-6668-5044				Ahrentzen S, 2003, J SOC ISSUES, V59, P547, DOI 10.1111/1540-4560.00077; [Anonymous], 2013, NO VACATION NATION R; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Coble TG, 2003, J LEISURE RES, V35, P1; Cole DN, 2010, ENVIRON BEHAV, V42, P806, DOI 10.1177/0013916509347248; Driver B. I., 1976, NAT AREA J, V16, P94; Ellemers N, 2012, SCIENCE, V336, P848, DOI 10.1126/science.1220987; Evans GW, 2007, J ENVIRON PSYCHOL, V27, P90, DOI 10.1016/j.jenvp.2006.10.002; Evans GW, 2002, J ENVIRON PSYCHOL, V22, P221, DOI 10.1006/jevp.2002.0256; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Gatersleben B, 2013, HEALTH PLACE, V20, P91, DOI 10.1016/j.healthplace.2013.01.001; Guite HF, 2006, PUBLIC HEALTH, V120, P1117, DOI 10.1016/j.puhe.2006.10.005; Hartig T, 1997, SCAND HOUS PLAN RES, V14, P175, DOI 10.1080/02815739708730435; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Hartig T, 2011, PSICOLOGIA AMBIENTAL; Hartig T., 2007, OPEN SPACE PEOPLE SP, P163; Hartig T., 2012, IN, P144, DOI [DOI 10.1016/B978-0-08-047163-1.00499-9, 10.1016/B978-0-08-047163-1.00499-9]; Hartig T, 2006, J ENVIRON PSYCHOL, V26, P215, DOI 10.1016/j.jenvp.2006.07.007; Herzog TR, 2013, ENVIRON BEHAV, V45, P504, DOI 10.1177/0013916511410422; Herzog TR, 2010, ENVIRON BEHAV, V42, P395, DOI 10.1177/0013916508328610; Herzog TR, 2009, ENVIRON BEHAV, V41, P387, DOI 10.1177/0013916508315351; Herzog TR, 2000, ENVIRON BEHAV, V32, P323, DOI 10.1177/0013916500323002; Irvine KN, 2013, INT J ENV RES PUB HE, V10, P417, DOI 10.3390/ijerph10010417; Jim CY, 2010, LAND USE POLICY, V27, P662, DOI 10.1016/j.landusepol.2009.08.027; Johansson M, 2011, APPL PSYCHOL-HLTH WE, V3, P261, DOI 10.1111/j.1758-0854.2011.01051.x; Kaplan R, 1989, EXPERIENCE NATURE PS; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; KAPLAN S, 1993, ENVIRON BEHAV, V25, P725, DOI 10.1177/0013916593256004; Karmanov D, 2008, LANDSCAPE URBAN PLAN, V86, P115, DOI 10.1016/j.landurbplan.2008.01.004; Knopf R. C., 1987, HDB ENV PSYCHOL, V1, P783; Korpela K., 2014, HDB SOLITUDE PSYCHOL, P351, DOI DOI 10.1002/9781118427378; Krenichyn K, 2004, J ENVIRON PSYCHOL, V24, P117, DOI 10.1016/S0272-4944(03)00053-7; Kuo FE, 2001, ENVIRON BEHAV, V33, P543, DOI 10.1177/00139160121973124; Laumann K, 2001, J ENVIRON PSYCHOL, V21, P31, DOI 10.1006/jevp.2000.0179; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lindal PJ, 2015, URBAN FOR URBAN GREE, V14, P200, DOI 10.1016/j.ufug.2015.02.001; Martens D, 2011, J ENVIRON PSYCHOL, V31, P36, DOI 10.1016/j.jenvp.2010.11.001; MILGRAM S, 1970, SCIENCE, V167, P1461, DOI 10.1126/science.167.3924.1461; Moser G, 2001, ENVIRON BEHAV, V33, P611, DOI 10.1177/00139160121973151; Nordh H, 2009, URBAN FOR URBAN GREE, V8, P225, DOI 10.1016/j.ufug.2009.06.003; Nordh H, 2011, URBAN FOR URBAN GREE, V10, P95, DOI 10.1016/j.ufug.2010.12.003; OECD, 2009, SOC GLANCE 2009 OECD, P19; Ouellette P, 2005, J ENVIRON PSYCHOL, V25, P175, DOI 10.1016/j.jenvp.2005.06.001; Parsons R, 1998, J ENVIRON PSYCHOL, V18, P113, DOI 10.1006/jevp.1998.0086; Peron E, 1998, ENVIRON BEHAV, V30, P282, DOI 10.1177/001391659803000302; Purcell T, 2001, ENVIRON BEHAV, V33, P93, DOI 10.1177/00139160121972882; Scopelliti M, 2004, J ENVIRON PSYCHOL, V24, P423, DOI 10.1016/j.jenvp.2004.11.002; Staats H, 2004, J ENVIRON PSYCHOL, V24, P199, DOI 10.1016/j.jenvp.2003.12.005; Staats H, 2003, J ENVIRON PSYCHOL, V23, P147, DOI 10.1016/S0272-4944(02)00112-3; Staats H, 2010, LEISURE SCI, V32, P401, DOI 10.1080/01490400.2010.510990; Stamps A. E, 2013, PSYCHOL AESTHETICS B; STAMPS AE, 1990, PERCEPT MOTOR SKILL, V71, P907, DOI 10.2466/pms.1990.71.3.907; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; Ulrich R. S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9_4, DOI 10.1007/978-1-4613-3539-9_4]; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; UN-Habitat, 2010, STAT WORLDS CIT 2010; van den Berg AE, 2003, J ENVIRON PSYCHOL, V23, P135, DOI 10.1016/S0272-4944(02)00111-1; White MP, 2013, J ENVIRON PSYCHOL, V35, P40, DOI 10.1016/j.jenvp.2013.04.002	60	69	69	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146213	10.1371/journal.pone.0146213	http://dx.doi.org/10.1371/journal.pone.0146213			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731272	gold, Green Published			2022-12-27	WOS:000367801400117
J	Tang, YF; Lv, PF; Sun, ZY; Han, L; Zhou, WP				Tang, Yufu; Lv, Pengfei; Sun, Zhongyi; Han, Lei; Zhou, Wenping			14-3-3 beta Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-kappa B Pathway	PLOS ONE			English	Article							ISOFORM-SPECIFIC EXPRESSION; VEIN TUMOR THROMBUS; CANCER CELLS; IN-VITRO; PROTEINS; 14-3-3-PROTEINS; 14-3-3-ZETA; METASTASIS; TISSUES; GROWTH	14-3-3 beta has been demonstrated to possess the oncogenic potential, and its increased expression has been detected in multiple types of carcinomas. However, majority of previous studies focused on the role of 14-3-3 beta in tumor cell proliferation and apoptosis, leaving much to be elucidated about its function in tumor cell invasion and metastasis. Hence, the present study aimed to investigate the role of 14-3-3 beta in the invasion of hepatocellular carcinoma (HCC) cells and the implications in the prognosis of HCC patients. We first examined the expression of 14-3-3 beta in the primary tumors of HCC patients with or without portal vein tumor thrombus (PVTT), and found that 14-3-3 beta expression was higher in the primary tumors with PVTT, and the level was even higher in the PVTTs. Kaplan-Meier curves and multivariate analysis revealed that high expression of 14-3-3 beta was associated with overall survival (OS) and time to recurrence (TTR) of HCC patients. In addition, ectopic expression of 14-3-3 beta in HCC cell lines led to enhanced migration ability and invasiveness, as well as up-regulation of matrix metalloproteinase 2 and 9, which could be suppressed by inhibiting the activation of Akt and nuclear factor-kappa B (NF-kappa B) signaling. Furthermore, we identified a correlated elevation of 14-3-3 beta and p-Akt in the primary tumors of HCC patients, and showed that a combinatory detection of 14-3-3 beta and p-Akt could better predict post-surgical outcome of HCC patients.	[Tang, Yufu; Lv, Pengfei; Sun, Zhongyi; Han, Lei; Zhou, Wenping] Shenyang Mil Area Command, Gen Hosp, Dept Hepatobiliary Surg, Shenyang, Peoples R China; [Tang, Yufu] Shenyang Mil Area Command, Postdoctoral Stn, Gen Hosp, Shenyang, Peoples R China		Han, L (corresponding author), Shenyang Mil Area Command, Gen Hosp, Dept Hepatobiliary Surg, Shenyang, Peoples R China.	hanlei1974@sina.com; zwp0132@163.com			Science and Technology Program of Liaoning Province [2013225220]; Postdoctoral Science Foundation of China [2015M572798]	Science and Technology Program of Liaoning Province; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was supported by grants from the Science and Technology Program of Liaoning Province (http://kjjh.lninfo.gov.cn/; No.: 2013225220; received by WZ) and the Postdoctoral Science Foundation of China (http://res.chinapostdoctor.org.cn/; No: 2015M572798; received by YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Kambach DM, 2014, ONCOGENE, V33, P589, DOI 10.1038/onc.2012.629; Katagiri S, 2014, SURG TODAY, V44, P219, DOI 10.1007/s00595-013-0585-6; Komiya Y, 2008, J BIOL CHEM, V283, P18753, DOI 10.1074/jbc.M802530200; Li ZM, 2009, AM J TRANSL RES, V1, P326; Liang SF, 2009, PROTEOM CLIN APPL, V3, P743, DOI 10.1002/prca.200800198; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Liu TA, 2011, AM J PATHOL, V179, P2698, DOI 10.1016/j.ajpath.2011.08.010; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006; Sugiyama A, 2003, CARCINOGENESIS, V24, P1549, DOI 10.1093/carcin/bgg113; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Torre LA, 2012, CA CANC J CLIN; Tseng CW, 2011, PROTEOMICS, V11, P2423, DOI 10.1002/pmic.201000449; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; WANG AZ, 1994, CLIN EXP RHEUMATOL, V12, P293; Wang RY, 2013, GASTROENTEROLOGY, V145, P1436, DOI 10.1053/j.gastro.2013.08.009; Wang T, 2010, BRIT J CANCER, V102, P1618, DOI 10.1038/sj.bjc.6605689; Wang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024843; Wen W, 2012, HEPATOLOGY, V55, P1787, DOI 10.1002/hep.25596; Yang XL, 2009, J NEUROL SCI, V276, P54, DOI 10.1016/j.jns.2008.08.040; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151	29	42	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146070	10.1371/journal.pone.0146070	http://dx.doi.org/10.1371/journal.pone.0146070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730736	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400087
J	Zhao, LM; Yang, YF				Zhao, Li-Ming; Yang, Yu-Fang			Lexical Planning in Sentence Production Is Highly Incremental: Evidence from ERPs	PLOS ONE			English	Article							CATEGORY INTERFERENCE; SEMANTIC INTERFERENCE; INFORMATION-FLOW; PICTURE; WORD; ACCESS; SCOPE; FACILITATION; SELECTION; CONTEXT	The scope of lexical planning, which means how far ahead speakers plan lexically before they start producing an utterance, is an important issue for research into speech production, but remains highly controversial. The present research investigated this issue using the semantic blocking effect, which refers to the widely observed effects that participants take longer to say aloud the names of items in pictures when the pictures in a block of trials in an experiment depict items that belong to the same semantic category than different categories. As this effect is often interpreted as a reflection of difficulty in lexical selection, the current study took the semantic blocking effect and its associated pattern of event-related brain potentials (ERPs) as a proxy to test whether lexical planning during sentence production extends beyond the first noun when a subject noun-phrase includes two nouns, such as "The chair and the boat are both red" and "The chair above the boat is red". The results showed a semantic blocking effect both in onset latencies and in ERPs during the utterance of the first noun of these complex noun-phrases but not for the second noun. The indication, therefore, is that the lexical planning scope does not encompass this second noun-phrase. Indeed, the present findings are in line with accounts that propose radically incremental lexical planning, in which speakers plan ahead only one word at a time. This study also provides a highly novel example of using ERPs to examine the production of long utterances, and it is hoped the present demonstration of the effectiveness of this approach inspires further application of ERP techniques in this area of research.	[Zhao, Li-Ming; Yang, Yu-Fang] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Zhao, Li-Ming] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Tianjin Normal University	Yang, YF (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	yangyf@psych.ac.cn			National Natural Science Foundation of China [61433018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). Grant number is 61433018. YY received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum PH, 2007, J EXP PSYCHOL LEARN, V33, P791, DOI 10.1037/0278-7393.33.4.791; Allum PH, 2009, J EXP PSYCHOL LEARN, V35, P1240, DOI 10.1037/a0016367; Aristei S, 2011, J COGNITIVE NEUROSCI, V23, P1567, DOI 10.1162/jocn.2010.21474; Belke E, 2005, Q J EXP PSYCHOL-A, V58, P667, DOI 10.1080/02724980443000142; Bock J.K., 1994, HDB PSYCHOLINGUISTIC, P945; Damian MF, 2001, COGNITION, V81, pB77, DOI 10.1016/S0010-0277(01)00135-4; Ferreira F, 2002, J MEM LANG, V46, P57, DOI 10.1006/jmla.2001.2797; Ferreira F, 2005, PSYCHOL REV, V98, P105; Garrett MF., 1975, PSYCHOL LEARN MOTIV, P133, DOI DOI 10.1016/S0079-7421(08)60270-4; Griffin ZM, 2001, COGNITION, V82, pB1, DOI 10.1016/S0010-0277(01)00138-X; Howard D, 2006, COGNITION, V100, P464, DOI 10.1016/j.cognition.2005.02.006; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Janssen N, 2011, NEUROIMAGE, V57, P1243, DOI 10.1016/j.neuroimage.2011.05.015; Jescheniak JD, 2003, COGNITIVE BRAIN RES, V15, P261, DOI 10.1016/S0926-6410(02)00198-2; Jescheniak JRD, 2002, J COGNITIVE NEUROSCI, V14, P951, DOI 10.1162/089892902760191162; KEMPEN G, 1987, COGNITIVE SCI, V11, P201, DOI 10.1207/s15516709cog1102_5; Konopka AE, 2012, J MEM LANG, V66, P143, DOI 10.1016/j.jml.2011.08.003; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Levelt W., 1981, CROSSING BOUNDARIES, P221, DOI [DOI 10.1007/978-94-009-8453-0_12, https://doi.org/10.1007/978-94-009-8453-0_12]; Levelt W., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 2000, EUR J COGN PSYCHOL, V12, P433, DOI 10.1080/095414400750050178; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; Mahon BZ, 2007, J EXP PSYCHOL LEARN, V33, P503, DOI 10.1037/0278-7393.33.3.503; Meyer AS, 2000, PSYCHON B REV, V7, P314, DOI 10.3758/BF03212987; Meyer AS, 1998, COGNITION, V66, pB25, DOI 10.1016/S0010-0277(98)00009-2; Meyer AS, 1996, J MEM LANG, V35, P477, DOI 10.1006/jmla.1996.0026; Navarrete E, 2010, ACTA PSYCHOL, V134, P279, DOI 10.1016/j.actpsy.2010.02.009; Proverbio Alice M, 2007, BMC Neurosci, V8, P24, DOI 10.1186/1471-2202-8-24; Roelofs A, 2007, J MEM LANG, V57, P232, DOI 10.1016/j.jml.2006.10.001; Schnur T. T., 2002, J COGNITIVE SCI, V3, P1; Schnur T. T., 2011, FRONT PSYCHOL, V2, P1; Schnur TT, 2006, J MEM LANG, V54, P199, DOI 10.1016/j.jml.2005.10.002; Schnur TT, 2006, J PSYCHOLINGUIST RES, V35, P189, DOI 10.1007/s10936-005-9011-6; Schriefers H, 1998, J MEM LANG, V39, P609, DOI 10.1006/jmla.1998.2578; Schriefers H, 1999, EUR J COGN PSYCHOL, V11, P17, DOI 10.1080/713752301; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Smith M, 2004, J EXP PSYCHOL LEARN, V30, P675, DOI 10.1037/0278-7393.30.3.675; Smith M, 1999, COGNITION, V73, P205, DOI 10.1016/S0010-0277(99)00053-0; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Wagner V, 2010, J EXP PSYCHOL LEARN, V36, P423, DOI 10.1037/a0018619; Wheeldon L. R., 2013, Q J EXPT PSYCHOL, V36, P423; Yang JC, 2008, LANG SPEECH, V51, P267, DOI 10.1177/0023830908098543; Zhao LM, 2015, APPL PSYCHOLINGUIST, V36, P1059, DOI 10.1017/S0142716414000046; [赵黎明 Zhao Liming], 2013, [心理学报, Acta Psychologica Sinica], V45, P599	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146359	10.1371/journal.pone.0146359	http://dx.doi.org/10.1371/journal.pone.0146359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26730731	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400159
J	Dorfman, A; Nielbo, KL; Eilam, D				Dorfman, Alex; Nielbo, Kristoffer Laigaard; Eilam, David			Traveling Companions Add Complexity and Hinder Performance in the Spatial Behavior of Rats	PLOS ONE			English	Article							MIXED-SPECIES FLOCKS; NORWAY RATS; PUBLIC INFORMATION; RATTUS-NORVEGICUS; SOCIAL INFLUENCES; MEMORY; SIZE; FOOD; CONSTRAINTS; MARKING	We sought to uncover the impact of the social environment on the spatial behavior of rats. Food-deprived rats were trained in a spatial task of collecting food items from 16 equispaced objects. Following training, they were tested, first alone and then with a similarly-trained cage-mate. It was found that the presence of another rat substantially altered the rats' spatial behavior. Lone rats collected the food items faster while traveling a shorter distance, reflecting a higher efficiency of task completion. When accompanied by a partner, however, the rats traveled together, visiting the same set of objects in each trip with one of them leading. Whether alone or with a partner, rats continued to revisit the same objects; however, more such revisits occurred with a partner. We argue that revisiting objects is not necessarily an error, since returning to past places is an important aspect of rats' natural behavior. Revisiting an object following food depletion implies that searching for food was not the main driving force in the rats' spatial behavior. Specifically, despite food deprivation, rats were more attentive to one another than to the food. This could be adaptive, since foraging and feeding in groups is a way of poison avoidance in wild rats. Finally, the addition of a social component added complexity to the environment since the rats organized their spatial behavior in reference to one another in addition to their organization in the physical surrounding. Consequently, when tested with a partner, spatial behavior was less structured, less predictable and more chaotic.	[Dorfman, Alex; Eilam, David] Tel Aviv Univ, Dept Zool, IL-69978 Ramat Aviv, Israel; [Nielbo, Kristoffer Laigaard; Eilam, David] Aarhus Univ, Interacting Minds Ctr, DK-8000 Aarhus C, Denmark	Tel Aviv University; Aarhus University	Eilam, D (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Ramat Aviv, Israel.	Eilam@post.tau.ac.il	Eilam, David/GOV-6655-2022	Eilam, David/0000-0002-4494-6928; Nielbo, Kristoffer/0000-0002-5116-5070	Israel Science Foundation (ISF) [230/13]	Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by Israel Science Foundation (ISF) 230/13 to DE: http://isf.org.il/english/default.asp. ISF had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY ML, 1994, ANIM BEHAV, V48, P1371, DOI 10.1006/anbe.1994.1373; Avery ML, 1996, ANIM BEHAV, V51, P1279, DOI 10.1006/anbe.1996.0132; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; BECK CHM, 1984, PHYSIOL BEHAV, V32, P941, DOI 10.1016/0031-9384(84)90282-8; Berdoy M, 2002, LAB RAT NATURAL HIST; BROWN CR, 1986, SCIENCE, V234, P83, DOI 10.1126/science.234.4772.83; Brown MF, 2007, J EXP PSYCHOL-ANIM B, V33, P213, DOI 10.1037/0097-7403.33.3.213; Brown MF, 2011, COMP COGN BEHAV REV, V6, P5, DOI 10.3819/ccbr.2011.60003; Capretta PJ, 1977, LEARNING MECH FOOD S, P99; Cheney DL., 1992, MONKEYS SEE WORLD IN; CLARK CW, 1984, AM NAT, V123, P626, DOI 10.1086/284228; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Dally JM, 2008, BEHAVIOUR, V145, P1101, DOI 10.1163/156853908784474470; DEGROOT P, 1980, ANIM BEHAV, V28, P1249, DOI 10.1016/S0003-3472(80)80113-8; Eilam D, 2003, BEHAV BRAIN RES, V141, P73, DOI 10.1016/S0166-4328(02)00322-4; EILAM D, 1989, BEHAV BRAIN RES, V34, P199, DOI 10.1016/S0166-4328(89)80102-0; Eilam D, 2015, SPRINGER P COMPLEXIT; Eilam D, 2014, NEUROSCI BIOBEHAV R, V47, P393, DOI 10.1016/j.neubiorev.2014.09.010; ELGAR MA, 1981, ANIM BEHAV, V29, P868, DOI 10.1016/S0003-3472(81)80022-X; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Etienne AS, 1999, WAYFINDING BEHAVIOR, P197; Ewer RF, 1971, ANIM BEHAV MONOGR, V4, P125, DOI DOI 10.1016/S0066-1856(71)80002-X; GALEF BG, 1995, J COMP PSYCHOL, V109, P99, DOI 10.1037/0735-7036.109.1.99; Galef BG, 1997, ANIM BEHAV, V54, P705; GALEF BG, 1985, BEHAV NEURAL BIOL, V43, P298, DOI 10.1016/S0163-1047(85)91645-0; GALEF BG, 1982, DEV PSYCHOBIOL, V15, P279, DOI 10.1002/dev.420150402; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Galef BG, 1996, ANIM BEHAV, V51, P765, DOI 10.1006/anbe.1996.0081; GALEF BG, 1977, LEARNING MECHANISMS, P123; GALLISTEL CR, 1989, ANNU REV PSYCHOL, V40, P155, DOI 10.1146/annurev.ps.40.020189.001103; Galton F., 1871, MACMILLANS MAGAZINE, V23, P353; GERRISH CJ, 1995, J COMP PSYCHOL, V109, P61, DOI 10.1037/0735-7036.109.1.61; GOLANI I, 1993, BEHAV BRAIN RES, V53, P21, DOI 10.1016/S0166-4328(05)80263-3; GOTMARK F, 1990, ANIM BEHAV, V39, P487, DOI 10.1016/S0003-3472(05)80413-0; Griffiths RA, 1998, J ZOOL, V245, P431, DOI 10.1017/S0952836998008061; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HUGHES RN, 1969, BRIT J PSYCHOL, V60, P385, DOI 10.1111/j.2044-8295.1969.tb01211.x; KRAUSE J, 1994, BIOL REV, V69, P187, DOI 10.1111/j.1469-185X.1994.tb01505.x; Krause J, 2002, LIVING GROUPS; KREBS JR, 1973, CAN J ZOOL, V51, P1275, DOI 10.1139/z73-181; KREBS JR, 1972, IBIS, V114, P507, DOI 10.1111/j.1474-919X.1972.tb00852.x; LALAND KN, 1993, ANIM LEARN BEHAV, V21, P35, DOI 10.3758/BF03197974; Li P, 2015, PHYSICA A, V419, P14, DOI 10.1016/j.physa.2014.09.062; MAGURRAN AE, 1983, BEHAV ECOL SOCIOBIOL, V12, P147, DOI 10.1007/BF00343206; Marwan N, 2005, P INT S NONL THEOR I, P630; Mason J.R., 1988, P99; MEANEY MJ, 1979, ANIM LEARN BEHAV, V7, P397, DOI 10.3758/BF03209692; MENZEL EW, 1973, SCIENCE, V182, P943, DOI 10.1126/science.182.4115.943; MENZEL EW, 1971, FOLIA PRIMATOL, V15, P220; Miller M, 2011, ANIM COGN, V14, P11, DOI 10.1007/s10071-010-0338-5; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OATEN A, 1977, THEOR POPUL BIOL, V12, P263, DOI 10.1016/0040-5809(77)90046-6; Olton D., 1978, COGNITIVE PROCESS, P341; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Tchernichovski O, 1996, BEHAVIOUR, V133, P519, DOI 10.1163/156853996X00198; Templeton JJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P105, DOI 10.1007/s002650050223; Thiel M, 2006, NONLINEAR DYNAM, V44, P299, DOI 10.1007/s11071-006-2010-9; Thorpe, 1963, LEARNING INSTINCT AN; Tolman E.C., 1932, PURPOSIVE BEHAV ANIM; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; WAITE TA, 1988, CONDOR, V90, P132, DOI 10.2307/1368442; Ward AJW, 2012, BEHAV ECOL SOCIOBIOL, V66, P223, DOI 10.1007/s00265-011-1270-7; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Webber CL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00382; Weber ET, 2005, PHYSL BEHAV IN PRESS; Weiss O, 2015, ANIMAL COGNITION; Weiss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040760; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; [No title captured]	75	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146137	10.1371/journal.pone.0146137	http://dx.doi.org/10.1371/journal.pone.0146137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727216	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500056
J	Gimenez, F; Mulik, S; Veiga-Parga, T; Bhela, S; Rouse, BT				Gimenez, Fernanda; Mulik, Sachin; Veiga-Parga, Tamara; Bhela, Siddheshvar; Rouse, Barry T.			Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CORNEAL NEOVASCULARIZATION; SIMPLEX-VIRUS; PATHOLOGICAL ANGIOGENESIS; IMMUNE PRIVILEGE; RECEPTOR; PATHOGENESIS; ROUNDABOUT	The cornea is a complex tissue that must preserve its transparency to maintain optimal vision. However, in some circumstances, damage to the eye can result in neovascularization that impairs vision. This outcome can occur when herpes simplex virus type 1 (HSV-1) causes the immunoinflammatory lesion stromal keratitis (SK). Potentially useful measures to control the severity of SK are to target angiogenesis which with herpetic SK invariably involves VEGF. One such way to control angiogenesis involves the endothelial receptor Robo4 (R4), which upon interaction with another protein activates an antiangiogenic pathway that counteracts VEGF downstream signaling. In this study we show that mice unable to produce R4 because of gene knockout developed significantly higher angiogenesis after HSV-1 ocular infection than did infected wild type (WT) controls. Moreover, providing additional soluble R4 (sR4) protein by subconjunctival administration to R4 KO HSV-1 infected mice substantially rescued theWT phenotype. Finally, administration of sR4 to WT HSV-1 infected mice diminished the extent of corneal angiogenesis compared to WT control animals. Our results indicate that sR4 could represent a useful therapeutic tool to counteract corneal angiogenesis and help control the severity of SK.	[Gimenez, Fernanda; Mulik, Sachin; Veiga-Parga, Tamara; Bhela, Siddheshvar; Rouse, Barry T.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Mulik, Sachin] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst, Boston, MA USA; [Mulik, Sachin] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Rouse, BT (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, 1414 Cumberland Ave, Knoxville, TN 37996 USA.	btr@utk.edu		Veiga-Parga, Tamara/0000-0002-5441-0959; MULIK, SACHIN/0000-0003-2568-3402	National Institute of Allergy and Infectious Diseases [AI 06335]; National Institutes of Health [EY 005093]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institute of Allergy and Infectious Diseases GrantAI 06335 and National Institutes of Health GrantEY 005093.	Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Biswas PS, 2005, MICROBES INFECT, V7, P799, DOI 10.1016/j.micinf.2005.03.003; Biswas PS, 2004, J LEUKOCYTE BIOL, V76, P868, DOI 10.1189/jlb.0504280; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Dana MR, 1998, CORNEA, V17, P403, DOI 10.1097/00003226-199807000-00011; Gimenez F, 2013, PROG RETIN EYE RES, V33, P1, DOI 10.1016/j.preteyeres.2012.07.002; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kim B, 2004, AM J PATHOL, V165, P2177, DOI 10.1016/S0002-9440(10)63267-1; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Marlow R, 2010, P NATL ACAD SCI USA, V107, P10520, DOI 10.1073/pnas.1001896107; Mulik S, 2012, AM J PATHOL, V181, P525, DOI 10.1016/j.ajpath.2012.04.014; Mulik S, 2011, J IMMUNOL, V186, P7195, DOI 10.4049/jimmunol.1100014; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Rajasagi NK, 2011, J IMMUNOL, V186, P1735, DOI 10.4049/jimmunol.1003456; Sharma S, 2011, J VIROL, V85, P5995, DOI 10.1128/JVI.00034-11; Streilein JW, 2003, J LEUKOCYTE BIOL, V74, P179, DOI 10.1189/jlb.1102574; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Suryawanshi A, 2011, J IMMUNOL, V186, P3653, DOI 10.4049/jimmunol.1003239; Zheng M, 2001, J VIROL, V75, P9828, DOI 10.1128/JVI.75.20.9828-9835.2001	27	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0141925	10.1371/journal.pone.0141925	http://dx.doi.org/10.1371/journal.pone.0141925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720197	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900003
J	Eckstrand, CD; Hillman, C; Smith, AL; Sparger, EE; Murphy, BG				Eckstrand, C. D.; Hillman, C.; Smith, A. L.; Sparger, E. E.; Murphy, B. G.			Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; BLOOD MONONUCLEAR-CELLS; T FOLLICULAR HELPER; RNA LOAD; REPLICATION; DISEASE; PLASMA; STAGE; LOCALIZATION; EXPRESSION	Background Examination of a cohort of cats experimentally infected with feline immunodeficiency virus (FIV) for 5.75 years revealed detectable proviral DNA in peripheral blood mononuclear cells (PBMCs) harvested during the asymptomatic phase, undetectable plasma viral RNA (FIV gag), and rarely detectable cell-associated viral RNA. Despite apparent viral latency in peripheral CD4+ T cells, circulating CD4+ T cell numbers progressively declined in progressor animals. The aim of this study was to explore this dichotomy of peripheral blood viral latency in the face of progressive immunopathology. The viral replication status, cellular immunophenotypes, and histopathologic features were compared between popliteal lymph nodes (PLNs) and peripheral blood. Also, we identified and further characterized one of the FIV-infected cats identified as a long-term non-progressor (LTNP). Results PLN-derived leukocytes from FIV-infected cats during the chronic asymptomatic phase demonstrated active viral gag transcription and FIV protein translation as determined by real-time RT-PCR, Western blot and in situ immunohistochemistry, whereas viral RNA in blood leukocytes was either undetectable or intermittently detectable and viral protein was not detected. Active transcription of viral RNA was detectable in PLN-derived CD4+ and CD21+ leukocytes. Replication competent provirus was reactivated ex vivo from PLN-derived leukocytes from three of four FIV-infected cats. Progressor cats showed a persistent and dramatically decreased proportion and absolute count of CD4+ T cells in blood, and a decreased proportion of CD4+ T cells in PLNs. A single long-term non-progressor (LTNP) cat persistently demonstrated an absolute peripheral blood CD4+ T cell count indistinguishable from uninfected animals, a lower proviral load in unfractionated blood and PLN leukocytes, and very low amounts of viral RNA in the PLN. Conclusion Collectively our data indicates that PLNs harbor important reservoirs of ongoing viral replication during the asymptomatic phase of infection, in spite of undetectable viral activity in peripheral blood. A thorough understanding of tissue-based lentiviral reservoirs is fundamental to medical interventions to eliminate virus or prolong the asymptomatic phase of FIV infection.	[Eckstrand, C. D.; Hillman, C.; Murphy, B. G.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Smith, A. L.] Univ Calif Davis, Sch Vet Med, Vet Med Teaching Hosp, Davis, CA 95616 USA; [Sparger, E. E.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Eckstrand, CD (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	cdeckstrand@ucdavis.edu	Eckstrand, Chrissy/C-8743-2018	Eckstrand, Chrissy/0000-0002-6844-0251	Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis [2013-11-F]; Bernice Barbour Foundation	Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); Bernice Barbour Foundation	This work was funded by the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis (Grant number 2013-11-F, http://www.vetmed.ucdavis.edu/ccah/index.cfm) and the Bernice Barbour Foundation (http://bernicebarbour.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLEY CD, 1990, J VIROL, V64, P5652, DOI 10.1128/JVI.64.11.5652-5655.1990; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; BARLOUGH JE, 1991, J ACQ IMMUN DEF SYND, V4, P219; Beczkowski PM, 2015, VET MICROBIOL, V176, P50, DOI 10.1016/j.vetmic.2014.12.023; BEEBE AM, 1994, J VIROL, V68, P3080, DOI 10.1128/JVI.68.5.3080-3091.1994; BROWN PJ, 1991, J COMP PATHOL, V104, P345, DOI 10.1016/S0021-9975(08)80145-4; BROWN WC, 1991, J VIROL, V65, P3359, DOI 10.1128/JVI.65.6.3359-3364.1991; CALLANAN JJ, 1992, VET IMMUNOL IMMUNOP, V35, P3, DOI 10.1016/0165-2427(92)90116-8; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; Connick E, 2014, J IMMUNOL, V193, P5613, DOI 10.4049/jimmunol.1401161; Dean GA, 1996, J VIROL, V70, P5165, DOI 10.1128/JVI.70.8.5165-5169.1996; Diehl LJ, 1996, J VIROL, V70, P2503, DOI 10.1128/JVI.70.4.2503-2507.1996; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; DIEHL LJ, 1995, J VIROL, V69, P2328, DOI 10.1128/JVI.69.4.2328-2332.1995; ENGLISH RV, 1993, J VIROL, V67, P5175, DOI 10.1128/JVI.67.9.5175-5186.1993; Hohdatsu T, 2002, ARCH VIROL, V147, P1517, DOI 10.1007/s00705-002-0827-1; Hong JJ, 2014, J IMMUNOL, V193, P797, DOI 10.4049/jimmunol.1400749; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; INOSHIMA Y, 1995, J VET MED SCI, V57, P487, DOI 10.1292/jvms.57.487; ISHIDA T, 1990, JPN J VET SCI, V52, P645; Kann RKC, 2014, VET J, V201, P181, DOI 10.1016/j.tvjl.2014.01.023; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Matrajt L, 2014, J VIROL, V88, P3202, DOI 10.1128/JVI.03428-13; McDonnel SJ, 2014, ANTIVIR RES, V108, P74, DOI 10.1016/j.antiviral.2014.05.014; McDonnel SJ, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-69; McDonnel SJ, 2012, VIRUSES-BASEL, V4, P878, DOI 10.3390/v4050878; Murphy B, 2014, VIRUS RES, V179, P34, DOI 10.1016/j.virusres.2013.11.017; Murphy B, 2012, VIRUS RES, V169, P117, DOI 10.1016/j.virusres.2012.07.017; Murphy B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-12; Obert LA, 2002, J VIROL, V76, P6311, DOI 10.1128/JVI.76.12.6311-6322.2002; Paiva DD, 1996, MEM I OSWALDO CRUZ, V91, P371, DOI 10.1590/S0074-02761996000300023; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Reggeti F, 2008, J GEN VIROL, V89, P277, DOI 10.1099/vir.0.83161-0; RIDEOUT BA, 1992, VET PATHOL, V29, P391, DOI 10.1177/030098589202900504; Rogers AB, 2002, AM J PATHOL, V161, P1143, DOI 10.1016/S0002-9440(10)64391-X; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sparger EE, 2005, ANIMAL MODELS HIV DI, P149; Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271; TOMONAGA K, 1995, J GEN VIROL, V76, P2193, DOI 10.1099/0022-1317-76-9-2193; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; WALKER C, 1994, VET IMMUNOL IMMUNOP, V44, P1, DOI 10.1016/0165-2427(94)90165-1; Willett BJ, 2003, J VIROL, V77, P709, DOI 10.1128/JVI.77.1.709-712.2003	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146285	10.1371/journal.pone.0146285	http://dx.doi.org/10.1371/journal.pone.0146285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741651	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600028
J	Picardo, R; Baron, AS; Anderson, AK; Todd, RM				Picardo, Rochelle; Baron, Andrew S.; Anderson, Adam K.; Todd, Rebecca M.			Tuning to the Positive: Age-Related Differences in Subjective Perception of Facial Emotion	PLOS ONE			English	Article							NEGATIVITY BIAS; EXPRESSIONS; AMYGDALA; ATTENTION; RESPONSES; FACES; PRESCHOOLERS; INFORMATION; CHILDREN; VALENCE	Facial expressions aid social transactions and serve as socialization tools, with smiles signaling approval and reward, and angry faces signaling disapproval and punishment. The present study examined whether the subjective experience of positive vs. negative facial expressions differs between children and adults. Specifically, we examined age-related differences in biases toward happy and angry facial expressions. Young children (5-7 years) and young adults (18-29 years) rated the intensity of happy and angry expressions as well as levels of experienced arousal. Results showed that young children-but not young adults-rated happy facial expressions as both more intense and arousing than angry faces. This finding, which we replicated in two independent samples, was not due to differences in the ability to identify facial expressions, and suggests that children are more tuned to information in positive expressions. Together these studies provide evidence that children see unambiguous adult emotional expressions through rose-colored glasses, and suggest that what is emotionally relevant can shift with development.	[Picardo, Rochelle; Baron, Andrew S.; Todd, Rebecca M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Anderson, Adam K.] Cornell Univ, Dept Human Dev, Ithaca, NY USA	University of British Columbia; Cornell University	Todd, RM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	becket.todd@psych.ubc.ca			National Science and Engineering Research Council (NSERC) [RGPIN-2014-04202]; Social Sciences and Humanities Research Council (SSHRC) [435-2013-0286]	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by a National Science and Engineering Research Council (NSERC) Discovery grant to RMT # RGPIN-2014-04202, http://www.nserc-crsng.gc.ca/index_eng.asp, and a Social Sciences and Humanities Research Council (SSHRC) grant to ASB, # 435-2013-0286, http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx.; We would like to thank Paniz Pasha and Joey Manaligod for their help with data collection. This research was supported by National Science and Engineering Research Council (NSERC) Discovery grant to R. M. Todd: # RGPIN-2014-04202 and by a Social Sciences and Humanities Research Council (SSHRC) grant to A.S. Baron: # 435-2013-0286.	Balconi M, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-32; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Cunningham WA, 2008, PSYCHOL SCI, V19, P152, DOI 10.1111/j.1467-9280.2008.02061.x; DENHAM SA, 1994, DEV PSYCHOL, V30, P928, DOI 10.1037/0012-1649.30.6.928; DERRYBERRY D, 1994, J PERS SOC PSYCHOL, V66, P1128, DOI 10.1037/0022-3514.66.6.1128; Durand K, 2007, J EXP CHILD PSYCHOL, V97, P14, DOI 10.1016/j.jecp.2006.12.001; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Gao XQ, 2010, J EXP CHILD PSYCHOL, V105, P98, DOI 10.1016/j.jecp.2009.09.001; Gao XQ, 2009, J EXP CHILD PSYCHOL, V102, P503, DOI 10.1016/j.jecp.2008.11.002; Hamlin JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096112; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kinzler KD, 2008, COGNITION, V107, P775, DOI 10.1016/j.cognition.2007.09.005; Kron A, 2013, PSYCHOL SCI, V24, P1503, DOI 10.1177/0956797613475456; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Mather M, 2004, PSYCHOL SCI, V15, P259, DOI 10.1111/j.0956-7976.2004.00662.x; Morales S, 2016, DEVELOPMENTAL SCI, V19, P853, DOI 10.1111/desc.12320; Moriceau S, 2004, J NEUROSCI, V24, P1182, DOI 10.1523/JNEUROSCI.4578-03.2004; Moutsiana C, 2013, P NATL ACAD SCI USA, V110, P16396, DOI 10.1073/pnas.1305631110; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Penton-Voak IS, 2013, PSYCHOL SCI, V24, P688, DOI 10.1177/0956797612459657; Pessoa L, 2010, NEUROPSYCHOLOGIA, V48, P3416, DOI 10.1016/j.neuropsychologia.2010.06.038; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pollak SD, 2003, J ABNORM PSYCHOL, V112, P323, DOI 10.1037/0021-843X.112.3.323; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Qu L, 2007, COGNITIVE DEV, V22, P456, DOI 10.1016/j.cogdev.2007.08.010; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Roelofs K, 2009, SOC COGN AFFECT NEUR, V4, P50, DOI 10.1093/scan/nsn036; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; SULLIVAN RM, 1991, PSYCHOBIOLOGY, V19, P308; Sullivan RM, 2000, NATURE, V407, P38, DOI 10.1038/35024156; Todd RM, 2012, TRENDS COGN SCI, V16, P365, DOI 10.1016/j.tics.2012.06.003; Todd RM, 2012, DEV COGN NEUROS-NETH, V2, P340, DOI 10.1016/j.dcn.2012.01.004; Todd RM, 2011, SOC COGN AFFECT NEUR, V6, P12, DOI 10.1093/scan/nsq007; Todd RM, 2009, NAT NEUROSCI, V12, P1217, DOI 10.1038/nn1009-1217; Tottenham N, 2013, EMOTION, V13, P92, DOI 10.1037/a0029431; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Volman I, 2011, CURR BIOL, V21, P1766, DOI 10.1016/j.cub.2011.08.050; Waters AM, 2008, BIOL PSYCHOL, V78, P10, DOI 10.1016/j.biopsycho.2007.12.005; Widen SC, 2004, COGNITIVE DEV, V19, P111, DOI 10.1016/j.cogdev.2003.11.004; Widen SC, 2013, EMOT REV, V5, P72, DOI 10.1177/1754073912451492	49	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145643	10.1371/journal.pone.0145643	http://dx.doi.org/10.1371/journal.pone.0145643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26734940	Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100029
J	Thompson, P; Batista-Navarro, RT; Kontonatsios, G; Carter, J; Toon, E; McNaught, J; Timmermann, C; Worboys, M; Ananiadou, S				Thompson, Paul; Batista-Navarro, Riza Theresa; Kontonatsios, Georgios; Carter, Jacob; Toon, Elizabeth; McNaught, John; Timmermann, Carsten; Worboys, Michael; Ananiadou, Sophia			Text Mining the History of Medicine	PLOS ONE			English	Article							QUERY EXPANSION; EVENT EXTRACTION; INFORMATION; RECOGNITION; CORPUS; RETRIEVAL; AGREEMENT; WORDNET; MODELS	Historical text archives constitute a rich and diverse source of information, which is becoming increasingly readily accessible, due to large-scale digitisation efforts. However, it can be difficult for researchers to explore and search such large volumes of data in an efficient manner. Text mining (TM) methods can help, through their ability to recognise various types of semantic information automatically, e.g., instances of concepts (places, medical conditions, drugs, etc.), synonyms/variant forms of concepts, and relationships holding between concepts (which drugs are used to treat which medical conditions, etc.). TM analysis allows search systems to incorporate functionality such as automatic suggestions of synonyms of user-entered query terms, exploration of different concepts mentioned within search results or isolation of documents in which concepts are related in specific ways. However, applying TM methods to historical text can be challenging, according to differences and evolutions in vocabulary, terminology, language structure and style, compared to more modern text. In this article, we present our efforts to overcome the various challenges faced in the semantic analysis of published historical medical text dating back to the mid 19th century. Firstly, we used evidence from diverse historical medical documents from different periods to develop new resources that provide accounts of the multiple, evolving ways in which concepts, their variants and relationships amongst them may be expressed. These resources were employed to support the development of a modular processing pipeline of TM tools for the robust detection of semantic information in historical medical documents with varying characteristics. We applied the pipeline to two large-scale medical document archives covering wide temporal ranges as the basis for the development of a publicly accessible semantically-oriented search system. The novel resources are available for research purposes, while the processing pipeline and its modules may be used and configured within the Argo TM platform.	[Thompson, Paul; Batista-Navarro, Riza Theresa; Kontonatsios, Georgios; Carter, Jacob; McNaught, John; Ananiadou, Sophia] Univ Manchester, Sch Comp Sci, Natl Ctr Text Min, Manchester, Lancs, England; [Toon, Elizabeth; Timmermann, Carsten; Worboys, Michael] Univ Manchester, Ctr Hist Sci Technol & Med, Manchester, Lancs, England	University of Manchester; University of Manchester	Thompson, P (corresponding author), Univ Manchester, Sch Comp Sci, Natl Ctr Text Min, Manchester, Lancs, England.	paul.thompson@manchester.ac.uk	Batista-Navarro, Riza/ABD-6210-2021; Timmermann, Carsten/AAV-3589-2021	Timmermann, Carsten/0000-0003-1381-9579; Batista-Navarro, Riza/0000-0001-6693-7531; Kontonatsios, Georgios/0000-0001-5935-4709	Arts and Humanities Research Council [AH/L00982X/1]; AHRC [AH/L00982X/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	SA received funding support from the Arts and Humanities Research Council (http://www.ahrc.ac.uk) Grant AH/L00982X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex B, 2012, P KONVENS 2012 LTHIS, P401; Alnazzawi N, 2014, P 5 INT WORKSH HLTH, P69; Alnazzawi N, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/1472-6947-15-S2-S3; American Medical Association Committee on Nomenclature, 1872, AM MED ASS M HELD PH; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Aronson AR, 1997, J AM MED INFORM ASSN, P485; Baron Alistair., 2008, P POSTGRADUATE C COR; Berberich K., 2009, 12 INT WORKSHOP WEB; Bjorne J, 2009, P 17 NORDIC C COMP L, P18; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Bollmann Marcel, 2013, P 7 LING ANN WORKSH, P11; Bontcheva K., 2002, Research and Advanced Technology for Digital Libraries. 6th European Conference, ECDL 2002. Proceedings (Lecture Notes in Computer Science Vol.2458), P613; Borin L., 2007, P WORKSHOP LANGUAGE, P1; Broda B, 2008, SIXTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, LREC 2008, P1800; Burns PR, MORPHADORNER V2 JAVA; Clifford J., 2014, P 8 WORKSH LANG TECH, P13; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Crane G, 2006, OPENING INFORMATION HORIZONS, P31; Dipper Stefanie, 2010, P 10 C NAT LANG PROC, P117; Dogan RI, 2014, J BIOMED INFORM, V47, P1, DOI 10.1016/j.jbi.2013.12.006; Furrer Lenz, 2011, P WORKSH LANG TECHN, P97; Grover C., 2014, P EACL LATECH WORKSH, P119; Grover C, 2008, SIXTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, LREC 2008, P1343; Hara T, 2005, LECT NOTES ARTIF INT, V3651, P199, DOI 10.1007/11562214_18; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hearst MA, 1998, LANG SPEECH & COMMUN, P131; Henriksson A, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-6; Hersh W, 2000, J AM MED INFORM ASSN, P344; Hinrichs U., 2014, P DH2014; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Jonnalagadda S, 2013, BIOMED INFORM INSIGH, V6, P17, DOI 10.4137/BII.S11664; Kaewphan S, 2014, P 8 INT WORKSH SEM E, P807; Karan M, 2012, P 8 LANG TECHN C, P111; Kelly L., 2014, P INT C CROSS LANGUA, P172, DOI DOI 10.1007/978-3-319-11382-1_17; Kim JD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-10; Klein Ewan, 2014, DIGGING DATA WHITE P; Kumar A, 2009, P JCDL 2009 WORKSH I; Lin D, 1998, P 36 ANN M ASS COMP, P768, DOI DOI 10.3115/980432.980696; Liu ZY, 2007, INFORM RETRIEVAL, V10, P173, DOI 10.1007/s10791-006-9020-6; Lopresti D, 2009, INT J DOC ANAL RECOG, V12, P141, DOI 10.1007/s10032-009-0094-8; Man, 2014, P 8 INT WORKSH SEM E, P54, DOI DOI 10.3115/V1/S14-2007; McCarthy D, 2004, P 42 ANN M ASS COMP, P280; McClosky D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S9; Mihaila C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-2; Miller D, 2000, 6TH APPLIED NATURAL LANGUAGE PROCESSING CONFERENCE/1ST MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE AND PROCEEDINGS OF THE ANLP-NAACL 2000 STUDENT RESEARCH WORKSHOP, P316; Mitchell J., 2008, P ASS COMP LING HUM, P236, DOI DOI 10.1039/9781847558633-00236; Miwa M, 2013, P BIONLP SHAR TASK 2, P94; Miwa M, 2012, BIOINFORMATICS, V28, P1759, DOI 10.1093/bioinformatics/bts237; Miwa Makoto, 2010, Journal of Bioinformatics and Computational Biology, V8, P131, DOI 10.1142/S0219720010004586; Miwa Makoto, 2014, P COLING, P2270; Moen H, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/1472-6947-15-S2-S2; Murrieta-Flores P, 2015, T GIS, V19, P296, DOI 10.1111/tgis.12106; Ohta Tomoko, 2012, P WORKSH DET STRUCT, P27; Packer T.L., 2010, P 4 WORKSH AN NOIS U, P19; Prasad R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-188; Pyysalo S, 2014, BIOINFORMATICS, V30, P868, DOI 10.1093/bioinformatics/btt580; Roberts A., 2008, P LREC 2008 WORKSHOP, P19; Rodriquez K.J., 2012, KONVENS, P410; Ruiz-Casado M, 2005, LECT NOTES COMPUT SC, V3513, P67; Rupp C. J., 2014, 2014 IEEE International Conference on Big Data (Big Data), P80, DOI 10.1109/BigData.2014.7004457; Rupp C. J., 2013, 2013 IEEE International Conference on Big Data, P59, DOI 10.1109/BigData.2013.6691671; Sanchez-Marco C., 2011, 2011 IEEE 73 VEHICUL, P1; SCHMID LA, 1994, INT CONF ACOUST SPEE, P41; Schneider G., 2012, STUDIES VARIATION CO, V10; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Stenetorp Pontus, 2012, P DEM 13 C EUR CHAPT, P102; Suominen H, 2013, LECT NOTES COMPUT SC, V8138, P212, DOI 10.1007/978-3-642-40802-1_24; Tahmasebi N., 2012, P 24 INT C COMPUTATI, P2553; Tanner TH, 1882, INDEX DIS THEIR TREA; Thompson P, 2015, P DIGITALHERITAGE; Thompson P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-349; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Tsuruoka Y, 2007, BIOINFORMATICS, V23, P2768, DOI 10.1093/bioinformatics/btm393; Tsuruoka Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S2; Turkel, 2014, J OFART HISTORIOGRAP, P1; Uzuner O, 2008, J AM MED INFORM ASSN, V15, P14, DOI 10.1197/jamia.M2408; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Wagholikar KB, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-3; Wang Y, 2015, J BIOMED INFORM, V54, P1, DOI 10.1016/j.jbi.2015.01.016; Worboys Michael, 2000, SPREADING GERMS DIS; Zhang SD, 2013, J BIOMED INFORM, V46, P1088, DOI 10.1016/j.jbi.2013.08.004	83	23	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144717	10.1371/journal.pone.0144717	http://dx.doi.org/10.1371/journal.pone.0144717			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734936	Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100011
J	Bairwa, SC; Rajapurohitam, V; Gan, XT; Mangat, R; Proctor, SD; Karmazyn, M				Bairwa, Suresh C.; Rajapurohitam, Venkatesh; Gan, Xiaohong Tracey; Mangat, Rabban; Proctor, Spencer D.; Karmazyn, Morris			Cardiomyocyte Antihypertrophic Effect of Adipose Tissue Conditioned Medium from Rats and Its Abrogation by Obesity is Mediated by the Leptin to Adiponectin Ratio	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIOVASCULAR-DISEASE; CARDIAC MYOCYTES; HEART-FAILURE; ADIPOKINES; HYPERTROPHY; MECHANISMS; ENDOCRINE; AMPK; CONTRACTION	White adipocytes are known to function as endocrine organs by secreting a plethora of bioactive adipokines which can regulate cardiac function including the development of hypertrophy. We determined whether adipose tissue conditioned medium (ATCM) generated from the epididymal regions of normal rats can affect the hypertrophic response of cultured rat ventricular myocytes to endothelin-1 (ET-1) administration. Myocytes were treated with ET-1 (10 nM) for 24 hours in the absence or presence of increasing ATCM concentrations. ATCM supressed the hypertrophic response to ET-1 in a concentration-dependent manner, an effect enhanced by the leptin receptor antagonist and attenuated by an antibody against the adiponectin AdipoR1 receptor. Antihypertrophic effects were also observed with ATCM generated from perirenal-derived adipose tissue. However, this effect was absent in ATCM from adipose tissue harvested from corpulent JCR:LA-cp rats. Detailed analyses of adipokine content in ATCM from normal and corpulent rats revealed no differences in the majority of products assayed, although a significant increase in leptin concentrations concomitant with decreased adiponectin levels was observed, resulting in a 11 fold increase in the leptin to adiponectin ratio in ATCM from JCR:LA-cp. The antihypertrophic effect of ATCM was associated with increased phosphorylation of AMP-activated protein kinase (AMPK), an effect abrogated by the AdipoR1 antibody. Moreover, the antihypertrophic effect of ATCM was mimicked by an AMPK activator. There was no effect of ET-1 on mitogen-activated protein kinase (MAPK) activities 24 hour after its addition either in the presence or absence of ATCM. Our study suggests that adipose tissue from healthy subjects exerts antihypertrophic effects via an adiponectin-dependent pathway which is impaired in obesity, most likely due to adipocyte remodelling resulting in enhanced leptin and reduced adiponectin levels.	[Bairwa, Suresh C.; Rajapurohitam, Venkatesh; Gan, Xiaohong Tracey; Karmazyn, Morris] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Mangat, Rabban; Proctor, Spencer D.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada; [Mangat, Rabban; Proctor, Spencer D.] Univ Alberta, Mazankowski Heart Inst, Edmonton, AB T6G 2E1, Canada	Western University (University of Western Ontario); University of Alberta; University of Alberta	Karmazyn, M (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.	morris.karmazyn@schulich.uwo.ca	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Proctor, Spencer/0000-0002-7597-5262	Canadian Institutes of Health Research [MOP 62764]; Natural Sciences and Engineering Research Council of Canada Discovery Grant Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research #MOP 62764 (http://www.cihr-irsc.gc.ca/e/193.html) (MK), and Natural Sciences and Engineering Research Council of Canada Discovery Grant Program (http://www.nserccrsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) (SDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan M, 2011, ENDOCRINOLOGY, V152, P1599, DOI 10.1210/en.2010-1106; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bluher M, 2015, METABOLISM, V64, P131, DOI 10.1016/j.metabol.2014.10.016; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Bupha-Intr T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043179; Cao T, ADIPOR1 APPL1 POTENT; Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013; Diez JJ, 2010, MINI-REV MED CHEM, V10, P856; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; Fujioka D, 2006, AM J PHYSIOL-HEART C, V290, pH2409, DOI 10.1152/ajpheart.00987.2005; Funahashi T, 2014, BEST PRACT RES CL EN, V28, P93, DOI 10.1016/j.beem.2013.09.002; Greulich S, 2012, CIRCULATION, V126, P2324, DOI 10.1161/CIRCULATIONAHA.111.039586; Guerre-Millo M, 2002, J ENDOCRINOL INVEST, V25, P855, DOI 10.1007/BF03344048; Hara Taketaka, 2003, J Atheroscler Thromb, V10, P234; Hatem SN, 2014, CARDIOVASC RES, V102, P205, DOI 10.1093/cvr/cvu045; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Iacobellis G, 2014, ENDOCRINE, V46, P8, DOI 10.1007/s12020-013-0099-4; Kappelle PJWH, 2012, EUR J INTERN MED, V23, P755, DOI 10.1016/j.ejim.2012.06.013; Karmazyn M, 2008, CARDIOVASC RES, V79, P279, DOI 10.1093/cvr/cvn115; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Krug AW, 2005, CELL MOL LIFE SCI, V62, P1359, DOI 10.1007/s00018-005-4555-z; Kuwahara K, 1999, FEBS LETT, V452, P314, DOI 10.1016/S0014-5793(99)00680-8; Lamounier-Zepter V, 2006, FASEB J, V20, P1653, DOI 10.1096/fj.05-5436com; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Leifheit-Nestler M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-170; Li H, 2014, MOL CELL ENDOCRINOL, V382, P998, DOI 10.1016/j.mce.2013.11.012; Liao YC, 2013, BIOMARKERS, V18, P44, DOI 10.3109/1354750X.2012.730550; Liao YL, 2005, CARDIOVASC RES, V67, P705, DOI 10.1016/j.cardiores.2005.04.018; Lindberg S, 2014, EUR J HEART FAIL, V16, P633, DOI 10.1002/ejhf.82; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Nakamura K, 2014, J CARDIOL, V63, P250, DOI 10.1016/j.jjcc.2013.11.006; Norata GD, 2007, STROKE, V38, P2844, DOI 10.1161/STROKEAHA.107.485540; Northcott JM, 2012, CAN J PHYSIOL PHARM, V90, P1029, DOI [10.1139/Y2012-053, 10.1139/y2012-053]; Park M, 2013, HEART FAIL REV, V18, P631, DOI 10.1007/s10741-012-9337-8; Purdham DM, 2004, AM J PHYSIOL-HEART C, V287, pH2877, DOI 10.1152/ajpheart.00499.2004; RUSSELL JC, 1986, ATHEROSCLEROSIS, V60, P119, DOI 10.1016/0021-9150(86)90004-3; Shi D, 2009, ENDOCRINOLOGY, V150, P4425, DOI 10.1210/en.2008-1612; Shimano M, 2010, J MOL CELL CARDIOL, V49, P210, DOI 10.1016/j.yjmcc.2010.02.021; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Siasos G, 2012, CURR MED CHEM, V19, P1193, DOI 10.2174/092986712799320583; Silha JV, 2003, EUR J ENDOCRINOL, V149, P331, DOI 10.1530/eje.0.1490331; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang C, 2010, J CELL PHYSIOL, V222, P149, DOI 10.1002/jcp.21931; Zhang L, 2006, AM J PHYSIOL-HEART C, V290, pH1235, DOI 10.1152/ajpheart.00906.2005; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	48	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145992	10.1371/journal.pone.0145992	http://dx.doi.org/10.1371/journal.pone.0145992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731409	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400073
J	Canney, M; O'Connell, MDL; Murphy, CM; O'Leary, N; Little, MA; O'Seaghdha, CM; Kenny, RA				Canney, Mark; O'Connell, Matthew D. L.; Murphy, Catriona M.; O'Leary, Neil; Little, Mark A.; O'Seaghdha, Conall M.; Kenny, Rose Anne			Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing	PLOS ONE			English	Article							MEDICATION USE; BETA-BLOCKERS; HYPOTENSION; MORTALITY; HYPERTENSION; PREVALENCE; HEART; FALLS	Background Impaired blood pressure (BP) stabilisation after standing, defined using beat-to-beat measurements, has been shown to predict important health outcomes. We aimed to define the relationship between individual classes of antihypertensive agent and BP stabilisation among hypertensive older adults. Methods Cross-sectional analysis from The Irish Longitudinal Study on Ageing, a cohort study of Irish adults aged 50 years and over. Beat-to-beat BP was recorded in participants undergoing an active stand test. We defined grade 1 hypertension according to European Society of Cardiology criteria (systolic BP [SBP] 140-159mmHg +/- diastolic BP [DBP] 90-99mmHg). Outcomes were: (i) initial orthostatic hypotension (IOH) (SBP drop >= 40mmHg +/- DBP drop >= 20mmHg within 15 seconds [s] of standing accompanied by symptoms); (ii) sustained OH (SBP drop >= 20mmHg +/- DBP drop >= 10mmHg from 60 to 110s inclusive); (iii) impaired BP stabilisation (SBP drop >= 20mmHg +/- DBP drop >= 10mmHg at any 10s interval during the test). Outcomes were assessed using multivariable-adjusted logistic regression. Results A total of 536 hypertensive participants were receiving monotherapy with a renin-angiotensin-aldosterone-system inhibitor (n = 317, 59.1%), beta-blocker (n = 89, 16.6%), calcium channel blocker (n = 89, 16.6%) or diuretic (n = 41, 7.6%). A further 783 untreated participants met criteria for grade 1 hypertension. Beta-blockers were associated with increased odds of initial OH (OR 2.05, 95% CI 1.31-3.21) and sustained OH (OR 3.36, 95% CI 1.87-6.03) versus untreated grade 1 hypertension. Multivariable adjustment did not attenuate the results. Impaired BP stabilisation was evident at 20s (OR 2.59, 95% CI 1.58-4.25) and persisted at 110s (OR 2.90, 95% CI 1.64-5.11). No association was found between the other agents and any study outcome. Conclusion Beta-blocker monotherapy was associated with a >2-fold increased odds of initial OH and a >3-fold increased odds of sustained OH and impaired BP stabilisation, compared to untreated grade 1 hypertension. These findings support existing literature questioning the role of beta-blockers as first line agents for essential hypertension.	[Canney, Mark; O'Connell, Matthew D. L.; Murphy, Catriona M.; O'Leary, Neil; Kenny, Rose Anne] Trinity Coll Dublin, Irish Longitudinal Study Ageing, Dublin, Ireland; [Canney, Mark; Little, Mark A.] Trinity Coll Dublin, Trinity Hlth Kidney Ctr, Dublin, Ireland; [O'Seaghdha, Conall M.] Beaumont Hosp, Dept Renal Med, Dublin 9, Ireland	Trinity College Dublin; Trinity College Dublin	Canney, M (corresponding author), Trinity Coll Dublin, Irish Longitudinal Study Ageing, Dublin, Ireland.	mcanney@tcd.ie	Little, Mark/O-2161-2019; Little, Mark/E-7072-2014	Little, Mark/0000-0001-6003-397X; Little, Mark/0000-0001-6003-397X; Murphy, Catriona/0000-0002-3262-1130; Kenny, Rose Anne/0000-0002-9336-8124; O'Leary, Neil/0000-0002-2765-7016; O'Connell, Matthew DL/0000-0002-9565-487X	Health Research Board [HPF-2014540]; Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health	Health Research Board; Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health	MC was supported by a Health Research Board research training fellowship grant (HPF-2014-540). Funding for TILDA was gratefully received from the Atlantic Philanthropies (www.atlanticphilanthropies.org), the Irish Government, and the Health Research Board (www.hrb.ie). TILDA was funded by the Department of Health and Atlantic Philanthropies, along with support from Irish Life in the form of a charitable gift. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benetos A, 2015, JAMA INTERN MED, V175, P989, DOI 10.1001/jamainternmed.2014.8012; Cleophas TJ, 2002, CIRCULATION, V105, P1669, DOI 10.1161/01.CIR.0000012745.50229.AC; De Caterina AR, 2010, AM J CARDIOL, V105, P1433, DOI 10.1016/j.amjcard.2009.12.068; Eigenbrodt ML, 2000, STROKE, V31, P2307, DOI 10.1161/01.STR.31.10.2307; Fedorowski A, 2010, AM J HYPERTENS, V23, P1209, DOI 10.1038/ajh.2010.150; Fedorowski A, 2010, EUR HEART J, V31, P85, DOI 10.1093/eurheartj/ehp329; Fedorowski A, 2009, J HYPERTENS, V27, P976, DOI 10.1097/HJH.0b013e3283279860; Finucane C, 2014, AGE AGEING, V43, pii17, DOI DOI 10.1093/AGEING/AFU130.3; Finucane C, 2014, CIRCULATION, V130, P1780, DOI 10.1161/CIRCULATIONAHA.114.009831; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Frewen J, 2014, J GERONTOL A-BIOL, V69, P878, DOI 10.1093/gerona/glt171; Heitterachi E, 2002, AGE AGEING, V31, P181, DOI 10.1093/ageing/31.3.181; Hiitola P, 2009, J HUM HYPERTENS, V23, P33, DOI 10.1038/jhh.2008.81; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kamaruzzaman S, 2010, AGE AGEING, V39, P51, DOI 10.1093/ageing/afp192; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; Lagro J, 2014, J GERONTOL A-BIOL, V69, P471, DOI 10.1093/gerona/glt111; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Monahan KD, 2007, AM J PHYSIOL-REG I, V293, pR3, DOI 10.1152/ajpregu.00031.2007; OConnell MD, 2014, J FRAILTY AGING S, V3; Poon IO, 2005, J CLIN PHARM THER, V30, P173, DOI 10.1111/j.1365-2710.2005.00629.x; Ricci F, 2015, EUR HEART J, V36, P1609, DOI 10.1093/eurheartj/ehv093; Richardson K, 2013, J CLIN EPIDEMIOL, V66, P1308, DOI 10.1016/j.jclinepi.2013.02.016; Romero-Ortuno R, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-73; Valbusa F, 2012, J HYPERTENS, V30, P53, DOI 10.1097/HJH.0b013e32834d3d73; van der Velde N, 2007, BLOOD PRESS MONIT, V12, P167, DOI 10.1097/MBP.0b013e3280b083bd; Whelan BJ, 2013, J AM GERIATR SOC, V61, pS265, DOI 10.1111/jgs.12199; WHO Collaborating Centre for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Wiysonge CS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002003.pub4; Xin W, 2014, HEART, V100, P406, DOI 10.1136/heartjnl-2013-304121; Zia A, 2015, POSTGRAD MED, V127, P186, DOI 10.1080/00325481.2015.996505	32	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146156	10.1371/journal.pone.0146156	http://dx.doi.org/10.1371/journal.pone.0146156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730962	gold, Green Published			2022-12-27	WOS:000367801400106
J	Coelho, A; Rugman-Jones, PF; Reigada, C; Stouthamer, R; Parra, JRP				Coelho, Aloisio, Jr.; Rugman-Jones, Paul F.; Reigada, Carolina; Stouthamer, Richard; Parra, Jose R. P.			Laboratory Performance Predicts the Success of Field Releases in Inbred Lines of the Egg Parasitoid Trichogramma pretiosum (Hymenoptera: Trichogrammatidae)	PLOS ONE			English	Article							CARVERAE HYMENOPTERA; QUALITY; SIZE; POPULATIONS; DISPERSAL; BRASSICAE; MANAGEMENT; FECUNDITY; FITNESS	In this study we assessed the relationship between the laboratory and field performance of different isofemale lines of Trichogramma pretiosum Riley. In comparative assays, we used three rare mitochondrial haplotypes as genetic markers of the isofemale lines, and by introgressing these mitochondrial haplotypes into each of 15 genetically different nuclear lines, also tested the assumption that mitochondria are neutral markers. In a laboratory trial, 45 isofemale lines (15 nuclear genotypes x three mitochondrial haplotypes) were ranked in three categories (best, intermediate and worst) according to the mean offspring production and the proportion of female offspring. Subsequently, lines from each of the three categories were selected for field releases to quantify field parasitism on Ephestia kuehniella. Temporally separate releases were done in a transgenic Bt cornfield, with four plots, each with 50 points of recapture. The points of recapture consisted of trap cards with eggs of E. kuehniella collected daily. The trap cards were maintained in the laboratory at 25 degrees C until the adult wasps emerged, and the maternal identity of the wasps was determined using qPCR and high-resolution melt curve analysis to determine the mitochondrial haplotype. The results showed that these measures of laboratory performance (fecundity and offspring sex ratio) were good predictors of field success in T. pretiosum. We also report strong evidence discrediting the assumption that mitochondria are neutral, in view of the correlation between performance and mitochondrial haplotype.	[Coelho, Aloisio, Jr.; Reigada, Carolina; Parra, Jose R. P.] Univ Sao Paulo, ESALQ, Piracicaba, SP, Brazil; [Rugman-Jones, Paul F.; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Universidade de Sao Paulo; University of California System; University of California Riverside	Coelho, A (corresponding author), Univ Sao Paulo, ESALQ, Piracicaba, SP, Brazil.	aloisiocoelho@usp.br	Reigada, Carolina/A-2297-2013; Parra, José Roberto Postali/AAW-6487-2020; Parra, José Roberto Postali/D-9282-2012; Coelho, Aloisio/A-3082-2014	Reigada, Carolina/0000-0002-0680-219X; Parra, José Roberto Postali/0000-0002-2393-8267; Coelho, Aloisio/0000-0001-6324-6671	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/17397-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was financed by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (http://www.fapesp.br/en/) awarded by the process 2011/17397-5.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Antolin MF, 1999, RES POPUL ECOL, V41, P29, DOI 10.1007/PL00011979; BAI BR, 1992, ENTOMOL EXP APPL, V64, P37, DOI 10.1007/BF00688992; Bartlett A.C., 1984, ADV CHALLENGES INSEC, P2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bennett DM, 1998, J ANIM ECOL, V67, P580, DOI 10.1046/j.1365-2656.1998.00218.x; BIGLER F, 1986, J APPL ENTOMOL, V101, P23, DOI 10.1111/j.1439-0418.1986.tb00829.x; Bigler F, 1994, BIOL CONTROL EGG PAR, P91; Bourchier RS, 1996, ENTOMOL EXP APPL, V80, P461, DOI 10.1007/BF00343469; BOUSH RT, 1995, ANN ENTOMOL SOC AM, V88, P713, DOI 10.1093/aesa/88.6.713; CERUTTI F, 1995, ENTOMOL EXP APPL, V75, P19, DOI 10.1007/BF02382775; Chailleux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048068; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; Bueno RCOD, 2012, B ENTOMOL RES, V102, P1, DOI 10.1017/S0007485311000289; Demetrio CGB., 1997, GLIM NEWS, V27, P19; Dutton A, 1996, ENTOMOL EXP APPL, V81, P71, DOI 10.1007/BF00187840; FABRITIUS K, 1984, ENTOMOL GEN, V9, P237; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fernandez OA, 2002, CONTROLE BIOL BRASIL, P115; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORSSE E, 1992, ENTOMOL EXP APPL, V62, P147, DOI 10.1007/BF00345486; Fournier F, 2000, ENVIRON ENTOMOL, V29, P55, DOI 10.1603/0046-225X-29.1.55; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Guzman-Larralde A, 2014, J APPL ENTOMOL, V138, P346, DOI 10.1111/jen.12073; Guzmán-Larralde Adriana, 2014, Acta Zool. Mex, V30, P378; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; HARTLEY JL, 1993, PCR METH APPL, V3, pS10; Hassan S.A., 1994, BIOL CONTROL EGG PAR; Hassan SA, 1997, TRICHOGRAMMA CONTROL, P173, DOI DOI 10.1007/S10526-011-9420-4; Hinde J, 1998, COMPUT STAT DATA AN, V27, P151, DOI 10.1016/S0167-9473(98)00007-3; HOPPER KR, 1993, ANNU REV ENTOMOL, V38, P27, DOI 10.1146/annurev.en.38.010193.000331; HOPPER KR, 1993, ECOL ENTOMOL, V18, P321, DOI 10.1111/j.1365-2311.1993.tb01108.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hufbauer RA, 2001, ECOLOGY, V82, P717, DOI 10.1890/0012-9658(2001)082[0717:PAPIHP]2.0.CO;2; KAZMER DJ, 1995, ECOLOGY, V76, P412, DOI 10.2307/1941200; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; LEGNER EF, 1979, ANN ENTOMOL SOC AM, V72, P114, DOI 10.1093/aesa/72.1.114; Li CC., 1955, POPULATION GENETICS; Luna MG, 2004, ENVIRON ENTOMOL, V33, P765, DOI 10.1603/0046-225X-33.3.765; Margan SH, 1998, ZOO BIOL, V17, P467; MORRISON R K, 1978, Southwestern Entomologist, V3, P62; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nunney L, 2002, P 8 9 WORKSH IOBC WO, P43; Omwega CO, 1996, AFR ENTOMOL, V4, P231; Parra JRP, 2015, AUGMENTATIV IN PRESS; PARRA JRP, 2010, SUGARCANE BIOETHANOL, P441, DOI DOI 10.5151/BLUCHEROA-SUGARCANESUGARCANEBIOETHANOL_41; Pimentel D, 2006, ENCY PEST MANAGEMENT, P1; PINTO JD, 1986, ANN ENTOMOL SOC AM, V79, P1019, DOI 10.1093/aesa/79.6.1019; Parra JRP, 2010, PROG BIOL CONTROL, V9, P267, DOI 10.1007/978-1-4020-9110-0_10; Prezotti L, 2004, BIOL CONTROL, V30, P174, DOI 10.1016/j.biocontrol.2004.01.011; Ritchie S W, 1986, CORN PLANT DEV; ROITBERG BD, 1988, EVOL ECOL, V2, P289, DOI 10.1007/BF02207562; Smith SM, 1996, ANNU REV ENTOMOL, V41, P375, DOI 10.1146/annurev.en.41.010196.002111; Sorati M, 1996, ENTOMOL EXP APPL, V78, P283, DOI 10.1111/j.1570-7458.1996.tb00792.x; STINNER RE, 1977, ANNU REV ENTOMOL, V22, P515, DOI 10.1146/annurev.en.22.010177.002503; Thomson LJ, 2002, J ECON ENTOMOL, V95, P912, DOI 10.1603/0022-0493-95.5.912; UNRUH TR, 1983, ENTOMOPHAGA, V28, P245, DOI 10.1007/BF02372175; van Lenteren JC, 1997, J APPL ENTOMOL, V121, P473, DOI 10.1111/j.1439-0418.1997.tb01437.x; van Lenteren JC, 2008, IOBC INTERNET BOOK B, P41; van Lenteren JC, 2010, PROG BIOL CONTROL, V9, P315, DOI 10.1007/978-1-4020-9110-0_12; Wajnberg E, 1998, J INSECT PHYSIOL, V44, P437, DOI 10.1016/S0022-1910(98)00032-8; Wajnberg Eric, 1994, P245; Wajnberg E, 2010, PROG BIOL CONTROL, V9, P149, DOI 10.1007/978-1-4020-9110-0_5; Woodworth LM, 2002, CONSERV GENET, V3, P277, DOI 10.1023/A:1019954801089	64	28	30	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146153	10.1371/journal.pone.0146153	http://dx.doi.org/10.1371/journal.pone.0146153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730735	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400105
J	Ferrere, G; Leroux, A; Wrzosek, L; Puchois, V; Gaudin, F; Ciocan, D; Renoud, ML; Naveau, S; Perlemuter, G; Cassard, AM				Ferrere, Gladys; Leroux, Anne; Wrzosek, Laura; Puchois, Virginie; Gaudin, Francoise; Ciocan, Dragos; Renoud, Marie-Laure; Naveau, Sylvie; Perlemuter, Gabriel; Cassard, Anne-Marie			Activation of Kupffer Cells Is Associated with a Specific Dysbiosis Induced by Fructose or High Fat Diet in Mice	PLOS ONE			English	Article							LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; MICROBIAL ECOLOGY; OBESITY; FIBROSIS; CONSUMPTION; INJURY; SUBPOPULATIONS; INFLAMMATION; MECHANISM	The increase consumption of fructose in diet is associated with liver inflammation. As a specific fructan substrate, fructose may modify the gut microbiota which is involved in obesityinduced liver disease. Here, we aimed to assess whether fructose-induced liver damage was associated with a specific dysbiosis, especially in mice fed a high fat diet (HFD). To this end, four groups of mice were fed with normal and HFD added or not with fructose. Body weight and glucose sensitivity, liver inflammation, dysbiosis and the phenotype of Kupffer cells were determined after 16 weeks of diet. Food intake was increased in the two groups of mice fed with the HFD. Mice fed with HFD and fructose showed a higher infiltration of lymphocytes into the liver and a lower inflammatory profile of Kupffer cells than mice fed with the HFD without fructose. The dysbiosis associated with diets showed that fructose specifically prevented the decrease of Mouse intestinal bacteria in HFD fed mice and increased Erysipelotrichi in mice fed with fructose, independently of the amount of fat. In conclusion, fructose, used as a sweetener, induced a dysbiosis which is different in presence of fat in the diet. Consequently, the activation of Kupffer cells involved in mice model of HFD-induced liver inflammation was not observed in an HFD/fructose combined diet. These data highlight that the complexity of diet composition could highly impact the development of liver lesions during obesity. Specific dysbiosis associated with the diet could explain that the progressions of liver damage are different.	[Ferrere, Gladys; Leroux, Anne; Wrzosek, Laura; Puchois, Virginie; Gaudin, Francoise; Ciocan, Dragos; Renoud, Marie-Laure; Naveau, Sylvie; Perlemuter, Gabriel; Cassard, Anne-Marie] Univ Paris Saclay, Univ Paris 11, INSERM, Inflammat Chemokines & Immunopathol UMR996, F-92140 Clamart, France; [Ferrere, Gladys; Leroux, Anne; Wrzosek, Laura; Puchois, Virginie; Ciocan, Dragos; Renoud, Marie-Laure; Naveau, Sylvie; Perlemuter, Gabriel; Cassard, Anne-Marie] Univ Paris 11, DHU Hepatinov, Labex LERMIT, F-92140 Clamart, France; [Gaudin, Francoise] IFR141, IPSIT, F-92140 Clamart, France; [Ciocan, Dragos; Naveau, Sylvie; Perlemuter, Gabriel] Hop Antoine Beclere, AP HP, Serv Hepatogastroenterol, F-92140 Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Cassard, AM (corresponding author), Univ Paris Saclay, Univ Paris 11, INSERM, Inflammat Chemokines & Immunopathol UMR996, F-92140 Clamart, France.	cassard.doulcier@u-psud.fr	CASSARD, Anne-Marie/B-6095-2019; Ciocan, Dragos/AAI-1457-2020	CASSARD, Anne-Marie/0000-0002-1813-5128; Ciocan, Dragos/0000-0003-0416-1584	INSERM; Universite Paris-Sud; Groupe Lipide Nutrition (GLN); National French Society of Gastroenterology (SNFGE); IRIS (institut de recherches internationales Servier); Association Francaise pour l'Etude du Foie (AFEF); National Program on diabetes Research (PNR-diabete); conseil regional d'Ile-de-France; Ministere de la recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Sud; Groupe Lipide Nutrition (GLN); National French Society of Gastroenterology (SNFGE); IRIS (institut de recherches internationales Servier)(Servier); Association Francaise pour l'Etude du Foie (AFEF); National Program on diabetes Research (PNR-diabete); conseil regional d'Ile-de-France(Region Ile-de-France); Ministere de la recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by INSERM, Universite Paris-Sud, Groupe Lipide Nutrition (GLN), the National French Society of Gastroenterology (SNFGE), IRIS (institut de recherches internationales Servier), Association Francaise pour l'Etude du Foie (AFEF) and National Program on diabetes Research (PNR-diabete). AL holds fellowships from conseil regional d'Ile-de-France and GF holds fellowships from the Ministere de la recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Bigorgne AE, 2008, GASTROENTEROLOGY, V134, P1459, DOI 10.1053/j.gastro.2008.02.055; Chung M, 2014, AM J CLIN NUTR, V100, P833, DOI 10.3945/ajcn.114.086314; Denou E, 2015, EMBO MOL MED, V7, P259, DOI 10.15252/emmm.201404169; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Minagawa M, 2004, GASTROENTEROLOGY, V126, P1387, DOI 10.1053/j.gastro.2004.01.022; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Rigottier-Gois L, 2003, FEMS MICROBIOL ECOL, V43, P237, DOI 10.1111/j.1574-6941.2003.tb01063.x; Schultz A, 2013, INT J MOL SCI, V14, P21873, DOI 10.3390/ijms141121873; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wada T, 2013, AM J PHYSIOL-ENDOC M, V305, pE1415, DOI 10.1152/ajpendo.00419.2013; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	32	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146177	10.1371/journal.pone.0146177	http://dx.doi.org/10.1371/journal.pone.0146177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731543	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400110
J	Gimnig, JE; Otieno, P; Were, V; Marwanga, D; Abong'o, D; Wiegand, R; Williamson, J; Wolkon, A; Zhou, Y; Bayoh, MN; Lobo, NF; Laserson, K; Kariuki, S; Hamel, MJ				Gimnig, John E.; Otieno, Peter; Were, Vincent; Marwanga, Doris; Abong'o, Daisy; Wiegand, Ryan; Williamson, John; Wolkon, Adam; Zhou, Ying; Bayoh, M. Nabie; Lobo, Neil F.; Laserson, Kayla; Kariuki, Simon; Hamel, Mary J.			The Effect of Indoor Residual Spraying on the Prevalence of Malaria Parasite Infection, Clinical Malaria and Anemia in an Area of Perennial Transmission and Moderate Coverage of Insecticide Treated Nets in Western Kenya	PLOS ONE			English	Article							VECTOR-CONTROL INTERVENTIONS; BED NETS; ANOPHELES-ARABIENSIS; LAMBDA-CYHALOTHRIN; CHILD-MORTALITY; IMPACT; TRIAL; AFRICA; HOUSE; SUSCEPTIBILITY	Background Insecticide treated nets (ITNs) and indoor residual spraying (IRS) have been scaled up for malaria prevention in sub-Saharan Africa. However, there are few studies on the benefit of implementing IRS in areas with moderate to high coverage of ITNs. We evaluated the impact of an IRS program on malaria related outcomes in western Kenya, an area of intense perennial malaria transmission and moderate ITN coverage (55-65% use of any net the previous night). Methods The Kenya Division of Malaria Control, with support from the US President's Malaria Initiative, conducted IRS in one lowland endemic district with moderate coverage of ITNs. Surveys were conducted in the IRS district and a neighboring district before IRS, after one round of IRS in July-Sept 2008 and after a second round of IRS in April-May 2009. IRS was conducted with pyrethroid insecticides. At each survey, 30 clusters were selected for sampling and within each cluster, 12 compounds were randomly selected. The primary outcomes measured in all residents of selected compounds included malaria parasitemia, clinical malaria (P. falciparum infection plus history of fever) and anemia (Hb<8) of all residents in randomly selected compounds. At each survey round, individuals from the IRS district were matched to those from the non-IRS district using propensity scores and multivariate logistic regression models were constructed based on the matched dataset. Results At baseline and after one round of IRS, there were no differences between the two districts in the prevalence of malaria parasitemia, clinical malaria or anemia. After two rounds of IRS, the prevalence of malaria parasitemia was 6.4% in the IRS district compared to 16.7% in the comparison district (OR = 0.36, 95% CI = 0.22-0.59, p<0.001). The prevalence of clinical malaria was also lower in the IRS district (1.8% vs. 4.9%, OR = 0.37, 95% CI = 0.20-0.68, p = 0.001). The prevalence of anemia was lower in the IRS district but only in children under 5 years of age (2.8% vs. 9.3%, OR = 0.30, 95% CI = 0.13-0.71, p = 0.006). Multivariate models incorporating both IRS and ITNs indicated that both had an impact on malaria parasitemia and clinical malaria but the independent effect of ITNs was reduced in the district that had received two rounds of IRS. There was no statistically significant independent effect of ITNs on the prevalence of anemia in any age group. Conclusions Both IRS and ITNs are effective tools for reducing malaria burden and when implemented in an area of moderate to high transmission with moderate ITN coverage, there may be an added benefit of IRS. The value of adding ITNs to IRS is less clear as their benefits may be masked by IRS. Additional monitoring of malaria control programs that implement ITNs and IRS concurrently is encouraged to better understand how to maximize the benefits of both interventions, particularly in the context of increasing pyrethroid resistance.	[Gimnig, John E.; Wiegand, Ryan; Williamson, John; Wolkon, Adam; Laserson, Kayla; Hamel, Mary J.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Otieno, Peter; Were, Vincent; Marwanga, Doris; Abong'o, Daisy; Bayoh, M. Nabie; Kariuki, Simon] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Zhou, Ying; Lobo, Neil F.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; University of Notre Dame	Gimnig, JE (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA.	jgimnig@cdc.gov	Kariuki, Simon/AFT-6596-2022	Were, Vincent/0000-0002-3554-795X; Wiegand, Ryan/0000-0002-9486-1850	Bill and Melinda Gates Foundation through the Malaria Transmission Consortium [45114]; United States President's Malaria Initiative	Bill and Melinda Gates Foundation through the Malaria Transmission Consortium; United States President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI))	This study was funded by the Bill and Melinda Gates Foundation (www.gatesfoundation.org), through the Malaria Transmission Consortium (Grant number 45114). The grant was to the University of Notre Dame with a sub-contract to the Kenya Medical Research Institute. This study was also funded by the United States President's Malaria Initiative (www.pmi.gov). The grant was to the Centers for Disease Control and Prevention with a cooperative agreement with the Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389; Curtis CF, 1999, T ROY SOC TROP MED H, V93, P453, DOI 10.1016/S0035-9203(99)90333-4; Eng JLV, 2007, AM J TROP MED HYG, V77, P393, DOI 10.4269/ajtmh.2007.77.393; Fritz ML, 2013, MED VET ENTOMOL, V27, P398, DOI 10.1111/j.1365-2915.2012.01063.x; Fullman N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-62; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hightower A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-183; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kim D, 2012, AM J TROP MED HYG, V87, P117, DOI 10.4269/ajtmh.2012.11-0620; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Kolaczinski K, 2007, T ROY SOC TROP MED H, V101, P852, DOI 10.1016/j.trstmh.2007.04.003; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Mashauri FM, 2013, AM J TROP MED HYG, V88, P841, DOI 10.4269/ajtmh.12-0412; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Misra SP, 1999, T ROY SOC TROP MED H, V93, P456, DOI 10.1016/S0035-9203(99)90335-8; Mnzava AEP, 1999, T ROY SOC TROP MED H, V93, P455, DOI 10.1016/S0035-9203(99)90334-6; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Ochomo E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-310; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Over M, 2004, AM J TROP MED HYG, V71, P214, DOI 10.4269/ajtmh.2004.71.214; Pinder M, 2015, LANCET, V385, P1436, DOI 10.1016/S0140-6736(14)61007-2; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Rehman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019205; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rowland M, 1999, T ROY SOC TROP MED H, V93, P458, DOI 10.1016/S0035-9203(99)90336-X; Skarbinski J, 2012, AM J TROP MED HYG, V86, P997, DOI 10.4269/ajtmh.2012.11-0621; Steinhardt LC, 2013, AM J TROP MED HYG, V88, P855, DOI 10.4269/ajtmh.12-0747; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; West PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115661; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHO, WORLD MAL REP 2013; World Health Organization, 2012, WORLD MAL REP 2012; Xu BZ, 1998, T ROY SOC TROP MED H, V92, P135, DOI 10.1016/S0035-9203(98)90719-2; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537	43	36	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145282	10.1371/journal.pone.0145282	http://dx.doi.org/10.1371/journal.pone.0145282			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731524	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400029
J	Jun, JC; Unnikrishnan, D; Schneider, H; Kirkness, J; Schwartz, AR; Smith, PL; Polotsky, VY				Jun, Jonathan C.; Unnikrishnan, Dileep; Schneider, Hartmut; Kirkness, Jason; Schwartz, Alan R.; Smith, Philip L.; Polotsky, Vsevolod Y.			Effect of Acute Intermittent CPAP Depressurization during Sleep in Obese Patients	PLOS ONE			English	Article							AIRWAY PRESSURE THERAPY; RESPIRATORY EVENTS; APNEA SYNDROME; NIGHT; VARIABILITY; WITHDRAWAL	Background Obstructive Sleep Apnea (OSA) describes intermittent collapse of the airway during sleep, for which continuous positive airway pressure (CPAP) is often prescribed for treatment. Prior studies suggest that discontinuation of CPAP leads to a gradual, rather than immediate return of baseline severity of OSA. The objective of this study was to determine the extent of OSA recurrence during short intervals of CPAP depressurization during sleep. Methods Nine obese (BMI = 40.4 +/- 3.5) subjects with severe OSA (AHI = 88.9 +/- 6.8) adherent to CPAP were studied during one night in the sleep laboratory. Nasal CPAP was delivered at therapeutic (11.1 +/- 0.6 cm H2O) or atmospheric pressure, in alternating fashion for 1-hour periods during the night. We compared sleep architecture and metrics of OSA during CPAP-on and CPAP-off periods. Results 8/9 subjects tolerated CPAP withdrawal. The average AHI during CPAP-on and CPAP-off periods was 3.6 +/- 0.6 and 15.8 +/- 3.6 respectively (p<0.05). The average 3% ODI during CPAP-on and CPAP-off was 4.7 +/- 2 and 20.4 +/- 4.7 respectively (p<0.05). CPAP depressurization also induced more awake (p<0.05) and stage N1 (p<0.01) sleep, and less stage REM (p<0.05) with a trend towards decreased stage N3 (p = 0.064). Conclusion Acute intermittent depressurization of CPAP during sleep led to deterioration of sleep architecture but only partial re-emergence of OSA. These observations suggest carryover effects of CPAP.	[Jun, Jonathan C.; Unnikrishnan, Dileep; Schneider, Hartmut; Kirkness, Jason; Schwartz, Alan R.; Smith, Philip L.; Polotsky, Vsevolod Y.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University	Jun, JC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	jjun2@jhmi.edu	C Unnikrishnan, Dileep/P-3048-2018	C Unnikrishnan, Dileep/0000-0001-6743-4792	National Institutes of Health [K08HL109475]; American Academy of Sleep Medicine Foundation [106-JF-14]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL109475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Sleep Medicine Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health K08HL109475 (JCJ), and American Academy of Sleep Medicine Foundation 106-JF-14 (JCJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2009, SLEEP BREATH, V13, P221, DOI 10.1007/s11325-008-0234-2; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Chediak AD, 1996, SLEEP, V19, P589, DOI 10.1093/sleep/19.7.589; Corda L, 2009, SLEEP BREATH, V13, P187, DOI 10.1007/s11325-008-0219-1; Daulatzai Mak Adam, 2011, Sleep Disord, V2011, P596879, DOI 10.1155/2011/596879; Eckert DJ, 2013, AM J RESP CRIT CARE, V188, P996, DOI 10.1164/rccm.201303-0448OC; Hon QYBMS, 2006, SLEEP, V29, P545, DOI 10.1093/sleep/29.4.545; Kohler M, 2011, AM J RESP CRIT CARE, V184, P1192, DOI 10.1164/rccm.201106-0964OC; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P1162, DOI 10.1164/ajrccm/147.5.1162; Le Bon O, 2000, CHEST, V118, P353, DOI 10.1378/chest.118.2.353; Loewen A, 2009, SLEEP, V32, P1355, DOI 10.1093/sleep/32.10.1355; McSharry D, 2012, RESP PHYSIOL NEUROBI, V183, P59, DOI 10.1016/j.resp.2012.05.024; Rossi VA, 2014, EUR RESPIR J, V43, P1387, DOI 10.1183/09031936.00180213; RYAN CF, 1991, AM REV RESPIR DIS, V144, P939, DOI 10.1164/ajrccm/144.4.939; SFORZA E, 1995, SLEEP, V18, P195; SMITH PL, 1988, J APPL PHYSIOL, V64, P789, DOI 10.1152/jappl.1988.64.2.789; Strohl KP, 2014, EUR RESPIR J, V43, P1227, DOI 10.1183/09031936.00003614; White LH, 2015, J CLIN SLEEP MED, V11, P149, DOI 10.5664/jcsm.4462; WOODSON BT, 1991, LARYNGOSCOPE, V101, P1318, DOI 10.1002/lary.5541011211	20	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146606	10.1371/journal.pone.0146606	http://dx.doi.org/10.1371/journal.pone.0146606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731735	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400192
J	Klose, J; Aistleitner, K; Horn, M; Krenn, L; Dirsch, V; Zehl, M; Bright, M				Klose, Julia; Aistleitner, Karin; Horn, Matthias; Krenn, Liselotte; Dirsch, Verena; Zehl, Martin; Bright, Monika			Trophosome of the Deep-Sea Tubeworm Riftia pachyptila Inhibits Bacterial Growth	PLOS ONE			English	Article							CHEMOAUTOTROPH SYMBIOTIC BACTERIA; FATTY-ACIDS; LIPID-COMPOSITION; VESTIMENTIFERAN TUBEWORMS; OLIGOBRACHIA-MASHIKOI; HYDROTHERMAL VENTS; JONES POGONOPHORA; GALAPAGOS RIFT; PARTIAL CYCLE; BEARD WORM	The giant tubeworm Riftia pachyptila lives in symbiosis with the chemoautotrophic gamma-proteobacterium Cand. Endoriftia persephone. Symbionts are released back into the environment upon host death in high-pressure experiments, while microbial fouling is not involved in trophosome degradation. Therefore, we examined the antimicrobial effect of the tubeworm's trophosome and skin. The growth of all four tested Gram-positive, but only of one of the tested Gram-negative bacterial strains was inhibited by freshly fixed and degrading trophosome (incubated up to ten days at either warm or cold temperature), while no effect on Saccharomyces cerevisiae was observed. The skin did not show antimicrobial effects. A liquid chromatography-mass spectrometric analysis of the ethanol supernatant of fixed trophosomes lead to the tentative identification of the phospholipids 1-palmitoleyl-2-lyso- phosphatidylethanolamine, 2-palmitoleyl-1-lyso-phosphatidylethanolamine and the free fatty acids palmitoleic, palmitic and oleic acid, which are known to have an antimicrobial effect. As a result of tissue autolysis, the abundance of the free fatty acids increased with longer incubation time of trophosome samples. This correlated with an increasing growth inhibition of Bacillus subtilis and Listeria welshimeri, but not of the other bacterial strains. Therefore, the free fatty acids produced upon host degradation could be the cause of inhibition of at least these two bacterial strains.	[Klose, Julia; Bright, Monika] Univ Vienna, Dept Limnol & Biooceanog, A-1090 Vienna, Austria; [Aistleitner, Karin; Horn, Matthias] Univ Vienna, Dept Microbiol & Ecosyst Sci, A-1090 Vienna, Austria; [Krenn, Liselotte; Dirsch, Verena; Zehl, Martin] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria; [Zehl, Martin] Univ Vienna, Dept Pharmaceut Chem, A-1090 Vienna, Austria	University of Vienna; University of Vienna; University of Vienna; University of Vienna	Klose, J (corresponding author), Univ Vienna, Dept Limnol & Biooceanog, Althanstr 14, A-1090 Vienna, Austria.	julia.klose@univie.ac.at	Horn, Matthias/G-1136-2011; Bright, Monika/I-5542-2012; Zehl, Martin/B-5901-2008; Bright, Monika/AAA-7015-2021	Horn, Matthias/0000-0002-8309-5855; Zehl, Martin/0000-0001-9685-0373; Bright, Monika/0000-0001-7066-1363; Krenn, Liselotte/0000-0002-9526-4396; Dirsch, Verena/0000-0002-9261-5293	European Marie Curie Initial Training Network Symbiomics [264774]; FP7-PEOPLE-ITN	European Marie Curie Initial Training Network Symbiomics; FP7-PEOPLE-ITN	This work was funded by the European Marie Curie Initial Training Network Symbiomics 264774 FP7-PEOPLE-2010-ITN granted to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the captains and the crew of L'Atalante with the submersible Nautile and R/V Atlantis with the ROV Jason and the chief scientists F. Lallier and S. Nooner for their support and sample collection throughout the cruises and the Core Facility of Cell Imaging and Ultrastructure at the University of Vienna for their technical advice. This work was funded by the European Marie Curie Initial Training Network Symbiomics 264774 FP7-PEOPLE-2010-ITN granted to M.B.	BOSCH C, 1984, CR ACAD SCI III-VIE, V299, P371; BOSCH C, 1984, CR ACAD SCI III-VIE, V299, P413; BRANEN AL, 1980, FOOD TECHNOL-CHICAGO, V34, P42; Bright M, 2000, MAR BIOL, V136, P621, DOI 10.1007/s002270050722; Bright M, 2005, SYMBIOSIS, V38, P1; Bright M, 2003, INVERTEBR BIOL, V122, P347; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; CHAMBERLAIN NR, 1991, INFECT IMMUN, V59, P4332, DOI 10.1128/IAI.59.12.4332-4337.1991; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Conway N., 1990, P553; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; DeBruyn EE, 1996, J ANTIMICROB CHEMOTH, V38, P349, DOI 10.1093/jac/38.3.349; Deguchi M, 2007, ACTA ZOOL-STOCKHOLM, V88, P129, DOI 10.1111/j.1463-6395.2007.00260.x; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Di Meo CA, 2000, APPL ENVIRON MICROB, V66, P651, DOI 10.1128/AEM.66.2.651-658.2000; Drazen JC, 2008, MAR ECOL PROG SER, V372, P157, DOI 10.3354/meps07707; Dyke KGH, 1979, J GEN MICROBIOL, V115, P233; Fang NB, 2003, J AGR FOOD CHEM, V51, P6676, DOI 10.1021/jf034793v; Felbeck H, 1998, PHYSIOL ZOOL, V71, P294, DOI 10.1086/515931; FELBECK H, 1985, PHYSIOL ZOOL, V58, P272, DOI 10.1086/physzool.58.3.30155998; Feldman RA, 1997, MOL MAR BIOL BIOTECH, V6, P268; FISHER CR, 1988, DEEP-SEA RES, V35, P1769, DOI 10.1016/0198-0149(88)90049-0; Fuchs Beate, 2008, V49, P541, DOI 10.1007/978-1-4020-8831-5_21; FULLARTON JG, 1995, J MAR BIOL ASSOC UK, V75, P455, DOI 10.1017/S0025315400018300; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P659, DOI 10.1111/j.1365-2672.1973.tb04151.x; Gardebrecht A, 2012, ISME J, V6, P766, DOI 10.1038/ismej.2011.137; Girguis PR, 2006, J EXP BIOL, V209, P3516, DOI 10.1242/jeb.02404; Goffredi SK, 1999, BIOL BULL-US, V196, P257, DOI 10.2307/1542950; Gollner S, 2015, MAR ECOL PROG SER, V520, P57, DOI 10.3354/meps11078; Harmer TL, 2008, APPL ENVIRON MICROB, V74, P3895, DOI 10.1128/AEM.02470-07; Hau TC, 2014, SAINS MALAYS, V43, P1873; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Ivanisevic J, 2011, J CHEM ECOL, V37, P537, DOI 10.1007/s10886-011-9943-2; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; KABARA JJ, 1981, J FOOD PROTECT, V44, P633, DOI 10.4315/0362-028X-44.8.633; Klose Julia, 2015, Proc Natl Acad Sci U S A, V112, P11300, DOI 10.1073/pnas.1501160112; Kubota N, 2007, MICROBES ENVIRONMENT, V22, P136, DOI 10.1264/jsme2.22.136; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; Le Bris N, 2003, DEEP-SEA RES PT I, V50, P737, DOI 10.1016/S0967-0637(03)00051-7; Le Bris N, 2006, CAH BIOL MAR, V47, P465; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Mayer RG, 2006, EMBALMING HIST THEOR, P112; MCKELLAR RC, 1992, FOOD MICROBIOL, V9, P67, DOI 10.1016/0740-0020(92)80063-A; Meylaers K, 2004, INSECT BIOCHEM MOLEC, V34, P43, DOI 10.1016/j.ibmb.2003.09.001; Mita M, 2006, J MAR BIOL ASSOC UK, V86, P283, DOI 10.1017/S0025315406013130; Nelson DC, 1991, APPL ENVIRON MICROB, V57, P082; Notter SJ, 2009, J FORENSIC SCI, V54, P195, DOI 10.1111/j.1556-4029.2008.00911.x; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Pflugfelder B, 2009, CELL TISSUE RES, V337, P149, DOI 10.1007/s00441-009-0811-0; Phleger CF, 2005, COMP BIOCHEM PHYS B, V141, P196, DOI 10.1016/j.cbpc.2005.03.001; Rieley G, 1995, GEOL SOC SPEC PUBL, V87, P329; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; RUSSELL AD, 1991, J APPL BACTERIOL, V71, P191, DOI 10.1111/j.1365-2672.1991.tb04447.x; Schimak MP, 2012, ACTA HISTOCHEM, V114, P122, DOI 10.1016/j.acthis.2011.03.008; SHEU CW, 1972, J BACTERIOL, V111, P516, DOI 10.1128/JB.111.2.516-524.1972; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Tsokos M, 2005, FOREN PATHOL REV, V3, P183, DOI 10.1007/978-1-59259-910-3_5; Tsokos M., 2005, ENCY FORENSIC LEGAL, P456, DOI [10.1016/B0-12-369399-3/00091-4, DOI 10.1016/B0-12-369399-3/00091-4]; Vass A.A., 2001, MICROBIOL TODAY, V28, P190; Vehovec T, 2010, J CHROMATOGR A, V1217, P1549, DOI 10.1016/j.chroma.2010.01.007; Zhou C, 2011, J FORENSIC LEG MED, V18, P6, DOI 10.1016/j.jflm.2010.10.003	65	5	5	4	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146446	10.1371/journal.pone.0146446	http://dx.doi.org/10.1371/journal.pone.0146446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730960	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400177
J	Perea, M; Marcet, A; Vergara-Martinez, M				Perea, Manuel; Marcet, Ana; Vergara-Martinez, Marta			Phonological-Lexical Feedback during Early Abstract Encoding: The Case of Deaf Readers	PLOS ONE			English	Article							DECISION; REPRESENTATIONS; PROGRAM; WORDS; CODE	In the masked priming technique, physical identity between prime and target enjoys an advantage over nominal identity in nonwords (GEDA-GEDA faster than geda-GEDA). However, nominal identity overrides physical identity in words (e.g., REAL-REAL similar to real-REAL). Here we tested whether the lack of an advantage of the physical identity condition for words was due to top-down feedback from phonological-lexical information. We examined this issue with deaf readers, as their phonological representations are not as fully developed as in hearing readers. Results revealed that physical identity enjoyed a processing advantage over nominal identity not only in nonwords but also in words (GEDA-GEDA faster than geda-GEDA; REAL-REAL faster than real-REAL). This suggests the existence of fundamental differences in the early stages of visual word recognition of hearing and deaf readers, possibly related to the amount of feedback from higher levels of information.	[Perea, Manuel; Marcet, Ana; Vergara-Martinez, Marta] Univ Valencia, Valencia, Spain	University of Valencia	Perea, M (corresponding author), Univ Valencia, Valencia, Spain.	mperea@uv.es	vergara, marta/ABC-7759-2021; Perea, Manuel/B-3345-2011; Marcet, Ana/I-8845-2016; Martinez, Marta Vergara/L-4622-2014	Perea, Manuel/0000-0002-3291-1365; Marcet, Ana/0000-0001-8755-5903; vergara martinez, marta/0000-0003-1931-0335	Spanish Ministry of Economy and Competitiveness [PSI2014-53444-P, BES-2015-074143]; Valencian Government; Conselleria d'Educacio, Cultura i Sports [GV/2014/067]; program "Iniciacio a la Investigacio" at the University of Valencia	Spanish Ministry of Economy and Competitiveness(Spanish Government); Valencian Government; Conselleria d'Educacio, Cultura i Sports; program "Iniciacio a la Investigacio" at the University of Valencia	The research reported in this article has been partially supported by Grants PSI2014-53444-P and BES-2015-074143 (Spanish Ministry of Economy and Competitiveness; http://www.mineco.gob.es/portal/site/mineco/) and GV/2014/067 (Valencian Government; Conselleria d'Educacio, Cultura i Sports; http://www.cece.gva.es). Ana Marcet was the recipient of a grant from the program "Iniciacio a la Investigacio" at the University of Valencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger NN, 2013, Q J EXP PSYCHOL, V66, P2237, DOI 10.1080/17470218.2013.780085; Belanger NN, 2012, SCI STUD READ, V16, P263, DOI 10.1080/10888438.2011.568555; BOLES DB, 1989, BEHAV RES METH INSTR, V21, P579, DOI 10.3758/BF03210580; Bowers JS, 1998, PSYCHON B REV, V5, P259, DOI 10.3758/BF03212948; Bowers JS, 1998, J EXP PSYCHOL HUMAN, V24, P1705, DOI 10.1037/0096-1523.24.6.1705; Carreiras M, 2014, TRENDS COGN SCI, V18, P90, DOI 10.1016/j.tics.2013.11.005; Cripps J. H., 2005, J 2 LANGUAGE ACQUISI, V12, P31; Davis CJ, 2005, BEHAV RES METHODS, V37, P665, DOI 10.3758/BF03192738; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; Emmorey K, 2013, BRAIN LANG, V126, P169, DOI 10.1016/j.bandl.2013.05.001; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Forster KI, 1998, J PSYCHOLINGUIST RES, V27, P203, DOI 10.1023/A:1023202116609; Gomez P, 2013, J EXP PSYCHOL HUMAN, V39, P1731, DOI 10.1037/a0032333; Grainger J, 2008, TRENDS COGN SCI, V12, P381, DOI 10.1016/j.tics.2008.06.006; Grainger J, 2008, LANG COGNITIVE PROC, V23, P1, DOI 10.1080/01690960701578013; JACOBS AM, 1995, PERCEPT PSYCHOPHYS, V57, P1101, DOI 10.3758/BF03208367; Kelly L.P., 2007, CHILDRENS COMPREHENS, P244; Okano K, 2013, COGN AFFECT BEHAV NE, V13, P390, DOI 10.3758/s13415-013-0149-7; Perea M, 2008, LANG COGNITIVE PROC, V23, P69, DOI 10.1080/01690960701578146; Perea M, 2006, Q J EXP PSYCHOL, V59, P1600, DOI 10.1080/17470210500298880; Perea M, 2015, J EXP CHILD PSYCHOL, V129, P140, DOI 10.1016/j.jecp.2014.09.005; Perea M, 2014, ACTA PSYCHOL, V148, P130, DOI 10.1016/j.actpsy.2014.01.014; Perea M, 2010, PSYCHON B REV, V17, P369, DOI 10.3758/PBR.17.3.369; Polk TA, 2009, COGN NEUROPSYCHOL, V26, P70, DOI 10.1080/02643290802618757; Pollatsek A, 2005, MEM COGNITION, V33, P557, DOI 10.3758/BF03193071; Pylkkanen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010793; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; Vergara-Martinez M, 2015, COGN AFFECT BEHAV NE, V15, P492, DOI 10.3758/s13415-014-0330-7; Wang XS, 2015, CEREB CORTEX, V25, P2416, DOI 10.1093/cercor/bhu044; Zawiszewski A, 2011, BILING-LANG COGN, V14, P400, DOI 10.1017/S1366728910000350	33	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146265	10.1371/journal.pone.0146265	http://dx.doi.org/10.1371/journal.pone.0146265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731110	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400134
J	Quecine, MC; Leite, TF; Bini, AP; Regiani, T; Franceschini, LM; Budzinski, IGF; Marques, FG; Labate, MTV; Guidetti-Gonzalez, S; Moon, DH; Labate, CA				Quecine, Maria Carolina; Leite, Thiago Falda; Bini, Andressa Peres; Regiani, Thais; Franceschini, Livia Maria; Frasson Budzinski, Ilara Gabriela; Marques, Felipe Garbelini; Veneziano Labate, Monica Teresa; Guidetti-Gonzalez, Simone; Moon, David Henry; Labate, Carlos Alberto			Label-Free Quantitative Proteomic Analysis of Puccinia psidii Uredospores Reveals Differences of Fungal Populations Infecting Eucalyptus and Guava	PLOS ONE			English	Article							IN-VITRO; SCLEROTINIA-SCLEROTIORUM; EXTRACELLULAR PROTEINS; ASPERGILLUS-FUMIGATUS; RUST; DISEASE; TOOL; IDENTIFICATION; PATHOGENICITY; PROHIBITINS	Puccinia psidii sensu lato (s.l.) is the causal agent of eucalyptus and guava rust, but it also attacks a wide range of plant species from the myrtle family, resulting in a significant genetic and physiological variability among populations accessed from different hosts. The uredo-spores are crucial to P. psidii dissemination in the field. Although they are important for the fungal pathogenesis, their molecular characterization has been poorly studied. In this work, we report the first in-depth proteomic analysis of P. psidii s.l. uredospores from two contrasting populations: guava fruits (PpGuava) and eucalyptus leaves (PpEucalyptus). NanoUPLC-MSE was used to generate peptide spectra that were matched to the UniProt Puccinia genera sequences (UniProt database) resulting in the first proteomic analysis of the phytopathogenic fungus P. psidii. Three hundred and fourty proteins were detected and quantified using Label free proteomics. A significant number of unique proteins were found for each sample, others were significantly more or less abundant, according to the fungal populations. In PpGuava population, many proteins correlated with fungal virulence, such as malate dehydrogenase, proteossomes subunits, enolases and others were increased. On the other hand, PpEucalyptus proteins involved in biogenesis, protein folding and translocation were increased, supporting the physiological variability of the fungal populations according to their protein reservoirs and specific host interaction strategies.	[Quecine, Maria Carolina; Leite, Thiago Falda; Bini, Andressa Peres; Regiani, Thais; Franceschini, Livia Maria; Frasson Budzinski, Ilara Gabriela; Marques, Felipe Garbelini; Veneziano Labate, Monica Teresa; Guidetti-Gonzalez, Simone; Moon, David Henry; Labate, Carlos Alberto] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil	Universidade de Sao Paulo	Labate, CA (corresponding author), Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	calabate@usp.br	Budzinski, Ilara G.F/J-3278-2012; Cataldi, Thais/H-5430-2018; Quecine, Maria C/B-8261-2016; Labate, Carlos Alberto/L-2183-2015; Bini, Andressa Peres/S-3293-2016; Quecine, Maria/N-4478-2016	Budzinski, Ilara G.F/0000-0002-0389-7023; Cataldi, Thais/0000-0002-9827-2017; Labate, Carlos Alberto/0000-0001-7309-1300; Bini, Andressa Peres/0000-0001-7290-9801; Labate, Monica Teresa Veneziano/0000-0002-6447-3718; Verdi, Maria/0000-0002-9524-941X; Quecine, Maria/0000-0002-9781-8479	FAPESP [2008/50361-1, 2010/50445-0, 2013/07596-6, 2011/17455-5, 2012/22227-4, 2010/15417-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Grant 2008/50361-1). The authors would also like to thank FAPESP for the fellowships to MCQ (Proc. no. 2010/50445-0), APB (2013/07596-6), FGM (2011/17455-5), IGFB (2012/22227-4) and SGG (2010/15417-6).	Aparecido Christiane C., 2003, Summa Phytopathologica, V29, P234; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bindschedler LV, 2009, MOL CELL PROTEOMICS, V8, P2368, DOI 10.1074/mcp.M900188-MCP200; Brownsey RW, 1997, BIOCHEM SOC T, V25, P1232, DOI 10.1042/bst0251232; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Cao T, 2009, PROTEOMICS, V9, P1177, DOI 10.1002/pmic.200800475; Carberry S, 2006, BIOCHEM BIOPH RES CO, V341, P1096, DOI 10.1016/j.bbrc.2006.01.078; Carnegie AJ, 2012, AUSTRALAS PLANT PATH, V41, P13, DOI 10.1007/s13313-011-0082-6; CASTRO H A D, 1984, Summa Phytopathologica, V10, P155; CASTRO H A D, 1983, Fitopatologia Brasileira, V8, P491; Coelho Lisias, 2001, Summa Phytopathologica, V27, P295; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper B, 2006, PROTEOMICS, V6, P2477, DOI 10.1002/pmic.200500630; Coutinho TA, 1998, PLANT DIS, V82, P819, DOI 10.1094/PDIS.1998.82.7.819; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Damerval C., 1986, ELECTROPHORESIS, V7, P53; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; Doyle S, 2011, FEMS MICROBIOL LETT, V321, P1, DOI 10.1111/j.1574-6968.2011.02292.x; Ebstrup T, 2005, PROTEOMICS, V5, P2839, DOI 10.1002/pmic.200401173; Ferrari JT, 1997, ACTA HORTIC, P55, DOI 10.17660/ActaHortic.1997.452.8; Ferreira F. A., 1983, Revista Arvore, V7, P91; Figueiredo M. B., 2001, O Biologico, V63, P69; Glen M, 2007, AUSTRALAS PLANT PATH, V36, P1, DOI 10.1071/AP06088; Godfrey D, 2009, PROTEOMICS, V9, P3222, DOI 10.1002/pmic.200800645; Gokce E, 2012, J PROTEOME RES, V11, P5827, DOI 10.1021/pr300604s; Goncalves S, 1929, PRELIMINARY LIST PLA, P1; Graca RN, 2013, MOL ECOL, V22, P6033, DOI 10.1111/mec.12545; Hodgetts S, 1996, FEMS IMMUNOL MED MIC, V16, P229, DOI 10.1016/S0928-8244(96)00088-0; Fernandez-Acero FJ, 2007, ARCH MICROBIOL, V187, P207, DOI 10.1007/s00203-006-0188-3; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; JOFFILY J., 1944, Bragantia, V4, P475; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kim ST, 2004, PROTEOMICS, V4, P3579, DOI 10.1002/pmic.200400969; Kim Y, 2007, TRENDS BIOTECHNOL, V25, P395, DOI 10.1016/j.tibtech.2007.07.008; Kimbrough JW, 1980, P FLORIDA STATE HORT, V93, P111; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064479; Liang Y, 2010, FUNGAL BIOL-UK, V114, P619, DOI 10.1016/j.funbio.2010.05.003; MacLachlan JD, 1938, PHYTOPATHOLOGY, V28, P157; Maier W, 2003, CAN J BOT, V81, P12, DOI [10.1139/B02-113, 10.1139/b02-113]; Mandelc S, 2009, EUR J PLANT PATHOL, V125, P159, DOI 10.1007/s10658-009-9467-6; Melin P, 2002, MOL GENET GENOMICS, V267, P695, DOI 10.1007/s00438-002-0695-0; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Monaco JJ, 1995, ANNU REV GENET, V29, P729, DOI 10.1146/annurev.ge.29.120195.003501; Morin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035434; Niwa H, 1998, PROTEIN EXPRES PURIF, V13, P403, DOI 10.1006/prep.1998.0914; Oda K, 2006, APPL ENVIRON MICROB, V72, P3448, DOI 10.1128/AEM.72.5.3448-3457.2006; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184; Qin GZ, 2007, MOL CELL PROTEOMICS, V6, P425, DOI 10.1074/mcp.M600179-MCP200; Quecine MC, 2014, PLANT DIS, V98, P16, DOI 10.1094/PDIS-03-13-0332-RE; Rayachhetry MB, 2001, BIOL CONTROL, V22, P38, DOI 10.1006/bcon.2001.0949; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Roux J, 2013, IMA FUNGUS, V4, P155, DOI 10.5598/imafungus.2013.04.01.14; Schmitt S, 2006, PROTEOMICS, V6, P72, DOI 10.1002/pmic.200402084; Shimizu M, 2005, FEMS MICROBIOL LETT, V247, P17, DOI 10.1016/j.femsle.2005.04.021; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Simpson JA, 2006, AUSTRALAS PLANT PATH, V35, P549, DOI 10.1071/AP06057; Song X, 2011, PROTEOMICS, V11, P944, DOI 10.1002/pmic.201000014; Tan Mui-Keng, 2014, Mycology, V5, P52; Tommerup I. C., 2003, New Zealand Journal of Forestry Science, V33, P420; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Van Aken O, 2007, PLANT J, V52, P850, DOI 10.1111/j.1365-313X.2007.03276.x; Walker J, 1983, AUSTR J BOT S, V10, P89; Wietholter N, 2003, FUNGAL GENET BIOL, V38, P320, DOI 10.1016/S1087-1845(02)00539-X; Winter G, 1884, HEDWIGIA, V23, P164; Xia YJ, 2004, CELL MICROBIOL, V6, P905, DOI 10.1111/j.1462-5822.2004.00438.x; Yajima W, 2006, PROTEOMICS, V6, P5995, DOI 10.1002/pmic.200600424; Zorn H, 2005, PROTEOMICS, V5, P4832, DOI 10.1002/pmic.200500015	72	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145343	10.1371/journal.pone.0145343	http://dx.doi.org/10.1371/journal.pone.0145343			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731728	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400031
J	Roland, F; Volodin, IA; Fritsch, G; Volodina, EV				Roland, Frey; Volodin, Ilya A.; Fritsch, Guido; Volodina, Elena V.			Potential Sources of High Frequency and Biphonic Vocalization in the Dhole (Cuon alpinus)	PLOS ONE			English	Article							RAT ULTRASOUND VOCALIZATION; ALOPEX-LAGOPUS-SEMENOVI; RED FOX; INDIVIDUAL RECOGNITION; NONLINEAR PHENOMENA; SOCIAL-BEHAVIOR; PREY SELECTION; MEDNYI ISLAND; ARCTIC FOXES; VOCAL-TRACT	Biphonation, i.e. two independent fundamental frequencies in a call spectrum, is a prominent feature of vocal activity in dog-like canids. Dog-like canids can produce a low (f0) and a high (g0) fundamental frequency simultaneously. In contrast, fox-like canids are only capable of producing the low fundamental frequency (f0). Using a comparative anatomical approach for revealing macroscopic structures potentially responsible for canid biphonation, we investigated the vocal anatomy for 4 (1 male, 3 female) captive dholes (Cuon alpinus) and for 2 (1 male, 1 female) wild red fox (Vulpes vulpes). In addition, we analyzed the acoustic structure of vocalizations in the same dholes that served postmortem as specimens for the anatomical investigation. All study dholes produced both high-frequency and biphonic calls. The anatomical reconstructions revealed that the vocal morphologies of the dhole are very similar to those of the red fox. These results suggest that the high-frequency and biphonic calls in dog-like canids can be produced without specific anatomical adaptations of the sound-producing structures. We discuss possible production modes for the high-frequency and biphonic calls involving laryngeal and nasal structures.	[Roland, Frey; Fritsch, Guido] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany; [Volodin, Ilya A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia; [Volodin, Ilya A.; Volodina, Elena V.] Moscow Zoo, Sci Res Dept, Moscow, Russia	Leibniz Institut fur Zoo und Wildtierforschung; Lomonosov Moscow State University	Volodina, EV (corresponding author), Moscow Zoo, Sci Res Dept, Moscow, Russia.	volodinsvoc@mail.ru	Volodina, Elena V./Q-7903-2018; Volodin, Ilya/Q-7903-2018	Volodina, Elena V./0000-0001-9755-4576; Volodin, Ilya/0000-0001-6278-0354	Russian Scientific Foundation; Russian Science Foundation [14-14-00237] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Scientific Foundation (http://www.rscf.ru/) funding to IAV and EVV. This research received no additional funding from any public, commercial or not-for-profit sectors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour F, 2007, ANN OTO RHINOL LARYN, V116, P135, DOI 10.1177/000348940711600210; ASHDOWN RR, 1979, J SMALL ANIM PRACT, V20, P675, DOI 10.1111/j.1748-5827.1979.tb06680.x; Bailly L, 2010, J ACOUST SOC AM, V127, P3212, DOI 10.1121/1.3365220; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; Bowles A.E., 1993, J ACOUST SOC AM, V93, P2378; BROWN CH, 1995, J COMP PSYCHOL, V109, P398, DOI 10.1037/0735-7036.109.4.398; Budras K-D, 2007, ANATOMY OF THE DOG A; Cavallini P, 1996, ETHOL ECOL EVOL, V8, P323; Cerveny J, 2011, BIOL LETTERS, V7, P355, DOI 10.1098/rsbl.2010.1145; CHANAUD RC, 1970, SCI AM, V222, P40, DOI 10.1038/scientificamerican0170-40; COHEN J A, 1985, Journal of the Bombay Natural History Society, V82, P183; Cohen J. A., 1977, Animal Regulation Stud, V1, P141; Darden SK, 2006, BEHAVIOUR, V143, P659, DOI 10.1163/156853906777791351; Darden SK, 2003, J MAMMAL, V84, P1417, DOI 10.1644/BEM-031; DAVIDAR E R C, 1973, Journal of the Bombay Natural History Society, V70, P373; Dollinger M, 2005, J ACOUST SOC AM, V117, P3174, DOI 10.1121/1.1871772; Filatova OA, 2009, ZOOL ZH, V88, P357; Finnegan EM, 2009, J VOICE, V23, P51, DOI 10.1016/j.jvoice.2007.01.004; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fitch WT, 2000, PHONETICA, V57, P205; Frommolt K-H, 1989, VOCAL ACTIVITY IN TH; Frommolt Karl-Heinz, 1999, Bioacoustics, V10, P219; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; GASKELL CJ, 1974, J SMALL ANIM PRACT, V15, P89, DOI 10.1111/j.1748-5827.1974.tb05666.x; Gogoleva SS, 2008, BIOACOUSTICS, V18, P99, DOI 10.1080/09524622.2008.9753595; Gogoleva SS, 2009, BEHAV PROCESS, V81, P369, DOI 10.1016/j.beproc.2009.03.012; Goltsman M, 2005, J ZOOL, V267, P405, DOI 10.1017/S0952836905007557; HEFFNER HE, 1983, BEHAV NEUROSCI, V97, P310, DOI 10.1037/0735-7044.97.2.310; HEMILA S, 1995, HEARING RES, V85, P31, DOI 10.1016/0378-5955(95)00031-X; Hemila S, 2006, J ACOUST SOC AM, V120, P3463, DOI 10.1121/1.2372712; Herzel H, 1997, FOLIA PHONIATR LOGO, V49, P216, DOI 10.1159/000266458; Herzel H-P, 1996, NONLINEAR CHAOTIC AD, P644; Hirano M., 1985, SPEECH SCI, P1; Hong KH, 1997, J VOICE, V11, P23; ISLEY TE, 1975, J MAMMAL, V56, P397, DOI 10.2307/1379369; JOHNSINGH AJT, 1992, MAMMALIA, V56, P517, DOI 10.1515/mamm.1992.56.4.517; JOHNSINGH AJT, 1982, J ZOOL, V198, P443, DOI 10.1111/jzo.1982.198.4.443; Johnsingh AJT, 2001, THE NEW ENCYCLOPEDIA, P66; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Koda H, 2012, AM J PHYS ANTHROPOL, V149, P347, DOI 10.1002/ajpa.22124; Kruchenkova EP, 2009, NATURWISSENSCHAFTEN, V96, P457, DOI 10.1007/s00114-008-0494-5; Ludwig Wolfgang, 2000, Zoologische Garten, V70, P39; Malkemper EP, 2015, HEARING RES, V320, P30, DOI 10.1016/j.heares.2014.12.001; Mason MJ, 2013, HEARING RES, V301, P4, DOI 10.1016/j.heares.2012.10.004; Mergell P, 1999, J ACOUST SOC AM, V105, P2020, DOI 10.1121/1.426735; Mergell P, 1997, SPEECH COMMUN, V22, P141, DOI 10.1016/S0167-6393(97)00016-2; Newton-Fisher Nick, 1993, Bioacoustics, V5, P1; Nickel R, 1987, LEHRBUCH DER ANATOMI, V2; OVSYANIKOV NG, 1988, ZOOL ZH, V67, P1371; Plotsky K, 2013, J ZOOL, V291, P76, DOI 10.1111/jzo.12048; RAMANATHAN S, 1982, Journal of the Bombay Natural History Society, V79, P665; Riede T, 2000, J ACOUST SOC AM, V108, P1435, DOI 10.1121/1.1289208; Riede T, 2013, J EXP ZOOL PART A, V319A, P213, DOI 10.1002/jez.1785; Riede T, 2011, J NEUROPHYSIOL, V106, P2580, DOI 10.1152/jn.00478.2011; Schassburger R.M., 1987, MAN WOLF ADV ISSUES, P313; Schneider JN, 2011, J ACOUST SOC AM, V130, P2275, DOI 10.1121/1.3628331; SoIntseva GN, 2007, MORPHOLOGY OF THE AU; SOLOMON NP, 1995, J VOICE, V9, P403, DOI 10.1016/S0892-1997(05)80202-4; Stansbury A, 2011, THESIS; Takada Y, 2009, MAMM STUDY, V34, P213, DOI 10.3106/041.034.0406; TEMBROCK G, 1976, BEHAV PROCESS, V1, P57, DOI 10.1016/0376-6357(76)90007-3; Tigges M, 1997, ACUSTICA, V83, P707; Titze I, 2008, J ACOUST SOC AM, V123, P1902, DOI 10.1121/1.2832339; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; Vazquez JM, 1998, ANAT HISTOL EMBRYOL, V27, P263, DOI 10.1111/j.1439-0264.1998.tb00191.x; Venkataraman AB, 1998, ETHOLOGY, V104, P671; Volodin IA, 2005, ZH OBSHCH BIOL, V66, P346; Volodin IA, 2006, CLASSIS IV HISTORIA, V47, P245; Volodin IA, 2001, ENTOMOL REV, V81, pS346; Volodin I, 2013, ACTA ETHOL, V16, P57, DOI 10.1007/s10211-012-0133-1; Volodin Ilya A., 2002, Bioacoustics, V13, P105; Volodina EV, 2006, ETHOLOGY, V112, P815, DOI 10.1111/j.1439-0310.2006.01231.x; Volodina EV, 2006, CLASSIS IV HISTORIA, V47, P257; Webster J, 2007, WILEY ENCY ELECT ELE, P1; Wilden I., 1998, Bioacoustics, V9, P171; Wilden I., 1997, PHONETISCHE VARIABIL	77	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146330	10.1371/journal.pone.0146330	http://dx.doi.org/10.1371/journal.pone.0146330			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730952	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400151
J	Campbell, JA; Ryan, MJ; Holmes, RB; Schroder-Adams, CJ				Campbell, James A.; Ryan, Michael J.; Holmes, Robert B.; Schroeder-Adams, Claudia J.			A Re-Evaluation of the Chasmosaurine Ceratopsid Genus Chasmosaurus (Dinosauria: Ornithischia) from the Upper Cretaceous (Campanian) Dinosaur Park Formation of Western Canada	PLOS ONE			English	Article							TYRANNOSAURIDAE DINOSAURIA; ALBERTA; PENTACERATOPS; ONTOGENY; SKULL; TAXONOMY; FRILL	Background The chasmosaurine ceratopsid Chasmosaurus is known from the Upper Cretaceous (Campanian) Dinosaur Park Formation of southern Alberta and Saskatchewan. Two valid species, Chasmosaurus belli and C. russelli, have been diagnosed by differences in cranial ornamentation. Their validity has been supported, in part, by the reported stratigraphic segregation of chasmosaurines in the Dinosaur Park Formation, with C. belli and C. russelli occurring in discrete, successive zones within the formation. Results/Conclusions An analysis of every potentially taxonomically informative chasmosaurine specimen from the Dinosaur Park Formation indicates that C. belli and C. russelli have indistinguishable ontogenetic histories and overlapping stratigraphic intervals. Neither taxon exhibits autapomorphies, nor a unique set of apomorphies, but they can be separated and diagnosed by a single phylogenetically informative character-the embayment angle formed by the posterior parietal bars relative to the parietal midline. Although relatively deeply embayed specimens (C. russelli) generally have relatively longer postorbital horncores than specimens with more shallow embayments (C. belli), neither this horncore character nor epiparietal morphology can be used to consistently distinguish every specimen of C. belli from C. russelli. Status of Kosmoceratops in the Dinosaur Park Formation Kosmoceratops is purportedly represented in the Dinosaur Park Formation by a specimen previously referred to Chasmosaurus. The reassignment of this specimen to Kosmoceratops is unsupported here, as it is based on features that are either influenced by taphonomy or within the realm of individual variation for Chasmosaurus. Therefore, we conclude that Kosmoceratops is not present in the Dinosaur Park Formation, but is instead restricted to southern Laramidia, as originally posited.	[Campbell, James A.; Ryan, Michael J.; Schroeder-Adams, Claudia J.] Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada; [Campbell, James A.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Ryan, Michael J.] Cleveland Museum Nat Hist, Dept Vertebrate Paleontol, Cleveland, OH USA; [Holmes, Robert B.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Carleton University; University of Calgary; Cleveland Museum of Natural History; University of Alberta	Campbell, JA (corresponding author), Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada.	james.campbell2@ucalgary.ca		Schroder-Adams, Claudia/0000-0002-0245-2559	Ontario Graduate Scholarship; Dr. George A. Jeletzky Memorial Scholarship; National Geographic Society's Young Explorer's Grant [9160-12]	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Dr. George A. Jeletzky Memorial Scholarship; National Geographic Society's Young Explorer's Grant(National Geographic Society)	This research was supported by an Ontario Graduate Scholarship (https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/PRD19842319.html), Dr. George A. Jeletzky Memorial Scholarship (http://earthsci.carleton.ca/future-students/graduate/funding), and National Geographic Society's Young Explorer's Grant (Grant Number 9160-12, http://www.nationalgeographic.com/explorers/grants-programs/young-explorers/) to JAC.	Benton MJ, 2001, TRENDS ECOL EVOL, V16, P405, DOI 10.1016/S0169-5347(01)02149-8; BROWN BARNUM, 1933, AMER MUS NOVITATES, V669, P1; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Brown CM, 2012, SYST BIOL, V61, P941, DOI 10.1093/sysbio/sys047; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Campbell JA, 2015, CAN J EARTH SCI, V52, P85, DOI 10.1139/cjes-2014-0172; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 2010, CAN J EARTH SCI, V47, P1213, DOI 10.1139/E10-035; Currie P.J., 2008, NEW HORNED DINOSAUR; Currie PJ, 2005, LIFE O PAST, P537; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; Eberth DA, 2013, CAN J EARTH SCI, V50, P701, DOI 10.1139/cjes-2012-0185; Eberth DA, 2005, LIFE O PAST, P54; Evans D.C., 2013, J VERTEBR PALEONTOL, P123; Farke AA, 2010, J VERTEBR PALEONTOL, V30, P1486, DOI 10.1080/02724634.2010.501436; Fastovsky DE, 2011, J PALEONTOL, V85, P1035; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff P, 2008, CLADISTICS, V24, P91; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; HERRING SW, 1974, ANAT EMBRYOL, V146, P167, DOI 10.1007/BF00315593; Holmes RB, 2001, CAN J EARTH SCI, V38, P1423, DOI 10.1139/e01-036; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Konishi T, 2015, CAN J EARTH SCI, V52, P608, DOI 10.1139/cjes-2014-0167; Lambe L., 1914, Ottawa Naturalist, V27; Lambe L., 1914, Ottawa Naturalist, V27; Lambe LM., 1902, CONTRIBUTIONS CANADI, V3, P25; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; Lehman T.M., 1990, P211, DOI 10.1017/CBO9780511608377.019; Lehman T.M., 1989, Journal of Vertebrate Paleontology, V9, P137; Lehman Thomas M., 2007, P259; LEHMAN TM, 1993, J PALEONTOL, V67, P279, DOI 10.1017/S0022336000032200; Lehman TM, 1998, J PALEONTOL, V72, P894, DOI 10.1017/S0022336000027220; Longrich NR, 2014, CRETACEOUS RES, V51, P292, DOI 10.1016/j.cretres.2014.06.011; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Longrich NR, 2010, J PALEONTOL, V84, P681, DOI 10.1666/09-114.1; Lucas Spencer G., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P367; LULL RICHARD SWANN, 1933, MEM PEABODY MUS NAT HIST, V3, P1; Maddison WP, 2011, MESQUITE MODULAR SYS; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Maidment SCR, 2011, ZOOTAXA, P1; Mallon JC, 2015, ZOOLOGICAL J LINNEAN; Mallon JC, 2014, CAN J EARTH SCI, V51, P618, DOI 10.1139/cjes-2014-0028; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Mallon JC, 2011, J VERTEBR PALEONTOL, V31, P1047, DOI 10.1080/02724634.2011.601484; Marsh O. C., 1890, American Journal of Science (3), Vxxxix, P81; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryan M.J., 2003, THESIS; Ryan MJ, 2007, J VERTEBR PALEONTOL, V27, P944, DOI 10.1671/0272-4634(2007)27[944:AROTLC]2.0.CO;2; Ryan MJ, 2014, NATURWISSENSCHAFTEN, V101, P505, DOI 10.1007/s00114-014-1183-1; Ryan MJ, 2012, CRETACEOUS RES, V35, P69, DOI 10.1016/j.cretres.2011.11.018; Ryan MJ, 2005, LIFE O PAST, P312; Ryan MJ, 2005, CAN J EARTH SCI, V42, P1369, DOI 10.1139/E05-029; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson Scott D., 2010, P405; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Sereno Paul C., 2010, P21; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STERNBERG C. M., 1940, JOUR PALEONTOL, V14, P468; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanke Darren H., 2007, P319	69	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145805	10.1371/journal.pone.0145805	http://dx.doi.org/10.1371/journal.pone.0145805			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726769	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500032
J	Gruel, G; Villagrasa, C; Voisin, P; Clairand, I; Benderitter, M; Bottollier-Depois, JF; Barquinero, JF				Gruel, Gaetan; Villagrasa, Carmen; Voisin, Pascale; Clairand, Isabelle; Benderitter, Marc; Bottollier-Depois, Jean-Francois; Barquinero, Joan Francesc			Cell to Cell Variability of Radiation-Induced Foci: Relation between Observed Damage and Energy Deposition	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE; MICRODOSIMETRIC DISTRIBUTIONS; X-RAYS; REPAIR; IRRADIATION; QUALITY; IR-192; SPREAD	Most studies that aim to understand the interactions between different types of photon radiation and cellular DNA assume homogeneous cell irradiation, with all cells receiving the same amount of energy. The level of DNA damage is therefore generally determined by averaging it over the entire population of exposed cells. However, evaluating the molecular consequences of a stochastic phenomenon such as energy deposition of ionizing radiation by measuring only an average effect may not be sufficient for understanding some aspects of the cellular response to this radiation. The variance among the cells associated with this average effect may also be important for the behaviour of irradiated tissue. In this study, we accurately estimated the distribution of the number of radiation-induced gamma H2AX foci (RIF) per cell nucleus in a large population of endothelial cells exposed to 3 macroscopic doses of gamma rays from Co-60. The number of RIF varied significantly and reproducibly from cell to cell, with its relative standard deviation ranging from 36% to 18% depending on the macroscopic dose delivered. Interestingly, this relative cell-to-cell variability increased as the dose decreased, contrary to the mean RIF count per cell. This result shows that the dose effect, in terms of the number of DNA lesions indicated by RIF is not as simple as a purely proportional relation in which relative SD is constant with dose. To analyse the origins of this observed variability, we calculated the spread of the specific energy distribution for the different target volumes and subvolumes in which RIF can be generated. Variances, standard deviations and relative standard deviations all changed similarly from dose to dose for biological and calculated microdosimetric values. This similarity is an important argument that supports the hypothesis of the conservation of the association between the number of RIF per nucleus and the specific energy per DNA molecule. This comparison allowed us to calculate a volume of 1.6 mu m(3) for which the spread of the specific energy distribution could explain the entire variability of RIF counts per cell in an exposed cell population. The definition of this volume may allow to use a microdosimetric quantity to predict heterogeneity in DNA damage. Moreover, this value is consistent with the order of magnitude of the volume occupied by the hydrated sugar-phosphate backbone of the DNA molecule, which is the part of the DNA molecule responsible for strand breaks.	[Gruel, Gaetan; Villagrasa, Carmen; Voisin, Pascale; Clairand, Isabelle; Benderitter, Marc; Bottollier-Depois, Jean-Francois; Barquinero, Joan Francesc] IRSN, Dept Human Hlth Radiat Protect, Fontenay Aux Roses, France		Gruel, G (corresponding author), IRSN, Dept Human Hlth Radiat Protect, Fontenay Aux Roses, France.	gaetan.gruel@irsn.fr	Barquinero, Joan Francesc/L-6487-2014	Barquinero, Joan Francesc/0000-0003-0084-5268; GRUEL, Gaetan/0000-0001-7856-818X				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Chappell LJ, 2010, RADIAT RES, V174, P691, DOI 10.1667/RR2204.1; CHMELEVSKY D, 1977, RADIAT ENVIRON BIOPH, V14, P123, DOI 10.1007/BF01332148; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Grudzenski S, 2010, P NATL ACAD SCI USA, V107, P14205, DOI 10.1073/pnas.1002213107; KELLERER AM, 1975, RADIAT ENVIRON BIOPH, V12, P321, DOI 10.1007/BF01323420; Kellerer AM, 2002, RADIAT RES, V158, P13, DOI 10.1667/0033-7587(2002)158[0013:ESATRO]2.0.CO;2; KELLERER AM, 1975, RADIAT ENVIRON BIOPH, V12, P61, DOI 10.1007/BF02339810; KELLERER AM, 1975, RADIAT ENVIRON BIOPH, V12, P205, DOI 10.1007/BF01327348; KLIAUGA P, 1978, RADIAT RES, V73, P1, DOI 10.2307/3574570; Lorat Y, 2015, DNA REPAIR, V28, P93, DOI 10.1016/j.dnarep.2015.01.007; Lorat Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038165; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Olive PL, 2004, METHOD CELL BIOL, V75, P355; Olive PL, 1998, RADIAT RES, V150, pS42, DOI 10.2307/3579807; Prise KM, 1998, INT J RADIAT BIOL, V74, P173, DOI 10.1080/095530098141564; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Villegas F, 2015, RADIAT PROT DOSIM, V166, P365, DOI 10.1093/rpd/ncv200; Villegas F, 2013, PHYS MED BIOL, V58, P6149, DOI 10.1088/0031-9155/58/17/6149; Ward JF, 1991, EARLY EFFECTS RAD DN, P1; Whalen MK, 2008, RADIAT RES, V170, P353, DOI 10.1667/RR1354.1	26	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145786	10.1371/journal.pone.0145786	http://dx.doi.org/10.1371/journal.pone.0145786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727594	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500031
J	Schulte, C; Molz, S; Appelbaum, S; Karakas, M; Ojeda, F; Lau, DM; Hartmann, T; Lackner, KJ; Westermann, D; Schnabel, RB; Blankenberg, S; Zeller, T				Schulte, Christian; Molz, Simon; Appelbaum, Sebastian; Karakas, Mahir; Ojeda, Francisco; Lau, Denise M.; Hartmann, Tim; Lackner, Karl J.; Westermann, Dirk; Schnabel, Renate B.; Blankenberg, Stefan; Zeller, Tanja			miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING MICRORNAS; BIOMARKERS; EXPRESSION; DIAGNOSIS; IMPACT; RISK	Background Circulating microRNAs (miRNAs) have been described as potential diagnostic biomarkers in cardiovascular disease and in particular, coronary artery disease (CAD). Few studies were undertaken to perform analyses with regard to risk stratification of future cardiovascular events. miR-126, miR-197 and miR-223 are involved in endovascular inflammation and platelet activation and have been described as biomarkers in the diagnosis of CAD. They were identified in a prospective study in relation to future myocardial infarction. Objectives The aim of our study was to further evaluate the prognostic value of these miRNAs in a large prospective cohort of patients with documented CAD. Methods Levels of miR-126, miR-197 and miR-223 were evaluated in serum samples of 873 CAD patients with respect to the endpoint cardiovascular death. miRNA quantification was performed using real time polymerase chain reaction (RT-qPCR). Results The median follow-up period was 4 years (IQR 2.78-5.04). The median age of all patients was 64 years (IQR 57-69) with 80.2% males. 38.9% of the patients presented with acute coronary syndrome (ACS), 61.1% were diagnosed with stable angina pectoris (SAP). Elevated levels of miRNA-197 and miRNA-223 reliably predicted future cardiovascular death in the overall group (miRNA-197: hazard ratio (HR) 1.77 per one standard deviation (SD) increase (95% confidence interval (CI) 1.20; 2.60), p = 0.004, C-index 0.78; miRNA-223: HR 2.23 per one SD increase (1.20; 4.14), p = 0.011, C-index 0.80). In ACS patients the prognostic power of both miRNAs was even higher (miRNA-197: HR 2.24 per one SD increase (1.25; 4.01), p = 0.006, C-index 0.89); miRA-223: HR 4.94 per one SD increase (1.42; 17.20), p = 0.012, C-index 0.89). Conclusion Serum-derived circulating miRNA-197 and miRNA-223 were identified as predictors for cardiovascular death in a large patient cohort with CAD. These results reinforce the assumption that circulating miRNAs are promising biomarkers with prognostic value with respect to future cardiovascular events.	[Schulte, Christian; Molz, Simon; Appelbaum, Sebastian; Karakas, Mahir; Ojeda, Francisco; Lau, Denise M.; Hartmann, Tim; Westermann, Dirk; Schnabel, Renate B.; Blankenberg, Stefan; Zeller, Tanja] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Appelbaum, Sebastian; Karakas, Mahir; Westermann, Dirk; Schnabel, Renate B.; Blankenberg, Stefan; Zeller, Tanja] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Luebeck Kiel, Hamburg, Germany; [Lackner, Karl J.] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Lackner, Karl J.] German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Mainz, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research	Zeller, T (corresponding author), Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany.	t.zeller@uke.de	Schulte, Christian/M-1289-2018; Schnabel, Renate B/ABE-6668-2021; Westermann, Dirk/D-1344-2011	Schulte, Christian/0000-0002-2643-7345; Schnabel, Renate B/0000-0001-7170-9509; Ojeda, Francisco/0000-0003-4037-144X; Westermann, Dirk/0000-0002-7542-1956; Zeller, Tanja/0000-0003-3379-2641	'Stiftung Rheinland-Pfalz fur Innovation', Ministry for Science and Education, Mainz, Germany [AZ 15202-386261/545]	'Stiftung Rheinland-Pfalz fur Innovation', Ministry for Science and Education, Mainz, Germany	The AtheroGene study was supported by a grant of the 'Stiftung Rheinland-Pfalz fur Innovation', Ministry for Science and Education (AZ 15202-386261/545), Mainz, Germany.	Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bostjancic E, 2014, WORLD J CARDIOL, V6, P939, DOI 10.4330/wjc.v6.i9.939; Bronze-da-Rocha E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/985408; Cheng C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088566; Contu R, 2010, CIRC RES, V107, P573, DOI 10.1161/CIRCRESAHA.110.227983; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; D'Alessandra Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080345; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Engelhardt S, 2012, J AM COLL CARDIOL, V60, P300, DOI 10.1016/j.jacc.2012.04.018; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; da Silva AMG, 2014, BIOMARKERS, V19, P631, DOI 10.3109/1354750X.2014.954001; Huang XY, 2013, INT J MOL SCI, V14, P14785, DOI 10.3390/ijms140714785; Jansen F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001249; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Li CJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-16; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Maegdefessel L, 2014, J INTERN MED, V276, P633, DOI 10.1111/joim.12298; Meyer SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038946; R Core Team, 2021, R LANGUAGE ENV STAT; Rupprecht HJ, 2001, CIRCULATION, V104, P25, DOI 10.1161/hc2601.091703; Schulte C, 2015, CARDIOVASC DIAGN THE, V5, P17, DOI 10.3978/j.issn.2223-3652.2014.12.03; Shan Z, 2015, J AM COLL CARDIOL, V65, P2526, DOI 10.1016/j.jacc.2015.03.570; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zeller T, 2014, EUR HEART J, V35, P2106, DOI 10.1093/eurheartj/ehu151; Zhang QW, 2011, BIOCHEM BIOPH RES CO, V405, P42, DOI 10.1016/j.bbrc.2010.12.119	35	135	141	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145930	10.1371/journal.pone.0145930	http://dx.doi.org/10.1371/journal.pone.0145930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720041	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510900026
J	Ardelean, IV; Keller, C; Scheidegger, C				Ardelean, Ioana Violeta; Keller, Christine; Scheidegger, Christoph			Effects of Management on Lichen Species Richness, Ecological Traits and Community Structure in the Rodnei Mountains National Park (Romania)	PLOS ONE			English	Article							EPIPHYTIC LICHENS; BOREAL FORESTS; FUNCTIONAL-GROUPS; BEECH FOREST; LAND-USE; DIVERSITY; BIODIVERSITY; INDICATORS; CONSERVATION; BRYOPHYTES	Lichens are valuable bio-indicators for evaluating the consequences of human activities that are increasingly changing the earth's ecosystems. Since a major objective of national parks is the preservation of biodiversity, our aim is to analyse how natural resource management, the availability of lichen substrates and environmental parameters influence lichen diversity in Rodnei Mountains National Park situated in the Eastern Carpathians. Three main types of managed vegetation were investigated: the transhumance systems in alpine meadows, timber exploitation in mixed and pure spruce forests, and the corresponding conserved sites. The data were sampled following a replicated design. For the analysis, we considered not only all lichen species, but also species groups from different substrates such as soil, trees and deadwood. The lichen diversity was described according to species richness, red-list status and substrate-specialist species richness. The variation in species composition was related to the environmental variables. Habitat management was found to negatively influence species richness and alter the lichen community composition, particularly for threatened and substrate-specialist species. It reduced the mean level of threatened species richness by 59%, when all lichen species were considered, and by 81%, when only epiphytic lichens were considered. Management-induced disturbance significantly decreased lichen species richness in forest landscapes with long stand continuity. The diversity patterns of the lichens indicate a loss of species richness and change in species composition in areas where natural resources are still exploited inside the borders of the national park. It is thus imperative for protected areas, in particular old-growth forests and alpine meadows, to receive more protection than they have received in the past to ensure populations of the characteristic species remain viable in the future.	[Ardelean, Ioana Violeta; Keller, Christine; Scheidegger, Christoph] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Ardelean, Ioana Violeta] Natl Inst Res & Dev Biol Sci, Cluj Napoca, Romania	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Ardelean, IV (corresponding author), Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland.	ioana.ardelean@icbcluj.ro	Scheidegger, Christoph/C-6547-2011	Scheidegger, Christoph/0000-0003-3713-5331	Sectoral Operational Programme for Human Resources Development; European Social Fund [POSDRU/107/1.5/S/76841]; Federal Office for the Environment (FOEN)	Sectoral Operational Programme for Human Resources Development; European Social Fund(European Social Fund (ESF)); Federal Office for the Environment (FOEN)	This work was supported by Sectoral Operational Programme for Human Resources Development 2007-2013, co-financed by the European Social Fund, under the project number POSDRU/107/1.5/S/76841 (http://granturi.ubbcluj.ro/76841/ and Federal Office for the Environment (FOEN) (http://www.bafu.admin.ch/index.html?lang=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APNMR, 2013, MAN PLAN 2013 RODN M; Aragon G, 2010, APPL VEG SCI, V13, P183, DOI 10.1111/j.1654-109X.2009.01060.x; Ardelean IV, 2013, FOLIA CRYPTOGAMICA E, V50, P101, DOI [10.12697/fce.2013.50.13, DOI 10.12697/FCE.2013.50.13]; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barton K., 2014, MULTIMODEL INFERENCE; Bergamini A, 2005, CONSERV BIOL, V19, P1051, DOI 10.1111/j.1523-1739.2005.00086.x; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Boncina A, 2000, GLOBAL ECOL BIOGEOGR, V9, P201, DOI 10.1046/j.1365-2699.2000.00155.x; Bruun HH, 2006, J VEG SCI, V17, P37, DOI 10.1111/j.1654-1103.2006.tb02421.x; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; Caruso A, 2009, BRYOLOGIST, V112, P520, DOI 10.1639/0007-2745-112.3.520; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Cieslinski Stanislaw, 2003, Monographiae Botanicae, V91, P13; Ciurchea M., 2004, KEY LICHENS ROMANIA; Clair LLS, 2007, ARCT ANTARCT ALP RES, V39, P603, DOI 10.1657/1523-0430(06-071)[STCLAIR]2.0.CO;2; Coidea G., MUNTII RODNEI STUDIU; Didukh Y, 2009, RED DATA BOOK UKRAIN; Dymytrova L, 2014, BIODIVERS CONSERV, V23, P1367, DOI 10.1007/s10531-014-0670-1; Ellis CJ, 2012, PERSPECT PLANT ECOL, V14, P131, DOI 10.1016/j.ppees.2011.10.001; Esseen PA, 1996, ECOL APPL, V6, P228, DOI 10.2307/2269566; Evju M, 2009, OECOLOGIA, V161, P77, DOI 10.1007/s00442-009-1358-1; Frank D, 2009, ECOL STUD-ANAL SYNTH, V207, P429, DOI 10.1007/978-3-540-92706-8_19; Frey E., 1958, ANTHROPOGENEN EINFLU, V33, P91; Fritz O, 2008, BIOL CONSERV, V3, P141; Fritz O, 2009, BRYOLOGIST, V112, P488, DOI 10.1639/0007-2745-112.3.488; Gauslaa Y, 1996, FUNCT ECOL, V10, P344, DOI 10.2307/2390282; Gignac LD, 2005, BRYOLOGIST, V108, P50, DOI 10.1639/0007-2745(2005)108[50:EOFSAH]2.0.CO;2; Gorduza V., 1983, PIETROSUL RODNEI 50, P56; Gustafsson L, 2001, PLOS ONE, V6; Hedenas H, 2007, BIOL CONSERV, V135, P388, DOI 10.1016/j.biocon.2006.10.011; Hubbell Stephen P., 2001, V32, pi; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; Hurdu Bogdan Iuliu, 2012, Contributii Botanice, V47, P25; Jonsson BG, 1999, BIODIVERS CONSERV, V8, P1417, DOI 10.1023/A:1008900309571; Knorn J, 2013, ENVIRON CONSERV, V40, P182, DOI 10.1017/S0376892912000355; Kohler F, 2006, FOLIA GEOBOT, V41, P289, DOI 10.1007/BF02904943; Korner C., 2007, TRENDS ECOL EVOL, V11, P22; Leppik E, 2013, BIODIVERS CONSERV, V22, P591, DOI 10.1007/s10531-012-0430-z; Moning C, 2009, ECOL INDIC, V9, P922, DOI 10.1016/j.ecolind.2008.11.002; Nascimbene J, 2009, BIODIVERS CONSERV, V2009, P18; Nascimbene J, 2007, FOREST ECOL MANAG, V247, P43, DOI 10.1016/j.foreco.2007.04.011; Nascimbene J, 2013, FOREST ECOL MANAG, V298, P27, DOI 10.1016/j.foreco.2013.03.008; Nascimbene J, 2012, PLANT ECOL DIVERS, V5, P355, DOI 10.1080/17550874.2012.735715; Nascimbene J, 2010, FOREST ECOL MANAG, V260, P603, DOI 10.1016/j.foreco.2010.05.016; Oksanen J., 2013, R PACKAGE VERSION 23, V2; Pinho P, 2012, ECOL INDIC, V15, P36, DOI 10.1016/j.ecolind.2011.09.022; Pisut I, 2011, OCHRANA PRIRODY, V20, P23; R-Core, 2014, PACKAGE CAR SECOND, V2, DOI DOI 10.1098/rstb.2005.1786; Rai H, 2012, BIODIVERS CONSERV, V21, P97, DOI 10.1007/s10531-011-0168-z; ROBERTS DW, 1986, VEGETATIO, V66, P123, DOI 10.1007/BF00039905; Rose F., 1976, Lichenology: progress and problems, P279; Scheidegger C, 2002, NATO SCI S SS IV EAR, V7, P359; Scheidegger C., 2015, Schweizerische Zeitschrift fur Forstwesen, V166, P75, DOI 10.3188/szf.2015.0075; Scheidegger C, 2002, NATO SCI S SS IV EAR, V7, P163; Scheidegger C., 2009, Forum fur Wissen, P39; SCHEIDEGGER C., 2002, LISTE ROUGE ESPECES; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Seaward MRD, 2008, LICHEN BIOLOGY, 2ND EDITION, P274, DOI 10.1017/CBO9780511790478.015; SELVA SB, 1994, BRYOLOGIST, V97, P424, DOI 10.2307/3243911; Smith C. W., 2009, LICHENS GREAT BRITAI; Spribille T, 2008, ECOGRAPHY, V31, P741, DOI 10.1111/j.1600-0587.2008.05503.x; Stofer S, 2006, LICHENOLOGIST, V38, P331, DOI 10.1017/S0024282906006207; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thor G, 1998, BIODIVERS CONSERV, V7, P59, DOI 10.1023/A:1008807729048; Watt A. D., 2007, V25, P135; Will-Wolf S., 2004, BIODIVERSITY FUNGI I, P173; Wirth V., 1995, FLECHTEN BADEN WURTT	67	19	22	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145808	10.1371/journal.pone.0145808	http://dx.doi.org/10.1371/journal.pone.0145808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717517	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500077
J	Langenfeld, F; Guarracino, Y; Arock, M; Trouve, A; Tchertanov, L				Langenfeld, Florent; Guarracino, Yann; Arock, Michel; Trouve, Alain; Tchertanov, Luba			How Intrinsic Molecular Dynamics Control Intramolecular Communication in Signal Transducers and Activators of Transcription Factor STAT5	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; LOCAL FEATURE ANALYSIS; X-RAY CRYSTALLOGRAPHY; PROTEIN-PHOSPHORYLATION; SH2 DOMAIN; EVOLUTIONARY CONSERVATION; 3-DIMENSIONAL STRUCTURES; TRANSACTIVATION DOMAINS; SERINE PHOSPHORYLATION; STATISTICAL-THEORY	Signal Transducer and Activator of Transcription STAT5 is a key mediator of cell proliferation, differentiation and survival. While STAT5 activity is tightly regulated in normal cells, its constitutive activation directly contributes to oncogenesis and is associated with a broad range of hematological and solid tumor cancers. Therefore the development of compounds able to modulate pathogenic activation of this protein is a very challenging endeavor. A crucial step of drug design is the understanding of the protein conformational features and the definition of putative binding site(s) for such modulators. Currently, there is no structural data available for human STAT5 and our study is the first footprint towards the description of structure and dynamics of this protein. We investigated structural and dynamical features of the two STAT5 isoforms, STAT5a and STAT5b, taken into account their phosphorylation status. The study was based on the exploration of molecular dynamics simulations by different analytical methods. Despite the overall folding similarity of STAT5 proteins, the MD conformations display specific structural and dynamical features for each protein, indicating first, sequence-encoded structural properties and second, phosphorylation-induced effects which contribute to local and long-distance structural rearrangements interpreted as allosteric event. Further examination of the dynamical coupling between distant sites provides evidence for alternative profiles of the communication pathways inside and between the STAT5 domains. These results add a new insight to the understanding of the crucial role of intrinsic molecular dynamics in mediating intramolecular signaling in STAT5. Two pockets, localized in close proximity to the phosphotyrosine-binding site and adjacent to the channel for communication pathways across STAT5, may constitute valid targets to develop inhibitors able to modulate the function-related communication properties of this signaling protein.	[Langenfeld, Florent; Guarracino, Yann; Arock, Michel] Univ Paris Saclay, CNRS, Ecole Normale Super Cachan, Lab Biol & Pharmacol Appl, Cachan, France; [Langenfeld, Florent; Trouve, Alain; Tchertanov, Luba] Univ Paris Saclay, CNRS, Ecole Normale Super, Ctr Math & Leurs Applicat, Cachan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Tchertanov, L (corresponding author), Univ Paris Saclay, CNRS, Ecole Normale Super, Ctr Math & Leurs Applicat, Cachan, France.	Luba.Tchertanov@ens-cachan.fr	, Tchertanov/CAF-3310-2022	/0000-0002-3184-3401	La Ligue Nationale contre le Cancer; Societe Francaise d'Hematologie; Fondation de France [SP00115300]; Institut Farman-ENS de Cachan [TOPDYN, TOPDYN2]	La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Societe Francaise d'Hematologie; Fondation de France(Fondation de France); Institut Farman-ENS de Cachan	Funding was provided by La Ligue Nationale contre le Cancer, www.ligue-cancer.net/ (FL: PhD funding); Societe Francaise d'Hematologie, http://sfh.hematologie.net/ (FL: PhD funding); Fondation de France, www.fondationdefrance.org/ (LT: SP00115300); and Institut Farman-ENS de Cachan, www.farman.ens-cachan.fr/ (LT, AT: TOPDYN, TOPDYN2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain A, 2014, FARADAY DISCUSS, V169, P303, DOI 10.1039/c4fd00024b; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Ando T, 2014, CELL REP, V6, P366, DOI 10.1016/j.celrep.2013.12.029; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger A, 2014, LEUKEMIA, V28, P629, DOI 10.1038/leu.2013.351; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernado P, 2009, PROTEIN SCI, V18, P716, DOI 10.1002/pro.83; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bibi S, 2014, IMMUNOL ALLERGY CLIN, V34, P239, DOI 10.1016/j.iac.2014.01.009; Bibi S, 2014, HAEMATOLOGICA, V99, P417, DOI 10.3324/haematol.2013.098442; Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Casetti Luana, 2013, Med Sci (Paris), V29, P693, DOI 10.1051/medsci/2013298005; Casetti L, 2013, CANCER RES, V73, P2052, DOI 10.1158/0008-5472.CAN-12-3955; Chebaro Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003012; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Cumaraswamy AA, 2014, ACS MED CHEM LETT, V5, P1202, DOI 10.1021/ml500165r; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Beauchene IC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003749; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elumalai, 2015, ANGEW CHEM, V127, P4840, DOI DOI 10.1002/ANGE.201410672; Eyal E, 2007, BIOINFORMATICS, V23, pI175, DOI 10.1093/bioinformatics/btm186; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Gomes PDFC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097519; Friedbichler K, 2011, FRONT BIOSCI-LANDMRK, V16, P3043, DOI 10.2741/3897; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Gianti E, 2015, J COMPUT AID MOL DES, V29, P451, DOI 10.1007/s10822-015-9835-6; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Husby J, 2012, J CHEM INF MODEL, V52, P1179, DOI 10.1021/ci200625q; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Kanai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086790; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Kornfeld JW, 2008, FRONT BIOSCI-LANDMRK, V13, P6237, DOI 10.2741/3151; Laine E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002661; Laine E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002068; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li Haiyan S, 2013, JAKSTAT, V2, pe25112, DOI 10.4161/jkst.25112; Liao ZY, 2011, AM J TRANSL RES, V3, P133; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Micheletti C, 2004, PROTEINS, V55, P635, DOI 10.1002/prot.20049; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Nam S, 2012, MOL ONCOL, V6, P276, DOI 10.1016/j.molonc.2012.02.002; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; Nelson EA, 2011, ONCOTARGET, V2, P518; Nkansah E, 2013, FEBS LETT, V587, P833, DOI 10.1016/j.febslet.2013.01.065; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Page BDG, 2012, J MED CHEM, V55, P1047, DOI 10.1021/jm200720n; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pawson T, 2000, GENE DEV, V14, P1027; Penev PS, 1996, NETWORK-COMP NEURAL, V7, P477, DOI 10.1088/0954-898X/7/3/002; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099391; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090275; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Razeto A, 2004, J MOL BIOL, V336, P319, DOI 10.1016/j.jmb.2003.12.057; Reich NC, 2007, CYTOKINE GROWTH F R, V18, P511, DOI 10.1016/j.cytogfr.2007.06.021; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Ren J, 2010, MOL CELL PROTEOMICS, V9, P623, DOI 10.1074/mcp.M900273-MCP200; Ren ZY, 2008, BIOCHEM BIOPH RES CO, V374, P1, DOI 10.1016/j.bbrc.2008.04.049; Ren Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077363; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scaglia PA, 2012, J CLIN ENDOCR METAB, V97, pE830, DOI 10.1210/jc.2011-2554; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Shelburne CP, 2002, MOL IMMUNOL, V38, P1187, DOI 10.1016/S0161-5890(02)00061-5; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Weber A, 2013, PHARMACEUTICALS, V6, P960, DOI 10.3390/ph6080960; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Zhang T, 2000, MOL CELL BIOL, V20, P7132, DOI 10.1128/MCB.20.19.7132-7139.2000; Zhang ZY, 2006, PROTEINS, V64, P391, DOI 10.1002/prot.20983	107	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145142	10.1371/journal.pone.0145142	http://dx.doi.org/10.1371/journal.pone.0145142			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717567	gold, Green Submitted, Green Published			2022-12-27	WOS:000367510500022
J	Gruszka, D; Herr, R; Hely, H; Hofmann, P; Klitscher, D; Hofmann, A; Rommens, PM				Gruszka, Dominik; Herr, Robert; Hely, Hans; Hofmann, Peer; Klitscher, Daniela; Hofmann, Alexander; Rommens, Pol Maria			Impact of Different Screw Designs on Durability of Fracture Fixation: In Vitro Study with Cyclic Loading of Scaphoid Bones	PLOS ONE			English	Article							HEADLESS COMPRESSION SCREWS; CAST IMMOBILIZATION; OPERATIVE TREATMENT; PLACEMENT; WAIST; MANAGEMENT	Purpose The use of new headless compression screws (HCSs) for scaphoid fixation is growing, but the nonunion rate has remained constant. The aim of this study was to compare the stability of fixation resulting from four modern HCSs using a simulated fracture model to determine the optimal screw design(s). Methods We tested 40 fresh-frozen cadaver scaphoids treated with the Acumed Acutrak 2 mini (AA), the KLS Martin HBS2 midi (MH), the Stryker TwinFix (ST) and the Synthes HCS 3.0 with a long thread (SH). The bones with simulated fractures and implanted screws were loaded uniaxially into flexion for 2000 cycles with a constant bending moment of 800 Nmm. The angulation of the fracture fragments was measured continuously. Data were assessed statistically using the univariate ANOVA test and linear regression analysis, and the significance level was set at p < 0.05. Results The median angulation of bone fragments phi allowed by each screw was 0.89 degrees for AA, 1.12 degrees for ST, 1.44 degrees for SH and 2.36 degrees for MH. With regards to linear regression, the most reliable curve was achieved by MH, with a coefficient of determination of R-2 = 0.827. This was followed by AA (R-2 = 0.354), SH (R-2 = 0.247) and ST (R-2 = 0.019). Data assessed using an adapted ANOVA model showed no statistically significant difference (p = 0.291) between the screws. Conclusions The continuous development of HCSs has resulted in very comparable implants, and thus, at this time, other factors, such as surgeons' experience, ease of handling and price, should be taken into consideration.	[Gruszka, Dominik; Herr, Robert; Klitscher, Daniela; Hofmann, Alexander; Rommens, Pol Maria] Johannes Gutenberg Univ Mainz, Dept Orthopaed & Traumatol, Univ Med Ctr, D-55122 Mainz, Germany; [Hely, Hans; Hofmann, Peer] RheinMain Univ Appl Sci, Div Phys, Wiesbaden, Germany	Johannes Gutenberg University of Mainz	Gruszka, D (corresponding author), Johannes Gutenberg Univ Mainz, Dept Orthopaed & Traumatol, Univ Med Ctr, D-55122 Mainz, Germany.	dominik.gruszka@unimedizin-mainz.de	Gruszka, Dominik/AAB-7785-2020; Gruszka, Dominik/ABE-5001-2020; Hofmann, Alexander/C-3943-2013	Gruszka, Dominik/0000-0001-8360-9441; 	Stryker SA	Stryker SA	Support to an Investigator Initiated Study was provided to The University Medical Center of Johannes Gutenberg University from the Stryker SA in the amount under 10.000 Euros. No benefits of any kind have been received or will be received directly by the authors from a commercial party. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson L, 2001, J HAND SURG-BRIT EUR, V26, P192, DOI 10.1054/jhsb.2001.0558; Arora R, 2007, ARCH ORTHOP TRAUM SU, V127, P39, DOI 10.1007/s00402-006-0229-z; Arora R, 2011, J BONE JOINT SURG AM, V93A, P2146, DOI 10.2106/JBJS.J.01597; Assari S, 2012, INJURY, V43, P1159, DOI 10.1016/j.injury.2012.03.015; Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Beadel GP, 2004, J HAND SURG-AM, V29A, P273, DOI 10.1016/j.jhsa.2003.12.006; Bond CD, 2001, J BONE JOINT SURG AM, V83A, P483, DOI 10.2106/00004623-200104000-00001; Buijze GA, 2011, J HAND SURG-AM, V36A, P1926, DOI 10.1016/j.jhsa.2011.09.012; Burkhart KJ, 2010, BIOMED TECH, V55, P361, DOI 10.1515/BMT.2010.043; Chan KW, 2004, J HAND SURG-AM, V29A, P74, DOI 10.1016/j.jhsa.2003.09.002; Dias JJ, 2011, J BONE JOINT SURG BR, V93B, P1433, DOI 10.1302/0301-620X.93B11.26934; Duckworth AD, 2012, J TRAUMA ACUTE CARE, V72, pE41, DOI 10.1097/TA.0b013e31822458e8; Grewal R, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-27; Gruszka DS, 2012, J HAND SURG-AM, V37A, P1142, DOI 10.1016/j.jhsa.2012.03.018; Haisman JM, 2006, J BONE JOINT SURG AM, V88A, P2750, DOI 10.2106/00004623-200612000-00026; HERBERT TJ, 1984, J BONE JOINT SURG BR, V66, P114, DOI 10.1302/0301-620X.66B1.6693468; Hove LM, 1999, SCAND J PLAST RECONS, V33, P423, DOI 10.1080/02844319950159145; Kawamura K, 2008, J HAND SURG-AM, V33A, P988, DOI 10.1016/j.jhsa.2008.04.026; Leventhal EL, 2009, J HAND SURG-AM, V34A, P677, DOI 10.1016/j.jhsa.2009.01.011; Levitz S, 2005, J HAND SURG-AM, V30A, P543, DOI 10.1016/j.jhsa.2004.12.014; Luria S, 2015, J HAND SURG-AM, V40, P508, DOI 10.1016/j.jhsa.2014.11.008; McQueen MM, 2008, J BONE JOINT SURG BR, V90B, P66, DOI 10.1302/0301-620X.90B1.19767; Meermans G, 2011, J HAND SURG-AM, V36A, P1669, DOI [10.1016/j.jhsa2011.06.023, 10.1016/j.jhsa.2011.06.023]; Menapace KA, 2001, J HAND SURG-AM, V26A, P883, DOI 10.1053/jhsu.2001.27755; Pensy Raymond A, 2009, J Surg Orthop Adv, V18, P182; RANKIN G, 1991, J HAND SURG-AM, V16A, P1002, DOI 10.1016/S0363-5023(10)80059-0; Schadel-Hopfner M, 2009, ARCH ORTHOP TRAUMA S, P1; Schmidle G, 2014, EUR RADIOL, V24, P1357, DOI 10.1007/s00330-014-3116-y; Slade JE, 2008, SCAND J SURG, V97, P280, DOI 10.1177/145749690809700402; Slade JF, 2006, CLIN ORTHOP RELAT R, P108, DOI 10.1097/01.blo.0000205886.66081.9d; Sugarman H., 2011, VIRTUAL REHABILITATI, P1; Toby EB, 1997, J BONE JOINT SURG AM, V79A, P1190, DOI 10.2106/00004623-199708000-00011; Todisco M, 2005, INT J ORAL MAX IMPL, V20, P898; Vinnars B, 2008, J BONE JOINT SURG AM, V90A, P1176, DOI 10.2106/JBJS.G.00673	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145949	10.1371/journal.pone.0145949	http://dx.doi.org/10.1371/journal.pone.0145949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741807	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600015
J	Gulfo, J; Ledda, A; Gea-Sorli, S; Bonjoch, L; Closa, D; Grasa, M; Esteve, M				Gulfo, Jose; Ledda, Angelo; Gea-Sorli, Sabrina; Bonjoch, Laia; Closa, Daniel; Grasa, Mar; Esteve, Montserrat			New Roles for Corticosteroid Binding Globulin and Opposite Expression Profiles in Lung and Liver	PLOS ONE			English	Article							ACUTE-PANCREATITIS; CORTISOL; GLUCOCORTICOIDS; INSUFFICIENCY; BIOSYNTHESIS; TYPE-1; TISSUE	Corticosteroid-binding globulin (CBG) is the specific plasma transport glycoprotein for glucocorticoids. Circulating CBG is mainly synthesized in liver but, its synthesis has been located also in other organs as placenta, kidney and adipose tissue with unknown role. Using an experimental model of acute pancreatitis in cbg(-/-) mice we investigated whether changes in CBG affect the progression of the disease as well as the metabolism of glucocorticoids in the lung. Lack of CBG does not modify the progression of inflammation associated to pancreatitis but resulted in the loss of gender differences in corticosterone serum levels. In the lung, CBG expression and protein level were detected, and it is noteworthy that these showed a sexual dimorphism opposite to the liver, i.e. with higher levels in males. Reduced expression of 11 beta-HSD2, the enzyme involved in the deactivation of corticosterone, was also observed. Our results indicate that, in addition to glucocorticoids transporter, CBG is involved in the gender differences observed in corticosteroids circulating levels and plays a role in the local regulation of corticosteroids availability in organs like lung.	[Gulfo, Jose; Ledda, Angelo; Grasa, Mar; Esteve, Montserrat] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain; [Gulfo, Jose; Ledda, Angelo; Grasa, Mar; Esteve, Montserrat] Inst Hlth Carlos III, CIBER Obes & Nutr, Madrid, Spain; [Gea-Sorli, Sabrina; Bonjoch, Laia; Closa, Daniel] IIBB CSIC IDIBAPS, Dept Expt Pathol, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Esteve, M (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain.	mesteve@ub.edu	Esteve, Montserrat/L-6272-2014; Remesar, Xavier/G-5703-2013; Esteve, Montserrat/AAR-4146-2021; Closa, Daniel/Y-3848-2019; Grasa Martínez, Maria del Mar/L-8031-2014; Gulfo, Jose/Z-1437-2019	Esteve, Montserrat/0000-0003-2128-7859; Remesar, Xavier/0000-0002-9707-7287; Esteve, Montserrat/0000-0003-2128-7859; Grasa Martínez, Maria del Mar/0000-0001-6362-0504; Gulfo, Jose/0000-0001-8862-7104; Bonjoch, Laia/0000-0002-3351-0037; Closa Autet, Daniel/0000-0003-3797-3095	Fondo Investigacion Sanitaria [PI09/00505, PI13/00019]; University of Barcelona; European and Sardinian scholarship "Master and Back"; Generalitat de Catalunya (AGAUR) [FI DGR 2013]	Fondo Investigacion Sanitaria(Instituto de Salud Carlos III); University of Barcelona; European and Sardinian scholarship "Master and Back"; Generalitat de Catalunya (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	Support was provided by: Fondo Investigacion Sanitaria PI09/00505 to ME MG; Fondo Investigacion Sanitaria PI13/00019 to DC SG-S; Predoctoral scholarship from the University of Barcelona to JG; European and Sardinian scholarship "Master and Back" to AL; Grant from Generalitat de Catalunya (AGAUR, Grant FI DGR 2013) to LB.	Andersson AK, 2007, IMMUNOL LETT, V109, P72, DOI 10.1016/j.imlet.2007.01.004; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Buter A, 2002, BRIT J SURG, V89, P298, DOI 10.1046/j.0007-1323.2001.02025.x; Cai TQ, 2001, J STEROID BIOCHEM, V77, P117, DOI 10.1016/S0960-0760(01)00041-3; Caldwell JD, 2014, STEROIDS, V81, P13, DOI 10.1016/j.steroids.2013.11.010; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; Closa D, 1999, ANN SURG, V229, P230, DOI 10.1097/00000658-199902000-00011; Closa D, 2007, WORLD J GASTROENTERO, V13, P170, DOI 10.3748/wjg.v13.i2.170; De Waele JJ, 2007, INTENS CARE MED, V33, P1754, DOI 10.1007/s00134-007-0747-3; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; Folch E, 1999, ANN SURG, V230, P792, DOI 10.1097/00000658-199912000-00008; Franco-Pons N, 2010, J PATHOL, V221, P175, DOI 10.1002/path.2691; Grasa MD, 2007, ENDOCRINOLOGY, V148, P4056, DOI 10.1210/en.2007-0331; Grasa MD, 2001, MOL CELL BIOCHEM, V228, P25, DOI 10.1023/A:1013304223967; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1991, J STEROID BIOCHEM, V40, P755, DOI 10.1016/0960-0760(91)90300-T; Heiniger CD, 2001, FEBS LETT, V507, P351, DOI 10.1016/S0014-5793(01)03004-6; JANSSON JO, 1989, J ENDOCRINOL, V122, P725, DOI 10.1677/joe.0.1220725; Jirikowski GF, 2007, J CHEM NEUROANAT, V34, P22, DOI 10.1016/j.jchemneu.2007.03.007; Minni AM, 2014, PSYCHONEUROENDOCRINO, V50, P252, DOI 10.1016/j.psyneuen.2014.07.029; Misao R, 1999, HORM RES, V51, P162, DOI 10.1159/000023351; Muller CA, 2006, CRIT CARE MED, V34, P1060, DOI 10.1097/01.CCM.0000206285.69499.72; Muller CA, 2007, SCAND J GASTROENTERO, V42, P1354, DOI 10.1080/00365520701416691; Pastor CM, 2003, LAB INVEST, V83, P471, DOI 10.1097/01.LAB.0000063928.91314.9F; Peng YS, 2009, CRIT CARE, V13, DOI 10.1186/cc7978; Perogamvros I, 2012, NAT REV ENDOCRINOL, V8, P717, DOI 10.1038/nrendo.2012.134; Petersen HH, 2006, MOL CELL BIOL, V26, P7236, DOI 10.1128/MCB.00400-06; Richard EM, 2010, ENDOCRINOLOGY, V151, P649, DOI 10.1210/en.2009-0862; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P910, DOI 10.1210/en.132.2.910; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P903, DOI 10.1210/en.132.2.903; Torpy DJ, 2007, CLIN ENDOCRINOL, V67, P161, DOI 10.1111/j.1365-2265.2007.02890.x; Tyan YC, 2005, PROTEOMICS, V5, P1062, DOI 10.1002/pmic.200401041; Yu J, 2012, INFLAMMATION, V35, P11, DOI 10.1007/s10753-010-9284-2; Yu M, 2014, INT J CLIN EXP PATHO, V7, P3647; Zhang J, HEPATOGASTROENTEROLO, V61, P215	37	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146497	10.1371/journal.pone.0146497	http://dx.doi.org/10.1371/journal.pone.0146497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741814	gold, Green Published, Green Submitted			2022-12-27	WOS:000367810600050
J	Cantonwine, DE; Ferguson, KK; Mukherjee, B; Chen, YH; Smith, NA; Robinson, JN; Doubilet, PM; Meeker, JD; McElrath, TF				Cantonwine, David E.; Ferguson, Kelly K.; Mukherjee, Bhramar; Chen, Yin-Hsiu; Smith, Nicole A.; Robinson, Julian N.; Doubilet, Peter M.; Meeker, John D.; McElrath, Thomas F.			Utilizing Longitudinal Measures of Fetal Growth to Create a Standard Method to Assess the Impacts of Maternal Disease and Environmental Exposure	PLOS ONE			English	Article							BIRTH-WEIGHT; INTRAUTERINE GROWTH; SMOKING; PREGNANCY; OBESE; TERM; RESTRICTION; CHILDREN; PRETERM; GAIN	Impaired or suboptimal fetal growth is associated with an increased risk of perinatalmorbidity andmortality. By utilizing readily available clinical data on the relative size of the fetus at multiple points in pregnancy, including delivery, future epidemiological research can improve our understanding of the impacts ofmaternal, fetal, and environmental factors on fetal growth at different windows during pregnancy. This study presentsmean and standard deviation ultrasound measurements froma clinically representative US population that can be utilized for creating Z-scores to this end. Between 2006 and 2012, 18, 904 non-anomalous pregnancies that received prenatal care, first and second trimester ultrasound evaluations, and ultimately delivered singleton newborns at Brigham and Women's hospital in Boston were used to create the standard population. To illustrate the utility of this standard, we created Z-scores for ultrasound and delivery measurements for a cohort study population and examined associations with factors known to be associated with fetal growth. In addition to cross-sectional regression models, we created linear mixed models and generalized additive mixed models to illustrate how these scores can be utilized longitudinally and for the identification of windows of susceptibility. After adjustment for a priori confounders, maternal BMI was positively associated with increased fetal size beginning in the second trimester in cross-sectional models. Female infants and maternal smoking were associated with consistently reduced fetal size in the longitudinal models. Maternal age had a non-significant association with increased size in the first trimester that was attenuated as gestation progressed. As the growth measurements examined here are widely available in contemporary obstetrical practice, these datamay be abstracted from medical records by investigators and standardized with the population means presented here. This will enable easy extension of clinical data to epidemiologic studies investigating novel maternal, fetal, and environmental factors that may impact fetal growth.	[Cantonwine, David E.; Smith, Nicole A.; Robinson, Julian N.; McElrath, Thomas F.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; [Ferguson, Kelly K.; Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Mukherjee, Bhramar; Chen, Yin-Hsiu] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Doubilet, Peter M.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital	Cantonwine, DE (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA.	dcantonwine@partners.org	Doubilet, Peter/AAY-7351-2021; Ferguson, Kelly/C-3745-2019	Ferguson, Kelly/0000-0001-8467-3250; Meeker, John/0000-0001-8357-5085	National Institute of Environmental Health Sciences, National Institutes of Health [R01ES018872]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885, R01ES018872, T32ES007062, P42ES017198, ZIAES103321] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The National Institute of Environmental Health Sciences, National Institutes of Health (R01ES018872), provided funding for the present analysis. Neither Abbott Diagnostics nor NIH had any role in the data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participants and field staff at BWH. Abbott Diagnostics assisted in the initial study design for the study cohort (9MZ-04-06N03). The National Institute of Environmental Health Sciences, National Institutes of Health (R01ES018872), provided funding for the present analysis. Neither Abbott Diagnostics nor NIH had any role in the data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qutob Raeda, 2004, Health Care Women Int, V25, P281, DOI 10.1080/07399330490272769; Alshimmiri MM, 2003, PAEDIATR PERINAT EP, V17, P355, DOI 10.1046/j.1365-3016.2003.00514.x; [Anonymous], 2014, Obstet Gynecol, V124, P863, DOI 10.1097/01.AOG.0000454932.15177.be; Bassan H, 2011, PEDIATR NEUROL, V44, P122, DOI 10.1016/j.pediatrneurol.2010.09.012; Bernstein IM, 2005, OBSTET GYNECOL, V106, P986, DOI 10.1097/01.AOG.0000182580.78402.d2; BUTLER NR, 1972, BMJ-BRIT MED J, V2, P127, DOI 10.1136/bmj.2.5806.127; Crume TL, 2014, OBESITY, V22, P608, DOI 10.1002/oby.20565; Elhddad AS, 2014, ACTA OBSTET GYN SCAN, V93, P771, DOI 10.1111/aogs.12427; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Galjaard S, 2013, OBESITY, V21, P1416, DOI 10.1002/oby.20348; Geelhoed JJM, 2011, BJOG-INT J OBSTET GY, V118, P755, DOI 10.1111/j.1471-0528.2011.02900.x; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Halileh S, 2008, MATERN CHILD HLTH J, V12, P606, DOI 10.1007/s10995-007-0226-z; Hindmarsh PC, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.0000020600.45753.78; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Jaddoe VWV, 2007, AM J EPIDEMIOL, V165, P1207, DOI 10.1093/aje/kwm014; Lin CC, 1998, OBSTET GYNECOL, V92, P1044, DOI 10.1016/S0029-7844(98)00328-7; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Raja UA, 2012, J OBSTET GYNAECOL, V32, P247, DOI 10.3109/01443615.2011.645920; Schrauwers C, 2009, J MATERN-FETAL NEO M, V22, P218, DOI 10.1080/14767050902801652; Szostak-Wegierek Dorota, 2011, Med Wieku Rozwoj, V15, P203; Upadhyay, 2011, Nepal Med Coll J, V13, P42; Varvarigou AA, 2010, J PERINAT MED, V38, P683, DOI [10.1515/JPM.2010.101, 10.1515/jpm.2010.101]; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Zaren B, 2000, PAEDIATR PERINAT EP, V14, P118, DOI 10.1046/j.1365-3016.2000.00247.x; Zhang ZY, 2014, MATERN CHILD HLTH J, V18, P1423, DOI 10.1007/s10995-013-1382-y	28	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146532	10.1371/journal.pone.0146532	http://dx.doi.org/10.1371/journal.pone.0146532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731406	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400189
J	Higuchi-Sanabria, R; Garcia, EJ; Tomoiaga, D; Munteanu, EL; Feinstein, P; Pon, LA				Higuchi-Sanabria, Ryo; Garcia, Enrique J.; Tomoiaga, Delia; Munteanu, Emilia L.; Feinstein, Paul; Pon, Liza A.			Characterization of Fluorescent Proteins for Three- and Four-Color Live-Cell Imaging in S. cerevisiae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; YEAST; SENSITIVITY; MODULES; GENES	Saccharomyces cerevisiae are widely used for imaging fluorescently tagged protein fusions. Fluorescent proteins can easily be inserted into yeast genes at their chromosomal locus, by homologous recombination, for expression of tagged proteins at endogenous levels. This is especially useful for incorporation of multiple fluorescent protein fusions into a single strain, which can be challenging in organisms where genetic manipulation is more complex. However, the availability of optimal fluorescent protein combinations for 3-color imaging is limited. Here, we have characterized a combination of fluorescent proteins, mTFP1/mCitrine/mCherry for multicolor live cell imaging in S. cerevisiae. This combination can be used with conventional blue dyes, such as DAPI, for potential four-color live cell imaging.	[Higuchi-Sanabria, Ryo; Garcia, Enrique J.; Pon, Liza A.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Munteanu, Emilia L.; Pon, Liza A.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Tomoiaga, Delia; Feinstein, Paul] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Tomoiaga, Delia; Feinstein, Paul] CUNY, Grad Ctr Biochem Biol & Biopsychol, New York, NY 10065 USA; [Tomoiaga, Delia; Feinstein, Paul] CUNY, Behav Neurosci Programs, New York, NY 10065 USA	Columbia University; Columbia University; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Pon, LA (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	lap5@columbia.edu		Garcia, Enrique/0000-0002-4779-5766	National Institutes of Health (NIH) [3 R01 GM45735, 1 R01 GM096445, SC1 GM088114, 5 T32 DK7647, 5 T32 GM007367]; Ellison Medical Foundation [AG-SS-2465-10]; Research Centers in Minority Institutions Program from National Institute on Minority Health and Health Disparities [MD007599]; NIH/NCI [5 P30 CA13696]; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122589, R01GM045735, R01GM096445, SC1GM088114, T32GM007367] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Research Centers in Minority Institutions Program from National Institute on Minority Health and Health Disparities; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the National Institutes of Health (NIH) (3 R01 GM45735 and 1 R01 GM096445) to LAP, (SC1 GM088114) to PF, (5 T32 DK7647) to RHS and (5 T32 GM007367) to EJG; the Ellison Medical Foundation (AG-SS-2465-10) to LAP; and the Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities (MD007599) to PF. The microscopes used for these studies are supported in part through a NIH/NCI grant (5 P30 CA13696). URL: National Institutes of Health-http://www.nih.gov, Ellison Medical Foundation-http://www.ellisonfoundation.org.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Bubnell J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074941; Chao JT, 2014, CELL, V158, P620, DOI 10.1016/j.cell.2014.06.033; Deng CH, 2009, MOL CELL PROTEOMICS, V8, P1413, DOI 10.1074/mcp.M800397-MCP200; Garcia-Rodriguez LJ, 2009, CURR BIOL, V19, P1730, DOI 10.1016/j.cub.2009.08.041; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo Mark A, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.top63; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; SUISSA M, 1984, EMBO J, V3, P1773, DOI 10.1002/j.1460-2075.1984.tb02045.x; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Yompakdee C, 1996, GENE, V171, P41, DOI 10.1016/0378-1119(96)00079-0; Young CL, 2012, YEAST, V29, P119, DOI 10.1002/yea.2895	24	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146120	10.1371/journal.pone.0146120	http://dx.doi.org/10.1371/journal.pone.0146120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727004	Green Published, gold			2022-12-27	WOS:000367681500054
J	Khor, KH; Moore, TA; Shiels, IA; Greer, RM; Arumugam, TV; Mills, PC				Khor, Kuan Hua; Moore, Tyson A.; Shiels, Ian A.; Greer, Ristan M.; Arumugam, Thiruma V.; Mills, Paul C.			A Potential Link between the C5a Receptor 1 and the beta(1)-Adrenoreceptor in the Mouse Heart	PLOS ONE			English	Article							RATE-VARIABILITY; SPECTRAL-ANALYSIS; BLOOD-PRESSURE; RAT; COMPLEMENT; ANTAGONIST; BLOCKADE; MICE; PROPRANOLOL; DYSFUNCTION	Purpose Inflammation may contribute to the pathogenesis of specific cardiovascular diseases, but it is uncertain if mediators released during the inflammatory process will affect the continued efficacy of drugs used to treat clinical signs of the cardiac disease. We investigated the role of the complement 5a receptor 1 (C5aR1/CD88) in the cardiac response to inflammation or atenolol, and the effect of C5aR1 deletion in control of baseline heart rate in an anesthetized mouse model. Methods An initial study showed that PMX53, an antagonist of C5aR1 in normal C57BL6/J (wild type, WT) mice reduced heart rate (HR) and appeared to have a protective effect on the heart following induced sepsis. C5aR1 knockout (CD88-/-) mice had a lower HR than wild type mice, even during sham surgery. A model to assess heart rate variability (HRV) in anesthetized mice was developed to assess the effects of inhibiting the beta 1-adrenoreceptor (beta 1-AR) in a randomized crossover study design. Results HR and LF Norm were constitutively lower and SDNN and HF Norm constitutively higher in the CD88-/-compared with WT mice (P< 0.001 for all outcomes). Administration of atenolol (2.5 mg/kg) reduced the HR and increased HRV (P< 0.05, respectively) in the wild type but not in the CD88-/-mice. There was no shift of the sympathovagal balance post-atenolol in either strains of mice (P> 0.05), except for the reduced LF/HF (Lower frequency/High frequency) ratio (P< 0.05) at 60 min post-atenolol, suggesting increased parasympathetic tone of the heart due to the effect of atenolol administration. The HR of the WT mice were lower post atenolol compared to the CD88-/-mice (P = 0.001) but the HRV of CD88-/-mice were significantly increased (P< 0.05), compared with WT mice. Conclusion Knockout of the C5aR1 attenuated the effect of beta(1)-AR in the heart, suggesting an association between the beta(1)-AR and C5aR1, although further investigation is required to determine if this is a direct or causal association.	[Khor, Kuan Hua; Shiels, Ian A.; Greer, Ristan M.; Mills, Paul C.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Moore, Tyson A.; Arumugam, Thiruma V.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Khor, Kuan Hua] Univ Putra Malaysia, Fac Vet Med, Upm Serdang, Selangor, Malaysia	University of Queensland; University of Queensland; Universiti Putra Malaysia	Mills, PC (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	p.mills@uq.edu.au	Greer, Ristan/ABB-9511-2021; Greer, Ristan Mary/N-6948-2015; Arumugam, Thiruma/AAG-6958-2019	Greer, Ristan Mary/0000-0002-1574-4729; Arumugam, Thiruma/0000-0002-3377-0939; Khor, Kuan Hua/0000-0003-1500-9705	Peter and Mary Ellen Stone Memorial Fund	Peter and Mary Ellen Stone Memorial Fund	Funded by Peter and Mary Ellen Stone Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JA, 2005, J FELINE MED SURG, V7, P195, DOI 10.1016/j.jfms.2004.12.003; Ackland GL, 2010, CRIT CARE MED, V38, P388, DOI 10.1097/CCM.0b013e3181c03dfa; Anderson KP, 2003, ANN NONINVAS ELECTRO, V8, P75, DOI 10.1046/j.1542-474X.2003.08112.x; Arumugam TV, 2002, J SURG RES, V103, P260, DOI 10.1006/jsre.2002.6369; Baudrie V, 2007, AM J PHYSIOL-REG I, V292, pR904, DOI 10.1152/ajpregu.00488.2006; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; BOLDT J, 1995, INTENS CARE MED, V21, P218, DOI 10.1007/BF01701475; Busche Marc N, 2010, Ger Med Sci, V8, DOI 10.3205/000109; Byrkjeland R, 2011, SCAND J CLIN LAB INV, V71, P598, DOI 10.3109/00365513.2011.598943; Camm AJ, 1996, EUR HEART J, V17, P354; Campen MJ, 2005, J APPL PHYSIOL, V99, P807, DOI 10.1152/japplphysiol.00039.2005; CARRE F, 1994, EUR HEART J, V15, P58, DOI 10.1093/eurheartj/15.suppl_D.58; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Everitt B, 2011, USE R, P1, DOI 10.1007/978-1-4419-9650-3; Fairchild KD, 2009, AM J PHYSIOL-REG I, V297, pR1019, DOI 10.1152/ajpregu.00132.2009; Farah VMA, 2006, PHYSIOL BEHAV, V89, P569, DOI 10.1016/j.physbeh.2006.07.015; Feldman D, 2010, VASC HEALTH RISK MAN, V6, P387; Frustaci A, 2007, EUR HEART J, V28, P733, DOI 10.1093/eurheartj/ehl525; GALLETLY DC, 1994, BRIT J ANAESTH, V72, P177, DOI 10.1093/bja/72.2.177; Gehrmann J, 2000, AM J PHYSIOL-HEART C, V279, pH733, DOI 10.1152/ajpheart.2000.279.2.H733; Harrison JL, 2010, AUTON NEUROSCI-BASIC, V152, P60, DOI 10.1016/j.autneu.2009.09.019; Hoesel LM, 2007, MOL IMMUNOL, V44, P95, DOI 10.1016/j.molimm.2006.06.009; JAPUNDZIC N, 1990, J AUTONOM NERV SYST, V30, P91, DOI 10.1016/0165-1838(90)90132-3; Joho S, 2007, AM J PHYSIOL-HEART C, V292, pH369, DOI 10.1152/ajpheart.00704.2006; Just A, 2000, AM J PHYSIOL-REG I, V279, pR2214, DOI 10.1152/ajpregu.2000.279.6.R2214; Khor KH, 2015, VET J, V203, P161, DOI 10.1016/j.tvjl.2014.11.018; Khor KH, 2014, VET J, V199, P229, DOI 10.1016/j.tvjl.2013.11.006; LEMMER B, 1985, N-S ARCH PHARMACOL, V330, P42, DOI 10.1007/BF00586708; Lewis MJ, 2010, SCAND J MED SCI SPOR, V20, P794, DOI 10.1111/j.1600-0838.2010.01150.x; Machackova J, 2011, J CELL MOL MED, V15, P545, DOI 10.1111/j.1582-4934.2010.01015.x; Mansier P, 1996, AM J PHYSIOL-HEART C, V271, pH1465, DOI 10.1152/ajpheart.1996.271.4.H1465; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Monsinjon T, 2001, FUND CLIN PHARMACOL, V15, P293, DOI 10.1046/j.1472-8206.2001.00040.x; Morgan M, 2008, EUR J PHARM SCI, V33, P390, DOI 10.1016/j.ejps.2008.01.009; Morner S, 2005, CLIN PHYSIOL FUNCT I, V25, P90, DOI 10.1111/j.1475-097X.2004.00595.x; Mullick A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022919; Opie LH, 2005, DRUGS FOR THE HEART; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; Voigt AM, 2013, AM J VET RES, V74, P665, DOI 10.2460/ajvr.74.5.665; Wang JF, 2005, AM J PHYSIOL-HEART C, V289, pH1577, DOI 10.1152/ajpheart.00258.2005; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; WILLIAMS CA, 1985, J NEUROIMMUNOL, V9, P29, DOI 10.1016/S0165-5728(85)80004-7; Woodruff TM, 2002, ARTHRITIS RHEUM-US, V46, P2476, DOI 10.1002/art.10449; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146022	10.1371/journal.pone.0146022	http://dx.doi.org/10.1371/journal.pone.0146022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727203	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500046
J	Machicao, F; Peter, A; Machann, J; Konigsrainer, I; Bohm, A; Lutz, SZ; Heni, M; Fritsche, A; Schick, F; Konigsrainer, A; Stefan, N; Haring, HU; Staiger, H				Machicao, Fausto; Peter, Andreas; Machann, Juergen; Koenigsrainer, Ingmar; Boehm, Anja; Lutz, Stefan Zoltan; Heni, Martin; Fritsche, Andreas; Schick, Fritz; Koenigsrainer, Alfred; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald			Glucose-Raising Polymorphisms in the Human Clock Gene Cryptochrome 2 (CRY2) Affect Hepatic Lipid Content	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CASEIN-KINASE-I; CIRCADIAN CLOCK; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; METABOLIC SYNDROME; HEALTHY-SUBJECTS; SHIFT WORK; OBESITY; EXPRESSION	Circadian rhythms govern vital functions. Their disruption provokes metabolic imbalance favouring obesity and type-2 diabetes. The aim of the study was to assess the role of clock genes in human prediabetes. To this end, genotype-phenotype associations of 121 common single nucleotide polymorphisms (SNPs) tagging ARNTL, ARNTL2, CLOCK, CRY1, CRY2, PER1, PER2, PER3, and TIMELESS were assessed in a study population of 1,715 non-diabetic individuals metabolically phenotyped by 5-point oral glucose tolerance tests. In subgroups, hyperinsulinaemic-euglycaemic clamps, intravenous glucose tolerance tests, and magnetic resonance imaging/spectroscopy were performed. None of the tested SNPs was associated with body fat content, insulin sensitivity, or insulin secretion. Four CRY2 SNPs were associated with fasting glycaemia, as reported earlier. Importantly, carriers of these SNPs' minor alleles revealed elevated fasting glycaemia and, concomitantly, reduced liver fat content. In human liver tissue samples, CRY2 mRNA expression was directly associated with hepatic triglyceride content. Our data may point to CRY2 as a novel switch in hepatic fuel metabolism promoting triglyceride storage and, concomitantly, limiting glucose production. The anti-steatotic effects of the glucose-raising CRY2 alleles may explain why these alleles do not increase type-2 diabetes risk.	[Machicao, Fausto; Peter, Andreas; Machann, Juergen; Boehm, Anja; Lutz, Stefan Zoltan; Heni, Martin; Fritsche, Andreas; Schick, Fritz; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Machicao, Fausto; Peter, Andreas; Machann, Juergen; Boehm, Anja; Lutz, Stefan Zoltan; Heni, Martin; Fritsche, Andreas; Schick, Fritz; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] German Ctr Diabet Res DZD, Tubingen, Germany; [Peter, Andreas; Boehm, Anja; Lutz, Stefan Zoltan; Heni, Martin; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen Hosp, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany; [Koenigsrainer, Ingmar; Koenigsrainer, Alfred] Univ Tubingen Hosp, Dept Gen Visceral & Transplant Surg, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Nutrit & Prevent Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Staiger, H (corresponding author), Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de		Heni, Martin/0000-0002-8462-3832; Moller, Anja/0000-0002-5344-8533; Schick, Fritz/0000-0002-4231-3406; Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595	German Federal Ministry of Education and Research (BMBF) [01GI0925]; Deutsche Forschungsgemeinschaft [STE 1096/3-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V.). Norbert Stefan is supported by a Heisenberg professorship from the Deutsche Forschungsgemeinschaft (STE 1096/3-1).	Barnea M, 2012, BBA-MOL BASIS DIS, V1822, P1796, DOI 10.1016/j.bbadis.2012.08.005; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Dibner C, 2015, J INTERN MED, V277, P513, DOI 10.1111/joim.12347; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Eide EJ, 2005, METHOD ENZYMOL, V393, P408, DOI 10.1016/S0076-6879(05)93019-X; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Garaulet M, 2010, J AM DIET ASSOC, V110, P917, DOI 10.1016/j.jada.2010.03.017; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; Kelly MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032670; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Machann J, 2006, MAGN RESON MED, V55, P913, DOI 10.1002/mrm.20825; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Peter A, 2012, INT J OBESITY, V36, P774, DOI 10.1038/ijo.2011.154; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Silbernagel G, 2012, J CLIN ENDOCR METAB, V97, pE2288, DOI 10.1210/jc.2012-2152; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Sookoian S, 2007, WORLD J GASTROENTERO, V13, P4242, DOI 10.3748/wjg.v13.i31.4242; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Szosland D, 2010, INT J OCCUP MED ENV, V23, P287, DOI 10.2478/v10001-010-0032-5; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; Tsuzaki K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-150; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	40	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145563	10.1371/journal.pone.0145563	http://dx.doi.org/10.1371/journal.pone.0145563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726810	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500022
J	Watari, A; Hasegawa, M; Yagi, K; Kondoh, M				Watari, Akihiro; Hasegawa, Maki; Yagi, Kiyohito; Kondoh, Masuo			Checkpoint Kinase 1 Activation Enhances Intestinal Epithelial Barrier Function via Regulation of Claudin-5 Expression	PLOS ONE			English	Article							TIGHT JUNCTIONS; DNA-REPAIR; CHK1; PERMEABILITY; MECHANISMS; DEFECTS	Several stressors are known to influence epithelial tight junction (TJ) integrity, but the association between DNA damage and TJ integrity remains unclear. Here we examined the effects of daunorubicin and rebeccamycin, two anti-tumor chemicals that induce DNA damage, on TJ integrity in human intestinal epithelial cells. Daunorubicin and rebeccamycin dose-dependently enhanced transepithelial electrical resistance (TER) and decreased flux of the 4 kDa FITC-dextran in Caco-2 cell monolayer. Daunorubicin-or rebeccamycin-induced enhancement of the TJ barrier function partly rescued attenuation of the barrier function by the inflammatory cytokines TNF-alpha and IFN-gamma. Daunorubicin and rebeccamycin increased claudin-5 expression and the product was distributed in the actin cytoskeleton fraction, which was enriched with TJ proteins. Caffeine, which is an inhibitor of ataxia telangiectasia mutated protein (ATM) and ataxia telangiectasia mutated and Rad3-related protein (ATR), and the Chk1 inhibitor inhibited the TER increases induced by daunorubicin and rebeccamycin, whereas a Chk2 inhibitor did not. Treatment with Chk1 siRNA also significantly inhibited the TER increases. Induction of claudin-5 expression was inhibited by Chk1 inhibitor and by siRNA treatment. Our results suggest that Chk1 activation by daunorubicin and rebeccamycin induced claudin-5 expression and enhanced TJ barrier function in Caco-2 cell monolayer, which suggests a link between DNA damage and TJ integrity in the human intestine.	[Watari, Akihiro; Hasegawa, Maki; Yagi, Kiyohito; Kondoh, Masuo] Osaka Univ, Grad Sch Pharmaceut Sci, Labs Biofunct Mol Chem, Suita, Osaka, Japan	Osaka University	Watari, A (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Labs Biofunct Mol Chem, Suita, Osaka, Japan.	akihiro@phs.osaka-u.ac.jp; masuo@phs.osaka-u.ac.jp			JSPS KAKENHI [26860078]; Suzuken Memorial Foundation; Mishima Kaiun Memorial Foundation; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by JSPS KAKENHI Grant No. 26860078; the Suzuken Memorial Foundation; the Mishima Kaiun Memorial Foundation; and the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Akazawa Y, 2013, SKIN PHARMACOL PHYS, V26, P15, DOI 10.1159/000343173; Amasheh S, 2005, CELL TISSUE RES, V321, P89, DOI 10.1007/s00441-005-1101-0; Amasheh S, 2009, BIOCHEM BIOPH RES CO, V378, P45, DOI 10.1016/j.bbrc.2008.10.164; AUBELSADRON G, 1984, BIOCHIMIE, V66, P333, DOI 10.1016/0300-9084(84)90018-X; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Biazik JM, 2008, ANAT REC, V291, P547, DOI 10.1002/ar.20677; Campbell M, 2009, P NATL ACAD SCI USA, V106, P17817, DOI 10.1073/pnas.0908561106; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Facompre M, 2002, EUR J MED CHEM, V37, P925, DOI 10.1016/S0223-5234(02)01423-X; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Gunzel D, 2012, COMPR PHYSIOL, V2, P1819, DOI 10.1002/cphy.c110045; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Hering NA, 2009, DIGEST DIS, V27, P450, DOI 10.1159/000233283; Jeansonne B, 2003, CELL MOL BIOL, V49, P13; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Lu Z, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24978; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nusrat A, 2000, J CELL SCI, V113, P1771; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Osanai M, 2007, MOL PHARMACOL, V71, P250, DOI 10.1124/mol.106.029579; Overgaard CE, 2011, ANTIOXID REDOX SIGN, V15, P1179, DOI 10.1089/ars.2011.3893; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Reyes JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/730789; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sawada N, 2013, PATHOL INT, V63, P1, DOI 10.1111/pin.12021; Schumann M, 2012, ANN NY ACAD SCI, V1258, P43, DOI 10.1111/j.1749-6632.2012.06565.x; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Takai H, 2000, GENE DEV, V14, P1439; Tamura A, 2014, SEMIN CELL DEV BIOL, V36, P177, DOI 10.1016/j.semcdb.2014.09.019; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Watari A, 2015, BIOTECHNOL LETT, V37, P1177, DOI 10.1007/s10529-015-1791-7; Watari A, 2012, BIOCHEM BIOPH RES CO, V426, P454, DOI 10.1016/j.bbrc.2012.08.083; WELSH MJ, 1985, J CLIN INVEST, V76, P1155, DOI 10.1172/JCI112071; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	47	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145631	10.1371/journal.pone.0145631	http://dx.doi.org/10.1371/journal.pone.0145631			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727128	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500025
J	Zhou, XH; Ji, LN; Ran, XW; Su, BL; Ji, QH; Pan, CY; Weng, JP; Ma, CS; Hao, CM; Zhang, DY; Hu, DY				Zhou, Xianghai; Ji, Linong; Ran, Xingwu; Su, Benli; Ji, Qiuhe; Pan, Changyu; Weng, Jianping; Ma, Changsheng; Hao, Chuanming; Zhang, Danyi; Hu, Dayi		CCMR Advisory Board; CCMR-3B Study Investigators	Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study	PLOS ONE			English	Article							BODY-MASS INDEX; OPTIMAL CUTOFF POINTS; RISK-FACTORS; WEIGHT-LOSS; CARDIOVASCULAR-DISEASES; HYPERTENSION; ASSOCIATION; MORTALITY; ADULTS; CARE	Background There are few data on the prevalence of obesity and its influence on achieving blood glucose, blood pressure, and blood lipid (3B) goals in Chinese type 2 diabetes outpatients. Methods Patient demographic data, anthropometric measurements, medications, and blood glucose and lipid profiles of 24,512 type 2 diabetes patients from a large, geographically diverse study (CCMR-3B) were analyzed. Using cut-points for body mass index (BMI) and waist circumference (WC) recommended by the Working Group on Obesity in China, overweight and obesity were defined as BMIs of 24-27.9kg/m(2) and >= 28.0kg/m(2). Central obesity was defined as a waist circumference >= 80cm in women and >= 85cm in men. The 3B therapeutic goals were HbA1c<7.0%, BP<140/90mmHg and LDL-C<2.6mmol/L. Results Overall, 43.0% of type 2 diabetes patients were overweight and 16.7% were obese; 13.3% of overweight and and 10.1% of obese patients achieved all the 3B target goals. Overweight or obese patients were less likely to achieve 3B goals than those with normal BMIs. More than a half the overweight or obese patients (69.6%) were centrally obese. Patients with abdominal obesity were less likely to achieve cardiometabolic targets than those without abdominal obesity. In multivariate logistic regression analysis, female, higher BMI and waist circumference, smoking, drinking, sedentary lifestyle, and longer diabetes duration were significantly correlated with failure to achieve 3B control goals. Conclusions Obesity is highly prevalent and associated with poor 3B control in Chinese type 2 diabetes patients. In clinical practice, more attention and resources should focus on weight loss for such patients.	[Zhou, Xianghai; Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Zhou, Xianghai; Ji, Linong] Peking Univ, Ctr Diabet, Beijing 100871, Peoples R China; [Ran, Xingwu] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China; [Su, Benli] Dalian Med Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Dalian, Peoples R China; [Ji, Qiuhe] Forth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian, Peoples R China; [Pan, Changyu] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing 100853, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol & Metab, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Changsheng] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [Ma, Changsheng] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Hao, Chuanming] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China; [Zhang, Danyi] Vital Strateg Res Inst, Berwyn, PA USA; [Hu, Dayi] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China	Peking University; Peking University; Sichuan University; Dalian Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Capital Medical University; Fudan University; Peking University	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020	Weng, Jianping/0000-0002-7889-1697	MSD China Holding Co., Ltd. [39103]	MSD China Holding Co., Ltd.	This study was supported by an unrestricted research grant (#39103) from MSD China Holding Co., Ltd.(www.msdchina.com.cn) to LJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2015, DIABETES CARE, V38, pS49, DOI 10.2337/dc15-S011; Belletti DA, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-7; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1066; Chehade JM, 2013, DRUGS, V73, P327, DOI 10.1007/s40265-013-0023-5; Chinese Medical Association Dm Credit Association, 2014, CHINESE J DIABETES, V6, P447, DOI DOI 10.3760/CMA.J.ISSN.1674-5809.2014.07.004; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; Daousi C, 2006, POSTGRAD MED J, V82, P280, DOI 10.1136/pmj.2005.039032; Fujioka K, 2000, DIABETES OBES METAB, V2, P175, DOI 10.1046/j.1463-1326.2000.00081.x; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Iwahashi H, 2012, J DIABETES INVEST, V3, P271, DOI 10.1111/j.2040-1124.2011.00180.x; Felix-Redondo FJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-542; Ji LN, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.035; Ji LN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063404, 10.1371/journal.pone.0057222]; Jones DW, 1999, AM J HYPERTENS, V12, P1175, DOI 10.1016/S0895-7061(99)00123-5; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Okafor CI, 2012, NIGER J CLIN PRACT, V15, P15, DOI 10.4103/1119-3077.94089; Pan CY, 2015, J DIABETES, V7, P222, DOI 10.1111/1753-0407.12179; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Qin L, 2010, EUR J EPIDEMIOL, V25, P5, DOI 10.1007/s10654-009-9395-y; REEDER BA, 1992, CAN MED ASSOC J, V146, P2009; Ryan AS, 2014, J AM GERIATR SOC, V62, P607, DOI 10.1111/jgs.12749; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Said Q, 2010, VALUE HEALTH, V13, P265, DOI 10.1111/j.1524-4733.2009.00649.x; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	30	29	34	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0144179	10.1371/journal.pone.0144179	http://dx.doi.org/10.1371/journal.pone.0144179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726883	gold, Green Published			2022-12-27	WOS:000367681500003
J	Kierulf-Lassen, C; Kristensen, MLV; Birn, H; Jespersen, B; Norregaard, R				Kierulf-Lassen, Casper; Kristensen, Marie Louise Vindvad; Birn, Henrik; Jespersen, Bente; Norregaard, Rikke			No Effect of Remote Ischemic Conditioning Strategies on Recovery from Renal Ischemia-Reperfusion Injury and Protective Molecular Mediators	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; NITRIC-OXIDE; ISCHAEMIA/REPERFUSION INJURY; PRECONDITIONING PROVIDES; VOLATILE ANESTHETICS; OXIDATIVE STRESS; EPITHELIAL-CELLS; HEME OXYGENASE-1; ISCHEMIA/REPERFUSION; ACTIVATION	Ischemia-reperfusion injury (IRI) is the major cause of acute kidney injury. Remote ischemic conditioning (rIC) performed as brief intermittent sub-lethal ischemia and reperfusion episodes in a distant organ may protect the kidney against IRI. Here we investigated the renal effects of rIC applied either prior to (remote ischemic preconditioning; rIPC) or during (remote ischemic perconditioning; rIPerC) sustained ischemic kidney injury in rats. The effects were evaluated as differences in creatinine clearance (CrCl) rate, tissue tubular damage marker expression, and potential kidney recovery mediators. One week after undergoing right-sided nephrectomy, rats were randomly divided into four groups: sham (n = 7), ischemia and reperfusion (IR; n = 10), IR+ rIPC (n = 10), and IR+ rIPerC (n = 10). The rIC was performed as four repeated episodes of 5-minute clamping of the infrarenal aorta followed by 5-minute release either before or during 37 minutes of left renal artery clamping representing the IRI. Urine and blood were sampled prior to ischemia as well as 3 and 7 days after reperfusion. The kidney was harvested for mRNA and protein isolation. Seven days after IRI, the CrCl change from baseline values was similar in the IR (delta: 0.74 mL/min/kg [-0.45 to 1.94]), IR+ rIPC (delta: 0.21 mL/min/kg [-0.75 to 1.17], p > 0.9999), and IR+ rIPerC (delta: 0.41 mL/min/kg [-0.43 to 1.25], p > 0.9999) groups. Kidney function recovery was associated with a significant up-regulation of phosphorylated protein kinase B (pAkt), extracellular regulated kinase 1/2 (pERK1/2), and heat shock proteins (HSPs) pHSP27, HSP32, and HSP70, but rIC was not associated with any significant differences in tubular damage, inflammatory, or fibrosis marker expression. In our study, rIC did not protect the kidney against IRI. However, on days 3-7 after IRI, all groups recovered renal function. This was associated with pAkt and pERK1/2 up-regulation and increased HSP expression at day 7.	[Kierulf-Lassen, Casper; Kristensen, Marie Louise Vindvad; Jespersen, Bente; Norregaard, Rikke] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Kierulf-Lassen, Casper; Birn, Henrik; Jespersen, Bente] Aarhus Univ Hosp, Dept Renal Med, DK-8000 Aarhus, Denmark; [Birn, Henrik] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kierulf-Lassen, C (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	cklassen@dadlnet.dk	Birn, Henrik/C-3931-2009	Birn, Henrik/0000-0003-3715-7266; Jespersen, Bente/0000-0001-7196-2870; Norregaard, Rikke/0000-0002-0580-373X; Norregaard, Rikke/0000-0002-1287-4181	Danish Society of Nephrology Research Foundation; Bjornows Foundation; P.A. Messerschmidt og hustrus Foundation; Department of Clinical Medicine; Lundbeck Foundation [R108-2012-10372] Funding Source: researchfish	Danish Society of Nephrology Research Foundation; Bjornows Foundation; P.A. Messerschmidt og hustrus Foundation; Department of Clinical Medicine; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Society of Nephrology Research Foundation, no grant number (www.nephrology.com); the Bjornows Foundation, no grant number (www.bjoernowsfond.dk); the P.A. Messerschmidt og hustrus Foundation, no grant number (www.bechbruun.com/da/Mennesker/JHW); and the Department of Clinical Medicine, no grant number (www.clin.au.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249; Andreucci M, 2003, KIDNEY INT, V64, P1189, DOI 10.1046/j.1523-1755.2003.00204.x; Athanasiadis D, 2015, J VASC RES, V52, P161, DOI 10.1159/000439219; Aufricht C, 2002, PEDIATR RES, V51, P722, DOI 10.1203/01.PDR.0000015128.65800.28; Bedir S, 2015, J ENDOUROL, V29, P590, DOI 10.1089/end.2014.0563; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Burnside WM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-48; Cao B, 2015, DERMATOL SURG, V41, P53, DOI 10.1097/DSS.0000000000000241; Chen H, 2008, TRANSPL INT, V21, P364, DOI 10.1111/j.1432-2277.2007.00606.x; Curci C, 2014, NEPHROL DIAL TRANSPL, V29, P799, DOI 10.1093/ndt/gft516; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; DRUGDEX&REG; Evaluations, 2015, BUPRENORPHINE MECH A; Dusmez D, 2014, TRANSPL P, V46, P33, DOI 10.1016/j.transproceed.2013.10.036; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; FINN WF, 1980, CIRC RES, V46, P440, DOI 10.1161/01.RES.46.3.440; FRIED TA, 1984, AM J PHYSIOL, V247, pF568, DOI 10.1152/ajprenal.1984.247.4.F568; Fukazawa K, 2014, J AM SOC NEPHROL, V25, P884, DOI 10.1681/ASN.2013111215; Fuller TF, 2005, TRANSPL P, V37, P377, DOI 10.1016/j.transproceed.2004.12.274; Gardner DS, 2014, AM J PHYSIOL-RENAL, V306, pF873, DOI 10.1152/ajprenal.00576.2013; Gassanov N, 2014, J AM SOC NEPHROL, V25, P216, DOI 10.1681/ASN.2013070708; Goligorsky MS, 2002, KIDNEY INT, V61, P855, DOI 10.1046/j.1523-1755.2002.00233.x; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Hausenloy DJ, 2010, CARDIOVASC DRUG THER, V24, P235, DOI 10.1007/s10557-010-6237-9; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Jang HS, 2013, BBA-MOL BASIS DIS, V1832, P1998, DOI 10.1016/j.bbadis.2013.07.001; Jang HS, 2012, NEPHROL DIAL TRANSPL, V27, P3762, DOI 10.1093/ndt/gfs097; Jerkic M, 1999, NEPHROL DIAL TRANSPL, V14, P1398, DOI 10.1093/ndt/14.6.1398; Joo JD, 2006, J AM SOC NEPHROL, V17, P3115, DOI 10.1681/ASN.2006050424; Kierulf-Lassen C, 2015, EUR SURG RES, V55, P151, DOI 10.1159/000437352; Kim J, 2011, FREE RADICAL RES, V45, P759, DOI 10.3109/10715762.2011.577426; Kim J, 2010, AM J PHYSIOL-RENAL, V298, pF158, DOI 10.1152/ajprenal.00474.2009; Kusch A, 2013, ACTA PHYSIOL, V208, P25, DOI 10.1111/apha.12089; Lee HT, 2008, AM J PHYSIOL-RENAL, V295, pF128, DOI 10.1152/ajprenal.00577.2007; Lee HT, 2007, AM J PHYSIOL-RENAL, V293, pF713, DOI 10.1152/ajprenal.00161.2007; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Lee JA, 2012, J KOREAN MED SCI, V27, P547, DOI 10.3346/jkms.2012.27.5.547; Lei BP, 2001, ANESTHESIOLOGY, V95, P445, DOI 10.1097/00000542-200108000-00029; Leung KCW, 2013, NAT REV NEPHROL, V9, P77, DOI 10.1038/nrneph.2012.280; Lifeng Z, 2013, CHONGQING MED; Mahfoudh-Boussaid A, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-71; McCafferty K, 2014, DIS MODEL MECH, V7, P1321, DOI 10.1242/dmm.016741; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Nakajima T, 1996, AM J PHYSIOL-RENAL, V271, pF846, DOI 10.1152/ajprenal.1996.271.4.F846; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; O'Neill S, 2014, NEPHRON EXP NEPHROL, V126, P167, DOI 10.1159/000363323; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; Ponticelli C, 2014, NEPHROL DIAL TRANSPL, V29, P1134, DOI 10.1093/ndt/gft488; Saenz-Morales D, 2009, CELL PHYSIOL BIOCHEM, V23, P285, DOI 10.1159/000218175; Schmid RA, 1996, ANN THORAC SURG, V61, P949, DOI 10.1016/0003-4975(95)01182-X; Sedaghat Z, 2013, CLIN EXP PHARMACOL P, V40, P97, DOI 10.1111/1440-1681.12044; Skrypnyk NI, 2013, JOVE-J VIS EXP, DOI 10.3791/50495; Song T, 2007, COMPARATIVE MED, V57, P200; Wang YP, 2001, CARDIOVASC RES, V49, P391, DOI 10.1016/S0008-6363(00)00266-2; Wever KE, 2013, NEPHROL DIAL TRANSPL, V28, P1721, DOI 10.1093/ndt/gfs601; Wever KE, 2012, TRANSPLANTATION, V94, pE1, DOI 10.1097/TP.0b013e318257ad76; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Wever KE, 2011, NEPHROL DIAL TRANSPL, V26, P3108, DOI 10.1093/ndt/gfr103; Wolfensohn S, 2003, HDB LAB ANIMAL MANAG, P59; Xie LP, 2006, NEPHROLOGY, V11, P207, DOI 10.1111/j.1440-1797.2006.00558.x; Yamabayashi K, 2013, J OSAKA DENT U, V47, P201; Yoon YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124130; Yun Y, 2009, TRANSPL P, V41, P3597, DOI 10.1016/j.transproceed.2009.06.203; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006	68	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146109	10.1371/journal.pone.0146109	http://dx.doi.org/10.1371/journal.pone.0146109			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720280	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510900044
J	Lam, JO; Lim, WY; Chow, KY; D'Souza, G				Lam, Jennifer O.; Lim, Wei-Yen; Chow, Khuan-Yew; D'Souza, Gypsyamber			Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012	PLOS ONE			English	Article							PAPILLOMAVIRUS-RELATED HEAD; ORAL-CAVITY; NECK-CANCER; INCIDENCE RATES; EPIDEMIOLOGY; BURDEN; INFECTION; SURVIVAL; RISK	In recent decades, several Western countries have reported an increase in oropharyngeal and anal cancers caused by human papillomavirus (HPV). Trends in HPV-associated cancers in Asia have not been as well described. We describe the epidemiology of potentially HPV-related cancers reported to the Singapore Cancer Registry from 1968-2012. Analysis included 998 oropharyngeal squamous cell carcinoma (OPSCC), 183 anal squamous cell carcinoma (ASCC) and 8,019 invasive cervical cancer (ICC) cases. Additionally, 368 anal non-squamous cell carcinoma (ANSCC) and 2,018 non-oropharyngeal head and neck carcinoma (non-OP HNC) cases were included as comparators. Age-standardized incidence rates (ASR) were determined by gender and ethnicity (Chinese, Malay and Indian). Join-point regression was used to evaluate annual percentage change (APC) in incidence. OPSCC incidence increased in both genders (men 1993-2012, APC = 1.9%, p<0.001; women 1968-2012, APC = 2.0%, p = 0.01) and was 5 times higher in men than women. In contrast, non-OP HNC incidence declined between 1968-2012 among men (APC = -1.6%, p<0.001) and women (APC = -0.4%, p = 0.06). ASCC and ANSCC were rare (ASR = 0.2 and 0.7 per 100,000 person-years, respectively) and did not change significantly over time except for increasing ANSCCs in men (APC = 2.8%, p<0.001). ICC was the most common HPV-associated cancer (ASR = 19.9 per 100,000 person-years) but declined significantly between 1968-2012 (APC = -2.4%). Incidence of each cancer varied across ethnicities. Similar to trends in Western countries, OPSCC incidence increased in recent years, while non-OP HNC decreased. ICC remains the most common HPV-related cancer in Singapore, but Pap screening programs have led to consistently decreasing incidence.	[Lam, Jennifer O.; D'Souza, Gypsyamber] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Lim, Wei-Yen] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Chow, Khuan-Yew] Natl Registry Dis Off, Singapore, Singapore	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National University of Singapore	D'Souza, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	gdsouza2@jhu.edu			National Institutes of Health [P30 CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [grant number P30 CA006973], www.nih.gov (GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Auluck A, 2010, CANCER-AM CANCER SOC, V116, P2635, DOI 10.1002/cncr.25087; Bahl A, 2014, HEAD NECK-J SCI SPEC, V36, P505, DOI 10.1002/hed.23317; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003]; Bown E, 2014, FUTURE ONCOL, V10, P1427, DOI [10.2217/FON.14.23, 10.2217/fon.14.23]; Boyle P, 1991, IARC Sci Publ, P126; Braakhuis BJM, 2014, ORAL ONCOL, V50, P670, DOI 10.1016/j.oraloncology.2014.03.008; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; CP Wild, 2014, WORLD CANC REPORT 20; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Department of Statistics Singapore, 2013, POP TRENDS 2013; Elwood JM, 2014, CANCER EPIDEMIOL, V38, P16, DOI 10.1016/j.canep.2013.12.004; Epidemiology and Disease Control Division, 2010, DING NAT HLTH SURV 2; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Giuliano AR, 2015, INT J CANCER, V136, P2752, DOI 10.1002/ijc.29082; Grulich AE, 2012, SEX HEALTH, V9, P504, DOI 10.1071/SH12070; Guha N, 2014, INT J CANCER, V135, P1433, DOI 10.1002/ijc.28643; Gupta PC, 2004, ANN ACAD MED SINGAP, V33, P31; Hwang TZ, 2015, INT J CANCER, V137, P395, DOI 10.1002/ijc.29330; Jin AZ, 2013, SINGAP MED J, V54, P96, DOI 10.11622/smedj.2013032; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Joseph AW, 2012, OTOLARYNG CLIN N AM, V45, P739, DOI 10.1016/j.otc.2012.04.003; Joseph DA, 2008, CANCER-AM CANCER SOC, V113, P2892, DOI 10.1002/cncr.23744; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Kurdgelashvili G, 2013, CANCER-AM CANCER SOC, V119, P2291, DOI 10.1002/cncr.27989; Lim TK, 2008, ANN ACAD MED SINGAP, V37, P363; Lim WY, 2014, LUNG CANCER, V84, P23, DOI 10.1016/j.lungcan.2014.01.007; Low JJH, 2012, ASIAN PAC J CANCER P, V13, P305, DOI 10.7314/APJCP.2012.13.1.305; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P81; Mork J, 2010, CANCER CAUSE CONTROL, V21, P1397, DOI 10.1007/s10552-010-9567-9; National Registry of Diseases Office, 2012, SING CANC REG INT AN; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Sankaranarayanan R, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-3; Shin A, 2013, LARYNGOSCOPE, V123, pE30, DOI 10.1002/lary.24243; Simard EP, 2014, ORAL ONCOL, V50, P387, DOI 10.1016/j.oraloncology.2014.01.016; StataCorp, 2011, STAT STAT SOFTW REL; Tay K, 2011, ASIA-PAC J CLIN ONCO, V7, P154, DOI 10.1111/j.1743-7563.2011.01396.x; Tay SK, 2008, VACCINE, V26, pM60, DOI 10.1016/j.vaccine.2008.05.042; Teo MCC, 2013, JPN J CLIN ONCOL, V43, P219, DOI 10.1093/jjco/hys230; Tsao SW, 2014, ORAL ONCOL, V50, P330, DOI 10.1016/j.oraloncology.2014.02.006; Wang H, 2004, ANN ACAD MED SINGAP, V33, P57; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002	50	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146185	10.1371/journal.pone.0146185	http://dx.doi.org/10.1371/journal.pone.0146185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720001	Green Submitted, gold, Green Published			2022-12-27	WOS:000367510900050
J	Lenkov, K; Lee, MH; Lenkov, OD; Swafford, A; Fernald, RD				Lenkov, Kapa; Lee, Mi H.; Lenkov, Olga D.; Swafford, Andrew; Fernald, Russell D.			Epigenetic DNA Methylation Linked to Social Dominance	PLOS ONE			English	Article							QUANTITATIVE BEHAVIORAL OBSERVATIONS; GONADOTROPIN-RELEASING-HORMONE; HAPLOCHROMIS-BURTONI; BRAIN; REACTIVATION; HONEYBEES; PROMOTER; GENES; FISH	Social status hierarchies are ubiquitous in vertebrate social systems, including humans. It is well known that social rank can influence quality of life dramatically among members of social groups. For example, high-ranking individuals have greater access to resources, including food and mating prerogatives that, in turn, have a positive impact on their reproductive success and health. In contrast low ranking individuals typically have limited reproductive success and may experience lasting social and physiological costs. Ultimately, social rank and behavior are regulated by changes in gene expression. However, little is known about mechanisms that transduce social cues into transcriptional changes. Since social behavior is a dynamic process, we hypothesized that a molecular mechanism such as DNA methylation might play a role these changes. To test this hypothesis, we used an African cichlid fish, Astatotilapia burtoni, in which social rank dictates reproductive access. We show that manipulating global DNA methylation state strongly biases the outcomes of social encounters. Injecting DNA methylating and de-methylating agents in low status animals competing for status, we found that animals with chemically increased methylation states were statistically highly likely to ascend in rank. In contrast, those with inhibited methylation processes and thus lower methylation levels were statistically highly unlikely to ascend in rank. This suggests that among its many roles, DNA methylation may be linked to social status and more generally to social behavior.	[Lenkov, Kapa; Lee, Mi H.; Lenkov, Olga D.; Swafford, Andrew; Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Fernald, RD (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.	rfernald@stanford.edu			Stanford Interdisciplinary Graduate Fellowship; Stanford UAR grant [NIH-NS 034950, NSF IOS-0923588]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034950, R01NS034950, R56NS034950] Funding Source: NIH RePORTER	Stanford Interdisciplinary Graduate Fellowship; Stanford UAR grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a Stanford Interdisciplinary Graduate Fellowship to KL, Stanford UAR grant to ML and grants NIH-NS 034950 and NSF IOS-0923588 to RDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7513; Broday L, 1999, MOL CELL BIOL, V19, P3198; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; DAVIS MR, 1990, J NEUROBIOL, V21, P1180, DOI 10.1002/neu.480210804; Day JJ, 2011, NEUROBIOL LEARN MEM, V96, P2, DOI 10.1016/j.nlm.2010.12.008; DiVall SA, 2007, MOL CELL ENDOCRINOL, V270, P64, DOI 10.1016/j.mce.2007.02.007; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; Fernald RD, 2015, ANIM BEHAV, V103, P259, DOI 10.1016/j.anbehav.2015.01.019; Fernald RD, 2012, ANNU REV NEUROSCI, V35, P133, DOI 10.1146/annurev-neuro-062111-150520; FRANCIS RC, 1993, P NATL ACAD SCI USA, V90, P7794, DOI 10.1073/pnas.90.16.7794; Gharizadeh B, 2006, J BIOTECHNOL, V124, P504, DOI 10.1016/j.jbiotec.2006.01.025; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Guidotti A, 2007, NEUROREPORT, V18, P57, DOI 10.1097/WNR.0b013e32800fefd7; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Ma YY, 2015, P NATL ACAD SCI USA, V112, P3805, DOI 10.1073/pnas.1421851112; Maleszka R, 2008, EPIGENETICS-US, V3, P188, DOI 10.4161/epi.3.4.6697; Maruska KP, 2011, ENDOCRINOLOGY, V152, P281, DOI 10.1210/en.2010-0875; Maruska Karen P., 2015, THE OXFORD HANDBOOK, P52; Mascaro O, 2012, P NATL ACAD SCI USA, V109, P6862, DOI 10.1073/pnas.1113194109; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tung J, 2012, P NATL ACAD SCI USA, V109, P6490, DOI 10.1073/pnas.1202734109; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; White SA, 2002, J EXP BIOL, V205, P2567; Wilson E.O., 1975, P1; Yoo J, 2011, J COMPUT AID MOL DES, V25, P555, DOI 10.1007/s10822-011-9441-1; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	36	24	26	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144750	10.1371/journal.pone.0144750	http://dx.doi.org/10.1371/journal.pone.0144750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717574	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500014
J	Taniwaki, MH; Pitt, JI; Iamanaka, BT; Massi, FP; Fungaro, MHP; Frisvad, JC				Taniwaki, Marta Hiromi; Pitt, John I.; Iamanaka, Beatriz T.; Massi, Fernanda P.; Fungaro, Maria Helena P.; Frisvad, Jens C.			Penicillium excelsum sp. nov from the Brazil Nut Tree Ecosystem in the Amazon Basin'	PLOS ONE			English	Article							ASPERGILLUS SECTION FLAVI; IDENTIFICATION; MYCOTOXINS; REGION; DNA	A new Penicillium species, P. excelsum, is described here using morphological characters, extrolite and partial sequence data from the ITS, beta-tubulin and calmodulin genes. It was isolated repeatedly using samples of nut shells and flowers from the brazil nut tree, Bertolletia excelsa, as well as bees and ants from the tree ecosystem in the Amazon rainforest. The species produces andrastin A, curvulic acid, penicillic acid and xanthoepocin, and has unique partial beta-tubulin and calmodulin gene sequences. The holotype of P. excelsum is CCT 7772, while ITAL 7572 and IBT 31516 are cultures derived from the holotype.	[Taniwaki, Marta Hiromi; Iamanaka, Beatriz T.] Inst Tecnol Alimentos, Ctr Ciencia & Qualidade Alimentos, Campinas, SP, Brazil; [Pitt, John I.] CSIRO Food & Nutr, N Ryde, NSW, Australia; [Massi, Fernanda P.; Fungaro, Maria Helena P.] Univ Estadual Londrina, Ctr Ciencias Biol, Londrina, Parana, Brazil; [Frisvad, Jens C.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade Estadual de Londrina; Technical University of Denmark	Taniwaki, MH (corresponding author), Inst Tecnol Alimentos, Ctr Ciencia & Qualidade Alimentos, Campinas, SP, Brazil.	marta@ital.sp.gov.br	Frisvad, Jens C/K-2818-2017; Taniwaki, Marta/ABF-9849-2021; Fungaro, Maria Helena P/H-7369-2014	Frisvad, Jens C/0000-0002-0573-4340; Taniwaki, Marta/0000-0002-1676-2101; Fungaro, Maria Helena P/0000-0002-6199-7030	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/50136-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil [578485/2008-7]; Brazilian Resolution of Genetic Heritage Management Council [MMA/CGEN 21/06]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil; Brazilian Resolution of Genetic Heritage Management Council	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Process 2011/50136-0, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Ministerio da Agricultura, Pecuaria e Abastecimento, (MAPA) Brazil, Process 578485/2008-7. This taxonomic study is supported by the Brazilian Resolution of Genetic Heritage Management Council (MMA/CGEN 21/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayman P, 2002, MYCOPATHOLOGIA, V155, P161, DOI 10.1023/A:1020419226146; Calderari TO, 2013, INT J FOOD MICROBIOL, V160, P267, DOI 10.1016/j.ijfoodmicro.2012.10.018; Freire FDO, 2000, MYCOPATHOLOGIA, V149, P13, DOI 10.1023/A:1007241827937; Frisvad JC, 2004, STUD MYCOL, P1; FRISVAD JC, 1990, NATO ADV SCI I A-LIF, V185, P159; FRISVAD JC, 1987, J CHROMATOGR, V404, P195, DOI 10.1016/S0021-9673(01)86850-3; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Goncalves JS, 2012, WORLD J MICROB BIOT, V28, P1817, DOI 10.1007/s11274-011-0956-3; Hocking AD, 2009, FUNGI AND FOOD SPOIL; Hong SB, 2006, INT J SYST EVOL MICR, V56, P477, DOI 10.1099/ijs.0.63980-0; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Houbraken J, 2011, INT J SYST EVOL MICR, V61, P1462, DOI 10.1099/ijs.0.025098-0; Mansouri S, 2013, ANTON LEEUW INT J G, V103, P1343, DOI 10.1007/s10482-013-9915-3; Massi FP, 2014, INT J FOOD MICROBIOL, V186, P14, DOI 10.1016/j.ijfoodmicro.2014.06.006; Olsen M, 2008, WORLD MYCOTOXIN J, V1, P123, DOI 10.3920/WMJ2008.1032; Pitt JI, 2000, LAB GUIDE COMMON PEN; Pitt JI, 1980, THE GENUS PENICILLIU; Sambrook JD, 2001, LAB MANUAL; Samson RA, 2010, CBS LABORATORY MANUA, V2; Schoch CL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau061; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sonjak S, 2007, ANTON LEEUW INT J G, V92, P43, DOI 10.1007/s10482-006-9133-3; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taniwaki MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042480; Visagie CM, 2014, STUD MYCOL, P343, DOI 10.1016/j.simyco.2014.09.001; Wadt LHO, 2005, FOREST ECOL MANAG, V211, P371, DOI 10.1016/j.foreco.2005.02.061; Wanscher JH, 1978, METHUEN HANDBOOK OF; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	30	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0143189	10.1371/journal.pone.0143189	http://dx.doi.org/10.1371/journal.pone.0143189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717519	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510500005
J	Bavinton, BR; Holt, M; Grulich, AE; Brown, G; Zablotska, IB; Prestage, GP				Bavinton, Benjamin R.; Holt, Martin; Grulich, Andrew E.; Brown, Graham; Zablotska, Iryna B.; Prestage, Garrett P.			Willingness to Act upon Beliefs about 'Treatment as Prevention' among Australian Gay and Bisexual Men	PLOS ONE			English	Article							HIV TREATMENT; RISK; COMMUNITY; STIGMA	HIV 'treatment as prevention' (TasP) is highly effective in reducing HIV transmission in serodiscordant couples. There has been little examination of gay and bisexual men's attitudes towards TasP, particularly regarding men's willingness to act on beliefs about TasP. We conducted an online cross-sectional survey of Australian men in late 2012 to investigate knowledge and beliefs about new developments in HIV prevention. Amongst 839 men (mean age 39.5 years), men tended to disagree that TasP was sufficiently effective to justify reduced condom use, although HIV-positive men had more favourable attitudes. Only a minority of men were aware of any evidence for TasP; and one-quarter incorrectly believed that evidence for the effectiveness of TasP already existed for the homosexual population. One-fifth (20.5%) of men reported that they would be willing to have condomless anal intercourse with an opposite-status sexual partner when the HIV-positive partner was taking HIV treatments. Factors independently associated with such willingness were: HIV-positive serostatus, reporting any serodiscordant or serononconcordant condomless anal intercourse with a regular male partner in the previous six months, reporting any condomless anal intercourse with a casual male partner in the previous six months, and having greater beliefs in the effectiveness of TasP. This indicated that the men most willing to rely on TasP to prevent transmission were already engaging in higher risk practices. Biomedical HIV prevention represents a rapidly changing environment with new research as well as community and policy responses emerging at a fast pace. For men with serodiscordant sexual partners to successfully apply TasP to reducing transmission risk, more support and education is needed to enable better utilisation of TasP in specific relational and sexual contexts.	[Bavinton, Benjamin R.; Grulich, Andrew E.; Zablotska, Iryna B.; Prestage, Garrett P.] Univ NSW Australia, Kirby Inst, Sydney, NSW, Australia; [Holt, Martin] Univ NSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [Brown, Graham; Prestage, Garrett P.] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; La Trobe University	Bavinton, BR (corresponding author), Univ NSW Australia, Kirby Inst, Sydney, NSW, Australia.	bbavinton@kirby.unsw.edu.au	Holt, Martin/X-6482-2019	Holt, Martin/0000-0002-2586-8274; Brown, Graham/0000-0003-4901-0974; Bavinton, Benjamin Robert/0000-0001-5834-8278; Prestage, Garrett/0000-0003-3917-8992	National Health and Medical Research Council (NHMRC) [568971]; Commonwealth of Australia Department of Health and Ageing	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth of Australia Department of Health and Ageing(Australian Government)	This study was commissioned by and funded through a National Health and Medical Research Council (NHMRC) program Grant # 568971 (www.nhmrc.gov.au). The Kirby Institute and the Australian Research Centre in Sex, Health and Society (ARCSHS) receive funding from the Commonwealth of Australia Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogowicz P, 2016, INT J STD AIDS, V27, P281, DOI 10.1177/0956462415575424; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Commonwealth of Australia, 2014, 7 NAT HIV STRAT 2014; Courtenay-Quirk C, 2006, AIDS EDUC PREV, V18, P56, DOI 10.1521/aeap.2006.18.1.56; Crawford JM, 2001, INT J STD AIDS, V12, P164, DOI 10.1258/0956462011916965; Grulich A, 2015, 22 C RETR OPP INF SE; Grulich AE, 2014, SEX HEALTH, V11, P439, DOI 10.1071/SH14122; Hammer SM, 2011, NEW ENGL J MED, V365, P561, DOI 10.1056/NEJMe1107487; Holt M, 2012, AIDS BEHAV, V16, P13, DOI 10.1007/s10461-010-9872-z; Holt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112349; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2013, AIDS BEHAV, V17, P2156, DOI 10.1007/s10461-012-0313-z; Jin FY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00086; Kalichman SC, 2010, HIV MED, V11, P502, DOI 10.1111/j.1468-1293.2009.00818.x; Kippax S, 2003, SOC SCI MED, V57, P1, DOI 10.1016/S0277-9536(02)00303-9; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mao L, 2006, AIDS CARE, V18, P942, DOI 10.1080/09540120500343144; Mao LM, 2013, AIDS BEHAV, V17, P1362, DOI 10.1007/s10461-012-0406-8; McFarland W, 2012, AIDS BEHAV, V16, P121, DOI 10.1007/s10461-011-9936-8; Montaner JSG, 2011, LANCET, V378, P208, DOI 10.1016/S0140-6736(11)60821-0; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Murray JM, 2013, JAIDS-J ACQ IMM DEF, V64, P409, DOI 10.1097/QAI.0b013e3182a6b20c; New South Wales Ministry of Health, 2012, NSW HIV STRAT 2012 2; Newcomb ME, 2016, JAIDS-J ACQ IMM DEF, V71, P200, DOI 10.1097/QAI.0000000000000819; Prestage G, 2013, AIDS BEHAV, V17, P1352, DOI 10.1007/s10461-012-0180-7; Prestage G, 2012, SEX TRANSM DIS, V39, P167, DOI 10.1097/OLQ.0b013e31823e67a9; Rafiee M, 2014, J AIDS CLIN RES, V5, DOI [10.4172/2155-6113.1000383, DOI 10.4172/2155-6113.1000383]; Rodger A, 2014, 21 C RETR OPP INF CR; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Vernazza P., 2008, B MED SUISSES, V89, P165; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Zablotska IB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113167; Zablotska IB, 2012, AIDS BEHAV, V16, P669, DOI 10.1007/s10461-011-9919-9	36	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145847	10.1371/journal.pone.0145847	http://dx.doi.org/10.1371/journal.pone.0145847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4ZD	26741143	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600011
J	Sammond, DW; Kastelowitz, N; Himmel, ME; Yin, H; Crowley, MF; Bomble, YJ				Sammond, Deanne W.; Kastelowitz, Noah; Himmel, Michael E.; Yin, Hang; Crowley, Michael F.; Bomble, Yannick J.			Comparing Residue Clusters from Thermophilic and Mesophilic Enzymes Reveals Adaptive Mechanisms	PLOS ONE			English	Article							METHIONINE AMINOPEPTIDASES; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN THERMOSTABILITY; STAPHYLOCOCCAL NUCLEASE; CRYSTAL-STRUCTURE; PACKING DENSITY; MUTATIONS; STABILITY; STABILIZATION; CELLOBIOHYDROLASE	Understanding how proteins adapt to function at high temperatures is important for deciphering the energetics that dictate protein stability and folding. While multiple principles important for thermostability have been identified, we lack a unified understanding of how internal protein structural and chemical environment determine qualitative or quantitative impact of evolutionary mutations. In this work we compare equivalent clusters of spatially neighboring residues between paired thermophilic and mesophilic homologues to evaluate adaptations under the selective pressure of high temperature. We find the residue clusters in thermophilic enzymes generally display improved atomic packing compared to mesophilic enzymes, in agreement with previous research. Unlike residue clusters from mesophilic enzymes, however, thermophilic residue clusters do not have significant cavities. In addition, anchor residues found in many clusters are highly conserved with respect to atomic packing between both thermophilic and mesophilic enzymes. Thus the improvements in atomic packing observed in thermophilic homologues are not derived from these anchor residues but from neighboring positions, which may serve to expand optimized protein core regions.	[Sammond, Deanne W.; Himmel, Michael E.; Crowley, Michael F.; Bomble, Yannick J.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Kastelowitz, Noah; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Kastelowitz, Noah; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Bomble, YJ (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.	Yannick.Bomble@nrel.gov	YIN, HANG HUBERT/O-2097-2014; crowley, michael/A-4852-2013	YIN, HANG HUBERT/0000-0002-9762-4818; crowley, michael/0000-0001-5163-9398; Bomble, Yannick/0000-0001-7624-8000	US Department of Energy's Bioenergy Technologies Office (DOE-BETO) [DE-AC36-08GO28308]; National Renewable Energy Laboratory; National Institutes of Health [NIH R01GM103843, F30CA180249]; NATIONAL CANCER INSTITUTE [F30CA180249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103843, T32GM008497] Funding Source: NIH RePORTER	US Department of Energy's Bioenergy Technologies Office (DOE-BETO)(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the US Department of Energy's Bioenergy Technologies Office (DOE-BETO), contract no. DE-AC36-08GO28308 with the National Renewable Energy Laboratory and the National Institutes of Health, NIH R01GM103843 (HY), F30CA180249 (NK).	Addlagatta A, 2005, BIOCHEMISTRY-US, V44, P7166, DOI 10.1021/bi0501176; Antranikian G, 2005, ADV BIOCHEM ENG BIOT, V96, P219, DOI 10.1007/b135786; Arimori T, 2013, J SYNCHROTRON RADIAT, V20, P884, DOI 10.1107/S0909049513021110; Baik SH, 2005, APPL ENVIRON MICROB, V71, P3285, DOI 10.1128/AEM.71.6.3285-3293.2005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Borgo B, 2012, P NATL ACAD SCI USA, V109, P1494, DOI 10.1073/pnas.1115172109; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang CM, 2013, PROTEINS, V81, P1192, DOI 10.1002/prot.24268; Chen JM, 2000, J MOL BIOL, V303, P125, DOI 10.1006/jmbi.2000.4140; Chen JM, 2004, J MOL BIOL, V344, P271, DOI 10.1016/j.jmb.2004.09.008; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Daniel RM, 1996, ENZYME MICROB TECH, V19, P74, DOI 10.1016/0141-0229(95)00174-3; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dong HJ, 2008, J MOL BIOL, V378, P264, DOI 10.1016/j.jmb.2008.02.039; dos Santos CR, 2012, J STRUCT BIOL, V177, P469, DOI 10.1016/j.jsb.2011.11.021; Esque J, 2010, J CHEM INF MODEL, V50, P947, DOI 10.1021/ci9004892; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Greaves RB, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-18; Gromiha MM, 2013, PROTEINS, V81, P715, DOI 10.1002/prot.24232; Himmel ME, 1997, APPL BIOCHEM BIOTECH, V63-5, P315, DOI 10.1007/BF02920433; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Kalimeri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113895; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liao H, 2005, PROTEIN ENG DES SEL, V18, P59, DOI 10.1093/protein/gzi009; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018; Momeni MH, 2014, ACTA CRYSTALLOGR D, V70, P2356, DOI 10.1107/S1399004714013844; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Ohmura T, 2001, PROTEIN SCI, V10, P313, DOI 10.1110/ps.37401; Olaleye O, 2010, CHEM BIOL, V17, P86, DOI 10.1016/j.chembiol.2009.12.014; Ostendorp R, 1996, PROTEIN SCI, V5, P862; Paredes DI, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-42; Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229; Podgornaia AI, 2015, SCIENCE, V347, P673, DOI 10.1126/science.1257360; Rastogi P A, 2000, Methods Mol Biol, V132, P47; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Shakhnovich BE, 2005, GENOME RES, V15, P385, DOI 10.1101/gr.3133605; Shaw M., 2008, ANALYSTSOFTS STATPLU, P20; Takai K, 2008, P NATL ACAD SCI USA, V105, P10949, DOI 10.1073/pnas.0712334105; Tsunasawa S, 1997, J BIOCHEM-TOKYO, V122, P843; Vamvaca K, 2008, J MOL BIOL, V382, P971, DOI 10.1016/j.jmb.2008.07.049; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Voutilainen SP, 2014, APPL MICROBIOL BIOT, V98, P2991, DOI 10.1007/s00253-013-5177-2; Wang ZO, 2007, J MOL EVOL, V65, P485, DOI 10.1007/s00239-007-9018-8; Wang ZYO, 2005, METHOD ENZYMOL, V395, P779, DOI 10.1016/S0076-6879(05)95040-4; Watanabe K, 1998, J MOL CATAL B-ENZYM, V4, P167, DOI 10.1016/S1381-1177(97)00031-3; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wilkins MR, 1999, METH MOL B, V112, P531; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yi ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084172	58	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145848	10.1371/journal.pone.0145848	http://dx.doi.org/10.1371/journal.pone.0145848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741367	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600012
J	Baldry, M; Kitir, B; Frokiaer, H; Christensen, SB; Taverne, N; Meijerink, M; Franzyk, H; Olsen, CA; Wells, JM; Ingmer, H				Baldry, Mara; Kitir, Betul; Frokiaer, Hanne; Christensen, Simon B.; Taverne, Nico; Meijerink, Marjolein; Franzyk, Henrik; Olsen, Christian A.; Wells, Jerry M.; Ingmer, Hanne			The agr Inhibitors Solonamide B and Analogues Alter Immune Responses to Staphylococccus aureus but Do Not Exhibit Adverse Effects on Immune Cell Functions	PLOS ONE			English	Article							EXPRESSION; GENE; PROTEIN	Staphylococcus aureus infections are becoming increasingly difficult to treat due to antibiotic resistance with the community-associated methicillin-resistant S. aureus (CA-MRSA) strains such as USA300 being of particular concern. The inhibition of bacterial virulence has been proposed as an alternative approach to treat multi-drug resistant pathogens. One interesting anti-virulence target is the agr quorum-sensing system, which regulates virulence of CA-MRSA in response to agr-encoded autoinducing peptides. Agr regulation confines exotoxin production to the stationary growth phase with concomitant repression of surface-expressed adhesins. Solonamide B, a non-ribosomal depsipeptide of marine bacterial origin, was recently identified as a putative anti-virulence compound that markedly reduced expression of a-hemolysin and phenol-solublemodulins. To further strengthen solonamide anti-virulence candidacy, we report the chemical synthesis of solonamide analogues, investigation of structure-function relationships, and assessment of their potential tomodulate immune cell functions. We found that structural differences between solonamide analogues confer significant differences in interference with agr, while immune cell activity and integrity is generally not affected. Furthermore, treatment of S. aureus with selected solonamides was found to only marginally influence the interaction with fibronectin and biofilm formation, thus addressing the concern that application of compounds inducing an agr-negative state may have adverse interactions with host factors in favor of host colonization.	[Baldry, Mara; Frokiaer, Hanne; Ingmer, Hanne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Kitir, Betul; Christensen, Simon B.; Franzyk, Henrik; Olsen, Christian A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Kitir, Betul; Olsen, Christian A.] Univ Copenhagen, Ctr Biopharmaceut, Copenhagen, Denmark; [Taverne, Nico; Meijerink, Marjolein; Wells, Jerry M.] Wageningen Univ, Host Microbes Interact Grp, NL-6700 AP Wageningen, Netherlands	University of Copenhagen; University of Copenhagen; University of Copenhagen; Wageningen University & Research	Ingmer, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	hi@sund.ku.dk		Olsen, Christian Adam/0000-0002-2953-8942; Christensen, Simon/0000-0002-5229-2127; Ingmer, Hanne/0000-0002-8350-5631; Baldry, Mara/0000-0001-6005-1078; Franzyk, Henrik/0000-0002-2822-1927	European Union's Seventh Framework Program [289285]; Lundbeck Foundation's Group Leader Fellowship; Carlsberg Foundation	European Union's Seventh Framework Program(European Commission); Lundbeck Foundation's Group Leader Fellowship; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the European Union's Seventh Framework Program for research, technological development and demonstration under grant agreement No 289285, the Lundbeck Foundation's Group Leader Fellowship (C.A.O.) and the Carlsberg Foundation (C.A.O.).	Bien J, 2011, J PATHOG, V2011, DOI 10.4061/2011/601905; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; George EA, 2008, J AM CHEM SOC, V130, P4914, DOI 10.1021/ja711126e; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kitir B, 2014, TETRAHEDRON, V70, P7721, DOI 10.1016/j.tet.2014.05.107; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lee LY, 2002, J CLIN INVEST, V110, P1461, DOI 10.1172/JC1200216318; Liu Y, 2011, FEBS LETT, V585, P899, DOI 10.1016/j.febslet.2011.02.021; Lowy FD, 2008, CLIN INFECT DIS, V46; Mansson M, 2011, MAR DRUGS, V9, P2537, DOI 10.3390/md9122537; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Nielsen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084992; Nielsen A, 2010, ANTIMICROB AGENTS CH, V54, P509, DOI 10.1128/AAC.00940-09; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1967, J EXP MED, V125, P45, DOI 10.1084/jem.125.1.45; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; SaraviaOtten P, 1997, J BACTERIOL, V179, P5259, DOI 10.1128/jb.179.17.5259-5263.1997; Shoham M, 2011, FUTURE MED CHEM, V3, P775, DOI [10.4155/FMC.11.43, 10.4155/fmc.11.43]; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Wang B, MOL CELL, V53, P929; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	29	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145618	10.1371/journal.pone.0145618	http://dx.doi.org/10.1371/journal.pone.0145618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731096	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400044
J	Barha, CK; Hanna, CW; Salvante, KG; Wilson, SL; Robinson, WP; Altman, RM; Nepomnaschy, PA				Barha, Cindy K.; Hanna, Courtney W.; Salvante, Katrina G.; Wilson, Samantha L.; Robinson, Wendy P.; Altman, Rachel M.; Nepomnaschy, Pablo A.			Number of Children and Telomere Length in Women: A Prospective, Longitudinal Evaluation	PLOS ONE			English	Article							OXIDATIVE STRESS; ENERGY-EXPENDITURE; ELDERLY-MEN; SENESCENCE; REPRODUCTION; MORTALITY; ASSOCIATION; PERFORMANCE; ALLOCATION; ESTRADIOL	Life history theory (LHT) predicts a trade-off between reproductive effort and the pace of biological aging. Energy invested in reproduction is not available for tissue maintenance, thus having more offspring is expected to lead to accelerated senescence. Studies conducted in a variety of non-human species are consistent with this LHT prediction. Here we investigate the relationship between the number of surviving children born to a woman and telomere length (TL, a marker of cellular aging) over 13 years in a group of 75 Kaqchikel Mayan women. Contrary to LHT's prediction, women who had fewer children exhibited shorter TLs than those who had more children (p = 0.045) after controlling for TL at the onset of the 13-year study period. An "ultimate" explanation for this apparently protective effect of having more children may lay with human's cooperative-breeding strategy. In a number of socioeconomic and cultural contexts, having more chilren appears to be linked to an increase in social support for mothers (e.g., allomaternal care). Higher social support, has been argued to reduce the costs of further reproduction. Lower reproductive costs may make more metabolic energy available for tissue maintenance, resulting in a slower pace of cellular aging. At a "proximate" level, mechanisms involved may include the actions of the gonadal steroid estradiol, which increases dramatically during pregnancy. Estradiol is known to protect TL from the effects of oxidative stress as well as increase telomerase activity, an enzyme that maintains TL. Future research should explore the potential role of social support as well as that of estradiol and other potential biological pathways in the trade-offs between reproductive effort and the pace of cellular aging within and among human as well as in non-human populations.	[Barha, Cindy K.; Salvante, Katrina G.; Nepomnaschy, Pablo A.] Simon Fraser Univ, Fac Hlth Sci, Maternal & Child Hlth Lab, Burnaby, BC V5A 1S6, Canada; [Hanna, Courtney W.; Wilson, Samantha L.; Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Hanna, Courtney W.; Wilson, Samantha L.; Robinson, Wendy P.] Child & Family Res Inst, Vancouver, BC V6T 1Z4, Canada; [Salvante, Katrina G.; Nepomnaschy, Pablo A.] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada; [Altman, Rachel M.] Simon Fraser Univ, Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; University of British Columbia; Child & Family Research Institute; Simon Fraser University; Simon Fraser University	Nepomnaschy, PA (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Maternal & Child Hlth Lab, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	pablo_nepomnaschy@sfu.ca	Robinson, Wendy/AAB-6420-2020; Robinson, Wendy P/I-9590-2014	Robinson, Wendy/0000-0002-2010-6174; Robinson, Wendy P/0000-0002-2010-6174; Wilson, Samantha/0000-0003-4346-9696; Hanna, Courtney/0000-0002-4063-5575; Salvante, Katrina/0000-0002-8608-8001; Wilson, Sarah L./0000-0001-8347-5156; Barha, Cindy/0000-0003-3149-5539; Nepomnaschy, Pablo/0000-0002-8989-7381	Canadian Institutes of Health Research Post-Doctoral Fellowship; Canadian Institutes of Health Research Training Grant; Child and Family Research Institute Graduate Studentship; Child and Family Research Institute; Natural Sciences and Engineering Research Council of Canada Discovery Grant; Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant [106705]; Simon Fraser University President's Start-up Grant; Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser University's Human Evolutionary Studies Program; Michael Smith Foundation for Health Research Career Investigator Scholar Award	Canadian Institutes of Health Research Post-Doctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Training Grant(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute Graduate Studentship; Child and Family Research Institute; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant(Canadian Institutes of Health Research (CIHR)); Simon Fraser University President's Start-up Grant; Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser University's Human Evolutionary Studies Program; Michael Smith Foundation for Health Research Career Investigator Scholar Award	This project was funded by a Canadian Institutes of Health Research Post-Doctoral Fellowship to CKB (http://www.cihr-irsc.gc.ca/e/193.html); a Canadian Institutes of Health Research Training Grant to CWH (http://www.cihr-irsc.gc.ca/e/193.html); a Child and Family Research Institute Graduate Studentship to SLW (http://www.cfri.ca/); a Child and Family Research Institute salary award to WPR (http://www.cfri.ca/); a Natural Sciences and Engineering Research Council of Canada Discovery Grant to RMA (http://www.nserc-crsng.gc.ca/index_eng.asp); a Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant #106705 (http://www.cihr-irsc.gc.ca/e/193.html), a Simon Fraser University President's Start-up Grant (https://www.sfu.ca/vpacademic/FinBdgt_Mgmnt/prsg.html), a Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser University's Human Evolutionary Studies Program (https://www.sfu.ca/vpresearch/ctef.html), and a Michael Smith Foundation for Health Research Career Investigator Scholar Award (http://www.msfhr.org/) to PAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Bauch C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2540; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Benetos A, 2013, AGING CELL, V12, P615, DOI 10.1111/acel.12086; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Boonekamp JJ, 2014, ECOL LETT, V17, P599, DOI 10.1111/ele.12263; Boudreau L, 2014, ANIM REPROD SCI, V145, P86, DOI 10.1016/j.anireprosci.2014.01.004; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carroll JE, 2013, PSYCHOSOM MED, V75, P171, DOI 10.1097/PSY.0b013e31828233bf; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Criscuolo F, 2006, PHYSIOL BIOCHEM ZOOL, V79, P514, DOI 10.1086/501065; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Ellison PT, 2003, FERTIL STERIL, V80, P1279, DOI 10.1016/S0015-0282(03)02158-7; Finch CE, 1990, LONGEVITY SENESCENCE; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Gadalla SM, 2010, AGING-US, V2, P867, DOI 10.18632/aging.100235; Gao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125674; Garratt M, 2013, J EXP BIOL, V216, P2879, DOI 10.1242/jeb.082669; Gray KE, 2014, EPIDEMIOLOGY, V25, P139, DOI 10.1097/EDE.0000000000000017; Gurven M, 2012, EXP GERONTOL, V47, P807, DOI 10.1016/j.exger.2012.05.006; Hamel S, 2010, ECOL LETT, V13, P915, DOI 10.1111/j.1461-0248.2010.01478.x; Hanna CW, 2009, HUM REPROD, V24, P1206, DOI 10.1093/humrep/dep007; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hayflick Leonard, 1998, Keio Journal of Medicine, V47, P174; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Helle S, 2005, P ROY SOC B-BIOL SCI, V272, P29, DOI 10.1098/rspb.2004.2944; Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; Jasienska G, 2001, FOUND HUM B, P59; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; King EDA, 2013, ECOL EVOL, V3, P4161, DOI 10.1002/ece3.786; Kipling D, 2001, MATURITAS, V38, P25, DOI 10.1016/S0378-5122(00)00189-4; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Kramer KL, 2010, EVOL ANTHROPOL, V19, P136, DOI 10.1002/evan.20265; Kramer KL, 2005, EVOL ANTHROPOL, V14, P224, DOI 10.1002/evan.20082; Kuznetsova T, 2010, AM J EPIDEMIOL, V172, P440, DOI 10.1093/aje/kwq142; Kyo S, 1999, CANCER RES, V59, P5917; Llodra ER, 2002, ADV MAR BIOL, V43, P87; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191; Masi S, 2014, EUR HEART J, V35, P3296, DOI 10.1093/eurheartj/ehu226; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; McCracken J, 2010, ENVIRON HEALTH PERSP, V118, P1564, DOI 10.1289/ehp.0901831; Meehan CL, 2013, AM J HUM BIOL, V25, P42, DOI 10.1002/ajhb.22336; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Nepomnaschy PA, 2004, AM J HUM BIOL, V16, P523, DOI 10.1002/ajhb.20057; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Plot V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040855; Puterman E, 2012, SOC PERSONAL PSYCHOL, V6, P807, DOI 10.1111/j.1751-9004.2012.00465.x; Reichert S, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00009; Reichert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081496; Ricklefs RE, 2010, AGING CELL, V9, P273, DOI 10.1111/j.1474-9726.2009.00542.x; Stearns S.C., 1992, pi; Sudyka J, 2014, J EVOLUTION BIOL, V27, P2258, DOI 10.1111/jeb.12479; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Theall KP, 2013, SOC SCI MED, V85, P50, DOI 10.1016/j.socscimed.2013.02.030; Valdes AM, 2010, NEUROBIOL AGING, V31, P986, DOI 10.1016/j.neurobiolaging.2008.07.012; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wong LSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023118; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006	72	32	32	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146424	10.1371/journal.pone.0146424	http://dx.doi.org/10.1371/journal.pone.0146424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731744	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400174
J	Basu, D; Tian, L; Debrosse, T; Poirier, E; Emch, K; Herock, H; Travers, A; Showalter, AM				Basu, Debarati; Tian, Lu; Debrosse, Tayler; Poirier, Emily; Emch, Kirk; Herock, Hayley; Travers, Andrew; Showalter, Allan M.			Glycosylation of a Fasciclin-Like Arabinogalactan-Protein (SOS5) Mediates Root Growth and Seed Mucilage Adherence via a Cell Wall Receptor-Like Kinase (FEI1/FEI2) Pathway in Arabidopsis	PLOS ONE			English	Article							EPIDERMAL-CELLS; CELLULOSE SYNTHESIS; COAT MUCILAGE; SECRETORY-CELLS; GENE-EXPRESSION; SYNTHASE; IDENTIFICATION; ENCODES; BIOSYNTHESIS; DEPOSITION	Fundamental processes that underpin plant growth and development depend crucially on the action and assembly of the cell wall, a dynamic structure that changes in response to both developmental and environmental cues. While much is known about cell wall structure and biosynthesis, much less is known about the functions of the individual wall components, particularly with respect to their potential roles in cellular signaling. Loss-of-function mutants of two arabinogalactan-protein (AGP)-specific galactosyltransferases namely, GALT2 and GALT5, confer pleiotropic growth and development phenotypes indicating the important contributions of carbohydrate moieties towards AGP function. Notably, galt2galt5 double mutants displayed impaired root growth and root tip swelling in response to salt, likely as a result of decreased cellulose synthesis. These mutants phenocopy a salt-overly sensitive mutant called sos5, which lacks a fasciclin-like AGP (SOS5/FLA4) as well as a fei1fei2 double mutant, which lacks two cell wall-associated leucine-rich repeat receptor-like kinases. Additionally, galt2gal5 as well as sos5 and fei2 showed reduced seed mucilage adherence. Quintuple galt2galt5sos5fei1fei2 mutants were produced and provided evidence that these genes act in a single, linear genetic pathway. Further genetic and biochemical analysis of the quintuple mutant demonstrated involvement of these genes with the interplay between cellulose biosynthesis and two plant growth regulators, ethylene and ABA, in modulating root cell wall integrity.	[Basu, Debarati; Tian, Lu; Debrosse, Tayler; Poirier, Emily; Emch, Kirk; Herock, Hayley; Travers, Andrew; Showalter, Allan M.] Ohio Univ, Dept Environm & Plant Biol, Mol & Cellular Biol Program, Athens, OH 45701 USA	University System of Ohio; Ohio University	Showalter, AM (corresponding author), Ohio Univ, Dept Environm & Plant Biol, Mol & Cellular Biol Program, Athens, OH 45701 USA.	showalte@ohio.edu		Showalter, Allan/0000-0003-0775-4991	National Science Foundation Grant [0918661]; Ohio University Baker Fund Award [FN1006071]	National Science Foundation Grant(National Science Foundation (NSF)); Ohio University Baker Fund Award	This work was supported by a National Science Foundation Grant (grant no. 0918661), http://www.nsf.gov/ and Ohio University Baker Fund Award FN1006071, http://www.ohio.edu/research/funding.cfm.	AESCHBACHER RA, 1995, GENE DEV, V9, P330, DOI 10.1101/gad.9.3.330; Arsovski AA, 2009, PLANT PHYSIOL, V150, P1219, DOI 10.1104/pp.109.138388; Baek D, 2011, PLANT CELL PHYSIOL, V52, P149, DOI 10.1093/pcp/pcq182; Baskin TI, 1992, CURRENT TOPICS PLANT, V11, P118; Basu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125624; Basu D, 2013, J BIOL CHEM, V288, P10132, DOI 10.1074/jbc.M112.432609; Ben-Tov D, 2015, PLANT PHYSIOL, V167, P711, DOI 10.1104/pp.114.240671; Boisson-Dernier A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001719; Bouquin T, 2003, J CELL SCI, V116, P791, DOI 10.1242/jcs.00274; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; De Cnodder T, 2005, NEW PHYTOL, V168, P541, DOI 10.1111/j.1469-8137.2005.01540.x; Dean G, 2011, MOL PLANT, V4, P1074, DOI 10.1093/mp/ssr040; Decreux A, 2005, PLANT CELL PHYSIOL, V46, P268, DOI 10.1093/pcp/pci026; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Francoz E, 2015, TRENDS PLANT SCI, V20, P515, DOI 10.1016/j.tplants.2015.04.008; Gish LA, 2011, PLANT J, V66, P117, DOI 10.1111/j.1365-313X.2011.04518.x; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Griffiths JS, 2015, PLANT PHYSIOL, V168, P502, DOI 10.1104/pp.15.00478; Griffiths JS, 2014, PLANT PHYSIOL, V165, P991, DOI 10.1104/pp.114.239400; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Hamann T, 2015, PHYTOCHEMISTRY, V112, P100, DOI 10.1016/j.phytochem.2014.09.019; Hamann T, 2011, PLANT SIGNAL BEHAV, V6, P1706, DOI 10.4161/psb.6.11.17782; Harpaz-Saad S, 2011, PLANT J, V68, P941, DOI 10.1111/j.1365-313X.2011.04760.x; He ZH, 1996, J BIOL CHEM, V271, P19789, DOI 10.1074/jbc.271.33.19789; HEIM DR, 1990, PLANT PHYSIOL, V93, P695, DOI 10.1104/pp.93.2.695; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Huang J, 2011, PLANT PHYSIOL, V156, P491, DOI 10.1104/pp.111.172023; Humphrey TV, 2007, NEW PHYTOL, V176, P7, DOI 10.1111/j.1469-8137.2007.02192.x; Ito S, 2005, BIOSCI BIOTECH BIOCH, V69, P1963, DOI 10.1271/bbb.69.1963; Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938; Johnson KL, 2003, PLANT PHYSIOL, V133, P1911, DOI 10.1104/pp.103.031237; Kohorn BD, 2006, PLANT J, V46, P307, DOI 10.1111/j.1365-313X.2006.02695.x; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Lamport DTA, 2006, NEW PHYTOL, V169, P479, DOI 10.1111/j.1469-8137.2005.01591.x; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Li J, 2010, PLANT J, V64, P482, DOI 10.1111/j.1365-313X.2010.04344.x; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Mendu V, 2011, PLANT PHYSIOL, V157, P441, DOI 10.1104/pp.111.179069; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; North HM, 2014, ANN BOT-LONDON, V114, P1251, DOI 10.1093/aob/mcu011; Ogawa-Ohnishi M, 2015, PLANT J, V81, P736, DOI 10.1111/tpj.12764; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Seifert GJ, 2014, ANN BOT-LONDON, V114, P1125, DOI 10.1093/aob/mcu010; SERPE MD, 1994, PLANTA, V193, P542, DOI 10.1007/BF02411560; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Steinwand BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098193; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Sullivan S, 2011, PLANT PHYSIOL, V156, P1725, DOI 10.1104/pp.111.179077; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Voiniciuc C, 2015, INT J MOL SCI, V16, P3452, DOI 10.3390/ijms16023452; Western TL, 2000, PLANT PHYSIOL, V122, P345, DOI 10.1104/pp.122.2.345; Western TL, 2004, PLANT PHYSIOL, V134, P296, DOI 10.1104/pp.103.035519; Willats WGT, 2001, PLANTA, V213, P37, DOI 10.1007/s004250000481; Wolf S, 2012, ANNU REV PLANT BIOL, V63, P381, DOI 10.1146/annurev-arplant-042811-105449; Xu J, 2018, PHYTOCHEMISTRY, V69, P1631; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; Xue H, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.989064; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yoneda A, 2010, PLANT J, V64, P657, DOI 10.1111/j.1365-313X.2010.04356.x; Zhu JH, 2010, PLANT J, V63, P128, DOI 10.1111/j.1365-313X.2010.04227.x; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	75	57	62	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145092	10.1371/journal.pone.0145092	http://dx.doi.org/10.1371/journal.pone.0145092			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731606	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400021
J	Budeus, B; Timm, J; Hoffmann, D				Budeus, Bettina; Timm, Joerg; Hoffmann, Daniel			SeqFeatR for the Discovery of Feature-Sequence Associations	PLOS ONE			English	Article							T-CELL RESPONSE; HIV-1; ADAPTATION; ALIGNMENT; PROTEIN; CANCER; CCR5	Specific selection pressures often lead to specifically mutated genomes. The open source software SeqFeatR has been developed to identify associations between mutation patterns in biological sequences and specific selection pressures ("features"). For instance, SeqFeatR has been used to discover in viral protein sequences new T cell epitopes for hosts of given HLA types. SeqFeatR supports frequentist and Bayesian methods for the discovery of statistical sequence-feature associations. Moreover, it offers novel ways to visualize results of the statistical analyses and to relate them to further properties. In this article we demonstrate various functions of SeqFeatR with real data. The most frequently used set of functions is also provided by a web server. SeqFeatR is implemented as R package and freely available from the R archive CRAN (http://cran.r-project.org/web/packages/SeqFeatR/index.html). The package includes a tutorial vignette. The software is distributed under the GNU General Public License (version 3 or later).	[Budeus, Bettina; Hoffmann, Daniel] Univ Duisburg Essen, Fac Biol, Res Grp Bioinformat, Essen, Nrw, Germany; [Timm, Joerg] Univ Hosp Dusseldorf, Inst Virol, Dusseldorf, Germany	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Hoffmann, D (corresponding author), Univ Duisburg Essen, Fac Biol, Res Grp Bioinformat, Essen, Nrw, Germany.	daniel.hoffmann@uni-due.de	Hoffmann, Daniel/B-1314-2018; Hoffmann, Daniel/P-5624-2019; Timm, Jörg/P-7652-2019	Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869; Timm, Jörg/0000-0001-7799-3045; Budeus, Bettina/0000-0002-9313-8636	Deutsche Forschungsgemeinschaft [TRR 60 / B1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding for this work was provided by Deutsche Forschungsgemeinschaft (http://www.dfg.de), grant TRR 60 / B1 to JT and DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JH, 1990, CAN J STAT, V18, P347, DOI 10.2307/3315841; ALBERT JH, 1982, ANN STAT, V10, P1261, DOI 10.1214/aos/1176345991; Albert J, 2009, USE R, P1, DOI 10.1007/978-0-387-92298-0_1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chute CG, 2013, GENET MED, V15, P802, DOI 10.1038/gim.2013.121; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; DSouza MP, 1996, NAT MED, V2, P1293, DOI 10.1038/nm1296-1293; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Epp LS, 2011, MOL ECOL RESOUR, V11, P842, DOI 10.1111/j.1755-0998.2011.03022.x; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Hansen NF, 2013, BIOINFORMATICS, V29, P1498, DOI 10.1093/bioinformatics/btt183; Heider D, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-14; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kefalakes H, 2015, HEPATOLOGY, V62, P47, DOI 10.1002/hep.27771; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Plummer M., 2003, P 3 INT WORKSH DISTR; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2013, R LANG ENV STAT COMP; Renteria Miguel E, 2013, Methods Mol Biol, V1019, P193, DOI 10.1007/978-1-62703-447-0_8; Ruhl M, 2012, J VIROL, V86, P991, DOI 10.1128/JVI.05603-11; Ruhl M, 2011, GASTROENTEROLOGY, V140, P2064, DOI 10.1053/j.gastro.2011.02.060; Schmidt C, 2015, NATURE, V527, pS10, DOI 10.1038/527S10a; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Wang Y., 2013, ADV CIV ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0058804; Xiao LH, 1998, VIROLOGY, V240, P83, DOI 10.1006/viro.1997.8924	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146409	10.1371/journal.pone.0146409	http://dx.doi.org/10.1371/journal.pone.0146409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731669	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400173
J	Fernandez, CE; Tenuta, LMA; Cury, JA				Fernandez, Constanza E.; Tenuta, Livia M. A.; Cury, Jaime A.			Validation of a Cariogenic Biofilm Model to Evaluate the Effect of Fluoride on Enamel and Root Dentine Demineralization	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS BIOFILM; IN-VITRO; ANTICARIES EFFICACY; SUCROSE EXPOSURE; CARIES LESIONS; PLAQUE; DENTIFRICE; SITU; TOOTHPASTES; INHIBITION	Due to gingival recession both enamel and root dentine are at risk of developing caries. Both tissues are exposed to a similar environment, however there is not a validated model to evaluate the effect of fluoride on these dental substrates simultaneously. Hence, this study aimed to validate a caries model to evaluate the effect of fluoride to prevent demineralization on enamel and root-dentine. Streptococcus mutans UA159 biofilms were formed on saliva-coated bovine enamel and root dentine slabs (n = 12 per group) mounted in the same well of culture plates. The biofilms were exposed 8x/day to 10% sucrose and treated 2x/day with fluoridated solutions containing 0, 150, 450, or 1,350 ppm F; thus, simulating the use of low to high fluoride concentration toothpastes. The pH values of the culture medium was monitored 2x/day as a biofilm acidogenicity indicator. After 96 h, biofilms were collected for fluoride concentration analysis. The percentage of surface hardness loss (% SHL) was calculated for slabs. The fluoride uptake by the enamel and dentine was also determined. The model showed a dose-response because the biofilm and fluoride uptake increased and % SHL decreased at increasing fluoride concentrations (p < 0.05). Fluoride in the biofilm formed on dentine and fluoride uptake by dentine were higher than those for enamel. With the same fluoride concentration treatment, the percentage of reduction of demineralization was lower for dentine than for enamel. In conclusion, the model was validated in terms of a dose-response effect of fluoride on enamel and root dentine. Furthermore, the findings support the clinical data, suggesting that higher fluoride concentrations are necessary to control caries of root dentine than of enamel.	[Fernandez, Constanza E.; Tenuta, Livia M. A.; Cury, Jaime A.] Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas	Cury, JA (corresponding author), Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Sao Paulo, Brazil.	jcury@unicamp.br	Cury, Jaime/AAV-6647-2021; Tenuta, Livia MA/D-2811-2012; Fernández, Constanza E./X-9554-2019; Cury, Jaime/G-3607-2012	Tenuta, Livia MA/0000-0003-4626-4477; Fernández, Constanza E./0000-0003-0979-7637; Cury, Jaime/0000-0003-1046-5605	Foundation of UNICAMP (FUNCAMP) [4252]; Government of Chile (CONICYT) [1166/2011]	Foundation of UNICAMP (FUNCAMP); Government of Chile (CONICYT)	This work was supported by Foundation of UNICAMP (FUNCAMP; Conv. 4252) http://www.funcamp.unicamp.br/site/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is based on the first author's doctorate thesis (Graduate Program in Dentistry, Cariology Area, Faculty of Dentistry of Piracicaba, State University of Campinas, UNICAMP, Brazil). During the doctorate, she received a scholarship from Government of Chile (CONICYT, Res. 1166/2011). Preliminary reports of this publication were presented at the 91th General Session of the IADR, Seattle, USA, 2013 and the 30th Annual Meeting of SBPqO (Brazilian Division of IADR), Brazil, 2013.	Aires CP, 2008, CARIES RES, V42, P380, DOI 10.1159/000154783; Aires CP, 2002, CARIES RES, V36, P167, DOI 10.1159/000059331; Baysan A, 2001, CARIES RES, V35, P41; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; Bratthall D, 1996, EUR J ORAL SCI, V104, P416, DOI 10.1111/j.1600-0722.1996.tb00104.x; Cavalcanti YW, 2014, BIOFOULING, V30, P579, DOI 10.1080/08927014.2014.905547; Ccahuana-Vásquez Renzo Alberto, 2010, Braz. oral res., V24, P135, DOI 10.1590/S1806-83242010000200002; Ribeiro CCC, 2012, BRAZ ORAL RES, V26, P300, DOI 10.1590/S1806-83242012000400003; Cury J A, 2008, Adv Dent Res, V20, P13; Cury JA, 2000, CARIES RES, V34, P491, DOI 10.1159/000016629; Cury JA, 1997, CARIES RES, V31, P356, DOI 10.1159/000262418; Cury Jaime Aparecido, 2004, Braz. Dent. J., V15, P167, DOI 10.1590/S0103-64402004000300001; Cury Jaime Aparecido, 2009, Braz. oral res., V23, P23, DOI 10.1590/S1806-83242009000500005; DUKE SA, 1982, BRIT DENT J, V152, P52, DOI 10.1038/sj.bdj.4804743; Ekstrand KR, 2013, CARIES RES, V47, P391, DOI 10.1159/000348581; Featherstone J D, 1994, Am J Dent, V7, P271; Fiske CH, 1925, J BIOL CHEM, V66, P375; Giacaman RA, 2014, J APPL MICROBIOL, V117, P846, DOI 10.1111/jam.12561; Giacaman RA, 2012, CARIES RES, V46, P460, DOI 10.1159/000339428; Hara AT, 2003, CARIES RES, V37, P339, DOI 10.1159/000072165; Hara AT, 2004, EUR J ORAL SCI, V112, P67, DOI 10.1111/j.0909-8836.2004.00093.x; HERKSTROTER FM, 1991, CARIES RES, V25, P317, DOI 10.1159/000261385; HOPPENBROUWERS PMM, 1986, J DENT RES, V65, P955, DOI 10.1177/00220345860650071101; Kawasaki K, 1997, J DENT RES, V76, P588, DOI 10.1177/00220345970760011001; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Koo RH, 1998, AM J DENT, V11, P173; Kusano SC, 2011, BRAZ ORAL RES, V25, P383, DOI 10.1590/S1806-83242011000500002; Laheij AMGA, 2010, CARIES RES, V44, P260, DOI 10.1159/000314673; Ledder RG, 2012, ARCH ORAL BIOL, V57, P139, DOI 10.1016/j.archoralbio.2011.08.004; Leme AFP, 2004, J DENT RES, V83, P71, DOI 10.1177/154405910408300114; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Marinho V C, 2003, Cochrane Database Syst Rev, pCD002278, DOI 10.1002/14651858.CD002278; MARINHO VC, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002781.PUB2; McBain Andrew J, 2009, Adv Appl Microbiol, V69, P99, DOI 10.1016/S0065-2164(09)69004-3; MORENO EC, 1974, J DENT RES, V53, P226, DOI 10.1177/00220345740530020901; Munoz-Sandoval Cecilia, 2012, Pediatr Dent, V34, pe197; Negri Helena Maria Decico, 2002, Pesqui Odontol Bras, V16, P361; NYVAD B, 1982, INT DENT J, V32, P312; OGAARD B, 1988, CARIES RES, V22, P302, DOI 10.1159/000261125; Petersen PE, 2005, COMMUNITY DENT ORAL, V33, P81, DOI 10.1111/j.1600-0528.2004.00219.x; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Santos APP, 2013, CARIES RES, V47, P382, DOI 10.1159/000348492; Shellis RP, 2010, CARIES RES, V44, P380, DOI 10.1159/000318224; Srinivasan M, 2014, COMMUNITY DENT ORAL, V42, P333, DOI 10.1111/cdoe.12090; Tan HP, 2010, J DENT RES, V89, P1086, DOI 10.1177/0022034510375825; ten Cate JM, 1998, CARIES RES, V32, P141, DOI 10.1159/000016444; ten Cate JM, 1999, ACTA ODONTOL SCAND, V57, P325, DOI 10.1080/000163599428562; TENCATE JM, 1995, EUR J ORAL SCI, V103, P362; Tenuta LMA, 2013, MONOGR ORAL SCI, V23, P108, DOI 10.1159/000350479; Tenuta Livia Maria Andalo, 2010, Braz Oral Res, V24 Suppl 1, P9, DOI 10.1590/S1806-83242010000500003; Thomas RZ, 2006, CARIES RES, V40, P281, DOI 10.1159/000093186; Thomas RZ, 2007, J DENT, V35, P547, DOI 10.1016/j.jdent.2007.03.002; Vale GC, 2011, J DENT RES, V90, P77, DOI 10.1177/0022034510383428; VOGEL GL, 1983, CARIES RES, V17, P23, DOI 10.1159/000260645; Walls A W G, 2012, Adv Dent Res, V24, P36, DOI 10.1177/0022034512453590; Walsh T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007868.pub2; Wang ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132512; Wefel J S, 1994, Am J Dent, V7, P261; Wierichs RJ, 2015, J DENT RES, V94, P261, DOI 10.1177/0022034514557330; Yeung C Albert, 2014, Evid Based Dent, V15, P8, DOI 10.1038/sj.ebd.6400981	60	39	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146478	10.1371/journal.pone.0146478	http://dx.doi.org/10.1371/journal.pone.0146478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731743	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400183
J	Lee, HF; Wu, LS; Chan, YH; Lee, CH; Liu, JR; Tu, HT; Wen, MS; Kuo, CT; Chen, WJ; Yeh, YH; See, LC; Chang, SH				Lee, Hsin-Fu; Wu, Lung-Sheng; Chan, Yi-Hsin; Lee, Cheng-Hung; Liu, Jia-Rou; Tu, Hui-Tzu; Wen, Ming-Shien; Kuo, Chi-Tai; Chen, Wei-Jan; Yeh, Yung-Hsin; See, Lai-Chu; Chang, Shang-Hung			Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ARTERY-BYPASS-SURGERY; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; CLINICAL-OUTCOMES; RENAL-DISEASE; CARDIOVASCULAR-DISEASE; IMPACT; RISK; SURVIVAL	Objective To investigate the efficacy and long-term clinical benefits of DES for dialysis patients. Background It is unclear whether percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation is associated with lower rates of major adverse cardiovascular events (MACE) or mortality compared to bare-metal stents (BMS). Methods From a nationwide cohort selected from Taiwan's National Health Insurance Research Database, we enrolled 2,835 dialysis patients who were hospitalized for PCI treatment with stent implantation from Dec 1, 2006. Follow-up was from the date of index hospitalization for PCI until the first MACE, date of death, or December 31, 2011, whichever came first. Results A total of 738 patients (26.0%) had DES implanted, and 2,097 (74%) had BMS implanted. The medium time to the first MACE was 0.53 years (interquartile range: 0.89 years; range: 0-4.62 years). At 1-year follow-up, patients treated with BMS had significantly, non-fatal myocardial infarction (MI), all-cause mortality, and composite MACE compared to those treated with DES. The overall repeat revascularization with coronary artery bypass graft (CABG), non-fatal MI, all-cause mortality, and composite MACE were significantly lower in patients treated with DES than those treated with BMS. Multivariate cox regression analysis showed that older age, history of diabetes, history of heart failure, history of stroke, and DES vs. BMS were independent significant predictors of MACE. Conclusions DES implantation conferred survival benefits in dialysis patients compared with BMS implantation.	[Lee, Hsin-Fu; Wu, Lung-Sheng; Chan, Yi-Hsin; Lee, Cheng-Hung; Wen, Ming-Shien; Kuo, Chi-Tai; Chen, Wei-Jan; Yeh, Yung-Hsin; Chang, Shang-Hung] Chang Gung Univ, Taipei, Taiwan; [Lee, Hsin-Fu; Wu, Lung-Sheng; Chan, Yi-Hsin; Lee, Cheng-Hung; Wen, Ming-Shien; Kuo, Chi-Tai; Chen, Wei-Jan; Yeh, Yung-Hsin; Chang, Shang-Hung] Chang Gung Mem Hosp, Dept Cardiol, Taipei 10591, Taiwan; [Liu, Jia-Rou; Tu, Hui-Tzu; See, Lai-Chu] Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan; [See, Lai-Chu] Chang Gung Univ, Mol Med Res Ctr, Biostat Core Lab, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	See, LC (corresponding author), Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan.	lichu@mail.cgu.edu.tw; afen.chang@gmail.com	Yeh, Yung-Hsin/ABD-9351-2021; Chan, Yi-Hsin/ABA-5023-2021; Lee, Hsin-Fu/AAC-1560-2019; Lee, Cheng-Hung/ABA-8070-2021	See, Lai-Chu/0000-0002-1379-8969; Chang, Shang-hung/0000-0003-0462-2344; Chan, Yi-Hsin/0000-0002-1406-8503	Chang Gung Memorial Hospital Linkou Medical Center [CMRPG3B1691]	Chang Gung Memorial Hospital Linkou Medical Center	This research was supported by the Chang Gung Memorial Hospital Linkou Medical Center, grant number CMRPG3B1691, to S.H. Chang (https://www.cgmh.org.tw/eng2002/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the subjects and staff involved in this study for their cooperation. The Chang Gung Memorial Hospital Linkou Medical Center provided grant support for this research. No potential conflicts of interest relevant to this article were reported.	Abdel-Latif A, 2010, CATHETER CARDIO INTE, V76, P942, DOI 10.1002/ccd.22562; Al Suwaidi J, 2002, CIRCULATION, V106, P974, DOI 10.1161/01.CIR.0000027560.41358.B3; Aoyama T, 2008, CIRC J, V72, P56, DOI 10.1253/circj.72.56; Berger PB, 2010, CIRCULATION, V121, P2575, DOI 10.1161/CIRCULATIONAHA.109.895342; BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231; Brilakis ES, 2013, JAMA-J AM MED ASSOC, V310, P189, DOI 10.1001/jama.2013.7086; Charytan DM, 2007, NEPHROL DIAL TRANSPL, V22, P1665, DOI 10.1093/ndt/gfl835; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; Das Pranab, 2006, J Invasive Cardiol, V18, P405; Fanelli F, 2014, CARDIOVASC INTER RAD, V37, P898, DOI 10.1007/s00270-014-0904-3; Halkin Amir, 2006, J Invasive Cardiol, V18, P577; Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB; Hoffmann R, 1999, AM J CARDIOL, V83, P1170, DOI 10.1016/S0002-9149(99)00053-3; Ishio N, 2007, CIRC J, V71, P1525, DOI 10.1253/circj.71.1525; Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3; Kim BK, 2009, J INTERV CARDIOL, V22, P411, DOI 10.1111/j.1540-8183.2009.00495.x; Liu JY, 2000, CIRCULATION, V102, P2973; Luo JC, 2011, CAN MED ASSOC J, V183, pE1345, DOI 10.1503/cmaj.110299; Meliga E, 2013, J INTERV CARDIOL, V26, P351, DOI 10.1111/joic.12034; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Montalescot G, 2008, INT J CARDIOL, V129, P379, DOI 10.1016/j.ijcard.2007.07.127; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; NOTOHAMIPRODJO M, 1986, Blood Purification, V4, P130, DOI 10.1159/000169436; O'Connor GT, 1999, J AM COLL CARDIOL, V34, P681, DOI 10.1016/S0735-1097(99)00267-3; Ohtake T, 2005, J AM SOC NEPHROL, V16, P1141, DOI 10.1681/ASN.2004090765; Okada T, 2008, CIRC J, V72, P1430, DOI 10.1253/circj.CJ-08-0010; Orford JL, 2002, J AM COLL CARDIOL, V40, P1567, DOI 10.1016/S0735-1097(02)02374-4; Otsuka Y, 2011, EUR HEART J, V32, P829, DOI 10.1093/eurheartj/ehq480; Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5; SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; VIENER A, 1986, NEPHRON, V43, P139, DOI 10.1159/000183813; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Wu CT, 2014, CIRC-CARDIOVASC INTE, V7, P80, DOI 10.1161/CIRCINTERVENTIONS.113.000475; Yachi S, 2009, AM J KIDNEY DIS, V54, P299, DOI 10.1053/j.ajkd.2009.01.263; Yang YW, 2011, STROKE, V42, P319, DOI 10.1161/STROKEAHA.110.596361; Yao Q, 2004, Minerva Urol Nefrol, V56, P237; Yasuda Hiroshi, 2015, World J Crit Care Med, V4, P40, DOI 10.5492/wjccm.v4.i1.40	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146343	10.1371/journal.pone.0146343	http://dx.doi.org/10.1371/journal.pone.0146343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731408	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400154
J	Yagi-Utsumi, M; Kato, K; Nishimura, K				Yagi-Utsumi, Maho; Kato, Koichi; Nishimura, Katsuyuki			Membrane-Induced Dichotomous Conformation of Amyloid beta with the Disordered N-Terminal Segment Followed by the Stable C-Terminal beta Structure	PLOS ONE			English	Article							SOLID-STATE NMR; ANGLE-SPINNING NMR; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; MOLECULAR-STRUCTURE; CROSS-POLARIZATION; FIBRILS; PEPTIDE; SHEET; A-BETA(1-40)	Various neurodegenerative disorders are ascribed to pathogenic molecular processes involving conformational transitions of amyloidogenic proteins into toxic aggregates characterized by their beta structures. Accumulating evidence indicates that neuronal cell membranes provide platforms for such conformational transitions of pathogenic proteins as best exemplified by amyloid beta (A beta). Therefore, membrane-bound A beta species can be promising targets for the development of novel drugs for Alzheimer's disease. In the present study, solid-state nuclear magnetic resonance spectroscopy has elucidated the membrane-induced conformation of A beta, in which the disordered N-terminal segment is followed by the stable C-terminal beta strand. The data provides an insight into the molecular processes of the conformational transition of A beta coupled with its assembly into parallel beta structures.	[Yagi-Utsumi, Maho] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Yagi-Utsumi, Maho; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Nishimura, Katsuyuki] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Nishimura, K (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	nishimur@ims.ac.jp		Yagi-Utsumi, Maho/0000-0001-8144-740X; Kato, Koichi/0000-0001-7187-9612	JSPS/MEXT KAKENHI [15K21680, 25410158, 25102001, 25102008]; National Center for Geriatrics and Gerontology [25-19]; Nanotechnology Platform Program of MEXT; Okazaki ORION Project; Grants-in-Aid for Scientific Research [25102008] Funding Source: KAKEN	JSPS/MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Center for Geriatrics and Gerontology; Nanotechnology Platform Program of MEXT; Okazaki ORION Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS/MEXT KAKENHI Grant-in-Aid for Young Scientists (B) (15K21680 to MY-U) (https://www.jsps.go.jp/english/e-grants/grants01.html), Grant-in-Aid for Scientific Research (C) (25410158 to KN) (https://www.jsps.go.jp/english/e-grants/grants01.html), Grant-in-Aid for Scientific Research on Innovative Areas (25102001 and 25102008 to KK) (https://www.jsps.go.jp/english/e-grants/grants01.html), Research Funding for Longevity Sciences (25-19) from the National Center for Geriatrics and Gerontology, the Nanotechnology Platform Program of MEXT (http://nanonet.mext.go.jp/english/), and the Okazaki ORION Project (http://www.oib.orion.ac.jp/English/index.html). All these grants were used in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Ms. Yukiko Isono for her help in preparing recombinant proteins. This work was supported in part by JSPS/MEXT KAKENHI Grant-in-Aid for Yong Scientists (B) (15K21680 to M.Y.-U.), Grant-in-Aid for Scientific research (C) (25410158 to K.N.), Grant-in-Aid for Scientific Research on Innovative Areas (25102001 and 25102008 to K.K.), Research Funding for Longevity Sciences (25-19) from the National Center for Geriatrics and Gerontology, the Nanotechnology Platform Program of MEXT, and the Okazaki ORION project.	Akinlolu RD, 2015, BIOCHEMISTRY-US, V54, P3416, DOI 10.1021/acs.biochem.5b00321; [Anonymous], 2010, INT J ALZHEIMERS DIS; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chen LL, 2006, J AM CHEM SOC, V128, P9992, DOI 10.1021/ja062347t; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Fantini J, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001602; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Lau TL, 2007, BBA-BIOMEMBRANES, V1768, P3135, DOI 10.1016/j.bbamem.2007.08.027; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Nakazawa Y, 2009, CHEM PHYS LIPIDS, V158, P54, DOI 10.1016/j.chemphyslip.2008.12.001; Niu Z, 2014, ANGEW CHEM INT EDIT, V53, P9294, DOI 10.1002/anie.201311106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2014, BIOCHEMISTRY-US, V53, P7503, DOI 10.1021/bi501003n; SCHAEFER J, 1979, J MAGN RESON, V34, P443, DOI 10.1016/0022-2364(79)90022-2; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Scherpelz KP, 2016, METHODS MOL BIOL, V1345, P299, DOI 10.1007/978-1-4939-2978-8_20; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x; Xiao Y, 2015, NAT STRUCT MOL BIOL; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	41	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146405	10.1371/journal.pone.0146405	http://dx.doi.org/10.1371/journal.pone.0146405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731546	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400172
J	Baker, SE; Sharp, TM; Macdonald, DW				Baker, Sandra E.; Sharp, Trudy M.; Macdonald, David W.			Assessing Animal Welfare Impacts in the Management of European Rabbits (Oryctolagus cuniculus), European Moles (Talpa europaea) and Carrion Crows (Corvus corone)	PLOS ONE			English	Article							PEST; PREDATION; CONSERVATION; CONSEQUENCES; DISLOCATION; AGGREGATION; THRESHOLDS; STRATEGIES; KNOWLEDGE; ATTITUDES	Human-wildlife conflict is a global issue. Attempts to manage this conflict impact upon wild animal welfare, an issue receiving little attention until relatively recently. Where human activities harm animal welfare these effects should be minimised where possible. However, little is known about the welfare impacts of different wildlife management interventions, and opinions on impacts vary widely. Welfare impacts therefore need to be assessed objectively. Our objectives were to: 1) establish whether an existing welfare assessment model could differentiate and rank the impacts of different wildlife management interventions (for decision-making purposes); 2) identify and evaluate any additional benefits of making formal welfare assessments; and 3) illustrate issues raised by application of the model. We applied the welfare assessment model to interventions commonly used with rabbits (Oryctolagus cuniculus), moles (Talpa europaea) and crows (Corvus corone) in the UK. The model ranked interventions for rabbits (least impact first: fencing, head shot, chest shot) and crows (shooting, scaring, live trapping with cervical dislocation). For moles, managing molehills and tunnels scored least impact. Both spring trapping, and live trapping followed by translocation, scored greater impacts, but these could not be compared directly as they scored on different axes of the model. Some rankings appeared counter-intuitive, highlighting the need for objective formal welfare assessments. As well as ranking the humaneness of interventions, the model highlighted future research needs and how Standard Operating Procedures might be improved. The model is a milestone in assessing wildlife management welfare impacts, but our research revealed some limitations of the model and we discuss likely challenges in resolving these. In future, the model might be developed to improve its utility, e. g. by refining the time-scales. It might also be used to reach consensus among stakeholders about relative welfare impacts or to identify ways of improving wildlife management practice in the field.	[Baker, Sandra E.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford, Oxon, England; [Sharp, Trudy M.] Univ New S Wales, Sch Biol Earth & Environm Sci, Fowlers Gap Arid Zone Res Stn, Ctr Ecosyst Sci, Kensington, NSW 2052, Australia	University of Oxford; University of New South Wales Sydney	Baker, SE (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, S Parks Rd, Oxford, Oxon, England.	sandra.baker@zoo.ox.ac.uk	Sharp, Trudy/AAE-9639-2019		Humane Society International/UK; Elinor Patterson Baker Foundation; Peoples' Trust for Endangered Species; Humane Society International	Humane Society International/UK; Elinor Patterson Baker Foundation; Peoples' Trust for Endangered Species; Humane Society International	SB was supported by a fellowship from the Humane Society International/UK (http://www.hsi.org/world/united_kingdom/) and the Elinor Patterson Baker Foundation (https://fdo.foundationcenter.org/grantmaker-profile?collection = grantmakers&key=BAKE011&page=8&from_search=1/). TS received no specific funding for this work. DM was supported by funding from Dr and Mrs Tom Kaplan and the Peoples' Trust for Endangered Species (http://ptes.org/). Publication fees were provided by the Humane Society International. The funders had no role in study design, data collection and analysis, or decision to publish. Andrew Rowan of HSI/US and Mark Jones previously of HSI/UK made helpful comments on an earlier draft of the paper but had no other role in preparation of the manuscript.	[Anonymous], 2011, MODEL CODE PRACTICE; [Anonymous], ADV VERTEBRATE PEST; [Anonymous], 2001, RESOLVING HUMAN WILD; ATKINSON RPD, 1994, MAMMAL REV, V24, P73, DOI 10.1111/j.1365-2907.1994.tb00136.x; ATKINSON RPD, 1994, J APPL ECOL, V31, P731, DOI 10.2307/2404163; AVMA Panel on Euthanasia. American Veterinary Medical Association, 2000, J AM VET MED ASSOC, V218, P669; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Baker SE, 2015, ANIM WELFARE, V24, P1, DOI 10.7120/09627286.24.1.001; Baker SE, 2012, ANIM WELFARE, V21, P613; Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; Baker SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039334; Baker SE, 2000, J RURAL STUD, V16, P185, DOI 10.1016/S0743-0167(99)00051-0; Beausoleil NJ, 2015, NEW ZEAL VET J, V63, P37, DOI 10.1080/00480169.2014.956832; Beausoleil N.J., 2012, ALTEX P, V1, P481; Botreau R, 2007, ANIMAL, V1, P1188, DOI 10.1017/S1751731107000547; Botreau R, 2007, ANIMAL, V1, P1179, DOI 10.1017/S1751731107000535; Broom DM, 2007, ANIM WELFARE, V16, P45; Broom D. M, 1999, ADV VERTEBRATE PEST, P309; Bush ER, 2014, CONSERV BIOL, V28, P663, DOI 10.1111/cobi.12240; Conner MM, 2008, ECOL MODEL, V219, P234, DOI 10.1016/j.ecolmodel.2008.09.008; Cornell HN, 2012, P ROY SOC B-BIOL SCI, V279, P499, DOI 10.1098/rspb.2011.0957; CROCKER J, 1984, NEW SCI, V101, P10; Dawkins MS, 2006, TRENDS ECOL EVOL, V21, P77, DOI 10.1016/j.tree.2005.10.017; Defra, 2009, SPRING TRAP COLL TES; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Farm Animal Welfare Council, 2013, 5 FREED; Fisher P, 2010, 201101 MIN AGR FOR B; Fraser D, 2010, ANIM WELFARE, V19, P121; Fraser D., 2008, UNDERSTANDING ANIMAL; Gorman M.L, 1990, NATURAL HIST MOLES; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; GREGORY NG, 1990, VET REC, V126, P570; Hampton JO, 2015, ANIM WELFARE, V24, P307, DOI 10.7120/09627286.24.3.307; Harrington LA, 2013, CONSERV BIOL, V27, P486, DOI 10.1111/cobi.12021; Harrison A, 2010, J APPL ECOL, V47, P926, DOI 10.1111/j.1365-2664.2010.01834.x; Henzell RP, 2008, WILDLIFE RES, V35, P633, DOI 10.1071/WR06164; Humane Vertebrate Pest Control Working Group, 2004, PROC RSPCA AUSTR AWC; Inglis IR, 1985, HUMANE CONTROL LAND, P83; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; ISO, 1999, TC191 ISO; Kirkwood JK, 2013, ANIM WELFARE, V22, P147, DOI 10.7120/09627286.22.1.147; KIRKWOOD JK, 1994, ANIM WELFARE, V3, P257; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Littin K, 2014, REV SCI TECH OIE, V33, P281, DOI 10.20506/rst.33.1.2281; Littin KE, 2004, NEW ZEAL VET J, V52, P1, DOI 10.1080/00480169.2004.36384; LONGAIR J, 1991, CAN VET J, V32, P724; Macdonald David W., 1996, P160; Marsh M., 2009, THESIS U YORK YORK; Martin J, 2010, AGR HIST REV, V58, P255; Marzluff JM, 2010, ANIM BEHAV, V79, P699, DOI 10.1016/j.anbehav.2009.12.022; MASON G, 1993, ANIM WELFARE, V2, P301; Mathews F, 2010, ANIM WELFARE, V19, P159; McKillop IG, 1999, CROP PROT, V18, P193, DOI 10.1016/S0261-2194(99)00016-2; Meerburg BG, 2008, PEST MANAG SCI, V64, P1205, DOI 10.1002/ps.1623; Mellanby K., 1971, THE MOLE; Mellor D, 2009, SCI ANIMAL WELFARE; Mellor DJ, 2001, AUST VET J, V79, P762, DOI 10.1111/j.1751-0813.2001.tb10895.x; Mellor DJ., 1993, IMPROVING WELL BEING, P3; Merck M., 2007, VET FORENSICS ANIMAL; Moorhouse TP, 2007, J ZOOL, V271, P19, DOI 10.1111/j.1469-7998.2006.00175.x; Moorhouse TP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138939; MORRIS P, 1966, J ZOOL, V149, P46; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Natural England, TIN0712009 NAT ENGL; Natural England, LIC GEN KILL TAK CER; Natural England, LICENCE GEN WML GL04; Natural England, TIN0332011 NAT ENGL; Natural England, RABB MAN OPT PREV DA; Nicholls J., 2010, MOLE CATCHING PRACTI; Packer JJ, 1999, MAMMAL REV, V29, P75, DOI 10.1046/j.1365-2907.1999.00039.x; Phillips C, 2001, WHAT IS A QALY; Polednikova K., 2013, HUMAN WILDLIFE CONFL, P81; Quammen D., 2004, MONSTER GOD MAN EATI; QUY R, 2004, REV METHODS USED EUR; Reynolds J. C., 1993, Gibier Faune Sauvage, V10, P319; Riordan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028904; Rodel HG, 2004, OIKOS, V104, P529; Rodel HG, 2009, J ANIM ECOL, V78, P789, DOI 10.1111/j.1365-2656.2009.01537.x; Sharp T, 2012, RAB009 GROUND SHOOTI; Sharp T, 2012, BIR001 SHOOTING PEST; Sharp T, 2012, BIR002 TRAPPING PEST; Sharp T, 2012, HUMANE CODES MODEL C; Sharp T, 2009, GROUND SHOOTING RABB; Talling JC, 2009, IMPROVEMENTS TRAPPIN; Teunissen W, 2008, IBIS, V150, P74, DOI 10.1111/j.1474-919X.2008.00861.x; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Treves A, 2010, URSUS, V21, P30, DOI 10.2192/09GR012.1; UK Government, 1958, SMALL GROUND VERM TR; van Niekerk H. N., 2010, THESIS FREE STATE U; Wanless RM, 2012, ANIM CONSERV, V15, P472, DOI 10.1111/j.1469-1795.2012.00534.x; Warburton B, 2009, J WILDLIFE MANAGE, V73, P158, DOI 10.2193/2007-313; Warburton B, 2012, ANIM WELFARE, V21, P141, DOI 10.7120/096272812X13345905674123; WARBURTON B, 1995, NEW ZEAL J ZOOL, V22, P39, DOI 10.1080/03014223.1995.9518022; White PCL, 2010, WILDLIFE RES, V37, P623, DOI 10.1071/WR10191; ZELIN S, 1983, J WILDLIFE MANAGE, V47, P863, DOI 10.2307/3808628	95	29	29	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146298	10.1371/journal.pone.0146298	http://dx.doi.org/10.1371/journal.pone.0146298			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726808	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500072
J	Kudlicki, AS				Kudlicki, Andrzej S.			G-Quadruplexes Involving Both Strands of Genomic DNA Are Highly Abundant and Colocalize with Functional Sites in the Human Genome	PLOS ONE			English	Article							I-MOTIF STRUCTURES; SECONDARY STRUCTURES; FORMING SEQUENCES; PROMOTER REGION; SMALL-MOLECULE; EXPRESSION; STABILITY; DYNAMICS	The G-quadruplex is a non-canonical DNA structure biologically significant in DNA replication, transcription and telomere stability. To date, only G4s with all guanines originating from the same strand of DNA have been considered in the context of the human nuclear genome. Here, I discuss interstrand topological configurations of G-quadruplex DNA, consisting of guanines from both strands of genomic DNA; an algorithm is presented for predicting such structures. I have identified over 550,000 non-overlapping interstrand G-quadruplex forming sequences in the human genome-significantly more than intrastrand configurations. Functional analysis of interstrand G-quadruplex sites shows strong association with transcription initiation, the results are consistent with the XPB and XPD transcriptional helicases binding only to G-quadruplex DNA with interstrand topology. Interstrand quadruplexes are also enriched in origin of replication sites. Several topology classes of interstrand quadruplex-forming sequences are possible, and different topologies are enriched in different types of structural elements. The list of interstrand quadruplex forming sequences, and the computer program used for their prediction are available at the web address http://moment.utmb.edu/allquads.	[Kudlicki, Andrzej S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Kudlicki, Andrzej S.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Kudlicki, Andrzej S.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kudlicki, AS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	askudlic@utmb.edu	Kudlicki, Andrzej/AAG-8537-2019	Kudlicki, Andrzej/0000-0001-8158-9600	Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences [UL1TR000071, UL1TR001439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071, UL1TR001439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112131] Funding Source: NIH RePORTER	Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1TR000071 and UL1TR001439) from the National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorf CM, 2014, J GENET GENOMICS, V41, P627, DOI 10.1016/j.jgg.2014.10.004; Beaume N, 2013, NUCLEIC ACIDS RES, V41, P76, DOI 10.1093/nar/gks1071; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cao KJ, 2012, METHODS, V57, P3, DOI 10.1016/j.ymeth.2012.05.002; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Comoglio F, 2015, CELL REP, V11, P821, DOI 10.1016/j.celrep.2015.03.070; Day HA, 2014, BIOORGAN MED CHEM, V22, P4407, DOI 10.1016/j.bmc.2014.05.047; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Du XJ, 2014, NUCLEIC ACIDS RES, V42, P12367, DOI 10.1093/nar/gku921; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Friedl J. E. F., 1997, MASTERING REGULAR EX; Nguyen GH, 2014, P NATL ACAD SCI USA, V111, P9905, DOI 10.1073/pnas.1404807111; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kendrick S, 2010, PURE APPL CHEM, V82, P1609, DOI 10.1351/PAC-CON-09-09-29; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lexa M, 2014, NUCLEIC ACIDS RES, V42, P968, DOI 10.1093/nar/gkt893; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Martin MM, 2011, GENOME RES, V21, P1822, DOI 10.1101/gr.124644.111; Nakken S, 2009, NUCLEIC ACIDS RES, V37, P5749, DOI 10.1093/nar/gkp590; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Phan AT, 2000, J BIOMOL STRUCT DYN, P245, DOI 10.1080/07391102.2000.10506628; Phan AT, 2002, NUCLEIC ACIDS RES, V30, P4618, DOI 10.1093/nar/gkf597; Qin MY, 2015, J PHYS CHEM B, V119, P3706, DOI 10.1021/jp512914t; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raiber EA, 2012, NUCLEIC ACIDS RES, V40, P1499, DOI 10.1093/nar/gkr882; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Singh RP, 2013, BIOPHYS J, V105, P2820, DOI [10.1016/j.bpj.2013.10.021, 10.1016/j.bpj.2013.10.02]; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Sun DY, 2003, CLIN CANCER RES, V9, p6122S; Tarsounas M, 2013, J MOL BIOL, V425, P4782, DOI 10.1016/j.jmb.2013.09.026; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Wong HM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/564946; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Zhang C, 2013, NUCLEIC ACIDS RES, V41, P7144, DOI 10.1093/nar/gkt443; Zhang R, 2008, NUCLEIC ACIDS RES, V36, pD372, DOI 10.1093/nar/gkm787	46	31	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146174	10.1371/journal.pone.0146174	http://dx.doi.org/10.1371/journal.pone.0146174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727593	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500061
J	Saldana-Alvarez, Y; Salas-Martinez, MG; Garcia-Ortiz, H; Luckie-Duque, A; Garcia-Cardenas, G; Vicenteno-Ayala, H; Cordova, EJ; Esparza-Aguilar, M; Contreras-Cubas, C; Carnevale, A; Chavez-Saldana, M; Orozco, L				Saldana-Alvarez, Yolanda; Guadalupe Salas-Martinez, Maria; Garcia-Ortiz, Humberto; Luckie-Duque, Angelica; Garcia-Cardenas, Gustavo; Vicenteno-Ayala, Hermenegildo; Cordova, Emilio J.; Esparza-Aguilar, Marcelino; Contreras-Cubas, Cecilia; Carnevale, Alessandra; Chavez-Saldana, Margarita; Orozco, Lorena			Gender-Dependent Association of FTO Polymorphisms with Body Mass Index in Mexicans	PLOS ONE			English	Article							OBESITY-ASSOCIATED GENE; FAT MASS; VARIANT; METAANALYSIS; CHILDHOOD; ORIGIN	To evaluate the associations between six single-nucleotide polymorphisms (SNPs) in intron 1 of FTO and body mass index (BMI), a case-control association study of 2314 unrelated Mexican-Mestizo adult subjects was performed. The association between each SNP and BMI was tested using logistic and linear regression adjusted for age, gender, and ancestry and assuming additive, recessive, and dominant effects of the minor allele. Association analysis after BMI stratification showed that all five FTO SNPs (rs1121980, rs17817449, rs3751812, rs9930506, and rs17817449), were significantly associated with obesity class II/III under an additive model (P< 0.05). Interestingly, we also documented a genetic model-dependent influence of gender on the effect of FTO variants on increased BMI. Two SNPs were specifically associated in males under a dominant model, while the remainder were associated with females under additive and recessive models (P< 0.05). The SNP rs9930506 showed the highest increased in obesity risk in females (odds ratio = 4.4). Linear regression using BMI as a continuous trait also revealed differential FTO SNP contributions. Homozygous individuals for the risk alleles of rs17817449, rs3751812, and rs9930506 were on average 2.18 kg/m(2) heavier than homozygous for the wild-type alleles; rs1121980 and rs8044769 showed significant but less-strong effects on BMI (1.54 kg/m(2) and 0.9 kg/m(2), respectively). Remarkably, rs9930506 also exhibited positive interactions with age and BMI in a gender-dependent manner. Women carrying the minor allele of this variant have a significant increase in BMI by year (0.42 kg/m(2), P = 1.17 x 10(-10)). Linear regression haplotype analysis under an additive model, confirmed that the TGTGC haplotype harboring all five minor alleles, increased the BMI of carriers by 2.36 kg/m(2) (P = 1.15 x 10(-5)). Our data suggest that FTO SNPs make differential contributions to obesity risk and support the hypothesis that gender differences in the mechanisms involving these variants may contribute to disease development.	[Saldana-Alvarez, Yolanda; Guadalupe Salas-Martinez, Maria; Garcia-Ortiz, Humberto; Cordova, Emilio J.; Contreras-Cubas, Cecilia; Orozco, Lorena] Inst Nacl Med Genom Secretaria Salud, Lab Immunogenom & Enfermedades Metab, Mexico City, DF, Mexico; [Guadalupe Salas-Martinez, Maria; Orozco, Lorena] Univ Autonoma Cd Mexico, Programa Ciencias Genom, Mexico City, DF, Mexico; [Luckie-Duque, Angelica] Hosp Reg 1 Octubre, ISSSTE, Mexico City, DF, Mexico; [Garcia-Cardenas, Gustavo] ISSSTE, Clin Diagnost Autorizado, Mexico City, DF, Mexico; [Vicenteno-Ayala, Hermenegildo] Hosp Reg Adolfo Lopez Mateos, ISSSTE, Mexico City, DF, Mexico; [Esparza-Aguilar, Marcelino] Secretaria Salud Mexico, Ctr Nacl Salud Infancia & Adolescencia, Mexico City, DF, Mexico; [Carnevale, Alessandra] Secretaria Salud Mexico, Inst Nacl Med Genom, Mexico City, DF, Mexico; [Chavez-Saldana, Margarita] Secretaria Salud Mexico, Inst Nacl Pediat, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica	Orozco, L (corresponding author), Inst Nacl Med Genom Secretaria Salud, Lab Immunogenom & Enfermedades Metab, Mexico City, DF, Mexico.	lorozco@inmegen.gob.mx	Chávez, Margarita/AAT-5804-2021	Orozco, Lorena/0000-0002-5801-9180; Garcia-Ortiz, Humberto/0000-0002-0453-980X; /0000-0003-1486-3651	Consejo Nacional de Ciencia y Tecnologia Mexico, (CONACyT) [SALUD-2008-C01-86867, SALUD-2014-233970]	Consejo Nacional de Ciencia y Tecnologia Mexico, (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the Consejo Nacional de Ciencia y Tecnologia Mexico, (CONACyT): grants SALUD-2008-C01-86867 and SALUD-2014-233970.	Albuquerque D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054370; Almen MS, 2012, GENOMICS, V99, P132, DOI 10.1016/j.ygeno.2011.12.007; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Larder R, 2011, TRENDS ENDOCRIN MET, V22, P53, DOI 10.1016/j.tem.2010.11.001; Leon-Mimila P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070640; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Mejia-Benitez A, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-21; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riffo B, 2012, PEDIATR DIABETES, V13, P392, DOI 10.1111/j.1399-5448.2011.00834.x; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sentinelli F, 2012, EXP DIABETES RES, DOI 10.1155/2012/872176; Shahid A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/324093; Tan LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096149; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zhang ZB, 2012, CANCER LETT, V319, P89, DOI 10.1016/j.canlet.2011.12.033	38	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145984	10.1371/journal.pone.0145984	http://dx.doi.org/10.1371/journal.pone.0145984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726774	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500042
J	Spira, D; Germann, T; Lehner, B; Hemmer, S; Akbar, M; Jesser, J; Weber, MA; Rehnitz, C				Spira, Daniel; Germann, Thomas; Lehner, Burkhard; Hemmer, Stefan; Akbar, Michael; Jesser, Jessica; Weber, Marc-Andre; Rehnitz, Christoph			CT-Guided Biopsy in Suspected Spondylodiscitis - The Association of Paravertebral Inflammation with Microbial Pathogen Detection	PLOS ONE			English	Article							PYOGENIC VERTEBRAL OSTEOMYELITIS; INFECTIOUS SPONDYLITIS; SPINAL INFECTION; ENHANCED MR; DIAGNOSIS; BONE	Objectives To search for imaging characteristics distinguishing patients with successful from those with futile microbiological pathogen detection by CT-guided biopsy in suspected spondylodiscitis. Methods 34 consecutive patients with suspected spondylodiscitis underwent CT-guided biopsy for pathogen detection. MR-images were assessed for inflammatory infiltration of disks, adjacent vertebrae, epidural and paravertebral space. CT-images were reviewed for arrosion of adjacent end plates and reduced disk height. Biopsy samples were sent for microbiological examination in 34/34 patients, and for additional histological analysis in 28/34 patients. Results Paravertebral infiltration was present in all 10/10 patients with positive microbiology and occurred in only 12/24 patients with negative microbiology, resulting in a sensitivity of 100% and a specificity of 50% for pathogen detection. Despite its limited sensitivities, epidural infiltration and paravertebral abscesses showed considerably higher specificities of 83.3% and 90.9%, respectively. Paravertebral infiltration was more extensive in patients with positive as compared to negative microbiology (p = 0.002). Even though sensitivities for pathogen detection were also high in case of vertebral and disk infiltration, or end plate arrosion, specificities remained below 10%. Conclusions Inflammatory infiltration of the paravertebral space indicated successful pathogen detection by CT-guided biopsy. Specificity was increased by the additional occurrence of epidural infiltration or paravertebral abscesses.	[Spira, Daniel; Germann, Thomas; Weber, Marc-Andre; Rehnitz, Christoph] Univ Heidelberg Hosp, Diagnost & Intervent Radiol, D-69120 Heidelberg, Germany; [Lehner, Burkhard; Hemmer, Stefan; Akbar, Michael] Univ Heidelberg Hosp, Clin Orthoped & Trauma Surg, D-69118 Heidelberg, Germany; [Jesser, Jessica] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Spira, D (corresponding author), Univ Heidelberg Hosp, Diagnost & Intervent Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	Daniel_Spira@yahoo.de	Weber, Marc-Andre/C-4452-2016; Weber, Marc/GXA-0612-2022					BATSON OV, 1957, AMER J ROENTGENOL RA, V78, P195; BONTOUX D, 1992, REV RHUM, V59, P401; CHANDNANI VP, 1990, RADIOLOGY, V174, P233, DOI 10.1148/radiology.174.1.2294554; Chew FS, 2001, RADIOLOGY, V218, P211, DOI 10.1148/radiology.218.1.r01ja06211; FRIEDMAN DP, 1994, AM J ROENTGENOL, V163, P699, DOI 10.2214/ajr.163.3.8079871; Gouliouris T, 2010, J ANTIMICROB CHEMOTH, V65, piii11, DOI 10.1093/jac/dkq303; Hong SH, 2009, RADIOGRAPHICS, V29, P599, DOI 10.1148/rg.292085137; Huang AJ, 2013, SKELETAL RADIOL, V42, P61, DOI 10.1007/s00256-012-1433-2; James SLJ, 2006, EUR J RADIOL, V58, P27, DOI 10.1016/j.ejrad.2005.12.002; Ledermann HP, 2003, RADIOLOGY, V228, P506, DOI 10.1148/radiol.2282020752; Lillie P, 2008, JCR-J CLIN RHEUMATOL, V14, P234, DOI 10.1097/RHU.0b013e318181addd; Longo M, 2003, EUR RADIOL, V13, P626, DOI 10.1007/s00330-002-1411-5; Maiuri F, 1997, SPINE, V22, P1741, DOI 10.1097/00007632-199708010-00012; MEYERS SP, 1991, ARCH INTERN MED, V151, P683, DOI 10.1001/archinte.151.4.683; Michel SCA, 2006, AM J ROENTGENOL, V186, P977, DOI 10.2214/AJR.05.0109; MODIC MT, 1984, RADIOLOGY, V152, P103, DOI 10.1148/radiology.152.1.6729099; Nolla JM, 2002, SEMIN ARTHRITIS RHEU, V31, P271, DOI 10.1053/sarh.2002.29492; POST MJD, 1990, J COMPUT ASSIST TOMO, V14, P721; Rieneck K, 1996, APMIS, V104, P755, DOI 10.1111/j.1699-0463.1996.tb04939.x; Rimondi E, 2008, EUR SPINE J, V17, P975, DOI 10.1007/s00586-008-0678-x; Schellinger D, 1996, AM J NEURORADIOL, V17, P953; Stabler A, 2001, RADIOL CLIN N AM, V39, P115, DOI 10.1016/S0033-8389(05)70266-9; THRUSH A, 1990, AM J NEURORADIOL, V11, P1171	23	27	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146399	10.1371/journal.pone.0146399	http://dx.doi.org/10.1371/journal.pone.0146399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727377	Green Published, Green Submitted, gold			2022-12-27	WOS:000367681500078
J	Qiu, SS; Dotor, J; Hontanilla, B				Qiu, Shan Shan; Dotor, Javier; Hontanilla, Bernardo			Effect of P144 (R) (Anti-TGF-beta) in an "In Vivo" Human Hypertrophic Scar Model in Nude Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SYNTHETIC PEPTIDE; ATHYMIC MICE; NORMAL SKIN; KELOIDS; THERAPY; FIBROBLASTS; FIBROSIS; TISSUE; MOUSE	Background Hypertrophic scars are one of the most important complications in surgery due to their cosmetic and functional impairments. Previous studies in tissue fibrotic disorders have shown promising results by inhibiting the biological activity effect of Transforming Growth Factor-beta 1 (TGF-beta 1). The aim of the current study was to determine the clinical effect of the inhibition of TGF-beta 1 signaling in human hypertrophic scars implanted in nude mice by topical application of an inhibitor of TGF-beta 1 (P144 (R)). Material and Methods A total of 30 human hypertrophic scars were implanted in 60 nude mice. The animals were divided in two groups, group A (placebo) and group B (treatment). Group C (basal) was considered as the preimplanted scar samples and they were not implanted in the nude mice. After the shedding period, topical application of a lipogel containing placebo (group A) or P144 (group B) was daily administered during two weeks. The animals were sacrificed upon completion of the study. Total area, thickness and collagen fibers area were measure and compared across all groups. Immunohistochemistry was also performed in order to quantify collagen type I and type III and elastic fiber expressions present in the dermis. Results Successful shedding was achieved in 83,3% of the xenografts. The mean time for shedding was 35 +/- 5.4 days. Statistically significant differences were found in the total area, collagen fibers area and thickness between the groups. Increased elastic fibers and decreased collagen I were found in the P144-treated group compared to the basal group. Conclusion Topical application of an inhibitor of TGF-beta 1 may promote scar maturation and clinical improvement of hypertrophic scar morphology features in an "in vivo" model in nude mice after two weeks of treatment.	[Qiu, Shan Shan; Hontanilla, Bernardo] Univ Navarra Clin, Dept Plast & Reconstruct Surg, Pamplona, Spain; [Dotor, Javier] Digna Biotech SL, Pamplona, Spain	University of Navarra	Hontanilla, B (corresponding author), Univ Navarra Clin, Dept Plast & Reconstruct Surg, Pamplona, Spain.	bhontanill@unav.es	Hontanilla, Bernardo/I-1756-2017	Hontanilla, Bernardo/0000-0001-6186-4791	Digna Biotech S. L. Pamplona	Digna Biotech S. L. Pamplona	Digna Biotech S. L. Pamplona provided support in the form of salaries for Javier Dotor, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	ABERGEL RP, 1985, J INVEST DERMATOL, V84, P384, DOI 10.1111/1523-1747.ep12265471; Alster T, 2003, DERMATOL SURG, V29, P25, DOI 10.1046/j.1524-4725.2003.29024.x; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; BERG JSV, 1985, ANN PLAS SURG, V14, P111, DOI 10.1097/00000637-198502000-00004; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; Brayton CF, 2012, VET PATHOL, V49, P85, DOI 10.1177/0300985811430696; Brissett A E, 2001, Facial Plast Surg, V17, P263, DOI 10.1055/s-2001-18827; Brown RJ, 2008, PLAST RECONSTR SURG, V121, P1165, DOI 10.1097/01.prs.0000302512.17904.2a; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Chalmers RL, 2011, INT WOUND J, V8, P218, DOI 10.1111/j.1742-481X.2011.00771.x; Chen Margaret A, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P242, DOI 10.1097/01.moo.0000170525.74264.f8; Cochrane C. A., 1996, Wound Repair and Regeneration, V4, P58, DOI 10.1046/j.1524-475X.1996.40111.x; COHEN I K, 1971, Surgical Forum (Chicago), V22, P488; Cuttle L, 2006, BURNS, V32, P806, DOI 10.1016/j.burns.2006.02.023; Dwyer RM, 2006, GENE THER, V13, P60, DOI 10.1038/sj.gt.3302599; Ezquerro IJ, 2003, CYTOKINE, V22, P12, DOI 10.1016/S1043-4666(03)00101-7; FRIEDMAN DW, 1993, J SURG RES, V55, P214, DOI 10.1006/jsre.1993.1132; Ghahary A, 1996, J INVEST DERMATOL, V106, P476, DOI 10.1111/1523-1747.ep12343658; Gomez R, 2010, EUR J PLAST SURG, V33, P135, DOI 10.1007/s00238-010-0406-8; Harunari N, 2006, BURNS, V32, P669, DOI 10.1016/j.burns.2006.03.015; Heinkelein M, 2005, CANCER GENE THER, V12, P947, DOI 10.1038/sj.cgt.7700855; Hermida N, 2009, CARDIOVASC RES, V81, P601, DOI 10.1093/cvr/cvn315; Hur GY, 2014, BURNS, V40, P1497, DOI 10.1016/j.burns.2014.08.007; Kamath NV, 2002, J CUTAN PATHOL, V29, P27, DOI 10.1034/j.1600-0560.2002.290105.x; KISCHER CW, 1989, ANAT REC, V225, P189; Lawrence JW, 2012, J BURN CARE RES, V33, P136, DOI 10.1097/BCR.0b013e3182374452; Liu JQ, 2012, J DERMATOL SCI, V65, P38, DOI 10.1016/j.jdermsci.2011.09.012; Liu W, 2004, CURR GENE THER, V4, P123, DOI 10.2174/1566523044578004; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; PALMIERI B, 1995, INT J DERMATOL, V34, P506, DOI 10.1111/j.1365-4362.1995.tb00628.x; PEACOCK EE, 1970, SOUTHERN MED J, V63, P755, DOI 10.1097/00007611-197007000-00002; Santiago B, 2005, J INVEST DERMATOL, V125, P450, DOI 10.1111/j.0022-202X.2005.23859.x; SHEFFIELD LG, 1988, J DAIRY SCI, V71, P68, DOI 10.3168/jds.S0022-0302(88)79526-0; SHETLAR MR, 1991, CONNECT TISSUE RES, V26, P23, DOI 10.3109/03008209109152161; SHETLAR MR, 1985, P SOC EXP BIOL MED, V179, P549; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; Sidgwick GP, 2012, J EUR ACAD DERMATOL, V26, P141, DOI 10.1111/j.1468-3083.2011.04200.x; Stavrou D, 2010, AESTHET PLAST SURG, V34, P646, DOI 10.1007/s00266-010-9496-8; Vrijman C, 2011, BRIT J DERMATOL, V165, P934, DOI 10.1111/j.1365-2133.2011.10492.x; Wang JF, 2011, WOUND REPAIR REGEN, V19, P274, DOI 10.1111/j.1524-475X.2011.00672.x; Wang RJ, 2000, WOUND REPAIR REGEN, V8, P128, DOI 10.1046/j.1524-475x.2000.00128.x; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wang Xi-Qiao, 2008, Int J Low Extrem Wounds, V7, P151, DOI 10.1177/1534734608322099; Wang YW, 2014, J INVEST DERMATOL, V134, P2016, DOI 10.1038/jid.2014.84; Yang DY, 2007, PLAST RECONSTR SURG, V119, P104, DOI 10.1097/01.prs.0000244828.80490.62; Yang Dong-Yun, 2004, Zhonghua Shao Shang Za Zhi, V20, P82; Yang JY, 2010, DERMATOL SURG, V36, P1942, DOI 10.1111/j.1524-4725.2010.01759.x; Zhang Z, 2012, BURNS, V38, P236, DOI 10.1016/j.burns.2011.08.012; Zhao R, 2013, MATRIX BIOL, V32, P265, DOI 10.1016/j.matbio.2013.02.004	51	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0144489	10.1371/journal.pone.0144489	http://dx.doi.org/10.1371/journal.pone.0144489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720517	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900005
J	Verheyen, A; Diels, A; Dijkmans, J; Oyelami, T; Meneghello, G; Mertens, L; Versweyveld, S; Borgers, M; Buist, A; Peeters, P; Cik, M				Verheyen, An; Diels, Annick; Dijkmans, Joyce; Oyelami, Tutu; Meneghello, Giulia; Mertens, Liesbeth; Versweyveld, Sofie; Borgers, Marianne; Buist, Arjan; Peeters, Pieter; Cik, Miroslav			Using Human iPSC-Derived Neurons to Model TAU Aggregation	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; PROTEIN-TAU; ABNORMAL PHOSPHORYLATION; SYNTHETIC TAU; TAUOPATHY; PATHOLOGY; HYPERPHOSPHORYLATION; NEURODEGENERATION; PROPAGATION	Alzheimer's disease and frontotemporal dementia are amongst the most common forms of dementia characterized by the formation and deposition of abnormal TAU in the brain. In order to develop a translational human TAU aggregation model suitable for screening, we transduced TAU harboring the pro-aggregating P301L mutation into control hiPSC-derived neural progenitor cells followed by differentiation into cortical neurons. TAU aggregation and phosphorylation was quantified using AlphaLISA technology. Although no spontaneous aggregation was observed upon expressing TAU-P301L in neurons, seeding with preformed aggregates consisting of the TAU-microtubule binding repeat domain triggered robust TAU aggregation and hyperphosphorylation already after 2 weeks, without affecting general cell health. To validate our model, activity of two autophagy inducers was tested. Both rapamycin and trehalose significantly reduced TAU aggregation levels suggesting that iPSC-derived neurons allow for the generation of a biologically relevant human Tauopathy model, highly suitable to screen for compounds that modulate TAU aggregation.	[Verheyen, An; Diels, Annick; Dijkmans, Joyce; Oyelami, Tutu; Meneghello, Giulia; Mertens, Liesbeth; Versweyveld, Sofie; Borgers, Marianne; Buist, Arjan; Peeters, Pieter; Cik, Miroslav] Janssen Res & Dev, Beerse, Belgium	Johnson & Johnson; Janssen Pharmaceuticals	Verheyen, A (corresponding author), Janssen Res & Dev, Beerse, Belgium.	AVerhey1@its.jnj.com			UK Medical Research Council [G0400074]; NIHR Newcastle Biomedical Research Centre and Unit; Brains for Dementia Research Programme - Alzheimer's Research UK; Brains for Dementia Research Programme - Alzheimer's Society; Innovative Medicines Initiative Joint Undertaking [115439]; European Union; EFPIA; European Commission, Marie Curie NAMASEN Network [264872]; Institute for the Promotion of Innovation by Science and Technology in Flanders [IWT 120511]; Janssen Research and Development, a division of Janssen Pharmaceutica N.V.; Medical Research Council [G0900652, MR/L016451/1, G0502157, G1100540, G0400074] Funding Source: researchfish; MRC [G0502157, G0900652, G1100540, G0400074, MR/L016451/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Newcastle Biomedical Research Centre and Unit; Brains for Dementia Research Programme - Alzheimer's Research UK; Brains for Dementia Research Programme - Alzheimer's Society; Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA; European Commission, Marie Curie NAMASEN Network; Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Janssen Research and Development, a division of Janssen Pharmaceutica N.V.; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AD and control brain tissue for this study was provided by the Newcastle Brain Tissue Resource, which is funded in part by a grant from the UK Medical Research Council (G0400074), by NIHR Newcastle Biomedical Research Centre and Unit awarded to the Newcastle upon Tyne NHS Foundation Trust and Newcastle University, and as part of the Brains for Dementia Research Programme jointly funded by Alzheimer's Research UK and Alzheimer's Society. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115439, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. This publication reflects only the author's views and neither the IMI JU nor EFPIA nor the European Commission are liable for any use that may be made of the information contained therein. Tutu Oyelami was funded by the 7th Framework Program of the European Commission, Marie Curie NAMASEN Network Grant No. 264872. Giulia Meneghello was supported by the Institute for the Promotion of Innovation by Science and Technology (IWT 120511) in Flanders. This work was funded by Janssen Research and Development, a division of Janssen Pharmaceutica N.V. The funder provided support in the form of salaries for authors AV, AD, JD, TO, GM, LM, SV, MB, AB, PP, and MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Chun W, 2011, METHODS MOL BIOL, V670, P109, DOI 10.1007/978-1-60761-744-0_9; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IOVINO M, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV222; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; Mertens J, 2013, AM J PATHOL, V182, P1769, DOI 10.1016/j.ajpath.2013.01.043; Ozcelik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062459; Peeraer E, 2015, NEUROBIOL DIS, V73, P83, DOI 10.1016/j.nbd.2014.08.032; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Sposito T, 2015, HUM MOL GENET, V24, P5260, DOI 10.1093/hmg/ddv246; Szekeres PG, 2008, J BIOMOL SCREEN, V13, P101, DOI 10.1177/1087057107312778; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	34	43	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146127	10.1371/journal.pone.0146127	http://dx.doi.org/10.1371/journal.pone.0146127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720731	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510900047
J	Kling, RC; Clark, T; Gmeiner, P				Kling, Ralf C.; Clark, Timothy; Gmeiner, Peter			Comparative MD Simulations Indicate a Dual Role for Arg132(3.50) in Dopamine-Dependent D2R Activation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-COUPLED RECEPTORS; DRY MOTIF; CRYSTAL-STRUCTURE; IONIC LOCK; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; MUTATIONS; COMPLEX; CONFORMATIONS	Residue Arg(3.50) belongs to the highly conserved DRY-motif of class A GPCRs, which is located at the bottom of TM3. On the one hand, Arg(3.50) has been reported to help stabilize the inactive state of GPCRs, but on the other hand has also been shown to be crucial for stabilizing active receptor conformations and mediating receptor-G protein coupling. The combined results of these studies suggest that the exact function of Arg(3.50) is likely to be receptor-dependent and must be characterized independently for every GPCR. Consequently, we now present comparative molecular-dynamics simulations that use our recently described inactive-state and Ga-bound active-state homology models of the dopamine D2 receptor (D2R), which are either bound to dopamine or ligand-free, performed to identify the function of Arg132(3.50) in D2R. Our results are consistent with a dynamic model of D2R activation in which Arg132(3.50) adopts a dual role, both by stabilizing the inactive-state receptor conformation and enhancing dopamine-dependent D2R-G protein coupling.	[Kling, Ralf C.; Gmeiner, Peter] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Kling, Ralf C.; Clark, Timothy] Univ Erlangen Nurnberg, Comp Chem Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Clark, Timothy] Univ Portsmouth, Ctr Mol Design, Portsmouth, Hants, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Portsmouth	Gmeiner, P (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany.	peter.gmeiner@fau.de	Gmeiner, Peter/N-5275-2015	Gmeiner, Peter/0000-0002-4127-197X				Babin V., 2008, AMBER; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Coley C, 2000, J NEUROCHEM, V74, P358, DOI 10.1046/j.1471-4159.2000.0740358.x; Costa EMF, 2001, J CLIN ENDOCR METAB, V86, P2680, DOI 10.1210/jc.86.6.2680; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Goetz A, 2011, J MOL BIOL, V414, P611, DOI 10.1016/j.jmb.2011.10.015; Haberl F, 2009, PROTEINS, V77, P857, DOI 10.1002/prot.22505; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hiller C, 2013, J MED CHEM, V56, P5130, DOI 10.1021/jm400520c; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kling RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100069; Kling RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067244; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; MIN KC, 1993, J BIOL CHEM, V268, P9400; Moller D, 2014, J MED CHEM, V57, P4861, DOI 10.1021/jm5004039; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; ROSENTHAL W, 1993, J BIOL CHEM, V268, P13030; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Schrodinger L., PYMOL MOL GRAPHICS S; Seibold A, 1998, RECEPTOR CHANNEL, V5, P375; Shan JF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002473; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P31973, DOI 10.1074/jbc.M112.348565; Vanni S, 2009, BIOCHEMISTRY-US, V48, P4789, DOI 10.1021/bi900299f; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146612	10.1371/journal.pone.0146612	http://dx.doi.org/10.1371/journal.pone.0146612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741139	Green Published, gold			2022-12-27	WOS:000367810600060
J	Urlacher, E; Soustelle, L; Parmentier, ML; Verlinden, H; Gherardi, MJ; Fourmy, D; Mercer, AR; Devaud, JM; Massou, I				Urlacher, Elodie; Soustelle, Laurent; Parmentier, Marie-Laure; Verlinden, Heleen; Gherardi, Marie-Julie; Fourmy, Daniel; Mercer, Alison R.; Devaud, Jean-Marc; Massou, Isabelle			Honey Bee Allatostatins Target Galanin/Somatostatin-Like Receptors and Modulate Learning: A Conserved Function?	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; LONG-TERM-MEMORY; PROBOSCIS EXTENSION RESPONSE; JUVENILE-HORMONE SYNTHESIS; RED FLOUR BEETLE; DROSOPHILA-MELANOGASTER; MUSHROOM BODIES; CONSTITUTIVE ACTIVITY; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY	Sequencing of the honeybee genome revealed many neuropeptides and putative neuropeptide receptors, yet functional characterization of these peptidic systems is scarce. In this study, we focus on allatostatins, which were first identified as inhibitors of juvenile hormone synthesis, but whose role in the adult honey bee (Apis mellifera) brain remains to be determined. We characterize the bee allatostatin system, represented by two families: allatostatin A (Apime-ASTA) and its receptor (Apime-ASTA-R); and C-type allatostatins (Apime-ASTC and Apime-ASTCC) and their common receptor (Apime-ASTC-R). Apime-ASTA-R and Apime-ASTC-R are the receptors in bees most closely related to vertebrate galanin and somatostatin receptors, respectively. We examine the functional properties of the two honeybee receptors and show that they are transcriptionally expressed in the adult brain, including in brain centers known to be important for learning and memory processes. Thus we investigated the effects of exogenously applied allatostatins on appetitive olfactory learning in the bee. Our results show that allatostatins modulate learning in this insect, and provide important insights into the evolution of somatostatin/allatostatin signaling.	[Urlacher, Elodie; Mercer, Alison R.] Dept Zool, Dunedin, Otago, New Zealand; [Urlacher, Elodie; Devaud, Jean-Marc; Massou, Isabelle] Ctr Rech Cognit Anim, UMR 5169, CNRS, Toulouse, France; [Urlacher, Elodie; Devaud, Jean-Marc; Massou, Isabelle] Univ Toulouse, UPS Ctr Rech Cognit Anim, UMR 5169, Toulouse, France; [Soustelle, Laurent; Parmentier, Marie-Laure] Inst Gen Fonct, CNRS, UMR 5203, Montpellier, France; [Soustelle, Laurent; Parmentier, Marie-Laure] INSERM, U1191, Montpellier, France; [Soustelle, Laurent; Parmentier, Marie-Laure] Univ Montpellier, UMR 5203, F-34059 Montpellier, France; [Verlinden, Heleen] Katholieke Univ Leuven, Inst Zool, Dept Anim Physiol & Neurobiol, Leuven, Belgium; [Gherardi, Marie-Julie; Fourmy, Daniel] Univ Toulouse, UPS, EA Receptorol & Ciblage Therapeut Cancerol 4552, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; KU Leuven; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Urlacher, E (corresponding author), Dept Zool, Dunedin, Otago, New Zealand.	elodie.urlacher@otago.ac.nz	Parmentier, Marie-Laure/N-9915-2017; Fourmy, Daniel/AAE-3703-2019; Verlinden, Heleen/D-1033-2011	Parmentier, Marie-Laure/0000-0001-6133-3413; Fourmy, Daniel/0000-0001-9910-4827; Verlinden, Heleen/0000-0001-6721-3973; Mercer, Alison/0000-0001-8110-4247; Soustelle, Laurent/0000-0003-1034-2955	Marsden grant [UOO1207, ANR-13-ADAP-0002]	Marsden grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by Marsden grant UOO1207, to EU, ARM and ANR-13-ADAP-0002 to JMD, IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2003, REGUL PEPTIDES, V115, P171, DOI 10.1016/S0167-0115(03)00165-4; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Audsley N, 2000, J COMP NEUROL, V424, P37, DOI 10.1002/1096-9861(20000814)424:1&lt;37::AID-CNE3&gt;3.0.CO;2-9; Audsley N, 2006, PEPTIDES, V27, P512, DOI 10.1016/j.peptides.2005.08.022; Audsley N, 2000, INSECT BIOCHEM MOLEC, V30, P681, DOI 10.1016/S0965-1748(00)00039-4; Audsley N, 2013, INSECT BIOCHEM MOLEC, V43, P65, DOI 10.1016/j.ibmb.2012.09.007; Badie-Mahdavi H, 2005, NEUROSCIENCE, V133, P591, DOI 10.1016/j.neuroscience.2005.02.042; Bates D, 2012, LME4 LINEAR MIXED EF; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Bendena WG, 2008, P NATL ACAD SCI USA, V105, P1339, DOI 10.1073/pnas.0709492105; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boerjan B, 2010, NEUROPHARMACOLOGY, V58, P248, DOI 10.1016/j.neuropharm.2009.06.026; Borbely E, 2013, NEUROPEPTIDES, V47, P439, DOI 10.1016/j.npep.2013.10.012; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Braissant O, 1998, BIOCHEMICA, V1, P10; BRAZEAU P, 1974, ENDOCRINOLOGY, V94, P184, DOI 10.1210/endo-94-1-184; Brockmann A, 2009, P NATL ACAD SCI USA, V106, P2383, DOI 10.1073/pnas.0813021106; Coast GM, 2011, PEPTIDES, V32, P620, DOI 10.1016/j.peptides.2010.11.006; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dickinson PS, 2009, J EXP BIOL, V212, P1140, DOI 10.1242/jeb.028621; Dutar P, 2002, NEUROSCIENCE, V112, P455, DOI 10.1016/S0306-4522(02)00074-X; Eisenhardt D, 2014, LEARN MEMORY, V21, P534, DOI 10.1101/lm.033118.113; Elsik CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-86; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Felix RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130347; Foucaud M, 2008, J BIOL CHEM, V283, P35860, DOI 10.1074/jbc.M805513200; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Girard C, 1998, TRANSGENIC RES, V7, P239, DOI 10.1023/A:1008813910751; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Haehnel M, 2012, J EXP BIOL, V215, P559, DOI 10.1242/jeb.059626; Haehnel M, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00161; Hammer M, 1998, LEARN MEMORY, V5, P146; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hentze JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11680; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hourcade B, 2010, J NEUROSCI, V30, P6461, DOI 10.1523/JNEUROSCI.0841-10.2010; Hourcade B, 2009, LEARN MEMORY, V16, P607, DOI 10.1101/lm.1445609; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Knapek S, 2013, J NEUROSCI, V33, P5340, DOI 10.1523/JNEUROSCI.2287-12.2013; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; KRAMER SJ, 1991, P NATL ACAD SCI USA, V88, P9458, DOI 10.1073/pnas.88.21.9458; Kreienkamp HJ, 2002, J BIOL CHEM, V277, P39937, DOI 10.1074/jbc.M206931200; Kreissl S, 2010, J COMP NEUROL, V518, P1391, DOI 10.1002/cne.22343; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Lange AB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00098; Larsen MJ, 2001, BIOCHEM BIOPH RES CO, V286, P895, DOI 10.1006/bbrc.2001.5476; Martin AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138463; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; McQuillan HJ, 2012, LEARN MEMORY, V19, P151, DOI 10.1101/lm.025353.111; Menzel R, 2014, J PHYSIOL-PARIS, V108, P84, DOI 10.1016/j.jphysparis.2014.07.004; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Mustard JA, 2003, MOL BRAIN RES, V113, P67, DOI 10.1016/S0169-328X(03)00091-3; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; Nassel DR, 2000, NATURWISSENSCHAFTEN, V87, P439, DOI 10.1007/s001140050756; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Ogren SO, 1998, ANN NY ACAD SCI, V863, P342, DOI 10.1111/j.1749-6632.1998.tb10706.x; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Pratavieira M, 2014, J PROTEOME RES, V13, P3054, DOI 10.1021/pr500224b; PRATT GE, 1989, BIOCHEM BIOPH RES CO, V163, P1243, DOI 10.1016/0006-291X(89)91111-X; Price MD, 2002, PEPTIDES, V23, P787, DOI 10.1016/S0196-9781(01)00649-0; R Core Team, 2021, R LANGUAGE ENV STAT; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Reiher W, 2011, J PROTEOME RES, V10, P1881, DOI 10.1021/pr101116g; REISINE T, 1995, NEUROSCIENCE, V67, P777, DOI 10.1016/0306-4522(95)00072-Q; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Rustay NR, 2005, NEUROPEPTIDES, V39, P239, DOI 10.1016/j.npep.2004.12.026; Sandoz JC, 2003, NEUROSCIENCE, V120, P1137, DOI 10.1016/S0306-4522(03)00384-1; Sandoz JC, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00098; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Sgourakis NG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-104; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinakevitch I, 2008, ARTHROPOD STRUCT DEV, V37, P260, DOI 10.1016/j.asd.2008.01.001; Stay B, 2007, ANNU REV ENTOMOL, V52, P277, DOI 10.1146/annurev.ento.51.110104.151050; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Strausfeld NJ, 2000, J COMP NEUROL, V424, P179, DOI 10.1002/1096-9861(20000814)424:1&lt;179::AID-CNE13&gt;3.0.CO;2-K; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Tallent MK, 2005, MOL CELL NEUROSCI, V30, P465, DOI 10.1016/j.mcn.2005.08.010; Urlacher E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113630; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Vanderveken M, 2014, ARCH INSECT BIOCHEM, V85, P76, DOI 10.1002/arch.21144; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P161, DOI 10.1016/j.ibmb.2008.10.014; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2009, P NATL ACAD SCI USA, V106, P20930, DOI 10.1073/pnas.0907563106; Verlinden H, 2015, J INSECT PHYSIOL, V80, P2, DOI 10.1016/j.jinsphys.2015.04.004; Verlinden H, 2015, INSECT BIOCHEM MOLEC, V56, P9, DOI 10.1016/j.ibmb.2014.11.002; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036059; Weaver RJ, 2009, ANN NY ACAD SCI, V1163, P316, DOI 10.1111/j.1749-6632.2009.04459.x; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; WOODHEAD AP, 1989, P NATL ACAD SCI USA, V86, P5997, DOI 10.1073/pnas.86.15.5997; Xu ZQD, 2005, NEUROPEPTIDES, V39, P269, DOI 10.1016/j.npep.2005.02.003; Zhang T, 2013, P NATL ACAD SCI USA, V110, P15431, DOI 10.1073/pnas.1308816110; ZITNAN D, 1993, DEV BIOL, V156, P117, DOI 10.1006/dbio.1993.1063	112	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146248	10.1371/journal.pone.0146248	http://dx.doi.org/10.1371/journal.pone.0146248			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741132	Green Submitted, Green Published, gold			2022-12-27	WOS:000367810600025
J	Zarafeta, D; Kissas, D; Sayer, C; Gudbergsdottir, SR; Ladoukakis, E; Isupov, MN; Chatziioannou, A; Peng, X; Littlechild, JA; Skretas, G; Kolisis, FN				Zarafeta, Dimitra; Kissas, Dimitrios; Sayer, Christopher; Gudbergsdottir, Soley R.; Ladoukakis, Efthymios; Isupov, Michail N.; Chatziioannou, Aristotelis; Peng, Xu; Littlechild, Jennifer A.; Skretas, Georgios; Kolisis, Fragiskos N.			Discovery and Characterization of a Thermostable and Highly Halotolerant GH5 Cellulase from an Icelandic Hot Spring Isolate	PLOS ONE			English	Article							DIRECTED EVOLUTION; ENZYMES; SEQUENCE; GENE; PURIFICATION; METAGENOME; PROTEINS; BACTERIA; XYLANASE; SITE	With the ultimate goal of identifying robust cellulases for industrial biocatalytic conversions, we have isolated and characterized a new thermostable and very halotolerant GH5 cellulase. This new enzyme, termed CelDZ1, was identified by bioinformatic analysis from the genome of a polysaccharide-enrichment culture isolate, initiated from material collected from an Icelandic hot spring. Biochemical characterization of CelDZ1 revealed that it is a glycoside hydrolase with optimal activity at 70 degrees C and pH 5.0 that exhibits good thermostability, high halotolerance at near-saturating salt concentrations, and resistance towards metal ions and other denaturing agents. X-ray crystallography of the new enzyme showed that CelDZ1 is the first reported cellulase structure that lacks the defined sugar-binding 2 subsite and revealed structural features which provide potential explanations of its biochemical characteristics.	[Zarafeta, Dimitra; Kissas, Dimitrios; Chatziioannou, Aristotelis; Skretas, Georgios] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece; [Zarafeta, Dimitra; Kissas, Dimitrios; Ladoukakis, Efthymios; Kolisis, Fragiskos N.] Natl Tech Univ Athens, Sch Chem Engn, Biotechnol Lab, Athens, Greece; [Sayer, Christopher; Isupov, Michail N.; Littlechild, Jennifer A.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Gudbergsdottir, Soley R.; Peng, Xu] Univ Copenhagen, Dept Biol, Danish Archaea Ctr, Copenhagen, Denmark	National Hellenic Research Foundation; National Technical University of Athens; University of Exeter; University of Copenhagen	Littlechild, JA (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	A.Littlechild@exeter.ac.uk; gskretas@eie.gr; kolisis@chemeng.ntua.gr	Zarafeta, Dimitra/AAC-9089-2021; Isupov, Mikhail/AAA-8280-2019; KOLISIS, FRAGKISKOS/GSN-7219-2022; Littlechild, Jenny/AAE-4096-2020; Peng, Xu/M-8980-2014	Peng, Xu/0000-0003-3926-7514; Kolisis, Frangiskos/0000-0001-7656-3975; Zarafeta, Dimitra/0000-0001-7692-6094; Isupov, Michail/0000-0001-6842-4289; Ladoukakis, Efthymios/0000-0002-4807-1292; Skretas, Georgios/0000-0003-1320-9092	European Union [265933]; BBSRC [BB/L002035/1]; University of Exeter	European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Exeter	This work has been carried out in the framework of the HotZyme Project (http://hotzyme.com, grant agreement no. 265933) financed by the European Union 7th Framework Programme FP7/2007-2013, an EU FP7 Collaborative programme. MNI would like to thank the BBSRC funded ERA-IB grant BB/L002035/1 and the University of Exeter for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083635; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bornscheuer UT, 2001, CURR OPIN CHEM BIOL, V5, P137, DOI 10.1016/S1367-5931(00)00182-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALDWELL P, 1978, P NATL ACAD SCI USA, V75, P5349, DOI 10.1073/pnas.75.11.5349; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Consortium U, 2014, NUCLEIC ACIDS RES; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dalby PA, 2011, CURR OPIN STRUC BIOL, V21, P473, DOI 10.1016/j.sbi.2011.05.003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Dutta T, 2007, LETT APPL MICROBIOL, V44, P206, DOI 10.1111/j.1472-765X.2006.02042.x; Elcock AH, 1998, J MOL BIOL, V280, P731, DOI 10.1006/jmbi.1998.1904; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; FUKUMORI F, 1986, J GEN MICROBIOL, V132, P2329; Graham JE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1373; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ito Y, 2013, PROTEIN ENG DES SEL, V26, P73, DOI 10.1093/protein/gzs072; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JW, 2006, BIOTECHNOL PROGR, V22, P1720, DOI 10.1021/bp060273j; Kim YS, 2000, APPL ENVIRON MICROB, V66, P788, DOI 10.1128/AEM.66.2.788-793.2000; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Klemm D, 2015, BIOPOLYME, DOI [10.1002/3527600035.bpol6010, DOI 10.1002/3527600035.BPOL6010]; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar N, 2012, BIOINFORMATICS, V28, P2687, DOI 10.1093/bioinformatics/bts510; Langer GG, 2013, ACTA CRYSTALLOGR D, V69, P635, DOI 10.1107/S0907444913000565; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Liang CN, 2011, APPL MICROBIOL BIOT, V89, P315, DOI 10.1007/s00253-010-2842-6; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lorenz P, 2002, CURR OPIN BIOTECH, V13, P572, DOI 10.1016/S0958-1669(02)00345-2; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Patel S, 2015, PERSPECTIVES APPL HA, P403; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Silva JCR, 2013, FOLIA MICROBIOL, V58, P561, DOI 10.1007/s12223-013-0245-7; Sa-Pereira P, 2002, ENZYME MICROB TECH, V30, P924, DOI 10.1016/S0141-0229(02)00034-0; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Varrot A, 2001, ACTA CRYSTALLOGR D, V57, P1739, DOI 10.1107/S0907444901013993; Voget S, 2006, J BIOTECHNOL, V126, P26, DOI 10.1016/j.jbiotec.2006.02.011; Wang FC, 2009, MICROBIOL RES, V164, P650, DOI 10.1016/j.micres.2008.12.002; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XZ, 2013, BIOPROCESSING TECHNOLOGIES IN BIOREFINERY FOR SUSTAINABLE PRODUCTION OF FUELS, CHEMICALS, AND POLYMERS, P131; Zhu W.Y., 2010, THESIS	63	53	53	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146454	10.1371/journal.pone.0146454	http://dx.doi.org/10.1371/journal.pone.0146454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741138	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600046
J	Brown, JL; Sillero, N; Glaw, F; Bora, P; Vieites, DR; Vences, M				Brown, Jason L.; Sillero, Neftali; Glaw, Frank; Bora, Parfait; Vieites, David R.; Vences, Miguel			Spatial Biodiversity Patterns of Madagascar's Amphibians and Reptiles	PLOS ONE			English	Article							SPECIES RICHNESS; BODY-SIZE; CONSERVATION; BIOGEOGRAPHY; PHYLOGEOGRAPHY; ENDEMISM; FROGS; DIVERSIFICATION; DIFFERENTIATION; DIVERSITY	Madagascar has become a model region for testing hypotheses of species diversification and biogeography, and many studies have focused on its diverse and highly endemic herpeto-fauna. Here we combine species distribution models of a near-complete set of species of reptiles and amphibians known from the island with body size data and a tabulation of herpetofaunal communities from field surveys, compiled up to 2008. Though taxonomic revisions and novel distributional records arose since compilation, we are confident that the data are appropriate for inferring and comparing biogeographic patterns among these groups of organisms. We observed species richness of both amphibians and reptiles was highest in the humid rainforest biome of eastern Madagascar, but reptiles also show areas of high richness in the dry and subarid western biomes. In several amphibian subclades, especially within the Mantellidae, species richness peaks in the central eastern geographic regions while in reptiles different subclades differ distinctly in their richness centers. A high proportion of clades and subclades of both amphibians and reptiles have a peak of local endemism in the topo-graphically and bioclimatically diverse northern geographic regions. This northern area is roughly delimited by a diagonal spanning from 15.5 degrees S on the east coast to ca. 15.0 degrees S on the west coast. Amphibian diversity is highest at altitudes between 800-1200m above sea-level whereas reptiles have their highest richness at low elevations, probably reflecting the comparatively large number of species specialized to the extended low-elevation areas in the dry and subarid biomes. We found that the range sizes of both amphibians and reptiles strongly correlated with body size, and differences between the two groups are explained by the larger body sizes of reptiles. However, snakes have larger range sizes than lizards which cannot be readily explained by their larger body sizes alone. Range filling, i.e., the amount of suitable habitat occupied by a species, is less expressed in amphibians than in reptiles, possibly reflecting their lower dispersal capacity. Taxonomic composition of communities assessed by field surveys is largely explained by bioclimatic regions, with communities from the dry and especially subarid biomes distinctly differing from humid and subhumid biomes.	[Brown, Jason L.] So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA; [Sillero, Neftali] Ctr Invest Ciencias Geoespaciais, Alameda Do Monte Virgem, Vila Nova De Ga, Portugal; [Glaw, Frank] Zool Staatssammlung, Munich, Germany; [Bora, Parfait] Univ Antananarivo, Dept Biol Anim, Antananarivo, Madagascar; [Vieites, David R.] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Braunschweig, Germany	Southern Illinois University System; Southern Illinois University; University Antananarivo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Braunschweig University of Technology	Brown, JL (corresponding author), So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA.	jason.brown@siu.edu; m.vences@tu-bs.de	Sillero, Neftali/C-1803-2008; Vieites, David/B-4481-2009	Sillero, Neftali/0000-0002-3490-3780; Vieites, David/0000-0001-5551-7419; Vences, Miguel/0000-0003-0747-0817	Volkswagen Foundation; Spanish Government [CGL2009-10198, CGL2013-40924-P]; National Science Foundation [0905905]; FCT (Portugal) [IF/01526/2013]	Volkswagen Foundation(Volkswagen); Spanish Government(Spanish GovernmentEuropean Commission); National Science Foundation(National Science Foundation (NSF)); FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission)	Fieldwork of MV and PhD studies of PB were funded by the Volkswagen Foundation. Fieldwork was supported by Spanish Government grants CGL2009-10198 and CGL2013-40924-P to DRV. JLB was supported by the National Science Foundation (Grant No. 0905905). NS is supported with a research contract (IF/01526/2013) by FCT (Portugal).; A large number of students, friends and colleagues provided crucial help during fieldwork and stimulating input during various discussions, among which Franco Andreone, Alison Cameron, Lauren Chan, Sebastian Gehring, Steve M. Goodman, Jorn Kohler, David C. Lees, Brice P. Noonan, Maciej Pabijan, Ted Townsend, Krystal Tolley, Roger Daniel Randrianiaina, Fanomezana Ratsoavina, Katharina C. Wollenberg, and Anne Yoder. Fieldwork of M.V. and PhD studies of P.B. were funded by the Volkswagen Foundation. Fieldwork was supported by Spanish Government grants CGL2009-10198 and CGL2013-40924-P to DRV. J.L.B. was supported by the National Science Foundation (Grant No. 0905905). NS is supported with a research contract (IF/01526/2013) by FCT (Portugal). Figures are published under Creative Commons Attribution License (S1 Information).	Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; ANDERSON S, 1992, AUST J ZOOL, V40, P627, DOI 10.1071/ZO9920627; Anderson S, 1984, AM MUSEUM NOVITATES; Andreone F, 2007, TROP ZOOL, V20, P19; Andreone F, 2005, CONSERV BIOL, V19, P1790, DOI 10.1111/j.1523-1739.2005.00249.x; Andreone F, 2003, J NAT HIST, V37, P2119, DOI 10.1080/00222930210130357; Andreone F, 2009, ITAL J ZOOL, V76, P92, DOI 10.1080/11250000802088603; ANDREONE F, 2000, MEMOIRES SOC BIOGEOG, P217; Angel F, 1942, LEZARDS MADAGASCAR; Battistini R, 1972, BIOGEOGRAPHY ECOLOGY, P501; Blanc CP, 1996, COLLOQ SEMI, P231; Blommers-Schlosser R.M.A., 1993, Faune de Madagascar, V75, P385; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bora P, 2010, HERPETOL CONSERV BIO, V5, P111; Bora Parfait, 2007, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V83, P170, DOI 10.1002/mmnz.200700007; Boumans L, 2007, MOL PHYLOGENET EVOL, V45, P822, DOI 10.1016/j.ympev.2007.05.028; Brown JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6046; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Corporation I, 2010, IBM SPSS STAT WIND 1; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; D'Cruze N, 2007, HERPETOL CONSERV BIO, V2, P87; D'Cruze Neil, 2009, Herpetological Review, V40, P19; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Gaston KJ, 1996, OIKOS, V75, P479, DOI 10.2307/3545889; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Glaw F, 2014, ZOOSYST EVOL, V90, P249, DOI 10.3897/zse.90.8705; Glaw F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031314; Goodman S.M., 1997, RECHERCHES DEV SB, V12, P110; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 2003, NATURAL HIST MADAGAS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Humbert H, 1955, ANN BIOL, V31, P439; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Jenkins RKB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100173; Kaffenberger N, 2012, MOL PHYLOGENET EVOL, V62, P555, DOI 10.1016/j.ympev.2011.09.023; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Klages J, 2013, ZOOTAXA, V3717, P280; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Krause David W., 1997, P3; KRAUSE DW, 1999, GSA TODAY, V9, P1; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Lees D.C., 2006, ECOL LETT, V9, P149, DOI [10.1111/j.1461-0248.2007.01040.x, DOI 10.1111/J.1461-0248.2007.01040.X]; Lees David C, 2007, Ecol Lett, V10, pE4, DOI 10.1111/j.1461-0248.2007.01040.x; Lees DC, 1996, COLLOQ SEMI, P479; Lees DC, 2007, ECOL LETT, V10, pE9; Martin RD, 1972, REV LECT ADAPTIVE RA, P295; Miraldo A, 2014, SYST BIOL; Miraldo Andreia, 2011, Insects, V2, P112, DOI 10.3390/insects2020112; moat J., 1997, SIMPLIFIED GEOLOGY M; Moen DS, 2009, EVOLUTION, V63, P3228, DOI 10.1111/j.1558-5646.2009.00810.x; Nagy ZT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034506; Nussbaum RA, 1999, FIELD ZOOL, P155; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Paulian R., 1961, Faune de Madagascar, V13, P1; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Perl RGB, 2014, AMPHIBIA-REPTILIA, V35, P197, DOI 10.1163/15685381-00002942; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rabemananjara FCE, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-1; RAKOTOMALALA D, 2003, RECHERCHES DEV SERIE, V19, P147; Rakotomalala Domoina, 2002, Boissiera, V59, P339; Ramanamanjato J, 2002, BIOL ASSESSMENT RESE, P98; Raselimanana A, 2004, HERPETOFAUNE FORET M, P37; Raselimanana A.P., 1998, RECHERCHES DEV SB, V13, P43; RASELIMANANA A.P, 1998, RECHERCHES DEV SB, V14, p[183, 1]; Raselimanana Achille P., 2000, Fieldiana Zoology, V97, P157; Raselimanana AP, 1999, RECHERCHES DEV SB, V15, p[81, 1]; Ratsoavina FM, 2013, SALAMANDRA, V49, P115; Raxworthy C.J., 1994, RECHERCHES DEV SB, P41; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Raxworthy Christopher J., 1997, P124; Raxworthy Christopher J., 1998, Fieldiana Zoology, V90, P79; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Raxworthy CJ, 1996, CONSERV BIOL, V10, P750, DOI 10.1046/j.1523-1739.1996.10030750.x; Raxworthy CJ, 1996, COLLOQ SEMI, P369; RAXWORTHY CJ, 1995, J ZOOL, V235, P525, DOI 10.1111/j.1469-7998.1995.tb01767.x; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Schatz GE., 2000, MEMOIRES SOC BIOGEOG, V1, P1, DOI DOI 10.1002/14356007; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Vences M, 2002, ITAL J ZOOL, V69, P263, DOI 10.1080/11250000209356469; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Williams Paul, 2000, British Journal of Entomology and Natural History, V13, P73; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Yoder AD, 2005, P NATL ACAD SCI USA, V102, P6587, DOI 10.1073/pnas.0502092102; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30	99	50	53	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144076	10.1371/journal.pone.0144076	http://dx.doi.org/10.1371/journal.pone.0144076			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735688	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100006
J	de Gier, B; Ponce, MC; Perignon, M; Fiorentino, M; Khov, K; Chamnan, C; de Boer, MR; Parker, ME; Burja, K; Dijkhuizen, MA; Berger, J; Polman, K; Wieringa, FT				de Gier, Brechje; Ponce, Maiza Campos; Perignon, Marlene; Fiorentino, Marion; Khov, Kuong; Chamnan, Chhoun; de Boer, Michiel R.; Parker, Megan E.; Burja, Kurt; Dijkhuizen, Marjoleine A.; Berger, Jacques; Polman, Katja; Wieringa, Frank T.			Micronutrient-Fortified Rice Can Increase Hookworm Infection Risk: A Cluster Randomized Trial	PLOS ONE			English	Article							IRON SUPPLEMENTATION; CHILD UNDERNUTRITION; HELMINTH INFECTIONS; FOLIC-ACID; GUT; FORTIFICATION; INFLAMMATION; MICROBIOME; DEFICIENCY; COUNTRIES	Background Fortification of staple foods is considered an effective and safe strategy to combat micronutrient deficiencies, thereby improving health. While improving micronutrient status might be expected to have positive effects on immunity, some studies have reported increases in infections or inflammation after iron supplementation. Objective To study effects of micronutrient-fortified rice on hookworm infection in Cambodian schoolchildren. Methods A double-blinded, cluster-randomized trial was conducted in 16 Cambodian primary schools partaking in the World Food Program school meal program. Three types of multi-micronutrient fortified rice were tested against placebo rice within the school meal program: UltraRice_original, UltraRice_improved and NutriRice. Four schools were randomly assigned to each study group (placebo n = 492, UltraRice_original n = 479, UltraRice_improved n = 500, NutriRice n = 506). Intestinal parasite infection was measured in fecal samples by Kato-Katz method at baseline and after three and seven months. In a subgroup (N = 330), fecal calprotectin was measured by ELISA as a marker for intestinal inflammation. Results Baseline prevalence of hookworm infection was 18.6%, but differed considerably among schools (range 0%-48.1%). Micronutrient-fortified rice significantly increased risk of new hookworm infection. This effect was modified by baseline hookworm prevalence at the school; hookworm infection risk was increased by all three types of fortified rice in schools where baseline prevalence was high (>15%), and only by UltraRice_original in schools with low baseline prevalence. Neither hookworm infection nor fortified rice was related to fecal calprotectin. Conclusions Consumption of rice fortified with micronutrients can increase hookworm prevalence, especially in environments with high infection pressure. When considering fortification of staple foods, a careful risk-benefit analysis is warranted, taking into account severity of micronutrient deficiencies and local prevalence of parasitic infections.	[de Gier, Brechje] Vrije Univ Amsterdam, Fac Earth & Life Sci, Athena Inst, Sect Hlth & Life Sci, Amsterdam, Netherlands; [Ponce, Maiza Campos; Polman, Katja] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Infect Dis Sect, Amsterdam, Netherlands; [Perignon, Marlene; Fiorentino, Marion; Berger, Jacques; Wieringa, Frank T.] Inst Rech Dev, NutriPass IRD UM SupAgro, UMR 204, Montpellier, France; [Khov, Kuong; Chamnan, Chhoun] Fisheries Adm, Dept Fisheries Postharvest Technol & Qual Control, Phnom Penh, Cambodia; [de Boer, Michiel R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Sect Methodol & Appl Biostat, Amsterdam, Netherlands; [Parker, Megan E.] PATH, Seattle, WA USA; [Burja, Kurt] United Nations World Food Programme, Phnom Penh, Cambodia; [Dijkhuizen, Marjoleine A.] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Polman, Katja] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Vrije Universiteit Amsterdam; University of Copenhagen; Institute of Tropical Medicine (ITM)	Wieringa, FT (corresponding author), Inst Rech Dev, NutriPass IRD UM SupAgro, UMR 204, Montpellier, France.	franck.wieringa@ird.fr	Wieringa, Frank Tammo/K-7565-2017	Wieringa, Frank Tammo/0000-0002-6010-355X; de Boer, Michiel/0000-0001-9240-0199; fiorentino, marion/0000-0002-1615-4579; PERIGNON, Marlene/0000-0003-2862-9030; Campos Ponce, Maiza/0000-0003-1700-4756	United States Department of Agriculture/FAS [FFE-442-2012/03800, 10.608]; WFP (WFP/DSM partnership); IRD	United States Department of Agriculture/FAS; WFP (WFP/DSM partnership); IRD	The research described in this paper received funding from United States Department of Agriculture/FAS through a grant (FFE-442-2012/03800, 10.608) to PATH and internal funding from WFP (through the WFP/DSM partnership) and IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutta ZA, 2013, BRIT MED BULL, V106, P7, DOI 10.1093/bmb/ldt015; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Casey GJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002146; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; de Gier B, 2014, AM J CLIN NUTR, V99, P1499, DOI 10.3945/ajcn.113.069955; Dostal A, 2014, BRIT J NUTR, V112, P547, DOI 10.1017/S0007114514001160; Fagerberg UL, 2003, J PEDIATR GASTR NUTR, V37, P468, DOI 10.1097/00005176-200310000-00013; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Hoddinott J, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P332; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Laillou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101159; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; Loukas A, 2001, CLIN MICROBIOL REV, V14, P689, DOI 10.1128/CMR.14.4.689-703.2001; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; National Institute of Statistics DGfH and ICF Macro, 2011, CAMB DEM HLTH SURV 2; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Perignon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112605; Rivera JA, 2003, J NUTR, V133, p4010S, DOI 10.1093/jn/133.11.4010S; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Sinuon Muth, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P254; Stoltzfus RJ, 1996, AM J TROP MED HYG, V55, P399, DOI 10.4269/ajtmh.1996.55.399; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; World Health Organization (WHO), 1994, BENCH AIDS DIAGN INT; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	31	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145351	10.1371/journal.pone.0145351	http://dx.doi.org/10.1371/journal.pone.0145351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735845	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100025
J	Cauwelaert, ND; Desbien, AL; Hudson, TE; Pine, SO; Reed, SG; Coler, RN; Orr, MT				Cauwelaert, Natasha Dubois; Desbien, Anthony L.; Hudson, Thomas E.; Pine, Samuel O.; Reed, Steven G.; Coler, Rhea N.; Orr, Mark T.			The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for T(H)1 Induction	PLOS ONE			English	Article							CD8 T-CELLS; IFN-GAMMA; DENDRITIC CELLS; I INTERFERONS; CLONAL EXPANSION; MYCOBACTERIUM-TUBERCULOSIS; TRANSCRIPTION FACTOR; SUBUNIT VACCINE; UP-REGULATION; CUTTING EDGE	The Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant formulated in a stable emulsion (GLA-SE) promotes strong T(H)1 and balanced IgG1/IgG2 responses to protein vaccine antigens. This enhanced immunity is sufficient to provide protection against many diseases including tuberculosis and leishmaniasis. To better characterize the adjuvant action it is important to understand how the different cytokines and transcription factors contribute to the initiation of immunity. In the present study using T-bet(-/-) and IL-12(-/-) mice and a blocking anti-IFN alpha R1 monoclonal antibody, we define mechanisms of adjuvant activity of GLA-SE. In accordance with previous studies of TLR4 agonist based adjuvants, we found that T(H)1 induction via GLA-SE was completely dependent upon T-bet, a key transcription factor for IFN Upsilon production and T(H)1 differentiation. Consistent with this, deficiency of IL-12, a cytokine canonical to T(H)1 induction, ablated T(H)1 induction via GLA-SE. Finally we demonstrate that the innate immune response to GLA-SE, including rapid IFN Upsilon production by memory CD8+ T cells and NK cells, was contingent on type I interferon, a cytokine group whose association with T(H)1 induction is contextual, and that they contributed to the adjuvant activity of GLA-SE.	[Cauwelaert, Natasha Dubois; Desbien, Anthony L.; Hudson, Thomas E.; Pine, Samuel O.; Reed, Steven G.; Coler, Rhea N.; Orr, Mark T.] Infect Dis Res Inst, Seattle, WA 98104 USA; [Reed, Steven G.; Coler, Rhea N.; Orr, Mark T.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Orr, MT (corresponding author), Infect Dis Res Inst, Seattle, WA 98104 USA.	mark.orr@idri.org		Orr, Mark/0000-0003-2684-4722; Dubois Cauwelaert, Natasha/0000-0003-4895-9117	National Institute of Allergy and Infectious Diseases [HHSN272200800045C]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a contract HHSN272200800045C from the National Institute of Allergy and Infectious Diseases (niaid.nih.gov) to RNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Byrnes AA, 2001, EUR J IMMUNOL, V31, P2026, DOI 10.1002/1521-4141(200107)31:7<2026::AID-IMMU2026>3.3.CO;2-L; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Chang JT, 2000, EUR J IMMUNOL, V30, P1113, DOI 10.1002/(SICI)1521-4141(200004)30:4<1113::AID-IMMU1113>3.0.CO;2-P; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Desbien AL, 2015, EUR J IMMUNOL, V45, P407, DOI 10.1002/eji.201444543; Favila MA, 2014, J IMMUNOL, V192, P5863, DOI 10.4049/jimmunol.1203230; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Gandhapudi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056855; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; Harandi AM, 2001, J VIROL, V75, P6705, DOI 10.1128/JVI.75.14.6705-6709.2001; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Khoo JJ, 2011, J INTERF CYTOK RES, V31, P13, DOI 10.1089/jir.2010.0095; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kurche JS, 2012, J IMMUNOL, V188, P585, DOI 10.4049/jimmunol.1102550; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Maxwell JR, 2006, J IMMUNOL, V177, P234, DOI 10.4049/jimmunol.177.1.234; McNab FW, 2014, J IMMUNOL, V193, P3600, DOI 10.4049/jimmunol.1401088; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Orr MT, 2014, J CONTROL RELEASE, V177, P20, DOI 10.1016/j.jconrel.2013.12.025; Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030; Orr MT, 2013, EUR J IMMUNOL, V43, P2398, DOI 10.1002/eji.201243124; Oxenius A, 1999, J IMMUNOL, V162, P965; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Pinto AK, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002407, DOI 10.1371/J0URNAL.PPAT.1002407]; Prchal M, 2009, VACCINE, V27, pG17, DOI 10.1016/j.vaccine.2009.10.016; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Puggioni F, 2005, ALLERGY, V60, P678, DOI 10.1111/j.1398-9995.2005.00762.x; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Raman VS, 2009, INFECT IMMUN, V77, P5623, DOI 10.1128/IAI.00508-09; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Schijns VECJ, 1998, J IMMUNOL, V160, P3958; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; TRINCHIERI G, 1994, BLOOD, V84, P4008, DOI 10.1182/blood.V84.12.4008.bloodjournal84124008; Wenner CA, 1996, J IMMUNOL, V156, P1442; Windish HP, 2011, VACCINE, V29, P7842, DOI 10.1016/j.vaccine.2011.07.094; Xing Z, 2000, J IMMUNOL, V164, P2575, DOI 10.4049/jimmunol.164.5.2575; Yoshimoto T, 1998, J IMMUNOL, V161, P3400	57	37	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146372	10.1371/journal.pone.0146372	http://dx.doi.org/10.1371/journal.pone.0146372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731269	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400162
J	Honaas, LA; Wafula, EK; Wickett, NJ; Der, JP; Zhang, YT; Edger, PP; Altman, NS; Pires, JC; Leebens-Mack, JH; dePamphilis, CW				Honaas, Loren A.; Wafula, Eric K.; Wickett, Norman J.; Der, Joshua P.; Zhang, Yeting; Edger, Patrick P.; Altman, Naomi S.; Pires, J. Chris; Leebens-Mack, James H.; dePamphilis, Claude W.			Selecting Superior De Novo Transcriptome Assemblies: Lessons Learned by Leveraging the Best Plant Genome	PLOS ONE			English	Article							RNA-SEQ; GENE-EXPRESSION; MODEL; QUANTIFICATION; SEQUENCES; ALIGNMENT; REVEALS; MARKERS; SEARCH; TOMATO	Whereas de novo assemblies of RNA-Seq data are being published for a growing number of species across the tree of life, there are currently no broadly accepted methods for evaluating such assemblies. Here we present a detailed comparison of 99 transcriptome assemblies, generated with 6 de novo assemblers including CLC, Trinity, SOAP, Oases, ABySS and NextGENe. Controlled analyses of de novo assemblies for Arabidopsis thaliana and Oryza sativa transcriptomes provide new insights into the strengths and limitations of transcriptome assembly strategies. We find that the leading assemblers generate reassuringly accurate assemblies for the majority of transcripts. At the same time, we find a propensity for assemblers to fail to fully assemble highly expressed genes. Surprisingly, the instance of true chimeric assemblies is very low for all assemblers. Normalized libraries are reduced in highly abundant transcripts, but they also lack 1000s of low abundance transcripts. We conclude that the quality of de novo transcriptome assemblies is best assessed through consideration of a combination of metrics: 1) proportion of reads mapping to an assembly 2) recovery of conserved, widely expressed genes, 3) N50 length statistics, and 4) the total number of unigenes. We provide benchmark Illumina transcriptome data and introduce SCERNA, a broadly applicable modular protocol for de novo assembly improvement. Finally, our de novo assembly of the Arabidopsis leaf transcriptome revealed similar to 20 putative Arabidopsis genes lacking in the current annotation.	[Honaas, Loren A.; Wafula, Eric K.; Wickett, Norman J.; Der, Joshua P.; Zhang, Yeting; dePamphilis, Claude W.] Penn State, Dept Biol, University Pk, PA 16802 USA; [Edger, Patrick P.; Pires, J. Chris] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Altman, Naomi S.] Penn State, Dept Stat, University Pk, PA 16802 USA; [Leebens-Mack, James H.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Missouri System; University of Missouri Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia	dePamphilis, CW (corresponding author), Penn State, Dept Biol, University Pk, PA 16802 USA.	cwd3@psu.edu	Pires, J. Chris/O-5122-2014; dePamphilis, Claude W/P-6652-2016; Edger, Patrick/ABE-6442-2020; Der, Joshua P/F-9551-2012; Edger, Patrick/AAP-3846-2021; Leebens-Mack, James/AAF-6770-2019; Wickett, Norman/AAV-8136-2021; Honaas, Loren/GWC-8659-2022	Pires, J. Chris/0000-0001-9682-2639; Der, Joshua P/0000-0001-9668-2525; Leebens-Mack, James/0000-0003-4811-2231; Wickett, Norman/0000-0003-0944-1956; Honaas, Loren/0000-0001-9187-8254	National Science Foundation Plant Genome Research Program [DBI-0638595, IOS-0922742, DBI-0701748, DBI-1238057]; Direct For Biological Sciences [1238057] Funding Source: National Science Foundation; Division Of Environmental Biology [1442199] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0922742] Funding Source: National Science Foundation	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation Plant Genome Research Program (www.nsf.gov) supported the work described in the manuscript under consideration via the following awards (funded authors listed): DBI-0638595 (CWD JHL), IOS-0922742 (CWD), DBI-0701748 (CWD), DBI-1238057 (CWD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angeloni F, 2011, MOL ECOL RESOUR, V11, P662, DOI 10.1111/j.1755-0998.2011.02990.x; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrero RA, 2011, BMC GENOMICS, V12; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Chang Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0596-2; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edger PP, 2015, P NATL ACAD SCI USA, V112, P8362, DOI 10.1073/pnas.1503926112; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Garsmeur O, 2014, MOL BIOL EVOL, V31, P448, DOI 10.1093/molbev/mst230; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Harkess A, 2015, NEW PHYTOL, V207, P883, DOI 10.1111/nph.13389; Honaas LA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-9; Huang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-648; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Joseph Bedell, 2003, BLAST; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kozik A, 2008, PLANT AND ANIMAL GEN; Krishnan NM, 2011, CURR SCI INDIA, V101, P1553; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lai Z, 2012, AM J BOT, V99, P209, DOI 10.3732/ajb.1100313; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeBlanc M, 2013, NEW PHYTOL, V200, P1225, DOI 10.1111/nph.12439; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074478; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064531; Lynch M, 2002, SCIENCE, V297, P945, DOI 10.1126/science.1075472; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Proost S, 2011, PLANT J, V66, P58, DOI 10.1111/j.1365-313X.2011.04521.x; Qian WF, 2014, GENOME RES, V24, P1356, DOI 10.1101/gr.172098.114; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sun Q, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-53; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Tang Q, 2011, BMC GENOMICS, P12; Thompson DA, 2013, ELIFE, V2, DOI [10.7554/eLife.01114, 10.7554/eLife.00603]; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Venturini L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-41; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Wickett NJ, 2011, CURR BIOL, V21, P2098, DOI 10.1016/j.cub.2011.11.011; Wilkening Stefan, 2004, J Biomol Tech, V15, P107; Williams JS, 2014, PLANT CELL, V26, P2873, DOI 10.1105/tpc.114.126920; Wong MML, 2011, BMC GENOMICS, P12; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xu JJ, 2013, PLANT MOL BIOL, V83, P77, DOI 10.1007/s11103-013-0025-4; Xu YJ, 2013, BMC GENOMICS, V14, P15; Yang ZZ, 2015, MOL BIOL EVOL, V32, P767, DOI 10.1093/molbev/msu343; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222	85	67	67	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146062	10.1371/journal.pone.0146062	http://dx.doi.org/10.1371/journal.pone.0146062			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731733	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400085
J	Kazyak, DC; Hilderbrand, RH; King, TL; Keller, SR; Chhatre, VE				Kazyak, David C.; Hilderbrand, Robert H.; King, Tim L.; Keller, Stephen R.; Chhatre, Vikram E.			Hiding in Plain Sight: A Case for Cryptic Metapopulations in Brook Trout (Salvelinus fontinalis)	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-STRUCTURE; LIFE-HISTORY; LANDSCAPE ECOLOGY; SAMPLING SCHEME; RIVER; DIVERSITY; INFERENCE; PROGRAM; HABITAT	A fundamental issue in the management and conservation of biodiversity is how to define a population. Spatially contiguous fish occupying a stream network have often been considered to represent a single, homogenous population. However, they may also represent multiple discrete populations, a single population with genetic isolation-by-distance, or a metapopulation. We used microsatellite DNA and a large-scale mark-recapture study to assess population structure in a spatially contiguous sample of Brook Trout (Salvelinus fontinalis), a species of conservation concern. We found evidence for limited genetic exchange across small spatial scales and in the absence of barriers to physical movement. Markrecapture and stationary passive integrated transponder antenna records demonstrated that fish from two tributaries very seldom moved into the opposite tributary, but movements between the tributaries and mainstem were more common. Using Bayesian genetic clustering, we identified two genetic groups that exhibited significantly different growth rates over three years of study, yet survival rates were very similar. Our study highlights the importance of considering the possibility of multiple genetically distinct populations occurring within spatially contiguous habitats, and suggests the existence of a cryptic metapopulation: a spatially continuous distribution of organisms exhibiting metapopulation-like behaviors.	[Kazyak, David C.; Hilderbrand, Robert H.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA; [Kazyak, David C.; King, Tim L.] US Geol Survey, Leetown Sci Ctr, Aquat Ecol Branch, Kearneysville, WV USA; [Keller, Stephen R.; Chhatre, Vikram E.] Univ Vermont, Dept Plant Biol, Burlington, VT USA	University System of Maryland; University of Maryland Center for Environmental Science; United States Department of the Interior; United States Geological Survey; University of Vermont	Kazyak, DC (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA.	dkazyak@gmail.com	Chhatre, Vikram/B-6649-2016; Keller, Stephen/J-6652-2013; Hilderbrand, Robert H/H-9807-2013; Chhatre, Vikram/O-2459-2019	Chhatre, Vikram/0000-0001-6627-2832; Keller, Stephen/0000-0001-8887-9213; Hilderbrand, Robert H/0000-0003-0923-7699; Chhatre, Vikram/0000-0001-6627-2832				Allendorf Fred W., 1996, P238; Apps CD, 2006, BIOL CONSERV, V130, P84, DOI 10.1016/j.biocon.2005.12.004; Armstrong JD, 1997, J FISH BIOL, V50, P445, DOI 10.1006/jfbi.1996.0304; Aunins A, 2015, CONSERV GENET, V16, P15, DOI 10.1007/s10592-014-0636-6; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 1998, NATO ADV SCI I A-LIF, V306, P39; Benda L, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002583; Brattstrom O, 2010, ECOL ENTOMOL, V35, P248, DOI 10.1111/j.1365-2311.2009.01163.x; Carlsson J, 2000, HEREDITAS, V132, P173, DOI 10.1111/j.1601-5223.2000.00173.x; Carlsson J, 1999, J FISH BIOL, V55, P1290, DOI 10.1111/j.1095-8649.1999.tb02076.x; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Conejeros P, 2014, T AM FISH SOC, V143, P586, DOI 10.1080/00028487.2014.880734; Cote D, 2009, LANDSCAPE ECOL, V24, P101, DOI 10.1007/s10980-008-9283-y; Docker MF, 2003, CONSERV GENET, V4, P227, DOI 10.1023/A:1023355114612; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; EXCOFFIER L, 1992, GENETICS, V131, P479; Fagan WF, 2002, ECOLOGY, V83, P3243, DOI 10.2307/3072074; Falush D, 2003, GENETICS, V164, P1567; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; HASLER AD, 1951, AM NAT, V85, P223, DOI 10.1086/281672; HASTINGS A, 1994, ANNU REV ECOL SYST, V25, P167; Haugen TO, 2000, J EVOLUTION BIOL, V13, P897, DOI 10.1046/j.1420-9101.2000.00242.x; Hecht BC, 2013, G3, V2, P1113; Heft A., 2006, MARYLAND BROOK TROUT; Hess JE, 2011, CAN J FISH AQUAT SCI, V68, P89, DOI 10.1139/F10-131; Hilderbrand RH, 2003, BIOL CONSERV, V110, P257, DOI 10.1016/S0006-3207(02)00224-0; Hindrikson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075765; HORRALL RM, 1981, CAN J FISH AQUAT SCI, V38, P1481, DOI 10.1139/f81-201; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kanno Y, 2014, FRESHWATER BIOL, V59, P142, DOI 10.1111/fwb.12254; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; Kazyak D, 2012, N AM J FISH MANAGE, V32, P49, DOI 10.1080/02755947.2012.655847; Keefer ML, 2006, CAN J FISH AQUAT SCI, V63, P1752, DOI 10.1139/F06-068; Kennedy BM, 2003, WEST N AM NATURALIST, V63, P215; Kiffney PM, 2006, CAN J FISH AQUAT SCI, V63, P2518, DOI 10.1139/F06-138; King TL, 2012, CONSERV GENET RESOUR, V4, P539, DOI 10.1007/s12686-012-9603-z; Koskinen MT, 2002, NATURE, V419, P826, DOI 10.1038/nature01029; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Krueger CC, 1986, FISH CULTURE FISHERI, P93; Letcher BH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001139; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Levins R., 1970, SOME MATH PROBLEMS B, P77; Lu GQ, 1999, EVOLUTION, V53, P1491, DOI 10.1111/j.1558-5646.1999.tb05413.x; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085171; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Neville HM, 2006, LANDSCAPE ECOL, V21, P901, DOI 10.1007/s10980-005-5221-4; Nyce LG, 2013, N AM J FISH MANAGE, V33, P432, DOI 10.1080/02755947.2013.768565; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petty JT, 2014, HYDROBIOLOGIA, V727, P151, DOI 10.1007/s10750-013-1794-0; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Power G, 1980, CHARRS SALMONID FISH, P141; Pritchard JK, 2000, GENETICS, V155, P945; Quinn TP, 2001, CAN J ZOOL, V79, P1782, DOI 10.1139/cjz-79-10-1782; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richards Amber L., 2008, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V62, P195; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Theriault V, 2003, J FISH BIOL, V63, P1144, DOI 10.1046/j.1095-8649.2003.00233.x; Torterotot JB, 2014, T AM FISH SOC, V143, P1577, DOI 10.1080/00028487.2014.952449; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; WISBY WARREN J., 1954, JOUR FISH RES BD CANADA, V11, P472	74	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146295	10.1371/journal.pone.0146295	http://dx.doi.org/10.1371/journal.pone.0146295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730588	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400140
J	Liu, L; Zhang, XY; Wang, SQ; Lu, XH; Ouyang, XY				Liu, Lei; Zhang, Xiuying; Wang, Shanqian; Lu, Xuehe; Ouyang, Xiaoying			A Review of Spatial Variation of Inorganic Nitrogen (N) Wet Deposition in China	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN; CHEMICAL-COMPOSITION; SULFUR; PRECIPITATION; INCREASE; AGROECOSYSTEM; ACIDIFICATION; CHEMISTRY; RAINWATER; GUIYANG	Atmospheric nitrogen (N) deposition (N-dep), an important component of the global N cycle, has increased sharply in recent decades in China. Although there were already some studies on N-dep on a national scale, there were some gaps on themagnitude and the spatial patterns of N-dep. In this study, a national-scale N-dep pattern was constructed based on 139 published papers from 2003 to 2014 and the effects of precipitation (P), energy consumption (E) and N fertilizer use (F-N) on spatial patterns of N-dep were analyzed. The wet deposition flux of NH4+-N, NO3--N and total N-dep was 6.83, 5.35 and 12.18 kg ha(-1) a(-1), respectively. N-dep exhibited a decreasing gradient from southeast to northwest of China. Through accuracy assessment of the spatial N-dep distribution and comparisons with other studies, the spatial N-dep distribution by Lu and Tian and this study both gained high accuracy. A strong exponential function was found between P and N-dep, FN and N-dep and E and N-dep, and P and FN had higher contribution than E on the spatial variation of N-dep. Fossil fuel combustion was themain contributor for NO3--N (86.0%) and biomass burning contributed 5.4% on the deposition of NO3--N. The ion of NH4+ was mainly from agricultural activities (85.9%) and fossil fuel combustion (6.0%). Overall, N-dep in China might be considerably affected by the high emissions of NOx and NH3 from fossil fuel combustion and agricultural activities.	[Liu, Lei; Zhang, Xiuying; Wang, Shanqian; Lu, Xuehe] Nanjing Univ, Int Inst Earth Syst Sci, Jiangsu Prov Key Lab Geog Informat Sci & Technol, Nanjing 210023, Jiangsu, Peoples R China; [Lu, Xuehe] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China; [Ouyang, Xiaoying] Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing 100101, Peoples R China	Nanjing University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Zhang, XY (corresponding author), Nanjing Univ, Int Inst Earth Syst Sci, Jiangsu Prov Key Lab Geog Informat Sci & Technol, Nanjing 210023, Jiangsu, Peoples R China.	lzhxy77@163.com			National Natural Science Foundation of China [41471343, 41101315]; Open Foundation of State Key Laboratory of Remote Sensing [OFSLRSS201312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of State Key Laboratory of Remote Sensing	This study is supported by the National Natural Science Foundation of China (No. 41471343 and 41101315), and the Open Foundation of State Key Laboratory of Remote Sensing (OFSLRSS201312).	Cao YZ, 2009, ATMOS RES, V94, P462, DOI 10.1016/j.atmosres.2009.07.004; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Comero S, 2014, CHEMOSPHERE, V95, P329, DOI 10.1016/j.chemosphere.2013.09.028; Cui J, 2014, ATMOS ENVIRON, V89, P102, DOI 10.1016/j.atmosenv.2014.02.007; Du E., 2014, NITROGEN DEPOSITION, P49; He NP, 2015, SCI TOTAL ENVIRON, V520, P302, DOI 10.1016/j.scitotenv.2015.03.063; Huang DY, 2010, ENVIRON MONIT ASSESS, V171, P429, DOI 10.1007/s10661-009-1289-7; Huang K, 2008, ATMOS RES, V89, P149, DOI 10.1016/j.atmosres.2008.01.006; Huang YL, 2013, ENVIRON MONIT ASSESS, V185, P113, DOI 10.1007/s10661-012-2537-9; Huanyong Hu, 1998, CHINA POPULATION TOD, V15, P20; Jia Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03763; Larssen T, 2011, ENVIRON SCI TECHNOL, V45, P1192, DOI 10.1021/es103426p; Li YH, 2011, ENVIRON SCI POLLUT R, V18, P1544, DOI 10.1007/s11356-011-0516-2; Liu XJ, 2015, SCI TOTAL ENVIRON, V520, P300, DOI 10.1016/j.scitotenv.2015.03.004; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lu CQ, 2014, ATMOS ENVIRON, V97, P68, DOI 10.1016/j.atmosenv.2014.07.061; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Pan YP, 2013, ATMOS CHEM PHYS, V13, P1675, DOI 10.5194/acp-13-1675-2013; Pan YP, 2012, ATMOS CHEM PHYS, V12, P6515, DOI 10.5194/acp-12-6515-2012; Pan YP, 2015, ATMOS ENVIRON, V101, P350, DOI 10.1016/j.atmosenv.2014.10.062; Qi JH, 2013, ATMOS ENVIRON, V81, P600, DOI 10.1016/j.atmosenv.2013.08.022; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Shi YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08118; Stevens CJ, 2009, ENVIRON POLLUT, V157, P313, DOI 10.1016/j.envpol.2008.06.033; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Xiao HW, 2013, J ATMOS CHEM, V70, P269, DOI 10.1007/s10874-013-9268-3; Xiao HY, 2002, ATMOS ENVIRON, V36, P5121, DOI 10.1016/S1352-2310(02)00649-0; Xie YX, 2008, ATMOS ENVIRON, V42, P5182, DOI 10.1016/j.atmosenv.2008.03.008; Xu H, 2011, ENVIRON MONIT ASSESS, V183, P581, DOI 10.1007/s10661-011-1963-4; Xu W, 2015, ATMOS CHEM PHYS, V15, P12345, DOI 10.5194/acp-15-12345-2015; Zhan X, 2015, ENVIRON POLLUT, V204, P1, DOI 10.1016/j.envpol.2015.03.016; Zhang NN, 2012, ATMOS RES, V106, P50, DOI 10.1016/j.atmosres.2011.11.006; Zhang XY, 2012, ATMOS RES, V116, P151, DOI 10.1016/j.atmosres.2012.03.014; Zhang Y, 2012, ATMOS ENVIRON, V46, P195, DOI 10.1016/j.atmosenv.2011.09.080; Zhao Min, 2013, Atmospheric and Climate Sciences, V3, P486; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; Zhu JX, 2015, SCI TOTAL ENVIRON, V511, P777, DOI 10.1016/j.scitotenv.2014.12.038	38	30	33	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146051	10.1371/journal.pone.0146051	http://dx.doi.org/10.1371/journal.pone.0146051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731264	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400081
J	Mahr, B; Unger, L; Hock, K; Pilat, N; Baranyi, U; Schwarz, C; Maschke, S; Farkas, AM; Wekerle, T				Mahr, Benedikt; Unger, Lukas; Hock, Karin; Pilat, Nina; Baranyi, Ulrike; Schwarz, Christoph; Maschke, Svenja; Farkas, Andreas Michael; Wekerle, Thomas			IL-2/alpha-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment	PLOS ONE			English	Article							LOW-DOSE INTERLEUKIN-2; IN-VIVO EXPANSION; TRANSPLANTATION TOLERANCE; SELECTIVE STIMULATION; MIXED CHIMERISM; RECEPTOR; MICE; PROLIFERATION; RAPAMYCIN; THERAPY	Cell therapy with recipient Tregs achieves engraftment of allogeneic bone marrow (BM) without the need for cytoreductive conditioning (i.e., without irradiation or cytotoxic drugs). Thereby mixed chimerism and transplantation tolerance are established in recipients conditioned solely with costimulation blockade and rapamycin. However, clinical translation would be substantially facilitated if Treg-stimulating pharmaceutical agents could be used instead of individualized cell therapy. Recently, it was shown that interleukin-2 (IL-2) complexed with a monoclonal antibody (mAb) (clone JES6-1A12) against IL-2 (IL-2 complexes) potently expands and activates Tregs in vivo. Therefore, we investigated whether IL-2 complexes can replace Treg therapy in a costimulation blockade-based and irradiation-free BM transplantation (BMT) model. Unexpectedly, the administration of IL-2 complexes at the time of BMT (instead of Tregs) failed to induce BM engraftment in non-irradiated recipients (0/6 with IL-2 complexes vs. 3/4 with Tregs, p<0.05). Adding IL-2 complexes to an otherwise effective regimen involving recipient irradiation (1Gy) but no Treg transfer indeed actively triggered donor BM rejection at higher doses (0/8 with IL-2 complexes vs. 9/11 without, p<0.01) and had no detectable effect at two lower doses (3/5 vs. 9/11, p>0.05). CD8 T cells and NK cells of IL-2 complex-treated naive mice showed an enhanced proliferative response towards donor antigens in vitro despite the marked expansion of Tregs. However, IL-2 complexes also expanded conventional CD4 T cells, CD8 T cells, NK cells, NKT cells and notably even B cells, albeit to a lesser extent. Notably, IL-2 complex expanded Tregs featured less potent suppressive functions than in vitro activated Tregs in terms of T cell suppression in vitro and BM engraftment in vivo. In conclusion, these data suggest that IL-2 complexes are less effective than recipient Tregs in promoting BM engraftment and in contrast actually trigger BM rejection, as their effect is not sufficiently restricted to Tregs but rather extends to several other lymphocyte populations.	[Mahr, Benedikt; Unger, Lukas; Hock, Karin; Pilat, Nina; Baranyi, Ulrike; Schwarz, Christoph; Maschke, Svenja; Farkas, Andreas Michael; Wekerle, Thomas] Med Univ Vienna, Dept Surg, Sect Transplantat Immunol, A-1090 Vienna, Austria	Medical University of Vienna	Wekerle, T (corresponding author), Med Univ Vienna, Dept Surg, Sect Transplantat Immunol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	thomas.wekerle@meduniwien.ac.at	Pilat, Nina/H-7940-2019; Unger, Lukas/I-8768-2019	Pilat, Nina/0000-0003-4071-9397; Unger, Lukas/0000-0002-8423-2268; Schwarz, Christoph/0000-0002-7676-2779; Baranyi, Ulrike/0000-0002-6327-3052; Mahr, Benedikt/0000-0001-5255-381X	Austrian Science Fund (FWF) [TRP 151-B19]; Austrian Science Fund (FWF) [TRP 151] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF, www.fwf.ac.at) Project No. TRP 151-B19 to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2006, SCAND J IMMUNOL, V64, P482, DOI 10.1111/j.1365-3083.2006.01832.x; Barao I, 2003, BIOL BLOOD MARROW TR, V9, P727, DOI 10.1016/j.bbmt.2003.09.002; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Charbonnier LM, 2012, AM J TRANSPLANT, V12, P2313, DOI 10.1111/j.1600-6143.2012.04184.x; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; COUSENS LP, 1995, J IMMUNOL, V155, P5690; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; GERDES J, 1984, J IMMUNOL, V133, P1710; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; HENNEY CS, 1981, NATURE, V291, P335, DOI 10.1038/291335a0; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim YS, 1998, J IMMUNOL, V160, P5742; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Kuess P, 2014, Z MED PHYS, V24, P363, DOI 10.1016/j.zemedi.2014.08.005; Lee SY, 2012, IMMUNOLOGY, V137, P305, DOI 10.1111/imm.12008; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Liu CL, 2011, MOL THER, V19, P1511, DOI 10.1038/mt.2011.61; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Pilat N, 2010, AM J TRANSPLANT, V10, P751, DOI 10.1111/j.1600-6143.2010.03018.x; Pilat N, 2014, J HEART LUNG TRANSPL, V33, P429, DOI 10.1016/j.healun.2013.11.004; Pilat N, 2011, TRANSPLANTATION, V92, P280, DOI 10.1097/TP.0b013e3182241133; Pilat N, 2010, NAT REV NEPHROL, V6, P594, DOI 10.1038/nrneph.2010.110; POZNIAK MA, 1995, CANCER, V75, P2737, DOI 10.1002/1097-0142(19950601)75:11<2737::AID-CNCR2820751117>3.0.CO;2-A; Riella LV, 2012, AM J TRANSPLANT, V12, P846, DOI 10.1111/j.1600-6143.2011.03929.x; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Robb RJ, 2012, BLOOD, V119, P5898, DOI 10.1182/blood-2011-12-396119; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; Schultz M, 2001, IMMUNOLOGY, V104, P127, DOI 10.1046/j.1365-2567.2001.01308.x; Shatry A, 2009, BIOL BLOOD MARROW TR, V15, P785, DOI 10.1016/j.bbmt.2009.03.011; Shevach EM, 2012, TRENDS IMMUNOL, V33, P626, DOI 10.1016/j.it.2012.07.007; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; VALLERA DA, 1994, TRANSPLANTATION, V57, P249, DOI 10.1097/00007890-199401001-00017; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Woerly G, 1996, CLIN EXP IMMUNOL, V103, P322, DOI 10.1046/j.1365-2249.1996.d01-616.x; Zhang P, 2013, J IMMUNOL, V191, P5291, DOI 10.4049/jimmunol.1301181; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; Zou T, 2012, J IMMUNOL, V189, P28, DOI 10.4049/jimmunol.1200507	55	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146245	10.1371/journal.pone.0146245	http://dx.doi.org/10.1371/journal.pone.0146245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731275	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400126
J	Segal-Salto, M; Sapir, T; Reiner, O				Segal-Salto, Michal; Sapir, Tamar; Reiner, Orly			Reversible Cysteine Acylation Regulates the Activity of Human Palmitoyl-Protein Thioesterase 1 (PPT1)	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; ENZYME REPLACEMENT THERAPY; PRECLINICAL MOUSE MODEL; DIRECTED GENE-THERAPY; SITE FATTY ACYLATION; MURINE MODEL; GABA(A) RECEPTORS; KNOCKOUT MICE; CELLS; INCL	Mutations in the depalmitoylating enzyme gene, PPT1, cause the infantile form of Neuronal Ceroid Lipofuscinosis (NCL), an early onset neurodegenerative disease. During recent years there have been different therapeutic attempts including enzyme replacement. Here we show that PPT1 is palmitoylated in vivo and is a substrate for two palmitoylating enzymes, DHHC3 and DHHC7. The palmitoylated protein is detected in both cell lysates and medium. The presence of PPT1 with palmitoylated signal peptide in the cell medium suggests that a subset of the protein is secreted by a nonconventional mechanism. Using a mutant form of PPT1, C6S, which was not palmitoylated, we further demonstrate that palmitoylation does not affect intracellular localization but rather that the unpalmitoylated form enhanced the depalmitoylation activity of the protein. The calculated Vmax of the enzyme was significantly affected by the palmitoylation, suggesting that the addition of a palmitate group is reminiscent of adding a noncompetitive inhibitor. Thus, we reveal the existence of a positive feedback loop, where palmitoylation of PPT1 results in decreased activity and subsequent elevation in the amount of palmitoylated proteins. This positive feedback loop is likely to initiate a vicious cycle, which will enhance disease progression. The understanding of this process may facilitate enzyme replacement strategies.	[Segal-Salto, Michal; Sapir, Tamar; Reiner, Orly] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reiner, O (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	orly.reiner@weizmann.ac.il	Reiner, Orly/E-9455-2010	Reiner, Orly/0000-0001-7560-9599	Fritz-Thyseen Foundation [Az. 10.11.2.161]; Israel Science Foundation [47/10]; Legacy Heritage Biomedical Program of the Israel Science Foundation [322/13]; Minerva foundation; Federal German Ministry for Education and Research; Yeda-Sela Center for Basic Research; Nella and Leon Benoziyo Center for Neurological diseases; Jeanne and Joseph Nissim Foundation for Life Sciences Research; Wohl Biology Endowment Fund; Lulu P. & David J. Levidow Fund for Alzheimers Diseases and Neuroscience Research; Helen and Martin Kimmel Stem Cell Research Institute; David and Fela Shapell Family Center for Genetic Disorders Research	Fritz-Thyseen Foundation; Israel Science Foundation(Israel Science Foundation); Legacy Heritage Biomedical Program of the Israel Science Foundation; Minerva foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Yeda-Sela Center for Basic Research; Nella and Leon Benoziyo Center for Neurological diseases; Jeanne and Joseph Nissim Foundation for Life Sciences Research; Wohl Biology Endowment Fund; Lulu P. & David J. Levidow Fund for Alzheimers Diseases and Neuroscience Research; Helen and Martin Kimmel Stem Cell Research Institute; David and Fela Shapell Family Center for Genetic Disorders Research	Our research has been supported in part by the Fritz-Thyseen Foundation (grant Az. 10.11.2.161), Israel Science Foundation (grant no. 47/10), the Legacy Heritage Biomedical Program of the Israel Science Foundation (grant no. 322/13), Minerva foundation with funding from the Federal German Ministry for Education and Research, Yeda-Sela Center for Basic Research, the Nella and Leon Benoziyo Center for Neurological diseases, Jeanne and Joseph Nissim Foundation for Life Sciences Research, Wohl Biology Endowment Fund, Lulu P. & David J. Levidow Fund for Alzheimers Diseases and Neuroscience Research, the Helen and Martin Kimmel Stem Cell Research Institute, and the David and Fela Shapell Family Center for Genetic Disorders Research.; We thank Drs. Masaki Fukata, Michael W. Davidson and Sandra Hofmann for providing us with useful plasmids. We thank Dr. Eli Arama, and current lab members for critical reading of this manuscript. O.R. is an Incumbent of the Berstein-Mason professorial chair of Neurochemistry. Our research has been supported in part by the Fritz-Thyseen Foundation (grant Az. 10.11.2.161), Israel Science Foundation (grant no. 47/10), the Legacy Heritage Biomedical Program of the Israel Science Foundation (grant no. 322/13), Minerva foundation with funding from the Federal German Ministry for Education and Research, Yeda-Sela Center for Basic Research, the Nella and Leon Benoziyo Center for Neurological diseases, Jeanne and Joseph Nissim Foundation for Life Sciences Research, Wohl Biology Endowment Fund, Lulu P. & David J. Levidow Fund for Alzheimers Diseases and Neuroscience Research, the Helen and Martin Kimmel Stem Cell Research Institute, and the David and Fela Shapell Family Center for Genetic Disorders Research.	Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Ahtiainen L, 2003, J COMP NEUROL, V455, P368, DOI 10.1002/cne.10492; Ahtiainen L, 2006, EXP CELL RES, V312, P1540, DOI 10.1016/j.yexcr.2006.01.034; Bellizzi JJ, 2000, P NATL ACAD SCI USA, V97, P4573, DOI 10.1073/pnas.080508097; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BERTHIAUME L, 1994, J BIOL CHEM, V269, P6498; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corvi MM, 2001, J BIOL CHEM, V276, P45704, DOI 10.1074/jbc.M102766200; Dawson G, 2010, BIOCHEM BIOPH RES CO, V395, P66, DOI 10.1016/j.bbrc.2010.03.137; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Finn R, 2013, J CHILD NEUROL, V28, P1159, DOI 10.1177/0883073813494480; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gavin M, 2013, JIMD REP, V11, P87, DOI 10.1007/8904_2013_226; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Griffey M, 2004, NEUROBIOL DIS, V16, P360, DOI 10.1016/j.nbd.2004.03.005; Griffey M, 2005, MOL THER, V12, P413, DOI 10.1016/j.ymthe.2005.04.018; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Hawkins-Salsbury JA, 2013, BBA-MOL BASIS DIS, V1832, P1906, DOI 10.1016/j.bbadis.2013.05.026; Heinonen O, 2000, MOL GENET METAB, V69, P123, DOI 10.1006/mgme.2000.2961; Hellsten E, 1996, EMBO J, V15, P5240, DOI 10.1002/j.1460-2075.1996.tb00909.x; Hu J, 2012, MOL GENET METAB, V107, P213, DOI 10.1016/j.ymgme.2012.05.009; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Kohan R, 2011, CURR PHARM BIOTECHNO, V12, P867, DOI 1389-2010/11 $58.00+.00; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; Lehtovirta M, 2001, HUM MOL GENET, V10, P69, DOI 10.1093/hmg/10.1.69; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lu JY, 2006, J LIPID RES, V47, P1352, DOI 10.1194/jlr.R600010-JLR200; Lu JY, 2015, MOL GENET METAB, V116, P98, DOI 10.1016/j.ymgme.2015.05.005; Lu JY, 2010, MOL GENET METAB, V99, P374, DOI 10.1016/j.ymgme.2009.12.002; Macauley SL, 2012, ANN NEUROL, V71, P797, DOI 10.1002/ana.23545; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mitchison HM, 1998, HUM MOL GENET, V7, P291, DOI 10.1093/hmg/7.2.291; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; Roberts MS, 2012, J INHERIT METAB DIS, V35, P847, DOI 10.1007/s10545-011-9446-x; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Salonen T, 2001, MOL CELL NEUROSCI, V18, P131, DOI 10.1006/mcne.2001.1010; Sarkar C, 2013, NAT NEUROSCI, V16, P1608, DOI 10.1038/nn.3526; Sarkar C, 2011, MOL GENET METAB, V104, P338, DOI 10.1016/j.ymgme.2011.05.021; Schriner JE, 1996, GENOMICS, V34, P317, DOI 10.1006/geno.1996.0292; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Sleat DE, 1996, J BIOL CHEM, V271, P19191, DOI 10.1074/jbc.271.32.19191; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; van Diggelen OP, 1999, MOL GENET METAB, V66, P240, DOI 10.1006/mgme.1999.2809; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Virmani T, 2005, NEUROBIOL DIS, V20, P314, DOI 10.1016/j.nbd.2005.03.012; Washbourne P, 2004, NEURON, V44, P901, DOI 10.1016/S0896-6273(04)00799-8; YE RD, 1988, J BIOL CHEM, V263, P4869; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451	73	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146466	10.1371/journal.pone.0146466	http://dx.doi.org/10.1371/journal.pone.0146466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731412	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400180
J	Svensson, E; Schouten, S; Hopmans, EC; Middelburg, JJ; Damste, JSS				Svensson, Elisabeth; Schouten, Stefan; Hopmans, Ellen C.; Middelburg, Jack J.; Damste, Jaap S. Sinninghe			Factors Controlling the Stable Nitrogen Isotopic Composition (delta N-15) of Lipids in Marine Animals	PLOS ONE			English	Article							AQUATIC FOOD-WEB; AMINO-ACIDS; FISH-TISSUES; TROPHIC RELATIONSHIPS; MASS-SPECTROMETRY; MEMBRANE-LIPIDS; CARBON ISOTOPES; ORGANIC-MATTER; NORTH-SEA; FRACTIONATION	Lipid extraction of biomass prior to stable isotope analysis is known to cause variable changes in the stable nitrogen isotopic composition (delta N-15) of residual biomass. However, the underlying factors causing these changes are not yet clear. Here we address this issue by comparing the delta N-15 of bulk and residual biomass of several marine animal tissues (fish, crab, cockle, oyster, and polychaete), as well as the delta N-15 of the extracted lipids. As observed previously, lipid extraction led to a variable offset in delta N-15 of biomass (differences ranging from -2.3 to +1.8%). Importantly, the total lipid extract (TLE) was highly depleted in N-15 compared to bulk biomass, and also highly variable (differences ranging from -14 to +0.7%). The TLE consisted mainly of phosphatidylcholines, a group of lipids with one nitrogen atom in the headgroup. To elucidate the cause for the N-15-depletion in the TLE, the delta N-15 of amino acids was determined, including serine because it is one of the main sources of nitrogen to N-containing lipids. Serine delta N-15 values differed by -7 to +2% from bulk biomass delta N-15, and correlated well with the N-15 depletion in TLEs. On average, serine was less depleted (-3%) than the TLE (-7%), possibly due to fractionation during biosynthesis of N-containing headgroups, or that other nitrogen-containing compounds, such as urea and choline, or recycled nitrogen contribute to the nitrogen isotopic composition of the TLE. The depletion in N-15 of the TLE relative to biomass increased with the trophic level of the organisms.	[Svensson, Elisabeth; Schouten, Stefan; Hopmans, Ellen C.; Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, Den Burg, Texel, Netherlands; [Schouten, Stefan; Middelburg, Jack J.; Damste, Jaap S. Sinninghe] Univ Utrecht, Fac Geosci, Dept Earth Sci, Utrecht, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	Svensson, E (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, Den Burg, Texel, Netherlands.	esvensson@pitt.edu; stefan.schouten@nioz.nl	Middelburg, Jack/B-4951-2011; Svensson, Elisabeth/H-8447-2019; Damste, Jaap S Sinninghe/F-6128-2011	Middelburg, Jack/0000-0003-3601-9072; Svensson, Elisabeth/0000-0002-5565-3266; Damste, Jaap S Sinninghe/0000-0002-8683-1854	Waddenfonds	Waddenfonds	The research was funded by Waddenfonds for the project "Waddensleutels" (http://www.waddenfonds.nl/Home.2702.0.html (ES, SS, JSSD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank two anonymous reviewers for their comments, which substantially improved the manuscript. This study is part of the Waddensleutels project, funded by the Waddenfonds. We thank the NIOZ SIBES team for providing benthic samples, and Vania Freitas, Hans Witte and Henk van der Veer for providing fish samples. Monique Verweij, Jort Ossebaar and Kevin Donkers are thanked for analytical assistance.	Bale NJ, 2013, BIOGEOSCIENCES, V10, P7195, DOI 10.5194/bg-10-7195-2013; Bodin N, 2007, J EXP MAR BIOL ECOL, V341, P168, DOI 10.1016/j.jembe.2006.09.008; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Brandsma J, 2012, LIMNOL OCEANOGR, V57, P959, DOI 10.4319/lo.2012.57.4.0959; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2014, ECOL EVOL, V4, P2423, DOI 10.1002/ece3.1103; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Elsdon TS, 2010, MAR ECOL PROG SER, V408, P195, DOI 10.3354/meps08518; ELWYN D, 1955, J BIOL CHEM, V213, P281; FRY B, 1977, GEOCHIM COSMOCHIM AC, V41, P1875, DOI 10.1016/0016-7037(77)90218-6; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; Herzka SZ, 2000, CAN J FISH AQUAT SCI, V57, P137, DOI 10.1139/cjfas-57-1-137; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hoen DK, 2014, J EXP MAR BIOL ECOL, V453, P76, DOI 10.1016/j.jembe.2014.01.006; Ingram T, 2007, LIMNOL OCEANOGR-METH, V5, P338, DOI 10.4319/lom.2007.5.338; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Logan JM, 2008, RAPID COMMUN MASS SP, V22, P1081, DOI 10.1002/rcm.3471; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; Metges CC, 1996, J MASS SPECTROM, V31, P367, DOI 10.1002/(SICI)1096-9888(199604)31:4<367::AID-JMS310>3.0.CO;2-V; Middelburg JJ, 2014, BIOGEOSCIENCES, V11, P2357, DOI 10.5194/bg-11-2357-2014; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MONSON KD, 1982, GEOCHIM COSMOCHIM AC, V46, P139, DOI 10.1016/0016-7037(82)90241-1; Murry BA, 2006, CAN J FISH AQUAT SCI, V63, P2167, DOI 10.1139/F06-116; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Schimmelmann A, 2009, RAPID COMMUN MASS SP, V23, P3513, DOI 10.1002/rcm.4277; Schouten S, 2008, APPL ENVIRON MICROB, V74, P2433, DOI 10.1128/AEM.01709-07; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; STEKOL JA, 1958, AM J CLIN NUTR, V6, P200, DOI 10.1093/ajcn/6.3.200; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; Svensson E, 2014, J EXP MAR BIOL ECOL, V457, P173, DOI 10.1016/j.jembe.2014.04.014; van der Veer HW, 2011, MAR ECOL PROG SER, V434, P143, DOI 10.3354/meps09209; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061	37	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146321	10.1371/journal.pone.0146321	http://dx.doi.org/10.1371/journal.pone.0146321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731720	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400148
J	Walz, JM; Boehringer, D; Deissler, HL; Faerber, L; Goepfert, JC; Heiduschka, P; Kleeberger, SM; Klettner, A; Krohne, TU; Schneiderhan-Marra, N; Ziemssen, F; Stahl, A				Walz, Johanna M.; Boehringer, Daniel; Deissler, Heidrun L.; Faerber, Lothar; Goepfert, Jens C.; Heiduschka, Peter; Kleeberger, Susannah M.; Klettner, Alexa; Krohne, Tim U.; Schneiderhan-Marra, Nicole; Ziemssen, Focke; Stahl, Andreas			Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders	PLOS ONE			English	Article							INTRAVITREAL INJECTION; MACULAR DEGENERATION; SERUM CONCENTRATIONS; RANDOMIZED-TRIAL; DOUBLE-BLIND; BEVACIZUMAB; VEGF; ANGIOGENESIS; RANIBIZUMAB; AFLIBERCEPT	Background Vascular endothelial growth factor-A (VEGF-A) is intensively investigated in various medical fields. However, comparing VEGF-A measurements is difficult because sample acquisition and pre-analytic procedures differ between studies. We therefore investigated which variables act as confounders of VEGF-A measurements. Methods Following a standardized protocol, blood was taken at three clinical sites from six healthy participants (one male and one female participant at each center) twice one week apart. The following pre-analytical parameters were varied in order to analyze their impact on VEGF-A measurements: analyzing center, anticoagulant (EDTA vs. PECT/CTAD), cannula (butterfly vs. neonatal), type of centrifuge (swing-out vs. fixed-angle), time before and after centrifugation, filling level (completely filled vs. half-filled tubes) and analyzing method (ELISA vs. multiplex bead array). Additionally, intrapersonal variations over time and sex differences were explored. Statistical analysis was performed using a linear regression model. Results The following parameters were identified as statistically significant independent confounders of VEGF-A measurements: analyzing center, anticoagulant, centrifuge, analyzing method and sex of the proband. The following parameters were no significant confounders in our data set: intrapersonal variation over one week, cannula, time before and after centrifugation and filling level of collection tubes. Conclusion VEGF-A measurement results can be affected significantly by the identified pre-analytical parameters. We recommend the use of CTAD anticoagulant, a standardized type of centrifuge and one central laboratory using the same analyzing method for all samples.	[Walz, Johanna M.; Boehringer, Daniel; Stahl, Andreas] Univ Freiburg, Ctr Eye, D-79106 Freiburg, Germany; [Walz, Johanna M.; Faerber, Lothar] Univ Regensburg, Dept Pharmacol & Toxicol, D-93053 Regensburg, Germany; [Deissler, Heidrun L.] Univ Ulm, Dept Ophthalmol, D-89069 Ulm, Germany; [Faerber, Lothar] Novartis Pharma AG, Nurnberg, Germany; [Goepfert, Jens C.; Schneiderhan-Marra, Nicole] Univ Tubingen, NMI Nat & Med Sci Inst, Reutlingen, Germany; [Heiduschka, Peter] Univ Munster, Dept Ophthalmol, D-48149 Munster, Germany; [Kleeberger, Susannah M.; Krohne, Tim U.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Klettner, Alexa] Univ Kiel, Dept Ophthalmol, Univ Med Ctr, Kiel, Germany; [Ziemssen, Focke] Univ Tubingen, Dept Ophthalmol, Tubingen, Germany	University of Freiburg; University of Regensburg; Ulm University; Novartis; Eberhard Karls University of Tubingen; University of Munster; University of Bonn; University of Kiel; Schleswig Holstein University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Stahl, A (corresponding author), Univ Freiburg, Ctr Eye, Hugstetter Str 55, D-79106 Freiburg, Germany.	andreas.stahl@uniklinik-freiburg.de	Krohne, Tim/D-1497-2013; Krohne, Tim/AAG-4412-2020; Ziemssen, Focke/AAY-1686-2021; Klettner, Alexa Karina/M-8344-2018; Heiduschka, Peter/AAX-3882-2021; , Ziemssen/B-9564-2009	Krohne, Tim/0000-0003-2280-925X; , Ziemssen/0000-0002-3873-0581; Klettner, Alexa/0000-0002-2709-1059; Deissler, Heidrun/0000-0003-0086-7811; Pfeil, Johanna Madeleine/0000-0002-2731-6094	Novartis, Germany	Novartis, Germany(Novartis)	This study was supported through a research grant from Novartis, Germany (www.novartis.de). The funder provided support in the form of salaries for authors [JMW, LF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Mahecha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038290; Alagappan VKT, 2013, CELL BIOCHEM BIOPHYS, V67, P219, DOI 10.1007/s12013-013-9713-6; Avery RL, 2014, BRIT J OPHTHALMOL, V98, P1636, DOI 10.1136/bjophthalmol-2014-305252; Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Bruhn MA, 2014, INT J CANCER, V135, P731, DOI 10.1002/ijc.28698; Carneiro AM, 2012, ACTA OPHTHALMOL, V90, pE25, DOI 10.1111/j.1755-3768.2011.02240.x; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Enders P, 2015, RETINA-J RET VIT DIS, V35, P454, DOI 10.1097/IAE.0000000000000320; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Grierson R, 2013, J OCUL PHARMACOL TH, V29, P530, DOI 10.1089/jop.2012.0013; HARTMANN RC, 1958, J CLIN INVEST, V37, P699, DOI 10.1172/JCI103656; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hoerster R, 2013, ACTA OPHTHALMOL, V91, pe74, DOI 10.1111/j.1755-3768.2012.02469.x; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Joulain F, 2013, BRIT J CANCER, V109, P1735, DOI 10.1038/bjc.2013.523; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kavsak PA, 2010, CLIN BIOCHEM, V43, P505, DOI 10.1016/j.clinbiochem.2009.11.004; Klettner A., 2014, J BIOCH PHARM RES, V2, P8; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Lankhorst S, 2014, CURRENT OPINION PH C, V21C, P7, DOI [10.1016/j.coph.2014.11.010, DOI 10.1016/J.C0PH.2014.11.010]; Lee KY, 2008, J ASTHMA, V45, P735, DOI 10.1080/02770900802216775; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Ma Y, 2012, AM J OPHTHALMOL, V153, P307, DOI 10.1016/j.ajo.2011.08.006; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Matsuyama K, 2010, BRIT J OPHTHALMOL, V94, P1215, DOI 10.1136/bjo.2008.156810; Mittal K, 2014, CANCER BIOL THER, V15, P975, DOI 10.4161/cbt.29187; Niers TMH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019873; Pommier AJC, 2014, BRIT J CANCER, V111, P1590, DOI 10.1038/bjc.2014.436; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Schlingemann RO, 2013, DIABETES CARE, V36, P1629, DOI 10.2337/dc12-1951; Schmidt-Erfurth U, 2011, OPHTHALMOLOGY, V118, P831, DOI 10.1016/j.ophtha.2010.09.004; Skaat A, 2012, AM J OPHTHALMOL, V153, p[214, e1], DOI [10.1016/j.ajo.2011.08.035, DOI 10.1016/J.AJ0.2011.08.035]; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Svendsen MN, 2010, SCAND J CLIN LAB INV, V70, P503, DOI 10.3109/00365513.2010.521254; Tabernero J, 2014, EUR J CANCER, V50, P320, DOI 10.1016/j.ejca.2013.09.013; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Wang XY, 2014, AM J OPHTHALMOL, V158, P738, DOI 10.1016/j.ajo.2014.06.009; Wu F. P. K., 2003, Angiogenesis, V6, P255, DOI 10.1023/B:AGEN.0000029410.32264.b0; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yoshida I, 2014, GRAEF ARCH CLIN EXP, V252, P1483, DOI 10.1007/s00417-014-2717-0; Zehetner C, 2013, BRIT J OPHTHALMOL, V97, P454, DOI 10.1136/bjophthalmol-2012-302451; Zimmermann R, 2005, CLIN CHEM, V51, P2365, DOI 10.1373/clinchem.2005.055558	50	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145375	10.1371/journal.pone.0145375	http://dx.doi.org/10.1371/journal.pone.0145375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730574	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400032
J	McAssey, EV; Gudger, EG; Zuellig, MP; Burke, JM				McAssey, Edward V.; Gudger, Ethan G.; Zuellig, Matthew P.; Burke, John M.			Population Genetics of the Rubber-Producing Russian Dandelion (Taraxacum kok-saghyz)	PLOS ONE			English	Article							AMERICAN LEAF-BLIGHT; EST-SSR MARKERS; MICROCYCLUS-ULEI; DIVERSITY; RESISTANCE; HISTORY; UTILITY; ROOT; TREE; PCR	The Russian dandelion, Taraxacum kok-saghyz (TKS), is a perennial species native to Central Asia that produces high quality, natural rubber. Despite its potential to help maintain a stable worldwide rubber supply, little is known about genetic variation in this species. To facilitate future germplasm improvement efforts, we developed simple-sequence repeat (SSR) markers from available expressed-sequence tag (EST) data and used them to investigate patterns of population genetic diversity in this nascent crop species. We identified numerous SSRs (1,510 total) in 1,248 unigenes from a larger set of 6,960 unigenes (derived from 16,441 ESTs) and designed PCR primers targeting 767 of these loci. Screening of a subset of 192 of these primer pairs resulted in the identification of 48 pairs that appeared to produce single-locus polymorphisms. We then used the most reliable 17 of these primer pairs to genotype 176 individuals from 17 natural TKS populations. We observed an average of 4.8 alleles per locus with population-level expected heterozygosities ranging from 0.28 to 0.50. An average pairwise FST of 0.11 indicated moderate but statistically significant levels of genetic differentiation, though there was no clear geographic patterning to this differentiation. We also tested these 17 primer pairs in the widespread common dandelion, T. officinale, and a majority successfully produced apparently single-locus amplicons. This result demonstrates the potential utility of these markers for genetic analyses in other species in the genus.	[McAssey, Edward V.; Gudger, Ethan G.; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Zuellig, Matthew P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Burke, JM (corresponding author), Univ Georgia, Dept Plant Biol, Miller Plant Sci Bldg, Athens, GA 30602 USA.	jmburke@uga.edu	Burke, John M/A-3502-2013	Burke, John M/0000-0002-1412-5539	National Science Foundation Plant Genome Research Program [DBI-0820451]	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by a grant (DBI-0820451) to JMB from the National Science Foundation Plant Genome Research Program (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barres B, 2012, HEREDITY, V109, P269, DOI 10.1038/hdy.2012.37; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-50; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Collins-Silva J, 2012, PHYTOCHEMISTRY, V79, P46, DOI 10.1016/j.phytochem.2012.04.015; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kirschner J, 2012, GENETIC RESOURCES CR, V60, P455, DOI DOI 10.1007/s10722-012-9848-0; Le Guen V, 2007, NEW PHYTOL, V173, P335, DOI 10.1111/j.1469-8137.2006.01911.x; Le Guen V, 2003, THEOR APPL GENET, V108, P160, DOI 10.1007/s00122-003-1407-9; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Lieberei R, 2007, ANN BOT-LONDON, V100, P1125, DOI 10.1093/aob/mcm133; Majesky L, 2015, PLANT SYST EVOL, V301, P2105, DOI 10.1007/s00606-015-1218-x; Majesky L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041868; Moccia MD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-243; Munt O, 2012, IND CROP PROD, V36, P289, DOI 10.1016/j.indcrop.2011.10.014; NEI M, 1978, GENETICS, V89, P583; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Peakall R., 2012, BIOINFORMATICS; R Core Team, 2013, R LANG ENV STAT COMP; Rivano F, 2013, IND CROP PROD, V44, P659, DOI 10.1016/j.indcrop.2012.09.005; Schmidt T, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-11; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shirasawa K, 2013, MOL BREEDING, V31, P101, DOI 10.1007/s11032-012-9774-z; Tata SK, 2012, IND CROP PROD, V40, P219, DOI 10.1016/j.indcrop.2012.03.012; van Beilen JB, 2007, CRIT REV BIOTECHNOL, V27, P217, DOI 10.1080/07388550701775927; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Wahler D, 2012, PROTEOMICS, V12, P901, DOI 10.1002/pmic.201000778; Whaley WG, 1947, MISC PUBL USDA, V618; Wills DM, 2005, THEOR APPL GENET, V110, P941, DOI 10.1007/s00122-004-1914-3; WRIGHT S, 1951, ANN EUGENIC, V15, P323; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	37	13	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146417	10.1371/journal.pone.0146417	http://dx.doi.org/10.1371/journal.pone.0146417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727474	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500079
J	Mendia-Iztueta, I; Monahan, K; Kyrolainen, H; Hynynen, E				Mendia-Iztueta, Ibai; Monahan, Kristen; Kyrolainen, Heikki; Hynynen, Esa			Assessment of Heart Rate Variability Thresholds from Incremental Treadmill Tests in Five Cross-Country Skiing Techniques	PLOS ONE			English	Article							VENTILATORY THRESHOLDS; ANAEROBIC THRESHOLD; EXERCISE	The assessment of heart rate variability (HRV) thresholds (HRVTs) as an alternative of Ventilatory thresholds (VTs) is a relatively new approach with increasing popularity which has not been conducted in cross-country (XC) skiing yet. The main purpose of the present study was to assess HRVTs in the five main XC skiing-related techniques, double poling (DP), diagonal striding (DS), Nordic walking (NW), V1 skating (V1), and V2 skating (V2). Ten competitive skiers completed these incremental treadmill tests until exhaustion with a minimum of one to two recovery days in between each test. Ventilatory gases, HRV and poling frequencies were measured. The first HRV threshold (HRVT1) was assessed using two time-domain analysis methods, and the second HRV threshold (HRVT2) was assessed using two non-time varying frequency-domain analysis methods. HRVT1 was assessed by plotting the mean successive difference (MSD) and standard deviation (SD) of normalized R-R intervals to workload. HRVT1 was assessed by plotting high frequency power (HFP) and the HFP relative to respiratory sinus arrhythmia (HFPRSA) with workload. HRVTs were named after their methods (HRVT1-SD; HRVT1-MSD; HRVT2-HFP; HRVT2-HFP-RSA). The results showed that the only cases where the proposed HRVTs were good assessors of VTs were the HRVT1-SD of the DS test, the HRVT1-MSD of the DS and V2 tests, and the HRVT2-HFP-RSA of the NWtest. The lack of a wider success of the assessment of HRVTs was reasoned to be mostly due to the high entrainment between the breathing and poling frequencies. As secondary finding, a novel Cardiolocomotor coupling mode was observed in the NWtest. This new Cardiolocoomtor coupling mode corresponded to the whole bilateral poling cycle instead of corresponding to each poling action as it was reported to the date by the existing literature.	[Mendia-Iztueta, Ibai; Monahan, Kristen; Kyrolainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland; [Hynynen, Esa] KIHU Res Inst Olymp Sports, Jyvaskyla, Finland	University of Jyvaskyla	Mendia-Iztueta, I (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland.	ibai.mendia.iztueta@gmail.com		Kyrolainen, Heikki/0000-0003-3822-1733	European Regional Development Fund [A32156]	European Regional Development Fund(European Commission)	This study was partly supported (salary and materials) by the European Regional Development Fund. The project number was A32156, and the funder's website was https://www.rakennerahastot.fi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; [Anonymous], 2004, ADV METHODS PROCESSI; Anosov O, 2000, EUR J APPL PHYSIOL, V83, P388, DOI 10.1007/s004210000302; Blain G, 2005, BRIT J SPORT MED, V39, P448, DOI 10.1136/bjsm.2004.014134; Blain G, 2009, AM J PHYSIOL-HEART C, V296, pH1651, DOI 10.1152/ajpheart.00881.2008; Buchheit M, 2007, PEDIATR EXERC SCI, V19, P192, DOI 10.1123/pes.19.2.192; Camm AJ, 1996, EUR HEART J, V17, P354; Cassirame J, HEART RATE VARIABILI, DOI [10.1080/17461391.2014.957729, DOI 10.1080/17461391.2014.957729]; Cottin F, 2007, INT J SPORTS MED, V28, P287, DOI 10.1055/s-2006-924355; Cottin F, 2006, INT J SPORTS MED, V27, P959, DOI 10.1055/s-2006-923849; Di Michele R, 2012, J STRENGTH COND RES, V26, P3059, DOI 10.1519/JSC.0b013e318245bde1; Dourado VZ, 2010, INT J SPORTS MED, V31, P698, DOI 10.1055/s-0030-1255110; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; Fabre N, 2012, J STRENGTH COND RES, V26, P381, DOI 10.1519/JSC.0b013e3182260455; Fabre N, 2007, INTJ SPORT PHYSIOL, V2, P46, DOI 10.1123/ijspp.2.1.46; FARIA IE, 1994, J SPORT SCI, V12, P255, DOI 10.1080/02640419408732171; Freeman JV, 2006, PROG CARDIOVASC DIS, V48, P342, DOI 10.1016/j.pcad.2005.11.003; Hartikainen JEK, 1998, CLIN GUIDE CARDIAC A, P149, DOI DOI 10.1007/978-94-017-1057-2_; Holmberg HC, 2007, RESP PHYSIOL NEUROBI, V157, P348, DOI 10.1016/j.resp.2006.12.013; Holmberg HC, 2005, MED SCI SPORT EXER, V37, P807, DOI 10.1249/01.MSS.0000162615.47763.C8; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Karapetian GK, 2008, INT J SPORTS MED, V29, P652, DOI 10.1055/s-2007-989423; Keskinen KL, 2007, KUNTOTESTAUKSEN KASI, V156, P269; Lamberts RP, 2009, J STRENGTH COND RES, V23, P1005, DOI 10.1519/JSC.0b013e3181a2dcdc; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; Mourot L, 2014, INT J SPORT PHYSIOL, V9, P695, DOI [10.1123/IJSPP.2013-0286, 10.1123/ijspp.2013-0286]; Westhoff M, 2013, DEUT MED WOCHENSCHR, V138, P275, DOI 10.1055/s-0032-1332843	27	7	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145875	10.1371/journal.pone.0145875	http://dx.doi.org/10.1371/journal.pone.0145875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727112	gold, Green Published, Green Submitted			2022-12-27	WOS:000367681500035
J	Montull, B; Menendez, R; Torres, A; Reyes, S; Mendez, R; Zalacain, R; Capelastegui, A; Rajas, O; Borderias, L; Martin-Villasclaras, J; Bello, S; Alfageme, I; de Castro, FR; Rello, J; Molinos, L; Ruiz-Manzano, J				Montull, Beatriz; Menendez, Rosario; Torres, Antoni; Reyes, Soledad; Mendez, Raul; Zalacain, Rafael; Capelastegui, Alberto; Rajas, Olga; Borderias, Luis; Martin-Villasclaras, Juan; Bello, Salvador; Alfageme, Inmaculada; Rodriguez de Castro, Felipe; Rello, Jordi; Molinos, Luis; Ruiz-Manzano, Juan		NAC Calidad Grp	Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia	PLOS ONE			English	Article							EPIDEMIOLOGY; EXPERIENCE; CRITERIA	Background Severe sepsis, may be present on hospital arrival in approximately one-third of patients with community-acquired pneumonia (CAP). Objective To determine the host characteristics and micro-organisms associated with severe sepsis in patients hospitalized with CAP. Results We performed a prospective multicenter cohort study in 13 Spanish hospital, on 4070 hospitalized CAP patients, 1529 of whom (37.6%) presented with severe sepsis. Severe sepsis CAP was independently associated with older age (>65 years), alcohol abuse (OR, 1.31; 95% CI, 1.07-1.61), chronic obstructive pulmonary disease (COPD) (OR, 1.75; 95% CI, 1.50-2.04) and renal disease (OR, 1.57; 95% CI, 1.21-2.03), whereas prior antibiotic treatment was a protective factor (OR, 0.62; 95% CI, 0.52-0.73). Bacteremia (OR, 1.37; 95% CI, 1.05-1.79), S pneumoniae (OR, 1.59; 95% CI, 1.31-1.95) and mixed microbial etiology (OR, 1.65; 95% CI, 1.10-2.49) were associated with severe sepsis CAP. Conclusions CAP patients with COPD, renal disease and alcohol abuse, as well as those with CAP due to S pneumonia or mixed micro-organisms are more likely to present to the hospital with severe sepsis.	[Montull, Beatriz; Menendez, Rosario; Reyes, Soledad; Mendez, Raul] Hosp Univ La Fe, ISS, CIBER Enfermedades Resp CIBERES, Dept Pneumol, Valencia, Spain; [Montull, Beatriz; Menendez, Rosario; Reyes, Soledad; Mendez, Raul] Politecn La Fe, ISS, CIBER Enfermedades Resp CIBERES, Dept Pneumol, Valencia, Spain; [Torres, Antoni] Hosp Clin Barcelona, CIBER Enfermedades Resp CIBERES, IDIBAPS, Dept Pneumol, Barcelona, Spain; [Zalacain, Rafael] Hosp Cruces, Dept Pneumol, Vizcaya, Spain; [Capelastegui, Alberto] Hosp Galdakao, Dept Pneumol, Vizcaya, Spain; [Rajas, Olga] Hosp La Princesa, Dept Pneumol, Madrid, Spain; [Borderias, Luis] Hosp San Jorge, Dept Pneumol, Huesca, Spain; [Martin-Villasclaras, Juan] Hosp Carlos Haya, Dept Pneumol, Malaga, Spain; [Bello, Salvador] Hosp Miguel Servet, Dept Pneumol, Zaragoza, Spain; [Alfageme, Inmaculada] Hosp Valme, Dept Pneumol, Seville, Spain; [Rodriguez de Castro, Felipe] Hosp Doctor Negrin Las Palmas, Dept Pneumol, Gran Canaria, Spain; [Rello, Jordi] Univ Autonoma Barcelona, Hosp Joan Tarragona 22, Crit Care Dept, E-08193 Barcelona, Spain; [Rello, Jordi] Univ Autonoma Barcelona, Hosp Vall Hebron, E-08193 Barcelona, Spain; [Molinos, Luis] Univ Oviedo, Hosp Cent Asturias, Dept Pneumol, E-33080 Oviedo, Asturias, Spain; [Ruiz-Manzano, Juan] Hosp Germans Trias & Pujol Badalona, Dept Pneumol, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitario Cruces; Galdakao Hospital; Hospital de La Princesa; Hospital Universidad San Jorge; Hospital Carlos Haya; Miguel Servet University Hospital; Hospital Valme; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Central University Hospital Asturias; University of Oviedo; Hospital Germans Trias i Pujol	Menendez, R (corresponding author), Hosp Univ La Fe, ISS, CIBER Enfermedades Resp CIBERES, Dept Pneumol, Valencia, Spain.	rosmenend@gmail.com	Torres, Antoni/H-6128-2017; Rello, Jordi/P-2402-2019; de Castro, Felipe Rodriguez/R-8416-2019; Alfageme, Inmaculada/K-2092-2014; Menéndez, Rosario/G-9723-2016; Méndez, Raúl/ABB-3328-2020	Torres, Antoni/0000-0002-8643-2167; Rello, Jordi/0000-0003-0676-6210; Alfageme, Inmaculada/0000-0002-5106-1669; Menéndez, Rosario/0000-0002-3592-3839; Méndez, Raúl/0000-0001-6300-9836; Rodriguez de Castro, Felipe/0000-0002-6812-2739; Borderias, Luis/0000-0003-3296-9644	PII (Programme of research of SEPAR) in respiratory infection; CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis [PI04/1150]; Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica) [2006/0237]; Beca de la Conselleria Sanitat Comunidad Valenciana [2007/0059]	PII (Programme of research of SEPAR) in respiratory infection; CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis; Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica); Beca de la Conselleria Sanitat Comunidad Valenciana	This work was supported by PII (Programme of research of SEPAR) in respiratory infection; CIBERES (Centro de investigacion en red de enfermedades respiratorias) an initiative of ISCIII (Instituto de Salud Carlos III); Beca Fis (PI04/1150); Beca SEPAR (Sociedad Espanola de Neumologia y Cirugia toracica) (2006/0237) and Beca de la Conselleria Sanitat Comunidad Valenciana (2007/0059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073271; Bertran M J, 2000, Enferm Infecc Microbiol Clin, V18, P445; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Cilloniz C, 2011, CRIT CARE, V15, DOI 10.1186/cc10444; de Roux A, 2006, EUR RESPIR J, V27, P795, DOI 10.1183/09031936.06.00058605; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; Dremsizov T, 2006, CHEST, V129, P968, DOI 10.1378/chest.129.4.968; Ewig S, 1998, AM J RESP CRIT CARE, V158, P1102, DOI 10.1164/ajrccm.158.4.9803114; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garcia-Vidal C, 2010, THORAX, V65, P77, DOI 10.1136/thx.2009.123612; HOSMER DW, 1989, APPL LOGISTIC REGRES; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Liapikou A, 2012, EUR RESPIR J, V39, P855, DOI 10.1183/09031936.00067111; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mehta AJ, 2012, AM J MED SCI, V343, P244, DOI 10.1097/MAJ.0b013e31823ede77; Menendez R, 2012, EUR RESPIR J, V39, P156, DOI 10.1183/09031936.00188710; Menendez R, CHEST; Rello J, 2008, CRIT CARE, V12, DOI 10.1186/cc7025; Restrepo MI, 2008, CHEST, V133, P610, DOI 10.1378/chest.07-1456; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P923, DOI 10.1164/ajrccm.160.3.9901107; Schaaf B, 2007, EUR RESPIR J, V30, P517, DOI 10.1183/09031936.00021007; Schaaf BM, 2003, AM J RESP CRIT CARE, V168, P476, DOI 10.1164/rccm.200210-1164OC; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Welte T, 2009, SEMIN RESP CRIT CARE, V30, P127, DOI 10.1055/s-0029-1202941	24	46	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145929	10.1371/journal.pone.0145929	http://dx.doi.org/10.1371/journal.pone.0145929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727202	Green Published, gold			2022-12-27	WOS:000367681500036
J	Chiang, Y; Yang, JCH; Hsu, FM; Chen, YH; Shih, JY; Lin, ZZ; Lan, KH; Cheng, AL; Kuo, SH				Chiang, Yun; Yang, James Chih-Hsin; Hsu, Feng-Ming; Chen, Yu-Hsuan; Shih, Jin-Yuan; Lin, Zhong-Zhe; Lan, Keng-Hsueh; Cheng, Ann-Lii; Kuo, Sung-Hsin			The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases	PLOS ONE			English	Article							PHASE-III; RADIATION-THERAPY; SUPPORTIVE CARE; CHEMOTHERAPY; SURVIVAL; TRIAL; SINGLE; IMPACT; LIFE	Background and Purpose For metastatic non-small cell lung cancer (NSCLC) patients with controlled extrathoracic disease after systemic treatment, stable or progressive primary lung lesions may cause respiratory symptoms and increase comorbidities. In the present study, we sought to investigate whether aggressive palliative thoracic radiotherapy (RT) can enhance local control and improve the survival for this subgroup of patients. Materials and Methods Between March 2006 and December 2014, 56 patients with metastatic NSCLC who had responsive or stable extrathoracic diseases after chemotherapy and/or molecular targets, and received thoracic RT for stable and progressive primary lung lesions were included. RT with a median dose of 55 Gy (range, 40-62 Gy) was administered in 1.8-2.5 Gy fractions to primary lung tumor and regional mediastinal lymph nodes using modern RT technique. Overall survival (OS) from diagnosis, and locoregional progression-free survival (LRPFS), and survival calculated from radiotherapy (OS-RT) were estimated using the Kaplan-Meier method. Results There were 37 men and 19 women with a median age of 60 years at diagnosis. The median interval from the diagnosis of metastatic disease to thoracic RT was 8 months. Following thoracic RT, 26 patients (46%) achieved complete or partial response (overall response rate, ORR). Patients with squamous cell carcinoma or poorly-differentiated carcinoma had a higher ORR than those with adenocarcinoma (63% vs. 34%, P = 0.034). EGFR mutations was closely associated with a better ORR (45% vs. 29%, P = 0.284). At a median follow-up time of 44 months, the median OS, LRPFS after RT, and OS-RT were 50 months, 15 months, and 18 months. Conclusion Radical palliative throractic RT is safe and might be beneficial for primary lung lesions of metastatic NSCLC patients with controlled extrathoracic diseases.	[Chiang, Yun; Hsu, Feng-Ming; Chen, Yu-Hsuan; Lan, Keng-Hsueh; Kuo, Sung-Hsin] Natl Taiwan Univ Hosp, Dept Oncol, Div Radiat Oncol, Taipei, Taiwan; [Shih, Jin-Yuan; Lin, Zhong-Zhe] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Yang, James Chih-Hsin; Lin, Zhong-Zhe; Cheng, Ann-Lii; Kuo, Sung-Hsin] Natl Taiwan Univ, Coll Med, Canc Res Ctr, Taipei 10764, Taiwan; [Yang, James Chih-Hsin; Lin, Zhong-Zhe; Cheng, Ann-Lii; Kuo, Sung-Hsin] Natl Taiwan Univ, Ctr Canc, Taipei 10764, Taiwan; [Yang, James Chih-Hsin; Cheng, Ann-Lii; Kuo, Sung-Hsin] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Kuo, SH (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Div Radiat Oncol, Taipei, Taiwan.	shkuo101@ntu.edu.tw	Yang, James Chih-Hsin/W-1587-2019; Chiang, Yun/GRJ-5251-2022	Yang, James Chih-Hsin/0000-0002-5586-5138; Cheng, Ann-Lii/0000-0002-9152-6512; Kuo, Sung-Hsin/0000-0003-0054-887X	Ministry of Science and Technology, Taiwan [MOST 104-2314-B-002-189-MY3, MOST 104-2811-B-002-058]; National Health Research Institutes, Taiwan [NHRI-EX104-10239BI]; National Taiwan University Hospital [NTUH 104-S2710]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Taiwan University Hospital(National Taiwan University)	The authors thank the Cancer Registry, Office of Medical Records, National Taiwan University Hospital for providing the necessary patient information. Grant Support: This study was supported by research grants MOST 104-2314-B-002-189-MY3 and MOST 104-2811-B-002-058 from the Ministry of Science and Technology, Taiwan, NHRI-EX104-10239BI from the National Health Research Institutes, Taiwan, and NTUH 104-S2710 from National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta O, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-166; Bezjak A, 2002, INT J RADIAT ONCOL, V54, P719, DOI 10.1016/S0360-3016(02)02989-9; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Chan C, 2014, J THORAC ONCOL, V9, P1598, DOI 10.1097/JTO.0000000000000346; Cheruvu P, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-80; De Ruysscher D, 2012, J THORAC ONCOL, V7, P1547, DOI 10.1097/JTO.0b013e318262caf6; De Ruysscher D, 2010, J CLIN ONCOL, V28, P5301, DOI 10.1200/JCO.2010.30.3271; Dehing-Oberije C, 2009, RADIOTHER ONCOL, V91, P421, DOI 10.1016/j.radonc.2008.12.002; Di BS, 2014, ASIAN PAC J CANCER P, V15, P3419, DOI 10.7314/APJCP.2014.15.8.3419; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Fairchild A, 2008, J CLIN ONCOL, V26, P4001, DOI 10.1200/JCO.2007.15.3312; Genestreti G, 2015, EXPERT REV ANTICANC, V15, P839, DOI 10.1586/14737140.2015.1052410; Gerber DE, 2013, J CLIN ONCOL, V31, P1009, DOI 10.1200/JCO.2012.43.7459; Gow CH, 2008, CLIN CANCER RES, V14, P162, DOI 10.1158/1078-0432.CCR-07-1468; Helsing M, 1998, EUR J CANCER, V34, P1036, DOI 10.1016/S0959-8049(97)10122-8; Kao HF, 2013, FUTURE ONCOL, V9, P991, DOI [10.2217/FON.13.56, 10.2217/fon.13.56]; Kramer GWPM, 2005, J CLIN ONCOL, V23, P2962, DOI 10.1200/JCO.2005.01.685; Kuo SH, 2005, LUNG CANCER, V48, P275, DOI 10.1016/j.lungcan.2004.10.004; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Guerra JLL, 2012, INT J RADIAT ONCOL, V84, pE61, DOI 10.1016/j.ijrobp.2012.02.054; Macbeth F R, 1996, Clin Oncol (R Coll Radiol), V8, P167, DOI 10.1016/S0936-6555(96)80041-0; Nichols L, 2012, ARCH PATHOL LAB MED, V136, P1552, DOI 10.5858/arpa.2011-0521-OA; Parikh RB, 2014, INT J RADIAT ONCOL, V89, P880, DOI 10.1016/j.ijrobp.2014.04.007; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sirzen F, 2003, ACTA ONCOL, V42, P493, DOI 10.1080/02841860310014453; Spiro SG, 2004, THORAX, V59, P828, DOI 10.1136/thx.2003.020164; Su SF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-474; U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute, COMMON TERMINOLOGY C; van Baardwijk A, 2010, J CLIN ONCOL, V28, P1380, DOI 10.1200/JCO.2009.24.7221; Werner-Wasik M, 2010, INT J RADIAT ONCOL, V76, pS86, DOI 10.1016/j.ijrobp.2009.05.070; Zhong CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058466	33	9	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145936	10.1371/journal.pone.0145936	http://dx.doi.org/10.1371/journal.pone.0145936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720170	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900027
J	Lu, JY; Zheng, J; Zhang, WZ; Huang, BT				Lu, Jia-Yang; Zheng, Jing; Zhang, Wu-Zhe; Huang, Bao-Tian			Flattening Filter-Free Beams in Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Sinonasal Cancer	PLOS ONE			English	Article							PARANASAL SINUS CANCER; UNFLATTENED PHOTON BEAMS; NASAL CAVITY; RADIATION-THERAPY; LINEAR-ACCELERATOR; MAXILLARY SINUS; PROSTATE-CANCER; IMRT; CARCINOMA; ACCURACY	Purpose To evaluate the dosimetric impacts of flattening filter-free (FFF) beams in intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) for sinonasal cancer. Methods For fourteen cases, IMRT and VMAT planning was performed using 6-MV photon beams with both conventional flattened and FFF modes. The four types of plans were compared in terms of target dose homogeneity and conformity, organ-at-risk (OAR) sparing, number of monitor units (MUs) per fraction, treatment time and pure beam-on time. Results FFF beams led to comparable target dose homogeneity, conformity, increased number of MUs and lower doses to the spinal cord, brainstem and normal tissue, compared with flattened beams in both IMRT and VMAT. FFF beams in IMRT resulted in improvements by up to 5.4% for sparing of the contralateral optic structures, with shortened treatment time by 9.5%. However, FFF beams provided comparable overall OAR sparing and treatment time in VMAT. With FFF mode, VMAT yielded inferior homogeneity and superior conformity compared with IMRT, with comparable overall OAR sparing and significantly shorter treatment time. Conclusions Using FFF beams in IMRT and VMAT is feasible for the treatment of sinonasal cancer. Our results suggest that the delivery mode of FFF beams may play an encouraging role with better sparing of contralateral optic OARs and treatment efficiency in IMRT, but yield comparable results in VMAT.	[Lu, Jia-Yang; Zhang, Wu-Zhe; Huang, Bao-Tian] Shantou Univ, Dept Radiat Oncol, Canc Hosp, Coll Med, Shantou, Guangdong, Peoples R China; [Zheng, Jing] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Lab, Shantou, Guangdong, Peoples R China	Shantou University; Sun Yat Sen University	Huang, BT (corresponding author), Shantou Univ, Dept Radiat Oncol, Canc Hosp, Coll Med, Shantou, Guangdong, Peoples R China.	tianjia2025@163.com			Shantou Medical Science and Technology Project [(2015)123]; Medical Scientific Research Foundation of Guangdong Province [A2015534]	Shantou Medical Science and Technology Project; Medical Scientific Research Foundation of Guangdong Province	This work was supported by Shantou Medical Science and Technology Project [Grant No. (2015)123] and Medical Scientific Research Foundation of Guangdong Province (Grant No. A2015534). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsbury EA, 2009, RADIAT RES, V172, P1, DOI 10.1667/RR1688.1; Cashmore J, 2008, PHYS MED BIOL, V53, P1933, DOI 10.1088/0031-9155/53/7/009; Chi A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-4; Dogan N, 2006, MED PHYS, V33, P4033, DOI 10.1118/1.2357835; Duprez F, 2012, INT J RADIAT ONCOL, V83, P252, DOI 10.1016/j.ijrobp.2011.06.1977; Dzierma Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094371; Gasic D, 2014, ACTA ONCOL, V53, P1005, DOI 10.3109/0284186X.2014.925578; Gay HA, 2007, PHYS MEDICA, V23, P115, DOI 10.1016/j.ejmp.2007.07.001; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Hoppe BS, 2007, INT J RADIAT ONCOL, V67, P691, DOI 10.1016/j.ijrobp.2006.09.023; Hrbacek J, 2014, MED PHYS, V41, DOI 10.1118/1.4866231; Jeong Y, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-193; Kan Monica W K, 2012, J Appl Clin Med Phys, V13, P3887, DOI 10.1120/jacmp.v13i6.3887; Nguyen K, 2013, MED DOSIM, V38, P225, DOI 10.1016/j.meddos.2013.01.006; Kragl G, 2011, RADIOTHER ONCOL, V100, P417, DOI 10.1016/j.radonc.2011.09.001; Kry SF, 2010, PHYS MED BIOL, V55, P2155, DOI 10.1088/0031-9155/55/8/003; Le QT, 1999, CANCER, V86, P1700, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1700::AID-CNCR11>3.3.CO;2-W; Lu JY, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140654; Mahalingappa YB, 2014, J LARYNGOL OTOL, V128, P654, DOI 10.1017/S0022215114001066; McGrath SD, 2010, RADIOTHER ONCOL, V95, P153, DOI 10.1016/j.radonc.2009.12.039; Mock U, 2004, INT J RADIAT ONCOL, V58, P147, DOI 10.1016/S0360-3016(03)01452-4; Murray LJ, 2015, PHYS MED BIOL, V60, P1237, DOI 10.1088/0031-9155/60/3/1237; Nicolini G, 2012, INT J RADIAT ONCOL, V84, P553, DOI 10.1016/j.ijrobp.2011.12.041; Ning ZH, 2015, STRAHLENTHER ONKOL, V191, P34, DOI 10.1007/s00066-014-0760-8; Orlandi E, 2014, RADIOTHER ONCOL, V113, P260, DOI 10.1016/j.radonc.2014.11.024; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Sheng K, 2007, RADIOTHER ONCOL, V82, P174, DOI 10.1016/j.radonc.2007.01.008; Siala W, 2009, CANCER RADIOTHER, V13, P709, DOI 10.1016/j.canrad.2009.05.006; Spruijt KH, 2013, INT J RADIAT ONCOL, V85, P506, DOI 10.1016/j.ijrobp.2012.03.040; Tiwari R, 2000, HEAD NECK-J SCI SPEC, V22, P164, DOI 10.1002/(SICI)1097-0347(200003)22:2<164::AID-HED8>3.0.CO;2-#; Vassiliev ON, 2006, PHYS MED BIOL, V51, P1907, DOI 10.1088/0031-9155/51/7/019; Zhuang MZ, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-120; Zwahlen DR, 2012, INT J RADIAT ONCOL, V83, P1655, DOI 10.1016/j.ijrobp.2011.10.019	34	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146604	10.1371/journal.pone.0146604	http://dx.doi.org/10.1371/journal.pone.0146604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734731	Green Published, Green Submitted, gold			2022-12-27	WOS:000367805100055
J	Piety, NZ; Yang, XX; Kanter, J; Vignes, SM; George, A; Shevkoplyas, SS				Piety, Nathaniel Z.; Yang, Xiaoxi; Kanter, Julie; Vignes, Seth M.; George, Alex; Shevkoplyas, Sergey S.			Validation of a Low-Cost Paper-Based Screening Test for Sickle Cell Anemia	PLOS ONE			English	Article							WHOLE-BLOOD SOLUBILITY; HEMOGLOBIN; HEMOLYSIS; DENSITY; DISEASE; ASSAY	Background The high childhood mortality and life-long complications associated with sickle cell anemia (SCA) in developing countries could be significantly reduced with effective prophylaxis and education if SCA is diagnosed early in life. However, conventional laboratory methods used for diagnosing SCA remain prohibitively expensive and impractical in this setting. This study describes the clinical validation of a low-cost paper-based test for SCA that can accurately identify sickle trait carriers (HbAS) and individuals with SCA (HbSS) among adults and children over 1 year of age. Methods and Findings In a population of healthy volunteers and SCA patients in the United States (n = 55) the test identified individuals whose blood contained any HbS (HbAS and HbSS) with 100% sensitivity and 100% specificity for both visual evaluation and automated analysis, and detected SCA (HbSS) with 93% sensitivity and 94% specificity for visual evaluation and 100% sensitivity and 97% specificity for automated analysis. In a population of post-partum women (with a previously unknown SCA status) at a primary obstetric hospital in Cabinda, Angola (n = 226) the test identified sickle cell trait carriers with 94% sensitivity and 97% specificity using visual evaluation (none of the women had SCA). Notably, our test permits instrument- and electricity-free visual diagnostics, requires minimal training to be performed, can be completed within 30 minutes, and costs about $0.07 in test-specific consumable materials. Conclusions Our results validate the paper-based SCA test as a useful low-cost tool for screening adults and children for sickle trait and disease and demonstrate its practicality in resource-limited clinical settings.	[Piety, Nathaniel Z.; Yang, Xiaoxi; Vignes, Seth M.; Shevkoplyas, Sergey S.] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Kanter, Julie] Tulane Univ, Sch Med, Sickle Cell Ctr Southern Louisiana, New Orleans, LA 70112 USA; [Kanter, Julie] Tulane Univ, Sch Med, Dept Pediat, Sect Hematol Oncol, New Orleans, LA 70112 USA; [George, Alex] Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX 77030 USA	Tulane University; Tulane University; Tulane University; Baylor College of Medicine	Shevkoplyas, SS (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	sshevkoplyas@uh.edu		Shevkoplyas, Sergey/0000-0002-8203-8365	National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute) [R01HL117329]; Baylor College of Medicine Center for Global Initiatives Pilot Award; Angola Sickle Cell Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117329] Funding Source: NIH RePORTER	National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute); Baylor College of Medicine Center for Global Initiatives Pilot Award; Angola Sickle Cell Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a 2012 National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute R01HL117329, PI: SSS) and a 2014 Baylor College of Medicine Center for Global Initiatives Pilot Award (PI: AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Ms. Sonia Serrano and Ms. Maria Rosa Lanzi for assistance in performing experiments at the Cabinda site; Ms. Dalia Lezzar for assistance in performing experiments at the Houston site; and Dr. Palka R. Patel, Dr. Damian Nirenberg, Dr. Gladstone Airewele and Dr. Joao Camanda for facilitating work at the Cabinda site. We acknowledge the support of the Angola Sickle Cell Initiative, a collaboration of the Angolan Ministry of Health, Texas Children's Hospital, Baylor College of Medicine, and Chevron.	Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Baumann E, 2000, ACTA HISTOCHEM, V102, P21, DOI 10.1078/0065-1281-00534; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Browning JA, 2007, CELL PHYSIOL BIOCHEM, V19, P165, DOI 10.1159/000099204; Clarke GM, 2000, CLIN CHEM, V46, P1284; Claster S, 2003, BRIT MED J, V327, P1151, DOI 10.1136/bmj.327.7424.1151; Edoh Dominic, 2006, Afr Health Sci, V6, P51; FLEISS JL, 1971, BRIT J PSYCHIAT, V119, P647, DOI 10.1192/bjp.119.553.647; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Head CE, 2004, J CLIN PATHOL, V57, P276, DOI 10.1136/jcp.2003.008037; HUNTSMAN RG, 1970, J CLIN PATHOL, V23, P781, DOI 10.1136/jcp.23.9.781; ITANO HA, 1953, ARCH BIOCHEM BIOPHYS, V47, P148, DOI 10.1016/0003-9861(53)90444-5; Jenkins MA, 1999, CLIN CHIM ACTA, V289, P121, DOI 10.1016/S0009-8981(99)00167-9; Kanter J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0473-6; Kumar AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114540; Kumar AA, 2014, P NATL ACAD SCI USA, V111, P14864, DOI 10.1073/pnas.1414739111; Makani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014699; McGann PT, 2013, AM J HEMATOL, V88, P984, DOI 10.1002/ajh.23578; Milligan C, 2013, J PHYSIOL-LONDON, V591, P1463, DOI 10.1113/jphysiol.2012.246579; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; NALBANDIAN RM, 1973, HEALTH SERV REP, V88, P165, DOI 10.2307/4594756; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Piety NZ, 2015, AM J HEMATOL, V90, P478, DOI 10.1002/ajh.23980; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Quinn CT, 2013, PEDIATR CLIN N AM, V60, P1363, DOI 10.1016/j.pcl.2013.09.006; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; Randolph Tim R, 2012, Clin Lab Sci, V25, P26; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Ryan K, 2010, BRIT J HAEMATOL, V149, P35, DOI 10.1111/j.1365-2141.2009.08054.x; SERJEANT BE, 1972, AM J CLIN PATHOL, V58, P11; Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Wong AP, 2008, LAB CHIP, V8, P2032, DOI 10.1039/b809830c; Wood DK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002738; Yang XX, 2013, CLIN CHEM, V59, P1506, DOI 10.1373/clinchem.2013.204701; Yang XX, 2013, LAB CHIP, V13, P1464, DOI 10.1039/c3lc41302k	39	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144901	10.1371/journal.pone.0144901	http://dx.doi.org/10.1371/journal.pone.0144901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735691	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100015
J	Wang, MZ; Liu, ZY; Luo, FL; Lei, GC; Li, HL				Wang, Mo-Zhu; Liu, Zheng-Yuan; Luo, Fang-Li; Lei, Guang-Chun; Li, Hong-Li			Do Amplitudes of Water Level Fluctuations Affect the Growth and Community Structure of Submerged Macrophytes?	PLOS ONE			English	Article							ELODEA-NUTTALLII; MYRIOPHYLLUM-SPICATUM; ALLELOPATHIC ACTIVITY; PLANTS; COMPETITION; RESPONSES; DEPTH; VEGETATION; BIOMASS; IMPACT	Submerged macrophytes are subjected to potential mechanical stresses associated with fluctuating water levels in natural conditions. However, few experimental studies have been conducted to further understand the effects of water level fluctuating amplitude on submerged macrophyte species and their assemblages or communities. We designed a controlled experiment to investigate the responses of three submerged macrophyte species (Hydrilla verticillata, Ceratophyllum demersum and Elodea nuttallii) and their combinations in communities to three amplitudes (static, +/- 30 cm, +/- 60 cm) of water level fluctuations. Results showed that water level fluctuating amplitude had little effects on the community performance and the three tested species responded differently. H. verticillata exhibited more growth in static water and it was negatively affected by either of the water level fluctuations amplitude, however, growth parameters of H. verticillata in two fluctuating water level treatments (i.e., +/- 30 cm, +/- 60 cm) were not significantly different. On the other hand, the growth of C. demersum was not significantly correlated with different amplitude treatments. However, it became more abundant when water levels fluctuated. E. nuttallii was inhibited by the two fluctuating water level treatments, and was less in growth parameters compared to the other species especially in water level fluctuating conditions. The inherent differences in the adaptive capabilities of the tested species indicate that C. demersum or other species with similar responses may be dominant species to restore submerged macrophyte communities with great fluctuating water levels. Otherwise, H. verticillata, E. nuttallii or other species with similar responses could be considered for constructing the community in static water conditions.	[Wang, Mo-Zhu; Liu, Zheng-Yuan; Luo, Fang-Li; Lei, Guang-Chun; Li, Hong-Li] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Li, HL (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	lihongli327@163.com	Guangchun, Lei/ABC-8081-2021		Fundamental Research Funds for the Central Universities [TD-JC-2013-1]; National Natural Science Foundation of China [31200313, 31470475]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Fundamental Research Funds for the Central Universities (TD-JC-2013-1) and the National Natural Science Foundation of China (No. 31200313 and 31470475).	Aroviita J, 2008, HYDROBIOLOGIA, V613, P45, DOI 10.1007/s10750-008-9471-4; Atapaththu KSS, 2015, HYDROBIOLOGIA, V747, P217, DOI 10.1007/s10750-014-2141-9; Bakker ES, 2010, BASIC APPL ECOL, V11, P432, DOI 10.1016/j.baae.2010.06.005; Barrat-Segretain MH, 2005, PLANT ECOL, V180, P153, DOI 10.1007/s11258-004-7374-7; Barrat-Segretain MH, 1998, AQUAT BOT, V60, P201, DOI 10.1016/S0304-3770(97)00091-0; Cao JJ, 2012, AQUAT BIOL, V17, P295, DOI 10.3354/ab00484; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; Coops H, 2003, HYDROBIOLOGIA, V506, P23, DOI 10.1023/B:HYDR.0000008595.14393.77; Deegan BM, 2007, AQUAT BOT, V86, P309, DOI 10.1016/j.aquabot.2006.11.006; Dong BC, 2015, PLANT SPEC BIOL, V30, P28, DOI 10.1111/1442-1984.12036; Ellawala C, 2011, AQUAT ECOL, V45, P417, DOI 10.1007/s10452-011-9364-x; Erhard D, 2006, AQUAT BOT, V85, P203, DOI 10.1016/j.aquabot.2006.04.002; Foroughi M, 2010, AFR J BIOTECHNOL, V9, P2125; Gross EM, 2003, HYDROBIOLOGIA, V506, P583, DOI 10.1023/B:HYDR.0000008539.32622.91; Haller W. T., 1975, Hyacinth Control Journal, V13, P48; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Kelly R, 2015, BIOL INVASIONS, V17, P2123, DOI 10.1007/s10530-015-0865-8; Keskinkan O, 2004, BIORESOURCE TECHNOL, V92, P197, DOI 10.1016/j.biortech.2003.07.011; Langeland Kenneth A., 1996, Castanea, V61, P293; Li HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142586; Netten JJC, 2010, FUND APPL LIMNOL, V177, P125, DOI 10.1127/1863-9135/2010/0177-0125; Nino FD, 2007, HYDROBIOLOGIE, V168, P335; Ozkan K, 2010, FRESHWATER BIOL, V55, P463, DOI 10.1111/j.1365-2427.2009.02297.x; Paillisson JM, 2011, ECOL ENG, V37, P241, DOI 10.1016/j.ecoleng.2010.11.017; Peng ZiRan, 2011, Journal of Shanghai Ocean University, V20, P457; Qin Xian-yan, 2010, Shengtaixue Zazhi, V29, P117; Riis T, 2002, AQUAT BOT, V74, P133, DOI 10.1016/S0304-3770(02)00074-8; Schutten J, 2005, J ECOL, V93, P556, DOI 10.1111/j.1365-2745.2005.00980.x; Valk AGVD, 2015, ENVIRON MANAGE, V55, P1; Van Geest GJ, 2005, HYDROBIOLOGIA, V539, P239, DOI 10.1007/s10750-004-4879-y; Van TK, 1999, AQUAT BOT, V62, P225, DOI 10.1016/S0304-3770(98)00100-4; Wei H, 2014, J FRESHWATER ECOL, V29, P101, DOI 10.1080/02705060.2013.833142; Xiao KY, 2007, HYDROBIOLOGIA, V589, P265, DOI 10.1007/s10750-007-0740-4; Xu Jing-Wei, 2007, Zhiwu Shengtai Xuebao, V31, P83; Xu NN, 2011, J PLANT ECOL, V4, P283, DOI 10.1093/jpe/rtq038; Yang YQ, 2004, J FRESHWATER ECOL, V19, P69, DOI 10.1080/02705060.2004.9664514; Yu LF, 2009, FUND APPL LIMNOL, V174, P295, DOI 10.1127/1863-9135/2009/0174-0295; Zhang Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04888; Zhang XK, 2015, HYDROBIOLOGIA, V747, P43, DOI 10.1007/s10750-014-2121-0; Zhang XK, 2013, J PLANT ECOL, V6, P64, DOI 10.1093/jpe/rts009; Zhu B, 2006, ECOSYSTEMS, V9, P1017, DOI 10.1007/s10021-005-0049-y; Zhu GR, 2012, HYDROBIOLOGIA, V696, P77, DOI 10.1007/s10750-012-1185-y	43	19	21	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146528	10.1371/journal.pone.0146528	http://dx.doi.org/10.1371/journal.pone.0146528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735689	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100051
J	Buccino, AP; Keles, HO; Omurtag, A				Buccino, Alessio Paolo; Keles, Hasan Onur; Omurtag, Ahmet			Hybrid EEG-fNIRS Asynchronous Brain-Computer Interface for Multiple Motor Tasks	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; SINGLE-TRIAL CLASSIFICATION; COMMON SPATIAL-PATTERNS; HAND MOVEMENT; IMAGERY; (DE)SYNCHRONIZATION; IMAGINATION; SIGNALS; FILTERS; FMRI	Non-invasive Brain-Computer Interfaces (BCI) have demonstrated great promise for neu-roprosthetics and assistive devices. Here we aim to investigate methods to combine Electroencephalography (EEG) and functional Near-Infrared Spectroscopy (fNIRS) in an asynchronous Sensory Motor rhythm (SMR)-based BCI. We attempted to classify 4 different executed movements, namely, Right-Arm-Left-Arm-Right-Hand-Left-Hand tasks. Previous studies demonstrated the benefit of EEG-fNIRS combination. However, since normally fNIRS hemodynamic response shows a long delay, we investigated new features, involving slope indicators, in order to immediately detect changes in the signals. Moreover, Common Spatial Patterns (CSPs) have been applied to both EEG and fNIRS signals. 15 healthy subjects took part in the experiments and since 25 trials per class were available, CSPs have been regularized with information from the entire population of participants and optimized using genetic algorithms. The different features have been compared in terms of performance and the dynamic accuracy over trials shows that the introduced methods diminish the fNIRS delay in the detection of changes.	[Buccino, Alessio Paolo; Keles, Hasan Onur; Omurtag, Ahmet] Univ Houston, Dept Biomed Engn, Houston, TX 77030 USA; [Buccino, Alessio Paolo] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy	University of Houston System; University of Houston; Polytechnic University of Milan	Buccino, AP (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77030 USA.	alessiop.buccino@gmail.com	Keles, Hasan Onur/L-3865-2018; Keles, Hasan Onur/AAJ-6014-2021; Buccino, Alessio/AAB-7655-2020	Keles, Hasan Onur/0000-0002-1892-520X; Keles, Hasan Onur/0000-0001-8493-2582; Buccino, Alessio/0000-0003-3661-527X; OMURTAG, AHMET/0000-0002-3773-8506	Department of Biomedical Engineering; Cullen College of Engineering at University of Houston	Department of Biomedical Engineering; Cullen College of Engineering at University of Houston	The authors would like to thank the Department of Biomedical Engineering and the Cullen College of Engineering at University of Houston for financial support.	Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Dornhege G, 2003, I IEEE EMBS C NEUR E, P595, DOI 10.1109/CNE.2003.1196898; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Gagnon L, 2012, NEUROIMAGE, V59, P3933, DOI 10.1016/j.neuroimage.2011.10.054; Graimann B, 2010, FRONT COLLECT, P1, DOI 10.1007/978-3-642-02091-9_1; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Hermes D, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025007; Hsu WY, 2009, J NEUROSCI METH, V176, P310, DOI 10.1016/j.jneumeth.2008.09.014; Kanoh S, 2009, IEEE ENG MED BIO, P594, DOI 10.1109/IEMBS.2009.5333710; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Lu HP, 2009, IEEE ENG MED BIO, P6599, DOI 10.1109/IEMBS.2009.5332554; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Penny WD, 2000, IEEE T REHABIL ENG, V8, P214, DOI 10.1109/86.847820; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1998, IEEE Trans Rehabil Eng, V6, P316, DOI 10.1109/86.712230; PFURTSCHELLER G, 1994, NEUROSCI LETT, V181, P43, DOI 10.1016/0304-3940(94)90556-8; Pfurtscheller G., 2009, COMPUT INTEL NEUROSC, DOI DOI 10.1155/2009/104180; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Reuderink B., 2008, ROBUSTNESS COMMON SP; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Wang T, 2004, J NEURAL ENG, V1, DOI 10.1088/1741-2560/1/1/001; Wolpaw JR, 2010, FRONT COLLECT, P29, DOI 10.1007/978-3-642-02091-9_2; Yamawaki N, 2006, IEEE T NEUR SYS REH, V14, P250, DOI 10.1109/TNSRE.2006.875567; Yuan H, 2008, IEEE T NEUR SYS REH, V16, P425, DOI 10.1109/TNSRE.2008.2003384; Yuan H, 2011, J NEUROSCI, V31, P9585, DOI 10.1523/JNEUROSCI.5312-10.2011; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	37	96	97	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146610	10.1371/journal.pone.0146610	http://dx.doi.org/10.1371/journal.pone.0146610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730580	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000367801400193
J	Horn, BW; Gell, RM; Singh, R; Sorensen, RB; Carbone, I				Horn, Bruce W.; Gell, Richard M.; Singh, Rakhi; Sorensen, Ronald B.; Carbone, Ignazio			Sexual Reproduction in Aspergillus flavus Sclerotia: Acquisition of Novel Alleles from Soil Populations and Uniparental Mitochondrial Inheritance	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; AFLATOXIN GENE-CLUSTER; MATING-TYPE; PETROMYCES-ALLIACEUS; SECTION FLAVI; UNITED-STATES; A-TAMARII; PARASITICUS; FUNGUS; RECOMBINATION	Aspergillus flavus colonizes agricultural commodities worldwide and contaminates them with carcinogenic aflatoxins. The high genetic diversity of A. flavus populations is largely due to sexual reproduction characterized by the formation of ascospore-bearing ascocarps embedded within sclerotia. A. flavus is heterothallic and laboratory crosses between strains of the opposite mating type produce progeny showing genetic recombination. Sclerotia formed in crops are dispersed onto the soil surface at harvest and are predominantly produced by single strains of one mating type. Less commonly, sclerotia may be fertilized during co-infection of crops with sexually compatible strains. In this study, laboratory and field experiments were performed to examine sexual reproduction in single-strain and fertilized sclerotia following exposure of sclerotia to natural fungal populations in soil. Female and male roles and mitochondrial inheritance in A. flavus were also examined through reciprocal crosses between sclerotia and conidia. Single-strain sclerotia produced ascospores on soil and progeny showed biparental inheritance that included novel alleles originating from fertilization by native soil strains. Sclerotia fertilized in the laboratory and applied to soil before ascocarp formation also produced ascospores with evidence of recombination in progeny, but only known parental alleles were detected. In reciprocal crosses, sclerotia and conidia from both strains functioned as female and male, respectively, indicating A. flavus is hermaphroditic, although the degree of fertility depended upon the parental sources of sclerotia and conidia. All progeny showed maternal inheritance of mitochondria from the sclerotia. Compared to A. flavus populations in crops, soil populations would provide a higher likelihood of exposure of sclerotia to sexually compatible strains and a more diverse source of genetic material for outcrossing.	[Horn, Bruce W.; Sorensen, Ronald B.] ARS, Natl Peanut Res Lab, USDA, Dawson, GA USA; [Gell, Richard M.; Singh, Rakhi; Carbone, Ignazio] N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Genet Program, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University	Carbone, I (corresponding author), N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Genet Program, Box 7616, Raleigh, NC 27695 USA.	icarbon@ncsu.edu			Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (NIFA) [2013-68004-20359]	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (NIFA)	The project was supported by the Agriculture and Food Research Initiative Competitive Grants Program grant no. 2013-68004-20359 from the USDA National Institute of Food and Agriculture (NIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas HK, 2011, FOOD ADDIT CONTAM A, V28, P198, DOI 10.1080/19440049.2010.544680; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; BENJAMIN CR, 1955, MYCOLOGIA, V47, P669, DOI 10.2307/3755578; BOJOVICCVETIC D, 1988, T BRIT MYCOL SOC, V91, P619, DOI 10.1016/S0007-1536(88)80036-6; Bruggeman J, 2003, FUNGAL GENET BIOL, V39, P136, DOI 10.1016/S1087-1845(03)00016-1; Carbone I, 2007, MOL ECOL, V16, P4401, DOI 10.1111/j.1365-294X.2007.03464.x; Chang PK, 2010, INT J FOOD MICROBIOL, V138, P189, DOI 10.1016/j.ijfoodmicro.2010.01.033; Chang PK, 2005, FUNGAL GENET BIOL, V42, P914, DOI 10.1016/j.fgb.2005.07.004; COTTY PJ, 1989, PHYTOPATHOLOGY, V79, P808, DOI 10.1094/Phyto-79-808; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Ehrlich KC, 2007, FEMS MICROBIOL LETT, V268, P231, DOI 10.1111/j.1574-6968.2006.00588.x; FENNELL DI, 1959, MYCOLOGIA, V51, P409, DOI 10.2307/3756060; Fukumori Youhei, 2004, Journal of General Plant Pathology, V70, P256, DOI 10.1007/s10327-004-0124-9; Garber RK, 1997, PHYTOPATHOLOGY, V87, P940, DOI 10.1094/PHYTO.1997.87.9.940; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Grubisha LC, 2010, MOL ECOL, V19, P269, DOI 10.1111/j.1365-294X.2009.04467.x; Grubisha LC, 2009, MOL ECOL RESOUR, V9, P264, DOI 10.1111/j.1755-0998.2008.02378.x; Holtz G., 2007, BOTRYTIS BIOL PATHOL, P9; Horn BW, 2014, PHYTOPATHOLOGY, V104, P75, DOI 10.1094/PHYTO-05-13-0129-R; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Horn BW, 2009, BIOCONTROL SCI TECHN, V19, P249, DOI 10.1080/09583150802696541; Horn BW, 2009, FUNGAL GENET BIOL, V46, P169, DOI 10.1016/j.fgb.2008.11.004; Horn BW, 1998, MYCOLOGIA, V90, P767, DOI 10.2307/3761317; HORN BW, 1995, MYCOLOGIA, V87, P324, DOI 10.2307/3760829; Horn BW, 1999, APPL ENVIRON MICROB, V65, P1444; Horn BW, 1996, MYCOLOGIA, V88, P574, DOI 10.2307/3761151; Kew MC, 2013, J GASTROINTEST LIVER, V22, P305; LEAL JA, 1982, T BRIT MYCOL SOC, V78, P323, DOI 10.1016/S0007-1536(82)80016-8; LESLIE JF, 1985, GENETICS, V111, P759; Leslie JF, 1996, GENETICS, V144, P557; LESLIE JF, 1995, CAN J BOT, V73, pS282, DOI 10.1139/b95-258; McAlpin CE, 2005, CAN J MICROBIOL, V51, P765, DOI [10.1139/W05-057, 10.1139/w05-057]; Monacell JT, 2014, BIOINFORMATICS, V30, P1488, DOI 10.1093/bioinformatics/btu055; Moore GG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003574; Moore GG, 2009, MOL ECOL, V18, P4870, DOI 10.1111/j.1365-294X.2009.04414.x; Nieuwenhuis BPS, 2012, J EVOLUTION BIOL, V25, P2397, DOI 10.1111/jeb.12017; Olarte RA, 2015, MOL ECOL, V24, P1889, DOI 10.1111/mec.13153; Olarte RA, 2012, MOL ECOL, V21, P1453, DOI 10.1111/j.1365-294X.2011.05398.x; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; RAJU NB, 1992, MYCOL RES, V96, P241, DOI 10.1016/S0953-7562(09)80934-9; Ramirez-Prado JH, 2008, FUNGAL GENET BIOL, V45, P1292, DOI 10.1016/j.fgb.2008.06.007; RUDOLPH ED, 1962, AM J BOT, V49, P71, DOI 10.2307/2439391; Saleh D, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-42; Sweany RR, 2011, PHYTOPATHOLOGY, V101, P952, DOI 10.1094/PHYTO-09-10-0243; Tadych M, 2014, MYCOLOGIA, V106, P181, DOI 10.3852/106.2.181; TEWARI JP, 1983, T BRIT MYCOL SOC, V80, P127, DOI 10.1016/S0007-1536(83)80173-9; UTKHEDE RS, 1979, PHYTOPATHOLOGY, V69, P295, DOI 10.1094/Phyto-69-295; Wada R, 2014, APPL MICROBIOL BIOT, V98, P325, DOI 10.1007/s00253-013-5314-y; Whittle CA, 2013, MOL BIOL EVOL, V30, P2435, DOI 10.1093/molbev/mst143; Wicklow D. T., 1987, MYCOL RES, V89, P131, DOI DOI 10.1016/S0007-1536(87)80073-6; WICKLOW DT, 1984, MYCOLOGIA, V76, P503, DOI 10.2307/3793332; WICKLOW DT, 1984, T BRIT MYCOL SOC, V83, P299, DOI 10.1016/S0007-1536(84)80151-5; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Wilson A. J., 2012, Mycology - An International Journal on Fungal Biology, V3, P158; Xu JP, 2002, GENETICS, V162, P1157; Zeng J, 2009, PLANT DIS, V93, P238, DOI 10.1094/PDIS-93-3-0238	56	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146169	10.1371/journal.pone.0146169	http://dx.doi.org/10.1371/journal.pone.0146169			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731416	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400109
J	Kucinska, M; Giron, MD; Piotrowska, H; Lisiak, N; Granig, WH; Lopez-Jaramillo, FJ; Salto, R; Murias, M; Erker, T				Kucinska, Malgorzata; Giron, Maria-Dolores; Piotrowska, Hanna; Lisiak, Natalia; Granig, Walter H.; Lopez-Jaramillo, Francisco-Javier; Salto, Rafael; Murias, Marek; Erker, Thomas			Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides	PLOS ONE			English	Article							BREAST-CANCER; HIGH-RISK; TAMOXIFEN; RALOXIFENE; ANALOGS; DERIVATIVES; SERMS; OSPEMIFENE; GENERATION; MANAGEMENT	The cytotoxicity of 27 benzanilides and dithiobenzanilides built on a stilbene scaffold and possessing various functional groups in aromatic rings previously described for their spasmolytic properties was assayed on three human cancer cell lines (A549 -lung adenocarcinoma, MCF-7 estrogen dependent breast adenocarcinoma and MDA-MB-231 estrogen independent breast adenocarcinoma) and 2 non-tumorigenic cell lines (CCD39Lu-lung fibroblasts, MCF-12A - breast epithelial). Three compounds (6, 15 and 18) showed selective antiproliferative activity against estrogen dependent MCF-7 cancer cells and their estrogenic activity was further confirmed in MCF-7 transfected with an estrogen receptor reporter plasmid and in HEK239 cells over-expressing the estrogen receptor alpha (ERa). Compound 18 is especially interesting as a potential candidate for therapy since it is highly toxic and selective towards estrogen dependent MCF7 cell lines (IC50 = 5.07 mu M versus more than 100 mu M for MDA-MB-231) and almost innocuous for normal breast cells (IC50 = 91.46 mu M for MCF-12A). Docking studies have shown that compound 18 interacts with the receptor in the same cavity as estradiol although the extra aromatic ring is involved in additional binding interactions with residue W383. The role of W383 and the extended binding mode were confirmed by site-directed mutagenesis.	[Kucinska, Malgorzata; Piotrowska, Hanna; Murias, Marek] Poznan Univ Med Sci, Dept Toxicol, Poznan, Poland; [Giron, Maria-Dolores; Salto, Rafael] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain; [Lisiak, Natalia] Poznan Univ Med Sci, Dept Clin Chem & Mol Diagnost, Poznan, Poland; [Granig, Walter H.; Erker, Thomas] Univ Vienna, Dept Med Chem, Vienna, Austria; [Lopez-Jaramillo, Francisco-Javier] Univ Granada, Sch Sci, Inst Biotechnol, Dept Organ Chem, Granada, Spain	Poznan University of Medical Sciences; University of Granada; Poznan University of Medical Sciences; University of Vienna; University of Granada	Murias, M (corresponding author), Poznan Univ Med Sci, Dept Toxicol, Poznan, Poland.	marek.murias@ump.edu.pl	Giron, Maria D/K-2487-2014; Lopez-Jaramillo, F. Javier/K-2988-2014; Murias, Marek/A-3776-2015; Salto, Rafael/A-6486-2011	Giron, Maria D/0000-0001-9638-988X; Lopez-Jaramillo, F. Javier/0000-0002-6030-7384; Murias, Marek/0000-0002-2903-4912; Salto, Rafael/0000-0002-7044-3611; , Malgorzata/0000-0002-3606-3623	Polish National Science Center [UMO-2011/01/B/NZ4/03499]; Ministerio Espanol de Ciencia e Innovacion; FEDER funds; Fundacion Marcelino Botin [CTQ2011-29299-C02-02]	Polish National Science Center; Ministerio Espanol de Ciencia e Innovacion(Spanish Government); FEDER funds(European Commission); Fundacion Marcelino Botin	This work was funded by Polish National Science Center, grant number UMO-2011/01/B/NZ4/03499, Ministerio Espanol de Ciencia e Innovacion (cofinanced by FEDER funds) and Fundacion Marcelino Botin (awarded to R. S.), CTQ2011-29299-C02-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, 3D QSAR DRUG DESIGN; Armstrong AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2756; Bernhaus A, 2009, INVEST NEW DRUG, V27, P393, DOI 10.1007/s10637-008-9183-7; Blizzard TA, 2005, BIOORG MED CHEM LETT, V15, P107, DOI 10.1016/j.bmcl.2004.10.036; Brunhofer G, 2008, BIOORGAN MED CHEM, V16, P5974, DOI 10.1016/j.bmc.2008.04.057; Brunhofer G, 2011, BIOORGAN MED CHEM, V19, P994, DOI 10.1016/j.bmc.2010.11.043; Brunhofer G, 2011, EUR J PHARM SCI, V42, P37, DOI 10.1016/j.ejps.2010.10.005; Calderone V, 2006, EUR J MED CHEM, V41, P761, DOI 10.1016/j.ejmech.2006.03.009; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Cummings SR, 2011, J BONE MINER RES, V26, P397, DOI 10.1002/jbmr.191; DeGregorio MW, 2014, STEROIDS, V90, P82, DOI 10.1016/j.steroids.2014.07.012; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Fan P, 2014, STEROIDS, V90, P44, DOI 10.1016/j.steroids.2014.06.002; Fang J, 2008, BIOORG MED CHEM LETT, V18, P5075, DOI 10.1016/j.bmcl.2008.07.121; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hassinen T, 2001, J COMPUT CHEM, V22, P1229, DOI 10.1002/jcc.1080; Hervouet E, 2013, EPIGENETICS-US, V8, P237, DOI 10.4161/epi.23790; Hu WP, 2008, BIOORGAN MED CHEM, V16, P5295, DOI 10.1016/j.bmc.2008.03.003; Kaur G, 2014, EUR J MED CHEM, V86, P211, DOI 10.1016/j.ejmech.2014.08.050; Kim HI, 2015, INT J ONCOL, V47, P280, DOI 10.3892/ijo.2015.3002; Kozic J, 2012, EUR J MED CHEM, V56, P108, DOI 10.1016/j.ejmech.2012.08.016; Laible Mark, 2009, J Vis Exp, DOI 10.3791/1135; Matysiak J, 2001, J AGR FOOD CHEM, V49, P5251, DOI 10.1021/jf0104230; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; Mirkin S, 2015, MATURITAS, V80, P52, DOI 10.1016/j.maturitas.2014.10.010; Mirkin S, 2013, INT J WOMENS HEALTH, V5, P465, DOI 10.2147/IJWH.S39455; Moradei O, 2008, CURR TOP MED CHEM, V8, P841, DOI 10.2174/156802608784911581; Nagao S, 2014, BIOORGAN MED CHEM, V22, P5513, DOI 10.1016/j.bmc.2014.07.020; Nass N, 2015, PATHOL RES PRACT, V211, P189, DOI 10.1016/j.prp.2015.01.004; Nazarali SA, 2014, BREAST CANCER-TARGET, V6, P29, DOI 10.2147/BCTT.S43763; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Shanle EK, 2010, ADV DRUG DELIVER REV, V62, P1265, DOI 10.1016/j.addr.2010.08.001; St John SE, 2013, BIOORGAN MED CHEM, V21, P6022, DOI 10.1016/j.bmc.2013.07.037; Stierand K, 2007, CHEMMEDCHEM, V2, P853, DOI 10.1002/cmdc.200700010; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Wardell SE, 2014, STEROIDS, V90, P30, DOI 10.1016/j.steroids.2014.07.013; Waters EA, 2012, BREAST CANCER RES TR, V134, P875, DOI 10.1007/s10549-012-2089-2; Williams-Brown MY, 2011, J STEROID BIOCHEM, V126, P78, DOI 10.1016/j.jsbmb.2011.05.001; Yoshida K, 1998, BIOORG MED CHEM LETT, V8, P2967, DOI 10.1016/S0960-894X(98)00538-1; Yue W, 2013, STEROIDS, V78, P161, DOI 10.1016/j.steroids.2012.11.001; Zoete V, 2010, J MOL RECOGNIT, V23, P457, DOI 10.1002/jmr.1012	47	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145615	10.1371/journal.pone.0145615	http://dx.doi.org/10.1371/journal.pone.0145615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730945	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400043
J	Jia, D; Qi, F; Xu, X; Feng, JX; Wu, H; Guo, JM; Lu, WZ; Peng, RH; Zhu, XS; Luo, YQ; Lin, GH				Jia, Dai; Qi, Fei; Xu, Xia; Feng, Jianxiang; Wu, Hao; Guo, Jiemin; Lu, Weizhi; Peng, Ronghao; Zhu, Xiaoshan; Luo, Yiqi; Lin, Guanghui			Co-Regulations of Spartina alterniflora Invasion and Exogenous Nitrogen Loading on Soil N2O Efflux in Subtropical Mangrove Mesocosms	PLOS ONE			English	Article							WASTE-WATER; OXIDE EMISSIONS; GRASSLAND SOIL; WETLAND; FLUXES; DENITRIFICATION; METHANE; GROWTH; CARBON; RHIZOSPHERE	Both plant invasion and nitrogen (N) enrichment should have significant impact on mangrove ecosystems in coastal regions around the world. However, how N2O efflux in mangrove wetlands responds to these environmental changes has not been well studied. Here, we conducted a mesocosm experiment with native mangrove species Kandelia obovata, invasive salt marsh species Spartina alterniflora, and their mixture in a simulated tide rotation system with or without nitrogen addition. In the treatments without N addition, the N2O effluxes were relatively low and there were no significant variations among the three vegetation types. A pulse loading of exogenous ammonium nitrogen increased N2O effluxes from soils but the stimulatory effect gradually diminished over time, suggesting that frequent measurements are necessary to accurately understand the behavior of N-induced response of N2O emissions. With the N addition, the N2O effluxes from the invasive S. alterniflora were lower than that from native K. obovata mesocosms. This result may be attributed to higher growth of S. alterniflora consuming most of the available nitrogen in soils, and thus inhibiting N2O production. We concluded that N loading significantly increased N2O effluxes, while the invasion of S. alterniflora reduced N2O effluxes response to N loading in this simulated mangrove ecosystem. Thus, both plant invasion and excessive N loading can co-regulate soil N2O emissions from mangrove wetlands, which should be considered when projecting future N2O effluxes from this type of coastal wetland.	[Jia, Dai; Peng, Ronghao; Lin, Guanghui] Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modeling, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Jia, Dai; Qi, Fei; Feng, Jianxiang; Wu, Hao; Guo, Jiemin; Lu, Weizhi; Zhu, Xiaoshan; Lin, Guanghui] Tsinghua Univ, Shenzhen Key Lab Coastal Ocean Dynam & Environm, Div Ocean Sci & Technol, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Qi, Fei; Lu, Weizhi] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Xu, Xia; Luo, Yiqi] Univ Oklahoma, Dept Microbiol & Plant Biol, Oklahoma City, OK USA	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Xiamen University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lin, GH (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modeling, Ctr Earth Syst Sci, Beijing 100084, Peoples R China.	lingh@tsinghua.edu.cn	Hao, Wu/AAS-8505-2021; Zhu, Xiaoshan/HCG-9804-2022; hao, wu/GXV-6924-2022; hao, wu/HDM-1705-2022; Zhu, Xiaoshan/B-2179-2015	Zhu, Xiaoshan/0000-0003-1223-1415; Wu, Hao/0000-0002-9227-2614	National Science Foundation of China [2013CB956601]; Ocean Public Fund Research Projects [201305021]; Shenzhen Key Laboratory for Coastal Ocean Dynamic and Environment [ZDSY20130402163735964]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ocean Public Fund Research Projects; Shenzhen Key Laboratory for Coastal Ocean Dynamic and Environment	This work was funded by National Science Foundation of China (2013CB956601) (http://www.nsfc.gov.cn/) to Guanghui Lin, by Ocean Public Fund Research Projects (201305021) (http://www.soa.gov.cn/) to Guanghui Lin, and by Shenzhen Key Laboratory for Coastal Ocean Dynamic and Environment (ZDSY20130402163735964) (http://hyxb.sz.tsinghua.edu.cn/) to Guanghui Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos D, 2014, GLOBAL CHANGE BIOL, V20, P265, DOI 10.1111/gcb.12350; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Allen DE, 2007, SOIL BIOL BIOCHEM, V39, P622, DOI 10.1016/j.soilbio.2006.09.013; An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; ANDO T, 1983, PLANT SOIL, V72, P57, DOI 10.1007/BF02185094; Bange HW, 1996, GLOBAL BIOGEOCHEM CY, V10, P197, DOI 10.1029/95GB03834; Bonham C.D., 1989, MEASUREMENTS TERREST, P338; Chen GC, 2010, SCI TOTAL ENVIRON, V408, P2761, DOI 10.1016/j.scitotenv.2010.03.007; Chen GC, 2012, SOIL BIOL BIOCHEM, V48, P175, DOI 10.1016/j.soilbio.2012.01.029; Chen LZ, 2009, J PLANT ECOL, V2, P45, DOI 10.1093/jpe/rtp009; Cheng XL, 2007, CHEMOSPHERE, V68, P420, DOI 10.1016/j.chemosphere.2007.01.004; CHIU CY, 1993, SOIL SCI PLANT NUTR, V39, P725, DOI 10.1080/00380768.1993.10419190; Cintron G., 1984, MANGROVE ECOSYSTEM R; Corredor JE, 1999, MAR POLLUT BULL, V38, P473, DOI 10.1016/S0025-326X(98)00172-6; CRUTZEN P J, 1977, Ambio, V6, P112; Edwards KR, 2006, ECOL ENG, V27, P153, DOI 10.1016/j.ecoleng.2006.02.004; Fontenot Q, 2007, BIORESOURCE TECHNOL, V98, P1700, DOI 10.1016/j.biortech.2006.07.031; Gui P, 2007, WATER SCI TECHNOL, V56, P49, DOI 10.2166/wst.2007.517; Hall SJ, 2007, GLOBAL CHANGE BIOL, V13, P2143, DOI 10.1111/j.1365-2486.2007.01410.x; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Inamori R, 2007, PROCESS BIOCHEM, V42, P363, DOI 10.1016/j.procbio.2006.09.007; Inamori R, 2008, CHEMOSPHERE, V73, P1071, DOI 10.1016/j.chemosphere.2008.07.064; Jin X, 1990, CRITERION LAKE EUTRO; KNOWLES R, 1982, MICROBIOL REV, V46, P43, DOI 10.1128/MMBR.46.1.43-70.1982; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kreuzwieser J, 2003, PLANT BIOLOGY, V5, P423, DOI 10.1055/s-2003-42712; Mckee KL, 2008, GLOBAL CHANGE BIOL, V14, P971, DOI 10.1111/j.1365-2486.2008.01547.x; Moseman-Valtierra S, 2011, ATMOS ENVIRON, V45, P4390, DOI 10.1016/j.atmosenv.2011.05.046; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Nagata O, 2005, PHYTON-ANN REI BOT A, V45, P299; NEVISON CD, 1995, J GEOPHYS RES-OCEANS, V100, P15809, DOI 10.1029/95JC00684; Personeni E, 2005, EUR J AGRON, V22, P217, DOI 10.1016/j.eja.2004.02.007; POORTER H, 1991, PHYSIOL PLANTARUM, V83, P469, DOI 10.1111/j.1399-3054.1991.tb00122.x; Rolletschek H, 1998, NEW PHYTOL, V140, P211, DOI 10.1046/j.1469-8137.1998.00275.x; RYDEN JC, 1983, J SOIL SCI, V34, P355, DOI 10.1111/j.1365-2389.1983.tb01041.x; Sasikala S, 2009, ECOL ENG, V35, P410, DOI 10.1016/j.ecoleng.2008.10.003; Stocker T. F., 2013, CLIMATE CHANGE 2013; Sun HY, 2013, ATMOS ENVIRON, V77, P544, DOI 10.1016/j.atmosenv.2013.05.058; Tam NFY, 2009, ECOL ENG, V35, P453, DOI 10.1016/j.ecoleng.2008.05.011; Tam NFY, 1998, ENVIRON POLLUT, V102, P233, DOI 10.1016/S0269-7491(98)00084-0; Tam NFY, 2000, ENVIRON POLLUT, V110, P195, DOI 10.1016/S0269-7491(99)00310-3; Tauchnitz N, 2008, PLANT SOIL, V303, P131, DOI 10.1007/s11104-007-9493-0; Vaiphasa C, 2007, HYDROBIOLOGIA, V591, P47, DOI 10.1007/s10750-007-0783-6; Van der Krift TAJ, 2001, J ECOL, V89, P555, DOI 10.1046/j.0022-0477.2001.00580.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Wu H, 2014, AQUACULTURE, V426, P204, DOI 10.1016/j.aquaculture.2014.02.009; Wu Y, 2008, MAR POLLUT BULL, V57, P727, DOI 10.1016/j.marpolbul.2008.02.026; Yuan JJ, 2015, GLOBAL CHANGE BIOL, V21, P1567, DOI 10.1111/gcb.12797; Zhang YH, 2013, ECOL ENG, V58, P77, DOI 10.1016/j.ecoleng.2013.06.011; Zhang YH, 2012, ECOLOGY, V93, P588, DOI 10.1890/11-1302.1	52	10	10	6	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146199	10.1371/journal.pone.0146199	http://dx.doi.org/10.1371/journal.pone.0146199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727205	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500066
J	Mao, XB; Gu, CS; Hu, HY; Tang, J; Chen, DW; Yu, B; He, J; Yu, J; Luo, JQ; Tian, G				Mao, Xiangbing; Gu, Changsong; Hu, Haiyan; Tang, Jun; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Luo, Junqiu; Tian, Gang			Dietary Lactobacillus rhamnosus GG Supplementation Improves the Mucosal Barrier Function in the Intestine of Weaned Piglets Challenged by Porcine Rotavirus	PLOS ONE			English	Article							GUT MICROBIOTA; ANTIOXIDATIVE PROPERTIES; IMMUNE-RESPONSES; CELL RESPONSES; DIARRHEA; MODULATION; PREVENTION; PROBIOTICS; INFECTION; CYTOKINES	Lactobacillus rhamnosus GG (LGG) has been regarded as a safe probiotic strain. The aim of this study was to investigate whether dietary LGG supplementation could alleviate diarrhea via improving jejunal mucosal barrier function in the weaned piglets challenged by RV, and further analyze the potential roles for apoptosis of jejunal mucosal cells and intestinal microbiota. A total of 24 crossbred barrows weaned at 21 d of age were assigned randomly to 1 of 2 diets: the basal diet and LGG supplementing diet. On day 11, all pigs were orally infused RV or the sterile essential medium. RV infusion increased the diarrhea rate, increased the RV-Ab, NSP4 and IL-2 concentrations and the Bax mRNA levels of jejunal mucosa (P< 0.05), decreased the villus height, villus height: crypt depth, the sIgA, IL-4 and mucin 1 concentrations and the ZO-1, occludin and Bcl-2 mRNA levels of jejunal mucosa (P< 0.05), and affected the microbiota of ileum and cecum (P< 0.05) in the weaned pigs. Dietary LGG supplementation increased the villus height and villus height: crypt depth, the sIgA, IL-4, mucin 1 and mucin 2 concentrations, and the ZO-1, occludin and Bcl-2 mRNA levels of the jejunal mucosa (P< 0.05) reduced the Bax mRNA levels of the jejunal mucosa (P< 0.05) in weaned pigs. Furthermore, dietary LGG supplementation alleviated the increase of diarrhea rate in the weaned pigs challenged by RV (P< 0.05), and relieve the effect of RV infection on the villus height, crypt depth and the villus height: crypt depth of the jejunal mucosa (P< 0.05), the NSP4, sIgA, IL-2, IL-4, mucin 1 and mucin 2 concentrations of jejunal mucosa (P< 0.05), the ZO-1, occludin, Bax and Bcl-2 mRNA levels of the jejunal mucosa (P< 0.05), and the microbiota of ileum and cecum (P< 0.05) in the weaned pigs challenged by RV. These results suggest that supplementing LGG in diets alleviated the diarrhea of weaned piglets challenged by RV via inhibiting the virus multiplication and improving the jejunal mucosal barrier function, which was possibly due to the decreasing apoptosis of jejunal mucosal cells and the improvement of intestinal microbiota.	[Mao, Xiangbing; Gu, Changsong; Hu, Haiyan; Tang, Jun; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Luo, Junqiu; Tian, Gang] Sichuan Agr Univ, Inst Anim Nutr, Yucheng Dist, Yaan, Peoples R China; [Mao, Xiangbing; Gu, Changsong; Hu, Haiyan; Tang, Jun; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Luo, Junqiu; Tian, Gang] Minist Educ, Key Lab Anim Dis Resistance Nutr, Yaan, Peoples R China	Sichuan Agricultural University	Mao, XB (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yucheng Dist, Yaan, Peoples R China.	acatmxb2003@163.com			Projects in the National Science and Technology Support Program during the Twelfth Five-year Plan Period [2011BAD26B02]; National Natural Science Foundation of China [31201812]; earmarked fund for the China Agriculture Research System [CARS-36]; Science and Technology Achievement Transformation Project of Sichuan Province [2014NC0018]	Projects in the National Science and Technology Support Program during the Twelfth Five-year Plan Period; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the China Agriculture Research System; Science and Technology Achievement Transformation Project of Sichuan Province	This study was financially supported by the grant from the Projects in the National Science and Technology Support Program during the Twelfth Five-year Plan Period (2011BAD26B02), the grant from National Natural Science Foundation of China (31201812), the earmarked fund for the China Agriculture Research System (CARS-36), and the grant from Science and Technology Achievement Transformation Project of Sichuan Province (2014NC0018).	Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; AU KS, 1989, J VIROL, V63, P4553, DOI 10.1128/JVI.63.11.4553-4562.1989; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; BARNETT B, 1983, MED CLIN N AM, V67, P1031, DOI 10.1016/S0025-7125(16)31165-8; Berin MC, 1999, AM J PHYSIOL-CELL PH, V276, pC1046, DOI 10.1152/ajpcell.1999.276.5.C1046; Bernardeau M, 2002, INT J FOOD MICROBIOL, V77, P19, DOI 10.1016/S0168-1605(02)00059-4; Boshuizen JA, 2005, VIROLOGY, V337, P210, DOI 10.1016/j.virol.2005.03.039; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Council N.R., 2012, NUTR REQ SWIN; Cross ML, 2002, MED MICROBIOL IMMUN, V191, P49, DOI 10.1007/s00430-002-0112-7; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; DONELLI GO, 1994, COMP IMMUNOL MICROB, V17, P305, DOI 10.1016/0147-9571(94)90050-7; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; GORBACH SL, 1987, LANCET, V2, P1519; Gorbach SL, 1996, NUTR TODAY, V31, P25, DOI DOI 10.1097/00017285-199611001-00002; Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P54, DOI 10.1097/00005176-200001000-00018; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Hou CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119505; Ji YS, 2012, BENEF MICROBES, V3, P13, DOI 10.3920/BM2011.0046; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Kandasamy S, 2014, GUT MICROBES, V5, P639, DOI 10.4161/19490976.2014.969972; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Kim HS, 2006, ASIAN AUSTRAL J ANIM, V19, P262; Korpela R, 1997, MILCHWISSENSCHAFT, V52, P503; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Liu FN, 2013, J PEDIATR GASTR NUTR, V57, P750, DOI 10.1097/MPG.0b013e3182a356e1; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Liu H, 2014, J AGR FOOD CHEM, V62, P860, DOI 10.1021/jf403288r; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mao XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137380; Mao XB, 2014, ARCH ANIM NUTR, V68, P1, DOI 10.1080/1745039X.2013.869988; Mao Xiangbing, 2011, Front Biosci (Elite Ed), V3, P1192; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Mrukowicz JZ, 1998, J VIROL, V72, P3088, DOI 10.1128/JVI.72.4.3088-3097.1998; Ouwehand AC, 1999, INT DAIRY J, V9, P623, DOI 10.1016/S0958-6946(99)00132-6; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; POTTEN CS, 1992, GUT, V33, P71, DOI 10.1136/gut.33.1.71; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SILVA M, 1987, ANTIMICROB AGENTS CH, V31, P1231, DOI 10.1128/AAC.31.8.1231; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; Tang Jun, 2015, Chinese Journal of Animal Nutrition, V27, P1787; Teran CG, 2009, INT J INFECT DIS, V13, P518, DOI 10.1016/j.ijid.2008.09.014; Tuomola EM, 1998, INT J FOOD MICROBIOL, V41, P45, DOI 10.1016/S0168-1605(98)00033-6; Vanderhoof JA, 1999, J PEDIATR-US, V135, P564, DOI 10.1016/S0022-3476(99)70053-3; Veckman V, 2004, J LEUKOCYTE BIOL, V75, P764, DOI 10.1189/jlb.1003461; Wang AN, 2013, J APPL MICROBIOL, V114, P1582, DOI 10.1111/jam.12188; Wang J, 2010, CARBOHYD POLYM, V82, P419, DOI 10.1016/j.carbpol.2010.04.082; Wen K, 2015, J PEDIATR GASTR NUTR, V60, P834, DOI 10.1097/MPG.0000000000000694; Wen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094504; Wittig BM, 2003, INT J COLORECTAL DIS, V18, P181, DOI 10.1007/s00384-002-0444-1; Wu SP, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-22; Yuan LJ, 1998, J VIROL, V72, P330, DOI 10.1128/JVI.72.1.330-338.1998; Zhang HS, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0039-8; Zhang L, 2010, VET MICROBIOL, V141, P142, DOI 10.1016/j.vetmic.2009.09.003; Zhang Z, 2013, PATHOG DIS, V67, P184, DOI 10.1111/2049-632X.12030; Zund G, 1996, J BIOL CHEM, V271, P7460	61	52	67	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146312	10.1371/journal.pone.0146312	http://dx.doi.org/10.1371/journal.pone.0146312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727003	Green Published, gold, Green Submitted			2022-12-27	WOS:000367681500074
J	Represas-Represas, C; Fernandez-Villar, A; Ruano-Ravina, A; Priegue-Carrera, A; Botana-Rial, M				Represas-Represas, Cristina; Fernandez-Villar, Alberto; Ruano-Ravina, Alberto; Priegue-Carrera, Ana; Botana-Rial, Maribel		Study Grp Validity COPD-6 Non-Spec	Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings	PLOS ONE			English	Article							AIR-FLOW OBSTRUCTION; COPD; SPIROMETRY; FEV1/FEV6; VALIDATION; DIAGNOSIS; LIFE; FEV6	Introduction and Objectives The underdiagnosis of chronic obstructive pulmonary disease (COPD) could be improved through screening using portable devices simpler than conventional spirometers in specific healthcare settings to reach a higher percentage of the at-risk population. This study was designed to assess the validity and reliability of the COPD-6 portable device to screen for COPD in non-specialized healthcare settings. Methods Prospective cohort study to validate a diagnostic test. Three cohorts were recruited: primary care (PC), emergency services (ES) and community pharmacies (CPh). Study population: individuals with risk factors for COPD (>40 years, smoking >10 pack-years, with respiratory symptoms). The values measured using the COPD-6 were FEV1, FEV6 and the FEV1/FEV6 ratio. Subsequently, participants underwent conventional spirometry at hospital, using a post-bronchodilator FEV1/FVC value <0.7 as the gold standard criterion for the COPD diagnosis. Results 437 participants were included, 362 were valid for the analysis. COPD was diagnosed in 114 patients (31.5%). The area under the ROC curve for the COPD-6 for COPD screening was 0.8. The best cut-off point for the FEV1/FEV6 ratio was 0.8 (sensitivity, 92.1%) using spirometry with the bronchodilator test as the gold standard. There were practically no differences in the COPD-6 performancein the different settings and also regarding age, gender and smoking status. Conclusions The COPD-6 device is a valid tool for COPD screening in non-specialized healthcare settings. In this context, the best cut-off point for the FEV1/FEV6 ratio is 0.8.	[Represas-Represas, Cristina; Fernandez-Villar, Alberto; Priegue-Carrera, Ana; Botana-Rial, Maribel] Univ Hosp Complex Vigo CHUVI, Estruct Org Xest Integrada Vigo EOXI Vigo, Pulmonol Dept NeumoVigoI Res Grp, Biomed Res Inst Vigo IBIV, Vigo, Spain; [Ruano-Ravina, Alberto] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Ruano-Ravina, Alberto] CIBERESP, CIBER Epidemiol & Salud Publ, Madrid, Spain	Complexo Hospitalario Universitario de Vigo; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Represas-Represas, C (corresponding author), Univ Hosp Complex Vigo CHUVI, Estruct Org Xest Integrada Vigo EOXI Vigo, Pulmonol Dept NeumoVigoI Res Grp, Biomed Res Inst Vigo IBIV, Vigo, Spain.	cristina.represas.represas@sergas.es	Ruano-Ravina, Alberto/M-5705-2018; Represas-Represas, Cristina/AAA-7143-2019	Ruano-Ravina, Alberto/0000-0001-9927-7453; Represas-Represas, Cristina/0000-0002-5908-6684; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249	Fundacion de la Sociedad Gallega de Patologia Respiratoria (SOGAPAR); European Union [316265]	Fundacion de la Sociedad Gallega de Patologia Respiratoria (SOGAPAR); European Union(European Commission)	This research was partially supported by Fundacion de la Sociedad Gallega de Patologia Respiratoria (SOGAPAR), and funding from the European Union Seventh Framework Programme [FP7/REGPOT-2012-2013.1] under grant agreement no 316265, BIOCAPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ARCHBRONCONEUMOL S1, V48, P1; Castillo D, 2015, RESP MED, V109, P475, DOI 10.1016/j.rmed.2015.02.009; Celli BR, 2015, EUR RESPIR J, V45, P879, DOI 10.1183/09031936.00009015; Diez JD, 2004, ARCH BRONCONEUMOL, V40, P431; Fernandez-Viltar A, 2005, PNEUMA, V2, P8; Frith P, 2011, PRIM CARE RESP J, V20, P190, DOI 10.4104/pcrj.2011.00040; Garcia-Rio F, 2013, ARCH BRONCONEUMOL, V49, P388, DOI 10.1016/j.arbres.2013.04.001; Jing JY, 2009, CHEST, V135, P991, DOI 10.1378/chest.08-0723; Kaufmann M, 2009, RESPIRATION, V78, P161, DOI 10.1159/000197466; Lopez Campos J L, 2013, CHEST, V144, P601, DOI [10.1378/chest.12-2690, DOI 10.1378/CHEST.12-2690]; Lopez Campos J L, 2014, ARCHBRONCONEUMOL, V50, P475; Ministerio de Sanidad y Politica Social, ESTR EPOC SIST NAC S; Miravitlles M, 2012, MED CLIN-BARCELONA, V139, P522, DOI 10.1016/j.medcli.2011.06.022; Perez-Padilla R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067960; Prats E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140855; Represas CR, 2010, ARCH BRONCONEUMOL, V46, P426, DOI 10.1016/j.arbres.2010.04.008; Represas-Represas C, 2013, ARCH BRONCONEUMOL, V49, P378, DOI 10.1016/j.arbres.2013.01.001; Schermer T, 2003, EUR RESPIR J, V22, P725, DOI 10.1183/09031936.03.00075203; Solidoro P, 2013, PANMINERVA MED, V55, P87; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Thorn J, 2012, PRIM CARE RESP J, V21, P159, DOI 10.4104/pcrj.2011.00104; van den Bemt L, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.33; Vial M, 2012, REV PNEUMOL CLIN, V68, P10, DOI 10.1016/j.pneumo.2011.06.009; Vollmer WM, 2009, EUR RESPIR J, V34, P588, DOI 10.1183/09031936.00164608	24	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145571	10.1371/journal.pone.0145571	http://dx.doi.org/10.1371/journal.pone.0145571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26726887	Green Submitted, Green Published, gold			2022-12-27	WOS:000367681500023
J	Zhang, ZY; Jiang, SH; Wang, N; Li, M; Ji, XH; Sun, SS; Liu, JX; Wang, DY; Xu, HF; Qi, SM; Wu, SJ; Fei, ZJ; Feng, SQ; Chen, XS				Zhang, Zongying; Jiang, Shenghui; Wang, Nan; Li, Min; Ji, Xiaohao; Sun, Shasha; Liu, Jingxuan; Wang, Deyun; Xu, Haifeng; Qi, Sumin; Wu, Shujing; Fei, Zhangjun; Feng, Shouqian; Chen, Xuesen			Identification of Differentially Expressed Genes Associated with Apple Fruit Ripening and Softening by Suppression Subtractive Hybridization	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SHELF-LIFE; ETHYLENE; MD-ACS1; COLD; BIOSYNTHESIS; MECHANISM; KIWIFRUIT; MUTATION; TEXTURE	Apple is one of the most economically important horticultural fruit crops worldwide. It is critical to gain insights into fruit ripening and softening to improve apple fruit quality and extend shelf life. In this study, forward and reverse suppression subtractive hybridization libraries were generated from 'Taishanzaoxia' apple fruits sampled around the ethylene climacteric to isolate ripening-and softening-related genes. A set of 648 unigenes were derived from sequence alignment and cluster assembly of 918 expressed sequence tags. According to gene ontology functional classification, 390 out of 443 unigenes (88%) were assigned to the biological process category, 356 unigenes (80%) were classified in the molecular function category, and 381 unigenes (86%) were allocated to the cellular component category. A total of 26 unigenes differentially expressed during fruit development period were analyzed by quantitative RT-PCR. These genes were involved in cell wall modification, anthocyanin biosynthesis, aroma production, stress response, metabolism, transcription, or were non-annotated. Some genes associated with cell wall modification, anthocyanin biosynthesis and aroma production were up-regulated and significantly correlated with ethylene production, suggesting that fruit texture, coloration and aroma may be regulated by ethylene in 'Taishanzaoxia'. Some of the identified unigenes associated with fruit ripening and softening have not been characterized in public databases. The results contribute to an improved characterization of changes in gene expression during apple fruit ripening and softening.	[Zhang, Zongying; Jiang, Shenghui; Wang, Nan; Li, Min; Ji, Xiaohao; Sun, Shasha; Liu, Jingxuan; Wang, Deyun; Xu, Haifeng; Wu, Shujing; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Zongying; Jiang, Shenghui; Wang, Nan; Li, Min; Ji, Xiaohao; Sun, Shasha; Liu, Jingxuan; Wang, Deyun; Xu, Haifeng; Wu, Shujing; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, Coll Hort Sci, Tai An, Shandong, Peoples R China; [Qi, Sumin] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Shandong Agricultural University; Shandong Agricultural University; Shandong Agricultural University; Cornell University; Boyce Thompson Institute for Plant Research	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Fei, Zhangjun/H-5152-2012; shi, zhensheng/GXN-3967-2022; Wang, Nan/GRY-3150-2022; Jiang, Shenghui/HHS-5691-2022	Jiang, Shenghui/0000-0003-3550-9037	Special Fund for Agro-scientific Research in the Public Interest of China [201303093]; Natural Science Foundation of China [31171932]; National Key Basic Research Program of China of the Ministry of Science and Technology and Agriculture of the People's Republic of China [2011CB100606]	Special Fund for Agro-scientific Research in the Public Interest of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China of the Ministry of Science and Technology and Agriculture of the People's Republic of China	This work was financially supported by the Special Fund for Agro-scientific Research in the Public Interest of China (to XSC, grant no. 201303093, http://www.most.gov.cn/), Natural Science Foundation of China (to XSC, grant no. 31171932, http://www.nsfc.gov.cn/), and National Key Basic Research Program of China (to XSC, grant no. 2011CB100606, http://www.most.gov.cn/) of the Ministry of Science and Technology and Agriculture of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-129; Atkinson RG, 2009, POSTHARVEST BIOL TEC, V51, P149, DOI 10.1016/j.postharvbio.2008.06.014; Bleecker AB, 1999, TRENDS PLANT SCI, V4, P269, DOI 10.1016/S1360-1385(99)01427-2; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; [曹佳强 Cao Jiaqiang], 2014, [分子植物育种, Molecular Plant Breeding], V12, P1034; [陈学森 Chen Xuesen], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P727; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Choudhury SR, 2010, PLANT CELL REP, V29, P813, DOI 10.1007/s00299-010-0866-0; Costa F, 2005, EUPHYTICA, V141, P181, DOI 10.1007/s10681-005-6805-4; Defilippi BG, 2005, J AGR FOOD CHEM, V53, P3133, DOI 10.1021/jf047892x; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Esteban-Garcia B, 2010, J PLANT PHYSIOL, V167, P1101, DOI 10.1016/j.jplph.2010.03.012; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fong WP, 2006, CELL MOL LIFE SCI, V63, P2881, DOI 10.1007/s00018-006-6089-4; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Gescher AJ, 2008, PLANTA MED, V74, P1523, DOI 10.1055/s-0028-1088300; Guo S, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL; Han SE, 2011, HORTIC ENVIRON BIOTE, V52, P413, DOI 10.1007/s13580-011-0213-6; Harb J, 2012, POSTHARVEST BIOL TEC, V64, P94, DOI 10.1016/j.postharvbio.2011.10.001; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Li M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058745, 10.1371/journal.pone.0078500, 10.1371/journal.pone.0059582, 10.1371/journal.pone.0079955]; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Lin XG, 2013, ACTA PHYSIOL PLANT, V35, P1997, DOI 10.1007/s11738-013-1238-5; Liu C C, 2011, PRILIMINARY STUDY SO; Liu Jin, 2012, Acta Horticulturae Sinica, V39, P1235; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Manrique-Trujillo SM, 2007, J PLANT PHYSIOL, V164, P1037, DOI 10.1016/j.jplph.2006.07.007; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Munoz-Bertomeu J, 2013, J PLANT PHYSIOL, V170, P1194, DOI 10.1016/j.jplph.2013.03.015; Ng JKT, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-183; Oraguzie NC, 2007, POSTHARVEST BIOL TEC, V44, P212, DOI 10.1016/j.postharvbio.2006.12.013; Palapol Y, 2009, PLANTA, V229, P1323, DOI 10.1007/s00425-009-0917-3; Payasi Anurag, 2009, Physiology and Molecular Biology of Plants, V15, P103, DOI 10.1007/s12298-009-0012-z; ROSS GS, 1994, PLANT PHYSIOL, V106, P521, DOI 10.1104/pp.106.2.521; Schaffer RJ, 2007, PLANT PHYSIOL, V144, P1899, DOI 10.1104/pp.106.093765; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Souleyre EJF, 2005, FEBS J, V272, P3132, DOI 10.1111/j.1742-4658.2005.04732.x; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang A, 2009, PLANT PHYSIOL, V151, P391, DOI 10.1104/pp.109.135822; Wang HaiBo, 2008, Acta Horticulturae Sinica, V35, P1419; Wang LX, 2013, EUR FOOD RES TECHNOL, V237, P875, DOI 10.1007/s00217-013-2055-1; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Zhang Bo, 2007, Acta Horticulturae Sinica, V34, P245; [张芮 Zhang Rui], 2015, [中国农业科学, Scientia Agricultura Sinica], V48, P3676; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453; Zhu YM, 2008, TREE GENET GENOMES, V4, P555, DOI 10.1007/s11295-007-0131-z	54	9	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146061	10.1371/journal.pone.0146061	http://dx.doi.org/10.1371/journal.pone.0146061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719904	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900040
J	Grottke, A; Ewald, F; Lange, T; Norz, D; Herzberger, C; Bach, J; Grabinski, N; Graser, L; Hoppner, F; Nashan, B; Schumacher, U; Jucker, M				Grottke, Astrid; Ewald, Florian; Lange, Tobias; Noerz, Dominik; Herzberger, Christiane; Bach, Johanna; Grabinski, Nicole; Graeser, Lareen; Hoeppner, Frank; Nashan, Bjoern; Schumacher, Udo; Juecker, Manfred			Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4	PLOS ONE			English	Article							TUMOR PROGRESSION; PROSTATE-CANCER; DISTINCT ROLES; E-CADHERIN; EXPRESSION; MICRORNAS; INVASION; MOTILITY; KINASE; ACTIVATION	Background Treatment of breast cancer patients with distant metastases represents one of the biggest challenges in today's gynecological oncology. Therefore, a better understanding of mechanisms promoting the development of metastases is of paramount importance. The serine/threonine kinase AKT was shown to drive cancer progression and metastasis. However, there is emerging data that single AKT isoforms (i.e. AKT1, AKT2 and AKT3) have different or even opposing functions in the regulation of cancer cell migration in vitro, giving rise to the hypothesis that inhibition of distinct AKT isoforms might have undesirable effects on cancer dissemination in vivo. Methods The triple negative breast cancer cell line MDA-MB-231 was used to investigate the functional roles of AKT in migration and metastasis. AKT single and double knockdown cells were generated using isoform specific shRNAs. Migration was analyzed using live cell imaging, chemotaxis and transwell assays. The metastatic potential of AKT isoform knockdown cells was evaluated in a subcutaneous xenograft mouse model in vivo. Results Depletion of AKT3, but not AKT1 or AKT2, resulted in increased migration in vitro. This effect was even more prominent in AKT2,3 double knockdown cells. Furthermore, combined downregulation of AKT2 and AKT3, as well as AKT1 and AKT3 significantly increased metastasis formation in vivo. Screening for promigratory proteins revealed that downregulation of AKT3 increases the expression of S100A4 protein. In accordance, depletion of S100A4 by siRNA approach reverses the increased migration induced by knockdown of AKT3. Conclusions We demonstrated that knockdown of AKT3 can increase the metastatic potential of triple negative breast cancer cells. Therefore, our results provide a rationale for the development of AKT isoform specific inhibitors.	[Grottke, Astrid; Noerz, Dominik; Herzberger, Christiane; Bach, Johanna; Grabinski, Nicole; Graeser, Lareen; Hoeppner, Frank; Juecker, Manfred] Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Signal Transduct, Ctr Med Expt, D-20246 Hamburg, Germany; [Ewald, Florian; Nashan, Bjoern] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, D-20246 Hamburg, Germany; [Lange, Tobias; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Dept Anat & Expt Morphol, Ctr Med Expt, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Jucker, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Signal Transduct, Ctr Med Expt, Martinistr 52, D-20246 Hamburg, Germany.	juecker@uke.de	Nashan, Björn/H-9087-2019; Lange, Tobias/K-8689-2015	Nashan, Björn/0000-0001-7587-9935; 	Hamburger Krebsgesellschaft e.V.	Hamburger Krebsgesellschaft e.V.	This study has been funded by the Hamburger Krebsgesellschaft e.V. (http://www.krebshamburg.de). FE is a fellow of the Faculty of Medicine, University of Hamburg (http://www.uke.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Castellanos-Martin A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0599-z; Che PL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08453; Chen M, 2011, AM J PHYSIOL-CELL PH, V300, pC1155, DOI 10.1152/ajpcell.00407.2010; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Chen N, 2014, BIOCHEM BIOPH RES CO, V447, P459, DOI 10.1016/j.bbrc.2014.04.025; Chin YR, 2014, CANCER RES, V74, P964, DOI 10.1158/0008-5472.CAN-13-2175; Chin YR, 2011, CELL ADHES MIGR, V5, P211, DOI 10.4161/cam.5.3.15790; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Chung S, 2013, ONCOGENE, V32, P422, DOI 10.1038/onc.2012.65; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Grabinski N, 2011, CELL SIGNAL, V23, P1952, DOI 10.1016/j.cellsig.2011.07.003; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Halterman JA, 2012, AM J PHYSIOL-CELL PH, V302, pC1, DOI 10.1152/ajpcell.00327.2011; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kim JH, 2009, ONCOL REP, V22, P41, DOI 10.3892/or_00000404; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuper C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00293; Lange T, 2012, CLIN CANCER RES, V18, P1364, DOI 10.1158/1078-0432.CCR-11-2900; Li JT, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0454-2; Linnerth-Petrik NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094595; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; McKenna LB, 2007, CELL MOL LIFE SCI, V64, P2723, DOI 10.1007/s00018-007-7247-z; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Nouraee N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073009; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Pedersen KB, BR J CANC, V87, P1281; Phung TL, 2015, CANCER RES, V75, P40, DOI 10.1158/0008-5472.CAN-13-2961; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sultana A, 2014, TRANSL ONCOL; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Virtakoivu R, 2012, MOL BIOL CELL, V23, P3357, DOI 10.1091/mbc.E12-03-0213; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang L, 2012, ACTA BIOCHIM POL, V59, P593; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1844; Xu M, 2012, CELL MOL LIFE SCI, V69, P3601, DOI 10.1007/s00018-012-1129-8; Yan XL, 2013, HEPATOLOGY, V57, P2274, DOI 10.1002/hep.26257; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zantl R, 2011, METHODS MOL BIOL, V769, P191, DOI 10.1007/978-1-61779-207-6_13; Zhou XM, 2013, AM J PHYSIOL-RENAL, V304, pF908, DOI 10.1152/ajprenal.00591.2012; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	52	45	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146370	10.1371/journal.pone.0146370	http://dx.doi.org/10.1371/journal.pone.0146370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741489	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600034
J	Iftikhar, R; Ashfaq, M; Rasool, A; Hebert, PDN				Iftikhar, Romana; Ashfaq, Muhammad; Rasool, Akhtar; Hebert, Paul D. N.			DNA Barcode Analysis of Thrips (Thysanoptera) Diversity in Pakistan Reveals Cryptic Species Complexes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MOLECULAR MARKERS; TABACI LINDEMAN; MELON THRIPS; IDENTIFICATION; INSECTA; POLYMORPHISM; LEPIDOPTERA; SEQUENCES; PRIMERS	Although thrips are globally important crop pests and vectors of viral disease, species identifications are difficult because of their small size and inconspicuous morphological differences. Sequence variation in the mitochondrial COI-5' (DNA barcode) region has proven effective for the identification of species in many groups of insect pests. We analyzed barcode sequence variation among 471 thrips from various plant hosts in north-central Pakistan. The Barcode Index Number (BIN) system assigned these sequences to 55 BINs, while the Automatic Barcode Gap Discovery detected 56 partitions, a count that coincided with the number of monophyletic lineages recognized by Neighbor-Joining analysis and Bayesian inference. Congeneric species showed an average of 19% sequence divergence (range = 5.6% -27%) at COI, while intraspecific distances averaged 0.6% (range = 0.0% - 7.6%). BIN analysis suggested that all intraspecific divergence >3.0% actually involved a species complex. In fact, sequences for three major pest species (Haplothrips reuteri, Thrips palmi, Thrips tabaci), and one predatory thrips (Aeolothrips intermedius) showed deep intraspecific divergences, providing evidence that each is a cryptic species complex. The study compiles the first barcode reference library for the thrips of Pakistan, and examines global haplotype diversity in four important pest thrips.	[Iftikhar, Romana; Ashfaq, Muhammad; Rasool, Akhtar] NIBGE, Faisalabad, Pakistan; [Ashfaq, Muhammad; Hebert, Paul D. N.] Univ Guelph, Ctr Biodivers Gen, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Pakistan Institute of Engineering & Applied Science; University of Guelph	Ashfaq, M (corresponding author), NIBGE, Faisalabad, Pakistan.	mashfaq@uoguelph.ca	Ashfaq, Muhammad/J-4723-2019	Ashfaq, Muhammad/0000-0003-1351-4126	Higher Education Commission Pakistan [20-1403/RD/09]; International Development Research Centre [106106001]; Government of Canada through Genome Canada; Ontario Genomics Institute	Higher Education Commission Pakistan(Higher Education Commission of Pakistan); International Development Research Centre; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This study was partly supported by the Higher Education Commission Pakistan by fellowship grant to RI and research grant (20-1403/R&D/09) to MA. PDNH was supported by International Development Research Centre (grant no. 106106001), and a grant from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life (iBOL) project.	Akram Waseem, 2003, Korean Journal of Entomology, V33, P53; Akram Waseem, 2002, Korean Journal of Entomology, V32, P251, DOI 10.1111/j.1748-5967.2002.tb00038.x; Akram Waseem, 2003, Korean Journal of Entomology, V33, P277, DOI 10.1111/j.1748-5967.2003.tb00082.x; Ali R., 1976, THESIS, P247; Ananthakrishnan TN, 2007, CURR SCI INDIA, V92, P1083; [Anonymous], 2010, J CELL MOL RES; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104485; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097268; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Asokan R, 2007, B ENTOMOL RES, V97, P461, DOI 10.1017/S0007485307005147; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bradley S. J., 1994, Journal of the Entomological Society of British Columbia, V91, P63; Brunner PC, 2002, AGR FOREST ENTOMOL, V4, P127, DOI 10.1046/j.1461-9563.2002.00132.x; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Buckman RS, 2013, SYST ENTOMOL, V38, P123, DOI 10.1111/j.1365-3113.2012.00650.x; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; Crespi B, 1996, SYST ENTOMOL, V21, P79; Dellicour S, 2015, SYST BIOL, V64, P900, DOI 10.1093/sysbio/syu130; Dickey AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123747; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Glover RH, 2010, MOL ECOL RESOUR, V10, P51, DOI 10.1111/j.1755-0998.2009.02723.x; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Triana LM, 2015, ZOOTAXA, V3936, P93, DOI 10.11646/zootaxa.3936.1.5; Hoddle MS, 2008, ANN ENTOMOL SOC AM, V101, P491, DOI 10.1603/0013-8746(2008)101[491:RASOST]2.0.CO;2; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar V, 2014, APPL ENTOMOL ZOOL, V49, P403, DOI 10.1007/s13355-014-0262-2; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mainali Bishwo Prasad, 2008, Journal of Asia-Pacific Entomology, V11, P45, DOI 10.1016/j.aspen.2008.03.001; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz G, 2001, THRIPS ID PEST THRIP; Mound LA, 2005, ANNU REV ENTOMOL, V50, P247, DOI 10.1146/annurev.ento.49.061802.123318; Muhammad Saeed, 1994, Pakistan Entomologist, V16, P59; Murai T., 2001, P 7 INT S THYS REGG, P377; Mutanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047214; Palmer JM, 1992, B BR MUS NAT HIS E, P61; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Prevot V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060736; Przybylska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122033; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Qiao Wei-Na, 2012, Acta Entomologica Sinica, V55, P344; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rebijith KB, 2014, FLA ENTOMOL, V97, P1328, DOI 10.1653/024.097.0407; ROSEN D, 1986, AGR ECOSYST ENVIRON, V15, P121, DOI 10.1016/0167-8809(86)90085-X; Roy V, 2014, MOL ECOL, V23, P902, DOI 10.1111/mec.12641; Rugman-Jones PF, 2010, J ECON ENTOMOL, V103, P877, DOI 10.1603/EC09300; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schon I, 2000, HEREDITY, V84, P161, DOI 10.1046/j.1365-2540.2000.00647.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toda S, 2002, B ENTOMOL RES, V92, P359, DOI 10.1079/BER2002177; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; Tyagi K, 2008, INSECT SYST EVOL, V39, P155, DOI 10.1163/187631208788784093; Umar Muhammad, 2004, Entomological Research, V34, P55, DOI 10.1111/j.1748-5967.2004.tb00091.x; Vaglia T, 2008, ZOOTAXA, P18, DOI 10.11646/zootaxa.1923.1.2; van Nieukerken EJ, 2012, CONTRIB ZOOL, V81, P1; Van Riel P, 2005, MOL PHYLOGENET EVOL, V37, P132, DOI 10.1016/j.ympev.2005.03.019; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Vitousek PM, 1996, AM SCI, V84, P468; Walsh K, 2005, J APPL ENTOMOL, V129, P272, DOI 10.1111/j.1439-0418.2005.00960.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Yong Hoi Sen, 2014, Sci Rep, V4, P5553, DOI 10.1038/srep05553; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zawirska I., 1976, Archiv fur Phytopathologie und Pflanzenschutz, V12, P411, DOI 10.1080/03235407609431780	77	37	38	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146014	10.1371/journal.pone.0146014	http://dx.doi.org/10.1371/journal.pone.0146014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741134	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600018
J	Lauhkonen, E; Koponen, P; Vuononvirta, J; Terasjarvi, J; Nuolivirta, K; Toikka, JO; Helminen, M; He, QS; Korppi, M				Lauhkonen, Eero; Koponen, Petri; Vuononvirta, Juho; Terasjarvi, Johanna; Nuolivirta, Kirsi; Toikka, Jyri O.; Helminen, Merja; He, Qiushui; Korppi, Matti			Gene Polymorphism of Toll-Like Receptors and Lung Function at Five to Seven Years of Age after Infant Bronchiolitis	PLOS ONE			English	Article							IMPULSE OSCILLOMETRY; PRESCHOOL-CHILDREN; YOUNG-CHILDREN; ASTHMA; RISK; RECOGNITION; ASSOCIATION; INFECTION; SUBFAMILY; IMPEDANCE	Aim Toll-like receptors (TLR) play a crucial role in innate immunity, protecting the host from pathogens such as viruses. Genetic variations in TLRs have been associated with the severity of viral bronchiolitis in infancy and with the later occurrence of post-bronchiolitis asthma. The aim of the present study was to evaluate if there are any exploratory associations between TLR gene polymorphisms and lung function at 5 to 7 years of age in former bronchiolitis patients. Methods We performed impulse oscillometry (IOS) at the median age of 6.3 years for 103 children who had been hospitalized for bronchiolitis at less than six months of age. The main parameters evaluated were airway resistance and reactance at 5Hz in baseline and post-exercise measurements. Data on single nucleotide polymorphisms (SNP) of TLR1 rs5743618, TLR2 rs5743708, TLR6 rs5743810 and TLR10 rs4129009 (TLR2 subfamily) and TLR3 rs3775291, TLR4 rs4986790, TLR7 rs179008, TLR8 rs2407992 and TLR 9 rs187084 were available for analyses. Results The TLR4 rs4986790 wild genotype A/A was associated with a greater Rrs5 response (0.72 vs. -0.42, p = 0.03) to exercise. In TLR6 rs5743810, the minor allele T was associated with greater Rrs5 response (0.80 vs. -0.03, p = 0.04) to exercise. In TLR7 rs179008, the major allele A was associated with baseline decline in dRrs/df (-1.03 vs 0.61, p = 0.01) and increased Fres (2.28 vs. 0.89, p = 0.01) in girls. Conclusion Among the nine studied TLRs, only TLR7 rs179008 showed some exploratory associations with post-bronchiolitis lung function deficiency, and polymorphisms of TLR4 rs4986790, and TLR6 rs5743810 in particular, with airway reactivity. These findings call for further confirmatory studies.	[Lauhkonen, Eero; Koponen, Petri; Helminen, Merja; Korppi, Matti] Tampere Univ, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Lauhkonen, Eero; Koponen, Petri; Helminen, Merja; Korppi, Matti] Tampere Univ Hosp, Tampere, Finland; [Vuononvirta, Juho; Terasjarvi, Johanna; He, Qiushui] Turku Univ, Dept Med Microbiol & Immunol, Turku, Finland; [Vuononvirta, Juho; Terasjarvi, Johanna; He, Qiushui] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland; [Nuolivirta, Kirsi] Seinajoki Cent Hosp, Seinajoki, Finland; [Toikka, Jyri O.] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Toikka, Jyri O.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Turku; Finland National Institute for Health & Welfare; Seinajoki Central Hospital; Tampere University; Tampere University Hospital; University of Turku	Lauhkonen, E (corresponding author), Tampere Univ, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	eero.lauhkonen@fimnet.fi		Lauhkonen, Eero/0000-0003-4654-7602				Ahmad-Nejad Parviz, 2009, V496, P73, DOI 10.1007/978-1-59745-553-4_7; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Etem EO, 2011, RHEUMATOL INT, V31, P1369, DOI 10.1007/s00296-010-1472-8; Grondahl-Yli-Hannuksela K, 2012, J INFECT DIS, V205, P1214, DOI 10.1093/infdis/jis182; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Helminen M, 2008, PEDIATR PULM, V43, P391, DOI 10.1002/ppul.20793; Klaassen EMM, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-10; Koponen P, 2012, EUR RESPIR J, V39, P76, DOI 10.1183/09031936.00040211; Koponen P, 2014, PEDIATR INFECT DIS J, V33, P463, DOI 10.1097/INF.0000000000000253; Lauhkonen E, 2015, PEDIATR PULM, V50, P389, DOI 10.1002/ppul.23039; Malmberg LP, 2008, PEDIATR PULM, V43, P538, DOI 10.1002/ppul.20805; Malmberg LP, 2002, CLIN PHYSIOL FUNCT I, V22, P64, DOI 10.1046/j.1365-2281.2002.00396.x; Marotta A, 2003, J ALLERGY CLIN IMMUN, V112, P317, DOI 10.1067/mai.2003.1627; Moller-Larsen S, 2008, THORAX, V63, P1064, DOI 10.1136/thx.2007.094128; Nuolivirta K, 2012, PEDIATR INFECT DIS J, V31, P920, DOI 10.1097/INF.0b013e31825aff25; Nuolivirta K, 2009, PEDIATR INFECT DIS J, V28, P1121, DOI 10.1097/INF.0b013e3181af37ee; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Prefontaine D, 2010, CLIN EXP ALLERGY, V40, P1648, DOI 10.1111/j.1365-2222.2010.03570.x; Pruikkonen H, 2014, ACTA PAEDIATR, V103, P1089, DOI 10.1111/apa.12704; Ramet M, 2011, PEDIATR PULM, V46, P101, DOI 10.1002/ppul.21348; Smith H, 2005, EUR RESP SOC MONOGR, V31, P75; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Streiner DL, 2015, AM J CLIN NUTR, V102, P721, DOI 10.3945/ajcn.115.113548; Tapping RI, 2007, BIOCHEM SOC T, V35, P1445, DOI 10.1042/BST0351445; Vuononvirta J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026198	34	17	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146526	10.1371/journal.pone.0146526	http://dx.doi.org/10.1371/journal.pone.0146526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741133	Green Published, gold, Green Submitted			2022-12-27	WOS:000367810600053
J	Reyes-Garcia, V; Pyhala, A; Diaz-Reviriego, I; Duda, R; Fernandez-Llamazares, A; Gallois, S; Gueze, M; Napitupulu, L				Reyes-Garcia, Victoria; Pyhala, Aili; Diaz-Reviriego, Isabel; Duda, Romain; Fernandez-Llamazares, Alvaro; Gallois, Sandrine; Gueze, Maximilien; Napitupulu, Lucentezza			Schooling, Local Knowledge and Working Memory: A Study among Three Contemporary Hunter-Gatherer Societies	PLOS ONE			English	Article							MAIZE DIVERSITY; RAIN-FOREST; INTELLIGENCE; AGRICULTURE; COGNITION; CULTURE; CHIAPAS; LIFE	Researchers have analysed whether school and local knowledge complement or substitute each other, but have paid less attention to whether those two learning models use different cognitive strategies. In this study, we use data collected among three contemporary hunter-gatherer societies with relatively low levels of exposure to schooling yet with high levels of local ecological knowledge to test the association between i) schooling and ii) local ecological knowledge and verbal working memory. Participants include 94 people (24 Baka, 25 Punan, and 45 Tsimane') from whom we collected information on 1) schooling and school related skills (i.e., literacy and numeracy), 2) local knowledge and skills related to hunting and medicinal plants, and 3) working memory. To assess working memory, we applied a multi-trial free recall using words relevant to each cultural setting. People with and without schooling have similar levels of accurate and inaccurate recall, although they differ in their strategies to organize recall: people with schooling have higher results for serial clustering, suggesting better learning with repetition, whereas people without schooling have higher results for semantic clustering, suggesting they organize recall around semantically meaningful categories. Individual levels of local ecological knowledge are not related to accurate recall or organization recall, arguably due to overall high levels of local ecological knowledge. While schooling seems to favour some organization strategies this might come at the expense of some other organization strategies.	[Reyes-Garcia, Victoria] ICREA, Barcelona, Spain; [Reyes-Garcia, Victoria; Pyhala, Aili; Diaz-Reviriego, Isabel; Duda, Romain; Fernandez-Llamazares, Alvaro; Gallois, Sandrine; Gueze, Maximilien; Napitupulu, Lucentezza] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, E-08193 Barcelona, Spain; [Pyhala, Aili; Fernandez-Llamazares, Alvaro] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Gallois, Sandrine] Museum Natl Hist Nat, F-75231 Paris, France	ICREA; Autonomous University of Barcelona; University of Helsinki; Museum National d'Histoire Naturelle (MNHN)	Reyes-Garcia, V (corresponding author), ICREA, Barcelona, Spain.	Victoria.reyes@uab.cat	Fernández-Llamazares, Álvaro/ABA-6096-2021; Gallois, Sandrine/AAG-4964-2019; Duda, Romain/ABD-9678-2020; /C-4552-2008	Gallois, Sandrine/0000-0002-4354-7685; Fernandez-Llamazares, Alvaro/0000-0002-7813-0222; Pyhala, Aili/0000-0001-7095-5994; Gueze, Maximilien/0000-0002-1402-6004; /0000-0002-2914-8055; Diaz-Reviriego, Isabel/0000-0002-0665-3833; Napitupulu, Lucentezza/0000-0003-1923-6921	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7) / ERC grant [FP7-261971-LEK]; ICREA Funding Source: Custom	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7) / ERC grant; ICREA(ICREA)	The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no. FP7-261971-LEK to Reyes-Garcia.	Acheson DJ, 2009, PSYCHOL BULL, V135, P50, DOI 10.1037/a0014411; Ardila A, 2000, J INT NEUROPSYCH SOC, V6, P789, DOI 10.1017/S1355617700677068; Ardila A, 2010, ARCH CLIN NEUROPSYCH, V25, P689, DOI 10.1093/arclin/acq079; BAHUCHET S, 1991, HUM ECOL, V19, P213, DOI 10.1007/BF00888746; Bahuchet S., 1991, J AFRICANISTES, V61, P5; Bank W, 1998, INDONESIA ED INDONES; Barltlett FC., 1932, REMEMBERING; Bentley JW, 2001, CURR ANTHROPOL, V42, P285, DOI 10.1086/320010; Benz B, 2007, CURR ANTHROPOL, V48, P289, DOI 10.1086/512986; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Berl REW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120180; BERLIN B, 1966, SCIENCE, V154, P273, DOI 10.1126/science.154.3746.273; Bernard H. R., 2017, RES METHODS ANTHR; Bonjour D, 2003, AM ECON REV, V93, P1799, DOI 10.1257/000282803322655554; Callaghan Tara, 2011, Monogr Soc Res Child Dev, V76, pvii, DOI 10.1111/j.1540-5834.2011.00603.x; Carlsson M, 2012, 18484 NBER; Carlsson M, EFFECT SCH COGNITIVE; Cole M., 1974, CULTURE THOUGHT; CORNELIUS SW, 1987, PSYCHOL AGING, V2, P144, DOI 10.1037/0882-7974.2.2.144; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Demps K, 2012, EVOL HUM BEHAV, V33, P460, DOI 10.1016/j.evolhumbehav.2011.12.008; Downey G, 2010, J ROY ANTHROPOL INST, V16, pS22, DOI 10.1111/j.1467-9655.2010.01608.x; Eilenberg Michael, 2005, BORNEO RES B, V36, P163; Gallois S, J ETHNOBIOL IN PRESS; Gallois S, THESIS; Gomez-Baggethun E, 2013, ECOL SOC, V18, DOI 10.5751/ES-06288-180472; Gutchess AH, 2009, PROG BRAIN RES, V178, P137, DOI 10.1016/S0079-6123(09)17809-3; Hernandez-Zavala M., 2006, QUALITY SCH QUALITY; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; Howard R, 2009, INT J EDUC DEV, V29, P583, DOI 10.1016/j.ijedudev.2008.11.003; Huntington H, 2004, AMBIO, P18; Kaskija L., 2012, IMAGES FOREST PEOPLE; Kosmidis MH, 2011, ARCH CLIN NEUROPSYCH, V26, P575, DOI 10.1093/arclin/acr063; LECLERC C, 2012, ADOPTION AGR CHEZ PY; Levang P, 2007, ECOL SOC, V12; Lim YY, 2012, ARCH CLIN NEUROPSYCH, V27, P136, DOI 10.1093/arclin/acr102; Limberg G, 2005, PROFIL DESA DESA KAB; Mantilla Maria Dolores Castro, 1997, VIVA VOZ TRIBUS TRAB; Marchand THJ, 2010, J ROY ANTHROPOL INST, V16, pS1, DOI 10.1111/j.1467-9655.2010.01607.x; Marchand THJ, 2010, J ROY ANTHROPOL INST, V16, pS100, DOI 10.1111/j.1467-9655.2010.01612.x; McCarter J, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-38; McDade TW, 2007, P NATL ACAD SCI USA, V104, P6134, DOI 10.1073/pnas.0609123104; Morelli GA, 2003, INT J BEHAV DEV, V27, P264, DOI 10.1080/01650250244000335; Morsello C, 2013, LEARN INDIVID DIFFER, V27, P223, DOI 10.1016/j.lindif.2013.03.005; Muhlenweg A, 2012, ECON EDUC REV, V31, P68, DOI 10.1016/j.econedurev.2012.02.004; OECD/Statistics, 2000, LIT INF AG; Ostrosky-Solis F, 1998, ARCH CLIN NEUROPSYCH, V13, P645, DOI 10.1016/S0887-6177(97)00094-2; Paradise R, 2009, ETHOS, V37, P102, DOI 10.1111/j.1548-1352.2009.01033.x; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Puri R., 2013, UNDIERSTANDING CULTU; Reyes-Garcia V., CURRENT ANT IN PRESS; Reyes-Garcia V, 2007, AMBIO, V36, P406, DOI 10.1579/0044-7447(2007)36[406:ESACOT]2.0.CO;2; Reyes-Garcia V, 2016, FIELD METHOD, V28, P345, DOI 10.1177/1525822X16629912; Reyes-Garcia V, 2014, J RURAL STUD, V34, P282, DOI 10.1016/j.jrurstud.2014.02.007; Reyes-Garcia V, 2010, INT J EDUC DEV, V30, P305, DOI 10.1016/j.ijedudev.2009.11.007; Reyes-Garcia V, 2009, EVOL HUM BEHAV, V30, P274, DOI 10.1016/j.evolhumbehav.2009.02.001; Reyes-Garcia Victoria, 2007, Journal of Ethnobiology, V27, P182, DOI 10.2993/0278-0771(2007)27[182:CAMISM]2.0.CO;2; ROGOFF B, 1982, CHILD DEV, V53, P1224, DOI 10.1111/j.1467-8624.1982.tb04158.x; Ross Norbert, 2005, FIELD METHOD, V17, P131; Rule NO, 2013, SOC NEUROSCI-UK, V8, P3, DOI 10.1080/17470919.2012.695293; Schank R. C., 1995, ADV SOCIAL COGNITION, P1, DOI [DOI 10.5860/CHOICE.33-3602, 10.5860/choice.33-3602]; Shelton JT, 2010, J EXP PSYCHOL LEARN, V36, P813, DOI 10.1037/a0019046; Sternberg RJ, 2001, INTELLIGENCE, V29, P401, DOI 10.1016/S0160-2896(01)00065-4; Vadez V, 2008, HUM ORGAN, V67, P384, DOI 10.17730/humo.67.4.45164623415rp7n8; Weller S. C., 1998, HDB METHODS CULTURAL, P365; Wolfe B., 2001, ACCOUNTING SOCIAL NO; Yassuda MS, 2009, ARCH CLIN NEUROPSYCH, V24, P71, DOI 10.1093/arclin/acp009; Zahodne LB, J WOS; Zarger R. K., 2010, ANTHR LEARNING CHILD, P341	69	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145265	10.1371/journal.pone.0145265	http://dx.doi.org/10.1371/journal.pone.0145265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XE	26735297	Green Submitted, Green Published, gold			2022-12-27	WOS:000367805100022
J	Bardien, N; Whitehead, CL; Tong, S; Ugoni, A; McDonald, S; Walker, SP				Bardien, Nadia; Whitehead, Clare L.; Tong, Stephen; Ugoni, Antony; McDonald, Susan; Walker, Susan P.			Placental Insufficiency in Fetuses That Slow in Growth but Are Born Appropriate for Gestational Age: A Prospective Longitudinal Study	PLOS ONE			English	Article							UMBILICAL ARTERY DOPPLER; FETAL-GROWTH; BIRTH-WEIGHT; REFERENCE RANGES; PREDICTION; COMPROMISE; TERM; IDENTIFICATION; STILLBIRTHS; RATIO	Objectives To determine whether fetuses that slow in growth but are then born appropriate for gestational age (AGA, birthweight >10th centile) demonstrate ultrasound and clinical evidence of placental insufficiency. Methods Prospective longitudinal study of 48 pregnancies reaching term and a birthweight >10th centile. We estimated fetal weight by ultrasound at 28 and 36 weeks, and recorded birthweight to determine the relative change in customised weight across two timepoints: 28-36 weeks and 28 weeks-birth. The relative change in weight centiles were correlated with fetoplacental Doppler findings performed at 36 weeks. We also examined whether a decline in growth trajectory in fetuses born AGA was associated with operative deliveries performed for suspected intrapartum compromise. Results The middle cerebral artery pulsatility index (MCA-PI) showed a linear association with fetal growth trajectory. Lower MCA-PI readings (reflecting greater diversion of blood supply to the brain) were significantly associated with a decline in fetal growth, both between 28-36 weeks (p = 0.02), and 28 weeks-birth (p = 0.0002). The MCA-PI at 36 weeks was significantly higher among those with a relative weight centile fall <20%, compared to those with a moderate centile fall of 20-30% (mean MCA-PI 1.94 vs 1.61; p<0.05), or severe centile fall of >30% (mean MCA-PI 1.94 vs 1.56; p<0.01). Of 43 who labored, operative delivery for suspected intrapartum fetal compromise was required in 12 cases; 9/18 (50%) cases where growth slowed, and 3/25 (12%) where growth trajectory was maintained (p = 0.01). Conclusions Slowing in growth across the third trimester among fetuses subsequently born AGA was associated with ultrasound and clinical features of placental insufficiency. Such fetuses may represent an under-recognised cohort at increased risk of stillbirth.	[Bardien, Nadia; Whitehead, Clare L.; Tong, Stephen; Walker, Susan P.] Mercy Hosp Women, Dept Perinatal Med, Melbourne, Vic, Australia; [Walker, Susan P.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Whitehead, Clare L.; Tong, Stephen] Univ Melbourne, Translat Obstet Grp, Melbourne, Vic, Australia; [Ugoni, Antony] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia; [Bardien, Nadia; McDonald, Susan] La Trobe Univ, Mercy Hosp Women, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; La Trobe University	Walker, SP (corresponding author), Mercy Hosp Women, Dept Perinatal Med, Melbourne, Vic, Australia.	spwalker@unimelb.edu.au		Tong, Stephen/0000-0002-2319-0586	National Health and Medical Research Council [1065854]; Career Development Fellowship [1050765]; Medical Research Foundation for Women and Babies	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Career Development Fellowship; Medical Research Foundation for Women and Babies	Support was provided by the National Health and Medical Research Council: Project Grant 1065854 (to SW) and Career Development Fellowship 1050765 (to ST), and by the Medical Research Foundation for Women and Babies (to SW).	Acharya G, 2005, AM J OBSTET GYNECOL, V192, P937, DOI 10.1016/j.ajog.2004.09.019; Akolekar R, 2015, ULTRASOUND OBST GYN, V46, P82, DOI 10.1002/uog.14842; Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007529.pub3; Baschat AA, 2010, J PERINAT MED, V38, P239, DOI [10.1515/JPM.2010.041, 10.1515/jpm.2010.041]; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Cruz-Martinez R, 2011, OBSTET GYNECOL, V117, P618, DOI 10.1097/AOG.0b013e31820b0884; de Jong CLD, 1999, ULTRASOUND OBST GYN, V13, P86, DOI 10.1046/j.1469-0705.1999.13020086.x; Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088; Francis A., CUSTOMISED WEIGHT CE; Francis JH, 2014, AUST NZ J OBSTET GYN, V54, P354, DOI 10.1111/ajo.12205; Fu J, 2011, ACTA OBSTET GYN SCAN, V90, P227, DOI 10.1111/j.1600-0412.2010.01042.x; Gardosi J, 2009, AM J OBSTET GYNECOL, V28, pe1, DOI DOI 10.1016/J.AJ0G.2009.04.034; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Hershkovitz R, 2000, ULTRASOUND OBST GYN, V15, P209, DOI 10.1046/j.1469-0705.2000.00079.x; Husslein H, 2012, J PERINAT MED, V0, P1; Illa M, 2009, J PERINAT MED, V37, P48, DOI 10.1515/JPM.2009.003; Iraola A, 2008, J PERINAT MED, V36, P531, DOI 10.1515/JPM.2008.100; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; Marconi AM, 2008, OBSTET GYNECOL, V112, P1227, DOI 10.1097/AOG.0b013e31818bdc7e; McCowan LME, 2000, BRIT J OBSTET GYNAEC, V107, P916, DOI 10.1111/j.1471-0528.2000.tb11092.x; Murata S, 2011, J OBSTET GYNAECOL RE, V37, P1433, DOI 10.1111/j.1447-0756.2011.01563.x; Odibo AO, 2011, J MATERN-FETAL NEO M, V24, P411, DOI 10.3109/14767058.2010.506566; Oros D, 2011, ULTRASOUND OBST GYN, V37, P191, DOI 10.1002/uog.7738; Prior T, 2014, OBSTET GYNECOL, V123, P1263, DOI 10.1097/AOG.0000000000000292; Royal College of Obstetricians and Gynaecologists, GREEN TOP GUID 31 IN; Sabdia S, 2015, PLACENTA, V36, P594, DOI 10.1016/j.placenta.2015.01.200; Schuit E, 2012, BJOG-INT J OBSTET GY, V119, P915, DOI 10.1111/j.1471-0528.2012.03334.x; Severi FM, 2002, ULTRASOUND OBST GYN, V19, P225, DOI 10.1046/j.1469-0705.2002.00652.x; Singh T, 2008, J OBSTET GYNAECOL, V28, P779, DOI 10.1080/01443610802431857; Smith-Bindman R, 2002, RADIOLOGY, V223, P153, DOI 10.1148/radiol.2231010876; Vashevnik S, 2007, AUST NZ J OBSTET GYN, V47, P302, DOI 10.1111/j.1479-828X.2007.00742.x	31	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0142788	10.1371/journal.pone.0142788	http://dx.doi.org/10.1371/journal.pone.0142788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730589	Green Published, gold			2022-12-27	WOS:000367801400005
J	Choi, KH; Yang, JH; Kim, JH; Song, YB; Hahn, JY; Choi, JH; Gwon, HC; Lee, SH; Choi, SH				Choi, Ki Hong; Yang, Jeong Hoon; Kim, Ji Hwan; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin-Ho; Gwon, Hyeon-Cheol; Lee, Sang Hoon; Choi, Seung-Hyuk			The Impact of Renal Dysfunction on the Long Term Clinical Outcomes of Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES; SERUM CREATININE; MORTALITY; RISK; INSUFFICIENCY; THROMBOSIS; PROGNOSIS; PROTEINURIA	Background Limited data are available regarding the association between renal dysfunction and clinical outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) in the drug-eluting stent (DES) era. Methods Between March 2003 and December 2010, 2,181 diabetic patients were enrolled in a single- center registry. We divided diabetic patients into a renal dysfunction group (n = 518) and a non-renal dysfunction group (n = 1,663) according to a baseline estimated glomerular filtration rate <60 mL/min/1.73 m(2). Propensity score matching analysis was also performed. The primary outcome was cardiac death. Results The median follow-up duration was 48 months. The rate of cardiac death was higher in the renal dysfunction group than in the non-renal dysfunction group (14.3% vs. 3.0%, adjusted hazard ratio [HR] 3.63, 95% confidence interval [CI] 2.47 to 5.35, p<0.001). Similarly, the incidence of stent thrombosis was significantly higher in the renal dysfunction group than in the non-renal dysfunction group (4.1% vs. 1.4%, adjusted HR 1.90, 95% CI 1.02 to 3.56, p = 0.04). After 1: 1 propensity score matching (502 pairs), patients with renal dysfunction still had a higher rate of cardiac death (13.3% vs. 4.8%, HR 2.58, 95% CI 1.52 to 4.38, p<0.001) although there was no significant difference in the rate of stent thrombosis (4.0% vs. 2.8%, HR 1.31, 95% CI 0.64 to 2.69, p = 0.47). Conclusions Renal dysfunction is associated with long-term mortality for diabetic patients undergoing PCI in the DES era.	[Choi, Ki Hong; Yang, Jeong Hoon; Kim, Ji Hwan; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin-Ho; Gwon, Hyeon-Cheol; Lee, Sang Hoon; Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Choi, Jin-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul, South Korea.	sh1214.choi@samsung.com	Hahn, Joo-Yong/AAU-7250-2020	Hahn, Joo-Yong/0000-0002-4412-377X; Choi, Ki Hong/0000-0001-7511-9581				Angiolillo DJ, 2010, J AM COLL CARDIOL, V55, P1139, DOI 10.1016/j.jacc.2009.10.043; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; CASTILLO R, 1986, BLOOD, V68, P337; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057; Goto K, 2008, INTERNAL MED, V47, P907, DOI 10.2169/internalmedicine.47.0932; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hojs R, 2003, RENAL FAILURE, V25, P247, DOI 10.1081/JDI-120018725; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Lambert ND, 2009, AM HEART J, V157, P688, DOI 10.1016/j.ahj.2009.01.009; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mezzano D, 1996, THROMB HAEMOSTASIS, V76, P312; Morel O, 2011, J AM COLL CARDIOL, V57, P399, DOI 10.1016/j.jacc.2010.09.032; Naidu SS, 2003, AM J CARDIOL, V92, P1160, DOI 10.1016/j.amjcard.2003.07.023; Nikolsky E, 2004, AM J CARDIOL, V94, P300, DOI 10.1016/j.amjcard.2004.04.023; Nodari S, 2012, EUR J CLIN INVEST, V42, P376, DOI 10.1111/j.1365-2362.2011.02593.x; Reeder GS, 2002, AM J CARDIOL, V89, P760, DOI 10.1016/S0002-9149(01)02350-5; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Wattanakit K, 2008, J AM SOC NEPHROL, V19, P135, DOI 10.1681/ASN.2007030308; Yeh RW, 2015, J AM COLL CARDIOL, V65, P787, DOI 10.1016/j.jacc.2015.01.004; Zhang RY, 2009, INT J CARDIOL, V136, P72, DOI 10.1016/j.ijcard.2008.04.028	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0141846	10.1371/journal.pone.0141846	http://dx.doi.org/10.1371/journal.pone.0141846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731526	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400002
J	Guo, LJ; Lin, S; Liu, TQ; Cao, CG; Li, CF				Guo, Li-Jin; Lin, Shan; Liu, Tian-Qi; Cao, Cou-Gui; Li, Cheng-Fang			Effects of Conservation Tillage on Topsoil Microbial Metabolic Characteristics and Organic Carbon within Aggregates under a Rice (Oryza sativa L.) -Wheat (Triticum aestivum L.) Cropping System in Central China	PLOS ONE			English	Article							PARTICLE-SIZE FRACTIONS; COMMUNITY COMPOSITION; FUNCTIONAL DIVERSITY; RESIDUE MANAGEMENT; SOIL AGGREGATION; MATTER; FERTILIZATION; SEQUESTRATION; DYNAMICS; BIOMASS	Investigating microbial metabolic characteristics and soil organic carbon (SOC) within aggregates and their relationships under conservation tillage may be useful in revealing the mechanism of SOC sequestration in conservation tillage systems. However, limited studies have been conducted to investigate the relationship between SOC and microbial metabolic characteristics within aggregate fractions under conservation tillage. We hypothesized that close relationships can exist between SOC and microbial metabolic characteristics within aggregates under conservation tillage. In this study, a field experiment was conducted from June 2011 to June 2013 following a split-plot design of a randomized complete block with tillage practices [conventional intensive tillage (CT) and no tillage (NT)] as main plots and straw returning methods [preceding crop residue returning (S, 2100-2500 kg C ha(-1)) and removal (NS, 0 kg C ha(-1))] as subplots with three replications. The objective of this study was to reveal the effects of tillage practices and residue-returning methods on topsoil microbial metabolic characteristics and organic carbon (SOC) fractions within aggregates and their relationships under a rice-wheat cropping system in central China. Microbial metabolic characteristics investigated using the Biolog system was examined within two aggregate fractions (>0.25 and <0.25 mm). NT treatments significantly increased SOC concentration of bulk soil, >0.25 aggregate, and <0.25 mm aggregate in the 0-5 cm soil layer by 5.8%, 6.8% and 7.9% relative to CT treatments, respectively. S treatments had higher SOC concentration of bulk soil (12.9%), >0.25 mm aggregate (11.3%), and <0.25 mm aggregate (14.1%) than NS treatments. Compared with CT treatments, NT treatments increased MBC by 11.2%, 11.5%, and 20%, and dissolved organic carbon (DOC) concentration by 15.5%, 29.5%, and 14.1% of bulk soil, >0.25 mm aggregate, and <0.25 mm aggregate in the 0-5 cm soil layer, respectively. Compared with NS treatments, S treatments significantly increased MBC by 29.8%, 30.2%, and 24.1%, and DOC concentration by 23.2%, 25.0%, and 37.5% of bulk soil, >0.25 mm aggregate, and <0.25 mm aggregate in the 0-5 cm soil layer, respectively. Conservation tillage (NT and S) increased microbial metabolic activities and Shannon index in >0.25 and <0.25 mm aggregates in the 0-5 cm soil layer. Redundancy analysis showed that the SOC and its fractions (DOC and MBC) were closely correlated with microbial metabolic activities. Structural equation modelling showed that the increase in microbial metabolic activities directly improved SOC by promoting DOC in >0.25 mm aggregate in the upper (0-5 cm) soil layer under conservation tillage systems, as well as directly and indirectly by promoting DOC and MBC in <0.25 mm aggregate. Our results suggested that conservation tillage increased SOC in aggregates in the topsoil by improving microbial metabolic activities.	[Guo, Li-Jin; Liu, Tian-Qi; Cao, Cou-Gui; Li, Cheng-Fang] Huazhong Agr Univ, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Cao, Cou-Gui; Li, Cheng-Fang] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou 434023, Hubei, Peoples R China; [Lin, Shan] Huazhong Agr Univ, Coll Resources & Environm, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Yangtze University; Huazhong Agricultural University	Li, CF (corresponding author), Huazhong Agr Univ, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China.	lichengfang@126.com			National Natural Science Foundation of China [31471454, 41201255]; Fundamental Research Funds for the Central Universities [2013PY106]; Major Scientific and Technological Innovation Projects in Hubei Province [2014ABA027]; National Technology Project for High Food Yield of China [2011BAD16B02]; Huazhong Agricultural University Independent Scientific & Technological Innovation Foundation [2014bs02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major Scientific and Technological Innovation Projects in Hubei Province; National Technology Project for High Food Yield of China; Huazhong Agricultural University Independent Scientific & Technological Innovation Foundation	Dr. Cheng-Fang Li was financially supported by the National Natural Science Foundation of China (31471454), Fundamental Research Funds for the Central Universities (2013PY106) and Major Scientific and Technological Innovation Projects in Hubei Province (2014ABA027), Dr. Shan Lin by the National Natural Science Foundation of China (41201255), Dr. Cou-Gui Cao by National Technology Project for High Food Yield of China (2011BAD16B02), and Li-Jin Guo by Huazhong Agricultural University Independent Scientific & Technological Innovation Foundation (2014bs02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CR, 2009, SOIL SCI SOC AM J, V73, P1242, DOI 10.2136/sssaj2008.0246; Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Bending GD, 2002, SOIL BIOL BIOCHEM, V34, P1073, DOI 10.1016/S0038-0717(02)00040-8; Boden T, 2013, RANKING WORLDS COUNT; Calonego JC, 2010, EUR J AGRON, V33, P242, DOI 10.1016/j.eja.2010.06.002; Carter MR., 1996, STRUCTURE ORGANIC MA, P3; Chiu CY, 2006, GEODERMA, V130, P265, DOI 10.1016/j.geoderma.2005.01.025; Chivenge P, 2011, AGR ECOSYST ENVIRON, V140, P361, DOI 10.1016/j.agee.2010.12.004; Choudhury SG, 2014, SOIL TILL RES, V136, P76, DOI 10.1016/j.still.2013.10.001; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Devine S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084988; Dikgwatlhe SB, 2014, SOIL TILL RES, V144, P110, DOI 10.1016/j.still.2014.07.014; Diosma G, 2006, SOIL TILL RES, V91, P236, DOI 10.1016/j.still.2005.12.008; Dong HY, 2014, SOIL BIOL BIOCHEM, V69, P275, DOI 10.1016/j.soilbio.2013.11.016; Dorodnikov M, 2009, GLOBAL CHANGE BIOL, V15, P1603, DOI 10.1111/j.1365-2486.2009.01844.x; dos Santos NZ, 2011, SOIL TILL RES, V111, P208, DOI 10.1016/j.still.2010.10.006; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Editorial Board of China Agriculture Yearbook, 2012, CHIN AGR YB 2009; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P223, DOI 10.1016/0038-0717(95)00113-1; Gartzia-Bengoetxea N, 2009, SOIL BIOL BIOCHEM, V41, P1674, DOI 10.1016/j.soilbio.2009.05.010; Gathala MK, 2011, SOIL SCI SOC AM J, V75, P1851, DOI 10.2136/sssaj2010.0362; Giller KE, 1997, APPL SOIL ECOL, V6, P3, DOI 10.1016/S0929-1393(96)00149-7; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Guo LJ, 2015, BIOL FERT SOILS, V51, P65, DOI 10.1007/s00374-014-0951-6; Helgason BL, 2010, SOIL BIOL BIOCHEM, V42, P2192, DOI 10.1016/j.soilbio.2010.08.015; Hobbs PR, 2008, PHILOS T R SOC B, V363, P543, DOI 10.1098/rstb.2007.2169; Hurisso TT, 2013, GEODERMA, V193, P68, DOI 10.1016/j.geoderma.2012.10.016; Jha P, 2012, SOIL TILL RES, V121, P57, DOI 10.1016/j.still.2012.01.018; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Jiang YJ, 2013, SOIL BIOL BIOCHEM, V60, P1, DOI 10.1016/j.soilbio.2013.01.006; Jing Q, 2010, AGR SYST, V103, P433, DOI 10.1016/j.agsy.2010.04.001; Jones J.B., 2001, LAB GUIDE CONDUCTING, V1st, P140, DOI DOI 10.1201/9781420025293; Kumari M, 2011, SOIL SCI SOC AM J, V75, P560, DOI 10.2136/sssaj2010.0185; LAVELLE P, 2004, SUSTAINING BIODIVERS; Lenka NK, 2013, SOIL TILL RES, V126, P78, DOI 10.1016/j.still.2012.08.011; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Liu C, 2014, GLOBAL CHANGE BIOL, V20, P1366, DOI 10.1111/gcb.12517; Lupwayi NZ, 2001, APPL SOIL ECOL, V16, P251, DOI 10.1016/S0929-1393(00)00123-2; Madejon E, 2009, SOIL TILL RES, V105, P55, DOI 10.1016/j.still.2009.05.007; Mathew R. P., 2012, Applied and Environmental Soil Science, V2012, P548620; Miltner A, 2012, BIOGEOCHEMISTRY, V111, P41, DOI 10.1007/s10533-011-9658-z; Minoshima H, 2007, SOIL SCI SOC AM J, V71, P952, DOI 10.2136/sssaj2006.0174; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Nautiyal CS, 2010, SOIL TILL RES, V109, P55, DOI 10.1016/j.still.2010.04.008; Nunes M.R., 2014, BRAZ J AGR RES, V38, P627; Pengthamkeerati P, 2011, APPL SOIL ECOL, V48, P71, DOI 10.1016/j.apsoil.2011.01.005; Pritchett K, 2011, SOIL SCI SOC AM J, V75, P605, DOI 10.2136/sssaj2009.0294; Puget P, 2000, EUR J SOIL SCI, V51, P595, DOI 10.1046/j.1365-2389.2000.00353.x; Schutter ME, 2002, SOIL SCI SOC AM J, V66, P142, DOI 10.2136/sssaj2002.0142; Simth AP, 2014, SOIL BIOL BIOCHEM, V77, P293; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Srinivasarao C, 2012, SOIL SCI SOC AM J, V76, P168, DOI 10.2136/sssaj2011.0184; Stewart CE, 2008, SOIL SCI SOC AM J, V72, P379, DOI 10.2136/sssaj2007.0104; Stirling GR, 2010, APPL SOIL ECOL, V46, P470, DOI 10.1016/j.apsoil.2010.08.015; Triberti L, 2008, EUR J AGRON, V29, P13, DOI 10.1016/j.eja.2008.01.009; Uren NC, 2007, RHIZOSPHERE BIOCH OR; Uri ND, 1999, WATER AIR SOIL POLL, V116, P621, DOI 10.1023/A:1005168928627; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wall DH, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P1; Wang JJ, 2014, EUR J SOIL BIOL, V65, P70, DOI 10.1016/j.ejsobi.2014.10.003; Wang JH, 2015, NUTR CYCL AGROECOSYS, V102, P371, DOI 10.1007/s10705-015-9710-9; White D. C., 1997, P371; Young IM, 2008, ADV AGRON, V100, P81, DOI 10.1016/S0065-2113(08)00604-4; ZAK JC, 1994, SOIL BIOL BIOCHEM, V26, P1101, DOI 10.1016/0038-0717(94)90131-7; Zhang PJ, 2007, COLLOID SURFACE B, V58, P264, DOI 10.1016/j.colsurfb.2007.03.018; Zhang SX, 2013, SOIL BIOL BIOCHEM, V62, P147, DOI 10.1016/j.soilbio.2013.03.023; Zhang ZS, 2015, ATMOS ENVIRON, V122, P636, DOI 10.1016/j.atmosenv.2015.09.065; Zhao H, 2012, GEODERMA, V189, P397, DOI 10.1016/j.geoderma.2012.06.001; Zhu LQ, 2015, ECOL INDIC, V53, P144, DOI 10.1016/j.ecolind.2015.01.038	74	40	42	14	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146145	10.1371/journal.pone.0146145	http://dx.doi.org/10.1371/journal.pone.0146145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731654	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400102
J	Jimenez-Carretero, D; Estepar, RS; Cacio, MD; Ledesma-Carbayo, MJ				Jimenez-Carretero, Daniel; Estepar, Raul San Jose; Diaz Cacio, Mario; Ledesma-Carbayo, Maria J.			Automatic Synthesis of Anthropomorphic Pulmonary CT Phantoms	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY SCANS; 3-DIMENSIONAL MODEL; LUNG; MULTISCALE; SEPARATION; ARTERIAL	The great density and structural complexity of pulmonary vessels and airways impose limitations on the generation of accurate reference standards, which are critical in training and in the validation of image processing methods for features such as pulmonary vessel segmentation or artery-vein (AV) separations. The design of synthetic computed tomography (CT) images of the lung could overcome these difficulties by providing a database of pseudorealistic cases in a constrained and controlled scenario where each part of the image is differentiated unequivocally. This work demonstrates a complete framework to generate computational anthropomorphic CT phantoms of the human lung automatically. Starting from biological and image-based knowledge about the topology and relationships between structures, the system is able to generate synthetic pulmonary arteries, veins, and airways using iterative growth methods that can be merged into a final simulated lung with realistic features. A dataset of 24 labeled anthropomorphic pulmonary CT phantoms were synthesized with the proposed system. Visual examination and quantitative measurements of intensity distributions, dispersion of structures and relationships between pulmonary air and blood flow systems show good correspondence between real and synthetic lungs (p > 0.05 with low Cohen's d effect size and AUC values), supporting the potentiality of the tool and the usefulness of the generated phantoms in the biomedical image processing field.	[Jimenez-Carretero, Daniel; Diaz Cacio, Mario; Ledesma-Carbayo, Maria J.] Univ Politecn Madrid, Biomed Image Technol, Madrid, Spain; [Jimenez-Carretero, Daniel; Diaz Cacio, Mario; Ledesma-Carbayo, Maria J.] CIBER BBN, Madrid, Spain; [Estepar, Raul San Jose] Brigham & Womens Hosp, Appl Chest Imaging Lab, Boston, MA 02115 USA	Universidad Politecnica de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Harvard University; Brigham & Women's Hospital	Jimenez-Carretero, D (corresponding author), Univ Politecn Madrid, Biomed Image Technol, Madrid, Spain.	daniel.jimenezc@die.upm.es	Ledesma-Carbayo, Maria J/D-5529-2009; San Jose Estepar, Raul/AAQ-5657-2020	Ledesma-Carbayo, Maria J/0000-0001-6846-3923; San Jose Estepar, Raul/0000-0002-3677-1996; Jimenez-Carretero, Daniel/0000-0001-7858-1907	Spanish Ministry of Economy [TEC2013-48251-C2]; Comunidad de Madrid [TOPUS P2013/MIT-3024]; FPU grant by the Spanish Ministry of Education; NIH NHLBI [K25 HL104085, 1R01HL116931, R01HL116473]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116931, R01HL116473] Funding Source: NIH RePORTER	Spanish Ministry of Economy(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); FPU grant by the Spanish Ministry of Education(German Research Foundation (DFG)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MJLC and DJC were supported by the Spanish Ministry of Economy, TEC2013-48251-C2 and by Comunidad de Madrid grant TOPUS P2013/MIT-3024. DJC was also supported by an FPU grant by the Spanish Ministry of Education. RSJE was funded by NIH NHLBI awards: K25 HL104085, 1R01HL116931, and R01HL116473.	Burrowes KS, 2008, PHILOS T R SOC A, V366, P3247, DOI 10.1098/rsta.2008.0073; Burrowes KS, 2005, J APPL PHYSIOL, V99, P731, DOI 10.1152/japplphysiol.01033.2004; Bushong SC, 1994, CLIN RADIOLOGY EDINB, V49, P292, DOI [10.1016/S0009-9260(05)81869-0, DOI 10.1016/S0009-9260(05)81869-0]; Cesar Jr Roberto M., 2010, PROGR PATTERN RECOGN, P477; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Estepar RSJ, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1479, DOI 10.1109/ISBI.2012.6235851; ESTEPAR RSJ, 2012, 9 IEEE INT S BIOM IM, P1467; Gao ZY, 2012, IEEE T BIO-MED ENG, V59, P3016, DOI 10.1109/TBME.2012.2212894; Hamarneh G, 2010, COMPUT MED IMAG GRAP, V34, P605, DOI 10.1016/j.compmedimag.2010.06.002; Helmberger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087515; Huang W, 1996, J APPL PHYSIOL, V81, P2123, DOI 10.1152/jappl.1996.81.5.2123; Huang W, 2008, INTRO TEXT BIOENGINE, V4; Jassi P., 2011, INSIGHT J; Jimenez-Carretero D, 2015, AUTOMATIC SYNTHESIS, DOI [http://dx.doi.org/10.5281/zenodo.20766, DOI 10.5281/ZEN0D0.20766]; Karch R, 1999, COMPUT BIOL MED, V29, P19, DOI 10.1016/S0010-4825(98)00045-6; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; Kitaoka H, 2002, MATH BIOSCI INTERAC, P39; Kretowski M, 2003, COMPUT METH PROG BIO, V70, P129, DOI 10.1016/S0169-2607(01)00200-0; Lee S, 1997, IEEE T VIS COMPUT GR, V3, P228, DOI 10.1109/2945.620490; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; MARTONEN TB, 1995, INT J BIOMED COMPUT, V40, P5, DOI 10.1016/0020-7101(95)01106-O; Meier V, 1999, THESIS; Mekada Y., 2006, P 7 AS PAC C CONTR M, P232; Miller W.S., 1947, LUNG, V2nd ed; Montaudon M, 2007, J ANAT, V211, P579, DOI 10.1111/j.1469-7580.2007.00811.x; Park S., 2006, COMPUTATIONAL MODELI, P23; Prusinkiewicz P., 1995, ARTIFICIAL LIFE GRAP, V7, P1; Ramya J, 2013, INT J COMPUTER APPL, V72; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Rolland Y, 1999, INVEST RADIOL, V34, P171, DOI 10.1097/00004424-199903000-00002; Ross JC, 2009, LECT NOTES COMPUT SC, V5762, P690, DOI 10.1007/978-3-642-04271-3_84; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Rudyanto RD, 2014, MED IMAGE ANAL, V18, P1217, DOI 10.1016/j.media.2014.07.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Saha PK, 2010, IEEE T MED IMAGING, V29, P840, DOI 10.1109/TMI.2009.2038224; SCHREINER W, 1993, IEEE T BIO-MED ENG, V40, P482, DOI 10.1109/10.243413; Sluimer I, 2006, IEEE T MED IMAGING, V25, P385, DOI 10.1109/TMI.2005.862753; Szczerba D., 2002, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2002. 5th International Conference. Proceedings, Part II (Lecture Notes in Computer Science Vol.2489), P284; Tawhai Merryn H, 2011, Pulm Circ, V1, P224, DOI 10.4103/2045-8932.83452; Tawhai MH, 2011, J APPL PHYSIOL, V110, P1466, DOI 10.1152/japplphysiol.01289.2010; van Ertbruggen C, 2005, J APPL PHYSIOL, V98, P970, DOI 10.1152/japplphysiol.00795.2004; West J. B., 2011, RESP PHYSL ESSENTIAL, V9th; Zhong HL, 2010, MED PHYS, V37, P970, DOI 10.1118/1.3302141	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146060	10.1371/journal.pone.0146060	http://dx.doi.org/10.1371/journal.pone.0146060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731653	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000367801400084
J	Yang, DP; Li, WQ				Yang, Duanpeng; Li, Weiqi			Methanol-Promoted Lipid Remodelling during Cooling Sustains Cryopreservation Survival of Chlamydomonas reinhardtii	PLOS ONE			English	Article							PHOSPHOLIPASE-D; MEMBRANE-LIPIDS; STRESS; TRIACYLGLYCEROL; DEGRADATION; TOLERANCE; INTEGRITY; ALGAE	Cryogenic treatments and cryoprotective agents (CPAs) determine the survival rate of organisms that undergo cryopreservation, but their mechanisms of operation have not yet been characterised adequately. In particular, the way in which membrane lipids respond to cryogenic treatments and CPAs is unknown. We developed comparative profiles of the changes in membrane lipids among cryogenic treatments and between the CPAs dimethyl sulfoxide (DMSO) and methanol (MeOH) for the green alga Chlamydomonas reinhardtii. We found that freezing in liquid nitrogen led to a dramatic degradation of lipids, and that thawing at warm temperature (35 degrees C) induced lipid remodelling. DMSO did not protect membranes, but MeOH significantly attenuated lipid degradation. The presence of MeOH during cooling (from 25 degrees C to -55 degrees C at a rate of 1 degrees C/min) sustained the lipid composition to the extent that membrane integrity was maintained; this phenomenon accounts for successful cryopreservation. An increase in monogalactosyldiacylglycerol and a decrease in diacylglycerol were the major changes in lipid composition associated with survival rate, but there was no transformation between these lipid classes. Phospholipase D-mediated phosphatidic acid was not involved in freezing-induced lipid metabolism in C. reinhardtii. Lipid unsaturation changed, and the patterns of change depended on the cryogenic treatment. Our results provide new insights into the cryopreservation of, and the lipid metabolism in, algae.	[Yang, Duanpeng; Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Peoples R China; [Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Peoples R China; [Yang, Duanpeng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, WQ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Peoples R China.	weiqili@mail.kib.ac.cn			National Natural Science Foundation of China [31070262]; Kunming Institute of Botany [KSCX2-EW-J-24]; Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute [540806321211]; 100-Talents Program of CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kunming Institute of Botany; Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute; 100-Talents Program of CAS(Chinese Academy of Sciences)	This research was supported by grants from the National Natural Science Foundation of China (31070262), Kunming Institute of Botany (KSCX2-EW-J-24), the Germplasm Bank of Wild Species and the CAS Innovation Program of Kunming Institute (540806321211), as well as the 100-Talents Program of CAS.	[Anonymous], 1984, PLANT HISTOCHEMISTRY; Benson EE, 2008, CRIT REV PLANT SCI, V27, P141, DOI 10.1080/07352680802202034; Bodas K, 1995, CRYO LETT; Brand JJ, 2004, NOVA HEDWIGIA, V79, P175, DOI 10.1127/0029-5035/2004/0079-0175; Chintalapati S, 2004, CELL MOL BIOL, V50, P631; Crutchfield ALM, 1999, EUR J PHYCOL, V34, P43; Day JG, 2005, CRYOLETTERS, V26, P231; Day John G., 2008, P95, DOI 10.1007/978-0-387-72276-4_6; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jia YX, 2013, PLOS ONE, V8; JOHNSON DE, 1993, TRENDS GENET, V9, P194; LEWIS JG, 1994, CRYOBIOLOGY, V31, P193, DOI 10.1006/cryo.1994.1023; Li AH, 2014, PLOS ONE, V9; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Lin L, 2014, CRYOLETTERS, V35, P129; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Moore TS, 2001, PLANT PHYSIOL, V125, P423, DOI 10.1104/pp.125.1.423; MORRIS GJ, 1979, CRYOBIOLOGY, V16, P401, DOI 10.1016/0011-2240(79)90052-X; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Piasecki BP, 2009, CRYOBIOLOGY, V58, P103, DOI 10.1016/j.cryobiol.2008.11.001; Rawyler A, 1999, PLANT PHYSIOL, V120, P293, DOI 10.1104/pp.120.1.293; REPOSITORIES E, 2005, CELL PRESERVATION TE, V3; Sakai A, 2007, CRYOLETTERS, V28, P151; Shibli RA, 2001, PLANT CELL REP, V20, P445, DOI 10.1007/s002990100347; Steponkus P.L., 1993, ADV LOW TEMPERATURE, V2, P211; Tada N, 2003, CURR OPIN LIPIDOL, V14, P29, DOI 10.1097/00041433-200302000-00006; Tanaka JY, 2001, CRYOBIOLOGY, V42, P286, DOI 10.1006/cryo.2001.2334; Taylor R, 1998, J APPL PHYCOL, V10, P481, DOI 10.1023/A:1008094622412; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Thompson GA, 1996, BBA-LIPID LIPID MET, V1302, P17, DOI 10.1016/0005-2760(96)00045-8; Urzica EI, 2013, J BIOL CHEM, V288, P30246, DOI 10.1074/jbc.M113.490425; Valledor L, 2013, MOL CELL PROTEOMICS, V12, P2032, DOI 10.1074/mcp.M112.026765; WANG XM, 1993, ARCH BIOCHEM BIOPHYS, V306, P486, DOI 10.1006/abbi.1993.1541; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Yamazaki T, 2014, CRYOLETTERS, V35, P180; Yoon K, 2012, PLANT CELL, V24, P3708, DOI 10.1105/tpc.112.100701; Yu XM, 2015, PLANT CELL ENVIRON, V38, P1391, DOI 10.1111/pce.12494; Zhang XD, 2013, BIOL PLANTARUM, V57, P149, DOI 10.1007/s10535-012-0137-8	44	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146255	10.1371/journal.pone.0146255	http://dx.doi.org/10.1371/journal.pone.0146255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731741	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400130
J	Lv, HQ; Zhang, ZM; Wu, XY; Wang, YX; Li, CL; Gong, WH; Gui, L; Wang, X				Lv, Huiqing; Zhang, Zhongmin; Wu, Xiaoyu; Wang, Yaoxia; Li, Chenglin; Gong, Weihong; Gui, Liang; Wang, Xin			Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent	PLOS ONE			English	Article							INDUCED APOPTOSIS; IN-VITRO; CANCER; INHIBITION; ACTIVATION; EXPRESSION; PERIFOSINE; MELANOMA; PATHWAY; GROWTH	Hepatocellular carcinoma (HCC) remains a global health threat. The search for novel anti-HCC agents is urgent. In the current study, we synthesized a liposomal C8 ceramide, and analyzed its anti-tumor activity in pre-clinical HCC models. The liposomal C8 (ceramide) potently inhibited HCC cell (HepG2, SMMC-7721 and Huh-7 lines) survival and proliferation, more efficiently than free C8 ceramide. Yet, non-cancerous HL7702 human hepatocytes were resistant to the liposomal C8 treatment. Liposomal C8 activated caspase-dependent apoptosis in HCC cells, and HCC cytotoxicity by liposomal C8 was significantly attenuated with co-treatment of caspase inhibitors. At the molecular level, we showed that liposomal C8 activated ASK1 (apoptosis signal-regulating kinase 1)-JNK (Jun N-terminal protein kinase) signaling in HCC cells. On the other hand, JNK pharmacological inhibition or dominant negative mutation, as well as ASK1 shRNA-knockdown remarkably inhibited liposomal C8-induced apoptosis in HCC cells. Further studies showed that liposomal C8 inhibited AKT-mTOR (mammalian target of rapamycin) activation in HCC cells. Restoring AKT-mTOR activation by introducing a constitutively-active AKT alleviated HepG2 cytotoxicity by liposomal C8. In vivo, intravenous (i.v.) injection of liposomal C8 significantly inhibited HepG2 xenograft growth in severe combined immuno-deficient (SCID) mice, and mice survival was significantly improved. These preclinical results suggest that liposomal C8 could be further studied as a valuable anti-HCC agent.	[Lv, Huiqing] Lin Yi Peoples Hosp, Dept Hyperbar Oxygen, Lin Yi, Peoples R China; [Zhang, Zhongmin; Wang, Yaoxia; Li, Chenglin; Gong, Weihong; Wang, Xin] Lin Yi Peoples Hosp, Dept Oncol, Lin Yi, Peoples R China; [Wu, Xiaoyu; Gui, Liang] Nanjing Med Univ, Affiliated Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Gui, L (corresponding author), Nanjing Med Univ, Affiliated Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	drguiliangnhc12@163.com; drwangxinlinyi8@163.com	wu, xiaoyu/HIK-3475-2022		National science foundation of China [81373990]	National science foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National science foundation of China (81373990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Chen MB, 2015, CARCINOGENESIS, V36, P1061, DOI 10.1093/carcin/bgv094; Chen MB, 2013, CELL SIGNAL, V25, P1993, DOI 10.1016/j.cellsig.2013.05.026; Dimanche-Boitrel MT, 2011, RECENT PAT ANTI-CANC, V6, P284, DOI 10.2174/157489211796957838; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gomez-Pinillos A, 2012, HEMATOL ONCOL CLIN N, V26, P483, DOI 10.1016/j.hoc.2012.02.014; Henry B., 2011, CANC LETT; Ji C, 2012, CELL SIGNAL, V24, P1781, DOI 10.1016/j.cellsig.2012.05.003; Kester M, 2015, BIOL CHEM, V396, P737, DOI 10.1515/hsz-2015-0129; Lin CF, 2006, CURR MED CHEM, V13, P1609, DOI 10.2174/092986706777441986; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Morales A, 2012, ANTI-CANCER AGENT ME, V12, P364, DOI 10.2174/187152012800228689; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh S, 2014, NAT REV GASTRO HEPAT, V11, P45, DOI 10.1038/nrgastro.2013.143; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Tanaka S, 2012, SEMIN ONCOL, V39, P486, DOI 10.1053/j.seminoncol.2012.05.005; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Xavier CPR, 2013, J NUTR BIOCHEM, V24, P706, DOI 10.1016/j.jnutbio.2012.04.004; Xu D, 2013, ONCOL REP, V29, P653, DOI 10.3892/or.2012.2138; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang L, 2015, EXP CELL RES; Yu T, 2013, BIOCHEM BIOPH RES CO, V441, P53, DOI 10.1016/j.bbrc.2013.10.008; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zolnik BS, 2008, DRUG METAB DISPOS, V36, P1709, DOI 10.1124/dmd.107.019679	30	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145195	10.1371/journal.pone.0145195	http://dx.doi.org/10.1371/journal.pone.0145195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727592	gold, Green Submitted, Green Published			2022-12-27	WOS:000367681500011
J	Korpar, M; Sosic, M; Blazeka, D; Sikic, M				Korpar, Matija; Sosic, Martin; Blazeka, Dino; Sikic, Mile			SW#db: GPU-Accelerated Exact Sequence Similarity Database Search	PLOS ONE			English	Article								In recent years we have witnessed a growth in sequencing yield, the number of samples sequenced, and as a result-the growth of publicly maintained sequence databases. The increase of data present all around has put high requirements on protein similarity search algorithms with two ever-opposite goals: how to keep the running times acceptable while maintaining a high-enough level of sensitivity. The most time consuming step of similarity search are the local alignments between query and database sequences. This step is usually performed using exact local alignment algorithms such as Smith-Waterman. Due to its quadratic time complexity, alignments of a query to the whole database are usually too slow. Therefore, the majority of the protein similarity search methods prior to doing the exact local alignment apply heuristics to reduce the number of possible candidate sequences in the database. However, there is still a need for the alignment of a query sequence to a reduced database. In this paper we present the SW#db tool and a library for fast exact similarity search. Although its running times, as a standalone tool, are comparable to the running times of BLAST, it is primarily intended to be used for exact local alignment phase in which the database of sequences has already been reduced. It uses both GPU and CPU parallelization and was 4-5 times faster than SSEARCH, 6-25 times faster than CUDASW++ and more than 20 times faster than SSW at the time of writing, using multiple queries on Swiss-prot and Uniref90 databases	[Korpar, Matija; Sosic, Martin; Blazeka, Dino; Sikic, Mile] Univ Zagreb, Fac Elect Engn & Comp, HR-10000 Zagreb, Croatia; [Sikic, Mile] ASTAR, Bioinformat Inst, Singapore 138671, Singapore	University of Zagreb; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Sikic, M (corresponding author), Univ Zagreb, Fac Elect Engn & Comp, Unska 3, HR-10000 Zagreb, Croatia.	mile.sikic@fer.hr	Sikic, Mile ms/A-9325-2015	Sikic, Mile ms/0000-0002-8370-0891	Croatian Science Foundation [O-1673-2014]; Agency for Science, Technology and Research, Singapore	Croatian Science Foundation; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	The work of Mile Sikic has been supported in part by Croatian Science Foundation, http://www.hrzz.hr/default.aspx?id=47, under the project no. O-1673-2014. Funding for open access charge: Agency for Science, Technology and Research, Singapore.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, ACC BLAST PERF TER B; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Korpar M, 2013, BIOINFORMATICS, V29, P2494, DOI 10.1093/bioinformatics/btt410; Liu YC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-117; Liu Yongchao, 2010, BMC Res Notes, V3, P93, DOI 10.1186/1756-0500-3-93; Liu Yongchao, 2009, BMC Res Notes, V2, P73, DOI 10.1186/1756-0500-2-73; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rognes T, 2000, BIOINFORMATICS, V16, P699, DOI 10.1093/bioinformatics/16.8.699; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sosic M, 2015, OPAL SIMD C C LIB MA; Zhao MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082138	16	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145857	10.1371/journal.pone.0145857	http://dx.doi.org/10.1371/journal.pone.0145857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26719890	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900024
J	Emmadi, R; Canestrari, E; Arbieva, ZH; Mu, WB; Dai, Y; Frasor, J; Wiley, E				Emmadi, Rajyasree; Canestrari, Emanuele; Arbieva, Zarema H.; Mu, Wenbo; Dai, Yang; Frasor, Jonna; Wiley, Elizabeth			Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER CELLS; GENE-EXPRESSION; PROLIFERATION; INVASIVENESS; RESISTANCE; PATHWAYS; SUBTYPES; TARGETS; MARKERS	Altered expression of miRNAs has been observed in many types of cancer, including breast cancer, and shown to contribute to cancer growth, aggressiveness, and response to therapies. In this pilot study, we investigated the possible correlation of miRNAs with risk of recurrence of estrogen receptor positive, lymph node-negative mammary carcinomas as determined by the Oncotype DX (R) Breast Cancer assay. To accomplish this, we extracted RNA from a collection of breast carcinomas that had previously been analyzed by Oncotype DX (R). Multiple Let-7 family members were negatively correlated with the recurrence score (RS), which is consistent with their tumor suppressor properties. Additional miRNAs were found to positively correlate with RS, including miR-377-5p, miR-633b, miR-548t and miR-3648. Pathway analysis of putative and validated targets suggests that these miRNAs may have a diverse range of functions that may contribute to tumor recurrence. Taken together, these findings provide evidence that a miRNA expression signature can be developed to aid existing methods to determine the risk of recurrence for women with estrogen receptor positive breast cancers treated with endocrine therapy.	[Emmadi, Rajyasree; Wiley, Elizabeth] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [Canestrari, Emanuele] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL USA; [Arbieva, Zarema H.] Univ Illinois, Core Genom Facil, Chicago, IL USA; [Mu, Wenbo; Dai, Yang] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Frasor, Jonna] Univ Illinois, Dept Physiol & Biophys, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Emmadi, R (corresponding author), Univ Illinois, Dept Psychol, Chicago, IL 60680 USA.	emmadi@uic.edu			National Institutes of Health [R01 CA130932-05]; University of Illinois at Chicago Chancellor's Discovery Fund; NATIONAL CANCER INSTITUTE [R01CA130932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago Chancellor's Discovery Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA130932-05 to JF), and University of Illinois at Chicago Chancellor's Discovery Fund (JF, EW, and YD).	Albain KS, 2009, BREAST, V18, pS141, DOI 10.1016/S0960-9776(09)70290-5; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kim K, 2013, HORM CANCER-US, V4, P78, DOI 10.1007/s12672-012-0129-3; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manavalan TT, 2011, CANCER LETT, V313, P26, DOI 10.1016/j.canlet.2011.08.018; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang V., 2007, J CANC MOL, V3, P133; Weier Heinz-Ulli G, 2013, J Data Mining Genomics Proteomics, V4, P127; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhao YC, 2011, MOL MED, V17, P1233, DOI 10.2119/molmed.2010.00225	31	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145346	10.1371/journal.pone.0145346	http://dx.doi.org/10.1371/journal.pone.0145346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717565	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500030
J	Sarabdjitsingh, RA; Pasricha, N; Smeets, JAS; Kerkhofs, A; Mikasova, L; Karst, H; Groc, L; Joels, M				Sarabdjitsingh, R. Angela; Pasricha, Natasha; Smeets, Johanna A. S.; Kerkhofs, Amber; Mikasova, Lenka; Karst, Henk; Groc, Laurent; Joels, Marian			Hippocampal Fast Glutamatergic Transmission Is Transiently Regulated by Corticosterone Pulsatility	PLOS ONE			English	Article							SURFACE TRAFFICKING; NEUROTRANSMITTER RECEPTOR; GLUCOCORTICOID-RECEPTOR; ULTRADIAN RHYTHM; HPA AXIS; HORMONE; RAT; RESPONSIVENESS; RESPONSES; PULSES	In recent years it has become clear that corticosteroid hormones (such as corticosterone) are released in ultradian pulses as a natural consequence of pituitary-adrenal interactions. All organs, including the brain, are thus exposed to pulsatile changes in corticosteroid hormone level, important to ensure full genomic responsiveness to stress-induced surges. However, corticosterone also changes neuronal excitability through rapid non-genomic pathways, particularly in the hippocampus. Potentially, background excitability of hippocampal neurons could thus be changed by pulsatile exposure to corticosteroids. It is currently unknown, though, how neuronal activity alters during a sequence of corticosterone pulses. To test this, hippocampal cells were exposed in vitro to four consecutive corticosterone pulses with a 60 min inter-pulse interval. During the pulses we examined four features of hippocampal signal transfer by the main excitatory transmitter glutamate-i.e., postsynaptic responses to spontaneous release of presynaptic vesicles, postsynaptic GluA2-AMPA receptor dynamics, basal (evoked) field responses, and synaptic plasticity, using a set of high resolution imaging and electrophysiological approaches. We show that the first pulse of corticosterone causes a transient increase in miniature EPSC frequency, AMPA receptor trafficking and synaptic plasticity, while basal evoked field responses are unaffected. This pattern is not maintained during subsequent applications: responses become more variable, attenuate or even reverse over time, albeit with different kinetics for the various experimental endpoints. This may indicate that the beneficial effect of ultradian pulses on transcriptional regulation in the hippocampus is not consistently accompanied by short-term perturbations in background excitability. In general, this could be interpreted as a means to keep hippocampal neurons responsive to incoming signals related to environmental challenges.	[Sarabdjitsingh, R. Angela; Pasricha, Natasha; Smeets, Johanna A. S.; Kerkhofs, Amber; Karst, Henk; Joels, Marian] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Pasricha, Natasha; Kerkhofs, Amber; Mikasova, Lenka; Groc, Laurent] Univ Bordeaux, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Pasricha, Natasha; Kerkhofs, Amber; Mikasova, Lenka; Groc, Laurent] CNRS, IINS UMR 5297, Bordeaux, France	Utrecht University; Utrecht University Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Sarabdjitsingh, RA (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	r.a.sarabdjitsingh@umcutrecht.nl	Karst, Henk/AAD-9281-2021; Joëls, Marian/P-6415-2016	Joels, Marian/0000-0002-4826-6209; Kerkhofs, Amber/0000-0002-4578-0536	Netherlands Organization for Scientific Research [863.13.021, 817.02.017, 024.001.003]; Federation of European Neuroscience Societies/Network of European Neuroscience Schools	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Federation of European Neuroscience Societies/Network of European Neuroscience Schools	This work was supported by Netherlands Organization for Scientific Research Grants 863.13.021 (to R.A.S.), 817.02.017 (to H.K.) and 024.001.003 (to M.J.); and by travel grants from Federation of European Neuroscience Societies/Network of European Neuroscience Schools (to N.P. and A.K.).	Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; Conway-Campbell BL, 2007, ENDOCRINOLOGY, V148, P5470, DOI 10.1210/en.2007-0585; Conway-Campbell BL, 2011, MOL ENDOCRINOL, V25, P944, DOI 10.1210/me.2010-0073; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; Dominguez R, 2010, J NEUROSCI, V30, P12589, DOI 10.1523/JNEUROSCI.1038-10.2010; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Groc L, 2008, MOL MEMBR BIOL, V25, P344, DOI 10.1080/09687680801958364; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Haller J, 2000, J NEUROENDOCRINOL, V12, P937, DOI 10.1046/j.1365-2826.2000.00568.x; Joels M, 2012, PHARMACOL REV, V64, P901, DOI 10.1124/pr.112.005892; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; McMaster A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015766; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; Pasricha N, 2011, J NEUROENDOCRINOL, V23, P143, DOI 10.1111/j.1365-2826.2010.02091.x; Qian XX, 2012, ENDOCRINOLOGY, V153, P4346, DOI 10.1210/en.2012-1484; Rankin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030978; Sarabdjitsingh RA, 2012, PHYSIOL BEHAV, V106, P73, DOI 10.1016/j.physbeh.2011.09.017; Sarabdjitsingh RA, 2010, J NEUROENDOCRINOL, V22, P862, DOI 10.1111/j.1365-2826.2010.02004.x; Sarabdjitsingh RA, 2014, NEUROPHARMACOLOGY, V81, P231, DOI 10.1016/j.neuropharm.2014.01.042; Sarabdjitsingh RA, 2010, ENDOCRINOLOGY, V151, P1177, DOI 10.1210/en.2009-1119; Sarabdjitsingh RA, 2010, ENDOCRINOLOGY, V151, P5369, DOI 10.1210/en.2010-0832; Sarabdjitsingh RA, 2014, P NATL ACAD SCI USA, V111, P14265, DOI 10.1073/pnas.1411216111; Spiga F, 2014, COMPR PHYSIOL, V4, P1273, DOI 10.1002/cphy.c140003; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Walker JJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001341; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001	35	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0145858	10.1371/journal.pone.0145858	http://dx.doi.org/10.1371/journal.pone.0145858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741493	Green Submitted, Green Published, gold			2022-12-27	WOS:000367810600013
J	Wang, XX; Mei, YD; Li, WN; Kong, YJ; Cong, XY				Wang, Xianxun; Mei, Yadong; Li, Weinan; Kong, Yanjun; Cong, Xiangyu			Influence of Sub-Daily Variation on Multi-Fractal Detrended Fluctuation Analysis of Wind Speed Time Series	PLOS ONE			English	Article							CROSS-CORRELATION ANALYSIS; MULTIFRACTALITY	Using multi-fractal detrended fluctuation analysis (MF-DFA), the scaling features of wind speed time series (WSTS) could be explored. In this paper, we discuss the influence of subdaily variation, which is a natural feature of wind, in MF-DFA of WSTS. First, the choice of the lower bound of the segment length, a significant parameter of MF-DFA, was studied. The results of expanding the lower bound into sub-daily scope shows that an abrupt declination and discrepancy of scaling exponents is caused by the inability to keep the whole diel process of wind in one single segment. Additionally, the specific value, which is effected by the sub-daily feature of local meteo-climatic, might be different. Second, the intra-day temporal order of wind was shuffled to determine the impact of diel variation on scaling exponents of MF-DFA. The results illustrate that disregarding diel variation leads to errors in scaling. We propose that during the MF-DFA of WSTS, the segment length should be longer than 1 day and the diel variation of wind should be maintained to avoid abnormal phenomena and discrepancy in scaling exponents.	[Wang, Xianxun; Mei, Yadong; Li, Weinan; Kong, Yanjun] Wuhan Univ, State Key Lab Water Resource & Hydropower Engn Sc, Wuhan 430072, Hubei, Peoples R China; [Wang, Xianxun; Mei, Yadong; Li, Weinan; Kong, Yanjun] Hubei Collaborat Innovat Ctr Water Resources Secu, Wuhan, Hubei, Peoples R China; [Cong, Xiangyu] POWERCHINA Kunming Engn Corp Ltd, Kunming, Yunnan, Peoples R China	Wuhan University	Mei, YD (corresponding author), Wuhan Univ, State Key Lab Water Resource & Hydropower Engn Sc, Wuhan 430072, Hubei, Peoples R China.	ydmei@whu.edu.cn	Wang, Xianxun/O-2389-2018	Wang, Xianxun/0000-0002-9690-2521	Major Program of National Natural Science Foundation of China [51239004]; Program of National Natural Science Foundation of China [51479140]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Major Program of National Natural Science Foundation of China, grant number: 51239004, (URLs: http://npd.nsfc.gov.cn/fundingProjectSearchAction.action), Recipient: Yadong Mei; and the Program of National Natural Science Foundation of China, grant number: 51479140 (URLs: http://npd.nsfc.gov.cn/fundingProjectSearchAction.action), Recipient: Yadong Mei. The funder provided support in experiment field and tools. The POWERCHINA Kunming Engineering Corporation Limited provided support in data collection. The funder and the commercial company did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ackermann T., 2012, WIND POWER POWER SYS, V2nd; Craig A., 2012, WIND POWER HYDROPOWE; dos Anjos PS, 2015, PHYSICA A, V424, P90, DOI 10.1016/j.physa.2015.01.003; Feder J, 1988, FRACTALS; Feng T, 2009, PHYS LETT A, V373, P4134, DOI 10.1016/j.physleta.2009.09.032; Garcia-Marin AP, 2013, CHAOS, V23, DOI 10.1063/1.4793781; Govindan RB, 2004, EUROPHYS LETT, V68, P184, DOI 10.1209/epl/i2004-10188-3; Grech D, 2012, ACTA PHYS POL A, V121, pB34; Hajian S, 2010, PHYSICA A, V389, P4942, DOI 10.1016/j.physa.2010.06.025; Hu J, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02066; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Jiang ZQ, 2008, PHYSICA A, V387, P3605, DOI 10.1016/j.physa.2008.02.015; Jiang ZQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016106; Jiang ZQ, 2009, PHYSICA A, V388, P433, DOI 10.1016/j.physa.2008.10.028; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kavasseri RG, 2005, CHAOS SOLITON FRACT, V24, P165, DOI 10.1016/j.chaos.2004.09.004; Kavasseri RG, 2004, IEEE T CIRCUITS-I, V51, P2255, DOI 10.1109/TCSI.2004.836846; Kocak K, 2009, ENERGY, V34, P1980, DOI 10.1016/j.energy.2009.08.006; Kristoufek L, 2011, EPL-EUROPHYS LETT, V95, P525; Oswiecimka P, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.023305; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Podobnik B, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.025104; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Qian XY, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062816; Rosas A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061906; Saichev A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011111; Shen CH, 2015, PHYSICA A, V419, P417, DOI 10.1016/j.physa.2014.10.058; Stanley HE, 1999, PHYSICA A, V270, P309, DOI 10.1016/S0378-4371(99)00230-7; [孙斌 Sun Bin], 2014, [电工技术学报, Transactions of China Electrotechnical Society], V29, P204; Telesca L., 2011, J STAT MECH-THEORY E, V7; Wang J, 2012, FRACTALS, V20, P271, DOI 10.1142/S0218348X12500259; Zhang C, 2015, PHYSICA A, V438, P114, DOI 10.1016/j.physa.2015.06.039; Zhou WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066211; Zorick T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068360	34	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146284	10.1371/journal.pone.0146284	http://dx.doi.org/10.1371/journal.pone.0146284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741491	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600027
J	Wiens, S; Szychowska, M; Nilsson, ME				Wiens, Stefan; Szychowska, Malina; Nilsson, Mats E.			Visual Task Demands and the Auditory Mismatch Negativity: An Empirical Study and a Meta-Analysis	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PUZZLINGLY HIGH CORRELATIONS; ATTENTIONAL LOAD; PERCEPTUAL LOAD; SELECTIVE ATTENTION; WORKING-MEMORY; DISTRACTION PARADIGM; CONFIDENCE-INTERVALS; COGNITIVE CONTROL; SOCIAL COGNITION	Because the auditory system is particularly useful in monitoring the environment, previous research has examined whether task-irrelevant, auditory distracters are processed even if subjects focus their attention on visual stimuli. This research suggests that attentionally demanding visual tasks decrease the auditory mismatch negativity (MMN) to simultaneously presented auditory distractors. Because a recent behavioral study found that high visual perceptual load decreased detection sensitivity of simultaneous tones, we used a similar task (n = 28) to determine if high visual perceptual load would reduce the auditory MMN. Results suggested that perceptual load did not decrease the MMN. At face value, these nonsignificant findings may suggest that effects of perceptual load on the MMN are smaller than those of other demanding visual tasks. If so, effect sizes should differ systematically between the present and previous studies. We conducted a selective meta-analysis of published studies in which the MMN was derived from the EEG, the visual task demands were continuous and varied between high and low within the same task, and the task-irrelevant tones were presented in a typical oddball paradigm simultaneously with the visual stimuli. Because the meta-analysis suggested that the present (null) findings did not differ systematically from previous findings, the available evidence was combined. Results of this meta-analysis confirmed that demanding visual tasks reduce the MMN to auditory distracters. However, because the meta-analysis was based on small studies and because of the risk for publication biases, future studies should be preregistered with large samples (n > 150) to provide confirmatory evidence for the results of the present meta-analysis. These future studies should also use control conditions that reduce confounding effects of neural adaptation, and use load manipulations that are defined independently from their effects on the MMN.	[Wiens, Stefan; Szychowska, Malina; Nilsson, Mats E.] Stockholm Univ, Dept Psychol, Gosta Ekman Lab, S-10691 Stockholm, Sweden; [Szychowska, Malina] Adam Mickiewicz Univ, Inst Acoust, Dept Phys, PL-60769 Poznan, Poland	Stockholm University; Adam Mickiewicz University	Wiens, S (corresponding author), Stockholm Univ, Dept Psychol, Gosta Ekman Lab, S-10691 Stockholm, Sweden.	sws@psychology.su.se	Wiens, Stefan/D-1268-2017; Szychowska, Malina/H-8132-2019	Wiens, Stefan/0000-0003-4531-4313; Szychowska, Malina/0000-0002-5807-6855; Nilsson, Mats/0000-0002-2081-7144	Stockholm University; Swedish Research Council [421-2010-1697]	Stockholm University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by internal funds from Stockholm University and a research grant from the Swedish Research Council (421-2010-1697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1992, ELECTROEN CLIN NEURO, V82, P356, DOI 10.1016/0013-4694(92)90005-3; ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Alho K, 2014, HEARING RES, V307, P29, DOI 10.1016/j.heares.2013.08.001; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Bartha-Doering L, 2015, PSYCHOPHYSIOLOGY, V52, P1115, DOI 10.1111/psyp.12459; Berti S, 2003, EUR J NEUROSCI, V17, P1119, DOI 10.1046/j.1460-9568.2003.02527.x; Bodatsch M, 2015, BIOL PSYCHIAT, V77, P951, DOI 10.1016/j.biopsych.2014.09.025; Borenstein M., 2009, INTRO META ANAL; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Calin-Jageman RJ, 2014, SOC PSYCHOL-GERMANY, V45, P239, DOI 10.1027/1864-9335/a000190; Campbell TA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01065; Chait M, 2012, NEUROIMAGE, V59, P1932, DOI 10.1016/j.neuroimage.2011.09.006; Cheng CH, 2013, INT J PSYCHOPHYSIOL, V90, P165, DOI 10.1016/j.ijpsycho.2013.06.026; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cumming G., 2012, UNDERSTANDING THE NE; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Cureton EE, 1950, EDUC PSYCHOL MEAS, V10, P94, DOI 10.1177/001316445001000107; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dittmann-Balcar A, 1999, NEUROREPORT, V10, P3749, DOI 10.1097/00001756-199912160-00005; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dyson BJ, 2005, COGN AFFECT BEHAV NE, V5, P319, DOI 10.3758/CABN.5.3.319; Erlbeck H, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00654; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Fishman YI, 2014, BRAIN TOPOGR, V27, P500, DOI 10.1007/s10548-013-0337-3; Glass G.V., 1976, ED RES, V5, P3, DOI [10.2307/1174772, DOI 10.3102/0013189X005010003, 10.2307/1174772ISSN0536-1036]; Harmony T, 2000, COGNITIVE BRAIN RES, V9, P53, DOI 10.1016/S0926-6410(99)00044-0; Haroush K, 2010, J COGNITIVE NEUROSCI, V22, P1440, DOI 10.1162/jocn.2009.21284; Hoekstra R, 2014, PSYCHON B REV, P1; Howell D. C., 2013, STATISTICAL METHODS; Ikezawa S, 2008, INT J PSYCHOPHYSIOL, V68, P41, DOI 10.1016/j.ijpsycho.2008.01.006; Ingre M, 2013, NEUROIMAGE, V81, P496, DOI 10.1016/j.neuroimage.2013.03.030; Ioannidis JPA, 2012, PERSPECT PSYCHOL SCI, V7, P645, DOI 10.1177/1745691612464056; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Kasai K, 2002, COGNITIVE BRAIN RES, V13, P305, DOI 10.1016/S0926-6410(01)00125-2; Kathmann N, 1999, CLIN NEUROPHYSIOL, V110, P317, DOI 10.1016/S1388-2457(98)00011-X; Keil A, 2014, PSYCHOPHYSIOLOGY, V51, P1, DOI 10.1111/psyp.12147; Kimura M, 2009, PSYCHOPHYSIOLOGY, V46, P402, DOI 10.1111/j.1469-8986.2008.00767.x; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kleinert S, 2014, LANCET, V384, P2176, DOI 10.1016/S0140-6736(14)62047-X; Klemen J, 2009, EUR J NEUROSCI, V29, P2426, DOI 10.1111/j.1460-9568.2009.06774.x; Konstantinou N, 2013, J EXP PSYCHOL HUMAN, V39, P919, DOI 10.1037/a0033037; Konstantinou N, 2012, J COGNITIVE NEUROSCI, V24, P2199, DOI 10.1162/jocn_a_00279; KRAMER AF, 1995, BIOL PSYCHOL, V40, P83, DOI 10.1016/0301-0511(95)05108-2; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lavie N, 2010, CURR DIR PSYCHOL SCI, V19, P143, DOI 10.1177/0963721410370295; Levanen S, 1996, CEREB CORTEX, V6, P288, DOI 10.1093/cercor/6.2.288; Luck S, 2005, AN INTRODUCTION TO T; Macmillan N. A, 2005, DETECTION THEORY A U; Matsubayashi J, 2008, BRAIN RES, V1236, P159, DOI 10.1016/j.brainres.2008.07.120; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Moreno R., 2015, P IET INT C RESILIEN, P1; Morlet D, 2014, BRAIN TOPOGR, V27, P467, DOI 10.1007/s10548-013-0335-5; Muller BW, 2002, NEUROREPORT, V13, P1317; Muller-Gass A, 2005, CLIN NEUROPHYSIOL, V116, P2142, DOI 10.1016/j.clinph.2005.05.012; Muller-Gass A, 2006, BRAIN RES, V1078, P112, DOI 10.1016/j.brainres.2005.12.125; Muller-Gass A, 2007, BRAIN RES, V1170, P71, DOI 10.1016/j.brainres.2007.07.023; Murphy JR, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-45; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 1983, ADV PSYCHOL, P119, DOI DOI 10.1016/S0166-4115(08)62036-1; Naatanen R, 2011, OXFORD HANDBOOK OF E; Nosek BA, 2014, SOC PSYCHOL-GERMANY, V45, P137, DOI 10.1027/1864-9335/a000192; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Otten LJ, 2000, NEUROREPORT, V11, P875, DOI 10.1097/00001756-200003200-00043; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; Pannese A, 2015, BRAIN TOPOGR, V28, P411, DOI 10.1007/s10548-014-0368-4; Parks NA, 2011, J COGNITIVE NEUROSCI, V23, P1113, DOI 10.1162/jocn.2010.21460; Pfister R, 2013, ADV COGN PSYCHOL, V9, P74, DOI [10.5709/acp-0133-x, 10.2478/v10053-008-0133-x]; Raveh D, 2015, ATTEN PERCEPT PSYCHO, V77, P483, DOI 10.3758/s13414-014-0776-2; Regenbogen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052267; Restuccia D, 2005, COGNITIVE BRAIN RES, V25, P891, DOI 10.1016/j.cogbrainres.2005.09.023; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Rinne Teemu, 2010, Open Neuroimag J, V4, P187, DOI 10.2174/1874440001004010187; Rissling AJ, 2013, SCHIZOPHR RES, V146, P326, DOI 10.1016/j.schres.2013.01.035; Roper ZJJ, 2014, PSYCHON B REV, V21, P549, DOI 10.3758/s13423-013-0503-3; Roper ZJJ, 2013, J EXP PSYCHOL HUMAN, V39, P1340, DOI 10.1037/a0031616; Rose M, 2005, CEREB CORTEX, V15, P1290, DOI 10.1093/cercor/bhi012; ROSNOW RL, 1995, PSYCHOL SCI, V6, P3, DOI 10.1111/j.1467-9280.1995.tb00297.x; Roye A, 2007, EUR J NEUROSCI, V26, P784, DOI 10.1111/j.1460-9568.2007.05685.x; Sand A, 2011, NEUROREPORT, V22, P348, DOI 10.1097/WNR.0b013e3283463cb1; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Sculthorpe LD, 2008, BRAIN RES, V1234, P78, DOI 10.1016/j.brainres.2008.07.031; Sculthorpe LD, 2009, BRAIN RES, V1290, P52, DOI 10.1016/j.brainres.2009.06.013; Singhal A, 2002, PSYCHOPHYSIOLOGY, V39, P236, DOI 10.1017/S0048577201392156; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sussman E, 2003, PSYCHON B REV, V10, P630, DOI 10.3758/BF03196525; Sussman ES, 2014, BRAIN TOPOGR, V27, P553, DOI 10.1007/s10548-013-0326-6; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Sussman ES, 2005, COGN AFFECT BEHAV NE, V5, P93, DOI 10.3758/CABN.5.1.93; Takegata R, 2005, COGNITIVE BRAIN RES, V25, P169, DOI 10.1016/j.cogbrainres.2005.05.006; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P319, DOI 10.1111/j.1745-6924.2009.01132.x; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wei JH, 2002, BRAIN RES BULL, V57, P221, DOI 10.1016/S0361-9230(01)00742-0; Wiens S, 2013, BIOL PSYCHOL, V94, P44, DOI 10.1016/j.biopsycho.2013.05.001; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Yucel G, 2005, J COGNITIVE NEUROSCI, V17, P1819, DOI 10.1162/089892905775008698; Yucel G, 2005, NEUROREPORT, V16, P1031, DOI 10.1097/00001756-200507130-00001; Zhang P, 2006, NEUROIMAGE, V33, P715, DOI 10.1016/j.neuroimage.2006.07.015	113	15	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146567	10.1371/journal.pone.0146567	http://dx.doi.org/10.1371/journal.pone.0146567			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741815	gold, Green Published, Green Submitted			2022-12-27	WOS:000367810600057
J	Hendrickx, C; Mateus, O; Buffetaut, E				Hendrickx, Christophe; Mateus, Octyvio; Buffetaut, Eric			Morphofunctional Analysis of the Quadrate of Spinosauridae (Dinosauria: Theropoda) and the Presence of Spinosaurus and a Second Spinosaurine Taxon in the Cenomanian of North Africa	PLOS ONE			English	Article							KEM KEM BEDS; ABELISAURIDAE DINOSAURIA; CARNIVOROUS DINOSAURS; EVOLUTION; MOROCCO; PHYLOGENY; SKULL; INFORMATION; PERFORMANCE; MORPHOLOGY	Six quadrate bones, of which two almost certainly come from the Kem Kem beds (Cenomanian, Upper Cretaceous) of south-eastern Morocco, are determined to be from juvenile and adult individuals of Spinosaurinae based on phylogenetic, geometric morphometric, and phylogenetic morphometric analyses. Their morphology indicates two morphotypes evidencing the presence of two spinosaurine taxa ascribed to Spinosaurus aegyptiacus and? Sigilmassasaurus brevicollis in the Cenomanian of North Africa, casting doubt on the accuracy of some recent skeletal reconstructions which may be based on elements from several distinct species. Morphofunctional analysis of the mandibular articulation of the quadrate has shown that the jaw mechanics was peculiar in Spinosauridae. In mature spinosaurids, the posterior parts of the two mandibular rami displaced laterally when the jaw was depressed due to a lateromedially oriented intercondylar sulcus of the quadrate. Such lateral movement of the mandibular ramus was possible due to a movable mandibular symphysis in spinosaurids, allowing the pharynx to be widened. Similar jaw mechanics also occur in some pterosaurs and living pelecanids which are both adapted to capture and swallow large prey items. Spinosauridae, which were engaged, at least partially, in a piscivorous lifestyle, were able to consume large fish and may have occasionally fed on other prey such as pterosaurs and juvenile dinosaurs.	[Hendrickx, Christophe; Mateus, Octyvio] Univ Nova Lisboa, Fac Ciencias & Tecnol, GeoBioTec, Caparica, Portugal; [Hendrickx, Christophe; Mateus, Octyvio] Museu Lourinha, Lourinha, Portugal; [Buffetaut, Eric] PSL Res Univ, Ecole Normale Super, Lab Geol, CNRS UMR 8538, Paris, France	Universidade Nova de Lisboa; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Hendrickx, C (corresponding author), Univ Witwatersrand, Ctr Excellence Palaeosci, Evolutionary Studies Inst, Johannesburg, South Africa.	christophendrickx@gmail.com	Mateus, Octávio/F-2910-2010; Hendrickx, Christophe/D-6120-2016	Mateus, Octávio/0000-0003-1253-3616; Hendrickx, Christophe/0000-0002-8500-2405	Association des Geologues Amateurs de Belgique (AGAB)	Association des Geologues Amateurs de Belgique (AGAB)	The Association des Geologues Amateurs de Belgique (AGAB), granted to C. H. for this research project at the Ulg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot Romain, 2004, Revue de Paleobiologie Volume Special, V9, P143; Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Araujo R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01924; Bakker Robert T., 2000, Gaia (Lisboa), V15, P145; Belvedere M, 2013, PALAEOGEOGR PALAEOCL, V383, P52, DOI 10.1016/j.palaeo.2013.04.026; Bennett S. C., 2001, PALAEONTOGR ABT A, V260, P1; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; BENTON M. J., 2015, VERTEBRATE PALAEONTO; Benyoucef M, 2015, CRETACEOUS RES, V55, P44, DOI 10.1016/j.cretres.2015.02.002; Bertin Tor, 2010, PalArch's Journal of Vertebrate Palaeontology, V7, P1; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brusatte S.L., 2012, DINOSAUR PALEOBIOLOG; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P902, DOI 10.1671/0272-4634(2007)27[902:ANSOCD]2.0.CO;2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Buffetaut E, 2004, NATURE, V430, P33, DOI 10.1038/430033a; Buffetaut E, 2002, B SOC GEOL FR, V173, P415, DOI 10.2113/173.5.415; Buffetaut E., 1992, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1992, P88; Buffetaut E., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1989, P79; BUFFETAUT E, 1989, ARCHOSAURIAN ARTICUL, V1, P65; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carroll RL, 1988, VERTEBRATE PALEONTOL; Cau A, 2013, CRETACEOUS RES, V40, P251, DOI 10.1016/j.cretres.2012.09.002; Cau A, 2012, ACTA PALAEONTOL POL, V57, P661, DOI 10.4202/app.2011.0043; Cau Andrea, 2009, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V150, P239; Cavin L, 2010, J AFR EARTH SCI, V57, P391, DOI 10.1016/j.jafrearsci.2009.12.007; CHARIG AJ, 1986, NATURE, V324, P359, DOI 10.1038/324359a0; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Choiniere JN, 2014, J SYST PALAEONTOL, V12, P177, DOI 10.1080/14772019.2013.781067; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Colbert E.H., 1990, P81, DOI 10.1017/CBO9780511608377.009; Coria RA, 2006, GEODIVERSITAS, V28, P71; Cuff AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065295; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; D'Anastasio R, 2004, Reumatismo, V56, P124; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Dutheil Didier B., 1999, P553; Dyke GJ, 2010, CURR BIOL, V20, pR983, DOI 10.1016/j.cub.2010.10.001; Eaton G. F., 1910, Memoirs of the Connecticut Academy of Arts and Sciences New Haven, V2; Eddy DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017932; Evans DC, 2015, GONDWANA RES, V27, P1034, DOI 10.1016/j.gr.2014.03.016; Evers S, 2015, PEERJ, V3, DOI 10.7717/peerj.1323; Fanti F, 2007, ACTA PALAEONTOL POL, V52, P155; Fitzinger L., 1843, SYSTEMA REPTILIUM FA; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hasegawa Yoshikazu, 2010, Bulletin of Gunma Museum of Natural History, V14, P11; Heckeberg N, 2009, 69TH ANNUAL MEETING, V29, p112A; Hendrickx C., 2012, 10 ANN M EUR ASS VER, V20, P101; Hendrickx C, 2014, PEER J PREPRINTS, V2, DOI [10.7287/peerj.preprints.380v2, DOI 10.7287/PEERJ.PREPRINTS.380V2]; Hendrickx Christophe, 2015, PalArch's Journal of Vertebrate Palaeontology, V12, P1; Hendrickx C, 2015, PEERJ, V3, DOI 10.7717/peerj.1245; Hendrickx C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088905; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Ibrahim N, 2008, 56TH ANNUAL SYMPOSIU, P29; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Ibrahim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090751; Ibrahim N, 2011, J VERTEBR PALEONTOL, V31, P130; Kellner Alexander W. A., 1996, Memoirs of the Queensland Museum, V39, P611; KITCHENER A, 1987, NATURE, V325, P114, DOI 10.1038/325114a0; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P769, DOI 10.1007/s00114-007-0258-7; Lang E, 2013, PALAEOGEOGR PALAEOCL, V381, P26, DOI 10.1016/j.palaeo.2013.04.011; Lamanna Matthew C., 2014, Bulletin of Gunma Museum of Natural History, V18, P1; Larson Peter, 2008, P233; Larson PL, 2014, PALAEONTOL ELECTRON, V17; Larsson HCE, 1999, J VERTEBR PALEONTOL, V19, P398, DOI 10.1080/02724634.1999.10011152; LAVOCAT R, 1951, CR HEBD ACAD SCI, V232, P169; Lavocat R, 1952, COMPTE RENDU SOMMAIR, V1-2, P12; Lavocat R., 1954, C S G OLOGIQUE INT C, V15, P65; LAVOCAT RENE, 1955, BULL MUS NATL HIST NAT, V27, P338; Le Loeuff Jean, 2012, Journal of Stratigraphy, V36, P486; Lio Gabriel, 2012, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V153, P119; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; Mannion PD, 2013, CRETACEOUS RES, V45, P49, DOI 10.1016/j.cretres.2013.07.007; Mannion PD, 2011, ZOOL J LINN SOC-LOND, V163, P155, DOI 10.1111/j.1096-3642.2011.00699.x; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Martill DM, 1996, J GEOL SOC LONDON, V153, P5, DOI 10.1144/gsjgs.153.1.0005; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Maryanska T, 1997, ACTA PALAEONTOL POL, V42, P361; McFeeters B, 2013, CAN J EARTH SCI, V50, P636, DOI 10.1139/cjes-2012-0129; McGowan AJ, 2009, GEOLOGY, V37, P843, DOI 10.1130/G30188A.1; Milner AC., 2003, ACT 2 JORN INT PAL D, V2, P129; Ministere de l'Energie des Mines de l'Eau et de l'Environnement., 2015, GUIDE DES PROCEDURES; Mortimer M, 1915, THE THEROPOD DATABAS; Norell MA, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)446<0001:ATDFUT>2.0.CO;2; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Novas Fernando E, 2012, Rev. Mus. Argent. Cienc. Nat., V14, P57; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P167; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Pol D, 2012, P ROY SOC B-BIOL SCI, V279, P3170, DOI 10.1098/rspb.2012.0660; Porchetti SD, 2011, RIV ITAL PALEONTOL S, V117, P463, DOI 10.13130/2039-4942/5986; Rage JC, 2008, PALAEONTOGR ABT A, V285, P1; Rauhut OWM, 2005, P ROY SOC B-BIOL SCI, V272, P1179, DOI 10.1098/rspb.2005.3071; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Rauhut OWM, 2000, THESIS; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Rayfield EJ, 2011, SPEC PAP PALAEONTOL, P241, DOI 10.1111/j.1475-4983.2011.01081.x; Richter U, 2013, PALAEONTOL Z, V87, P291, DOI 10.1007/s12542-012-0153-1; Riff Douglas, 2004, Arquivos do Museu Nacional Rio de Janeiro, V62, P217; Russell DA, 2003, CRETACEOUS RES, V24, P569, DOI 10.1016/S0195-6671(03)00072-7; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Sadleir RW, 2008, JOURNAL OF VERTEBRAT, V18, p74A; Sakamoto M, 2010, P ROY SOC B-BIOL SCI, V277, P3327, DOI 10.1098/rspb.2010.0794; Sampson S.D., 2007, SOC VERTEBRATE PALEO, V8, P32, DOI DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO; SCHREIBER RW, 1975, AUK, V92, P649, DOI 10.2307/4084778; Sedlmayr J. C., 2002, THESIS; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; Tahara R, 2011, J VERTEBR PALEONTOL, V31, P127, DOI 10.1080/02724634.2011.539646; TAQUET P, 1984, CR ACAD SCI II, V299, P217; Taquet P, 1998, CR ACAD SCI II A, V327, P347, DOI 10.1016/S1251-8050(98)80054-2; Therrien F, 2005, LIFE O PAST, P179; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Tong Haiyan, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P133; Tortosa T, 2014, ANN PALEONTOL, V100, P63, DOI 10.1016/j.annpal.2013.10.003; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Wellnhofer P., 1980, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V20, P95; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Wilson JA, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.1000701; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Witton M.P., 2013, ACTA PALAEONTOLOGICA	134	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0144695	10.1371/journal.pone.0144695	http://dx.doi.org/10.1371/journal.pone.0144695			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26734729	gold, Green Published			2022-12-27	WOS:000367805100010
J	Gray, CA				Gray, Charles A.			Effects of Fishing and Fishing Closures on Beach Clams: Experimental Evaluation across Commercially Fished and Non-Fished Beaches before and during Harvesting	PLOS ONE			English	Article							DELTOIDES BIVALVIA DONACIDAE; SERRA RODING BIVALVIA; SANDY BEACH; SPATIAL VARIATION; MARINE RESERVES; DONAX; POPULATIONS; PATTERNS; GROWTH; SIZE	Management responses to reconcile declining fisheries typically include closed areas and times to fishing. This study evaluated this strategy for a beach clam fishery by testing the hypothesis that changes in the densities and size compositions of clams from before to during harvesting would differ between commercially fished and non-fished beaches. Sampling was spatially stratified across the swash and dry sand habitats on each of two commercially fished and two non-fished beaches, and temporally stratified across three six-week blocks: before, early and late harvesting. Small-scale spatio-temporal variability in the densities and sizes of clams was prevalent across both habitats and the components of variation were generally greatest at the lowest levels examined. Despite this, differences in the densities and sizes of clams among individual beaches were evident, but there were few significant differences across the commercially fished versus non-fished beaches from before to during harvesting. There was no evidence of reduced densities or truncated size compositions of clams on fished compared to non-fished beaches, contrasting reports of some other organisms in protected areas. This was probably due to a combination of factors, including the current levels of commercial harvests, the movements and other local-scale responses of clams to ecological processes acting independently across individual beaches. The results identify the difficulties in detecting fishing-related impacts against inherent levels of variability in clam populations. Nevertheless, continued experimental studies that test alternate management arrangements may help refine and determine the most suitable strategies for the sustainable harvesting of beach clams, ultimately enhancing the management of sandy beaches.	[Gray, Charles A.] WildFish Res, Sydney, NSW, Australia		Gray, CA (corresponding author), WildFish Res, Sydney, NSW, Australia.	charles.gray@wildfishresearch.com.au		Gray, Charles/0000-0001-9939-9995	Australian Government as part of the Fisheries Research and Development Corporation Project [2012/018]; NSW Government as part of the Fisheries Research and Development Corporation Project [2012/018]	Australian Government as part of the Fisheries Research and Development Corporation Project(Fisheries R&D Corp); NSW Government as part of the Fisheries Research and Development Corporation Project	The Australian and NSW Governments collaboratively funded this research as part of the Fisheries Research and Development Corporation Project No. 2012/018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bianchi G, 2000, ICES J MAR SCI, V57, P558, DOI 10.1006/jmsc.2000.0727; Blanchette CA, 2007, J EXP MAR BIOL ECOL, V340, P126, DOI 10.1016/j.jembe.2006.09.022; Brazeiro A, 1999, MAR ECOL PROG SER, V182, P127, DOI 10.3354/meps182127; Broadhurst MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099434; Broadhurst MK, 2000, REV FISH BIOL FISHER, V10, P27, DOI 10.1023/A:1008936820089; Butcher PA, 2014, MAR ECOL PROG SER, V508, P163, DOI 10.3354/meps10865; Chapman MG, 2010, MAR ECOL PROG SER, V398, P33, DOI 10.3354/meps08328; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; Defeo O, 2005, MAR ECOL PROG SER, V295, P1, DOI 10.3354/meps295001; DEFEO O, 1995, MAR ECOL PROG SER, V123, P73, DOI 10.3354/meps123073; Defeo O, 2003, J COASTAL RES, P56; DONN TE, 1990, J COASTAL RES, V6, P903; Dugan JE, 1999, J EXP MAR BIOL ECOL, V234, P111, DOI 10.1016/S0022-0981(98)00145-2; Edgar GJ, 2012, ENVIRON CONSERV, V39, P271, DOI 10.1017/S0376892912000185; ELLERS O, 1995, BIOL BULL, V189, P120, DOI 10.2307/1542462; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; Fiori S, 2006, J COASTAL RES, V22, P872, DOI 10.2112/04-0409.1; Fletcher DJ, 2002, J EXP MAR BIOL ECOL, V273, P89, DOI 10.1016/S0022-0981(02)00142-9; Franco AD, 2009, MARINE ECOLOGY PROGR, V387, P275; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Gray CA, 2016, J EXP MAR BIOL ECOL, V474, P1, DOI 10.1016/j.jembe.2015.09.013; Gray CA, 2014, FISH RES, V154, P205, DOI 10.1016/j.fishres.2014.02.027; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Henry GW, 2003, NATL RECREATIONAL IN; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; James RJ, 1995, MAR FRESHWATER RES, V46, P1093, DOI 10.1071/MF9951093; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; LEBER KM, 1982, MAR ECOL PROG SER, V7, P297, DOI 10.3354/meps007297; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lubchenco J, 2003, ECOL APPL, V13, pS3; Marty L, 2014, MAR ECOL PROG SER, V497, P179, DOI 10.3354/meps10580; MCLACHLAN A, 1984, MAR ECOL PROG SER, V19, P133, DOI 10.3354/meps019133; McLachlan A, 1996, OCEANOGR MAR BIOL, V34, P163; McLachlan A, 1998, J MOLLUS STUD, V64, P492, DOI 10.1093/mollus/64.4.492; MCLACHLAN A, 1995, J EXP MAR BIOL ECOL, V187, P147, DOI 10.1016/0022-0981(94)00176-E; McShane PE, 1995, NEW ZEAL J MAR FRESH, V29, P603, DOI 10.1080/00288330.1995.9516691; MIKKEISEN PS, 1981, VELIGER, V23, P230; MORRISEY DJ, 1992, J EXP MAR BIOL ECOL, V164, P233, DOI 10.1016/0022-0981(92)90177-C; Murray-Jones S, 2000, FISH RES, V44, P219, DOI 10.1016/S0165-7836(99)00095-8; MurrayJones SE, 1997, MAR BIOL, V128, P83, DOI 10.1007/s002270050071; Ortega L, 2012, MAR ECOL PROG SER, V469, P71, DOI 10.3354/meps10016; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PETERSON CH, 1989, ECOLOGY, V70, P1390, DOI 10.2307/1938198; Rochet MJ, 1998, ICES J MAR SCI, V55, P371, DOI 10.1006/jmsc.1997.0324; Rowling K, 2010, SYDNEY AUSTR NSW IND, V392, P43; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Saunders TM, 2009, MAR BIOL, V156, P1255, DOI 10.1007/s00227-009-1167-4; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Short A., 2007, BEACHES NEW S WALES; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; UNDERWOOD AJ, 1995, ECOL APPL, V5, P232, DOI 10.2307/1942066; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Ward TM, 2014, SUPPORT HARVEST STRA; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9	63	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146122	10.1371/journal.pone.0146122	http://dx.doi.org/10.1371/journal.pone.0146122			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731102	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400098
J	Lin, CJ; Liao, WC; Lin, HJ; Hsu, YM; Lin, CL; Chen, YA; Feng, CL; Chen, CJ; Kao, MC; Lai, CH; Kao, CH				Lin, Chun-Jung; Liao, Wei-Chih; Lin, Hwai-Jeng; Hsu, Yuan-Man; Lin, Cheng-Li; Chen, Yu-An; Feng, Chun-Lung; Chen, Chih-Jung; Kao, Min-Chuan; Lai, Chih-Ho; Kao, Chia-Hung			Statins Attenuate Helicobacter pylori CagA Translocation and Reduce Incidence of Gastric Cancer: In Vitro and Population-Based Case-Control Studies	PLOS ONE			English	Article							LIPID RAFTS; EPITHELIAL-CELLS; KAPPA-B; RISK; CHOLESTEROL; SIMVASTATIN; THERAPY; CARCINOGENESIS; LOCALIZATION; INFECTION	Gastric cancer is the second leading cause of cancer-related death worldwide. The correlation of Helicobacter pylori and the etiology of gastric cancer was substantially certain. Cholesterol-rich microdomains (also called lipid rafts), which provide platforms for signaling, are associated with H. pylori-induced pathogenesis leading to gastric cancer. Patients who have been prescribed statins, inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase, have exhibited a reduced risk of several types of cancer. However, no studies have addressed the effect of statins on H. pylori-associated gastric cancer from the antineoplastic perspective. In this study, we showed that treatment of gastric epithelial cells with simvastatin reduced the level of cellular cholesterol and led to attenuation of translocation and phosphorylation of H. pylori cytotoxin-associated gene A (CagA), which is recognized as a major determinant of gastric cancer development. Additionally, a nationwide case-control study based on data from the Taiwanese National Health Insurance Research Database (NHIRD) was conducted. A population-based case-control study revealed that patients who used simvastatin exhibited a significantly reduced risk of gastric cancer (adjusted odds ratio (OR) = 0.76, 95% confidence interval (CI) = 0.70-0.83). In patients exhibiting H. pylori infection who were prescribed simvastatin, the adjusted OR for gastric cancer was 0.25 (95% CI = 0.12-0.50). Our results combined an in vitro study with a nationwide population analysis reveal that statin use might be a feasible approach to prevent H. pylori-associated gastric cancer.	[Lin, Chun-Jung] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Lin, Chun-Jung; Liao, Wei-Chih; Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Liao, Wei-Chih] China Med Univ Hosp, Dept Pulm & Crit Care Med, Taichung, Taiwan; [Lin, Hwai-Jeng] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, New Taipei, Taiwan; [Hsu, Yuan-Man] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Yu-An; Lai, Chih-Ho] China Med Univ, Sch Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Feng, Chun-Lung] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Chen, Chih-Jung] Chang Gung Childrens Hosp, Dept Paediat, Div Paediat Infect Dis, Taoyuan, Taiwan; [Chen, Chih-Jung] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Lai, Chih-Ho] Asia Univ, Dept Nursing, Taichung, Taiwan; [Kao, Min-Chuan; Lai, Chih-Ho] Chang Gung Univ, Grad Inst Biomed Sci, Dept Microbiol & Immunol, Taoyuan, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Dept Nucl Med, Taichung, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Shuang Ho Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Asia University Taiwan; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lai, CH (corresponding author), China Med Univ, Sch Med, Grad Inst Basic Med Sci, Taichung, Taiwan.	chlai@mail.cgu.edu.tw; d10040@mail.cmuh.org.tw	Hsu, Yuan-Man/K-7074-2015	Hsu, Yuan-Man/0000-0002-4575-7475; Lin, Chun-Jung/0000-0002-2955-6913	China Medical University and Hospital [DMR-103-018, DMR-103-020, CMU102-BC-2, CMU102-S-28]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence [MOHW103-TD-B-111-03]; Ministry of Science and Technology [103-2633-B-182-001, 104-2320-B-182-040]; Chang Gung Memorial Hospital [CMRPD1F0011-3]; Tomorrow Medicine Foundation	China Medical University and Hospital(China Medical University); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Tomorrow Medicine Foundation	This study was supported by grants (DMR-103-018, DMR-103-020, CMU102-BC-2, and CMU102-S-28) provided by China Medical University and Hospital, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW103-TD-B-111-03), the Ministry of Science and Technology (103-2633-B-182-001 and 104-2320-B-182-040), Chang Gung Memorial Hospital (CMRPD1F0011-3), and Tomorrow Medicine Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonovas S, 2014, DRUGS, V74, P1841, DOI 10.1007/s40265-014-0309-2; Bonovas S, 2009, GASTROENTEROLOGY, V137, P740, DOI 10.1053/j.gastro.2009.02.088; Boyd AR, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-73; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Chaudhry MZ, 2008, SURG INFECT, V9, P183, DOI 10.1089/sur.2006.077; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Chiba Y, 2008, AM J PHYSIOL-LUNG C, V294, pL705, DOI 10.1152/ajplung.00531.2007; Chiu HF, 2011, AM J GASTROENTEROL, V106, P2098, DOI 10.1038/ajg.2011.277; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Corcos L, 2013, DIGEST LIVER DIS, V45, P795, DOI 10.1016/j.dld.2013.02.002; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; El-Serag HB, 2009, GASTROENTEROLOGY, V136, P1601, DOI 10.1053/j.gastro.2009.01.053; Erkkila L, 2005, ANTIMICROB AGENTS CH, V49, P3959, DOI 10.1128/AAC.49.9.3959-3962.2005; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Haukka J, 2010, INT J CANCER, V126, P279, DOI 10.1002/ijc.24536; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jerwood S, 2008, J ANTIMICROB CHEMOTH, V61, P362, DOI 10.1093/jac/dkm496; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; Kodach LL, 2011, GUT, V60, P1544, DOI 10.1136/gut.2011.237495; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Lai CH, 2006, J ANTIMICROB CHEMOTH, V57, P466, DOI 10.1093/jac/dki479; Lai CH, 2008, INFECT IMMUN, V76, P3293, DOI 10.1128/IAI.00365-08; Lai CH, 2013, BIOMEDICINE-TAIWAN, V3, P27, DOI 10.1016/j.biomed.2012.12.002; Lai CH, 2011, FEMS MICROBIOL LETT, V323, P155, DOI 10.1111/j.1574-6968.2011.02372.x; Lai SW, 2013, AM J GASTROENTEROL, V108, P147, DOI 10.1038/ajg.2012.341; Long E, 2014, THER ADV GASTROENTER, V7, P247, DOI 10.1177/1756283X14538689; Lu DY, 2012, INFECT IMMUN, V80, P1823, DOI 10.1128/IAI.05856-11; Lu H, 2005, CURR OPIN GASTROEN, V21, P653, DOI 10.1097/01.mog.0000181711.04529.d5; Marshall B, 2002, CLIN MED, V2, P147, DOI 10.7861/clinmedicine.2-2-147; Motzkus-Feagans CA, 2012, GUT, V61, P1538, DOI 10.1136/gutjnl-2011-301378; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Niessner A, 2006, ATHEROSCLEROSIS, V189, P408, DOI 10.1016/j.atherosclerosis.2005.12.022; Nseir W, 2012, ALIMENT PHARM THER, V36, P231, DOI 10.1111/j.1365-2036.2012.05161.x; Nseir W, 2010, HELICOBACTER, V15, P510, DOI 10.1111/j.1523-5378.2010.00803.x; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Parsonnet J, 1998, INFECT DIS CLIN N AM, V12, P185, DOI 10.1016/S0891-5520(05)70417-7; Peng YC, 2015, BRIT J CLIN PHARMACO, V80, P755, DOI 10.1111/bcp.12641; Rao S, 1999, P NATL ACAD SCI USA, V96, P7797, DOI 10.1073/pnas.96.14.7797; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shen TC, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000096; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Singh PP, 2013, ANN ONCOL, V24, P1721, DOI 10.1093/annonc/mdt150; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Stewart B, 2014, WORLD CANC REPORT 20; Toyoda T, 2009, CANCER PREV RES, V2, P751, DOI 10.1158/1940-6207.CAPR-09-0082; Varro A, 2004, CANCER RES, V64, P1695, DOI 10.1158/0008-5472.CAN-03-2399; Vinogradova Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-409; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Wu XD, 2013, EUR J CLIN PHARMACOL, V69, P1855, DOI 10.1007/s00228-013-1547-z; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Yamato M, 2007, DIGEST DIS SCI, V52, P2833, DOI 10.1007/s10620-006-9638-7; Yeganeh B, 2014, PHARMACOL THERAPEUT, V143, P87, DOI 10.1016/j.pharmthera.2014.02.007; Yu O, 2014, J CLIN ONCOL, V32, P5, DOI 10.1200/JCO.2013.49.4757; Zeaiter Z, 2008, CELL MICROBIOL, V10, P781, DOI 10.1111/j.1462-5822.2007.01084.x	63	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146432	10.1371/journal.pone.0146432	http://dx.doi.org/10.1371/journal.pone.0146432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730715	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400176
J	Oliver, CR; Gourgou, E; Bazopoulou, D; Chronis, N; Hart, AJ				Oliver, C. Ryan; Gourgou, Eleni; Bazopoulou, Daphne; Chronis, Nikos; Hart, A. John			On-Demand Isolation and Manipulation of C. elegans by In Vitro Maskless Photopatterning	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; RESOLUTION; STEREOLITHOGRAPHY; MICROFLUIDICS; LOCOMOTION	Caenorhabditis elegans (C. elegans) is a model organism for understanding aging and studying animal behavior. Microfluidic assay techniques have brought widespread advances in C. elegans research; however, traditional microfluidic assays such as those based on soft lithography require time-consuming design and fabrication cycles and offer limited flexibility in changing the geometric environment during experimentation. We present a technique for maskless photopatterning of a biocompatible hydrogel on an NGM (Agar) substrate, enabling dynamic manipulation of the C. elegans culture environment in vitro. Maskless photopatterning is performed using a projector-based microscope system largely built from off-the-shelf components. We demonstrate the capabilities of this technique by building micropillar arrays during C. elegans observation, by fabricating free-floating mechanisms that can be actuated by C. elegans motion, by using freehand drawing to isolate individual C. elegans in real time, and by patterning arrays of mazes for isolation and fitness testing of C. elegans populations. In vitro photopatterning enables rapid and flexible design of experiment geometry as well as real-time interaction between the researcher and the assay such as by sequential isolation of individual organisms. Future adoption of image analysis and machine learning techniques could be used to acquire large datasets and automatically adapt the assay geometry.	[Oliver, C. Ryan; Gourgou, Eleni; Bazopoulou, Daphne; Chronis, Nikos] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Oliver, C. Ryan; Hart, A. John] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Oliver, C. Ryan; Hart, A. John] MIT, Lab Mfg & Prod, Cambridge, MA 02139 USA; [Chronis, Nikos] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Hart, AJ (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	ajhart@mit.edu	Gourgou, Eleni/AAC-9120-2019; CHRONIS, NIKOS/AAJ-5084-2021; Hart, A. John/A-9027-2010	Gourgou, Eleni/0000-0003-1561-5545; CHRONIS, NIKOS/0000-0003-3830-1979; Hart, A. John/0000-0002-7372-3512; Bazopoulou, Daphne/0000-0002-1898-8155	Microfluidics in Biomedical Sciences Training Program through the National Institute of Health [5T32-EB005582]; Force Office of Scientific Research Young Investigator Program [FA9550-11-1-0089]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005582] Funding Source: NIH RePORTER	Microfluidics in Biomedical Sciences Training Program through the National Institute of Health; Force Office of Scientific Research Young Investigator Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	C.R.O. was supported by the Microfluidics in Biomedical Sciences Training Program through the National Institute of Health (www.nih.gov, 5T32-EB005582). A.J.H Funding for construction of the lithography system, and for materials and characterization was provided by the Air Force Office of Scientific Research Young Investigator Program (www.afosr.af.mil, FA9550-11-1-0089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaute K, 2006, ANN BIOMED ENG, V34, P1429, DOI 10.1007/s10439-006-9156-y; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Bahney CS, 2011, EUR CELLS MATER, V22, P43, DOI 10.22203/eCM.v022a04; BRENNER S, 1974, GENETICS, V77, P71; Chan KF, 2003, J MICROLITH MICROFAB, V2, P331, DOI 10.1117/1.1611182; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chronis N, 2010, LAB CHIP, V10, P432, DOI 10.1039/b919983g; Chung SE, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2759988; Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031; Curley JL, 2011, JOVE-J VIS EXP, DOI 10.3791/2636; Dendukuri D, 2008, MACROMOLECULES, V41, P8547, DOI 10.1021/ma801219w; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Hansotte EJ, HIGH SPEED MASKLESS; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; Hwang H, 2014, LAB CHIP, V14, P3498, DOI 10.1039/c4lc00697f; Jung YS, 2010, NANO LETT, V10, P1000, DOI 10.1021/nl904141r; Kim J, 2011, NAT MATER, V10, P747, DOI [10.1038/nmat3090, 10.1038/NMAT3090]; Krajniak J, 2010, LAB CHIP, V10, P1862, DOI 10.1039/c001986k; Lake J, 2009, LOW COST MASKLESS GR, V100, P1889; Lee DH, 2010, J OPT SOC KOREA, V14, P266, DOI 10.3807/JOSK.2010.14.3.266; Lee SA, 2009, LAB CHIP, V9, P1670, DOI 10.1039/b819999j; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; Majmudar T, 2012, J R SOC INTERFACE, V9, P1809, DOI 10.1098/rsif.2011.0856; Mata A, 2005, BIOMED MICRODEVICES, V7, P281, DOI 10.1007/s10544-005-6070-2; Milton Silverstein R., 1981, SPECTROMETRIC IDENTI; Mondal S, 2012, JOVE-J VIS EXP, DOI 10.3791/3780; Pandey S., 2011, Advances in Bioscience and Biotechnology, V2, P409; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Seol YJ, 2013, BIOTECHNOL BIOENG, V110, P1444, DOI 10.1002/bit.24794; Spotts JM, 2008, SYST BIOL STEVENAGE; Totsu K, 2006, SENSOR ACTUAT A-PHYS, V130, P387, DOI 10.1016/j.sna.2005.12.008; Wu H, 2003, FABRICATION COMPLEX, P554	33	5	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145935	10.1371/journal.pone.0145935	http://dx.doi.org/10.1371/journal.pone.0145935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730604	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400068
J	Pedersen, SR; Christensen, JP; Buus, S; Rasmussen, M; Korsholm, KS; Nielsen, M; Claesson, MH				Pedersen, Sara Ram; Christensen, Jan Pravsgaard; Buus, Soren; Rasmussen, Michael; Korsholm, Karen Smith; Nielsen, Morten; Claesson, Mogens Helweg			Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides	PLOS ONE			English	Article							T-CELL RESPONSES; MICE LACKING; BINDING; EPITOPES; IDENTIFICATION; PREDICTION; NETMHCPAN; ANTIGENS; VARIOLA	The aim of the present study was to identify influenza A-derived peptides which bind to both HLA class I and -II molecules and by immunization lead to both HLA class I and class II restricted immune responses. Eight influenza A-derived 9-11 mer peptides with simultaneous binding to both HLA-A*02:01 and HLA-DRB1*01:01 molecules were identified by bioinformatics and biochemical technology. Immunization of transgenic HLA-A*02:01/HLA-DRB1* 01: 01 mice with four of these double binding peptides gave rise to both HLA class I and class II restricted responses by CD8 and CD4 T cells, respectively, whereas four of the double binding peptides did result in HLA-A*02:01 restricted responses only. According to their cytokine profile, the CD4 T cell responses were of the Th2 type. In influenza infected mice, we were unable to detect natural processing in vivo of the double restricted peptides and in line with this, peptide vaccination did not decrease virus titres in the lungs of intranasally influenza challenged mice. Our data show that HLA class I and class II double binding peptides can be identified by bioinformatics and biochemical technology. By immunization, double binding peptides can give rise to both HLA class I and class I restricted responses, a quality which might be of potential interest for peptide-based vaccine development.	[Pedersen, Sara Ram; Christensen, Jan Pravsgaard; Buus, Soren; Rasmussen, Michael; Claesson, Mogens Helweg] Univ Copenhagen, Fac Hlth & Med Sci, Inst Microbiol & Immunol, Copenhagen, Denmark; [Korsholm, Karen Smith] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Nielsen, Morten] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Nielsen, Morten] Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	University of Copenhagen; Statens Serum Institut; Technical University of Denmark	Claesson, MH (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Inst Microbiol & Immunol, Copenhagen, Denmark.	claesson@sund.ku.dk	Christensen, Jan Pravsgaard/I-4782-2017; Nielsen, Morten/E-7754-2011; Nielsen, Morten/AAL-8700-2020	Christensen, Jan Pravsgaard/0000-0002-4299-9479; Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Christensen, Jan/0000-0003-1114-7465	Danish Medical Research Council [0602-02531B]; Danish Council for Strategic Research: Centre for Nano-Vaccine [0603-00322B]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Strategic Research: Centre for Nano-Vaccine	This work was supported by a grant from the Danish Medical Research Council no. 0602-02531B (MHC) and the Danish Council for Strategic Research: Centre for Nano-Vaccine (contract no. 0603-00322B) (KSK).	BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Christensen JP, 2003, J IMMUNOL, V171, P4733, DOI 10.4049/jimmunol.171.9.4733; Doherty PC, 1996, IMMUNOL REV, V150, P23, DOI 10.1111/j.1600-065X.1996.tb00694.x; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Justesen Sune, 2009, Immunome Res, V5, P2, DOI 10.1186/1745-7580-5-2; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Keskin DB, 2015, P NATL ACAD SCI USA, V112, P2151, DOI 10.1073/pnas.1423482112; Korsholm KS, 2014, VACCINE, V32, P3927, DOI 10.1016/j.vaccine.2014.05.050; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Pedersen LO, 2001, EUR J IMMUNOL, V31, P2986, DOI 10.1002/1521-4141(2001010)31:10<2986::AID-IMMU2986>3.0.CO;2-R; Swain SL, 2006, IMMUNOL REV, V213, P256; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Tang ST, 2008, ARCH VIROL, V153, P1833, DOI 10.1007/s00705-008-0194-7; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Wang M, 2009, CLIN EXP IMMUNOL, V155, P441, DOI 10.1111/j.1365-2249.2008.03856.x; Wang M, 2012, MAJOR HISTOCOMPATIBI; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wang MJ, 2011, IMMUNOLOGY, V132, P482, DOI 10.1111/j.1365-2567.2010.03383.x; Wang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010533; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	25	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145629	10.1371/journal.pone.0145629	http://dx.doi.org/10.1371/journal.pone.0145629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731261	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400045
J	Rousk, K; Michelsen, A				Rousk, Kathrin; Michelsen, Anders			The Sensitivity of Moss-Associated Nitrogen Fixation towards Repeated Nitrogen Input	PLOS ONE			English	Article							BOREAL FORESTS; FEATHER MOSSES; CLIMATE-CHANGE; ARCTIC HEATH; N DEPOSITION; N-2 FIXATION; 2 DECADES; CYANOBACTERIA; PEATLANDS	Nitrogen (N-2) fixation is a major source of available N in ecosystems that receive low amounts of atmospheric N deposition. In boreal forest and subarctic tundra, the feather moss Hylocomium splendens is colonized by N-2 fixing cyanobacteria that could contribute fundamentally to increase the N pool in these ecosystems. However, N-2 fixation in mosses is inhibited by N input. Although this has been shown previously, the ability of N-2 fixation to grow less sensitive towards repeated, increased N inputs remains unknown. Here, we tested if N-2 fixation in H. splendens can recover from increased N input depending on the N load (0, 5, 20, 80, 320 kg N ha(-1) yr(-1)) after a period of N deprivation, and if sensitivity towards increased N input can decrease after repeated N additions. Nitrogen fixation in the moss was inhibited by the highest N addition, but was promoted by adding 5 kg N ha(-1) yr(-1), and increased in all treatments during a short period of N deprivation. The sensitivity of N-2 fixation towards repeated N additions seem to decrease in the 20 and 80 kg N additions, but increased in the highest N addition (320 kg N ha(-1) yr(-1)). Recovery of N in leachate samples increased with increasing N loads, suggesting low retention capabilities of mosses if N input is above 5 kg N ha(-1) yr(-1). Our results demonstrate that the sensitivity towards repeated N additions is likely to decrease if N input does not exceed a certain threshold.	[Rousk, Kathrin; Michelsen, Anders] Univ Copenhagen, Dept Biol, Terr Ecol Sect, DK-2100 Copenhagen, Denmark; [Rousk, Kathrin; Michelsen, Anders] Univ Copenhagen, Ctr Permafrost CENPERM, DK-1350 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Rousk, K (corresponding author), Univ Copenhagen, Dept Biol, Terr Ecol Sect, Univ Parken 15, DK-2100 Copenhagen, Denmark.	kathrin.rousk@bio.ku.dk	Rousk, Kathrin/H-8836-2013; Michelsen, Anders/L-5279-2014	Rousk, Kathrin/0000-0003-3140-9864; Michelsen, Anders/0000-0002-9541-8658	Danish Council for Independent Research [1325-00025]; Danish National Research Foundation [DNRF 100]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond)	KR was supported by the Danish Council for Independent Research (grant number: 1325-00025, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research). Additionally, the Danish National Research Foundation supported the work in the Center for Permafrost (CENPERM), DNRF 100, (http://dg.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann K, 2012, ECOSYSTEMS, V15, P986, DOI 10.1007/s10021-012-9562-y; [Anonymous], 2014, R LANG ENV STAT COMP; Bay G, 2013, NEW PHYTOL, V200, P54, DOI 10.1111/nph.12403; Berg A, 2013, PLANT SOIL, V362, P271, DOI 10.1007/s11104-012-1278-4; Campioli M, 2009, PLANT ECOL, V202, P41, DOI 10.1007/s11258-008-9527-6; CARLETON TJ, 1991, CAN J BOT, V69, P778, DOI 10.1139/b91-101; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; DeLuca TH, 2008, SCIENCE, V320, P1181, DOI 10.1126/science.1154836; Dormann CF, 2002, FUNCT ECOL, V16, P4, DOI 10.1046/j.0269-8463.2001.00596.x; Faubert P, 2012, PLANT SOIL, V352, P199, DOI 10.1007/s11104-011-0989-2; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gundale MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0797; Gundale MJ, 2011, GLOBAL CHANGE BIOL, V17, P2743, DOI 10.1111/j.1365-2486.2011.02407.x; Hobara S, 2006, ARCT ANTARCT ALP RES, V38, P363, DOI 10.1657/1523-0430(2006)38[363:NFISSA]2.0.CO;2; Ininbergs K, 2011, NEW PHYTOL, V192, P507, DOI 10.1111/j.1469-8137.2011.03809.x; Kaplan-Levy RN, 2010, TOP CURR GENET, V21, P5, DOI 10.1007/978-3-642-12422-8_2; Karlsson GP, 2011, KRONDROPPSNATETS OVE; Larmola T, 2014, PNAS, V2, P734; Larmola T, 2010, ECOLOGY, V91, P2356, DOI 10.1890/09-1343.1; Leppanen SM, 2013, ENVIRON EXP BOT, V90, P62, DOI 10.1016/j.envexpbot.2012.12.006; Michelsen A, 2012, AMBIO, V41, P218, DOI 10.1007/s13280-012-0303-4; Novak M, 2015, BIOGEOCHEMISTRY, V123, P307, DOI 10.1007/s10533-015-0076-5; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; Rousk K, 2015, MICROB ECOL, V69, P778, DOI 10.1007/s00248-014-0534-y; Rousk K, 2014, PLANT SOIL, V374, P513, DOI 10.1007/s11104-013-1908-5; Rousk K, 2013, SOIL BIOL BIOCHEM, V61, P86, DOI 10.1016/j.soilbio.2013.02.011; Sorensen PL, 2012, PLANT ECOL, V213, P695, DOI 10.1007/s11258-012-0034-4; Street LE, 2015, NEW PHYTOL, V206, P682, DOI 10.1111/nph.13265; Vile MA, 2014, BIOGEOCHEMISTRY, V121, P317, DOI 10.1007/s10533-014-0019-6; Wiedermann MM, 2009, OIKOS, V118, P449, DOI 10.1111/j.1600-0706.2008.17129.x; Zackrisson O, 2004, ECOLOGY, V85, P3327, DOI 10.1890/04-0461; Zackrisson O, 2009, OECOLOGIA, V160, P309, DOI 10.1007/s00442-009-1299-8	33	14	17	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146655	10.1371/journal.pone.0146655	http://dx.doi.org/10.1371/journal.pone.0146655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731691	gold, Green Published, Green Submitted			2022-12-27	WOS:000367801400201
J	Weng, CL; Tseng, YC; Chen, DYT; Chen, CJ; Hsu, HL				Weng, Chi-Lun; Tseng, Ying-Chi; Chen, David Yen-Ting; Chen, Chi-Jen; Hsu, Hui-Ling			Spectral Imaging for Intracranial Stents and Stent Lumen	PLOS ONE			English	Article							ARTERIAL-STENOSIS; ENDOVASCULAR TREATMENT; WINGSPAN STENT; ANGIOGRAPHY; RESTENOSIS	Introduction Application of computed tomography for monitoring intracranial stents is limited because of stent-related artifacts. Our purpose was to evaluate the effect of gemstone spectral imaging on the intracranial stent and stent lumen. Materials and Methods In vitro, we scanned Enterprise stent phantom and a stent-cheese complex using the gemstone spectral imaging protocol. Follow-up gemstone spectral images of 15 consecutive patients with placement of Enterprise from January 2013 to September 2014 were also retrospectively reviewed. We used 70-keV, 140-keV, iodine (water), iodine (calcium), and iodine (hydroxyapatite) images to evaluate their effect on the intracranial stent and stent lumen. Two regions of interest were individually placed in stent lumen and adjacent brain tissue. Contrast-to-noise ratio was measured to determine image quality. The maximal diameter of stent markers was also measured to evaluate stent-related artifact. Two radiologists independently graded the visibility of the lumen at the maker location by using a 4-point scale. The mean of grading score, contrast/noise ratio and maximal diameter of stent markers were compared among all modes. All results were analyzed by SPSS version 20. Results In vitro, iodine (water) images decreased metallic artifact of stent makers to the greatest degree. The most areas of cheese were observed on iodine (water) images. In vivo, iodine (water) images had the smallest average diameter of stent markers (0.33 +/- 0.17mm; P < .05) and showed the highest mean grading score (2.94 +/- 0.94; P < .05) and contrast/noise ratio of in-stent lumen (160.03 +/- 37.79; P < .05) among all the modes. Conclusion Iodine (water) images can help reduce stent-related artifacts of Enterprise and enhance contrast of in-stent lumen. Spectral imaging may be considered a noninvasive modality for following-up patients with in-stent stenosis.	[Weng, Chi-Lun; Tseng, Ying-Chi; Chen, David Yen-Ting; Chen, Chi-Jen; Hsu, Hui-Ling] Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei, Taiwan; [Weng, Chi-Lun; Tseng, Ying-Chi; Chen, David Yen-Ting; Chen, Chi-Jen; Hsu, Hui-Ling] Taipei Med Univ, Coll Med, Sch Med, Dept Radiol, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Hsu, HL (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei, Taiwan.	anne.hlh@gmail.com						Amin-Hanjani S, 2010, STROKE, V41, P2534, DOI 10.1161/STROKEAHA.110.594739; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Dawkins AA, 2007, NEURORADIOLOGY, V49, P753, DOI 10.1007/s00234-007-0252-y; Fiorella D, 2007, STROKE, V38, P881, DOI 10.1161/01.STR.0000257963.65728.e8; Jiang WJ, 2007, NEUROLOGY, V68, P420, DOI 10.1212/01.wnl.0000252939.60764.8e; Jin M, 2013, STROKE, V44, P2990, DOI 10.1161/STROKEAHA.113.001824; Karcaaltincaba M, 2011, DIAGN INTERV RADIOL, V17, P181, DOI 10.4261/1305-3825.DIR.3860-10.0; Lovblad KO, 2006, J MAGN RESON IMAGING, V24, P418, DOI 10.1002/jmri.20642; Suh DC, 2008, AM J NEURORADIOL, V29, P781, DOI 10.3174/ajnr.A0922; Trossbach M, 2004, NEURORADIOLOGY, V46, P459, DOI 10.1007/s00234-004-1205-3; Vajda Z, 2012, NEUROSURGERY, V70, P91, DOI 10.1227/NEU.0b013e31822dff0f; Yoon KW, 2010, J KOREAN NEUROSURG S, V48, P485, DOI 10.3340/jkns.2010.48.6.485; Zaidat OO, 2008, NEUROLOGY, V70, P1518, DOI 10.1212/01.wnl.0000306308.08229.a3	14	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145999	10.1371/journal.pone.0145999	http://dx.doi.org/10.1371/journal.pone.0145999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731534	Green Published, gold, Green Submitted			2022-12-27	WOS:000367801400074
J	da Silva, AD; de Brito, SR; Vijaykumar, NL; da Rocha, CAJ; Monteiro, MD; Costa, JCWA; Frances, CRL				da Silva, Aleksandra do Socorro; de Brito, Silvana Rossy; Vijaykumar, Nandamudi Lankalapalli; Jorge da Rocha, Claudio Alex; Monteiro, Maurilio de Abreu; Weyl Albuquerque Costa, Joao Crisostomo; Lisboa Frances, Carlos Renato			Social Network Analysis and Mining to Monitor and Identify Problems with Large-Scale Information and Communication Technology Interventions	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; GOVERNMENT; VILLAGE; SYSTEMS; FIELD	The published literature reveals several arguments concerning the strategic importance of information and communication technology (ICT) interventions for developing countries where the digital divide is a challenge. Large-scale ICT interventions can be an option for countries whose regions, both urban and rural, present a high number of digitally excluded people. Our goal was to monitor and identify problems in interventions aimed at certification for a large number of participants in different geographical regions. Our case study is the training at the Telecentros. BR, a program created in Brazil to install telecenters and certify individuals to use ICT resources. We propose an approach that applies social network analysis and mining techniques to data collected from Telecentros. BR dataset and from the socioeconomics and telecommunications infrastructure indicators of the participants' municipalities. We found that (i) the analysis of interactions in different time periods reflects the objectives of each phase of training, highlighting the increased density in the phase in which participants develop and disseminate their projects; (ii) analysis according to the roles of participants (i. e., tutors or community members) reveals that the interactions were influenced by the center (or region) to which the participant belongs (that is, a community contained mainly members of the same region and always with the presence of tutors, contradicting expectations of the training project, which aimed for intense collaboration of the participants, regardless of the geographic region); (iii) the social network of participants influences the success of the training: that is, given evidence that the degree of the community member is in the highest range, the probability of this individual concluding the training is 0.689; (iv) the North region presented the lowest probability of participant certification, whereas the Northeast, which served municipalities with similar characteristics, presented high probability of certification, associated with the highest degree in social networking platform.	[da Silva, Aleksandra do Socorro; de Brito, Silvana Rossy] Fed Rural Univ Amazon, Cyberspace Inst, Belem Do Para, Para, Brazil; [Vijaykumar, Nandamudi Lankalapalli] Natl Inst Space Res, Special Technol Ctr, Sao Paulo, Brazil; [Jorge da Rocha, Claudio Alex] Fed Inst Educ Sci & Technol Para, Informat, Belem Do Para, Para, Brazil; [Monteiro, Maurilio de Abreu] Fed Univ Para, Amazon Higher Studies Nucleus, BR-66059 Belem, Para, Brazil; [Weyl Albuquerque Costa, Joao Crisostomo; Lisboa Frances, Carlos Renato] Fed Univ Para, Inst Technol, BR-66059 Belem, Para, Brazil	Instituto Nacional de Pesquisas Espaciais (INPE); Instituto Federal do Para; Universidade Federal do Para; Universidade Federal do Para	da Silva, AD (corresponding author), Fed Rural Univ Amazon, Cyberspace Inst, Belem Do Para, Para, Brazil.	aleksandra.silva@ufra.edu.br	Monteiro, Maurilio/H-1115-2012; Frances, Carlos Renato Lisboa/D-9783-2019; costa, Joao weyl/O-5146-2018; Monteiro, Maurilio/ABE-9570-2020	Frances, Carlos Renato Lisboa/0000-0003-0305-7662; costa, Joao weyl/0000-0003-4482-6886; Monteiro, Maurilio/0000-0002-0494-1751	CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [0645-14-1]	CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SRB received financial support (scholarship) from CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, 0645-14-1, www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 1999, J INF SCI, V25, P307, DOI 10.1177/016555159902500407; Andrade AD, 2012, INFORM TECHNOL DEV, V18, P281, DOI 10.1080/02681102.2011.643204; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2013, IND DES HUM MUN BRAS; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Asgarkhani M, 2005, PUBLIC MANAG REV, V7, P465, DOI 10.1080/14719030500181227; Ashraf M, 2009, INFORM SYST FRONT, V11, P155, DOI 10.1007/s10796-008-9133-0; Avgerou C, 2008, J INF TECHNOL, V23, P133, DOI 10.1057/palgrave.jit.2000136; Basu S., 2004, INT REV LAW COMPUTER, V18, P109, DOI [DOI 10.1080/13600860410001674779, 10.1080/13600860410001674779]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Braa J, 2004, MIS QUART, V28, P337; Calvani A, 2012, COMPUT EDUC, V58, P797, DOI 10.1016/j.compedu.2011.10.004; Chang SI, 2012, INFORM SYST FRONT, V14, P693, DOI 10.1007/s10796-011-9297-x; Chen Z, 2001, DATA MINING UNCERTAI; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Datta P, 2011, INFORM SYST J, V21, P3, DOI 10.1111/j.1365-2575.2009.00344.x; De Nooy W., 2005, EXPLORATORY SOCIAL N; Farhadi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048903; Luna-Reyes LF, 2012, GOV INFORM Q, V29, P324, DOI 10.1016/j.giq.2012.03.001; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Heeks R, 2007, GOV INFORM Q, V24, P243, DOI 10.1016/j.giq.2006.06.005; Korb K.B., 2004, COM SCI DAT; McLean S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071238; Mutula SM, 2006, INT J INFORM MANAGE, V26, P212, DOI 10.1016/j.ijinfomgt.2006.02.004; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Rotta R., 2011, J EXP ALGORITHMICS, V16, p2.1, DOI DOI 10.1145/1963190.1970376; Rowley TJ, 1997, ACAD MANAGE REV, V22, P887, DOI 10.2307/259248; Teles A, 2011, TELEMAT INFORM, V28, P191, DOI 10.1016/j.tele.2010.09.003; Venkatesh V, 2013, INFORM SYST RES, V24, P239, DOI 10.1287/isre.1110.0409; Wasserman S., 1992, J QUANTITATIVE ANTHR, V4, P23; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White G.R.T., 2014, E COMMERCE PLATFORM, P23, DOI DOI 10.1007/978-3-319-06121-4_2; Wolfe AW, 1997, AM ETHNOL, V24, P219, DOI 10.1525/ae.1997.24.1.219; Wong AMK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040591	39	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0146220	10.1371/journal.pone.0146220	http://dx.doi.org/10.1371/journal.pone.0146220			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA3FF	26727472	gold, Green Submitted, Green Published			2022-12-27	WOS:000367681500069
J	Maria, Z; Campolo, AR; Lacombe, VA				Maria, Zahra; Campolo, Allison R.; Lacombe, Veronique A.			Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria	PLOS ONE			English	Article							SKELETAL-MUSCLE; HEART-FAILURE; CONTRACTILE DYSFUNCTION; VENTRICULAR MYOCYTES; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; RAT HIPPOCAMPUS; ADIPOSE-TISSUE; TUG; TRAFFICKING	Although diabetes has been identified as a major risk factor for atrial fibrillation, little is known about glucose metabolism in the healthy and diabetic atria. Glucose transport into the cell, the rate-limiting step of glucose utilization, is regulated by the Glucose Transporters (GLUTs). Although GLUT4 is the major isoform in the heart, GLUT8 has recently emerged as a novel cardiac isoform. We hypothesized that GLUT-4 and -8 translocation to the atrial cell surface will be regulated by insulin and impaired during insulin-dependent diabetes. GLUT protein content was measured by Western blotting in healthy cardiac myocytes and type 1 (streptozotocin-induced, T1Dx) diabetic rodents. Active cell surface GLUT content was measured using a biotinylated photolabeled assay in the perfused heart. In the healthy atria, insulin stimulation increased both GLUT-4 and -8 translocation to the cell surface (by 100% and 240%, respectively, P<0.05). Upon insulin stimulation, we reported an increase in Akt (Th308 and s473 sites) and AS160 phosphorylation, which was positively (P<0.05) correlated with GLUT4 protein content in the healthy atria. During diabetes, active cell surface GLUT-4 and -8 content was downregulated in the atria (by 70% and 90%, respectively, P<0.05). Akt and AS160 phosphorylation was not impaired in the diabetic atria, suggesting the presence of an intact insulin signaling pathway. This was confirmed by the rescued translocation of GLUT-4 and -8 to the atrial cell surface upon insulin stimulation in the atria of type 1 diabetic subjects. In conclusion, our data suggest that: 1) both GLUT-4 and -8 are insulin-sensitive in the healthy atria through an Akt/AS160 dependent pathway; 2) GLUT-4 and -8 trafficking is impaired in the diabetic atria and rescued by insulin treatment. Alterations in atrial glucose transport may induce perturbations in energy production, which may provide a metabolic substrate for atrial fibrillation during diabetes.	[Maria, Zahra; Campolo, Allison R.; Lacombe, Veronique A.] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA; [Maria, Zahra] Oklahoma State Univ, Dept Mech & Aerosp Engn, Stillwater, OK 74078 USA; [Lacombe, Veronique A.] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lacombe, VA (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.	veronique.lacombe@okstate.edu			Harold Hamm Diabetes Center Enrichment Funding Program; Oklahoma State Center for Veterinary Health Sciences Seed Funding Program; Tom J Cunningham distinguished graduate student fellowship	Harold Hamm Diabetes Center Enrichment Funding Program; Oklahoma State Center for Veterinary Health Sciences Seed Funding Program; Tom J Cunningham distinguished graduate student fellowship	This work was supported by the Harold Hamm Diabetes Center Enrichment Funding Program (VAL), the Oklahoma State Center for Veterinary Health Sciences Seed Funding Program (VAL) and by the Tom J Cunningham distinguished graduate student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; BING RJ, 1953, AM J MED, V15, P284, DOI 10.1016/0002-9343(53)90082-5; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; D'Souza A, 2009, MOL CELL BIOCHEM, V331, P89, DOI 10.1007/s11010-009-0148-8; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; Gorovits N, 2003, ENDOCRINOLOGY, V144, P1703, DOI 10.1210/en.2002-220968; Huang JP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-77; International Diabetes Federation, 2014, DIAB FCTS FIG; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Kato T, 2006, J CARDIOVASC ELECTR, V17, P890, DOI 10.1111/j.1540-8167.2006.00528.x; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kranstuber AL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00292; Lacombe VA, 2007, AM J PHYSIOL-REG I, V293, pR1787, DOI 10.1152/ajpregu.00059.2007; Laviola L, 2001, DIABETES, V50, P2709, DOI 10.2337/diabetes.50.12.2709; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Lin Y., 2013, SCI WORLD J, V2013, DOI DOI 10.1155/2013/209428; Lionetti V, 2007, AM J PHYSIOL-HEART C, V293, pH2747, DOI 10.1152/ajpheart.00592.2007; Lip GYH, 2005, INT J CARDIOL, V105, P319, DOI 10.1016/j.ijcard.2005.03.003; Miller EJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1922, DOI 10.1152/ajpendo.00170.2006; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Peterson LR, 2006, J AM SOC ECHOCARDIOG, V19, P749, DOI 10.1016/j.echo.2006.01.009; Piroli GG, 2004, BRAIN RES, V1006, P28, DOI 10.1016/j.brainres.2004.01.044; Piroli GG, 2002, J COMP NEUROL, V452, P103, DOI 10.1002/cne.10368; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Schmidt S, 2009, AM J PHYSIOL-ENDOC M, V296, pE614, DOI 10.1152/ajpendo.91019.2008; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Sridhar A, 2006, AM J PHYSIOL-HEART C, V291, pH2192, DOI 10.1152/ajpheart.01146.2005; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; STUDELSKA DR, 1992, AM J PHYSIOL, V263, pE102, DOI 10.1152/ajpendo.1992.263.1.E102; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Ueda S, 2008, BIOL CELL, V100, P645, DOI 10.1042/BC20070160; Walden AP, 2009, J MOL CELL CARDIOL, V46, P463, DOI 10.1016/j.yjmcc.2008.11.003; Waller AP, 2011, BBA-MOL BASIS DIS, V1812, P1098, DOI 10.1016/j.bbadis.2011.02.007; Waller AP, 2011, J VET INTERN MED, V25, P315, DOI 10.1111/j.1939-1676.2010.0674.x; Waller AP, 2015, BBA-MOL BASIS DIS, V1852, P873, DOI 10.1016/j.bbadis.2015.01.009; Waller AP, 2013, BBA-MOL BASIS DIS, V1832, P121, DOI 10.1016/j.bbadis.2012.09.013; Ware B, 2011, AM J PHYSIOL-REG I, V301, pR1300, DOI 10.1152/ajpregu.00822.2010; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; ZANINETTI D, 1988, BIOCHEM J, V250, P277, DOI 10.1042/bj2500277	53	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146033	10.1371/journal.pone.0146033	http://dx.doi.org/10.1371/journal.pone.0146033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720696	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900038
J	Otsuka, S; Matsumoto, K; Nakajima, M; Tanaka, T; Ogura, SI				Otsuka, Shimpei; Matsumoto, Kentaro; Nakajima, Motowo; Tanaka, Tohru; Ogura, Shun-Ichiro			Oxygen Availability for Porphyrin Biosynthesis Enzymes Determines the Production of Protoporphyrin IX (PpIX) during Hypoxia	PLOS ONE			English	Article							CELLS IN-VITRO; 5-AMINOLEVULINIC ACID; GENE-EXPRESSION; BLADDER-CANCER; THERAPY; BINDING; TRANSPORTER; PROTEIN; ALPHA; HIF-1	5-Aminolevulinic acid (ALA), a precursor of porphyrin, is specifically converted to the fluorescent substance protoporphyrin IX (PpIX) in tumors to be used as a prodrug for photodynamic therapy and diagnosis. Hypoxia, a common feature of solid tumors, decreases the efficacy of ALA-based photodynamic therapy and diagnosis. This decrease results from the excretion of porphyrin precursor coproporphyrinogen III (CPgenIII), an intermediate in the biosynthesis of PpIX. However, the mechanism of CPgenIII excretion during hypoxia remains unclear. In this study, we revealed the importance of mitochondrial respiration for the production of PpIX during hypoxia. Porphyrin concentrations were estimated in human gastric cancer cell lines by HPLC. Expression levels of porphyrin biosynthesis genes were measured by qRT-PCR and immunoblotting. Blockage of porphyrin biosynthesis was an oxygen-dependent phenomenon resulting from decreased PpIX production in mitochondria under hypoxic conditions. PpIX production was increased by the inhibition of mitochondrial respiration complexes, which indicates that the enzymes of porphyrin biosynthesis compete with respiration complexes for molecular oxygen. Our results indicate that targeting the respiration complexes is a rationale for enhancing the effect of ALA-mediated treatment and diagnosis.	[Otsuka, Shimpei; Matsumoto, Kentaro; Ogura, Shun-Ichiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nakajima, Motowo; Tanaka, Tohru] SBI Pharmaceut CO LTD, Minato Ku, Tokyo 1066020, Japan	Tokyo Institute of Technology; SBI Pharmaceuticals	Ogura, SI (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 B47 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	sogura@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26430141]; SBI Pharmaceuticals CO., LTD.	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SBI Pharmaceuticals CO., LTD.	This study was supported by the Grant-in-Aid for Scientific Research (C) (No. 26430141) from the Ministry of Education, Culture, Sports, Science and Technology. SBI Pharmaceuticals CO., LTD., provided support in the form of salaries for authors [MN, TT] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Fukuhara H, 2011, INT J UROL, V18, P585, DOI 10.1111/j.1442-2042.2011.02789.x; Georgakoudi I, 1999, BRIT J CANCER, V79, P1372, DOI 10.1038/sj.bjc.6690220; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Hagiya Y, 2012, PHOTODIAGN PHOTODYN, V9, P204, DOI 10.1016/j.pdpdt.2011.12.004; Inoue K, 2013, PHOTODIAGN PHOTODYN, V10, P484, DOI 10.1016/j.pdpdt.2013.05.002; Inoue K, 2012, CANCER-AM CANCER SOC, V118, P1062, DOI 10.1002/cncr.26378; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Liu YYL, 2004, LIFE SCI, V75, P2035, DOI 10.1016/j.lfs.2004.03.027; Matsumoto K, 2015, PHOTODIAGN PHOTODYN, V12, P45, DOI 10.1016/j.pdpdt.2014.12.008; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Rebeiz N, 1996, ARCH BIOCHEM BIOPHYS, V333, P475, DOI 10.1006/abbi.1996.0417; SANO S, 1961, J BIOL CHEM, V236, P1173; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; TOMARO ML, 1981, BIOCHIM BIOPHYS ACTA, V676, P31, DOI 10.1016/0304-4165(81)90006-4; Vargas PD, 2008, FEBS J, V275, P5947, DOI 10.1111/j.1742-4658.2008.06723.x; WANG GL, 1993, BLOOD, V82, P3610; WILSON DF, 1988, J BIOL CHEM, V263, P2712; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wyld L, 1998, BRIT J CANCER, V77, P1621, DOI 10.1038/bjc.1998.265; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	26	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146026	10.1371/journal.pone.0146026	http://dx.doi.org/10.1371/journal.pone.0146026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717566	gold, Green Published, Green Submitted			2022-12-27	WOS:000367510500118
J	Marais, A; Faure, C; Candresse, T				Marais, Armelle; Faure, Chantal; Candresse, Thierry			New Insights into Asian Prunus Viruses in the Light of NGS-Based Full Genome Sequencing	PLOS ONE			English	Article							FAMILY FLEXIVIRIDAE; GENETIC DIVERSITY; LATENT VIRUS; IDENTIFICATION; CHERRY; PEACH; FOVEAVIRUS; GERMPLASM; DISEASE; MOTTLE	Double stranded RNAs were purified from five Prunus sources of Asian origin and submitted to 454 pyrosequencing after a random, whole genome amplification. Four complete genomes of Asian prunus virus 1 (APV1), APV2 and APV3 were reconstructed from the sequencing reads, as well as four additional, near-complete genome sequences. Phylogenetic analyses confirmed the close relationships of these three viruses and the taxonomical position previously proposed for APV1, the only APV so far completely sequenced. The genetic distances in the respective polymerase and coat protein genes as well as their gene products suggest that APV2 should be considered as a distinct viral species in the genus Foveavirus, even if the amino acid identity levels in the polymerase are very close to the species demarcation criteria for the family Betaflexiviridae. However, the situation is more complex for APV1 and APV3, for which opposite conclusions are obtained depending on the gene (polymerase or coat protein) analyzed. Phylogenetic and recombination analyses suggest that recombination events may have been involved in the evolution of APV. Moreover, genome comparisons show that the unusually long 3' non-coding region (3' NCR) is highly variable and a hot spot for indel polymorphisms. In particular, two APV3 variants differing only in their 3' NCR were identified in a single Prunus source, with 3' NCRs of 214-312 nt, a size similar to that observed in other foveaviruses, but 567-850 nt smaller than in other APV3 isolates. Overall, this study provides critical genome information of these viruses, frequently associated with Prunus materials, even though their precise role as pathogens remains to be elucidated.	[Marais, Armelle; Faure, Chantal; Candresse, Thierry] INRA, UMR BFP 1332, Villenave Dornon, France; [Marais, Armelle; Faure, Chantal; Candresse, Thierry] Univ Bordeaux, UMR BFP 1332, Villenave Dornon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Marais, A (corresponding author), INRA, UMR BFP 1332, Villenave Dornon, France.	amarais@bordeaux.inra.fr		Candresse, Thierry/0000-0001-9757-1835; Marais, Armelle/0000-0003-2482-1543				Abou Ghanem-Sabanadzovic N, 2013, ARCH VIROL, V158, P445, DOI 10.1007/s00705-012-1484-7; Adams M. J., 2012, VIRUS TAXONOMY, P920, DOI DOI 10.1016/B978-0-12-384684-6.00078-1; Alabi OJ, 2014, PHYTOPATHOLOGY, V104, P548, DOI 10.1094/PHYTO-06-13-0179-R; Barba M, 2014, VIRUSES-BASEL, V6, P106, DOI 10.3390/v6010106; Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007; Candresse T, 2013, PHYTOPATHOLOGY, V103, P293, DOI 10.1094/PHYTO-10-12-0275-R; Desvignes J.-C., 1999, VIRUS DIS FRUIT TREE; Foissac X, 2005, PHYTOPATHOLOGY, V95, P617, DOI 10.1094/PHYTO-95-0617; Gentit P, 2001, ARCH VIROL, V146, P1453, DOI 10.1007/s007050170071; Gibson PG, 2001, ACTA HORTIC, P309, DOI 10.17660/ActaHortic.2001.550.44; Hadidi A., 1994, Bulletin OEPP, V24, P633, DOI 10.1111/j.1365-2338.1994.tb01077.x; Hari V, 1995, ACTA HORTIC, P78, DOI 10.17660/ActaHortic.1995.386.7; James D., 1994, Bulletin OEPP, V24, P605, DOI 10.1111/j.1365-2338.1994.tb01074.x; James D, 2013, ARCH VIROL, V158, P1877, DOI 10.1007/s00705-013-1678-7; James D, 2014, ARCH VIROL, V159, P2463, DOI 10.1007/s00705-014-2075-6; Marais A, 2006, VIRUS RES, V120, P176, DOI 10.1016/j.virusres.2006.03.004; Marais A, 2004, ACTA HORTIC, P87, DOI 10.17660/ActaHortic.2004.657.9; Marais A, 2012, PLANT PATHOL, V61, P195, DOI 10.1111/j.1365-3059.2011.02488.x; Marais A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129469; Marais A, 2014, PHYTOPATHOLOGY, V104, P660, DOI 10.1094/PHYTO-08-13-0229-R; Marini DB, 2009, ARCH VIROL, V154, P1375, DOI 10.1007/s00705-009-0443-4; Martelli GP, 2007, ANNU REV PHYTOPATHOL, V45, P73, DOI 10.1146/annurev.phyto.45.062806.094401; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029; Simmonds P, 2015, J GEN VIROL, V96, P1193, DOI 10.1099/jgv.0.000016; Singh L, 2012, ARCH VIROL, V157, P531, DOI 10.1007/s00705-011-1190-x; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Villamor DEV, 2013, PHYTOPATHOLOGY, V103, P1287, DOI 10.1094/PHYTO-05-13-0140-R; Wu QF, 2015, ANNU REV PHYTOPATHOL, V53, P425, DOI 10.1146/annurev-phyto-080614-120030; Yoon JY, 2014, PLANT PATHOLOGY J, V30, P195, DOI 10.5423/PPJ.NT.02.2014.0015; Youssef F, 2011, VIRUS RES, V155, P440, DOI 10.1016/j.virusres.2010.11.013; Zanardo LG, 2014, ARCH VIROL, V159, P727, DOI 10.1007/s00705-013-1879-0	33	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2016	11	1							e0146420	10.1371/journal.pone.0146420	http://dx.doi.org/10.1371/journal.pone.0146420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4ZD	26741704	Green Published, Green Submitted, gold			2022-12-27	WOS:000367810600042
J	Nosal, AP; Chao, Y; Farrara, JD; Chai, F; Hastings, PA				Nosal, Andrew P.; Chao, Yi; Farrara, John D.; Chai, Fei; Hastings, Philip A.			Olfaction Contributes to Pelagic Navigation in a Coastal Shark	PLOS ONE			English	Article							MAGNETIC-FIELD DETECTION; DATA ASSIMILATION SCHEME; FEMALE LEOPARD SHARKS; SMELLS LIKE HOME; TRIAKIS-SEMIFASCIATA; SOUTHERN-CALIFORNIA; POSSIBLE MECHANISMS; MOVEMENT PATTERNS; GALEOCERDO-CUVIER; DIMETHYL SULFIDE	How animals navigate the constantly moving and visually uniform pelagic realm, often along straight paths between distant sites, is an enduring mystery. The mechanisms enabling pelagic navigation in cartilaginous fishes are particularly understudied. We used shoreward navigation by leopard sharks (Triakis semifasciata) as a model system to test whether olfaction contributes to pelagic navigation. Leopard sharks were captured along-shore, transported 9 km offshore, released, and acoustically tracked for approximately 4 h each until the transmitter released. Eleven sharks were rendered anosmic (nares occluded with cotton wool soaked in petroleum jelly); fifteen were sham controls. Mean swimming depth was 28.7 m. On average, tracks of control sharks ended 62.6% closer to shore, following relatively straight paths that were significantly directed over spatial scales exceeding 1600 m. In contrast, tracks of anosmic sharks ended 37.2% closer to shore, following significantly more tortuous paths that approximated correlated random walks. These results held after swimming paths were adjusted for current drift. This is the first study to demonstrate experimentally that olfaction contributes to pelagic navigation in sharks, likely mediated by chemical gradients as has been hypothesized for birds. Given the similarities between the fluid three-dimensional chemical atmosphere and ocean, further research comparing swimming and flying animals may lead to a unifying paradigm explaining their extraordinary navigational abilities.	[Nosal, Andrew P.; Hastings, Philip A.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92037 USA; [Chao, Yi; Farrara, John D.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Chao, Yi; Farrara, John D.] Univ Calif Los Angeles, Joint Inst Reg Earth Syst Sci & Engn, Los Angeles, CA 90095 USA; [Chai, Fei] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Maine System; University of Maine Orono	Nosal, AP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92037 USA.	anosal@ucsd.edu		Hastings, Philip/0000-0002-9867-6601	DeLaCour Postdoctoral Fellowship - Birch Aquarium at Scripps Institution of Oceanography; National Oceanic and Atmospheric Administration (NOAA) through the Integrated Ocean Observing System (IOOS) Regional Associations of the Southern California Coastal Ocean Observing System (SCCOOS); National Oceanic and Atmospheric Administration (NOAA) through Central and Northern California Ocean Observing System (CeNCOOS)	DeLaCour Postdoctoral Fellowship - Birch Aquarium at Scripps Institution of Oceanography; National Oceanic and Atmospheric Administration (NOAA) through the Integrated Ocean Observing System (IOOS) Regional Associations of the Southern California Coastal Ocean Observing System (SCCOOS); National Oceanic and Atmospheric Administration (NOAA) through Central and Northern California Ocean Observing System (CeNCOOS)	AN was supported by a DeLaCour Postdoctoral Fellowship awarded by the Birch Aquarium at Scripps Institution of Oceanography, which included a research allowance to cover the cost of field experiments. YC and JF were funded by the National Oceanic and Atmospheric Administration (NOAA) through the Integrated Ocean Observing System (IOOS) Regional Associations of the Southern California Coastal Ocean Observing System (SCCOOS) and Central and Northern California Ocean Observing System (CeNCOOS).	Batschelet E, 1981, CIRCULAR STAT BIOL; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Chai F, 2002, DEEP-SEA RES PT II, V49, P2713, DOI 10.1016/S0967-0645(02)00055-3; Combes V, 2013, PROG OCEANOGR, V109, P78, DOI 10.1016/j.pocean.2012.10.001; CULLEN JJ, 1981, OCEANOL ACTA, V4, P23; DACEY JWH, 1986, SCIENCE, V233, P1314, DOI 10.1126/science.233.4770.1314; Deane GB, 2000, J ACOUST SOC AM, V107, P177, DOI 10.1121/1.428299; DeBose JL, 2008, J CHEM ECOL, V34, P867, DOI 10.1007/s10886-008-9493-4; Dittman AH, 1996, J EXP BIOL, V199, P83; Dove ADM, 2015, BIOL BULL-US, V228, P65, DOI 10.1086/BBLv228n1p65; Ebert D. A., 2003, SHARKS RAYS CHIMAERA; Edren SMC, 2005, ENVIRON BIOL FISH, V72, P267, DOI 10.1007/s10641-004-2583-4; EMLEN ST, 1970, SCIENCE, V170, P1198, DOI 10.1126/science.170.3963.1198; EMLEN ST, 1967, AUK, V84, P463, DOI 10.2307/4083330; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Farrara JD, 2015, ESTUARINE COAS UNPUB; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Gardiner JM, 2007, J EXP BIOL, V210, P1925, DOI 10.1242/jeb.000075; Gardiner JM, 2015, INTEGR COMP BIOL, V55, P495, DOI 10.1093/icb/icv087; Gardiner JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093036; Gardiner JM, 2010, CURR BIOL, V20, P1187, DOI 10.1016/j.cub.2010.04.053; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Guo L, 2014, OCEAN DYNAM, V64, P1137, DOI 10.1007/s10236-014-0721-x; Hart NS, 2011, NATURWISSENSCHAFTEN, V98, P193, DOI 10.1007/s00114-010-0758-8; Hawryshyn CW, 2000, PHILOS T ROY SOC B, V355, P1187, DOI 10.1098/rstb.2000.0664; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Hueter RE, 2004, CRC MAR BIOL SER, P325; Jacobs LF, 2012, P NATL ACAD SCI USA, V109, P10693, DOI 10.1073/pnas.1201880109; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kalmijn A.J., 1984, P525; KALMIJN AJ, 1982, SCIENCE, V218, P916, DOI 10.1126/science.7134985; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Kowalewsky S, 2006, BIOL LETT-UK, V2, P106, DOI 10.1098/rsbl.2005.0380; Kramer G., 1952, Ibis, V94, P265, DOI 10.1111/j.1474-919X.1952.tb01817.x; Li ZJ, 2013, CONT SHELF RES, V63, pS209, DOI 10.1016/j.csr.2012.06.018; Li ZJ, 2008, J ATMOS OCEAN TECH, V25, P2074, DOI 10.1175/2008JTECHO594.1; Li ZJ, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004042; Lohmann KJ, 2008, J EXP BIOL, V211, P1719, DOI 10.1242/jeb.015792; Luschi Paolo, 2013, ISRN Zoology, P1; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Marchesiello P, 2001, OCEAN MODEL, V3, P1, DOI 10.1016/s1463-5003(00)00013-5; Martin RA, 2007, FISH RES, V84, P10, DOI 10.1016/j.fishres.2006.11.010; Meredith TL, 2010, J EXP BIOL, V213, P3449, DOI 10.1242/jeb.045849; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Milne BT, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P32; Mitamura H, 2005, J EXP MAR BIOL ECOL, V322, P123, DOI 10.1016/j.jembe.2005.02.010; Montgomery JC, 2001, ENVIRON BIOL FISH, V60, P109, DOI 10.1023/A:1007679005704; MOORE BR, 1980, BIOMETRIKA, V67, P175; Muscarella PA, 2014, CONT SHELF RES, V73, P41, DOI 10.1016/j.csr.2013.11.009; Nams VO, 2006, ANIM BEHAV, V72, P1197, DOI 10.1016/j.anbehav.2006.04.005; Nams VO, 2006, ACTA BIOTHEOR, V54, P1, DOI 10.1007/s10441-006-5954-8; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Nosal AP, 2014, MAR ECOL PROG SER, V499, P157, DOI 10.3354/meps10632; Nosal AP, 2013, ENVIRON BIOL FISH, V96, P865, DOI 10.1007/s10641-012-0083-5; Papastamatiou YP, 2011, J ANIM ECOL, V80, P864, DOI 10.1111/j.1365-2656.2011.01815.x; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; PARKER GH, 1914, B US BUR FISH, V33, P61; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; RICHARDSON WJ, 1990, EXPERIENTIA, V46, P416, DOI 10.1007/BF01952175; Ryan LA, 2015, MAR BIOL, V162, P1307, DOI 10.1007/s00227-015-2670-4; Shchepetkin A.F., 2006, HDB NUMERICAL ANAL S; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Sheldon RE, 1911, J EXP ZOOL, V10, P51, DOI 10.1002/jez.1400100105; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Steck K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-5; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wallraff HG, 2013, BIOGEOSCIENCES, V10, P6929, DOI 10.5194/bg-10-6929-2013; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Weihs D., 1977, P333; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; Yamamoto Y, 2013, ZOOL SCI, V30, P607, DOI 10.2108/zsj.30.607; Yopak KE, 2015, BRAIN STRUCT FUNCT, V220, P1127, DOI 10.1007/s00429-014-0705-0; Yopak KE, 2010, P NATL ACAD SCI USA, V107, P12946, DOI 10.1073/pnas.1002195107; Zar JH, 1999, BIOSTATISTICAL ANAL	79	22	22	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0143758	10.1371/journal.pone.0143758	http://dx.doi.org/10.1371/journal.pone.0143758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735492	gold, Green Published, Green Submitted			2022-12-27	WOS:000367805100005
J	Perez-Moreno, G; Cantizani, J; Sanchez-Carrasco, P; Ruiz-Perez, LM; Martin, J; el Aouad, N; Perez-Victoria, I; Tormo, JR; Gonzalez-Menendez, V; Gonzalez, I; de Pedro, N; Reyes, F; Genilloud, O; Vicente, F; Gonzalez-Pacanowska, D				Perez-Moreno, Guiomar; Cantizani, Juan; Sanchez-Carrasco, Paula; Miguel Ruiz-Perez, Luis; Martin, Jesus; el Aouad, Noureddine; Perez-Victoria, Ignacio; Ruben Tormo, Jose; Gonzalez-Menendez, Victor; Gonzalez, Ignacio; de Pedro, Nuria; Reyes, Fernando; Genilloud, Olga; Vicente, Francisca; Gonzalez-Pacanowska, Dolores			Discovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural Products	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; DRUG DISCOVERY; BIOLOGICAL EVALUATION; ASSAY; ANTIMALARIALS; FLUORESCENCE; INHIBITORS; MARINE	Due to the low structural diversity within the set of antimalarial drugs currently available in the clinic and the increasing number of cases of resistance, there is an urgent need to find new compounds with novel modes of action to treat the disease. Microbial natural products are characterized by their large diversity provided in terms of the chemical complexity of the compounds and the novelty of structures. Microbial natural products extracts have been underexplored in the search for new antiparasitic drugs and even more so in the discovery of new antimalarials. Our objective was to find new druggable natural products with antimalarial properties from the MEDINA natural products collection, one of the largest natural product libraries harboring more than 130,000 microbial extracts. In this work, we describe the optimization process and the results of a phenotypic high throughput screen (HTS) based on measurements of Plasmodium lactate dehydrogenase. A subset of more than 20,000 extracts from the MEDINA microbial products collection has been explored, leading to the discovery of 3 new compounds with antimalarial activity. In addition, we report on the novel antiplasmodial activity of 4 previously described natural products.	[Perez-Moreno, Guiomar; Sanchez-Carrasco, Paula; Miguel Ruiz-Perez, Luis; Gonzalez-Pacanowska, Dolores] CSIC, Inst Parasitol & Biomed Lopez Neyra, Armilla 18016, Granada, Spain; [Cantizani, Juan; Martin, Jesus; el Aouad, Noureddine; Perez-Victoria, Ignacio; Ruben Tormo, Jose; Gonzalez-Menendez, Victor; Gonzalez, Ignacio; de Pedro, Nuria; Reyes, Fernando; Genilloud, Olga; Vicente, Francisca] Fdn MEDINA, Armilla 18016, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Gonzalez-Pacanowska, D (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Parque Tecnol Ciencias Salud,Ave Conocimiento S-N, Armilla 18016, Granada, Spain.	dgonzalez@ipb.csic.es	EL AOUAD, Noureddine/AFL-8316-2022; González, Ignacio/I-1089-2015; Martín-Serrano, Jesús/M-1937-2014; Genilloud, Olga/I-2779-2015; Reyes, Fernando/G-4027-2013; Tormo, Jose R/M-1044-2014	EL AOUAD, Noureddine/0000-0002-4864-9306; González, Ignacio/0000-0002-8490-2401; Martín-Serrano, Jesús/0000-0001-7487-2790; Genilloud, Olga/0000-0002-4202-1219; Reyes, Fernando/0000-0003-1607-5106; PEREZ MORENO, GUIOMAR/0000-0002-6892-6083; Ruiz-Perez, Luis M./0000-0001-7681-4471; Gonzalez-Menendez, Victor/0000-0001-9859-6284; Tormo, Jose R/0000-0001-6984-2941; Gonzalez-Pacanowska, Dolores/0000-0002-4303-5209	Junta de Andalucia [BIO-199, P09-CVI-5367]; VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Institut de Salud Carlos III-Subdireccion General de Redes y Centros de Investigacion Cooperativa-Red de Investigacion Cooperative en Enfermedades Tropicales (RICET FIS Network) [RD1210018/0017]; Plan NacionaL [SAF2013-48999-R]; EU; PARAMET network [FP7-PEOPLE-2011-ITN.GA290080]; Institut de Salud Carlos III-Subdireccion General de Redes y Centros de Investigacion Cooperativa-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET FIS Network) [RD1210018/0005]	Junta de Andalucia(Junta de Andalucia); VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Institut de Salud Carlos III-Subdireccion General de Redes y Centros de Investigacion Cooperativa-Red de Investigacion Cooperative en Enfermedades Tropicales (RICET FIS Network); Plan NacionaL; EU(European Commission); PARAMET network; Institut de Salud Carlos III-Subdireccion General de Redes y Centros de Investigacion Cooperativa-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET FIS Network)	This work was supported by the Junta de Andalucia [BIO-199, P09-CVI-5367], the VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011, Institut de Salud Carlos III-Subdireccion General de Redes y Centros de Investigacion Cooperativa-Red de Investigacion Cooperative en Enfermedades Tropicales (RICET FIS Network: RD1210018/0017),the Plan Nacional (SAF2013-48999-R), the FEDER funds from the EU and the PARAMET network (FP7-PEOPLE-2011-ITN.GA290080) to DG-P. Research of FV and OG was supported by the Institut de Salud Carlos III-Subdireccion General de Redes y Centros de Investigacion Cooperativa-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET FIS Network: RD1210018/0005) and the FEDER funds from the EU and the PARAMET network (FP7-PEOPLE-2011-ITN.GA290080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13838; Annang F, 2015, J BIOMOL SCREEN, V20, P82, DOI 10.1177/1087057114555846; Aviles E, 2015, BIOORG MED CHEM LETT, V25, P5339, DOI 10.1016/j.bmcl.2015.09.033; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Beghyn T, 2008, CHEM BIOL DRUG DES, V72, P3, DOI 10.1111/j.1747-0285.2008.00673.x; BUNKERS GJ, 1991, MYCOL RES, V95, P347, DOI 10.1016/S0953-7562(09)81246-X; Che PL, 2012, ASSAY DRUG DEV TECHN, V10, P61, DOI 10.1089/adt.2011.0378; Cui HQ, 2012, J MED CHEM, V55, P10948, DOI 10.1021/jm301328h; Cui HQ, 2010, EUR J MED CHEM, V45, P5140, DOI 10.1016/j.ejmech.2010.08.026; de Macedo-Silva ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083247; Duffy S, 2012, AM J TROP MED HYG, V86, P84, DOI 10.4269/ajtmh.2012.11-0302; El Aouad N, 2012, J NAT PROD, V75, P1228, DOI 10.1021/np3002942; Gademann K, 2009, CHEM REC, V9, P187, DOI 10.1002/tcr.200900001; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Green RCE, 2009, COMPUT BIOL CHEM, V33, P189, DOI 10.1016/j.compbiolchem.2009.01.001; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Henrich CJ, 2013, NAT PROD REP, V30, P1284, DOI 10.1039/c3np70052f; Kaur K, 2009, BIOORGAN MED CHEM, V17, P3229, DOI 10.1016/j.bmc.2009.02.050; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Lucumi E, 2010, ANTIMICROB AGENTS CH, V54, P3597, DOI 10.1128/AAC.00431-10; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Martin J, 2014, J NAT PROD, V77, P2118, DOI 10.1021/np500577v; Martin JP-V I., 2012, PLANTA MED, V78; Newman DJ, 2012, J NAT PRODUCTS, V75, P311, DOI DOI 10.1021/NP200906S; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; SHIMA A, 1990, CELL STRUCT FUNCT, V15, P53, DOI 10.1247/csf.15.53; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Smit FJ, 2015, EUR J MED CHEM, V90, P33, DOI 10.1016/j.ejmech.2014.11.016; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Sturz GR, 2011, CHEM SENSES, V36, P375, DOI 10.1093/chemse/bjq146; UMEZAWA H, 1970, J ANTIBIOT, V23, P259, DOI 10.7164/antibiotics.23.259; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152; Zou L, 2002, PHYTOMEDICINE, V9, P263, DOI 10.1078/0944-7113-00121	35	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0145812	10.1371/journal.pone.0145812	http://dx.doi.org/10.1371/journal.pone.0145812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735308	Green Published, gold, Green Submitted			2022-12-27	WOS:000367805100031
J	Abu Choudhury, M; Marsh, N; Banu, S; Paterson, DL; Rickard, CM; McMillan, DJ				Abu Choudhury, Md; Marsh, Nicole; Banu, Shahera; Paterson, David L.; Rickard, Claire M.; McMillan, David J.			Molecular Comparison of Bacterial Communities on Peripheral Intravenous Catheters and Matched Skin Swabs	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; ARTERIAL CATHETERS; MICROBIAL BIOFILMS; INFECTION; DIVERSITY; METHYLOBACTERIUM; DIAGNOSIS; CHLORHEXIDINE; PREVENTION; HEALTH	Skin bacteria at peripheral intravenous catheter (PIVC) insertion sites pose a serious risk of microbial migration and subsequent colonisation of PIVCs, and the development of catheter related bloodstream infections (CRBSIs). Common skin bacteria are often associated with CRBSIs, therefore the bacterial communities at PIVC skin sites are likely to have major implications for PIVC colonisation. This study aimed to determine the bacterial community structures on skin at PIVC insertion sites and to compare the diversity with associated PIVCs. A total of 10 PIVC skin site swabs and matching PIVC tips were collected by a research nurse from 10 hospitalised medical/surgical patients at catheter removal. All swabs and PIVCs underwent traditional culture and high-throughput sequencing. The bacterial communities on PIVC skin swabs and matching PIVCs were diverse and significantly associated (correlation coefficient = 0.7, p<0.001). Methylobacterium spp. was the dominant genus in all PIVC tip samples, but not so for skin swabs. Sixty-one percent of all reads from the PIVC tips and 36% of all reads from the skin swabs belonged to this genus. Staphylococcus spp., (26%), Pseudomonas spp., (10%) and Acinetobacter spp. (10%) were detected from skin swabs but not from PIVC tips. Most skin associated bacteria commonly associated with CRBSIs were observed on skin sites, but not on PIVCs. Diverse bacterial communities were observed at skin sites despite skin decolonization at PIVC insertion. The positive association of skin and PIVC tip communities provides further evidence that skin is a major source of PIVC colonisation via bacterial migration but microbes present may be different to those traditionally identified via culture methods. The results provide new insights into the colonisation of catheters and potential pathogenesis of bacteria associated with CRBSI, and may assist in developing new strategies designed to reduce the risk of CRBSI.	[Abu Choudhury, Md; Marsh, Nicole; Rickard, Claire M.] Griffith Univ, Menzies Hlth Inst Queensland, NHMRC Ctr Res Excellence Nursing NCREN, Brisbane, Qld 4111, Australia; [Abu Choudhury, Md; Marsh, Nicole; Rickard, Claire M.; McMillan, David J.] Griffith Univ, Alliance Vasc Access Teaching & Res, Brisbane, Qld 4111, Australia; [Abu Choudhury, Md; McMillan, David J.] Univ Sunshine Coast, Sch Hlth & Sports Sci, Inflammat & Healing Res Cluster, Brisbane, Qld, Australia; [Marsh, Nicole; Rickard, Claire M.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Banu, Shahera] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Paterson, David L.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; University of the Sunshine Coast; Royal Brisbane & Women's Hospital; Queensland University of Technology (QUT); University of Queensland	McMillan, DJ (corresponding author), Griffith Univ, Alliance Vasc Access Teaching & Res, Brisbane, Qld 4111, Australia.	david.mcmillan@usc.edu.au	McMillan, David/P-5582-2016; Rickard, Claire M./C-3440-2008; Choudhury/T-2659-2019	McMillan, David/0000-0002-9339-0639; Rickard, Claire M./0000-0002-6341-7415; Marsh, Nicole/0000-0002-5779-1304; Choudhury, Nahid/0000-0002-6527-4876; Paterson, David/0000-0003-2079-4437	National Health and Medical Council of Australia [APP1041910]; University of the Sunshine Coast	National Health and Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of the Sunshine Coast	The work was supported by a grant from National Health and Medical Council of Australia (APP1041910) and the University of the Sunshine Coast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by a grant from National Health and Medical Council of Australia (APP1041910) and the University of the Sunshine Coast.	Barnett AG, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003587; Bek-Thomsen M, 2008, J CLIN MICROBIOL, V46, P3355, DOI 10.1128/JCM.00799-08; Bouza E, 2005, CLIN INFECT DIS, V40, P1096, DOI 10.1086/428576; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Colwell R R, 2000, J Infect Chemother, V6, P121, DOI 10.1007/PL00012151; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Ducel G, 2002, PREVENTION HOSP ACQU; Ezingeard E, 2009, J HOSP INFECT, V72, P169, DOI 10.1016/j.jhin.2009.01.007; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fletcher S, 2005, BJA EDUC, V5, P49, DOI 10.1093/bjaceaccp/mki011; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HIRAISHI A, 1995, APPL ENVIRON MICROB, V61, P2099, DOI 10.1128/AEM.61.6.2099-2107.1995; KAYE KM, 1992, CLIN INFECT DIS, V14, P1010, DOI 10.1093/clinids/14.5.1010; Kim W, 2014, P NATL ACAD SCI USA, V111, pE1639, DOI 10.1073/pnas.1323632111; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Kovaleva J, 2014, J CLIN MICROBIOL, V52, P1317, DOI 10.1128/JCM.03561-13; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Lai CC, 2011, J CLIN MICROBIOL, V49, P3329, DOI 10.1128/JCM.01241-11; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; MAKI DG, 1991, LANCET, V338, P339, DOI 10.1016/0140-6736(91)90479-9; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Perez E, 2014, J CLIN MICROBIOL, V52, P823, DOI 10.1128/JCM.02220-13; Ponnusamy V, 2014, ACTA PAEDIATR, V103, P1233, DOI 10.1111/apa.12779; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; RUSSELL AD, 1986, INFECTION, V14, P212, DOI 10.1007/BF01644264; Safdar N, 2004, INTENS CARE MED, V30, P62, DOI 10.1007/s00134-003-2045-z; Smith K, 2008, J ANTIMICROB CHEMOTH, V61, P78, DOI 10.1093/jac/dkm395; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07; Winsley T, 2012, APPL ENVIRON MICROB, V78, P5938, DOI 10.1128/AEM.01299-12; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Zhang L, 2014, EUR J CLIN MICROBIOL, V33, P1189, DOI 10.1007/s10096-014-2058-2; Zhang L, 2013, EUR J CLIN MICROBIOL, V32, P1083, DOI 10.1007/s10096-013-1854-4; Zhang L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-266	43	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146354	10.1371/journal.pone.0146354	http://dx.doi.org/10.1371/journal.pone.0146354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731737	Green Published, gold			2022-12-27	WOS:000367801400157
J	Cheng, H; Furnham, A				Cheng, Helen; Furnham, Adrian			The Big-Five Personality Traits, Maternal Smoking during Pregnancy, and Educational Qualifications as Predictors of Tobacco Use in a Nationally Representative Sample	PLOS ONE			English	Article							CIGARETTE-SMOKING; 5-FACTOR MODEL; METAANALYSIS; MORTALITY; HEALTH	Objective To investigate the associations between the Big-Five personality traits, parental social class, maternal smoking status during pregnancy, childhood cognitive ability, education and occupation, and tobacco use in a longitudinal birth cohort study. Method 17,415 babies born in Great Britain in 1958 and followed up at 11, 33, and 50 years of age. Lifelong tobacco use status (ever/never) and current tobacco use status (yes/no) at age 50 years were the outcome measures respectively. Results Logistic regression analyses showed that among the 5,840 participants with complete data, whilst maternal smoking status, educational qualifications, and all the big-5 personality traits were significant predictors of adult lifelong tobacco use; educational qualifications, own occupational levels, traits Extraversion, Conscientiousness, and Openness were significant predictors of current smoking status. In lifelong measure men tended to have a greater rate of tobacco use than women (52.1% in men and 49.2% in women). However, the sex effect on lifelong tobacco use ceased to be significant once a set of socio-economic and psychological variables in childhood and adulthood were taken into account. Conclusion Educational qualifications and the Big-Five personality traits were significantly associated with both current and lifelong tobacco use status.	[Cheng, Helen; Furnham, Adrian] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [Cheng, Helen] UCL, Inst Educ, ESRC Ctr Learning & Life Chances Knowledge Econ &, London WC1H 0AL, England; [Furnham, Adrian] BI Norwegian Business Sch, N-0484 Oslo, Norway	University of London; University College London; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of London; University College London; UCL Institute of Education; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England.	a.furnham@ucl.ac.uk	Furnham, Adrian/ABB-2072-2020					Aycicegi-Dinn A, 2014, PROCD SOC BEHV, V159, P232, DOI 10.1016/j.sbspro.2014.12.363; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Campbell S., 2014, J ADDICTION RES THER, V5, P191, DOI DOI 10.4172/2155-6105.1000191; Douglas James W.B, 1964, HOME SCH; del Rio EF, 2015, PERS INDIV DIFFER, V80, P41, DOI 10.1016/j.paid.2015.02.030; Ferri E., 2003, CHANGING BRITAIN CHA; Friedman HS, 2008, BRAIN BEHAV IMMUN, V22, P668, DOI 10.1016/j.bbi.2007.09.004; Friedman HS, 2014, ANNU REV PSYCHOL, V65, P719, DOI 10.1146/annurev-psych-010213-115123; FRIEDMAN HS, 1993, J PERS SOC PSYCHOL, V65, P176, DOI 10.1037/0022-3514.65.1.176; Furnham A., 2008, PERSONALITY INTELLIG; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Leete R, 1977, POPULATION TRENDS, V8, P1; Leon DA, 2009, INTELLIGENCE, V37, P520, DOI 10.1016/j.intell.2008.11.004; MARSH C, 1986, KEY VARIABLES SOCIAL; Munafo MR, 2007, NICOTINE TOB RES, V9, P405, DOI 10.1080/14622200701188851; Plewis I, 2004, NATL CHILD DEV STUDY; Revelle W., 1997, SCI STUDY HUMAN NATU, P189; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Weston SJ, 2015, J RES PERS, V54, P61, DOI 10.1016/j.jrp.2014.04.008; Wilkinson R., 2003, THE SOLID FACTS; World Health Organization, 2008, WHO REP GLOB TOB EP; Zvolensky MJ, 2015, J PSYCHIATR RES, V63, P91, DOI 10.1016/j.jpsychires.2015.02.008	24	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145552	10.1371/journal.pone.0145552	http://dx.doi.org/10.1371/journal.pone.0145552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4VZ	26731730	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400040
J	Cheng, M; Yoshiyasu, H; Okano, K; Ohtake, H; Honda, K				Cheng, Maria; Yoshiyasu, Hayato; Okano, Kenji; Ohtake, Hisao; Honda, Kohsuke			Redirection of the Reaction Specificity of a Thermophilic Acetolactate Synthase toward Acetaldehyde Formation	PLOS ONE			English	Article							PYRUVATE DECARBOXYLASE; THERMAL-STABILITY; ENZYME; EVOLUTION; ACID; HYPERTHERMOPHILES; THERMOSTABILITY; IMPROVEMENT; INSIGHTS; FEATURES	Acetolactate synthase and pyruvate decarboxylase are thiamine pyrophosphate-dependent enzymes that convert pyruvate into acetolactate and acetaldehyde, respectively. Although the former are encoded in the genomes of many thermophiles and hyperthermophiles, the latter has been found only in mesophilic organisms. In this study, the reaction specificity of acetolactate synthase from Thermus thermophilus was redirected to catalyze acetaldehyde formation to develop a thermophilic pyruvate decarboxylase. Error-prone PCR and mutant library screening led to the identification of a quadruple mutant with 3.1-fold higher acetaldehyde-forming activity than the wild-type. Site-directed mutagenesis experiments revealed that the increased activity of the mutant was due to H474R amino acid substitution, which likely generated two new hydrogen bonds near the thiamine pyrophosphate-binding site. These hydrogen bonds might result in the better accessibility of H+ to the substrate-cofactor-enzyme intermediate and a shift in the reaction specificity of the enzyme.	[Cheng, Maria; Yoshiyasu, Hayato; Okano, Kenji; Ohtake, Hisao; Honda, Kohsuke] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Honda, Kohsuke] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Osaka University; Japan Science & Technology Agency (JST)	Honda, K (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	honda@bio.eng.osaka-u.ac.jp	Okano, Kenji/U-2001-2019; 孝祐, 本田/V-8668-2019	Okano, Kenji/0000-0002-9112-3211; Honda, Kohsuke/0000-0001-9069-7574	Japan Science and Technology Agency (JST), CREST program; Japan Society for the Promotion of Science (JSPS), KAKENHI Grant [26450088]	Japan Science and Technology Agency (JST), CREST program; Japan Society for the Promotion of Science (JSPS), KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Science and Technology Agency (JST), CREST program, and the Japan Society for the Promotion of Science (JSPS), KAKENHI Grant (26450088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut N, 2013, J BIOTECHNOL, V164, P123, DOI 10.1016/j.jbiotec.2012.12.016; Atomi H, 2005, CURR OPIN CHEM BIOL, V9, P166, DOI 10.1016/j.cbpa.2005.02.013; Atomi H, 2011, CURR OPIN BIOTECH, V22, P618, DOI 10.1016/j.copbio.2011.06.010; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Berezovsky IN, 2005, P NATL ACAD SCI USA, V102, P12742, DOI 10.1073/pnas.0503890102; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Bruins ME, 2001, APPL BIOCHEM BIOTECH, V90, P155, DOI 10.1385/ABAB:90:2:155; Bunik VI, 2013, FEBS J, V280, P6412, DOI 10.1111/febs.12512; Chipman D, 1998, BBA-PROTEIN STRUCT M, V1385, P401, DOI 10.1016/S0167-4838(98)00083-1; Chipman DM, 2005, CURR OPIN CHEM BIOL, V9, P475, DOI 10.1016/j.cbpa.2005.07.002; Cripps RE, 2009, METAB ENG, V11, P398, DOI 10.1016/j.ymben.2009.08.005; DAWES EA, 1966, BIOCHEM J, V98, P795, DOI 10.1042/bj0980795; Denard CA, 2015, CURR OPIN CHEM BIOL, V25, P55, DOI 10.1016/j.cbpa.2014.12.036; Ding HT, 2013, ENZYME MICROB TECH, V53, P365, DOI 10.1016/j.enzmictec.2013.08.001; Duggleby RG, 2008, PLANT PHYSIOL BIOCH, V46, P309, DOI 10.1016/j.plaphy.2007.12.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eram MS, 2014, ARCHAEA, V2014, DOI 10.1155/2014/349379; Eram MS, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030578; FAGAIN C, 1995, BBA-PROTEIN STRUCT M, V1252, P1, DOI 10.1016/0167-4838(95)00133-F; Guterl JK, 2012, CHEMSUSCHEM, V5, P2165, DOI 10.1002/cssc.201200365; Huang CY, 2001, EUR J BIOCHEM, V268, P3558, DOI 10.1046/j.1432-1327.2001.02260.x; Jorda J, 2011, ARCHAEA, V2011, DOI 10.1155/2011/409156; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; KIMURA S, 1992, J BIOL CHEM, V267, P21535; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; Koyama Y, 2013, PROTEIN ENG DES SEL, V26, P755, DOI 10.1093/protein/gzt049; Krutsakorn B, 2013, METAB ENG, V20, P84, DOI 10.1016/j.ymben.2013.09.006; Krutsakorn B, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-91; Labrou NE, 2005, BIOMOL ENG, V22, pVII, DOI 10.1016/j.bioeng.2005.02.001; Liese A, 2008, ENZYME CATALYSIS ORG, P1419, DOI [10.1002/9783527618262, DOI 10.1002/9783527618262.CH19]; Ma K, 1997, P NATL ACAD SCI USA, V94, P9608, DOI 10.1073/pnas.94.18.9608; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meyer D, 2012, P NATL ACAD SCI USA, V109, P10867, DOI 10.1073/pnas.1201280109; Meyer D, 2011, J AM CHEM SOC, V133, P3609, DOI 10.1021/ja110236w; Meyer D, 2010, BIOCHEMISTRY-US, V49, P8197, DOI 10.1021/bi100828r; Naderi M, 2015, PROTEIN PEPTIDE LETT, V22, P23; Opgenorth PH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5113; Pang SS, 2004, J BIOL CHEM, V279, P2242, DOI 10.1074/jbc.M304038200; Pei XY, 2010, BIOCHEMISTRY-US, V49, P1727, DOI 10.1021/bi901864j; Raj KC, 2001, ARCH MICROBIOL, V176, P443, DOI 10.1007/s002030100348; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rojkova AM, 1999, FEBS LETT, V445, P183, DOI 10.1016/S0014-5793(99)00127-1; Sakai G, 2015, BIOTECHNOL LETT, V37, P1091, DOI 10.1007/s10529-015-1774-8; Sergienko EA, 2001, BIOCHEMISTRY-US, V40, P7369, DOI 10.1021/bi002856m; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Van Zyl LJ, 2014, APPL MICROBIOL BIOT, V98, P1247, DOI 10.1007/s00253-013-5380-1; Yamada R, 2014, J BIOTECHNOL, V192, P248, DOI 10.1016/j.jbiotec.2014.10.030; Yokoyama S, 2000, PROG BIOPHYS MOL BIO, V73, P363, DOI 10.1016/S0079-6107(00)00012-2; Yun HS, 2013, J IND MICROBIOL BIOT, V40, P1223, DOI 10.1007/s10295-013-1330-2	49	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146146	10.1371/journal.pone.0146146	http://dx.doi.org/10.1371/journal.pone.0146146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26731734	Green Submitted, gold, Green Published			2022-12-27	WOS:000367801400103
J	Low, JSY; Chin, YM; Mushiroda, T; Kubo, M; Govindasamy, GK; Pua, KC; Yap, YY; Yap, LF; Subramaniam, SK; Ong, CA; Tan, TY; Khoo, ASB; Ng, CC				Low, Joyce Siew Yong; Chin, Yoon Ming; Mushiroda, Taisei; Kubo, Michiaki; Govindasamy, Gopala Krishnan; Pua, Kin Choo; Yap, Yoke Yeow; Yap, Lee Fah; Subramaniam, Selva Kumar; Ong, Cheng Ai; Tan, Tee Yong; Khoo, Alan Soo Beng; Ng, Ching Ching		Malaysian NPC Study Grp	A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci	PLOS ONE			English	Article							SUSCEPTIBILITY LOCUS; POOR-PROGNOSIS; DNA-REPAIR; CANCER; EXPRESSION; CELLS; PROTEIN; GENE; MICA; NEUROBLASTOMA	Background Nasopharyngeal carcinoma (NPC) is a neoplasm of the epithelial lining of the nasopharynx. Despite various reports linking genomic variants to NPC predisposition, very few reports were done on copy number variations (CNV). CNV is an inherent structural variation that has been found to be involved in cancer predisposition. Methods A discovery cohort of Malaysian Chinese descent (NPC patients, n = 140; Healthy controls, n = 256) were genotyped using Illumina (R) HumanOmniExpress BeadChip. PennCNV and cnvPartition calling algorithms were applied for CNV calling. Taqman CNV assays and digital PCR were used to validate CNV calls and replicate candidate copy number variant region (CNVR) associations in a follow-up Malaysian Chinese (NPC cases, n = 465; and Healthy controls, n = 677) and Malay cohort (NPC cases, n = 114; Healthy controls, n = 124). Results Six putative CNVRs overlapping GRM5, MICA/HCP5/HCG26, LILRB3/LILRA6, DPY19L2, RNase3/RNase2 and GOLPH3 genes were jointly identified by PennCNV and cnvPartition. CNVs overlapping GRM5 and MICA/HCP5/HCG26 were subjected to further validation by Taqman CNV assays and digital PCR. Combined analysis in Malaysian Chinese cohort revealed a strong association at CNVR on chromosome 11q14.3 (P-combined = 1.54x10(-5); odds ratio (OR) = 7.27; 95% CI = 2.96-17.88) overlapping GRM5 and a suggestive association at CNVR on chromosome 6p21.3 (P-combined = 1.29x10(-3); OR = 4.21; 95% CI = 1.75-10.11) overlapping MICA/HCP5/HCG26 genes. Conclusion Our results demonstrated the association of CNVs towards NPC susceptibility, implicating a possible role of CNVs in NPC development.	[Low, Joyce Siew Yong; Chin, Yoon Ming; Ng, Ching Ching] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Low, Joyce Siew Yong; Chin, Yoon Ming; Ng, Ching Ching] Univ Malaya, Translat Genom Lab, Kuala Lumpur, Malaysia; [Mushiroda, Taisei] RIKEN Ctr Integrat Med Sci, Lab Pharmacogenet, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Govindasamy, Gopala Krishnan] Univ Malaya, Fac Med, Dept Otorhinolaryngol, Kuala Lumpur, Malaysia; [Pua, Kin Choo] Hosp Pulau Pinang, Dept Otorhinolaryngol, George Town, Malaysia; [Yap, Yoke Yeow] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Surg, Kuala Lumpur, Malaysia; [Yap, Lee Fah] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur, Malaysia; [Yap, Lee Fah] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Subramaniam, Selva Kumar] Sarawak Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Sarawak, Malaysia; [Ong, Cheng Ai] Queen Elizabeth Hosp, ENT Dept, Kota Kinabalu, Sabah, Malaysia; [Tan, Tee Yong] Sarawak Gen Hosp, Dept Otorhinolaryngol, Kuching, Sarawak, Malaysia; [Khoo, Alan Soo Beng] Inst Med Res, Canc Res Ctr, Mol Pathol Unit, Kuala Lumpur 50588, Malaysia	Universiti Malaya; Universiti Malaya; RIKEN; RIKEN; Universiti Malaya; Universiti Putra Malaysia; Universiti Malaya; Universiti Malaya; Kementerian Kesihatan Malaysia	Ng, CC (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	ccng@um.edu.my	NG, CHING CHING/B-9221-2010; Yap, Lee-Fah/M-1065-2016; Sim, Edmund Ui-Hang/J-2863-2019	Yap, Lee-Fah/0000-0002-6815-3607; Sim, Edmund Ui-Hang/0000-0001-8652-8495; Prepageran, Narayanan/0000-0001-5670-9340; Mohana Kumaran, Nethia/0000-0002-2162-8409	 [UM.C/625/1/1HIR/MOHE/CHAN-02 (H-50001-A000023)]		This work was supported by High Impact Research Grant UM.C/625/1/1HIR/MOHE/CHAN-02 (H-50001-A000023).	ARMSTRONG RW, 1974, BRIT J CANCER, V30, P86, DOI 10.1038/bjc.1974.116; Armstrong RW, 2000, INT J EPIDEMIOL, V29, P991, DOI 10.1093/ije/29.6.991; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Cavalheiro EA, 2001, P NATL ACAD SCI USA, V98, P5947, DOI 10.1073/pnas.121179198; CHAN SH, 1983, INT J CANCER, V32, P171, DOI 10.1002/ijc.2910320206; Chin YM, 2014, INT J CANC; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P1100; Choi KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/pnas.1107304108; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Corti C, 2003, J BIOL CHEM, V278, P33105, DOI 10.1074/jbc.M212380200; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Dodd LE, 2006, CANCER EPIDEM BIOMAR, V15, P2216, DOI 10.1158/1055-9965.EPI-06-0455; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Glessner JT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1346; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hatin WI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018312; Hepeng Jia, 2008, Science, V321, P1154, DOI 10.1126/science.321.5893.1154; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Hua X, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-127; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Jia WH, 2005, EUR J HUM GENET, V13, P248, DOI 10.1038/sj.ejhg.5201305; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Kumar V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044743; Lan YY, 2012, J VIROL, V86, P6656, DOI 10.1128/JVI.00174-12; Lange CM, 2013, J HEPATOL, V59, P504, DOI 10.1016/j.jhep.2013.04.032; Li SY, 2005, INT J ONCOL, V27, P1329; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; Maeda T, 2002, J BIOCHEM, V132, P737, DOI 10.1093/oxfordjournals.jbchem.a003281; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; McCredie M, 1999, BRIT J CANCER, V79, P1277, DOI 10.1038/sj.bjc.6690205; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Okada Y, 2014, HUMAN MOL GENETICS; Omar ZA, 2006, MALAYSIAN CANC STAT; Ota M, 2000, TISSUE ANTIGENS, V56, P268, DOI 10.1034/j.1399-0039.2000.560309.x; Park SY, 2007, ONCOL REP, V17, P81; Peng JZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107362; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; SIMONS MJ, 1974, INT J CANCER, V13, P122, DOI 10.1002/ijc.2910130114; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian W, 2006, IMMUNOGENETICS, V58, P113, DOI 10.1007/s00251-006-0093-6; Tse KP, 2011, HUM MOL GENET, V20, P2889, DOI 10.1093/hmg/ddr191; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Tulalamba Warut, 2012, Int J Cell Biol, V2012, P594681, DOI 10.1155/2012/594681; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Zhang Y, 2014, TUMOR BIOL, V35, P10833, DOI 10.1007/s13277-014-2357-3	57	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0145774	10.1371/journal.pone.0145774	http://dx.doi.org/10.1371/journal.pone.0145774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730743	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400051
J	Naluyima, P; Eller, LA; Ouma, BJ; Kyabaggu, D; Kataaha, P; Guwatudde, D; Kibuuka, H; Wabwire-Mangen, F; Robb, ML; Michael, NL; de Souza, MS; Sandberg, JK; Eller, MA				Naluyima, Prossy; Eller, Leigh Anne; Ouma, Benson J.; Kyabaggu, Denis; Kataaha, Peter; Guwatudde, David; Kibuuka, Hannah; Wabwire-Mangen, Fred; Robb, Merlin L.; Michael, Nelson L.; de Souza, Mark S.; Sandberg, Johan K.; Eller, Michael A.			Sex and Urbanicity Contribute to Variation in Lymphocyte Distribution across Ugandan Populations	PLOS ONE			English	Article							REFERENCE INTERVALS; IMMUNE-RESPONSES; REFERENCE VALUES; REFERENCE RANGES; HEALTHY-ADULTS; VACCINE; EOSINOPHILS; CHILDREN; GENDER; RACE	Management of patient care and interpretation of research data require evaluation of laboratory results in the context of reference data from populations with known health status to adequately diagnose disease or make a physiological assessment. Few studies have addressed the diversity of lymphocyte subsets in rural and urban Ugandan populations. Here, 663 healthy blood bank donors from semi-urban centers of Kampala consented to participate in a study to define lymphocyte reference ranges. Whole blood immunophenotyping was performed to determine the frequency and absolute counts of T, B, and NK cells using clinical flow cytometry. Results from blood bank donors were compared to a rural cohort from the district of Kayunga and more urban clinical trial participants from the capital city, Kampala. Relationships between hematological and lymphocyte parameters were also explored. In the semi-urban blood donors, females were significantly different from males in all parameters except the frequency of CD8 T and B cells. Females had higher absolute counts of CD4 T, CD8 T and B cells, whereas males had higher NK cell counts. NK cell frequency and counts were significantly higher in semi-urban blood donors, regardless of sex, compared to more urban study participants. CD8 T cell frequency and counts were significantly higher in the blood donors compared to the rural participants, irrespective of sex. Interestingly, basophil counts were positively associated with overall T cell counts. These findings suggest that both sex and level of cohort urbanicity may influence lymphocyte subset distributions in Ugandans.	[Naluyima, Prossy; Ouma, Benson J.; Kyabaggu, Denis; Kibuuka, Hannah; Wabwire-Mangen, Fred] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Naluyima, Prossy; Sandberg, Johan K.] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden; [Eller, Leigh Anne; Robb, Merlin L.; Michael, Nelson L.; Eller, Michael A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 21218 USA; [Eller, Leigh Anne; Robb, Merlin L.; Eller, Michael A.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Kataaha, Peter] Uganda Natl Blood Transfus Serv, Kampala, Uganda; [Guwatudde, David; Wabwire-Mangen, Fred] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [de Souza, Mark S.] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand	Makerere University; Karolinska Institutet; Karolinska University Hospital; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Makerere University; Thai Red Cross Society	Eller, MA (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 21218 USA.	meller@hivresearch.org	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Sandberg, Johan/0000-0002-6275-0750; Kyabaggu, Denis/0000-0002-1826-5459; Naluyima, Prossy/0000-0001-6911-2199	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-11-2-0174]; U.S. Department of Defense (DoD) [W81XWH-11-2-0174]; Swedish Research Council; Swedish Cancer Society; Stockholm County Council; Karolinska Institutet; Division of Intramural Research, NIAID, NIH	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DoD)(United States Department of Defense); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a cooperative agreement (W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DoD). Additional support was provided by the Swedish Research Council, the Swedish Cancer Society, the Stockholm County Council, Karolinska Institutet, and the Division of Intramural Research, NIAID, NIH.	Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; Afolabi J K, 2017, J Int Assoc Provid AIDS Care, V16, P359, DOI 10.1177/2325957414530472; Bernin H, 2014, J INFECT DIS, V209, pS107, DOI 10.1093/infdis/jit610; Bunders M, 2006, ANN TROP PAEDIATR, V26, P169, DOI 10.1179/146532806X120255; Coad J, 2011, CURR OPIN CLIN NUTR, V14, P625, DOI 10.1097/MCO.0b013e32834be6fd; Garcia-Dabrio MC, 2012, ACTA HAEMATOL-BASEL, V127, P244, DOI 10.1159/000337051; Das Indranil, 2014, J Nat Sci Biol Med, V5, P158, DOI 10.4103/0976-9668.127317; Eller LA, 2007, J CLIN MICROBIOL, V45, P3281, DOI 10.1128/JCM.00894-07; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Eller MA, 2007, VACCINE, V25, P7737, DOI 10.1016/j.vaccine.2007.08.056; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Furuta GT, 2014, ANN ALLERG ASTHMA IM, V113, P3, DOI 10.1016/j.anai.2014.04.002; Garenne M, 2015, J INFECT DIS, V211, P331, DOI 10.1093/infdis/jiu448; Geering B, 2013, TRENDS IMMUNOL, V34, P398, DOI 10.1016/j.it.2013.04.002; Guwatudde D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004145; Karasuyama H, 2014, CURR OPIN IMMUNOL, V31, P1, DOI 10.1016/j.coi.2014.07.004; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Kirsch S, 2012, J CLIN IMMUNOL, V32, P1381, DOI 10.1007/s10875-012-9730-z; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Kollmann TR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00081; Torres AJL, 2013, REV INST MED TROP SP, V55, P323, DOI 10.1590/S0036-46652013000500005; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; McClelland EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063632; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; NCCLS, 2000, C28 HOW DEF DET REF, V2nd ed, P59; Ruzagira E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105089; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Sempa JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073190; Smolen KK, 2014, J IMMUNOL, DOI [10.4049/jimmunol.1400895, DOI 10.4049/JIMMUN0L.1400895]; Stevens W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002043; Toxqui L, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-71; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; van Lunzen J, 2014, J INFECT DIS, V209, pS79, DOI 10.1093/infdis/jiu159; Vaucher P, 2009, VACCINE, V27, P1928, DOI 10.1016/j.vaccine.2009.01.107; WHO, 2014, WORLD HLTH STAT 2014, P180; WHO, 2013, CONS GUI US ARV DRUG, P9; World Health Organization, 2013, COMPREHENSIVE CERVIC; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146196	10.1371/journal.pone.0146196	http://dx.doi.org/10.1371/journal.pone.0146196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730706	Green Submitted, Green Published, gold			2022-12-27	WOS:000367801400114
J	Ozyurt, IB; Grethe, JS; Martone, ME; Bandrowski, AE				Ozyurt, Ibrahim Burak; Grethe, Jeffrey S.; Martone, Maryann E.; Bandrowski, Anita E.			Resource Disambiguator for the Web: Extracting Biomedical Resources and Their Citations from the Scientific Literature	PLOS ONE			English	Article							NEUROSCIENCE; FRAMEWORK	The NIF Registry developed and maintained by the Neuroscience Information Framework is a cooperative project aimed at cataloging research resources, e.g., software tools, databases and tissue banks, funded largely by governments and available as tools to research scientists. Although originally conceived for neuroscience, the NIF Registry has over the years broadened in the scope to include research resources of general relevance to biomedical research. The current number of research resources listed by the Registry numbers over 13K. The broadening in scope to biomedical science led us to re-christen the NIF Registry platform as SciCrunch. The NIF/SciCrunch Registry has been cataloging the resource landscape since 2006; as such, it serves as a valuable dataset for tracking the breadth, fate and utilization of these resources. Our experience shows research resources like databases are dynamic objects, that can change location and scope over time. Although each record is entered manually and human-curated, the current size of the registry requires tools that can aid in curation efforts to keep content up to date, including when and where such resources are used. To address this challenge, we have developed an open source tool suite, collectively termed RDW: Resource Disambiguator for the (Web). RDW is designed to help in the upkeep and curation of the registry as well as in enhancing the content of the registry by automated extraction of resource candidates from the literature. The RDW toolkit includes a URL extractor from papers, resource candidate screen, resource URL change tracker, resource content change tracker. Curators access these tools via a web based user interface. Several strategies are used to optimize these tools, including supervised and unsupervised learning algorithms as well as statistical text analysis. The complete tool suite is used to enhance and maintain the resource registry as well as track the usage of individual resources through an innovative literature citation index honed for research resources. Here we present an overview of the Registry and show how the RDW tools are used in curation and usage tracking.	[Ozyurt, Ibrahim Burak; Grethe, Jeffrey S.; Martone, Maryann E.; Bandrowski, Anita E.] UCSD, CRBS, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Bandrowski, AE (corresponding author), UCSD, CRBS, La Jolla, CA 92093 USA.	abandrowski@ucsd.edu		Grethe, Jeffrey/0000-0001-5212-7052; Bandrowski, Anita/0000-0002-5497-0243	HHS/United States [HHSN271200577531C/PHS]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U24DA039832] Funding Source: NIH RePORTER	HHS/United States; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by HHSN271200577531C/PHS HHS/United States.; This work was supported by contract number HHSN271200577531C/PHS HHS/United States, administered by NIDA. We thank Andrea Arnaud-Stagg and Christie Wang for their help preparing the data for Fig 2 and Elsevier for allowing us to use their papers to train several of the algorithms.	[Anonymous], 2001, CONDITIONAL RANDOM F; Bandrowski AE, 2012, HYBRID HUMAN MACH RE, V2012; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Broder AZ, 1997, SYNTACTIC CLUSTERING, P1997; Bug WJ, 2008, NEUROINFORMATICS, V6, P175, DOI 10.1007/s12021-008-9032-z; Cachat J, 2012, INT REV NEUROBIOL, V103, P39, DOI 10.1016/B978-0-12-388408-4.00003-4; de la Calle G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-320; Duck G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-194; Gardner D, 2008, NEUROINFORMATICS, V6, P149, DOI 10.1007/s12021-008-9024-z; Imam Fahim T., 2012, Frontiers in Genetics, V3, P111, DOI 10.3389/fgene.2012.00111; Joachims T., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P137, DOI 10.1007/BFb0026683; Joachims T, 1999, MACHINE LEARNING, PROCEEDINGS, P200; Marenco LN, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00058; McCallum, 2002, MALLET MACHINE LEARN; Muller HM, 2008, NEUROINFORMATICS, V6, P195, DOI 10.1007/s12021-008-9031-0; Ozyurt IB, 2008, P 21 INT FLOR ART IN, P189; Palmer DD, 1997, COMPUT LINGUIST, V23, P241; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Tenenbaum JD, 2011, J BIOMED INFORM, V44, P137, DOI 10.1016/j.jbi.2010.10.003; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Yamamoto Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-287	21	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146300	10.1371/journal.pone.0146300	http://dx.doi.org/10.1371/journal.pone.0146300			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730820	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400142
J	Vaisvaser, S; Modai, S; Farberov, L; Lin, T; Sharon, H; Gilam, A; Volk, N; Admon, R; Edry, L; Fruchter, E; Wald, I; Bar-Haim, Y; Tarrasch, R; Chen, A; Shomron, N; Hendler, T				Vaisvaser, Sharon; Modai, Shira; Farberov, Luba; Lin, Tamar; Sharon, Haggai; Gilam, Avital; Volk, Naama; Admon, Roee; Edry, Liat; Fruchter, Eyal; Wald, Ilan; Bar-Haim, Yair; Tarrasch, Ricardo; Chen, Alon; Shomron, Noam; Hendler, Talma			Neuro-Epigenetic Indications of Acute Stress Response in Humans: The Case of MicroRNA-29c	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; GENE-EXPRESSION; FUNCTIONAL CONNECTIVITY; ANTERIOR INSULA; BRAIN NETWORKS; FMRI; MEMORY; VULNERABILITY; RESILIENCE; PLASTICITY	Stress research has progressively become more integrative in nature, seeking to unfold crucial relations between the different phenotypic levels of stress manifestations. This study sought to unravel stress-induced variations in expression of human microRNAs sampled in peripheral blood mononuclear cells and further assess their relationship with neuronal and psychological indices. We obtained blood samples from 49 healthy male participants before and three hours after performing a social stress task, while undergoing functional magnetic resonance imaging (fMRI). A seed-based functional connectivity (FC) analysis was conducted for the ventro-medial prefrontal cortex (vmPFC), a key area of stress regulation. Out of hundreds of microRNAs, a specific increase was identified in microRNA-29c (miR-29c) expression, corresponding with both the experience of sustained stress via self-reports, and alterations in vmPFC functional connectivity. Explicitly, miR-29c expression levels corresponded with both increased connectivity of the vmPFC with the anterior insula (alns), and decreased connectivity of the vmPFC with the left dorso-lateral prefrontal cortex (dlPFC). Our findings further revealed that miR-29c mediates an indirect path linking enhanced vmPFC-alns connectivity during stress with subsequent experiences of sustained stress. The correlative patterns of miR-29c expression and vmPFC FC, along with the mediating effects on subjective stress sustainment and the presumed localization of miR-29c in astrocytes, together point to an intriguing assumption; miR-29c may serve as a biomarker in the blood for stress-induced functional neural alterations reflecting regulatory processes. Such a multi-level model may hold the key for future personalized intervention in stress psychopathology.	[Vaisvaser, Sharon; Lin, Tamar; Sharon, Haggai; Hendler, Talma] Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, Tel Aviv, Israel; [Vaisvaser, Sharon; Modai, Shira; Farberov, Luba; Sharon, Haggai; Gilam, Avital; Edry, Liat; Shomron, Noam; Hendler, Talma] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Vaisvaser, Sharon; Bar-Haim, Yair; Tarrasch, Ricardo; Shomron, Noam; Hendler, Talma] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Volk, Naama; Chen, Alon] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Admon, Roee] Harvard Univ, Sch Med, McLean Hosp, Ctr Depress Anxiety & Stress Res, Boston, MA USA; [Fruchter, Eyal] IDF, Med Corps, Div Mental Hlth, Ramat Gan, Israel; [Lin, Tamar; Wald, Ilan; Bar-Haim, Yair; Hendler, Talma] Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel; [Tarrasch, Ricardo] Tel Aviv Univ, Sch Educ, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Weizmann Institute of Science; Harvard University; Harvard Medical School; McLean Hospital; Tel Aviv University; Tel Aviv University	Shomron, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	nshomron@post.tau.ac.il; talma@tasmc.health.gov.il	Admon, Roee/AAO-6866-2021; fruchter, eyal/AAE-2325-2020; Vaisvaser, Sharon/AAD-1141-2020; Tarrasch, Ricardo/H-9197-2013	Admon, Roee/0000-0002-9886-5111; Bar-Haim, Yair/0000-0002-4630-9180; Tarrasch, Ricardo/0000-0003-1677-6615; Sharon, Haggai/0000-0003-1981-658X; Vaisvaser, Sharon/0000-0003-0156-2243; Chen, Alon/0000-0003-3625-8233	U.S. Department of Defense [W81XWH-11-2-0008]; Israel Ministry of Defense; Tel-Aviv University; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [51/11]	U.S. Department of Defense(United States Department of Defense); Israel Ministry of Defense; Tel-Aviv University; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This research was supported by the U.S. Department of Defense award number W81XWH-11-2-0008, Israel Ministry of Defense, Tel-Aviv University, and the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (Grant No. 51/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the U.S. Department of Defense award number W81XWH-11-2-0008, Israel Ministry of Defense, Tel-Aviv University, and the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (Grant No. 51/11). The authors thank Harel Zalts, Eyal Mor and Sharon Tzadok for their assistance and Vicki Myers and Aliya Solski for their help in editing the manuscript.	Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Admon R, 2009, P NATL ACAD SCI USA, V106, P14120, DOI 10.1073/pnas.0903183106; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Babenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029441; Banigan MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048814; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Bland ST, 2003, NEUROPSYCHOPHARMACOL, V28, P1589, DOI 10.1038/sj.npp.1300206; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Cisler JM, 2014, J PSYCHIATR RES, V48, P47, DOI 10.1016/j.jpsychires.2013.09.013; Cole SW, 2010, PSYCHONEUROENDOCRINO, V35, P955, DOI 10.1016/j.psyneuen.2010.06.008; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dedovic K, 2009, CAN J PSYCHIAT, V54, P6, DOI 10.1177/070674370905400104; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Farberov L, 2015, J CELL SCI, V128, P1607, DOI 10.1242/jcs.167817; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garland EL, 2009, HEALTH SOC WORK, V34, P191, DOI 10.1093/hsw/34.3.191; Glatt SJ, 2013, AM J MED GENET B, V162B, P313, DOI 10.1002/ajmg.b.32167; Griggs EM, 2013, J NEUROSCI, V33, P1734, DOI 10.1523/JNEUROSCI.2873-12.2013; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Jinks AL, 1997, BRAIN RES, V772, P181, DOI 10.1016/S0006-8993(97)00810-X; Kalisch R, 2006, NEUROIMAGE, V30, P1458, DOI 10.1016/j.neuroimage.2005.11.011; Kamanu TKK, 2013, SCI REP-UK, V3, DOI 10.1038/srep02940; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Karssen AM, 2007, MOL PSYCHIATR, V12, P1089, DOI 10.1038/sj.mp.4002095; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lee KH, 2012, SOC COGN AFFECT NEUR, V7, P521, DOI 10.1093/scan/nsp001; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lin Q, 2011, NAT NEUROSCI, V14, P1115, DOI 10.1038/nn.2891; Longe O, 2009, J COGNITIVE NEUROSCI, V21, P141, DOI 10.1162/jocn.2009.21012; Maier SF, 2010, BRAIN RES, V1355, P52, DOI 10.1016/j.brainres.2010.08.039; Malan-Muller S, 2013, MOL NEUROBIOL, V47, P726, DOI 10.1007/s12035-012-8374-6; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Martins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025443; Meerson A, 2010, J MOL NEUROSCI, V40, P47, DOI 10.1007/s12031-009-9252-1; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Mor E, 2013, BIOESSAYS, V35, P881, DOI 10.1002/bies.201200157; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Nikolova YS, 2014, NAT NEUROSCI, V17, P1153, DOI 10.1038/nn.3778; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Phan KL, 2004, NEUROREPORT, V15, P527, DOI 10.1097/00001756-200403010-00029; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Qu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061910; Radom-Aizik S, 2012, CTS-CLIN TRANSL SCI, V5, P32, DOI 10.1111/j.1752-8062.2011.00384.x; Ries ML, 2012, NEUROPSYCHOLOGIA, V50, P603, DOI 10.1016/j.neuropsychologia.2011.12.014; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65; Segman RH, 2005, MOL PSYCHIATR, V10, P514, DOI 10.1038/sj.mp.4001654; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594738; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Vaisvaser S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00313; van der Werff SJA, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00039; van Eden CG, 2000, PROG BRAIN RES, V126, P49; Wang HT, 2010, CELL MOL NEUROBIOL, V30, P437, DOI 10.1007/s10571-009-9468-1; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102	71	25	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2016	11	1							e0146236	10.1371/journal.pone.0146236	http://dx.doi.org/10.1371/journal.pone.0146236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4VZ	26730965	Green Published, Green Submitted, gold			2022-12-27	WOS:000367801400124
J	Zhu, Y; Blum, M; Hoff, U; Wesser, T; Fechner, M; Westphal, C; Gurgen, D; Catar, RA; Philippe, A; Wu, KY; Bubalo, G; Rothe, M; Weldon, SM; Dragun, D; Schunck, WH				Zhu, Ye; Blum, Maximilian; Hoff, Uwe; Wesser, Tim; Fechner, Mandy; Westphal, Christina; Guergen, Dennis; Catar, Rusan Ali; Philippe, Aurelie; Wu, Kaiyin; Bubalo, Gordana; Rothe, Michael; Weldon, Steven M.; Dragun, Duska; Schunck, Wolf-Hagen			Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ARACHIDONIC-ACID METABOLITES; ISCHEMIA-REPERFUSION INJURY; BLOOD-PRESSURE REGULATION; 20-HYDROXYEICOSATETRAENOIC ACID; GENE DELETION; EPOXYEICOSATRIENOIC ACIDS; CYTOCHROME-P450 ENZYMES; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS	Aim 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs) are cytochrome P450 (CYP)-dependent eicosanoids that play opposite roles in the regulation of vascular tone, inflammation, and apoptosis. 20-HETE aggravates, whereas EETs ameliorate ischemia/reperfusion (I/R)-induced organ damage. EETs are rapidly metabolized to dihydroxyeicosatrienoic acids (DHETs) by the soluble epoxide hydrolase (sEH). We hypothesized that sEH gene (EPHX2) deletion would increase endogenous EET levels and thereby protect against I/R-induced acute kidney injury (AKI). Methods Kidney damage was evaluated in male wildtype (WT) and sEH-knockout (KO)-mice that underwent 22-min renal ischemia followed by two days of reperfusion. CYP-eicosanoids were analyzed by liquid chromatography tandem mass spectrometry. Results Contrary to our initial hypothesis, renal function declined more severely in sEH-KO mice as indicated by higher serum creatinine and urea levels. The sEH-KO-mice also featured stronger tubular lesion scores, tubular apoptosis, and inflammatory cell infiltration. Plasma and renal EET/DHET-ratios were higher in sEH-KO than WT mice, thus confirming the expected metabolic consequences of sEH deficiency. However, CYP-eicosanoid profiling also revealed that renal, but not plasma and hepatic, 20-HETE levels were significantly increased in sEH-KO compared to WT mice. In line with this finding, renal expression of Cyp4a12a, the murine 20-HETE-generating CYP-enzyme, was up-regulated both at the mRNA and protein level, and Cyp4a12a immunostaining was more intense in the renal arterioles of sEH-KO compared with WT mice. Conclusion These results indicate that the potential beneficial effects of reducing EET degradation were obliterated by a thus far unknown mechanism leading to kidney-specific up-regulation of 20-HETE formation in sEH-KO-mice.	[Zhu, Ye; Hoff, Uwe; Fechner, Mandy; Guergen, Dennis; Catar, Rusan Ali; Philippe, Aurelie; Bubalo, Gordana; Dragun, Duska] Charite Med Fac, Nephrol & Intens Care Med, Berlin, Germany; [Zhu, Ye; Hoff, Uwe; Fechner, Mandy; Guergen, Dennis; Catar, Rusan Ali; Philippe, Aurelie; Bubalo, Gordana; Dragun, Duska] Charite Med Fac, Ctr Cardiovasc Res, Berlin, Germany; [Zhu, Ye] Sun Yat Sen Univ, Affiliated Hosp 5, Zhuhai, Guangdong, Peoples R China; [Blum, Maximilian; Wesser, Tim; Westphal, Christina; Schunck, Wolf-Hagen] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wu, Kaiyin] Charite Campus Mitte, Inst Pathol, D-10117 Berlin, Germany; [Rothe, Michael] Lipidomix GmbH, Berlin, Germany; [Weldon, Steven M.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sun Yat Sen University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Boehringer Ingelheim	Schunck, WH (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	schunck@mdc-berlin.de	Philippe, Aurelie/AAK-9707-2020; Catar, Rusan Ali/I-3948-2019	Philippe, Aurelie/0000-0003-1269-9763; Catar, Rusan Ali/0000-0002-7000-7860; Dragun, Duska/0000-0002-0310-9269	German Research Foundation (DFG) [FOR 1368]; China Scholarship Council [2011638025]; Boehringer Ingelheim Pharmaceuticals Inc; Lipidomix GmbH	German Research Foundation (DFG)(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Boehringer Ingelheim Pharmaceuticals Inc(Boehringer Ingelheim); Lipidomix GmbH	This study was supported in part by grants from the German Research Foundation (DFG, FOR 1368) to DD and WHS. YZ was supported by the China Scholarship Council (2011638025). Boehringer Ingelheim Pharmaceuticals Inc and Lipidomix GmbH provided support in the form of salaries for authors [SMW] [MR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Aydin Z, 2007, NEPHROL DIAL TRANSPL, V22, P342, DOI 10.1093/ndt/gfl690; Batchu SN, 2012, CAN J PHYSIOL PHARM, V90, P811, DOI [10.1139/Y2012-082, 10.1139/y2012-082]; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; Elmarakby AA, 2012, AM J PHYSIOL-REG I, V302, pR321, DOI 10.1152/ajpregu.00606.2011; Elmarakby AA, 2011, AM J PHYSIOL-REG I, V301, pR1307, DOI 10.1152/ajpregu.00759.2010; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Gross ER, 2004, J MOL CELL CARDIOL, V37, P1245, DOI 10.1016/j.yjmcc.2004.10.008; Gross GJ, 2005, CARDIOVASC RES, V68, P18, DOI 10.1016/j.cardiores.2005.06.007; Harris TR, 2013, GENE, V526, P61, DOI 10.1016/j.gene.2013.05.008; Hoff U, 2011, KIDNEY INT, V79, P57, DOI 10.1038/ki.2010.377; Hou HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13524; Hou HH, 2012, CARDIOVASC RES, V93, P120, DOI 10.1093/cvr/cvr267; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Imig JD, 2013, PROSTAG OTH LIPID M, V104, P2, DOI 10.1016/j.prostaglandins.2013.01.002; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Inoue K, 2009, AM J PHYSIOL-RENAL, V297, pF875, DOI 10.1152/ajprenal.00364.2009; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Ishizuka T, 2008, J PHARMACOL EXP THER, V324, P103, DOI 10.1124/jpet.107.130336; Jung O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011979; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Keseru B, 2010, CARDIOVASC RES, V85, P232, DOI 10.1093/cvr/cvp281; Kim J, 2015, AM J PHYSIOL-RENAL, V308, pF131, DOI 10.1152/ajprenal.00531.2014; Kim J, 2014, AM J PHYSIOL-RENAL, V307, pF971, DOI 10.1152/ajprenal.00256.2014; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Kusch A, 2013, ACTA PHYSL OXF; Lameire N, 2005, LANCET, V365, P417; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Lee JP, 2011, AM J PHYSIOL-RENAL, V300, pF1283, DOI 10.1152/ajprenal.00733.2010; Lee SH, 2008, TRANSPL P, V40, P1353, DOI 10.1016/j.transproceed.2008.03.137; Li LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094092; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Luria A, 2009, AM J PHYSIOL-ENDOC M, V297, pE375, DOI 10.1152/ajpendo.00131.2009; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; McGiff JC, 1999, AM J PHYSIOL-REG I, V277, pR607, DOI 10.1152/ajpregu.1999.277.3.R607; Miyata N, 2005, J PHARMACOL EXP THER, V314, P77, DOI 10.1124/jpet.105.083964; Monti J, 2008, NAT GENET, V40, P529, DOI 10.1038/ng.129; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Motoki A, 2008, AM J PHYSIOL-HEART C, V295, pH2128, DOI 10.1152/ajpheart.00428.2008; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Nilakantan V, 2008, AM J PHYSIOL-RENAL, V294, pF562, DOI 10.1152/ajprenal.00387.2007; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Regner KR, 2009, KIDNEY INT, V75, P511, DOI 10.1038/ki.2008.600; Roman RJ, 2011, KIDNEY INT, V79, P10, DOI 10.1038/ki.2010.396; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Siew ED, 2014, KIDNEY INT; Vanella L, 2015, PROSTAG OTH LIPID M, V120, P139, DOI 10.1016/j.prostaglandins.2015.04.004; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; Wu CC, 2013, J AM SOC NEPHROL; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494	61	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2016	11	1							e0145645	10.1371/journal.pone.0145645	http://dx.doi.org/10.1371/journal.pone.0145645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA3FF	26727266	Green Published, Green Accepted, gold			2022-12-27	WOS:000367681500027
J	Chen, J; Jin, Y; Wang, H; Wei, SS; Chen, D; Ying, L; Zhou, Q; Li, G; Li, J; Gao, JM; Kato, N; Hu, W; Li, YG; Wang, YP				Chen, Jie; Jin, Ye; Wang, Hong; Wei, Sisi; Chen, Dan; Ying, Li; Zhou, Qing; Li, Gang; Li, Joyce; Gao, Jimin; Kato, Naoya; Hu, Wei; Li, Yigang; Wang, Yuepeng			A Haplotype of Two Novel Polymorphisms in delta-Sarcoglycan Gene Increases Risk of Dilated Cardiomyopathy in Mongoloid Population	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHIES; HYPERTROPHIC CARDIOMYOPATHY; TRANSCRIPTION FACTORS; GLYCOPROTEIN COMPLEX; JAPANESE PATIENTS; BETA-SARCOGLYCAN; SKELETAL-MUSCLE; MUTATION; IDENTIFICATION; BINDING	The role of genetic abnormality of delta-sarcoglycan (delta-SG) gene in dilated (DCM) and hypertrophied (HCM) cardiomyopathy patients is still unfolding. In this study we first defined the promoter region and then searched for polymorphisms/mutations among the promoter, 5'-untranslated region, and the encoding exons in delta-SG gene in 104 Chinese patients with DCM, 145 with HCM, and 790 normal controls. Two novel polymorphisms were found, an 11 base-pair (bp) deletion (c.(-100 similar to-110); -) in the promoter region and a missense polymorphism of A848G resulting in p.Q283R in the highly conserved C-terminus. The prevalence of homozygous genotype -/- of c.-(-100 similar to-110) was slightly higher in DCM (14.42%) and HCM patients (14.48%), as compared with normal controls (11.01%). The prevalence of genotype of 848A/G was significantly higher in DCM (6.73%; OR = 9.43; p = 0.0002), but not in HCM patients (1.38%; OR = 1.37; p = 0.62), as compared with controls (0.76%). Haplotype -_G consisting c.-(-100 similar to-110) and A848G was associated with increased risk of DCM (OR = 17.27; 95% CI = 3.19-93.56; p = 0.001) but not associated with HCM (OR = 1.90; 95% CI = 0.38-9.55; p = 0.44). Co-occurrence of the genotypes -/- of c.(-100 similar to-110) and 848A/G was found in 5 patients with DCM (4.81%; OR = 39.85; p = 0.0001), none of HCM patients, and only 1 of the controls (0.13%). Both polymorphisms were also found in the Japanese population, but not in the Africans and Caucasians. C.(-100 similar to-110) resulted in a decrease of delta-SG promoter activity to 64 +/- 3% of the control level (p<0.01). Both co-immunoprecipitation and in vitro protein pull-down assays demonstrated that delta-SG-283R interacts normally to beta- and gamma-SG, but significantly decreased localization of beta/delta/gamma-SG on the plasma membrane. In conclusion, haplotype -_G composed of c.(-100 similar to-110) and A848G confers higher susceptibility to DCM in the Mongoloid population.	[Chen, Jie; Wang, Hong; Wei, Sisi; Ying, Li; Zhou, Qing; Li, Gang; Li, Yigang; Wang, Yuepeng] Shanghai Jiao Tong Univ, Affiliated Xinhua Hosp, Sch Med, Dept Cardiol,Mol Cardiol Res Lab, Shanghai 200030, Peoples R China; [Jin, Ye] Shanghai Jiao Tong Univ, Affiliated Xinhua Hosp, Sch Med, Dept Ultrasound, Shanghai 200030, Peoples R China; [Chen, Dan] Shanghai Jiao Tong Univ, Affiliated Xinhua Hosp, Sch Med, Minist Educ, Shanghai 200030, Peoples R China; [Chen, Dan] Shanghai Jiao Tong Univ, Affiliated Xinhua Hosp, Sch Med, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Gao, Jimin] Wenzhou Med Coll, Key Lab Lab Med, Chinese Minist Educ, Wenzhou, Peoples R China; [Kato, Naoya] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Li, Joyce] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Hu, Wei] Fudan Univ, Cent Hosp Minhang Dist, Sch Med, Dept Cardiol, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Wenzhou Medical University; University of Tokyo; University of Massachusetts System; University of Massachusetts Worcester; Fudan University	Hu, W (corresponding author), Fudan Univ, Cent Hosp Minhang Dist, Sch Med, Dept Cardiol, Shanghai 200433, Peoples R China.	whcardio@hotmail.com; drliyigang@outlook.com; ypwang555@aliyun.com	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034	Welcome Trust for New Principal Investigator of Xinhua Hospital; Pujiang Project for Extraordinary Scientist of the Science and Technology Commission of Shanghai Municipality [12PJ1406400]; Natural Science Foundation of Zhejiang Province [Y2101019]; Natural Science Foundation of China [81170302, 81370257, 81270258, 81470497]	Welcome Trust for New Principal Investigator of Xinhua Hospital; Pujiang Project for Extraordinary Scientist of the Science and Technology Commission of Shanghai Municipality; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Welcome Trust for New Principal Investigator of Xinhua Hospital (YW), the Pujiang Project for Extraordinary Scientist of the Science and Technology Commission of Shanghai Municipality 12PJ1406400 (YW), Natural Science Foundation of Zhejiang Province Y2101019 (YW); the Natural Science Foundation of China No. 81170302 (YW), No. 81370257 (YW), No. 81270258 (YL), and No. 81470497 (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambra R, 2002, LIFE SCI, V71, P2369, DOI 10.1016/S0024-3205(02)02020-9; Bauer R, 2009, EUR J HUM GENET, V17, P1148, DOI 10.1038/ejhg.2009.17; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; Chan YM, 1998, J CELL BIOL, V143, P2033, DOI 10.1083/jcb.143.7.2033; Chen JW, 2006, EXP CELL RES, V312, P1610, DOI 10.1016/j.yexcr.2006.01.024; Date M, 2000, AM J CARDIOL, V85, P1315, DOI 10.1016/S0002-9149(00)00762-1; Delgado-Olguin P, 2008, BBA-GENE REGUL MECH, V1779, P74, DOI 10.1016/j.bbagrm.2007.09.002; Dincer P, 2000, NEUROMUSCULAR DISORD, V10, P247, DOI 10.1016/S0960-8966(00)00100-0; Dincer P, 2000, J MED GENET, V37, P361, DOI 10.1136/jmg.37.5.361; Duggan DJ, 1997, NEUROGENETICS, V1, P49, DOI 10.1007/s100480050008; Fanin M, 2003, NEUROMUSCULAR DISORD, V13, P303, DOI 10.1016/S0960-8966(02)00280-8; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Heydemann A, 2007, HUM MOL GENET, V16, P355, DOI 10.1093/hmg/ddl453; Ho CY, 2012, CIRCULATION, V125, P1432, DOI 10.1161/CIRCULATIONAHA.110.017277; Honda T, 2007, CIRC J, V71, P1263, DOI 10.1253/circj.71.1263; Karkkainen S, 2003, J MOL MED-JMM, V81, P795, DOI 10.1007/s00109-003-0480-5; KATO M, 1995, LANCET, V345, P1247, DOI 10.1016/S0140-6736(95)92034-X; Landstrom AP, 2010, CIRCULATION, V122, P2441, DOI 10.1161/CIRCULATIONAHA.110.954446; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Hernandez-Hernandez JM, 2009, J MOL BIOL, V394, P1, DOI 10.1016/j.jmb.2009.08.057; Ordonez-Razo RM, 2010, GENET TEST MOL BIOMA, V14, P237, DOI 10.1089/gtmb.2009.0147; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Moreira ES, 1998, J MED GENET, V35, P951, DOI 10.1136/jmg.35.11.951; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; Ordonez-Razo RM, 2012, GENET TEST MOL BIOMA, V16, P855, DOI 10.1089/gtmb.2011.0343; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Rutschow D, 2014, EUR J HUM GENET, V22, P119, DOI 10.1038/ejhg.2013.97; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; Shi WX, 2004, MUSCLE NERVE, V29, P409, DOI 10.1002/mus.10566; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sylvius N, 2003, AM J MED GENET A, V120A, P8, DOI 10.1002/ajmg.a.20003; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; Ueda H, 2001, J HISTOCHEM CYTOCHEM, V49, P529, DOI 10.1177/002215540104900413; Vainzof M, 1996, HUM MOL GENET, V5, P1963, DOI 10.1093/hmg/5.12.1963; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wakabayashi-Takai E, 2001, EUR J BIOCHEM, V268, P948, DOI 10.1046/j.1432-1327.2001.01954.x; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Zatz M, 2003, NEUROMUSCULAR DISORD, V13, P532, DOI 10.1016/S0960-8966(03)00100-7; Zou YB, 2004, AM J MED, V116, P14, DOI 10.1016/j.amjmed.2003.05.009	45	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145602	10.1371/journal.pone.0145602	http://dx.doi.org/10.1371/journal.pone.0145602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720722	Green Published, gold, Green Submitted			2022-12-27	WOS:000367510900015
J	Garcia-Castro, IL; Garcia-Lopez, G; Avila-Gonzalez, D; Flores-Herrera, H; Molina-Hernandez, A; Portillo, W; Ramon-Gallegos, E; Diaz, NF				Lydia Garcia-Castro, Irma; Garcia-Lopez, Guadalupe; Avila-Gonzalez, Daniela; Flores-Herrera, Hector; Molina-Hernandez, Anayansi; Portillo, Wendy; Ramon-Gallegos, Eva; Fabian Diaz, Nestor			Markers of Pluripotency in Human Amniotic Epithelial Cells and Their Differentiation to Progenitor of Cortical Neurons	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN FETAL MEMBRANES; GROUND-STATE; SELF-RENEWAL; INDUCTION; MAINTENANCE; EXPRESSION; CIRCUITRY; PLACENTA; EPIBLAST	Human pluripotent stem cells (hPSC) have promise for regenerative medicine due to their auto-renovation and differentiation capacities. Nevertheless, there are several ethical and methodological issues about these cells that have not been resolved. Human amniotic epithelial cells (hAEC) have been proposed as source of pluripotent stem cells. Several groups have studied hAEC but have reported inconsistencies about their pluripotency properties. The aim of the present study was the in vitro characterization of hAEC collected from a Mexican population in order to identify transcription factors involved in the pluripotency circuitry and to determine their epigenetic state. Finally, we evaluated if these cells differentiate to cortical progenitors. We analyzed qualitatively and quantitatively the expression of the transcription factors of pluripotency (OCT4, SOX2, NANOG, KLF4 and REX1) by RT-PCR and RT-qPCR in hAEC. Also, we determined the presence of OCT4, SOX2, NANOG, SSEA3, SSEA4, TRA-1-60, E-cadherin, KLF4, TFE3 as well as the proliferation and epigenetic state by immunocytochemistry of the cells. Finally, hAEC were differentiated towards cortical progenitors using a protocol of two stages. Here we show that hAEC, obtained from a Mexican population and cultured in vitro (P0-P3), maintained the expression of several markers strongly involved in pluripotency maintenance (OCT4, SOX2, NANOG, TFE3, KLF4, SSEA3, SSEA4, TRA-1-60 and E-cadherin). Finally, when hAEC were treated with growth factors and small molecules, they expressed markers characteristic of cortical progenitors (TBR2, OTX2, NeuN and beta-III-tubulin). Our results demonstrated that hAEC express naive pluripotent markers (KLF4, REX1 and TFE3) as well as the cortical neuron phenotype after differentiation. This highlights the need for further investigation of hAEC as a possible source of hPSC.	[Lydia Garcia-Castro, Irma; Ramon-Gallegos, Eva] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Unidad Profes Adolfo Lopez Mateos, Lab Citopatol Ambiental, Mexico City, DF, Mexico; [Lydia Garcia-Castro, Irma; Garcia-Lopez, Guadalupe; Avila-Gonzalez, Daniela; Molina-Hernandez, Anayansi; Fabian Diaz, Nestor] Inst Nacl Perinatol, Dept Biol Celular, Mexico City 11000, DF, Mexico; [Flores-Herrera, Hector] Inst Nacl Perinatol, Dept Inmunobioquim, Mexico City 11000, DF, Mexico; [Portillo, Wendy] UNAM, Inst Neurobiol, Dept Neurobiol Conductal & Cognit, Queretaro, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Diaz, NF (corresponding author), Inst Nacl Perinatol, Dept Biol Celular, Montes Urales 800,Col Lomas Virreyes, Mexico City 11000, DF, Mexico.	nestor.diaz@inper.mx	Avila, Daniela/AAI-2510-2019; Flores-Herrera, Héctor/AAL-1757-2021; López, Guadalupe García/AAF-3944-2021	Portillo, Wendy/0000-0002-5651-4815; Ramon-Gallegos, Eva/0000-0003-2262-5207	Instituto Nacional de Perinatologia [21041, 21081, 21051]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [140917, 130627, 21650, 180178]; CONACyT [216250]	Instituto Nacional de Perinatologia; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by Instituto Nacional de Perinatologia grants 21041 (NFD), 21081 (NFD), and 21051 (AM), and Consejo Nacional de Ciencia y Tecnologia (CONACyT) grants 140917 (NFD), 130627 (NFD), 21650, and 180178 (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper is part of the experimental work of Irma Lydia Garcia-Castro for obtaining the Ph.D. under the IPN Programa en Biomedicina y Biotecnologia Molecular. We thank CONACyT for supporting her studies (216250). The authors would like to thank Dr. Dorothy Pless and Francisco Camacho for their excellent technical assistance.	Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Cai N, 2012, J MOL CELL BIOL, V4, P262, DOI 10.1093/jmcb/mjs031; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Diaz NF, 2009, J NEUROENDOCRINOL, V21, P730, DOI 10.1111/j.1365-2826.2009.01891.x; Diaz NF, 2009, INT J DEV NEUROSCI, V27, P493, DOI 10.1016/j.ijdevneu.2009.04.002; Evangelista M, 2008, CYTOTECHNOLOGY, V58, P33, DOI 10.1007/s10616-008-9162-z; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Garcia-Lopez G, 2015, GAC MED MEX, V151, P76; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Kalkan T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0540; Koike C, 2014, CELL REPROGRAM, V16, P298, DOI 10.1089/cell.2013.0090; Lippmann ES, 2014, STEM CELLS, V32, P1032, DOI 10.1002/stem.1622; Marti M, 2013, NAT PROTOC, V8, P223, DOI 10.1038/nprot.2012.154; Mascetti VL, 2014, NAT BIOTECHNOL, V32, P68, DOI 10.1038/nbt.2789; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki T, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt66; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Moussaieff A, 2015, STEM CELLS, V33, P2374, DOI 10.1002/stem.2041; Murphy Sean, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e06s13; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niknejad H, 2010, EUR CELLS MATER, V19, P22, DOI 10.22203/eCM.v019a03; Oka M, 2013, J BIOL CHEM, V288, P15085, DOI 10.1074/jbc.M112.448837; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136; Ramakrishna S, 2014, CELL REPROGRAM, V16, P108, DOI 10.1089/cell.2013.0077; Rodriguez-Martinez G, 2012, NEUROSCIENCE, V216, P10, DOI 10.1016/j.neuroscience.2012.04.049; Sakuragawa N, 1996, NEUROSCI LETT, V209, P9, DOI 10.1016/0304-3940(96)12599-4; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Soncin F, 2011, GENES-BASEL, V2, P229, DOI 10.3390/genes2010229; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; Wolbank S, 2009, TISSUE ENG PT A, V15, P1843, DOI 10.1089/ten.tea.2008.0205; Zhou KX, 2013, CELL REPROGRAM, V15, P55, DOI 10.1089/cell.2012.0021	42	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0146082	10.1371/journal.pone.0146082	http://dx.doi.org/10.1371/journal.pone.0146082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720151	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900043
J	Zhang, SL; Zheng, SY; Wang, X; Shi, QK; Wang, X; Yuan, ST; Wang, GZ; Ji, ZL				Zhang, Shulong; Zheng, Shuyun; Wang, Xin; Shi, Qiankun; Wang, Xiang; Yuan, Shoutao; Wang, Guozheng; Ji, Zhenling			Carbon Monoxide-Releasing Molecule-2 Reduces Intestinal Epithelial Tight-Junction Damage and Mortality in Septic Rats	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BARRIER FUNCTION; BACTERIAL TRANSLOCATION; SEPSIS; PROTEINS; INTERLEUKIN-1-BETA; INHIBITION; PATHWAYS; FAILURE; INJURY	Objective Damage to intestinal epithelial tight junctions plays an important role in sepsis. Recently we found that Carbon Monoxide-Releasing Molecule-2 (CORM-2) is able to protect LPS-induced intestinal epithelial tight junction damage and in this study we will investigate if CORM-2 could protect intestinal epithelial tight junctions in the rat cecal ligation and puncture (CLP) model. Materials and Methods The CLP model was generated using male Sprague-Dawley (SD) rats according to standard procedure and treated with CORM-2 or inactive CORM-2 (iCORM-2), 8 mg/kg, i.v. immediately after CLP induction and euthanized after 24h or 72h (for mortality rate only). Morphological changes were investigated using both transmission electron and confocal microscopy. The levels of important TJ proteins and phosphorylation of myosin light chain (MLC) were examined using Western blotting. Cytokines, IL-1 beta and TNF-alpha were measured using ELISA kits. The overall intestinal epithelial permeability was evaluated using FD-4 as a marker. Results CORM-2, but not iCORM-2, significantly reduced sepsis-induced damage of intestinal mucosa (including TJ disruption), TJ protein reduction (including zonula occludens-l (ZO-1), claudin-1 and occludin), MLC phosphorylation and proinflammatory cytokine release. The overall outcomes showed that CORM-2 suppressed sepsis-induced intestinal epithelial permeability changes and reduced mortality rate of those septic rats. Conclusions Our data strongly suggest that CORM-2 could be a potential therapeutic reagent for sepsis by suppressing inflammation, restoring intestinal epithelial barrier and reducing mortality.	[Zhang, Shulong; Wang, Xin; Ji, Zhenling] Southeast Univ, Zhongda Hosp, Sch Med, Dept Gen Surg, Nanjing 210009, Jiangsu, Peoples R China; [Zheng, Shuyun; Shi, Qiankun; Wang, Xiang; Yuan, Shoutao] Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, Nanjing 210006, Jiangsu, Peoples R China; [Wang, Guozheng] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England	Southeast University - China; Nanjing Medical University; University of Liverpool	Ji, ZL (corresponding author), Southeast Univ, Zhongda Hosp, Sch Med, Dept Gen Surg, Nanjing 210009, Jiangsu, Peoples R China.	zlji@seu.edu.cn			National Natural Science Foundation of China [81171786, 81272148, 81071546]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal0/default.htm), No. 81171786, 81272148, and No. 81071546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz MJ, 2008, CURR PHARM DESIGN, V14, P465, DOI 10.2174/138161208783597362; Bucker R, 2011, J INFECT DIS, V204, P1283, DOI 10.1093/infdis/jir504; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Condette CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102217; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Duffy HS, 2000, J NEUROSCI, V20; Fink M P, 1994, Semin Respir Infect, V9, P256; Fischer A, 2013, AM J PHYSIOL-GASTR L, V304, pG970, DOI 10.1152/ajpgi.00183.2012; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Hollenberg SM, 2001, AM J RESP CRIT CARE, V164, P891, DOI 10.1164/ajrccm.164.5.2010073; Horie T, 1999, PLANTA MED, V65, P545, DOI 10.1055/s-1999-14023; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; Ivanov AI, 2013, ADV EXP MED BIOL, V763, P132; Jiang LY, 2013, INDIAN J MED RES, V138, P904; Labus J, 2014, J NEUROSCI METH, V228, P35, DOI 10.1016/j.jneumeth.2014.03.002; Lee JM, 2014, TUBERC RESPIR DIS, V77, P6, DOI 10.4046/trd.2014.77.1.6; Lee S, 2014, ANTIOXID REDOX SIGN, V20, P432, DOI 10.1089/ars.2013.5368; Lei Qi, 2014, Int J Mol Med, V34, P1629, DOI 10.3892/ijmm.2014.1965; Li QR, 2008, FEBS J, V275, P411, DOI 10.1111/j.1742-4658.2007.06210.x; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Mu XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104032; Ozaki KS, 2012, TRANSPL INT, V25, P107, DOI 10.1111/j.1432-2277.2011.01363.x; Puleo F, 2011, SEMIN RESP CRIT CARE, V32, P626, DOI 10.1055/s-0031-1287871; Quiros M, 2014, SEMIN CELL DEV BIOL, V36, P194, DOI 10.1016/j.semcdb.2014.09.003; Rao Yan-Xia, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P976; Rubin DT, 2000, EUR J GASTROEN HEPAT, V12, P855, DOI 10.1097/00042737-200012080-00004; Ryter SW, 2013, KOREAN J INTERN MED, V28, P123, DOI 10.3904/kjim.2013.28.2.123; Schorr CA, 2014, TRENDS MOL MED, V20, P192, DOI 10.1016/j.molmed.2014.02.001; Schwer CI, 2013, INT J BIOCHEM CELL B, V45, P201, DOI 10.1016/j.biocel.2012.09.020; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Wang X, 2012, WORLD J GASTROENTERO, V18, P5719, DOI 10.3748/wjg.v18.i40.5719; Wei YW, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-42; Yu P, 2000, CRIT CARE MED, V28, P2573, DOI 10.1097/00003246-200007000-00065; Yue C, 2012, INFLAMMATION, V35, P1880, DOI 10.1007/s10753-012-9510-1	42	15	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2015	10	12							e0145988	10.1371/journal.pone.0145988	http://dx.doi.org/10.1371/journal.pone.0145988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TR	26720630	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510900030
J	Fosgaard, TR; Piovesan, M				Fosgaard, Toke R.; Piovesan, Marco			Nudge for (the Public) Good: How Defaults Can Affect Cooperation	PLOS ONE			English	Article							PUNISHMENT; PROVISION	In this paper we test the effect of non-binding defaults on the level of contribution to a public good. We manipulate the default numbers appearing on the decision screen to nudge subjects toward a free-rider strategy or a perfect conditional cooperator strategy. Our results show that the vast majority of our subjects did not adopt the default numbers, but their stated strategy was affected by the default. Moreover, we find that our manipulation spilled over to a subsequent repeated public goods game where default was not manipulated. Here we found that subjects who previously saw the free rider default were significantly less cooperative than those who saw the perfect conditional cooperator default.	[Fosgaard, Toke R.] Univ Copenhagen, Dept Food & Resource Econ, DK-1958 Frederiksberg C, Denmark; [Piovesan, Marco] Univ Copenhagen, Dept Econ, DK-1353 Copenhagen K, Denmark	University of Copenhagen; University of Copenhagen	Fosgaard, TR (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Rolighedsvej 23, DK-1958 Frederiksberg C, Denmark.	tf@ifro.ku.dk	Fosgaard, Toke R/E-6666-2015	Fosgaard, Toke R/0000-0003-0659-5490; Piovesan, Marco/0000-0002-5721-3053	Department of Economics of the University of Copenhagen; Danish Council for Independent Research [10-093637]	Department of Economics of the University of Copenhagen; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	TRF and MP thank the Department of Economics of the University of Copenhagen for their generous support. No grant number applies (www.econ.ku.dk). TRF thanks the Danish Council for Independent Research for the generous funding Grant # 10-093637. (http://ufm.dk/forskning-og-innovation/tilskud-til-forskning-og-innovation/hvem-har-modtaget-tilskud/2010/bevillinger-fra-det-frie-forskningsrad-samfund-og-erhverv-fse-november-2010#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann S, 2011, IMPACT COOPERATION D; [Anonymous], 1965, LOGIC COLLECTIVE ACT; [Anonymous], 2012, ACT RES ETHICS REV H; Ariely D, 2006, J ECON BEHAV ORGAN, V60, P1, DOI 10.1016/j.jebo.2004.10.003; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; Cappelletti D, 2014, J ECON BEHAV ORGAN, V108, P331, DOI 10.1016/j.jebo.2014.01.002; Choi J.J., 2004, BETTER WORSE DEFAULT, P81; Drouvelis M, 2015, THEOR DECIS, V79, P479, DOI 10.1007/s11238-015-9481-4; Falkinger J, 2000, AM ECON REV, V90, P247, DOI 10.1257/aer.90.1.247; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Fosgaard TR, 2014, J PUBLIC ECON, V120, P134, DOI 10.1016/j.jpubeco.2014.09.004; Fosgaard TR, SCAND J EC; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; ISAAC RM, 1985, J PUBLIC ECON, V26, P51; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Kosfeld M, 2009, AM ECON REV, V99, P1335, DOI 10.1257/aer.99.4.1335; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Nowak MA, 2011, SUPERCOOPERATOR ALTR; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Reuben E, 2010, EUR J POLIT ECON, V26, P25, DOI 10.1016/j.ejpoleco.2009.10.002; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Thaler R.H., 2021, NUDGE FINAL EDITION; Yohanes E. Riyanto, OPT IN VS OPT OUT VO; Zelmer J., 2003, Experimental Economics, V6, P299, DOI 10.1023/A:1026277420119	29	5	5	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145488	10.1371/journal.pone.0145488	http://dx.doi.org/10.1371/journal.pone.0145488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717569	Green Submitted, Green Published, gold			2022-12-27	WOS:000367510500038
J	Skieterska, K; Rondou, P; Lintermans, B; Van Craenenbroeck, K				Skieterska, Kamila; Rondou, Pieter; Lintermans, Beatrice; Van Craenenbroeck, Kathleen			KLHL12 Promotes Non-Lysine Ubiquitination of the Dopamine Receptors D-4.2 and D-4.4, but Not of the ADHD-Associated D-4.7 Variant	PLOS ONE			English	Article							N-TERMINAL UBIQUITINATION; MEDIATES UBIQUITINATION; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; DEGRADATION; RESIDUES; SERINE; UBIQUITYLATION; METAANALYSIS; CONJUGATION	Dopamine D-4 Receptor Polymorphism The dopamine D-4 receptor has an important polymorphism in its third intracellular loop that is intensively studied and has been associated with several abnormal conditions, among others, attention deficit hyperactivity disorder. KLHL12 Promotes Ubiquitination of the Dopamine D-4 Receptor on Non-Lysine Residues In previous studies we have shown that KLHL12, a BTB-Kelch protein, specifically interacts with the polymorphic repeats of the dopamine D-4 receptor and enhances its ubiquitination, which, however, has no influence on receptor degradation. In this study we provide evidence that KLHL12 promotes ubiquitination of the dopamine D-4 receptor on non-lysine residues. By using lysine-deficient receptor mutants and chemical approaches we concluded that ubiquitination on cysteine, serine and/or threonine is possible. Differential Ubiquitination of the Dopamine D-4 Receptor Polymorphic Variants Additionally, we show that the dopamine D-4.7 receptor variant, which is associated with a predisposition to develop attention deficient hyperactivity disorder, is differentially ubiquitinated compared to the other common receptor variants D-4.2 and D-4.4. Together, our study suggests that GPCR ubiquitination is a complex and variable process.	[Skieterska, Kamila; Rondou, Pieter; Lintermans, Beatrice; Van Craenenbroeck, Kathleen] Univ Ghent, Lab GPCR Express & Signal Transduct L GEST, B-9000 Ghent, Belgium	Ghent University	Van Craenenbroeck, K (corresponding author), Univ Ghent, Lab GPCR Express & Signal Transduct L GEST, B-9000 Ghent, Belgium.	kathleen.vancraenenbroeck@ugent.be			FWO (Fonds voor Wetenschappelijk onderzoek-Research Foundation Flanders) [G010909N]	FWO (Fonds voor Wetenschappelijk onderzoek-Research Foundation Flanders)	This work was supported by FWO (Fonds voor Wetenschappelijk onderzoek-Research Foundation Flanders), G010909N, http://www.fwo.be/. KS has a pre-doctoral FWO scholarship. PR and KVC have postdoctoral FWO fellowships.	Anania VG, 2013, INT J PROTEOMICS, V2013, DOI DOI 10.1155/2013/557915; ASGHARI V, 1994, MOL PHARMACOL, V46, P364; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Dores MR, 2012, MOL PHARMACOL, V82, P563, DOI 10.1124/mol.112.079418; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Gustin JK, 2012, J BIOL CHEM, V287, P14837, DOI 10.1074/jbc.M112.349928; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Helmeste DM, 2000, JPN J PHARMACOL, V82, P1; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jeram SM, 2009, PROTEOMICS, V9, P922, DOI 10.1002/pmic.200800666; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Rondou P, 2010, CELL SIGNAL, V22, P900, DOI 10.1016/j.cellsig.2010.01.014; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Skieterska K, 2015, NEUROMETHODS, V96, P139, DOI 10.1007/978-1-4939-2196-6_8; Skieterska K, 2013, METHOD CELL BIOL, V117, P323, DOI 10.1016/B978-0-12-408143-7.00017-7; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2012, TRAFFIC, V13, P19, DOI 10.1111/j.1600-0854.2011.01269.x; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145654	10.1371/journal.pone.0145654	http://dx.doi.org/10.1371/journal.pone.0145654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717573	Green Published, Green Submitted, gold			2022-12-27	WOS:000367510500054
J	Perez, MF; Contreras, L; Garnica, NM; Fernandez-Zenoff, MV; Farias, ME; Sepulveda, M; Ramallo, J; Dib, JR				Florencia Perez, Maria; Contreras, Luciana; Mercedes Garnica, Nydia; Veronica Fernandez-Zenoff, Maria; Eugenia Farias, Maria; Sepulveda, Milena; Ramallo, Jacqueline; Rafael Dib, Julian			Native Killer Yeasts as Biocontrol Agents of Postharvest Fungal Diseases in Lemons	PLOS ONE			English	Article							PICHIA-MEMBRANIFACIENS; KLUYVEROMYCES-LACTIS; BIOLOGICAL-CONTROL; TOXIN; SACCHAROMYCES; MECHANISMS; PLASMIDS; FRUITS; APPLE; IDENTIFICATION	Economic losses caused by postharvest diseases represent one of the main problems of the citrus industry worldwide. The major diseases affecting citrus are the "green mold" and "blue mold", caused by Penicillium digitatum and P. italicum, respectively. To control them, synthetic fungicides are the most commonly used method. However, often the emergence of resistant strains occurs and their use is becoming more restricted because of toxic effects and environmental pollution they generate, combined with trade barriers to international markets. The aim of this work was to isolate indigenous killer yeasts with antagonistic activity against fungal postharvest diseases in lemons, and to determine their control efficiency in in vitro and in vivo assays. Among 437 yeast isolates, 8.5% show to have a killer phenotype. According to molecular identification, based on the 26S rDNA D1/D2 domain sequences analysis, strains were identified belonging to the genera Saccharomyces, Wickerhamomyces, Kazachstania, Pichia, Candida and Clavispora. Killers were challenged with pathogenic molds and strains that caused the maximum in vitro inhibition of P. digitatum were selected for in vivo assays. Two strains of Pichia and one strain of Wickerhamomyces depicted a significant protection (p < 0.05) from decay by P. digitatum in assays using wounded lemons. Thus, the native killer yeasts studied in this work showed to be an effective alternative for the biocontrol of postharvest fungal infections of lemons and could be promising agents for the development of commercial products for the biological control industry.	[Florencia Perez, Maria; Contreras, Luciana; Mercedes Garnica, Nydia; Eugenia Farias, Maria; Rafael Dib, Julian] Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc Ind Microbiol, San Miguel De Tucuman, Argentina; [Veronica Fernandez-Zenoff, Maria; Rafael Dib, Julian] Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Microbiol, Ayacucho 471, RA-4000 San Miguel De Tucuman, Argentina; [Sepulveda, Milena; Ramallo, Jacqueline] SA San Miguel, Lab Desarrollo & Invest, Lavalle 4001,T4000BAB, San Miguel De Tucuman, Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman	Dib, JR (corresponding author), Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc Ind Microbiol, San Miguel De Tucuman, Argentina.; Dib, JR (corresponding author), Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Microbiol, Ayacucho 471, RA-4000 San Miguel De Tucuman, Argentina.	jdib@proimi.org.ar	Shenoy, Vivek/ABD-5075-2021; Dib, Julian Rafael Dib/AAG-9240-2019; Cao, Xuan/AAI-6307-2020	Dib, Julian Rafael Dib/0000-0002-8965-8372; Farias, Maria Eugenia/0000-0002-2771-8915; Perez, Maria Florencia/0000-0002-7868-425X	Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK058123] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The financial support from the Alexander von Humboldt Foundation is gratefully acknowledged.; The financial support from the Alexander von Humboldt Foundation is gratefully acknowledged. We thank to Dr. John Paluszynski for manuscript editing. We also thank Ing. Gabriela Fogliata from "Estacion Experimental Obispo Colombres" for providing pure cultures of plant pathogens and to Nathalia Iriarte, Prof. Friedhelm Meinhardt and Dr. Alene Kast for providing reference yeast strains.	Bajaj BK, 2013, J BASIC MICROB, V53, P645, DOI 10.1002/jobm.201200187; Bocco A, 1998, J AGR FOOD CHEM, V46, P2123, DOI 10.1021/jf9709562; Chanchalchaovivat A, 2007, BIOL CONTROL, V42, P326, DOI 10.1016/j.biocontrol.2007.05.016; Ciani M, 2015, CURR OPIN FOOD SCI, V1, P1, DOI 10.1016/j.cofs.2014.07.001; Coelho AR, 2007, BRAZ ARCH BIOL TECHN, V50, P725, DOI 10.1590/S1516-89132007000400019; de Lima JR, 2013, J BASIC MICROB, V53, P590, DOI 10.1002/jobm.201200049; Di Rienzo J.A., 2015, INFOSTAT VERSI6N 201, DOI DOI 10.1111/j.1469-8137.2006.01787.x; Droby S, 2009, POSTHARVEST BIOL TEC, V52, P137, DOI 10.1016/j.postharvbio.2008.11.009; Druvefors UA, 2005, APPL ENVIRON MICROB, V71, P1865, DOI 10.1128/AEM.71.4.1865-1869.2005; El-Tarabily Khaled A., 2006, Mycoscience, V47, P25, DOI 10.1007/s10267-005-0268-2; ENTIAN KD, 1980, MOL GEN GENET, V178, P633, DOI 10.1007/BF00337871; Fan Q, 2000, PLANT DIS, V84, P1212, DOI 10.1094/PDIS.2000.84.11.1212; Federcitrus, 2015, ACT CITR ARG 2014; Fredericq P., 1948, REV BELGE PATH    S4, V4, P1; Giobbe S, 2007, FEMS YEAST RES, V7, P1389, DOI 10.1111/j.1567-1364.2007.00301.x; Golubev WI, 2013, MICROBIOLOGY+, V82, P290, DOI 10.1134/S0026261713030065; GRATIA A, 1946, CR SOC BIOL, V140, P1053; Grevesse C, 2003, PHYTOPATHOLOGY, V93, P1145, DOI 10.1094/PHYTO.2003.93.9.1145; GUNGE N, 1981, J BACTERIOL, V147, P155, DOI 10.1128/JB.147.1.155-160.1981; Hadacek F, 2000, PHYTOCHEM ANALYSIS, V11, P137, DOI 10.1002/(SICI)1099-1565(200005/06)11:3&lt;137::AID-PCA514&gt;3.0.CO;2-I; HAYMAN GT, 1991, CURR GENET, V19, P389, DOI 10.1007/BF00309600; Izgu DA, 2011, ANTON LEEUW INT J G, V99, P85, DOI 10.1007/s10482-010-9527-0; KAEMPER J, 1991, Current Genetics, V19, P109; Kaiser C., 1994, METHODS YEAST GENETI; Kishida M, 1996, BIOSCI BIOTECH BIOCH, V60, P798, DOI 10.1271/bbb.60.798; Klassen R, 2002, PLASMID, V48, P142, DOI 10.1016/S0147-619X(02)00101-4; Krcmery V, 1999, FEMS IMMUNOL MED MIC, V23, P75, DOI 10.1111/j.1574-695X.1999.tb01719.x; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Li BB, 2006, SEP PURIF TECHNOL, V48, P182, DOI 10.1016/j.seppur.2005.07.005; Liu GL, 2015, CRIT REV BIOTECHNOL, V35, P222, DOI 10.3109/07388551.2013.833582; Lopes CA, 2010, REV ARGENT MICROBIOL, V42, P298, DOI 10.1590/S0325-75412010000400011; Lopez-Garcia B, 2003, INT J FOOD MICROBIOL, V89, P163, DOI 10.1016/S0168-1605(03)00118-1; Makower M., 1963, 11 INT C GEN OXF; McGuire RG, 2000, PHYTOPATHOLOGY, V90, P1217, DOI 10.1094/PHYTO.2000.90.11.1217; Nakagawa Y, 2004, MED MYCOL, V42, P267, DOI 10.1080/13693780310001597674; Nantawanit N, 2010, BIOL CONTROL, V52, P145, DOI 10.1016/j.biocontrol.2009.10.011; Ochigava I, 2011, ANTON LEEUW INT J G, V99, P559, DOI 10.1007/s10482-010-9524-3; Palou L., 2007, REV ESPECIAL COMUNID, P82; Palou L., 2008, STEWART POSTHARVEST, V4, DOI DOI 10.2212/SPR.2008.2.2; PFEIFFER P, 1984, ARCH MICROBIOL, V137, P357, DOI 10.1007/BF00410734; Pimenta R.S., 2009, YEAST BIOTECHNOLOGY, P199, DOI [10.1007/978-1-4020-8292-4_10, DOI 10.1007/978-1-4020-8292-4_10]; Pitt J., 1985, FUNGI FOOD SPOILAGE; Platania C, 2012, FOOD MICROBIOL, V30, P219, DOI 10.1016/j.fm.2011.12.010; Radosavljevic M, 1999, J CLIN MICROBIOL, V37, P475, DOI 10.1128/JCM.37.2.475-477.1999; Robiglio A, 2011, INT J FOOD MICROBIOL, V147, P211, DOI 10.1016/j.ijfoodmicro.2011.04.007; ROGERS D, 1978, J GEN MICROBIOL, V105, P199, DOI 10.1099/00221287-105-2-199; Sanchez-Torres P, 2011, POSTHARVEST BIOL TEC, V59, P159; Sangorrin MP, 2007, INT J FOOD MICROBIOL, V119, P351, DOI 10.1016/j.ijfoodmicro.2007.04.010; Santos A, 2004, MICROBIOL-SGM, V150, P2527, DOI 10.1099/mic.0.27071-0; Santos A, 2004, YEAST, V21, P151, DOI 10.1002/yea.1069; Savastano G, 1929, J AGRIC RES, V39, P0163; Sepulveda M, 2015, SCI HORTIC-AMSTERDAM, V192, P387, DOI 10.1016/j.scienta.2015.06.021; SIEGEL MR, 1977, NETH J PLANT PATHOL, V83, P121, DOI 10.1007/BF03041427; STUMM C, 1977, A VAN LEEUW J MICROB, V43, P125, DOI 10.1007/BF00395667; Sugita T, 2003, J CLIN MICROBIOL, V41, P4695, DOI 10.1128/JCM.41.10.4695-4699.2003; Tripathi P, 2004, POSTHARVEST BIOL TEC, V32, P235, DOI 10.1016/j.postharvbio.2003.11.005; Tuset J. J., 1987, PODREDUMBRES FRUTOS; Vaudano E., 2014, IND MED ENV APPL MIC, P304; Vero S, 2013, FEMS YEAST RES, V13, P189, DOI 10.1111/1567-1364.12021; Wisniewski M, 2007, BIOLOGICAL CONTROL: A GLOBAL PERSPECTIVE, P262, DOI 10.1079/9781845932657.0262; WOODS DR, 1968, J GEN MICROBIOL, V51, P115, DOI 10.1099/00221287-51-1-115; Yao HJ, 2005, J APPL MICROBIOL, V98, P941, DOI 10.1111/j.1365-2672.2004.02531.x; YOUNG TW, 1978, A VAN LEEUW J MICROB, V44, P59, DOI 10.1007/BF00400077; Zenoff VF, 2006, APPL ENVIRON MICROB, V72, P7857, DOI 10.1128/AEM.01333-06; Zhao Y, 2008, POSTHARVEST BIOL TEC, V49, P113, DOI 10.1016/j.postharvbio.2008.01.001	66	125	125	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165590	10.1371/journal.pone.0165590	http://dx.doi.org/10.1371/journal.pone.0165590			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	26735954	Green Published, gold, Green Submitted			2022-12-27	WOS:000389537000035
J	Perepelyuk, M; Chin, LK; Cao, X; van Oosten, A; Shenoy, VB; Janmey, PA; Wells, RG				Perepelyuk, Maryna; Chin, LiKang; Cao, Xuan; van Oosten, Anne; Shenoy, Vivek B.; Janmey, Paul A.; Wells, Rebecca G.			Normal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TRANSIENT ELASTOGRAPHY; EXTRACELLULAR-MATRIX; LATENT TGF-BETA-1; FIBROSIS; STIFFNESS; BEHAVIOR; CULTURE; DECELLULARIZATION; DIFFERENTIATION	Tissues including liver stiffen and acquire more extracellular matrix with fibrosis. The relationship between matrix content and stiffness, however, is non-linear, and stiffness is only one component of tissue mechanics. The mechanical response of tissues such as liver to physiological stresses is not well described, and models of tissue mechanics are limited. To better understand the mechanics of the normal and fibrotic rat liver, we carried out a series of studies using parallel plate rheometry, measuring the response to compressive, extensional, and shear strains. We found that the shear storage and loss moduli G' and G" and the apparent Young's moduli measured by uniaxial strain orthogonal to the shear direction increased markedly with both progressive fibrosis and increasing compression, that livers shear strain softened, and that significant increases in shear modulus with compressional stress occurred within a range consistent with increased sinusoidal pressures in liver disease. Proteoglycan content and integrin-matrix interactions were significant determinants of liver mechanics, particularly in compression. We propose a new non-linear constitutive model of the liver. A key feature of this model is that, while it assumes overall liver incompressibility, it takes into account water flow and solid phase compressibility. In sum, we report a detailed study of non-linear liver mechanics under physiological strains in the normal state, early fibrosis, and late fibrosis. We propose a constitutive model that captures compression stiffening, tension softening, and shear softening, and can be understood in terms of the cellular and matrix components of the liver.	[Perepelyuk, Maryna; Wells, Rebecca G.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chin, LiKang; van Oosten, Anne; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Chin, LiKang; Janmey, Paul A.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chin, LiKang] Tokushima Univ Hosp, Clin Res Ctr Diabet, Tokushima, Japan; [Cao, Xuan; Shenoy, Vivek B.] Univ Penn, Sch Engn & Appl Sci, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [van Oosten, Anne] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Tokushima University; University of Pennsylvania; University of Pennsylvania	Janmey, PA (corresponding author), Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.	janmey@mail.med.upenn.edu; rgwells@mail.med.upenn.edu	Shenoy, Vivek/ABD-5075-2021; Dib, Julian Rafael Dib/AAG-9240-2019; Cao, Xuan/AAI-6307-2020	Dib, Julian Rafael Dib/0000-0002-8965-8372; Farias, Maria Eugenia/0000-0002-2771-8915; Perez, Maria Florencia/0000-0002-7868-425X	National Institutes of Health (University of Pennsylvania/National Institute for Diabetes Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core) [R01 EB17753, R01 DK058123, T32 HL007954, P30 DK050306]; Fulbright Science and Technology Award; Prins Bernhard Cultuurfonds-Kuitse Fonds; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK058123] Funding Source: NIH RePORTER	National Institutes of Health (University of Pennsylvania/National Institute for Diabetes Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core); Fulbright Science and Technology Award; Prins Bernhard Cultuurfonds-Kuitse Fonds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01 EB17753 (to PAJ, VBS, and RGW), R01 DK058123 (to RGW), T32 HL007954 (for LC), P30 DK050306 (which supports the University of Pennsylvania/National Institute for Diabetes Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core), Fulbright Science and Technology Award (to AvO) and the Prins Bernhard Cultuurfonds-Kuitse Fonds (to AvO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsebaey A, 2015, WORLD J HEPATOL, V7, P1149, DOI 10.4254/wjh.v7.i8.1149; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Calvete JJ, 2003, BIOCHEM J, V372, P725, DOI 10.1042/BJ20021739; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; DUNN GD, 1973, AM J MED SCI, V265, P175, DOI 10.1097/00000441-197303000-00001; Evans DW, 2013, BIOMECH MODEL MECHAN, V12, P569, DOI 10.1007/s10237-012-0426-3; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Hansen LK, 2006, CURR TOP DEV BIOL, V72, P205, DOI 10.1016/S0070-2153(05)72004-4; Isgro G, 2013, J GASTROENTEROL, V48, P921, DOI 10.1007/s00535-012-0694-9; Lai VK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024350; Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19; Liu Z, 2000, BIORHEOLOGY, V37, P191; Liu ZZ, 2002, BIORHEOLOGY, V39, P735; Mattei G, 2014, ACTA BIOMATER, V10, P875, DOI 10.1016/j.actbio.2013.10.023; Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079; Miller K, 2000, J BIOMECH, V33, P367, DOI 10.1016/S0021-9290(99)00196-7; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Mori M, 2011, HEPATOL RES, V41, P897, DOI 10.1111/j.1872-034X.2011.00842.x; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Parker KJ, 2014, PHYS MED BIOL, V59, P4443, DOI 10.1088/0031-9155/59/15/4443; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Poynard T, 2014, J HEPATOL, V60, P706, DOI 10.1016/j.jhep.2013.11.016; Ren HZ, 2013, LIVER INT, V33, P448, DOI 10.1111/liv.12088; SAITO M, 1987, AM J GASTROENTEROL, V82, P1057; Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328; Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546; Simonetto DA, 2015, HEPATOLOGY, V61, P648, DOI 10.1002/hep.27387; Sparks JL, 2008, ANN BIOMED ENG, V36, P1883, DOI 10.1007/s10439-008-9555-3; Tan K, 2013, J BIOMECH, V46, P1060, DOI 10.1016/j.jbiomech.2013.01.028; Tang A, 2015, AM J ROENTGENOL, V205, P33, DOI 10.2214/AJR.15.14553; van Oosten ASG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19270; Wells R G., 2007, TXB HEPATOLOGY BASIC; Wilder J, 2014, MED DEVICES-EVID RES, V7, P107, DOI 10.2147/MDER.S46943; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Wu FM, 2011, CONGENIT HEART DIS, V6, P190, DOI 10.1111/j.1747-0803.2011.00504.x; Yin M, 2016, RADIOLOGY, V278, P114, DOI 10.1148/radiol.2015142141; Yusko EC, 2014, MOL BIOL CELL, V25, P3717, DOI 10.1091/mbc.E13-12-0707; Zhu Y, 2014, J ZHEJIANG UNIV-SC B, V15, P375, DOI 10.1631/jzus.B1300121	47	125	125	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146588	10.1371/journal.pone.0146588	http://dx.doi.org/10.1371/journal.pone.0146588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735954	Green Submitted, gold, Green Published			2022-12-27	WOS:000367805100054
